<SEC-DOCUMENT>0001213900-19-011793.txt : 20190628
<SEC-HEADER>0001213900-19-011793.hdr.sgml : 20190628
<ACCEPTANCE-DATETIME>20190628172642
ACCESSION NUMBER:		0001213900-19-011793
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		26
FILED AS OF DATE:		20190628
DATE AS OF CHANGE:		20190628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			American BriVision (Holding) Corp
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-228387
		FILM NUMBER:		19930540

	BUSINESS ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		845-551-8728

	MAIL ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ecology Coatings, Inc.
		DATE OF NAME CHANGE:	20070711
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>fs12018a2_americanbrivision.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"> <B>As filed with the
Securities and Exchange Commission on June 28, 2019</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No.&nbsp;333-228387</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
No. 2</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5084</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26-0014658</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or other jurisdiction of</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation or organization)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary
    Standard Industrial</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification Code Number)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
                                         Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        Number)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>44370
Old Warm Springs Blvd., </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fremont,
CA 94538</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(845)
291-1291 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Howard Doong</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>44370
Old Warm Springs Blvd., </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fremont,
CA 94538</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(845)
291-1291- telephone</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>With
copies to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jay
    Kaplowitz, Esq.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Louis
    Taubman, Esq.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
    Manno, Esq.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guillaume
    de Sampigny, Esq. </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Huan
    Lou, Esq.</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hunter
    Taubman Fischer &amp; Li LLC </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sichenzia
    Ross Ference LLP</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1450
    Broadway, 26th Floor </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1185
    Avenue of Americas, 37th Floor</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, New York 10018 </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, NY 10036</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(917)
    512-0827- telephone</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
    930-9700&nbsp;&ndash;&nbsp;telephone</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale of the securities to the public: </B>As soon as practicable after this registration statement
is declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box.&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 18%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 19%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 23%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company&nbsp;&#9746;</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company &#9744;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 5pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; padding-left: 10pt; text-indent: -10pt"> Title of Each Class
    of Securities to be Registered </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Amount to be<BR>
    Registered(1) </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per<BR>
    Share(2) </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Proposed<BR>
    Maximum<BR>
    Aggregate<BR>
    Offering<BR>
    Price(6) </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Amount of<BR>
    Registration<BR>
    Fee(3) </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; padding-left: 10pt; text-indent: -10pt"> Shares of Series A Convertible Preferred Stock, $0.001 par
    value per share </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> &nbsp; </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 7.00 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 23,000,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 2,787.60 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt"> Shares of Common Stock, par value $0.001 per share,
    issuable upon conversion of the Series A Convertible Preferred Stock (4) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt"> Underwriter Warrants (5) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt"> Shares of Common Stock, par value $ .001 per share underlying Underwriter
    Warrants </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> N/A </TD><TD STYLE="text-align: left"></TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 1,610,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 195.13 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Total Registration Fee </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 24,610,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 2,982.73 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 25px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule
    416(a) of the Securities Act of 1933, as amended, this Registration Statement also covers any additional shares of Series
    A Convertible Preferred Stock which may become issuable to prevent dilution from stock splits, stock dividends and similar
    events.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule
    457(c) of the Securities Act of 1933, as amended, calculated on the basis of the proposed maximum aggregate offering price.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registration
    fee for securities to be offered by the Registrant is based on an estimate of the proposed maximum aggregate offering price
    of the securities and includes the additional securities to be sold should the Underwriter exercise its option to increase
    the maximum number of securities to be offered, and such estimate is solely for the purpose of calculating the registration
    fee pursuant to Rule 457(o). The registration fee has been paid.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee pursuant
    to Rule 457(i) under the Securities Act.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have agreed
    to issue warrants, exercisable in whole or in part, commencing on the closing date of the offering contemplated in this
    registration     statement and expiring on the five-year anniversary thereof, representing 7% of the number of shares of
    Common Stock to be     issued upon conversion of the Series A Preferred Stock issued in the offering (the &ldquo;Underwriter
    Warrants&rdquo;) to Boustead     Securities LLC&nbsp;(the &ldquo;Underwriter&rdquo;). The Underwriter Warrants are
    exercisable at a per share strike price     equal to the Series A Convertible Preferred Stock public offering price. Resales
    of the     Underwriter Warrants on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as
    amended, are     registered hereby. Resales of shares issuable upon exercise of the Underwriter Warrants are also being
    similarly registered     on a delayed or continuous basis hereby. See &ldquo;Underwriting.&rdquo; In accordance with Rule
    457(g) under the Securities     Act, because the shares of Common Stock underlying the Underwriter Warrants are registered
    hereby, no separate registration     fee is required with respect to the Underwriter Warrants registered
    hereby.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes the
    additional securities to be sold should the Underwriter exercise its option to increase the maximum number of securities to
    be offered</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the Registrant shall file a further amendment that specifically states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall
become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell and is not soliciting
an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
TO COMPLETION, DATED June 28, 2019</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minimum
Offering: 1,428,571 Shares of Series A Convertible Preferred Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
into 1,428,571 Shares of Common Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
Offering: 2,857,143 Shares of Series A Convertible Preferred Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
into 2,857,143 Shares of Common Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Increased
Maximum Offering: 3,285,714 Shares of Series A Convertible Preferred Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
into 3,285,714 Shares of Common Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a &ldquo;best efforts&rdquo; public offering of securities of American BriVision (Holding) Corporation (referred to herein
as &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo;, &ldquo;ABVC&rdquo;, &ldquo;Registrant&rdquo;, or the &ldquo;Company&rdquo;).
We are selling a minimum of 1,428,571 and a maximum of 2,857,143 shares of Series A Convertible Preferred Stock, par value $0.001
per share (the &ldquo;Series A Preferred Stock&rdquo;) for an aggregate of $10,000,000 dollars at minimum and $20,000,000 dollars
at maximum, with the underwriter&rsquo;s option to increase the maximum offering to an aggregate of 3,285,714 shares of Series
A Convertible Preferred Stock at any time during the term of this offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the laws of Nevada, we will pay cumulative dividends on the Series A Convertible Preferred Stock on each anniversary from
the date of original issue for a period of four calendar years. We will reserve twenty percent (20%) of the fund raised from
this offering (the &ldquo;Dividend Reserve&rdquo;) in an escrow account (the &ldquo;Escrow Account&rdquo;) maintained by
Sutter Securities Clearing, LLC (the &ldquo;Escrow Agent&rdquo;) and distribute five percent (5%) of the Dividend Reserve in
cash at each anniversary for four years to each holder of Series A Convertible Preferred Stock. The Series A Convertible
Preferred Stock will rank senior to our outstanding common stock, par value $0.001 (the &ldquo;Common Stock&rdquo;) with
respect to dividend rights, rights upon liquidation, dissolution or winding up in the amount of accrued but unpaid dividend.
Holders of the Series A Convertible Preferred Stock will have the same voting rights as our Common Stock holders. Each share
of Series A Convertible Preferred Stock is initially convertible at any time at the option of the holder into one share of
Common Stock and automatically converts into one share of Common Stock on the four-year anniversary of its
issuance.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is quoted on the OTC Markets under the symbol &ldquo;ABVC.&rdquo; On June 20, 2019, the last reported sale price
per share of our Common Stock was $13.00. The recent market price of our Common Stock set forth herein will not be used to determine
the offering price of the Series A Convertible Preferred Stock. There is no established public market for the Series A Convertible
Preferred Stock. The offering price of the Series A Convertible Preferred Stock will be arbitrarily determined and will not necessarily
bear any relationship to our assets, results of operations, or book value, or to any other generally accepted criteria of valuation.
The offering price is determined through negotiations with the underwriters. The underwriters and the Company have set $7.00 per
share for the offering price, which will be finalized prior to closing of the offering. We intend to list both our Common Stock
and Series A Convertible Preferred Stock on the Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;). The Common Stock will be traded under
the same symbol and the Series A Convertible Preferred Stock will be traded under the symbol &ldquo;[&#9679;]&rdquo;, subject
to Nasdaq approval. Currently there is no established public trading market for either our Common Stock or Series A Convertible
Preferred Stock and the prices quoted on the OTCQB may not be indicative of the market price of our Common Stock or Series A Convertible
Preferred Stock on Nasdaq. If the application to Nasdaq is approved, trading of our Common Stock and Series A Convertible Preferred
Stock is expected to begin within five (5) days after the date of issuance of the Series A Convertible Preferred Stock registered
herein. We cannot assure you that either of our application to list the Common Stock or Series A Convertible Preferred Stock will
be approved; however, we will not complete this offering without a listing approval letter of our Series A Convertible Preferred
Stock and Common Stock from Nasdaq.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boustead
Securities, LLC (&ldquo;Boustead&rdquo; or the &ldquo;Underwriter&rdquo;) has agreed to act as our exclusive underwriter to offer
shares of Series A Convertible Preferred Stock to prospective investors on a best efforts basis. The Underwriter is not purchasing
any shares of Series A Convertible Preferred Stock offered by us and is required to sell at least $10,000,000 of Series A Convertible
Preferred Stock in the offering for this offering to close. In connection with the sale of the Series A Convertible Preferred
Stock, Boustead will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act of 1933, as amended,
or &ldquo;Securities Act,&rdquo; and the compensation of Boustead will be deemed to be underwriting commissions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering will terminate at the earlier of (i) the date at which $23,000,000 of Series A Convertible Preferred Stock has been sold;
(ii) the date on which this offering is terminated by the Company in its sole discretion; or (iii) one hundred and eighty (180)
days from the effectiveness of this Registration Statement. Until the offering terminates, the proceeds of the offering will be
held in the offering deposit account (&ldquo;Offering Deposit Account&rdquo;) and FinTech Clearing, LLC will serve as the Deposit
Account Agent.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus, together with additional information described under the headings &ldquo;Incorporation of Certain
Information by Reference&rdquo; and &ldquo;Where You Can Find More Information&rdquo;, carefully before you invest in any of our
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See &ldquo;Risk Factors&rdquo; starting on page 11 of this prospectus.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Number&nbsp;of&nbsp;Shares&nbsp;of
    Series A<BR> &nbsp;Convertible Preferred Stock<BR> Offered by&nbsp;Us </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Public<BR>
    Offering<BR> Price&nbsp;per&nbsp;Share </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Total&nbsp;Initial<BR>
    Public<BR> Offering<BR> Price </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Underwriting<BR>
    Commissions (1) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Proceeds&nbsp;to
    Our<BR> Company Before<BR> Expenses and <BR> Dividend Reserve </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font: bold 10pt Times New Roman, Times, Serif"> Minimum </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,428,571 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 700,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,300,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Maximum </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,857,143 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,400,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,600,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Increased Maximum </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,285,714 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 23,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,610,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,390,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Delivery
of the shares of our </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A Convertible
Preferred Stock <FONT STYLE="background-color: white">is expected to be made on or about , 2019. We have granted the Underwriter
an option to increase the maximum offering to 3,285,714 shares of Series A Convertible Preferred Stock during the term of the
offering.</FONT></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(1)
We have agreed to issue warrants, exercisable in whole or in part, commencing on the closing date of the offering contemplated
in this registration statement and expiring on the five-year anniversary thereof, representing 7% of the number of shares of Common
Stock to be issued upon conversion of the Series A Preferred Stock issued in the offering to the Underwriter. For a description
of other terms of the Underwriter Warrants and a description of the other compensation to be received by the Underwriter, please
see &ldquo;Underwriting&rdquo; beginning on page 113.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is ______, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in; width: 93%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_001">PROSPECTUS CONVENTIONS</A></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: center">ii</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002"><B>INDUSTRY AND MARKET DATA</B></A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">ii</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_003">MERGERS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">iii</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_004">PROSPECTUS SUMMARY</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_005">THE OFFERING</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_006">SELECTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_007">RISK FACTORS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_008">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">32</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_009">USE OF PROCEEDS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">34</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_010">DIVIDEND POLICY</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">35</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_011">CAPITALIZATION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">36</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_012">DILUTION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">37</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_013">MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS&nbsp;OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">38</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_014">BIOLITE&rsquo;S MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">52</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_015">BIOKEY&rsquo;S MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">66</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_016">BUSINESS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">75</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_017">MANAGEMENT</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">91</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_018">EXECUTIVE COMPENSATION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">95</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OUTSTANDING
    EQUITY AWARDS AT FISCAL&nbsp;YEAR-END</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_019">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">97</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_020">UNAUDITED CONDENSED CONSOLIDATED COMBINED PRO FORMA FINANCIAL INFORMATION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">98</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_021">RELATED PARTY TRANSACTIONS OF DIRECTORS AND EXECUTIVE OFFICERS OF THE COMBINED COMPANY</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">104</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_022">DESCRIPTION OF SECURITIES</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">107</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_023">SHARES ELIGIBLE FOR FUTURE SALE</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">111</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_024">UNDERWRITING</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">113</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_025">LEGAL MATTERS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">119</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_026">EXPERTS</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">119</TD>
    </TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#a_027">WHERE YOU CAN FIND MORE INFORMATION</A></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">119</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus or in any free writing prospectus that we may specifically authorize
to be delivered or made available to you. We and our Underwriter have not authorized anyone to provide you with any information
other than that contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available
to you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others
may give you. This prospectus may only be used where it is legal to offer and sell our securities. The information in this prospectus
is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities.
Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an
offer of these securities in any jurisdiction where the offer is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context otherwise requires, the terms &ldquo;ABVC,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; in this
prospectus refer to American BriVision (Holding) Corporation, and &ldquo;this offering&rdquo; refers to the offering contemplated
in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_001"></A>PROSPECTUS
CONVENTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
where the context otherwise requires and for purposes of this prospectus only:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Common
Stock&rdquo; is the Common Stock of American BriVision (Holding) Corporation, par value US$0.001 per share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Series
A Convertible Preferred Stock&rdquo; is the Series A convertible preferred stock of American BriVision (Holding) Corporation,
par value US$0.001 per share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;APR&rdquo;
or &ldquo;annual percentage rate&rdquo; refers to the annual rate that is charged to borrowers, including a fixed interest rate
and a transaction fee rate, expressed as a single percentage number that represents the actual yearly cost of borrowing over the
life of a loan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the Company,&rdquo; &ldquo;our Company&rdquo; or &ldquo;ABVC&rdquo;
refers to American BriVision (Holding) Corporation, a Nevada corporation, and all of the Subsidiaries as defined herein unless
the context specifies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&ldquo;Board&rdquo; or &ldquo;Board of Directors&rdquo; refers to the board of directors of the Company including the new directors
appointed as a result of the Merger which closed on February 8, 2019;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Subsidiary&rdquo;
or &ldquo;Subsidiaries,&rdquo; refer to American BriVision Corporation, sometimes referred to as &ldquo;BriVision&rdquo;, BioLite
Holding, Inc. or BioLite and BioKey, Inc. or BioKey;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision Corporation refers to a Delaware corporation and wholly-owned subsidiary of ABVC;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
means BioLite Holding, Inc. refers to a Nevada corporation and a wholly-owned subsidiary of ABVC;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
means BioKey, Inc. refers to a California corporation and wholly-owned subsidiary of ABVC;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Acquisition Corp. or Merger Sub 1 refers to a Nevada corporation, which was a direct wholly-owned subsidiary of ABVC prior to
the completion of the Mergers;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
Acquisition Corp. or Merger Sub 2, refers to a California corporation, which was a direct wholly-owned subsidiary of ABVC prior
to the completion of the Mergers;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement means the Agreement and Plan of Merger dated as of January 31, 2018, pursuant to which the Company, BioLite,
BioKey, Merger Sub 1, and Merger Sub 2 completed a business combination on February 8, 2019 where ABVC acquired BioLite and BioKey
via the issuance of additional shares of Common Stock to the shareholders of BioLite and BioKey;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;China&rdquo;,
&ldquo;mainland China&rdquo; and &ldquo;P.R.C.&rdquo; refer to the People&rsquo;s Republic of China, excluding Taiwan, Hong Kong
or Macau for purposes of this prospectus;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;R.O.C.&rdquo;
or &ldquo;Taiwan&rdquo; refers to Taiwan, the Republic of China;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to &ldquo;NTD&rdquo; and &ldquo;New Taiwan Dollars&rdquo; are to the legal currency of R.O.C.; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to &ldquo;U.S. dollars&rdquo;, &ldquo;dollars&rdquo;, and &ldquo;$&rdquo; are to the legal currency of the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus specifies certain NTD amounts and in parenthesis the approximate U.S. dollar amounts at the exchange rate on the date
of this prospectus. The conversion rates regarding NTD and U.S. dollars are subject to change and, therefore, we can provide no
assurance that U.S. dollar amounts specified in this prospectus will not change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
clarification, this prospectus follows English naming convention of first name followed by last name, regardless of whether an
individual&rsquo;s name is Chinese or English.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>INDUSTRY
AND MARKET DATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus includes information with respect to market and industry conditions and market share from third-party sources or based
upon estimates using such sources when available. We have not, directly or indirectly, sponsored or participated in the publication
of any of such materials. We believe that such information and estimates are reasonable and reliable. We also assume the information
extracted from publications of third-party sources has been accurately reproduced. We understand that the Company would be liable
for the information included in this prospectus if any part of the information was incorrect, misleading or imprecise to a material
extent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>MERGERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in a registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009520/fs42018_americanbrivision.htm">Form S-4</A> filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on
July 23, 2018, as amended from time to time, the Company, BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), BioKey, Inc. (&ldquo;BioKey&rdquo;),
BioLite Acquisition Corp., a direct wholly-owned subsidiary of the Company (&ldquo;Merger Sub 1&rdquo;), and BioKey Acquisition
Corp., a direct wholly-owned subsidiary of the Company (&ldquo;Merger Sub 2&rdquo;) were in the process of completing a business
combination pursuant to the Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) dated as of January 31, 2018 where
ABVC would acquire BioLite and BioKey via the issuance of additional shares of Common Stock of ABVC to the shareholders of BioLite
and BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the parties of the Merger Agreement consummated the merger transactions. Pursuant to the terms of the Merger
Agreement, BioLite and BioKey became two wholly-owned subsidiaries of the Company on February 8, 2019. The Company issued an aggregate
of 104,558,777 shares (prior to the stock reverse split) of Common Stock as consideration to the shareholders of BioLite and BioKey
pursuant to the registration statement (the &ldquo;Registration Statement on S-4&rdquo;) on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019000796/fs42018a3_americanbrivision.htm">Form S-4</A> Amendment No. 3 filed with
the SEC on January 16, 2019 which became effective by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our securities, you should carefully read this entire prospectus,
including our&nbsp;financial statements and the related notes and the information set forth under the headings &ldquo;Risk Factors&rdquo;
and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in each case included
elsewhere in this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
is a clinical stage biopharmaceutical company focused on utilizing its licensed technology to (i) further the development of pharmaceutical
products with focuses on cancer and central nervous system (&ldquo;CNS&rdquo;) indications and medical devices for eye indications,
(ii) seek regulatory approvals for their drug and medical device candidates, (iii) after receiving necessary regulatory approval,
collaborate with selected pharmaceutical companies to commercialize such pharmaceutical products in various markets, and (iv)
provide pharmaceutical and nutraceutical services. ABVC&rsquo;s business model includes the following stages: 1) engaging qualified
medical research institutions to conduct clinical trials of translational drug candidates for Proof of Concept (&ldquo;POC&rdquo;)
on behalf of the Company; 2) retaining ownership of the research results by the Company, and 3) out-licensing the research results
and data to qualified pharmaceutical companies that will develop its research results to commercially ready pharmaceutical products.
The Company currently concentrates on, among other things, clinical research and development of six new drug candidates and one
Class III medical device, which collectively constitute its primary business operations and research projects. As of the date
of this prospectus, the Company has not generated substantial revenue from its research and development of new drugs and medical
devices. The six new drug candidates were licensed from BioLite, Inc. (&ldquo;BioLite Taiwan&rdquo;), a company formed in Taiwan
that is a subsidiary of BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), a wholly-owned subsidiary of the Company. The six new drug
candidates under our development are named as follows: ABV-1504 for the treatment of Major Depressive Disorder, ABV-1505 to treat
Attention-Deficit Hyperactivity Disease, ABV-1501 for the treatment of Triple Negative Breast Cancer, ABV-1703 for the treatment
of Pancreatic Cancer, ABV-1702 to treat Myelodysplastic syndromes, and ABV-1601 Depression in Cancer Patients. The Class III medical
device was licensed from and codeveloped with BioFirst Corporation (&ldquo;BioFirst&rdquo;), a company formed under the laws of
Taiwan, and a related party to the Company. The internal name of ABVC&rsquo;s Class III medical device is ABV-1701 Vitargus for
the treatments of Retinal Detachment or Vitreous Hemorrhage. ABV-1701 is being co-developed by the Company and BioFirst and the
research data, intellectual property and licensing revenue generated from the collaboration will be shared equally between the
Company and BioFirst. The Company and BioFirst have the sole license to develop and commercialize ABV-1701 by the end of 2030.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
is a clinical stage pharmaceutical company focused on translational research of botanical and natural active pharmaceutical ingredients
(&ldquo;API&rdquo;) based products in the fields of central nervous system, oncology/ hematology and autoimmune diseases. Because
BioLite believes natural substances have many healing powers, BioLite focuses its research resources to the development of botanical
products, which include plant materials, algae, macroscopic fungi and combinations thereof. BioLite mostly uses traditional cultivation,
fermentation and purification techniques, excluding genetic modifications, to process the active natural constituents of its drug
candidates. Its operational activities primarily focus on researching and developing novel botanical and natural drugs utilizing
scientific methodology and approaches in compliance with the procedures and protocols prescribed by the U.S. Food and Drug Administration
(the &ldquo;FDA&rdquo;). BioLite&rsquo;s primary operations are located in Taiwan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey,
Inc., a California corporation and wholly-owned subsidiary of the Company, (&ldquo;BioKey&rdquo;), is a specialty pharmaceutical
company that has two main business lines: i) platform-based control release technology of active pharmaceutical ingredients and
ii) integrated pharmaceutical services, such as clinical research contracting services, generic drug development, drug manufacturing
and related pharmaceutical consulting. BioKey&rsquo;s core expertise is the application of its proprietary oral control release
technology to develop generic and branded pharmaceuticals and nutraceuticals. BioKey has four abbreviated new drug applications
(&ldquo;ANDA&rdquo;s) approved by the FDA and more than ten generic and ANDA product candidates in the pipeline. In addition,
BioKey provides integrated pharmaceutical services, including analytical services and pharmaceutical and nutraceutical product
development and manufacturing.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the Mergers on February 8, 2019, both BioLite and BioKey have become two wholly-owned subsidiaries of ABVC and became
integrated into our three strategic business units (&ldquo;SBUs&rdquo;), which are the New Drug Development SBU, the Innovative
Medical Devices SBU and the CDMO SBU. The following chart illustrates the current corporate structure of ABVC:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_003.jpg" ALT="" STYLE="width: 450px; height: 336px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Mission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
devote our resources to building a sophisticated biotech company and becoming a pioneer in the biopharmaceutical industry in the
U.S. and Taiwan with a global vision. Dr. Howard Doong, our Chief Executive Officer, and Dr. Tsung-Shann Jiang, the founder and
majority shareholder of the Company, understand the challenges and opportunities of the biotech industry in Taiwan and the U.S.
ABVC&rsquo;s mission is to provide therapeutic solutions to significant unmet medical needs and to improve health and quality
of human life by developing innovative botanical drugs to treat central nervous system (&ldquo;CNS&rdquo;), oncology/ hematology
and eye diseases.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Collaborative
Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2017, American BriVision Corporation (&ldquo;BriVision&rdquo;), a wholly-owned subsidiary of ABVC, entered into an agreement
with BioFirst (the &ldquo;BioFirst Agreement&rdquo;), pursuant to which BioFirst granted BriVision the global license to co-develop
ABV-1701 Vitreous Substitute for Vitrectomy for medical use. BioFirst is a related party to ABVC because BioFirst and YuanGene
Corporation (&ldquo;YuanGene&rdquo;), ABVC&rsquo;s controlling shareholder, are under the common control of the controlling beneficiary
shareholder of YuanGene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the BioFirst Agreement, ABVC and BriVision agreed to co-develop and commercialize ABV-1701 with BioFirst and ABVC agreed to
pay BioFirst $3,000,000 in cash or Common Stock on or before September 30, 2018 in two installments. BioFirst is also entitled
to receive 50% of the future net licensing income or net sales profit when ABV-1701 is sublicensed or commercialized. As of the
date of this prospectus, BioFirst and ABVC are negotiating the per share price of the Common Stock to be issued to BioFirst as
payment under the BioFirst Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>
</DIV>
<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, BriVision entered into a co-development agreement (the &ldquo;ABVC-Rgene Co-development Agreement&rdquo;) with Rgene
Corporation (&ldquo;Rgene&rdquo;) to co-develop and commercialize in the global markets three new drug products that originate
from Maitake Combination Therapy. The three drugs licensed from BriVision to Rgene are ABV-1507 HER-2/neu Positive Breast Cancer
Combination Therapy, ABV-1703 Pancreatic Cancer Combination Therapy and ABV-1527 Ovarian Cancer Combination Therapy. Rgene shall
prepare the IND applications for the Phase II trials of ABV-1507 HER-2/neu Positive Breast Cancer Combination Therapy and ABV-1527
Ovarian Cancer Combination Therapy.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the ABVC-Rgene Co-development Agreement, Rgene was to pay to the Company $3,000,000 in cash or stock of Rgene with equivalent
value by August 15, 2017 in three installments. The payment is for the compensation of BriVision&rsquo;s past research before
the ABVC-Rgene Co-development Agreement was signed and it does not relate to any future commitments made by BriVision and Rgene
in this ABVC-Rgene Co-development Agreement. In addition to the $3,000,000 payment, the Company is entitled to receive 50% of
the future net licensing income or net sales profit earned by Rgene, if any, and any development cost shall be equally shared
by both BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, BriVision delivered all research, technical, data and development data to Rgene. Since both Rgene and ABVC are related
parties controlled by a controlling beneficiary shareholder of YuanGene, who is also the controlling beneficiary shareholder of
the Company, ABVC has recorded the full amount of $3,000,000 in connection with the ABVC-Rgene Co-development Agreement as additional
paid-in capital during the year ended September 30, 2017. BriVision and Rgene agreed that Rgene should pay BriVision $450,000
in cash and the rest in Rgene&rsquo;s stock. As of the date of this prospectus, ABVC received $450,000 in cash and $2,550,000
worth of shares of Rgene&rsquo;s Common Stock at a per share price of 50NTD (equivalent to $1.62 USD).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
Results</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2019, the Company announced the Phase II clinical study results of ABV-1504 for Major Depression Disorder (&ldquo;MDD&rdquo;).
The clinical study results showed that PDC-1421, the active pharmaceutical ingredient of ABV-1504, met the pre-specified primary
endpoint of the Phase II clinical trial and significantly improved the symptoms of MDD.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Phase II clinical study was a randomized, double-blind, placebo-controlled, multi-center trial, in which 60 adult patients with
confirmed moderate to severe MDD were treated with PDC-1421 in either low dose (380 mg) or high dose (2 x 380 mg) compared with
placebo administration, three times a day for six weeks. PDC-1421 high dose (2 x 380 mg) met the pre-specified primary endpoint
by demonstrating a highly significant 13.2-point reduction in the Montgomery-&Aring;sberg Depression Rating Scale (MADRS) total
score by Intention-To-Treat (ITT) analysis, averaged over the 6-week treatment period (overall treatment effect) from baseline,
as compared to 9.2-point reduction of the placebo group. By Per-Protocol (PP) analysis, PDC-1421 showed a dose dependent efficacy
toward MDD in which high dose (2 x 380 mg) gave 13.4-point reduction in MADRS total score from baseline and low dose (380 mg)
gave 10.4-point reduction as compared to a 8.6-point in the placebo group. The treatment in both PDC-1421 low dose (380 mg, TID)
and high dose (2 x 380 mg, TID) were found safe and well tolerated with no serious adverse events and responsive to MDD. The Company
has decided to use the high dose formular in the Phase III clinical trial of ABV-1504.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
elements of our business strategy include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Focusing
    on completing the Phase I study of ABV-1701 Vitargus for the treatments of Retinal Detachment or Vitreous Hemorrhage, which
    we expect to generate revenues in the future.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Focusing
    on licensing ABV-1504 for the treatmnt of major depressive disorder after the succssful completion of its Phase II clinical
    trials. </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    translational medical research form lab research accomplishments for POC clinical trials, which are Phase I and Phase II trials.
    Major product pipeline includes six investigational new drugs, the INDs of all of which have been approved by the FDA and
    one Class III medical device, the clinical trial of which is being conducted in Australia. The seven products are comprised
    of the following: ABV-1504 for the treatment of Major Depressive Disorder, ABV-1505 to treat Attention-Deficit Hyperactivity
    Disease, ABV-1501 for the treatment of Triple Negative Breast Cancer, ABV-1703 to the treatment of Pancreatic Cancer, ABV-1702
    to treat Myelodysplastic syndromes, and ABV-1601 Depression in Cancer Patients, as well as a medical device, ABV-1701 Vitargus
    for the treatments of Retinal Detachment or Vitreous Hemorrhage.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out
    licensing drug candidates and medical device candidates to major pharmaceutical companies for phase III and pivotal clinical
    trials, as applicable, and further marketing if approved by the FDA.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>
</DIV>
<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to augment our core research and development capability and assets by conducting Phase I and II clinical trials for investigational
new drugs and medical devices in the fields of CNS, Hematology/Oncology and Ophthalmology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team has extensive experiences across a wide range of new drug and medical device development and we have in-licensed
new drug and medical device candidates from large research institutes and universities in both the U.S. and Taiwan. Through an
assertive product development approach, we expect that we will build a substantial portfolio of Oncology/ Hematology, CNS and
Ophthalmology products. We believe the initial two phases of clinical trials add great value to investigational new drug development.
Because we primarily focus on Phase I and II research of new drug candidates and out license the post-Phase-II products to pharmaceutical
companies, we do not expect to devote substantial efforts and resources to building the disease-specific distribution channels.
We expect to continue this strategy which we believe has been effective for the past ten years of our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Material
Risks and Challenges</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face substantial competition from a great many established and emerging pharmaceutical and biotech companies that develop, distribute
or sell therapeutics to treat the same indications that our drug candidates are designed to treat. Our current and potential competitors
include large pharmaceutical and biotechnology companies, and specialty pharmaceutical and generic drug companies. Many of our
current and potential competitors have substantially greater financial, technical and human resources than we do and significantly
more experience in the marketing, commercialization, discovery, development and regulatory approvals of products, which could
place us at a significant competitive disadvantage or deny our marketing exclusivity rights. Typically, our competitors will most
likely have more capital resources to support their products than we do. In addition, you should <FONT STYLE="background-color: white">carefully
consider the risks described under the &ldquo;Risk Factors&rdquo; section beginning on page 11 before investing in us. Some of
these risks are:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    associated with our profitability including, but not limited to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have never generated revenue and will continue to be unprofitable in the foreseeable future.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    associated with clinical trials and the development of our products, including but not limited to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    trials are expensive and time consuming, and their outcome is uncertain;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    clinical trials could be delayed or unsuccessful, and we may not be able to obtain regulatory approval for any of our drug
    candidates when expected, or at all;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may experience delays in our clinical trials that could adversely affect our business and operations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on third parties to conduct our preclinical studies and clinical trials and if such third parties do not meet our deadlines
    or otherwise conduct the studies as required, we may be delayed in progressing, or ultimately may not be able to progress,
    our drug candidates to clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to secure and maintain research institutions to conduct our future trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to secure co-developers or partners to further post-Phase II clinical trials and eventually commercialize
    our drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>
</DIV>
<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may need to prioritize the development of our most promising candidates at the expense of the development of other products;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Physicians,
    patients, third-party payors or others in the medical community may not be receptive to our products, and we may not generate
    any future revenue from the sale or licensing of our products.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    associated with intellectual property including but not limited to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be successful in obtaining or maintaining patent or other relating rights necessary to the development of our drug
    candidates in the pipeline;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    intellectual property rights underlying our exclusive licensing rights may expire or be terminated due to lack of maintenance;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    associated with competition and manufacturing including, but not limited to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    face competition from entities that have developed or are developing products for our target disease indications, including
    companies developing novel treatments and technologies similar to ours; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    depend primarily upon a sole supplier of our key extract for three drug candidates and could incur significant costs and delays
    if we are unable to promptly find a replacement for such supplier if the supplier fails to deliver the extract pursuant to
    our orders.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    associated with government regulations including without limitation:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we do not obtain the necessary governmental approvals, we will be unable to sub-license or commercialize our pharmaceutical
    products; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
    if we obtain regulatory approval for a drug candidate, our products may remain subject to regulatory scrutiny.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    associated with our Series A Convertible Preferred Stock, Common Stock, and this Offering including without limitation:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market prices and trading volumes of the Common Stock and Series A Convertible Preferred Stock may be volatile and may be
    affected by economic conditions beyond our control;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    is no established trading market for either our Common Stock or Series A Convertible Preferred Stock and such market may never
    develop;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    may be arbitrage opportunities due to the trading price differences of the Common Stock and Series A Convertible Preferred
    Stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
    purchasing shares of the Series A Convertible Preferred Stock will suffer immediate and substantial dilution; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency
    fluctuations may adversely affect the prices of our Common Stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
and other risks described in this prospectus could materially and adversely impact our business, financial condition, operating
results and cash flow, which could cause the trading price of our Common Stock to decline and could result in a loss of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
was incorporated under the laws of the State of Nevada on February 6, 2002. BriVision was incorporated in the State of Delaware
on July 21, 2015. BioLite was incorporated in the State of Nevada on July 27, 2016. BioKey was incorporated in the State of California
on November 20, 2000. BriVision, BioLite and BioKey are three operating Subsidiaries wholly owned by the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive office is located at 44370 Old Warm Springs Blvd., Fremont, CA 94538. Our telephone number at our principal
executive office is (845) 291-1291. Our corporate website of BriVision is http://www.ambrivis.com<I>.</I> The information on our
corporate website is not part of, and is not incorporated by reference into, this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>
<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_005"></A>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    offering price per share of Series A Convertible Preferred Stock</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 59%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    currently estimate that the public offering price will be US$7.00 per share (&ldquo;Public Offering Price&rdquo;).</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A Convertible Preferred Stock offered by us</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    minimum of 1,428,571 shares of Series A Convertible Preferred Stock on a &ldquo;best-efforts&rdquo; basis up to a maximum
    of 2,857,143 shares of Series A Convertible Preferred Stock on a &ldquo;best efforts&rdquo; basis at an anticipated offering
    price of $7.00 per share. If we do not raise the aggregate minimum offering amount of $10,000,000, we will not conduct a closing
    of our offering and will return to investors all amounts previously deposited by them in escrow, without interest or deduction.
    Prior to the closing of our offering, all funds delivered as payment for the securities offering hereby shall be deposited
    in a non-interest bearing escrow account (&ldquo;Escrow Account&rdquo;) at Pacific Mercantile Bank maintained by FinTech Clearing,
    LLC (the &ldquo;Deposit Account Agent&rdquo;) as deposit account agent for the investors in the offering.&nbsp;We have granted
    the Underwriter an option, exercisable at any time during the term of this offering, to increase the maximum size of the
    offering to 3,285,714 shares of Series A Convertible Preferred Stock </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock outstanding immediately before and after this offering without giving effect to the conversion (the &ldquo;Conversion&rdquo;)
    of any Series A Convertible Preferred Stock*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,694,289
    shares of Common Stock as of June 20, 2019, after the stock reverse split effective on May 8, 2019 and the issuance of shares
    of Common Stock pursuant to the Registration Statement on Form S-4 which became effective on or about February 5, 2019. </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Series A Convertible Preferred Stock outstanding immediately before this offering </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Series A Convertible Preferred Stock outstanding immediately after this offering without giving effect to the Conversion</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,428,571
    shares at minimum, 2,857,143 shares at maximum and 3,285,714 shares if the Underwriter exercises its option to increase the
    maximum offering amount. Each share of Series A Convertible Preferred Stock is initially convertible at any time at the option
    of the holder into one share of Common Stock and automatically converts into one share of Common Stock on its four-year anniversary
    of the original issuance. </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Proceeds</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$10,000,000
    at minimum, $20,000,000 at maximum and $23,000,000 if the Underwriter exercises its option to increase the maximum offering
    amount. </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter
    Warrants </FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue to the Underwriter warrants to purchase up to a total of up to 230,000 shares of Common Stock (equal
    to 7% of the increased maximum number of shares of Common Stock convertible from the Series A Preferred Stock sold in this
    offering assuming the Underwriter exercised its option to increase the maximum size of the offering) and to also register
    herein such underlying shares. The warrants will be exercisable, in whole or in part, commencing on the closing date of the
    offering contemplated in this registration statement and expiring on the five-year anniversary of the effective date of this
    registration statement, and shall be exercisable at a price equal to the Public Offering Price.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>
</DIV>
<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    of Our Offering</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 59%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Series A Convertible Preferred Stock is being offered by the Company for a period of one hundred and eighty (180) days commencing
    on the date of this prospectus. If the minimum amount of the Company&rsquo;s offering is not raised within such period, all
    subscription funds in the Offering Deposit Account will be returned to the investors promptly without interest or deduction
    of any fees. The Company&rsquo;s offering may close or terminate, as the case may be, on the earlier of (i) the date at which
    the Increased Maximum Amount of Series A Convertible Preferred Stock has been sold; (ii) the date on which this offering is
    terminated by the Company in its sole discretion; or (iii) one hundred and eighty (180) days from the effective date of this
    prospectus, or the expiration date. The Company&rsquo;s offering shall not be closed unless our Comon Stock and Series A Convertible
    Preferred Stock are listed on the Nasdaq Stock Market.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    Deposit Account</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    gross proceeds from the sale of the shares of the Series A Convertible Preferred Stock in this offering will be deposited
    in a non-interest bearing escrow account maintained by the deposit account agent, Fintech Clearing, LLC (the &ldquo;Deposit
    Account Agent&rdquo;). The Deposit Account Agent is affiliated with the Underwriter, as the Deposit Account Agent is under
    the same indirect common ownership as the Underwriter. All checks will be deposited directly into the Offering Deposit Account
    and all wire transfers will be wired directly to the Offering Deposit Account at Pacific Mercantile Bank. The funds will be
    held in escrow until the Deposit Account Agent has advised us and the Underwriter that it has received a minimum of&thinsp;$10,000,000,
    the minimum offering, in cleared funds. If we do not receive the minimum of&thinsp;$10,000,000 by [&#9679;], 2019, all funds
    will be returned to purchasers in this offering on the next business day after the termination of the offering, without charge,
    deduction or interest. Prior to [&#9679;], 2019, in no event will funds be returned to you unless the offering is terminated.
    You will only be entitled to receive a refund of your subscription price if we do not raise a minimum of&thinsp;$10,000,000
    by [&#9679;], 2019. No interest will be paid either to us or to you. See &ldquo;Underwriting&thinsp;&mdash;&thinsp;Deposit
    Account Agent and Deposit of Offering Proceeds.&rdquo;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    plan to use the net proceeds we will receive from this offering for general corporate purposes, including without limitation,
    investment in product research and development, sales and marketing activities, technology infrastructure, team development,
    capital expenditures, improvement of corporate facilities and other general and administrative matters. We may also use a
    portion of these proceeds for the acquisition of, or investment in, technologies, solutions or businesses that complement
    our business, although we have no present commitments or agreements to enter into any acquisitions or investments. See &ldquo;Use
    of Proceeds&rdquo; on page 34 for more information.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    factors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &ldquo;Risk Factors&rdquo; and other information included in this prospectus for a discussion of the risks relating to investing
    in our Series A Convertible Preferred Stock and Common Stock. You should carefully consider these risks before deciding to
    invest in our Series A Convertible Preferred Stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to have the Common Stock listed on the Nasdaq under the symbol &ldquo;ABVC&rdquo; and Series A Convertible Preferred
    Stock under the symbol [&ldquo;&#9679;&rdquo;] However, we cannot assure you that either of our Common Stock or Series A Convertible
    Preferred Stock will be listed on the Nasdaq. We will not complete this offering without a listing approval letter of our
    Series A Convertible Preferred Stock and Common Stock from the Nasdaq. </FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of Common Stock outstanding immediately after this offering, as set forth in the table above excludes shares
    of Common Stock issuable upon the exercise of the Underwriter Warrants.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>
<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>SELECTED
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma data presented herein reflects events that are directly attributable to the described transactions, factually
supportable, and as it relates to the unaudited pro forma condensed consolidated combined statement of operations, expected to
have a continuing impact. The unaudited pro forma data presented herein also reflects certain assumptions which management believes
are reasonable. Such pro forma data is not necessarily indicative of financial results that would have been attained had the described
transactions occurred on the dates indicated above, or the results of the combined company that may be achieved in the future.
The adjustments are based on currently available information and certain estimates and assumptions. Therefore, the actual results
may differ from the pro forma results indicated herein. However, management believes that the assumptions provide a reasonable
basis for presenting the significant effects of the transactions as contemplated and that the pro forma adjustments give appropriate
effect to those assumptions and are properly applied in the unaudited pro forma condensed consolidated combined financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined financial statements are provided for illustrative purposes only and are not
intended to represent or be indicative of the consolidated results of operations or consolidated financial position of the combined
company that would have been recorded had the Merger been completed as of the dates presented, and they should not be taken as
representative of the expected future results of operations or financial position of the combined company. The unaudited pro forma
condensed consolidated combined financial statements do not reflect the impacts of any potential operational efficiencies, asset
dispositions, cost savings or economies of scale that the combined company may achieve with respect to the operations of the combined
company. Additionally, the unaudited pro forma condensed consolidated combined statement of operations does not include&nbsp;non-recurring&nbsp;charges
or credits, and the related tax effects, which result directly from the Mergers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>
</DIV>
<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELECTED
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED COMBINED BALANCE SHEET DATA<BR>
</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
OF DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> ABVC </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioKey </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioLite </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Note </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Combined </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> ASSETS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,044 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 636,666 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 186,644 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 863,354 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Restricted cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accounts receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accounts receivable - related parties, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Other receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Due from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,287 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (59,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {f} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,477 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Prepaid expense and other
    current assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 136 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,759 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,895 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 827,718 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 530,013 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (59,810 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,394,194 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Property and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 568,216 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Goodwill, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,531,445 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,531,445 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Long-term investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,488,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,448,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Deferred tax assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Security Deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,858 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,471,635 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,367,877 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> LIABILITIES AND EQUITY </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Short-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Long-term
    bank loan - current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Accrued
    expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 555,449 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 687,709 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,326,184 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,462,775 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,341,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {f} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,745,096 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Convertible
    notes payable, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Convertible
    notes payable - related parties, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,568,224 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,478,246 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,070,812 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Long-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Tenant security deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Convertible notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Convertible
    notes payable - related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Accrued interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"> Total
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,845,691 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,493,503 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,366,416 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Preferred stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,633,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,633,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {c} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Common stock
    (Pre - reverse stock split) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,927 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 774,293 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 318,486 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,998 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (771,793 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {b} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {b} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,133 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {c} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Additional paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,914,556 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 82,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (70,877 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,018,959 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> (Pre - reverse stock split) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (82,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,312,285 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (10,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Stock subscription receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accumulated deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (19,877,901 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,677,586 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (11,445,109 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,677,586 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (12,209,446 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,817,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,295,716 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Other comprehensive income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 670,541 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (14,689 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g,h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 655,852 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Treasury stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,750,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,350,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> {h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    Stockholders&rsquo; equity (deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,548 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,530,319 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 38,683,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Noncontrolling interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"> Total
    Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 410,158 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,530,319 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,001,461 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total Liabilities and Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,471,635 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,367,877 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>
<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELECTED
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS DATA</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEAR ENDED DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> ABVC </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioKey </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioLite </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Note </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Combined </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,197 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,956 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 517,153 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 185,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 190,089 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,324 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 327,064 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,148 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,322 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,258,040 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Research
    and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,668 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,917 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,419,638 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,100,239 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,706,478 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,390,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,379,414 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 93 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (462,751 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Impairment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (396,025 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain/Loss on foreign exchange&nbsp;changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Gain/Loss
    on investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (192,463 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,741,914 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 630 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,524 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,705,837 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,228 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,639,836 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Loss
    before provision for income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,099,453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (589,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,330,174 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,019,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (364,297 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,654,953 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Net loss
    attributable to noncontrolling interests </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Net loss
    attributable to ABVC and subsidiaries </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,067 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,144,104 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Foreign
    currency translation adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Income (Loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,560,862 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,230,890 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
</DIV>
<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our securities includes a high degree of risk. Prior to making a decision about investing in our securities, you should consider
carefully the specific factors discussed below, together with all of the other information contained in this prospectus. If any
of the following risks actually occurs, our business, financial condition, results of operations and future prospects would likely
be materially and adversely affected. This could cause the market price of our Common Stock to decline and could cause you to
lose all or part of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Company&rsquo;s Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company is a development stage biopharmaceutical company and is thus subject to the risks associated with new businesses in that
industry.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquired the sole licensing rights to develop and commercialize for therapeutic purposes six compounds from BioLite and
the right to co-develop with BioFirst a medical device (collectively the &ldquo;ABVC Pipeline Products&rdquo;). As such, the Company
is a clinical stage biopharmaceutical company with operations that generate unsubstantial revenues. The Company is establishing
and implementing many important functions necessary to operate a business, including the clinical research and development of
the ABVC Pipeline Products, further establishment of the Company&rsquo;s managerial and administrative structure, accounting systems
and internal financial controls. Before the Mergers, the Company faced costs, uncertainties, delays and difficulties frequently
encountered by pre-revenue stage biopharmaceutical companies. Upon completion of the Mergers and full integration of BioLite and
BioKey into the Company, the Company will have limited revenue and remain unprofitable for an indefinite period of time.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
you should consider the Company&rsquo;s prospects in light of the risks and uncertainties that a pharmaceutical company with a
limited operating history and revenue faces. In particular, potential investors should consider that there are significant risks
that the Company will not be able to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">implement
    or execute its current business plan, or generate profits;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract
    and maintain a skillful management team;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">raise
    sufficient funds in the capital markets or otherwise to effectuate its business plan;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that the processes and technologies that it has developed are commercially viable; and/or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into contracts with commercial partners, such as licensors and suppliers.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the above risks occurs, the Company&rsquo;s business may fail, in which case you may lose the entire amount of your investment
in the Company. The Company cannot assure that any of its efforts in business operations will be successful or result in the timely
development of new products, or ultimately produce any material revenue and profits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, after the Mergers, as a pre-profit biopharmaceutical company, the Company needs to transition from a company with a
research and development focus to a company capable of supporting commercial activities. The Company may not be able to reach
such transition point or make such a transition, which would have affect our business, financial condition, results of operations
and prospects.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the Company fails to raise additional capital, its ability to implement its business model and strategy could be compromised.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has limited capital resources and operations. The CDMO Unit generates limited amount of revenue that could partially support
the operations of the Company. To date, its operations have been&nbsp;funded partially from the proceeds from financings or loans
from its shareholders and management. From time to time, we may seek additional financing to provide the capital required to expand
our production facilities, research and development (&ldquo;R&amp;D&rdquo;) initiatives and/or working capital, as well as to
repay outstanding loans if cash flow from operations is insufficient to do so.&nbsp;We cannot predict with certainty the timing
or amount of any such capital requirements.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company does not raise sufficient capital to fund its ongoing development activities, it is likely that it will be unable
to carry out its business plans, including R&amp;D development and expansion of production facilities. The Company may not be
able to obtain additional financing on terms acceptable, or at all. Even if the Company obtains financing for near term operations
and product development, the Company may require additional capital beyond the near term. If the Company is unable to raise capital
when needed, its business, financial condition and results of operations would be materially adversely affected, and it could
be forced to reduce or discontinue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company has no history in obtaining regulatory approval for, or commercializing, any new drug candidate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
limited operating history, the Company has never obtained regulatory approval for, or commercialized, any new drug candidate.
It is possible that the FDA may refuse to accept our planned New Drug Application (or &ldquo;NDA&rdquo;) for any of the six drug
products for substantive review, or may conclude after review of our data that our application is insufficient to obtain regulatory
approval of the new drug candidates or the medical device. Although our CDMO strategic business department has experience in obtaining
abbreviated new drug application (or &ldquo;ANDA&rdquo;) approvals, the processes and timelines of obtaining an NDA approval and
ANDA approval can differentiate substantially. If the FDA does not accept or approve our planned NDA for our product candidates,
it may require that we conduct additional clinical, preclinical or manufacturing validation studies, which may be costly. Depending
on the FDA required studies, approval of any NDA or application that we submit may be significantly delayed, possibly for several
years, or may require us to expend more resources than we have. Any delay in obtaining, or inability to obtain, regulatory approvals
of any of our drug candidate will prevent us from sublicensing such product. It is also possible that additional studies, if performed
and completed, may not be considered sufficient by the FDA. If any of these outcomes occurs, we may be forced to abandon our planned
NDA for such drug candidate, which materially adversely affects our business and could potentially cause us to cease operations.
We face similar regulatory risks in a foreign jurisdiction.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
growth is dependent on our ability to successfully develop, acquire or license new drugs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth is supported by continuous investment in time, resources and capital to identify and develop new products or new formulations
for the market via&nbsp;geographic expansion and market penetration. If we are unable to either develop new products on our own
or acquire licenses for new products from other parties, our ability to grow revenues and market share will be adversely affected.&nbsp;In
addition, we may not be able to recover our investment in the development of new drugs and medical devices, given that projects
may be interrupted, unsuccessful, not as profitable as initially contemplated or we may not be able to obtain necessary financing
for such development. Similarly, there is no assurance that we can successfully secure such rights from third parties on an economically
feasible basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
current products have certain side effects. If the side effects associated with our current or future products are not identified
prior to their marketing and sale, we may be required to withdraw such products from the market, perform lengthy additional clinical
trials or change the labeling of our products, any of which could adversely impact our growth.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company researches and develops the following six drug products and one medical device: ABV-1501, ABV-1504, ABV-1505, ABV-1701,
ABV-1702, ABV-1601 and ABV-1703. Each of these seven products may cause serious adverse effects to their users. For example, the
API of ABV-1501, ABV-1702 and ABV-1703 is Maitake mushroom extract. Side effects, or adverse events, associated with Maitake mushroom
extract include blood bilirubin increase, lymphocyte count decrease, neutrophil count decrease, platelet count decrease, white
blood cell decrease, headache, and hyperglycemia. Serious adverse events (collectively, the &ldquo;SAE&rdquo;) associated with
this compound include leukocytosis, platelet count decrease, eye disorders, abdominal pain, gastrointestinal disorders, aphonia,
lung infection, muscle weakness right-sided, confusion, edema cerebral, stroke, dyspnea, wheezing, and pruritus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1504
and ABV-1505 have the same API, &ldquo;Radix Polygala&rdquo;, which is known as Polygala tenuifolia Willd or PDC-1421 Capsule
(&ldquo;Polygala tenuifolia Willd&rdquo;). Side effects, or adverse events, associated with ABV-1504 and ABV-1505, coming from
administration of the trial medicine or examination procedure such as the procedure of taking blood (fainting, pain and/or bruising),
may lead to gastrointestinal disorders (abdominal fullness and constipation), nervous system disorders (drowsiness, sleepiness,
and oral ulcer). In addition, long-term use may cause miscarriages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the Company is processing Phase I clinical trial of ABV-1701 and is not aware of any serious side
effects associated therewith. However, new serious side effects of ABV-1701 may be uncovered as the clinical trials continue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence of any of those adverse events would harm our future sales of these medicines and substantially increase the costs
and expenses of marketing these medicines, which in turn could cause our revenues and net income to decline.&nbsp;In addition,
the reputation and sales of our future medicines could be adversely affected due to the severe side effects discovered.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to product liability claims in the future, which could divert our resources, cause us to incur substantial liabilities
and limit commercialization of any products that we may develop.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face an inherent business risk of exposure to product liability claims in the event that the uses of our products are alleged
to have caused adverse side effects.&nbsp;Side effects or marketing or manufacturing problems pertaining to any of our products
could result in product liability claims or adverse publicity.&nbsp;These risks will exist for those products in clinical development
and with respect to those products that receive regulatory approval for commercial sale.&nbsp;Furthermore, although we have not
historically experienced any problems associated with claims by users of our products, we do not currently maintain product liability
insurance and&nbsp;there could be no assurance that we are able to acquire product liability insurance with terms that are commercially
feasible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face an inherent risk of product liability claims as a result of the clinical testing of our products and potentially commercially
selling any products that we may develop. For example, we may be sued if any product we develop allegedly causes injury or is
found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims
may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product,
negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If
we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required
to limit commercialization of our product candidate. Regardless of the merits or eventual outcome, liability claims may result
in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
    demand for our product candidates or products that we may develop;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
    to our reputation and significant negative media attention;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
    of clinical trial participants;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    costs to defend resulting litigation;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
    monetary awards to trial participants or patients;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
    of revenue;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    resources of our management to pursue our business strategy; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to commercialize any products that we may develop.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have insurance policies to cover liabilities under the clinic trials but do not maintain general liability insurance;
and even if we have a general liability insurance in the future, this insurance may not fully cover potential liabilities that
we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial.
We would need to increase our insurance coverage if and when we begin selling any product candidate that receives marketing approval.
In addition, insurance coverage is becoming increasingly expensive. If we are unable to obtain or maintain sufficient insurance
coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit
the development and commercial production and sale of our product candidate, which could adversely affect our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have conducted, and may in the future conduct, clinical trials for certain of our product candidates at sites outside the United
States, and the FDA may not accept data from trials conducted in such locations.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have conducted and may in the future choose to conduct one or more of our clinical trials outside the United States. Although
the FDA may accept data from clinical trials conducted outside the United States, acceptance of this data is subject to certain
conditions imposed by the FDA. For example, the clinical trial must be well designed and conducted and performed by qualified
investigators in accordance with ethical principles. The trial population must also adequately represent the U.S. population,
and the data must be applicable to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful.
In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the data will be dependent
upon its determination that the trials also complied with all applicable U.S. laws and regulations. There can be no assurance
that the FDA will accept data from trials conducted outside of the United States. If the FDA does not accept the data from any
of our clinical trials that we determine to conduct outside the United States, it would likely result in the need for additional
trials, which would be costly and time-consuming and delay or permanently halt our development of the product candidate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the conduct of clinical trials outside the United States could have a significant impact on us. Risks inherent in conducting
international clinical trials include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    regulatory requirements that could restrict or limit our ability to conduct our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">administrative
    burdens of conducting clinical trials under multiple foreign regulatory schema;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    exchange fluctuations; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diminished
    protection of intellectual property in some countries.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
clinical trials of our product candidates fail to demonstrate safety and efficacy to the satisfaction of the FDA and comparable
non-U.S. regulators, we may incur additional costs or experience delays in completing, or ultimately be unable to complete the
development and commercialization of our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not permitted to commercialize, market, promote or sell any product candidate in the United States without obtaining marketing
approval from the FDA. Comparable non-U.S. regulatory authorities impose similar restrictions. We may never receive such approvals.
We must complete extensive preclinical development and clinical trials to demonstrate the safety and efficacy of our product candidate
in humans before we will be able to obtain these approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
testing is expensive, difficult to design and implement, can take many years to complete and is inherently uncertain as to outcome.
Any inability to successfully complete preclinical and clinical development could result in additional costs to us and impair
our ability to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if
(1) we are required to conduct additional clinical trials or other testing of our product candidate beyond the trials and testing
that we contemplate, (2) we are unable to successfully complete clinical trials of our product candidate or other testing, (3)
the results of these trials or tests are unfavorable, uncertain or are only modestly favorable, or (4) there are unacceptable
safety concerns associated with our product candidate, we, in addition to incurring additional costs, may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    delayed in obtaining marketing approval for our product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    obtain marketing approval at all;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    approval for indications or patient populations that are not as broad as we intended or desired;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    approval with labeling that includes significant use or distribution restrictions or significant safety warnings, including
    boxed warnings;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    subject to additional post-marketing testing or other requirements; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    required to remove the product from the market after obtaining marketing approval.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if any of our product candidates receives marketing approval, it may fail to achieve the degree of market acceptance by physicians,
patients, third party payors and others in the medical community necessary for commercial success and the market opportunity for
the product candidate may be smaller than we estimate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never completed a new drug or new medical device FDA application process from Phase I to FDA approval and commercialization.
Even if our products are approved by the appropriate regulatory authorities for marketing and sale, they may nonetheless fail
to gain sufficient market acceptance by physicians, patients, third party payors and others in the medical community. For example,
physicians are often reluctant to switch their patients from existing therapies even when new and potentially more effective or
convenient treatments enter the market. Further, patients often acclimate to the therapy that they are currently taking and do
not want to switch unless their physicians recommend switching products or they are required to switch therapies due to lack of
reimbursement for existing therapies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
potential market opportunities for our products are difficult to estimate precisely. Our estimates of the potential market opportunities
are predicated on many assumptions, including industry knowledge and publications, third party research reports and other surveys.
While we believe that our internal assumptions are reasonable, these assumptions involve the exercise of significant judgment
on the part of our management, are inherently uncertain and the reasonableness of these assumptions has not been assessed by an
independent source. If any of the assumptions proves to be inaccurate, the actual markets for our products could be smaller than
our estimates of the potential market opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may seek to enter into collaborations with third parties for the development and commercialization of our product candidates.
If we fail to enter into such collaborations, or such collaborations are not successful, we may not be able to capitalize on the
market potential of our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek third-party collaborators for development and commercialization of our products. Our likely collaborators for any marketing,
distribution, development, licensing or broader collaboration arrangements include large and mid-size pharmaceutical companies,
regional and national pharmaceutical companies, non-profit organizations, government agencies, and biotechnology companies. Our
ability to generate revenues from these arrangements will depend on our collaborators&rsquo;&nbsp;abilities to successfully perform
the functions assigned to them in these arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborations
involving our products will pose the following risks to us:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may have significant discretion in determining the efforts and resources that they will apply to these collaborations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may not pursue development and commercialization of our product candidate or may elect not to continue or renew development
    or commercialization programs based on preclinical or clinical trial results, changes in the collaborators&rsquo;&nbsp;strategic
    focus or available funding, or external factors such as an acquisition that diverts resources or creates competing priorities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product
    candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    could independently develop, or develop with third parties, products that compete directly or indirectly with our product
    candidate if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized
    under terms that are more economically attractive than ours;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution
    of such product or products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way
    as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose
    us to potential litigation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
    may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization
    of our product candidate or that result in costly litigation or arbitration that diverts management attention and resources;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborations
    may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization
    of the applicable product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborative
agreements may not lead to development or commercialization of our product candidate in the most efficient manner or at all. If
a collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development
or commercialization program could be delayed, diminished or terminated.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC,
through BioLite, may not be able to receive the full amounts available under the collaboration agreement by and between BioLite,
Inc. and BioHopeKing, which could increase its burden to seek additional capital to fund the business operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February and December 2015, BioLite, Inc., a subsidiary of BioLite, entered into a total of three collaboration agreements with
BioHopeKing to jointly develop ABV-1501 for TNBC (or BLI-1401-2 as used by BioLite internally) and ABV-1504 for MDD (or BLI-1005
as used by BioLite internally) in most Asian countries and BLI-1006, which has been later replaced with BLI-1008 for ADHD in Asia,
excluding Japan. ABVC and BioLite are co-developing ABV-1501 for TNBC and ABV-1504 for MDD pursuant to the Collaboration Agreement
and its Addendum entered by and between BriVision and BioLite Taiwan where ABVC and BriVision are responsible for the clinical
trials of such two new drug candidates. In accordance with the terms of the BioHopeKing Collaboration Agreement for ABV-1501 or
BLI-1401-2 and the Addendum thereto, BioLite shall receive payments of a total of $10 million in cash and equity of BioHopeKing
or equity securities owned by it at various stages on a schedule dictated by BioLite&rsquo;s achievements of certain milestones
and twelve per cent (12%) of net sales of the drug products when ABV-1501 or BLI-1401-2 is approved for sale in the licensed territories.
If BioLite fails to reach any of the milestones in a timely manner, it may not receive the rest of the payments from BioHopeKing.
As a result of BioLite&rsquo;s potential inability to receive the full payments under those collaboration agreements with BioHopeKing,
ABVC may have to seek other sources of financing to fund its operation activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC
and its Subsidiaries may not be successful in establishing and maintaining additional strategic partnerships, which could adversely
affect ABVC&rsquo;s ability to develop and commercialize products, negatively impacting its operating results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to ABVC&rsquo;s current collaboration with BioHopeKing for selected Asian markets, a part of its strategy is to evaluate
and, as deemed appropriate, enter into additional partnerships in the future with major biotechnology or pharmaceutical companies.
ABVC&rsquo;s products may prove to be difficult to effectively license out as planned. Various regulatory, commercial and manufacturing
factors may impact ABVC&rsquo;s ability to seek co-developers of or grow revenues from licensing out any of the six products in
the pipeline, none of which has been fully licensed out. Specifically, ABVC may encounter difficulty by virtue of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    inability to effectively identify and align with commercial partners in the U.S. to collaborate the development of ABV-1504
    for the treatment of Major Depressive Disorder, ABV-1505 to treat Attention-Deficit Hyperactivity Disease, ABV-1501 for the
    treatment of Triple Negative Breast Cancer, ABV-1703 to the treatment of Pancreatic Cancer, ABV-1601 to treat Depression in
    Cancer Patients and ABV-1702 to treat Myelodysplastic syndromes and ABV-1701 Vitargus for the treatments of Retinal Detachment
    or Vitreous Hemorrhage;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    inability to secure appropriate contract research organizations (&ldquo;CRO&rdquo;s) to conduct data analysis, lab research
    and FDA communication; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">its
    inability to effectively continue clinical studies on and secure positive research results of all of our investigational new
    drugs to attract additional commercial collaborators outside the U.S.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
faces significant competition in seeking appropriate partners for its therapeutic candidates, and the negotiation process is time-consuming
and complex. In order for ABVC to successfully partner its autoimmune, CNS and hematology therapeutic candidates, potential partners
must view these medicinal candidates as economically valuable in markets they determine to be attractive in light of the terms
that ABVC is seeking and compared to other available products for licensing by other companies. Even if ABVC is successful in
its efforts to establish new strategic partnerships, the terms that ABVC agrees upon may not be favorable, and it may not be able
to maintain such strategic partnerships if, for example, development or approval of an autoimmune therapeutic is delayed or sales
of an approved product are disappointing. Any delay in entering into new strategic partnership agreements related to any of ABVC&rsquo;s
therapeutic candidates could delay the development and commercialization of such candidates and reduce its competitiveness even
if it reaches the market.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
ABVC fails to establish and maintain additional strategic partnerships or collaboration related to its therapeutic candidates
that have not been fully licensed, it will bear all of the risk and costs related to the development of any such drug candidate,
and it may need to seek additional financing, hire additional employees and otherwise develop expertise for which it has not budgeted.
This could negatively affect the development of any incompletely partnered new drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC&rsquo;s
licensors may choose to terminate any of the license agreements with ABVC. As a result, ABVC&rsquo;s research and development
of the new drug candidate which contains the underlying API may be terminated abruptly. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
ABVC&rsquo;s Subsidiary BioLite materially breaches any license agreements it has with Yukiguni Maitake Co. (&ldquo;Yukiguni&rdquo;),
Medical and Pharmaceutical Industry Technology and Development Center (&ldquo;MPITDC&rdquo;) or Industrial Technology Research
Institute (&ldquo;ITRI&rdquo;), or any of such license agreement terminates unexpectedly, BioLite may not be able to continue
its research and development of the new drug candidate which contains the underlying API whose license has been terminated. Pursuant
to the Yukiguni License Agreement, if BioLite fails to meet the milestone sales requirement or submit certain applications to
the appropriate health authorities on a schedule prescribed therein, Yukiguni shall have the right to terminate the Yukiguni License
Agreement. If the Yukiguni License Agreement is terminated involuntarily, BioLite will be forced to discontinue its new drug development
of ABV-1702, ABV-1502 and ABV-1501 and terminate the collaboration agreements relating to the three new drug candidates. The termination
of the right to use the underlying API will materially disrupt the operations of ABVC. Pursuant to the license agreement between
BioLite Taiwan and ITRI, if BioLite Taiwan fails to complete the research submission milestones according to the schedule set
forth therein without reasons or with reasons unstatisfied with ITRI, ITRI shall have the right to terminate the license agreement
with BioLite Taiwan without refund to BioLite Taiwan. BioLite Taiwan and BioLite have submitted the IND for PDC-1421 and subsequently
conducted Phase II clinical trials of two drug candidiates developed from PDC-1421 according to the schedule listed in the license
agreement between BioLite Taiwan and MPITDC.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC&rsquo;s
Subsidiary BioLite depends on one supplier for the API of ABV-1702, ABV-1502 and ABV-1501 and any failure of such supplier to
deliver sufficient quantities of the API that meets its quality standard could have a material adverse effect on its research
of these three drug candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently
BioLite relies primarily on Yukiguni, a Japanese supplier, to provide Yukiguni Maitake Extract 404, the API which is contained
in ABV-1702, ABV-1502 and ABV-1501, three of the six drug candidates in BioLite&rsquo;s oncology/hematology portfolio. It has
entered into the Yukiguni License Agreement, among other things, for the delivery of Yukiguni Maitake Extract 404, which is patented
in Japan and China. BioLite agrees to fulfill its demand of the Yukiguni Maitake Extract 404 by purchasing first from Yukiguni
respecting the therapeutic products and Yukiguni represents that it will provide sufficient quantities of such API that meets
cGMP standards. If the supplies of Yukiguni Maitake Extract 404 were interrupted for any reason, BioLite&rsquo;s research and
development activities of these three drug candidates could be delayed. These delays could be extensive and expensive, especially
in situations where a substitution is not readily available.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
BioLite may negotiate with other vendors that could provide Yukiguni Maitake Extract 404, it cannot guarantee that it will be
able to find such vendors. Failure to obtain adequate supplies of high quality Yukiguni Maitake Extract 404 in a timely manner
could have a disruptive effect on ABVC and BioLite&rsquo;s research and development activities of ABV-1702, ABV-1502 and ABV-1501,
resulting in a material adverse effect on the Company&rsquo;s business, financial condition and results of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>With
respect to generic drugs, ABVC &rsquo;s sales and marketing functionare currently very limited and ABVC currently relies on third
parties to promote its products to physicians in the U.S. and rely on its foreign partners with respect to marketing and distribution
of its generic drugs outside the U.S. Failure to maintain commercial marketing and sales partners or attract qualified marketing
and sales personnel will have material adverse effects on the results of the Company&rsquo;s operations.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
has marketing personnel to develop clientele for its CDMO business line but does not have marketing and sales human capital for
its generic drug products. ABVC heavily relies on third parties to promote its products to physicians in the U.S. and rely on
its foreign partners to conduct marketing and sales outside the U.S. ABVC will need to maintain its commercial marketing and sales
partners and attract others or be in a position to afford qualified or experienced marketing and sales personnel to market its
generic drug products. Failure to maintain commercial marketing and sales partners or attract qualified marketing and sales personnel
will have material adverse effects on the results of the Company&rsquo;s operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC
may use hazardous chemicals and biological materials in its business. Any claims relating to improper handling, storage or disposal
of these materials could be time consuming and costly. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
research and development may involve the controlled use of hazardous materials, including chemicals and biological materials.
ABVC cannot eliminate the risk of accidental contamination or discharge and any resulting injury from these materials. ABVC may
be sued for any injury or contamination that results from its use or the use by third parties of these materials, and its liability
may exceed any insurance coverage and its total assets. Federal, state and local laws and regulations govern the use, manufacture,
storage, handling and disposal of these hazardous materials and specified waste products, as well as the discharge of pollutants
into the environment and human health and safety matters. Although ABVC makes its best efforts to comply with environmental laws
and regulations despite the associated high costs and inconvenience, ABVC cannot guarantee that it will not mishandle any hazardous
materials in the future. If it fails to comply with these requirements or any improper handling of hazardous materials occurs,
it could incur substantial costs, including civil or criminal fines and penalties, clean-up costs or capital expenditures for
control equipment or operational changes necessary to achieve and maintain compliance. In addition, ABVC cannot predict the impact
on its business of new or amended environmental laws or regulations or any changes in the way existing and future laws and regulations
are interpreted and enforced.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
facilities where the samples of drug candidates are manufactured need to be maintained and monitored in compliance with the good
manufacturing practice standards, the failure of such maintenance could contaminate the results of our clinical trials and adversely
affect our operations.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
Subsidiary BioKey operates a laboratory facility that is a certified good manufacturing practice facility (&ldquo;cGMP&rdquo;)
and some of its contract clinical trial service providers use cGMP facilities to conduct clinical studies. ABVC cannot be certain
that ABVC or its present or future contract manufacturers or suppliers will be able to comply with cGMPs regulations and other
FDA regulatory requirements. Failure to comply with these requirements may result in, among other things, total or partial suspension
of production activities, failure of the FDA to grant approval for marketing, and withdrawal, suspension, or revocation of marketing
approvals.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Risks
Related to Intellectual Property</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pharmaceutical
patents and patent applications involve highly complex legal and factual questions, which, if determined adversely to the Company,
could negatively impact its respective licensors&rsquo; patent position and interrupt its research activities. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent positions of pharmaceutical companies and research institutions can be highly uncertain and involve complex legal and factual
questions. The interpretation and breadth of claims allowed in some patents covering pharmaceutical compositions may be uncertain
and difficult to determine, and are often affected materially by the facts and circumstances that pertain to the patented compositions
and the related patent claims. The standards of the U.S. Patent and Trademark Office, or USPTO, are sometimes uncertain and could
change in the future. Consequently, the issuance and scope of patents cannot be predicted with certainty. Patents, if issued,
may be challenged, invalidated or circumvented. U.S. patents and patent applications may also be subject to interference proceedings,
and U.S. patents may be subject to re-examination proceedings, post-grant review and/or inter parties review in the USPTO. Foreign
patents may be subject to opposition or comparable proceedings in the corresponding foreign patent office, which could result
in either loss of the patent or denial of the patent application or loss or reduction in the scope of one or more of the claims
of the patent or patent application. In addition, such interference, re-examination, post-grant review, inter parties review and
opposition proceedings may be costly. Accordingly, rights under any issued patents may not provide the Company with sufficient
protection against competitive products or processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, changes in or different interpretations of patent laws in the U.S. and foreign countries may permit others to use discoveries
of the Company or to develop and commercialize their new drug candidates without providing any compensation thereto, or may limit
the number of patents or claims the Company can obtain. The laws of some countries do not protect intellectual property rights
to the same extent as U.S. laws and those countries may lack adequate rules and procedures for defending the intellectual property
rights of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company fails to obtain and maintain patent protection and trade secret protection of its respective products, the Company
could lose their competitive advantages and competition it faces would increase, reducing any potential revenues and adversely
affecting its ability to attain or maintain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Developments
in patent law could have a negative impact on the Company&rsquo;s Licensors&rsquo; patent positions and the Company&rsquo;s business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability
and any such changes could have a negative impact on the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Leahy-Smith America Invents Act, or the America Invents Act, which was signed into law in 2011, includes a number
of significant changes to U.S. patent law. These changes include a transition from a &ldquo;first-to-invent&rdquo; system to a
&ldquo;first-to-file&rdquo; system, changes the way issued patents are challenged, and changes the way patent applications are
disputed during the examination process. These changes may favor larger and more established companies that have greater resources
to devote to patent application filing and prosecution. The USPTO has developed regulations and procedures to govern the full
implementation of the America Invents Act, and many of the substantive changes to patent law associated with the America Invents
Act, and, in particular, the first-to-file provisions, became effective on March 16, 2013. Substantive changes to patent law associated
with the America Invents Act may affect the Company, BioLite and BioKey&rsquo;s ability to obtain patents, and if obtained, to
enforce or defend them. Accordingly, it is not clear what, if any, impact the America Invents Act will ultimately have on the
cost of prosecuting the Company&rsquo;s patent applications, its ability to obtain patents based on its discoveries and its ability
to enforce or defend its patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the Company is unable to protect the confidentiality of its trade secrets, its business and competitive position would be harmed,
respectively. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to patent protection, because the Company operates in the highly technical field of discovery and development of therapies,
it relies in part on trade secret protection in order to protect its proprietary technology and processes. However, trade secrets
are difficult to protect. The Company has entered into confidentiality and non-disclosure agreements with its employees, consultants,
outside scientific and commercial collaborators, sponsored researchers, and other advisors. These agreements generally require
that the other party keep confidential and not disclose to third parties any confidential information developed by the party or
made known to the party by the Company during the course of the party&rsquo;s relationship therewith. These agreements also generally
provide that inventions conceived by the party in the course of rendering services to the Company will be ABVC&rsquo;s exclusive
property. However, these agreements may not be honored and may not effectively assign intellectual property rights to the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to contractual measures, the Company tries to protect the confidential nature of its proprietary information using physical
and technological security measures. Such measures may not, for example, in the case of misappropriation of a trade secret by
an employee or third party with authorized access, provide adequate protection for the Company. The Company&rsquo;s security measures
may not prevent an employee or consultant from misappropriating its trade secrets and providing them to a competitor, and recourse
it takes against such misconduct may not provide an adequate remedy to protect the Company&rsquo;s interests fully. Enforcing
a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive, and time-consuming, and
the outcome is unpredictable. In addition, courts outside the U.S. may be less willing to protect trade secrets. Trade secrets
may be independently developed by others in a manner that could prevent legal recourse by the Company. If the Company&rsquo;s
confidential or proprietary information, such as the trade secrets, were to be disclosed or misappropriated, or if any such information
was independently developed by a competitor, its competitive position could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Third
parties may assert that the Company&rsquo;s employees or consultants have wrongfully used or disclosed confidential information
or misappropriated trade secrets. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company might employ individuals who were previously employed at universities or other biopharmaceutical companies, including
its competitors or potential competitors. Although through certain non-disclosure covenants and employment agreements with its
officers and employees, the Company tries to ensure that its employees and consultants do not use the proprietary information
or know-how of others in the work for the Company, the Company may be subject to claims that it or its employees, consultants
or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or
other proprietary information, of a former employer or other third parties. Litigation may be necessary to defend against these
claims. If the Company fails in defending any such claims, in addition to paying monetary damages, the Company may lose valuable
intellectual property rights or personnel. Even if the Company is successful in defending against such claims, litigation could
result in substantial costs and be a distraction to the Company&rsquo;s management and other employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC&rsquo;s
ability to compete may decline if it does not adequately protect its proprietary rights or if it is barred by the intellectual
property rights of others. </I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
commercial success depends on obtaining and maintaining proprietary rights to its drug candidates as well as successfully defending
these rights against third-party challenges. ABVC obtains its rights to use and research certain proprietary information to further
develop the drug candidates primarily from three institutions, MPITDC, ITRI and Yukiguni (collectively the &ldquo;Licensors&rdquo;).
These three institutions own the intellectual property rights in the products that have been licensed to us and may prosecute
new patents of the drug candidates that are invented or discovered within the licensed scope of use under the respective license
agreements. ABVC will only be able to protect its new drug candidates from unauthorized use by third parties to the extent that
its valid and enforceable patents, or effectively protected trade secrets and know-how, cover them.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
ability to obtain new patent protection for its new drug candidates is uncertain due to a number of factors, including that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    may not have been the first to make the inventions covered by pending patent applications or issued patents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    may not have been the first to file patent applications for its new drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
    may independently develop identical, similar or alternative products or compositions and uses thereof;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
    disclosures in patent applications may not be sufficient to meet the statutory requirements for patentability;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    or all of ABVC&rsquo;s pending patent applications may not result in issued patents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    may not seek or obtain patent protection in countries that may eventually provide a significant business opportunity;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    patents issued to ABVC may not provide a basis for commercially viable products, may not provide any competitive advantages,
    or may be successfully challenged by third parties;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
    methods may not be patentable;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
    licensors may successfully challenge that ABVC&rsquo;s new patent application fall outside the licensed use of the products;
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
    may design around ABVC&rsquo;s patent claims to produce competitive products which fall outside of the scope of its patents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if ABVC has or obtains new patents covering its new drug candidates, ABVC may still be barred from making, using and selling them
because of the patent rights of others. Others may have filed, and in the future may file, patent applications covering products
that are similar or identical to ABVC. There are many issued U.S. and foreign patents relating to therapeutic products and some
of these relate to ABVC&rsquo;s new drug candidates. These could materially affect ABVC&rsquo;s ability to develop its drug candidates.
Because patent applications can take many years to issue, there may be currently pending applications unknown to ABVC that may
later result in issued patents that its new drug candidates may infringe. These patent applications may have priority over patent
applications filed by ABVC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company and its respective licensors may not be able to enforce their intellectual property rights throughout the world. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the U.S. Many companies
have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions.
The legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual
property protection, especially those relating to pharmaceuticals and medical devices. This could make it difficult for the Company
and its respective licensors to stop the infringement of some of the Licensors&rsquo; patents, or the misappropriation of their
other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner
must grant licenses to third parties. In addition, many countries limit the enforceability of patents against third parties, including
government agencies or government contractors. In these countries, patents may provide limited or no benefit. Patent protection
must ultimately be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes.
Accordingly, the Company and its licensors have chosen in the past and may choose in the future not to seek patent protection
in certain countries, and as a result the Company will not have the benefit of patent protection in such countries. Moreover,
the Company may choose in the future not to seek patent protection in certain countries, and as a result it will not have the
benefit of patent protection in such countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceedings
to enforce the Company&rsquo;s and its licensors&rsquo; patent rights in foreign jurisdictions could result in substantial costs
and divert its efforts and attention from other aspects of the businesses. Accordingly, the efforts to protect the Company&rsquo;s
intellectual property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts
in the U.S. and foreign countries may affect the Company&rsquo;s ability to obtain adequate protection for its technology and
the enforcement of intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Regulatory
Risks Relating to Biopharmaceutical Development Business</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company is subject to various government regulations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacture and sale of human therapeutic and diagnostic products in the U.S. and foreign jurisdictions are governed by a variety
of statutes and regulations. These laws require approval of manufacturing facilities, controlled research and testing of products
and government review and approval of a submission containing manufacturing, preclinical and clinical data in order to obtain
marketing approval based on establishing the safety and efficacy of the product for each use sought, including adherence to current
PIC/S Guide to Good Manufacturing Practice for Medicinal products during production and storage, and control of marketing activities,
including advertising and labeling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
products the Company is currently developing will require significant development, preclinical and clinical testing and investment
of substantial funds prior to its commercialization. The process of obtaining required approvals can be costly and time-consuming,
and there can be no assurance that future products will be successfully developed and will prove to be safe and effective in clinical
trials or receive applicable regulatory approvals. Markets other than the U.S. have similar restrictions. Potential investors
and shareholders should be aware of the risks, problems, delays, expenses and difficulties which we may encounter in view of the
extensive regulatory environment which controls our business.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company cannot be certain that it will be able to obtain regulatory approval for, or successfully commercialize, any of its current
or future product candidates. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may not be able to develop any current or future product candidates. The Company&rsquo;s new drug candidates will require
substantial additional clinical development, testing, and regulatory approval before the commencement of commercialization. The
clinical trials of the Company&rsquo;s drug candidates are, and the manufacturing and marketing of our new drug candidates will
be subject to extensive and rigorous review and regulation by numerous government authorities in the U.S. and in other countries
where the Company intend to test and, if approved, market any new drug candidate. Before obtaining regulatory approvals for the
commercial sale of any product candidate, the Company must demonstrate through pre-clinical testing and clinical trials that the
product candidate is safe and effective for use in each target indication. This process can take many years and may include post-marketing
studies and surveillance, which will require the expenditure of substantial resources. Of the large number of drugs in development
in the U.S., only a small percentage successfully completes the FDA regulatory approval process and is commercialized. Accordingly,
even if the Company is able to obtain the requisite financing to continue to fund its development and clinical programs, it cannot
assure the investors that any of the product candidates will be successfully developed or commercialized.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not permitted to market a therapeutic product in the U.S. until it receives approval of an NDA or ANDA, for that product
from the FDA, or in any foreign countries until they receive the requisite approval from such countries. Obtaining approval of
an NDA is a complex, lengthy, expensive and uncertain process, and the FDA may delay, limit or deny approval of any product candidate
for many reasons, including, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unable
    to demonstrate that a product candidate is safe and effective to the satisfaction of the FDA;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    results of the Company&rsquo;s clinical trials may not meet the level of statistical or clinical significance required by
    the FDA for marketing approval;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may not approve the formulation of any product candidate;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    CROs, that BioLite or the Company retains to conduct its clinical trials may take actions outside of its control that materially
    adversely impact its clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in patient enrollment, variability in the number and types of patients available for clinical trials, and lower-than anticipated
    retention rates for patients in clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may find the data from pre-clinical studies and clinical trials insufficient to demonstrate that a product candidate&rsquo;s
    clinical and other benefits outweigh its safety risks, such as the risk of drug abuse by patients or the public in general;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may disagree with the interpretation of data from the Company&rsquo;s pre-clinical studies and clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may not accept data generated at the Company&rsquo;s clinical trial sites;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    an NDA, if and when submitted, is reviewed by an advisory committee, the FDA may have difficulties scheduling an advisory
    committee meeting in a timely manner or the advisory committee may recommend against approval of our application or may recommend
    that the FDA require, as a condition of approval, additional pre-clinical studies or clinical trials, limitations on approved
    labeling or distribution and use restrictions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may require development of a Risk Evaluation and Mitigation Strategy, or REMS, as a condition of approval or post-approval;
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    FDA may change its approval policies or adopt new regulations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
same risks apply to applicable foreign regulatory agencies from which the Company, through BioLite, may seek approval for any
of our new drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these factors, many of which are beyond the Company&rsquo;s control, could jeopardize its ability to obtain regulatory approval
for and successfully market any new drug candidate. As a result, any such setback in the Company&rsquo;s pursuit of initial or
additional regulatory approval would have a material adverse effect on its business and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company does not successfully complete pre-clinical and Phase I and II clinical development, it will be unable to receive
full payments under their respective collaboration agreements, find future collaborators or partners to take the drug candidates
to Phase III clinical trials. Even if the Company successfully completes all Phase I and II clinical trials, those results are
not necessarily predictive of results of additional trials that may be needed before an NDA for Phase III trials may be submitted
to the FDA. Although there are a large number of drugs in development in the U.S. and other countries, only a very small percentage
result in commercialization, and even fewer achieve widespread physician and consumer acceptance following the regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company may encounter delays or drug candidate rejections based on new governmental regulations, future legislative
or administrative actions, or changes in FDA policy or interpretation during the period of product development. If the Company
obtains required regulatory approvals, such approvals may later be withdrawn. Delays or failures in obtaining regulatory approvals
may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">varying
    interpretations of data and commitments by the FDA and similar foreign regulatory agencies; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diminishment
    of any competitive advantages that such drug candidates may have or attain.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if the Company fails to comply with applicable FDA and other regulatory requirements at any stage during this regulatory process,
the Company may encounter or be subject to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or termination in clinical trials or commercialization;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    by the FDA or similar foreign regulatory agencies to review pending applications or supplements to approved applications;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    recalls or seizures;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    of manufacturing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawals
    of previously approved marketing applications; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
    civil penalties, and criminal prosecutions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company faces substantial competition from companies with considerably more resources and experience than the Company has, which
may result in others discovering, developing, receiving approval for, or commercializing products before or more successfully
than the Company. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company competes with companies that research, develop, manufacture and market already-existing and new pharmaceutical products
in the fields of CNS, hematology/oncology and autoimmune. The Company anticipates that it will face increased competition in the
future as new companies enter the market with new drugs and/or technologies and/or their competitors improve their current products.
One or more of their competitors may offer new drugs superior to the Company&rsquo;s and render the Company&rsquo;s drugs uneconomical.
A lot of the Company&rsquo;s current competitors, as well as many of its respective potential competitors, have greater name recognition,
more substantial intellectual property portfolios, longer operating histories, significantly greater resources to invest in new
drug development, more substantial experience in product marketing and new product development, greater regulatory expertise,
more extensive manufacturing capabilities and the distribution channels to deliver products to customers. If the Company is not
able to compete successfully, it may not generate sufficient revenue to become profitable. The Company&rsquo;s ability to compete
successfully will depend largely on its ability to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
    commercialize its drug candidates with commercial partners;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discover
    and develop new drug candidates that are superior to other products in the market;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    its collaborators, obtain required regulatory approvals;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract
    and retain qualified personnel; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    patent and/or other proprietary protection for its product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Established
pharmaceutical companies devote significant financial resources to discovering, developing or licensing novel compounds that could
make the Company&rsquo;s products and product candidates obsolete. Our competitors may obtain patent protection, receive FDA approval,
and commercialize medicines before we do. Other companies are or may become engaged in the discovery of compounds or botanical
materials that may compete with the drug candidates the Company is developing.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company competes with a large number of well-established pharmaceutical companies that may have more resources than the Company
does in developing therapeutics in the fields of CNS, oncology/hematology and ophthalmology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
new drug candidate the Company is developing or commercializing that competes with a currently-approved product must demonstrate
compelling advantages in efficacy, convenience, tolerability and/or safety in order to address price competition and be commercially
successful. If the Company is not able to compete effectively against its current and future competitors, its business will not
grow and its financial condition and operations will suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Risks
Relating to Doing Business Outside the United States</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
part of ABVC&rsquo;s pharmaceutical research and development is conducted outside of the U.S., the Company is subject to the risks
of doing business internationally, including periodic foreign economic downturns and political instability, which may adversely
affect the Company&rsquo;s revenue and cost of doing business in Taiwan.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
collaborates with partners whose primary place of business is in Taiwan, Republic of China and the Company has certain key employees
in Taiwan. Foreign economic downturns may affect our results of operations in the future. Additionally, other facts relating to
the operation of the Company&rsquo;s business outside of the U.S. may have a material adverse effect on the Company&rsquo;s business,
financial condition and results of operations, including:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">international
    economic and political changes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    imposition of governmental controls or changes in government regulations, including tax laws, regulations and treaties;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in, or impositions of, legislative or regulatory requirements regarding the pharmaceutical industry;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with U.S. and international laws involving international operations, including the Foreign Corrupt Practices Act and export
    control laws;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in achieving headcount reductions due to unionized labor and works councils;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on transfers of funds and assets between jurisdictions; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China-
    Taiwan geo-political instability.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Company continues to operate its business globally, its success will depend in part, on its ability to anticipate and effectively
manage these risks. The impact of any one or more of these factors could materially adversely affect the Company&rsquo;s business,
financial condition and results of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company may be exposed to liabilities under the U.S. Foreign Corrupt Practices Act (&ldquo;FCPA&rdquo;) and Chinese anti-corruption
law.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to the FCPA, and other laws that prohibit improper payments or offers of payments to foreign governments, foreign
government officials and political parties by U.S. persons as defined by the statute for purposes of obtaining or retaining businesses.
The Company may have agreements with third parties who may make sales in mainland China and the U.S., during the process of which
the Company may be exposed to corruption. Activities in Taiwan create the risk of unauthorized payments or offers of payments
by an employee, consultant or agent of the Company, because these parties are not always subject to the Company&rsquo;s control.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company believes to date it has complied in all material aspects with the provisions of the FCPA and Chinese anti-corruption
law, the existing safeguards and any future improvements may prove to be less than effective and any of the Company&rsquo;s employees,
consultants or agents may engage in corruptive conduct for which the Company might be held responsible. Violations of the FCPA
or Chinese anti-corruption law may result in severe criminal or civil sanctions against the Company and individuals and therefore
could negatively affect the Company&rsquo;s business, operating results and financial condition. In addition, the Taiwanese government
may seek to hold the Company liable as a successor for FCPA violations committed by companies in which the Company invests or
acquires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the Company becomes directly subject to the recent scrutiny, criticism and negative publicity involving U.S.-listed Chinese companies,
we may have to expend significant resources to investigate and resolve the matters. Any unfavorable results from the investigations
could harm our business operations, this offering and our reputation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently,
U.S. public companies that have substantially all of their operations in China, have been subjects of intense scrutiny, criticism
and negative publicity by investors, financial commentators and regulatory agencies, such as the SEC. Much of the scrutiny, criticism
and negative publicity has centered on financial and accounting irregularities, lack of effective internal control over financial
accountings, inadequate corporate governance and ineffective implementation thereof and, in many cases, allegations of fraud.
As a result of enhanced scrutiny, criticism and negative publicity, the publicly traded stocks of many U.S. listed Chinese companies
have sharply decreased in value and, in some cases, have become virtually worthless or illiquid. Many of these companies are now
subject to shareholder lawsuits and SEC enforcement actions and are conducting internal and external investigations into the allegations.
It is not clear what effects the sector-wide investigations will have on the Company. If the Company becomes a subject of any
unfavorable allegations, whether such allegations are proven to be true or untrue, the Company will have to expend significant
resources to investigate such allegations and defend the Company. If such allegations were not proven to be baseless, the Company
would be severely hampered and the price of the stock of the Company could decline substantially. If such allegations were proven
to be groundless, the investigation might have significantly distracted the attention of the Company&rsquo;s management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>International
operations expose the Company to currency exchange and repatriation risks, and the Company cannot predict the effect of future
exchange rate fluctuations on its business and operating results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has business operations in Taiwan and collaborative activities in the U.S. and Japan. Substantial amounts of revenues
are received and expenses are incurred in New Taiwan Dollars and U.S. dollars. Thus, the Company has exposure to currency fluctuations.
The Company cannot assure you that the effect of currency exchange fluctuations will not materially affect its revenues and net
income in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I></I></B></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ABVC&rsquo;s
business could be adversely affected by changes in the U.S. presidential administration</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
new U.S. presidential administration came to power in January 2017 and President Trump has taken certain efforts to impose importation
tariffs from certain countries such as China and Mexico which could affect the cost of certain ABVC&rsquo;s product components
and the sales of certain ABVC&rsquo;s products and services. In addition, the Trump Administration has and will appoint and employ
many new secretaries, directors and the like into positions of authority in the U.S. Federal government dealing with the pharmaceutical
and healthcare industries that may potentially have a negative impact on the prices and the regulatory pathways for certain pharmaceuticals,
nutritional supplements and health care products such as those developed, marketed or sold by ABVC and its licensees. Such changes
in the regulatory pathways could adversely affect and or delay ABVC&rsquo;s ability to develop, market and sell their products
in the U.S.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Risks
Related to the Company&rsquo;s Financial Condition</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
existing indebtedness may adversely affect our ability to obtain additional funds and may increase our vulnerability to economic
or business downturns. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to a number of risks associated with our indebtedness, including: 1) we must dedicate a portion of our cash flows
from operations to pay debt service costs, and therefore we have less funds available for operations and other purposes; 2) it
may be more difficult and expensive to obtain additional funds through financings, if available at all; 3) we are more vulnerable
to economic downturns and fluctuations in interest rates, less able to withstand competitive pressures and less flexible in reacting
to changes in our industry and general economic conditions; and 4) if we default under any of our existing credit facilities or
if our creditors demand payment of a portion or all of our indebtedness, we may not have sufficient funds to make such payments.
As of December 31, 2018 (on a pro forma basis as if the Mergers were closed then) and March 31, 2019, our outstanding current
liabilities were approximately $11 million and $12.4 million, respectively, which consisted primarily of advances due to related
parties.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
disclosure controls and procedures were not effective as of March 31, 2019 and as a result of such we do not expect that our disclosure
controls and procedures will prevent all errors and all instances of fraud. The ineffective disclosure controls and procedures
may lead to restatement of our financial statements, harm our operating results, subject us to regulatory scrutiny and sanction,
cause investors to lose confidence in our reported financial information and have a negative effect on the market prices for our
Series A Convertible Preferred Stock and Common Stock.</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. We maintain a system
of internal control over financial reporting, which is defined as a process designed by, or under the supervision of, our principal
executive officer and principal financial officer, or persons performing similar functions, and effected by our board of directors,
management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures designed to provide reasonable assurance that material information required to be
disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized
and reported within the time periods specified in the SEC&rsquo;s rules and forms, and that the information is accumulated and
communicated to our management, including our Chief Executive Officer and interim Chief Financial Officer, as appropriate to allow
timely decisions regarding required disclosure. We performed an evaluation, under the supervision and with the participation of
our management, including our Chief Executive Officer and interim Chief Financial Officer, of the effectiveness of the design
and operation of our disclosure controls and procedures as of the end of the period covered by this prospectus. Based on their
evaluation, our management, including our Chief Executive Officer and interim Chief Financial Officer, concluded that our disclosure
controls and procedures were not effective as of March 31, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls
and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives
of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the
fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent
limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute
assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls
and procedures is also based partly on certain assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving its stated goals under all potential future conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
articles of incorporation allow for our board to create new series of preferred stock without further approval by our stockholders,
which could adversely affect the rights of the holders of our Common Stock. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has the authority to fix and determine the relative rights and preferences of preferred stock without stockholder
approval. As a result, our Board of Directors could authorize the issuance of a series of preferred stock that would grant to
holders the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed
to the holders of Common Stock and the right to the redemption of the shares, together with a premium, prior to the redemption
of our Common Stock. In addition, our Board of Directors could authorize the issuance of a series of preferred stock that has
greater voting power than our Common Stock or that is convertible into our Common Stock, which could decrease the relative voting
power of our Common Stock or result in dilution to our existing stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to issue Series A Convertible Preferred Stock which has senior dividend rights than Common Stock in this offering. We may
create any additional series of preferred stock and issue such shares in the future although we do not have any present intention
of doing so.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
independent auditors have issued an audit opinion for our company, which includes a statement describing our going concern status.
Our financial status creates a doubt whether we will continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
auditors have issued a going concern opinion regarding our company. This means there is substantial doubt we can continue as an
ongoing business for the next twelve months. The financial statements do not include any adjustments that might result from the
uncertainty regarding our ability to continue in business. As such we may have to cease operations and investors could lose part
or all of their investment in our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
internal computer systems, or those of our third-party contractors or consultants, may fail or suffer security breaches, which
could result in a material disruption of our product development programs. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the implementation of security measures, our internal computer systems and those of our third-party contractors and consultants
are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and
electrical failures. While we do not believe that we have experienced any such system failure, accident, or security breach to
date, if such an event were to occur and cause interruptions in our operations, it could result in a loss of clinical trial data
for our new drug candidates which could result in delays in our regulatory approval efforts and significantly increase our costs
to recover or reproduce the data. To the extent that any disruption or security breach results in a loss of or damage to our data
or applications or other data or applications relating to our technology or new drug candidates, or inappropriate disclosure of
confidential or proprietary information, we could incur liabilities and the further development of our product candidates could
be delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
offering is being conducted on a &ldquo;best efforts&rdquo; basis and as a result, we may not be able to raise enough funds to
fully implement our business plan and our investors may lose their entire investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering is on a &ldquo;best efforts&rdquo; basis and requires a Minimum Amount of $10,000,000 to be raised. We need to reserve
20% of the funds raised in this offering in escrow for the distribution of dividend to holders of Series A Convertible Preferred
Stock. If we only raise the Minimum Amount, we will only receive $7,300,000 in proceeds before expenses and we may not be able
to fund our operations for a period of time as desired, and our growth opportunities may be materially adversely affected. This
could increase the likelihood that an investor may lose its, his or her entire investment.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investors&rsquo;
funds will be placed in escrow during the offering period and investors will not have use of their funds during the offering period.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter is offering the Series A Convertible Preferred Stock on a best efforts basis. No commitment by anyone exists to purchase
all or any part of the shares offered hereby. Those investor&rsquo;s funds deposited will be held in escrow pending closing of
this offering and such funds may be escrowed for as long as one hundred and eighty (180) days. Investors will not have use of
any funds deposited for the shares during the offering period. See &ldquo;Underwriting.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no public market for the Series A Convertible Preferred Stock and prospective investors may not be able to resell their shares
at or above the offering price, if at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no market for our Series A Convertible Preferred Stock and no assurance can be given that an active trading market will develop
for the Series A Convertible Preferred Stock or, if one does develop, that it will be maintained. In the absence of a public trading
market, an investor may be unable to liquidate his investment in our company. The Public Offering Price of this offering is not
indicative of future market prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock market in general may experience extreme price and volume fluctuations. Continued market fluctuations could result in extreme
volatility in the price of the Common Stock, which could cause a decline in the value of the Common Stock and the Series A Convertible
Preferred Stock. Prospective investors should also be aware that price volatility may be worse if the trading volume of the Common
Stock or Series A Convertible Preferred Stock is low.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to list both our Common Stock and Series A Convertible Preferred Stock on Nasdaq. We cannot assure you that either of our
application to list the Common Stock or Series A Convertible Preferred Stock will be approved; however, we will not complete this
offering without a listing approval letter of our Series A Convertible Preferred Stock and Comon Stock from Nasdaq. The liquidity
of the trading market, if any, and future trading prices of the Series A Convertible Preferred Stock will depend on many factors,
including, among other things, the market price of our Common Stock, prevailing interest rates, our operating results, financial
performance and prospects, the market for similar securities and the overall securities market, and may be adversely affected
by unfavorable changes in these factors. It is possible that the market for the Series A Convertible Preferred Stock will be subject
to disruptions which may have a negative effect on the holders of the Series A Convertible Preferred Stock, regardless of our
operating results, financial performance or prospects.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
share price of our Common Stock is volatile, the trading price of our Series A Convertible Preferred Stock could be volatile,
and both may be influenced by numerous factors, some of which are beyond our control. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently only a limited public market for our Common Stock, which is listed on the OTCQB Market, and there can be no assurance
that a trading market will develop further or be maintained for either our Common Stock or Series A Convertible Preferred Stock
in the future. The trading price of our Common Stock is likely to be highly volatile, and could be subject to wide fluctuations
in response to various factors, some of which are beyond our control. In addition to the factors discussed in this &ldquo;Risk
Factors&rdquo; section and elsewhere in this prospectus, these factors include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    new drug candidates we acquire for commercialization;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    product candidates we seek to pursue, and our ability to obtain rights to develop those product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical trial;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated adverse results or delays in our pre-clinical studies and clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    failure to get any of our new drug candidates approved;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    serious safety and environmental concerns related to the use and research activities of any of our new drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overall
    performance of the equity markets and other factors that may be unrelated to our operating performance or the operating performance
    of our competitors, including changes in market valuations of similar companies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
    or trends in the healthcare, biotechnology and pharmaceutical industries;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
    of new products offered by us or our competitors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us or our competitors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain an adequate rate of growth and manage such growth;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuances
    of debt or equity securities by us;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our securities by us or our stockholders in the future, or the perception that such sales could occur;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
    volume of our Common Stock or Series A Convertible Preferred Stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ineffectiveness
    of our internal control over financial reporting or disclosure controls and procedures;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    political and economic conditions in U.S. and other countries and territories where we conduct our business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">effects
    of natural or man-made catastrophic events; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    regulatory decisions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key scientific or management personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in laws or regulations applicable to our product candidates, including without limitation clinical trial requirements for
    approvals;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
    or other developments relating to patents and other proprietary rights and our ability to obtain protection for our products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on third parties, including CROs and scientific and medical advisors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to meet or exceed any financial guidance or expectations regarding development milestones that we may provide to the public;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated variations in quarterly operating results;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to meet or exceed the estimates and projections of the investment community;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    events or factors, many of which are beyond our control.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market in general, and the stocks of small-cap healthcare, biotechnology and pharmaceutical companies in particular,
have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance
of these companies. Broad market and industry factors may negatively affect the market price of our Common Stock, regardless of
our actual operating performance. The realization of any of the above risks or any of a broad range of other risks, including
those described in these &ldquo;Risk Factors,&rdquo; could have a dramatic and material adverse impact on the market price of
our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
automatic conversion feature may not adequately compensate holders of Series A Convertible Preferred Stock and may make it more
difficult for a party to take over our company or discourage a party from taking over our company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the four-year anniversary of issuance, each share of Series A Convertible Preferred Stock automatically converts into one share
of Common Stock. See &ldquo;Description of Securities.&rdquo; If the Common Stock price is less than the price paid for each share
of Series A Convertible Preferred Stock, the value of the Series A Convertible Preferred Stock will be less than the price paid
for the Series A Convertible Preferred Stock excluding the dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to pay dividends is limited by the requirements of Nevada law.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to pay dividends on the Series A Convertible Preferred Stock is limited by the laws of Nevada. Under applicable Nevada
law, we, as a Nevada corporation, generally may not make a distribution if i) we would not be able to pay our debts as they become
due in the usual course of business, or ii) our total assets would be less than the sum of our total liabilities plus the amount
that would be needed, if we were to be dissolved at the time of distribution, to satisfy the preferential rights upon dissolution
of stockholders whose preferential rights are superior to those receiving the distribution. Although we will have Dividend Reserve
in escrow upon closing of this offering, we cannot guarantee that we can distribute such dividend when due under the laws of Nevada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends
on the Series A Convertible Preferred Stock will be taxable.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
from &ldquo;qualified dividends&rdquo; payable to U.S. stockholders that are individuals, trusts and estates are generally subject
to tax at preferential rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our
stock price and any trading volume could decline. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
trading market for our Common Stock and Series A Convertible Prferred Stock that may develop will depend in part on the research
and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently,
and may never, publish research on us or our business. If no securities or industry analysts commence coverage of our company,
the trading prices for our Common Stock and/ or Series A Convertible Preferred Stock could be negatively affected. If securities
or industry analysts initiate coverage, and one or more of those analysts downgrade our stock or publish inaccurate or unfavorable
research about our business, our stock price would likely decline. If one or more of these analysts cease coverage of our company
or fail to publish reports on us regularly, demand for our Common Stock and/ or Series A Convertible Preferred Stock could decrease,
which might cause our stock price and any trading volume to decline.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
sales and issuances of our Common Stock or rights to purchase Common Stock, including pursuant to our equity incentive plan or
otherwise, could result in dilution of the percentage ownership of our stockholders and could cause our stock price to fall. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will need significant additional capital in the future to continue our planned operations. To raise capital, we
may sell Common Stock, convertible securities or other equity securities in one or more transactions at prices and in a manner
we determine from time to time. If we sell Common Stock, convertible securities or other equity securities in more than one transaction,
including issuance of equity securities pursuant to any future stock incentive plan to our officers, directors, employees and
non-employee consultants for their services to us, investors in a prior transaction may be materially diluted by subsequent sales.
Additionally, any such sales may result in material dilution to our existing stockholders, and new investors could gain rights,
preferences and privileges senior to those of holders of our Common Stock. Further, any future sales of our Common Stock by us
or resales of our Common Stock by our existing stockholders could cause the market price of our Common Stock to decline. Any future
grants of options, warrants or other securities exercisable or convertible into our Common Stock, or the exercise or conversion
of such shares, and any sales of such shares in the market, could have an adverse effect on the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
elimination of personal liability against our directors and officers under Nevada law and the existence of indemnification rights
held by our directors, officers and employees may result in substantial expenses. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
Bylaws eliminate the personal liability of our directors and officers to us and our stockholders for damages for breach of fiduciary
duty as a director or officer to the extent permissible under Nevada law. Further, our Bylaws provide that we are obligated to
indemnify each of our directors or officers to the fullest extent authorized by Nevada law and, subject to certain conditions,
advance the expenses incurred by any director or officer in defending any action, suit or proceeding prior to its final disposition.
Those indemnification obligations could expose us to substantial expenditures to cover the cost of settlement or damage awards
against our directors or officers, which we may be unable to afford. Further, those provisions and resulting costs may discourage
us or our stockholders from bringing a lawsuit against any of our current or former directors or officers for breaches of their
fiduciary duties, even if such actions might otherwise benefit our stockholders.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Common Stock may be subject to the &ldquo;penny stock&rdquo; rules of the Securities and Exchange Commission, which may make it
more difficult for stockholders to sell our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted Rule 15g-9 which establishes the definition of a &ldquo;penny stock,&rdquo; for the purposes relevant to us, as
any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. For any transaction involving
a penny stock, unless exempt, the rules require that a broker or dealer approve a person&rsquo;s account for transactions in penny
stocks, and the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity
and quantity of the penny stock to be purchased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to approve a person&rsquo;s account for transactions in penny stocks, the broker or dealer must obtain financial information
and investment experience objectives of the person, and make a reasonable determination that the transactions in penny stocks
are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating
the risks of transactions in penny stocks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form sets forth the basis on which the broker or dealer made the suitability determination,
and that the broker or dealer received a signed, written agreement from the investor prior to the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
brokers may be less willing to execute transactions in securities subject to the &ldquo;penny stock&rdquo; rules. This may make
it more difficult for investors to dispose of the Company&rsquo;s Common Stock if and when such shares are eligible for sale and
may cause a decline in the market value of its stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the
rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to
be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements that involve risks and uncertainties, including statements based on our current
expectations, assumptions, estimates and projections about us, our industry and the regulatory environment in which we and companies
integral to our ecosystem operate. The forward-looking statements are contained principally in the sections entitled &ldquo;Prospectus
Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Use of Proceeds,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis of
Financial Condition and Results of Operations&rdquo; and &ldquo;Business.&rdquo; These statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from
those expressed or implied by the forward-looking statements. In some cases, these forward-looking statements can be identified
by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;is/are likely to&rdquo; or other similar expressions. The forward-looking statements included in this prospectus relate
to, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    and uncertainties associated with our research and development activities, including our clinical trials and preclinical studies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing or likelihood of regulatory filings and approvals or of alternative regulatory pathways for our drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential market opportunities for commercializing our drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expectations regarding the potential market size and the size of the patient populations for our drug candidates, if approved
    for commercial use, and our ability to serve such markets;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimates
    of our expenses, future revenue, capital requirements and our needs for additional financing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to develop, acquire and advance our product candidates into, and successfully complete, clinical trials and preclinical
    studies and obtain regulatory approvals;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    implementation of our business model and strategic plans for our business and drug candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    initiation, cost, timing, progress and results of future preclinical studies and clinical trials, and our research and development
    programs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of future licensing arrangements, and whether we can enter into such arrangements at all;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">timing
    and receipt or payments of licensing and milestone revenues, if any;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    scope of protection we are able to establish and maintain for intellectual property rights covering our drug candidates and
    our ability to operate our business without infringing the intellectual property rights of others;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    developments in the United States and foreign countries;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    performance of our third party suppliers and manufacturers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain and establish collaborations or obtain additional funding;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    success of competing therapies that are currently or may become available;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue as a going concern;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    financial performance; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    and projections relating to our competitors and our industry.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made
in this prospectus or in the documents incorporated by reference in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have based the forward-looking statements contained in this prospectus and in the documents incorporated by reference in this
prospectus primarily on our current expectations and projections about future events and trends that we believe may affect our
business, financial condition, results of operations and prospects. The outcomes of the events described in these forward-looking
statements are subject to risks, uncertainties and other factors that could cause actual results and experience to differ from
those projected, including, but not limited to, the risk factors described herein and the risk factors set forth in Part I - Item
1A, &ldquo;Risk Factors&rdquo;, in our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019006364/f10k2018_americanbrivision.htm">Form
10-K</A> for the year ended December 31, 2018, as filed with the SEC on April 15, 2019, and elsewhere in the documents incorporated
by reference into this prospectus. Moreover, we operate in a very competitive and challenging environment. New risks and uncertainties
emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the
forward-looking statements contained in this prospectus and in the documents incorporated by reference in this prospectus. We
cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur,
and actual results, events or circumstances could differ materially from those described in the forward-looking statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements contained in this prospectus and in the documents incorporated by reference in this prospectus relate
only to events as of the date on which the statements are made. We do not undertake any obligation to release publicly any revisions
to such forward-looking statements to reflect events or circumstances after the date of this prospectus or to reflect the occurrence
of unanticipated events. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements
and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential
impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will receive net proceeds from this offering of approximately $9.3 million at minimum, $18.6 million at maximum,
and $21.39 million at the increased maximum from the sale of Series A Preferred Stock, after deducting underwriting commissions
and the estimated offering expenses payable by us. We will reserve $2 million at minimum, $4 million at maximum and $4,600,000
at the increased maximum in escrow for the distribution of dividends to the holders of Series A Preferred Stock. After deducting
the Dividend Reserve and underwriting discounts and commission, we estimate that we will receive proceeds from this offering of
approximately $7.3 million at minimum, $14.6 million at maximum and $16.79 million at the increased maximum. These estimates are
based upon an assumed public offering price of US$7.00 per share, the price shown on the front cover page of this prospectus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$1.00 increase (decrease) in the assumed public offering price of $7.00 per share would increase (decrease) the net proceeds to
us from this offering by approximately $1.4&nbsp;million at minimum, $2.9 million at maximum and $3.3 million at the increased
maximum, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and
after deducting the estimated underwriting commissions and offering expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to use the net proceeds of this offering for the business development purposes, which may include but not limited to research
and development (&ldquo;R&amp;D&rdquo;) activities for our six drug candidates and one medical device candidate, marketing, repayment
of certain loans, and general working capital. The loans that we intend to repay from the net proceeds of the offering are the
credit line (the &ldquo;Cathay Bank Credit Line&rdquo;) owed by us to Cathay Bank and three convertible notes (the &ldquo;Convertible
Notes&rdquo;) purchased by three investors in the aggregate amount of $800,000. As of the date of this prospectus, we drew $1,000,000
under the Cathay Bank Credit Line and expect to use the full credit line of $1,000,000 before the closing of this offering. The
Cathay Bank Credit Line provides for a revolving line of credit in the principal amount of $1,000,000 with a maturity date (the
&ldquo;Maturity Date&rdquo;) of January 1, 2020 and bears an interest rate equal to the sum of one percent (1%) and the prime
rate as published in the Wall Street Journal (the &ldquo;Index&rdquo;) and the accrued interest are payable each month from February
1, 2019. The Cathay Bank Credit Line is fully disclosed in a current report on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119_americanbrivision.htm">Form 8-K</A> filed with the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) on February 1, 2019. As of the date of this prospectus, the Company issued three Convertible
Notes that bear an interest rate of 8% per annum for a period of 18 months and may be converted into our Common Stock at the option
of the holder at a conversion price equal to the lower of i) $2.00 per share subject to adjustment and ii) 80% of the offering
price of any completed equity offering of the Company in an amount exceeding $500,000. One of the holders of the Convertible Note
is Keypoint Inc., an entity under control of the Company&rsquo;s controlling shareholders. As of the date of this prospectus,
the principal amount outstanding under Keypoint Inc.&rsquo;s Convertible Note was $250,000. The <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009746/xslFormDX01/primary_doc.xml">Form D</A> related to the offering
of the Convertible Notes was filed with the SEC on July 27, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart provides the approximate distribution of proceeds from this offering in the event that we are able to raise $10
million, $15 million, $20 million and $23 million.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Use&nbsp;of&nbsp;Proceeds</FONT> </TD><TD STYLE="width: 1%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Capital&nbsp;Raised</FONT> </TD><TD STYLE="width: 1%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="width: 6%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">10,000,000</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="width: 6%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">15,000,000</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="width: 6%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">20,000,000</FONT> </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-weight: normal; font-style: normal">$</FONT> </TD>
    <TD STYLE="width: 6%; text-align: right"> <FONT STYLE="font-weight: normal; font-style: normal">23,000,000</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Dividend
    Reserve</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"></TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2,000,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">3,000,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">4,000,000</FONT> </TD>
    <TD> <FONT STYLE="font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-weight: normal; font-style: normal">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-weight: normal; font-style: normal">4,600,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Net
    proceeds after deduction of underwriting discounts and Dividend Reserve</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"></TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">7,300,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">10,950,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">14,600,000</FONT> </TD>
    <TD> <FONT STYLE="font-weight: normal; font-style: normal">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-weight: normal; font-style: normal">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-weight: normal; font-style: normal">18,400,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">R&amp;D expenses</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated cost</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000
                                         (for six months) </FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,530,000
                                         </FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(for twelve
                                         months) </FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4,065,000&nbsp;&nbsp;(for
                                         eighteen months)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> $ </TD>
    <TD STYLE="text-align: right"> 8,146,000 </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">ABV-1701 Vitargus pilot production
    line</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated cost</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,000,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,000,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,000,000</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> $ </TD>
    <TD STYLE="text-align: right"> 2,000,000 </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Loan repayment</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated cost</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,800,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,800,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,800,000</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> $ </TD>
    <TD STYLE="text-align: right"> 1,800,000 </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Marketing and management expenses</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated cost</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
                                         600,000 (for six months) </FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,100,000&nbsp;</FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif">(for twelve months)</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,600,000
                                         (for eighteen months) </FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> $ </TD>
    <TD STYLE="text-align: right"> 3,600,000 </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">General working capital</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Estimated cost</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,619,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,239,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,854,000</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> $ </TD>
    <TD STYLE="text-align: right"> 2,854,000 </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Estimated
    Total Cost</B></FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7,019,000</B></FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9,669,000</B></FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14,319,000</B></FONT> </TD>
    <TD> <B>&nbsp;</B> </TD>
    <TD> <B>$</B> </TD>
    <TD STYLE="text-align: right"> <B>18,400,000</B> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts and timing of our use of the net proceeds from this offering will depend on a number of factors, such as the timing and
progress of our research and development efforts, regulatory compliance, the progress of our clinical trials, our licensing development,
the progress of any our collaborative or strategic partners, the credit environment in Taiwan and the competitive environment
for our new drug candidates. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for
the net proceeds to us from this offering. Accordingly, our management will have broad discretion in the timing and application
of these proceeds. Pending application of the net proceeds as described above, we intend to temporarily invest the proceeds in
short-term, interest-bearing instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="a_010"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid our holders of Common Stock any cash dividends, and currently intend to retain future earnings, if any, to finance
the expansion of its business. As a result, we do not anticipate paying any cash dividends on our Common Stock in the foreseeable
future as we intend to retain any earnings for use in our business. Any future determination to pay dividends to the holders of
our Common Stock will be at the discretion of our Board of Directors.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay cumulative dividends from the Dividend Reserve on the Series A Convertible Preferred Stock at each anniversary from the
date of original issue for a period of four calendar years. We will distribute five percent (5%) of the Dividend Reserve in cash
at each anniversary of this offering for four years to each holder of Series A Convertible Preferred Stock. The distribution of
dividends on our Series A Convertible Preferred Stock is subject to the laws of Nevada. Section 78.288 of the Revised Nevada Statute
provides that no distribution may be made if, after giving it effect, i) a company would not be able to pay its debts as they
become due in the usual course of business or ii) the company&rsquo;s total assets would be less than the sum of its total liabilities
plus the amount that would be needed, if the company were to be dissolved at the time of distribution, to satisfy the preferential
rights upon dissolution of stockholders whose preferential rights are superior to those receiving the distribution. As a result
of such, our distribution of dividend to Series A Convertible Preferred Stock is subject to the limitations set forth in Section
78.288 of the Revised Nevada Statute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our cash and cash equivalents and capitalization as of March 31, 2019. Such information is set forth
on the following basis:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma basis; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis to reflect the sale by us of 1,428,571 shares at minimum, 2,857,143 shares at maximum, and 3,285,714
    shares at the increased maximum of Series A Convertible Preferred Stock in this offering at a public offering price of $7.00
    per share, after deducting underwriting commissions and estimated offering expenses.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consider this table in conjunction with &ldquo;Description of Securities&rdquo; on page 107 and our financial statements
and the notes to those financial statements included elsewhere in this prospectus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
of March 31, 2019</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro&nbsp;Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Pro&nbsp;Forma </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>Increased</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As&nbsp;Adjusted </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Increased
</B></FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Actual </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Minimum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Maximum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> Maximum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Minimum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Maximum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 26.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 981,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,981,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,981,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 23,981,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,281,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,581,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,771,341 </TD><TD STYLE="width: 0.5%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; equity: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Share capital: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Share of Series A Convertible
    Preferred Stock, $.0001 par value per share, 20,000,000 shares authorized, 0 shares issued and outstanding, actual; share
    of Series A Convertible Preferred Stock issued and outstanding, $.0001 par value per share, 20,000,000 shares authorized,
    1,428,571 shares at minimum, 2,857,143 shares at maximum, and 3,285,714 at the increased maximum issued and outstanding, pro
    forma; share of Series A Convertible Preferred Stock, $.0001 par value per share, 20,000,000 shares authorized, 1,428,571
    shares at minimum, 2,857,143 shares at maximum, and 3,285,714 shares at the issued and outstanding, pro forma as adjusted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,389 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,778 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,286 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,389 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,778 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,286 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Share of Common Stock, $.001 par value per share,
    20,000,000 shares authorized, 17,693,625 shares issued and outstanding, actual; share of Common Stock, $.001 par value per
    share, 20,000,000 shares authorized, 17,693,625 shares issued and outstanding, pro forma; share of Common Stock, $.001 par
    value per share, 20,000 shares authorized, 17,693,625 shares issued and outstanding, pro forma as adjusted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Additional paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,680,674 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 25,679,285 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 35,677,896 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 38,677,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,979,285 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 30,277,896 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 32,467,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accumulated deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,177 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Other comprehensive income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Treasury stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Noncontrolling interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Total shareholders&rsquo; equity(deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,526,346 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,473,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,473,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,473,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,773,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,073,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,263,654 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Total capitalization </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,450,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,450,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,450,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 30,450,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,750,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,050,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 24,240,191 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_012"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our Series A Convertible Preferred Stock, your interest will be diluted to the extent of the difference between
the public offering price per share of our Series A Convertible Preferred Stock and the pro forma as adjusted net tangible book
value per share of our Series A Convertible Preferred Stock immediately after this offering. The pro forma net tangible book value
of our Common Stock as of March 31, 2019 was $&nbsp;(5.53) million, or $&nbsp;(0.31) per share. Pro forma net tangible book value
per share represents our total tangible assets less our total liabilities, divided by the number of shares of outstanding Common
Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> After giving effect to the receipt
of the net proceeds from our sale of 1,428,571 shares at minimum, 2,857,143 shares at maximum, and 3,285,714 at the increased
maximum of Series A Convertible Preferred Stock in this offering at an assumed public offering price of $ 7.00&nbsp;per share,
as set forth on the cover page of this prospectus, after deducting underwriting discounts, Dividend Reserve and estimated offering
expenses payable by us, our pro forma as adjusted net tangible book value as of March 31,2019 would have been $1.77&nbsp;million
at minimum, $9.07 million at maximum, or $11.26 million at the increased maximum, or $0.10&nbsp;per share at minimum, $0.51 per
share at maximum, or $0.64 per share at the increased maximum. This represents an immediate increase in pro forma as adjusted
net tangible book value of $0.41&nbsp;per share at minimum, $0.82 per share at maximum, or $0.95 per share at the increased maximum
to existing stockholders and an immediate dilution of $0.01 per share at minimum, $0.07 per share at maximum, or $0.10 per share
at the increased maximum to new investors purchasing Series A Convertible Preferred Stock at a conversion ratio of 1:1 in this
offering. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates this dilution on a per share basis to new investors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Per
    Share </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>Increased</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Minimum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Maximum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> Maximum </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font: 10pt Times New Roman, Times, Serif"> Assumed public offering price per share </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7.00 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Net tangible book value per share as of March 31, 2019 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.31 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.31 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.31 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Pro forma net tangible book value per share of Common Stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.25 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.82 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.99 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Pro forma net tangible book value per share, after
    giving effect to this offering </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.23 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.71 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.83 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Amount of
    dilution in pro forma net tangible book value per share of Series A Convertible Preferred Stock to new investors in this Offering </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.09 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.44 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.54 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> A $1.00 increase (decrease) in the
assumed public offering price of $7.00&nbsp;per share of Series A Convertible Preferred Stock, which is set forth on the cover
page of this prospectus, would increase (decrease) the pro forma net tangible book value, as adjusted to give effect to this offering,
by $0.06 (0.06)&nbsp;per share at minimum, $0.12 (0.12)&nbsp;per share at maximum, and or $0.14 (0.14) per share at the increased
maximum and the dilution to new investors by $0.05 (0.05)&nbsp;per share at minimum, $0.10 (0.10)&nbsp;per share at maximum, and
or $0.11 (0.11) per share at the increased maximum, assuming the number of shares offered by us, as set forth on the cover page
of this prospectus, remains the same, and after deducting underwriting commissions and estimated expenses payable by us. Similarly,
each increase (decrease) of one million shares in the number of shares of Series A Convertible Preferred Stock offered by us would
increase (decrease) the pro forma net tangible book value, as adjusted to give effect to this offering, by $0.35 (0.38)&nbsp;per
share at minimum, $0.30 (0.34)&nbsp;per share at maximum, and or $0.28 (0.29) per share at the increased maximum, and the dilution
to new investors by $0.26 (0.28)&nbsp;per share at minimum, $0.23 (0.24)&nbsp;per share at maximum and or $0.21 (0.23) per share
at the increased maximum, assuming the assumed public offering price remains the same and after deducting underwriting discounts
and commissions and estimated expenses payable by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_013"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS&nbsp;OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion and analysis should be read together with our financial statements and the related notes appearing elsewhere
in this prospectus. This discussion contains forward-looking statements reflecting our current expectations that involve risks
and uncertainties. See &ldquo;Cautionary Note Regarding Forward-Looking Statements and Industry Data&rdquo; for a discussion of
the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ
materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under
&ldquo;Risk Factors&rdquo; and elsewhere in this prospectus.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical stage biopharmaceutical company focused on development of new drugs and medical devices in the fields of oncology,
ophthalmology and central nervous system. We operate our business through our wholly owned subsidiaries, American BriVision Corporation
(&ldquo;BriVision&rdquo;), a Delaware corporation, with a focus on medical device development, BioLite Holding Inc. (&ldquo;BioLite&rdquo;),
a Nevada corporation, with the key business of new drug development, and BioKey Inc. (BioKey&rdquo;), a California corporation,
a contract service organization.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently concentrates on clinical research and development of six new drug candidates and one Class III medical device,
which collectively constitute its primary business operations and research projects. BriVision was incorporated in 2015 in the
State of Delaware. It currently focuses on the development of ABV-1701 Vitreous Substitute for Vitrectomy.&nbsp;BioLite was formed
in July 2016 under the laws of Nevada. Through BioLite, we conduct clinical research and trials of six new drug candidates which
were licensed from BioLite, Inc. (&ldquo;BioLite Taiwan&rdquo;), a company formed in Taiwan that is a subsidiary of BioLite. The
six new drug candidates under our development are named as follows: ABV-1504 for the treatment of Major Depressive Disorder, ABV-1505
to treat Attention-Deficit Hyperactivity Disease, ABV-1501 for the treatment of Triple Negative Breast Cancer, ABV-1703 for the
treatment of Pancreatic Cancer, ABV-1702 to treat Myelodysplastic syndromes and ABV-1601 Depression in Cancer Patients. BioKey
was formed under the laws of California in November 2000. It is engaged primarily in research and development, manufacturing,
and distribution of generic drugs and nutraceuticals with strategic partners. BioKey provides a wide range of services, including,
API characterization, pre-formulation studies, formulation development, analytical method development, stability studies, IND/NDA/ANDA/510K
submissions, and manufacturing clinical trial materials (phase I through phase III) and commercial manufacturing. It also licenses
out its technologies and initiates joint research and development processes to other biotechnology, pharmaceutical, and nutraceutical
companies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a clinical stage biopharmaceutical company, we utilize our licensed technology to (i) further the development of pharmaceutical
products with focuses on oncology, ophthalmology and central nervous system indications, (ii) target patients that may potentially
respond to such pharmaceutical products and (iii) obtain regulatory approvals for and commercialize such pharmaceutical products
in various markets. The business model of the Company includes the following steps and stages: 1) engaging medical research institutions,
such as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) and MD Anderson Cancer Center, to coordinate clinical trials
of translational medicine for Proof of Concept (&ldquo;POC&rdquo;) on behalf of the Company; 2) retaining ownership of the research
results developed by the Company, and 3) out-licensing the research results and data to pharmaceutical companies who will further
develop and commercialize the products.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
its inception, the Company has not generated substantial revenue from its medical device and new drug development. For the three
months ended March 31, 2019, the Company generated $212,242 in revenue, mainly from its CDMO business unit.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing
of the Mergers</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2018, the Company, BioLite, BioKey, BioLite Acquisition Corp., a Nevada company and direct wholly-owned subsidiary
of Parent (&ldquo;Merger Sub 1&rdquo;), and BioKey Acquisition Corp., a California company and direct wholly-owned subsidiary
of Parent (&ldquo;Merger Sub 2&rdquo;) entered into a definitive Agreement and Plan of Merger, providing for the acquisition of
BioLite and BioKey by ABVC, which we refer to as the &ldquo;Merger Agreement.&rdquo;&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019 (the &ldquo;Closing Date&rdquo;), the Company closed the transactions contemplated under the Merger Agreement
(the &ldquo;Closing&rdquo;), pursuant to which BioLite merged with Merger Sub 1 with BioLite as the surviving corporation, which
we refer to as the &ldquo;BioLite Merger,&rdquo; and BioKey merged with Merger Sub 2 with BioKey as the surviving corporation,
which is referred as the &ldquo;BioKey Merger.&rdquo; On the Closing Date, BioLite filed the Article of Merger of the BioLite
Merger with the State of Nevada, pursuant to which BioLite became a wholly-owned subsidiary of the Company. On the same day, BioKey
filed the Agreement of Merger of the BioKey Merger with the State of California, pursuant to which BioKey became a wholly-owned
subsidiary of the Company. In addition, in accordance with the terms of the Merger Agreement and as consideration for the acquisition
of BioLite and BioKey, the Company issued 1.82 shares of its Common Stock, par value $0.001 per share, for each share of BioLite&rsquo;s
common stock to each BioLite shareholder and one share of ABVC&rsquo;s Common Stock for each share of BioKey&rsquo;s capital stock
to each BioKey equity holder. The Company issued an aggregate of approximately 104,558,777 shares of Common Stock to both BioLite
shareholders and BioKey shareholders under a registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009520/fs42018_americanbrivision.htm">Form S-4</A> (File Number 333-226285), which became effective
by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Closing, the Company operates as a single entity with three relatively separate but integrated special business units (&ldquo;SBU&rdquo;s),
which are 1) the New Drug Development SBU, including the new drug pipeline products from BioLite and the patented controlled release
drug delivery technology from BioKey, 2) the Innovative Medical Devices SBU, currently focusing on the development of Vitargus,
a new invention of a biocompatible vitreous substitute for the treatment of retinal detachment and vitreous hemorrhage, and 3)
the CDMO SBU, providing contract services for pharmaceutical companies in the U. S. and as abroad to develop and manufacture new
drug products in BioKey&rsquo;s good manufacturing practice (&ldquo;GMP&rdquo;) facility and prepare studies to obtain ANDAs to
launch certain new pharmaceutical products in the U.S.&nbsp;While each of these SBUs is operated independently of one another,
they report to the same management team and supervised by the board of directors (the &ldquo;Board&rdquo;) of the Company and
share common resources and functions, including, but not limited to, administration, accounting, human resources, research and
development, business development, legal, manufacturing facilities, and office and laboratory spaces. The Board has representatives
from each board of directors of BioLite, BioKey and ABVC. The Board consists of the following members: Eugene Jiang, Dr. Tsang
Ming Jiang, Dr. Ming-Fong Wu, Norimi Sakamoto, Yen-Hsin Chou, Dr. Tsung-Shann (T.S.) Jiang, Dr. Chang-Jen Jiang, Dr. Shin-Yu Miao,
Yoshinobu Odaira, Shih-Chen Tzeng, and Dr. Hwalin Lee.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock Reverse Split&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 12, 2019, the Board by unanimous written consent in lieu of a meeting approved to i) effect a stock reverse split at the
ratio of 1-for-18 (the &ldquo;Reverse Split&rdquo;) of both the authorized Common Stock of the Company and the issued and outstanding
Common Stock and ii) to amend the articles of incorporation of the Company to reflect the Reverse Split. The Board approved and
authorized the Reverse Split without obtaining approval of the Company&rsquo;s shareholders pursuant to Section 78.207 of Nevada
Revised Statutes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 3, 2019, the Company filed a certificate of amendment to the Company&rsquo;s articles of incorporation (the &ldquo;Amendment&rdquo;)
to effect the Reverse Split with the Secretary of State of the State of Nevada. The Reverse Split took effect on May 8, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
Agreements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
agreements with BHK</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On February 24, 2015, BioLite Taiwan and BioHopeKing Corporation (&ldquo;BHK&rdquo;) entered into a co-development agreement (the
&ldquo;BHK Co-Development Agreement&rdquo;) pursuant to which BioLite Taiwan, a subsidiary of the Company, is collaborating with
BHK to research, develop and commercialize BLI-1401-2 (Botanical Drug) Triple Negative Breast Cancer (TNBC) Combination Therapy
(BLI-1401-2 Products) in Asian countries excluding Japan. The development costs shall be shared 50/50 between BHK and BioLite
Taiwan. The BHK Co-Development Agreement will remain in effect for fifteen years from the date of first commercial sale of the
Product in in Asia excluding Japan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2016, BioLite Taiwan and BHK agreed to amend the payment terms of the milestone payment in an aggregate amount of $10
million based on the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the signing of the BHK Co-Development Agreement: $1 million, or 10% of total payment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the first Investigational New Drug (IND) submission and BioLite Taiwan delivering all data to BHK according to FDA requirement:
$1 million, or 10% of total payment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the completion of first phase II clinical trial: $1 million, or 10% of total payment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the initiation of phase III of clinical trial research: $3 million, or 30% of total payment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the New Drug Application (NDA) submission: $4 million, or 40% of total payment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2015, BHK paid a non-refundable upfront cash payment of $1 million, or 10% of $10,000,000, pursuant to the BHK Co-Development
Agreement. The Company concluded that the deliverables are considered separate units of accounting as the delivered items have
value to the customer on a standalone basis and recognized this cash receipt as collaboration revenue when all research, technical,
and development data was delivered to BHK in 2015. The receipt is for the compensation of past research efforts and contributions
made by BioLite Taiwan before this collaborative agreement was signed and it does not relate to any future commitments made by
BioLite Taiwan and BHK in this collaborative agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2016, the Company received the second milestone payment of NT$31,649,000, approximately equivalent to $1 million, and recognized
collaboration revenue for the year ended December 31, 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this propsectus, the Company has not completed the first phase II clinical trial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the milestone payments, BioLite Taiwan is entitled to receive royalties on 12% of BHK&rsquo;s net sales related to
BLI-1401-2 Products. As of March 31, 2019 and December 31, 2018, the Company had not earned any royalties under the BHK Co-Development
Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
On December 9, 2015, BioLite Taiwan entered into another two collaborative agreements (the &ldquo;BHK Collaborative Agreements&rdquo;),
pursuant to which BioLite Taiwan is collaborating with BHK to co-develop and commercialize BLI-1005 for &ldquo;Targeting Major
Depressive Disorder&rdquo; (BLI-1005 Products) and BLI-1006 for &ldquo;Targeting Inflammatory Bowel Disease&rdquo; (BLI-1006 Products)
in Asia excluding Japan. The development costs shall be shared 50/50 between BHK and BioLite Taiwan. The BHK Collaborative Agreements
will remain in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan. On May
18, 2018, BioLite Taiwan and BHK amended the BHK Collaborative Agreements to replace the drug candidate from BLI-1006 to BLI-1008
for ADHD.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, BioLite Taiwan recognized a cash receipt in a total of NT$50 million, approximately equivalent to $1.6 million, as collaboration
revenue when all research, technical, and development data was delivered to BHK. BioLite Taiwan concluded that the deliverables
were considered separate units of accounting as the delivered items had value to the customer on a standalone basis and recognized
this payment as collaboration revenue when all research, technical, data and development data was delivered to BHK. The cash receipt
was for the compensation of past research efforts and contributions made by BioLite Taiwan before the BHK Collaborative Agreements
were signed and it does not relate to any future commitments made by BioLite Taiwan and BHK in the BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of
the future net licensing income or net sales profit. As of March 31, 2019 and 2018, the Company had not earned any royalties under
the BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Co-Development
agreement with Rgene Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, American BriVision Corporation (&ldquo;BriVision&rdquo;), a wholly-owned subsidiary of the Company, entered into
a co-development agreement (the &ldquo;Co-Dev Agreement&rdquo;) with Rgene Corporation (&ldquo;Rgene&rdquo;), a related party
under control by a controlling beneficiary shareholder of YuanGene Corporation who also controls the Company. Pursuant to the
Co-Dev Agreement, BriVision and Rgene agreed to co-develop and commercialize ABV-1507 HER2/ neu Positive Breast Cancer Combination
Therapy, ABV-1511 Pancreativc Cancer Combination Therapy and ABV-1527 Ovary Cancer Combination Therapy. Under the terms of the
Co-Dev Agreement, Rgene had to pay BriVision $3,000,000 in cash or stock of Rgene with equivalent value by August 15, 2017. The
payment is for the compensation of BriVision&rsquo;s past research efforts and contributions made by BriVision before the Co-Dev
Agreement was signed and it does not relate to any future commitments made by BriVision and Rgene in this Co-Dev Agreement. Besides
of $3,000,000, BriVision is entitled to receive 50% of the future net licensing income or net sales profit earned by Rgene, if
any, and any development cost shall be equally shared by both BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, BriVision delivered all research, technical, data and development data to Rgene. Since both Rgene and BriVision
are related parties and controlled by a controlling beneficiary shareholder of Yuangene Corporation who is also the controlling
beneficiary shareholder of the Company, BriVision has recorded the full amount of $3,000,000 in connection with the Co-Dev Agreement
as additional paid-in capital during the year ended September 30, 2017. During the year ended December 31, 2017, BriVision received
$450,000 in cash. On August 23, 2018, BriVision and Rgene agreed and acknowledged in an Addendum to the Co-Dev Agreement that
the remaining balance of the licensing fee owed to BriVision could be paid in stock of Rgene of the equivalent value of $2,550,000.
On December 24, 2018, BriVision received the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s
common stock, at the price of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares,
which accounted for equity method long-term investment as of December 31, 2018. During the year ended December 31, 2018, BriVision
recognized investment loss of $549. On December 31, 2018, BriVision determined to fully write off this investment based on the
Company&rsquo;s assessment of the severity and duration of the impairment, and qualitative and quantitative analysis of the operating
performance of the investee, adverse changes in market conditions and the regulatory or economic environment, changes in the operating
structure of Rgene, additional funding requirements, and Rgene&rsquo;s ability to remain in business. However, all projects that
have been initiated and scheduled will be continuously managed and supported by BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
agreement with BioFirst Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2017, BriVision entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;) with BioFirst
Corporation (&ldquo;BioFirst&rdquo;), pursuant to which BioFirst granted BriVision the global licensing right for medical use
of the product (the &ldquo;Product&rdquo;): BFC-1401 Vitreous Substitute for Vitrectomy. BioFirst is a related party to the Company
because a controlling beneficiary shareholder of Yuangene Corporation and the Company is one of the directors and Common Stock
shareholders of BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioFirst Collaborative Agreement, BriVision will co-develop and commercialize the Product with BioFirst and pay BioFirst
a total amount of $3,000,000 in cash or stock of BriVision before September 30, 2018. The amount of $3,000,000 was in connection
with the compensation for BioFirst&rsquo;s past research efforts and contributions made by BioFirst before the BioFirst Collaborative
Agreement was signed and it does not relate to any future commitments made by BioFirst and BriVision in this BioFirst Collaborative
Agreement. In addition, BioFirst is entitled to receive 50% of the future net licensing income or net sales profit, if any, and
any development cost shall be equally shared by both BriVision and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2017, BioFirst delivered all research, technical data and development data to BriVision. No payment has been made
by BriVision as of the date of this prospectus. The Company determined to fully expense the entire amount of $3,000,000 since
currently the related licensing rights do not have alternative future uses. According to ASC 730-10-25-1, absent alternative future
uses the acquisition of product rights to be used in research and development activities must be charged to research and development
expenses immediately. Hence, the entire amount of $3,000,000 was fully expensed as research and development expense during the
year ended September 30, 2017 of the Company on a consolidated basis.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Loan
Agreement</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cathay
United Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2016, BioLite Taiwan and Cathay United Bank entered into a one-year bank loan agreement (the &ldquo;Cathay United Loan
Agreement&rdquo;) in an amount of NT$7,500,000, equivalent to $243,000. The term started June 28, 2016 with maturity date at June
28, 2017. The loan balance bears interest at a floating rate of prime rate plus 1.15%. The prime rate is based on term deposit
saving interest rate of Cathay United Bank. On September 6, 2017, BioLite Taiwan extended the Cathay United Loan Agreement for
one year, which was due on September 6, 2018, with the principal amount of NT$7,500,000, equivalent to $243,000. On October 1,
2018, BioLite Taiwan extended the Cathay United Loan Agreement with the same principal amount of NT$7,500,000, equivalent to $243,0050
for one year, which is due on September 6, 2019. As of March 31, 2019 and December 31, 2018, the effective interest rates per
annum were 2.22%. The loan is collateralized by the building and improvement of BioLite Taiwan, and is also personally guaranteed
by the chairman of BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CTBC
Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 12, 2017 and July 19, 2017, BioLite Taiwan and CTBC Bank entered into short-term saving secured bank loan agreements (the
&ldquo;CTBC Loan Agreements&rdquo;) in an amount of NT$10,000,000, equivalent to $324,000, and NT$10,000,000, equivalent to $324,000,
respectively. Both two loans with the same maturity date at January 19, 2018. In February 2018, BioLite Taiwan combined two loans
and extended the loan contract with CTBC for one year. On January 18, 2019, BioLite Taiwan and CTBC Bank agreed to extend the
loan with a new maturity date, which is July 18, 2019. The loan balances bear interest at a fixed rate of 1.63% per annum. The
loan is secured by the money deposited in a savings account with the CTBC Bank. This loan is also personally guaranteed by the
chairman of BioLite Taiwan and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cathay
Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019, the Company received a loan in aggregate of $1,000,000 from Cathay Bank pursuant to a business
loan agreement (the &ldquo;Loan Agreement&rdquo;) entered by and between the Company and Cathay Bank on January 8, 2019 and a
promissory note (the &ldquo;Note&rdquo;) executed by the Company on the same day. The Loan Agreement provides for a revolving
line of credit in the principal amount of $1,000,000 with a maturity date (the &ldquo;Maturity Date&rdquo;) of January&nbsp;1,
2020. The Note executed in connection with the Loan Agreement bears an interest rate (the &ldquo;Regular Interest Rate&rdquo;)
equal to the sum of one percent (1%) and the prime rate as published in the Wall Street Journal (the &ldquo;Index&rdquo;). Pursuant
to the Note, the Company shall pay the entire outstanding principal plus accrued unpaid interest on the Maturity Date and may
prepay portion or all of the Note before the Maturity Date without penalty. If the Company defaults on the Note, the default interest
rate shall become five percent (5%) plus the Regular Interest Rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Note and Loan Agreement, on January 8, 2019, each of Dr. Tsung Shann Jiang and Dr. George Lee executed a commercial
guaranty (the &ldquo;Guaranty&rdquo;) to guaranty the loans for the Company pursuant to the Loan Agreement and Note, severally
and individually, in the amount not exceeding $500,000 each until the principal amount of the Note and accrued interest is fully
paid and satisfied. Dr. Tsung Shann Jiang is a director and the Chief Strategy Officer of the Company, the Chairman and Chief
Executive Officer of BioLite, a subsidiary of the Company. Dr. George Lee serves as the Chairman of the board of directors of
BioKey, another subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on January 8, 2019, each of the Company and BriVision signed a commercial security agreement (the &ldquo;Security Agreement&rdquo;)
to secure the loans under the Loan Agreement and the Note. Pursuant to the Security Agreements, each of the Company and BriVision
(each, a &ldquo;Grantor&rdquo;, and collectively, the &ldquo;Grantors&rdquo;) granted security interest in the collaterals as
defined therein, comprised of almost all of the assets of each Grantor, to secure such loans for the benefit of Cathay Bank.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Generation</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of our licensed products are still under development and trial stage. During the three months ended March 31, 2019 and 2018, we
generated $212,242 and $0 in revenues, respectively, primarily from the CDMO business unit.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019 and 2018, we spent approximately&nbsp;$421,956 and $248,111 on research and development,
respectively, which consisted primarily of research and development and payroll expenses. Such payroll expenses were settled in
both cash and common stock issued by the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Critical
Accounting Policies and Estimates</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the following accounting policies are the most critical to aid you in fully understanding and evaluating this &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operation.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of Presentation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited consolidated financial statements have been prepared in accordance with the generally accepted accounting
principles in the United States of America (the &ldquo;U.S. GAAP&rdquo;). All significant intercompany transactions and account
balances have been eliminated.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
basis of accounting involves the application of accrual accounting and consequently, revenues and gains are recognized when earned,
and expenses and losses are recognized when incurred. The Company&rsquo;s financial statements are expressed in U.S. dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fiscal
Year</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company changed its fiscal year from the period beginning on October 1<SUP>st</SUP>&nbsp;and ending on September 30<SUP>th</SUP>&nbsp;to
the period beginning on January 1<SUP>st</SUP>&nbsp;and ending on December 31<SUP>st</SUP>, beginning January 1, 2018.&nbsp;All
references herein to a fiscal year prior to December 31, 2017 refer to the twelve months ended September 30<SUP>th</SUP>&nbsp;of
such year.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the amount of revenues and expenses
during the reporting periods. Actual results could differ materially from those results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventory</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of raw materials, work-in-process, finished goods, and merchandise. Inventories are stated at the lower of cost or market
and valued on a moving weighted average cost basis. Market is determined based on net realizable value. The Company periodically
reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value,
and incurs a charge to operations for known and anticipated inventory obsolescence.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reclassifications</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification
had no impact on previously reported net loss or accumulated deficit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Forward
Stock Split</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2016, the Board of Directors and the majority of the shareholders of the Company approved an amendment to the Articles
of Incorporation to effect a forward split at a ratio of 1 to 3.141 and increase the number of our authorized shares of common
stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016. As a result, all shares outstanding for
all periods have been retroactively restated to reflect Company&rsquo;s 1 to 3.141 forward stock split.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reverse
Stock Split</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 12, 2019, the Board of Directors by unanimous written consent in lieu of a meeting approved resolutions to i) effect a reverse
stock split at the ratio of 1-for-18 (the &ldquo;Reverse Split&rdquo;) of both the authorized Common Stock and the issued and
outstanding Common Stock and ii) to amend the Articles of Incorporation to reflect the Reverse Split. The Board of Directors approved
and authorized the Reverse Split without obtaining approval of the Company&rsquo;s shareholders pursuant to Section 78.207 of
Nevada Revised Statutes. On May 3, 2019, the Company filed a certificate of amendment to the Company&rsquo;s Articles of Incorporation
(the &ldquo;Amendment&rdquo;) to effect the Reverse Split with the Secretary of State of Nevada. The Financial Industry Regulatory
Authority (&ldquo;FINRA&rdquo;) informed the Company that the Reverse Split was effective on May 8, 2019. Unless specified otherwise,
all shares and related financial information in this propsectus reflect this 1-for-18 reverse stock split.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial and nonfinancial assets and liabilities
that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements.
It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable
units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the
inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair
value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs
by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants
would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable
inputs are inputs that reflect the Company&rsquo;s own assumptions about the assumptions market participants would use in pricing
the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs
into three broad levels based on the reliability of the inputs as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access
at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based
on quoted prices in active markets that are readily and regularly available.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that
are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that incorporate
the assumptions a market participant would use in pricing the asset or liability.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, restricted cash, accounts
receivable, due from related parties, inventory, prepaid expenses and other current assets, accounts payable, accrued liabilities,
and due to related parties approximate fair value due to their relatively short maturities. The carrying value of the Company&rsquo;s
short-term bank loan, convertible notes payable, and accrued interest approximates their fair value as the terms of the borrowing
are consistent with current market rates and the duration to maturity is short. The carrying value of the Company&rsquo;s long-term
bank loan approximates fair value because the interest rates approximate market rates that the Company could obtain for debt with
similar terms and maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As
of March 31, 2019 and December 31, 2018, the Company&rsquo;s cash and cash equivalents amounted to $981,341 and $226,688, respectively.
Some&nbsp;of the Company&rsquo;s cash deposits are held in financial institutions located in Taiwan where there is currently regulation
mandated on obligatory insurance of bank accounts. The Company believes this financial institution is of high credit quality.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
cash equivalents primarily consist of cash held in a reserve bank account in Taiwan. As of March 31, 2019 and December 31, 2018,
the Company&rsquo;s restricted cash equivalents amounted to $16,093.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentration
of Credit Risk</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents.
The Company places its cash and temporary cash investments in high quality credit institutions, but these investments may be in
excess of Taiwan Central Deposit Insurance Corporation and the U.S. Federal Deposit Insurance Corporation&rsquo;s insurance limits.
The Company does not enter into financial instruments for hedging, trading or speculative purposes.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Goodwill</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate
the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative
assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment
test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets
to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors
indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment
as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of
the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales
and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company completed the required testing of goodwill for impairment as of March 31, 2019, and determined that goodwill was impaired
because of the current financial condition of the Company and the Company&rsquo;s inability to generate future operating income
without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows
indicate that the recoverability of goodwill is not reasonably assured.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development Expenses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for R&amp;D costs in accordance with FASB ASC 730, &ldquo;Research and Development&rdquo; (&ldquo;ASC 730&rdquo;).
Research and development expenses are charged to expense as incurred unless there is an alternative future use in other research
and development projects or otherwise. Research and development expenses are comprised of costs incurred in performing research
and development activities, including personnel-related costs, share-based compensation, and facilities-related overhead, outside
contracted services including clinical trial costs, manufacturing and process development costs for both clinical and preclinical
materials, research costs, upfront and development milestone payments under collaborative agreements and other consulting services.
Non-refundable advance payment for goods and services that will be used in future research and development activities are expensed
when the activity has been performed or when the goods have been received rather than when the payment is made. In instances where
the Company enters into agreements with third parties to provide research and development services, costs are expensed as services
are performed. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments,
monthly payments, and payments upon the completion of milestones or receipt of deliverables.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
its CDMO business unit, the Company accounts for R&amp;D costs in accordance with ASC 730. Research and development expenses are
charged to expense as incurred unless there is an alternative future use in other research and development projects or otherwise.
Research and development expenses are comprised of costs incurred in performing research and development activities, including
personnel-related costs, facilities-related overhead, and outside contracted services including clinical trial costs, manufacturing
and process development costs for both clinical and preclinical materials, research costs, and other consulting services. Non-refundable
advance payment for goods and services that will be used in future research and development activities are expensed when the activity
has been performed or when the goods have been received rather than when the payment is made. In instances where the Company enters
into agreements with third parties to provide research and development services, costs are expensed as services are performed.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-based
Compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures expenses associated with all employee stock-based compensation awards using a fair value method and recognizes
such expense in the consolidated financial statements on a straight-line basis over the requisite service period in accordance
with FASB ASC Topic 718 &ldquo;Compensation-Stock Compensation&rdquo;. Total employee stock-based compensation expenses were $0
for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for stock-based compensation to non-employees in accordance with FASB ASC Topic 718 &ldquo;Compensation-Stock
Compensation&rdquo; and FASB ASC Topic 505-50 &ldquo;Equity-Based Payments to Non-Employees&rdquo; which requires that the cost
of services received from non-employees is measured at fair value at the earlier of the performance commitment date or the date
service is completed and recognized over the period the service is provided. Total non-employee stock-based compensation expenses
were $8,550 and $5,626 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Beneficial
Conversion Feature</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial
conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which
the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation
of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value
of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital.
The debt discount is amortized to interest expense over the life of the note using the effective interest method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred
tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,
deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred
tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future
deductibility is uncertain.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
FASB ASC Topic 740 &ldquo;Income Taxes&rdquo;, a tax position is recognized as a benefit only if it is&nbsp;&ldquo;more likely
than not&rdquo;&nbsp;that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur.
The evaluation of a tax position is a two-step process. The first step is to determine whether it is more-likely-than-not that
a tax position will be sustained upon examination, including the resolution of any related appeals or litigations based on the
technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold
to determine the amount of benefits recognized in the financial statements. A tax position is measured at the largest amount of
benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Tax positions that previously failed
to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold
is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the
first subsequent financial reporting period in which the threshold is no longer satisfied. Penalties and interest incurred related
to underpayment of income tax are classified as income tax expense in the year incurred. No significant penalty or interest relating
to income taxes has been incurred for the three months ended March 31, 2019 and 2018, respectively. GAAP also provides guidance
on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures and transition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete. In March 2018, the FASB issued ASU 2018-05,
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05
provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S.
Tax Cuts and Jobs Act (the &ldquo;2017 Tax Act&rdquo;). In accordance with this guidance, the Company&rsquo;s financial results
reflect provisional amounts for those specific income tax effects of the 2017 Tax Act for which the accounting under ASC Topic
740 is incomplete but a reasonable estimate could be determined. If a company cannot determine a provisional estimate to be included
in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were in effect
immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact of the reduction
in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates,
due to, among other things, changes in its interpretations and assumptions, additional guidance that may be issued by the I.R.S.,
and actions that the Company may take. The Company is continuing to gather additional information to determine the final impact.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended March 31, 2019 and 2018, the Company&rsquo;s income tax expense amounted $0 and $0, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss
Per Share of Common Stock</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates net loss per share in accordance with ASC Topic 260, &ldquo;Earnings per Share&rdquo;. Basic loss per share
is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss
per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional
common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional
common shares were dilutive. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments
and Contingencies</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC Topic 450 &ldquo;Contingencies&rdquo; subtopic 20, in determining its accruals and disclosures with respect
to loss contingencies. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information
available before financial statements are issued or are available to be issued indicates that it is probable that an asset had
been impaired or a liability had been incurred at the date of the financial statements and the amount of the loss can be reasonably
estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably
estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that
a material loss could be incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (&ldquo;Topic 820&rdquo;): Disclosure Framework - Changes to
the Disclosure Requirements for Fair Value Measurement (&ldquo;ASU 2018-13&rdquo;). The ASU modifies the disclosure requirements
in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying
existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing
the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value
measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable
inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods
and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect,
if any, that the ASU 2018-13 will have on its financial statements.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limited
Operating History; Need for Additional Capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no assurance that future financing will be available to us on acceptable terms, or at all. If financing is not available
on satisfactory terms, we may be unable to continue, develop or expand our operations. Equity financing could result in additional
dilution to existing shareholders.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to raise additional capital to maintain our operations in the future, we may be unable to carry out our full business
plan or we may be forced to cease operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion and analysis should be read in conjunction with the unaudited financial statements of&nbsp;the Company&nbsp;for
the period ended March 31, 2019 and 2018 and accompanying notes that appear in this prospectus and the financial statements included
in this Registration Statement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments
relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be
unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We
expect to raise additional capital through, among other things, the sale of equity or debt securities, but we cannot guarantee
that we will be able to achieve the same.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations &mdash; Year Ended December 31, 2018 Compared to Year Ended December 31, 2017.</B>&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents, for the period indicated, our consolidated statements of operations information, prior to the closing
the Mergers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year&nbsp;Ended<BR>
    December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit (loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Selling, general and administrative
    expenses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,148 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 811,685 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,668 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,171,665 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Stock based compensation
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 155,400 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp;Total operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,393,616 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,138,750 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,138,750 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income(expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 93 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 180 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (103,460 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Investment Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> Loss
    on investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,705,837 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 103,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss from continuing operations before provision
    income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,099,453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,030 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenues.
</I></B>We did not generate any revenue during the year ended December 31, 2018 and 2017. As such, we did not incur any cost associated
with revenues during the same periods.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses.&nbsp;</I></B>Our operating expenses were $1,393,616 for the year ended December 31, 2018 as compared to $4,138,750 for
the year ended December 31, 2017. The decrease in operating expenses in the amount of $2,745,134 or (66.33)% in the year ended
December 31, 2018 was primarily caused by the decrease in research and development expense, which was operating at a normal rate
in 2018, after the Company has established meaningful collaborative agreements with strategic partners, such as BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Loss
on investment in equity securities.&nbsp;</I></B>The loss on investment in equity securities was $2,549,451 for the year ended
December 31, 2018 as compared to $0 for the year ended December 31, 2017. The increase of expenses by $2,549,451 was attributable
to the other-than temporary impairment on equity investment for Rgene due to the operating performance and adverse changes in
market conditions of Rgene. However, all projects that have been initiated and scheduled will be continuously managed and supported
by the Company and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Loss.</I></B>&nbsp;As a result of the above factors, the net loss was $4,101,303 and $4,242,860 for the years ended December 31,
2018 and 2017. The decrease of net loss in the year ended December 31, 2018 as compared to the same period ended December 31,
2017 was in an amount of $141,557 or by (3.34)%.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Working
Capital Summary</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December&nbsp;31, 2018<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December&nbsp;31, 2017<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,643,332 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,568,224 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,400,247 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Working Capital (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,471,951 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,756,915 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Flows</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Years Ended </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December
    31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash Flows Used in Operating Activities </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (630,195 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,485,313 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Cash Flows Provided by Financing
    Activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 593,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,560,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net (Decrease) Increase in
    Cash During Period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (37,195 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,687 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Operating Activities</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2018 and 2017, the net cash used in operating activities were $630,195 and $1,485,313, respectively,
reflecting a decrease of $855,118 or (57.57)%. Such decrease was primarily caused by the recognition of loss on investment in
equity securities and the change in accrued expenses and due to related parties during the year ended December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Investing Activities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was no net cash used or generated from investing activities during the years ended December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Financing Activities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018 and 2017, net cash generated from financing activities was 593,000 and $1,560,000, respectively.
The decrease of $967,000 or (61.99)% in net cash generated from financing activities was because the Company borrowed less money
from related parties and also made repayments for outstanding loans in the fiscal year of 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Critical
Accounting Policy and Estimates</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe that the following accounting policies are the most critical to aid you in fully understanding and evaluating this &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operation.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Going
Concern Consideration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred losses since its inception resulting in an accumulated deficit of $19,877,901 and $15,776,598 as of December 31,
2018 and 2017, respectively, and net loss of $4,101,303 during the fiscal year ended December 31, 2018. These conditions raise
substantial doubt about our ability to continue as a going concern for the next twelve months.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to finance operations primarily through capital contributions from the principal shareholders and other sources. Our continuing
operation depends on the success of our financing, including both debt and equity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current
or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures, or capital resources that is material to investors.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations &mdash; Three Months Ended March 31, 2019 Compared to March 31, 2018.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents, for the three months indicated, our consolidated statements of operations information.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March
    31,<BR> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March
    31,<BR> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 212,242 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,499 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 210,743 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Selling, general and administrative
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,803 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 420,462 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 421,956 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 248,111 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,550 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,626 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 941,309 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 674,199 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (730,566 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (674,199 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 189 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (129,886 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (106,854 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,891 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain (loss) on foreign exchange&nbsp;changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,515 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain (loss) on investment in
    equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (66,205 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,567 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (500 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (200,296 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (133,705 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss before provision for income tax (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (930,862 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (807,904 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (57,545 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (94,282 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (873,317 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (713,622 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss attributable to noncontrolling interests </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (81,646 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (112,235 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss attributable to ABVC and subsidiaries </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (791,671 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (601,387 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Foreign currency translation
    adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,994 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Income (Loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (878,457 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (536,393 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss per share attributable to common stockholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Weighted average number of common shares outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,965,665 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,599,911 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenues.&nbsp;</I></B>We
generated $212,242 and $0 in revenues; $1,499 and $0 in cost of revenues for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses.</I></B>&nbsp;Our operating expenses were $941,309 for the three months ended March 31, 2019 as compared to $674,199
for the three months ended March 31, 2018. The increase in operating expenses was primarily caused by R&amp;D expenses that were
scheduled for existing drug candidates research.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Interest
Expense. </I></B>The interest expense was $129,886 for the three months ended March 31, 2019 as compared to $106,854 for the three
months ended March&nbsp;31, 2018. The increase in interest expense is primarily due to interest incurred on the new business loan
from Cathay Bank.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Loss.</I></B>&nbsp;The net loss was $873,317 for the three months ended March 31, 2019 compared to $713,622 for the three months
ended March 31, 2018. The increase in net loss was primarily caused by professional services fees and R&amp;D expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Working
Capital</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of&nbsp;<BR> March 31,<BR> 2019<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of<BR> December 31,<BR> 2018<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,527,182 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 566,476 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 12,435,155 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,987,786 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Working Capital (deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (10,907,793 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (10,421,310 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Flows</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Three Months Ended </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March
    31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash Flows Used in Operating Activities </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (599,528 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (525,510 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash Flows Used in Investing Activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (17,801 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash Flows Provided by Financing Activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,373,791 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 349,737 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Effect of exchange rate changes
    on cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (40 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net (Decrease) Increase in
    Cash During Period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 754,653 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (175,813 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Operating Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019 and 2018, the net cash used in operating activities were $599,528 and $525,510, respectively.
The increase in the amount of $74,018 is primarily due to net loss of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Investing Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019 and 2018, the Company spent $17,801 and $0 in investing activities, respectively. The decrease
in the amount of $17,801 was due to company stock buyback from a previous employee.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow from Financing Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019 and 2018, the net cash provided by financing activities was $1,373,791 and $349,737, respectively,
reflecting an increase of $1,024,054. The increase in the net cash provided by financing activities was primarily attributed to
the loan in the total amount of $1,000,000 from Cathay Bank.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2019, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or
future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures, or capital resources that is material to investors.</FONT> </P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_014"></A>BIOLITE&rsquo;S
MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND
RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
following discussion and analysis should be read in conjunction with the restated Consolidated Financial Statements and related
notes included elsewhere in this prospectus. The following discussion includes certain forward-looking statements. For a discussion
of important factors which could cause actual results to differ materially from the results referred to in the forward-looking
statements, see &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo;. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
is a clinical stage pharmaceutical company focused on translational research of botanical and natural API-based products in the
fields of central nervous system, oncology/ hematology and autoimmune diseases. Because we believe natural substances have many
healing powers, BioLite focuses its research resources to the development of botanical products, which include plant materials,
algae, macroscopic fungi and combinations thereof. We mostly use traditional cultivation, fermentation and purification techniques,
excluding genetic modifications, to process the active natural constituents of our drug candidates. The operational activities
primarily focus on researching and developing novel botanical and natural drugs utilizing scientific methodology and approaches
in compliance with the procedures and protocols prescribed by the FDA. The names of all of our medicinal products are in an alphanumeric
form, starting with &ldquo;BLI&rdquo; which stands for &ldquo;BioLite&rdquo; and followed by Arabic numbers. For example, BLI-1005
is the name of one of our products that is intended to treat certain types of depression. BioLite seeks to add value to new drug
development by taking pre-clinical stage new drug candidates to Phase II and proving the concept of the new drug candidates. As
a result of the consummation of the Mergers, BioLite became a wholly-owned subsidiary of the Company on February 8, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite&rsquo;s
research and development team is devoted primarily to preclinical studies, Phase I and II clinical trials of new drug candidates
in its fields with goals of translating pharmacology-related research results and theories to medicinal drug candidates that are
ready for clinical trials on a large scale, such as Phase III trials, and future commercialization. BioLite acquires licenses
from universities, government and other research institutes to further preclinical research in order to select new drug candidates
for clinical trials, including Phase I and Phase II. BioLite currently focuses on the areas of CNS, oncology/ hematology and autoimmune,
where it is seeking to build a portfolio of novel therapeutics that serve large unmet medical needs. As part of the business strategy,
BioLite plans to cooperate with well-established pharmaceutical companies in the U.S. and other countries with major medicinal
markets to further develop and commercialize the products in its portfolio for which we receive positive clinical trial results
from Phase II trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CNS</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
acquired exclusive global rights to develop and license two investigational new drugs to treat central nervous system diseases,
both of which are based on novel formulas of extracts from Chinese, Korean and Japanese herbs that have shown promise in treating
insomnia, anxiety and other mental disorders. BioLite has successfully completed the stage 1, Phase II study of BLI-1005, a novel
capsule product to treat MDD. BioLite is in the process of recruiting sixty patients to carry out the stage 2, Phase II trial
of BLI-1005. BLI-1005 is intended to treat MDD and we believe that it offers multiple advantages over currently available antidepressants.
In addition, BioLite received from the FDA an approval on the IND application of BLI-1008 for the treatment of ADHD in January
2016 and is scheduled to commence the Phase II trial in the foruth quarter of 2018, subject to the availability of sufficient
funds. BLI-1005 and BLI-1008 are two indications deriving from the same API, PDC-1421, as a result of which, BLI-1008 shares the
BLI-1005 Phase I clinical trial results. The Phase I clinical trial results of both drug candidates showed no serious adverse
events and none of the trial subjects, namely healthy volunteers displayed any signs of suicidal intention or behavior. Suicidal
intention and behaviors measure suicidal risks which are related to possibility of serious adverse effects. BioLite has a hypothesis
that BLI-1005 and BLI-1008 may be less susceptible to drug abuse and dependence because we think both drug candidates will be
classified as non-stimulants which are known for low abuse tendency or dependence.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Oncology/
Hematology</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
currently has exclusive global rights to develop four innovative botanical drugs, BLI- 1301 to treat Myelodysplastic syndromes
(&ldquo;MDS&rdquo;), BLI-1401-1 designed to treat solid tumors, BLI-1401-2 for the treatment of TNBC and BLI-1501 intended to
treat chronic lymphocytic leukemia (&ldquo;CLL&rdquo;), all of which constitute our oncology/hematology portfolio. Each of the
four investigational new drugs is designed to be used as part of a combination therapy for its targeted cancer because our research
results indicate each of the four drugs&rsquo; ability to improve cancer patients&rsquo; immunity and counter the various types
of side effects, respectively, caused by the traditional therapies, such as chemotherapies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MDS
are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood
cells. We have received from the FDA an IND approval to conduct Phase II trial of BLI- 1301 to treat MDS and plan to start such
trial in the fourth quarter of 2018 subject to the sufficiency of working capital. A MDS is a relatively rare type of leukemia.
If BioLite can prove to the FDA that our BLI-1301 has sufficient potential to treat MDS, BioLite may receive an orphan drug designation
for it. Currently BioLite is processing the application for such orphan drug designation for BLI- 1301, which was initiated in
2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
received the FDA IND approval for BLI-1401-2 for the treatment of TNBC in March 2016. We are currently co-developing BLI-1501
candidate with Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) to conduct preclinical studies. Through collaboration
with BHK, BioLite and we are preparing the FDA IND applications for the Phase II clinical trials of BLI-1401-1 and conducting
the early stage preclinical studies of BLI-1501.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Autoimmune</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
has a focused pipeline of investigational drugs that are designed for the treatment of autoimmune diseases, including BLI-1006
to treat inflammatory bowel disease (&ldquo;IBD&rdquo;) and BLI-1007 for rheumatoid arthritis (&ldquo;RA&rdquo;). BioLite has
received the exclusive global rights on these two autoimmune products from the Industrial Technology Research Institute in Taiwan
which holds patents on both drug candidates in certain Asian, North American and European countries. BioLite is preparing the
IND Phase I application for BLI-1006. BioLite is currently conducting preclinical studies of BLI-1007.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, BioLite will look to acquire and conduct clinical research on additional investigational botanical new drugs to further
the FDA clearance process. BioLite&rsquo;s management team&rsquo;s prior experience has involved screening pre-clinical products,
compliance with FDA procedures and identifying co-developers to continue the FDA process and commercialize new drugs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Factors Affecting BioLite&rsquo;s Results of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite&rsquo;s
core operation activities include research and development of botanic new drug candidates with focuses on preclinical development,
Phase I and Phase II clinical trials and license-in and license-out collaboration with research institutions and respected biotech
companies, respectively. Any research results or regulatory results have substantial impacts on our operation results and financial
performance. In addition, the relationships with BioLite&rsquo;s licensors, CROs or third party researchers and collaborators
are critical to the success of our business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies and Significant Judgments and Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
Reporting </I></B>&mdash; BioLitefollows the provisions of ASC Topic 280, &ldquo;Segment Reporting&rdquo;, which establishes standards
for reporting information about operating segments, which uses a &ldquo;management&rdquo; approach for determining segments. The
management approach designates the internal organization that is used by management for making operating decisions and assessing
performance as the source of BioLite&rsquo;s reportable segments. ASC Topic 280, &ldquo;Segment Reporting,&rdquo; also requires
disclosures about products or services, geographic areas, and major customers. BioLite&rsquo;s management reporting structure
provided for only one segment in 2018 and 2017. Accordingly, no separate segment information is presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of Estimates</B> &mdash; The preparation of financial statements in conformity with accounting principles generally accepted in
the United States of America (&ldquo;U.S. GAAP&rdquo;) requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the balance sheet date and the reported
amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of Credit Risk </I></B>&mdash; BioLite&rsquo;s financial instruments that are exposed to concentrations of credit risk consist
primarily of cash and cash equivalents and restricted cash. BioLite places its cash and temporary cash investments in high quality
credit institutions in Taiwan, but these investments may be in excess of Taiwan Central Deposit Insurance Corporation&rsquo;s
insurance limits. BioLite does not enter into financial instruments for hedging, trading, or speculative purposes. Concentration
of credit risk with respect to accounts receivables is limited due to the wide variety of customers and markets in which BioLite
transacts business, as well as their dispersion across many geographical areas. BioLite performs ongoing credit evaluations of
its customers and generally does not require collateral, but does require advance deposits on certain transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents &mdash; </I></B>BioLite considers all highly liquid investments with maturities of three months or less at
the date of purchase to be cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Restricted
Cash Equivalents &mdash; </I></B>Restricted cash equivalents primarily consist of cash held in a reserve bank account associated
with short-term bank loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounts
Receivable, Receivable from Collaboration Partners, and Other Receivable &mdash; </I></B>Accounts receivable, receivable from
collaboration partners, and other receivables are stated at carrying value less estimates made for doubtful receivables. An allowance
for impairment of trade receivable, receivable from collaboration partners, and other receivables is established if the collection
of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that BioLite will not be able
to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor,
probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are
considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset&rsquo;s
carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventory
&mdash; </I></B>Inventory consists of raw materials, work-in-process, finished goods, and merchandise. Inventories are stated
at the lower of cost or market and valued on a moving weighted average cost basis. Market is determined based on net realizable
value. BioLite periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete
or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence. As of December 31,
2018 and 2017, the allowance for slow-moving inventory was $180,387 and $0, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Property
and Equipment &mdash; </I></B>Property and equipment is carried at cost net of accumulated depreciation. Repairs and maintenance
are expensed as incurred. Expenditures that improve the functionality of the related asset or extend the useful life are capitalized.
When property and equipment is retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold
improvements are depreciated on the straight-line method over the shorter of the remaining lease term or estimated useful life
of the asset. Depreciation is calculated on the straight-line method, including property and equipment under capital leases, generally
based on the following useful lives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Estimated&nbsp;Life <BR> in Years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Buildings and leasehold improvements</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: center">5 ~ 50</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Machinery and equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">5 ~ 6</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Office equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">3 ~ 6</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impairment
of Long-Lived Assets </I></B>&mdash;BioLite has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and
Equipment (&ldquo;ASC 360-10&rdquo;). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and
used by BioLite be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. BioLite evaluates its long lived assets for impairment annually or more often if events and circumstances
warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses,
or a forecasted inability to achieve break-even operating results over an extended period. Should impairment in value be indicated,
the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the
use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying
amount or the fair value less costs to sell. Management has determined that no impairments of long-lived assets currently exist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value Measurements </I></B>&mdash; FASB ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial
and nonfinancial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and
expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value
on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It
establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases
the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs
and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are
inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained
from sources independent of BioLite. Unobservable inputs are inputs that reflect BioLite&rsquo;s own assumptions about the assumptions
market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.
The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that BioLite has the ability to access
    at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based
    on quoted prices in active markets that are readily and regularly available.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
    date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
    that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
    and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that
    incorporate the assumptions a market participant would use in pricing the asset or liability.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of BioLite, such as cash and cash equivalents, restricted cash, accounts receivable,
other receivable, due from related parties, inventory, prepaid expenses and other current assets, accounts payable, accrued liabilities,
and due to related parties approximate fair value due to their relatively short maturities. The carrying value of BioLite&rsquo;s
short-term bank loan and notes payable approximates their fair value as the terms of the borrowing are consistent with current
market rates and the duration to maturity is short. The carrying value of BioLite&rsquo;s long-term bank loan approximates fair
value because the interest rates approximate market rates that BioLite could obtain for debt with similar terms and maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Long-term
Equity Investment </I></B>&mdash; BioLite acquires these equity investments to promote business and strategic objectives. BioLite
accounts for non-marketable equity and other equity investments for which BioLite does not have control over the investees as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    method investments when BioLite has the ability to exercise significant influence, but not control, over the investee. Its
    proportionate share of the income or loss is recognized monthly and is recorded in gains (losses) on equity investments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    cost method investments when the equity method does not apply.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
judgment is required to identify whether an impairment exists in the valuation of BioLite&rsquo;s non-marketable equity investments,
and therefore BioLite considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative
factors that may have a significant impact on the investee&rsquo;s fair value. Qualitative analysis of its investments involves
understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee&rsquo;s
industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair
value of its investments are developed using the market and income approaches. The market approach includes the use of comparable
financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted
cash flow model, which requires significant estimates regarding the investees&rsquo; revenue, costs, and discount rates. BioLite&rsquo;s
assessment of these factors in determining whether an impairment exists could change in the future due to new developments or
changes in applied assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other-Than-Temporary
Impairment</I></B> &mdash; BioLite&rsquo;s long-term equity investments are subject to a periodic impairment review. Impairments
affect earnings as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    equity securities include the consideration of general market conditions, the duration and extent to which the fair value
    is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of
    value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the
    business outlook for, the investee, which may include industry and sector performance, changes in technology, operational
    and financing cash flow factors, and changes in the investee&rsquo;s credit rating. We record other-than-temporary impairments
    on marketable equity securities and marketable equity method investments in gains (losses) on equity investments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative
    analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory or economic
    environment; changes in operating structure or management of the investee; additional funding requirements; and the investee&rsquo;s
    ability to remain in business. A series of operating losses of an investee or other factors may indicate that a decrease in
    value of the investment has occurred that is other than temporary and that shall be recognized even though the decrease in
    value is in excess of what would otherwise be recognized by application of the equity method. A loss in value of an investment
    that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but would not necessarily
    be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain
    an earnings capacity that would justify the carrying amount of the investment. BioLite records other-than-temporary impairments
    for non-marketable cost method investments and equity method investments in gains (losses) on equity investments. Other-than-temporary
    impairments of non-marketable equity investments were $33,532 and $4,277,708 for the years ended December 31, 2018 and 2017,
    respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Post-retirement
and post-employment benefits &mdash; </I></B>BioLite adopted the government mandated defined contribution plan pursuant to the
Labor Pension Act (the &ldquo;Act&rdquo;) in Taiwan. Such labor regulations require that the rate of contribution made by an employer
to the Labor Pension Fund per month shall not be less than 6% of the worker&rsquo;s monthly salaries. Pursuant to the Act, BioLite
makes monthly contribution equal to 6% of employees&rsquo; salaries to the employees&rsquo; pension fund. BioLite has no legal
obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as
incurred, were $19,486 and $26,263 for the years ended December 31, 2018 and 2017, respectively. Other than the above, BioLite
does not provide any other post-retirement or post-employment benefits.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Recognition &mdash;</I></B> During the fiscal year 2018, BioLite adopted Accounting Standards Codification (&ldquo;ASC&rdquo;),
Topic 606 (ASC 606), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were
not completed as of January 1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated
deficit at the beginning of 2018 for the cumulative effect. The results for BioLite&rsquo;s reporting periods beginning on and
after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under
the accounting standards in effect for the prior period. Based on BioLite&rsquo;s review of existing collaborative agreements
as of January 1, 2018, BioLite concluded that the adoption of the new guidance did not have a significant change on BioLite&rsquo;s
revenue during all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, BioLite recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects
the consideration that BioLite expects to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that BioLite determines is within the scope of ASC 606, BioLite performs the following five steps: (i) identify the
contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price;
(iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) BioLite
satisfies a performance obligation. BioLite only applies the five-step model to contracts when it is probable that BioLite will
collect the consideration BioLite is entitled to in exchange for the goods or services BioLite transfers to the customers. At
inception of the contract, once the contract is determined to be within the scope of ASC 606, BioLite assesses the goods or services
promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service
is distinct. BioLite then recognizes as revenue the amount of the transaction price that is allocated to the respective performance
obligation when (or as) the performance obligation is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are examples of when BioLite recognizes revenue based on the types of payments BioLite receives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Merchandise
Sales&nbsp;<I>&mdash;&nbsp;</I></B>BioLite recognizes net revenues from dietary supplements product sales when customers obtain
control of BioLite&rsquo;s products, which typically occurs upon delivery to customer. Product revenues are recorded at the net
sales price, or &ldquo;transaction price,&rdquo; which includes applicable reserves for variable consideration, including discounts,
allowances, and returns.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trade
discount and allowances</I>: BioLite generally provides invoice discounts on product sales to its customers for prompt payment.
BioLite estimates that, based on its experience, its customers will earn these discounts and fees, and deducts the full amount
of these discounts and fees from its gross product revenues and accounts receivable at the time such revenues are recognized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Product
returns</I>: BioLite estimates the amount of each product that will be returned and deducts these estimated amounts from its gross
revenues at the time the revenues are recognized. BioLite&rsquo;s customers have the right to return unopened packages, subject
to contractual limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, product allowance and returns have been minimal and, based on its experience, BioLite believes that returns of its products
will continue to be minimal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
Revenues &mdash;&nbsp;</B>BioLite recognizes collaborative revenues generated through collaborative research, development and/or
commercialization agreements. The terms of these agreements typically include payment to BioLite related to one or more of the
following: nonrefundable upfront license fees, development and commercial milestones, partial or complete reimbursement of research
and development costs, and royalties on net sales of licensed products. Each type of payments results in collaborative revenues
except for revenues from royalties on net sales of licensed products, which are classified as royalty revenues. To date, we have
not received any royalty revenues. Revenue is recognized upon satisfaction of a performance obligation by transferring control
of a good or service to the collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the accounting for these arrangements, BioLite applies judgment to determine whether the performance obligations are distinct,
and develop assumptions in determining the stand-alone selling price for each distinct performance obligation identified in the
collaboration agreements. To determine the stand-alone selling price, BioLite relies on assumptions which may include forecasted
revenues, development timelines, reimbursement rates for R&amp;D personnel costs, discount rates and probabilities of technical
and regulatory success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
had multiple deliverables under the collaborative agreements, including deliverables relating to grants of technology licenses,
regulatory and clinical development, and marketing activities. Estimation of the performance periods of BioLite&rsquo;s deliverables
requires the use of management&rsquo;s judgment. Significant factors considered in management&rsquo;s evaluation of the estimated
performance periods include, but are not limited to, BioLite&rsquo;s experience in conducting clinical development, regulatory
and manufacturing activities. BioLite reviews the estimated duration of its performance periods under its collaborative agreements
on an annually basis, and makes any appropriate adjustments on a prospective basis. Future changes in estimates of the performance
period under its collaborative agreements could impact the timing of future revenue recognition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonrefundable
    upfront payments</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a license to BioLite&rsquo;s intellectual property is determined to be distinct from the other performance obligations identified
in an arrangement, BioLite recognizes revenue from the related nonrefundable upfront payments based on the relative standalone
selling price prescribed to the license compared to the total selling price of the arrangement. The revenue is recognized when
the license is transferred to the collaboration partners and the collaboration partners who are able to use and benefit from the
license. To date, the receipt of nonrefundable upfront fees was solely for the compensation of past research efforts and contributions
made by BioLite before the collaborative agreements entered into and it does not relate to any future obligations and commitments
made between BioLite and the collaboration partners in the collaborative agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone
    payments</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
is eligible to receive milestone payments under the collaborative agreement with collaboration partners based on achievement of
specified development, regulatory and commercial events. Management evaluated the nature of the events triggering these contingent
payments, and concluded that these events fall into two categories: (a) events which involve the performance of BioLite&rsquo;s
obligations under the collaborative agreement with collaboration partners, and (b) events which do not involve the performance
of BioLite&rsquo;s obligations under the collaborative agreement with collaboration partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
former category of milestone payments consists of those triggered by development and regulatory activities in the territories
specified in the collaborative agreements. Management concluded that each of these payments constitute substantive milestone payments.
This conclusion was based primarily on the facts that (i) each triggering event represents a specific outcome that can be achieved
only through successful performance by BioLite of one or more of its deliverables, (ii) achievement of each triggering event was
subject to inherent risk and uncertainty and would result in additional payments becoming due to BioLite, (iii) each of the milestone
payments is nonrefundable, (iv) substantial effort is required to complete each milestone, (v) the amount of each milestone payment
is reasonable in relation to the value created in achieving the milestone, (vi) a substantial amount of time is expected to pass
between the upfront payment and the potential milestone payments, and (vii) the milestone payments relate solely to past performance.
Based on the foregoing, BioLite recognizes any revenue from these milestone payments in the period in which the underlying triggering
event occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
    Element Arrangements</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
evaluates multiple element arrangements to determine (1)&nbsp;the deliverables included in the arrangement and (2)&nbsp;whether
the individual deliverables represent separate units of accounting or whether they must be accounted for as a combined unit of
accounting. This evaluation involves subjective determinations and requires management to make judgments about the individual
deliverables and whether such deliverables are separate from other aspects of the contractual relationship. Deliverables are considered
separate units of accounting provided that: (i)&nbsp;the delivered item(s) has value to the customer on a standalone basis and
(ii)&nbsp;if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of
the undelivered item(s) is considered probable and substantially within its control. In assessing whether an item under a collaboration
has standalone value, BioLite considers factors such as the research, manufacturing, and commercialization capabilities of the
collaboration partner and the availability of the associated expertise in the general marketplace. BioLite also considers whether
its collaboration partners can use the other deliverable(s) for their intended purpose without the receipt of the remaining element(s),
whether the value of the deliverable is dependent on the undelivered item(s), and whether there are other vendors that can provide
the undelivered element(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
recognizes arrangement consideration allocated to each unit of accounting when all of the revenue recognition criteria in ASC
606 are satisfied for that particular unit of accounting. In the event that a deliverable does not represent a separate unit of
accounting, BioLite recognizes revenue from the combined unit of accounting over BioLite&rsquo;s contractual or estimated performance
period for the undelivered elements, which is typically the term of BioLite&rsquo;s research and development obligations. If there
is no discernible pattern of performance or objectively measurable performance measures do not exist, then BioLite recognizes
revenue under the arrangement on a straight-line basis over the period BioLite is expected to complete its performance obligations.
Conversely, if the pattern of performance in which the service is provided to the customer can be determined and objectively measurable
performance measures exist, then BioLite recognizes revenue under the arrangement using the proportional performance method. Revenue
recognized is limited to the lesser of the cumulative amount of payments received or the cumulative amount of revenue earned,
as determined using the straight-line method or proportional performance method, as applicable, as of the period ending date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the inception of an arrangement that includes milestone payments, BioLite evaluates whether each milestone is substantive and
at risk to both parties on the basis of the contingent nature of the milestone. This evaluation includes an assessment of whether:
(1)&nbsp;the consideration is commensurate with either BioLite&rsquo;s performance to achieve the milestone or the enhancement
of the value of the delivered item(s) as a result of a specific outcome resulting from its performance to achieve the milestone,
(2)&nbsp;the consideration relates solely to past performance and (3)&nbsp;the consideration is reasonable relative to all of
the deliverables and payment terms within the arrangement. BioLite evaluates factors such as the scientific, clinical, regulatory,
commercial, and other risks that must be overcome to achieve the particular milestone and the level of effort and investment required
to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether
a milestone satisfies all of the criteria required to conclude that a milestone is substantive. Milestones that are not considered
substantive are recognized as earned if there are no remaining performance obligations or over the remaining period of performance,
assuming all other revenue recognition criteria are met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties
    and Profit Sharing Payments</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the collaborative agreement with the collaboration partners, BioLite is entitled to receive royalties on sales of products, which
is at certain percentage of the net sales. BioLite recognizes revenue from these events based on the revenue recognition criteria
set forth in ASC 606. Based on those criteria, BioLite considers these payments to be contingent revenues, and recognizes them
as revenue in the period in which the applicable contingency is resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Taxes </I></B>&mdash; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the enactment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Valuation
of Deferred Tax Assets </I></B>&mdash; A valuation allowance is recorded to reduce our deferred tax assets to the amount that
is more likely than not to be realized. In assessing the need for the valuation allowance, management considers, among other things,
projections of future taxable income and ongoing prudent and feasible tax planning strategies. If BioLite determines that sufficient
negative evidence exists, then it will consider recording a valuation allowance against a portion or all of the deferred tax assets
in that jurisdiction. If, after recording a valuation allowance, BioLite&rsquo;s projections of future taxable income and other
positive evidence considered in evaluating the need for a valuation allowance prove, with the benefit of hindsight, to be inaccurate,
it could prove to be more difficult to support the realization of our deferred tax assets. As a result, an additional valuation
allowance could be required, which would have an adverse impact on its effective income tax rate and results. Conversely, if,
after recording a valuation allowance, BioLite determines that sufficient positive evidence exists in the jurisdiction in which
the valuation allowance was recorded, it may reverse a portion or all of the valuation allowance in that jurisdiction. In such
situations, the adjustment made to the deferred tax asset would have a favorable impact on its effective income tax rate and results
in the period such determination was made. See Note 13 of our Financial Statements for information related to income taxes, including
the recorded balances of its valuation allowance related to deferred tax assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
applied the provisions of ASC 740-10-50, &ldquo;Accounting For Uncertainty In Income Taxes&rdquo;, which provides clarification
related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods
remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute
of limitations for a given audit period could result in an adjustment to BioLite&rsquo;s liability for income taxes. Any such
adjustment could be material to BioLite&rsquo;s results of operations for any given quarterly or annual period based, in part,
upon the results of operations for the given period. As of December 31, 2018 and 2017, management considered that BioLite had
no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share-Based
Compensation &mdash;</I></B> <FONT STYLE="background-color: white">BioLite accounts for its stock-based compensation in accordance
with ASC 718, Compensation&mdash;Stock Compensation, which establishes accounting for stock-based awards granted to employees
for services and requires companies to expense the estimated fair value of these awards over the requisite service period. </FONT>BioLite
recognizes share-based compensation expense for share-based compensation awards granted to its employees and officers. Compensation
expense for share-based compensation awards granted is based on the grant date fair value estimate for each award as determined
by its board of directors. BioLite recognizes these compensation costs on a straight-line basis over the requisite service period
of the award, which is generally one to two years. As share-based compensation expense recognized is based on awards ultimately
expected to vest, such expense is reduced for estimated forfeitures. During the years ended December 31, 2018 and 2017, BioLite
did not record any employee stock-based compensation expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
estimates the fair value of stock-based compensation awards at the date of grant using the Black-Scholes option pricing model,
which requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, expected term
of the option, expected volatility of the price of its Common Stock, risk-free interest rates, and the expected dividend yield
of our Common Stock. The assumptions used in BioLite&rsquo;s option-pricing model represent management&rsquo;s best estimates.
These estimates involve inherent uncertainties and the application of management&rsquo;s judgment. If factors change and different
assumptions are used, BioLite&rsquo;s stock-based compensation expense could be materially different in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
assumptions and estimates are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value of the underlying Common Stock. Because BioLite&rsquo;s stocks are not publicly traded, the assumptions used in the
    valuation model are based on future expectations combined with management judgment. In the absence of a public trading market,
    the board of directors, with input from management, exercised significant judgment and considered numerous objective and subjective
    factors to determine the fair value of our Common Stock as of the date of each option grant, including the following factors:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
contemporaneous valuations performed by unrelated third-party specialists;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
the lack of marketability of its Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
BioLite&rsquo;s actual operating and financial performance, and current business conditions and projections;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
BioLite&rsquo;s hiring of key personnel and the experience of our management;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
BioLite&rsquo;s history and the timing of the introduction of new products and services;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
valuing the Common Stock, the fair value of the underlying Common Stock was determined by using the value indications under a
combination of valuation approaches, including a discounted cash flow analysis under the income approach, market approaches, and
the latest round of equity financing at grant date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term. The expected term represents the period that the stock-based compensation awards are expected to be outstanding. Since
    BioLite did not have sufficient historical information to develop reasonable expectations about future exercise behavior,
    it used the simplified method to compute expected term, which represents the average of the time-to-vesting and the contractual
    life.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility. As BioLite does not have a trading history for its Common Stock, the expected stock price volatility for its Common
    Stock was estimated by taking the mean standard deviation of stock prices for selected companies in biotechnogy industry listed
    in Taiwan&rsquo;s stock markets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero
    coupon U.S. Treasury notes with maturities approximately equal to the expected term of the options.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividend yield. BioLite has never declared or paid any cash dividends and do not presently plan to declare or pay cash dividends
    in the foreseeable future. Consequently, we used an expected dividend yield of zero.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuations are highly complex and subjective. Following the completion of this offering, Common Stock valuations will no longer
be necessary as BioLite will rely on market prices to determine the fair value of its Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreign-currency
Transactions</I></B> &mdash; For BioLite&rsquo;s subsidiaries in Taiwan, the foreign-currency transactions are recorded in New
Taiwan dollars (&ldquo;NTD&rdquo;) at the rates of exchange in effect when the transactions occur. Gains or losses resulting from
the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars, or when
foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement.
On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates
and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares
of stock where such differences are accounted for as translation adjustments under Equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Translation
Adjustment</I></B> &mdash; The accounts of BioLite Taiwan were maintained, and its financial statements were expressed, in New
Taiwan Dollar (&ldquo;NT$&rdquo;). Such financial statements were translated into U.S. Dollars (&ldquo;$&rdquo; or &ldquo;USD&rdquo;)
in accordance ASC 830, &ldquo;Foreign Currency Matters&rdquo;, with the NT$ as the functional currency. According to the Statement,
all assets and liabilities are translated at the current exchange rate, stockholder&rsquo;s deficit are translated at the historical
rates and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments
are reported under other comprehensive income as a component of stockholders&rsquo; equity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development </I></B>&mdash; BioLite accounts for R&amp;D costs in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
730, Research and Development (&ldquo;ASC 730&rdquo;). Research and development expenses are charged to expense as incurred unless
there is an alternative future use in other research and development projects or otherwise. Research and development expenses
are comprised of costs incurred in performing research and development activities, including personnel-related costs, share-based
compensation, and facilities-related overhead, outside contracted services including clinical trial costs, manufacturing and process
development costs for both clinical and preclinical materials, research costs, upfront and development milestone payments under
collaborative agreements and other consulting services. Non-refundable advance payment for goods and services that will be used
in future research and development activities are expensed when the activity has been performed or when the goods have been received
rather than when the payment is made. In instances where BioLite enters into agreements with third parties to provide research
and development services, costs are expensed as services are performed. Amounts due under such arrangements may be either fixed
fee or fee for service, and may include upfront payments, monthly payments, and payments upon the completion of milestones or
receipt of deliverables. <FONT STYLE="background-color: white">Research and development expense was $319,053 and $256,682 for
the years ended December 31, 2018 and 2017, respectively.</FONT></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Promotional
and Advertising Costs</I></B></FONT> <B> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;
</FONT></B><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Promotional and advertising costs are classified as selling
and general and administrative expenses, and are expensed as incurred. Promotional and advertising expenses consist primarily
of the costs of designing, producing, and distributing materials promoting BioLite and its products, including its corporate website.
Promotional and advertising costs were $419 and $842 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Statement
of Cash Flows</I> &mdash; </B>Cash flows from BioLite&rsquo;s operations are based upon the local currencies. As a result, amounts
related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding
balances on the balance sheet. In November 2016, the FASB issued ASU 2016-18, Restricted Cash , which requires amounts generally
described as restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the total
beginning and ending amounts for the periods shown on the statement of cash flows. BioLite adopted ASU 2016-18 in the fourth quarter
of 2018 and the impact on its consolidated financial statements is not material as BioLite's restricted cash balances are immaterial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comprehensive
Income</I></B> &mdash; Comprehensive income includes accumulated foreign currency translation gains and losses. BioLite has reported
the components of comprehensive income in its statements of operations and comprehensive income (loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
Issued Accounting Pronouncements</I></B> &mdash; In February 2016, the FASB issued ASU No. 2016-02, &ldquo;Leases.&rdquo; The
core principle of the ASU is that a lessee should recognize the assets and liabilities that arise from its leases other than those
that meet the definition of a short-term lease. The ASU requires extensive qualitative and quantitative disclosures, including
with respect to significant judgments made by management. Subsequently, the FASB issued ASU No. 2017-13, in September 2017 and
ASU No. 2018-01, in January 2018, which amends and clarifies ASU 2016-02. The Company adopted FASB Accounting Standards Codification,
Topic 842, Leases (&ldquo;ASC 842&rdquo;) using the modified retrospective approach, electing the practical expedient that allows
the Company not to restate its comparative periods prior to the adoption of the standard on January 1, 2019. As such, the disclosures
required under ASC 842 are not presented for periods before the date of adoption. For the comparative periods prior to adoption,
the Company presented the disclosures which were required under ASC 840.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2016, the FASB issued ASU No. 2016-18,&nbsp;Statement of Cash Flows: Restricted Cash. This ASU&nbsp;<FONT STYLE="background-color: white">requires
changes in restricted cash during the period to be included with cash and cash equivalents when reconciling the beginning-of-period
and end-of-period total amounts shown on the statement of cash flows. If cash, cash equivalents and restricted cash are presented
in more than one line item on the balance sheet, the new guidance requires a reconciliation of the total in the statement of cash
flows to the related captions in the balance sheet. </FONT>This guidance was effective for annual and interim periods of public
entities beginning after December 15, 2017<FONT STYLE="background-color: white">. The amendments in this ASU are applied retrospectively
to all periods presented.&nbsp;BioLite</FONT> adopted this guidance in the fourth quarter of 2018.&nbsp;<FONT STYLE="background-color: white">The
adoption of this ASU&nbsp;</FONT>increased&nbsp;BioLite&rsquo;s beginning and ending cash balances within its consolidated statements
of cash flows. The adoption had no other material impacts to its consolidated statements of cash flows and had no impact on its
results of operations or financial position.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the FASB issued Accounting Standards Update No. 2018-02 (ASU 2018-02), Income Statement - Reporting Comprehensive
Income (Topic 220). The guidance in ASU 2018-02 allows an entity to elect to reclassify the stranded tax effects related to the
Tax Cuts and Jobs Act (the Tax Act) of 2017 from accumulated other comprehensive income into retained earnings. ASU 2018-02 is
effective for fiscal years beginning after December 15, 2018, with early adoption permitted. Early adoption of the amendments
in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods
for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial
statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period
of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income
tax rate in the Tax Cuts and Jobs Act is recognized. BioLite does not expect the adoption of this standard to have a material
effect on its consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (&ldquo;Topic 820&rdquo;): Disclosure Framework - Changes to
the Disclosure Requirements for Fair Value Measurement. The ASU modifies the disclosure requirements in Topic 820, Fair Value
Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying existing disclosure requirements
related to measurement uncertainty and adding new disclosure requirements, such as disclosing the changes in unrealized gains
and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end
of the reporting period and disclosing the range and weighted average of significant unobservable inputs used to develop Level
3 fair value measurements. This ASU is effective for public companies for annual reporting periods and interim periods within
those annual periods beginning after December 15, 2019. BioLite is currently evaluating the effect, if any, that the ASU will
have on its financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the FASB issued ASU 2018-18,&nbsp;Collaborative arrangements (Topic 808): Clarifying the interaction between Topic
808 and Topic 606. ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should
be accounted for under ASC 606 when the counterparty is a customer and precludes an entity from presenting consideration from
a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for
that transaction. For public business entities, these amendments are effective for fiscal years beginning after December 2019,
and interim periods therein. Early adoption is permitted, including adoption in any interim period, for entities that have adopted
ASC 606. BioLite is currently evaluating the impact that ASU 2018-18 will have on its consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations- Year Ended December 31, 2018 compared to Year Ended December 31, 2017</B></FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The following tables set forth a summary
of BioLite&rsquo;s results of operations for the periods indicated. This information should be read together with BioLite&rsquo;s
financial statements and related notes included elsewhere in this prospectus. The operating results in any period are not necessarily
indicative of the results that may be expected for any future period. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Net revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Merchandise sales </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,324 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 940 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Merchandise
    sales-related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 632 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,256 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    net revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,956 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,196 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Cost of revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> &nbsp;Merchandise sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,893 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,249 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> &nbsp;Inventory
    valuation reserve </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 180,387 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0.25in"> &nbsp;Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 185,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,249 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,324 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 256,682 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,735,931 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,992,613 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,390,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,991,666 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,207 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (222,060 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,814 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (34,139 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain (loss) on foreign exchange
    changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (409,170 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (256,126 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,443,876 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 51,574 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,038,650 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Loss before income taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,330,174 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,030,316 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income taxes
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (360,395 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,669,921 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Net loss attributable to
    noncontrolling interests, net of tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,621,650 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss attributable to BioLite Holding, Inc. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,076 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,048,271 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Foreign currency translation
    adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,573 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,560,862 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,352,698 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2018, BioLite had total revenue of $6,956 compared to the total revenue of $3,196 for the year ended
December 31, 2017, representing an increase of $3,760, or 117.6%. BioLite&rsquo;s revenue increased in an insignificant amount
during the fiscal year of 2018 mainly because the increased demand from our clients.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
of Revenue</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
cost of revenue, which comprised mainly cost of merchandise sales and inventory valuation reserve, was $185,280 for the year ended
December 31, 2018 as compared to $2,249 for the year ended December 31, 2017, reflecting an increase of $183,031 or 8138%. The
significant year-to-year increase in cost of revenue was driven by the increase in inventory valuation reserve on inventories.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of BioLite&rsquo;s operating expenses for the years ended December 31, 2018 and 2017,
respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Operating expenses: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development
    expenses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 256,682 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,735,931 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,992,613 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs consist of clinical trials, sponsored research, and miscellaneous expenditures in laboratories. Research
and development expenses were $319,053 and $256,682 during the years ended December 31, 2018, and 2017, which represents an increase
of $62,371 or 24%. Such increase was primarily attributable to payments to our in-licensing collaborative partners for on-going
projects and for patent and licensing fees.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
incurred $893,570 in selling, general and administrative expenses for the fiscal year of 2018 as compared to $1,735,931 during
the fiscal year of 2017. The amounts of operating expenses for the year of 2018 decreased by $842,361 or (49)% from that of 2017
primarily because of the decrease in payroll and payroll related expenses, professional service fees, rent expenses, and entertainment
expenses during the year ended December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
income and expense </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the breakdown of our other income for the years ended December 31, 2018 and 2017, respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,207 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (222,060 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,884 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (34,139 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain (Loss) on foreign exchange
    changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (409,170 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (256,126 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,443,876 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 51,574 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,038,650 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
income or expenses </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
incurred interest expenses in the amounts of $306,821 and $222,060 during the years ended December 31, 2018 and 2017, respectively,
which reflected an increase of $84,761, or 38%. Such increase was due to the convertible notes issued in the fiscal year of 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
recognized investment loss of $395,476 and $34,139 during the years ended December 31, 2018 and 2017, respectively, which represented
an increase of $361,337, or 1058% in loss on disposition of equity securities. During the year ended December 31, 2018, Biolite
sold 552,000 shares of common stock of BioHopeKing at prices ranging from NT$25, equivalent $0.82, to NT$32, equivalent $1.05,
to two directors of BioHopeKing and 25 individuals, resulting in a recognition of investment loss of $395,476 for the same period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite&rsquo;s
position on loss on investment in equity securities substantially decreased, from $4,443,876 in 2017 to $256,126 in 2018, representing
a decrease of $4,187,750, or 94%. This decrease in loss on investment was primarily attributable to that BioLite recognized the
other-than-temporary impairments of non marketable equity investments of $4,277,708 during the year ended December 31, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
loss</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above, BioLite&rsquo;s net loss for the year ended December 31, 2018 was $1,963,227 as compared to a net loss
of $6,669,921 for the year ended December 31, 2017, which reflects a substantial decrease in net loss in the amount of $4,706,694
or (71)%. The decrease in net loss was due to the reasons described above.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
Flows</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes BioLite&rsquo;s cash flows for the year ended December 31, 2018 and 2017:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net Cash Used In Operating Activities </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (270,336 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,683,497 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net Cash Used In Investing Activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (156,372 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,708,126 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net Cash Provided By Financing Activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 303,864 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,325,297 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Effect of exchange rate changes
    on cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,016 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,979 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Net increase (decrease) in
    cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (126,860 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (57,347 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Cash and cash equivalents,
    beginning balance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 313,504 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 370,851 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Cash and cash equivalents,
    ending balance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 186,644 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 313,504 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $270,336 for the year ended December 31, 2018, which reflected a decline of $1,413,161 or
84% from cash used in operating activities of $1,683,497 for the year ended December 31, 2017. The decrease was mainly due to
the decreased net loss and loss on investment in equity securities, and the increased in accrued expenses and other current liabilities
and due to related parties.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities for the year ended December 31, 2018 was $156,372, which reflected a substantial decrease of
$7,551,754 or 98% as compared to net cash used in investing activities of $7,708,126 for the year ended December 31, 2017. The
decrease in net cash used in investing activities primarily because BioLite made more equity investments in collaborative partners
in Asia during the year ended December 31, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Financing
activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities for the year ended December 31, 2018 was $303,864, which was a substantial decrease of $9,021,433
or 97%, from net cash provided by financing activities of $9,325,297 for the year ended December 31, 2017. The decrease in net
cash provided by financing activities was mainly attributable to that BioLite didn&rsquo;t issue additional shares for cash in
2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_015"></A>BIOKEY&rsquo;S
MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</B><BR>
<B>AND RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
was incorporated on August 9, 2000 in the State of California. It is engaged primarily in research and development, manufacturing,
and distribution of generic drugs and nutraceuticals with strategic partners. BioKey provides a wide range of services, including,
API characterization, pre-formulation studies, formulation development, analytical method development, stability studies, IND/NDA/ANDA/510K
submissions, and manufacturing clinical trial materials (phase I through phase III) and commercial manufacturing. BioKey also
licenses out its technologies and initiates joint research and development processes with other biotechnology, pharmaceutical,
and nutraceutical companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey&rsquo;s
headquarters and GMP facility are located at 44370 Old Warm Springs Blvd., Fremont, CA, 94538.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey&rsquo;s
customers include new drug development companies, research institutions and nutraceutical companies in the United States, Taiwan,
China and other Asian countries. BioKey has a handful of clients that count for the majority of its revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
became a wholly-owned subsidiary of BioKey upon the closing of the Mergers on February 8, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Segments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
has primarily three business lines which provide complementary solutions to the market. Each has a different customer focus and
&ldquo;go to market&rdquo; approach. They are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Controlled-
    release platforms and ANDA applications</I></B>: provides various control-released platforms to both new and generic drug
    products to make the drug administration process smooth and convenient. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Generic
    drug development</I></B>: processes ANDA for drugs whose patents are expiring or expired and uses third-party distributors
    to sell the generic drugs that are approved by the FDA. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Contract
    development &amp; manufacturing organization (the &ldquo;CDMO&rdquo;)</I></B>: provides contracting, developing and manufacturing
    services to new drug development companies and research institutions.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations &mdash; Fiscal Year Ended December 31, 2018 Compared to the Year Ended December 31, 2017.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents, for the period indicated, BioKey&rsquo;s statements of operations information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> For
    The Years Ended<BR> December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,197 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 983,218 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,312 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Gross profit (loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,388 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 965,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Selling, general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,322 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 767,504 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Research and development
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,917 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 497,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,100,239 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,265,451 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (299,545 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income(expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,742 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> Other
    income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 630 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 459 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Total
    other income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,228 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,201 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss before provision income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (589,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (292,344 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (293,144 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenues.&nbsp;</I></B>BioKey
generated revenue of $510,197 and $983,218 during the years ended December 31, 2018 and 2017, respectively, which reflected a
decrease of $473,021 or 48%. Such decrease was primarily due to the substantial business changes of two of BioKey&rsquo;s major
customers, which resulted in significantly less demand of BioKey&rsquo;s CDMO services. Such changes were beyond BioKey&rsquo;s
control and BioKey intends to focus more on its own product development and simultaneously strengthen its marketing and sales
with respect to its contracting services. However, there is no assurance that BioKey or the new management of the combined entity
will be able to increase the revenue of the CDMO in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
of Revenues. </I></B>BioKey incurred costs of revenues in the amounts of $4,809 and $17,312 during the years ended December 31,
2018 and 2017. Costs of revenues of BioKey consist primarily of purchase of materials, outsourced services, and logistics expenses.
The cost of revenues decreased by $12,503 or 72% from the fiscal year of 2017 to the fiscal year of 2018 because BioKey reduced
the outsourcing activities and provided more services in-house to increase the efficiency and save overall costs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Gross
Profit.</I></B> As a result of the changes in revenues and cost of revenues, BioKey&rsquo;s gross profit decreased from $965,906
for the year ended December 31, 2017 to $505,388 for the year ended December 31, 2018, which represents a decrease of approximately
$460,518 or 48%.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses. </I></B>BioKey&rsquo;s operating expenses consist of research and development expenses and selling, general and administrative
expenses for the years ended December 31, 2018 and 2017. BioKey incurred $430,917 and $497,947 in research and development expenses
for the years ended December 31, 2018 and 2017, respectively. There was no substantial change in the research and development
expenses during the fiscal years of 2018 and 2017. BioKey incurred $669,322 and $767,504 in selling, general and administrative
expenses for the years ended December 31, 2018 and 2017, respectively, which reflected a decrease of $98,182 or 12.8%. Such decrease
was mainly attributable to the reduction of the senior management&rsquo;s salaries in 2018, partially offset by the increase in
professional service fees.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Loss.</I></B> The net loss was $590,423 and $293,144 for the years ended December 31, 2018 and 2017, respectively. The increase
in net loss was due to the reasons described above.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Working
Capital Summary</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December&nbsp;31, 2018<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December&nbsp;31, 2017<BR> ($) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 827,718 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,418,789 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,757 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Working Capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 744,692 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,339,032 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Flows</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Years Ended </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December
    31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows used in operating activities </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (552,469 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (240,071 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows used in investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (46,262 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,794 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Cash flows provided by financing
    activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net decrease in cash and cash
    equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (588,731 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (247,865 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flows from Operating Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $552,469 and $240,071 during the years ended December 31, 2018 and 2017, respectively, representing
an increase of $312,398, or 130%. This increase was primarily driven by the operating loss during the year ended December 31,
2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flows from Investing Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities was $46,262 during the year ended December 31, 2018 compared to $7,794 in the comparable period
of 2017, representing an increase of $38,468, or 493%. This increase was primarily driven by purchasing additional equipment for
operational use.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flows from Financing Activities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $10,000 during the year ended December 31, 2018 compared to $0 in the comparable period
of 2017, representing an increase of $10,000 or 100%. The increase in net cash provided by financing activities was due to the
issuance of common stocks of BioKey for cash.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
Obligations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
leases its main office in Fremont, California, under operating leases expiring on February 28, 2021. The monthly rent is approximately
$23,600. BioKey also leases office equipment with monthly payment of approximately $220 expiring on August 31, 2019. The total
rent expenses were $278,961 and $274,978 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payments under BioKey&rsquo;s operating leases are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <B>As of December
    31,</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Amount</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left"> 2019 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 304,726 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> 2020 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 310,239 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> 2021 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 51,910 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 666,875 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018 and December 31, 2017, BioKey had cash totaling approximately $636,666 and $1,225,397, respectively. Net
cash used in operating activities totaled approximately $552,469 and $240,071 for the years ended December 31, 2018 and 2017,
respectively. Net loss totaled approximately $590,423 and $293,144 for the years ended December 31, 2018 and 2017, respectively.
Total current assets were $827,718 and $1,418,789 as of December 31, 2018 and December 31, 2017, respectively. Total current liabilities
were $83,026 and $79,757 as of December 31, 2018 and December 31, 2017, respectively. Accordingly, BioKey had working capital
of $744,692and $1,339,032 as of December 31, 2018 and December 31, 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, BioKey did not have any off-balance sheet arrangements that have or are reasonably likely to have a current
or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures, or capital resources that is material to investors.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
summary of BioKey&rsquo;s significant accounting policies is as follows:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
of presentation:</B> The accompanying financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of estimates: </B>The preparation of financial statements in conformity with generally accepted accounting principles of United
States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
and cash equivalents: </B>For purposes of reporting cash flows, BioKey considers all highly liquid debt instruments purchased
with a maturity of three months or less to be cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts
receivable and other receivable: </B>Accounts receivable and other receivable are stated at carrying value less estimates made
for doubtful receivables. An allowance for impairment of trade receivable and other receivable is established if the collection
of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that BioKey will not be able
to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor,
probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are
considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset&rsquo;s
carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
and equipment: </B>Property and equipment are recorded at cost. Depreciation is computed on the straight-line method over the
estimated useful lives of the related assets as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 85%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laboratory
    and manufacturing equipment</FONT></TD>
    <TD STYLE="width: 15%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    ~5 years</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    ~8 years</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and fixtures</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8~15
    years</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
for major renewals and betterment that extend the useful lives of property and equipment are capitalized. Expenditures for repairs
and maintenance are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the asset
and accumulated depreciation are removed from the accounts and the resulting profit or loss is reflected in the statement of income
for the period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impairment
of long-lived assets: </B>BioKey reviews its long-lived assets whenever events or circumstances indicate that the carrying amount
of such assets may not be recoverable. Impairment is evaluated by comparing the carrying value of the long-lived assets with the
estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition.
Should the sum of the expected future net cash flows be less than the carrying value, BioKey would recognize an impairment loss
at that date. An impairment loss would be measured by comparing the amount by which the carrying value exceeds the fair value
(estimated discounted future cash flows) of the long-lived assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
recognition: </B>During fiscal year 2018, BioKey adopted Accounting Standards Codification (&ldquo;ASC&rdquo;), Topic 606 (ASC
606), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were not completed
as of January 1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at
the beginning of 2018 for the cumulative effect. The results for BioKey&rsquo;s reporting periods beginning on and after January
1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting
standards in effect for the prior period. Based on BioKey&rsquo;s review of existing contracts as of January 1, 2018, BioKey concluded
that the adoption of the new guidance did not have a significant change on BioKey&rsquo;s revenue during all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, BioKey recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects
the consideration that BioKey expects to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that BioKey determines is within the scope of ASC 606, BioKey performs the following five steps: (i) identify the
contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price;
(iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) BioKey
satisfies a performance obligation. BioKey only applies the five-step model to contracts when it is probable that BioKey will
collect the consideration BioKey is entitled to in exchange for the goods or services BioKey transfers to the customers. At inception
of the contract, once the contract is determined to be within the scope of ASC 606, BioKey assesses the goods or services promised
within each contract, determines those that are performance obligations, and assesses whether each promised good or service is
distinct. BioKey then recognizes as revenue the amount of the transaction price that is allocated to the respective performance
obligation when (or as) the performance obligation is satisfied. Generally, BioKey's performance obligations are transferred to
customers at a point in time, typically upon delivery.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
currently only has one major revenue source, which is research and development activities services.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
related to research and development and regulatory activities are recognized when the related services or activities are performed,
in accordance with the contract terms. BioKey typically has only one performance obligation at the inception of a contract, which
is to perform research and development services. BioKey may also provide its customers with an option to request that BioKey provides
additional goods or services in the future, such as active pharmaceutical ingredient, API, or IND/NDA/ANDA/510K submissions. BioKey
evaluates whether these options are material rights at the inception of the contract. If BioKey determines an option is a material
right, BioKey will consider the option a separate performance obligation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
BioKey is entitled to reimbursement from its customers for specified research and development expenses, BioKey accounts for the
related services that it provides as separate performance obligations if it determines that these services represent a material
right. BioKey also determines whether the reimbursement of research and development expenses should be accounted for as revenues
or an offset to research and development expenses in accordance with provisions of gross or net revenue presentation. BioKey recognizes
the corresponding revenues or records the corresponding offset to research and development expenses as it satisfies the related
performance obligations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
then determines the transaction price by reviewing the amount of consideration BioKey is eligible to earn under the contracts,
including any variable consideration. Under the outstanding contracts, consideration typically includes fixed consideration and
variable consideration in the form of potential milestone payments. At the start of an agreement, BioKey&rsquo;s transaction price
usually consists of the payments made to or by BioKey based on the number of full-time equivalent researchers assigned to the
project and the related research and development expenses incurred. BioKey does not typically include any payments that BioKey
may receive in the future in its initial transaction price because the payments are not probable. BioKey would reassess the total
transaction price at each reporting period to determine if BioKey should include additional payments in the transaction price.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
receives payments from its customers based on billing schedules established in each contract. Upfront payments and fees may be
recorded as advance from customers upon receipt or when due, and may require deferral of revenue recognition to a future period
until BioKey performs its obligations under these arrangements. Amounts are recorded as accounts receivable when the right of
BioKey to consideration is unconditional. BioKey does not assess whether a contract has a significant financing component if the
expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods
or services to the customers will be one year or less.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advertising
costs: </B>Advertising costs are expensed as incurred. The total advertising and marketing expenses were $0 for the years ended
December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and development:</B> BioKey accounts for R&amp;D costs in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
730, Research and Development (&ldquo;ASC 730&rdquo;). Research and development expenses are charged to expense as incurred unless
there is an alternative future use in other research and development projects or otherwise. Research and development expenses
are comprised of costs incurred in performing research and development activities, including personnel-related costs, facilities-related
overhead, and outside contracted services including clinical trial costs, manufacturing and process development costs for both
clinical and preclinical materials, research costs, and other consulting services. Non-refundable advance payment for goods and
services that will be used in future research and development activities are expensed when the activity has been performed or
when the goods have been received rather than when the payment is made. In instances where BioKey enters into agreements with
third parties to provide research and development services, costs are expensed as services are performed.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
taxes: </B>BioKey accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that BioKey recognize deferred
tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets
and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit
(expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when,
in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized. BioKey
provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuation
of deferred tax assets: </B>A valuation allowance is recorded to reduce its deferred tax assets to the amount that is more likely
than not to be realized. In assessing the need for the valuation allowance, management considers, among other things, projections
of future taxable income and ongoing prudent and feasible tax planning strategies. If BioKey determines that sufficient negative
evidence exists, then it will consider recording a valuation allowance against a portion or all of the deferred tax assets in
that jurisdiction. If, after recording a valuation allowance, BioKey&rsquo;s projections of future taxable income and other positive
evidence considered in evaluating the need for a valuation allowance prove, with the benefit of hindsight, to be inaccurate, it
could prove to be more difficult to support the realization of its deferred tax assets. As a result, an additional valuation allowance
could be required, which would have an adverse impact on its effective income tax rate and results. Conversely, if, after recording
a valuation allowance, BioKey determines that sufficient positive evidence exists in the jurisdiction in which the valuation allowance
was recorded, it may reverse a portion or all of the valuation allowance in that jurisdiction. In such situations, the adjustment
made to the deferred tax asset would have a favorable impact on its effective income tax rate and results in the period such determination
was made. In determining the need for a valuation allowance, management reviewed both positive and negative evidence pursuant
to the requirements of ASC Topic 740. At December 31, 2018, management concluded that it is more likely than not that BioKey would
not realize benefits of its net deferred tax assets. BioKey will continue to evaluate the need for a valuation allowance in future
periods based upon the criteria as provided for under ASC Topic 740.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
applied the provisions of ASC 740-10-50, &ldquo;Accounting For Uncertainty In Income Taxes&rdquo;, which provides clarification
related to the process associated with accounting for uncertain tax positions recognized in its financial statements. Audit periods
remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute
of limitations for a given audit period could result in an adjustment to BioKey&rsquo;s liability for income taxes. Any such adjustment
could be material to BioKey&rsquo;s results of operations for any given quarterly or annual period based, in part, upon the results
of operations for the given period. As of December 31, 2018 and 2017, management considered that BioKey had no uncertain tax positions,
and will continue to evaluate for uncertain positions in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concentration
of credit risks: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
and cash equivalents: </B>BioKey maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.
Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. As of December 31, 2018 and 2017,
BioKey had $342,063 and $963,763 in excess of FDIC insured limits, respectively. BioKey has not experienced any losses in such
accounts.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Customers</B>:
BioKey performs ongoing credit evaluations of its customers&rsquo; financial condition and generally, requires no collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2018, Two customers who accounted for more than 10% of BioKey&rsquo;s total net sales revenues, representing
approximately 38.8% and 15% of total net sales revenues, and 0% and 0% of accounts receivable in aggregate at December 31, 2018,
respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> <B>Customer</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Net
    sales&nbsp;for the year </B><BR> <B>2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Accounts</B><BR>
    <B>receivable </B><BR>
    <B>balance&nbsp;as of</B><BR> <B>December&nbsp;31,</B><BR> <B>2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> A </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 167,596 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> B </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,746 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2017, five customers who accounted for more than 10% of BioKey&rsquo;s total net sales revenues, representing
approximately 28%, 15%, 14%, 10%, and 10% of total net sales revenues, and 0%, 8%, 0%, 1%, and 69% of accounts receivable in aggregate
at December 31, 2017, respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> <B>Customer</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Net
    sales for the year </B><BR> <B>2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Accounts
    receivable balance&nbsp;as of </B><BR> <B>December&nbsp;31,</B><BR> <B>2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> A </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 273,966 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> B </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 150,450 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,950 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> C </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 141,674 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> D </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,300 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> E </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 88,085 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 134,312 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> * </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Related party transactions (See Note 3).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suppliers:
</B>BioKey currently is not entering any significant purchase agreements with suppliers for the years ended December 31, 2018
and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
value measurements:</B> FASB ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial and nonfinancial
assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures
about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price,
maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a
hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency
and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing
the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect
the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources
independent of BioKey. Unobservable inputs are inputs that reflect BioKey&rsquo;s own assumptions about the assumptions market
participants would use in pricing the asset or liability developed based on the best information available in the circumstances.
The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that BioKey has the ability to access
    at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based
    on quoted prices in active markets that are readily and regularly available.</FONT> </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
    date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
    that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
    and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that
    incorporate the assumptions a market participant would use in pricing the asset or liability.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of BioKey, such as cash and cash equivalents, accounts receivable, accounts
payable, accrued liabilities, and advance from customers, approximate fair value due to their relatively short maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-based
compensation: </B><FONT STYLE="background-color: white">BioKey accounts for its stock-based compensation in accordance with ASC
718, Compensation&mdash;Stock Compensation, which establishes accounting for stock-based awards granted to employees for services
and requires companies to expense the estimated fair value of these awards over the requisite service period. BioKey estimates
the fair value of all awards granted using the Black-Scholes valuation model. Key inputs and assumptions include the expected
term of the option, stock price volatility, risk-free interest rate, dividend yield, stock price and exercise price. Many of the
assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation
expense. BioKey elected an accounting policy to record forfeitures as they occur. BioKey recognizes employee stock-based compensation
expense based on the fair value of the award on the date of the grant. The compensation expense is recognized over the vesting
period under the straight-line method. </FONT>During the years ended December 31, 2018 and 2017, BioKey did not record any employee
stock-based compensation expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">BioKey
accounts for options awards granted to nonemployee consultants and directors under ASC 505 Equity. The fair value of the option
issued or committed to be issued is used to measure the transaction, as this is more reliable than the fair value of the services
received. The fair value is measured at the value of BioKey&rsquo;s common stock at the earlier of the date that the commitment
for performance by the counterparty has been reached or the counterparty&rsquo;s performance is complete. Awards granted to nonemployees
are remeasured to fair value at each period end date until vested and expensed on a straight-line basis over the vesting period.
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2018
and 2017, the stock-based compensation expenses to non-employee consultants were $833 and $0, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Profit
sharing plan:</B> BioKey has a 401 (k) profit sharing plan for employees who have reached the age of twenty-one and have completed
one year of eligibility service. BioKey&rsquo;s contribution is based on management&rsquo;s discretion. In addition, BioKey may
make a nonelective contributions to the plan. The amount of the nonelective contribution is determined by its Board of Directors
on an annual basis. Total contributions that BioKey made to the plan were $0 for the years ended December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recently
issued accounting pronouncements: </B>In February 2016, the FASB issued ASU No. 2016-02, &ldquo;Leases.&rdquo; The core principle
of the ASU is that a lessee should recognize the assets and liabilities that arise from its leases other than those that meet
the definition of a short-term lease. The ASU requires extensive qualitative and quantitative disclosures, including with respect
to significant judgments made by management. Subsequently, the FASB issued ASU No. 2017-13, in September 2017 and ASU No. 2018-01,
in January 2018, which amends and clarifies ASU 2016-02. The ASU will be effective for BioKey beginning January 1, 2019, including
interim periods in the fiscal year 2019. Early adoption is permitted. BioKey is in the process of determining the method of adoption
and assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete. In March 2018, the FASB issued ASU 2018-05,
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05
provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S.
Tax Cuts and Jobs Act (the &ldquo;2017 Tax Act&rdquo;). To the extent that a company&rsquo;s accounting for certain income tax
effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate
to be included in the financial statements. If a company cannot determine a provisional estimate to be included in the financial
statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were in effect immediately
before the enactment of the Tax Act. While BioKey is able to make reasonable estimates of the impact of the reduction in corporate
rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates, due to, among
other things, changes in our interpretations and assumptions, additional guidance that may be issued by the I.R.S., and actions
we may take. BioKey is continuing to gather additional information to determine the final impact.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2018, the FASB issued ASU 2018-07, Compensation &ndash; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based
Payment Accounting. This new standard simplifies the accounting for share-based payments granted to nonemployees for goods and
services. The standard supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payment arrangements
related to the acquisition of goods and services from both nonemployees and employees. As such, among others, the measurement
date for nonemployee awards would generally be the grant date same as the measurement date for employee equity awards and for
performance-based awards, an entity is required to recognize any cost on the basis of the probable outcome of the performance&nbsp;conditions
using the grant-date fair value of the award. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including
interim periods within those fiscal years. <FONT STYLE="background-color: white">BioKey is continuing to gather additional information
to determine the final impact and</FONT> expects to adopt this guidance when effective.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &mdash; Changes to
the Disclosure Requirements for Fair Value Measurement. This standard changes the fair value measurement disclosure requirements
of ASC 820. The new standard eliminated certain disclosures, added new disclosures with regard to unrealized gains or losses included
in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range
and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements, as well as modified
certain disclosure. ASU 2018-13 is effective for all entities for fiscal years beginning after December 15, 2019, including interim
periods therein. Early adoption is permitted. The ASU requires application of the prospective method of transition for the aforementioned
new disclosure requirements and for modified disclosure with regard to measurement uncertainty while all other amendments made
by the ASU must be applied retrospectively to all periods presented. BioKey is in the process of assessing the impact of this
standard on its financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
and disagreements with accountants on accounting and financial disclosure</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, BioKey had no changes in and disagreements with accountants on accounting and financial disclosure.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quantitative
and Qualitative Disclosures about Market Risks</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_016"></A>BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Industry</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology industry focuses on developing breakthrough products and technologies to combat various types of diseases through
efficient industrial manufacturing process. Such industry is an important business sector in the world&rsquo;s economies&nbsp;and
plays a key role in human health. Biotechnology&nbsp;companies generally require large amounts of capital investment for their
research &amp; development activities. It may take up to tens of years to develop and commercialize a new drug or a new medical
device. American BriVision (Holding) Corporation (&ldquo;we&rdquo; or the &ldquo;Company&rdquo;) is an early stage biotechnology
company with a pipeline of six new drugs and one medical device under development, all of which are licensed&nbsp;from related
parties of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Overview</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical stage biopharmaceutical company focused on utilizing our licensed technology to (i) further the development of
pharmaceutical products with focuses on cancer and central nervous system indications, (ii) target patients that may potentially
respond to such pharmaceutical products and (iii) obtain regulatory approvals for and commercialize such pharmaceutical products
in various markets. Our business model includes the following steps and stages: 1) engaging medical research institutions, such
as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) and MD Anderson Cancer Center, to conducting clinical trials of
translational medicine for Proof of Concept (&ldquo;POC&rdquo;) on behalf of the Company; 2) retaining ownership of the research
results by the Company, and 3) out-licensing the research results and data to pharmaceutical companies who will develop the products.
We currently have no revenue generated from clinical research and development of six new drugs and one medical device, which is
our primary business operations. Currently, we concentrate on the research and development of six new drugs licensed to us by
BioLite Inc. (&ldquo;BioLite Taiwan&rdquo;), a subsidiary of the Company. The six new drugs are ABV- 1501 Triple Negative Breast
Cancer, ABV-1504 Major Depressive Disorder, ABV-1505 Attention Deficit Hyperactivity Disorder and Maitake Combination Therapy,
ABV-1703 for the treatment of Pancreatic Cancer, ABV-1702 to treat Myelodysplastic syndromes and ABV-1601&nbsp;Treating Depression
in Cancer Patients. In addition, we are licensed to research and develop a medical device, ABV-1701 Vitargus for the treatments
of Retinal Detachment or Vitreous Hemorrhage, a new medical device licensed from BioFirst Corporation, (&ldquo;BioFirst&rdquo;).
BioFirst is a related party of the Company because a controlling beneficiary shareholder of YuanGene Corporation and the Company
is one of the directors and primary shareholder of BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consummation
of the Mergers&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in a registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009520/fs42018_americanbrivision.htm">Form S-4</A> filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on
July 23, 2018, as amended from time to time, the Company, BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), BioKey, Inc. (&ldquo;BioKey&rdquo;),
BioLite Acquisition Corp., a direct wholly-owned subsidiary of the Company (&ldquo;Merger Sub 1&rdquo;), and BioKey Acquisition
Corp., a direct wholly-owned subsidiary of the Company (&ldquo;Merger Sub 2&rdquo;) were in the process of completing business
combination pursuant to the Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) dated as of January 31, 2018 where
ABVC would acquire BioLite and BioKey via issuing additional shates of Common Stock to the shareholders of BioLite and BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed on a current report on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019002622/f8k020819_americanbrivision.htm">Form 8-k</A> filed with the SEC on February 14, 2019, on February 8, 2019, the parties to the Merger
Agreement consummated the merger transactions contemplated thereunder. Pursuant to the terms of the Merger Agreement, BioLite
and BioKey have become two wholly-owned subsidiaries of the Company on February 8, 2019. The Company issued an aggregate of approximately
104,558,777 shares of its Common Stock as consideration to the shareholders of BioLite and BioKey pursuant to the registration
statement (the &ldquo;Registration Statement on S-4&rdquo;) on Form S-4, as amended, which became effective by operation of law
on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our&nbsp;Compounds
Licensed from BioLite</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently co-developing six new drug candidates with BioLite and BioLite Taiwan. Below is the description of each of the six
new drug candidates.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-
    1501 Triple Negative Breast Cancer - Combination therapy for Triple Negative Breast Cancer (&ldquo;TNBC&rdquo;)</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-
    1501 is developed from BLI-1401-2 whose active pharmaceutical ingredient is Yukiguni Maitake Extract 404. MSKCC conducted
    the Phase I clinical trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom), which is very similar to
    Yukiguni Maitake Extract 404. The Phase I trial focused on Grifola frondosa extract&rsquo;s immunological effects on breast
    cancer patients. The results of the Phase I trial showed that oral administration of a polysaccharide extract from Maitake
    mushroom is associated with both immunologically stimulatory and inhibitory measurable effects in peripheral blood. </FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Investigational New Drug (&ldquo;IND&rdquo;) application of ABV-1501 for the Phase II clinical trials referenced with MSKCC
    Maitake and such Phase II IND was approved in March 2016 by the U.S. FDA.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are currently collaborating with BHK and in the process to file clinical trial application to the Taiwan FDA (&ldquo;TFDA&rdquo;)
    for conducting this combination therapy trial in Taiwan.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1504
    Major Depressive Disorder (&ldquo;MDD&rdquo;)&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine. Prior to clinical trials,
we, through BioLite Taiwan, conducted radioligand-binding assay tests on ABV-1504. Radioligand-binding assays are used to characterize
the binding effects of a drug to its target receptor. In the case of ABV-1504, the receptors of radioligand-binding assays are
norepinephrine, dopamine and serotonin. The radioligand-binding assay test on norepinephrine was conducted from May 3 to May 8,
2007 and the radioligand-binding assay test on dopamine and serotonin was administered from November 26 to December 5, 2007. The
result of radioligand-binding assay to norepinephrine of ABV-1504was 2.102 &mu;g/ml of IC50, which indicated ABV-1504&rsquo;s
high inhibitory efficiency on norepinephrine. The results of radioligand-binding assay to dopamine and serotonin were not as good
as to norepinephrine, which indicated lower inhibitory efficiency. Because research has shown that norepinephrine inhibitors can
alleviate the level of depression, our research team saw ABV-1504&rsquo;s potential to treat depression and decided to commence
the clinical trial process of ABV-1504.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2013, ABVC, through BioLite, successfully completed the Phase I clinical trial of ABV-1504. The primary objective of the Phase
I study was to assess the safety profile of ABV-1504. The safety endpoint was assessed based on the results of physical examinations,
vital signs, laboratory data, electrocardiograms (&ldquo;ECG&rdquo;), Columbia-Suicide Severity Rating Scale evaluation and a
number of adverse events during the study period. We began recruiting healthy people as subjects for the Phase I trial in Taiwan
on October 30, 2012. For the Phase I trial, we screened 85 healthy volunteers at the Taipei Veterans General Hospital and eventually
enrolled 30 people as trial subjects. We divided the subjects into four cohort groups and administered ABV-1504oral capsules of
380 mg, 1140 mg, 2280 mg, and 3800 mg to the subjects in each cohort group, respectively. BioLite visited the first subject the
first time on November 13, 2012 and the last subject the last time on July 5, 2013. During the said period, no subject had a serious
adverse event nor discontinued the trial due to any adverse events. ABVC did not observe any clinically significant findings in
physical examinations, vital signs, electrocardiogram, laboratory measurements, and C-SSRS throughout the treatment period. However,
ABVC observed the following mild adverse events: two subjects with flatulence and one subject with constipation in the single-dose
380mg cohort of seven subjects; one subject with somnolence and one subject with stomatitis ulcer in the single-dose 2,280 mg
cohort. Comparatively, two subjects with somnolence and one subject with stomatitis ulcer were observed in the placebo group of
seven subjects. ABVC did not observe any suicidal ideation or behavior throughout the trial period. ABV-1504&rsquo;s Phase I clinical
trial results reflected that the oral administration of ABV-1504 to healthy volunteers was safe and well-tolerated at the dose
levels of from 380 mg to 3,800 mg.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
received an IND approval to proceed with the Phase II clinical trial of ABV-1504 from the F.D.A. in March 2014 and an IND approval
of its Phase II trial from the Taiwan F.D.A. in June 2014. For the Phase II trial, BioLite administered oral capsules to 72 MDD
patients (the trial subjects) in a randomized, double-blind study with a placebo control group to assess ABV-1504&rsquo;s efficacy
and safety profile, primarily in accordance with the Montgomery-&Aring;sberg Depression Rating Scale (&ldquo;MADRS&rdquo;). ABVC
via BioLite began recruiting Phase II subjects in March 2015 at the following study sites, Taipei Veterans General Hospital, Linkou
Chang Gung Memorial Hospital, Taipei City Hospital-Songde Branch, Tri-Service General Hospital, Wan Fang Hospital and started
recruiting MDD patients at Stanford Depression Research Clinic. The first five sites are in Taiwan and the last one is in the
United States. The primary endpoint of the Phase II trial is to see changes of the subjects&rsquo; MADRS total scores from the
baseline scores of the placebo subjects within the first six weeks. The secondary objectives of the Phase II trial are to evaluate
the efficacy and safety profile of ABV-1504 on other rating scales with secondary endpoints of (i) demonstrating changes in MADRS
total scores from baseline scores within the second to seventh weeks and (ii) showing changes in the total scores on Hamilton
Rating Scale for Depression (HAM-D-17), Hamilton Rating Scale for Anxiety (HAM-A), Depression and Somatic Symptoms Scale (DSSS),
Clinical Global Impression Scale (CGI) from the baseline scores in the second, fourth, sixth and seventh week. ABVC plans to measure
the percentages of partial responders (subjects with a 25% to 50% decrease of total MADRS scores from the baseline score) and
responders (subjects with 50% or more decrease of total MADRS scores from the baseline score) by the second, fourth, sixth and
seventh week. Additionally, ABVC intends to monitor the subjects&rsquo; performance in accordance with the Safety Assessments
and Columbia-Suicide Severity Rating Scale from the screening stage to each subject&rsquo;s last visit as well as to analyze the
differences in the mean changes of MADRS, HAM-D-17, HAM-A, DSSS, CGI and Columbia-Suicide Severity Rating Scale scores of the
subjects administered with ABV-1504 and the placebo group in the second, fourth, sixth and seventh week.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this propsectus, ABVC completed the Phase II study of ABV-1504. On May 23, 2019, the Company announced the Phase
II clinical study results of ABV-1504. The clinical study results showed that PDC-1421, the active pharmaceutical ingredient of
ABV-1504, met the pre-specified primary endpoint of the Phase II clinical trial and significantly improved the symptoms of MDD.
The Phase II clinical study was a randomized, double-blind, placebo-controlled, multi-center trial, in which sixty (60) adult
patients with confirmed moderate to severe MDD were treated with PDC-1421 in either low dose (380 mg) or high dose (2 x 380 mg)
compared with placebo administration, three times a day for six weeks. PDC-1421 high dose (2 x 380 mg) met the pre-specified primary
endpoint by demonstrating a highly significant 13.2-point reduction in the Montgomery-&Aring;sberg Depression Rating Scale (MADRS)
total score by Intention-To-Treat (ITT) analysis, averaged over the 6-week treatment period (overall treatment effect) from baseline,
as compared to 9.2-point reduction of the placebo group. By Per-Protocol (PP) analysis, PDC-1421 showed a dose dependent efficacy
toward MDD in which high dose (2 x 380 mg) gave 13.4-point reduction in MADRS total score from baseline and low dose (380 mg)
gave 10.4-point reduction as compared to a 8.6-point in the placebo group.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
treatment in both PDC-1421 low dose (380 mg, TID) and high dose (2 x 380 mg, TID) were found safe and well tolerated with no serious
adverse events and responsive to MDD. Based on the trial results as set forth above, the Company has decided to use the high dose
formula for ABV-1504&rsquo;s Phase III clinical trial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">III.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1505
    Attention Deficit Hyperactivity Disorder (&ldquo;ADHD&rdquo;)</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
via BioLite, developed the ADHD indication from the same API of ABV-1504. Also ABV-1505 shares the similar pharmaceutical mechanism
of action as ABV-1504 in as much as ABV-1505 shows the potential of increasing the level of norepinephrine in the human&rsquo;s
nervous system by inhibiting its reabsorption. Because of ABV-1505&rsquo;s sufficient similarity with ABV-1504, in January 2016
the FDA approved our IND application to conduct ABV-1505&rsquo;s Phase II clinical trial based on its pretrial research and Phase
I trial results of ABV-1504.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Phase II trial, ABVC plans to recruit a maximum number of 105 ADHD patients as trial subjects in the United States, to whom
ABVC intends to administer ABV-1505 oral capsules. ABVC together with its CROs designed a randomized, double-blind dose escalation
study with a placebo-controlled group to assess the efficacy and safety profile of ABV-1505, primarily against the ADHD Rating
Scale-IV (&ldquo;ADHD-RS-IV&rdquo;). The primary endpoint of the Phase II trial is a 40% or higher improvement on the ADHD-RS-IV
from the respective baseline scores within a period of up to eight weeks. The secondary objective is to determine the efficacy
and safety profile of ABV-1505 on other rating scales with secondary endpoints of (i) improvements of the total ADHD symptom scores
from the respective baseline scores on the Conners&rsquo; Adult ADHD Rating Scale-Self Report: Short Version (&ldquo;CAARS-S:S&rdquo;)
18-Item for a treatment period of eight weeks at maximum;and (ii) achievement of scores of two or lower on both the Clinical Global
Impression-ADHD- Severity (&ldquo;CGI-ADHD-S&rdquo;) and Clinical Global Impression-ADHD-Improvement (&ldquo;CGI-ADHD-I&rdquo;)
from the subjects&rsquo; respective baseline scores. As of the date of this prospectus, ABVC was engaging with the Univesity of
California San Fransisco (&ldquo;UCSF&rdquo;) for conducting the Phase II trial which consists of Part I and Part II. Part I clinical
protocol, which is an open trial, has been approved by UCSF IRB Committee and the US FDA and will be initiated in the second quarter
of 2019, subject to our financial resources. We cannot guaranty that ABVC will begin the Part I Phase II clinical study of ABV-1505
as planned.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IV.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1702
    to treat Myelodysplastic syndromes (&ldquo;MDS&rdquo;)</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
BioLite, ABVC started the preparation for ABV-1702&rsquo;s Phase II clinical trials after receiving its IND approval from the
FDA in July 2016. ABVC plans to recruit fifty-two subjects in the United States who are diagnosed with either IPSS int-1, IPSS
int-2 or high risk MDS or CMML and may take azacitidine as part of the subjects&rsquo; prescription. Azacitidine is an FDA-approved
drug used to treat MDS. ABVC intends to administer ABV-1702 in the oral liquid form along with azacitidine. The Phase II trial
is divided into two parts, where Part 1 is to determine the safety and recommended dose level (&ldquo;RDL&rdquo;) of ABV-1702
in combination with azacitidine and Part 2 is to determine whether ABV-1702 under the established RDL reduces bactericidal and
fungicidal infection in the subjects&rsquo; respiratory systems. The primary endpoint of Part 1 Phase II trial is to assess the
safety and RDL profile of ABV-1702 administered with azacitidine by measuring ABV-1702&rsquo;s prohibited toxicity. The secondary
endpoints of Phase II Part 1 are to determine the safety, time-to-first infection after first dose (Day 1) of the first azacitidine
treatment cycle, reduction in treatment requirements and duration of infections, enhancement of immune responses, improvements
of response rates, progression, and survival rates of the subjects under such ABV-1702 - azacitidine combination treatment. The
primary endpoint of Part 2 of Phase II is to determine whether ABV-1702 under the established RDL reduces bactericidal and fungicidal
infection risks in the subjects&rsquo; respiratory systems in combination with azacitidine as compared to the control group with
incidence of infections and incidence/frequency of inpatient hospitalization due to infections. The secondary endpoints of Part
2 of Phase II are to determine the safety, time-to-first infection after first dose (Day 1) of the first azacitidine treatment
cycle, reduction in required dosage and duration of infection, enhancement of immune responses, improvement of response rate,
progression, and survival rates of the subjects under the trial conditions. In April 2016, BioLite submitted a letter to the FDA
in response to its queries with additional information about the proposed Phase II trial.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, ABVC intends to commence the Phase II clinical trials of ABV-1702 in the fourth quarter of 2019
although neither BioLite nor ABVC can guaranty that the Phase II trial will be initiated as planned. Due to the scarcity of MDS
cases, BioLite applied for the orphan drug designation for ABV-1702 or BLI-1301.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">V.</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1703
    Pancreatic Cancer</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
developed a new indication for Pancreatic Cancer from Maitake Extract, which is named as ABV-1703 and out licensed it to Rgene
for the preparation of its IND application with the FDA. On August 25, 2017, ABV-1703&rsquo;s Phase II trial was approved by FDA.
Pursuant to the ABVC-Rgene Co-development Agreement, ABVC is responsible for coordinating and conducting the clinical trials of
ABV-1703 globally and Rgene is responsible for preparing the related FDA applications. As of the date of this prospectus, we are
engaging Cedars-Sinai Medical Center in the U.S. to conduct the Phase II clinical trial and plan to initiate the Phase II trial
in the fourth quarter of 2019. We plan to submit ABV-1703&rsquo;s Phase II clinical trial IND to the Taiwan FDA after we commence
the clinical trials in the United States.&nbsp;However, there is no guaranty that we would be able to launch the Phase II trials
of ABV-1703 as planned in either the U.S. or Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VI.</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1601&nbsp;Treating
    Depression in Cancer Patients</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
developed the treatment of depression in cancer patient indication from the same API as ABV-1504. In addition, ABV-1601 shares
the similar pharmaceutical mechanism of action of ABV-1504 in as much as ABV-1601 shows the potential of increasing the level
of norepinephrine in human&rsquo;s nervous system by inhibiting its reabsorption. Because of ABV-1601&rsquo;s sufficient similarity
with ABV-1504, the FDA approved our ABV-1601-001 clinical protocol under IND 112567 (the same IND as for ABV-1504) in December
2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Phase II trial, ABVC plans to recruit a maximum number of 54 cancer patients with depression, to whom ABVC intends to administer
ABV-1601 oral capsules. ABVC is engaging the Principal Investigator at Cedars-Sinai Medical Center in the U.S. which designed
a randomized, double-blind dose escalation study with a comparator-controlled group to assess the efficacy and safety profile
of ABV-1601, primarily against Montgomery-&Aring;sberg Depression Rating Scale (MADRS) total score. The primary endpoint of the
Phase II trial is change in MADRS, Hospital Anxiety and Depression Scale (HADS), and subscales (HADS-A and HADS-D), and Clinical
Global Impression Scale (CGI) total scores from baseline in patients taking PDC-1421 compared to the comparator. As of the date
of this prospectus, the Part I of Phase II clinical protocol, which is an open trial, has been submitted to Cedars-Sinai Medical
Center IRB Committee for review and approval.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 24px"></TD><TD STYLE="width: 24px; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VII.</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABV-1701
                                         Vitreous Substitute for Vitrectomy and Collaboration Agreement with BioFirst</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2017, BriVision, one of our wholly-owned subsidiaries entered into a collaboration agreement (the &ldquo;BioFirst Agreement&rdquo;)
with BioFirst Corporation (&ldquo;BioFirst&rdquo;), a corporation incorporated under the laws of Taiwan, pursuant to which BioFirst
granted BriVision the global license to co-develop BFC-1401 Vitreous Substitute for Vitrectom (&ldquo;BFC-1401&rdquo;) for medical
purposes. BioFirst is a related party to the Company because BioFirst and Yuangene Corporation (&ldquo;Yuangene&rdquo;), the Company&rsquo;s
controlling shareholder, are under common control, being both controlled by the controlling beneficiary shareholder of Yuangene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the BioFirst Agreement, we are to co-develop and commercialize BFC-1401 or ABV-1701 with BioFirst and are obligated to pay
BioFirst $3,000,000 (the &ldquo;Total Payment&rdquo;) in cash or common stock of BriVision on or before September 30, 2018 in
two installments. An upfront payment of $300,000, representing 10% of the Total Payment due under the Collaboration Agreement,
was to be paid upon execution of the BioFirst Agreement. BriVision is entitled to receive 50% of the future net licensing income
or net sales profit when ABV-1701 is sublicensed or commercialized. For more information about the BioFirst Agreement, please
refer to the current report on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017007869/f8k072417_americanbrivision.htm">Form 8-K</A> filed on July 24, 2017. As of date of this prospectus, the Company has not made the payment
of $3,000,000 to BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2016, the application of Phase I clinical trial prepared and submitted by BioFirst was approved by the Human Research
Ethics Committee, Australia (&ldquo;HREC&rdquo;), and on November 14, 2016, it was approved by the Therapeutic Goods Administration,
Australia (&ldquo;TGA&rdquo;).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
successfully finished the Phase I clinical trial of ABV-1701 at Sydney Retina Clinic and Day Surgery, a clinic located in Sydney,
Australia. This was the only site for this Phase I clinical trial. The trial started on November 17, 2016, and was completed with
positive results in July 2018. The Protocol Title is &ldquo;A Phase I, single center, safety and tolerability study of Vitargus
in the treatment of Retinal Detachment.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint of this Phase I clinical trial was to evaluate the safety and tolerability of a single intravitreal dose of Vitargus
in patients as a vitreous substitute during vitrectomy surgery for retinal detachment. Intravitreal is a route of administration
of a drug or other substance, in which the substance is delivered into the eyes. The secondary endpoint of this Phase I clinical
trial is to assess retinal attachment and Virtagus degradation at day 90 and to assess best corrected visual acuity (&ldquo;BVCA&rdquo;)
after vitrectomy surgery. BVCA refers to the best possible vision a person can achieve. The primary and second endpoints are required
by HREC for the purpose of evaluation of our Phase I clinical trial application. We enrolled an aggregate number of 10 patient
subjects in this trial. On November 17, 2016, we received the approval from the Data and Safety Monitoring Board for the first
subject, and nine more subjects were enrolled thereafter. In this trial, Vitargus was injected into the vitreous cavity of vitrectomised
eyes, whose vitreous gel was removed from the vitreous cavity after a vitrectomy surgery. As of the date of this prospectus, we
were in the process of preparing the final clinical study report for the Phase I trial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are planning the pivotal study for ABV-1701 which is the next step after the successful completion of the Phase I clinical trial
and the necessary step to obtain the Premarket Approval for this device. The pivotal study for ABV-1701 is designed to be a multi-nation
and multi-site clinical trial involving several countries, including Australia, the U.S.A., Japan, Thailand, Taiwan, and the People&rsquo;s
Republic of China.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Co-development
Agreement with Rgene</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, BriVision entered into a co-development agreement (the &ldquo;Co-Dev Agreement&rdquo;) with Rgene Corporation, a
corporation incorporated under the laws of Taiwan (&ldquo;Rgene&rdquo;), to co-develop and commercialize in the global markets
three new drug products that are ABV-1507 HER2/neu Positive Breast Cancer Combination Therapy, ABV-1511 Pancreatic Cancer Combination
Therapy and ABV-1527 Ovary Cancer Combination Therapy.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Co-Dev Agreement, Rgene had to pay to the Company $3,000,000 in cash or stock of Rgene with equivalent value by August
15, 2017 in three installments. The payment is for the compensation of BriVision&rsquo;s past research efforts and contributions
made by BriVision before the Co-Dev Agreement was signed and it does not relate to any future commitments made by BriVision and
Rgene in this Co-Dev Agreement. Besides the $3,000,000 payment, the Company is entitled to receive 50% of the future net licensing
income or net sales profit earned by Rgene, if any, and any development cost shall be equally shared by both BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, the Company delivered all research, technical, data and development data to Rgene. Because both Rgene and the Company
are related parties and under common control, being both controlled by a controlling beneficiary shareholder of Yuangene Corporation
and the Company, the Company has recorded the full amount of $3,000,000 in connection with the Co-Dev Agreement as additional
paid-in capital during the fiscal year ended September 30, 2017. As of the date of this prospectus, the Company received $450,000
in cash and the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s common stock, at the price
of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares, which were accounted for
as long-term investment as of December 31, 2018. For more information about the Co-Dev Agreement, please refer to the current
report on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017005978/f8k052617_americanbrivision.htm">Form 8-K</A> we filed on May 30, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of date of this prospectus, no net licensing income and/or net sales profit have occurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Control
Release Technologies</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
through BioKey, has developed a proprietary control release system that may delay the release of drugs into human bodies at various
controlled paces. ABVC has at least ten more drugs in the Company&rsquo;s development pipeline, such as BK102 Metaxalone to treat
skeletal muscle pain or injury and BK503 Clarithromycin XR for the purpose of treating bacterial infections. In addition to the
existing development pipeline, ABVC is reviewing potential drug candidates for potential licensing and co-development opportunities.
ABVC focuses on the drug candidates that meet one or more of the following criteria:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niche
                                         market potential;</FONT> </TD>
</TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliable
                                         control of API sources with DMF (Drug Master File) readily in place;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitive
                                         pricing for the APIs;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
                                         development barrier;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic
                                         co-development with distributors; and</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feasible
                                         with the Company&rsquo;s skill sets and facility capacity</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NDA
Products</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BK501</B>:
ABVC, through BioKey, has developed a new controlled release dosage form of an immediate release antithrombotic drug which has
high frequency of side effects. We are hoping that BK501 will vastly improve patient compliance by reducing side effects. Through
this joint venture, ABVC will pass portion of the financial burden to our strategic alliance and expand its product market to
Asia.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BK502</B>:
ABVC, through BioKey, has acquired the exclusive right to the U.S. patent application for BK502 from a Delaware corporation which
has developed a novel multi-component anti-diabetes drug designed to significantly improve both blood glucose and lipid profiles.
This product is based primarily on Metformin, an oral anti-hyperglycemic drug used in the management of non-insulin-dependent
diabetes mellitus, currently marketed by Bristol-Myers Squibb under the trade name of Glucophage. Metformin lowers blood sugar
by keeping the liver from making too much sugar. However, most type 2 diabetics have problems not only with blood sugar but also
with high cholesterol and triglycerides. BK502 is designed to lower not only the blood sugar but also lower the fatty blood components&mdash;triglycerides
and cholesterol in the patient.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANDA
Products</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC,
through BioKey, has developed a proprietary control release systems that may delay the release of drugs at various controlled
paces. ABVC, through BioKey, has at least ten more drugs in its development pipeline, such as BK503 Clarithromycin XR for the
purpose of treating bacterial infections, BK504 XL for treating depression, and BK509 for lowering cholesterol. In addition to
the existing developments in the pipeline, ABVC constantly reviews potential drug candidates for potential licensing and co-development
opportunities. More candidates screened for the ANDA product pipeline include BK601 for obesity, BK602 for diabetes, BK603 for
hypertension, and BK604 for Schizophrenia and bipolar disorder, etc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CDMO
Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
CDMO SBU provides a wide range of services, including API characterization, pre-formulation studies, formulation development,
analytical method development, stability studies, IND/NDA/ANDA/510K submissions, and manufacturing clinical trial materials (from
Phase 1 through Phase 3) and commercial manufacturing of pharmaceutical products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
CDMO SBU provides a variety of regulatory services tailored to the needs of its customers, which include proofreading and regulatory
review of submission documents related to formulation development, clinical trials, marketed products, generics, nutraceuticals
and OTC products and training presentations. In addition to supporting ABVC&rsquo;s new drug development, ABVC&rsquo;s CDMO SBU
submits INDs, NDAs, ANDAs, and DMFs to the FDA, on behalf of clients, in compliance with new electronic submission guidelines
of the FDA. ABVC provides regulatory consulting services for the entire lifecycle of its clients&rsquo; drug development projects.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Analytical
Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
analytical laboratory offers HPLC method development and validation, degradation studies, dissolution method development, cleaning
validation and raw material testing. ABVC&rsquo;s experienced chemists and developers adopt analytical assay methods with various
columns (reversed phase, ion chromatography, and size exclusion) and UV and reflective index detectors to analyze pharmaceutical
compounds that feature with or without chromophores. With respect to degradation studies, ABVC&rsquo;s senior laboratory researchers
conduct stressed sample degradation studies to determine potential degradants and impurity profiles. ABVC&rsquo;s degradation
studies generally involve identification process using diode array analysis of peak purity to develop a stability indicating chromatographic
method. In addition, ABVC&rsquo;s researchers and scientists help the clients to develop and perform dissolution profile studies
for immediate release and extended release of finished products (tablets and capsules) in various media and pH buffer solutions
such as simulated intestinal fluid (&ldquo;SIF&rdquo;), simulated gastric fluid (&ldquo;SGF&rdquo;), and acetate. ABVC provides
its clients with services of developing and validating sensitive methods for swab samples and rinsing samples and total organic
carbon to test and evaluate the cleanness of certain pharmaceutical equipment. ABVC&rsquo;s laboratory has the capacity to use
FT-IR to identify materials, such as APIs. ABVC&rsquo;s laboratory may conduct basic physical/chemical testing according to various
methods such as pH, turbidity, density, solubility profile over pH range, melting point, loss on drying, loss on ignition, viscosity
and conductivity testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Product
Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
provides services for formulation and process development of pharmaceutical products. ABVC supports its clients with FDA regulatory
process, including sketches to ANDA, IND, and NDA filings. ABVC endeavors to satisfy the needs of its clients in a time-efficient
and cost-saving manner. ABVC&rsquo;s formulation and process development teams have deep scientific knowledge and extensive experience
in this area. ABVC&rsquo;s highly trained scientists and researchers endeavor to optimize the performance of its clients&rsquo;
products, formulations and processes, using flexible scientific approaches, such as Design of Experiments (&ldquo;DOE&rdquo;)
and Quality by Design (QbD).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GMP
Manufacturing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
owns a certified GMP manufacturing facility that is qualified to conduct clinical trials from Phase 1 to Phase 3 of drugs in oral
solid dosage forms. ABVC&rsquo;s cGMP manufacturing facility can manufacture the following forms of pharmaceutical products and
processes for its clients: direct API or blend fill-in capsules, manual and automated encapsulation, wet granulation or tray drying
process, tablet compression and coating process, packaging solid dosage forms for ANDA and IND submission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
GMP facility consists of the GMP suite, product development area, analytical laboratory, food processing area, caged area and
receiving area. The facility was established in December 2008 and received its first drug manufacturing license in June 2009.
ABVC&rsquo;s current drug manufacturing license allows it to manufacture drugs thereon until the expiration of such license on
December 2, 2019. ABVC plans to renew its drug manufacturing license in a timely manner before its expiration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Opportunity and Growth Strategy/Business Plan</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC&rsquo;s
research and development department aims to translate the laboratory research results to new drug candidates ready for Phase III
clinical trials together with its CDMO SBU. Botanical products may be classified as foods, dietary supplements, drugs, medical
devices or cosmetics, depending on their &ldquo;intended use.&rdquo; There is a fine line separating drugs from foods and dietary
supplements. We focus primarily on developing botanical drugs, which by definition are intended for use in the diagnosis, cure,
mitigation or treatment of disease in humans. Together with ABVC&rsquo;s strategic partners, it plans to market, distribute and
sell its drug products internationally, in areas such as the United States, Canada and Japan. ABVC needs to have the drug candidates
comply with the local authorities regulating drugs and foods, for example the FDA and the Taiwan Food and Drug Administration
(&ldquo;TFDA&rdquo;), in order to market our drug products in the respective areas. Currently, a lot of countries follow the International
Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (the &ldquo;ICH&rdquo;)
guidelines that are published by the European Medicines to provide guidance on quality and safety of pharmaceutical development
and new drug commercialization among Japan, the United States and Europe. Based on ABVC&rsquo;s new drug development experience,
ABVC made a strategic decision to have its drug candidates go through the FDA process for new drug development first and then
seek regulatory approvals on the FDA approved drugs from the authorities equivalent to the FDA in the jurisdictions where ABVC
plans to market its new drug products.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B>&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new drug candidates are dependent on, or are the subject of the following patents and patent applications.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> No. </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Status </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Patent
    No. </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Patent
    Starting Date </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"> <B>Patent
                                         Expiration</B> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"> <B>Date</B> </P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Patent
    Name </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Territory </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patent</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owner<SUP>(1)(2)</SUP></B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: center"> 1 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> 6911222 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> 6/28/2005 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 29%; font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition
    Containing Polygala Extract, Part 1 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 7175861 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/13/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract, Part 2 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 7179496 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/20/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract, Part 3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 7223425 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 5/29/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract, Part 4 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 5 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 0001337647 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/31/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Italy </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 4%"> 6 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> CH693499 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> &nbsp;9/15/2003 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 29%"> Anti-depression Pharmaceutical Composition
    Containing Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> Switzerland </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 7 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10220149 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp;4/26/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Germany </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 8 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> GB2383951 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp;6/7/2006 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> United Kingdom </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 9 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4109907 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 6/6/2002 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 6/5/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Japan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> FR2834643 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp;7/18/2003 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> France </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 11 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> I295576 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4/11/2008 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 1/10/2022 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Anti-depression Pharmaceutical Composition Containing
    Polygala Extract </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Taiwan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 12 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap"> DE202007003503 U1 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 8/23/2007 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 9/20/2026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Novel Polygalatenosides and use thereof as an
    antidepressant agent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Germany </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 13 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 7531519 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 5/12/2009 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 9/20/2026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Novel Polygalatenosides and use thereof as an
    antidepressant agent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 14 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4620652 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 11/20/2006 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 11/19/2026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Novel Polygalatenosides and use thereof as an
    antidepressant agent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Japan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 15 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> I 314453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 9/21/2006 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 9/20/2026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Novel Polygalatenosides and use thereof as an
    antidepressant agent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Taiwan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> MPITDC </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 16 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> I389713 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 3/21/2013 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10/13/2030 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cross-linked
    oxidized hyaluronic acid for use as a vitreous substitute <B><SUP>(3)</SUP></B></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Taiwan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 17 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> US 8197849 B2 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 6/12/2012 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 8/30/2030 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> The U.S. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
</TABLE>

<P STYLE="margin: 0"> &nbsp; </P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 4%"> 18 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> AU 2011/215775 B2 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> 4/17/2014 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> 2/9/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 29%"> Cross-linked oxidized hyaluronic acid
    for use as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> Australia </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 19 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> KR 10-1428898 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 8/4/2014 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/9/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Korea </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 20 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> CA 2786911 (C) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10/6/2015 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/10/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Canada </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 21 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> WO2011100469 A1 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A<SUP>(4)</SUP></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A<SUP>(4)</SUP></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> PCT </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 22 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> EP 2534200 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4/8/2015 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/9/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> European Union (Germany, United Kingdom, France,
    Switzerland, Spain, Italy) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 23 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &#29305;&#35377;&#31532; 5885349&#34399; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/9/2011 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/9/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cross-linked oxidized hyaluronic acid for use
    as a vitreous substitute </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Japan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 24 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> ZL 201180005494.7 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 12/24/2014 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 2/9/2031 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cross-linked
    oxidized hyaluronic acid for use as a vitreous substitute<B><SUP>(3)</SUP></B></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> China </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 25 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> HK1178188 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 3/6/2015 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 6/21/2030 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cross-linked
    oxidized hyaluronic acid for use as a vitreous substitute<B><SUP>(3)</SUP></B></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong
    Kong<SUP>&nbsp;(5)&nbsp;</SUP></FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> NHRI </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;MPITDC&rdquo;
stands for Medical and Pharmaceutical Industry Technology and Development Center, Taiwan.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;NHRI&rdquo;
stands for National Health Research Institutes, Taiwan.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent name is translated into English and the original patent name is written as &ldquo;&#20132;&#32852;&#27687;&#21270;&#36879;&#26126;&#36136;&#37240;&#20316;&#20026;&#30524;&#29699;&#29627;&#29827;&#20307;&#20043;&#26367;&#20195;&#29289;.&rdquo;</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
starting date and expiration date of patents under PTC are subject to the laws of the specific participating jurisdiction where
the patent application is filed. We have subsequently submitted such patent to the jurisdictions listed in No.22 herein above.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NHRI
has obtained standard patent in Hong Kong based on the registration of the patent (listed as No.24 herein) granted by the State
Intellectual Property Office, People&rsquo;s Republic of China.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
History and Structure</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
was incorporated under the laws of the State of Nevada on February 6, 2002 and has three wholly-owned Subsidiaries: BriVision,
BioLite Holding, Inc. and BioKey, Inc. BriVision was incorporated in July 2015 in the State of Delaware and is in the business
of developing pharmaceutical products in North America.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Holding was incorporated under the laws of the State of Nevada on July 27, 2016, with 500,000,000 shares authorized, par value
$0.0001. Its key Subsidiaries include BioLite BVI, Inc. (&ldquo;BioLite BVI&rdquo;) that was incorporated in the British Virgin
Islands on September 13, 2016 and BioLite Inc. (&ldquo;BioLite Taiwan&rdquo;), a Taiwanese corporation that was founded in February
2006. BioLite Taiwan has been in the business of developing new drugs for over twelve years. Certain shareholders of BioLite Taiwan
exchanged approximately 73% of equity securities in BioLite Taiwan for the Common Stock in BioLite Holding in accordance with
a share purchase/ exchange agreement (the &ldquo;Share Purchase/ Exchange Agreement&rdquo;). As a result, BioLite Holding owns
via BioLite BVI approximately 73% of BioLite Taiwan. The other shareholders who did not enter this Share Purchase/ Exchange Agreement
retain their equity ownership in BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
in California on November 20, 2000, BioKey has chosen to initially focus on developing generic drugs to ride the opportunity of
the booming industry.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the Mergers on February 8, 2019, BioLite and BioKey became two wholly-owned subsidiaries of ABVC.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart illustrates the corporate structure of ABVC:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;<IMG SRC="img_003.jpg" ALT="" STYLE="width: 450px; height: 336px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
healthcare industry is highly competitive and subject to significant and rapid technological change as researchers learn more
about diseases and develop new technologies and treatments. Significant competitive factors in our industry include product efficacy
and safety; quality and breadth of an organization&rsquo;s technology; skill of an organization&rsquo;s employees and its ability
to recruit and retain key employees; timing and scope of regulatory approvals; the average selling price of products; the availability
of raw materials and qualified manufacturing capacity; manufacturing costs; intellectual property and patent rights and their
protection; and our capabilities of securing competent collaborators. Market acceptance of our current products and product candidates
will depend on a number of factors, including: (i) potential advantages over existing or alternative therapies or tests, (ii)
the actual or perceived safety of similar classes of products, (iii) the effectiveness of sales, marketing, and distribution capabilities,
and (iv) the scope of any approval provided by the FDA or foreign regulatory authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a very small biopharmaceutical company compared to other companies that we are competing against. Our current and potential
competitors include large pharmaceutical and biotechnology companies, and specialty pharmaceutical and generic drug companies.
Many of our current and potential competitors have substantially greater financial, technical and human resources than we do and
significantly more experience in the marketing, commercialization, discovery, development and regulatory approvals of products,
which could place us at a significant competitive disadvantage or deny us marketing exclusivity rights. Typically, our competitors
will most likely have more capital resources to support their products than we do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that we will face intense and increasing competition when and as our new drug candidates enter the markets, as advanced
technologies become available and as generic forms of currently branded products become available. Finally, the development of
new treatment methods for the diseases we are targeting could render our products non-competitive or obsolete.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that any of our new drug candidates that we successfully develop will be clinically superior or scientifically
preferable to products developed or introduced by our competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart lists representative biopharmaceutical companies that research, develop, commercialize, distribute or sell drugs
that are in competition with our drug candidates. Please be advised that this list does not necessarily include all competitors
of ours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 31%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disease</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Drug
    Name</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pharmaceutical
    </B><BR>
    <B>Companies</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Headquarters</B></FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Major
    Depressive Disorder</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cymbalta
    oral</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli
    Lilly and Co., Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lexapro
    oral</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forest
    Laboratories, Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NJ</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pfizer
    Pharmaceuticals, Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CT</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Attention-Deficit
    </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adderall
    XR</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shire
    Development LLC</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MA</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hyperactivity
    Disease</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ritalin</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Novartis
    Pharmaceuticals Corporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NJ</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dexedrine</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amedra
    Pharmaceuticals LLC</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PA</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Myelodysplastic</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vidaza</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celgene
    Corporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NJ</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Syndromes</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dacogen</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Astex
    Pharmaceuticals, Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Triple
    Negative Breast Cancer</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avastin</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genentech,
    Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erbitux
    (Cetuximab)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ImClone
    Systems Incorporated</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NY</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pancreatic
    Cancer</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abraxane,
    Abraxis BioScience LLC</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los
    Angeles</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Novartis
    Pharma Stein AG</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stein</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vitargus
    for the treatments</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alcon
    Laboratories, Inc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
    Worth</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TX</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        Retinal Detachment or</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vitreous
        Hemorrhage</B></FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arcadophta</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Toulouse</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competitive
Advantages</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our drug candidates possess their respective competitive advantages over other therapeutic products that are currently
available. However, due to limited information and resources, we cannot compare our drug candidates with all other drug candidates
under development and research by other research institutions and/or biopharmaceutical companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
competitive advantages of our business model include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Once we successfully complete POC of any product in the pipeline, we will seek strategic partners, such as respected pharmaceutical
companies in the United States and boutique qualified clinics, to co-develop such mature product. In consideration for our licensing
of the mature product, we expect to receive capital which we plan to use for our research and development of other products in
the pipeline or selection of other new drugs or medical devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Sublicensing our products that pass Phase II clinic trials to other pharmaceutical companies saves us the time and resources to
conduct Phase III clinical trials and provides a quicker return on our investment in our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
We have new drug products related to central nervous system, cancers and autoimmune and one new medical device for vitreous substitutes
under development. This development portfolio diversifies our research risks by focusing on three different medical fields.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently negotiating with potential medical center partners regarding conducting clinical trials on certain compounds in
our pipeline. However, we cannot provide any assurance that we will find a qualified medical center to conduct clinical trials
of any of our new drug products or enter into a definitive licensing agreement with any pharmaceutical companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
ABVC is developing pharmaceutical candidates as of the date of this prospectus, it may in the future acquire more proprietary
technologies to expand its drug candidate portfolio. Currently, ABVC is focusing on the research and development ofseven therapeutic
candidates in the fields of CNS, oncology/hematology and autoimmune, for which regulatory approval must be received before it
can market and sell them. In addition, our c-GMP facility is subject to review by the FDA. Regulatory approval processes and FDA
regulations for ABVC&rsquo;s current and any future product candidates are discussed below.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Approval
Process for Pharmaceutical Products</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FDA
Approval Process for Pharmaceutical Products</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S., pharmaceutical products are subject to extensive regulation by the FDA. The Federal Food, Drug and Cosmetic Act (the
&ldquo;FDC Act&rdquo;), and other federal and state statutes and regulations, govern, among other things, the research, development,
testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring
and reporting, sampling, and import and export of pharmaceutical products. Failure to comply with applicable U.S. requirements
may subject a company to a variety of administrative or judicial sanctions, such as FDA refusal to approve pending NDAs, warning
letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil
penalties, and criminal prosecution. Pharmaceutical product development in the U.S. typically involves the performance of satisfactory
nonclinical, also referred to as pre-clinical, laboratory and animal studies under the FDA&rsquo;s Good Laboratory Practice, or
GLP, regulation, the development and demonstration of manufacturing processes, which conform to FDA mandated current good manufacturing
requirements, or cGMPs, including a quality system regulating manufacturing, the submission and acceptance of an IND application,
which must become effective before human clinical trials may begin in the U.S., obtaining the approval of Institutional Review
Boards, or IRBs, at each site where we plan to conduct a clinical trial to protect the welfare and rights of human subjects in
clinical trials, adequate and well-controlled clinical trials to establish the safety and effectiveness of the drug for each indication
for which FDA approval is sought, and the submission to the FDA for review and approval of an NDA. Satisfaction of FDA requirements
typically takes many years and the actual time required may vary substantially based upon the type, complexity, and novelty of
the product or disease.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-clinical
tests generally include laboratory evaluation of a product candidate, its chemistry, formulation, stability and toxicity, as well
as certain animal studies to assess its potential safety and efficacy. Results of these pre-clinical tests, together with chemistry,
manufacturing controls and analytical data and the clinical trial protocol, which details the objectives of the trial, the parameters
to be used in monitoring safety, and the effectiveness criteria to be evaluated, along with other requirements must be submitted
to the FDA as part of an IND, which must become effective before human clinical trials can begin. The entire clinical trial and
its protocol must be in compliance with what are referred to as good clinical practice, or GCP, requirements. The term, GCP, is
used to refer to various FDA laws and regulations, as well as international scientific standards intended to protect the rights,
health and safety of patients, define the roles of clinical trial sponsors and assure the integrity of clinical trial data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns
or questions about the intended conduct of the trials and imposes what is referred to as a clinical hold. Pre-clinical studies
generally take several years to complete, and there is no guarantee that an IND based on those studies will become effective,
allowing clinical testing to begin. In addition to FDA review of an IND, each medical site that desires to participate in a proposed
clinical trial must have the protocol reviewed and approved by an independent IRB or Ethics Committee, or EC. The IRB considers,
among other things, ethical factors, and the selection and safety of human subjects. Clinical trials must be conducted in accordance
with the FDA&rsquo;s GCP requirements. The FDA and/or IRB may order the temporary, or permanent, discontinuation of a clinical
trial or that a specific clinical trial site be halted at any time, or impose other sanctions for failure to comply with requirements
under the appropriate entity jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials to support NDAs for marketing approval are typically conducted in three sequential phases, but the phases may overlap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Phase 1 clinical trials, a product candidate is typically introduced either into healthy human subjects or patients with the medical
condition for which the new drug is intended to be used. The main purpose of the trial is to assess a product candidate&rsquo;s
safety and the ability of the human body to tolerate the product candidate. Phase 1 clinical trials generally include less than
50 subjects or patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
Phase 2 trials, a product candidate is studied in an exploratory trial or trials in a limited number of patients with the disease
or medical condition for which it is intended to be used in order to: (i) further identify any possible adverse side effects and
safety risks, (ii) assess the preliminary or potential efficacy of the product candidate for specific target diseases or medical
conditions, and (iii) assess dosage tolerance and determine the optimal dose for Phase 3 trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
3 trials are generally undertaken to demonstrate clinical efficacy and to further test for safety in an expanded patient population
with the goal of evaluating the overall risk-benefit relationship of the product candidate. Phase 3 trials are generally designed
to reach a specific goal or endpoint, the achievement of which is intended to demonstrate the candidate product&rsquo;s clinical
efficacy and adequate information for labeling of the approved drug.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has 60 days from its receipt of an NDA to determine whether the application will be accepted for filing based on the FDA&rsquo;s
threshold determination that it is sufficiently complete to permit substantive review. Once the submission is accepted for filing,
the FDA begins an in-depth review. The FDA has agreed to certain performance goals in the review of NDAs. Most applications for
standard review drug products are reviewed within ten months; most applications for priority review drugs are reviewed within
six months. Priority review can be applied to drugs that the FDA determines offer major advances in treatment, or provide a treatment
where no adequate therapy exists. The review process for both standard and priority review may be extended by the FDA for three
additional months to consider certain late-submitted information, or information intended to clarify information already provided
in the submission. The FDA may also refer applications for novel drug products, or drug products which present difficult questions
of safety or efficacy, to an advisory committee&nbsp;&mdash;&nbsp;typically a panel that includes clinicians and other experts&nbsp;&mdash;&nbsp;for
review, evaluation, and a recommendation as to whether the application should be approved. The FDA is not bound by the recommendation
of an advisory committee, but it generally follows such recommendations. Before approving an NDA, the FDA will typically inspect
one or more clinical sites to assure compliance with GCP. Additionally, the FDA will inspect the facility or the facilities at
which the drug is manufactured. The FDA will not approve the product unless compliance with cGMPs is satisfactory and the NDA
contains data that provide substantial evidence that the drug is safe and effective in the indication studied.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the FDA evaluates the NDA and the manufacturing facilities, it issues either an approval letter or a complete response letter.
A complete response letter generally outlines the deficiencies in the submission and may require substantial additional testing
or information in order for the FDA to reconsider the application. If and when those deficiencies have been addressed to the FDA&rsquo;s
satisfaction in a resubmission of the NDA, the FDA will issue an approval letter. The FDA has committed to reviewing such resubmissions
in two or six months depending on the type of information included. An approval letter authorizes commercial marketing of the
drug with specific prescribing information for specific indications. As a condition of NDA approval, the FDA may require a risk
evaluation and mitigation strategy, or REMS, to help ensure that the benefits of the drug outweigh the potential risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REMS
can include medication guides, communication plans for healthcare professionals, and elements to assure safe use, or ETASU. ETASU
can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain
circumstances, special monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential
market and profitability of the drug. Moreover, product approval may require substantial post-approval testing and surveillance
to monitor the drug&rsquo;s safety or efficacy. Once granted, product approvals may be withdrawn if compliance with regulatory
standards is not maintained or problems are identified following initial marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Post-Approval
Regulations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if a product candidate receives regulatory approval, the approval is typically limited to specific clinical indications. Further,
even after regulatory approval is obtained, subsequent discovery of previously unknown problems with a product may result in restrictions
on its use or even complete withdrawal of the product from the market. Any FDA-approved products manufactured or distributed by
us are subject to continuing regulation by the FDA, including record-keeping requirements and reporting of adverse events or experiences.
Further, drug manufacturers and their subcontractors are required to register their establishments with the FDA and state agencies,
and are subject to periodic inspections by the FDA and state agencies for compliance with cGMPs, which impose rigorous procedural
and documentation requirements upon us and our contract manufacturers. ABVC cannot be certain that ABVC or its present or future
contract manufacturers or suppliers will be able to comply with cGMPs regulations and other FDA regulatory requirements. Failure
to comply with these requirements may result in, among other things, total or partial suspension of production activities, failure
of the FDA to grant approval for marketing, and withdrawal, suspension, or revocation of marketing approvals.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the FDA approves one or more of our product candidates, ABVC must provide certain updated safety and efficacy information. Product
changes, as well as certain changes in the manufacturing process or facilities where the manufacturing occurs or other post-approval
changes may necessitate additional FDA review and approval. The labeling, advertising, promotion, marketing and distribution of
a drug must be in compliance with FDA and Federal Trade Commission, or FTC, requirements which include, among others, standards
and regulations for direct-to-consumer advertising, off-label promotion, industry sponsored scientific and educational activities,
and promotional activities involving the Internet. The FDA and FTC have very broad enforcement authority, and failure to abide
by these regulations can result in penalties, including the issuance of a warning letter directing us to correct deviations from
regulatory standards and enforcement actions that can include seizures, fines, injunctions and criminal prosecution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
Regulatory Approval</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
of the U.S., ABVC&rsquo;s ability to market our product candidates will be contingent also upon its receiving marketing authorizations
from the appropriate foreign regulatory authorities, whether or not FDA approval has been obtained. The foreign regulatory approval
process in most industrialized countries generally encompasses risks similar to those ABVC will encounter in the FDA approval
process. The requirements governing conduct of clinical trials and marketing authorizations, and the time required to obtain requisite
approvals, may vary widely from country to country and differ from those required for FDA approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
will be subject to additional regulations in other countries in which we market, sell and import our products, including Canada.
ABVC or its distributors must receive all necessary approvals or clearance prior to marketing and/or importing our products in
those markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Regulatory Matters</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing,
sales, promotion and other activities following product approval are also subject to regulation by numerous regulatory authorities
in addition to the FDA, including, in the U.S., the Centers for Medicare &amp; Medicaid Services, other divisions of the Department
of Health and Human Services, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission,
the Occupational Safety &amp;Health Administration, the Environmental Protection Agency and state and local governments. In the
U.S., sales, marketing and scientific/educational programs must also comply with state and federal fraud and abuse laws. Pricing
and rebate programs must comply with the Medicaid rebate requirements of the U.S. Omnibus Budget Reconciliation Act of 1990 and
more recent requirements in the Health Care Reform Law, as amended by the Health Care and Education Affordability Reconciliation
Act, or ACA. If products are made available to authorized users of the Federal Supply Schedule of the General Services Administration,
additional laws and requirements apply. The handling of any controlled substances must comply with the U.S. Controlled Substances
Act and Controlled Substances Import and Export Act. Products must meet applicable child-resistant packaging requirements under
the U.S. Poison Prevention Packaging Act. Manufacturing, sales, promotion and other activities are also potentially subject to
federal and state consumer protection and unfair competition laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive recordkeeping,
licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure to comply with regulatory requirements subjects firms to possible legal or regulatory action. Depending on the circumstances,
failure to meet applicable regulatory requirements can result in criminal prosecution, fines, imprisonment or other penalties,
injunctions, recall or seizure of products, total or partial suspension of production, denial or withdrawal of product approvals,
or refusal to allow a firm to enter into supply contracts, including government contracts. In addition, even if a firm complies
with FDA and other requirements, new information regarding the safety or effectiveness of a product could lead the FDA to modify
or withdraw product approval. Prohibitions or restrictions on sales or withdrawal of future products marketed by us could materially
affect our business in an adverse way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for
example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall
or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they
could adversely affect the operation of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Properties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended December 31, 2017 and 2018, ABVC leased its office at the address of 11 Sawyers Peak Drive, Goshen, NY
10924, which is approximately 1,000 square feet without rental expenses. On October 2, 2018, ABVC entered into a sublease agreement
with BioKey pursuant to which ABVC leases one office, 110B, for a total rent of $800 per month, utilities included. ABVC and BioKey
may terminate the sublease agreement with one month notice. ABVC and BriVision operate together at the office sublet from BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
has its laboratories located in Hsinchu Biomedical Science Park, with an address of 20, Sec. 2, Shengyi Rd., 2<SUP>nd</SUP> Floor,
Zhubei City, Hsinchu County 302, Taiwan (R.O.C.). BioLite rented its office from Lion Art Promotion Inc. (&ldquo;LION&rdquo;),
a related party of BioLite and its lease is renewable annually. BioLite paid $37,592 for the years ended December 31, 2017, respectively.
The lease from LION was terminated on March 31, 2018 and BioLite paid $9,553 for the twelve months ended December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2015, BioLite Taiwan entered into a lease agreement with the National Science Park Administrative Office (Hsinchu City)
under which it rents two dormitory buildings in Hsinchu City, Taiwan for a period of five years. The rent increases by a small
percentage each year during the term of the lease agreement. During the fiscal years of 2018 and 2017, BioLite paid approximately
$29,200 and $29,200, respectively, and for the three months ended March 31, 2019, BioLite Taiwan paid approximately $7,300 under
the lease for the dormitories. In addition, BioLite Taiwan leases four spaces as its laboratories in Hsinchu City, Taiwan. BioLite
Taiwan and the National Science Park Administrative Office (Hsinchu City) entered into four five-year term leases which commenced
respectively on May 12, 2014, January 1, 2015, January 1, 2016 and January 1, 2016. The aggregate leasing area leased by BioLite
Taiwan amounts to approximately 678 square meters (equivalent to approximately 7,298 square feet) on the second floor of the building.
In the fiscal year of 2018 and 2017, BioLite incurred rental expenses relating the laboratory spaces in the amount of approximately
$9,000 per month. One of the leases expired in May 2019 and BioLite Taiwan renewed the lease. BioLite and BioLite BVI operate
together with BioLite Taiwan and share the office spaces.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
is headquartered in Fremont, California. BioKey&rsquo;s office lease will end on February 28, 2021 and the office occupies approximately
28,186 square feet. BioKey&rsquo;s space consists of offices, research and production laboratories, and manufacturing facilities.
BioKey has an option to extend the lease for its offices in Fremont a period of five years commencing February 28, 2021, and BioKey
may exercise this option for 5 more years. The total BioKey&rsquo;s rental expenses were $281,965 and $274,978 for the years ended
December 31, 2018 and 2017, and $77,525 for the three months ended March 31, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus does not discuss any affiliates of the Company that is not controlled by the Company, such as BioFirst and BioFirst
Australia, because affiliates not controlled by the Company do not appear in our combined and consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time ABVC and its Subsidiaries may become involved in legal proceedings and claims, or be threatened with other legal
actions and claims, arising in the ordinary course of business relating to its intellectual property, product liability, regulatory
compliance and/or marketing and advertising of its products. As of the date of this prospectus, ABVC and its Subsidiaries were
not involved or threatened with any legal actions and regulatory proceedings.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Environment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
seeks to comply with all applicable statutory and administrative requirements concerning environmental quality. Expenditures for
compliance with federal state and local environmental laws have not had, and are not expected to have, a material effect on ABVC&rsquo;s
capital expenditures, results of operations or competitive position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, ABVC, including its Subsidiaries, had 38 employees, located in the U.S. and Taiwan. The following
table sets forth the number of our employees by function:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Number of </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> Functional Area </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Employees </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Senior management </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Research and development </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 12 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> International development </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Public relations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Marketing </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Internal control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Accounting </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 38 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
believes that it maintains a good working relationship with its employees. ABVC offers its employees competitive benefits, including
a pleasant and rewarding work environment, career-oriented training, and career growth opportunities. ABVC believes its employees
are devoted to delivering superb services. ABVC did not experience any significant labor disputes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_017"></A>MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table lists the names, ages and positions as of the date of the prospectus of the individuals who serve as executive
officers and directors of the Company after the completion of the Mergers:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
    Jiang</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 55%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Interim Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Tsang Ming Jiang</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Ming-Fong Wu</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norimi
    Sakamoto</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yen-Hsin
    Chou</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Tsung-Shann (T.S.) Jiang</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Strategy Officer and Director </FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Chang-Jen Jiang</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Shin-Yu Miao</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoshinobu
    Odaira</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shih-Chen
    Tzeng</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Hwalin Lee</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    </FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Howard Doong</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Chi-Hsin (Richard) King</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Technology Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is certain biographical information regarding each of our directors and executive officers as of the date of this
prospectus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eugene
Jiang, Chairman and interim CFO,</B>&nbsp;served as our CEO and President from the Company&rsquo;s inception in July 2015 until
he resigned on September 15, 2017. He remains the Chairman of the Board. Mr. Jiang was appointed as our Interim Chief Financial
Officer on May 9, 2018 while the Company is still conducting a search to secure a permanent CFO. From June 2015 until present,
Mr. Jiang also serves as Director for&nbsp;BioLite&nbsp;Incorporation. He also serves as&nbsp;CEO for&nbsp;Genepro&nbsp;Investment
Company since March 2010.&nbsp;Mr.&nbsp;Jiang obtained an EMBA degree from the University of&nbsp;Texas&nbsp;in Arrington in 2009
and in 2008, Mr. Jiang received a bachelor&rsquo;s degree in Physical Education from Fu-Jen Catholic University.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Howard Doong, Ph. D. and M.D., CEO,</B>&nbsp;was appointed as the Company&rsquo;s new CEO on September 15, 2017. In addition to
the position at the Company, Dr. Doong also serves as the CEO and Chief Scientific Officer (&ldquo;CSO&rdquo;) of LifeCode Biotechnology
Company (&ldquo;LifeCode&rdquo;), a Taiwan company in the biotechnology business, since 2017. At the same time, he also serves
as the CSO of Wuhan Frasergen Genomic Medicine Company (&ldquo;Wuhan Frasergen Genomic&rdquo;), a Chinese company in the biotechnology
business, since 2016. He served as the CSO of Cold Spring Biotech Corporation, a Taiwan corporation in the biotechnology business
from 2014 to 2016. He served as the CEO of iKnowledge-Care Bioscience Corp, a Taiwan company in the biotechnology business from
2014 to 2015. He served as the director of Taipei Veteran General Hospital-LilPao Laboratory of Cancer Genomic Medicine from 2012
to 2013. He served as the Vice President and director of Quality Assurance, TrimGen Corporation, a Maryland corporation in the
biotechnology business from 2009 to 2011. Dr. Doong received his Ph.D. degree from University of Chicago, the Department of Organismal
Biology and Anatomy and the Department of Surgery. He received his M.D and Ph.D. degree from Harvard-MIT Division of Health Sciences
and Technology. He received his M.S. degree from the University of New Hampshire, Genetics Program and B.S. degree from Fu-Jen
Catholic University, Taiwan, Department of Biology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
T.S. Jiang, Chief Strategy Officer and Director,</B>&nbsp;was appointed as the Company&rsquo;s Chief Strtaegy Officer on and elected
as a director on our Board of Directors on February 8, 2019, the closing date of the Mergers. He has been the chairman of BioLite,
Inc., a subsidiary of BioLite, Inc., since January 2010. Prior to BioLite, Dr. Jiang served as the president and/or chairman of
multiple biotech companies in Taiwan, including PhytoHealth Corporation from 1998 to 2009 and AmCad BioMed Corporation from 2008
to 2009. In addition, Dr. Jiang is a director on various biotech associations, such as the Taiwan Bio Industry Organization (Taiwan)
from 2006 to 2008 and the Chinese Herbs and Biotech Development Association in Taiwan from 2003 to 2006. Dr. Jiang was an assistant
professor at University of Illinois from 1981 to 1987 and an associate professor at Rutgers, the State University of New Jersey
from 1987 to 1990 and served as a professor at a few Taiwanese universities during a period from 1990 to 1993, such as National
Taiwan University, National Cheng Kung University and Tunghai University. Dr. Jiang obtained his bachelor degree in Engineering
and Chemical Engineering from National Taiwan University in Taiwan in 1976, masters and Ph.D. from Northwestern University in
the U.S. in 1981 and Executive Master of Business Administration (&ldquo;EMBA&rdquo;) from National Taiwan University in Taiwan
in 2007. As a successful entrepreneur, Dr. Jiang has developed and commercialized PG2 Lyo Injection, a new drug to treat cancer
related fatigue. From 1998 to 2009, Dr. T. S. Jiang served as President of Phyto Health Corporation where he led a project team
to develop PG2 Injectable. This product was extracted, isolated and purified from a type of Traditional Chinese Medicine. PG2
Injection was intended for cancer patients who had trouble recovering from severe fatigue. Dr. Jiang oversaw and managed the R&amp;D
department, daily corporate operations and business of Phyto Health Corporation when he was the President. PG2 Lyo Injection received
approval on its NDA from Taiwan Food and Drug Administration in 2010 and later was launched into the Taiwan market in 2012. We
believe that Dr. Jiang provides leadership and technological guidance on our strategic development and operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dr.
Chi-Hsin Richard King&mdash;Chief Scientific Officer</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 15, 2017, the Board appointed Dr. Chi-Hsin Richard King as the CSO of the Company. Dr. Chi-Hsin Richard King, 69, served
as the consultant at TaiGen Biotechnology Co. Ltd (&ldquo;TaiGen&rdquo;), a Taiwan company in the biotechnology business, from
August 2016 to July 2017, the Senior Vice President at TaiGen from July 2008 to August 2016 and as the Vice President at Research
and Development of TaiGen from June 2005 to July 2008. Dr. King served as the Director at Albany Molecular Research Inc. (&ldquo;AMRI&rdquo;),
a New York corporation, from January 2003 to June 2005, the Assistant Director at Medicinal Chemistry Department of AMRI from
January 2000 to December 2002 and the Assistant Director at Chemical Development Department of AMRI from August 1997 to January
2000. Dr. King received the Ph. D. degree of organic chemistry from University of Utah in March 1980, and B.S. degree of chemistry
from National Taiwan Normal University in July 1972.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Tsang Ming Jiang, Director</B>, was elected as a director on our Board of Directors on November 23, 2017. He has served as a technical
director at the Industrial Technology Research Institute in Taiwan since January 2017. Prior to joining the Industrial Technology
Research Institute as a technical director, Dr. Jiang worked at the Company as chief information officer from November 2016 to
January 2017, Ericsson as engineering manager from 2013 to 2016 and the Industrial Technology Research Institute as deputy director
from October 2011 to February 2013. In addition, Dr. Jiang worked at several other research institutes, including University of
Alaska Fairbanks, National Taiwan University and Chung Cheng University, with his research interest in cloud computing and Internet
security, especially in the areas of virtualization, software-defined data centers, SDN enabled networks and big data analytics.
Dr. Jiang received his Bachelor of Science in electrical engineering in 1982 and Master of Science in electrical engineering in
1984, both from National Taiwan University, and his Ph.D. in electrical engineering and computer science from University of Illinois
at Chicago in 1988. Dr. Tsang Ming Jiang is a brother of Dr. Tsung-Shann Jiang, who together with his wife collectively owns 80%
of Lion Arts Promotion, Inc. which has approximately 69.3% of ownership interest in the Company through YuanGene Corporation,
a wholly-owned subsidiary of Lion Arts Promotion, Inc.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Ming-Fong Wu, Director</B>, was elected as a director on our Board of Directors on November 23, 2017. He currently is a senior
physician at Taoyuan Hanqun Orthopedic Clinic and has been since 2012. Prior to Taoyuan Hanqun Orthopedic Clinic, Dr. Wu worked
as a physician at various private and public hospitals and clinics, such as National Taiwan University Hospital. Dr. Wu graduated
from National Taiwan University College of Medicine in 2000 and has obtained his license to practice medicine and orthopedist&rsquo;s
license in Republic of China.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Norimi
Sakamoto, Director</B>, was elected as a director on our Board of Directors on November 23, 2017, She currently serves with Shogun
Maitake Canada Co., Ltd. as an executive officer and business development manager from 2015, with Shogun Maitake Odaira Enterprise
Ltd as an executive officer from 2017, with Odaira Corporation Co., Ltd. as chief executive officer since 2014 and with MyLife
Corporation as president and chief executive officer since 2012. Ms. Sakamoto started her career in 1997 with Sumitomo Corporation
Hokkaido Co., Ltd. in Japan. Ms. Sakamoto received her Bachelor Degree of Arts in travel and tourism from Davis and Elkins College
in 1993 and Master of Science in urban studies from the University of New Orleans in 1995.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Yen-Hsin
Chou, Director</B>, was elected as a director on our Board of Directors on November 23, 2017, She has served as a clerk at Mega
Securities Co., Ltd. since 2011. Ms. Chou&rsquo;s responsibilities primarily include selling various types of securities, including
futures, funds and insurance, managing clients&rsquo; accounts and business development. Ms. Chou received a Bachelor Degree from
Yuan Chi University School of Economics in 2011.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Chang-Jen Jiang, Director,</B>&nbsp;was elected as a director on our Board of Directors on November 23, 2017. He has been an attending
doctor at the department of pediatrics of Eugene Women and Children Clinic since 2008. Previously, Dr. Chang-Jen worked as an
attending doctor at the department of pediatrics of Keelung Hospital, the Ministry of Health and Welfare in Taiwan from 1994 to
2008. Before his position at Keelung Hospital, he was a chief doctor at the department of pediatrics, hematology and oncology
of Mackay Memorial Hospital in Taiwan for three years until 1994. Dr. Chang-Jen Jiang obtained his doctor of medicine degree (the
Taiwanese equivalent degree of MD) from Taipei Medical University in Taiwan in 1982 and started his career in Mackay Memorial
Hospital. We believe that the Company will benefit from Dr. Jiang&rsquo;s knowledge in biology and experiences in medical practice.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Shin-Yu Miao, Director,</B>&nbsp;was elected as a director on our Board of Directors on February 8, 2019. She has served as an
associate professor at Ling Tung University Department of Applied Foreign Languages since 2004. She served as a lecturer from
1996 to 2004. Ms. Miao received her M.S. in Adult Education from the University of Manchester in 1995 and Ph.D. in Adult Education
from the University of South Australia in 2004. We believe that Ms. Miao&rsquo;s familiarity with biotech research centers will
be a valuable resource for our drug development.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Yoshinobu
Odaira, Director,</B>&nbsp;was elected as a director on our Board of Directors on February 8, 2019 . He is an entrepreneur and
has founded a number of Japanese agricultural companies, including Yukiguni Maitake, our licensing partner. In 1983, Mr. Odaira
established Yukiguni Maitake, which became a public company in Japan in 1994. In 2015, Bain Capital Private Equity purchased Yukiguni
Maitake through a tender offer. In addition to his success with Yukiguni Maitake, Mr. Odaira served as the CEO of Yukiguni Shoji
Co., Ltd. since 1988 and the CEO of Odaira Shoji Co., Ltd. from 1989. In 2015, Mr. Odaira founded two new companies, Shogun Maitake
Canada Co., Ltd. in Canada and Odaira Kinoko Research Co., Ltd. in Japan. Yoshinobu Odaira graduated from the Ikazawa Junior High
School in 1963. We believe that we will benefit from Mr. Odaira&rsquo;s successful business experience.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shih-Chen
Tzeng, Director,</B>&nbsp;was elected as a director on our Board of Directors on February 8, 2019 . He has served as a sales manager
at SinoPac Securities Corp. (&ldquo;SinoPac Securities&rdquo;), a well-established brokerage firm in Taiwan, since 2000. SinoPac
Securities has fifty-eight (58) branch offices in Taiwan and subsidiaries in Hong Kong, Shanghai and London. Shih-Chen Tszeng
graduated from Dam Kang University in 1978 with a bachelor degree in Accounting. We believe the Company will benefit from Ms.
Tszeng&rsquo;s knowledge and experience with the securities industries.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr.
Hwalin Lee, Director<I>,</I></B>&nbsp;was elected as a director on our Board of Directors on February 8, 2019. He serves as the
chairman of Phoeng Foundation since 2011. From 1986, Dr. Lee has been the chairman of the Chuan Lyu Foundation. From
1973 to 1989, Dr. Lee was the president of Deltan Corporation and prior to that he was senior research chemist at a couple of
chemical companies. Dr. Hwalin Lee obtained a B.S. in pharmacy from National Taiwan University in 1957 and a Ph.D. in Pharmaceutical
Chemistry from University of California, San Francisco in 1966. Dr. Lee qualifies as a director of the Company because he has
extensive work experience in chemical companies and educational background in pharmaceutical chemistry.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among the executive officers and directors&nbsp;of the Company who are expected take office upon the
consummation of the Mergers except that Dr. Tsang Ming Jiang, Dr. Tsung-Shann Jiang and Dr. Chang-Jen Jiang are brothers and Mr.
Eugene Jiang is Dr. Tsung-Shann Jiang&rsquo;s son.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Involvement
in Certain Legal Proceedings</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past ten years, none of our current directors, executive officers, promoters, control persons, or nominees has been:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    subject of any bankruptcy petition filed by or against any business of which such person was a general partner or executive
    officer either at the time of the bankruptcy or within two years prior to that time;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">convicted
    in a criminal proceeding or is subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction
    or any Federal or State authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement
    in any type of business, securities or banking activities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">found
    by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have
    violated a federal or state securities or commodities law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently
    reversed, suspended or vacated, relating to an alleged violation of (a) any Federal or State securities or commodities law
    or regulation; (b) any law or regulation respecting financial institutions or insurance companies including, but not limited
    to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent
    cease-and-desist order, or removal or prohibition order; or (c) any law or regulation prohibiting mail or wire fraud or fraud
    in connection with any business entity; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
    organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined
    in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or
    organization that has disciplinary authority over its members or persons associated with a member.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Board is in the process of establishing the audit committee, compensation committee and nominating and corporate
governance committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may establish other committees to facilitate the management of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not adopted a code of ethics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
this regard, it is expected that the Company will not provide compensation to non-employee directors which is in line with ABVC&rsquo;s
current practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
ABVC does not require directors and officers to own a specific minimum number of shares of ABVC&rsquo;s Common Stock, it believes
that each director and corporate officer should have a substantial personal investment in the Company. Directors and officers
may not engage in short sales or put or call transactions with respect to ABVC securities. The Company plans to issue equity awards
to all directors (non-employee and employee) for their service in the future. The Company believes that the future arrangements
may align the interests of the Board of Directors with the long-term interests of the Company&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_018"></A>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth, for each of the last two completed fiscal years of us, the total compensation awarded to, earned by
or paid to any person who was a principal executive officer during the preceding fiscal year and every other highest compensated
executive officers earning more than $100,000 during the last fiscal year (together, the &ldquo;Named Executive Officers&rdquo;).
The tables set forth below reflect the compensation of the Named Executive Officers. The following table provides information
regarding the named executive officers of ABVC during the fiscal year ended December 31, 2017 and 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name&nbsp;and&nbsp;Principal&nbsp;Position</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
    Awards</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
    Awards</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Equity
    Incentive Plan Compensation</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
    in Pension</B><BR>
    <B>Value&nbsp;and</B><BR>
    <B>Nonqualified Deferred Compensation Earnings</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
    Other Compensation</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B><BR>
    <B>($)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 22%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
    Doong (1)</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 6%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 5%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 3%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 4%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 4%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 5%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 5%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chun
    Mu Hung (2)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,434</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,434</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,333</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,333</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
    Jiang (3)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kira
    Huang (4)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Doong was appointed as the CEO on September 15, 2017.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hung was appointed as the CFO, Secretary and Treasury on September 15, 2017 and resigned as the CFO, Secretary and Treasurer on
May 4, 2018.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Jiang resigned as the CEO and President of the Company on September 15, 2017 and accepted the interim Chief Financial Officer
position on May 9, 2018.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Huang resigned as the CFO, Secretary and Treasurer of the Company on September 15, 2017.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Narrative
Disclosure to Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than set out below, there are no arrangements or plans in which we provide pension, retirement or similar benefits for directors
or executive officers. Our directors and executive officers may receive share options at the discretion of our board of directors
in the future. We do not have any material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or
may be paid to our directors or executive officers, except that share options may be granted at the discretion of our board of
directors.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Option Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grants
of Plan-Based Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopted an Equity Incentive Plan on February 17, 2016 (the &ldquo;2016 Plan&rdquo;). In fiscal year 2016, the Company awarded
10,000 shares of Common Stock to each of five employees. Due to the forward split detailed in our 10-Q filed June 30, 2016, each
of such employees has been awarded 31,410 shares of the Company&rsquo;s Common Stock. As a result, an aggregate of 157,050 shares
were granted to the employees pursuant to the 2016 Plan as of December 31, 2017 and an aggregate of 211,878 shares were granted
to the former and current employees and consultants under the 2016 Plan as of the date of this prospectus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not issue any additional securities under the 2016 Plan during the fiscal year of 2018. An aggregate of 157,050 shares were
granted to the employees pursuant to the 2016 Plan as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
Exercises and Stock Vested</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
options have been awarded by the Company as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
of Directors</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any agreements for compensating our directors for their services in their capacity as directors as of December 31,
2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pension,
Retirement or Similar Benefit Plans</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers.
We have no material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors
or executive officers, except that stock options may be granted at the discretion of the board of directors or a committee thereof.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
Agreements </I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&nbsp;entered
into an employment contract with Kira Huang on March 1, 2016 according to which, among other terms, Ms. Huang was required to
perform duties and undertake the responsibilities&nbsp;in a professional manner as a Chief Financial Officer. Ms. Huang resigned
from the position as CFO, Secretary and Treasurer on September 15, 2017 and terminated the employment agreement with the Company.
We paid Ms. Huang $3,000 for each month of September and October 2017 for her continuous consulting services and thereafter have
not had any outstanding obligations towards Ms. Huang under such employment agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Howard Doong has entered into an employment agreements (the &ldquo;Doong Employment Agreement&rdquo;) with the Company, pursuant
to which he shall receive an annual base salary of $100,000. As of December 31, 2017, we paid Mr. Doong 20,833&nbsp;shares of
the Company&rsquo;s common stock at a per share price of $1.60 il lieu of cash compensation. Under the Doong Employment Agreement,
Dr. Doong is employed as our CEO and President of the Company. We may terminate his employment for cause, at any time, without
notice or remuneration, for certain acts of the executive officer, such as conviction or plea of guilty to a felony or grossly
negligent or dishonest acts to our detriment, or misconduct or a failure to perform agreed duties. In such case, the executive
officer will not be entitled to receive payment of any severance benefits or other amounts by reason of the termination, and the
executive officer&rsquo;s right to all other benefits will terminate, except as required by any applicable law. We may also terminate
an executive officer&rsquo;s employment without cause upon one-month advance written notice. In such case of termination by us,
we are required to provide compensation to the executive officer, including severance pay equal to 12 months of base salary. The
executive officer may terminate the employment at any time with a one-month advance written notice if there is any significant
change in the executive officer&rsquo;s duties and responsibilities or a material reduction in the executive officer&rsquo;s annual
salary. In such case, the executive officer will be entitled to receive compensation equivalent to 12 months of the executive
officer&rsquo;s base salary.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Chun Mu Hung has entered into an employment agreement with the Company, pursuant to which he shall receive an annual base salary
of $40,000. On May 4, 2018, Mr. Hung resigned as the CFO, Secretary and Treasurer of the Company, effective immediately.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Chi-Hsin Richard King has entered into an employment agreements (the &ldquo;King Employment Agreement&rdquo;) with the Company,
pursuant to which he shall receive an annual base salary of $50,000. As of December 31, 2017, we paid Mr. King 10,416 shares of
the Company&rsquo;s common stock at a per share price of $1.60 in lieu of cash compensation. Under the King Employment Agreement,
Dr. King is employed as the CSO of the Company. We may terminate his employment for cause, at any time, without notice or remuneration,
for certain acts of the executive officer, such as conviction or plea of guilty to a felony or grossly negligent or dishonest
acts to our detriment, or misconduct or a failure to perform agreed duties. In such case, the executive officer will not be entitled
to receive payment of any severance benefits or other amounts by reason of the termination, and the executive officer&rsquo;s
right to all other benefits will terminate, except as required by any applicable law. We may also terminate an executive officer&rsquo;s
employment without cause upon one-month advance written notice. In such case of termination by us, we are required to provide
compensation to the executive officer, including severance pay equal to 12 months of base salary. The executive officer may terminate
the employment at any time with a one-month advance written notice if there is any significant change in the executive officer&rsquo;s
duties and responsibilities or a material reduction in the executive officer&rsquo;s annual salary. In such case, the executive
officer will be entitled to receive compensation equivalent to 12 months of the executive officer&rsquo;s base salary.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
completion of the Mergers did not trigger any termination payments as set forth in the various employment agreements stated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_019"></A>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding beneficial ownership of our common stock as of&nbsp;June 20, 2019 (i)
each person (or group of affiliated persons) who is known by us to own more than five percent (5%) of the outstanding shares of
our Common Stock, (ii) each director, executive officer and director nominee, and (iii) all of our directors, executive officers
and director nominees as a group.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities.
For purposes of this table, a person or group of persons is deemed to have&nbsp;&ldquo;beneficial ownership&rdquo;&nbsp;of any
shares of common stock that such person has the right to acquire within 60 days of the date of the respective table. For purposes
of computing the percentage of outstanding shares of our common stock held by each person or group of persons named above, any
shares that such person or persons has the right to acquire within 60 days of the date of the respective table is deemed to be
outstanding for such person, but is not deemed to be outstanding for the purpose of computing the percentage ownership of any
other person. The inclusion herein of any shares listed as beneficially owned does not constitute an admission of beneficial ownership.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, the business address of each beneficial owner listed is&nbsp;44370 Old Warm Springs Blvd., Fremont, CA 94538.
Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our
common stock owned by them, except to the extent that power may be shared with a spouse.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of&nbsp;June 20, 2019, we had&nbsp;17,694,289 shares of common stock issued and outstanding.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"> Name of
    Beneficial Owner </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amount
    and<BR> Nature of<BR> Beneficial<BR> Ownership </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent</B><BR>
                                         <B>of</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Howard Doong </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,403 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Eugene Jiang (1) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,146 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Yen-Hsin Chou </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,014 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Shin-Yu Miao (2) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,214 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Tsang-Ming Jiang (3) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 395 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Ming-Fong Wu </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Norimi Sakamoto </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Tsung-Shann Jiang (4) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,771,759 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 38.27 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Chang-Jen Jiang </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Yoshinobu Odaira </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Shih-Chen Tzeng </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Dr. Hwalin Lee </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> All officers and directors as a group (Twelve
    (12) persons) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,848,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 38.71 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> YuanGene&nbsp;Corporation (4) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,194,048 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 46.31 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;less
than 1%.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
Jiang held 1,146 shares of the Company&rsquo;s common stock through his ownership in BioLite, Inc., which held 271,440 shares
of the Company&rsquo;s common stock.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Shin-Yu Miao held 659 shares of the Company&rsquo;s common stock through her ownership in BioLite, Inc. and the rest through direct
ownership. Dr. Shin-Yu Miao is not a control person of BioLite, Inc. and does not have voting power over her indirect ownership
of the Common Stock of the Company of 659 shares.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Tsang-Ming Jiang held his shares of common stock in the Company through his ownership in BioLite, Inc.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Tsung-Shann Jiang held 6,555,238 shares of common stock through his ownership in YuanGene Corporation, 40,625 shares of the Company&rsquo;s
common stock through LionArts Promotion Inc., 116,905 shares through Rgene Corporation and 6,495 shares through BioLite, Inc.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_020"></A>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
CONDENSED CONSOLIDATED COMBINED</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRO
FORMA&nbsp;FINANCIAL INFORMATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2018, American BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;, the &ldquo;Company&rdquo;) entered into an agreement
and plan of merger (the &ldquo;Merger Agreement&rdquo;) with BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), a Nevada corporation,
BioKey, Inc. (&ldquo;BioKey&rdquo;), a California corporation, BioLite Acquisition Corp. (&ldquo;Merger Sub 1&rdquo;), a Nevada
corporation and wholly-owned subsidiary of the Company, and BioKey Acquisition Corp. (&ldquo;Merger Sub 2&rdquo;), a California
corporation and wholly-owned subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, on or before the closing of the Mergers, each issued and outstanding share of BioLite shall be converted
into the right to receive one point eighty-two (1.82) validly issued, fully-paid and non-assessable shares of the Company and
all shares of BioLite shall be cancelled and cease to exist. Also on or before the closing of the Mergers, each issued and outstanding
share of BioKey shall be converted into the right to receive one (1) validly issued, fully-paid and non-assessable share of the
Company and all shares of BioKey shall be cancelled and cease to exist. Simultaneously upon closing, BioLite and Merger Sub 1
shall merge together with Merger Sub 1&rsquo;s articles of incorporation and bylaws as the surviving corporation&rsquo;s (the
&ldquo;BioLite Surviving Corporation&rdquo;) articles of incorporation and bylaws and all shares of Merger Sub 1 shall be converted
into one share of Common Stock of the BioLite Surviving Corporation, which shall remain a wholly-owned subsidiary of the Company.
In addition, upon closing, BioKey and Merger Sub 2 shall merge together with Merger Sub 2&rsquo;s articles of incorporation and
bylaws as the surviving corporation&rsquo;s (the &ldquo;BioKey Surviving Corporation&rsquo;s&rdquo;) articles of incorporation
and bylaws and all shares of Merger Sub 2 shall be converted into one share of Common Stock of the BioKey Surviving Corporation,
which shall remain a wholly-owned subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed consolidated combined financial statements reflect the combination of the historical consolidated
results of ABVC and its subsidiaries, BioLite, and BioKey on a pro forma basis to give effect to the Merger Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined balance sheet of the combined company is based on (i)&nbsp;the audited historical
consolidated balance sheet of ABVC as of December&nbsp;31, 2018, (ii)&nbsp;the audited historical balance sheet of BioLite as
of December&nbsp;31, 2018, and the (iii) the audited historical balance sheet of BioKey as of December 31, 2018, and includes
pro forma adjustments as of the Mergers had occurred on December&nbsp;31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined statement of operations of the combined company are based on&nbsp;the following
details, and includes pro forma adjustments as of the Merger had occurred on January 1, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    unaudited historical consolidated statement of operations of ABVC for the year ended December 31, 2018.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    audited historical statement of operations of BioLite for the year ended December 31, 2018.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    audited historical statement of operations of BioKey for the year ended December 31, 2018.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma data presented herein reflects events that are directly attributable to the described transactions, factually
supportable, and as it relates to the unaudited pro forma condensed consolidated combined statement of operations, expected to
have a continuing impact. The unaudited pro forma data presented herein also reflects certain assumptions which management believes
are reasonable. Such pro forma data is not necessarily indicative of financial results that would have been attained had the described
transactions occurred on the dates indicated above, or the results of the combined company that may be achieved in the future.
The adjustments are based on currently available information and certain estimates and assumptions. Therefore, the actual results
may differ from the pro forma results indicated herein. However, management believes that the assumptions provide a reasonable
basis for presenting the significant effects of the transactions as contemplated and that the pro forma adjustments give appropriate
effect to those assumptions and are properly applied in the unaudited pro forma condensed consolidated combined financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined financial statements are provided for illustrative purposes only and are not
intended to represent or be indicative of the consolidated results of operations or consolidated financial position of the combined
company that would have been recorded had the Merger been completed as of the dates presented, and they should not be taken as
representative of the expected future results of operations or financial position of the combined company. The unaudited pro forma
condensed consolidated combined financial statements do not reflect the impacts of any potential operational efficiencies, asset
dispositions, cost savings or economies of scale that the combined company may achieve with respect to the operations of the combined
company. Additionally, the unaudited pro forma condensed consolidated combined statement of operations does not include&nbsp;non-recurring&nbsp;charges
or credits, and the related tax effects, which result directly from the Mergers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
PRO FORMA CONDENSED CONSOLIDATED COMBINED BALANCE SHEET</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
OF DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">Pro
    Forma</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">Pro
    Forma</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">ABVC</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">BioKey</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">BioLite</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">Adjustment</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">Note</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-size: 9pt">Combined</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">ASSETS</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">Current Assets</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Cash and
    cash equivalents</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">40,044</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">636,666</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">186,644</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">863,354</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Restricted cash and
    cash equivalents</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">16,093</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">16,093</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Accounts receivable,
    net</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,204</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,204</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Accounts receivable
    - related parties, net</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">147,848</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">147,848</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Other receivable</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">39,005</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">39,005</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Due from related parties</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">40,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">79,287</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(59,810</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{f}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">59,477</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">Inventory</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,318</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,318</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">Prepaid
    expense and other current assets</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">136</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">223,759</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">223,895</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> <FONT STYLE="font-size: 9pt">Total
    Current Assets</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">96,273</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">827,718</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">530,013</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(59,810</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,394,194</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Property and equipment,
    net</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">58,150</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">510,066</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">568,216</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Goodwill, net</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,531,445</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{e}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,531,445</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Long-term investments</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">3,488,169</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">3,448,169</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Deferred tax assets</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,347,995</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,347,995</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">Security
    Deposits</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">10,440</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">27,418</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">37,858</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">Total
    Assets</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">96,273</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">896,308</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,903,661</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,471,635</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">50,367,877</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">LIABILITIES AND
    EQUITY</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Current Liabilities</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Short-term
    bank loan</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">899,250</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">899,250</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Long-term
    bank loan - current portion</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">39,835</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">39,835</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Notes
    payable</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">510,447</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">510,447</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Accrued
    expenses and other current liabilities</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">555,449</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">83,026</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">687,709</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,326,184</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Due
    to related parties</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">4,462,775</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">3,341,005</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(58,684</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{f}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">7,745,096</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Convertible
    notes payable, current portion</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">300,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">300,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Convertible
    notes payable - related parties, current portion</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">250,000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">250,000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> <FONT STYLE="font-size: 9pt">Total
    Current Liabilities</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,568,224</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">83,026</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,478,246</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(58,684</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">11,070,812</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Long-term bank loan</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">15,257</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">15,257</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Tenant security deposit</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">2,880</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">2,880</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Convertible notes payable</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> <FONT STYLE="font-size: 9pt">Convertible
    notes payable - related parties</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">250,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">250,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">Accrued
    interest</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">27,467</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">27,467</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"> <FONT STYLE="font-size: 9pt">Total
    Liabilities</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,845,691</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">85,906</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,493,503</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(58,684</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">11,366,416</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">Equity</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Preferred stock</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">18,633,097</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(18,633,097</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{c}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Common stock</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">213,927</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">774,293</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">4,121</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(4,121</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{a}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">318,486</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">74,998</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{a}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(771,793</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{b}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">7,428</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{b}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">22,133</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{c}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Additional paid-in
    capital</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">13,914,556</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">82,265</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">10,862,995</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(70,877</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{a}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">59,018,959</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(82,265</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{e}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">44,312,285</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{e}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(10,000,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{g}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Stock subscription
    receivable</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(1,667</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">1,667</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{e}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Accumulated deficit</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(19,877,901</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(18,677,586</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(11,445,109</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">18,677,586</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{e}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(12,209,446</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">6,817,848</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{g}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">2,295,716</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{h}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">10,000,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{g}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Other comprehensive
    income</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">670,541</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(14,689</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{g,h}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">655,852</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">Treasury stock</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(6,750,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-size: 9pt">{g}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(9,100,000</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(2,350,000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">{h}</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> <FONT STYLE="font-size: 9pt">Total
    Stockholders&rsquo; deficit</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(5,749,418</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">810,402</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">92,548</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,530,319</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">38,683,851</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">Noncontrolling
    interest</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">317,610</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">-</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">317,610</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"> <FONT STYLE="font-size: 9pt">Total
    Equity</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">(5,749,418</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">810,402</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">410,158</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,530,319</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">39,001,461</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">Total
    Liabilities and Equity</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">96,273</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">896,308</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">5,903,661</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">$</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">43,471,635</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-size: 9pt">50,367,877</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-size: 9pt">&nbsp;</FONT> </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEAR ENDED DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> ABVC </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioKey </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioLite </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Note </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Combined </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,197 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,956 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 517,153 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 185,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 190,089 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,324 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 327,064 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,148 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,322 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,258,040 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,668 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,917 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,419,638 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,100,239 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,706,478 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,390,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,379,414 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 93 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (462,751 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Impairment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (396,025 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Gain/Loss
    on foreign exchange&nbsp;changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Gain/Loss
    on investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (192,463 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,741,914 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 630 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,524 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,705,837 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,228 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,639,836 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss before provision for income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,099,453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (589,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,330,174 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,019,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (364,297 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,654,953 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Net loss
    attributable to noncontrolling interests </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Net loss
    attributable to ABVC and subsidiaries </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,067 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,144,104 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Foreign
    currency translation adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Income (Loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,560,862 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,230,890 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Net loss
    per share attributable to common stockholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.03 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Weighted
    average number of common shares outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,884,105 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 214,156,988 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Notes
to the Unaudited Pro Forma Condensed Consolidated Combined Financial Statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Basis of Presentation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined balance sheet as of December 31, 2018 is based on the audited consolidated
balance sheet of ABVC, the audited consolidated balance sheet of BioLite, and the audited balance sheet of BioKey as if the Merger
had occurred on December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined statement of operations for the year ended December 31, 2018 is based on the
audited consolidated statement of operations of ABVC for the year ended December 31, 2018, the audited consolidated statement
of operations of BioLite for the year ended December 31, 2018, and the audited statement of operations of BioKey for the year
ended December 31, 2018, as if the Merger had occurred on December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
and the Company are related parties because the two companies are under common control by Dr. Tsung-Shann Jiang. BioKey is not
a related party to the Company or BioLite.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Pro Forma Adjustments</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following adjustments were made in the preparation of the audited pro forma condensed consolidated combined balance sheet and
unaudited pro forma condensed consolidated combined statements of operations:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{a}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
    of ABVC common stock to be issued to BioLite shareholders:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
    Outstanding shares as of December 31, 2018</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,207,444</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    of each BioLite share of common stock outstanding as of December 31, 2018, for 1.82 shares of ABVC common stock</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.82</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioLite as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,997,548</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    value $0.001 per share of ABVC</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,998</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{b}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey shareholders in exchange of BioKey&rsquo;s common stock outstanding:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
    Outstanding shares as of December 31, 2018</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,428,134</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    of each BioKey share of common stock outstanding as of December 31, 2018, for one share of ABVC common stock</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,428,134</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    value $0.001 per share of ABVC</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,428</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{c}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey shareholders in exchange of BioKey&rsquo;s preferred stock outstanding:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
    Outstanding shares as of December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; padding-left: 9pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000,000
    shares of Series A</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000,000</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,160,000
    shares of Series B</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,160,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,973,097
    shares of Series C</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,973,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey&rsquo;s
    total shares of preferred stock outstanding as of December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    of each BioKey share of preferred stock outstanding as of December 31, 2018, for one share of ABVC common stock</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    value $0.001 per share of ABVC</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{d}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock outstanding as of December 31, 2018 following the Merger:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock issued as of December 31, 2018</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,926,475</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock held by BioLite pursuant to the BioLite Collaborative Agreement (see Note {g})</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,487,500</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock held by BioLite for cash issuance (see Note {h})</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,468,750</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioLite as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,997,548</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,561,231</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    common stock of the combined company outstanding following the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,529,004</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{e}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, adjustments to reflect the elimination of BioKey&rsquo;s total equity, the estimated value of consideration
    to be paid in the Merger and to adjust, where required, the historical book values of BioKey&rsquo;s assets and liabilities
    as of December 31, 2018 to the preliminary estimated fair value, in accordance with the acquisition method of accounting.
    The preliminary valuations were determined as of and, where applicable, are based on the bid-and-ask share price of ABVC common
    stock on the final day of trading, February 5, 2019. The fair value of the consideration given and assets and liabilities
    acquired will be determined based on the underlying fair values as of February 5, 2019.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    consideration:</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock (1)</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,341,847</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Fair Value of Assets Acquired:</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">636,666</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,204</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable - related parties</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">147,848</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,150</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    deposits</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,440</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets acquired</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">896,308</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Fair Value of Liabilities Assumed:</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to shareholders</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses and other current liabilities</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,026</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tenant
    security deposit</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,880</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities assumed</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,906</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    net assets acquired</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,402</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
    as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,531,445</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,561,231
    shares of ABVC common stock to be issued to BioKey in connection with the Merger. Those shares were valued at $1.50 per share,
    the closing share price of ABVC on February 5, 2019.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{f}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2018, BioLite had $59,810 due from ABVC; and ABVC had $58,684 due to BioLite. The difference was mainly due
    to the translation adjustment, which would be reflected in accumulated other comprehensive income in equity section.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{g}</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
    agreement with BioLite Inc., a related party</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2015, American BriVision Corporation (&ldquo;BriVision&rdquo;) entered into a collaborative agreement (the &ldquo;BioLite
Collaborative Agreement&rdquo;) with BioLite, a related party, pursuant to which BioLite granted BriVision sole licensing rights
for drug and therapeutic use of five products, including BLI-1005 CNS-Major Depressive Disorder, BLI-1008 CNS-Attention Deficit
Hyperactivity Disorder, BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1, BLI-1401-2 Anti-Tumor Combination
Therapy-Triple Negative Breast Cancer, and BLI-1501 Hematology-Chronic Lymphocytic Leukemia, in the U.S.A and Canada. Under the
BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of BriVision with equivalent value,
according to the following schedule:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upfront
    payment shall upon the signing of this BioLite Collaborative Agreement: 3.5% of total payment. After receiving upfront payment
    from BriVision, BioLite has to deliver all data to BriVision in one week.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the first IND submission, BriVision shall pay, but no later than December 15, 2016: 6.5% of total payment. After receiving
    second payment from BriVision, BioLite has to deliver IND package to BriVision in one week.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    the completion of first phase II clinical trial, BriVision shall pay: 15% of total payment. After receiving third payment from
    BriVision, BioLite has to deliver phase II clinical study report to BriVision in three months.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the phase III IND submission, BriVision shall pay: 20% of total payment. After receiving forth payment from BriVision, BioLite
    has to deliver IND package to BriVision in one week.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    the completion of phase III, BriVision shall pay: 25% of total payment. After receiving fifth payment from BriVision, BioLite
    has to deliver phase III clinical study report to BriVision in three months.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the NDA submission, BriVision shall pay BriVision shall pay: 30% of total payment. After receiving sixth payment from BriVision,
    BioLite has to deliver NDA package to BriVision in one week.&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
BioLite Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial
sales of the Product in the Territory and automatically renew for five more years unless either party gives the other party six
month written notice of termination prior to the expiration date of the term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, an upfront payment of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5%
of total payments due under the BioLite Collaborative Agreement, was to be paid by BriVision upon signing of that agreement. On
May 6, 2016, BriVision and BioLite agreed to amend the BioLite Collaborative Agreement, and BriVision agreed to pay the Milestone
Payment to BioLite with $2,600,000 in cash and $900,000 in the form of newly issued shares of its common stock, at the price of
$1.60 per share, for an aggregate number of 562,500 shares. The cash payment and shares issuance were completed in June 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which
was submitted in March 2016. On February 2017, BriVision agreed to pay this amount to BioLite with $650,000 in cash and $5,850,000
in the form of newly issued shares of its common stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares.
The cash payment and shares issuance were completed in February 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 15% of total payment, $15,000,000 shall be made at the completion of first phase II
clinical trial. As of December 31, 2018 and, 2017, the first phase II clinical trial research had not been completed yet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of shares of common stock of American BriVision Corporation issued to BioLite pursuant to the BioLite Collaborative
Agreement was 3,487,500 shares, the value of which was $6,750,000. The unaudited pro forma adjustments were made as if the Merger
occurred on December 31, 2018. As such, these shares of common stock of BriVision held by BioLite shall not be treated as outstanding
shares, and shall be reflected as treasury shares. The corresponding long-term investment of BioLite has been written off in full
amount, included in the accumulated deficit as of December 31, 2018. Such amount has been eliminated in the pro forma condensed
balance sheet. Investment loss recognized as a result of the write-off amounted to $4,313,725 for the year ended December 31,
2018. Such amount has been eliminated in the pro forma condensed statement of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision Corporation determined to fully expense the amount of $10,000,000 according to ASC 730-10-25-1. That amount was
fully expensed as research and development expense during the year ended December 31, 2016 and included in the accumulated
deficit of ABVC as of December 31, 2018. The aggregate amount of $10,000,000 was recorded and remained as additional paid-in
capital on BioLite as of December 31, 2018. Such amount has been eliminated in the pro forma condensed balance
sheet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{h}</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 26, 2016, ABVC issued 1,468,750 shares of common stock, par value $0.001 to BioLite pursuant to that certain Stock
    Purchase Agreement dated August 26, 2016. The purchase price per share was $1.60. The net proceeds to the Company from the
    sale of such shares were approximately $2,350,000. The unaudited pro forma adjustments were made as if the Merger occurred
    on December 31, 2018. As such, these shares of common stock of ABVC held by BioLite shall be treated be treated as outstanding
    shares, and shall be reflected as treasury shares. The corresponding long-term investment of BioLite has been written off
    in full amount, included in the accumulated deficit as of December 31, 2018. Such amount has been eliminated in the pro forma
    condensed balance sheet.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_021"></A>RELATED
PARTY TRANSACTIONS OF DIRECTORS AND EXECUTIVE OFFICERS OF THE COMBINED COMPANY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaboration
Agreement with BioLite, Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2015, American BriVision Corporation entered into a Collaborative Agreement with BioLite Inc., a related party, pursuant
to which BioLite granted the Company sole licensing rights for drug and therapeutic use of five products: BLI-1005 CNS-Major Depressive
Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1;
BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia,
in USA and Canada. Under the Collaborative Agreement, BriVision would be required to pay a total of $100,000,000 in cash or stock
of BriVision with equivalent value, according to the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, an upfront payment of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5%
of total payments due under the BioLite Collaborative Agreement, was to be paid by the Company upon signing of that agreement.
On May 6, 2016, the Company and BioLite agreed to amend the BioLite Collaborative Agreement, and the Company agreed to pay the
Milestone Payment to BioLite with $2,600,000 in cash and $900,000 in the form of newly issued shares of its common stock, at the
price of $1.60 per share, for an aggregate number of 562,500 shares. The cash payment and shares issuance were completed in June
2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which
was submitted in March 2016. On February 2017, the Company agreed to pay this amount to BioLite with $650,000 in cash and $5,850,000
in the form of newly issued shares of its common stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares.
The cash payment and shares issuance were completed in February 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 15% of total payment, $15,000,000 shall be made at the completion of first phase II
clinical trial. As of September 30, 2017, the first phase II clinical trial research has not completed yet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2017, the Company entered into an Addendum (the &ldquo;Addendum&rdquo;) to the BioLite Collaborative Agreement which
was previously entered into with BioLite. Pursuant to the Addendum, the Company and BioLite agreed to include one more product,
namely, &ldquo;Maitake Combination Therapy&rdquo; as one of the Products defined in the BioLite Collaborative Agreement (the &ldquo;Sixth
Product&rsquo;) and defined the Territory of the Sixth Product to be worldwide and restate the Territory of the Five Products
to be the U.S.A and Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018 and 2017, the amount due to BioLite is $0 and $6,500,000 respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advances
from BioLite</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2018 and 2017, BioLite has advanced funds to the Company for working capital purpose. The advances
bear 0% interest rate and are due on demand. As of December 31, 2018 and 2017, the outstanding advance balance was $58,684 and
$109,220, respectively. As of March 31, 2019, the outstanding advance balances in aggregate were $62,058.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaboration
agreement with BioFirst Corporation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2017, American BriVision Corporation entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;)
with BioFirst Corporation (&ldquo;BioFirst&rdquo;), pursuant to which BioFirst granted BriVision the global licensing right for
medical use of the product (the &ldquo;Product&rdquo;): BFC-1401 Vitreous Substitute for Vitrectomy. BioFirst is a related party
to the Company because a controlling beneficiary shareholder of Yuangene Corporation who is the controlling shareholder of Brivision
trhough the Company is one of the directors and common stock shareholders of BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioFirst Collaborative Agreement, Brivision will co-develop and commercialize the Product with BioFirst and pay BioFirst
in a total amount of $3,000,000 in cash or stock of Brivision before September 30, 2018. On September 25, 2017, BioFirst has delivered
all research, technical, data and development data to BriVision. No payment has been made by Brivision as of the date of this
prospectus.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loan
from BioFirst</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2017, BriVision and BioFirst entered into a loan agreement for a total commitment (non-secured indebtedness) of $950,000
to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent
to 12% per annum) and the Company is required to pay interest monthly to the lender. The loan matured on February 2, 2019 and
the parties extended the loan for another year until February 1, 2020. As of March 31, 2019 and December 31, 2018, the outstanding
loan balance was $233,000 and $692,980, respectively, and accrued interest was $11,971 and $281, respectively. Interest expenses
in connection with this loan were $11,710 and $9,500 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Co-Development
agreement with Rgene Corporation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, American BriVision Corporation entered into a co-development agreement (the &ldquo;Co-Dev Agreement&rdquo;) with
Rgene Corporation (&ldquo;Rgene&rdquo;), a related party controlled by the controlling beneficiary shareholder of YuanGene Corporation,
who is the controlling shareholder of Brivision trhough the Company. Pursuant to Co-Dev Agreement, BriVision and Rgene agreed
to co-develop and commercialize certain products that are included in the Sixth Product as defined in the Addendum. Under the
terms of the Co-Dev Agreement, Rgene is to pay the Company $3,000,000 in cash or stock of Rgene with equivalent value by August
15, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, BriVision has delivered all research, technical, data and development data to Rgene. Since both Rgene and Brivision
are related parties controlled by the controlling beneficiary shareholder of YuanGene Corporation who is the controlling shareholder
of Brivision trhough the Company, Brivison has recorded the full amount of $3,000,000 in connection with the Co-Dev Agreement
as additional paid-in capital during the year ended September 30, 2017. As of the date of this report, Brivision has received
$450,000 in cash and the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s common stock, at
the price of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares, which accounted
for equity method long-term investment as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AsianGene
Related Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AsianGene
and ABVC are controlled by the same controlling beneficiary shareholder of Yuangene. During the year ended September 30, 2017,
the Company entered an operating lease agreement with Asiangene for an office space in Taiwan for the period from October 1, 2016
to July 31, 2017. Rent expenses under this lease agreement amounted to $0 and $52,205 for the years ended December 31, 2018 and
2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2017, AsianGene entered into an investment and equity transfer agreement (the &ldquo;Investment and Equity Transfer
Agreement&rdquo;) with Everfront Biotech Inc. (&ldquo;Everfront&rdquo;), a third party. Pursuant to the Investment and Equity
Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsianGene at $1.60 per share
in a total amount of $3,200,000, of which $160,000 was due before September 15, 2017 and the remaining amount of $3,040,000 was
due before December 15, 2017. As of June 30, 2018 and December 31, 2017, Everfront purchased 100,000 shares of ABVC&rsquo;s common
stock from AsianGene for an aggregate amount of $160,000 which was paid to AsianGene and AsianGene in return loaned such amount
to ABVC for working capital purposes. On January 16, 2018, AsianGene and the Company entered into a loan agreement. Pursuant to
the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay
interest monthly to AsianGene. The loan was due on demand. As of March 31, 2019 and December 31, 2018, the outstanding loan balance
was $160,000 and accrued interest was $17,600 and $12,866, respectively. Interest expenses in connection with this loan were $4,734
and $3,945 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
Notes</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Keypoint Note&rdquo;)
in the aggregate principal amount of $250,000 to Keypoint Technology Ltd. (&ldquo;Keypoint&rdquo;). The Company received $250,000
which bears interest at 8% per annum. Interest expenses in connection with this Keypoint Note were $5,000 and $0 for the three
months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 25, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Odaira Note&rdquo;)
in the aggregate principal amount of $250,000 to Yoshinobu Odaira, a director of the Company (&ldquo;Odaira&rdquo;). The Company
received $250,000 on November 29, 2018 which bears interest at 8% per annum. Interest expense in connection with this Odaira Note
was $5,000 and $0 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
                                         As of March 31, 2019, Mr. Tsung-Shann Jiang and his spouse Ms. Shu-Ling Jiang had advanced
                                         funds to the Company for working capital purposes. The advances bear interest at 1% per
                                         month (or equivalent to 12% per annum) and are due on demand. As of March 31, 2019, the
                                         outstanding advance balance was $157,140 and the accrued interest was $10,454.</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
        of March 31, 2019, Lion Arts Promotion Inc. (&ldquo;LION&rdquo;), LionGene Corporation (&ldquo;LionGene&rdquo;), and Mr.
        Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Mr. Eugene Jiang (&ldquo;the Jiangs&rdquo;) have also advanced funds to the
        Company         for working capital purpose. The advances bear 0% interest rate and are due on demand. As of March 31, 2019,
        the outstanding         advance balances in aggregate were $926,395. Mr. Tsung-Shann Jiang and Ms. Shu-Ling Jiang are husband
        and wife. Eugene         Jiang is the child of Mr. Jiang and Mrs. Jiang. LionGene and the Company are under common control of
        YuanGene. The chairperson         of LION is Ms. Shu-Ling Jiang.</FONT> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Promoters
and Certain Control Persons</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our management or other control persons were &ldquo;promoters&rdquo; (within the meaning of Rule&nbsp;405 under the Securities
Act), and none of such persons took the initiative in the formation of our business or received any of our debt or equity securities
or any of the proceeds from the sale of such securities in exchange for the contribution of property or services, during the last
five years.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_022"></A>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s authorized capital stock consists of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000
    shares of Common Stock, $0.001 par value per share; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000
    shares of preferred stock, $0.001 par value per share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock may be issued for such consideration as may be fixed from time to time by our board of directors. Our board of directors
may issue such shares of our Common Stock in one or more series, with such voting powers, shall be stated in the resolution or
resolutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 3, 2019, there were 17,694,156 shares of our Common Stock issued and outstanding giving the effect of the Merger. Holders
of Common Stock are entitled to cast one vote for each share on all matters submitted to a vote of shareholders, including the
election of directors. The holders of Common Stock are entitled to receive ratably such dividends, if any, as may be declared
by the Board out of funds legally available therefore. Such holders do not have any preemptive or other rights to subscribe for
additional shares. All holders of Common Stock are entitled to share ratably in any assets for distribution to shareholders upon
the liquidation, dissolution or winding up of the Company, subject to prior distribution rights of preferred stock then outstanding.
There are no conversions, redemptions or sinking fund provisions applicable to the Common Stock. All outstanding shares of Common
Stock are fully paid and non-assessable.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 20, 2019, there is no preferred stock outstanding. Pursuant to the articles of incorporation of the Company, the Board
of Directors is expressly granted the authority to&nbsp;issue preferred stock up to 20,000,000 shares and prescribe its designations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of preferred stock and the description of the terms of any particular series of preferred stock of the Company
are not complete. The Company&rsquo;s Board of Directors has the authority, without further action by the shareholders, to issue
shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions granted to or
imposed upon the preferred stock. Any or all of these rights may be greater than the rights of the Company&rsquo;s Common Stock.
These descriptions are qualified in their entirety by reference to the Company&rsquo;s Articles of Incorporation, as amended,
and the certificate of designation relating to each such series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
A Convertible Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the material terms and provisions of our Series A Convertible Preferred Stock does not purport to be complete
and is qualified in its entirety by reference to our articles of incorporation, including the certificate of designation filed
with the State of Nevada on June 28, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors intends to designate 4,500,000 shares of our authorized but unissued Preferred Stock as Series A Convertible
Preferred Stock. When issued in accordance with this prospectus, the Series A Convertible Preferred Stock will be validly issued,
fully paid and non-assessable. Our board of directors may authorize the issuance and sale of additional shares of Series A Convertible
Preferred Stock from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ranking</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Convertible Preferred Stock will rank, with respect to dividend rights and rights upon voluntary or involuntary liquidation,
dissolution or winding up of our affairs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">senior
    to all classes or series of our Common Stock and to any other class or series of our capital stock expressly designated as
    ranking junior to the Series A Convertible Preferred Stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    parity any class or series of our capital stock expressly designated as ranking on parity with the Series A Convertible Preferred
    Stock, none of which exists on the date hereof; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">junior
    to any other class or series of our capital stock expressly designated as ranking senior to the Series A Convertible Preferred
    Stock, none of which exists on the date hereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;capital stock&rdquo; does not include convertible or exchangeable debt securities, which, prior to conversion or exchange,
rank senior in right of payment to the Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock will also
rank junior in right of payment to our other existing and future debt obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividends</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the preferential rights of the holders of any class or series of our capital stock ranking senior to the Series A Convertible
Preferred Stock with respect to dividend rights, holders of shares of the Series A Convertible Preferred Stock are entitled to
receive, when declared by us out of Dividend Reserve legally available for the payment of dividends, cumulative cash dividends
at the rate of&nbsp;5.0% of the Public Offering Price per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on the Series A Convertible Preferred Stock will accrue and be cumulative from and including the date of original issue and will
be payable to holders on record annually in arrears commencing from the date of issuance of Series A Convertible Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on the Series A Convertible Preferred Stock will accrue whether or not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have earnings;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
    are funds legally available for the payment of those dividends; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    dividends are authorized or declared.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
dividend payment made on the Series A Convertible Preferred Stock will first be credited against the earliest accrued but unpaid
dividends due with respect to those shares which remain payable. Accrued but unpaid dividends on the Series A Convertible Preferred
Stock will accumulate as of the dividend payment date on which they first become payable. Holders of shares of Series A Convertible
Preferred Stock are also entitled to any dividend declared by the board of directors of the Company to the holders of our Common
Stock, whether such dividend payable in cash, property or shares of capital stock, in excess of full cumulative dividends on the
Series A Convertible Preferred Stock as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
dividends on Series A Convertible Preferred Stock will be authorized by our board of directors and declared by us or paid or set
apart for payment if such authorization, declaration or payment is restricted or prohibited by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidation
Preference</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
any voluntary or involuntary liquidation, dissolution or winding up of our affairs, before any distribution or payment shall be
made to holders of shares of our common stock or any other class or series of capital stock ranking, as to rights upon any voluntary
or involuntary liquidation, dissolution or winding up of our affairs, junior to the Series A Convertible Preferred Stock, holders
of shares of Series A Convertible Preferred Stock will be entitled to be paid out of our assets legally available for distribution
to our stockholders only to the extent of the accrued but unpaid dividend at that time, after payment of or provision for our
debts and other liabilities. If, upon our voluntary or involuntary liquidation, dissolution or winding up, we have assets legally
available for distribution after payments of the aggregate accrued but unpaid dividend on Series A Convertible Preferred Stock,
the holders of Series A Convertible Preferred Stock and Common Stock shall have the same liquidation preference with respect to
such residual assets. If, upon our voluntary or involuntary liquidation, dissolution or winding up, our available assets are insufficient
to pay the full amount of the accrued but unpaid dividend on all outstanding shares of Series A Convertible Preferred Stock, then
holders of shares of Series A Convertible Preferred Stock will share ratably in any distribution of assets in proportion to the
full liquidating distributions to which they would otherwise be respectively entitled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Series A Convertible Preferred Stock is initially convertible at any time at the option of the holders into one share
of Common Stock and automatically converts into one share of Common Stock (the &ldquo;Conversion Ratio&rdquo;) on its four-year
anniversary of issuance and without the payment of additional consideration by the holder thereof.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares shall be issued upon conversion of Series A Convertible Preferred Stock into Common Stock and no payment. In
lieu of delivering fractional shares, we will pay to the holder, to the extent permitted by law, an amount in cash equal to the
current fair market value of such fractional share as determined in good faith by our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
Maturity, Sinking Fund or Mandatory Redemption</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Convertible Preferred Stock has no maturity date and we are not required to redeem the Series A Convertible Preferred
Stock at any time. However, we may choose to convert all the outstanding shares of the Series A Convertible Preferred Stock into
our Common Stock at the same Conversion Ratio at any time, provided that we have prepaid and distributed all the dividend accrued
and to be accrued at the end of the four-year period since issuance thereof. Accordingly, the Series A Convertible Preferred Stock
will remain outstanding until automatically converted to Common Stock on the four-year anniversary of issuance, unless the holders
of the Series A Convertible Preferred Stock or we choose to convert the Series A Convertible Preferred Stock into the Common Stock.
The Series A Convertible Preferred Stock is also not subject to any sinking fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of shares of the Series A Convertible Preferred Stock shall have the same voting rights as of the holders of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants
and Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 3, 2019, we had no options or warrants of the Company outstanding giving the effect of the Mergers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock&nbsp;is:&nbsp;Olde&nbsp;Monmouth Stock Transfer, Inc.; Address: 200 Memorial
Pkwy, Atlantic Highlands, NJ 07716;&nbsp;Phone:&nbsp;(732) 872-2727;&nbsp;website:www.oldemonmouth.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nevada
Revised Statutes</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acquisition
of Controlling Interest Statutes</U>. Nevada&rsquo;s &ldquo;acquisition of controlling interest&rdquo; statutes contain provisions
governing the acquisition of a controlling interest in certain Nevada corporations. These &ldquo;control share&rdquo; laws provide
generally that any person that acquires a &ldquo;controlling interest&rdquo; in certain Nevada corporations may be denied certain
voting rights, unless a majority of the disinterested stockholders of the corporation elects to restore such voting rights. These
statutes provide that a person acquires a &ldquo;controlling interest&rdquo; whenever a person acquires shares of a subject corporation
that, but for the application of these provisions of the Nevada Revised Statutes, would enable that person to exercise (1) one-fifth
or more, but less than one-third, (2) one-third or more, but less than a majority or (3) a majority or more, of all of the voting
power of the corporation in the election of directors. Once an acquirer crosses one of these thresholds, shares which it acquired
in the transaction taking it over the threshold and within the 90 days immediately preceding the date when the acquiring person
acquired or offered to acquire a controlling interest become &ldquo;control shares&rdquo; to which the voting restrictions described
above apply. Our articles of incorporation and bylaws currently contain no provisions relating to these statutes, and unless our
articles of incorporation or bylaws in effect on the tenth day after the acquisition of a controlling interest were to provide
otherwise, these laws would apply to us if we were to (i) have 200 or more stockholders of record (at least 100 of which have
addresses in the State of Nevada appearing on our stock ledger) and (ii) do business in the State of Nevada directly or through
an affiliated corporation. If these laws were to apply to us, they might discourage companies or persons interested in acquiring
a significant interest in or control of the Company, regardless of whether such acquisition may be in the interest of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Combinations
with Interested Stockholders Statutes</U>. Nevada&rsquo;s &ldquo;combinations with interested stockholders&rdquo; statutes prohibit
certain business &ldquo;combinations&rdquo; between certain Nevada corporations and any person deemed to be an &ldquo;interested
stockholder&rdquo; for two years after such person first becomes an &ldquo;interested stockholder&rdquo; unless (i) the corporation&rsquo;s
board of directors approves the combination (or the transaction by which such person becomes an &ldquo;interested stockholder&rdquo;)
in advance, or (ii) the combination is approved by the board of directors and sixty percent of the corporation&rsquo;s voting
power not beneficially owned by the interested shareholder, its affiliates and associates. Furthermore, in the absence of prior
approval certain restrictions may apply even after such two-year period. For purposes of these statutes, an &ldquo;interested
stockholder&rdquo; is any person who is (x) the beneficial owner, directly or indirectly, of ten percent or more of the voting
power of the outstanding voting shares of the corporation, or (y) an affiliate or associate of the corporation and at any time
within the two previous years was the beneficial owner, directly or indirectly, of ten percent or more of the voting power of
the then outstanding shares of the corporation. The definition of the term &ldquo;combination&rdquo; is sufficiently broad to
cover most significant transactions between the corporation and an &ldquo;interested stockholder&rdquo;. Subject to certain timing
requirements set forth in the statutes, a corporation may elect not to be governed by these statutes. We have not included any
such provision in our articles of incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of these statutes may be to potentially discourage parties interested in taking control of the Company from doing so if
it cannot obtain the approval of our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to have our Common Stock and the Series A Convertible Preferred Stock approved for listing on Nasdaq. We have applied for
listing on Nasdaq of our Common Stock under the same symbol &ldquo;ABVC&rdquo; and will apply for listing on Nasdaq of the Series
A Convertible Preferred Stock under the symbol of &ldquo;___.&rdquo; We will not consummate and close this offering without a
listing approval letter of the Common Stock and Series A Convertible Preferred Stock from Nasdaq. Our receipt of a listing approval
letter is not the same as an actual listing on Nasdaq.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our securities, such as Common Stock and Series A Convertible Preferred Stock, are listed on Nasdaq, we will be subject
to continued listing requirements and corporate governance standards. We expect these new rules and regulations to significantly
increase our legal, accounting and financial compliance costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_023"></A>SHARES
ELIGIBLE FOR FUTURE SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been very limited public market for our capital stock. Future sales of our Common Stock or the Series
A Convertible Preferred Stock in the public market, or the availability of such shares for sale in the public market, could adversely
affect market prices prevailing from time to time. As described below, only a limited number of shares will be available for sale
shortly after this offering due to contractual and legal restrictions on resale. Nevertheless, sales of a substantial number of
shares of our Common Stock or the Series A Convertible Preferred Stock in the public market after such restrictions lapse, or
the perception that those sales may occur, could adversely affect the prevailing market price at such time and our ability to
raise equity-related capital at a time and price we deem appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sales
of Restricted Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of this offering, 1,428,571 shares at minimum, 2,857,143 shares at maximum, and 3,285,714 shares at the increased
maximum, of Series A Convertible Preferred Stock on an as-converted basis will be outstanding. Of these shares, all of the shares
of the Series A Convertible Preferred Stock sold in this offering, converted or not converted, will be freely tradable without
restriction or further registration under the Securities Act, unless the shares are held by any of our &ldquo;affiliates&rdquo;
as such term is defined in Rule 144 under the Securities Act.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining shares of Common Stock not registered under any registration statement, including the Registration Statement on S-4,
held by existing stockholders will be deemed &ldquo;restricted securities&rdquo; as such term is defined under Rule 144. The restricted
securities were issued and sold by us in private transactions and are eligible for public sale only if registered under the Securities
Act or if they qualify for an exemption from registration under Rule 144 or Rule 701 under the Securities Act, which rules are
summarized below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the lock-up agreements described below and the provisions of Rule 144 and Rule 701 under the Securities Act, all of
the shares of our Common Stock (excluding the shares to be sold in this offering) will be available for sale in the public market
upon the expiration of the lockup agreements, beginning 180 days after the date of this prospectus (subject to extension) and
when permitted under Rule 144 or Rule 701.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
144</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144 as currently in effect, once we have been a reporting company subject to the reporting requirements of
Section 13 or 15(d) of the Exchange Act for 90 days, a person (or persons whose shares are aggregated) who is not deemed to have
been an affiliate of ours at any time during the three months preceding a sale, and who has beneficially owned restricted securities
within the meaning of Rule 144 for at least six months (including any period of consecutive ownership of preceding non-affiliated
holders) would be entitled to sell those shares, subject only to the availability of current public information about us. A non-affiliated
person who has beneficially owned restricted securities within the meaning of Rule 144 for at least one year would be entitled
to sell those shares without regard to the provisions of Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
we have been a reporting company subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act for 90 days,
a person (or persons whose shares are aggregated) who is deemed to be an affiliate of ours and who has beneficially owned restricted
securities within the meaning of Rule 144 for at least six months would be entitled to sell within any three-month period a number
of shares that does not exceed the greater of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
    percent of the then outstanding shares of our Common Stock and the Series A Convertible Preferred Stock as converted, which
    will equal approximately 191,227shares at minimum, 205,513shares at maximum or 209,799 shates at the increased maximum immediately
    after this offering, based upon the number of shares of Common Stock outstanding as of June 3, 2019; and</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Nasdaq average weekly trading volume of our Common Stock and the Series A Convertible Preferred Stock as converted reported
    during the four calendar weeks preceding the filing of notice of the sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
sales are also subject to certain manner of sale provisions, notice requirements and the availability of current public information
about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees,
directors, officers, consultants or advisors who purchase shares from us in connection with a compensatory stock or option plan
or other written compensatory agreement in accordance with Rule 701 before the effective date of the registration statement are
entitled to sell such shares 90 days after the effective date of the registration statement in reliance on Rule 144 without having
to comply with the holding period requirement of Rule 144 and, in the case of non-affiliates, without having to comply with the
public information, volume limitation or notice filing provisions of Rule 144. The SEC has indicated that Rule 701 will apply
to typical stock options granted by an issuer before it becomes subject to the reporting requirements of the Exchange Act, along
with the shares acquired upon exercise of such options, including exercises after the date of this prospectus. However, all Rule
701 shares are subject to lock-up agreements as described below and under &ldquo;Underwriting&rdquo; included elsewhere in this
prospectus and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our directors and officers and existing beneficial owners of 5% or more of our outstanding Common Stock have agreed not to
sell or otherwise transfer or dispose of any Common Stock for a period of one hundred and eighty (180) days from the date of this
prospectus, subject to certain exceptions and extensions. See &ldquo;Underwriting&rdquo; for a description of these lock-up provisions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_024"></A>UNDERWRITING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to enter into an underwriting agreement with the Underwriter named therein with respect to the Series A Convertible Preferred
Stock in our offering. Under the terms and subject to the conditions contained in the underwriting agreement, we have agreed to
issue and sell a minimum offering amount of the Series A Convertible Preferred Stock and a maximum offering&nbsp;amount of the
Series A Convertible Preferred Stock on a best efforts basis with the Underwriter having the discretion at any time during the
offering period to increase the maximum amount of the offering by offering up to an additional 15% shares of Series A Convertible
Preferred Stock. The offering is being made without a firm commitment by the Underwriter, which has no obligation or commitment
to purchase any securities. The Underwriter is not required to sell any specific dollar amount of Series A Convertible Preferred
Stock but will use its best efforts to sell the Series A Convertible Preferred Stock offered.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to close this offering unless we sell at least a minimum number of shares, at the price per share set forth on the
cover page of this prospectus, to result in sufficient proceeds to list the Series A Convertible Preferred Stock on Nasdaq. We
intend to apply to list the Series A Convertible Preferred Stock on Nasdaq under the symbol &ldquo;____&rdquo;. Because this is
a best efforts offering, the Underwriter does not have an obligation to purchase any securities, and, as a result, we may not
be able to sell the minimum number of Series A Convertible Preferred Stock. Our exclusive engagement with the Underwriter with
respect to this offering may terminate, as the case may be, on the earlier of (i) any time after the minimum offering amount of
the Series A Convertible Preferred Stock is raised, or (ii) one hundred and eighty (180) days from the date of this prospectus,
or the expiration date. If we can successfully raise the minimum offering amount within the offering period, the proceeds from
the offering will be released to us.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that delivery of the Series A Convertible Preferred Stock will be made to investors through the book-entry facilities of
the Olde Monmouth Stock Transfer Co., Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligation of the Underwriter to sell the Series A Convertible Preferred Stock, on a
best efforts basis, is subject to certain conditions precedent, including but not limited to (1) obtaining listing approval on
Nasdaq, (2) delivery of legal opinions and (3) delivery of auditor comfort letters. The Underwriter is under no obligation to
purchase any Series A Convertible Preferred Stock for its own account. Trading in the Series A Convertible Preferred Stock will
commence within five days after the date of the initial issuance of the Series A Convertible Preferred Stock pursuant to this
prospectus. As an offering on a best efforts basis, there can be no assurance that the offering contemplated hereby will ultimately
be consummated. The Underwriter may, but is not obligated to, retain other selected dealers that are qualified to offer and sell
the shares and that are members of the Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an offering deposit account agent agreement to be entered by and among us, the Underwriter and the Deposit Account Agent until
at least 1,428,571 shares of Series A Convertible Preferred Stock are sold, all funds received in payment for securities sold
in this offering will be required to be submitted by subscribers to a non-interest bearing escrow account with the Deposit Account
Agent at Pacific Mercantile Bank and will be held by the Deposit Account Agent for such account. The Deposit Account Agent is
affiliated with the Underwriter, as the Deposit Account Agent is under the same indirect common ownership as the Underwriter.
The Underwriter and we shall require all investor checks for payment for the securities to be made payable to &ldquo;FinTech Clearing,
as Deposit Account Agent for the Investors in American Brivision (Holding) Corporation.&rdquo; All subscription agreements and
checks should be delivered to FinTech Clearing, LLC, Attention: Brian Park. Failure to do so will result in checks being returned
to the investor who submitted the check. The investors will have sole claim to the proceeds held in trust prior to the receipt
of the minimum offering proceeds. The funds are held for the benefit of the investors until the minimum is reached. Prior to reaching
the minimum claims may not be reached by creditors of the Company. If the Underwriter does not sell at least 1,428,571 shares
of Series A Convertible Preferred Stock by the Termination Date, all funds will be returned promptly to subscribers without interest
or deduction. If this Offering completes, then on the closing date, net proceeds will be delivered to us and we will issue the
shares of Series A Convertible Preferred Stock to purchasers. Unless purchasers instruct us otherwise, we will deliver the shares
of Series A Convertible Preferred Stock electronically upon receipt of purchaser funds to the accounts of those purchasers who
hold accounts at the Underwriter, or elsewhere, as specified by the purchaser, as soon as practical upon the closing of the Offering.
Alternately, purchasers who do not carry an account at the Underwriter may request that the shares be held in book-entry at the
Company&rsquo;s transfer agent, or may be issued in book-entry at the Company&rsquo;s transfer agent and subsequently delivered
electronically to the purchasers&rsquo; respective brokerage account upon request of the purchasers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees,
Commissions and Expense Reimbursement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter will receive an underwriting commission equal to 7% of the gross amount to be raised in this offering, between $700,000
in the case of the minimum offering amount, $1,400,000 in the case of the maximum offering amount, and $1,610,000 in the case
of the increased maximum amount.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows, for each of the minimum and maximum offering amounts, the per share and maximum total public offering price,
underwriting fees and commissions to be paid to the Underwriter by us, and proceeds to us, before expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Initial
    Public Offering Price </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Underwriting
    Commissions </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Proceeds
    to Our Company Before Expenses </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Minimum Offering Amount </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 700,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,300,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Maximum Offering Amount </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,400,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,600,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Increased Maximum Offering Amount </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 23,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,610,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,390,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the actual amount to be raised in this offering is uncertain, the actual total offering commissions are not presently determinable
and may be substantially less than the maximum or increased maximum amounts set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
obligation to issue and sell Series A Convertible Preferred Stock to investors is subject to the conditions set forth in the subscription
agreement, which may be waived by us at our discretion. An investor&rsquo;s obligation to purchase securities is subject to the
conditions set forth in the subscription agreement as well, which may also be waived.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the underwriting agreement, we would agree to reimburse the Underwriter&rsquo;s reasonable out-of-pocket expenses incurred by
the Underwriter in connection with this offering, including i) legal fees up to $75,000 ($25,000 of which have already been paid),
ii) due diligence expenses up to $75,000 ($50,000 of which have already been paid), iii) road show, travel, platform on-boarding
fees and other reasonable out-of-pocket expenses up to $50,000, and iv) $6,000 for background checks on Company&rsquo;s officers,
directors and major shareholders. The reimbursable accountable expenses shall not exceed $250,000 and shall be refundable to us
the extent actually not incurred by the Underwriter in accordance with FINRA Rule&nbsp;5110(f)(2)(C). We have advanced a total
of $15,000 in accountable expenses as of the date hereof.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to grant to the Underwriter warrants covering a number of shares of Common Stock equal to seven percent of the
aggregate number of shares underlying the Series A Convertible Preferred Stock being sold in the offering. The Underwriter Warrants
will be exercisable, in whole or in part, during a period commencing on the date of issuance and will expire on the five-year
anniversary of the effective date of our offering pursuant to FINRA Rule 5110(f)(2)(G)(i). The Underwriter Warrants will be exercisable
at a price equal to the Public Offering Price. We will register the shares of Common Stock underlying
the Underwriter Warrants and will file all necessary undertakings in connection therewith. The Underwriter Warrants may not be
sold, transferred, assigned, pledged, hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction
that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following
the SEC&rsquo;s declaration of effectiveness of our registration statement on Form S-1, of which this prospectus forms a part
(in accordance with FINRA Rule 5110(g)(i)), except as may be permitted under FINRA Rule 5110(g)(2)A)(ii). The Underwriter Warrants
may be exercised as to all or a lesser number of shares, will provide for cashless exercise and will contain provisions for one
demand registration of the sale of underlying shares at our expense, an additional demand registration at the Underwriter Warrants&rsquo;
holders&rsquo; expenses, and unlimited &ldquo;piggyback&rdquo; registration rights at our expense for a period of three years
after the effective date of the Offering pursuant to FINRA Rule 5110(f)(2)(G)(iv). The demand for registration may be made at
any time one year after the effective date of the Offering but no later than three years the effective date of the Offering pursuant
to FINRA Rule 5110(f)(2)(G)(v). We are registering the Underwriter Warrants and the shares of Common Stock underlying the Underwriter
Warrants in this offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay our expenses related to the offering. We estimate that our total expenses related to this offering, excluding
the estimated commissions to the Underwriter and payment of the Underwriter&rsquo;s expenses referred to above, will be approximately
US$[&#9679;], all of which are payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter intends to offer our to their retail customers only in states in which we are permitted to offer our Series A Convertible
Preferred Stock. We have relied on an exemption to the blue sky registration requirements afforded to &ldquo;covered securities.&rdquo;
Securities listed on the Nasdaq Capital Market are &ldquo;covered securities.&rdquo; If we were unable to meet the Nasdaq Capital
Market&rsquo;s listing standards, then we would be unable to rely on the covered securities exemption to blue sky registration
requirements and we would need to register the offering in each state in which we planned to sell shares. Consequently, we will
not complete this offering unless we meet the Nasdaq Capital Market&rsquo;s listing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not purport to be a complete statement of the terms and conditions of the underwriting agreement and subscription
agreement. The underwriting agreement and a form of subscription agreement are included as exhibits to the registration statement
of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deposit
Account Agent and Deposit of Offering Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter and the Company have agreed in accordance with the provisions of SEC Rule&nbsp;15c2-4 to cause all funds received
by the Underwriter for the sale of the Series A Convertible Preferred Stock to be promptly deposited in a non-interest bearing
escrow account (&ldquo;Offering Deposit Account&rdquo;) at Pacific Mercantile Bank maintained by FinTech Clearing, LLC (the &ldquo;Deposit
Account Agent&rdquo;) as deposit account agent for the investors in the offering. The purpose of the Offering Deposit Account
is for (i) the deposit of all subscription monies (checks or wire transfers) which are received by the Underwriter from prospective
purchasers of our offered Series A Convertible Preferred Stock and are delivered by the Underwriter to the Deposit Account Agent,
(ii) the holding of amounts of subscription monies which are collected through the banking system, and (iii) the disbursement
of collected funds. The Deposit Account Agent will exercise signature control on the escrow account and will act based on joint
instructions from our Company and the Underwriter. On the closing date for the offering, and presuming that all conditions to
closing have been attained (i.e. Nasdaq approval and other conditions described herein) proceeds in the escrow account maintained
by the Deposit Account Agent will be delivered to our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter shall promptly deliver to the Deposit Account Agent all funds in the form of checks or wire transfers which it receives
from prospective purchasers of our Series A Convertible Preferred Stock by noon of the next business day following receipt where
internal supervisory review is conducted at the same location at which subscription documents and funds are received. Simultaneously
with each deposit to the Offering Deposit Account, the Underwriter shall inform the Deposit Account Agent about the subscription
information for each prospective purchaser. Upon the Deposit Account Agent&rsquo;s receipt of such monies, they shall be credited
to the Deposit Account. All checks delivered to the Deposit Account Agent shall be made payable to &ldquo;FinTech Clearing, LLC,
as Deposit Account Agent for American Brivision (Holding) Corporation.&rdquo; The Deposit Account Agent shall not be required
to accept for credit to the Offering Deposit Account or for deposit into the Offering Deposit Account checks which are not accompanied
by the appropriate subscription information. Wire transfers representing payments by prospective purchasers shall not be deemed
deposited in the Offering Deposit Account until the Deposit Account Agent has received in writing the subscription information
required with respect to such payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
interest will be available for payment to either us or the investors (since the funds are being held in a non-interest bearing
account). All subscription funds will be held in trust pending the raising of the minimum offering amount and no funds will be
released to us until the completion of the offering. Release of the funds to us is based upon the Deposit Account Agent reviewing
the records of the depository institution holding the escrow to verify that the funds received have cleared the banking system
prior to releasing the funds to us. All subscription information and subscription funds through checks or wire transfers should
be delivered to the Deposit Account Agent. Failure to do so will result in subscription funds being returned to the investor.
In event that the offering is terminated, all subscription funds from the escrow account will be returned to investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not terminate this offering before the offering is terminated, all amounts will be promptly returned to the investors as
described below. In the event of any dispute between us and the Underwriter, including whether and how funds are to be reimbursed,
the Deposit Account Agent is entitled to petition a court of competent jurisdiction to resolve any such dispute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
must pay in full for Series A Convertible Preferred Stock at the time of investment. Payment for the shares may be made by wire
made payable to &ldquo;FinTech Clearing, LLC, as Deposit Account Agent for American Brivision (Holding) Corporation.&rdquo; The
Underwriter will inform prospective investors of the anticipated date of closing.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
deposited in the Offering Deposit Account held by Deposit Account Agent may not be withdrawn by investors prior to the earlier
of the closing of the offering or the date the offering is terminated. If the offering is withdrawn or canceled or terminated
and proceeds therefrom are not received by us on or prior to the date the offering is terminated, all proceeds will be promptly
returned by the Deposit Account Agent without interest or deduction to the persons from which they are received (within one business
day) in accordance with applicable securities laws. All such proceeds will be placed in a non-interest bearing account pending
such time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
twelve (12) months from the closing of this public offering, the Underwriter shall have an irrevocable right of first refusal
to act as lead or managing Underwriter, exclusive financial advisor or in any other similar capacity, on the representative&rsquo;s
customary terms and conditions, in the event we pursue a registered, underwritten public offering of securities (in addition to
this offering), a public or private offering of securities (debt or equity), a merger, acquisition of another company or business,
change of control, sale of substantially all assets, business combination, recapitalization or other similar transaction (regardless
of whether we would be considered an acquiring party, a selling party or neither in such transaction). The Underwriter shall have
the sole right to determine whether or not any other broker-dealer shall have the right to participate in any such offering and
the economic terms of any such participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our directors, executive officers and existing beneficial owners of 5% or more of our outstanding Common Stock has agreed that,
subject to certain exceptions, such director, executive officer or beneficial owner of 5% or more of our outstanding Common Stock
will not, without the prior written consent of the Underwriter, during the 180-day period from the effectiveness of the registration
statement on Form S-1:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer,
    pledge, sell, contract to sell, grant, lend or otherwise transfer or dispose of, directly or indirectly, any Common Stock,
    Series A Convertible Preferred Stock or securities convertible into or exercisable or exchangeable for Common Stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
    of the Common Stock, Series A Convertible Preferred Stock or securities convertible into or exercisable or exchangeable for
    Common Stock; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    any demand for or exercise any right with respect to, the registration of any Common Stock, Series A Convertible Preferred
    Stock or securities convertible into or exercisable or exchangeable for Common Stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
any such transaction described above is to be settled by delivery of Common Stock, Series A Convertible Preferred Stock or securities
convertible into or exercisable or exchangeable for Common Stock, in cash or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this Offering, there has been no established public market for our Common Stock and Series A Convertible Preferred Stock. The
public offering price of the Series A Convertible Preferred Stock will be determined by negotiations between us and the Underwriter.
In determining the public offering price of the Series A Convertible Preferred Stock, we and the Underwriter expect to consider
a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    information set forth in this prospectus and otherwise available to the representatives;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    prospects and the history and prospects for the industry in which we compete;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    assessment of our management;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    prospects for future earnings;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    general condition of the securities markets at the time of this offering;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    recent market prices of, and demand for, publicly traded securities of generally comparable companies; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    factors deemed relevant by the Underwriter and us.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated public offering price set forth on the cover page of this preliminary prospectus is subject to change as a result of
market conditions and other factors. Neither we nor the Underwriter can assure investors that an active trading market will develop
for our Series A Convertible Preferred Stock, or that the shares will trade in the public market at or above the public offering
price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
of Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act. If we are
unable to provide this indemnification, we will contribute to payments that the Underwriter may be required to make for these
liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Terms
of the Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering, on a best efforts basis, a minimum of approximately 1,428,571 shares, a maximum of approximately 2,857,143 shares
of Series A Convertible Preferred Stock, with the Underwriter having the discretion at any time during the Offering period to
increase the maximum amount of shares by up to an additional 15% shares of Series A Convertible Preferred Stock, bringing the
increased maximum to approximatley 3,285,714 shares of the Series A Convertible Preferred Stock. The Offering is being made without
a firm commitment by the Underwriter, which has no obligation or commitment to purchase any securities. The Underwriter is not
required to sell any specific number of dollar amount of Series A Convertible Preferred Stock but will use its best efforts to
sell the Series A Convertible Preferred Stock. The shares of Series A Convertible Preferred Stock are being offered for a period
not to exceed 180 days. If the minimum offering amount is not raised within 180 days from the date of this prospectus, all subscription
funds from the Offering Deposit Account will be returned to investors promptly without interest (since the funds are being held
in a non-interest bearing account) or deduction of fees. The offering will terminate upon the earlier of: (i)&nbsp;a date mutually
acceptable to us and our Underwriter after which the minimum offering is sold or (ii) one hundred and eighty (180) days from the
effective date of this registration statement, unless extended by the Company or the Underwriter (the &ldquo;Termination Date&rdquo;).
If we can successfully raise at least the minimum offering amount within the offering period, the proceeds from the Offering will
be released to us. On the closing date, the following will occur:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will receive funds in the amount of the aggregate purchase price of the shares of Series A Convertible Preferred Stock being
    sold by us on such closing date;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will cause to be delivered the Series A Convertible Preferred Stock being sold on such closing date in book-entry form; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    will pay the Underwriter its commissions and expenses.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
Stabilization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter will be required to comply with the Securities Act and the Exchange Act, including without limitation, Rule 10b-5
and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of shares of
capital stock by the Underwriter acting as principal. Under these rules and regulations, the Underwriter:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    not engage in any stabilization activity in connection with our securities; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than
    as permitted under the Exchange Act, until it has completed its participation in the distribution.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Offer, Sale and Distribution of Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus in electronic format may be delivered to potential investors by the Underwriter. The prospectus in electronic format
will be identical to the paper version of such prospectus. Other than the prospectus in electronic format, the information on
the Underwriter&rsquo;s website and any information contained in any other website maintained by the Underwriter is not part of
the prospectus or the registration statement of which this Prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Regulatory Restrictions on Purchase of our Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not taken any action to permit a public offering of our shares outside the United States or to permit the possession or distribution
of this prospectus outside the United States. People outside the United States who come into possession of this prospectus must
inform themselves about and observe any restrictions relating to this Offering of our shares and the distribution of this prospectus
outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
for Nasdaq Listing.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied for listing on Nasdaq of our Common Stock under the same symbol &ldquo;ABVC&rdquo; and will apply for listing on
Nasdaq of the Series A Convertible Preferred Stock under the symbol of &ldquo;___.&rdquo; We will not consummate and close this
offering without a listing approval letter of the Common Stock and Series A Convertible Preferred Stock from Nasdaq. Our receipt
of a listing approval letter is not the same as an actual listing on Nasdaq.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our securities, such as Common Stock and Series A Convertible Preferred Stock, are listed on Nasdaq, we will be subject
to continued listing requirements and corporate governance standards. We expect the compliance with these new rules and regulations
to significantly increase our legal, accounting and financial compliance costs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_025"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities being offered by this prospectus been passed upon for us by Sichenzia Ross Ference LLP, New York, New
York. Certain legal matters in connection with this offering will be passed upon for the Underwriter by&nbsp;Hunter Taubman Fischer
&amp; Li LLC.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_026"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of American BriVision (Holding) Corporation as of December 31, 2018 and 2017 included elsewhere
in this prospectus have been audited by KCCW Accountancy Corp., independent registered public accounting firm, as set forth in
their report appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as
experts in accounting and auditing.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_027"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a reporting company and file annual, quarterly and special reports, and other information with the SEC. Copies of the reports
and other information may be read and copied at the SEC&rsquo;s Public Reference Room at 100 F Street N.E., Washington, D.C. 20549.
You can request copies of such documents by writing to the SEC and paying a fee for the copying cost. You may obtain information
on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a web site at <U>http://www.sec.gov
</U>that contains reports, proxy and information statements and other information regarding registrants that file electronically
with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement on Form S-1 that we filed with the SEC. Certain information in the registration
statement has been omitted from this prospectus in accordance with the rules and regulations of the SEC. We have also filed exhibits
and schedules with the registration statement that are excluded from this prospectus. For further information you may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">read
    a copy of the registration statement, including the exhibits and schedules, without charge at the SEC&rsquo;s Public Reference
    Room; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    a copy from the SEC upon payment of the fees prescribed by the SEC.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file periodic reports, proxy statements, and other information with the SEC. These periodic reports, proxy statements, and other
information will be available for inspection and copying at the SEC&rsquo;s public reference facilities and the website of the
SEC referred to above. After the closing of this offering, you may access our annual reports on Form 10-K, quarterly reports on
Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d)
of the Exchange Act with the SEC free of charge as soon as reasonably practicable after such material is electronically filed
with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not incorporated
by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>INDEX
TO FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>American
    BriVision (Holding) Corporation and Subsidiaries</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Balance Sheets</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Operations for the years ended December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Stockholders&rsquo; Equity (Deficit) for the years ended December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Cash Flows for the years ended December 1, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to Consolidated Financial Statements</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7
    &ndash; F-34</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<TR>
    <TD STYLE="vertical-align: top; width: 43%"> <IMG SRC="img_004.jpg" ALT=""> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 56%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><U>A</U></B><U>udit<B>&nbsp;&#9679; T</B>ax<B>&nbsp;&#9679;
        C</B>onsulting<B>&nbsp;&#9679;&nbsp;F</B>inancial<B>&nbsp;A</B>dvisory</U>&nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Registered with Public Company Accounting Oversight
        Board (PCAOB)</I> </P></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_01"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Shareholders of</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision (Holding) Corporation and Subsidiaries</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Opinion
on the Financial Statements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of American BriVision (Holding) Corporation and subsidiaries (collectively
&ldquo;the Company&rdquo;) as of December 31, 2018 and 2017, the related statement of operations, stockholders&rsquo; equity(deficit),
and cash flows for the years ended December 31, 2018 and 2017, and the related notes&nbsp;<FONT STYLE="background-color: white">(collectively
referred to as the &ldquo;financial statements&rdquo;)</FONT>. In our opinion, the financial statements present fairly, in all
material respects, the consolidated financial position of the Company at&nbsp;December&nbsp;31, 2018&nbsp;and&nbsp;2017, and the
consolidated results of its operations and its cash flows for the years ended December&nbsp;31, 2018 and 2017, in conformity with
the U.S. generally accepted accounting principles.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the&nbsp;<FONT STYLE="background-color: white">Public
Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;)&nbsp;</FONT>and are required to be independent with respect
to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement<FONT STYLE="background-color: white">,
whether due to error or fraud.</FONT>&nbsp;The Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal
control over financial reporting. Accordingly, we express no such opinion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that American BriVision (Holding) Corporation and subsidiaries
will continue as a going concern. As described in Note 3 to the consolidated financial statements, the Company has incurred losses
from operations, has a working capital deficit, and is in need of additional capital to grow its operations so that it can become
profitable. These factors raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. Management&rsquo;s
plans with regard to these matters are described in Note 3. The accompanying consolidated financial statements do not include
any adjustments that might result from the outcome of this uncertainty.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    KCCW Accountancy Corp.</FONT> </TD>
    <TD STYLE="width: 53%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company&rsquo;s auditor since 2017.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diamond
    Bar, California</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    4, 2019</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 49.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 49.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KCCW
Accountancy Corp.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3333
South Brea Canyon Rd. #206, Diamond Bar, CA 91765, USA</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:&nbsp;+1
909 348 7228&nbsp;&#9679; Fax: +1 909 895 4155 &#9679; info@kccwcpa.com</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_02"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEETS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Current assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> Cash </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,044 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 93,332 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Restricted cash and cash
    equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Receivable from collaboration
    partners &ndash; related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,550,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Due from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Prepaid
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 136 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,643,332 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.125in"> Total
    Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,643,332 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Liabilities and Stockholders&rsquo; Deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Accrued expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 555,449 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 170,927 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,462,775 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,229,320 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Convertible notes payable, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Convertible notes payable
    - related parties, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Total Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,568,224 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,400,247 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Convertible notes payable
    - related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Accrued
    interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.125in"> Total Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,845,691 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,400,247 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Commitments and Contingencies </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Stockholders&rsquo; deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Common
    Stock 360,000,000 authorized at $0.001 par value; shares issued and outstanding 213,926,475 and 213,746,647 at December&nbsp;31,&nbsp;2018
    and December 31, 2017, respectively </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,927 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,747 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Additional paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,914,556 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,805,936 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Accumulated deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (19,877,901 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15,776,598 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Total stockholders&rsquo;
    deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,756,915 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Total Liabilities and
    Stockholders&rsquo; Deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,643,332 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these consolidated financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_03"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF OPERATIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31&nbsp;<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Selling, general
    and administrative expenses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,148 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 811,685 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Research and development
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,668 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,171,665 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 155,400 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,138,750 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,138,750 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 93 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 180 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (103,460 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Loss
    on investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,705,837 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (103,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss before provision income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,099,453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,030 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Net loss per share: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.25in"> Basic
    and diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Weighted average number of common shares outstanding: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.25in"> Basic
    and diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,884,105 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,321,921 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these consolidated financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_04"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&rsquo; EQUITY (DEFICIT)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Common
    Stock </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Additional </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> Stockholders&rsquo; </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Number of </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> paid-in </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Accumulated </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> equity </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> shares </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amount </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> capital </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> deficit </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> (deficit) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"> Balance at December 31, 2016 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 210,821,647 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 210,822 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,803,461 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,533,738 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,519,455 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> Issuance of common shares </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,925,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,925 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,847,075 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,850,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Stock based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,400 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,400 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Capital
    contribution from related parties under common control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,070,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,070,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Net
    loss for the period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Balance at December 31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,746,647 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,747 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,805,936 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (15,776,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,756,915 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> Issuance of common shares </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 179,828 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 180 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,820 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 80,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Stock based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Net
    loss for the period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Balance at December 31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,926,475 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,927 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,914,556 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (19,877,901 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these consolidated financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_05"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> Cash flows from operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Net loss from continuing
    operations </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Adjustments to reconcile net
    loss to net cash used in operating activities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Stock based compensation for
    nonemployees </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 155,400 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,549,451 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Changes in operating assets
    and liabilities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 30pt"> Decrease (increase) in prepaid
    expenses and deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (136 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 30pt"> Decrease (increase) in due from
    related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (40,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 30pt"> Increase (decrease) in accrued
    expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 491,989 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 132,827 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"> Increase
    (decrease) in due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 440,455 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,469,320 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 40pt"> Net
    cash used in operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (630,195 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,485,313 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows from financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Capital contribution from related
    parties under common control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 450,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Proceeds from convertible notes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 800,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt"> Borrowings from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,110,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> Repayment
    of borrowings from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (257,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 40pt"> Net
    cash provided by financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 593,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,560,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Effect of exchange rate
    changes on cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Net increase (decrease)
    in cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (37,195 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,687 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"> Beginning </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 93,332 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,645 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 10pt"> Ending </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,137 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 93,332 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Supplemental disclosure of cash flows </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> Cash paid during the year for: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 20pt"> Interest
    expense paid </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 127,056 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 20pt"> Income
    taxes paid </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Non-cash financing and investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt"> Common
    shares issued for employees and consultants </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 80,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt"> Common
    shares issued for due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,850,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt"> Capital
    contribution from related parties under common control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,550,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these consolidated financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_06"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DECEMBER
31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
ORGANIZATION AND DESCRIPTION OF BUSINESS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision (Holding) Corporation (the &ldquo;Company&rdquo; or &ldquo;Holding entity&rdquo;), a Nevada corporation, through the
Company&rsquo;s operating entity, American BriVision Corporation (the &ldquo;BriVision&rdquo;), which was incorporated in July
2015 in the State of Delaware, engages in biotechnology and focuses on the development of new drugs and innovative medical devices
to fulfill unmet medical needs. The business model of the Company is to integrate research achievements from world-famous institutions
(such as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) and MD Anderson Cancer Center), conduct clinical trials
of translational medicine for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and
exploit global markets. BriVision had to predecessor operations prior to its formation on July 21, 2015.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reverse
Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2016, a Share Exchange Agreement (the &ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American
BriVision (Holding) Corporation, American BriVision Corporation&nbsp;(&ldquo;BriVision&rdquo;), and Euro-Asia Investment &amp;
Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of the People&rsquo;s
Republic of China (&ldquo;Euro-Asia&rdquo;), being the owners of record of 164,387,376 (52,336,000 pre-stock split) shares of
Common Stock of the Company, and the owners of record of all of the issued share capital of BriVision (the&nbsp;&ldquo;BriVision
Stock&rdquo;).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Share Exchange Agreement, upon surrender by the BriVision Shareholders and the cancellation by BriVision of the certificates
evidencing the BriVision Stock as registered in the name of each BriVision Shareholder, and pursuant to the registration of the
Company in the register of members maintained by BriVision as the new holder of the BriVision Stock and the issuance of the certificates
evidencing the aforementioned registration of the BriVision Stock in the name of the Company, the Company should issue 166,273,921(52,936,583
pre-stock split) shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to adjustment for fractionalized shares as set forth
below) of the Company&rsquo;s Common Stock to the BriVision Shareholders (or their designees), and 163,159,952 (51,945,225 pre-stock
split) shares of the Company&rsquo;s Common Stock owned by Euro-Asia should be cancelled and retired to treasury. The Acquisition
Stock collectively should represent 79.70% of the issued and outstanding Common Stock of the Company immediately after the Closing,
in exchange for the BriVision Stock, representing 100% of the issued share capital of BriVision in a reverse merger (the &ldquo;Merger&rdquo;).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger, all of the issued and outstanding common shares of BriVision were converted, at an exchange ratio of 0.2536-for-1,
into an aggregate of 166,273,921(52,936,583pre-stock split) common shares of the Company and BriVision has become a wholly owned
subsidiary of the Company. The holders of Company&rsquo;s Common Stock as of immediately prior to the Merger held an aggregate
of 205,519,223(65,431,144 pre-stock split) shares of Company&rsquo;s Common Stock.&nbsp;Because of the exchange of the BriVision
Stock for the Acquisition Stock (the&nbsp;&ldquo;Share Exchange&rdquo;), BriVision has become a wholly owned subsidiary (the &ldquo;Subsidiary&rdquo;)
of the Company and there was a change of control of the Company following the closing. There were no warrants, options or other
equity instruments issued in connection with the share exchange agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because&nbsp;of
the consummation of the Share Exchange,&nbsp;BriVision&nbsp;is now our wholly owned subsidiary and its shareholders own approximately&nbsp;79.70%
of our issued and outstanding Common Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Share Exchange, we have abandoned our prior business plan and we are now pursuing&nbsp;BriVision&rsquo;s&nbsp;historically
proposed businesses, which focus on the development of new drugs and innovative medical devices to fulfill unmet medical needs.
The business model of the Company is to integrate research achievements from world-famous institutions, conduct clinical trials
of translational medicine for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and
exploit global markets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounting
Treatment of the Reverse Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Share Exchange represents a &ldquo;reverse merger&rdquo;&nbsp;rather than a business combination
and&nbsp;BriVision&nbsp;is deemed the accounting acquirer in the transaction. The&nbsp;Share Exchange is being accounted for as
a reverse-merger and recapitalization. BriVision&nbsp;is the acquirer for financial reporting purposes and the&nbsp;Company&nbsp;is
the acquired company. Consequently, the assets and liabilities and the operations reflected in the historical financial statements
prior to the Share Exchange will be those of&nbsp;BriVision&nbsp;and recorded at the historical cost basis of&nbsp;BriVision.
In addition, the consolidated financial statements after completion of the Share Exchange will include the assets and liabilities
of the Company and BriVision, and the historical operations of&nbsp;BriVision&nbsp;and operations of the Combined Company from
the closing date of the Share Exchange.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in a registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009520/fs42018_americanbrivision.htm">Form S-4</A> filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on
July 23, 2018, as amended from time to time, the Company, BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), BioKey, Inc. (&ldquo;BioKey&rdquo;),
BioLite Acquisition Corp., a direct wholly-owned subsidiary of Parent (&ldquo;Merger Sub 1&rdquo;), and BioKey Acquisition Corp.,
a direct wholly-owned subsidiary of Parent (&ldquo;Merger Sub 2&rdquo;) (<FONT STYLE="background-color: white">collectively referred
to as the &ldquo;Parties&rdquo;)</FONT>&nbsp;were in the process of completing business combination pursuant to the Agreement
and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) dated as of January 31, 2018 where ABVC would acquire BioLite and BioKey
via issuing additional Common Stock of ABVC to the shareholders of BioLite and BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Parties of the Merger Agreement consummated the Merger transactions. Pursuant to the terms of the Merger
Agreement, BioLite and BioKey became two wholly-owned subsidiaries of the Company on February 8, 2019. As of the date of this
prospectus, the Company is in the process of issuing shares of its Common Stock as Merger Consideration to the shareholders of
BioLite and BioKey pursuant to the registration statement (the &ldquo;Registration Statement on S-4&rdquo;) on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019000796/fs42018a3_americanbrivision.htm">Form&nbsp;S-4</A> Amendment
No. 3 filed with the SEC on January 16, 2019 which became effective by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of Presentation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with the generally accepted accounting principles
in the United States of America (the &ldquo;U.S. GAAP&rdquo;). All significant intercompany transactions and account balances
have been eliminated.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
basis of accounting involves the application of accrual accounting and consequently, revenues and gains are recognized when earned,
and expenses and losses are recognized when incurred. The Company&rsquo;s financial statements are expressed in U.S. dollars.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fiscal
Year</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company changed its fiscal year from the period beginning on October 1st and ending on September 30th to the period beginning
on January 1st and ending on December 31st, beginning January 1, 2018. All references herein to a fiscal year prior to December
31, 2017 refer to the twelve months ended September 30th of such year.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the amount of revenues and expenses
during the reporting periods. Actual results could differ materially from those results.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reclassifications</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification
had no impact on previously reported net loss or accumulated deficit.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Forward
Stock split</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3.141 and increase the number of our authorized shares of Common Stock, par value $0.001 per share, to 360,000,000,
which was effective on April 8, 2016. The majority of the shareholders of the Company approved the amendment to Articles of Incorporation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the provisions of ASC Subtopic 820-10,&nbsp;&ldquo;Fair Value Measurements&rdquo;,&nbsp;for fair value measurements
of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed
at fair value in the financial statements. ASC 820 also establishes a framework for measuring fair value and expands disclosures
about fair value measurements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. When determining the fair value measurements for assets and liabilities,
the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market
participants would use when pricing the asset or liability.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of
unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of
the fair value hierarchy are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets
                                         or liabilities in active markets.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> &#9679; </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         2 inputs to the valuation methodology include quoted prices for similar assets and liabilities
                                         in active markets, and inputs that are observable for the assets or liability, either
                                         directly or indirectly, for substantially the full term of the financial instruments.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> &#9679; </TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                         3 inputs to the valuation methodology are unobservable and significant to the fair value.</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, due from related parties,
accrued expenses, and due to related parties approximate fair value due to their relatively short maturities. The carrying value
of the Company&rsquo;s convertible notes payable and accrued interest approximates their fair value as the terms of the borrowing
are consistent with current market rates.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As
of December 31, 2018 and 2017, the Company&rsquo;s cash and cash equivalents amounted $40,044 and $93,332, respectively. Some&nbsp;of
the Company&rsquo;s cash deposits are held in financial institutions located in Taiwan where there is currently regulation mandated
on obligatory insurance of bank accounts. The Company believes this financial institution is of high credit quality.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
cash equivalents primarily consist of cash held in a reserve bank account in Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentration
of Credit Risk</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents.
The Company places its cash and temporary cash investments in high quality credit institutions, but these investments may be in
excess of Taiwan Central Deposit Insurance Corporation and the U.S. Federal Deposit Insurance Corporation&rsquo;s insurance limits.
The Company does not enter into financial instruments for hedging, trading or speculative purposes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company has yet to realize revenues from operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year 2018, the Company adopted Accounting Standards Codification (&ldquo;ASC&rdquo;), Topic 606 (ASC 606), Revenue
from Contracts with Customers, using the modified retrospective method to all contracts that were not completed as of January
1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at the beginning
of 2018 for the cumulative effect. The results for the Company&rsquo;s reporting periods beginning on and after January 1, 2018
are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards
in effect for the prior period. Based on the Company&rsquo;s review of existing collaborative agreements as of January 1, 2018,
the Company concluded that the adoption of the new guidance did not have a significant change on the Company&rsquo;s revenue during
all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that
reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition
for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i)
identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction
price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or
as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable
that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers
to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company
assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses
whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price
that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are examples of when the Company recognizes revenue based on the types of payments the Company receives.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Collaborative
Revenues</I>&nbsp;<B>&mdash;&nbsp;</B>The Company recognizes collaborative revenues generated through collaborative research,
development and/or commercialization agreements. The terms of these agreements typically include payment to the Company related
to one or more of the following: nonrefundable upfront license fees, development and commercial milestones, partial or complete
reimbursement of research and development costs, and royalties on net sales of licensed products. Each type of payments results
in collaborative revenues except for revenues from royalties on net sales of licensed products, which are classified as royalty
revenues. To date, we have not received any royalty revenues. Revenue is recognized upon satisfaction of a performance obligation
by transferring control of a good or service to the collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the accounting for these arrangements, the Company applies judgment to determine whether the performance obligations are
distinct, and develop assumptions in determining the stand-alone selling price for each distinct performance obligation identified
in the collaboration agreements. To determine the stand-alone selling price, the Company relies on assumptions which may include
forecasted revenues, development timelines, reimbursement rates for R&amp;D personnel costs, discount rates and probabilities
of technical and regulatory success.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had multiple deliverables under the collaborative agreements, including deliverables relating to grants of technology
licenses, regulatory and clinical development, and marketing activities. Estimation of the performance periods of the Company&rsquo;s
deliverables requires the use of management&rsquo;s judgment. Significant factors considered in management&rsquo;s evaluation
of the estimated performance periods include, but are not limited to, the Company&rsquo;s experience in conducting clinical development,
regulatory and manufacturing activities. The Company reviews the estimated duration of its performance periods under its collaborative
agreements on an annually basis, and makes any appropriate adjustments on a prospective basis. Future changes in estimates of
the performance period under its collaborative agreements could impact the timing of future revenue recognition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonrefundable
    upfront payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a license to the Company&rsquo;s intellectual property is determined to be distinct from the other performance obligations identified
in an arrangement, the Company recognizes revenue from the related nonrefundable upfront payments based on the relative standalone
selling price prescribed to the license compared to the total selling price of the arrangement. The revenue is recognized when
the license is transferred to the collaboration partners and the collaboration partners are able to use and benefit from the license.
To date, the receipt of nonrefundable upfront fees was solely for the compensation of past research efforts and contributions
made by the Company before the collaborative agreements entered into and it does not relate to any future obligations and commitments
made between the Company and the collaboration partners in the collaborative agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone
    payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is eligible to receive milestone payments under the collaborative agreement with collaboration partners based on achievement
of specified development, regulatory and commercial events. Management evaluated the nature of the events triggering these contingent
payments, and concluded that these events fall into two categories: (a) events which involve the performance of the Company&rsquo;s
obligations under the collaborative agreement with collaboration partners, and (b) events which do not involve the performance
of the Company&rsquo;s obligations under the collaborative agreement with collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
former category of milestone payments consists of those triggered by development and regulatory activities in the territories
specified in the collaborative agreements. Management concluded that each of these payments constitute substantive milestone payments.
This conclusion was based primarily on the facts that (i) each triggering event represents a specific outcome that can be achieved
only through successful performance by the Company of one or more of its deliverables, (ii) achievement of each triggering event
was subject to inherent risk and uncertainty and would result in additional payments becoming due to the Company, (iii) each of
the milestone payments is nonrefundable, (iv) substantial effort is required to complete each milestone, (v) the amount of each
milestone payment is reasonable in relation to the value created in achieving the milestone, (vi) a substantial amount of time
is expected to pass between the upfront payment and the potential milestone payments, and (vii) the milestone payments relate
solely to past performance. Based on the foregoing, the Company recognizes any revenue from these milestone payments in the period
in which the underlying triggering event occurs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
    Element Arrangements</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates multiple element arrangements to determine (1)&nbsp;the deliverables included in the arrangement and (2)&nbsp;whether
the individual deliverables represent separate units of accounting or whether they must be accounted for as a combined unit of
accounting. This evaluation involves subjective determinations and requires management to make judgments about the individual
deliverables and whether such deliverables are separate from other aspects of the contractual relationship. Deliverables are considered
separate units of accounting provided that: (i)&nbsp;the delivered item(s) has value to the customer on a standalone basis and
(ii)&nbsp;if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of
the undelivered item(s) is considered probable and substantially within its control. In assessing whether an item under a collaboration
has standalone value, the Company considers factors such as the research, manufacturing, and commercialization capabilities of
the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers
whether its collaboration partners can use the other deliverable(s) for their intended purpose without the receipt of the remaining
element(s), whether the value of the deliverable is dependent on the undelivered item(s), and whether there are other vendors
that can provide the undelivered element(s).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes arrangement consideration allocated to each unit of accounting when all of the revenue recognition criteria
in ASC 606 are satisfied for that particular unit of accounting. In the event that a deliverable does not represent a separate
unit of accounting, the Company recognizes revenue from the combined unit of accounting over the Company&rsquo;s contractual or
estimated performance period for the undelivered elements, which is typically the term of the Company&rsquo;s research and development
obligations. If there is no discernible pattern of performance or objectively measurable performance measures do not exist, then
the Company recognizes revenue under the arrangement on a straight-line basis over the period the Company is expected to complete
its performance obligations. Conversely, if the pattern of performance in which the service is provided to the customer can be
determined and objectively measurable performance measures exist, then the Company recognizes revenue under the arrangement using
the proportional performance method. Revenue recognized is limited to the lesser of the cumulative amount of payments received
or the cumulative amount of revenue earned, as determined using the straight-line method or proportional performance method, as
applicable, as of the period ending date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the inception of an arrangement that includes milestone payments, the Company evaluates whether each milestone is substantive
and at risk to both parties on the basis of the contingent nature of the milestone. This evaluation includes an assessment of
whether: (1)&nbsp;the consideration is commensurate with either the Company&rsquo;s performance to achieve the milestone or the
enhancement of the value of the delivered item(s) as a result of a specific outcome resulting from its performance to achieve
the milestone, (2)&nbsp;the consideration relates solely to past performance and (3)&nbsp;the consideration is reasonable relative
to all of the deliverables and payment terms within the arrangement. The Company evaluates factors such as the scientific, clinical,
regulatory, commercial, and other risks that must be overcome to achieve the particular milestone and the level of effort and
investment required to achieve the particular milestone in making this assessment. There is considerable judgment involved in
determining whether a milestone satisfies all of the criteria required to conclude that a milestone is substantive. Milestones
that are not considered substantive are recognized as earned if there are no remaining performance obligations or over the remaining
period of performance, assuming all other revenue recognition criteria are met.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties
    and Profit Sharing Payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the collaborative agreement with the collaboration partners, the Company is entitled to receive royalties on sales of products,
which is at certain percentage of the net sales. The Company recognizes revenue from these events based on the revenue recognition
criteria set forth in ASC 606. Based on those criteria, the Company considers these payments to be contingent revenues, and recognizes
them as revenue in the period in which the applicable contingency is resolved.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Receivable
from Collaboration Partners</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivable
from collaboration partners is stated at carrying value less estimates made for doubtful receivables. An allowance for impairment
of receivable from collaboration partners is established if the collection of a receivable becomes doubtful. Such receivable becomes
doubtful when there is objective evidence that the Company will not be able to collect all amounts due according to the original
terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy
or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired.
The amount of the allowance is the difference between the asset&rsquo;s carrying amount and the present value of estimated future
cash flows, discounted at the original effective interest rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Long-term
Equity Investment</U>&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquires the equity investments to promote business and strategic objectives. The Company accounts for non-marketable
equity and other equity investments for which the Company does not have control over the investees as:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    method investments when the Company has the ability to exercise significant influence, but not control, over the investee.
    Its proportionate share of the income or loss is recognized monthly and is recorded in gains (losses) on equity investments.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    cost method investments when the equity method does not apply.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
judgment is required to identify whether an impairment exists in the valuation of the Company&rsquo;s non-marketable equity investments,
and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative
factors that may have a significant impact on the investee&rsquo;s fair value. Qualitative analysis of its investments involves
understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee&rsquo;s
industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair
value of its investments are developed using the market and income approaches. The market approach includes the use of comparable
financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted
cash flow model, which requires significant estimates regarding the investees&rsquo; revenue, costs, and discount rates. The Company&rsquo;s
assessment of these factors in determining whether an impairment exists could change in the future due to new developments or
changes in applied assumptions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other-Than-Temporary
Impairment</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    equity securities include the consideration of general market conditions, the duration and extent to which the fair value
    is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of
    value in the foreseeable future. The Company also considers specific adverse conditions related to the financial health of,
    and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational
    and financing cash flow factors, and changes in the investee&rsquo;s credit rating. The Company records other-than-temporary
    impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    equity investments based on the Company&rsquo;s assessment of the severity and duration of the impairment, and qualitative
    and quantitative analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory
    or economic environment; changes in operating structure or management of the investee; additional funding requirements; and
    the investee&rsquo;s ability to remain in business. A series of operating losses of an investee or other factors may indicate
    that a decrease in value of the investment has occurred that is other than temporary and that shall be recognized even though
    the decrease in value is in excess of what would otherwise be recognized by application of the equity method. A loss in value
    of an investment that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but
    would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of
    the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company records
    other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses)
    on equity investments. Other-than-temporary impairments of equity investments were $2,549,451 and $0 for the years ended December
    31, 2018 and 2017, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development Expenses</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the cost of using licensing rights in research and development cost according to ASC Topic 730-10-25-1. This
guidance provides that absent alternative future uses the acquisition of product rights to be used in research and development
activities must be charged to research and development expenses when incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-based
Compensation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures expense associated with all employee stock-based compensation awards using a fair value method and recognizes
such expense in the consolidated financial statements on a straight-line basis over the requisite service period in accordance
with FASB ASC Topic 718 &ldquo;Compensation-Stock Compensation&rdquo;. Total employee stock-based compensation expenses were $0
for the years ended December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for stock-based compensation to non-employees in accordance with FASB ASC Topic 718 &ldquo;Compensation-Stock
Compensation&rdquo; and FASB ASC Topic 505-50 &ldquo;Equity-Based Payments to Non-Employees&rdquo; which requires that the cost
of services received from non-employees is measured at fair value at the earlier of the performance commitment date or the date
service is completed and recognized over the period the service is provided. Total non-employee stock-based compensation expenses
were $28,800 and $155,400 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Beneficial
Conversion Feature</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial
conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which
the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation
of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value
of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital.
The debt discount is amortized to interest expense over the life of the note using the effective interest method.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred
tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,
deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred
tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future
deductibility is uncertain.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC 740, a tax position is recognized as a benefit only if it is&nbsp;&ldquo;more likely than not&rdquo;&nbsp;that the tax position
would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a
two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The
second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized
in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely
of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions
that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period
in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified
as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred for
the years ended December 31, 2018 and 2017. GAAP also provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosures and transition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete. To the extent that a company&rsquo;s accounting
for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record
a provisional estimate to be included in the financial statements. If a company cannot determine a provisional estimate to be
included in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were
in effect immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact
of the reduction in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from
these estimates, due to, among other things, changes in our interpretations and assumptions, additional guidance that may be issued
by the I.R.S., and actions we may take. The Company is continuing to gather additional information to determine the final impact.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2018 and 2017, the Company&rsquo;s income tax expense amounted $1,850 and $830, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss
Per Share of Common Stock</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates net loss per share in accordance with ASC Topic 260, &ldquo;Earnings per Share&rdquo;. Basic loss per share
is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss
per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional
common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional
common shares were dilutive. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments
and Contingencies</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC Topic 450 &ldquo;Contingencies&rdquo; subtopic 20, in determining its accruals and disclosures with respect
to loss contingencies. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information
available before financial statements are issued or are available to be issued indicates that it is probable that an assets had
been impaired or a liability had been incurred at the date of the financial statements and the amount of the loss can be reasonably
estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably
estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that
a material loss could be incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the Financial Accounting Standards Board (the &ldquo;FASB&rdquo;) issued ASU 2016-02, Leases (ASC 842), which was
amended by ASU 2018-11, Leases (ASC 842): Targeted Improvements. The new guidance requires lessee recognition on the balance sheet
of a right-of-use (ROU) asset and a lease liability, initially measured at the present value of the lease payments. It further
requires recognition in the income statement of a single lease cost, calculated so that the cost of the lease is allocated over
the lease term generally on a straight-line basis. Finally, it requires classification of all cash payments within operating activities
in the statement of cash flows. The standard is effective for public companies for fiscal years beginning after December 15, 2018
and early adoption is permitted. The standard requires a transition adoption election using either 1) a modified retrospective
approach with periods prior to the adoption date being recast or 2) a prospective adoption approach with a cumulative-effect adjustment
recognized to the opening balance of retained earnings on the adoption date with prior periods not recast. The Company anticipates
adopting this standard with an effective date of January 1, 2019 using the prospective adoption approach. The Company has evaluated
the changes from this standard to its future financial reporting and disclosures, and has designed and implemented related processes
and controls to address these changes. The Company believes the most significant effects relate to (1) the recognition of new
ROU assets and lease liabilities on its balance sheet for its office operating lease; and (2) providing significant new disclosures
about its leasing activities related to the amount, timing and uncertainty of cash flows arising from leases. The Company is continuing
its assessment, which may identify additional impacts this guidance will have on its financial statements and disclosures.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete.&nbsp;<FONT STYLE="background-color: white">In
March 2018, the FASB issued ASU 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (SEC Update),
Income Taxes (Topic 740). ASU 2018-05 provides guidance regarding the recording of tax impacts where uncertainty exists, in the
period of adoption of the 2017 U.S. Tax Cuts and Jobs Act (the &ldquo;2017 Tax Act&rdquo;).</FONT>To the extent that a company&rsquo;s
accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must
record a provisional estimate to be included in the financial statements. If a company cannot determine a provisional estimate
to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws
that were in effect immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of
the impact of the reduction in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may
differ from these estimates, due to, among other things, changes in its interpretations and assumptions, additional guidance that
may be issued by the I.R.S., and actions that the Company may take. The Company has accounted for the tax effects of the Tax Cuts
and Jobs Act under the guidance of SAB 118, on a provisional basis. The Company&rsquo;s accounting for certain income tax effects
is incomplete, but the Company has determined reasonable estimates for those effects The Company is continuing to gather additional
information to determine the final impact on its condensed consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the FASB issued Accounting Standards Update No. 2018-02 (&ldquo;ASU 2018-02&rdquo;), Income Statement - Reporting
Comprehensive Income (Topic 220). The guidance in ASU 2018-02 allows an entity to elect to reclassify the stranded tax effects
related to the Tax Cuts and Jobs Act (the Tax Act) of 2017 from accumulated other comprehensive income into retained earnings.
ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is currently
evaluating the effect this standard will have on its condensed consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments
(&ldquo;ASU 2018-07&rdquo;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring
goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after
December 15, 2018, with early adoption permitted, but no earlier than the Company&rsquo;s adoption date of Topic 606. U</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nder
the new guidance, the measurement of nonemployee equity awards is fixed on the grant date.&nbsp;<FONT STYLE="background-color: white">The
new guidance is required to be applied retrospectively with the cumulative effect recognized at the date of initial application.
The Company is currently evaluating the effect ASU 2018-07 will have on the condensed consolidated financial statements.</FONT></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (&ldquo;Topic 820&rdquo;): Disclosure Framework - Changes to
the Disclosure Requirements for Fair Value Measurement (&ldquo;ASU 2018-13&rdquo;). The ASU modifies the disclosure requirements
in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying
existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing
the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value
measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable
inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods
and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect,
if any, that the ASU 2018-13 will have on its financial statements.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
GOING CONCERN</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company
has incurred losses since its inception resulting in an accumulated deficit of $19,877,901 and $15,776,598 as of December 31,
2018 and 2017, respectively, and incurred net loss of $4,101,303 and $4,242,860 for the years ended December 31, 2018 and 2017,
respectively. The Company also had working capital deficiency of $5,471,951 and $1,756,915 at December 31, 2018 and 2017, respectively.
The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or
obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when
they become due. These consolidated financial statements do not include any adjustments to the recoverability and classification
of recorded asset amounts and classification of liabilities that might be necessary should the Company upon signing of that agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&rsquo;s
plans to obtain such resources for the Company include&nbsp;(1) obtaining capital from the sale of its equity securities (2) short-term
and long-term borrowings from banks and third-parties, and (3) short-term borrowings from stockholders or other related party(ies)
when needed. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its
plans.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described
in the preceding paragraph and eventually to secure other sources of financing and attain profitable operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;COLLABORATIVE
AGREEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
agreement with BioLite Inc., a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2015, American BriVision Corporation entered into a collaborative agreement (the &ldquo;BioLite Collaborative Agreement&rdquo;)
with BioLite Inc. (the &ldquo;BioLite&rdquo;), a related party (See Note 8), pursuant to which BioLite granted BriVision sole
licensing rights for drug and therapeutic use of five products, including BLI-1005 CNS-Major Depressive Disorder, BLI-1008 CNS-Attention
Deficit Hyperactivity Disorder, BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1, BLI-1401-2 Anti-Tumor Combination
Therapy-Triple Negative Breast Cancer, and BLI-1501 Hematology-Chronic Lymphocytic Leukemia, in the U.S.A and Canada. Under the
BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of BriVision with equivalent value,
according to the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upfront
                                         payment shall upon the signing of this BioLite Collaborative Agreement: 3.5% of total
                                         payment. After receiving upfront payment from BriVision, BioLite has to deliver all data
                                         to BriVision in one week.</FONT> </TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         the first IND submission, BriVision shall pay, but no later than December 15, 2016: 6.5%
                                         of total payment. After receiving second payment from BriVision, BioLite has to deliver
                                         IND package to BriVision in one week.</FONT> </TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                                                                                                                                                               the completion of first phase II clinical trial, BriVision shall pay: 15% of total payment. After receiving third payment from
                                                                                                                                                                               BriVision,                                          BioLite has to deliver phase II clinical study report to BriVision in
                                                                                                                                                                               three months.</FONT> </TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                                                                                                                                                               the phase III IND submission, BriVision shall pay: 20% of total payment. After receiving forth payment from BriVision, BioLite
                                                                                                                                                                               has to deliver                                          IND package to BriVision in one week.</FONT> </TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                         the completion of phase III, BriVision shall pay: 25%
                                         of total payment. After receiving fifth payment from BriVision, BioLite has to deliver
                                         phase III clinical study report to BriVision in three months.</FONT> </TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         the NDA submission, BriVision shall pay BriVision
                                         shall pay: 30% of total payment. After receiving sixth payment from BriVision, BioLite
                                         has to deliver NDA package to BriVision in one week.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
BioLite Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial
sales of the Product in the Territory and automatically renew for five more years unless either party gives the other party six
month written notice of termination prior to the expiration date of the term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, an upfront payment of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5%
of total payments due under the BioLite Collaborative Agreement, was to be paid by the Company upon signing of that agreement.
On May 6, 2016, the Company and BioLite agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone
Payment Agreement, whereby the Company agreed to pay the Milestone Payment to BioLite with $2,600,000 in cash and $900,000 in
the form of newly issued shares of its Common Stock, at the price of $1.60 per share, for an aggregate number of 562,500 shares.
The cash payment and shares issuance were completed in June 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which
was submitted in March 2016. On February 2017, the Company agreed to pay this amount to BioLite with $650,000 in cash and $5,850,000
in the form of newly issued shares of its Common Stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares.
The cash payment and shares issuance were completed in February 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 15% of total payment, $15,000,000 shall be made at the completion of first phase II
clinical trial. As of December 31, 2018, the first phase II clinical trial research has not completed yet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined to fully expense the amount of $10,000,000 since currently the related licensing rights do not have
alternative future uses. According to ASC 730-10-25-1, absent alternative future uses the acquisition of product rights to be
used in research and development activities must be charged to research and development expenses immediately. Hence the entire
amount is fully expensed as research and development expense.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2017, the Company entered into an Addendum (the &ldquo;Addendum&rdquo;) to the BioLite Collaborative Agreement which
was previously entered into with BioLite. Pursuant to the Addendum, the Company and BioLite agreed to include one more product,
namely, &ldquo;Maitake Combination Therapy&rdquo; as one of the Products defined in the BioLite Collaborative Agreement (the &ldquo;Sixth
Product&rsquo;) and defined the Territory of the Sixth Product to be worldwide and restate the Territory of the Five Products
to be the U.S.A and Canada.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Co-Development
agreement with Rgene Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, American BriVision Corporation entered into a co-development agreement (the &ldquo;Co-Dev Agreement&rdquo;) with
Rgene Corporation (the &ldquo;Rgene&rdquo;), a related party under common control by controlling beneficiary shareholder of YuanGene
Corporation and the Company (See Note 8). Pursuant to Co-Dev Agreement, BriVision and Rgene agreed to co-develop and commercialize
certain products that are included in the Sixth Product as defined in the Addendum. Under the terms of the Co-Dev Agreement, Rgene
should pay the Company $3,000,000 in cash or stock of Rgene with equivalent value by August 15, 2017. The payment is for the compensation
of BriVision&rsquo;s past research efforts and contributions made by BriVision before the Co-Dev Agreement was signed and it does
not relate to any future commitments made by BriVision and Rgene in this Co-Dev Agreement. Besides of $3,000,000, the Company
is entitled to receive 50% of the future net licensing income or net sales profit earned by Rgene, if any, and any development
cost shall be equally shared by both BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, the Company has delivered all research, technical, data and development data to Rgene. Since both Rgene and the
Company are related parties and under common control by a controlling beneficiary shareholder of Yuangene Corporation and the
Company, the Company has recorded the full amount of $3,000,000 in connection with the Co-Dev Agreement as additional paid-in
capital during the year ended September 30, 2017. During the year ended December 31, 2017, the Company has received $450,000 in
cash. On December 24, 2018, the Company received the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s
Common Stock, at the price of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares,
which accounted for equity method long-term investment as of December 31, 2018. During the year ended December 31, 2018, the Company
has recognized investment loss of $549. On December 31, 2018, the Company has determined to fully write off this investment based
on the Company&rsquo;s assessment of the severity and duration of the impairment, and qualitative and quantitative analysis of
the operating performance of the investee, adverse changes in market conditions and the regulatory or economic environment, changes
in operating structure of Rgene, additional funding requirements, and Rgene&rsquo;s ability to remain in business. However, all
projects that have been initiated and scheduled will be continuously managed and supported by the Company and Rgene (See Note
5).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Collaborative
agreement with BioFirst Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 24, 2017, American BriVision Corporation entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;)
with BioFirst Corporation (&ldquo;BioFirst&rdquo;), pursuant to which BioFirst granted the Company the global licensing right
for medical use of the product (the &ldquo;Product&rdquo;): BFC-1401 Vitreous Substitute for Vitrectomy. BioFirst is a related
party to the Company because a controlling beneficiary shareholder of Yuangene Corporation and the Company is one of the directors
and Common Stock shareholders of BioFirst (See Note 8).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioFirst Collaborative Agreement, the Company will co-develop and commercialize the Product with BioFirst and pay BioFirst
in a total amount of $3,000,000 in cash or stock of the Company before September 30, 2018. The amount of $3,000,000 is in connection
with the compensation for BioFirst&rsquo;s past research efforts and contributions made by BioFirst before the BioFirst Collaborative
Agreement was signed and it does not relate to any future commitments made by BioFirst and BriVision in this BioFirst Collaborative
Agreement. In addition, the Company is entitled to receive 50% of the future net licensing income or net sales profit, if any,
and any development cost shall be equally shared by both BriVision and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2017, BioFirst has delivered all research, technical, data and development data to BriVision. No payment has been
made by the Company as of the date of this propsectus. The Company determined to fully expense the entire amount of $3,000,000
since currently the related licensing rights do not have alternative future uses. According to ASC 730-10-25-1, absent alternative
future uses the acquisition of product rights to be used in research and development activities must be charged to research and
development expenses immediately. Hence, the entire amount of $3,000,000 is fully expensed as research and development expense
during the year ended September 30, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
LONG-TERM INVESTMENT</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 24, 2018, the Company received the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s
Common Stock, at the price of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares(See
Note 4). As of December 31, 2018, the Company owns 23.90% common stock shares of Rgene, accounting for its equity interest using
the equity method to its equity investment as prescribed in ASC 323, Investments&mdash;Equity Method and Joint Ventures (&ldquo;ASC
323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of investee&rsquo;s income or loss and
other adjustments required by the equity method.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ownership percentages of the investee are listed as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership
    percentage</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related party</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>treatment</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 62%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.90</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; width: 13%; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Method</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    extent the investee relies on the company for its business are summarized as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 35%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related party</B></FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 64%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    extent the investee relies on the Company for its business</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with the Company to develop and commercialize drugs</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    investment mainly consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 77%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Method Investments, net of impairment</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
    financial information for the Company&rsquo;s equity method investee, Rgene, is as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheets</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 77%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Assets</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,168</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent
    Assets</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,779</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Liabilities</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261,685</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
    Deficit</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(148,738</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"> Statements of operation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> For
    the Years Ended December&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross Profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (120,065 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of loss from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses
    on Equity Investments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of losses on equity investments for each period were as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> For
    the Years Ended<BR> December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of equity method investee losses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Impairments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.125in"> Total losses on equity investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,550,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
ACCRUED EXPENSES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses as of December 31, 2018 and 2017 consisted of:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 77%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    payroll</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">444,400</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,800</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    rent</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,941</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    interest expense &ndash; related party (Note 7)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,868</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,460</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,240</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,667</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">555,449</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,927</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
CONVERTIBLE NOTES PAYABLE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Yu and Wei Note&rdquo;)
in an aggregate principal amount of $300,000 to Guoliang Yu and Yingfei Wei Family Trust (the &ldquo;Yu and Wei&rdquo;), pursuant
to which the Company received $300,000. The Yu and Wei Note bears interest at 8% per annum. The Company shall pay to the Yu and
Wei an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18) month anniversary
of the issuance date of the Yu and Wei Note, which is on November 8, 2019. In the event that the Company raises gross proceeds
from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days of the closing
for such offering, the Company must repay the outstanding amount of this Yu and Wei Note. At any time from the date hereof until
this Yu and Wei Note has been satisfied, the Yu and Wei may convert the unpaid and outstanding principal plus any accrued and
unpaid interest and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Yu and Wei Note is outstanding, subject to adjustments set forth
in the Yu and Wei Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Yu and Wei Note as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Keypoint Note&rdquo;)
in the aggregate principal amount of $250,000 to Keypoint Technology Ltd. (&ldquo;Keypoint&rdquo;), a related party, pursuant
to which the Company received $250,000. The Keypoint Note bears interest at 8% per annum. The Company shall pay to the Keypoint
an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18) month anniversary
of the issuance date of the Keypoint Note, which is on December 26, 2019. In the event that the Company raises gross proceeds
from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days of the closing
for such offering, the Company must repay the outstanding amount of this Keypoint Note. At any time from the date hereof until
this Keypoint Note has been satisfied, Keypoint may convert the unpaid and outstanding principal plus any accrued and unpaid interest
and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Keypoint Note is outstanding, subject to adjustments set forth
in the Keypoint Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Keypoint Note as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 25, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Odaira Note&rdquo;)
in the aggregate principal amount of $250,000 to the Company&rsquo;s director, Yoshinobu Odaira. (&ldquo;Odaira), pursuant to
which the Company received $250,000 on November 29, 2018. The Odaira Note bears interest at 8% per annum. The Company shall pay
to the Odaira an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18)
month anniversary of the issuance date of the Odaira Note, which is on February 24, 2020. In the event that the Company raises
gross proceeds from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days
of the closing for such offering, the Company must repay the outstanding amount of this Odaira Note. At any time from the date
hereof until this Odaira Note has been satisfied, Odaira may convert the unpaid and outstanding principal plus any accrued and
unpaid interest and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Odaira Note is outstanding, subject to adjustments set forth
in the Odaira Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Odaira Note as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the aggregate carrying values of the convertible debentures and accrued convertible interest were $800,000
and $27,467, respectively. Interest expense was $27,467 and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
RELATED PARTIES TRANSACTIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
related parties of the company with whom transactions are reported in these financial statements are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 51%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of entity or Individual</B></FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; width: 48%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationship
    with the Company and its subsidiaries</B></FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
    Inc.&nbsp;(the &ldquo;BioLite&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company; entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation (the &ldquo;BioFirst&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    (Australia) Pty Ltd. (the BioFirst (Australia)&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%
    owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation (the &ldquo;Rgene&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company; entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LionGene
    Corporation (the &ldquo;LionGene&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company; entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YuanGene
    Corporation (the &ldquo;YuanGene&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controlling
    beneficiary shareholder of the Company</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AsianGene
    Corporation (the &ldquo;AsianGene&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder;
    entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
    Jiang</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
    President and Chairman</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keypoint
    Technology Ltd. (the &ldquo;Keypoint&rsquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Chairman of Keypoint is Eugene Jiang&rsquo;s mother.</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoshinobu
    Odaira (the &ldquo;Odaira&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    of the Company</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euro-Asia
    Investment &amp; Finance Corp Ltd. (the &ldquo;Euro-Asia&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kimho
    Consultants Co., Ltd. (the &ldquo;Kimho&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey,
    Inc. (the &ldquo;BioKey&rdquo;)</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
    of wholly-owned subsidiaries of ABVC upon closing of the Mergers on February 8, 2019</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
receivable - related parties</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
due from related parties consisted of the following as of the periods indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> BioFirst (Australia) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 0.125in"> Total </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Due
to related parties</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
due to related parties consisted of the following as of the periods indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> BioLite Inc. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,684 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 109,220 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> BioFirst Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,151,301 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,957,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> AsianGene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> YuanGene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,690 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Eugene Jiang </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 100 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 100 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 0.125in"> Total </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 4,462,775 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 4,229,320 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Related
party transactions</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years ended December 31, 2018 and 2017, BioLite has advanced funds to the Company for working capital purpose. The advances
    bear 0% interest rate and are due on demand. As of December 31,2018 and 2017, the outstanding advance balance was $58,684
    and $109,2220, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2017, the Company and BioFirst entered into a loan agreement for a total commitment (non-secured indebtedness)
    of $950,000 to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month
    (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender. The loan will be matured
    on February 1, 2018. As of December 31, 2018 and 2017, the outstanding loan balance is $692,980 and $950,000, and accrued
    interest is $281 and $17,460, respectively. Interest expenses in connection with this loan were $104,331 and $103,460 for
    the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 24, 2017, BriVision entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;) with
    BioFirst (See Note 4). On September 25, 2017, BioFirst has delivered all research, technical, data and development data to
    BriVision, and the Company has recorded the full amount of $3,000,000 due to BioFirst. No payment has been made by the Company
    as of the date of this propsectus.</FONT> </TD></TR>

</TABLE>

<P STYLE="margin: 0"> &nbsp; </P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the years ended December 31, 2018 and 2017, BioFirst has also advanced funds to the Company for working capital purpose. The
    advances bear 0% interest rate and are due on demand. As of December 31,2018 and 2017, the outstanding advance balance was
    $458,321 and $7,000, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    September 2017, AsianGene entered an investment and equity transfer agreement (the &ldquo;Investment and Equity Transfer Agreement&rdquo;)
    with Everfront Biotech Inc. (the &ldquo;Everfront&rdquo;), a third party. Pursuant to the Investment and Equity Transfer Agreement,
    Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsianGene at $1.60 per share in a total amount
    of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December
    15, 2017. AsianGene also agreed to loan the proceeds to the Company for working capital purpose. The non-secured loan bears
    0% interest rate and is due on demand. As of December 31, 2018 and 2017, the outstanding loan balance was $160,000 and accrued
    interest was $12,866 and $0, respectively. Interest expenses in connection with this loan were $18,411 and $0 for the years
    ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2018 and 2017, YuanGene Corporation has advanced an aggregate amount of $42,690 and $3,000, respectively,
    to the Company for working capital purpose. The advances bear 0% interest rate and are due on demand.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 18, 2018, the Company and YuanGene entered into a loan agreement for a total of $50,000 to meet its working capital
    needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and
    the Company is required to pay interest monthly to the lender. The maturity date of this loan is January 19, 2019. As of December
    31, 2018 and December 31, 2017, the outstanding loan balance was $50,000 and $0, and accrued interest was $5,721 and $0, respectively.
    Interest expenses in connection with this loan were $5,721 and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2018 and December 31, 2017, the Chairman, Eugene Jiang, of the Company has advanced an aggregate amount of
    $100 to the Company for working capital purpose. The advances bear 0% interest rate and are due on demand.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Keypoint Note&rdquo;)
    in the aggregate principal amount of $250,000 to Keypoint Technology Ltd. (&ldquo;Keypoint&rdquo;) (See Note 7). The Company
    received $250,000 which bears interest at 8% per annum. Interest expense in connection with this Keypoint Note was $10,222
    and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 25, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Odaira Note&rdquo;)
    in the aggregate principal amount of $250,000 to Yoshinobu Odaira (&ldquo;Odaira&rdquo;) (See Note 7). The Company received
    $250,000 on November 29, 2018 which bears interest at 8% per annum. Interest expense in connection with this Odaira Note was
    $1,778 and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 1, 2017, Kimho Consultants Co., Ltd. and the Company entered into a service agreement (the &ldquo;Kimho Agreement&rdquo;)
    for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31, 2018 and 2017, the
    Company recognized non-employee stock based compensation expenses of $0 and $90,000 in connection with the terms in the Kimho
    Agreement, respectively.</FONT> </TD></TR>

</TABLE>

<P STYLE="margin: 0"> &nbsp; </P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 29px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 1, 2017, Euro-Asia Investment &amp; Finance Corp Ltd. and the Company entered into a service agreement (the &ldquo;Euro-Asia
    Agreement&rdquo;) for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31,
    2018 and 2017, the Company recognized non-employee stock based compensation expenses of $0 and $60,000 in connection with
    the terms in the Euro-Asia Agreement, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2017, the Company provided a one-time consulting service to LionGene Corporation for $70,000.
    Since both LionGene and the Company are related parties and under common control by a controlling beneficiary shareholder
    of YuanGene Corporation, the Company has recorded the full amount of $70,000 as additional paid-in capital during the year
    ended September 30, 2017.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended September 30, 2017, the Company entered an operating lease agreement with AsianGene for an office space in
    Taiwan for the period from October 1, 2016 to July 31, 2017. The monthly base rent is approximately $5,000. Rent expenses
    under this lease agreement amounted to $0 and $52,205 for the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 2, 2018, the Company and BioKey entered into an operating lease agreement for an office space in Fremont, California.
    The lease can be terminated one month in advance provided with written notice. The monthly base rent is $800. Rent expenses
    under this lease agreement amounted to $2,400 and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
EQUITY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
October 2015, $350,000 of subscription receivable was fully collected from the shareholders.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2016, a Share Exchange Agreement (&ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American BriVision
(Holding) Corporation (the&nbsp;&ldquo;Company&rdquo;), American BriVision Corporation&nbsp;(&ldquo;BriVision&rdquo;), Euro-Asia
Investment &amp; Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of People&rsquo;s
Republic of China (&ldquo;Euro-Asia&rdquo;), being the owners of record of 164,387,376 (52,336,000 pre-stock split) shares of
Common Stock of the Company, and the owners of record of all of the issued share capital of BriVision (the&nbsp;&ldquo;BriVision
Stock&rdquo;). Pursuant to the Share Exchange Agreement, upon surrender by the BriVision Shareholders and the cancellation by
BriVision of the certificates evidencing the BriVision Stock as registered in the name of each BriVision Shareholder, and pursuant
to the registration of the Company in the register of members maintained by BriVision as the new holder of the BriVision Stock
and the issuance of the certificates evidencing the aforementioned registration of the BriVision Stock in the name of the Company,
the Company should issue 166,273,921(52,936,583 pre-stock split) shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to
adjustment for fractionalized shares as set forth below) of the Company&rsquo;s Common Stock to the BriVision Shareholders (or
their designees), and 163,159,952 (51,945,225 pre-stock split) shares of the Company&rsquo;s Common Stock owned by Euro-Asia should
be cancelled and retired to treasury. The Acquisition Stock collectively should represent 79.70% of the issued and outstanding
Common Stock of the Company immediately after the Closing, in exchange for the BriVision Stock, representing 100% of the issued
share capital of BriVision in a reverse merger, or the Merger. Pursuant to the Merger, all of the issued and outstanding shares
of BriVision&rsquo;s Common Stock were converted, at an exchange ratio of 0.2536-for-1, into an aggregate of 166,273,921(52,936,583
pre-stock split) shares of Company&rsquo;s Common Stock and BriVision became a wholly owned subsidiary, of the Company. The holders
of Company&rsquo;s Common Stock as of immediately prior to the Merger held an aggregate of 205,519,223 (65,431,144 pre-stock split)
shares of Company&rsquo;s Common Stock,&nbsp;Because of the exchange of the BriVision Stock for the Acquisition Stock (the&nbsp;&ldquo;Share
Exchange&rdquo;), BriVision became a wholly owned subsidiary (the &ldquo;Subsidiary&rdquo;) of the Company and there was a change
of control of the Company following the closing. There were no warrants, options or other equity instruments issued in connection
with the share exchange agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2016, pursuant to the 2016 Equity Incentive Plan (the &ldquo;2016 Plan&rdquo;), 157,050 (50,000 pre-stock split)
shares were granted to the employees.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3:141 (the &ldquo;Forward&nbsp;Stock&nbsp;Split&rdquo;) and increase the number of our authorized shares of
Common Stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of the shareholders of the Company approved the amendment to Articles of Incorporation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 6, 2016, the Company and BioLite agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone Payment
Agreement, whereby the Company has agreed to issue shares of our Common Stock, at the price of $1.60 per share, for an aggregate
number of 562,500 shares, as part of our first installation of payment pursuant to the Milestone Payment. The shares issuance
was completed in June 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 26, 2016, the Company issued 1,468,750 shares (&ldquo;Shares&rdquo;) of the Company&rsquo;s Common Stock, par value $0.001
(the &ldquo;Offering&rdquo;) to BioLite, Inc., a non-U.S. accredited investor (the &ldquo;Purchaser&rdquo;) pursuant to a certain
Stock Purchase Agreement dated August 26, 2016 (the &ldquo;SPA&rdquo;). The Shares are exempt from the registration requirements
of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), pursuant to Regulation&nbsp;S of the Securities
Act promulgated thereunder. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from the Offering
are approximately $2,350,000. The proceeds may be used for general corporate purposes.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement (See Note 4), BriVision should pay a total of $100,000,000 in cash or stock of the Company
with equivalent value according to the milestone achieved. The agreement requires that 6.5% of total payment, $6,500,000 shall
be made upon the first IND submission which was submitted in March 2016. In February 2017, the Company remitted this amount to
BioLite with $650,000 in cash and $5,850,000 in the form of newly issued shares of our Common Stock, at the price of $2.0 per
share, for an aggregate number of 2,925,000 shares.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2016, the Company entered into a consulting agreement with Kazunori Kameyama (&ldquo;Kameyama&rdquo;) for the provision
of services related to the clinical trials and other administrative work, public relation work, capital raising, trip coordination,
In consideration for providing such services, the Company agreed to indemnify the consultant in an amount of $150 per hour in
cash up to $3,000 per month, and issue to Kameyama the Company&rsquo;s Common Stock at $1.00 per share for any amount exceeding
$3,000. The Company&rsquo;s stocks shall be calculated and issued in December every year. On October 1, 2017, the Company and
Kameyama agreed to extend the service period for one more year expiring on September 30, 2018. As a result, the non-employee stock-based
compensation related to this consulting agreement was $28,800 and $5,400 for the years ended December 31, 2018 and 2017, respectively.
On March 28, 2018, the Company issued 4,828 shares of the Company&rsquo;s common stock at $1.60 per share in a total of $7,725
to Kameyama in connection with this consulting agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2017, Euro-Asia Investment &amp; Finance Corp Ltd. and the Company entered into a service agreement (the &ldquo;Euro-Asia
Agreement&rdquo;) for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31, 2018
and 2017, the Company recognized non-employee stock based compensation expenses of $0 and $60,000 in connection with the terms
in the Euro-Asia Agreement, respectively. On March 28, 2018, the Company issued 50,000 shares of the Company&rsquo;s common stock
at $1.60 per share in a total of $80,000 to Euro-Asia in connection with the Euro-Asia Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2017, Kimho Consultants Co., Ltd. and the Company entered into a service agreement (the &ldquo;Kimho Agreement&rdquo;)
for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31, 2018 and 2017, the Company
recognized non-employee stock based compensation expenses of $0 and $90,000 in connection with the terms in the Kimho Agreement,
respectively. On March 28, 2018, the Company issued 75,000 shares of the Company&rsquo;s common stock at $1.60 per share in a
total of $120,000 to Kimho in connection with the Kimho Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 505-50-30, the transactions with the non-employees were measured based on the fair value of the equity instruments issued
as the Company determined that the fair value of the equity instruments issued in a stock-based payment transaction with nonemployees
was more reliably measurable than the fair value of the consideration received. The Company measured the fair value of the equity
instruments in these transactions using the stock price on the date at which the commitments Kameyama, Euro-Asia, and Kimho for
performance were rendered.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2018, the Company also issued an aggregate of 50,000 shares of the Company&rsquo;s common stock at $1.60 per share for
salaries in a total of $80,000 to three officers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
INCOME TAX</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction, and various state and local jurisdictions. The Company is no
longer subject to U.S. federal, state and local income tax examinations by tax authorities for years before 2013.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the &ldquo;Tax Act&rdquo;) was enacted. Among the significant
changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (&ldquo;Federal Tax Rate&rdquo;)
from 35% to 21% effective January 1, 2018. The 21% Federal Tax Rate will apply to earnings reported for the full 2018 fiscal year.
In addition, the Company must re-measure its net deferred tax assets and liabilities using the Federal Tax Rate that will apply
when these amounts are expected to reverse. As of December 31, 2017, the Company can determine a reasonable estimate for certain
effects of tax reform and recorded that estimate as a provisional amount. The provisional remeasurement of the deferred tax assets
and allowance valuation of deferred tax assets at December 31, 2017 resulted in a net effect of $0 discrete tax expenses (benefit)
which lowered the effective tax rate by 14% for the year ended December 31, 2017. The provisional remeasurement amount is anticipated
to change as data becomes available allowing more accurate scheduling of the deferred tax assets and liabilities primarily related
to net operating loss carryover.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components
of income tax (benefits) for the twelve months ended December 31, 2018 and 2017 are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year
    ended&nbsp;<BR> December 31, 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year
    ended&nbsp;<BR> December 31, 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Federal </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> State </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Total </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Federal </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> State </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Total </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif"> Current </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Deferred </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 830 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
components of the Company&rsquo;s deferred tax accounts at December 31, 2018 and September 30, 2017:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December
    31,<BR> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December
    31,<BR> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Deferred Tax Account - noncurrent: </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Tax losses carryforwards </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 913,954 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 594,501 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Less: Valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (913,954 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,501 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.375in"> Total deferred tax account
    - noncurrent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined
by applying the applicable statutory U.S. tax rate are analyzed below:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Years
    ended&nbsp;<BR> December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Statutory federal tax benefit, net
    of state tax effects </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 19 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 31 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> State income taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8.84 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8.84 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Provisional remeasurement of deferred taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Nondeductible/nontaxable items </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Change in valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (26.84 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (22.84 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Effective income tax rate </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 0 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 0 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
LOSS PER SHARE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the year. Diluted
loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common
shares outstanding during the years ended December 31, 2018 and 2017.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Years
    Ended<BR> December&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Numerator: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Denominator: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Weighted-average shares outstanding: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Weighted-average shares outstanding
    - Basic </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,884,105 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,321,921 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Stock options </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Weighted-average shares outstanding
    - Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,884,105 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,321,921 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Loss per share </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> -Basic </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> -Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
loss per share takes into account the potential dilution that could occur if securities or other contracts to issue Common Stock
were exercised and converted into Common Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
COMMITMENTS AND CONTINGENCIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
Commitment</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leased an office space in Taiwan under non-cancelable operating leases expired on June 30, 2018. As of December 31, 2018,
there was no future minimum lease payments under non-cancelable operating and capital leases.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental
expense was $7,497 and $49,245 for the years ended December 31, 2018 and 2017, respectively.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
PRO FORMA FINANCIAL STATEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2018, American BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;, the &ldquo;Company&rdquo;) entered into an agreement
and plan of merger (the &ldquo;Merger Agreement&rdquo;) with BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), a Nevada corporation,
BioKey, Inc. (&ldquo;BioKey&rdquo;), a California corporation, BioLite Acquisition Corp. (&ldquo;Merger Sub 1&rdquo;), a Nevada
corporation and wholly-owned subsidiary of the Company, and BioKey Acquisition Corp. (&ldquo;Merger Sub 2&rdquo;), a California
corporation and wholly-owned subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, on or before the Closing of the Merger, each issued and outstanding share of BioLite shall be converted
into the right to receive one point eighty-two (1.82) validly issued, fully-paid and non-assessable shares of the Company and
all shares of BioLite shall be cancelled and cease to exist. Also on or before the Closing of the Merger, each issued and outstanding
share of BioKey shall be converted into the right to receive one (1) validly issued, fully-paid and non-assessable share of the
Company and all shares of BioKey shall be cancelled and cease to exist. Simultaneously upon Closing, BioLite and Merger Sub 1
shall merge together with Merger Sub 1&rsquo;s articles of incorporation and bylaws as the surviving corporation&rsquo;s (the
&ldquo;BioLite Surviving Corporation&rdquo;) articles of incorporation and bylaws and all shares of Merger Sub 1 shall be converted
into one share of Common Stock of the BioLite Surviving Corporation, which shall remain a wholly-owned subsidiary of the Company.
In addition, upon Closing, BioKey and Merger Sub 2 shall merge together with Merger Sub 2&rsquo;s articles of incorporation and
bylaws as the surviving corporation&rsquo;s (the &ldquo;BioKey Surviving Corporation&rsquo;s&rdquo;) articles of incorporation
and bylaws and all shares of Merger Sub 2 shall be converted into one share of Common Stock of the BioKey Surviving Corporation,
which shall remain a wholly-owned subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed consolidated combined financial statements reflect the combination of the historical consolidated
results of ABVC and its subsidiaries, BioLite, and BioKey on a pro forma basis to give effect to the Merger Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined balance sheet of the combined company is based on (i)&nbsp;the audited historical
consolidated balance sheet of ABVC as of December&nbsp;31, 2018, (ii)&nbsp;the audited historical balance sheet of BioLite as
of December&nbsp;31, 2018, and the (iii) the audited historical balance sheet of BioKey as of December 31, 2018, and includes
pro forma adjustments as of the Merger had occurred on December&nbsp;31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined statement of operations of the combined company are based on&nbsp;the following
details, and includes pro forma adjustments as of the Merger had occurred on January 1, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    unaudited historical consolidated statement of operations of ABVC for the year ended December 31, 2018.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    audited historical statement of operations of BioLite for the year ended December 31, 2018.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    audited historical statement of operations of BioKey for the year ended December 31, 2018.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma data presented herein reflects events that are directly attributable to the described transactions, factually
supportable, and as it relates to the unaudited pro forma condensed consolidated combined statement of operations, expected to
have a continuing impact. The unaudited pro forma data presented herein also reflects certain assumptions which management believes
are reasonable. Such pro forma data is not necessarily indicative of financial results that would have been attained had the described
transactions occurred on the dates indicated above, or the results of the combined company that may be achieved in the future.
The adjustments are based on currently available information and certain estimates and assumptions. Therefore, the actual results
may differ from the pro forma results indicated herein. However, management believes that the assumptions provide a reasonable
basis for presenting the significant effects of the transactions as contemplated and that the pro forma adjustments give appropriate
effect to those assumptions and are properly applied in the unaudited pro forma condensed consolidated combined financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined financial statements are provided for illustrative purposes only and are not
intended to represent or be indicative of the consolidated results of operations or consolidated financial position of the combined
company that would have been recorded had the Merger been completed as of the dates presented, and they should not be taken as
representative of the expected future results of operations or financial position of the combined company. The unaudited pro forma
condensed consolidated combined financial statements do not reflect the impacts of any potential operational efficiencies, asset
dispositions, cost savings or economies of scale that the combined company may achieve with respect to the operations of the combined
company. Additionally, the unaudited pro forma condensed consolidated combined statement of operations does not include&nbsp;non-recurring&nbsp;charges
or credits, and the related tax effects, which result directly from the Merger.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
PRO FORMA CONDENSED CONSOLIDATED COMBINED BALANCE SHEET</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
OF DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> ABVC </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioKey </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioLite </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Note </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Combined </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> ASSETS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Cash
    and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,044 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 636,666 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 186,644 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 863,354 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Restricted
    cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Accounts
    receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Accounts
    receivable - related parties, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Other receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Due from
    related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,287 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (59,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {f} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,477 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> Inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Prepaid
    expense and other current assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 136 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,759 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,895 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -10pt"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 827,718 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 530,013 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (59,810 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,394,194 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Property
    and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 568,216 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Goodwill,
    net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,531,445 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,531,445 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Long-term
    investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,488,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,448,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Deferred
    tax assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Security
    Deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,858 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt"> Total
    Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,471,635 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,367,877 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> LIABILITIES
    AND EQUITY </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Current
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Short-term
    bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Long-term
    bank loan - current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Accrued
    expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 555,449 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 687,709 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,326,184 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Due to related
    parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,462,775 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,341,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {f} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,745,096 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Convertible
    notes payable, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -10pt"> Convertible
    notes payable - related parties, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -10pt"> Total
    Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,568,224 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,478,246 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,070,812 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Long-term
    bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Tenant security
    deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Convertible
    notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Convertible
    notes payable - related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Accrued
    interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in; text-indent: -10pt"> Total
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,845,691 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,493,503 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (58,684 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,366,416 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Preferred
    stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,633,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,633,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {c} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Common stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,927 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 774,293 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 318,486 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,998 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (771,793 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {b} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {b} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,133 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {c} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Additional
    paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,914,556 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 82,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (70,877 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {a} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,018,959 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (82,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,312,285 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (10,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Stock subscription
    receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Accumulated
    deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (19,877,901 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,677,586 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (11,445,109 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,677,586 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {e} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (12,209,446 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,817,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,295,716 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Other comprehensive
    income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 670,541 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (14,689 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g,h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 655,852 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> Treasury
    stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,750,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> {g} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,350,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> {h} </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -10pt"> Total
    Stockholders&rsquo; deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,548 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,530,319 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 38,683,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Noncontrolling
    interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in; text-indent: -10pt"> Total
    Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 410,158 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,530,319 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,001,461 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt"> Total
    Liabilities and Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,471,635 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,367,877 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEAR ENDED DECEMBER 31, 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Pro Forma </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> ABVC </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioKey </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> BioLite </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Adjustment </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Note </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Combined </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: bold 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,197 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,956 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 517,153 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 185,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 190,089 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,324 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 327,064 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -10pt"> Selling, general and administrative
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,148 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,322 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,258,040 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,668 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,917 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,419,638 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 28,800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,100,239 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,706,478 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,393,616 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,390,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,379,414 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 93 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,930 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (462,751 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Impairment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (63,663 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (549 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (396,025 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain/Loss on foreign exchange&nbsp;changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in; text-indent: -0.125in"> Gain/Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,549,451 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (192,463 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,741,914 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 630 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,524 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,705,837 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,228 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,639,836 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Loss before provision for income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,099,453 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (589,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,330,174 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,019,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (364,297 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,654,953 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Net loss attributable to noncontrolling interests </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Net loss attributable to ABVC and subsidiaries </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,067 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,144,104 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> Foreign currency translation
    adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Income (Loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,560,862 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,230,890 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> Net loss per share attributable to common stockholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.02 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.03 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"> Weighted average number of common shares outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Basic and
    diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 213,884,105 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 214,156,988 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Notes
to the Unaudited Pro Forma Condensed Consolidated Combined Financial Statements</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Basis of Presentation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined balance sheet as of December 31, 2018 is based on the audited consolidated
balance sheet of ABVC, the audited consolidated balance sheet of BioLite, and the audited balance sheet of BioKey as if the Merger
had occurred on December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed consolidated combined statement of operations for the year ended December 31, 2018 is based on the
audited consolidated statement of operations of ABVC for the year ended December 31, 2018, the audited consolidated statement
of operations of BioLite for the year ended December 31, 2018, and the audited statement of operations of BioKey for the year
ended December 31, 2018, as if the Merger had occurred on January 1, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
and the Company are related parties because the two companies are under common control by Dr. Tsung-Shann Jiang.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Pro Forma Adjustments</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following adjustments were made in the preparation of the audited pro forma condensed consolidated combined balance sheet and
unaudited pro forma condensed consolidated combined statements of operations:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{a}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
    of ABVC common stock to be issued to BioLite shareholders:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> BioLite
    Outstanding shares as of December 31, 2018 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 41,207,444 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Exchange of
    each BioLite share of common stock outstanding as of December 31, 2018, for 1.82 shares of ABVC common stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1.82 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> ABVC common
    stock to be issued to BioLite as a result of the Merger </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,997,548 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> Par value
    $0.001 per share of ABVC </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 74,998 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{b}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey shareholders in exchange of BioKey&rsquo;s common stock outstanding:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> BioKey
    Outstanding shares as of December 31, 2018 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428,134 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Exchange of each BioKey share of common stock outstanding
    as of December 31, 2018, for one share of ABVC common stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> ABVC common
    stock to be issued to BioKey as a result of the Merger </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428,134 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: -9pt; padding-left: 9pt"> Par value
    $0.001 per share of ABVC </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{c}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey shareholders in exchange of BioKey&rsquo;s preferred stock outstanding:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey
    Outstanding shares as of December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000,000
    shares of Series A</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000,000</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,160,000
    shares of Series B</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,160,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,973,097
    shares of Series C</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,973,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey&rsquo;s
    total shares of preferred stock outstanding as of December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    of each BioKey share of preferred stock outstanding as of December 31, 2018, for one share of ABVC common stock</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABVC
    common stock to be issued to BioKey as a result of the Merger</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133,097</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    value $0.001 per share of ABVC</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,133</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{d}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock outstanding as of December 31, 2018 following the Merger:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify"> ABVC common stock issued as of December 31, 2018 </TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 213,926,475 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"> ABVC common stock held by BioLite pursuant to the BioLite Collaborative Agreement (see Note {g}) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (3,487,500 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"> ABVC common stock held by BioLite for cash issuance (see Note {h}) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (1,468,750 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"> ABVC common stock to be issued to BioLite as a result of the Merger </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 74,997,548 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"> ABVC common stock to be issued to BioKey as a result of the Merger </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 29,561,231 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt"> Total common stock of the combined company outstanding following the Merger </TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 313,529,004 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; padding-bottom: 8pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{e}</FONT> </TD>
    <TD STYLE="padding-bottom: 8pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, adjustments to reflect the elimination of BioKey&rsquo;s total equity, the estimated value of consideration
    to be paid in the Merger and to adjust, where required, the historical book values of BioKey&rsquo;s assets and liabilities
    as of December 31, 2018 to the preliminary estimated fair value, in accordance with the acquisition method of accounting.
    The preliminary valuations were determined as of and, where applicable, are based on the bid-and-ask share price of ABVC common
    stock on the final day of trading, February 5, 2019. The fair value of the consideration given and assets and liabilities
    acquired will be determined based on the underlying fair values as of the February 5, 2019.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Purchase consideration: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Common stock (1) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,341,847 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Estimated Fair Value of Assets Acquired: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 636,666 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accounts receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accounts receivable - related
    parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Property and equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Security
    deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    assets acquired </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Estimated Fair Value of Liabilities Assumed: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Due to shareholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accrued expenses and other current
    liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Tenant
    security deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    liabilities assumed </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    net assets acquired </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.25in"> Goodwill
    as a result of the Merger </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,531,445 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,561,231
    shares of ABVC common stock to be issued to BioKey in connection with the Merger. Those shares were valued at $1.50 per share,
    the closing share price of ABVC on February 5, 2019.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{f}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2018, BioLite had $59,810 due from ABVC; and ABVC had $58,684 due to BioLite. The difference was mainly due
    to the translation adjustment, which would be reflected in accumulated other comprehensive income in equity section.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{g}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
    agreement with BioLite Inc., a related party</U></B></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2015, American BriVision Corporation (&ldquo;BriVision&rdquo;) entered into a collaborative agreement (the &ldquo;BioLite
Collaborative Agreement&rdquo;) with BioLite, a related party, pursuant to which BioLite granted BriVision sole licensing rights
for drug and therapeutic use of five products, including BLI-1005 CNS-Major Depressive Disorder, BLI-1008 CNS-Attention Deficit
Hyperactivity Disorder, BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1, BLI-1401-2 Anti-Tumor Combination
Therapy-Triple Negative Breast Cancer, and BLI-1501 Hematology-Chronic Lymphocytic Leukemia, in the U.S.A and Canada. Under the
BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of BriVision with equivalent value,
according to the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upfront
    payment shall upon the signing of this BioLite Collaborative Agreement: 3.5% of total payment. After receiving upfront payment
    from BriVision, BioLite has to deliver all data to BriVision in one week.</FONT> </TD></TR>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the first IND submission, BriVision shall pay, but no later than December 15, 2016: 6.5% of total payment. After receiving
    second payment from BriVision, BioLite has to deliver IND package to BriVision in one week.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    the completion of first phase II clinical trial, BriVision shall pay: 15% of total payment.
    After receiving third payment from BriVision, BioLite has to deliver phase II clinical study report to BriVision in three
    months.</FONT> </TD></TR>
</TABLE>

<P STYLE="margin: 0"> &nbsp; </P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the phase III IND submission, BriVision shall pay: 20% of total payment. After receiving
    forth payment from BriVision, BioLite has to deliver IND package to BriVision in one week.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    the completion of phase III, BriVision shall pay: 25% of total payment. After receiving
    fifth payment from BriVision, BioLite has to deliver phase III clinical study report to BriVision in three months.</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    the NDA submission, BriVision shall pay BriVision shall pay: 30% of total payment. After
    receiving sixth payment from BriVision, BioLite has to deliver NDA package to BriVision in one week.&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
BioLite Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial
sales of the Product in the Territory and automatically renew for five more years unless either party gives the other party six
month written notice of termination prior to the expiration date of the term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, an upfront payment of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), which is 3.5%
of total payments due under the BioLite Collaborative Agreement, was to be paid by BriVision upon signing of that agreement. On
May 6, 2016, BriVision and BioLite agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone Payment
Agreement, whereby BriVision agreed to pay the Milestone Payment to BioLite with $2,600,000 in cash and $900,000 in the form of
newly issued shares of its common stock, at the price of $1.60 per share, for an aggregate number of 562,500 shares. The cash
payment and shares issuance were completed in June 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which
was submitted in March 2016. On February 2017, BriVision agreed to pay this amount to BioLite with $650,000 in cash and $5,850,000
in the form of newly issued shares of its common stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares.
The cash payment and shares issuance were completed in February 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioLite Collaborative Agreement, the 15% of total payment, $15,000,000 shall be made at the completion of first phase II
clinical trial. As of December 31, 2018 and, 2017, the first phase II clinical trial research has not completed yet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate common stock shares of American BriVision Corporation issued to BioLite pursuant to the BioLite Collaborative Agreement
was 3,487,500 shares, the value of which was $6,750,000. The unaudited pro forma adjustments were made as if the Merger occurred
on December 31, 2018. As such, these common stock shares of ABVC held by BioLite shall not be treated as outstanding shares, and
shall be reflected as treasury shares. The corresponding long-term investment of BioLite has been written off in full amount,
included in the accumulated deficit as of December 31, 2018. Such amount has been eliminated in the pro forma condensed balance
sheet. Investment loss recognized as a result of the write-off amounted to $4,313,725 for the year ended December 31, 2018. Such
amount has been eliminated in the pro forma condensed statement of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision Corporation determined to fully expense the amount of $10,000,000 according to ASC 730-10-25-1. That amount was
fully expensed as research and development expense during the year ended December 31, 2016 and included in the accumulated
deficit of ABVC as of December 31, 2018. The aggregate amount of $10,000,000 was recorded and remained as additional paid-in
capital on BioLite as of December 31, 2018. Such amount has been eliminated in the pro forma condensed balance
sheet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">{h}</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 26, 2016, ABVC issued 1,468,750 shares of common stock, par value $0.001 to BioLite pursuant to a certain Stock Purchase
    Agreement dated August 26, 2016. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from
    the Offering are approximately $2,350,000. The unaudited pro forma adjustments were made as if the Merger occurred on December
    31, 2018. As such, these common stock shares of ABVC held by BioLite shall be treated be treated as outstanding shares, and
    shall be reflected as treasury shares. The corresponding long-term investment of BioLite has been written off in full amount,
    included in the accumulated deficit as of December 31, 2018. Such amount has been eliminated in the pro forma condensed balance
    sheet.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
SUBSEQUENT EVENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 21, 2019, the Company received a loan in the amount of $500,000 from Cathay Bank (the &ldquo;Bank&rdquo;) pursuant to
a business loan agreement (the &ldquo;Loan Agreement&rdquo;) entered by and between the Company and Bank on January 8, 2019 and
a promissory note (the &ldquo;Note&rdquo;) executed by the Company on the same day. The Loan Agreement provides for a revolving
line of credit in the principal amount of $1,000,000 with a maturity date (the &ldquo;Maturity Date&rdquo;) of January 1, 2020.
The Note executed in connection with the Loan Agreement bears an interest rate (the &ldquo;Regular Interest Rate&rdquo;) equal
to the sum of one percent (1%) and the prime rate as published in the Wall Street Journal (the &ldquo;Index&rdquo;) and the accrued
interest shall become payable each month from February 1, 2019. Pursuant to the Note, the Company shall pay the entire outstanding
principal plus accrued unpaid interest on the Maturity Date and may prepay portion or all of the Note before the Maturity Date
without penalty. If the Company defaults on the Note, the default interest rate shall become five percent (5%) plus the Regular
Interest Rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Note and Loan Agreement, on January 8, 2019, each of Dr. Tsung Shann Jiang and Dr. George Lee, executed a
commercial guaranty (the &ldquo;Guaranty&rdquo;) to guaranty the loans for the Company pursuant to the Loan Agreement and Note,
severally and individually, in the amount not exceeding $500,000 each until the entire Note plus interest are fully paid and satisfied.
Dr. Tsung Shann Jiang is the Chairman and Chief Executive Officer of BioLite Holding, Inc. and Dr. George Lee serves as the Chairman
of the board of directors of BioKey, Inc, which became a wholly-owned subsidiaries of the Company effective by operation of law
on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on January 8, 2019, each of the Company and BriVision, a wholly-owned subsidiary of the Company, signed a commercial
security agreement (the &ldquo;Security Agreement&rdquo;) to secure the loans under the Loan Agreement and the Note. Pursuant
to the Security Agreements, each of the Company and BriVision (each, a &ldquo;Grantor&rdquo;, and collectively, the &ldquo;Grantors&rdquo;)
granted security interest in the collaterals as defined therein, comprised of almost all of the assets of each Grantor, to secure
such loans for the benefit of the Bank.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through the date which the financial statements were available to be issued. All subsequent
events requiring recognition as of December 31, 2018 have been incorporated into these financial statements and there are no subsequent
events that require disclosure in accordance with FASB ASC Topic 855, &ldquo;Subsequent Events.&rdquo;&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">******</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>





<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEETS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March&nbsp;31,<BR>
    2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> ASSETS </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Cash
    and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 981,341 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 226,688 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Restricted
    cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,093 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Accounts
    receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 162,619 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Accounts
    receivable - related parties, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 142,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Other receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Due from
    related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,225 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,477 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 0.25in"> Inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 521 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Prepaid
    expense and other current assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 166,118 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,895 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,527,182 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 566,476 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Property and
    equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 547,520 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Operating
    lease right-of-use assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,305 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Goodwill,
    net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Long-term
    investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,407,763 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,488,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Deferred tax
    assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,396,023 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Prepaid expenses
    &ndash; noncurrent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 33,004 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Security
    deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 33,394 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.5in"> Total
    Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,450,191 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,940,124 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> LIABILITIES
    AND EQUITY </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Accounts
    payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,558 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Short-term
    bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,891,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Long-term
    bank loan - current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,688 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 499,284 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Accrued
    expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,558,629 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,243,158 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Operating
    lease liability &ndash; current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 286,212 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Due to
    related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,594,784 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,745,096 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Convertible
    notes payable &ndash; current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 300,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Convertible
    notes payable - related parties, current portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.5in"> Total Current
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 12,435,155 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,987,786 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Long-term
    bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,388 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Tenant security
    deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Operating
    lease liability &ndash; noncurrent portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 239,647 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Convertible
    notes payable &ndash; related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 250,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Accrued
    interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.5in"> Total
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 12,976,537 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,280,510 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Preferred
    stock, $0.001 par value, 20,000,000 authorized, nil shares issued and outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Common
    stock, $0.001 par value, 20,000,000 authorized, 17,693,625 and 11,884,804 issued and outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,885 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Additional
    paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,680,674 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,983,714 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Accumulated
    deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (12,209,446 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Other comprehensive
    income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 655,851 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Treasury
    stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Total Stockholders&rsquo;
    deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,762,310 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,657,996 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Noncontrolling
    interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.5in"> Total
    Equity (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,526,346 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,340,386 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> Total
    Liabilities and Equity (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,450,191 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,940,124 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF OPERATIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE&nbsp;<FONT STYLE="background-color: white">THREE MONTHS</FONT>&nbsp;ENDED MARCH 31, 2019 AND 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(UNAUDITED)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March&nbsp;31,<BR>
    2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: bold 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 212,242 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Cost
    of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,499 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Gross
    profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 210,743 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Operating
    expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,803 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 420,462 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Research
    and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 421,956 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 248,111 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Stock
    based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,550 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,626 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 941,309 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 674,199 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Loss
    from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (730,566 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (674,199 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Interest
    income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 189 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Interest
    expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (129,886 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (106,854 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Rental
    income, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,891 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Gain (loss)
    on foreign exchange&nbsp;changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (3 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,515 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Gain (loss)
    on investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (66,205 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,567 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Other
    income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (500 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (200,296 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (133,705 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Loss
    before provision for income tax (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (930,862 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (807,904 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Provision
    for income tax (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (57,545 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (94,282 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (873,317 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (713,622 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Net loss attributable
    to noncontrolling interests </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (81,646 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (112,235 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Net loss attributable
    to ABVC and subsidiaries </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (791,671 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (601,387 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Foreign
    currency translation adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,994 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> Comprehensive
    Income (Loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (878,457 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (536,393 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Net loss per
    share attributable to common stockholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.25in"> Basic
    and diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> Weighted average number of common
    shares outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.25in"> Basic
    and diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,965,665 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,599,911 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE&nbsp;<FONT STYLE="background-color: white">THREE MONTHS</FONT>&nbsp;ENDED MARCH 31, 2019 AND 2018</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(UNAUDITED)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Mar
    31,<BR> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Mar
    31,<BR> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Cash flows from operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Net
    loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (873,317 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (713,622 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Adjustments
    to reconcile net loss to net cash used in operating activities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 0.25in"> Depreciation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,940 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,420 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Stock-based
    compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,550 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,626 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Other non-cash
    income and expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (553 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Loss on
    investment in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 66,205 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 38,567 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Deferred
    tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (48,028 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (96,132 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Changes
    in assets and liabilities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Decrease
    (increase) in accounts receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (116,334 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Decrease
    (increase) in prepaid expenses and deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 29,237 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,642 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Decrease
    (increase) in other receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Decrease
    (increase) in due from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,252 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 19,594 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Decrease
    (increase) in inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 797 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 584 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Increase
    (decrease) in accounts payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (37,353 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 27pt"> Increase
    (decrease) in accrued expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 305,214 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 137,288 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> Increase
    (decrease) in due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,857 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 73,972 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.5in"> Net
    cash used in operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (599,528 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (525,510 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Cash flows
    from investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Long-term
    equity investment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (17,801 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.5in"> Net
    cash used in investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (17,801 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Cash flows
    from financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Issuance
    of common stock for acquisition </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 531,147 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Net proceeds
    from short-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,000,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Net proceeds
    from short-term borrowing from third-parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 312,824 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Borrowings
    from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 312,660 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 50,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Repayment
    of borrowings from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (460,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,087 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Repayment
    of bank loans </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (10,016 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 45pt"> Net
    cash provided by financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,373,791 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 349,737 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Effect
    of exchange rate changes on cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (40 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"> Net
    increase (decrease) in cash, cash equivalents, and restricted cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 754,653 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (175,813 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Cash, cash
    equivalents, and restricted cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"> Beginning </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 242,781 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 350,257 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.25in"> Ending </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 997,434 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 174,444 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -9pt; padding-left: 9pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Supplemental
    disclosure of cash flows </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Cash paid
    during the year for: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.25in"> Income
    tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,250 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,850 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 0.25in"> Interest
    expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 26,592 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 66,914 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CHANGES IN EQUITY&nbsp;</B></FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR THE&nbsp;<FONT STYLE="background-color: white">THREE
MONTHS</FONT>&nbsp;ENDED MARCH 31, 2019 AND 2018</B></FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(UNAUDITED)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Common Stock Number of </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Additional Paid-in </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Accumulated </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Comprehensive </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Treasury </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Noncontrolling </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Stockholders&rsquo; Equity </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> shares </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amounts </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Capital </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Deficit </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Income </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Stock </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Interest </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> (Deficit) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt"> Balance
    at December&nbsp;31, 2017 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,874,814 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,875 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,874,924 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,634,067 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 743,763 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 806,761 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 703,256 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -5pt; padding-left: 10pt"> Issuance of common shares </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,990 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,990 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 80,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -5pt; padding-left: 10pt"> Stock based
    compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,626 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,626 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -5pt; padding-left: 10pt"> Net loss
    for the period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (601,387 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (112,235 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (713,622 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 10pt"> Cumulative
    transaction adjustments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,994 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,994 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-indent: -5pt; padding-left: 5pt"> Balance
    at March&nbsp;31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,884,804 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,885 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,960,540 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,235,454 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 808,757 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 694,526 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 140,254 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Common Stock Number of </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Additional Paid-in </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Accumulated </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Comprehensive </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Treasury </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Noncontrolling </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Stockholders&rsquo; Equity </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> shares </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amounts </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Capital </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Deficit </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Income </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Stock </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Interest </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> (Deficit) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt"> Balance
    at December&nbsp;31, 2018 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,884,804 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,885 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,983,714 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (12,209,446 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 655,851 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,340,386 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -5pt; padding-left: 10pt"> Issuance of common shares </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,642,291 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,642 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 692,577 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 694,219 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -5pt; padding-left: 10pt"> Effects from
    restructuring </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,166,530 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,167 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,167 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -5pt; padding-left: 10pt"> Stock based
    compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,550 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,550 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -5pt; padding-left: 10pt"> Net loss
    for the period </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (791,671 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (81,646 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (873,317 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 10pt"> Cumulative
    transaction adjustments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15,412 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15,412 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-indent: -5pt; padding-left: 5pt"> Balance
    at March&nbsp;31, 2019 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,693,625 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,694 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,680,674 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (13,001,117 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 640,439 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,100,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 235,964 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,526,346 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>*</B></FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
shares outstanding for all periods have been retroactively recast to reflect Company&rsquo;s 1-for-18 stock reverse split, which
was effective on May 8, 2019.</B></FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMERICAN
BRIVISION (HOLDING) CORPORATION AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MARCH
31, 2019</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
ORGANIZATION AND DESCRIPTION OF BUSINESS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision (Holding) Corporation (the &ldquo;Company&rdquo; or &ldquo;Holding entity&rdquo;), a Nevada corporation, through the
Company&rsquo;s operating entity, American BriVision Corporation (the &ldquo;BriVision&rdquo;), which was incorporated in July
2015 in the State of Delaware, engages in biotechnology and focuses on the development of new drugs and innovative medical devices
to fulfill unmet medical needs. The business model of the Company is to integrate research achievements from world-famous institutions
(such as Memorial Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) and MD Anderson Cancer Center), conduct clinical trials
of translational medicine for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and
exploit global markets. BriVision had to predecessor operations prior to its formation on July 21, 2015.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reverse
Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2016, a Share Exchange Agreement (the &ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American
BriVision (Holding) Corporation, American BriVision Corporation&nbsp;(&ldquo;BriVision&rdquo;), and Euro-Asia Investment &amp;
Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of the People&rsquo;s
Republic of China (&ldquo;Euro-Asia&rdquo;), being the owners of record of 164,387,376 (52,336,000 pre-stock split) shares of
Common Stock of the Company, and the owners of record of all of the issued share capital of BriVision (the&nbsp;&ldquo;BriVision
Stock&rdquo;).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Share Exchange Agreement, upon surrender by the BriVision Shareholders and the cancellation by BriVision of the certificates
evidencing the BriVision Stock as registered in the name of each BriVision Shareholder, and pursuant to the registration of the
Company in the register of members maintained by BriVision as the new holder of the BriVision Stock and the issuance of the certificates
evidencing the aforementioned registration of the BriVision Stock in the name of the Company, the Company issued 166,273,921(52,936,583
pre-stock split) shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to adjustment for fractionalized shares as set forth
below) of the Company&rsquo;s Common Stock to the BriVision Shareholders (or their designees), and 163,159,952 (51,945,225 pre-stock
split) shares of the Company&rsquo;s Common Stock owned by Euro-Asia were cancelled and retired to treasury. The Acquisition Stock
collectively represented 79.70% of the issued and outstanding Common Stock of the Company immediately after the Closing, in exchange
for the BriVision Stock, representing 100% of the issued share capital of BriVision in a reverse merger (the &ldquo;Merger&rdquo;).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger, all of the issued and outstanding common shares of BriVision were converted, at an exchange ratio of 0.2536-for-1,
into an aggregate of 166,273,921(52,936,583pre-stock split) common shares of the Company and BriVision had become a wholly owned
subsidiary of the Company. The holders of Company&rsquo;s Common Stock as of immediately prior to the Merger held an aggregate
of 205,519,223(65,431,144 pre-stock split) shares of Company&rsquo;s Common Stock.&nbsp;Because of the exchange of the BriVision
Stock for the Acquisition Stock (the&nbsp;&ldquo;Share Exchange&rdquo;), BriVision had become a wholly owned subsidiary (the &ldquo;Subsidiary&rdquo;)
of the Company and there was a change of control of the Company following the closing. There were no warrants, options or other
equity instruments issued in connection with the share exchange agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the consummation of the Share Exchange,&nbsp;BriVision&nbsp;became our wholly owned subsidiary of the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Share Exchange, we have abandoned our prior business plan and we are now pursuing&nbsp;BriVision&rsquo;s&nbsp;historically
proposed businesses, which focus on the development of new drugs and innovative medical devices to fulfill unmet medical needs.
The business model of the Company is to integrate research achievements from world-famous institutions, conduct clinical trials
of translational medicine for Proof of Concept (&ldquo;POC&rdquo;), out-license to international pharmaceutical companies, and
explore global markets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounting
Treatment of the Reverse Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Share Exchange represents a &ldquo;reverse merger&rdquo;&nbsp;rather than a business combination
and BriVision is deemed the accounting acquirer in the transaction. The Share Exchange is being accounted for as a reverse-merger
and recapitalization. BriVision is the acquirer for financial reporting purposes and the Company is the acquired company. Consequently,
the assets and liabilities and the operations reflected in the historical financial statements prior to the Share Exchange will
be those of BriVision and recorded at the historical cost basis of BriVision. In addition, the consolidated financial statements
after completion of the Share Exchange will include the assets and liabilities of the Company and BriVision, and the historical
operations of BriVision and operations of the Combined Company from the closing date of the Share Exchange.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Company, BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), BioKey, Inc. (&ldquo;BioKey&rdquo;), BioLite Acquisition
Corp., a direct wholly-owned subsidiary of Parent (&ldquo;Merger Sub 1&rdquo;), and BioKey Acquisition Corp., a direct wholly-owned
subsidiary of Parent (&ldquo;Merger Sub 2&rdquo;) (<FONT STYLE="background-color: white">collectively referred to as the &ldquo;Parties&rdquo;)</FONT>&nbsp;completed
the business combination pursuant to the Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) dated as of January
31, 2018 where ABVC acquired BioLite and BioKey via issuing additional Common Stock of ABVC to the shareholders of BioLite and
BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Merger Agreement, BioLite and BioKey became two wholly-owned subsidiaries of the Company on February 8, 2019.
ABVC issued an aggregate of 104,558,777 shares (prior to the reverse stock split in 2019) to the shareholders of both BioLite
and BioKey under a registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018009520/fs42018_americanbrivision.htm">Form S-4</A> (file number 333-226285), which became effective by operation of law on
or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Holding, Inc. (the &ldquo;BioLite Holding&rdquo;) was incorporated under the laws of the State of Nevada on July 27, 2016. BioLite
BVI, Inc. (the &ldquo;BioLite BVI&rdquo;), a wholly owned subsidiary of BioLite Holding, was incorporated in the British Virgin
Islands on September 13, 2016. BioLite Holding and BioLite BVI are holding companies and have not carried out substantive business
operations of their own.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite,
Inc., (the &ldquo;BioLite Taiwan&rdquo;) was incorporated on February 13, 2006 under the laws of Taiwan. BioLite is in the business
of developing and commercialization of new botanical drugs with application in central nervous system, autoimmunity, inflammation,
hematology, and oncology. In addition, BioLite Taiwan distributes dietary supplements made from extracts of Chinese herbs and
Maitake mushroom.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, BioLite Holding, BioLite BVI, BioLite Taiwan, and certain shareholders of BioLite Taiwan entered into a share purchase
/ exchange agreement (the &ldquo;BioLite Share Purchase / Exchange Agreement&rdquo;). Pursuant to the BioLite Share Purchase /
Exchange Agreement, the shareholder participants to the BioLite Share Purchase / Exchange Agreement have sold their equity in
BioLite Taiwan and were using the proceeds from such sales to purchase shares of Common Stock of BioLite Holding at the same price
per share, resulting in their owning the same number of shares of Common Stock as they owned in the BioLite Taiwan. Upon closing
of the Share Purchase/ Exchange Agreement in August 2017, BioLite Holding ultimately owns via BioLite BVI approximately 73% of
BioLite Taiwan. The other shareholders who did not enter this Share Purchase/ Exchange Agreement retain their equity ownership
in BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioKey,
Inc. was incorporated on August 9, 2000 in the State of California. It is engaged primarily in research and development, manufacturing,
and distribution of generic drugs and nutraceuticals with strategic partners. BioKey provides a wide range of services, including,
API characterization, pre-formulation studies, formulation development, analytical method development, stability studies, IND/NDA/ANDA/510K
submissions, and manufacturing clinical trial materials (phase 1 through phase 3) and commercial manufacturing. It also licenses
out its technologies and initiates joint research and development processes with other biotechnology, pharmaceutical, and nutraceutical
companies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounting
Treatment of the Merger</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASC 805, &ldquo;Business Combination&rdquo; to record the merger transactions of BioKey. Since the Company and
BioLite Holding are the entities under Dr. Tsung-Shann Jiang&rsquo;s common control, the transaction is accounted for as a restructuring
transaction.&nbsp;All the assets and liabilities of BioLite Holding, BioLite BVI, and BioLite Taiwan were transferred to the Company
at their respective carrying amounts on the closing date of the Merger. The Company has recast prior period financial statements
to reflect the conveyance of BioLite Holding&rsquo;s common shares as if the restructuring transaction had occurred as of the
earliest date of the financial statements. All material intercompany accounts, transactions, and profits have been eliminated
in consolidation. The nature of and effects on earnings per share (EPS) of nonrecurring intra-entity transactions involving long-term
assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of
the transferred net assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of Presentation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with the generally accepted accounting principles
in the United States of America (the &ldquo;U.S. GAAP&rdquo;). All significant intercompany transactions and account balances
have been eliminated.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
basis of accounting involves the application of accrual accounting and consequently, revenues and gains are recognized when earned,
and expenses and losses are recognized when incurred. The Company&rsquo;s financial statements are expressed in U.S. dollars.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fiscal
Year</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company changed its fiscal year from the period beginning on October 1st and ending on September 30th to the period beginning
on January 1st and ending on December 31st, beginning January 1, 2018. All references herein to a fiscal year prior to December
31, 2017 refer to the twelve months ended September 30th of such year.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the amount of revenues and expenses
during the reporting periods. Actual results could differ materially from those results.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventory</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of raw materials, work-in-process, finished goods, and merchandise. Inventories are stated at the lower of cost or market
and valued on a moving weighted average cost basis. Market is determined based on net realizable value. The Company periodically
reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value,
and incurs a charge to operations for known and anticipated inventory obsolescence.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reclassifications</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification
had no impact on previously reported net loss or accumulated deficit.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Forward
Stock Split</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3.141 and increase the number of our authorized shares of Common Stock, par value $0.001 per share, to 360,000,000,
which was effective on April 8, 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
Reverse Split</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 12, 2019, the Board of Directors of the Company by unanimous written consent in lieu of a meeting approved to i) effect
a stock reverse split at the ratio of 1-for-18 (the &ldquo;Reverse Split&rdquo;) of both the authorized common stock of the Company
(the &ldquo;Common Stock&rdquo;) and the issued and outstanding Common Stock and ii) to amend the articles of incorporation of
the Company to reflect the Reverse Split. The Board approved and authorized the Reverse Split without obtaining approval of the
Company&rsquo;s shareholders pursuant to Section 78.207 of Nevada Revised Statutes. On May 3, 2019, the Company filed a certificate
of amendment to the Company&rsquo;s articles of incorporation (the &ldquo;Amendment&rdquo;) to effect the Reverse Split with the
Secretary of State of Nevada. The Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;) informed the Company that the
Reverse Split was effective on May 8, 2019. All shares and related financial information in this Form 10-Q reflect this 1-for-18
reverse stock split.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial and nonfinancial assets and liabilities
that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements.
It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable
units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the
inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair
value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs
by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants
would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable
inputs are inputs that reflect the Company&rsquo;s own assumptions about the assumptions market participants would use in pricing
the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs
into three broad levels based on the reliability of the inputs as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability
    to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations
    are based on quoted prices in active markets that are readily and regularly available.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
    date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
    that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
    and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that
    incorporate the assumptions a market participant would use in pricing the asset or liability.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, restricted cash, accounts
receivable, due from related parties, inventory, prepaid expenses and other current assets, accounts payable, accrued liabilities,
and due to related parties approximate fair value due to their relatively short maturities. The carrying value of the Company&rsquo;s
short-term bank loan, convertible notes payable, and accrued interest approximates their fair value as the terms of the borrowing
are consistent with current market rates and the duration to maturity is short. The carrying value of the Company&rsquo;s long-term
bank loan approximates fair value because the interest rates approximate market rates that the Company could obtain for debt with
similar terms and maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. As
of March 31, 2019 and December 31, 2018, the Company&rsquo;s cash and cash equivalents amounted $981,341 and $226,688, respectively.
Some&nbsp;of the Company&rsquo;s cash deposits are held in financial institutions located in Taiwan where there is currently regulation
mandated on obligatory insurance of bank accounts. The Company believes this financial institution is of high credit quality.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
cash equivalents primarily consist of cash held in a reserve bank account in Taiwan. As of March 31, 2019 and December 31, 2018,
the Company&rsquo;s restricted cash equivalents amounted $16,093.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentration
of Credit Risk</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents.
The Company places its cash and temporary cash investments in high quality credit institutions, but these investments may be in
excess of Taiwan Central Deposit Insurance Corporation and the U.S. Federal Deposit Insurance Corporation&rsquo;s insurance limits.
The Company does not enter into financial instruments for hedging, trading or speculative purposes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year 2018, the Company adopted Accounting Standards Codification (&ldquo;ASC&rdquo;), Topic 606 (ASC 606), Revenue
from Contracts with Customers, using the modified retrospective method to all contracts that were not completed as of January
1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at the beginning
of 2018 for the cumulative effect. The results for the Company&rsquo;s reporting periods beginning on and after January 1, 2018
are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards
in effect for the prior period. Based on the Company&rsquo;s review of existing collaborative agreements as of January 1, 2018,
the Company concluded that the adoption of the new guidance did not have a significant change on the Company&rsquo;s revenue during
all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that
reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition
for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i)
identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction
price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or
as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable
that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers
to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company
assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses
whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price
that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are examples of when the Company recognizes revenue based on the types of payments the Company receives.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Merchandise
Sales &mdash;&nbsp;</B>The Company recognizes net revenues from dietary supplements product sales when customers obtain control
of the Company&rsquo;s products, which typically occurs upon delivery to customer. Product revenues are recorded at the net sales
price, or &ldquo;transaction price,&rdquo; which includes applicable reserves for variable consideration, including discounts,
allowances, and returns.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trade
discount and allowances</I>: The Company generally provides invoice discounts on product sales to its customers for prompt payment.
The Company estimates that, based on its experience, its customers will earn these discounts and fees, and deducts the full amount
of these discounts and fees from its gross product revenues and accounts receivable at the time such revenues are recognized.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Product
returns:</I>&nbsp;The Company estimates the amount of each product that will be returned and deducts these estimated amounts from
its gross revenues at the time the revenues are recognized. The Company&rsquo;s customers have the right to return unopened packages,
subject to contractual limitations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products
will continue to be minimal.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
Revenues &mdash;</B>&nbsp;The Company recognizes collaborative revenues generated through collaborative research, development
and/or commercialization agreements. The terms of these agreements typically include payment to the Company related to one or
more of the following: nonrefundable upfront license fees, development and commercial milestones, partial or complete reimbursement
of research and development costs, and royalties on net sales of licensed products. Each type of payments results in collaborative
revenues except for revenues from royalties on net sales of licensed products, which are classified as royalty revenues. To date,
we have not received any royalty revenues. Revenue is recognized upon satisfaction of a performance obligation by transferring
control of a good or service to the collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the accounting for these arrangements, the Company applies judgment to determine whether the performance obligations are
distinct, and develop assumptions in determining the stand-alone selling price for each distinct performance obligation identified
in the collaboration agreements. To determine the stand-alone selling price, the Company relies on assumptions which may include
forecasted revenues, development timelines, reimbursement rates for R&amp;D personnel costs, discount rates and probabilities
of technical and regulatory success.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had multiple deliverables under the collaborative agreements, including deliverables relating to grants of technology
licenses, regulatory and clinical development, and marketing activities. Estimation of the performance periods of the Company&rsquo;s
deliverables requires the use of management&rsquo;s judgment. Significant factors considered in management&rsquo;s evaluation
of the estimated performance periods include, but are not limited to, the Company&rsquo;s experience in conducting clinical development,
regulatory and manufacturing activities. The Company reviews the estimated duration of its performance periods under its collaborative
agreements on an annually basis, and makes any appropriate adjustments on a prospective basis. Future changes in estimates of
the performance period under its collaborative agreements could impact the timing of future revenue recognition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonrefundable
    upfront payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a license to the Company&rsquo;s intellectual property is determined to be distinct from the other performance obligations identified
in an arrangement, the Company recognizes revenue from the related nonrefundable upfront payments based on the relative standalone
selling price prescribed to the license compared to the total selling price of the arrangement. The revenue is recognized when
the license is transferred to the collaboration partners and the collaboration partners are able to use and benefit from the license.
To date, the receipt of nonrefundable upfront fees was solely for the compensation of past research efforts and contributions
made by the Company before the collaborative agreements entered into and it does not relate to any future obligations and commitments
made between the Company and the collaboration partners in the collaborative agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone
    payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is eligible to receive milestone payments under the collaborative agreement with collaboration partners based on achievement
of specified development, regulatory and commercial events. Management evaluated the nature of the events triggering these contingent
payments, and concluded that these events fall into two categories: (a) events which involve the performance of the Company&rsquo;s
obligations under the collaborative agreement with collaboration partners, and (b) events which do not involve the performance
of the Company&rsquo;s obligations under the collaborative agreement with collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
former category of milestone payments consists of those triggered by development and regulatory activities in the territories
specified in the collaborative agreements. Management concluded that each of these payments constitute substantive milestone payments.
This conclusion was based primarily on the facts that (i) each triggering event represents a specific outcome that can be achieved
only through successful performance by the Company of one or more of its deliverables, (ii) achievement of each triggering event
was subject to inherent risk and uncertainty and would result in additional payments becoming due to the Company, (iii) each of
the milestone payments is nonrefundable, (iv) substantial effort is required to complete each milestone, (v) the amount of each
milestone payment is reasonable in relation to the value created in achieving the milestone, (vi) a substantial amount of time
is expected to pass between the upfront payment and the potential milestone payments, and (vii) the milestone payments relate
solely to past performance. Based on the foregoing, the Company recognizes any revenue from these milestone payments in the period
in which the underlying triggering event occurs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
    Element Arrangements</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates multiple element arrangements to determine (1) the deliverables included in the arrangement and (2) whether
the individual deliverables represent separate units of accounting or whether they must be accounted for as a combined unit of
accounting. This evaluation involves subjective determinations and requires management to make judgments about the individual
deliverables and whether such deliverables are separate from other aspects of the contractual relationship. Deliverables are considered
separate units of accounting provided that: (i) the delivered item(s) has value to the customer on a standalone basis and (ii)
if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered
item(s) is considered probable and substantially within its control. In assessing whether an item under a collaboration has standalone
value, the Company considers factors such as the research, manufacturing, and commercialization capabilities of the collaboration
partner and the availability of the associated expertise in the general marketplace. The Company also considers whether its collaboration
partners can use the other deliverable(s) for their intended purpose without the receipt of the remaining element(s), whether
the value of the deliverable is dependent on the undelivered item(s), and whether there are other vendors that can provide the
undelivered element(s).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes arrangement consideration allocated to each unit of accounting when all of the revenue recognition criteria
in ASC 606 are satisfied for that particular unit of accounting. In the event that a deliverable does not represent a separate
unit of accounting, the Company recognizes revenue from the combined unit of accounting over the Company&rsquo;s contractual or
estimated performance period for the undelivered elements, which is typically the term of the Company&rsquo;s research and development
obligations. If there is no discernible pattern of performance or objectively measurable performance measures do not exist, then
the Company recognizes revenue under the arrangement on a straight-line basis over the period the Company is expected to complete
its performance obligations. Conversely, if the pattern of performance in which the service is provided to the customer can be
determined and objectively measurable performance measures exist, then the Company recognizes revenue under the arrangement using
the proportional performance method. Revenue recognized is limited to the lesser of the cumulative amount of payments received
or the cumulative amount of revenue earned, as determined using the straight-line method or proportional performance method, as
applicable, as of the period ending date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the inception of an arrangement that includes milestone payments, the Company evaluates whether each milestone is substantive
and at risk to both parties on the basis of the contingent nature of the milestone. This evaluation includes an assessment of
whether: (1) the consideration is commensurate with either the Company&rsquo;s performance to achieve the milestone or the enhancement
of the value of the delivered item(s) as a result of a specific outcome resulting from its performance to achieve the milestone,
(2) the consideration relates solely to past performance and (3) the consideration is reasonable relative to all of the deliverables
and payment terms within the arrangement. The Company evaluates factors such as the scientific, clinical, regulatory, commercial,
and other risks that must be overcome to achieve the particular milestone and the level of effort and investment required to achieve
the particular milestone in making this assessment. There is considerable judgment involved in determining whether a milestone
satisfies all of the criteria required to conclude that a milestone is substantive. Milestones that are not considered substantive
are recognized as earned if there are no remaining performance obligations or over the remaining period of performance, assuming
all other revenue recognition criteria are met.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties
    and Profit Sharing Payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the collaborative agreement with the collaboration partners, the Company is entitled to receive royalties on sales of products,
which is at certain percentage of the net sales. The Company recognizes revenue from these events based on the revenue recognition
criteria set forth in ASC 606. Based on those criteria, the Company considers these payments to be contingent revenues, and recognizes
them as revenue in the period in which the applicable contingency is resolved.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Property
and Equipment</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is carried at cost net of accumulated depreciation. Repairs and maintenance are expensed as incurred. Expenditures
that improve the functionality of the related asset or extend the useful life are capitalized. When property and equipment is
retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold improvements are depreciated
on the straight-line method over the shorter of the remaining lease term or estimated useful life of the asset. Depreciation is
calculated on the straight-line method, including property and equipment under capital leases, generally based on the following
useful lives:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 87%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 12%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated&nbsp;Life&nbsp;</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in Years</B></FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings
    and leasehold improvements</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    ~ 50</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    ~ 10</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    ~ 6</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of Long-Lived Assets</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (&ldquo;ASC 360-10&rdquo;).
ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company
evaluates its long-lived assets for impairment annually or more often if events and circumstances warrant. Events relating to
recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability
to achieve break-even operating results over an extended period. Should impairment in value be indicated, the carrying value of
intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition
of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value
less costs to sell.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Long-term
Equity Investment</U>&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acquires the equity investments to promote business and strategic objectives. The Company accounts for non-marketable
equity and other equity investments for which the Company does not have control over the investees as:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    method investments when the Company has the ability to exercise significant influence, but not control, over the investee.
    Its proportionate share of the income or loss is recognized monthly and is recorded in gains (losses) on equity investments.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    cost method investments when the equity method does not apply.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
judgment is required to identify whether an impairment exists in the valuation of the Company&rsquo;s non-marketable equity investments,
and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative
factors that may have a significant impact on the investee&rsquo;s fair value. Qualitative analysis of its investments involves
understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee&rsquo;s
industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair
value of its investments are developed using the market and income approaches. The market approach includes the use of comparable
financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted
cash flow model, which requires significant estimates regarding the investees&rsquo; revenue, costs, and discount rates. The Company&rsquo;s
assessment of these factors in determining whether an impairment exists could change in the future due to new developments or
changes in applied assumptions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other-Than-Temporary
Impairment</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s long-term equity investments are subject to a periodic impairment review. Impairments affect earnings as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    equity securities include the consideration of general market conditions, the duration and extent to which the fair value
    is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of
    value in the foreseeable future. The Company also considers specific adverse conditions related to the financial health of,
    and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational
    and financing cash flow factors, and changes in the investee&rsquo;s credit rating. The Company records other-than-temporary
    impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    equity investments based on the Company&rsquo;s assessment of the severity and duration of the impairment, and qualitative
    and quantitative analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory
    or economic environment; changes in operating structure or management of the investee; additional funding requirements; and
    the investee&rsquo;s ability to remain in business. A series of operating losses of an investee or other factors may indicate
    that a decrease in value of the investment has occurred that is other than temporary and that shall be recognized even though
    the decrease in value is in excess of what would otherwise be recognized by application of the equity method. A loss in value
    of an investment that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but
    would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of
    the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company records
    other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses)
    on equity investments. Other-than-temporary impairments of equity investments were $0 for the three months ended March 31,
    2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Goodwill</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate
the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative
assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment
test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets
to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors
indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment
as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of
the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales
and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company completed the required testing of goodwill for impairment at the closing of Merger of BioKey on February 8, 2019, and
determined that goodwill was impaired because of the current financial condition of the Company and the Company&rsquo;s inability
to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company
anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development Expenses</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the cost of using licensing rights in research and development cost according to ASC Topic 730-10-25-1. This
guidance provides that absent alternative future uses the acquisition of product rights to be used in research and development
activities must be charged to research and development expenses when incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
CDMO business unit, the Company accounts for R&amp;D costs in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
730, Research and Development (&ldquo;ASC 730&rdquo;). Research and development expenses are charged to expense as incurred unless
there is an alternative future use in other research and development projects or otherwise. Research and development expenses
are comprised of costs incurred in performing research and development activities, including personnel-related costs, facilities-related
overhead, and outside contracted services including clinical trial costs, manufacturing and process development costs for both
clinical and preclinical materials, research costs, and other consulting services. Non-refundable advance payment for goods and
services that will be used in future research and development activities are expensed when the activity has been performed or
when the goods have been received rather than when the payment is made. In instances where the Company enters into agreements
with third parties to provide research and development services, costs are expensed as services are performed.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Post-retirement
and post-employment benefits</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s subsidiaries in Taiwan adopted the government mandated defined contribution plan pursuant to the Labor Pension
Act (the &ldquo;Act&rdquo;) in Taiwan. Such labor regulations require that the rate of contribution made by an employer to the
Labor Pension Fund per month shall not be less than 6% of the worker&rsquo;s monthly salaries. Pursuant to the Act, the Company
makes monthly contribution equal to 6% of employees&rsquo; salaries to the employees&rsquo; pension fund. The Company has no legal
obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as
incurred, were $4,424 and $5,586 for the three months ended March 31, 2019 and 2018, respectively. Other than the above, the Company
does not provide any other post-retirement or post-employment benefits.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-based
Compensation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures expense associated with all employee stock-based compensation awards using a fair value method and recognizes
such expense in the consolidated financial statements on a straight-line basis over the requisite service period in accordance
with FASB ASC Topic 718 &ldquo;Compensation-Stock Compensation&rdquo;. Total employee stock-based compensation expenses were $0
for the three months ended March 31, 2019 and 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for stock-based compensation to non-employees in accordance with FASB ASC Topic 718 &ldquo;Compensation-Stock
Compensation&rdquo; and FASB ASC Topic 505-50 &ldquo;Equity-Based Payments to Non-Employees&rdquo; which requires that the cost
of services received from non-employees is measured at fair value at the earlier of the performance commitment date or the date
service is completed and recognized over the period the service is provided. Total non-employee stock-based compensation expenses
were $8,550 and $5,626 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Beneficial
Conversion Feature</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial
conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which
the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation
of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value
of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital.
The debt discount is amortized to interest expense over the life of the note using the effective interest method.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.2pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability approach which allows the recognition and measurement of deferred
tax assets to be based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach,
deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred
tax assets if it is more likely than not these items will expire before the Company is able to realize their benefits, or future
deductibility is uncertain.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC 740, a tax position is recognized as a benefit only if it is&nbsp;&ldquo;more likely than not&rdquo;&nbsp;that the tax position
would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a
two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including the resolution of any related appeals or litigations based on the technical merits of that position. The
second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits recognized
in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely
of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition
threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions
that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period
in which the threshold is no longer satisfied. Penalties and interest incurred related to underpayment of income tax are classified
as income tax expense in the year incurred. No significant penalty or interest relating to income taxes has been incurred for
the three months ended March 31, 2019 and 2018. GAAP also provides guidance on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosures and transition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete. To the extent that a company&rsquo;s accounting
for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record
a provisional estimate to be included in the financial statements. If a company cannot determine a provisional estimate to be
included in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were
in effect immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact
of the reduction in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from
these estimates, due to, among other things, changes in our interpretations and assumptions, additional guidance that may be issued
by the I.R.S., and actions the Company may take. The Company is continuing to gather additional information to determine the final
impact.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Valuation
of Deferred Tax Assets&nbsp;</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
valuation allowance is recorded to reduce the Company&rsquo;s deferred tax assets to the amount that is more likely than not to
be realized. In assessing the need for the valuation allowance, management considers, among other things, projections of future
taxable income and ongoing prudent and feasible tax planning strategies. If the Company determines that sufficient negative evidence
exists, then it will consider recording a valuation allowance against a portion or all of the deferred tax assets in that jurisdiction.
If, after recording a valuation allowance, the Company&rsquo;s projections of future taxable income and other positive evidence
considered in evaluating the need for a valuation allowance prove, with the benefit of hindsight, to be inaccurate, it could prove
to be more difficult to support the realization of its deferred tax assets. As a result, an additional valuation allowance could
be required, which would have an adverse impact on its effective income tax rate and results. Conversely, if, after recording
a valuation allowance, the Company determines that sufficient positive evidence exists in the jurisdiction in which the valuation
allowance was recorded, it may reverse a portion or all of the valuation allowance in that jurisdiction. In such situations, the
adjustment made to the deferred tax asset would have a favorable impact on its effective income tax rate and results in the period
such determination was made.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss
Per Share of Common Stock</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates net loss per share in accordance with ASC Topic 260, &ldquo;Earnings per Share&rdquo;. Basic loss per share
is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss
per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional
common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional
common shares were dilutive. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments
and Contingencies</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC Topic 450 &ldquo;Contingencies&rdquo; subtopic 20, in determining its accruals and disclosures with respect
to loss contingencies. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information
available before financial statements are issued or are available to be issued indicates that it is probable that an assets had
been impaired or a liability had been incurred at the date of the financial statements and the amount of the loss can be reasonably
estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably
estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that
a material loss could be incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Foreign-currency
Transactions&nbsp;</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Company&rsquo;s subsidiaries in Taiwan, the foreign-currency transactions are recorded in New Taiwan dollars (&ldquo;NTD&rdquo;)
at the rates of exchange in effect when the transactions occur. Gains or losses resulting from the application of different foreign
exchange rates when cash in foreign currency is converted into New Taiwan dollars, or when foreign-currency receivables or payables
are settled, are credited or charged to income in the year of conversion or settlement. On the balance sheet dates, the balances
of foreign-currency assets and liabilities are restated at the prevailing exchange rates and the resulting differences are charged
to current income except for those foreign currencies denominated investments in shares of stock where such differences are accounted
for as translation adjustments under the Statements of Stockholders&rsquo; Equity (Deficit).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Translation
Adjustment&nbsp;</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounts of the Company&rsquo;s subsidiaries in Taiwan were maintained, and their financial statements were expressed, in New
Taiwan Dollar (&ldquo;NT$&rdquo;). Such financial statements were translated into U.S. Dollars (&ldquo;$&rdquo; or &ldquo;USD&rdquo;)
in accordance ASC 830, &ldquo;Foreign Currency Matters&rdquo;, with the NT$ as the functional currency. According to the Statement,
all assets and liabilities are translated at the current exchange rate, stockholder&rsquo;s deficit are translated at the historical
rates and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments
are reported under other comprehensive income (loss) as a component of stockholders&rsquo; equity (deficit).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (&ldquo;Topic 820&rdquo;): Disclosure Framework - Changes to
the Disclosure Requirements for Fair Value Measurement (&ldquo;ASU 2018-13&rdquo;). The ASU modifies the disclosure requirements
in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying
existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing
the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value
measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable
inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods
and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect,
if any, that the ASU 2018-13 will have on its consolidated financial statements.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
GOING CONCERN</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company
has incurred losses since its inception resulting in an accumulated deficit of $13,001,117 and $12,209,446 as of March 31, 2019
and December 31, 2018, respectively, and incurred net loss of $873,317 and $713,622 for the three months ended March 31, 2019
and 2018, respectively. The Company also had working capital deficiency of $10,907,973 and $10,421,310 at March 31, 2019 and December
31, 2018, respectively. The ability to continue as a going concern is dependent upon the Company generating profitable operations
in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business
operations when they become due. These consolidated financial statements do not include any adjustments to the recoverability
and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company upon
signing of that agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&rsquo;s
plans to obtain such resources for the Company include&nbsp;(1) obtaining capital from the sale of its equity securities (2) short-term
and long-term borrowings from banks and third-parties, and (3) short-term borrowings from stockholders or other related party(ies)
when needed. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its
plans.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described
in the preceding paragraph and eventually to secure other sources of financing and attain profitable operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
COLLABORATIVE AGREEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
agreements with BHK</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On February 24, 2015, BioLite Taiwan and BioHopeKing Corporation (the &ldquo;BHK&rdquo;) entered into a co-development agreement,
(the &ldquo;BHK Co-Development Agreement&rdquo;), pursuant to which it is collaborative with BHK to develop and commercialize
BLI-1401-2 (Botanical Drug) Triple Negative Breast Cancer (TNBC) Combination Therapy (BLI-1401-2 Products) in Asian countries
excluding Japan for all related intellectual property rights, and has developed it for medicinal use in collaboration with outside
researchers. The development costs shall be shared 50/50 between BHK and the Company. The BHK Co-Development Agreement will remain
in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2016, BioLite Taiwan and BHK agreed to amend the payment terms of the milestone payment in an aggregate amount of $10
million based on the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the signing of the BHK Co-Development Agreement: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the first Investigational New Drug (IND) submission and BioLite Taiwan will deliver all data to BHK according to FDA Reviewing
    requirement: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the completion of first phase II clinical trial: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the initiation of phase III of clinical trial research: $3 million, or 30% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the New Drug Application (NDA) submission: $4 million, or 40% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2015, BHK has paid a non-refundable upfront cash payment of $1 million, or 10% of $10,000,000, upon the signing of BHK
Co-Development Agreement. The Company concluded that the deliverables are considered separate units of accounting as the delivered
items have value to the customer on a standalone basis and recognized this cash receipt as collaboration revenue when all research,
technical, and development data was delivered to BHK in 2015. The receipt is for the compensation of past research efforts and
contributions made by BioLite Taiwan before this collaborative agreement was signed and it does not relate to any future commitments
made by BioLite Taiwan and BHK in this collaborative agreement. In August 2016, the Company has received the second milestone
payment of NT$31,649,000, approximately equivalent to $1 million, and recognized collaboration revenue for the year ended December
31, 2016. As of the date of this prospectus, the Company has not completed the first phase II clinical trial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the milestone payments, BioLite Taiwan is entitled to receive royalty on 12% of BHK&rsquo;s net sales related to BLI-1401-2
Products. As of March 31, 2019 and December 31, 2018, the Company has not earned the royalty under the BHK Co-Development Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
On December 9, 2015, BioLite Taiwan entered into another two collaborative agreements (the &ldquo;BHK Collaborative Agreements&rdquo;),
pursuant to which it is collaborative with BHK to co-develop and commercialize BLI-1005 for &ldquo;Targeting Major Depressive
Disorder&rdquo; (BLI-1005 Products) and BLI-1006 for &ldquo;Targeting Inflammatory Bowel Disease&rdquo; (BLI-1006 Products) in
Asia excluding Japan for all related intellectual property rights, and has developed it for medicinal use in collaboration with
outside researchers. The development costs shall be shared 50/50 between BHK and the Company. The BHK Co-Development Agreement
will remain in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the Company recognized the cash receipt in a total of NT$50 million, approximately equivalent to $1.6 million, as collaboration
revenue when all research, technical, and development data was delivered to BHK. The Company concluded that the deliverables are
considered separate units of accounting as the delivered items have value to the customer on a standalone basis and recognized
this payment as collaboration revenue when all research, technical, data and development data was delivered to BHK. The cash receipt
is for the compensation of past research efforts and contributions made by BioLite Taiwan before this BHK Collaborative Agreements
was signed and it does not relate to any future commitments made by BioLite Taiwan and BHK in this BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of
the future net licensing income or net sales profit. As of March 31, 2019 and December 31, 2018, the Company has not earned the
royalty under the BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Co-Development
agreement with Rgene Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2017, American BriVision Corporation entered into a co-development agreement (the &ldquo;Co-Dev Agreement&rdquo;) with
Rgene Corporation (the &ldquo;Rgene&rdquo;), a related party under common control by controlling beneficiary shareholder of YuanGene
Corporation and the Company (See Note 8). Pursuant to Co-Dev Agreement, BriVision and Rgene agreed to co-develop and commercialize
certain products that are included in the Sixth Product as defined in the Addendum. Under the terms of the Co-Dev Agreement, Rgene
should pay the Company $3,000,000 in cash or stock of Rgene with equivalent value by August 15, 2017. The payment is for the compensation
of BriVision&rsquo;s past research efforts and contributions made by BriVision before the Co-Dev Agreement was signed and it does
not relate to any future commitments made by BriVision and Rgene in this Co-Dev Agreement. Besides of $3,000,000, the Company
is entitled to receive 50% of the future net licensing income or net sales profit earned by Rgene, if any, and any development
cost shall be equally shared by both BriVision and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2017, the Company has delivered all research, technical, data and development data to Rgene. Since both Rgene and the
Company are related parties and under common control by a controlling beneficiary shareholder of Yuangene Corporation and the
Company, the Company has recorded the full amount of $3,000,000 in connection with the Co-Dev Agreement as additional paid-in
capital during the year ended September 30, 2017. During the year ended December 31, 2017, the Company has received $450,000 in
cash. On December 24, 2018, the Company received the remaining balance of $2,550,000 in the form of newly issued shares of Rgene&rsquo;s
Common Stock, at the price of NT$50 (approximately equivalent to $1.60 per share), for an aggregate number of 1,530,000 shares,
which accounted for equity method long-term investment as of December 31, 2018. During the year ended December 31, 2018, the Company
has recognized investment loss of $549. On December 31, 2018, the Company has determined to fully write off this investment based
on the Company&rsquo;s assessment of the severity and duration of the impairment, and qualitative and quantitative analysis of
the operating performance of the investee, adverse changes in market conditions and the regulatory or economic environment, changes
in operating structure of Rgene, additional funding requirements, and Rgene&rsquo;s ability to remain in business. However, all
projects that have been initiated and scheduled will be continuously managed and supported by the Company and Rgene.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Collaborative
agreement with BioFirst Corporation, a related party</U></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2017, American BriVision Corporation entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;)
with BioFirst Corporation (&ldquo;BioFirst&rdquo;), pursuant to which BioFirst granted the Company the global licensing right
for medical use of the product (the &ldquo;Product&rdquo;): BFC-1401 Vitreous Substitute for Vitrectomy. BioFirst is a related
party to the Company because a controlling beneficiary shareholder of Yuangene Corporation and the Company is one of the directors
and Common Stock shareholders of BioFirst (See Note 11).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the BioFirst Collaborative Agreement, the Company will co-develop and commercialize the Product with BioFirst and pay BioFirst
in a total amount of $3,000,000 in cash or stock of the Company before September 30, 2018. The amount of $3,000,000 is in connection
with the compensation for BioFirst&rsquo;s past research efforts and contributions made by BioFirst before the BioFirst Collaborative
Agreement was signed and it does not relate to any future commitments made by BioFirst and BriVision in this BioFirst Collaborative
Agreement. In addition, the Company is entitled to receive 50% of the future net licensing income or net sales profit, if any,
and any development cost shall be equally shared by both BriVision and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2017, BioFirst has delivered all research, technical data and development data to BriVision. No payment has been
made by the Company as of the date of this prospectus. The Company determined to fully expense the entire amount of $3,000,000
since currently the related licensing rights do not have alternative future uses. According to ASC 730-10-25-1, absent alternative
future uses the acquisition of product rights to be used in research and development activities must be charged to research and
development expenses immediately. Hence, the entire amount of $3,000,000 is fully expensed as research and development expense
during the year ended September 30, 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
INVENTORY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of the following:</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Mar&nbsp;31,<BR>
    2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> Merchandise </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 521 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Finished goods </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 91,891 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 100,736 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Work-in-process </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,057 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,243 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Raw materials </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,171 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,691 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Allowance for inventory valuation
    and obsolescence loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (168,119 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (177,670 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Inventory, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 521 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
PROPERTY AND EQUIPMENT</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of March 31, 2019 and December 31, 2018 are summarized as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March&nbsp;31,<BR>
    2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,&nbsp;<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Land </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 360,081 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 363,416 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Buildings and leasehold improvements </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,115,155 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 290,403 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Machinery and equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,236,493 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 87,356 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Office equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,178 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,292 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,738,907 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 762,467 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Less: accumulated depreciation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,191,387 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (252,401 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Property and equipment,
    net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 547,520 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses were $13,940 and $11,420 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
LONG-TERM INVESTMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ownership percentages of each investee are listed as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership
    percentage</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related party</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2019</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>treatment</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 63%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Braingenesis
    Biotechnology Co., Ltd.</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 13%; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    Method</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genepharm
    Biotech Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.72</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.72</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    Method</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioHopeKing
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    Method</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.14</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.84</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Method</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.63</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.62</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Method</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    extent the investee relies on the company for its business are summarized as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 30%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related party</B></FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 69%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    extent the investee relies on the Company for its business</B></FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Braingenesis
    Biotechnology Co., Ltd.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    specific business relationship</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genepharm
    Biotech Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    specific business relationship</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioHopeKing
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with the Company to develop and commercialize drugs</FONT> </TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loaned
    from the investee and provides research and development support service</FONT> </TD></TR>
<TR STYLE="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with the Company to develop and commercialize drugs</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    investment mainly consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2019</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    Cost Method Investments, net</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 76%; padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Braingenesis
    Biotechnology Co., Ltd.</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,147</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,213</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genepharm
    Biotech Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,819</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,021</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioHopeKing
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,938,480</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,956,429</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sub
    total</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,967,446</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,985,663</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Method Investments, net</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,440,317</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,502,506</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,407,763</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,488,169</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation (the &ldquo;BioFirst):</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds an equity interest in BioFirst Corporation, (the &ldquo;BioFirst&rdquo;), accounting for its equity interest using
the equity method to accounts for its equity investment as prescribed in ASC 323, Investments&mdash;Equity Method and Joint Ventures
(&ldquo;ASC 323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of investee&rsquo;s income
or loss and other adjustments required by the equity method. As of March 31, 2019 and December 31, 2018, the Company owns 16.14%
and 15.84% common stock shares of BioFirst, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
financial information for the Company&rsquo;s equity method investee, BioFirst, is as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheet</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March
    31,<BR> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,324,390 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,551,898 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,639,340 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,608,460 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,805,325 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,648,206 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 36,502 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,121,903 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,512,152 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statement
of operation</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Three
    Months Ended<BR> March&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,334 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,022 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,882 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,372 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (307,034 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,294 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of losses from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (66,205 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,567 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation (the &ldquo;Rgene&rdquo;)</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Rgene and the Company are under common control by Dr. Tsung-Shann Jiang, the CEO and chairman of the Company. Since Dr. Tsung-Shann
Jiang is able to exercise significant influence, but not control, over the Rgene, the Company determined to use the equity method
to accounts for its equity investment as prescribed in ASC 323, Investments&mdash;Equity Method and Joint Ventures (&ldquo;ASC
323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of investee&rsquo;s income or loss and
other adjustments required by the equity method. As of March 31, 2019 and December 31, 2018, the Company owns 31.63% and 31.62%
Common Stock shares of Rgene, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
financial information for the Company&rsquo;s equity method investee, Rgene, is as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheets</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> March&nbsp;31,<BR>
    2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 94,305 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,168 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,541 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,779 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 292,588 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 261,685 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,424 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; Equity (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (170,166 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (148,738 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statement
of operations</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Three
    Months Ended&nbsp;<BR> March&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross Profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (22,662 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (36,041 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of loss from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposition
    of long-term investment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018, the Company sold 552,000 shares of common stock of BioHopeKing Corporation (the &ldquo;BHK&rdquo;)
at prices ranging from NT$25, equivalent $0.82, to NT$32, equivalent $1.05, to two directors of BHK and 25 individuals. As a result
of the transactions, the Company recognized investment loss of $395,476 for the same period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2018 and November 2, 2018, the Company subsequently purchased an aggregate of 200,000 and 366,200 shares of common
stock of BHK at NT$10, equivalent to $0.33, and NT$50, equivalent $1.64, from one of directors of BHK and eleven shareholders
of BHK, respectively. The percentage of ownership accordingly increased to 7.13% as of March 31, 2019 and December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses
    on Equity Investments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of losses on equity investments for each period were as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Three
    Months Ended&nbsp;<BR> Mar&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> (Unaudited) </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of equity method investee losses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (66,205 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,567 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Impairments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Total losses
    on equity investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (66,205 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,567 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
CONVERTIBLE NOTES PAYABLE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Yu and Wei Note&rdquo;)
in an aggregate principal amount of $300,000 to Guoliang Yu and Yingfei Wei Family Trust (the &ldquo;Yu and Wei&rdquo;), pursuant
to which the Company received $300,000. The Yu and Wei Note bears interest at 8% per annum. The Company shall pay to the Yu and
Wei an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18) month anniversary
of the issuance date of the Yu and Wei Note, which is on November 8, 2019. In the event that the Company raises gross proceeds
from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days of the closing
for such offering, the Company must repay the outstanding amount of this Yu and Wei Note. At any time from the date hereof until
this Yu and Wei Note has been satisfied, the Yu and Wei may convert the unpaid and outstanding principal plus any accrued and
unpaid interest and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Yu and Wei Note is outstanding, subject to adjustments set forth
in the Yu and Wei Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Yu and Wei Note as of March 31, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Keypoint Note&rdquo;)
in the aggregate principal amount of $250,000 to Keypoint Technology Ltd. (&ldquo;Keypoint&rdquo;), a related party, pursuant
to which the Company received $250,000. The Keypoint Note bears interest at 8% per annum. The Company shall pay to the Keypoint
an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18) month anniversary
of the issuance date of the Keypoint Note, which is on December 26, 2019. In the event that the Company raises gross proceeds
from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days of the closing
for such offering, the Company must repay the outstanding amount of this Keypoint Note. At any time from the date hereof until
this Keypoint Note has been satisfied, Keypoint may convert the unpaid and outstanding principal plus any accrued and unpaid interest
and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Keypoint Note is outstanding, subject to adjustments set forth
in the Keypoint Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Keypoint Note as of March 31, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 25, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Odaira Note&rdquo;)
in the aggregate principal amount of $250,000 to the Company&rsquo;s director, Yoshinobu Odaira. (&ldquo;Odaira), pursuant to
which the Company received $250,000 on November 29, 2018. The Odaira Note bears interest at 8% per annum. The Company shall pay
to the Odaira an amount in cash representing all outstanding principal and accrued and unpaid interest on the Eighteenth (18)
month anniversary of the issuance date of the Odaira Note, which is on February 24, 2020. In the event that the Company raises
gross proceeds from the sale of its common stock of at least $5,000,000 (an &ldquo;Equity Offering&rdquo;) then within five days
of the closing for such offering, the Company must repay the outstanding amount of this Odaira Note. At any time from the date
hereof until this Odaira Note has been satisfied, Odaira may convert the unpaid and outstanding principal plus any accrued and
unpaid interest and or default interest, if any, into shares of the Company&rsquo;s common stock at a conversion price (the &ldquo;Conversion
Price&rdquo;) equal to the lower of (i) $2.00 per share (the &ldquo;Fixed Conversion Price&rdquo;), subject to adjustment or (ii)
80% of the per share offering price (the &ldquo;Alternative Conversion Price&rdquo;) of any completed equity offering of the Company
in an amount exceeding $500,000 that occurs when any part of the Odaira Note is outstanding, subject to adjustments set forth
in the Odaira Note. In accordance with FASB ASC 470-20, the Company recognized none of the intrinsic value of embedded beneficial
conversion feature present in the Odaira Note as of March 31, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2019 and December 31, 2018, the aggregate carrying values of the convertible debentures were $800,000 and accrued
convertible interest was $43,467 and $27,467, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
interest expenses in connection with the above convertible notes payable were $16,000 and $0 for the three months ended March
31 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BANK
    LOANS</B></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">

    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    bank loan consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2019</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 77%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cathay
    United Bank</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">243,000</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,250</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTBC
    Bank</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">648,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">654,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cathay
    Bnak</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,891,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">899,250</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cathay
United Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2016, BioLite Taiwan and Cathay United Bank entered into a one-year bank loan agreement (the &ldquo;Cathay United Loan
Agreement&rdquo;) in an amount of NT$7,500,000, equivalent to $243,000. The term started June 28, 2016 with maturity date at June
28, 2017. The loan balance bears interest at a floating rate of prime rate plus 1.15%. The prime rate is based on term deposit
saving interest rate of Cathay United Bank. On September 6, 2017, BioLite Taiwan extended the Cathay United Loan Agreement for
one year, which was due on September 6, 2018, with the principal amount of NT$7,500,000, equivalent to $243,000. On October 1,
2018, BioLite Taiwan extended the Cathay United Loan Agreement with the same principal amount of NT$7,500,000, equivalent to $243,0050
for one year, which is due on September 6, 2019. As of March 31, 2019 and December 31, 2018, the effective interest rates per
annum were 2.22%. The loan is collateralized by the building and improvement of BioLite Taiwan, and is also personal guaranteed
by the chairman of BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $1,330 and $1,402 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CTBC
Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 12, 2017 and July 19, 2017, BioLite Taiwan and CTBC Bank entered into short-term saving secured bank loan agreements (the
&ldquo;CTBC Loan Agreements&rdquo;) in an amount of NT$10,000,000, equivalent to $324,000, and NT$10,000,000, equivalent to $324,000,
respectively. Both two loans with the same maturity date at January 19, 2018. In February 2018, BioLite Taiwan combined two loans
and extended the loan contract with CTBC for one year. On January 18, 2019, BioLite Taiwan and CTBC Bank agreed to extend the
loan with a new maturity date, which is July 18, 2019. The loan balances bear interest at a fixed rate of 1.63% per annum. The
loan is secured by the money deposited in a savings account with the CTBC Bank. This loan is also personal guaranteed by the chairman
of BioLite Taiwan and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $2,604 and $2,736 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cathay
Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019, the Company received a loan in aggregate of $1,000,000 from Cathay Bank (the &ldquo;Bank&rdquo;)
pursuant to a business loan agreement (the &ldquo;Cathay Loan Agreement&rdquo;) entered by and between the Company and Bank on
January 8, 2019 and a promissory note (the &ldquo;Note&rdquo;) executed by the Company on the same day. The Cathay Loan Agreement
provides for a revolving line of credit in the principal amount of $1,000,000 with a maturity date (the &ldquo;Maturity Date&rdquo;)
of January 1, 2020. The Note executed in connection with the Cathay Loan Agreement bears an interest rate (the &ldquo;Regular
Interest Rate&rdquo;) equal to the sum of one percent (1%) and the prime rate as published in the Wall Street Journal (the &ldquo;Index&rdquo;)
and the accrued interest shall become payable each month from February 1, 2019. Pursuant to the Note, the Company shall pay the
entire outstanding principal plus accrued unpaid interest on the Maturity Date and may prepay portion or all of the Note before
the Maturity Date without penalty. If the Company defaults on the Note, the default interest rate shall become five percent (5%)
plus the Regular Interest Rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Note and Cathay Loan Agreement, on January 8, 2019, each of Dr. Tsung Shann Jiang and Dr. George Lee, executed
a commercial guaranty (the &ldquo;Guaranty&rdquo;) to guaranty the loans for the Company pursuant to the Cathay Loan Agreement
and Note, severally and individually, in the amount not exceeding $500,000 each until the entire Note plus interest are fully
paid and satisfied. Dr. Tsung Shann Jiang is the Chairman and Chief Executive Officer of BioLite Holding, Inc. and Dr. George
Lee serves as the Chairman of the board of directors of BioKey, Inc, which became a wholly-owned subsidiaries of the Company effective
by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on January 8, 2019, each of the Company and BriVision, a wholly-owned subsidiary of the Company, signed a commercial
security agreement (the &ldquo;Cathay Security Agreement&rdquo;) to secure the loans under the Cathay Loan Agreement and the Note.
Pursuant to the Cathay Security Agreements, each of the Company and BriVision (each, a &ldquo;Grantor&rdquo;, and collectively,
the &ldquo;Grantors&rdquo;) granted security interest in the collaterals as defined therein, comprised of almost all of the assets
of each Grantor, to secure such loans for the benefit of the Bank.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $9,527 and $0 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    bank loan consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> March&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Cathay United Bank </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 45,076 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 55,092 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Less: current portion
    of long-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (39,688 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (39,835 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,388 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2010, BioLite Taiwan entered into a seven-year bank loan of NT$8,900,000, equivalent to $288,360, with Cathay United
Bank. The term started April 30, 2010 with maturity date at April 30, 2017. On April 30, 2017, BioLite Taiwan extended the original
loan agreement for additional three years with the new maturity date at April 30, 2020. The loan balance bears interest at a floating
rate of prime rate plus variable rates from 0.77% to 1.17%. The prime rate is based on term deposit saving interest rate of Cathay
United Bank. As of March 31, 2019 and December 31, 2018, the actual interest rates per annum were 2.24%. The loan is collateralized
by the building and improvement of BioLite Taiwan, and is also personal guaranteed by the chairman of BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $284 and $680 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10. NOTES PAYABLE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2017, BioLite Taiwan and Cheng-Chi International Co., Ltd., a Taiwanese company, entered into a promissory note for
borrowing an aggregate amount of NT$6,000,000, equivalent to $196,200, for the period from November 27, 2017 to January 11, 2018.
The principal of promissory note bears interest at 12% per annum. This promissory note is secured by 700,000 Common Stock shares
of ABVC and is also personal guaranteed by the Company&rsquo;s chairman. On January 11, 2018, the principal and accrued interest
totaling NT$6,090,000, equivalent to $199,143, has been paid in full.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2018, BioLite Taiwan and two individuals entered into a promissory note, (the &ldquo;Hsu and Chow Promissory Note&rdquo;),
for borrowing an aggregate amount of NT$4,660,000, equivalent to $152,382, for the period from March 27, 2018 to June 26, 2018.
On September 26, 2018, the company extended the original loan agreement through December 26, 2018. As of the date of this prospectus,
BioLite Taiwan and Hsu and Chow are still negotiating to extend this promissory note. The principal of the Hsu and Chow Promissory
Note bears interest at 13.6224% per annum. This Hsu and Chow Promissory Note was secured by common stock shares of ABVC and was
also personal guaranteed by the Company&rsquo;s chairman. Interest expense was $5,085 and $1,807 for the three months ended March
31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2019, BioLite Taiwan also entered various unsecured loan agreements bearing interest at fixed rates between 12% and
13.6224% per annum with three individuals to advance in aggregate of NT$10,750,000, equivalent to $348,300, for working capital
purpose. The term of the loan varies from one month to three months with various maturity dates through May 25, 2018. As of the
date of this prospectus, BioLite Taiwan is still in discussion with the three individuals with respect to the terms of extension
for the unsecured loans. Interest expense was $10,768 and $8,834 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2018, BioLite Taiwan issued a promissory note of NT$450,000, equivalent to $14,715, to Taipei Veterans General Hospital
to repay the clinical experiment costs. The note has been paid in full on January 2, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
RELATED PARTIES TRANSACTIONS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
related parties of the company with whom transactions are reported in these financial statements are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 51%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of entity or Individual</B></FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 48%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationship
    with the Company and its subsidiaries</B></FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation (the &ldquo;BioFirst&rdquo;)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    controlled by controlling beneficiary shareholder of Yuangene</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    (Australia) Pty Ltd. (the &ldquo;BioFirst (Australia)&rdquo;)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%
    owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lion
    Arts Promotion Inc. (the &ldquo;LION&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controlling
    shareholder of BioLite Inc.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LionGene
    Corporation (the &ldquo;LionGene&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company; entity controlled by controlling beneficiary shareholder of YuanGene</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation (the &ldquo;Rgene&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    of the Company; entity controlled by controlling beneficiary shareholder of Yuangene</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yuangene
    Corporation (the &ldquo;Yuangene&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controlling
    beneficiary shareholder of the Company</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AsianGene
    Corporation (the &ldquo;AsianGene&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder;
    entity controlled by controlling beneficiary shareholder of Yuangene</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keypoint
    Technology Ltd. (the &ldquo;Keypoint&rsquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Chairman of Keypoint is Eugene Jiang&rsquo;s mother.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoshinobu
    Odaira (the &ldquo;Odaira&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    of the Company</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GenePharm
    Inc. (the &ldquo;GenePharm&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    George Lee, the Director and Chairman of Biokey, is the Chairman of Genepharm.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Mr. Eugene Jiang (the &ldquo;Jiangs&rdquo;)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene,
                                         the chairman and CEO of the BioLite Inc. and the President and a member of board of directors
                                         of BioFirst,</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
        Shu-Ling Jiang, Mr. Tsung-Shann Jiang&rsquo;s wife, is a member of board of directors of the Company and the chairman
        of LION and BioFirst.</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
        Eugene Jiang is Mr. and Ms. Jiang&rsquo;s son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company
        and a member of board of directors of BioLite Inc.</FONT> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounts
receivable &ndash; related parties&nbsp;</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable due from related parties consisted of the following as of the periods indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> March 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> GenePharm Inc. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 142,265 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 9pt"> Total </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 142,265 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Due
from related parties</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
due from related parties consisted of the following as of the periods indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> March 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Rgene Corporation </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,550 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 19,477 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> BioFirst (Australia) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,675 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 9pt"> Total </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 58,225 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 59,477 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Due
to related parties</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
due to related parties consisted of the following as of the periods indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> March 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December 31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Lion Arts Promotion Inc. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,964 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 65,495 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> LionGene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,940 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 458,348 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> BioFirst Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,248,105 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,428,643 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> AsianGene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> YuanGene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,690 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,690 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> The Jiangs </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 598,085 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 539,920 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 10pt"> Total </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 7,594,784 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"> 7,745,096 </TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Related
party transactions</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2017, BriVision and BioFirst entered into a loan agreement for a total commitment (non-secured indebtedness) of
    $950,000 to meet its working capital needs. On February 2, 2019, BriVision and BioFirst agreed to extend the remaining loan
    balance of $693,000 for one year matured on February 1, 2020. Under the terms of the loan agreement, the loan bears interest
    at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender. As of
    March 31, 2019 and December 31, 2018, the outstanding loan balance is $233,000 and $692,980, and accrued interest was $11,971
    and $281, respectively. Interest expenses in connection with this loan were $11,710 and $9,500 for the three months ended
    March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 28, 2017, October 31, 2017, and November 13, 2017, BioLite Taiwan and BioFirst entered into three loan agreements
    for a total amount of NTD$27,800,000, equivalent to $900,720, to meet its working capital needs. Under the terms of the loan
    agreements, the loans bear interest at 1% per month (or equivalent to 12% per annum). BioLite Taiwan repaid NTD$7,500,000,
    equivalent to $243,000, of the loan in 2018. The remaining balance was NTD$20,300,000, equivalent to $657,720 with the interest
    rate and term remain unchanged. The three loans will be matured on September 27, 2019, October 30, 2019, and November 12,
    2019, respectively. As of March 31, 2019 and December 31, 2018, the outstanding loan balance was $657,720 and $663,810, and
    accrued interest was $146,274 and $127,976, respectively. Interest expenses in connection with this loan were $19,472 and
    $28,500 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 12, 2017, BioLite BVI and BioFirst entered into a loan agreement for NTD$30,000,000, equivalent to $972,000 to meet
    its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to
    12% per annum). BioLite BVI and BioFirst extended the loan with the same interest rate and amount for one year. The loan will
    be matured on May 11, 2019. As of March 31, 2019 and December 31, 2018, the outstanding loan balance was $972,000 and $981,000,
    and accrued interest was $250,771 and $222,000, respectively. Interest expenses in connection with this loan were $28,771
    and $29,978 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 24, 2017, BriVision entered into a collaborative agreement (the &ldquo;BioFirst Collaborative Agreement&rdquo;) with
    BioFirst (See Note 4). On September 25, 2017, BioFirst has delivered all research, technical, data and development data to
    BriVision, and the Company has recorded the full amount of $3,000,000 due to BioFirst. No payment has been made by the Company
    as of the date of this prospectus.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of March 31, 2019, BioFirst has also advanced funds to the Company for working capital purpose. The advances bear 0% interest
    rate and are due on demand. As of March 31, 2019, the outstanding advance balance was $517,949.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    September 2017, AsianGene entered an investment and equity transfer agreement (the &ldquo;Investment and Equity Transfer Agreement&rdquo;)
    with Everfront Biotech Inc. (the &ldquo;Everfront&rdquo;), a third party. Pursuant to the Investment and Equity Transfer Agreement,
    Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsianGene at $1.60 per share in a total amount
    of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December
    15, 2017. AsianGene also agreed to loan the proceeds to the Company for working capital purpose. The non-secured loan bears
    0% interest rate and is due on demand. As of March 31, 2019 and December 31, 2018, the outstanding loan balance was $160,000
    and accrued interest was $17,600 and $12,866, respectively. Interest expenses in connection with this loan were $4,734 and
    $3,945 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of March 31, 2019 and December 31, 2018, YuanGene Corporation has advanced an aggregate amount of $42,690 to the Company for
    working capital purpose. The advances bear 0% interest rate and are due on demand.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 18, 2018, the Company and YuanGene entered into a loan agreement for a total of $50,000 to meet its working capital
    needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and
    the Company is required to pay interest monthly to the lender. The maturity date of this loan is January 19, 2019. As of March
    31, 2019 and December 31, 2018, the outstanding loan balance was $50,000 and accrued interest was $7,200 and $5,721, respectively.
    Interest expenses in connection with this loan were $1,479 and $1,200 for the three months ended March 31, 2019 and 2018,
    respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Keypoint Note&rdquo;)
    in the aggregate principal amount of $250,000 to Keypoint Technology Ltd. (&ldquo;Keypoint&rdquo;) (See Note 8). The Company
    received $250,000 which bears interest at 8% per annum. Interest expenses in connection with this Keypoint Note were $5,000
    and $0 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 25, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the &ldquo;Odaira Note&rdquo;)
    in the aggregate principal amount of $250,000 to Yoshinobu Odaira (&ldquo;Odaira&rdquo;) (See Note 8). The Company received
    $250,000 on November 29, 2018 which bears interest at 8% per annum. Interest expense in connection with this Odaira Note was
    $5,000 and $0 for the three months ended March 31, 2019 and 2018, respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of March 31, 2019, Mr. Tsung-Shann Jiang and Ms. Shu-Ling Jiang have also advanced funds to the Company for working capital
    purpose. The advances bears interest at 1% per month (or equivalent to 12% per annum) and are due on demand. As of March 31,
    2019, the outstanding advance balance was $157,140 and the accrued interest was $10,454.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of March 31, 2019, LION, LionGene, and the Jiangs have also advanced funds to the Company for working capital purpose. The
    advances bear 0% interest rate and are due on demand. As of March 31, 2019, the outstanding advance balances in aggregate
    were $926,395.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
EQUITY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
October 2015, $350,000 of subscription receivable was fully collected from the shareholders.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2016, a Share Exchange Agreement (&ldquo;Share Exchange Agreement&rdquo;) was entered into by and among American BriVision
(Holding) Corporation (the&nbsp;&ldquo;Company&rdquo;), American BriVision Corporation&nbsp;(&ldquo;BriVision&rdquo;), Euro-Asia
Investment &amp; Finance Corp. Limited, a company incorporated under the laws of Hong Kong Special Administrative Region of People&rsquo;s
Republic of China (&ldquo;Euro-Asia&rdquo;), being the owners of record of 164,387,376 (52,336,000 pre-stock split) shares of
Common Stock of the Company, and the owners of record of all of the issued share capital of BriVision (the&nbsp;&ldquo;BriVision
Stock&rdquo;). Pursuant to the Share Exchange Agreement, upon surrender by the BriVision Shareholders and the cancellation by
BriVision of the certificates evidencing the BriVision Stock as registered in the name of each BriVision Shareholder, and pursuant
to the registration of the Company in the register of members maintained by BriVision as the new holder of the BriVision Stock
and the issuance of the certificates evidencing the aforementioned registration of the BriVision Stock in the name of the Company,
the Company should issue 166,273,921(52,936,583 pre-stock split) shares (the&nbsp;&ldquo;Acquisition Stock&rdquo;) (subject to
adjustment for fractionalized shares as set forth below) of the Company&rsquo;s Common Stock to the BriVision Shareholders (or
their designees), and 163,159,952 (51,945,225 pre-stock split) shares of the Company&rsquo;s Common Stock owned by Euro-Asia should
be cancelled and retired to treasury. The Acquisition Stock collectively should represent 79.70% of the issued and outstanding
Common Stock of the Company immediately after the Closing, in exchange for the BriVision Stock, representing 100% of the issued
share capital of BriVision in a reverse merger, or the Merger. Pursuant to the Merger, all of the issued and outstanding shares
of BriVision&rsquo;s Common Stock were converted, at an exchange ratio of 0.2536-for-1, into an aggregate of 166,273,921(52,936,583
pre-stock split) shares of Company&rsquo;s Common Stock and BriVision became a wholly owned subsidiary, of the Company. The holders
of Company&rsquo;s Common Stock as of immediately prior to the Merger held an aggregate of 205,519,223 (65,431,144 pre-stock split)
shares of Company&rsquo;s Common Stock,&nbsp;Because of the exchange of the BriVision Stock for the Acquisition Stock (the&nbsp;&ldquo;Share
Exchange&rdquo;), BriVision became a wholly owned subsidiary (the &ldquo;Subsidiary&rdquo;) of the Company and there was a change
of control of the Company following the closing. There were no warrants, options or other equity instruments issued in connection
with the share exchange agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2016, pursuant to the 2016 Equity Incentive Plan (the &ldquo;2016 Plan&rdquo;), 157,050 (50,000 pre-stock split)
shares were granted to the employees.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2016, the Board of Directors of the Company approved an amendment to Articles of Incorporation to effect a forward split
at a ratio of 1 to 3:141 (the &ldquo;Forward&nbsp;Stock&nbsp;Split&rdquo;) and increase the number of our authorized shares of
Common Stock, par value $0.001 per share, to 360,000,000, which was effective on April 8, 2016.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 6, 2016, the Company and BioLite Taiwan agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone
Payment Agreement, whereby the Company has agreed to issue shares of Common Stock of the Company, at the price of $1.60 per share,
for an aggregate number of 562,500 shares, as part of the Company&rsquo;s first installation of payment pursuant to the Milestone
Payment. The shares issuance was completed in June 2016.&nbsp;On August 26, 2016, the Company issued 1,468,750 shares (&ldquo;Shares&rdquo;)
of the Company&rsquo;s Common Stock, par value $0.001 (the &ldquo;Offering&rdquo;) to BioLite Taiwan pursuant to a certain Stock
Purchase Agreement dated August 26, 2016 (the &ldquo;SPA&rdquo;). The Shares are exempt from the registration requirements of
the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), pursuant to Regulation&nbsp;S of the Securities Act
promulgated thereunder. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from the Offering
are approximately $2,350,000. Pursuant to the BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in
cash or stock of the Company with equivalent value according to the milestone achieved. The agreement requires that 6.5% of total
payment, $6,500,000 shall be made upon the first IND submission which was submitted in March 2016. In February 2017, the Company
remitted this amount to BioLite with $650,000 in cash and $5,850,000 in the form of newly issued shares of the Company&rsquo;s
Common Stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares. Upon the consummation of the restructuring
transaction between the Company and BioLite on February 8, 2019, the Company&rsquo;s Common Stock held by BioLite Taiwan was accounted
for treasury stocks in the statement of equity (deficit).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 3, 2019, the Company filed a Certificate of Amendment with the Secretary of State of Nevada, which was effective May 8, 2019
upon its receipt of the written notice from Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;). Pursuant to the Certificate
of Amendment, the Company effectuated a 1-for-18 reverse stock split of its issued and outstanding shares of common stock, $0.001
par value, whereby 318,485,252 outstanding shares of the Company&rsquo;s common stock were exchanged for 17,693,625 shares of
the Company&rsquo;s Common Stock. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse
stock split.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2016, the Company entered into a consulting agreement with Kazunori Kameyama (&ldquo;Kameyama&rdquo;) for the provision
of services related to the clinical trials and other administrative work, public relation work, capital raising, trip coordination,
In consideration for providing such services, the Company agreed to indemnify the consultant in an amount of $150 per hour in
cash up to $3,000 per month, and issue to Kameyama the Company&rsquo;s Common Stock at $1.00 per share for any amount exceeding
$3,000. The Company&rsquo;s stocks shall be calculated and issued in December every year. On October 1, 2017, the Company and
Kameyama agreed to extend the service period for one more year expiring on September 30, 2018. As a result, the non-employee stock-based
compensation related to this consulting agreement was $28,800 and $5,400 for the years ended December 31, 2018 and 2017, respectively.
On March 28, 2018, the Company issued 4,828 shares of the Company&rsquo;s common stock at $1.60 per share in a total of $7,725
to Kameyama in connection with this consulting agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2017, Euro-Asia Investment &amp; Finance Corp Ltd. and the Company entered into a service agreement (the &ldquo;Euro-Asia
Agreement&rdquo;) for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31, 2018
and 2017, the Company recognized non-employee stock based compensation expenses of $0 and $60,000 in connection with the terms
in the Euro-Asia Agreement, respectively. On March 28, 2018, the Company issued 50,000 shares of the Company&rsquo;s common stock
at $1.60 per share in a total of $80,000 to Euro-Asia in connection with the Euro-Asia Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2017, Kimho Consultants Co., Ltd. and the Company entered into a service agreement (the &ldquo;Kimho Agreement&rdquo;)
for the maintenance of the listing in the U.S. stock exchange market. During the years ended December 31, 2018 and 2017, the Company
recognized non-employee stock based compensation expenses of $0 and $90,000 in connection with the terms in the Kimho Agreement,
respectively. On March 28, 2018, the Company issued 75,000 shares of the Company&rsquo;s common stock at $1.60 per share in a
total of $120,000 to Kimho in connection with the Kimho Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 505-50-30, the transactions with the non-employees were measured based on the fair value of the equity instruments issued
as the Company determined that the fair value of the equity instruments issued in a stock-based payment transaction with nonemployees
was more reliably measurable than the fair value of the consideration received. The Company measured the fair value of the equity
instruments in these transactions using the stock price on the date at which the commitments Kameyama, Euro-Asia, and Kimho for
performance were rendered.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2018, the Company also issued an aggregate of 50,000 shares of the Company&rsquo;s common stock at $1.60 per share for
salaries in a total of $80,000 to three officers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, after the Merger, the Company issued 74,997,546 shares to the shareholders of BioLite and 29,561,231 shares
to the shareholders of BioKey.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
LOSS PER SHARE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the year. Diluted
loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common
shares outstanding during the years ended March 31, 2019 and 2018.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Mar
    31,<BR> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dec
                                         31,</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Numerator: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss attributable to common stockholders </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (791,671 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (601,387 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Denominator: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Weighted-average shares outstanding: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Weighted-average shares outstanding
    - Basic </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,965,665 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,599,911 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Stock options </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Weighted-average shares outstanding
    - Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,965,665 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,599,911 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Loss per share </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> -Basic </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> -Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.05 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
loss per share takes into account the potential dilution that could occur if securities or other contracts to issue Common Stock
were exercised and converted into Common Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
LEASE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted FASB Accounting Standards Codification, Topic 842, Leases (&ldquo;ASC 842&rdquo;) using the modified retrospective
approach, electing the practical expedient that allows the Company not to restate its comparative periods prior to the adoption
of the standard on January 1, 2019. As such, the disclosures required under ASC 842 are not presented for periods before the date
of adoption. For the comparative periods prior to adoption, the Company presented the disclosures which were required under ASC
840.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applied the following practical expedients in the transition to the new standard and allowed under ASC 842:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reassessment
    of expired or existing contracts: The Company elected not to reassess, at the application date, whether any expired or existing
    contracts contained leases, the lease classification for any expired or existing leases, and the accounting for initial direct
    costs for any existing leases.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of hindsight: The Company elected to use hindsight in determining the lease term (that is, when considering options to extend
    or terminate the lease and to purchase the underlying asset) and in assessing impairment of right-to-use assets.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reassessment
    of existing or expired land easements: The Company elected not to evaluate existing or expired land easements that were not
    previously accounted for as leases under ASC 840, as allowed under the transition practical expedient. Going forward, new
    or modified land easements will be evaluated under ASU No. 2016-02.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation
    of lease and non- lease components: Lease agreements that contain both lease and non-lease components are generally accounted
    for separately.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    lease recognition exemption: The Company also elected the short-term lease recognition exemption and will not recognize ROU
    assets or lease liabilities for leases with a term less than 12 months.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new leasing standard requires recognition of leases on the consolidated balance sheets as right-of-use (&ldquo;ROU&rdquo;) assets
and lease liabilities. ROU assets represent the Company&rsquo;s right to use underlying assets for the lease terms and lease liabilities
represent the Company&rsquo;s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating
lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement
date. The Company&rsquo;s future minimum based payments used to determine the Company&rsquo;s lease liabilities mainly include
minimum based rent payments. As most of Company&rsquo;s leases do not provide an implicit rate, the Company uses its estimated
incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing
operating leases longer than twelve months as of January 1, 2019. The ROU assets were adjusted per ASC 842 transition guidance
for existing lease-related balances of accrued and prepaid rent, unamortized lease incentives provided by lessors, and restructuring
liabilities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
adoption of ASC 842 had a substantial impact on the Company&rsquo;s consolidated balance sheets. The most significant impact was
the recognition of the operating lease right-of-use assets and the liability for operating leases. Accordingly, adoption of this
standard resulted in the recognition of operating lease right-of-use assets of $577,830 and operating lease liabilities of $598,937
comprised of $301,105 of current operating lease liabilities and $297,832 of non-current operating lease liabilities on the condensed
consolidated balance sheet as of January 1, 2019. The adoption of ASC 842 also resulted in a cumulative-effect adjustment of $(21,107)
to the opening balance of accumulated deficit.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the adoption of the standard did not have a material impact on the Company&rsquo;s results of operations or cash flows.
Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in Selling,
general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses
are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based
occur.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no finance leases. The Company&rsquo;s leases primarily include various office and laboratory spaces, copy machine,
and vehicles under various operating lease arrangements. The Company&rsquo;s operating leases have remaining lease terms of up
to approximately two years.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Mar
    31,<BR> 2019 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> ASSETS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Operating lease right-of-use
    assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,305 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> LIABILITIES </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating lease liabilities (current) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 286,212 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating lease liabilities (noncurrent) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 239,647 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Supplemental
Information</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents supplemental information related to operating leases during the&nbsp;three months ended March 31, 2019</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for amounts included in the measurement of operating lease liabilities</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,802</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average remaining lease term</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.86
    years</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average discount rate</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.55</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
minimum future annual payments under non-cancellable leases during the next five years and thereafter, at rates now in force,
are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operating
    leases</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 89%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2019
    (excluding the three months ended March 31, 2019)</B></FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">228,117</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,642</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,240</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    future minimum lease payments, undiscounted</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">527,999</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Less:
    Imputed interest</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,140</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Present
    value of future minimum lease payments</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">525,859</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
BUSINESS COMBINATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Company consummated the Merger transactions of BioLite and BioKey (See Note 1). Pursuant to the terms of
the Merger Agreement, BioLite and BioKey became two wholly-owned subsidiaries of the Company on February 8, 2019. The Company
adopted ASC 805, &ldquo;Business Combination&rdquo; to record the merger transactions of BioKey. The acquisition was accounted
for as a business combination under the purchase method of accounting. BioKey&rsquo;s results of operations were included in the
Company&rsquo;s results beginning February 8, 2019. The purchase price has been allocated to the assets acquired and the liabilities
assumed based on their fair value at the acquisition date as summarized in the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Purchase consideration: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Common Stock (*) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,341,847 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Allocation of the purchase price: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 531,147 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accounts receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 188,550 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Property and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,075 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating lease right-of-use assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 485,684 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Security deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Total assets acquired </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,271,896 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accounts payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (56,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accrued expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (251,335 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating lease liability </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (267,256 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Tenant security deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,880 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Total liabilities assumed </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (577,675 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Total net assets acquired </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 694,221 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Goodwill as a result of the
    Merger </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,647,626 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,561,231
shares of ABVC common stock issued to BioKey in connection with the Merger. Those shares were valued at $1.50 per share, based
on the bid-and-ask share price of ABVC Common Stock on the final day of trading, February 8, 2019.</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Company has recorded a 100% goodwill write-down of $43,647,626. Goodwill was determined to have been impaired
because of the current financial condition of the Company and the Company&rsquo;s inability to generate future operating income
without substantial increase in sales volume, which is highly uncertain. Furthermore, the Company&rsquo;s anticipated future cash
flows indicate that the recoverability of goodwill is not reasonably assured. The goodwill write-down was reflected as a decrease
in additional paid-in capital in the statement of equity upon the consummation of the Merger.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
SUBSEQUENT EVENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through the date which the financial statements were available to be issued. All subsequent
events requiring recognition as of March 31, 2019 have been incorporated into these financial statements and there are no subsequent
events that require disclosure in accordance with FASB ASC Topic 855, &ldquo;Subsequent Events.&rdquo;&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
TO FINANCIAL INFORMATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt; width: 90%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BioLite
    Holding, Inc.</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements for the Years Ended December 31, 2018 and 2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-68</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Balance Sheets as of December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-69
    </FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-70</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Equity for the years ended December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-71</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Cash Flows for the years ended December 31, 2018 and 2017</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-72</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_12"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to Consolidated Financial Statements</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-73
    &ndash; F-98</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<TR>
    <TD STYLE="vertical-align: top; width: 43%"> <IMG SRC="img_004.jpg" ALT=""> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 56%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><U>A</U></B><U>udit<B>&nbsp;&#9679; T</B>ax<B>&nbsp;&#9679;
        C</B>onsulting<B>&nbsp;&#9679;&nbsp;F</B>inancial<B>&nbsp;A</B>dvisory</U>&nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Registered with Public Company Accounting Oversight
        Board (PCAOB)</I> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_07"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Report
of Independent Registered Public Accounting Firm</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
the Stockholders and the Board of Directors of BioLite Holding, Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Financial Statements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of BioLite Holding, Inc. and its subsidiaries ( collectively referred
to as &ldquo;the Company&rdquo;) as of&nbsp;December&nbsp;31, 2018&nbsp;and&nbsp;2017, the related consolidated statements of
operations and comprehensive income (loss), equity, and cash flows for each of the two years in the period ended&nbsp;December&nbsp;31,
2018, and the related notes (collectively referred to as the &ldquo;financial statements&quot;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company at&nbsp;December&nbsp;31, 2018&nbsp;and&nbsp;2017,
and the results of its operations and its cash flows for each of the two years in the period ended&nbsp;December&nbsp;31, 2018,
in conformity with U.S. generally accepted accounting principles.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but
not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that BioLite Holding, Inc. and its subsidiaries will
continue as a going concern. As described in Note 2 to the consolidated financial statements, the Company has incurred losses
from operations, has a working capital deficit, and is in need of additional capital to grow its operations so that it can become
profitable. These factors raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. Management&rsquo;s
plans in regard to these matters are described in Note 2. The accompanying consolidated financial statements do not include any
adjustments that might result from the outcome of this uncertainty.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    KCCW Accountancy Corp.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company's auditor since 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diamond
    Bar, California</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                         1, 2019</FONT> </P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KCCW
    Accountancy Corp.</B></FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3333
    S Brea Canyon Rd. #206, Diamond Bar, CA 91765, USA</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    +1 909 348 7228 &#9679; Fax: +1 909 895 4155 &#9679; info@kccwcpa.com</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <A NAME="s_08"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOLITE
HOLDING, INC. AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEETS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> ASSETS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Cash and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 186,644 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 256,925 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Restricted cash </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,579 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accounts receivable - related
    parties, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,475 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Other receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,005 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Due from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,287 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 153,953 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Inventory, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 199,708 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Prepaid
    expenses and other current assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 223,759 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 90,333 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 530,013 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 760,973 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Property and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 570,576 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Long-term investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,488,169 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,185,969 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Deferred tax assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,017,897 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Security deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 27,418 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 68,876 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.5in"> Total
    Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,604,291 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> LIABILITIES AND EQUITY </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Short-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 927,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Long-term bank loan - current
    portion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 39,835 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,203 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Notes payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,447 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 202,429 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accrued expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 486,572 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 511,212 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Other payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 201,137 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,288 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Due to
    related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,341,005 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,390,498 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,478,246 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,088,430 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Long-term
    bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 55,690 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 55,690 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,493,503 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,144,120 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"> Common Stock,
    $0.0001 par value, 500,000,000 shares authorized, 41,207,444 shares issued and outstanding </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Additional paid-in capital </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accumulated deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (11,445,109 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,971,033 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Other comprehensive income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 670,541 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 757,327 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    Stockholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,548 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,653,410 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Noncontrolling Interest </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 806,761 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 410,158 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,460,171 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total Liabilities and
    Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,903,661 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,604,291 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_09"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOLITE
HOLDING, INC. AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Net revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Merchandise sales </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,324 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 940 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Merchandise
    sales-related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 632 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,256 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    net revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,956 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,196 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Cost of revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"> Merchandise sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,893 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,249 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Inventory valuation
    reserve </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 180,387 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0.25in"> Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 185,280 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,249 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (178,324 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 319,053 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 256,682 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 893,570 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,735,931 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,212,623 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,992,613 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,390,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,991,666 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Other income (expense) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,119 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,207 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (306,821 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (222,060 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Rental income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,924 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,814 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (34,139 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Gain (loss) on foreign exchange
    changes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,307 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (409,170 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (256,126 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,443,876 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,154 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 51,574 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income (expenses) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (939,227 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,038,650 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Loss before income taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,330,174 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,030,316 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income taxes
    (benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (360,395 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,669,921 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Net loss attributable to
    noncontrolling interests, net of tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 489,151 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,621,650 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss attributable to BioLite Holding, Inc. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,076 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,048,271 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Foreign currency translation
    adjustment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,573 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Comprehensive Loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,560,862 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,352,698 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss per share attributable to Common Stockholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Basic and Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.04 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (0.16 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Weighted average number of common shares outstanding: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Basic and Diluted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 41,207,444 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 30,720,246 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><A NAME="s_10"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOLITE
HOLDING, INC. AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF EQUITY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR&nbsp;THE
YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Additional </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Other </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Non- </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Common
    Stocks </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> Paid-in </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> Accumulated </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> Comprehensive </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> controlling </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Shares </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amounts </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Capital </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Deficit </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Income
    (Loss) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Interest </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Total </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"> Balance
    at December 31, 2016 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,000,000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,000 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,303,457 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,922,762 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 61,754 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,412,029 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,856,478 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"> Capital
    Contribution </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,207,444 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,121 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,679,786 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,681,907 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"> Effects
    from restructuring </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (8,120,248 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,382 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (8,103,866 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,048,271 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,621,650 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,669,921 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"> Cumulative
    translation adjustments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,573 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 695,573 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"> Balance
    at December 31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 41,207,444 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (9,971,033 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 757,327 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 806,761 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,460,171 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"> Net income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,474,076 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (489,151 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"> Cumulative
    translation adjustments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (86,786 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"> Balance
    at December 31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 41,207,444 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,121 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,862,995 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (11,445,109 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 670,541 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 317,610 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 410,158 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_11"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOLITE
HOLDING, INC. AND SUBSIDIARIES </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Cash flows from operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,963,227 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (6,669,921 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Adjustments to reconcile net loss to net cash used
    in operating activities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Depreciation &amp; amortization </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,610 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,996 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Allowance for inventory valuation
    and obsolescence loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 180,387 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Investment loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 395,476 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 34,139 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Loss on investment in equity
    securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 256,126 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,443,876 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Deferred tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (360,395 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Changes in assets and liabilities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Decrease (increase) in
    accounts receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,420 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (724 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Decrease (increase) in
    receivable from collaboration revenue </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,054,913 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Decrease (increase) in
    due from related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 47,807 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (167,197 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Decrease (increase) in
    inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,798 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,469 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Decrease (increase) in
    prepaid expenses and other deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (98,350 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (56,973 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Increase (decrease) in
    accrued expenses and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 302,695 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (338,236 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Increase
    (decrease) in due to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 913,869 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 329,556 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in"> Net cash used in operating
    activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (270,336 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,683,497 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows from investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Net proceeds from sales of investment
    in equity securities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 517,920 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 128,480 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Loan to related parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (32,893 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Long-term
    equity investment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (674,292 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,803,713 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in"> Net cash used in investing
    activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (156,372 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,708,126 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows from financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Net proceeds from the issuance
    of common stock </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,681,907 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Proceeds from loan from related
    parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 161,020 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 914,427 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Capital contribution from related
    parties under common control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,579 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Net proceeds from short-term
    bank loans </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 657,861 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Net proceeds from short-term
    borrowing from third-parties </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 181,272 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,679 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Repayment
    of long-term bank loans </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (38,428 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (34,156 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in"> Net cash provided by
    financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 303,864 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,325,297 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Effect of exchange rate changes
    on cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,016 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,979 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in"> Net decrease in cash
    and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (126,860 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (57,347 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0.125in"> Beginning </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 313,504 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 370,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 0.125in"> Ending </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 186,644 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 313,504 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Supplemental disclosure of cash flows </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash paid during the year for: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Interest
    expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,480 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 92,238 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Non-cash financing and investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Capital
    contribution from related parties under common control </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,316 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
accompanying notes are an integral part of these financial statements</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_12"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOLITE
HOLDING, INC. AND SUBSIDIARIES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DECEMBER
31, 2018 </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1. ORGANIZATION AND BUSINESS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Holding, Inc. (the &ldquo;BioLite Holding&rdquo;) was incorporated under the laws of the State of Nevada on July 27, 2016. BioLite
BVI, Inc. (the &ldquo;BioLite BVI&rdquo;), a wholly owned subsidiary of BioLite Holding, was incorporated in the British Virgin
Islands on September 13, 2016. BioLite Holding and BioLite BVI are holding companies and have not carried out substantive business
operations of their own.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite,
Inc., (the &ldquo;BioLite Taiwan&rdquo;) was incorporated on February 13, 2006 under the laws of Taiwan. BioLite is in the business
of developing and commercialization of new botanical drugs with application in central nervous system, autoimmunity, inflammation,
hematology, and oncology. In addition, BioLite Taiwan distributes dietary supplements made from extracts of Chinese herbs and
Maitake mushroom.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, BioLite Holding, BioLite BVI, BioLite Taiwan, and certain shareholders of BioLite Taiwan entered into a share purchase
/ exchange agreement (the &ldquo;BioLite Share Purchase / Exchange Agreement&rdquo;). Pursuant to the BioLite Share Purchase /
Exchange Agreement, the shareholder participants to the BioLite Share Purchase / Exchange Agreement have sold their equity in
BioLite Taiwan and were using the proceeds from such sales to purchase shares of Common Stock of BioLite Holding at the same price
per share, resulting in their owning the same number of shares of Common Stock as they owned in the BioLite Taiwan. Upon closing
of the Share Purchase/ Exchange Agreement in August 2017, BioLite Holding ultimately owns via BioLite BVI approximately 73% of
BioLite Taiwan. The other shareholders who did not enter this Share Purchase/ Exchange Agreement retain their equity ownership
in BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fiscal year of BioLite Holding, BioLite BVI, and BioLite Taiwan (collectively referred to as &ldquo;the Company&rdquo;) ends on
December 31st.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
of Presentation and Principles of Consolidation </I></B>&mdash; The accompanying consolidated financial statements, including
the accounts of BioLite Holding, BioLite BVI, and BioLite Taiwan, have been prepared in conformity with accounting principles
generally accepted in the United States of America. Since BioLite Holding, BioLite BVI, and BioLite Taiwan are the entities under
Dr. Tsung-Shann Jiang&rsquo;s common control prior to the Share Purchase / Exchange Agreement, the transaction is accounted for
as a restructuring transaction.&nbsp;All the assets and liabilities of BioLite Taiwan were transferred to BioLite Holding at their
respective carrying amounts on the closing date of Share Purchase / Exchange transaction. The Company has recast prior period
financial statements to reflect the conveyance of BioLite Taiwan&rsquo;s common shares as if the restructuring transaction had
occurred as of the earliest date of the financial statements. All material intercompany accounts, transactions, and profits have
been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of nonrecurring intra-entity transactions
involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings
(or losses) of the transferred net assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of BioLite Taiwan is the New Taiwan dollars, however the accompanying consolidated financial statements have
been translated and presented in United States Dollars ($).&nbsp;In the accompanying consolidated financial statements and notes,
&ldquo;$&rdquo;, &ldquo;US$&rdquo; and &ldquo;U.S. dollars&rdquo; mean United States dollars, and &ldquo;NT$&rdquo; and &ldquo;NT
dollars&rdquo; mean New Taiwan dollars.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern</I></B> &mdash; The accompanying consolidated financial statements have been prepared assuming the Company will continue
as a going concern. The Company has incurred losses since its inception resulting in an accumulated deficit of $11,445,109 and
$9,971,033 as of December 31, 2018 and 2017, respectively, and incurred net loss attributable to BioLite Holding, Inc. of $1,474,076
and $5,048,271 for the years ended December 31, 2018 and 2017, respectively. The Company also had working capital deficiency of
$4,948,233 and $3,327,457 at December 31, 2018 and 2017, respectively. The ability to continue as a going concern is dependent
upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations
and repay its liabilities arising from normal business operations when they become due. These consolidated financial statements
do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities
that might be necessary should the Company upon signing of that agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to continue as a going concern, the Company will need, among other things, additional capital resources. Management&rsquo;s
plans to obtain such resources for the Company include (1) obtaining capital from the sale of its equity securities (2) short-term
and long-term borrowings from banks and third-parties, and (3) short-term borrowings from stockholders or other related party(ies)
when needed. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its
plans.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described
in the preceding paragraph and eventually to secure other sources of financing and attain profitable operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
Reporting </I></B>&mdash; The Company follows the provisions of ASC Topic 280, &ldquo;Segment Reporting&rdquo;, which establishes
standards for reporting information about operating segments, which uses a &ldquo;management&rdquo; approach for determining segments.
The management approach designates the internal organization that is used by management for making operating decisions and assessing
performance as the source of the Company&rsquo;s reportable segments. ASC Topic 280, &ldquo;Segment Reporting,&rdquo; also requires
disclosures about products or services, geographic areas, and major customers. The Company&rsquo;s management reporting structure
provided for only one segment in 2018 and 2017. Accordingly, no separate segment information is presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of Estimates</B> &mdash; The preparation of financial statements in conformity with accounting principles generally accepted in
the United States of America (&ldquo;U.S. GAAP&rdquo;) requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the balance sheet date and the reported
amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of Credit Risk </I></B>&mdash; The Company&rsquo;s financial instruments that are exposed to concentrations of credit risk consist
primarily of cash and cash equivalents and restricted cash. The Company places its cash and temporary cash investments in high
quality credit institutions in Taiwan, but these investments may be in excess of Taiwan Central Deposit Insurance Corporation&rsquo;s
insurance limits. The Company does not enter into financial instruments for hedging, trading, or speculative purposes. Concentration
of credit risk with respect to accounts receivables is limited due to the wide variety of customers and markets in which the Company
transacts business, as well as their dispersion across many geographical areas. The Company performs ongoing credit evaluations
of its customers and generally does not require collateral, but does require advance deposits on certain transactions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents &mdash; </I></B>The Company considers all highly liquid investments with maturities of three months or less
at the date of purchase to be cash equivalents.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Restricted
Cash Equivalents &mdash; </I></B>Restricted cash equivalents primarily consist of cash held in a reserve bank account associated
with short-term bank loans.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounts
Receivable, Receivable from Collaboration Partners, and Other Receivable &mdash; </I></B>Accounts receivable, receivable from
collaboration partners, and other receivables are stated at carrying value less estimates made for doubtful receivables. An allowance
for impairment of trade receivable, receivable from collaboration partners, and other receivables is established if the collection
of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not
be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the
debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments
are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset&rsquo;s
carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventory
&mdash; </I></B>Inventory consists of raw materials, work-in-process, finished goods, and merchandise. Inventories are stated
at the lower of cost or market and valued on a moving weighted average cost basis. Market is determined based on net realizable
value. The Company periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete
or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence. As of December 31,
2018 and 2017, the allowance for slow-moving inventory was $180,387 and $0, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Property
and Equipment &mdash; </I></B>Property and equipment is carried at cost net of accumulated depreciation. Repairs and maintenance
are expensed as incurred. Expenditures that improve the functionality of the related asset or extend the useful life are capitalized.
When property and equipment is retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold
improvements are depreciated on the straight-line method over the shorter of the remaining lease term or estimated useful life
of the asset. Depreciation is calculated on the straight-line method, including property and equipment under capital leases, generally
based on the following useful lives:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 79%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated&nbsp;Life
    </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in Years</B></FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings
    and leasehold improvements</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    ~ 50</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery
    and equipment</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    ~ 6</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    ~ 6</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impairment
of Long-Lived Assets </I></B>&mdash;The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant
and Equipment (&ldquo;ASC 360-10&rdquo;). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held
and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount
of an asset may not be recoverable. The Company evaluates its long lived assets for impairment annually or more often if events
and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions,
recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. Should impairment
in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash
flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported
at the lower of the carrying amount or the fair value less costs to sell. Management has determined that no impairments of long-lived
assets currently exist.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value Measurements </I></B>&mdash; FASB ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial
and nonfinancial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and
expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value
on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It
establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases
the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs
and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are
inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained
from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&rsquo;s own assumptions about
the assumptions market participants would use in pricing the asset or liability developed based on the best information available
in the circumstances. The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability
    to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations
    are based on quoted prices in active markets that are readily and regularly available.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
    date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
    that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
    and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that
    incorporate the assumptions a market participant would use in pricing the asset or liability.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, restricted cash, accounts
receivable, other receivable, due from related parties, inventory, prepaid expenses and other current assets, accounts payable,
accrued liabilities, and due to related parties approximate fair value due to their relatively short maturities. The carrying
value of the Company&rsquo;s short-term bank loan and notes payable approximates their fair value as the terms of the borrowing
are consistent with current market rates and the duration to maturity is short. The carrying value of the Company&rsquo;s long-term
bank loan approximates fair value because the interest rates approximate market rates that the Company could obtain for debt with
similar terms and maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Long-term
Equity Investment </I></B>&mdash; The Company acquires these equity investments to promote business and strategic objectives.
The Company accounts for non-marketable equity and other equity investments for which the Company does not have control over the
investees as:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    method investments when the Company has the ability to exercise significant influence, but not control, over the investee.
    Its proportionate share of the income or loss is recognized monthly and is recorded in gains (losses) on equity investments.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    cost method investments when the equity method does not apply.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
judgment is required to identify whether an impairment exists in the valuation of the Company&rsquo;s non-marketable equity investments,
and therefore the Company considers this a critical accounting estimate. Its yearly analysis considers both qualitative and quantitative
factors that may have a significant impact on the investee&rsquo;s fair value. Qualitative analysis of its investments involves
understanding the financial performance and near-term prospects of the investee, changes in general market conditions in the investee&rsquo;s
industry or geographic area, and the management and governance structure of the investee. Quantitative assessments of the fair
value of its investments are developed using the market and income approaches. The market approach includes the use of comparable
financial metrics of private and public companies and recent financing rounds. The income approach includes the use of a discounted
cash flow model, which requires significant estimates regarding the investees&rsquo; revenue, costs, and discount rates. The Company&rsquo;s
assessment of these factors in determining whether an impairment exists could change in the future due to new developments or
changes in applied assumptions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other-Than-Temporary
Impairment</I></B> &mdash; The Company&rsquo;s long-term equity investments are subject to a periodic impairment review. Impairments
affect earnings as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable
    equity securities include the consideration of general market conditions, the duration and extent to which the fair value
    is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of
    value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the
    business outlook for, the investee, which may include industry and sector performance, changes in technology, operational
    and financing cash flow factors, and changes in the investee&rsquo;s credit rating. We record other-than-temporary impairments
    on marketable equity securities and marketable equity method investments in gains (losses) on equity investments.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-marketable
    equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative
    analysis of the operating performance of the investee; adverse changes in market conditions and the regulatory or economic
    environment; changes in operating structure or management of the investee; additional funding requirements; and the investee&rsquo;s
    ability to remain in business. A series of operating losses of an investee or other factors may indicate that a decrease in
    value of the investment has occurred that is other than temporary and that shall be recognized even though the decrease in
    value is in excess of what would otherwise be recognized by application of the equity method. A loss in value of an investment
    that is other than a temporary decline shall be recognized. Evidence of a loss in value might include, but would not necessarily
    be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain
    an earnings capacity that would justify the carrying amount of the investment. The Company records other-than-temporary impairments
    for non-marketable cost method investments and equity method investments in gains (losses) on equity investments. Other-than-temporary
    impairments of non-marketable equity investments were $33,532 and $4,277,708 for the years ended December 31, 2018 and 2017,
    respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Post-retirement
and post-employment benefits &mdash; </I></B>The Company adopted the government mandated defined contribution plan pursuant to
the Labor Pension Act (the &ldquo;Act&rdquo;) in Taiwan. Such labor regulations require that the rate of contribution made by
an employer to the Labor Pension Fund per month shall not be less than 6% of the worker&rsquo;s monthly salaries. Pursuant to
the Act, the Company makes monthly contribution equal to 6% of employees&rsquo; salaries to the employees&rsquo; pension fund.
The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits,
which were expensed as incurred, were $19,486 and $26,263 for the years ended December 31, 2018 and 2017, respectively. Other
than the above, the Company does not provide any other post-retirement or post-employment benefits.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Recognition &mdash;</I></B> During the fiscal year 2018, the Company adopted Accounting Standards Codification (&ldquo;ASC&rdquo;),
Topic 606 (ASC 606), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were
not completed as of January 1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated
deficit at the beginning of 2018 for the cumulative effect. The results for the Company&rsquo;s reporting periods beginning on
and after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported
under the accounting standards in effect for the prior period. Based on the Company&rsquo;s review of existing collaborative agreements
as of January 1, 2018, the Company concluded that the adoption of the new guidance did not have a significant change on the Company&rsquo;s
revenue during all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that
reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition
for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i)
identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction
price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or
as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable
that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers
to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company
assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses
whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price
that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are examples of when the Company recognizes revenue based on the types of payments the Company receives.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Merchandise
Sales&nbsp;<I>&mdash;&nbsp;</I></B>The Company recognizes net revenues from dietary supplements product sales when customers obtain
control of the Company&rsquo;s products, which typically occurs upon delivery to customer. Product revenues are recorded at the
net sales price, or &ldquo;transaction price,&rdquo; which includes applicable reserves for variable consideration, including
discounts, allowances, and returns.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trade
discount and allowances</I>: The Company generally provides invoice discounts on product sales to its customers for prompt payment.
The Company estimates that, based on its experience, its customers will earn these discounts and fees, and deducts the full amount
of these discounts and fees from its gross product revenues and accounts receivable at the time such revenues are recognized.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Product
returns</I>: The Company estimates the amount of each product that will be returned and deducts these estimated amounts from its
gross revenues at the time the revenues are recognized. The Company&rsquo;s customers have the right to return unopened packages,
subject to contractual limitations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products
will continue to be minimal.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
Revenues &mdash;&nbsp;</B>The Company recognizes collaborative revenues generated through collaborative research, development
and/or commercialization agreements. The terms of these agreements typically include payment to the Company related to one or
more of the following: nonrefundable upfront license fees, development and commercial milestones, partial or complete reimbursement
of research and development costs, and royalties on net sales of licensed products. Each type of payments results in collaborative
revenues except for revenues from royalties on net sales of licensed products, which are classified as royalty revenues. To date,
we have not received any royalty revenues. Revenue is recognized upon satisfaction of a performance obligation by transferring
control of a good or service to the collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the accounting for these arrangements, the Company applies judgment to determine whether the performance obligations are
distinct, and develop assumptions in determining the stand-alone selling price for each distinct performance obligation identified
in the collaboration agreements. To determine the stand-alone selling price, the Company relies on assumptions which may include
forecasted revenues, development timelines, reimbursement rates for R&amp;D personnel costs, discount rates and probabilities
of technical and regulatory success.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had multiple deliverables under the collaborative agreements, including deliverables relating to grants of technology
licenses, regulatory and clinical development, and marketing activities. Estimation of the performance periods of the Company&rsquo;s
deliverables requires the use of management&rsquo;s judgment. Significant factors considered in management&rsquo;s evaluation
of the estimated performance periods include, but are not limited to, the Company&rsquo;s experience in conducting clinical development,
regulatory and manufacturing activities. The Company reviews the estimated duration of its performance periods under its collaborative
agreements on an annually basis, and makes any appropriate adjustments on a prospective basis. Future changes in estimates of
the performance period under its collaborative agreements could impact the timing of future revenue recognition.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonrefundable
    upfront payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a license to the Company&rsquo;s intellectual property is determined to be distinct from the other performance obligations identified
in an arrangement, the Company recognizes revenue from the related nonrefundable upfront payments based on the relative standalone
selling price prescribed to the license compared to the total selling price of the arrangement. The revenue is recognized when
the license is transferred to the collaboration partners and the collaboration partners who are able to use and benefit from the
license. To date, the receipt of nonrefundable upfront fees was solely for the compensation of past research efforts and contributions
made by the Company before the collaborative agreements entered into and it does not relate to any future obligations and commitments
made between the Company and the collaboration partners in the collaborative agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone
    payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is eligible to receive milestone payments under the collaborative agreement with collaboration partners based on achievement
of specified development, regulatory and commercial events. Management evaluated the nature of the events triggering these contingent
payments, and concluded that these events fall into two categories: (a) events which involve the performance of the Company&rsquo;s
obligations under the collaborative agreement with collaboration partners, and (b) events which do not involve the performance
of the Company&rsquo;s obligations under the collaborative agreement with collaboration partners.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
former category of milestone payments consists of those triggered by development and regulatory activities in the territories
specified in the collaborative agreements. Management concluded that each of these payments constitute substantive milestone payments.
This conclusion was based primarily on the facts that (i) each triggering event represents a specific outcome that can be achieved
only through successful performance by the Company of one or more of its deliverables, (ii) achievement of each triggering event
was subject to inherent risk and uncertainty and would result in additional payments becoming due to the Company, (iii) each of
the milestone payments is nonrefundable, (iv) substantial effort is required to complete each milestone, (v) the amount of each
milestone payment is reasonable in relation to the value created in achieving the milestone, (vi) a substantial amount of time
is expected to pass between the upfront payment and the potential milestone payments, and (vii) the milestone payments relate
solely to past performance. Based on the foregoing, the Company recognizes any revenue from these milestone payments in the period
in which the underlying triggering event occurs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
    Element Arrangements</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates multiple element arrangements to determine (1)&nbsp;the deliverables included in the arrangement and (2)&nbsp;whether
the individual deliverables represent separate units of accounting or whether they must be accounted for as a combined unit of
accounting. This evaluation involves subjective determinations and requires management to make judgments about the individual
deliverables and whether such deliverables are separate from other aspects of the contractual relationship. Deliverables are considered
separate units of accounting provided that: (i)&nbsp;the delivered item(s) has value to the customer on a standalone basis and
(ii)&nbsp;if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of
the undelivered item(s) is considered probable and substantially within its control. In assessing whether an item under a collaboration
has standalone value, the Company considers factors such as the research, manufacturing, and commercialization capabilities of
the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers
whether its collaboration partners can use the other deliverable(s) for their intended purpose without the receipt of the remaining
element(s), whether the value of the deliverable is dependent on the undelivered item(s), and whether there are other vendors
that can provide the undelivered element(s).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes arrangement consideration allocated to each unit of accounting when all of the revenue recognition criteria
in ASC 606 are satisfied for that particular unit of accounting. In the event that a deliverable does not represent a separate
unit of accounting, the Company recognizes revenue from the combined unit of accounting over the Company&rsquo;s contractual or
estimated performance period for the undelivered elements, which is typically the term of the Company&rsquo;s research and development
obligations. If there is no discernible pattern of performance or objectively measurable performance measures do not exist, then
the Company recognizes revenue under the arrangement on a straight-line basis over the period the Company is expected to complete
its performance obligations. Conversely, if the pattern of performance in which the service is provided to the customer can be
determined and objectively measurable performance measures exist, then the Company recognizes revenue under the arrangement using
the proportional performance method. Revenue recognized is limited to the lesser of the cumulative amount of payments received
or the cumulative amount of revenue earned, as determined using the straight-line method or proportional performance method, as
applicable, as of the period ending date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the inception of an arrangement that includes milestone payments, the Company evaluates whether each milestone is substantive
and at risk to both parties on the basis of the contingent nature of the milestone. This evaluation includes an assessment of
whether: (1)&nbsp;the consideration is commensurate with either the Company&rsquo;s performance to achieve the milestone or the
enhancement of the value of the delivered item(s) as a result of a specific outcome resulting from its performance to achieve
the milestone, (2)&nbsp;the consideration relates solely to past performance and (3)&nbsp;the consideration is reasonable relative
to all of the deliverables and payment terms within the arrangement. The Company evaluates factors such as the scientific, clinical,
regulatory, commercial, and other risks that must be overcome to achieve the particular milestone and the level of effort and
investment required to achieve the particular milestone in making this assessment. There is considerable judgment involved in
determining whether a milestone satisfies all of the criteria required to conclude that a milestone is substantive. Milestones
that are not considered substantive are recognized as earned if there are no remaining performance obligations or over the remaining
period of performance, assuming all other revenue recognition criteria are met.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 29px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties
    and Profit Sharing Payments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the collaborative agreement with the collaboration partners, the Company is entitled to receive royalties on sales of products,
which is at certain percentage of the net sales. The Company recognizes revenue from these events based on the revenue recognition
criteria set forth in ASC 606. Based on those criteria, the Company considers these payments to be contingent revenues, and recognizes
them as revenue in the period in which the applicable contingency is resolved.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Taxes </I></B>&mdash; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the enactment date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Valuation
of Deferred Tax Assets </I></B>&mdash; A valuation allowance is recorded to reduce our deferred tax assets to the amount that
is more likely than not to be realized. In assessing the need for the valuation allowance, management considers, among other things,
projections of future taxable income and ongoing prudent and feasible tax planning strategies. If the Company determines that
sufficient negative evidence exists, then it will consider recording a valuation allowance against a portion or all of the deferred
tax assets in that jurisdiction. If, after recording a valuation allowance, the Company&rsquo;s projections of future taxable
income and other positive evidence considered in evaluating the need for a valuation allowance prove, with the benefit of hindsight,
to be inaccurate, it could prove to be more difficult to support the realization of our deferred tax assets. As a result, an additional
valuation allowance could be required, which would have an adverse impact on its effective income tax rate and results. Conversely,
if, after recording a valuation allowance, the Company determines that sufficient positive evidence exists in the jurisdiction
in which the valuation allowance was recorded, it may reverse a portion or all of the valuation allowance in that jurisdiction.
In such situations, the adjustment made to the deferred tax asset would have a favorable impact on its effective income tax rate
and results in the period such determination was made. See Note 13 for information related to income taxes, including the recorded
balances of its valuation allowance related to deferred tax assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applied the provisions of ASC 740-10-50, &ldquo;Accounting For Uncertainty In Income Taxes&rdquo;, which provides clarification
related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods
remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute
of limitations for a given audit period could result in an adjustment to the Company&rsquo;s liability for income taxes. Any such
adjustment could be material to the Company&rsquo;s results of operations for any given quarterly or annual period based, in part,
upon the results of operations for the given period. As of December 31, 2018 and 2017, management considered that the Company
had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share-Based
Compensation &mdash;</I></B> <FONT STYLE="background-color: white">The Company accounts for its stock-based compensation in accordance
with ASC 718, Compensation&mdash;Stock Compensation, which establishes accounting for stock-based awards granted to employees
for services and requires companies to expense the estimated fair value of these awards over the requisite service period. </FONT>The
Company recognizes share-based compensation expense for share-based compensation awards granted to its employees and officers.
Compensation expense for share-based compensation awards granted is based on the grant date fair value estimate for each award
as determined by its board of directors. The Company recognizes these compensation costs on a straight-line basis over the requisite
service period of the award, which is generally one to two years. As share-based compensation expense recognized is based on awards
ultimately expected to vest, such expense is reduced for estimated forfeitures. During the years ended December 31, 2018 and 2017,
the Company did not record any employee stock-based compensation expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of stock-based compensation awards at the date of grant using the Black-Scholes option pricing
model, which requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, expected
term of the option, expected volatility of the price of its Common Stock, risk-free interest rates, and the expected dividend
yield of our Common Stock. The assumptions used in the Company&rsquo;s option-pricing model represent management&rsquo;s best
estimates. These estimates involve inherent uncertainties and the application of management&rsquo;s judgment. If factors change
and different assumptions are used, the Company&rsquo;s stock-based compensation expense could be materially different in the
future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
assumptions and estimates are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value of the underlying Common Stock. Because the Company&rsquo;s stocks are not publicly traded, the assumptions used in
    the valuation model are based on future expectations combined with management judgment. In the absence of a public trading
    market, the board of directors, with input from management, exercised significant judgment and considered numerous objective
    and subjective factors to determine the fair value of our Common Stock as of the date of each option grant, including the
    following factors:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
contemporaneous valuations performed by unrelated third-party specialists;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
the lack of marketability of its Common Stock;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
the Company&rsquo;s actual operating and financial performance, and current business conditions and projections;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
the Company&rsquo;s hiring of key personnel and the experience of our management;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
the Company&rsquo;s history and the timing of the introduction of new products and services;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
valuing the Common Stock, the fair value of the underlying Common Stock was determined by using the value indications under a
combination of valuation approaches, including a discounted cash flow analysis under the income approach, market approaches, and
the latest round of equity financing at grant date</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term. The expected term represents the period that the stock-based compensation awards are expected to be outstanding. Since
    the Company did not have sufficient historical information to develop reasonable expectations about future exercise behavior,
    it used the simplified method to compute expected term, which represents the average of the time-to-vesting and the contractual
    life.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility. As the Company does not have a trading history for its Common Stock, the expected stock price volatility for its
    Common Stock was estimated by taking the mean standard deviation of stock prices for selected companies in biotechnogy industry
    listed in Taiwan&rsquo;s stock markets.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero
    coupon U.S. Treasury notes with maturities approximately equal to the expected term of the options.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividend yield. The Company has never declared or paid any cash dividends and do not presently plan to declare or pay cash
    dividends in the foreseeable future. Consequently, we used an expected dividend yield of zero.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuations are highly complex and subjective. Following the completion of this offering, Common Stock valuations will no longer
be necessary as the Company will rely on market prices to determine the fair value of its Common Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreign-currency
Transactions</I></B> &mdash; For the Company&rsquo;s subsidiaries in Taiwan, the foreign-currency transactions are recorded in
New Taiwan dollars (&ldquo;NTD&rdquo;) at the rates of exchange in effect when the transactions occur. Gains or losses resulting
from the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars, or
when foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement.
On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates
and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares
of stock where such differences are accounted for as translation adjustments under Equity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Translation
Adjustment</I></B> &mdash; The accounts of BioLite Taiwan was maintained, and its financial statements were expressed, in New
Taiwan Dollar (&ldquo;NT$&rdquo;). Such financial statements were translated into U.S. Dollars (&ldquo;$&rdquo; or &ldquo;USD&rdquo;)
in accordance ASC 830, &ldquo;Foreign Currency Matters&rdquo;, with the NT$ as the functional currency. According to the Statement,
all assets and liabilities are translated at the current exchange rate, stockholder&rsquo;s deficit are translated at the historical
rates and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments
are reported under other comprehensive income as a component of stockholders&rsquo; equity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development </I></B>&mdash; The Company accounts for R&amp;D costs in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
730, Research and Development (&ldquo;ASC 730&rdquo;). Research and development expenses are charged to expense as incurred unless
there is an alternative future use in other research and development projects or otherwise. Research and development expenses
are comprised of costs incurred in performing research and development activities, including personnel-related costs, share-based
compensation, and facilities-related overhead, outside contracted services including clinical trial costs, manufacturing and process
development costs for both clinical and preclinical materials, research costs, upfront and development milestone payments under
collaborative agreements and other consulting services. Non-refundable advance payment for goods and services that will be used
in future research and development activities are expensed when the activity has been performed or when the goods have been received
rather than when the payment is made. In instances where the Company enters into agreements with third parties to provide research
and development services, costs are expensed as services are performed. Amounts due under such arrangements may be either fixed
fee or fee for service, and may include upfront payments, monthly payments, and payments upon the completion of milestones or
receipt of deliverables. <FONT STYLE="background-color: white">Research and development expense was $319,053 and $256,682 for
the years ended December 31, 2018 and 2017, respectively.</FONT></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Promotional
and Advertising Costs</I></B></FONT> <B> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;
</FONT></B><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Promotional and advertising costs are classified as selling
and general and administrative expenses, and are expensed as incurred. Promotional and advertising expenses consist primarily
of the costs of designing, producing, and distributing materials promoting the Company and its products, including its corporate
website. Promotional and advertising costs were $419 and $842 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Statement
of Cash Flows</I> &mdash; </B>Cash flows from the Company&rsquo;s operations are based upon the local currencies. As a result,
amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the
corresponding balances on the balance sheet. In November 2016, the FASB issued ASU 2016-18, Restricted Cash , which requires amounts
generally described as restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling
the total beginning and ending amounts for the periods shown on the statement of cash flows. The Company adopted ASU 2016-18 in
the fourth quarter of 2018 and the impact on its consolidated financial statements is not material as the Company's restricted
cash balances are immaterial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comprehensive
Income</I></B> &mdash; Comprehensive income includes accumulated foreign currency translation gains and losses. The Company has
reported the components of comprehensive income in its statements of operations and comprehensive income (loss).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
Issued Accounting Pronouncements</I></B> &mdash; In February 2016, the FASB issued ASU No. 2016-02, &ldquo;Leases.&rdquo; The
core principle of the ASU is that a lessee should recognize the assets and liabilities that arise from its leases other than those
that meet the definition of a short-term lease. The ASU requires extensive qualitative and quantitative disclosures, including
with respect to significant judgments made by management. Subsequently, the FASB issued ASU No. 2017-13, in September 2017 and
ASU No. 2018-01, in January 2018, which amends and clarifies ASU 2016-02. The ASU will be effective for the Company beginning
January 1, 2019, including interim periods in the fiscal year 2019. Early adoption is permitted. The Company is in the process
of determining the method of adoption and assessing the impact of this ASU on its consolidated results of operations, cash flows,
financial position and disclosures.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2016, the FASB issued ASU No. 2016-18,&nbsp;Statement of Cash Flows: Restricted Cash. This ASU&nbsp;<FONT STYLE="background-color: white">requires
changes in restricted cash during the period to be included with cash and cash equivalents when reconciling the beginning-of-period
and end-of-period total amounts shown on the statement of cash flows. If cash, cash equivalents and restricted cash are presented
in more than one line item on the balance sheet, the new guidance requires a reconciliation of the total in the statement of cash
flows to the related captions in the balance sheet. </FONT>This guidance was effective for annual and interim periods of public
entities beginning after December 15, 2017<FONT STYLE="background-color: white">. The amendments in this ASU are applied retrospectively
to all periods presented.&nbsp;The Company</FONT> adopted this guidance in the fourth quarter of 2018.&nbsp;<FONT STYLE="background-color: white">The
adoption of this ASU&nbsp;</FONT>increased&nbsp;the Company&rsquo;s beginning and ending cash balances within its consolidated
statements of cash flows. The adoption had no other material impacts to its consolidated statements of cash flows and had no impact
on its results of operations or financial position.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the FASB issued Accounting Standards Update No. 2018-02 (ASU 2018-02), Income Statement - Reporting Comprehensive
Income (Topic 220). The guidance in ASU 2018-02 allows an entity to elect to reclassify the stranded tax effects related to the
Tax Cuts and Jobs Act (the Tax Act) of 2017 from accumulated other comprehensive income into retained earnings. ASU 2018-02 is
effective for fiscal years beginning after December 15, 2018, with early adoption permitted. Early adoption of the amendments
in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods
for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial
statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period
of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income
tax rate in the Tax Cuts and Jobs Act is recognized. The Company does not expect the adoption of this standard to have a material
effect on its consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (&ldquo;Topic 820&rdquo;): Disclosure Framework - Changes to
the Disclosure Requirements for Fair Value Measurement. The ASU modifies the disclosure requirements in Topic 820, Fair Value
Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying existing disclosure requirements
related to measurement uncertainty and adding new disclosure requirements, such as disclosing the changes in unrealized gains
and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end
of the reporting period and disclosing the range and weighted average of significant unobservable inputs used to develop Level
3 fair value measurements. This ASU is effective for public companies for annual reporting periods and interim periods within
those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect, if any, that the ASU will
have on its financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, the FASB issued ASU 2018-18,&nbsp;Collaborative arrangements (Topic 808): Clarifying the interaction between Topic
808 and Topic 606. ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should
be accounted for under ASC 606 when the counterparty is a customer and precludes an entity from presenting consideration from
a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for
that transaction. For public business entities, these amendments are effective for fiscal years beginning after December 2019,
and interim periods therein. Early adoption is permitted, including adoption in any interim period, for entities that have adopted
ASC 606. The Company is currently evaluating the impact that ASU 2018-18 will have on its consolidated financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3. COLLABORATIVE AGREEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
    agreements with BHK</B></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On February 24, 2015, BioLite Taiwan and BioHopeKing Corporation (the &ldquo;BHK&rdquo;) entered into a co-development agreement,
(the &ldquo;BHK Co-Development Agreement&rdquo;), pursuant to which it is collaborative with BHK to develop and commercialize
BLI-1401-2 (Botanical Drug) Triple Negative Breast Cancer (TNBC) Combination Therapy (BLI-1401-2 Products) in Asian countries
excluding Japan for all related intellectual property rights, and has developed it for medicinal use in collaboration with outside
researchers. The development costs shall be shared 50/50 between BHK and the Company. The BHK Co-Development Agreement will remain
in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2016, BioLite Taiwan and BHK agreed to amend the payment terms of the milestone payment in an aggregate amount of $10
million based on the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the signing of the BHK Co-Development Agreement: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the first Investigational New Drug (IND) submission and BioLite Taiwan will deliver all data to BHK according to FDA Reviewing
    requirement: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the completion of first phase II clinical trial: $1 million, or 10% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the initiation of phase III of clinical trial research: $3 million, or 30% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the New Drug Application (NDA) submission: $4 million, or 40% of total payment</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2015, BHK has paid a non-refundable upfront cash payment of $1 million, or 10% of $10,000,000, upon the signing of BHK
Co-Development Agreement. The Company concluded that the deliverables are considered separate units of accounting as the delivered
items have value to the customer on a standalone basis and recognized this cash receipt as collaboration revenue when all research,
technical, and development data was delivered to BHK in 2015. The receipt is for the compensation of past research efforts and
contributions made by BioLite Taiwan before this collaborative agreement was signed and it does not relate to any future commitments
made by BioLite Taiwan and BHK in this collaborative agreement. In August 2016, the Company has received the second milestone
payment of NT$31,649,000, approximately equivalent to $1 million, and recognized collaboration revenue for the year ended December
31, 2016. As of the date of this report, the Company has not completed the first phase II clinical trial.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the milestone payments, BioLite Taiwan&nbsp;is entitled to receive royalty on 12% of BHK&rsquo;s net sales related
to BLI-1401-2 Products. As of December 31, 2018 and 2017, the Company has not earned the royalty under the BHK Co-Development
Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
On December 9, 2015, BioLite Taiwan entered into another two collaborative agreements (the &ldquo;BHK Collaborative Agreements&rdquo;),
pursuant to which it is collaborative with BHK to co-develop and commercialize BLI-1005 for &ldquo;Targeting Major Depressive
Disorder&rdquo; (BLI-1005 Products) and BLI-1006 for &ldquo;Targeting Inflammatory Bowel Disease&rdquo; (BLI-1006 Products) in
Asia excluding Japan for all related intellectual property rights, and has developed it for medicinal use in collaboration with
outside researchers. The development costs shall be shared 50/50 between BHK and the Company. The BHK Co-Development Agreement
will remain in effect for fifteen years from the date of first commercial sale of the Product in in Asia excluding Japan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the Company recognized the cash receipt in a total of NT$50 million, approximately equivalent to $1.6 million, as collaboration
revenue when all research, technical, and development data was delivered to BHK. The Company concluded that the deliverables are
considered separate units of accounting as the delivered items have value to the customer on a standalone basis and recognized
this payment as collaboration revenue when all research, technical, data and development data was delivered to BHK. The cash receipt
is for the compensation of past research efforts and contributions made by BioLite Taiwan before this BHK Collaborative Agreements
was signed and it does not relate to any future commitments made by BioLite Taiwan and BHK in this BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the total of NT$50 million, approximately equivalent to $1.60 million, BioLite Taiwan is entitled to receive 50% of
the future net licensing income or net sales profit. As of December 31, 2018 and 2017, the Company has not earned the royalty
under the BHK Collaborative Agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collaborative
    Agreement with BriVision</B></FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2015, BioLite Taiwan and BriVision entered into a collaborative agreement (the &ldquo;BriVision Collaborative Agreement&rdquo;),
pursuant to which it is collaborative with BriVision to develop and commercialize five products, including BLI-1005 CNS-Major
Depressive Disorder, BLI-1008 CNS-Attention Deficit Hyperactivity Disorder, BLI-1401-1 Anti-Tumor Combination Therapy &ndash;
Solid Tumor with Anti-PD-1, BLI-1401-2 Anti-Tumor Combination Therapy &ndash; Triple Negative Breast Cancer, and BLI-1501 Hematology-Chronic
Lymphocytic Leukemia ( collectively &ldquo;Five Products&rdquo;) in the United States of America and Canada for all related intellectual
property rights, and has developed it for medicinal use in collaboration with outside researchers. On January 12, 2017, BioLite
Taiwan entered into an Addendum (the &ldquo;Addendum&rdquo;) to the BriVision Collaborative Agreement, pursuant to which BioLite
Taiwan and BriVision agreed to include one more product, namely, &ldquo;Maitake Combination Therapy&rdquo; as one of the Products
defined in the BioLite Collaborative Agreement (the &ldquo;Sixth Product&rdquo;) and defined the Territory of the Sixth Product
to be worldwide and restate the Territory of the Five Products to be the U.S.A and Canada. The BriVision Collaborative Agreement
will remain in effect for fifteen years from the date of first commercial sale of the Five Products in the North America Region.
Either party may terminate upon thirty days&rsquo; prior written notice for breach or insolvency.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of BriVision with equivalent
value, according to the following schedule:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upfront
    payment shall be made upon the signing of this BioLite Collaborative Agreement: 3.5% of total payment. After receiving upfront
    payment from BriVision, BioLite Taiwan has to deliver all data to BriVision in one week</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the first IND submission, BriVision shall pay, but no later than December 15, 2016: 6.5% of total payment. After receiving
    second payment from BriVision, BioLite has to deliver IND package to BriVision in one week.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the completion of first phase II clinical trial, BriVision shall pay: 15% of total payment.
    After receiving third payment from BriVision, BioLite has to deliver phase II clinical study report to BriVision in three
    months.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the phase III IND submission, BriVision shall pay: 20% of total payment. After receiving
    forth payment from BriVision, BioLite has to deliver IND package to BriVision in one week.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the completion of phase III, BriVision shall pay: 25% of total payment. After receiving
    fifth payment from BriVision, BioLite has to deliver phase III clinical study report to BriVision in three months.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 48px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    the NDA submission, BriVision shall pay BriVision shall pay: 30% of total payment. After
    receiving sixth payment from BriVision, BioLite has to deliver NDA package to BriVision in one week.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
upfront payment of $3,500,000 (the &ldquo;Milestone Payment&rdquo;), or 3.5% of $100,000,000, was due in December 2015 under the
BriVision Collaborative Agreement. On May 6, 2016, BioLite Taiwan and BriVision amended the payment terms under the BriVision
Collaborative Agreement, whereby BriVision has agreed to pay the upfront payment to the Company $2,600,000 in cash and $900,000
in newly issued shares of Common Stock of BriVision&rsquo;s holding company, American BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;),
a Nevada company, at the price of $1.60 per share, for an aggregate number of 562,500 shares. The cash payment and shares issuance
were completed in June 2016. The Company concluded that the deliverables are considered separate units of accounting as the delivered
items have value to the customer on a standalone basis. The receipt is for the compensation of past research efforts and contributions
made by BioLite Taiwan before this collaborative agreement was signed and it does not relate to any future commitments made by
BioLite Taiwan and BriVision in this collaborative agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2016, BioLite Taiwan has submitted the first IND and delivered the IND package to BriVision. In February 2017, BriVision
agreed to pay the 6.5% of total payment, $6,500,000 to BioLite Taiwan with $650,000 in cash and $5,850,000 in the form of newly
issued shares of Common Stock of ABVC, at the price of $2.0 per share based on the quoted price (for the shares) provided by OTC
Markets Group Inc., for an aggregate number of 2,925,000 shares. Since the Common Stock shares of ABVC are lightly traded in the
over-the-counter market, the Company considered to utilize other fair value inputs, such as the bid-ask spread, in determining
the fair value of the shares at December 31, 2017. As of the date of this report, the first phase II clinical trial research has
not completed yet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
both BioLite Taiwan, BriVision, and ABVC are related parties and under common control by Dr. Tsung-Shann Jiang, the Company has
recorded the full amount of $6,500,000 and $3,500,000 in connection with the BriVision Collaborative Agreement as additional paid-in
capital during the years ended December 31, 2016 and 2015, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the BriVision Collaborative Agreement, BioLite Taiwan is also entitled to 5% of net sales of the Products. There have not been
any commercial sales since the BriVision Collaborative Agreement became effective.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the various collaboration agreements in accordance with the provisions of ASC Topic 606. The Company&rsquo;s
arrangement with BHK contains the following deliverables: (i)&nbsp;the license right to develop and use proprietary technology
and confidential information for BLI-1401-2 Products, and its related intellectual property rights (the &ldquo;BLI-1401-2 Deliverable&rdquo;),
(ii) the license right to develop and use proprietary technology and confidential information for BLI-1005 Products, and its related
intellectual property rights (the &ldquo;BLI-1005 Deliverable&rdquo;), and (iii)&nbsp;the license right to develop and use proprietary
technology and confidential information for BLI-1006 Products, and its related intellectual property rights (the &ldquo;BLI-1006
Deliverable&rdquo;). The Company&rsquo;s arrangement with BriVision contains the license right to develop and use proprietary
technology and confidential information for the Five Products and the Sixth Product, and their related intellectual property rights
(the &ldquo;Five Products and the Sixth Product Deliverable).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has concluded that each of herein deliverables identified at the inception of the arrangement has standalone value from
each of the elements based on their nature. Factors considered in this determination included, among other things, the capabilities
of the collaboration partner, whether any other vendor sells the item separately, whether the value of the deliverable is dependent
on the other elements in the arrangement, whether there are other vendors that can provide the items and if the customer could
use the item for its intended purpose without the other deliverables in the arrangement. Additionally, the Collaboration Agreements
do not include a general right of return. Accordingly, each of herein deliverables included in the BHK and BriVision arrangements
qualifies as a separate unit of accounting. Therefore, the Company has identified seven units of accounting in connection with
its obligations under the collaboration arrangement with BHK and BriVision as follows: (i) BLI-1005 Products, (ii) BLI-1006 Products,
(iii) BLI-1008 Products, (iv) BLI-1401-1 Products, (v) BLI-1401-2 Products, (vi) BLI-1401-2 Products, and (vii) Maitake Product
(the Sixth Product).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4. INVENTORY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> Merchandise </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,951 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Finished goods </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 100,736 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 104,454 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Work-in-process </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,243 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,885 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Raw materials </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 56,691 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 69,418 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Allowance for inventory valuation
    and obsolescence loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (177,670 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> &nbsp;Inventory, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,318 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 199,708 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5. LONG-TERM INVESTMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ownership percentages of each investee are listed as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Ownership percentage </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> Name of related party </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Accounting
    treatment </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 59%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Braingenesis Biotechnology Co., Ltd. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.23 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.23 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: center"> Cost Method </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Genepharm Biotech Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.98 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.98 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cost Method </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> BioHopeKing Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9.71 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9.60 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Cost Method </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> BioFirst Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 21.56 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 21.51 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Equity Method </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> American BriVision (Holding) Corp. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2.28 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2.32 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Equity Method </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Rgene Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9.69 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13.04 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Equity Method </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    extent the investee relies on the company for its business are summarized as follows:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 33%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related party</B></FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 66%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    extent the investee relies on the company for its business</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Braingenesis
    Biotechnology Co., Ltd.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    specific business relationship</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genepharm
    Biotech Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    specific business relationship</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioHopeKing
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with the Company to develop and commercialize drugs</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
    BriVision (Holding) Corp. </FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborating
    with the Company to develop and commercialize drugs</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    working capital to the investee </FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; background-color: White"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan
    from the investee and provide research and development support service</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    investment mainly consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Non-marketable Cost Method Investments, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Braingenesis Biotechnology
    Co., Ltd. </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,213 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,442 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Genepharm Biotech Corporation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,021 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,720 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> BioHopeKing
    Corporation (NOTE 3 &amp; 12) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,956,429 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,261,524 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Sub
    total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,985,663 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,291,686 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Equity Method Investments, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> BioFirst Corporation (NOTE 12) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,502,506 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,894,283 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> American BriVision (Holding)
    Corp. (NOTE 3 &amp; 12) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Rgene
    Corporation (NOTE 12) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 0.25in"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,488,169 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,185,969 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation (the &ldquo;BioFirst):</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds an equity interest in BioFirst Corporation, (the &ldquo;BioFirst&rdquo;), accounting for its equity interest using
the equity method to accounts for its equity investment as prescribed in ASC 323, Investments&mdash;Equity Method and Joint Ventures
(&ldquo;ASC 323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of investee&rsquo;s income
or loss and other adjustments required by the equity method. As of December 31, 2018 and 2017, the Company owns 21.56% and 21.51%
Common Stock shares of BioFirst, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
financial information for the Company&rsquo;s equity method investee, BioFirst, is as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheets</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,551,898 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,903,042 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,608,460 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,730,701 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,648,206 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 318,074 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,512,152 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,315,669 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statement
of operations</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,694 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,030,034 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross Profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,055 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,003,885 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net income (loss) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,569,813 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,665,472 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of loss from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 222,594 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 358,243 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
    BriVision (Holding) Corp. (the &ldquo;ABVC&rdquo;):</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
ABVC and the Company are under common control by Dr. Tsung-Shann Jiang, the CEO and chairman of the Company. Since Dr. Tsung-Shann
Jiang is able to exercise significant influence, but not control, over the American BriVision (Holding) Corp., (the &ldquo;ABVC&rdquo;),
the Company determined to use the equity method to accounts for its equity investment as prescribed in ASC 323, Investments&mdash;Equity
Method and Joint Ventures (&ldquo;ASC 323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of
investee&rsquo;s income or loss and other adjustments required by the equity method. As of December 31, 2018 and 2017, the Company
owns 2.28% and 2.32% Common Stock shares of ABVC, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
financial information for the Company&rsquo;s equity method investee, ABVC, is as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheets</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 96,273 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,643,332 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,568,224 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,400,247 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 277,467 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; Equity (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,749,418 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,756,915 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statement
of operations</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross Profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,101,303 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,242,860 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of loss from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (98,434 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rgene
    Corporation (the &ldquo;Rgene&rdquo;):</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Rgene and the Company are under common control by Dr. Tsung-Shann Jiang, the CEO and chairman of the Company. Since Dr. Tsung-Shann
Jiang is able to exercise significant influence, but not control, over the Rgene, the Company determined to use the equity method
to accounts for its equity investment as prescribed in ASC 323, Investments&mdash;Equity Method and Joint Ventures (&ldquo;ASC
323&rdquo;). Equity method adjustments include the Company&rsquo;s proportionate share of investee&rsquo;s income or loss and
other adjustments required by the equity method. As of December 31, 2018 and 2017 the Company owns 9.69% and 13.04% Common Stock
shares of Rgene, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
financial information for the Company&rsquo;s equity method investee, Rgene, is as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Balance
Sheets</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> As
    of December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Assets </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,168 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 48,557 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Noncurrent Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,779 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 81 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 261,685 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,118,897 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Shareholders&rsquo; Equity (Deficit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (148,738 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,070,259 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Statement
of operations</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Year
    Ended December 31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Net sales </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Gross Profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (120,065 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (3,266,696 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of loss from investments accounted for using
    the equity method </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (425,977 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposition
                                         of long-term investment</FONT> </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018, the Company sold 552,000 shares of common stock of BioHopeKing Corporation (the &ldquo;BHK&rdquo;)
at prices ranging from NT$25, equivalent $0.82, to NT$32, equivalent $1.05, to two directors of BHK and 25 individuals. As a result
of the transactions, the Company recognized investment loss of $395,476 for the same period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2018 and November 2, 2018, the Company subsequently purchased an aggregate of 200,000 and 366,200 shares of common
stock of BHK at NT$10, equivalent to $0.33, and NT$50, equivalent $1.64, from one of directors of BHK and eleven shareholders
of BHK, respectively. The percentage of ownership accordingly increased to 9.71% as of December 31, 2018.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains
    (Losses) on Equity Investments</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of gains (losses) on equity investments for each period were as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> For
    the Year Ended December&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Share of equity method investee losses </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (222,594 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (166,168 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Impairments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (33,532 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,277,708 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total gains (losses) on equity
    investments </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (256,126 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,443,876 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6. PROPERTY AND EQUIPMENT</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of December 31, 2018 and 2017 are summarized as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,
    <BR> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Land </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 363,416 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 374,953 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Buildings and leasehold improvements </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 290,403 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 299,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Machinery and equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 87,356 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 90,130 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Office equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,292 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 21,968 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 762,467 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 786,674 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Less: accumulated depreciation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (252,401 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (216,098 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Property and equipment,
    net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,066 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 570,576 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses were $43,610 and $43,996 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7. BANK LOANS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    bank loan consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Cathay United Bank </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 245,250 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 253,036 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> CTBC Bank </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 654,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 674,764 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 899,250 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 927,800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cathay
United Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2016, BioLite Taiwan and Cathay United Bank entered into a one-year bank loan agreement (the &ldquo;Cathay United Loan
Agreement&rdquo;) in an amount of NT$7,500,000, equivalent to $245,250. The term started June 28, 2016 with maturity date at June
28, 2017. The loan balance bears interest at a floating rate of prime rate plus 1.15%. The prime rate is based on term deposit
saving interest rate of Cathay United Bank. On September 6, 2017, BioLite Taiwan extended the Cathay United Loan Agreement for
one year, which was due on September 6, 2018, with the principal amount of NT$7,500,000, equivalent to $245,250. On October 1,
2018, BioLite Taiwan extended the Cathay United Loan Agreement with the same principal amount of NT$7,500,000, equivalent to $245,250
for one year, which is due on September 6, 2019. As of December 31, 2018 and 2017, the effective interest rates per annum were
2.22%. The loan is collateralized by the building and improvement of BioLite Taiwan, and is also personal guaranteed by the Company&rsquo;s
chairman.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $5,073 and $4,096 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CTBC
Bank</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 12, 2017 and July 19, 2017, BioLite Taiwan and CTBC Bank entered into short-term saving secured bank loan agreements (the
&ldquo;CTBC Loan Agreements&rdquo;) in an amount of NT$10,000,000, equivalent to $327,000, and NT$10,000,000, equivalent to $327,000,
respectively. Both two loans with the same maturity date at January 19, 2018. In February 2018, BioLite Taiwan combined two loans
and extended the loan contract with CTBC for one year. On January 18, 2019, BioLite Taiwan and CTBC Bank agreed to extend the
loan with a new maturity date, which is July 18, 2019. The loan balances bear interest at a fixed rate of 1.63% per annum. The
loan is secured by the money deposited in a savings account with the CTBC Bank. This loan is also personal guaranteed by the Company&rsquo;s
chairman and BioFirst.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $10,919 and $4,849 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    bank loan consists of the following:</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Cathay United Bank </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 55,092 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 95,893 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Less: current portion
    of long-term bank loan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (39,835 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (40,203 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,257 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 55,690 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2010, BioLite Taiwan entered a seven-year bank loan of NT$8,900,000, equivalent to $291,030, with Cathay United Bank.
The term started April 30, 2010 with maturity date at April 30, 2017. On April 30, 2017, BioLite Taiwan extended the original
loan agreement for additional three years with the new maturity date at April 30, 2020. The loan balance bears interest at a floating
rate of prime rate plus variable rates from 0.77% to 1.17%. The prime rate is based on term deposit saving interest rate of Cathay
United Bank. As of December 31, 2018 and 2017, the actual interest rates per annum were 2.24%. The loan is collateralized by the
building and improvement of BioLite Taiwan, and is also personal guaranteed by the Company&rsquo;s chairman.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expenses were $1,719 and $2,305 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8. NOTES PAYABLE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2017, BioLite Taiwan and Cheng-Chi International Co., Ltd., a Taiwanese company, entered into a promissory note for
borrowing an aggregate amount of NT$6,000,000, equivalent to $196,200, for the period from November 27, 2017 to January 11, 2018.
The principal of promissory note bears interest at 12% per annum. This promissory note is secured by 700,000 Common Stock shares
of ABVC and is also personal guaranteed by the Company&rsquo;s chairman. On January 11, 2018, the principal and accrued interest
totaling NT$6,090,000, equivalent to $199,143, has been paid in full.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2018, BioLite Taiwan and two individuals entered into a promissory note, (the &ldquo;Hsu and Chow Promissory Note&rdquo;),
for borrowing an aggregate amount of NT$4,660,000, equivalent to $152,382, for the period from March 27, 2018 to June 26, 2018.
On September 26, 2018, the company extended the original loan agreement through December 26, 2018. As of the date of this report,
BioLite Taiwan and Hsu and Chow are still negotiating to extend this promissory note. The principal of the Hsu and Chow Promissory
Note bears interest at 13.6224% per annum. This Hsu and Chow Promissory Note was secured by common stock shares of ABVC and was
also personal guaranteed by the Company&rsquo;s chairman. Interest expense was $16,315 and $0 for the years ended December 31,
2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018, BioLite Taiwan also entered various unsecured loan agreements bearing interest at fixed rates
between 12% and 13.6224% per annum with three individuals to advance in aggregate of NT$10,500,000, equivalent to $343,350, for
working capital purpose. The term of the loan varies from one month to three months with various maturity dates through May 25,
2018. As of the date of this report, BioLite Taiwan is still in discussion with the three individuals with respect to the terms
of extension for the unsecured loans. Interest expense was $46,636 and $0 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2018, BioLite Taiwan issued a promissory note of NT$450,000, equivalent to $14,715, to Taipei Veterans General Hospital
to repay the clinical experiment costs. The note has been paid in full on January 2, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9. ACCRUED EXPENSES</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses mainly consist of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued salaries and bonus </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 120,914 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 45,862 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued employee benefits and pension expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,502 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,390 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued professional service fees </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 32,457 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8,300 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 23,179 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,656 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued cost of collaboration revenue payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 274,028 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 400,600 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Accrued litigation payable (Note 15) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,181 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Others </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,311 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 44,404 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 486,572 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 511,212 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10. OTHER PAYABLE</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
payable mainly consists of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Other payable </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,689 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,532 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Taiwan income tax withholding payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 70,940 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,756 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Temporary receipts </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 124,508 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 201,137 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 16,288 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11. SHARE-BASED COMPENSATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 15, 2013, the Board of Directors of BioLite Taiwan approved the adoption of the 2013 Stock Option and Incentive Plan,
(the &ldquo;2013 Plan&rdquo;), providing for the issuance under 2013 Plan of options and rights to purchase up to two million
seventy thousand (2,070,000) shares of Common Stock. Awards of incentive options may be granted under the 2013 Plan until December
31, 2017. As of December 31, 2018 and 2017, there were 0 and 487,000 shares available for issuance under the 2013 Plan, respectively,
which provides for the grant of share-based awards to employees and officers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Plan
Administration</I></B> &#9472; The 2013 Plan may be administered by the full Board of Directors of BioLite Taiwan. The Board of
BioLite Taiwan has full power to select, from among the individuals eligible for awards, the individuals to whom awards will be
granted, to make any combination of awards to participants, and to determine the specific terms and conditions of each award,
subject to the provisions of the 2013 Plan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eligibility
</I>&#9472; </B>Persons eligible to participate in 2013 Plan will be those full-time employees and officers of the Company as
selected from time to time by the Board of BioLite Taiwan in its discretion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Limits
&#9472; </I></B>Under 2013 Plans, stock options granted to any individual employee cannot exceed 25% of the Plan, neither to exceed
3% of the total Common Stock shares issued by BioLite Taiwan.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Options &#9472; </I></B>The option exercise price of each option under both plans was determined by the Company&rsquo;s status
at the date of grant: (i) before public offering date: the option exercise price would be NT$12.5, equivalent to $0.39, per share
and NT$15.0, equivalent to $0.46, per share for the 2013 Plan, respectively, (ii) after public offering date: the exercise price
would be decided by the Board of BioLite Taiwan, and not less than the book value per share on the latest financial report before
the date of grant, (iii) after been listed on the secondary market, the option exercise price would be the market price, but not
less than the par value of the Common Stock. The exercise price of an option may not be reduced after the date of the option grant,
other than to appropriately reflect changes in our capital structure. The term of the option was determined by the Board of Directors
of BioLite Taiwan, under the 2013 Plan, employees could exercise 50%, 75%, and 100% of the options at 6 months, 12 months and
24 months after the date of grant. In general, unless otherwise permitted by the Board of BioLite Taiwan, no option granted under
2013 Plan are transferable by the optionee other than by will or by the laws of descent and distribution, and options may be exercised
during the optionee&rsquo;s lifetime only by the optionee, or by the optionee&rsquo;s legal representative or guardian in the
case of the optionee&rsquo;s incapacity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
2013 Plan, upon exercise of options, the option exercise price must be paid in full either in cash, by certified or bank check,
or other instrument acceptable to the Board BioLite Taiwan. Subject to applicable law, the exercise price may also be delivered
to BioLite Taiwan by a broker pursuant to irrevocable instructions to the broker from the optionee. To qualify as incentive options,
options must meet additional tax requirements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Tax
Withholding &#9472; </I></B>Participants in the 2013 Plan are responsible for the payment of any taxes that BioLite Taiwan is
required by law to withhold upon the exercise of options or vesting of other awards. Subject to approval by the Board, participants
may elect to have the minimum tax withholding obligations satisfied by authorizing BioLite Taiwan to withhold shares of Common
Stock to be issued pursuant to the exercise or vesting.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendments
and Termination &#9472; </I></B>The Board of Directors of BioLite Taiwan may at any time amend or discontinue the 2013 Plan, and
the Board of BioLite Taiwan may at any time amend or cancel any outstanding award for the purpose of satisfying changes in the
law or for any other lawful purpose. However, no such action may adversely affect any rights under any outstanding award without
the holder&rsquo;s consent. Any amendments that materially change the terms of 2013 Plan will be subject to approval by the administrative
authorities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the stock option activity under the 2013 Plan, and related information:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="17" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Options
    Outstanding </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Number of </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Weighted- </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Shares </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Weighted- </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Average </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Underlying </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Average </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Remaining </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Aggregate </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Outstanding </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Exercise </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Contractual </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Intrinsic </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Options </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Price </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Life
    (Years) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Value </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif"> Outstanding &ndash; January&nbsp;1, 2017 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 487,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 0.4600 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2.13 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Exercised </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Forfeited
    or cancelled </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Outstanding &ndash; December&nbsp;31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 487,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 0.4600 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 2.13 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Granted </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Exercised </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Forfeited
    or cancelled </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (487,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Outstanding &ndash; December&nbsp;31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Exercisable &ndash; December 31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Vested and expected to vest
    &ndash; December 31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Exercisable &ndash; December&nbsp;31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 487,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 0.4600 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 2.13 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Vested and expected to vest
    &ndash; December&nbsp;31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 487,000 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 0.4600 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"> 2.13 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
expense related to share-based transactions is measured and recognized in general and administrative expenses in the financial
statements based on the fair value of the awards granted. The share-based compensation expense, net of forfeitures, is recognized
on a straight-line basis over the requisite service periods of the awards, which is generally a half year to two years. As of
December 31, 2018 and 2017, all stock options under 2013 Plan were either fully vested or forfeited. Accordingly, the Company
recognized stock-based compensation expense of $0 for the years ended December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
12. RELATED-PARTY TRANSACTION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
parties:</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lion
    Arts Promotion Inc. (hereinafter, &ldquo;LION&rdquo;) was incorporated on March 17, 1997 under the laws of Taiwan. LION is
    in the business of art related promotion and is a controlling shareholder of BioLite Taiwan.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioFirst
    Corporation (hereinafter, &ldquo;BioFirst&rdquo;) was incorporated on November 7, 2006 under the laws of Taiwan. BioFirst
    is in the business of researching, developing, manufacturing, and marketing of innovative patented medical products. As of
    December 31, 2018 and 2017, the Company owns 21.56% and 21.51% Common Stock shares of BioFirst (See NOTE 5), respectively.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
    BriVision Corporation (hereinafter, &ldquo;BriVision&rdquo;) was incorporated on July 21, 2015 in the State of Delaware, engaging
    in biotechnology and focuses on the development of new drugs and innovative medical devices to fulfill unmet medical needs.
    In 2015, BriVision entered into a collaborative agreement with the Company (See NOTE 3). On May 6, 2016, BioLite Taiwan and
    BriVision entered into an addendum to the collaborative agreement, whereby BriVision has agreed to pay the upfront payment
    to the Company $2,600,000 in cash and $900,000 in newly issued shares of Common Stock of BriVision&rsquo;s holding company,
    American BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;), a Nevada company, at the price of $1.60 per share, for an aggregate
    number of 562,500 shares. In August 2016, BioLite Taiwan made additional equity investment of $2,350,000 in cash to acquire
    1,468,750 shares of Common Stock of ABVC. In February 2017, the Company received $650,000 in cash and $5,850,000 <FONT STYLE="background-color: white">in
    the form of newly issued 2,925,000 shares of Common Stock of ABVC, at the price of $2.0 per share for the first milestone
    payment. As of December 31, 2018 and 2017, BioLite Taiwan</FONT> owns 2.28% and 2.32% Common Stock of ABVC, respectively (See
    NOTE 5). On February 8, 2019, the Company became one of wholly-owned subsidiaries of ABVC (See NOTE 15).</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regene
    Corporation (hereinafter, &ldquo;Rgene&rdquo;) was incorporated on June 24, 2010 under the laws of Taiwan. Rgene is in the
    business of research and development and innovation of various drugs. On March 23, 2017, BioLite Taiwan acquired 600,000 shares
    of Common Stock of Rgene for NT$15,000,000 (equivalent approximately $506,000) in cash. On November 28, 2018, Rgene agreed
    to pay the debt of NT$1,010,000 (equivalent to $33,027) due to BioLite Taiwan in the form of newly issued 20,200 shares of
    common stock of Rgene. As of December 31, 2018 and 2017, the Company owned 9.69% and 13.04% common stock of Rgene, respectively
    (See NOTE 5).</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AsianGene
                                         Corporation (hereinafter, &ldquo;AsianGene&rdquo;) was incorporated on December 16, 2013
                                         under the laws of Taiwan. AsianGene is in the business of real estate development. AsianGene
                                         is one of the shareholders of the Company.</FONT> </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LionGene
    Corporation (hereinafter, &ldquo;LionGene&rdquo;) was incorporated on November 23, 2009 under the laws of Taiwan. LionGene
    is in the business of biotechnology services. LionGene and the Company are related parties and under common control by a controlling
    beneficiary shareholder of the Company.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Tsung-Shann Jiang is the chairman and CEO of the Company and the President and a member of board of directors of BioFirst.
    Mr. Jiang is also the controlling beneficiary shareholder of ABVC, BriVision, and Rgene. Ms. Shu-Ling Jiang, Mr. Tsung-Shann
    Jiang&rsquo;s wife, is the chairman of LION and BioFirst, and a member of board of directors of the Company. Mr. Eugene Jiang
    is Mr. and Ms. Jiang&rsquo;s son. Mr. Eugene Jiang is a member of board of directors of the Company, and is also the chairman,
    and majority shareholder of ABVC. Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang, and Mr. Eugene Jiang hereinafter are collectively
    called &ldquo;JIANGS&rdquo;.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
party transactions:</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended and at December 31, 2018, the related party transactions are summarized as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Merchandise Sales / </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Amounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Amounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Service </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Accounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Loan to </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Rent </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> due
    from </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> due
    to </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Revenue </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> receivable </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> (Loan&nbsp;from) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Expenses&nbsp;(a) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif"> LION </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 65,557 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 632 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,480 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> BioFirst </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,604,380 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (663,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ABVC &amp; BriVision </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Rgene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 19,477 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> AsianGene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> LionGene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 467,211 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> JIANGS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 540,047 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,287 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,677,195 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 632 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (663,810 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 9,480 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended and at December 31, 2017, the related party transactions are summarized as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Merchandise Sales / </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Amounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Amounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Service </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Accounts </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Loan to </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Rent </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> due
    from </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> due
    to </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Revenue </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> receivable </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> (Loan&nbsp;from) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Expenses&nbsp;(a) </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif"> LION </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 23,171 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,256 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,350 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,592 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> BioFirst </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,118,361 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,894 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,125 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (937,922 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ABVC &amp; BriVision </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 115,168 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Rgene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,316 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 33,738 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> AsianGene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,731 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> LionGene </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> JIANGS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 311,044 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 120,215 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,452,576 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,150 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,475 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (904,184 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,592 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company leased its office from LION. The monthly base rent was approximately $3,000. The lease was terminated on March 31,
    2018. Rent expense under this lease agreement amounted to $9,480 and $37,592 for the years ended December 31, 2018 and 2017,
    respectively</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
13. INCOME TAX</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>U.S.A</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Holding, Inc. files income tax returns in the U.S. federal jurisdiction, and state and local jurisdictions. The Company is not
currently under examination by the Internal Revenue Service or any state income tax authorities. The 2015 through 2017 tax years
remain subject to examination by the Internal Revenue Service.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On&nbsp;December
22, 2017<I>&nbsp;</I>H.R.&nbsp;1<I>,</I>&nbsp;originally known as the Tax Cuts and Jobs Act, (the &ldquo;Tax Act&rdquo;) was enacted.
Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate
(&ldquo;Federal Tax Rate&rdquo;) from&nbsp;35%&nbsp;to&nbsp;21%&nbsp;effective January 1, 2018<I>.&nbsp;</I>The&nbsp;21%&nbsp;Federal
Tax Rate will apply to earnings reported for the full&nbsp;2018&nbsp;fiscal year. In addition, the Company must re-measure its
net deferred tax assets and liabilities using the Federal Tax Rate that will apply when these amounts are expected to reverse.
As of&nbsp;December 31,&nbsp;2018,&nbsp;the Company can determine a reasonable estimate for certain effects of tax reform and
is recording that estimate as a provisional amount. The provisional remeasurement of the deferred tax assets and allowance valuation
of deferred tax assets at December 31, 2018 resulted in a&nbsp;net effect of $0 discrete tax expenses (benefit) which lowered
the effective tax rate by&nbsp;14%&nbsp;for the years ended December 31, 2018. The provisional remeasurement amount is anticipated
to change as data becomes available allowing more accurate scheduling of the deferred tax assets and liabilities primarily related
to net operating loss carryover.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>British
Virgin Islands</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
BVI, Inc. was incorporated in British Virgin Islands, which does not tax income.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Taiwan</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Inc. was incorporated in Taiwan. According to the amendments to the &ldquo;Income Tax Act&rdquo; enacted by the office of the
President of Taiwan on February 7, 2018, an increase in the statutory income tax rate from 17% to 20% and decrease in the undistributed
earning tax from 10% to 5% are effective from January 1, 2018. No income tax liabilities existed as of December 31, 2018 and 2017
due to the Company&rsquo;s continuing operating losses. As of December 31, 2018, the Company had deferred tax assets related to
tax loss and credit carryforwards totaling $1,347,995 that begin to expire in 2026.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
for income tax(benefit) consists of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Current provision </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> U.S.A </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"> Taiwan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Sub
    total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Deferred provision </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> U.S.A </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 9pt"> Taiwan </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (360,395 </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total provision for income
    tax(benefit) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (366,947 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (360,395 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of deferred tax assets consisted of the following</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> December&nbsp;31,<BR>
    2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Deferred tax assets: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"> U.S.A </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Tax loss and credit
    carryforwards </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 156,019 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 155,612 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Less:
    Valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (156,019 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (155,612 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 27pt"> Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; padding-left: 9pt"> Taiwan </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Loss on disposal of assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 673,429 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 694,810 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Tax loss and credit carryforwards </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,017,897 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Less:
    Valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (673,429 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (694,810 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 27pt"> Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,017,897 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,017,897 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.5in"> Total
    deferred tax assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,347,995 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,017,897 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
difference between the combined effective income tax rate reflected in the provision for income tax on income (loss) before taxes
and the amounts determined by applying the applicable the U.S. statutory income tax rate and Taiwan unified income tax rate <FONT STYLE="background-color: white">for
the years ended December 31, 2018 and 2017 </FONT>are analyzed below:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> For
    the Years Ended<BR> December&nbsp;31, </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> U.S. statutory income tax rate </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 21 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 35 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Taiwan unified income tax rate </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 17 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Provisional remeasurement of deferred taxes (U.S.
    &amp; Taiwan) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (11 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Changes in valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (53.7 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (46 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Effective combined income
    tax rate </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (15.7 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
14. COMMITMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operating
lease commitment:</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s operating leases include lease contracts of office spaces, laboratory space, vehicle, and employees&rsquo; dormitory
with various maturity dates. Future minimum lease payments under the operating leases are summarized as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"> Fiscal
    Year </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amount </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> 2019 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 71,529 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> 2020 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,351 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> 2021 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,121 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,001 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>In-Licensing
collaborative agreement commitment:</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 1, 2011, BioLite Taiwan entered into a collaborative agreement (the &ldquo;PITDC Collaborative Agreement&rdquo;) with
    Medical and Pharmaceutical Industry Technology and Development Center (&ldquo;PITDC&rdquo;), a Taiwanese Company. Pursuant
    to the PITDC Collaborative Agreement, PITDC granted BioLite Taiwan the sole licensing right for drug and therapeutic use of
    depressive disorders related patent and technology expired in November 2026. The total consideration for obtaining such grant
    was NT$17,000,000 (equivalent approximately $555,900), of which NT$3,400,000 (equivalent approximately $111,180) was due within
    30 days upon signing the agreement and the remaining balance of NT$13,600,000 (equivalent approximately $444,720) was due
    pursuant to a milestone payment schedule. In addition, BioLite Taiwan is required to pay PITDC 10% of sublicensing revenues
    net of related research and development cost and royalties at a range from 1% to 3% of sales of drugs.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioLite
Taiwan paid the upfront payment of NT$3,400,000 (equivalent approximately $111,180) in 2011, the first milestone payment of NT$2,550,000
(equivalent approximately $83,385) in 2012, and the third milestone payment of NT$2,125,000 (equivalent approximately $69,488)
in 2013. BioLite Taiwan has recorded these amounts as research and development expenses when incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PITDC Collaborative Agreement, BioLite Taiwan is also required to pay PITDC 10% of sublicensing revenues to PITDC. During
the years ended December 31, 2018 and 2017, BioLite Taiwan has paid $0 to PITDC accounting for 10% of sublicensing revenues net
of related research and development cost and royalties. As of December 31, 2018 and 2017, BioLite Taiwan has accrued milestone
payments payable of $274,028 and $282,728 to PITDC.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 10, 2011, BioLite Taiwan entered into a collaborative agreement (the &ldquo;ITRI Collaborative Agreement I&rdquo;)
    with Industrial Technology Research Institute (&ldquo;ITRI&rdquo;), a Taiwanese Company. Pursuant to the ITRI Collaborative
    Agreement I, ITRI granted BioLite Taiwan the sole licensing right for drug and therapeutic use of colon inflammation related
    patent and technology expired in February 2031. The total consideration for obtaining such grant was NT$20,000,000 (equivalent
    approximately to $654,000), of which NT$2,000,000 (equivalent approximately $65,400) was due sixth days upon signing the agreement
    and the remaining balance of NT$18,000,000(equivalent approximately $588,600) was due pursuant to a milestone payment schedule.
    BioLite Taiwan paid the upfront payment of NT$2,000,000 (equivalent approximately$65,400) in 2011 and the first milestone
    payment of NT$2,000,000 (equivalent approximately $65,400) in 2016. The Company recorded these amounts as research and development
    expenses when incurred.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the ITRI Collaborative Agreement I, BioLite Taiwan is also required to pay ITRI 10% of sublicensing revenues net of related
research and development cost and royalties at a range from 3% to 5% of sales of drugs. During the year ended December 31, 2018
and 2017, the Company paid $114,245 in terms of 70,330 shares of common stock of ABVC owned by BioLite Taiwan and $0 to ITRI,
respectively, accounting for 10% of sublicensing revenues net of related research and development cost and royalties. As of December
31, 2018 and 2017, BioLite Taiwan has accrued collaboration revenue payable of $0 and $117,872 to ITRI, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    February 10, 2011, BioLite Taiwan entered into another collaborative agreement (the &ldquo;ITRI Collaborative Agreement II&rdquo;)
    with Industrial Technology Research Institute (&ldquo;ITRI&rdquo;), a Taiwanese Company. Pursuant to the ITRI Collaborative
    Agreement II, ITRI granted BioLite Taiwan the sole licensing right for drug and therapeutic use of rheumatoid arthritis related
    patent and technology expired in February 2031. The total consideration for obtaining such grant was NT$35,000,000 (equivalent
    approximately $1,144,500), of which NT$3,500,000 (equivalent approximately $114,450) was due sixth days upon signing the agreement
    and the remaining balance of NT$31,500,000 (equivalent approximately $1,030,050) was due pursuant to a milestone payment schedule.
    BioLite Taiwan paid the upfront payment of NT$3,500,000(equivalent approximately $114,450) in 2011. BioLite Taiwan recorded
    these amounts as research and development expenses when incurred</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the ITRI Collaborative Agreement II, BioLite Taiwan is also required to pay ITRI 10% of sublicensing revenues net of related
research and development cost and royalties at a range from 3% to 5% of sales of drugs. As of December 31, 2018 and 2017, the
Company has not sublicensed the licensing right for drug and therapeutic use of rheumatoid arthritis related patent and technology
to any companies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 27, 2016, BioLite Taiwan entered into a collaborative agreement (the &ldquo;Yukiguni Collaborative Agreement&rdquo;)
    with Yukiguni Maitake Co., Ltd (&ldquo;YUKIGUNI&rdquo;), a Japanese company. Pursuant to the Yukiguni Collaborative Agreement,
    YUKIGUNI granted BioLite Taiwan the right for selling Maitake dry powder and Maitake extract manufactured by YUKIGUNI, and
    the right for using Maitake related patent and technology expired in December 2036 or fifteen years after the date when the
    new product developed by BioLite Taiwan is first sold, whichever is earlier. The total consideration for obtaining such grant
    would be $305,000. During the years ended December 31, 2018 and 2017, BioLite Taiwan has paid YUKIGUNI an aggregate of $175,000
    and $0, respectively, to obtain some Maitake related patent and technology.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
15. CONTINGENCIES AND LEGAL PROCEEDINGS </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2018, a former employee of BioLite Taiwan, (the &ldquo;Plaintiff&rdquo;), filed a class action civil complaint against
BioLite Taiwan at Taiwan Hsin-Chu District Court. The Plaintiff alleged the following causes of action under the Labor Standards
Act of Taiwan: (1) failure to pay employees for all hours worked; (2) failure to pay for overtime work on weekends; (3) failure
to pay severance payments; and (4) failure to distribute retirement pension to pension trust. The case went to trial on July 12,
2018, and on July 31, 2018, the court pronounced its judgment that BioLite Taiwan is obligated to pay the compensation amount
of NT$226,738, equivalent $7,414 to the Plaintiff. An appeal was filed by BioLite Taiwan in August 2018. On December 26, 2018,
BioLite Taiwan and the Plaintiff have reached a settlement, pursuant to which BioLite Taiwan is required to pay the compensation
amount including the interest in aggregate of $255,699, equivalent $8,361, to the Plaintiff. As of December 31, 2018, the Company
has paid the Plaintiff a partial amount of NT$66,667(equivalent to $2,180) and has recorded the remaining balance of NT$189,032
(equivalent to $6,181) pursuant to Topic 450, &ldquo;Contingencies Loss Contingencies Recognition&rdquo;.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
16. SUBSEQUENT EVENT </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;), BioLite Holding, Inc. (the &ldquo;Company&rdquo; or &ldquo;BioLite&rdquo;),
BioKey, Inc. (&ldquo;BioKey&rdquo;), BioLite Acquisition Corp., a direct wholly-owned subsidiary of ABVC (&ldquo;Merger Sub 1&rdquo;),
and BioKey Acquisition Corp., a direct wholly-owned subsidiary of ABVC (&ldquo;Merger Sub 2&rdquo;) (<FONT STYLE="background-color: white">collectively
referred to as the &ldquo;Parties&rdquo;),</FONT> entered into a definitive Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;)
dated as of January 31, 2018, providing for the acquisition of BioLite and BioKey by ABVC. Pursuant to the terms of the Merger
Agreement, BioLite will merge with Merger Sub 1 with BioLite as the surviving corporation, which is referred to as the &ldquo;BioLite
Merger.&rdquo; BioKey will merge with Merger Sub 2 with BioKey as the surviving corporation, which is referred as the &ldquo;BioKey
Merger.&rdquo; BioLite Merger and BioKey Merger together are sometimes referred to as the Mergers.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Parties of the Merger Agreement consummated the Merger transactions. Pursuant to the terms of the Merger
Agreement, BioLite and BioKey became two wholly-owned subsidiaries of ABVC on February 8, 2019. As of the date of this report,
the Company is in the process of issuing shares of common stocks of ABVC as merger considerations to the shareholders of BioLite
and BioKey pursuant to ABVC&rsquo;s registration statement (the &ldquo;Registration Statement on S-4&rdquo;) on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019000796/fs42018a3_americanbrivision.htm">Form&nbsp;S-4</A> Amendment
No. 3 filed with the SEC on January 16, 2019 which became effective by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through the date which the financial statements were available to be issued. All subsequent
events requiring recognition as of December 31, 2018 have been incorporated into these financial statements and there are no subsequent
events that require disclosure in accordance with FASB ASC Topic 855, &ldquo;Subsequent Events.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">******</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
TO FINANCIAL INFORMATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 90%; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BioKey,
    Inc.</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements for the Years Ended December 31, 2018 and 2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_13"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-100</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_14"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    Sheets</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-101</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_15"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Operations</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-102</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_16"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Stockholders&rsquo; Equity</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-103</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_17"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Cash Flows</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-104</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; padding-left: 10pt; text-indent: -10pt; font: 10pt Times New Roman, Times, Serif"> <A HREF="#s_18"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to the Financial Statements</FONT></A> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-105
    &ndash; F-115</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<TR>
    <TD STYLE="vertical-align: top; width: 43%"> <IMG SRC="img_004.jpg" ALT=""> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 56%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><U>A</U></B><U>udit<B>&nbsp;&#9679; T</B>ax<B>&nbsp;&#9679;
        C</B>onsulting<B>&nbsp;&#9679;&nbsp;F</B>inancial<B>&nbsp;A</B>dvisory</U>&nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Registered with Public Company Accounting Oversight
        Board (PCAOB)</I> </P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_13"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Report
of Independent Registered Public Accounting Firm</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
the Stockholders and the Board of Directors of BioKey, Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Financial Statements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of BioKey, Inc. (the Company) as of&nbsp;December&nbsp;31, 2018&nbsp;and&nbsp;2017,
the related statements of operations, stockholders&rsquo; equity, and cash flows for each of the two years in the period ended&nbsp;December&nbsp;31,
2018, and the related notes (collectively referred to as the &ldquo;financial statements&quot;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company at&nbsp;December&nbsp;31, 2018&nbsp;and&nbsp;2017,
and the results of its operations and its cash flows for each of the two years in the period ended&nbsp;December&nbsp;31, 2018,
in conformity with U.S. generally accepted accounting principles.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but
not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement
of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also
included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    KCCW Accountancy Corp.</FONT> </TD>
    <TD STYLE="width: 20%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company's auditor since 2018.</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diamond
    Bar, California</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
                                         5, 2019</FONT> </P></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KCCW
    Accountancy Corp.</B></FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3333
    S Brea Canyon Rd. #206, Diamond Bar, CA 91765, USA</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    +1 909 348 7228 &#9679; Fax: +1 909 895 4155 &#9679; info@kccwcpa.com</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_14"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOKEY,
INC.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BALANCE
SHEETS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> December&nbsp;31, </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> ASSETS </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Cash and cash equivalents </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 636,666 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,225,397 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accounts receivable, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 43,204 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 59,080 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Accounts
    receivable - related parties, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 147,848 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 134,312 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Current Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 827,718 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,418,789 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Property and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,150 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,600 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Security deposits </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,440 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total Assets </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,466,829 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> LIABILITIES AND STOCKHLDERS&rsquo; EQUITY </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accounts payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,777 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,396 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Due to shareholders </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accrued expenses and other current
    liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 65,083 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 57,576 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Advance
    from customers </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,166 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,985 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 83,026 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 79,757 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Non-current Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Tenant
    security deposit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,880 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 85,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 82,637 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Stockholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Preferred stock, no par value, 23,562,000 shares authorized: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> 7,000,000 shares of Series
    A issued and outstanding at December 31, 2018 and 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,500,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,500,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> 1,160,000 shares of Series
    A issued and outstanding at December 31, 2018 and 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,160,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> 13,973,097 shares of Series
    C issued and outstanding at December 31, 2018 and 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,973,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 13,973,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in; padding-left: 0.25in"> Common
    Stock, no par value; 30,000,000 shares authorized, 7,428,134 and 6,498,134 shares issued and outstanding at December 31, 2018
    and 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 774,293 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 541,793 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Additional paid-in capital - stock options </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 82,265 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 296,465 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Stock subscription receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Accumulated deficit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,677,586 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,087,163 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Total
    Stockholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,384,192 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Total Liabilities and
    Stockholders&rsquo; Equity </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 896,308 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,466,829 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_15"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOKEY,
INC.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATEMENTS
OF OPERATIONS </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017 </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> Revenues </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 510,197 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 983,218 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Cost of revenues </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,809 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 17,312 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Gross profit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 505,388 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 965,906 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Operating expenses: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Research and development expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 430,917 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 497,947 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Selling,
    general and administrative expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 669,322 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 767,504 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Total operating expenses </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,100,239 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,265,451 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Loss from operations </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (594,851 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (299,545 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Other income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Interest income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,598 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,742 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"> Other
    income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 630 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 459 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Total
    other income </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,228 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,201 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Loss before income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (589,623 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (292,344 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Provision for income tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Net loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (293,144 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_16"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOKEY,
INC.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATEMENTS
OF STOCKHOLDERS&rsquo; EQUITY</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017 </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>Additional</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>Stock</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Preferred
    Stock</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Common
    Stocks</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <B>Paid-in</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <B>Subscription</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> <B>Accumulated</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Shares</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Amounts</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Shares</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Amounts</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Capital</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Receivable</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Deficit</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Total</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-indent: -10pt"> Balance at December
    31, 2016 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,133,097 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,633,097 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,498,134 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 541,793 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 296,465 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (17,794,019 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,677,336 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> &nbsp;Net
    loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (293,144 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (293,144 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> Balance
    at December 31, 2017 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,133,097 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,633,097 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,498,134 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 541,793 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 296,465 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,087,163 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,384,192 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> &nbsp;Issuance
    common stock for cash </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 40,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> &nbsp;Issuance
    common stock for stock options </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 880,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 220,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (220,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> &nbsp;Issuance
    common stock for consulting service </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,500 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,667 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 833 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt; text-indent: -10pt"> &nbsp;Capital
    contribution by shareholders through debt conversion </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,800 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt"> &nbsp;Net
    loss </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt"> Balance
    at December 31, 2018 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 22,133,097 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,633,097 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,428,134 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 774,293 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 82,265 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (1,667 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> (18,677,586 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 810,402 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_17"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOKEY,
INC.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATEMENTS
OF CASH FLOWS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2018 AND 2017 </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2018 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> 2017 </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Cash flows from operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Net loss </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (590,423 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> (293,144 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 0.25in"> Adjustments
    to reconcile net loss to net cash used in operating activities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Depreciation and amortization </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 25,712 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 11,380 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Share-based compensation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 833 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Changes in assets and liabilities: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 27pt"> Decrease (increase) in accounts
    receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,340 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 57,285 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 27pt"> Decrease (increase) in other
    receivable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 27pt"> Increase (decrease) in accounts
    payable </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,381 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (19,089 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 27pt"> Increase (decrease) in accrued&nbsp;expenses
    and other current liabilities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 7,507 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,964 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 27pt"> Increase
    (decrease) in advanced from customers </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 181 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,467 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in"> Net
    cash used in operating activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (552,469 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (240,071 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows from investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 27pt"> Purchase of equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (46,262 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,794 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in"> Net
    cash used in investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (46,262 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (7,794 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash flows from financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in"> Issuance of common
    stock for cash </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.5in"> Net cash provided by
    financing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 10,000 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Net decrease in cash and
    cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (588,731 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (247,865 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Cash and cash equivalents </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0.25in"> Beginning </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,225,397 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,473,262 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 0.25in"> Ending </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 636,666 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,225,397 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Supplemental disclosure of cash flows </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in"> Cash paid during the year
    for: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 27pt"> Income
    tax </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 27pt"> Interest
    expense </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 27pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -27pt; padding-left: 27pt"> Non-cash
    financing and investing activities </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 27pt"> Related
    party debt forgiven </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <A NAME="s_18"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BIOKEY,
INC. </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO THE FINAICAL STATEMENTS</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DECEMBER
31, 2018 </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1. Nature of Business and Significant Accounting Policies</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nature
of business: </B>BioKey, Inc., (hereinafter, &ldquo;the Company&rdquo;), was incorporated on August 9, 2000 in the State of California.
It is engaged primarily in research and development, manufacturing, and distribution of generic drugs and nutraceuticals with
strategic partners. The Company provides a wide range of services, including, API characterization, pre-formulation studies, formulation
development, analytical method development, stability studies, IND/NDA/ANDA/510K submissions, and manufacturing clinical trial
materials (phase 1 through phase 3) and commercial manufacturing. The Company also licenses out its technologies and initiates
joint research and development processes with other biotechnology, pharmaceutical, and nutraceutical companies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
summary of the Company&rsquo;s significant accounting policies is as follows:</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
of presentation:</B> The accompanying financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of estimates: </B>The preparation of financial statements in conformity with generally accepted accounting principles of United
States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
and cash equivalents: </B>For purposes of reporting cash flows, the Company considers all highly liquid debt instruments purchased
with a maturity of three months or less to be cash equivalents.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts
receivable and other receivable: </B>Accounts receivable and other receivable are stated at carrying value less estimates made
for doubtful receivables. An allowance for impairment of trade receivable and other receivable is established if the collection
of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not
be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the
debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments
are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset&rsquo;s
carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
and equipment: </B>Property and equipment are recorded at cost. Depreciation is computed on the straight-line method over the
estimated useful lives of the related assets as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 85%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laboratory
    and manufacturing equipment</FONT> </TD>
    <TD STYLE="width: 15%; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    ~5 years</FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    ~8 years</FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and fixtures</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8~15
    years</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
for major renewals and betterment that extend the useful lives of property and equipment are capitalized. Expenditures for repairs
and maintenance are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the asset
and accumulated depreciation are removed from the accounts and the resulting profit or loss is reflected in the statement of income
for the period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impairment
of long-lived assets: </B>The Company reviews its long-lived assets whenever events or circumstances indicate that the carrying
amount of such assets may not be recoverable. Impairment is evaluated by comparing the carrying value of the long-lived assets
with the estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from
disposition. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize
an impairment loss at that date. An impairment loss would be measured by comparing the amount by which the carrying value exceeds
the fair value (estimated discounted future cash flows) of the long-lived assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
recognition: </B>During the fiscal year 2018, the Company adopted Accounting Standards Codification (&ldquo;ASC&rdquo;), Topic
606 (ASC 606), Revenue from Contracts with Customers, using the modified retrospective method to all contracts that were not completed
as of January 1, 2018, and applying the new revenue standard as an adjustment to the opening balance of accumulated deficit at
the beginning of 2018 for the cumulative effect. The results for the Company&rsquo;s reporting periods beginning on and after
January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the
accounting standards in effect for the prior period. Based on the Company&rsquo;s review of existing contracts as of January 1,
2018, the Company concluded that the adoption of the new guidance did not have a significant change on the Company&rsquo;s revenue
during all periods presented.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that
reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition
for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i)
identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction
price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or
as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable
that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers
to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company
assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses
whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price
that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Generally, the
Company's performance obligations are transferred to customers at a point in time, typically upon delivery.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently only has one major revenue source, which is research and development activities services.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
related to research and development and regulatory activities are recognized when the related services or activities are performed,
in accordance with the contract terms. The Company typically has only one performance obligation at the inception of a contract,
which is to perform research and development services. The Company may also provide its customers with an option to request that
the Company provides additional goods or services in the future, such as active pharmaceutical ingredient, API, or IND/NDA/ANDA/510K
submissions. The Company evaluates whether these options are material rights at the inception of the contract. If the Company
determines an option is a material right, the Company will consider the option a separate performance obligation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is entitled to reimbursement from its customers for specified research and development expenses, the Company accounts
for the related services that it provides as separate performance obligations if it determines that these services represent a
material right. The Company also determines whether the reimbursement of research and development expenses should be accounted
for as revenues or an offset to research and development expenses in accordance with provisions of gross or net revenue presentation.
The Company recognizes the corresponding revenues or records the corresponding offset to research and development expenses as
it satisfies the related performance obligations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company then determines the transaction price by reviewing the amount of consideration the Company is eligible to earn under the
contracts, including any variable consideration. Under the outstanding contracts, consideration typically includes fixed consideration
and variable consideration in the form of potential milestone payments. At the start of an agreement, the Company&rsquo;s transaction
price usually consists of the payments made to or by the Company based on the number of full-time equivalent researchers assigned
to the project and the related research and development expenses incurred. The Company does not typically include any payments
that the Company may receive in the future in its initial transaction price because the payments are not probable. The Company
would reassess the total transaction price at each reporting period to determine if the Company should include additional payments
in the transaction price.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company receives payments from its customers based on billing schedules established in each contract. Upfront payments and fees
may be recorded as advance from customers upon receipt or when due, and may require deferral of revenue recognition to a future
period until the Company performs its obligations under these arrangements. Amounts are recorded as accounts receivable when the
right of the Company to consideration is unconditional. The Company does not assess whether a contract has a significant financing
component if the expectation at contract inception is such that the period between payment by the customers and the transfer of
the promised goods or services to the customers will be one year or less.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advertising
costs: </B>Advertising costs are expensed as incurred. The total advertising and marketing expenses were $0 for the years ended
December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and development:</B> The Company accounts for R&amp;D costs in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;)
730, Research and Development (&ldquo;ASC 730&rdquo;). Research and development expenses are charged to expense as incurred unless
there is an alternative future use in other research and development projects or otherwise. Research and development expenses
are comprised of costs incurred in performing research and development activities, including personnel-related costs, facilities-related
overhead, and outside contracted services including clinical trial costs, manufacturing and process development costs for both
clinical and preclinical materials, research costs, and other consulting services. Non-refundable advance payment for goods and
services that will be used in future research and development activities are expensed when the activity has been performed or
when the goods have been received rather than when the payment is made. In instances where the Company enters into agreements
with third parties to provide research and development services, costs are expensed as services are performed.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
taxes: </B>The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize
deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis
of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income
tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is
recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be
realized. The Company provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax position.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuation
of deferred tax assets: </B>A valuation allowance is recorded to reduce its deferred tax assets to the amount that is more likely
than not to be realized. In assessing the need for the valuation allowance, management considers, among other things, projections
of future taxable income and ongoing prudent and feasible tax planning strategies. If the Company determines that sufficient negative
evidence exists, then it will consider recording a valuation allowance against a portion or all of the deferred tax assets in
that jurisdiction. If, after recording a valuation allowance, the Company&rsquo;s projections of future taxable income and other
positive evidence considered in evaluating the need for a valuation allowance prove, with the benefit of hindsight, to be inaccurate,
it could prove to be more difficult to support the realization of its deferred tax assets. As a result, an additional valuation
allowance could be required, which would have an adverse impact on its effective income tax rate and results. Conversely, if,
after recording a valuation allowance, the Company determines that sufficient positive evidence exists in the jurisdiction in
which the valuation allowance was recorded, it may reverse a portion or all of the valuation allowance in that jurisdiction. In
such situations, the adjustment made to the deferred tax asset would have a favorable impact on its effective income tax rate
and results in the period such determination was made. In determining the need for a valuation allowance, management reviewed
both positive and negative evidence pursuant to the requirements of ASC Topic 740. At December 31, 2018, management concluded
that it is more likely than not that the Company would not realize benefits of its net deferred tax assets. The Company will continue
to evaluate the need for a valuation allowance in future periods based upon the criteria as provided for under ASC Topic 740.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applied the provisions of ASC 740-10-50, &ldquo;Accounting For Uncertainty In Income Taxes&rdquo;, which provides clarification
related to the process associated with accounting for uncertain tax positions recognized in its financial statements. Audit periods
remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute
of limitations for a given audit period could result in an adjustment to the Company&rsquo;s liability for income taxes. Any such
adjustment could be material to the Company&rsquo;s results of operations for any given quarterly or annual period based, in part,
upon the results of operations for the given period. As of December 31, 2018 and 2017, management considered that the Company
had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concentration
of credit risks: </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
and cash equivalents: </B>The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured
limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. As of December 31, 2018 and
2017, the Company had $342,063 and $963,763 in excess of FDIC insured limits, respectively. The Company has not experienced any
losses in such accounts.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Customers</B>:
The Company performs ongoing credit evaluations of its customers&rsquo; financial condition and generally, requires no collateral.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2018, Two customers who accounted for more than 10% of the Company&rsquo;s total net sales revenues,
representing approximately 38.8% and 15% of total net sales revenues, and 0% and 0% of accounts receivable in aggregate at December
31, 2018, respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> <B>Customer</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Net&nbsp;sales&nbsp;for the year <BR> 2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Accounts
    receivable balance&nbsp;as of<BR> December&nbsp;31,<BR> 2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> A </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 167,596 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> B </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 64,746 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2017, five customers who accounted for more than 10% of the Company&rsquo;s total net sales revenues,
representing approximately 28%, 15%, 14%, 10%, and 10% of total net sales revenues, and 0%, 8%, 0%, 1%, and 69% of accounts receivable
in aggregate at December 31, 2017, respectively:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> <B>Customer</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Net&nbsp;sales&nbsp;for the year <BR> 2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Accounts
    receivable balance&nbsp;as of <BR> December&nbsp;31,<BR> 2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> A </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 273,966 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> B </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 150,450 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 15,950 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> C </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 141,674 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> D </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 98,000 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,300 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> E </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 88,085 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 134,312 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> * </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Related party transactions (See Note 3).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suppliers:
</B>The Company currently is not entering any significant purchase agreements with suppliers for the years ended December 31,
2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
value measurements:</B> FASB ASC 820, &ldquo;Fair Value Measurements&rdquo; defines fair value for certain financial and nonfinancial
assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures
about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price,
maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a
hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency
and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing
the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect
the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources
independent of the Company. Unobservable inputs are inputs that reflect the Company&rsquo;s own assumptions about the assumptions
market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.
The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 24px; text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1 &ndash; Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability
    to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations
    are based on quoted prices in active markets that are readily and regularly available.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2 &ndash; Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement
    date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
    that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3 &ndash; Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets
    and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that
    incorporate the assumptions a market participant would use in pricing the asset or liability.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, accounts
payable, accrued liabilities, and advance from customers, approximate fair value due to their relatively short maturities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-based
compensation: </B><FONT STYLE="background-color: white">The Company accounts for its stock-based compensation in accordance with
ASC 718, Compensation&mdash;Stock Compensation, which establishes accounting for stock-based awards granted to employees for services
and requires companies to expense the estimated fair value of these awards over the requisite service period. The Company estimates
the fair value of all awards granted using the Black-Scholes valuation model. Key inputs and assumptions include the expected
term of the option, stock price volatility, risk-free interest rate, dividend yield, stock price and exercise price. Many of the
assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation
expense. The Company elected an accounting policy to record forfeitures as they occur. The Company recognizes employee stock-based
compensation expense based on the fair value of the award on the date of the grant. The compensation expense is recognized over
the vesting period under the straight-line method. </FONT>During the years ended December 31, 2018 and 2017, the Company did not
record any employee stock-based compensation expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company accounts for options awards granted to nonemployee consultants and directors under ASC 505 Equity. The fair value of the
option issued or committed to be issued is used to measure the transaction, as this is more reliable than the fair value of the
services received. The fair value is measured at the value of the Company&rsquo;s common stock at the earlier of the date that
the commitment for performance by the counterparty has been reached or the counterparty&rsquo;s performance is complete. Awards
granted to nonemployees are remeasured to fair value at each period end date until vested and expensed on a straight-line basis
over the vesting period.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years
ended December 31, 2018 and 2017, the stock-based compensation expenses to non-employee consultants were $833 and $0, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Profit
sharing plan:</B> The Company has a 401 (k) profit sharing plan for employees who have reached the age of twenty-one and have
completed one year of eligibility service. The Company&rsquo;s contribution is based on management&rsquo;s discretion. In addition,
the Company may make a nonelective contributions to the plan. The amount of the nonelective contribution is determined by its
Board of Directors on an annual basis. Total contributions that the Company made to the plan were $0 for the years ended December
31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recently
issued accounting pronouncements: </B>In February 2016, the FASB issued ASU No. 2016-02, &ldquo;Leases.&rdquo; The core principle
of the ASU is that a lessee should recognize the assets and liabilities that arise from its leases other than those that meet
the definition of a short-term lease. The ASU requires extensive qualitative and quantitative disclosures, including with respect
to significant judgments made by management. Subsequently, the FASB issued ASU No. 2017-13, in September 2017 and ASU No. 2018-01,
in January 2018, which amends and clarifies ASU 2016-02. The ASU will be effective for the Company beginning January 1, 2019,
including interim periods in the fiscal year 2019. Early adoption is permitted. The Company is in the process of determining the
method of adoption and assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position
and disclosures.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 22, 2017, the SEC issued Staff Accounting Bulletin (&ldquo;SAB 118&rdquo;), which provides guidance on accounting for
tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment
date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax
effects of those aspects of the Act for which the accounting under ASC 740 is complete. In March 2018, the FASB issued ASU 2018-05,
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (SEC Update), Income Taxes (Topic 740). ASU 2018-05
provides guidance regarding the recording of tax impacts where uncertainty exists, in the period of adoption of the 2017 U.S.
Tax Cuts and Jobs Act (the &ldquo;2017 Tax Act&rdquo;). To the extent that a company&rsquo;s accounting for certain income tax
effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate
to be included in the financial statements. If a company cannot determine a provisional estimate to be included in the financial
statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were in effect immediately
before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact of the reduction in
corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates, due
to, among other things, changes in our interpretations and assumptions, additional guidance that may be issued by the I.R.S.,
and actions we may take. The Company is continuing to gather additional information to determine the final impact.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2018, the FASB issued ASU 2018-07, Compensation &ndash; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based
Payment Accounting. This new standard simplifies the accounting for share-based payments granted to nonemployees for goods and
services. The standard supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payment arrangements
related to the acquisition of goods and services from both nonemployees and employees. As such, among others, the measurement
date for nonemployee awards would generally be the grant date same as the measurement date for employee equity awards and for
performance-based awards, an entity is required to recognize any cost on the basis of the probable outcome of the performance&nbsp;conditions
using the grant-date fair value of the award. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including
interim periods within those fiscal years. <FONT STYLE="background-color: white">The Company is continuing to gather additional
information to determine the final impact and</FONT> expects to adopt this guidance when effective.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &mdash; Changes to
the Disclosure Requirements for Fair Value Measurement. This standard changes the fair value measurement disclosure requirements
of ASC 820. The new standard eliminated certain disclosures, added new disclosures with regard to unrealized gains or losses included
in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range
and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements, as well as modified
certain disclosure. ASU 2018-13 is effective for all entities for fiscal years beginning after December 15, 2019, including interim
periods therein. Early adoption is permitted. The ASU requires application of the prospective method of transition for the aforementioned
new disclosure requirements and for modified disclosure with regard to measurement uncertainty while all other amendments made
by the ASU must be applied retrospectively to all periods presented. The Company is in the process of assessing the impact of
this standard on its financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2. Property and Equipment</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the Company&rsquo;s property and equipment as of December 31, 2018 and 2017:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Laboratory and manufacturing equipment </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 876,261 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 829,999 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Office equipment </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,081 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,081 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Leasehold improvements </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,994,585 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,994,585 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Furniture and fixtures </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 106,510 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 106,510 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"> Subtotal </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,983,437 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,937,175 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Less: accumulated depreciation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,925,287 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,899,575 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 9pt"> Property
    and equipment, net </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 58,150 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 37,600 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
depreciation expense was $25,712 and $11,380 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3. Related Party Transactions</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Operating
lease</U></I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has subleased a portion of its office space to Amkey Ventures, LLC, (the &ldquo;Amkey&rdquo;) since June 21, 2001. The
sublease is automatically renewed on an annual basis. Amkey is incorporated in the State of California on April 23, 2001. Mr.
George J Lee, the Chairman of the Company, is one of managers of Amkey. The rental income was $4,800 for the years ended December
31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Company has become one of wholly-owned subsidiaries of American BriVision (Holding) Corporation (the &ldquo;ABVC&rdquo;),
a Nevada company, pursuant to the definitive Agreement and Plan of Merger dated at January 31, 2018. On October 2, 2018, the Company
and ABVC entered into an operating lease agreement to sublease a portion of its office space to ABVC. The lease can be terminated
one month in advance provided with written notice. The rental income was $2,400 and $0 for the years ended December 31, 2018 and
2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subleases above are classified as an operating lease and the original lessee shall continue to account for the original lease
as it did before commencement of the sublease. Pursuant to ASC 842-20-35-14, the nature of this sublease is such that the original
lessee is not relieved of the primary obligation under the original lease, the original lessee (as sublessor) shall continue to
account for the original lease. Accordingly, the Company recorded the rental income as a reduction of rent expenses for the years
ended December 31, 2018 and 2017.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Related
party sales transaction</U></I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genepharm
Inc., (the &ldquo;Genepharm&rdquo;), was incorporated on March 6, 2000 in the State of California. Mr. George J Lee is the Chairman
of both Genepharm and the Company. The Company had net sales of $18,900 and $88,085 to Genepharm for the years ended December
31, 2018 and 2017, respectively. As of December 31, 2018 and 2017, the Company also had accounts receivable of $142,225 and $134,312
due from Genepharm, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Due
to shareholders</U></I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has advanced funds from its shareholder and Chairman for working capital purposes. The Company has not entered into any
agreement on the repayment terms for these advances. The advances bore no interest rate and were due upon demand by its shareholder
and Chairman.&nbsp;<FONT STYLE="background-color: white">During the year ended December 31, 2018, the debt of $5,800 was forgiven
by&nbsp;</FONT>its shareholder and Chairman&nbsp;<FONT STYLE="background-color: white">and the Company recorded the debt forgiveness
as additional paid in capital.&nbsp;</FONT>As of December 31, 2018 and 2017, the outstanding advances were $0 and 5,800, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4. Accrued Expenses and Other Current Liabilities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other current liabilities as of December 31, 2018 and 2017 consisted of:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left"> Accrued professional fees </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 35,970 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 35,756 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Accrued vacation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,641 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 19,541 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Others </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 14,472 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,279 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 65,083 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 57,576 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5. Stock-Based Compensation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>2015
Stock Plan</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s board of directors adopted, and its stockholders approved its 2015 Stock Plan (the &ldquo;2015 Plan&rdquo;) in
March 2015, providing for the issuance under 2015 Plan of options and rights to purchase up to Four million two hundred and fifty
thousand (4,250,000) shares of Common Stock. As of December 31, 2018 and 2017, there were 308,455 and 918,843 shares available
for issuance under the Company&rsquo;s 2015 Plan, respectively, which provides for the grant of incentive stock options and nonstatutory
stock options to employees, directors, and consultants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price of incentive stock options under the 2015 Plan shall be no less than 100% of the fair market value per share of
the Common Stock on the date of grant. Notwithstanding the above, if an incentive stock option is granted to an employee who owns
more than ten percent of the total combined voting power of all classes of stock of the Company or any subsidiary, the exercise
price shall be no less than 110% of the fair market value per share of the Common Stock on the date of grant. The exercise price
of nonstatutory stock options under the 2015 Plan shall be no less than 100% of the fair market value per share of the Common
Stock on the date of grant.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
stock options under the 2015 Plan have a term of no greater than 10 years from the date of grant. However, in the case of an option
granted to an optionee who, at the time the optionee is granted, owns stock representing more than ten percent of the voting power
of all classes of stock of the Company or subsidiary, the term of the option shall be 5 years from the date of grant or such shorter
term as may be provided in the option agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
of stock options is determined by the board of directors of the Company. No stock option may be exercised subsequent to its termination
date. The purchase price of a right to purchase Common Stock and the termination date of the offer under the 2015 Plan is determined
by the board of directors of the Company. The Company shall have the right to repurchase all or a portion of the shares acquired
pursuant to the exercise of this option in the event that the participant&rsquo;s continuous service should terminate for any
reason whatsoever.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
fair value of each stock option granted under 2015 Plan was estimated on the date of grant using the Black-Scholes option pricing
model with the following assumptions:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
    Ended </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December 31,</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average fair value of Common Stock on date of grant</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.30</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.30</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average exercise price of the options</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A
    </FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average exercise price of options outstanding at end of period</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term of the options (years)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility (%)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.0</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.0</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    yield</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    forfeiture per year (%)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average fair value of the options per unit</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.30</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.30</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*
No stock options were granted&nbsp;during the years ended December 31, 2018 and 2017</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Compensation
expense related to stock-based transactions is measured and recognized in the financial statements based on the fair value of
the awards granted. The stock-based compensation expense, net of forfeitures, is recognized on a straight-line basis over the
requisite service periods of the awards, which is generally three to four years.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Use
of the Black-Scholes</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">option pricing model
<FONT STYLE="background-color: white">requires the input of subjective assumptions, including the fair value of the underlying
Common Stock, expected term of the option, expected volatility of the price of the Common Stock, risk-free interest rates, and
expected dividend yield of the Common Stock. The assumptions used in the option-pricing model represent management&rsquo;s best
estimates.</FONT></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">These
assumptions and estimates are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Fair
Value of Common Stock</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
fair value of the Common Stock underlying its stock-based awards was primarily based on the latest financing rounds of issuing
equity interest near the option grant date. It was determined by the Company&rsquo;s board of directors, with input from management
and a third-party valuation firm.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Expected
Term </U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
expected term assumptions were determined based on the vesting terms, exercise terms, and contractual lives of the options.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Expected
Volatility</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expected volatility of stock options is estimated based upon the historical volatility of a number of publicly traded companies
in similar stages of development and comparable industries for a period commensurate with the expected life.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Risk-Free
Interest Rate</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury
notes with maturities approximately equal to the option&rsquo;s expected term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Dividend
Yield</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company has never declared or paid any cash dividends and does not presently plan to pay cash dividends in the foreseeable future.
Consequently, an expected dividend yield of zero was utilized.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Expected
Forfeitures</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers many factors when estimating expected forfeitures, including economic environment, and historical experience.
The Company updates its estimated forfeiture rate annually.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the stock option activity under the 2015 Plan and related information:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="13" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Outstanding</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Weighted-</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>Price</B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life&nbsp;(Years)</FONT></B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></B> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 67%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    &ndash; January&nbsp;1, 2017</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,767</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 8%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.97</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or cancelled</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32,356</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    &ndash; December&nbsp;31, 2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,411</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.72</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 9pt; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or cancelled</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,411</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    &ndash; December&nbsp;31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NA</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable
    &ndash; December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    and expected to vest &ndash; December 31, 2018</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable
    &ndash; December&nbsp;31, 2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,411</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.72</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    and expected to vest &ndash; December&nbsp;31, 2017</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,411</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.72</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average grant-date fair value of options granted during the years ended December 31, 2018 and 2017 was $nil and $0.25
per share, respectively. The total fair value of options vested during the years ended December 31, 2018 and 2017 was $0.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6. Operating Lease Obligation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its main office in Fremont, California, under operating leases expiring on February 28, 2021. The monthly rent
is approximately $23,600. The Company also leases an office equipment with monthly payment of approximately $220 expiring on August
31, 2019. The total rent expenses were $278,961 and $274,978 for the years ended December 31, 2018 and 2017, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payments under the Company&rsquo;s operating leases are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <B>As of December
    31,</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Amount</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left"> 2019 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 304,726 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> 2020 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 310,239 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> 2021 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 51,910 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 666,875 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7. Income Taxes</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction, and California state and local jurisdictions. The Company is
not currently under examination by the Internal Revenue Service or any state income tax authorities. The 2015 through 2017 tax
years remain subject to examination by the Internal Revenue Service. The 2014 through 2017 tax years generally remain subject
to examination by California.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On&nbsp;December
22, 2017<I>&nbsp;</I>H.R<I>.&nbsp;</I>1,&nbsp;originally known as the Tax Cuts and Jobs Act, (the &ldquo;Tax Act&rdquo;) was enacted.
Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate
(&ldquo;Federal Tax Rate&rdquo;) from&nbsp;35%&nbsp;to&nbsp;21%&nbsp;effective January 1, 2018<I>.&nbsp;</I>The&nbsp;21%&nbsp;Federal
Tax Rate will apply to earnings reported for the full&nbsp;2018<I>&nbsp;</I>fiscal year. In addition, the Company must re-measure
its net deferred tax assets and liabilities using the Federal Tax Rate that will apply when these amounts are expected to reverse.
As of&nbsp;December 31,&nbsp;2018,&nbsp;the Company can determine a reasonable estimate for certain effects of tax reform and
is recording that estimate as a provisional amount. The provisional remeasurement of the deferred tax assets and allowance valuation
of deferred tax assets at December 31, 2018 and 2017 resulted in a&nbsp;net effect of $0 discrete tax expenses (benefit) which
lowered the effective tax rate by&nbsp;14%&nbsp;for the years ended December 31, 2018 and 2017. The provisional remeasurement
amount is anticipated to change as data becomes available allowing more accurate scheduling of the deferred tax assets and liabilities
primarily related to net operating loss carryover.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components
of income tax (benefits) for the years ended December 31, 2018 and 2017 are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>For
    the year ended December 31, 2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>For
    the year ended December 31, 2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Federal</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>State</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Total</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Federal</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>State</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>Total</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif"> Current </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> Deferred </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 800 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
components of the Company&rsquo;s deferred tax accounts at December 31, 2018 and 2017:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>December&nbsp;31,<BR>
    2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>December&nbsp;31,<BR>
    2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Deferred Tax Account - noncurrent: </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Allowance for Doubtful
    Accounts </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,514 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,846 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Reserve for Obsolete Inventory </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 177 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 177 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accrued Vacation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,097 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 5,468 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Accumulated Depreciation </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (4,792 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (2,703 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> Tax Net Operating Loss Carryforwards </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,824,558 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,740,797 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt"> General Business Credit </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,348,855 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,316,980 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"> Less:
    Valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,175,409 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (5,081,565 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 27pt"> Total deferred
    tax account - noncurrent </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined
by applying the applicable statutory U.S. tax rate are analyzed below:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2018</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <B>&nbsp;</B> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <B>2017</B> </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <B>&nbsp;</B> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: justify"> Statutory tax benefit, net of state
    effects </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 19 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 31 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> State income taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8.84 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 8.84 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Provisional remeasurement of deferred taxes </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> (12 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Nondeductible/nontaxable items </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> Change in valuation allowance </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (27.84 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> (27.84 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> )% </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"> Effective income tax rate </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> % </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8. Subsequent Events</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
BriVision (Holding) Corporation (&ldquo;ABVC&rdquo;), BioLite Holding, Inc. (&ldquo;BioLite&rdquo;), BioKey, Inc. (the &ldquo;Company&rdquo;
or &ldquo;BioKey&rdquo;), BioLite Acquisition Corp., a direct wholly-owned subsidiary of ABVC (&ldquo;Merger Sub 1&rdquo;), and
BioKey Acquisition Corp., a direct wholly-owned subsidiary of ABVC (&ldquo;Merger Sub 2&rdquo;) (<FONT STYLE="background-color: white">collectively
referred to as the &ldquo;Parties&rdquo;),</FONT> entered into a definitive Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;)
dated as of January 31, 2018, providing for the acquisition of BioLite and BioKey by ABVC. Pursuant to the terms of the Merger
Agreement, BioLite will merge with Merger Sub 1 with BioLite as the surviving corporation, which is referred to as the &ldquo;BioLite
Merger.&rdquo; BioKey will merge with Merger Sub 2 with BioKey as the surviving corporation, which is referred as the &ldquo;BioKey
Merger.&rdquo; BioLite Merger and BioKey Merger together are sometimes referred to as the Mergers.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2019, the Parties of the Merger Agreement consummated the Merger transactions. Pursuant to the terms of the Merger
Agreement, BioLite and BioKey became two wholly-owned subsidiaries of ABVC on February 8, 2019. As of the date of this prospectus,
the Company is in the process of issuing shares of common stocks of ABVC as merger considerations to the shareholders of BioLite
and BioKey pursuant to ABVC&rsquo;s registration statement (the &ldquo;Registration Statement on S-4&rdquo;) on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019000796/fs42018a3_americanbrivision.htm">Form S-4</A> Amendment
No. 3 filed with the SEC on January 16, 2019 which became effective by operation of law on or about February 5, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through the date which the financial statements were available to be issued. All subsequent
events requiring recognition as of December 31, 2018 have been incorporated into these financial statements and there are no subsequent
events that require disclosure in accordance with FASB ASC Topic 855, &ldquo;Subsequent Events.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">******</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>





<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PART
II&nbsp;&mdash;&nbsp;INFORMATION NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
13. <I>Other Expenses of Issuance and Distribution</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table sets forth all expenses to be paid by the Registrant, other than estimated placement agents&rsquo; fees, in connection
with our public offering. All amounts shown are estimates except for the SEC registration fee and the FINRA filing fee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,593.68</FONT> </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
    filing fee</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,710.00</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;250,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    agent and registrar fees</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous
    fees and expenses</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD>
    <TD STYLE="border-bottom: black 4.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 29px; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">*</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Estimated.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
14. <I>Indemnification of Directors and Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Neither
our Articles of Incorporation nor Bylaws prevent us from indemnifying our officers, directors and agents to the extent permitted
under the Nevada Revised Statute (&ldquo;NRS&rdquo;). NRS Section 78.7502 provides that a corporation shall indemnify any director,
officer, employee or agent of a corporation against expenses, including attorneys&rsquo; fees, actually and reasonably incurred
by him in connection with any the defense to the extent that a director, officer, employee or agent of a corporation has been
successful on the merits or otherwise in defense of any action, suit or proceeding referred to Section 78.7502(1) or 78.7502(2),
or in defense of any claim, issue or matter therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NRS
78.7502(1) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except
an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent
of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against expenses, including att&rsquo;rneys&rsquo; fees, judgments,
fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding
if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be
in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable
cause to believe his conduct was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NRS
Section 78.7502(2) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor
by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the
request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
or other enterprise against expenses, including amounts paid in settlement and atto&rsquo;rneys&rsquo; fees actually and reasonably
incurred by him in connection with the defense or settlement of the action or suit if he: (a) is not liable pursuant to NRS 78.138;
or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation.
Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent
jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation or for amounts paid in settlement to
the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent
jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably
entitled to indemnity for such expenses as the court deems proper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NRS
Section 78.747 provides that except as otherwise provided by specific statute, no director or officer of a corporation is individually
liable for a debt or liability of the corporation, unless the director or officer acts as the alter ego of the corporation. The
court as a matter of law must determine the question of whether a director or officer acts as the alter ego of a corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 116; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
us pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, we will, unless in the opinion of our counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by us is against public policy as expressed hereby in the Securities Act and we will be governed by the final adjudication of
such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Articles
of Incorporation and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation, as amended, do not include specific provisions relating to the indemnification of our directors or
officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
bylaws provide that the Company may indemnify and advance litigation expenses to its directors, officers, employees and agents
to the extent permitted by law, the Company&rsquo;s Articles or Bylaws, and shall indemnify and advance litigation expenses to
its directors, officers, employees and agents to the extent required by law, the Company&rsquo;s Articles of Incorporation or
Bylaws. The Company&rsquo;s obligations of indemnification, if any, shall be conditioned on the Company receiving prompt notice
of the claim and the opportunity to settle and defend the claim. The Company may, to the extent permitted by law, purchase and
maintain insurance on behalf of an individual who is or was a director, officer, employee or agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
15. <I>Recent Sales of Unregistered Securities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as disclosed in ABVC&rsquo;s quarterly reports and annual reports filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018006355/f10q0318_americanbrivision.htm">May 15, 2018</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390018004408/f10kt2017_americanbrivision.htm">April 13, 2018</A>, December
29, 2017, March 19, 2018, <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009907/f10k2016a3_americanbrivision.htm">September 22, 2017</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416006781/s103894_10q.htm">August 15, 2016</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416005453/s103274_10q.htm">May 16, 2016</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416004285/s102675_10q.htm">February 23, 2016</A>, we have no sales of unregistered
securities during the fiscal years of 2018, 2017 and 2016. From January 1, 2018 to the date of this prospectus, the Company issued
convertible notes of an aggregate amount of $800,000 to three non-U.S. investors for the Company&rsquo;s general working capital
purposes in reliance on an exemption from registration set forth in section 4(2) of the Securities Act of 1933, as amended.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
16. <I>Exhibits and Financial Statement Schedules </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex1-1_american.htm">Form of Underwriting Agreement by and among the Registrant and the Underwriters named therein</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Exchange Agreement, dated February 8, 2016 (1)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000113789202000063/fex301ai.txt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
    of Incorporation of the Company (2)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000113789202000063/fex302bl.txt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws
    of the Registrant, as amended and currently in effect (3)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416004635/s102891_4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on March 21, 2016 (4)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416007154/s104086_ex3-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on December 21, 2016 (5)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019008025/f8k050319ex3-1_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation, filed on May 3, 2019 and currently in effect (6)</FONT></A> </TD></TR>

<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex3-6_american.htm">Certificate of Designations for Series A Convertible Preferred Stock</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex4-1_american.htm">Form of the Registrant&rsquo;s Common Stock certificate</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex4-2_american.htm">Form of Underwriter&rsquo;s Warrant</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex5-1_american.htm">Legal Opinion of Sichenzia Ross Ference LLP</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex10-1_american.htm">Form of Subscription Agreement</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement dated December 29, 2015 (7)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416005823/s103448_ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborative
    Agreement and Milestone Payment Agreement dated June 9, 2016 (8)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017001707/f8k0217ex99i_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum
    to the Collaboration Agreement dated January 12, 2017 (9)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017007869/f8k072417ex10i_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement with BioFirst dated July 24, 2017 (10)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017005978/f8k052617ex99i_american.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Deve
    Agreement with Rgene dated May 26, 2017 (11)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-1_americanbriv.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Howard Doong (12)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-3_americanbriv.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Chi-Hsin Richard King (13)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-1_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Loan Agreement entered by and between Cathay Bank and American BriVision (Holding) Corporation (14)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-2_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    Note entered by American BriVision (Holding) Corporation (15)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-3_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Commercial Security Agreement (16)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416008325/s104643_ex14-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
    of Ethics (17)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019002588/fs12018a1ex21-1_americanbri.htm">List
    of significant subsidiaries of ABVC*</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Sichenzia Ross Ference LLP (18)</FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex23-2_american.htm">Consent of KCCW Accountancy Corp</A></FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.3in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 16, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.01 to the Company&rsquo;s Form SB-2 filed on June 28, 2002.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.02 to the Company&rsquo;s Form SB-2, filed on June 28, 2002.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed on March 28, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.4 to the Company&rsquo;s Form S-1, filed on September 13, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.1 in the current report on Form 8-K with the Securities and Exchange Commission on May 8, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.2 the Company&rsquo;s Current Report on Form 8-K, filed on February 16, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on June 9, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 22, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on July 24, 2017.</FONT> </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.3in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on May 30, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on September 20, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K, filed on September 20, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.2 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 14.1 to the Company&rsquo;s Amendment No.1 to Form S-1, filed on November 14, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included as Exhibit
    5.1.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> * </TD><TD STYLE="text-align: justify"> previously filed. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Item
17. Undertakings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
undersigned Registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)
To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)
If the Registrant is relying on Rule 430B (&sect;230.430B of this chapter):&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(A)
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as
of the date the filed prospectus was deemed part of and included in the registration statement; and&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(B)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information
required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale
of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and
any person that is at that date an Underwriter, such date shall be deemed to be a new effective date of the registration statement
relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by
reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with
a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date;
or&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)
If the Registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating
to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A,
shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part
of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such date of first use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)
That, for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial
distribution of the securities, the undersigned Registrant undertakes that in a primary offering of securities of the undersigned
registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser,
if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant
will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(i)
Any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant
to Rule 424;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred
to by the undersigned Registrant;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
Registrant or its securities provided by or on behalf of the undersigned registrant; and&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
undersigned Registrant hereby undertakes to provide to the Underwriters at the closing specified in the underwriting agreement
certificates in such denominations and registered in such names as required by the Underwriters to permit prompt delivery to each
purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers, and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any
action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in
the Act and will be governed by the final adjudication of such issue.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement on Form S-1 to be
signed on its behalf by the undersigned, thereunto duly authorized in the City of Fremont, California on June 28, 2019.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AMERICAN
    BRIVISION (HOLDING) CORPORATION</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Howard Doong</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Howard
    Doong</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President
    and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 55%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
    Doong</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
    Doong</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
    Jiang</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Financial Officer and Chairman of the Board of Directors</FONT> </TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">June
28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eugene
    Jiang</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tsang
    Ming Jiang</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ming-Fong
    Wu</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yen-Hsin
    Chou&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norimi
    Sakamoto</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Strategy Officer and Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tsung-Shann
    Jiang</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chang-Jen
    Jiang</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shin-Yu
    Miao</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoshinobu
    Odaira</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shih-Chen
    Tzeng</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, 2019</FONT> </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hwalin
    Lee</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 4%; white-space: nowrap"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> *By:&nbsp; </P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 24%; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <U>Howard
                                         Doong</U> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 21%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Attorney- in Fact </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 122; Options: NewSection; Value: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex1-1_american.htm">Form of Underwriting Agreement by and among the Registrant and the Underwriters named therein</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Exchange Agreement, dated February 8, 2016 (1)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000113789202000063/fex301ai.txt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
    of Incorporation of the Company (2)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000113789202000063/fex302bl.txt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws
    of the Registrant, as amended and currently in effect (3)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416004635/s102891_4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on March 21, 2016 (4)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416007154/s104086_ex3-4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on December 21, 2016 (5)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019008025/f8k050319ex3-1_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation, filed on May 3, 2019 and currently in effect (6)</FONT></A> </TD></TR>

<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex3-6_american.htm">Certificate of Designations for Series A Convertible Preferred Stock</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex4-1_american.htm">Form of the Registrant&rsquo;s Common Stock certificate</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex4-2_american.htm">Form of Underwriter&rsquo;s Warrant</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex5-1_american.htm">Legal Opinion of Sichenzia Ross Ference LLP</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex10-1_american.htm">Form of Subscription Agreement</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement dated December 29, 2015 (7)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416005823/s103448_ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborative
    Agreement and Milestone Payment Agreement dated June 9, 2016 (8)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017001707/f8k0217ex99i_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum
    to the Collaboration Agreement dated January 12, 2017 (9)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017007869/f8k072417ex10i_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement with BioFirst dated July 24, 2017 (10)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017005978/f8k052617ex99i_american.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Deve
    Agreement with Rgene dated May 26, 2017 (11)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-1_americanbriv.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Howard Doong (12)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-3_americanbriv.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Chi-Hsin Richard King (13)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-1_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Loan Agreement entered by and between Cathay Bank and American BriVision (Holding) Corporation (14)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-2_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    Note entered by American BriVision (Holding) Corporation (15)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-3_americanbri.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Commercial Security Agreement (16)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000161577416008325/s104643_ex14-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
    of Ethics (17)</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390019002588/fs12018a1ex21-1_americanbri.htm">List
    of significant subsidiaries of ABVC*</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex5-1_american.htm">Consent of Sichenzia Ross Ference LLP (18)</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="fs12018a2ex23-2_american.htm">Consent of KCCW Accountancy Corp</A></FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.3in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 16, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.01 to the Company&rsquo;s Form SB-2 filed on June 28, 2002.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.02 to the Company&rsquo;s Form SB-2, filed on June 28, 2002.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed on March 28, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.4 to the Company&rsquo;s Form S-1, filed on September 13, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 3.1 in the current report on Form 8-K with the Securities and Exchange Commission on May 8, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.2 the Company&rsquo;s Current Report on Form 8-K, filed on February 16, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on June 9, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 22, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on July 24, 2017.</FONT> </TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 123; Value: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.3in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K, filed on May 30, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on September 20, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K, filed on September 20, 2017.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.2 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K, filed on February 1, 2019.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
    by reference to Exhibit 14.1 to the Company&rsquo;s Amendment No.1 to Form S-1, filed on November 14, 2016.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included as Exhibit
    5.1.</FONT> </TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> * </TD><TD STYLE="text-align: justify"> Previously filed. </TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">II-9</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>fs12018a2ex1-1_american.htm
<DESCRIPTION>FORM OF UNDERWRITING AGREEMENT BY AND AMONG THE REGISTRANT AND THE UNDERWRITERS NAMED THEREIN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMERICAN BRIVISION (HOLDING) CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">[&#9679;], 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6 Venture, Suite 265</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>As Representative of the Underwriters named on <U>Annex A</U>
hereto</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This underwriting agreement
(this &ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement between <FONT STYLE="color: #231F20"><B>AMERICAN BRIVISION (HOLDING)
CORPORATION</B></FONT>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), on the one hand, and the several underwriters
named on <U>Annex A</U> hereto (such underwriters, for whom Boustead Securities, LLC is acting as representative, in such capacity,
the &ldquo;<B>Representative</B>&rdquo;, and if there are no underwriters other than the Representative, reference to multiple
underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, collectively,
the &ldquo;<B>Underwriters</B>&rdquo; and each an &ldquo;<B>Underwriter</B>&rdquo;), on the other hand, pursuant to which the Underwriters
shall serve as the underwriters for the Company in connection with the proposed offering (the &ldquo;<B>Offering</B>&rdquo;) on
an &ldquo;best efforts&rdquo; basis for the minimum offering amount of $10,000,000 (the &ldquo;<B>Minimum Amount</B>&rdquo;) up
to a maximum offering amount of $20,000,000 (the &ldquo;<B>Maximum Amount</B>&rdquo;) of shares (such shares sold in the Offering,
the &ldquo;<B>Offered Shares</B>&rdquo;), of Series A Convertible Preferred Stock, $0.001 par value per share, of the Company (&ldquo;<B>Series
A Convertible Preferred Stock</B>&rdquo;) with the discretion at any time during the Offering Period to increase the maximum amount
of the Offering to $23,000,000 (the &ldquo;<B>Increased Maximum</B>&rdquo;) by offering up to an additional 15% shares of Series
A Convertible Preferred Stock (the &ldquo;<B>Additional Shares</B>&rdquo;, and collectively with the Offered Shares, the &ldquo;<B>Shares</B>&rdquo;)
to various investors (each an &ldquo;<B>Investor</B>&rdquo; and collectively, the &ldquo;<B>Investors</B>&rdquo;) at a purchase
price of $7.00 per Share (the &ldquo;<B>Purchase Price</B>&rdquo;). The Shares are to be offered to the public at the Purchase
Price. The Company hereby confirms its agreement with the Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Section 1. Agreement to Act as Underwriters</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) On the basis of the
representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions of this
Agreement, the Underwriters shall be the exclusive underwriters in connection with the Offering, which shall be undertaken pursuant
to the Company&rsquo;s Registration Statement (as defined below), with the terms of such Offering to be subject to market conditions
and negotiations between the Company and the Underwriters. The Underwriters will act on a best efforts basis and the Company agrees
and acknowledges that there is no guarantee of the successful sale of the Offered Shares, or any portion thereof, in the prospective
Offering. Under no circumstances will the Underwriters or any of their respective &ldquo;Affiliates&rdquo; (as defined below) be
obligated to financially underwrite or purchase any of the Offered Shares for their own account or otherwise provide any financing.
The Underwriters&rsquo; appointment shall commence upon the date of the execution of this Agreement, and shall continue for a period
(such period, including any extension thereof as hereinafter provided, being herein called the &ldquo;<B>Offering Period</B>&rdquo;)
of 180 calendar days from the Effective Date (as defined below) (and for a period of up to 45 additional days if extended by agreement
of the Company and the Representative), unless all of the Shares have previously been subscribed for. The Underwriters shall act
solely as the Company&rsquo;s agents and not as principals. The Underwriters shall have no authority to bind the Company with respect
to any prospective offer to purchase Offered Shares and the Company shall have the sole right to accept offers to purchase Offered
Shares and may reject any such offer, in whole or in part. Subject to the Company&rsquo;s written consent, which consent shall
not be unreasonably withheld, conditioned, or delayed, the Underwriters may (i) create a selling syndicate of additional underwriters
for the Offering comprised of broker-dealers who are members of the Financial Industry Regulatory Authority, Inc. (&ldquo;<B>FINRA</B>&rdquo;)
and/or (ii) rely on such soliciting dealers who are FINRA members to participate in placing a portion of the Offering. The Underwriters
may also retain other brokers or dealers to act as sub-agents or selected dealers on their behalf in connection with the Offering.
Subject to the terms and conditions hereof, payment of the Purchase Price for, and delivery of, the Offered Shares shall be made
at one or more closings (each, a &ldquo;<B>Closing</B>&rdquo;, and the date on which a Closing occurs, the &ldquo;<B>Closing Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Representative
may, in its sole discretion, increase the Maximum Offering Amount up to the amount of the Increased Maximum and offer and sell
the Additional Shares in order to satisfy increased demand by Investors. The Representative may choose to increase the Maximum
Offering Amount and offer and sell the Additional Shares at any time during the Offering Period. The purchase price to be paid
per Additional Share shall be equal to the Purchase Price. The Underwriters shall not be under any obligation to offer or sell
any Additional Shares. The Representative shall provide notice to the Company, which shall be confirmed in writing via overnight
mail or facsimile or email or other electronic transmission (the &ldquo;<B>Increase Notice</B>&rdquo;). Upon receipt of the Increase
Notice with respect to all or any portion of the Additional Shares, subject to the terms and conditions set forth herein, the Company
shall become obligated to sell to the Investors up to the number of Additional Shares specified in such Increase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) As compensation
for services rendered, on the Closing Date the Company shall pay to the Underwriters or their respective designees their pro rata
portion (based on the number of Shares sold) of the fees and expenses set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Underwriters&rsquo;
Commissions</U>. A commission in cash (the &ldquo;<B>Cash Fee</B>&rdquo;) equal to seven percent of the gross proceeds received
by the Company from the sale of the Offered Shares or the Additional Shares at the Closing, if any, which such Cash Fee will be
paid to and allocated by the Underwriters among the selling syndicate and soliciting dealers in their sole discretion, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Representative&rsquo;s
Warrant</U>. The Company hereby agrees to issue to the Representative (and/or its designees) on the Closing Date warrants to purchase
such number of shares of the Company&rsquo;s common stock, par value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;) equal
to seven percent of the aggregate number of shares underlying the Series A Convertible Preferred Stock sold in the Offering (&ldquo;<B>Representative&rsquo;s
Warrant</B>&rdquo;). The Representative&rsquo;s Warrant, in the form attached hereto as <U>Exhibit A</U>, shall be exercisable,
in whole or in part, commencing on the Closing Date and expiring on the five-year anniversary of the effective date of the Registration
Statement (the date the Commission (as hereinafter defined) declares the Registration Statement being hereinafter referred to as
the &ldquo;<B>Effective Date</B>&rdquo;) at an initial exercise price per share of Common Stock equal to the Purchase Price. The
Representative&rsquo;s Warrant shall include a &ldquo;cashless&rdquo; exercise feature, and shall contain provisions for &ldquo;piggyback&rdquo;
registration rights until expiration or until the shares underlying the warrants are eligible for resale pursuant to an exemption
from registration; provided, however that no such &ldquo;<FONT STYLE="background-color: white">piggyback&rdquo; registration rights
shall be exercisable after the last day of the seventh year following the Effective Date</FONT>. The Representative understands
and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s
Warrant and the underlying shares of Common Stock during the 180 days after the Effective Date and by its acceptance thereof shall
agree that it will not sell, transfer, assign, pledge or hypothecate the Representative&rsquo;s Warrant, or any portion thereof,
or have the Representative&rsquo;s Warrant be the subject of any hedging, short sale, derivative, put or call transaction that
would result in the effective economic disposition of such securities for a period of 180 days following the Effective Date to
anyone other than the acceptable persons set forth in FINRA Rule 5110(g)(2)(A), provided such transferee agrees to the foregoing
lock-up restrictions. Delivery of the Representative&rsquo;s Warrant shall be made on the Closing Date and shall be issued in the
name or names and in such authorized denominations as the Representative may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <U>Expenses</U>.
The Company&rsquo;s expenses are set forth in <U>Section 6</U> below, but the parties acknowledge that the Underwriters may assist
the Company in carrying out some of the activities associated with such expenses. Therefore, subject to the terms below, whether
or not the transactions contemplated by this Agreement and the Registration Statement are consummated or this Agreement is terminated,
the Company also hereby agrees to pay all of the Underwriters&rsquo; costs and expenses incident to the Offering up to an aggregate
amount of $250,000 (the &ldquo;<B>Underwriters Expense Cap</B>&rdquo;). However, in the event that this Agreement is terminated
pursuant to <U>Section 9</U> hereof, or subsequent to a Material Adverse Change, the Company will only pay for documented out-of-pocket
expenses of the Underwriters (including but not limited to fees and disbursements of Underwriters&rsquo; counsel, expenses associated
with a due diligence report and reasonable travel) that are actually incurred in connection herewith as allowed under FINRA Rule
5110. All fees and expenses already paid by the Company shall be reimbursed to the extent not actually incurred in accordance with
FINRA Rule 5110(f)(2)(C). In addition to the activities set forth in <U>Section 6</U>, the Underwriters Expense Cap may also include
reimbursement for the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">A. Fees and disbursements
of Underwriters&rsquo; counsel, which shall not exceed $75,000 (the &ldquo;<B>Legal Fees</B>&rdquo;) and shall be paid in the following
installments: (i) $25,000 have been paid prior to the date hereof (which shall be reimbursable to the Company to the extent not
actually incurred); (ii) an additional $25,000 shall be paid upon obtaining a &ldquo;No Objections Letter&rdquo; from FINRA after
completion of filing with FINRA and any requisite state securities regulators; and (iii) the balance of $25,000 upon completion
of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">B. any reasonable costs
and expenses incurred by the Underwriters in conducting background checks of the Company's officers and directors by a background
search firm acceptable to the Representative, up to an amount of $6,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">C. all travel and lodging
expenses of the Underwriters, including any reasonable expenses incurred in connection with attending or hosting meetings with
prospective purchasers of the Shares, up to an amount of $50,000, which shall be paid upon the issuance of a no objections letter
from FINRA, and is reimbursable to the issuer to the extent not actually incurred.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">D. third-party due diligence
expenses in an amount of $75,000, $50,000 of which have already been paid and which shall be reimbursable to the Company to the
extent not actually incurred); and,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">E. a reasonable advance
of out-of-pocket accountable expenses, such as those described in this <U>Section 1(c)(iii)</U> and <U>Section 6</U>, <FONT STYLE="background-color: white">actually
anticipated to be incurred by the Underwriters, </FONT>in the amount of $15,000, which amount was already paid to the Underwriters
as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) The term of the Underwriters&rsquo;
exclusive engagement will be until the closing of the Offering in accordance with the Registration Statement (the &ldquo;<B>Exclusive
Term</B>&rdquo;); <I><U>provided</U></I>, <I><U>however</U></I>, that a party hereto may terminate the engagement with respect
to itself at any time upon 15 days written notice to the other party, or as practical as possible. Notwithstanding anything to
the contrary contained herein, the provisions concerning confidentiality, indemnification and contribution contained herein will
survive any expiration or termination of this Agreement, and the Company&rsquo;s obligation to pay fees actually earned and payable
and to reimburse expenses actually incurred and reimbursable pursuant to <U>Section 1</U> hereof and which are permitted to be
reimbursed under FINRA Rule 5110(f)(2)(D), will survive any expiration or termination of this Agreement. Nothing in this Agreement
shall be construed to limit the ability of any the Underwriters or their respective Affiliates to pursue, investigate, analyze,
invest in, or engage in investment banking, financial advisory or any other business relationship with Persons (as defined below)
other than the Company. As used herein (i) &ldquo;<B>Affiliate</B>&rdquo; means any Person that, directly or indirectly through
one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and
construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), and (ii) &ldquo;<B>Persons</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) In connection with
this Offering, the Company grants the Representative a right of first refusal, for a period of twelve (12) months following the
effectiveness, to act as placement agent or underwriter or to act as lead or managing underwriter, exclusive financial advisor
or in any other similar capacity, on the Representative&rsquo;s customary terms and conditions, in the event the Company pursues
a registered, underwritten public offering of securities (in addition to this offering), a public or private offering of securities
(debt or equity), a merger, acquisition of another company or business, change of control, sale of substantially all assets, business
combination, recapitalization or other similar transaction (regardless of whether the Company would be considered an acquiring
party, a selling party or neither in such transaction). The Representative shall have the sole right to determine whether or not
any other broker-dealer shall have the right to participate in any such offering and the economic terms of any such participation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If during the Exclusive
Term, or within 12 months after the date of termination or expiration of this Agreement if no closing has occurred, securities
are sold by the Company to investors directly introduced to the Company by the Underwriters on behalf of the Company, then the
Company shall pay to the Underwriters, at the time of each such sale, the Cash Fee set forth in this <U>Section 1(a)(i)</U> with
respect to any such sale. Upon termination of this Agreement and at the request of the Company, the Underwriters will provide the
Company with a list of investors so identified by the Underwriters, respectively, on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>Section 2. Representations,
Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to each of the Underwriters,
as of the date hereof and as of the Closing Date, except as set out in the Registration Statement, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Securities Law
Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) a registration statement
on Form S-1, as amended (Registration File No. 333-228387) under the Securities Act and the rules and regulations (the &ldquo;<B>Rules
and Regulations</B>&rdquo;) of the Commission promulgated thereunder. At the time of the Effective Date, the registration statement
and amendments will materially meet the requirements of Form S-1 under the Securities Act. The Company will file with the Commission
pursuant to Rules 430A and 424(b) under the Securities Act, a final prospectus included in such registration statement relating
to the Offering and the plan of distribution thereof and has advised the Underwriters of all further information (financial and
other) with respect to the Company required to be set forth therein. Such registration statement, including the exhibits thereto,
as amended at the date of this Agreement, is hereinafter called the &ldquo;<B>Registration Statement</B>.&rdquo; Each prospectus
used prior to the effectiveness of the Registration Statement, and each prospectus that omitted information deemed to be a part
thereof as of the Effective Date pursuant to paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;<B>Rule 430A
Information</B>&rdquo;) that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein
called a &ldquo;<B>Preliminary Prospectus</B>.&rdquo; All references in this Agreement to financial statements and schedules and
other information that is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set
forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement or the Prospectus (and all other references of like import)
shall be deemed to mean and include all such financial statements and schedules and other information that is or is deemed to be
incorporated by reference in the Registration Statement or the Prospectus, as the case may be. The Registration Statement has been
declared effective by the Commission on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Exchange Act.
</U>The Company has filed with the Commission a Form 8-A (File Number [&#9679;]) providing for the registration pursuant to Section
12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), of the Offered Shares. The
registration of the Offered Shares under the Exchange Act has become effective on or prior to the date hereof. The Company has
taken no action designed to, or likely to have the effect of, terminating the registration of the Offered Shares under the Exchange
Act, nor has the Company received any notification that the Commission is contemplating terminating such registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <FONT STYLE="font-size: 10pt"><U>No
Stop Orders, etc</U><I>. </I>Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued
any order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <FONT STYLE="font-size: 10pt"><U>Assurances</U>.
The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective,
at all other subsequent times until the Closing and at the Closing Date complied in all material respects with the Securities Act
and the applicable Rules and Regulations and did not and, as amended or supplemented, if applicable, will not, contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading (<I><U>provided</U></I>, <I><U>however</U></I>, that the preceding representations and warranties contained
in this sentence shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished
in writing to the Company by the Underwriters expressly for use therein (the &ldquo;<B>Underwriters Information</B>&rdquo;)). The
Prospectus, as of its date, complies in all material respects with the Securities Act and the applicable Rules and Regulations.
As of its date, the Prospectus did not and will not contain as of the date thereof any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading; <I><U>provided</U></I>, <I><U>however</U></I>, that the preceding representations and warranties contained
in this sentence shall not apply to any Underwriters Information. All post-effective amendments to the Registration Statement reflecting
facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information
set forth therein have been so filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Disclosure of
Agreements</U>. The agreements and documents described in the Registration Statement and the Prospectus conform in all material
respects to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities
Act and the Rules and Regulations to be described in the Registration Statement and the Prospectus or to be filed with the Commission
as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however
characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is filed
as an exhibit to the Registration Statement and the Prospectus, or (ii) is material to the Company&rsquo;s business, has been duly
authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against
the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such
enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally,
(y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws,
and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments
has been assigned by the Company, and neither the Company nor, to the Company&rsquo;s knowledge, any other party is in default
thereunder and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or
both, would constitute a default thereunder, except for any default or event which would not reasonably be expected to result in
a Material Adverse Effect. To the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements
or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any
governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each,
a &ldquo;<B>Governmental Entity</B>&rdquo;), including, without limitation, those relating to environmental laws and regulations,
except for any violation which would not reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Free Writing Prospectuses</U>.
The Company will not, without the prior consent of the Underwriters, prepare, use or refer to, any free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Offering Materials</U>.
The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed copies of the Registration
Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration
Statement (without exhibits) and the Prospectus, as amended or supplemented, in such quantities and at such places as the Underwriters
reasonably request. Neither the Company nor any of its directors and officers has distributed and none of them will distribute,
prior to the Closing Date, any offering material in connection with the offering and sale of the Offered Shares other than the
Prospectus, the Registration Statement, and any other materials permitted by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;) are described in the Registration
Statement to the extent necessary. Except as described in the Registration Statement and the Prospectus, the Company owns, directly
or indirectly, all of its capital stock or other equity interests of each Subsidiary free and clear of any liens, charges, security
interests, encumbrances, rights of first refusal, preemptive rights or other restrictions (collectively, &ldquo;<B>Liens</B>&rdquo;),
and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Organization and
Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing (where applicable) under the laws of the jurisdiction of its incorporation or organization, with the requisite
power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability
of this Agreement or any other agreement entered into between the Company and the Investors, (ii) a material adverse effect on
the results of operations, assets, business, prospects (as such prospects are described in the Prospectus) or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s
ability to perform in any material respect on a timely basis its obligations under this Agreement or the Offering (any of (i),
(ii) or (iii), a &ldquo;<B>Material Adverse Effect</B>&rdquo;) and to the best knowledge of the Company, no action, claim, suit,
investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition),
whether commenced or threatened (&ldquo;<B>Proceeding</B>&rdquo;) has been instituted in any such jurisdiction revoking, limiting
or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and the Offering and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by
all necessary action on the part of the Company and no further action is required by the Company, the Company&rsquo;s Board of
Directors (the &ldquo;<B>Board of Directors</B>&rdquo;) or the Company&rsquo;s shareholders in connection therewith other than
in connection with the Required Approvals (as defined below). This Agreement has been duly executed by the Company and, when delivered
in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company
in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by
laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the transactions contemplated hereby do not and will
not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of
the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to
which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such conflict,
default or violation could not reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <U>Filings, Consents
and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person
in connection with the execution, delivery and performance by the Company of this Agreement and the transactions contemplated hereby,
other than: (i) the filing with the Commission of the final Prospectus as required by Rule 424 under the Securities Act, (ii) application(s)
to the Nasdaq Capital Market (the &ldquo;<B>Trading Market</B>&rdquo;) for the listing of the Offered Shares for trading thereon
in the time and manner required thereby and (iii) such filings as are required to be made under applicable state securities laws
(collectively, the &ldquo;<B>Required Approvals</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) <U>Issuance of the
Offered Shares; Registration</U>. The Offered Shares are duly authorized and, when issued and paid for in accordance with this
Agreement and the terms of the Offering as described in the Prospectus, will be duly and validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Company has sufficient authorized shares of (i) Series A Convertible Preferred
Stock for the issuance of the maximum number of Offered Shares issuable pursuant to the Offering as described in the Prospectus,
and (ii) Common Stock for the issuance of shares of Common Stock upon conversion of the maximum number of Offered Shares issuable
pursuant to this Offering as described in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) <U>Issuance of the
Representative&rsquo;s Warrant</U>. The Representative&rsquo;s Warrant has been duly authorized for issuance. The Company has reserved
a sufficient number of shares of Common Stock for issuance upon exercise of the Representative&rsquo;s Warrant (the &ldquo;<B>Warrant
Shares</B>&rdquo;) and, when issued and paid for in accordance with the terms thereof, such Warrant Shares will be validly issued,
fully paid and non-assessable. The issuance of the Warrant Shares will not be subject to any preemptive rights, or other similar
rights to subscribe for or purchase securities of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) <U>Capitalization</U>.
The capitalization of the Company is as set forth in the Prospectus. Except for those disclosed in the Registration Statement,
the Company has not issued any shares of Common Stock or any securities exercisable or convertible into shares of Common Stock
since the date of filing of the Prospectus. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by this Agreement and the transactions contemplated pursuant
to the Prospectus. Except as disclosed in the Registration Statement and the Prospectus, if applicable, there are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights
or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to issue additional shares of Common Stock or any securities exercisable or convertible into shares of Common
Stock. Except as set forth in the Registration Statement and the Prospectus, the issuance and sale of the Offered Shares will not
obligate the Company to issue shares of Common Stock or shares of Series A Convertible Preferred Stock or other securities to any
Person (other than the Investors and the Underwriters) and will not result in a right of any holder of Company securities to adjust
the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of Common Stock of
the Company are validly issued, fully paid and nonassessable, have been issued in compliance with the laws of the State of Nevada,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any shareholder or the Board of Directors of the Company or others is required
for the issuance and sale of the Offered Shares. Except as disclosed in the Registration Statement, there are no shareholders agreements,
voting agreements or other similar agreements with respect to the shares of Common Stock or shares of Series A Convertible Preferred
Stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p) <U>Material Changes;
Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the Registration Statement, except as specifically disclosed in the Registration Statement and the Prospectus, (i) there has been
no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii)
the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred
in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s
financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method
of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders
or purchased, redeemed or made any agreements to purchase or redeem any shares of Common Stock or shares of Series A Convertible
Preferred Stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Offered Shares contemplated by the Prospectus or as disclosed in the Registration
Statement or the Prospectus, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably
expected to occur or exist with respect to the Company or its Subsidiaries or their respective business, prospects (as such prospects
are described in the Prospectus), properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly
disclosed at least one trading day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q) <U>Litigation</U>.
Except for such matter disclosed in the Registration Statement, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any
of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an &ldquo;<B>Action</B>&rdquo;) which (i) adversely affects or challenges
the legality, validity or enforceability of any of this Agreement and the Offering or the Offered Shares, or (ii) could, if there
were an unfavorable decision, reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has within the last 10 years been the subject of any Action involving a claim of violation
of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current
or former director or officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r) <U>Labor Relations</U>.
No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. No executive officer, to the knowledge of the Company, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the
continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with
respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and
hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s) <U>Compliance</U>.
Except as set forth in the Registration Statement or the Prospectus, neither the Company nor any Subsidiary: (i) is in default
under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would
result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that
it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) is in violation of any judgment, decree or order of any court, arbitrator or governmental body or (iii) is or has been in
violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign,
federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and
safety and employment and labor matters, except in each case as could not reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state,
local or foreign regulatory authorities necessary to conduct their respective businesses as described in the Prospectus, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<B>Material
Permits</B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case
free and clear of all Liens, except for Liens disclosed in the Prospectus, Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties.
Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting
and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) <U>Intellectual Property</U>.
The Company and its Subsidiaries own, possess, license or have other adequate rights to use, on reasonable terms, all material
patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses,
inventions, trade secrets, technology, know-how and other intellectual property necessary for the conduct of the Company&rsquo;s
and each of its Subsidiary&rsquo;s business as now conducted (collectively, the &ldquo;<B>Intellectual Property</B>&rdquo;), except
to the extent such failure to own, possess or have other rights to use such Intellectual Property would not result in a Material
Adverse Effect. Except as set forth in the Registration Statement: (a) no party has been granted an exclusive license to use any
portion of such Intellectual Property owned by the Company or its Subsidiaries; (b) to the knowledge of the Company, there is no
infringement by third parties of any such Intellectual Property owned by or exclusively licensed to the Company or its Subsidiaries;
(c) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging
the Company&rsquo;s or any of its Subsidiaries&rsquo; rights in or to any Intellectual Property, and the Company and its Subsidiaries
are unaware of any facts which would form a reasonable basis for any such claim; (d) there is no pending or, to the knowledge of
the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope or enforceability of any
such Intellectual Property, and the Company and its Subsidiaries are unaware of any facts which would form a reasonable basis for
any such claim; and (e) there is no pending, or to the knowledge of the Company, threatened action, suit, proceeding or claim by
others that the Company&rsquo;s or any of its Subsidiaries&rsquo; business as now conducted infringes or otherwise violates any
patent, trademark, copyright, trade secret or other proprietary rights of others, and the Company and its Subsidiaries are unaware
of any other fact which would form a reasonable basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w) <U>Environmental
Laws</U>. The business and operations of the Company, and each of its Subsidiaries, have been and are being conducted in compliance
with all applicable laws, ordinances, rules, regulations, licenses, permits, approvals, plans, authorizations or requirements relating
to occupational safety and health, or pollution, or protection of health or the environment (including, without limitation, those
relating to emissions, discharges, releases or threatened releases of pollutants, contaminants or hazardous or toxic substances,
materials or wastes into ambient air, surface water, groundwater or land, or relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of chemical substances, pollutants, contaminants or hazardous or toxic
substances, materials or wastes, whether solid, gaseous or liquid in nature) of any governmental department, commission, board,
bureau, agency or instrumentality of any national, state or political subdivision thereof, or any foreign jurisdiction (&ldquo;<B>Environmental
Laws</B>&rdquo;), and all applicable judicial or administrative agency or regulatory decrees, awards, judgments and orders relating
thereto, except where the failure to be in such compliance would not be reasonably expected, individually or in the aggregate,
to have a Material Adverse Effect; and neither the Company nor any of its Subsidiaries has received any notice from any governmental
instrumentality or any third party alleging any material violation thereof or liability thereunder (including, without limitation,
liability for costs of investigating or remediating sites containing hazardous substances and/or damages to natural resources).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x) <U>Hazardous Materials</U>.
There has been no storage, generation, transportation, use, handling, treatment, Release or threat of Release of Hazardous Materials
(as defined below) by or caused by the Company or any of its Subsidiaries (or, to the knowledge of the Company, any other entity
(including any predecessor) for whose acts or omissions the Company or any of its Subsidiaries is or could reasonably be expected
to be liable) at, on, under or from any property or facility now or previously owned, operated or leased by the Company or any
of its Subsidiaries, or at, on, under or from any other property or facility, in violation of any Environmental Laws or in a manner
or amount or to a location that could reasonably be expected to result in any liability under any Environmental Law, except for
any violation or liability which would not, individually or in the aggregate, have a Material Adverse Effect. &ldquo;<B>Hazardous
Materials</B>&rdquo; means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent
thereof, in any form or amount, including petroleum (including crude oil or any fraction thereof) and petroleum products, natural
gas liquids, asbestos and asbestos containing materials, naturally occurring radioactive materials, brine, and drilling mud, regulated
or which can give rise to liability under any Environmental Law. &ldquo;<B>Release</B>&rdquo; means any spilling, leaking, seepage,
pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, disposing, depositing, dispersing, or
migrating in, into or through the environment, or in, into from or through any building or structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y) <U>Insurance</U>.
The Company and its Subsidiaries are insured with insurers with appropriately rated claims paying abilities against such losses
and risks and in such amounts as are prudent and customary for the businesses in which they are engaged; all policies of insurance
and fidelity or surety bonds insuring the Company, each Subsidiary or their respective businesses, assets, employees, officers
and directors are in full force and effect; and there are no claims by the Company or its Subsidiary under any such policy or instrument
as to which any insurance company is denying liability or defending under a reservation of rights clause; neither the Company nor
any Subsidiary has been refused any insurance coverage sought or applied for; and neither the Company nor any Subsidiary has any
reason to believe that it shall not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business at a cost that is not materially greater than
the current cost. The Company has obtained director&rsquo;s and officer&rsquo;s insurance in such amounts as is customary for a
similarly situated company engaging in an initial public offering of securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z) <U>Transactions With
Affiliates and Employees</U>. Except as set forth in the Registration Statement and the Prospectus, none of the officers or directors
of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement
for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock
option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Except as set forth in the Prospectus: (i) the Company is in compliance in all material respects
with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and
all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof, as of the
Closing Date; (ii) the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (A) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (B) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(C) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (D) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences; and (iii) the Company has established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and designed such disclosure controls and procedures to ensure that information required
to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the Commission&rsquo;s rules and forms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb) <U>Certain Fees</U>.
Except as set forth herein and in the Prospectus, contemplated by this Agreement, or a separate agreement regarding the Offering
with a soliciting dealer in the sole discretion of the Underwriters, no brokerage or finder&rsquo;s fees or commissions are or
will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank
or other Person with respect to the transactions contemplated by this Agreement and the Offering. The Investors shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in
this Section that may be due in connection with the transactions contemplated by this Agreement and the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc) <U>Investment Company</U>.
The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Offered Shares, will not be or
be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd) <U>Registration
Rights</U>. Except as set forth in the Registration Statement or the Prospectus, no Person has any right to cause the Company to
effect the registration under the Securities Act of any securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee) <U>No Integrated
Offering</U>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Offered Shares to be integrated with prior offerings by the Company or would otherwise negate any securities exemption
or registration relied on by the Company in connection with the Offered Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff) <U>Solvency</U>.
The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The Prospectus sets forth
as of the date of the latest audited financial statements included within the Registration Statement all outstanding secured and
unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;Indebtedness&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $500,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s balance
sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions
in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required
to be capitalized in accordance with GAAP. Except as described in the Prospectus, neither the Company nor any Subsidiary is in
default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg) <U>Tax Status</U>.
Except as would not be likely to have, individually or in the aggregate, a Material Adverse Effect, the Company and each Subsidiary
(1) has timely filed all federal, state, provincial, local and foreign tax returns that are required to be filed by such entity
through the date hereof, which returns are true and correct, or has received timely extensions for the filing thereof, and (2)
has paid all taxes, assessments, penalties, interest, fees and other charges due or claimed to be due from the Company, other than
(A) any such amounts being contested in good faith and by appropriate proceedings and for which adequate reserves have been provided
in accordance with GAAP or (B) any such amounts currently payable without penalty or interest. There are no tax audits or investigations
pending, which if adversely determined could have a Material Adverse Effect; nor to the knowledge of the Company are there any
proposed additional tax assessments against the Company or any Subsidiary which could have, individually or in the aggregate, a
Material Adverse Effect. No transaction, stamp, capital or other issuance, registration, transaction, transfer or withholding tax
or duty is payable by or on behalf of the Underwriters to any foreign government outside the United States or any political subdivision
thereof or any authority or agency thereof or therein having the power to tax in connection with (i) the issuance, sale and delivery
of the Shares by the Company; (ii) the purchase from the Company, and the initial sale and delivery of the Shares to Investors
thereof; or (iii) the execution and delivery of this Agreement or any other document to be furnished hereunder. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or
of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh) <U>Foreign Corrupt
Practices</U>. Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company,
has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related
to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees
or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution
made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or
(iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Anti-Money Laundering
Laws</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material
respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B>Anti-Money
Laundering Laws</B>&rdquo;) and no material action, suit or proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Anti-Money Laundering Laws is pending
or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer,
agent or employee of the Company or any of its Subsidiaries is currently subject to any U.S. sanctions (the &ldquo;<B>Sanctions
Regulations</B>&rdquo;) administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B>OFAC</B>&rsquo;);
and the Company shall not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of
any person currently subject to any U.S. sanctions administered by OFAC or listed on the OFAC Specially Designated Nationals and
Blocked Persons List. The Company shall not, directly or indirectly, use the proceeds of the offering of the Offered Shares hereunder,
or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity,
for the purpose of financing the activities of any person currently subject to any Sanctions Regulations or to support activities
in or with countries sanctioned by said authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk) <U>Accountants</U>.
KKCW Accountancy Corp., is the Company&rsquo;s independent registered public accounting firm. To the knowledge and belief of the
Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) has expressed
its opinion with respect to the financial statements of the Company for the years ended December 31, 2017 and 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Investor&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm) <U>Bank Holding
Company Act</U>. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal
Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent (5%)
or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn) <U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to any of the Underwriters or to counsel for any of the Underwriters
shall be deemed to be a representation and warranty by the Company to the Underwriters as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo) <U>Reliance</U>.
The Company acknowledges that the Underwriters will rely upon the accuracy and truthfulness of the foregoing representations and
warranties and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp) <U>Forward-Looking
Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in either the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or
has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq) <U>Statistical or
Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the
Registration Statement or the Prospectus, are based on or derived from sources that the Company reasonably and in good faith believes
to be reliable and accurate, and such data agree with the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(rr) <U>FINRA Affiliations</U>.
Except as disclosed in the Prospectus, there are no affiliations with any FINRA member firm among the Company&rsquo;s officers,
directors or, to the knowledge of the Company, any five percent (5%) or greater shareholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ss) <U>Loans; Guarantees</U>.
There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees
of indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of their respective
family members. The Company has not directly or indirectly, including through its Subsidiaries, extended or maintained credit,
arranged for the extension of credit, or renewed any extension of credit, in the form of a personal loan to or for any director
or executive officer of the Company or any of their respective related interests, other than any extensions of credit that ceased
to be outstanding prior to the initial filing of the Registration Statement. No transaction has occurred between or among the Company
and any of its officers or directors, stockholders, customers, suppliers or any affiliate or affiliates of the foregoing that is
required to be described or filed as an exhibit to in the Registration Statement or the Prospectus and is not so described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(tt) <U>Nasdaq</U>. The
Offered Shares have been approved for listing, subject to notice of issuance on the Nasdaq, under the symbol &ldquo;[&#9679;]&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(uu) <U>Transfer taxes</U>.
On the Closing Date, all stock transfer or other taxes (other than income taxes) which are required to be paid in connection with
the sale and transfer of the Offered Shares to be issued and sold on the Closing Date shall be, or shall have been, fully paid
or provided for by the Company and all laws imposing such taxes shall be or shall have been fully complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3. Delivery
and Payment</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Closing for the
Offered Shares</U>. The Closing shall occur at the office of the Underwriters&rsquo; counsel, Hunter Taubman Fischer &amp; Li LLC,
located at 1450 Broadway, 26th Floor, New York, NY 10018 (or at such other place as shall be agreed upon by the Representative
and the Company) and may also be conducted electronically via the remote exchange of closing documentation. Subject to the terms
and conditions hereof, and except as may otherwise be agreed or arranged between the parties, at the Closing payment of the purchase
price for the Offered Shares sold on the Closing Date shall be made by federal funds wire transfer from the Offering Deposit Account
(as defined below), against delivery of such Offered Shares, and such Offered Shares shall be registered in such name or names
and shall be in such denominations, as provided by the Underwriters at least one business day prior to the Closing. All actions
taken at the Closing shall be deemed to have occurred simultaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Payment for the
Shares</U>. The Shares are being sold to the Investors at an aggregate initial public offering price per Share as set forth in
the Prospectus. The purchase of Shares by each of the Investors shall be evidenced by the receipt of funds in the Offering Deposit
Account (as defined below) and execution of a subscription agreement by each such Investor and the Company. <FONT STYLE="background-color: white">On
or prior to the date of the commencement of the Offering, the parties shall establish a non-interest-bearing deposit account with
the Offering Deposit Account Agent (as defined below) , which account shall be entitled &ldquo;</FONT>FinTech Clearing, as Offering
Deposit Account Agent for the Investors in <FONT STYLE="background-color: white">AMERICAN BRIVISION (HOLDING) CORPORATION&rdquo;
(the &ldquo;<B>Offering Deposit Account</B>&rdquo;).</FONT> In the event that any of the Underwriters receive any payment from
an Investor in connection with the purchase of any Shares by such Investor, such payment shall be promptly transmitted to and deposited
into the Offering Deposit Account, which shall be administered by FinTech Clearing, LLC, a broker-dealer registered with the Securities
and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;), having an office at 6 Venture, Suite 265, Irvine, CA 92618 USA (&ldquo;<B>Offering
Deposit Account Agent</B>&rdquo;), <FONT STYLE="background-color: white">in compliance with Rule 15c2-4 of the Commission</FONT>.
Among other things, the Underwriters shall forward any checks so received by the Underwriters to the Offering Deposit Account by
<FONT STYLE="background-color: white">noon of the next business day. The Underwriters and the Company shall instruct Investors
to make wire transfer payments to </FONT>&ldquo;FinTech Clearing, LLC as offering deposit account agent for AMERICAN BRIVISION
(HOLDING) CORPORATION,&rdquo; <FONT STYLE="background-color: white">with the name and address of the Investor making payment. Payment
by the Investors out of the Offering Deposit Account for the Offered Shares to be sold by the Company shall be made on the Closing
Date to the Company in compliance with Rule 15c2-4 of the Commission. If the Minimum Amount is not received on or before the end
of the Offering Period, the Underwriters shall promptly instruct the Offering Deposit Account Agent to, and the Company shall also
return any such funds received, to the respective Investors. If, following a Closing on the Minimum Amount, additional funds are
received in the Offering Deposit Account or by the Company, but for which a Closing does not occur on or before the end of the
Offering Period, the Underwriters shall promptly instruct the Offering Deposit Account Agent to, and the Company shall also return
all such funds to the respective Investors whose funds remained in the Offering Deposit Account or the Company&rsquo;s account,
respectively. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <FONT STYLE="background-color: white"><U>Delivery
of Shares</U>. Delivery of the Shares shall be made through the facilities of The Depository Trust Company unless the Underwriters
shall otherwise instruct. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4. Covenants
and Agreements of the Company</B>. The Company further covenants and agrees with each of the Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Registration Statement
Matters</U>. The Registration Statement and any amendments thereto have been declared effective, and if Rule 430A is used or the
filing of the Prospectus is otherwise required under Rule 424(b), the Company will file the Prospectus (properly completed if Rule
430A has been used) pursuant to Rule 424(b) within the prescribed time period and will provide evidence satisfactory to the Underwriters
of such timely filing. The Company will advise the Underwriters promptly after they receive notice thereof of the time when any
amendment to the Registration Statement has been filed or becomes effective or any supplement or amendment to the Prospectus has
been filed and will furnish the Underwriters with copies thereof. The Company will file promptly all reports and any definitive
proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d)
of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection
with the Offering. The Company will advise the Underwriters, promptly after it receives notice thereof (i) of any request by the
Commission to amend the Registration Statement or to amend or supplement the Prospectus or for additional information, and (ii)
of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective
amendment thereto or any order preventing or suspending the use of the Prospectus or any amendment or supplement thereto or any
post-effective amendment to the Registration Statement, of the suspension of the qualification of the Offered Shares for offering
or sale in any jurisdiction, of the institution or threatened institution of any proceeding for any such purpose, or of any request
by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information.
The Company shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use.
If the Commission shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will
use its commercially reasonable efforts to obtain the lifting of such order at the earliest possible moment, or will file a new
registration statement and use its best efforts to have such new registration statement declared effective as soon as practicable.
Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable,
under the Securities Act, including with respect to the timely filing of documents thereunder, and will use its reasonable efforts
to confirm that any filings made by the Company under such Rule 424(b) are received in a timely manner by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Blue Sky Compliance</U>.
The Company will cooperate with the Underwriters in endeavoring to qualify the Offered Shares for sale under the securities laws
of such jurisdictions (United States and foreign) as the Underwriters may reasonably request and will make such applications, file
such documents, and furnish such information as may be reasonably required for that purpose, <I><U>provided</U></I> the Company
shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction
where it is not now so qualified or required to file such a consent, and <I><U>provided further</U></I> that the Company shall
not be required to produce any new disclosure document other than the Prospectus. The Company will, from time to time, prepare
and file such statements, reports and other documents as are or may be required to continue such qualifications in effect for so
long a period as the Underwriters may reasonably request for distribution of the Offered Shares. The Company will advise the Underwriters
promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Offered Shares for offering,
sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the
issuance of any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain
the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Amendments and
Supplements to the Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and
the rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Offered Shares
as contemplated in this Agreement and the Prospectus. If during the period in which a prospectus is required by law to be delivered
in connection with the distribution of Offered Shares contemplated by the Prospectus (the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;),
any event shall occur as a result of which, in the judgment of the Company or in the opinion of any of the Underwriters or counsel
for any of the Underwriters, it becomes necessary to amend or supplement the Prospectus in order to make the statements therein,
in the light of the circumstances under which they were made, as the case may be, not misleading, or if it is necessary at any
time to amend or supplement the Prospectus to comply with any law, the Company will promptly prepare and file with the Commission,
and furnish at its own expense to the Underwriters and to dealers, an appropriate amendment to the Registration Statement or supplement
to the Registration Statement or the Prospectus that is necessary in order to make the statements in the Prospectus as so amended
or supplemented, in the light of the circumstances under which they were made, as the case may be, not misleading, or so that the
Registration Statement or the Prospectus, as so amended or supplemented, will comply with law. Before amending the Registration
Statement or supplementing the Prospectus in connection with the Offering, the Company will furnish the Underwriters with a copy
of such proposed amendment or supplement and will not file any such amendment or supplement to which the Underwriters reasonably
object.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Copies of any
Amendments and Supplements to the Prospectus</U>. The Company will furnish the Underwriters, without charge, during the period
beginning on the date hereof and ending on the Closing Date, as many copies of the Prospectus and any amendments and supplements
thereto as the Underwriters may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Free Writing Prospectus</U>.
The Company covenants that it will not, unless it obtains the prior consent of the Underwriters, make any offer relating to the
Offered Shares that would constitute a Company Free Writing Prospectus or that would otherwise constitute a &ldquo;free writing
prospectus&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained
by the Company under Rule 433 of the Securities Act. In the event that the Underwriters expressly consent in writing to any such
free writing prospectus (a &ldquo;<B>Permitted Free Writing Prospectus</B>&rdquo;), the Company covenants that it shall (i) treat
each Permitted Free Writing Prospectus as a Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164
and 433 of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with
the Commission, legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Transfer Agent</U>.
The Company will maintain, at its expense, a registrar and transfer agent for the Offered Shares for so long as the Offered Shares
are publicly-traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Earnings Statement</U>.
As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later than
18 months after the last Closing Date, the Company will make generally available to its security holders and to the Underwriters
an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies
the provisions of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Periodic Reporting
Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission all
reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Additional Documents</U>.
The Company will enter into any subscription, purchase or other customary agreements as the Underwriters deem necessary or appropriate
to consummate the Offering, all of which will be in form and substance reasonably acceptable to the Company and the Underwriters.
The Company agrees that the Underwriters may rely upon, and each is a third party beneficiary of, the representations and warranties
set forth in any such purchase, subscription or other agreement with Investors in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <U>No Manipulation
of Price</U>. The Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted
or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by any of the Underwriters to the Company is solely for the benefit and use of the
Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without such Underwriter&rsquo;s
prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <U>Restriction on
Continuous Offerings</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior written consent
of the Representative, it will not, for a period of 12 months after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market&rdquo;
continuous or other dilutive equity transaction, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose
of shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital
stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5. Conditions
of the Obligations of the Underwriters</B>. The obligations of the Underwriters hereunder shall be subject to the accuracy of the
representations and warranties on the part of the Company set forth in <U>Section 2</U> hereof, in each case as of the date hereof,
as of the Closing Date, as though then made, to the timely performance by each of the Company of its covenants and other obligations
hereunder on and as of such dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Accountants&rsquo;
Comfort Letter</U>. On the date hereof, the Underwriters shall have received, and the Company shall have caused to be delivered
to the Underwriters, a letter from KCCW Accountancy Corp., the independent registered public accounting firm of the Company, addressed
to the Underwriters, dated as of the date hereof, in form and substance satisfactory to the Underwriters. The letter shall not
disclose any change in the condition (financial or other), earnings, operations, business or prospects of the Company from that
set forth in the Prospectus, which, in the Underwriters&rsquo; sole judgment, is material and adverse and that makes it, in the
Underwriters&rsquo; sole judgment, impracticable or inadvisable to proceed with the offering of the Offered Shares as contemplated
by the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Compliance with
Registration Requirements; No Stop Order; No Objection from the FINRA</U>. The Registration Statement shall have become effective
and all necessary regulatory and listing approvals shall have been received not later than 5:30 P.M., New York City time, on the
date of this Agreement, or at such later time and date as shall have been consented to in writing by the Underwriters. The Prospectus
(in accordance with Rule 424(b)) and &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Securities Act), if any,
shall have been duly filed with the Commission in a timely fashion in accordance with the terms thereof. At or prior to the Closing
Date and the actual time of the Closing, no stop order suspending the effectiveness of the Registration Statement or any part thereof
shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing
or suspending the use of the Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or
threatened by the Commission; no order having the effect of ceasing or suspending the distribution of the Offered Shares or any
other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange
and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated
by any securities commission, securities regulatory authority or stock exchange; all requests for additional information on the
part of the Commission shall have been complied with; and the FINRA shall have raised no objection to the fairness and reasonableness
of the placement terms and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Corporate Proceedings</U>.
All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and the Prospectus,
and the registration, sale and delivery of the Offered Shares, shall have been completed or resolved in a manner reasonably satisfactory
to the Underwriters&rsquo; respective counsels, and such counsel shall have been furnished with such papers and information as
it may reasonably have requested to enable such counsels to pass upon the matters referred to in this <U>Section 5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>No Material Adverse
Effect</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Underwriters&rsquo;
sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <U>Opinion of Counsel
for the Company</U>. The Underwriters shall have received on the Closing Date the favorable opinions of: (i) Sichenzia Ross Ference
LLP, U.S. securities counsel; and (ii) [&#9679;], Taiwan counsel, each dated as of such Closing Date, including, without limitation,
a customary negative assurance letter, addressed to the Underwriters in reasonable and customary form satisfactory to the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <U>Officers&rsquo;
Certificate</U>. The Underwriters shall have received on the Closing Date a certificate of the Company, dated as of such Closing
Date, signed by each of the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Underwriters
shall be satisfied that, the signers of such certificate have reviewed the Registration Statement and the Prospectus, and this
Agreement and to the further effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) The representations
and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and the Company
has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such
Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) No stop order
suspending the effectiveness of the Registration Statement or the use of the Prospectus has been issued and no proceedings for
that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no
order having the effect of ceasing or suspending the distribution of the Offered Shares or any other securities of the Company
has been issued by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings
for that purpose have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission,
securities regulatory authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) When the Registration
Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate, the
Registration Statement, when it became effective, contained all material information required to be included therein by the Securities
Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed
to the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder, as the case may
be, and the Registration Statement, did not and does not include any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading (<I><U>provided</U></I>, <I><U>however</U></I>, that the preceding representations and warranties contained
in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriters
Information) and, since the effective date of the Registration Statement, there has occurred no event required by the Securities
Act and the rules and regulations of the Commission thereunder to be set forth in the Registration Statement which has not been
so set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) Subsequent to
the respective dates as of which information is given in the Registration Statement and the Prospectus, there has not been: (a)
any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as a whole, except
transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material to the
Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary
course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding
stock options or warrants or conversion of outstanding indebtedness into shares of Common Stock) or outstanding indebtedness of
the Company or any Subsidiary (except for the conversion of such indebtedness into shares of Common Stock); (e) any dividend or
distribution of any kind declared, paid or made on the shares of Common Stock of the Company; or (f) any loss or damage (whether
or not insured) to the property of the Company or any Subsidiary which has been sustained or will have been sustained which has
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <U>Bring-down Comfort
Letter</U>. On the Closing Date, the Underwriters shall have received from KCCW Accountancy Corp., or such other independent registered
public accounting firm engaged by the Company at such time, a letter dated as of such Closing Date, in form and substance satisfactory
to the Underwriters, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (a) of
this <U>Section 5</U>, except that the specified date referred to therein for the carrying out of procedures shall be no more than
three business days prior to such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <U>Stock Exchange
Listing</U>. The Offered Shares shall be registered under the Exchange Act and shall be approved to be listed on the Nasdaq Capital
Market, and the Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the
registration of the Offered Shares under the Exchange Act or delisting or suspending from trading the Offered Shares from the Nasdaq
Capital Market, nor shall the Company have received any information suggesting that the Commission or the Nasdaq Capital Market
is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Additional Documents</U>.
On or before the Closing Date, the Underwriters and counsel for the Underwriters shall have received such customary information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Offered
Shares as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction
of any of the conditions or agreements, herein contained. If any condition specified in this <U>Section 5</U> is not satisfied
when and as required to be satisfied, this Agreement may be terminated by the Underwriters by notice to the Company at any time
on or prior to the Closing Date, which termination shall be without liability on the part of any party to any other party, except
that <U>Section 6</U> (<I>Payment of Expenses</I>), <U>Section 7</U> (<I>Indemnification and Contribution</I>) and <U>Section 8</U>
(<I>Representations and Indemnities to Survive Delivery</I>) shall at all times be effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) Subsequent to the
execution and delivery of this Agreement or, if earlier, the dates as of which information is given in the Registration Statement
(exclusive of any amendment thereof) and the Prospectus (exclusive of any supplement thereto), there shall not have been any change
in the capital stock or long-term debt of the Company (other than as described in the Registration Statement or the Prospectus)
or any change or development involving a change, whether or not arising from transactions in the ordinary course of business, in
the business, condition (financial or otherwise), results of operations, shareholders' equity, properties or prospects of the Company,
taken as a whole, including but not limited to the occurrence of any fire, flood, storm, explosion, accident, act of war or terrorism
or other calamity, the effect of which, in any such case described above, is, in the sole reasonable judgment of the Underwriters,
so material and adverse as to make it impracticable or inadvisable to proceed with the sale of Offered Shares or Offering as contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) Subsequent to the
execution and delivery of this Agreement and up to the Closing Date, there shall not have occurred any of the following: (i) trading
in securities generally on the Nasdaq Capital Market or any trading markets shall not have commenced, (ii) a banking moratorium
shall have been declared by federal or state authorities or a material disruption has occurred in commercial banking or securities
settlement or clearance services in the United States, (ii) the United States shall have become engaged in hostilities in which
it is not currently engaged, the subject of an act of terrorism, there shall have been an escalation in hostilities involving the
United States, or there shall have been a declaration of a national emergency or war by the United States, or (iii) there shall
have occurred any other calamity or crisis or any change in general economic, political or financial conditions in the United States
or elsewhere, if the effect of any such event in clause (ii) or (iii) makes it, in the sole judgment of the Underwriters, impracticable
or inadvisable to proceed with the sale or delivery of the Offered Shares on the terms and in the manner contemplated by the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) The Underwriters
shall have received a lock-up agreement from each Lock-Up Party set forth on <U>Schedule A</U>, duly executed by the applicable
Lock-Up Party, in each case substantially in the form attached as <U>Schedule B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) FINRA shall have
confirmed that it has not raised any objection with respect to the fairness and reasonableness of the placement terms and arrangements.
In addition, the Company shall, if requested by the Underwriters, make or authorize the Underwriters&rsquo; counsel to make on
the Company's behalf an Issuer Filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to
the Registration Statement and pay all filing fees required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) No action shall have
been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Offered Shares; and
no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent
the issuance or sale of the Offered Shares or materially and adversely affect or potentially materially and adversely affect the
business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) The Company and the
Underwriters shall have entered into deposit account agreement with the Offering Deposit Account Agent pursuant to which the Investors
shall deposit their subscription funds in the Offering Deposit Account and the Company and the Underwriters shall authorize the
disbursement of the funds from such deposit account. All Investor checks delivered to the Deposit Account Agent shall be made payable
to &ldquo;FinTech Clearing, LLC as offering deposit account agent for AMERICAN BRIVISION (HOLDING) CORPORATION.&rdquo; The Company
shall pay the agreed fees of the Offering Deposit Account Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p) The Company will
enter into a customary subscription agreement with Investors and will deliver any additional customary certificates or documents
as the Underwriters deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably
acceptable to the Underwriters. The Company agrees that each Underwriter may rely upon, and is a third party beneficiary of, the
representations and warranties and applicable covenants set forth in the purchase agreement with Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If any of the conditions
specified in this <U>Section 5</U> shall not have been fulfilled when and as required by this Agreement, or if any of the certificates,
opinions, written statements or letters furnished to the Underwriters or to Underwriters&rsquo; counsel pursuant to this <U>Section
5</U> shall not be reasonably satisfactory in form and substance to the Underwriters and to Underwriters&rsquo; counsel, all obligations
of the Underwriters hereunder may be cancelled by the Underwriters at, or at any time prior to, the consummation of the Offering.
Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly
thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6. Payment of Company Expenses</B>.
Whether borne by the Company or the Underwriters, the Company agrees to pay all costs, fees and expenses incurred by the Company
or the Underwriters in connection with the performance of its obligations hereunder and in connection with the transactions contemplated
hereby and in the Registration Statement, including, without limitation: (i) all expenses incident to the issuance, delivery and
qualification of the Offered Shares (including all printing and engraving costs); (ii) all fees and expenses of the registrar and
transfer agent of the Offered Shares, including those that are part of the Offered Shares; (iii) all necessary issue, transfer
and other stamp taxes in connection with the issuance and sale of the Offered Shares; (iv) all fees and expenses of the Company&rsquo;s
counsel, independent public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection
with the preparation, printing, formatting for EDGAR, filing, shipping and distribution of the Registration Statement (including
financial statements, exhibits, schedules, consents and certificates of experts), the Prospectus, and all amendments and supplements
thereto, and this Agreement and the mailing and delivering of copies thereof to the Underwriters and dealers; (vi) all filing fees,
reasonable attorneys&rsquo; fees and expenses incurred by the Company or the Underwriters in connection with qualifying or registering
(or obtaining exemptions from the qualification or registration of) all or any part of the Offered Shares for offer and sale under
the state securities or blue sky laws or the securities laws of any other country, and, if reasonably requested by the Underwriters,
preparing and printing a &ldquo;Blue Sky Survey,&rdquo; an &ldquo;International Blue Sky Survey&rdquo; or other memorandum, and
any supplements thereto, advising any of the Underwriters of such qualifications, registrations and exemptions; (vii) all fees
and expenses in connection with filings with FINRA's Public Offering System; (viii) the fees and expenses associated with including
the Offered Shares on the Trading Market; (ix) all costs and expenses incident to the travel and accommodation of the Company&rsquo;s
employees on the &ldquo;roadshow,&rdquo; if any; (x) any stock transfer taxes incurred in connection with this Agreement or the
Offering; (xi) and (x) all other fees, costs and expenses referred to in Part II of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7. Indemnification</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Indemnification
by the Company</I>. The Company shall indemnify and hold harmless each Underwriter, its affiliates and its directors, officers,
members, employees and agents and each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities
Act of or Section 20 of the Exchange Act (collectively the &ldquo;<B>Underwriter Indemnified Parties</B>,&rdquo; and each an &ldquo;<B>Underwriter
Indemnified Party</B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever (or any action, investigation or
proceeding in respect thereof), to which such Underwriter Indemnified Party may become subject, under the Securities Act or otherwise,
insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding arises out of or is based upon (A)
any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus
or the Prospectus or any amendment or supplement thereto, (B) the omission or alleged omission to state in the Registration Statement,
any Preliminary Prospectus or the Prospectus, or in any amendment or supplement thereto, a material fact required to be stated
therein or necessary to make the statements therein not misleading, or (C) any breach of the representations and warranties of
the Company contained herein or failure of the Company to perform its obligations hereunder or pursuant to any law, any act or
failure to act, or any alleged act or failure to act, by the Underwriters in connection with, or relating in any manner to, this
Agreement, the Offered Shares or the Offering, and which is included as part of or referred to in any loss, claim, damage, expense,
liability, action, investigation or proceeding arising out of or based upon matters covered by subclause (A), (B) or (C) above
of this <U>Section 7(a)</U>; and shall reimburse the Underwriter Indemnified Parties promptly upon demand for any legal fees or
other expenses reasonably incurred by the Underwriter Indemnified Parties in connection with investigating, or preparing to defend,
or defending against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss,
claim, damage, expense, liability, action, investigation or proceeding, as such fees and expenses are incurred; <I>provided</I>,
<I>however</I>, that the Company shall not be liable in the case of any matter covered by subclause (C) to the extent that it is
determined in a final judgment by a court of competent jurisdiction that such loss, claim, damage, expense or liability resulted
directly from any such act or failure to act undertaken or omitted to be taken by the Underwriters through fraud, gross negligence
or willful misconduct; and <I>provided</I>, <I>further</I>, that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage, expense or liability arises out of or is based upon an untrue statement in, or omission from
the Registration Statement or the Prospectus, or any such amendment or supplement thereto, made in reliance upon and in conformity
with the Underwriters Information. The indemnification obligation under this <U>Section 7(a)</U> is not exclusive and will be in
addition to any liability, which the Company might otherwise have and shall not limit any rights or remedies which may otherwise
be available at law or in equity to each Underwriter Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Indemnification
by the Underwriters</I>. The Underwriters shall, severally and not jointly, indemnify and hold harmless the Company and the Company&rsquo;s
affiliates, directors, officers, employees, agents and each person, if any, who controls the Company within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;<B>Company Indemnified Parties</B>&rdquo; and
each a &ldquo;<B>Company Indemnified Party</B>&rdquo;) against any loss, claim, damage, expense or liability whatsoever (or any
action, investigation or proceeding in respect thereof), to which such Company Indemnified Party may become subject, under the
Securities Act or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding arises
out of or is based upon (i) any untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus
or the Prospectus, or any amendment or supplement thereto, in reliance upon and in conformity with the Underwriters Information,
(ii) the omission to state in the Registration Statement, any Preliminary Prospectus or the Prospectus, or any amendment or supplement
thereto, a material fact required to be stated therein or necessary to make the statements therein not misleading, but in each
case only to the extent that the untrue statement or omission was made in reliance upon and in conformity with the Underwriters
Information, or (iii) any payment of compensation or other fees owed to one of more selected dealers pursuant to any selected dealer
agreements, and shall reimburse the Company for any legal or other expenses reasonably incurred by such party in connection with
investigating or preparing to defend or defending against or appearing as third party witness in connection with any such loss,
claim, damage, liability, action, investigation or proceeding, as such fees and expenses are incurred. Notwithstanding the provisions
of this <U>Section 7(b)</U>, in no event shall any indemnity by the Underwriters under this <U>Section 7(b)</U> exceed the total
commission received by the Underwriters in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Procedure</I>.
Promptly after receipt by an indemnified party under this <U>Section 7</U> of notice of the commencement of any action, the indemnified
party shall, if a claim in respect thereof is to be made against an indemnifying party under this <U>Section 7</U>, notify such
indemnifying party in writing of the commencement of that action; <I>provided</I>, <I>however</I>, that the failure to notify the
indemnifying party shall not relieve it from any liability which it may have under this <U>Section 7</U> except to the extent it
has been materially adversely prejudiced by such failure; and, <I>provided</I>, <I>further</I>, that the failure to notify an indemnifying
party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this <U>Section 7</U>.
If any such action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying
party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying
party, to assume the defense of such action with counsel reasonably satisfactory to the indemnified party (which counsel shall
not, except with the written consent of the indemnified party, be counsel to the indemnifying party). After notice from the indemnifying
party to the indemnified party of its election to assume the defense of such action, except as provided herein, the indemnifying
party shall not be liable to the indemnified party under <U>Section 7.(a) or 7(b)</U>, as applicable, for any legal or other expenses
subsequently incurred by the indemnified party in connection with the defense of such action other than reasonable costs of investigation;
<I>provided</I>, <I>however</I>, that any indemnified party shall have the right to employ separate counsel in any such action
and to participate in the defense of such action at its own expense unless (i) the employment thereof has been specifically authorized
in writing by the Company in the case of a claim for indemnification under <U>Section 7(a)</U>, (ii) such indemnified party shall
have been advised by its counsel that there may be one or more legal defenses available to it which are different from or additional
to those available to the indemnifying party, or (iii) the indemnifying party has failed to assume the defense of such action and
employ counsel reasonably satisfactory to the indemnified party within a reasonable period of time after notice of the commencement
of the action or the indemnifying party does not diligently defend the action after assumption of the defense, in which case, if
such indemnified party notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the
indemnifying party, the indemnifying party shall not have the right to assume the defense of (or, in the case of a failure to diligently
defend the action after assumption of the defense, to continue to defend) such action on behalf of such indemnified party and the
indemnifying party shall be responsible for legal or other expenses subsequently incurred by such indemnified party in connection
with the defense of such action; <I>provided</I>, <I>however</I>, that the indemnifying party shall not, in connection with any
one such action or separate but substantially similar or related actions in the same jurisdiction arising out of the same general
allegations or circumstances, be liable for the reasonable fees and expenses of more than one separate firm of attorneys at any
time any such indemnified party (in addition to any local counsel), which firm shall be designated in writing by the Underwriters
if the indemnified party under this <U>Section 7</U> is an Underwriter Indemnified Party or by the Company if an indemnified party
under this <U>Section 7</U> is a Company Indemnified Party. Subject to this <U>Section 7(c)</U>, the amount payable by an indemnifying
party under <U>Section 7</U> shall include, but not be limited to, (x) reasonable legal fees and expenses of counsel to the indemnified
party and any other expenses in investigating, or preparing to defend or defending against, or appearing as a third party witness
in respect of, or otherwise incurred in connection with, any action, investigation, proceeding or claim, and (y) all amounts paid
in settlement of any of the foregoing. No indemnifying party shall, without the prior written consent of the indemnified parties,
settle or compromise or consent to the entry of judgment with respect to any pending or threatened action or any claim whatsoever,
in respect of which indemnification or contribution could be sought under this <U>Section 7</U> (whether or not the indemnified
parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release
of each indemnified party in form and substance reasonably satisfactory to such indemnified party from all liability arising out
of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by
or on behalf of any indemnified party. Subject to the provisions of the following sentence, no indemnifying party shall be liable
for settlement of any pending or threatened action or any claim whatsoever that is effected without its written consent (which
consent shall not be unreasonably withheld or delayed), but if settled with its written consent, if its consent has been unreasonably
withheld or delayed or if there be a judgment for the plaintiff in any such matter, the indemnifying party agrees to indemnify
and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment. In addition,
if at any time an indemnified party shall have requested that an indemnifying party reimburse the indemnified party for fees and
expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated herein
effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying
party of the request for reimbursement, (ii) such indemnifying party shall have received notice of the terms of such settlement
at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified
party in accordance with such request prior to the date of such settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Contribution</I>.
If the indemnification provided for in this <U>Section 7</U> is unavailable or insufficient to hold harmless an indemnified party
under <U>Section 7(a)</U>, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the
amount paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense or liability
(or any action, investigation or proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate to
reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand from the offering
of the Offered Shares, or (ii) if the allocation provided by clause (i) of this <U>Section 7(d)</U> is not permitted by applicable
law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) of this <U>Section
7(d)</U> but also the relative fault of the Company on the one hand and the Underwriters on the other with respect to the statements,
omissions, acts or failures to act which resulted in such loss, claim, damage, expense or liability (or any action, investigation
or proceeding in respect thereof) as well as any other relevant equitable considerations. The relative benefits received by the
Company or on the one hand and the Underwriters on the other with respect to such offering shall be deemed to be in the same proportion
as the total proceeds from the offering of the Offered Shares purchased by investors as contemplated by this Agreement (before
deducting expenses) received by the Company bear to the total underwriting commissions received by the Underwriters in connection
with the Offering, in each case as set forth in the table on the cover page of the Final Prospectus. The relative fault of the
Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge,
access to information and opportunity to correct or prevent such untrue statement, omission, act or failure to act; <I>provided</I>
that the parties hereto agree that the written information furnished to the Company by the Underwriters for use in the Registration
Statement or the Prospectus, or any amendment or supplement thereto, consists solely of the Underwriters Information. The Company
and the Underwriters agree that it would not be just and equitable if contributions pursuant to this <U>Section 7(d)</U> be determined
by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage, expense, liability, action,
investigation or proceeding referred to above in this <U>Section 7(d)</U> shall be deemed to include, for purposes of this <U>Section
7(d)</U>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating, preparing
to defend or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with, any
such loss, claim, damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this <U>Section
7(d)</U>, the Underwriters shall not be required to contribute any amount in excess of the total commission received in cash by
the Underwriters in connection with the Offering less the amount of any damages that the Underwriters have otherwise paid or become
liable to pay by reason of any untrue or alleged untrue statement, omission or alleged omission, act or alleged act or failure
to act or alleged failure to act. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8. Representations
and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements
of the Company or any person controlling the Company, of its officers, and of the Underwriters set forth in or made pursuant to
this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Underwriters,
the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive
delivery of and payment for the Offered Shares sold hereunder and any termination of this Agreement. A successor to the Underwriters,
or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity,
contribution and reimbursement agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9. Termination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <FONT STYLE="font-size: 10pt">This
Agreement shall become effective upon the later of: (i) receipt by the Underwriters and the Company of notification of the effectiveness
of the Registration Statement or (ii) the execution of this Agreement. The Underwriters shall have the right to terminate this
Agreement at any time upon 15 days written notice to the Company, or as practical as possible prior to the consummation of the
Closing if: (i) any domestic or international event or act or occurrence has materially disrupted, or in the opinion of the Underwriters
will in the immediate future materially disrupt, the market for the Company's securities or securities in general; or (ii) trading
on the NASDAQ Capital Market has been suspended or made subject to material limitations, or minimum or maximum prices for trading
have been fixed, or maximum ranges for prices for securities have been required, on the NASDAQ Capital Market or by order of the
Commission, FINRA or any other governmental authority having jurisdiction; or (iii) a banking moratorium has been declared by any
state or federal authority or any material disruption in commercial banking or securities settlement or clearance services has
occurred; or (iv) (A) there has occurred any outbreak or escalation of hostilities or acts of terrorism involving the United States
or there is a declaration of a national emergency or war by the United States or (B) there has been any other calamity or crisis
or any change in political, financial or economic conditions, if the effect of any such event in (A) or (B), in the reasonable
judgment of the Underwriters, is so material and adverse that such event makes it impracticable or inadvisable to proceed with
the offering, sale and delivery of the Offered Shares on the terms and in the manner contemplated by the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Any notice of termination
pursuant to this <U>Section 9</U> shall be in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) If this Agreement
shall be terminated pursuant to any of the provisions hereof, or if the sale of the Offered Shares provided for herein is not consummated
because any condition to the obligations of the Underwriters set forth herein is not satisfied or because of any refusal, inability
or failure on the part of the Company to perform any agreement herein or comply with any provision hereof, the Company will, subject
to demand by the Underwriters, reimburse the Underwriters for only those out-of-pocket expenses (including the reasonable fees
and expenses of their counsel, and expenses associated with a due diligence report), actually incurred by the Underwriters in connection
herewith as allowed under FINRA Rule 5110, less any amounts previously paid by the Company; provided, however, that all such expenses
shall not exceed $250,000 in the aggregate (of which a maximum of $75,000 can be allocated to legal expenses, a maximum of $50,000
to road show, travel, platform on-boarding fees and other reasonable out-of-pocket expenses, a maximum of $75,000 ($50,000 of which
have already been paid) to third-party due diligence, and a maximum of $6,000 for conducting background checks of the Company&rsquo;s
officers and directors, less any amounts previously reimbursed by the Company including but not limited to $25,000 retainer paid
to Underwriters&rsquo; counsel and $15,000 paid to the Underwriters as out-of-pocket accountable expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10. Notices</B>.
All communications hereunder shall be in writing and shall be mailed, hand delivered, delivered by reputable overnight courier
(i.e., Federal Express) or delivered by e-mail transmission to the parties hereto as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>If to the Underwriters, then
to: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">6 Venture, Suite 265</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attn: Keith Moore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attn: Daniel J. McClory</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: Keith@boustead1828.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: Dan@boustead1828.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>With a copy (which shall not
constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Hunter Taubman Fischer &amp;
Li LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1450 Broadway, 26th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attn: Louis Taubman, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: ltaubman@htflawyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>If to the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">American Brivision (Holding)
Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">44370 Old Warm Springs Blvd.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Fremont, CA 94538</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attn: Dr. Howard Doong, Chief
Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: howard.doong@ambrivis.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>With a copy (which shall not
constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Sichenzia Ross Ference LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1185 Avenue of Americas, 37th
Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">New York, NY 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Attn: Jay Kaplowitz, Esq</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">David Manno, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Huan Lou, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: jKaplowitz@SRF.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: DManno@SRF.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: hlou@SRF.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any party hereto may
change the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10. Successors</B>.
This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers
and directors and controlling persons referred to in <U>Section 7</U> hereof, and to their respective successors, and no other
person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 11. Partial
Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect
the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this
Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 12. Governing
Law Provisions</B>. This Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction,
effect and in all other respects by the internal laws of the State of California, without regard to the conflict of laws principles
thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this
Agreement shall be brought and enforced in the state courts located in Orange County, or in the United States District Court for
the Central District of California located in the City of Santa Ana, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified
mail, return receipt requested, postage prepaid, addressed to it at the address set forth in <U>Section 9</U> hereof. Such mailing
shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company
and the Underwriters agree that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection with
the preparation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 13. General
Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) This Agreement constitutes
the entire agreement of the parties to this Agreement and supersedes all prior agreements and understandings (whether written or
oral) between the Company and the Underwriters, solely with respect to the Offering contemplated by this Agreement. For elimination
of doubt, nothing in this Agreement or contemplated hereby, including without limitation the immediately previous sentence, shall
supersede, curtail, limit, terminate, eliminate or invalidate any provision of the engagement letter, dated as of January 31, 2019,
by and between the Representative and the Company, [as amended by that certain First Amendment to Engagement Letter effective as
of [&#9679;]] ([as so amended,] the &ldquo;<B>Engagement Letter</B>&rdquo;) not related to the transactions contemplated by the
Registration Statement, any Preliminary Prospectus and the Prospectus, each of which provisions shall remain in full force and
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) This Agreement may
be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto
and hereto were upon the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) This Agreement may
not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be
waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein are for the convenience
of the parties only and shall not affect the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) The Company acknowledges
that in connection with the offering of the Offered Shares: (i) each of the Underwriters has acted at arm&rsquo;s length, are not
agents of, and owe no fiduciary duties to the Company or any other person, (ii) each of the Underwriters owes the Company only
those duties and obligations set forth in this Agreement and (iii) each of the Underwriters may have interests that differ from
those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against any of the
Underwriters arising from an alleged breach of fiduciary duty in connection with the offering of the Offered Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) This Agreement is
expressed in the English language. If this Agreement is translated by either party to another language for any purpose, the English
language version shall govern over any translation in the event of any inconsistency, discrepancy or conflict in interpretation.
All communications, notices, and other actions relating to this Agreement shall be in the English language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page has been
intentionally left blank</I>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is
in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts
hereof, shall become a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><B>AMERICAN BRIVISION (HOLDING) CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: Howard Doong</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accepted by the Representative, acting
for itself and as Representative of the Underwriters named on <U>Annex A</U> hereto, as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>BOUSTEAD SECURITIES, LLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: Keith Moore</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: justify; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Boustead Securities, LLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>[&#9679;]</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SCHEDULE A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LOCK-UP PARTY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boustead Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6 Venture, Suite 265</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>AMERICAN BRIVISION (HOLDING) CORPORATION &ndash; Lock-Up
Agreement</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement (the
&ldquo;<B>Lock-Up Agreement</B>&rdquo;) is being delivered to you in connection with the Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) between AMERICAN BRIVISION (HOLDING) CORPORATION, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
and Boustead Securities, LLC, acting as a representative (the &ldquo;<B>Representative</B>&rdquo;) of the several underwriters
(&ldquo;<B>Underwriters</B>&rdquo;) in the proposed public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of a minimum of
1,388,889 shares of Series A Convertible Preferred Stock and a maximum of 2,777,778 Series A Convertible Preferred Stock, par value
$0.001 per share, of the Company (&ldquo;<B>Series A Convertible Preferred Stock</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce the Underwriters
to continue their efforts in connection with the Public Offering, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the undersigned hereby agrees for the benefit of the Company and the Underwriters
that, without the Representative&rsquo;s prior written consent, the undersigned will not, during the period commencing on the date
hereof and ending 180 days following Effective Date of the Registration Statement (the &ldquo;<B>Lock-Up Period</B>&rdquo;), directly
or indirectly (1) offer, pledge, assign, encumber, announce the intention to sell, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer
or dispose of, any shares of Series A Convertible Preferred Stock or any securities directly or indirectly convertible into or
exercisable or exchangeable for shares of Series A Convertible Preferred Stock owned either of record or beneficially (as defined
in the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;)), by the undersigned on the date hereof
or hereafter acquired, or (2) enter into any swap or other agreement or arrangement that transfers, in whole or in part, any of
the economic consequences of ownership of the shares of Series A Convertible Preferred Stock, whether any such transaction described
in clause (1) or (2) above is to be settled by delivery of shares Series A Convertible Preferred Stock or such other securities,
in cash or otherwise, or publicly announce an intention to do any of the foregoing. If the undersigned is an officer or director
of the Company, the undersigned further agrees that the foregoing restrictions shall be equally applicable to any issuer-directed
shares of Series A Convertible Preferred Stock the undersigned may purchase in the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing shall
not apply to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify">the sale of shares of Series A Convertible Preferred
Stock pursuant to the Public Offering;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify">transactions relating to shares of Series A Convertible
Preferred Stock acquired in open market transactions after the completion of the Public Offering; <I>provided </I>that, no filing
by any party under the Exchange Act or other public announcement shall be required or shall be voluntarily made in connection
with such transfer;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">iii.</TD><TD STYLE="text-align: justify">(a) exercises of stock options or equity awards granted
pursuant to an equity incentive or other plan or warrants to purchase shares of Series A Convertible Preferred Stock or other
securities (including by cashless exercise to the extent permitted by the instruments representing such stock options or warrants
so long as such cashless exercise is effected solely by the surrender of outstanding stock options or warrants to the Company
and the Company&rsquo;s cancellation of all or a portion thereof to pay the exercise price), provided that in any such case the
securities issued upon exercise shall remain subject to the provisions of this Agreement (as defined below); (b) transfers of
shares of Series A Convertible Preferred Stock or other securities to the Company in connection with the vesting or exercise of
any equity awards granted pursuant to an equity incentive or other plan and held by the undersigned to the extent, but only to
the extent, as may be necessary to satisfy tax withholding obligations pursuant to the Company&rsquo;s equity incentive or other
plans;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">iv.</TD><TD STYLE="text-align: justify">transfers of shares Series A Convertible Preferred
Stock or any security directly or indirectly convertible into or exercisable or exchangeable for Shares as a bona fide gift or
in connection with estate planning, including, but not limited to, dispositions to any trust for the direct or indirect benefit
of the undersigned or the &ldquo;immediate family member(s)&rdquo; (as defined in Item 404(a) of Regulation S-K under the Exchange
Act) of the undersigned and dispositions from any grantor retained annuity trust established for the direct benefit of the undersigned
or a member of the immediate family of the undersigned, or by will or intestacy;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">v.</TD><TD STYLE="text-align: justify">any transfer pursuant to a qualified domestic relations
order or in connection with a divorce;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">vi.</TD><TD STYLE="text-align: justify">(a) any distributions or transfers without consideration
of shares of Series A Convertible Preferred Stock or any security directly or indirectly convertible into or exercisable or exchangeable
for Shares to any member participating in the offering and the officers or partners thereof or other acceptable persons pursuant
to FINRA Rule 5110(g)(2)(A) ; (b) any transfer made in connection with the sale or other bona fide transfer in a single transaction
of all or substantially all of the undersigned&rsquo;s capital stock, partnership interests, membership interests or other similar
equity interests, as the case may be, or all or substantially all of the undersigned&rsquo;s assets, in any such case not undertaken
for the purpose of avoiding the restrictions imposed by this Agreement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">vii.</TD><TD STYLE="text-align: justify">the establishment of a trading plan pursuant to Rule
10b 5-1 under the Exchange Act for the transfer of shares of Series A Convertible Preferred Stock, <I>provided </I>that such plan
does not provide for the transfer of Shares during the Lock-Up Period; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">viii.</TD><TD STYLE="text-align: justify">by will or the laws of descent and distribute or to
one or more trusts for bona fide estate planning purposes;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>provided</I>, <I>however</I>,
that (a) in the case of any transfer or distribution pursuant to clause (iv) or (vi), each donee or distributee shall sign and
deliver a lock-up letter agreement substantially in the form of this letter agreement (the &ldquo;<B>Agreement</B>&rdquo;) and
(b) in the case of any transaction pursuant to clauses (iv), (vi) or (vii), such transaction is not required to be reported during
the Lock-Up Period by anyone in any public report or filing with the Securities and Exchange Commission or otherwise (other than
a required filing on Form 5, Schedule 13D or Schedule 13G (or 13D/A or 13G/A) and no such filing shall be made voluntarily during
the Lock-Up Period. In addition, the undersigned agrees that, without the Representative&rsquo;s prior written consent, it will
not, during the Lock-Up Period, make any demand for or exercise any right with respect to, the registration of any shares of Series
A Convertible Preferred Stock or any security directly or indirectly convertible into or exercisable or exchangeable for shares
of Series A Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby
further agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this Agreement
during the period from the date of this Agreement to the expiration of the Lock-Up Period, it will give notice thereof to the Company
and will not consummate such transaction or take such action unless it has received written confirmation from the Company that
the Lock-Up Period has expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In furtherance of the
foregoing, (1) the undersigned also agrees and consents to the entry of stop transfer instructions with any duly appointed transfer
agent for the registration or transfer of the securities described herein against the transfer of any such securities except in
compliance with the foregoing restrictions, and (2) the Company, and any duly appointed transfer agent for the registration or
transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer
would constitute a violation or breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the undersigned
is an officer or director of the Company, (i) the Representative agrees that, at least three business days before the effective
date of any release or waiver of the foregoing restrictions in connection with a transfer of Shares, the Representative will notify
the Company of the impending release or waiver, and (ii) the Company has agreed in the Underwriting Agreement to announce the impending
release or waiver by press release through a major news service at least two business days before the effective date of the release
or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective
two business days after the publication date of such press release. The provisions of this paragraph will not apply if (a) the
release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to
be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the
time of the transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby
represents and warrants that the undersigned has full power and authority to enter into this Agreement. The undersigned hereby
waives any applicable notice requirement concerning the Company&rsquo;s intention to file the registration statement and applicable
exhibits (the &ldquo;<B>Registration Statement</B>&rdquo;) and sell shares of Series A Convertible Preferred Stock thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Company and the Underwriters are relying upon this Agreement in proceeding toward consummation of the Public Offering.
The undersigned further understands that this Agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs,
legal representatives, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned acknowledges
that whether or not the Public Offering actually occurs depends on a number of factors, including market conditions, that any Public
Offering will be made only pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company
and the Representative and that there is no assurance that the Company and the Representative will enter into an Underwriting Agreement
with respect to the Public Offering or that the Public Offering will be consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall
automatically terminate upon the earliest to occur, if any, of (1) either the Representative, on the one hand, or the Company,
on the other hand, advising the other in writing, prior to the execution of the Underwriting Agreement, that they have determined
not to proceed with the Public Offering, (2) termination of the Underwriting Agreement before the sale of any shares of Series
A Convertible Preferred Stock pursuant to the Underwriting Agreement, (3) the withdrawal of the Registration Statement filed with
the Securities and Exchange Commission with respect to the Public Offering, or (4) the Underwriting Agreement having not been executed
by [&#9679;] or such other date as may be agreed as the final date of the Public Offering if the Company and the Representative
extend the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall
be governed by and construed in accordance with the laws of the State of California, without regard to the conflict of laws principles
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>SIGNATURE PAGE FOLLOWS</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Name - Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Signature)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Name of Signatory, in the case of entities - Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(Title of Signatory, in the case of entities - Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Please see attached]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.6
<SEQUENCE>3
<FILENAME>fs12018a2ex3-6_american.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATIONS FOR SERIES A CONVERTIBLE PREFERRED STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>Exhibit 3.6</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_001.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_002.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_003.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_004.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_005.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_006.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_007.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_008.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_009.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-6_010.jpg" ALT="" STYLE="width: 850px; height: 1100px"></P>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>fs12018a2ex4-1_american.htm
<DESCRIPTION>FORM OF THE REGISTRANT?S COMMON STOCK CERTIFICATE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><IMG SRC="img_ex4-1.jpg" ALT="" STYLE="height: 696px; width: 900px"><FONT STYLE="color: White"></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-size: 7pt"><B><FONT STYLE="color: White">&nbsp;</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.6pt 0 0 86.95pt; color: #727070"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">FULLY
PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF $.001 PAR VALUE EACH OF</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.85pt 199.55pt 0 206.4pt; text-align: center"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">AMERICAN
BRIVISION (HOLDING) CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 23.3pt 0 32.2pt; text-align: justify; text-indent: 0.25pt"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">transferable
on the books of the Corporation in person or by duly authorized attorney upon surrender of this certificate duly endorsed or assigned.
This certificate and the shares represented hereby are subject to the laws of the State of Nevada, and to the Articles of Incorporation
and Bylaws of the Corporation, as now or hereafter amended. This certificate is not valid until countersigned by the Transfer
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 5.7pt 0 0 68.25pt"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">WITNESS
the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 407.9pt; color: #727070"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">COUNTERSIGNED:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 5.55pt 0 0; text-align: right"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">OLDE
MONMOUTH STOCK TRANSFER CO., INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.8pt 6pt 0 0; text-align: right"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">200
MEMORIAL PARKWAY, ATLANTIC HIGHLANDS , NJ 07716</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 1.6pt 5.95pt 0 0; text-align: right; color: #727070"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">TRANSFER
AGENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 1.3pt 12.1pt 0 206.4pt; text-align: center"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">BY:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.9pt 0 0; text-align: right; color: #727070"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">AUTHORIZED
SIGNATURE</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0"><FONT STYLE="font-size: 1pt; color: White; letter-spacing: 0; line-height: 0; vertical-align: 0; word-spacing: 0">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.65pt 0 0 29.6pt; color: #CD7E85"></P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>5
<FILENAME>fs12018a2ex4-2_american.htm
<DESCRIPTION>FORM OF UNDERWRITER'S WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">THE REGISTERED HOLDER OF THIS WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL
NOT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE (AS DEFINED BELOW) OF THE REGISTRATION STATEMENT:
(A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS WARRANT TO ANYONE OTHER THAN OFFICERS OR PARTNERS OF BOUSTEAD SECURITIES,
LLC, EACH OF WHOM SHALL HAVE AGREED TO THE RESTRICTIONS CONTAINED HEREIN, IN ACCORDANCE WITH FINRA CONDUCT RULE 5110(G)(1), OR
(B) CAUSE THIS WARRANT OR THE SECURITIES ISSUABLE HEREUNDER TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL
TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS WARRANT OR THE SECURITIES HEREUNDER, EXCEPT AS PROVIDED
FOR IN FINRA RULE 5110(G)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS WARRANT IS NOT EXERCISABLE PRIOR TO
[&#9679;], 2019. VOID AFTER 5:00 P.M., EASTERN TIME, [&#9679;], 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMERICAN BRIVISION (HOLDING) CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Warrant Shares: ______</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: right"><FONT STYLE="font-size: 10pt">Initial Exercise Date: ________, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Issue Date: ________, 2019</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, <B>Boustead Securities, LLC</B>, the registered
holder hereof or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, at any time on or after [&#9679;], 2019, being any date after the issuance of this Warrant
(the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to the close of business on the five year anniversary of the Initial
Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <B>AMERICAN BRIVISION
(HOLDING) CORPORATION</B>, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to [&#9679;] shares of common stock, par
value $0.001 per share (&ldquo;<U>Common Stock</U>&rdquo;), of the Company<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT>
(as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Underwriting Agreement
(the &ldquo;<U>Underwriting Agreement</U>&rdquo;), dated [&#9679;], 2019, among the Company and the Holder, as representative of
the several underwriters listed on Schedule A thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a) Exercise
of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as
it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company)
of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto. Within three trading
days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in <U>Section 2(c)</U> below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been
exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three trading
days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number
of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise within one business day of receipt of such notice. The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase
of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may
be less than the amount stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">The amount of the Warrant Shares is equal to the aggregate
of 7% of the shares issued and issuable by the Company on a Closing Date to the Investors in the Offering.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$[&#9679;]<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2</SUP></FONT></B>,
subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c) <U>Cashless
Exercise</U>. At any time during the term of this Warrant, this Warrant may also be exercised, in whole or in part, at such time
by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal
to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(A) =</TD><TD STYLE="text-align: justify">the Closing Price of the Common Stock on the trading
market on the trading day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &ldquo;cashless
exercise,&rdquo; as set forth in the applicable Notice of Exercise;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&ldquo;<U>Closing Price</U>&rdquo;
means, for any date, the closing price determined by the first of the following clauses that applies: (a) if the Common Stock is
then listed or quoted on a United States national stock exchange, the closing price of the Common Stock for such date (or the nearest
preceding date) on such trading market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a trading day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if OTCQB or OTCQX is the trading market,
the closing price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in
the &ldquo;Pink Sheets&rdquo; published by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of
reporting prices), the most recent bid price per share of Common Stock so reported, or (d)in all other cases, the fair market value
of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Company&rsquo;s
stock transfer agent and registrar (the &ldquo;<U>Transfer Agent</U>&rdquo;) to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system
(&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration
statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, or (B) this Warrant is being
exercised via cashless exercise, and otherwise by physical delivery of a certificate (if requested), in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
by the Holder in the Notice of Exercise by the date that is three trading days after the Company receives the Notice of Exercise
(such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Within two trading days following an exercise of this Warrant
as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of
such exercise multiplied by the number of Warrant Shares as to which this Warrant is so exercised in cash or via wire transfer
of immediately available funds if, subject to the provisions of <U>Section 2(c)</U>, the Holder does not notify the Company in
such Notice of Exercise that such exercise is made pursuant to a cashless exercise at a time and under circumstances which permit
a cashless exercise. The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be
named therein shall be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the date the Warrant
has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required
to be paid by the Holder, if any, pursuant to <U>Section 2(d)(vi)</U> prior to the issuance of such Warrant Shares, having been
paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the Closing Price of the Common Stock on the date of the applicable Notice
of Exercise), $10 per trading day (increasing to $20 per trading day on the fifth trading day after such liquidated damages begin
to accrue) for each trading day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify">The exercise price shall be equal to the public offering
price per share in the Offering.</TD>
</TR></TABLE>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the
Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm
otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the
Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the
Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the
shares of Common Stok so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company
was required to deliver to the Holder in connection with the exercise at issue times by (2) the price at which the sell order giving
rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be
required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any
other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that in the event Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees
to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">vii. <U>Closing
of Books</U>. The Company will not close its register of members, shareholder books or records in any manner which prevents the
timely exercise of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">viii. <U>Net
Cash Settlement</U>. In no event may the Holder net cash settle this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e) <U>Lockup</U>.
The Holder represents that it (or permitted assignees under FINRA Rule 5110(g)(1)) will not sell, transfer, assign, pledge, or
hypothecate this Warrant or the securities underlying the Warrant, nor will it engage in any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a
period of 180 days from the Effective Date of the Registration Statement for the Offering, which includes the registration of the
shares underlying the Warrant, except as provided for in FINRA Rule 5110(g)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a) <U>Share
Capitalizations and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) effects a share capitalization
or otherwise pays a dividend or other distribution on its shares of Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of share consolidation) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
reclassification of the shares of Common Stock any shares of the Company, then in each case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall
become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company grants,
issues or sells any securities of the Company which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into
or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (&ldquo;<U>Common Stock Equivalents</U>&rdquo;)
or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of shares of Common
Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such
Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken,
the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase
Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets
in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of shares of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the shareholders holding 50% or more of
the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any
reclassification, reorganization or recapitalization of the shares of Common Stock or any compulsory share exchange pursuant to
which the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the
Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group
of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other
Persons making or party to, such share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common
Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of share of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity
in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this <U>Section 3(d)</U> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of such Successor Entity (or its
parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares, such number of shares and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
Warrant and the other transaction documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 67.5pt">e) <U>Calculations</U>.
All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of shares of Common Stock rights or warrants to subscribe for or purchase any
shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of
all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address
as it shall appear upon the Warrant Register (as defined in <U>Section 4(c)</U> below) of the Company, at least 20 calendar days
prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date
as of which the holders of shares of Common Stock of record to be entitled to such dividend, distributions, redemption, rights
or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of shares of Common Stock
of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any
defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in
part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company
shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion
of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant
in full, in which case, the Holder shall surrender this Warrant to the Company within three trading days of the date the Holder
delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned in accordance herewith,
may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in
such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial
issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.</U> <U>Piggyback
Registration Rights. </U>To the extent the Company does not maintain an effective registration statement for the Warrant Shares
and in the further event that the Company plans to file a registration statement with the SEC covering the sale of its shares of
Common Stock (other than a registration statement on Form S-4 or S-8 or any similar successor forms thereto, or on another form,
or in another context, in which such &ldquo;piggyback&rdquo; registration would be inappropriate), then, for a period commencing
on the Initial Exercise Date and terminating on the Termination Date, the Company shall give written notice (the &ldquo;<U>Piggyback
Notice</U>&rdquo;) of such proposed filing to the holders of Warrant Shares as soon as practicable but in no event less than five
business days before the anticipated filing date, which notice shall describe the amount and type of securities to be included
in such offering, the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters, if
any, of the offering, and offer to the holders of Warrant Shares in such notice the opportunity to register the sale of such number
of shares of Warrant Shares as such holders may request in writing within three business days after receipt of such Piggyback Notice
(a &ldquo;<U>Piggyback Registration</U>&rdquo;). Notwithstanding the foregoing, the Company may delay any Piggyback Notice to any
holders of Warrant Shares, including until after filing a registration statement, so long as all recipients of such notice have
the same amount of time to determine whether to participate in an offering as they would have had if such notice had not been so
delayed. The Company shall cause such Warrant Shares to be included in such registration and shall use its best efforts to cause
the managing underwriter or underwriters of a proposed underwritten offering to permit the Warrant Shares requested to be included
in a Piggyback Registration on the same terms and conditions as any similar securities of the Company and to permit the sale or
other disposition of such Warrant Shares in accordance with the intended method(s) of distribution thereof. All holders of Warrant
Shares proposing to distribute their securities through a Piggyback Registration that involves an underwriter or underwriters shall
enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 6</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a) <U>No
Rights as Shareholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a shareholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except as expressly set forth
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate (if any) relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share
certificate (if any), if mutilated, the Company will make and deliver a new Warrant or share certificate (if any) of like tenor
and dated as of such cancellation, in lieu of such Warrant or share certificate (if any).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a business day, then, such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">i. The
Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of executing share certificate (if any)s to execute and issue the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure
that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the trading market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued
upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by
this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect
of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">ii. Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its memorandum and articles of association or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise
of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">iii. Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e) <U>Governing
Law; Jurisdiction</U>. This Warrant shall be governed by and construed and enforced in accordance with the laws of the State of
California, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding
or claim against it arising out of, or relating in any way to this Warrant shall be brought and enforced in the state courts located
in Orange County, or in the United States District Court for the Central District of California located in the City of Santa Ana,
and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to
such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served upon the
Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid,
addressed to it at the address set forth in <U>Section 6(h)</U> below. Such mailing shall be deemed personal service and shall
be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees
and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">f) <U>Registration</U>.
The issuance of the Warrant and the Warrant Shares shall be registered in the Company&rsquo;s effective registration statement
on S-1 with commission file No. 333-[&#9679;]. The Company shall file periodic filings with the Securities and Exchange Commission
(&ldquo;<U>SEC</U>&rdquo;) during the term of this Warrant as required by the rules and regulations issued by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
to the Holder at its last address as it shall appear upon the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any shares of Common Stock or as a shareholder of the Company, whether such liability is asserted by
the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>AMERICAN BRIVISION (HOLDING) CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; text-indent: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>AMERICAN BRIVISION
(HOLDING) CORPORATION</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) <FONT STYLE="font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) <FONT STYLE="font-size: 10pt">Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful
money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; [if permitted
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in <U>Section 2(c)</U>,
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in <U>Section 2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) <FONT STYLE="font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to
the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of
Investing Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><I>(To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 50%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><U> </U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><U> </U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:_____________________<U> </U></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:_____________________<U> </U></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>fs12018a2ex5-1_american.htm
<DESCRIPTION>LEGAL OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">+</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="image_005.jpg" ALT="https:||www.sec.gov|Archives|edgar|data|1711754|000164033418002253|inmune_correspimg4.jpg" STYLE="height: 768px; width: 24px"></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="image_006.jpg" ALT="https:||www.sec.gov|Archives|edgar|data|1711754|000164033418002253|inmune_correspimg5.jpg" STYLE="height: 120px; width: 132px"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">June 28, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">American Brivision (Holding) Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">44370 Old Warm Springs Blvd</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fremont, California 94538</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">We have acted as counsel
        to American BriVision (Holding) Corporation), a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the Registration
        Statement on Form S-1, Registration No. 333-22837 (the &ldquo;Registration Statement&rdquo;) filed with the Securities and Exchange
        Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;), with respect to
        the registration of (i) an aggregate of 3,285,714 shares (the &ldquo;Series A Preferred Stock&rdquo;) of the Company&rsquo;s Series
        A Convertible Preferred Stock, par value $.001 per share, (ii) 3,285,714 shares of common stock, par value par value $.001 per
        share (&ldquo;Common Stock&rdquo;) issuable on conversion of the Series A Preferred Stock, (iii) warrants representing seven percent
        (7.00%) of the aggregate number of shares of Common Stock to be issued upon conversion of the Series A Preferred Stock issued in
        the Offering exercisable at a per share price equal to the Series A Preferred Stock public offering price per share in the offering
        (the &ldquo;Underwriter Warrants&rdquo;), and (iv) all shares of Common Stock issuable upon exercise of the Underwriter Warrants.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">We have examined originals
        or copies, certified or otherwise identified to our satisfaction, of such corporate records of the Company and other certificates
        and documents of officials of the Company, public officials and others as we have deemed appropriate for purposes of this letter.
        We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity
        to authentic original documents of all copies submitted to us as conformed and certified or reproduced copies.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">With respect to the Series
        A Preferred Stock, the Series A Preferred Stock has been duly authorized and, when issued and delivered in accordance with the
        Certificate of Designations for Series A Convertible Preferred Stock and as contemplated by the Registration Statement, the Series
        A Preferred Stock will be validly issued, fully paid and nonassessable and will be valid and binding obligations of the Company
        enforceable against the Company in accordance with its terms.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">With respect to the shares
        of Common Stock issuable upon conversion of the Series A Preferred Stock, the Common Stock has been duly authorized and, when issued
        and delivered in accordance with the Certificate of Designations for Series A Convertible Preferred Stock and as contemplated by
        the Registration Statement, the Common Stock will be validly issued, fully paid and nonassessable and will be valid and binding
        obligations of the Company enforceable against the Company in accordance with its terms.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">With respect to the Underwriter
        Warrants, the Underwriter Warrants have been duly authorized and, when issued and delivered in accordance with the underwriting
        agreement between the Company and the underwriter (the &ldquo;Underwriting Agreement&rdquo;) and as contemplated by the Registration
        Statement, the Underwriter Warrants will be validly issued, fully paid and nonassessable and will be valid and binding obligations
        of the Company enforceable against the Company in accordance with their terms.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">With respect to the shares
        issuable upon exercise of the Underwriter Warrants (the &ldquo;Warrant Shares&rdquo;), the Warrant Shares have been duly authorized
        and, when such shares have been issued and delivered against payment of the purchase price therefor in accordance with the Underwriting
        Agreement and as contemplated by the Registration Statement, the Warrant Shares will be validly issued, fully paid and nonassessable
        and will be valid and binding obligations of the Company enforceable against the Company in accordance with their terms.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">The information set forth
        herein is as of the date hereof. We assume no obligation to advise you of changes that may hereafter be brought to our attention.
        We do not express any opinion concerning the laws of any jurisdiction other than (i) the State of New York, (ii) the Federal laws
        of the United States, and (iii) the Nevada Private Corporations Chapter of the Nevada Revised Statutes. Our opinion is based on
        statutory laws and judicial decisions that are in effect on the date hereof, and we do not opine with respect to any law, regulation,
        rule or governmental policy that may be enacted or adopted after the date hereof, nor do we assume any responsibility to advise
        you of future changes in our opinion. We do not express an opinion on any matters other than those expressly set forth in this
        letter.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt">We hereby consent to
        the use and filing of this opinion as an exhibit to the Registration Statement as filed with the Securities and Exchange Commission
        and to the reference to our firm under the heading &ldquo;Legal Matters&rdquo; in the Prospectus and the Registration Statement.</P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 33%">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Sichenzia Ross Ference LLP</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Sichenzia Ross Ference LLP</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">1185 Avenue of the Americas&nbsp;<B>|</B>&nbsp;37<SUP>th</SUP>&nbsp;Floor&nbsp;<B>|</B>&nbsp;New
York, NY&nbsp;<B>|</B>&nbsp;10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 8pt">T (212) 930 9700&nbsp;<B>|</B>&nbsp;F (212) 930 9725&nbsp;<B>|</B>&nbsp;WWW.SRF.LAW.COM</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>fs12018a2ex10-1_american.htm
<DESCRIPTION>FORM OF SUBSCRIPTION AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>Subscription Agreement of American Brivision (Holding) Corp.<BR>
Series A Convertible Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Subscription Agreement (this &ldquo;<B>Subscription
Agreement</B>&rdquo;) is dated [&#9679;], 2019, by and between the investor identified on the signature page hereto (the &ldquo;<B>Investor</B>&rdquo;)
and American Brivision (Holding) Corp., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;). The parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD><U>Subscription</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investor agrees to buy and the Company
agrees to sell to Investor such number of shares (the &ldquo;<B>Shares</B>&rdquo;) of the Company&rsquo;s Series A Convertible
Preferred Stock, $0.001 par value per share (the &ldquo;<B>Preferred Stock</B>&rdquo;), as set forth on the signature page hereto,
for an aggregate purchase price (the &ldquo;<B>Purchase Price</B>&rdquo;) equal to the product of (x) the aggregate number of Shares
the Investor has agreed to purchase and (y) the purchase price per share as set forth on the signature page hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares are being registered for sale
pursuant to a Registration Statement on Form S-1, as amended, Registration No. 333-228387 (the &ldquo;<B>Registration Statement</B>&rdquo;).
The Registration Statement has been declared effective by the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
prior to issuance of any Shares and acceptance of any Investor&rsquo;s subscription. The prospectus, however, is subject to change.
A final prospectus and/or prospectus supplement will be delivered to the Investor as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares are being offered by Boustead
Securities, LLC (the &ldquo;<B>Underwriter</B>&rdquo;) as Underwriter on a &ldquo;best efforts&rdquo; up to $20,000,000. The Underwriter
also has the option for a period of 45 days to increase the maximum offering size up to $[&#9679;] solely to cover over-subscription,
if any. The completion of the purchase and sale of the Shares (the &ldquo;<B>Closing</B>&rdquo;) shall take place at a place and
time (the &ldquo;<B>Closing Date</B>&rdquo;) to be specified by the Company and Underwriter in accordance with Rule 15c6-1 promulgated
under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;). Upon satisfaction or waiver of all
the conditions to closing set forth in the preliminary prospectus contained in the Registration Statement when it is declared effective
by the Commission, at the Closing (i) the Purchase Price deposited by the Investor subsequent to the declaration of effectiveness
of the Registration Statement by wire transfer of immediately available funds to the Company&rsquo;s escrow account per wire instructions
as provided on the signature line below shall be released to the Company, and (ii) the Company shall cause the Shares to be delivered
to the Investor (A) through the facilities of The Depository Trust Company&rsquo;s DWAC system in accordance with the instructions
set forth on the signature page attached hereto under the heading &ldquo;DWAC Delivery Instructions,&rdquo; or (B) if requested
by the Investor on the signature page hereto or if the Company is unable to make the delivery through the facilities of The Depository
Trust Company&rsquo;s DWAC system, through the book-entry delivery of Shares on the books and records of the transfer agent in
accordance with the instructions set forth on the signature page attached hereto under the heading &ldquo;DRS Electronic Book Entry
Delivery Instructions.&rdquo; If delivery is made by book entry on the books and records of the transfer agent, the Company shall
send written confirmation of such delivery to the Investor at the address indicated on the Signature Page hereof. No fractional
Shares shall be purchased and any excess funds representing fractional Shares shall be returned to the Investor. By payment of
the Shares, the Investor acknowledges receipt of the Registration Statement and any amendment, the terms of which govern the investment
in the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of the Underwriter and any participating
broker dealers (the &ldquo;<B>Members</B>&rdquo;) shall confirm, via the sales agency agreement, selected dealer agreement or master
selected dealer agreement, as applicable, that it will comply with Rule 15c2-4 of the Exchange Act (&ldquo;<B>Rule 15c2-4</B>&rdquo;).
As per Rule 15c2-4 and Notice to Members 84-7 issued by the Financial Industry Regulatory Authority, Inc. (&ldquo;<B>Notice 84-7</B>&rdquo;),
all checks that are accompanied by a subscription agreement will be promptly sent along with the subscription agreements to the
Offering Deposit Account by noon the next business day. In regard to monies being wired from an investor&rsquo;s bank account,
the Members shall request the investors to send their wires by the business day immediately following the receipt of a completed
subscription document, however, the Company cannot insure the investors will forward their respective monies as per Notice 84-7.
In regards to monies being sent from an investors account held at the participating broker, the funds will be &ldquo;promptly transmitted&rdquo;
to the escrow agent following the receipt of a completed subscription document and completed wire instructions by the investor
to send funds to the Offering Deposit Account. Absent unusual circumstances, funds in customer accounts will be transmitted by
noon of the next business day. In the event that the offering does not close for any reason prior to the termination date set forth
in the Registration Statement, all funds deposited in the escrow account will be returned to investors promptly in accordance with
the terms of the Offering Deposit Account Agency Agreement and applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD><U>Certifications, Representations and Warranties</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to induce the Company to accept
this Subscription Agreement for the Shares and as further consideration for such acceptance, the Investor hereby makes, adopts,
confirms and agrees to all of the following covenants, acknowledgments, representations and warranties with the full knowledge
that the Company and its affiliates will expressly rely thereon in making a decision to accept or reject this Subscription Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">The Investor understand that the Company reserves the right to, in its sole discretion, accept
or reject this Subscription Agreement, in whole or in part, for any reason whatsoever, and to the extent not accepted, unused funds
transmitted herewith shall be returned to the undersigned in full, with any interest accrued thereon.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The Investor has received the Registration Statement or otherwise had access to the electronic
filing on the SEC website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">The Investor is purchasing the Shares for its own account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d.</TD><TD STYLE="text-align: justify">The Investor has reviewed and accurately filled out the information set forth in <U>Exhibit A</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e.</TD><TD STYLE="text-align: justify">The Investor has reviewed and accurately filled out the information set forth in <U>Exhibit B</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">f.</TD><TD STYLE="text-align: justify">If the Investor is not a &ldquo;U.S. Person&rdquo; as defined in Rule 902 under the Securities
Act, such Investor is resident in the jurisdiction set out under on the signature page of this Subscription Agreement and Investor
has reviewed and accurately filled out the information set forth in <U>Exhibit C</U> attached hereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">g.</TD><TD STYLE="text-align: justify">If the Investor is an &ldquo;accredited investor&rdquo;, as such term is defined in Rule 501(a)
of Regulation D under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), the information set forth
on <U>Exhibit D</U> hereto is complete and accurate; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">h.</TD><TD STYLE="text-align: justify">The Investor hereby represents and warrants that the Investor is not, and is not acting as an agent,
representative, intermediary or nominee for any person identified on the list of blocked persons maintained by the Office of Foreign
Assets Control, U.S. Department of Treasury. In addition, the Investor has complied with all applicable U.S. laws, regulations,
directives, and executive orders relating to anti-money laundering including but not limited to the following laws: (1) the Uniting
and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56;
and (2) Executive Order 13224 (Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support
Terrorism) of September 23, 2001.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>By making the foregoing representations,
Investor has not waived any right of action Investor may have under federal or state securities laws. Any such waiver would be
unenforceable. The Company will assert Investor&rsquo;s representations as a defense in any subsequent litigation where such assertion
would be relevant. This Subscription Agreement and all rights hereunder shall be governed by, and interpreted in accordance with,
the laws of the State of California without giving effect to the principles of conflict of laws.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD><U>Miscellaneous</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Subscription may be executed in any
number of counterparts, all of which taken together shall constitute one and the same instrument and shall become effective when
counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties need
not sign the same counterpart. Execution may be made by delivery by facsimile or via electronic format. All communications hereunder,
except as otherwise specifically provided herein, shall be in writing and shall be mailed, hand delivered, sent by a recognized
overnight courier service such as Federal Express, or sent via facsimile or e-mail transmission, to the party to whom it is addressed
at the following addresses or such other address as such party may advise the other in writing (i) to the Company: as set forth
on the signature page hereto and (ii) to the Investor: as set forth on the signature page hereto. All notices hereunder shall be
effective upon receipt by the party to which it is addressed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>SIGNATURE PAGE FOLLOWS</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[<I>Signature Page to Subscription Agreement
for American BriVision (Holding) Corporation</I>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the foregoing correctly sets forth the
agreement of the parties, please confirm this by signing and returning to us the duplicate copy of this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Number of Shares:</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>AMERICAN BRIVISION (HOLDING) CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Purchase Price per Share: $</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Aggregate Purchase Price: $</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Address Notice:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">American BriVision (Holding) Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">44370 Old Warm Springs Blvd.,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fremont, CA 94538</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Dr. Howard Doong, Chief Executive Officer</P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt"><B>INVESTOR</B></FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; width: 35%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; width: 20%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Phone:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">SSN or EIN:</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&Oslash;</FONT></TD><TD STYLE="text-align: justify"><U>Check Method of Payment</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  &#9744; Check enclosed:
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>OR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  &#9744; Please wire
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
from my account held at:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Account Title: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> Account Number:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the following instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">ABA Routing No: 122242869</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">SWIFT Code: PMERUS66</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Bank Name: Pacific
Mercantile Bank</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Bank Address: 949
South Coast Dr., Costa Mesa, CA 92626</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Beneficiary Account
Name: FinTech Clearing as Agent for the Investors in American BriVision (Holding) Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Beneficiary Account
No: 45764168</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.3pt">Beneficiary Address:
6 Venture, Suite 265, Irvine, CA 92618</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.3pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&Oslash;</FONT></TD><TD STYLE="text-align: justify"><U>Check Method of Delivery of The Shares</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744; DWAC Delivery
Instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="width: 0.2in; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">___________________________________________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name of DTC Participant (broker dealer at which the account or accounts to be credited with the Shares are maintained)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">___________________________________________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">DTC Participant Number</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">_______________________________________________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name of Account at DTC Participant being credited with the Shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">_______________________________________________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Account Number of DTC Participant being credited with the Shares</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>OR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744; DRS Electronic Book Entry Delivery
Instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name in which Shares should be issued:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address: ________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: ________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Telephone No.: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Please email back the completed Subscription
Agreement to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>angela@boustead1828.com or fax to +1(949)
266-5789</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Certificate For The
Purchase of Initial Public Offerings of Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Pursuant to FINRA Rule 5130 (formerly
NASD Rule 2790) (the &ldquo;<B><U>New Issue Rule</U></B>&rdquo;), firms may not sell or cause to be sold a new issue (as defined
in the New Issue Rule; generally, initial public offerings of equity securities) to any account in which a <B>restricted person
</B>holds a <B>beneficial interest </B>unless the account qualifies for a <B>general exemption </B>under the New Issue Rule. We
require that you sign and return this Certificate indicating whether or not your account is eligible to purchase Shares in accordance
with the New Issue Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">In addition, pursuant to FINRA
Rule 5131 (the &ldquo;<B><U>IPO Allocation Rule</U></B>&rdquo;), firms may not under certain circumstances allocate shares of a
new issue to any account in which an executive officer or director of a <B>public company </B>or a <B>covered non-public company</B>,
or a person <B>materially supported </B>by such executive officer or director (collectively, &ldquo;<B><U>Covered Persons</U></B>&rdquo;),
has a <B>beneficial interest </B>unless the account qualifies for a <B>general exemption</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.95pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">In addition, in connection
with any new issue, you hereby represent that you will not act as a finder or in a fiduciary capacity to any managing underwriter
of any new issue and that you shall notify us immediately in the event that such representation ceases to be true and correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 20.95pt">All bolded terms
relating to the <B>New Issue Rule </B>or the <B>IPO Allocation Rule </B>are defined in <U>Annex A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><B>SECTION A. <U>NEW ISSUE RULE
(FINRA RULE 5130)</U></B> (CHECK ONE BOX ONLY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">The undersigned hereby certifies,
on behalf of each account for which it purchases new issues on or after the date hereof, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.2pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">The account(s) is eligible to purchase new issues either
because no restricted person (which includes those accounts that satisfy a general exemption listed on <U>Annex A</U> and/or,
are not restricted persons based on the definition set forth in <U>Annex A</U>) holds a beneficial interest in the account(s),
or because the account(s) has implemented procedures to reduce the beneficial interests of all restricted persons with respect
to new issues to below in the aggregate 10%, and the undersigned hereby represents that it will follow such procedures in connection
with the purchase by the account(s) of all new issues;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.2pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>OR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.2pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">The undersigned is a conduit (such as a bank, foreign bank,
broker/dealer or investment adviser) and all purchases of new issues are, and will be, in compliance with the New Issue Rule.
If the beneficial interests of all restricted persons in any one account(s) exceeds in the aggregate 10% of the account(s) but
the account(s) has implemented procedures to reduce the beneficial interest of all restricted persons with respect to new issues
to below in the aggregate 10%, the Investor hereby represents that it will follow such procedures in connection with the purchase
by the account(s) of all new issues.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><B>SECTION B. <U>IPO ALLOCATION
RULE (FINRA RULE 5131)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">The undersigned hereby certifies,
on behalf of each account for which it purchases new issues on or after the date hereof, that such account is eligible to purchase
new issues either because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i)&nbsp;No
person that holds a beneficial interest in the account is a Covered Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>OR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii)&nbsp;The
account is eligible to purchase new issues because the account (A) meets a general exemption (See <U>Annex A</U>), or (B) has implemented
procedures to reduce the beneficial interests of all Covered Persons of a particular company with respect to new issues to in the
aggregate below 25%, and the Investor hereby represents that it will follow such procedures in connection with the purchase by
the account of all new issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">For purposes of clause (ii) above,
the undersigned is entitled to presume that any beneficial interests in an account held by a Qualifying Private Fund (except for
interests of beneficial owners that are control persons of the investment adviser to that Qualifying Private Fund) are not held
by a Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">The undersigned hereby certifies
that the undersigned is authorized to provide this Certification and that the undersigned, or an authorized representative of the
account, will promptly notify Boustead Securities in the event this Certification ceases to be true and correct. In connection
with the U.S. Securities &amp; Exchange Commission&rsquo;s electronic delivery of information requirements, the undersigned agrees
to receive electronic mail for the purpose of recertifying this Certification through negative consent and to notify Boustead Securities
in writing if the undersigned does not agree to receive such communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Institution Name</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address, City, State, Zip</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Authorized Signatory</B></FONT></TD>
    <TD STYLE="width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date (mm/dd/yy)</B></FONT></TD>
    <TD STYLE="width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax ID / EIN / Reg No</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of Authorized Signatory</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature of Authorized Signatory</B></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Email Address</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.8pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><U>General Exemptions</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">An investment company registered under the Investment Company Act of 1940.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">A common trust fund or similar fund as described in Section 3(a)(12)(A)(iii) of the Securities
Exchange Act of 1934, provided that: (i) the fund has investments from 1,000 or more accounts, and (ii) the fund does not limit
beneficial interests in the fund principally to trust accounts of restricted persons.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">An insurance company general, separate or investment account, provided: (i) the account is funded
by premiums from 1,000 or more policyholders or, if a general account, the insurance company has 1,000 or more policyholders, and
(ii) the insurance company does not limit the policyholders whose premiums are used to fund the account principally to restricted
persons, or if a general account, the insurance company does not limit its policyholders principally to restricted persons.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">An account, including a fund, limited partnership, joint back office broker-dealer or other entity,
if the beneficial interests of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.8pt; text-align: justify; text-indent: -17.6pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 68.2pt"></TD><TD STYLE="width: 17.6pt">a.</TD><TD STYLE="text-align: justify">For purposes of Section A, restricted persons, in the aggregate, do not exceed 10% of the account
under the New Issue Rule (FINRA Rule 5130);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.8pt; text-align: justify; text-indent: -17.6pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 68.2pt"></TD><TD STYLE="width: 17.6pt">b.</TD><TD STYLE="text-align: justify">For purposes of Section B, covered persons of a particular company, in the aggregate, do not exceed
25% of the account under the IPO Allocation Rule (FINRA Rule 5131).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.9pt"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">A publicly traded entity (other than a broker-dealer authorized to engage in the public offering
of new issues either as a selling group member or underwriter, or an affiliate of such a broker-dealer) that is: (i) listed on
a U.S. national securities exchange, (ii) a non-U.S. issuer whose securities meet the quantitative designation criteria for listing
on a national securities exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">An investment company organized under the laws of a non-U.S. jurisdiction, provided that: (i) the
investment company is listed on a non-U.S. exchange or authorized for sale to the public by a non-U.S. regulatory authority, and
(ii) no person owning 5% or more of the shares of the investment company is a restricted person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">An ERISA benefit plan that is qualified under Section 401(a) of the Internal Revenue Code; provided
that the plan is not sponsored solely by a broker-dealer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">A state or municipal government benefits plan that is subject to state or municipal regulation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify">A tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.9pt"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify">A church plan under Section 414(e) of the Internal Revenue Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.8pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 0.25in"><B><U>Restricted Persons/Entities
under the New Issue Rule</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">A FINRA member firm or other broker-dealer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">An officer, director, general partner, <B>associated person or employee of a FINRA member firm</B>
or any other broker-dealer (other than a <B>limited business broker-dealer</B>).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">An agent of a FINRA member firm or any other broker-dealer (other than a limited business broker-dealer)
that is engaged in the investment banking or securities business.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">A person who has authority to buy or sell securities for a bank, savings and loan association,
insurance company, investment company, investment adviser (whether or not registered as an investment adviser) or <B>collective
investment account</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">A person listed, or required to be listed, on one of the following schedules to Form BD as filed,
or required to be filed, with the SEC by a broker- dealer (other than with respect to a limited broker-dealer): (i) Schedule A,
unless the person is identified by an ownership code of less than 10%; (ii) Schedule B, unless the person&rsquo;s listing on Schedule
B relates to an ownership interest in a person that is listed on Schedule A and identified by an ownership code of less than 10%;
or (iii) Schedule C, unless the person would be excluded under the percentage ownership criteria for Schedule A or B above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">A person that directly or indirectly owns an interest, in the amounts specified below, of a public
reporting company listed, or required to be listed, on Schedule A or B of Form BD relating to a broker-dealer (other than a limited
business broker-dealer), unless the public reporting company is listed on a national securities exchange: (i) 10% or more of a
public reporting company listed, or required to be listed, on Schedule A; or (ii) 25% or more of a public reporting company listed,
or required to be listed, on Schedule B.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">A person acting: (i) as a <B>finder</B> in connection with any new issue in which the person is
participating or (ii) in a fiduciary capacity to the managing underwriter(s) in connection with any new issue in which the person
is participating.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">An <B>immediate family member</B> of: (i) a person specified in items 2-7 that <B>materially supports</B>,
or receives support from, that person; (ii) a person specified in items 2-3 that is employed by or associated with the FINRA member
or its affiliate selling the new issue to the immediate family member, or that has an ability to control the allocation of the
new issue; or (iii) a person specified in items 5-6 that is an owner of the FINRA member or its affiliate selling the new issue
to the immediate family member, or that has an ability to control the allocation of the new issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.8pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><U>Other New Issue Rule and
IPO Allocation Rule Definitions</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify"><B><U>Associated person or employee of a FINRA member firm</U></B>. (1) Any natural person registered
with FINRA and (2) any natural person, whether or not registered or exempt from registration with FINRA, who is a sole proprietor,
partner, officer, director, or branch manager of a FINRA member firm, or any natural person occupying a similar status or performing
similar functions, or any natural person engaged in the investment banking or securities business who is directly or indirectly
controlling or controlled by a FINRA member firm (for example, any employee).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify"><B><U>Beneficial interest</U></B>. Any economic interest, including the right to share in gains
or losses, other than management or performance based fees for operating a collective investment account, or other fees for acting
in a fiduciary capacity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><B><U>Collective investment account</U></B>. Any hedge fund, investment partnership, investment
corporation, or any other collective investment vehicle that is engaged primarily in the purchase and sale of securities, but not
(1) a legal entity that is beneficially owned solely by immediate family members or (2) an investment club comprising a group of
friends, neighbors, business associates or others who pool their money to invest in stock or other securities and are collectively
responsible for making investment decisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify"><B><U>Covered non-public company</U></B>. Any non-public company satisfying the following criteria:
(i) income of at least $1 million in the last fiscal year or in two of the last three fiscal years and shareholders' equity of
at least $15 million; (ii) shareholders' equity of at least $30 million and a two-year operating history; or (iii) total assets
and total revenue of at least $75 million in the latest fiscal year or in two of the last three fiscal years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify"><B><U>Covered Person</U>. </B>An executive officer or director of a public company or a covered
non-public company, or a person materially supported by such executive officer or director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify"><B><U>Executive officer or director</U></B>. Any (i) person named as an executive officer or director
in a U.S. public company&rsquo;s most recent proxy filed with the SEC or in an annual report filed with the SEC on Form 10-K or
Form 20-F, (ii) executive officer or director of a foreign company that is registered with the SEC under the &rsquo;34 Act, as
amended, or (iii) executive officer or director of a covered non-public company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify"><B><U>Finder</U></B>. A person who receives compensation for identifying potential investors in
an offering.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify"><B><U>FINRA Member.</U></B> A member of the Financial Industry Regulatory Authority or any person
or entity associated with a FINRA member firm.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify"><B><U>Immediate family member</U></B>. A person&rsquo;s parents, mother-in-law or father-in-law,
spouse, brother or sister, brother-in-law or sister-in-law, son-in-law or daughter-in-law and children, and any other individual
to whom the person provides material support.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify"><B><U>IPO Allocation Rule</U></B>. FINRA Rule 5131.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify"><B><U>Limited business broker-dealer</U></B>. Any broker-dealer whose authorization to engage in
the securities business is limited solely to the purchase and sale of investment company/variable contracts securities and direct
participation program securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD STYLE="text-align: justify"><B><U>Material support</U></B>. Directly or indirectly providing more than 25% of a person&rsquo;s
income in the prior calendar year. Members of the immediate family living in the same household are deemed to be providing each
other with material support.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.</TD><TD STYLE="text-align: justify"><B><U>New Issue Rule</U></B>. FINRA Rule 5130.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">14.</TD><TD STYLE="text-align: justify"><B><U>Public Company</U></B>. Any company that is registered under Section 12 of the Securities
Exchange or files period reports pursuant to Section 15(d) thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">15.</TD><TD STYLE="text-align: justify"><B><U>Qualifying Private Fund</U></B>. An unaffiliated private fund invested in an account that:
(i) is managed by an investment adviser; (ii) has assets greater than $50 million; (iii) owns less than 25% of the account and
is not a fund in which a single investor has a beneficial interest of 25% or more; and (iv) was not formed for the specific purpose
of investing in the account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.2pt; text-align: justify; text-indent: -18.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">16.</TD><TD STYLE="text-align: justify"><B><U>Unaffiliated Private Fund</U></B>: A &ldquo;private fund&rdquo;, as defined in Section 202(a)(29)
of the Investment Advisers Act, whose investment adviser does not have a control person in common with the investment adviser to
the account. A control person of an investment adviser for these purposes is a person with direct or indirect &ldquo;control&rdquo;
over the investment adviser, as that term is defined in Form ADV.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT B</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Suitability Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Each responding individual must complete
his/her own Suitability Questionnaire)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Name of Individual Investor OR Name of Person Answering Questions
on behalf of an Entity/Trust/IRA Investor: </B>__________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>A.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Please list all of the educational institutions you have attended
(including colleges, and specialized training schools) and indicate the dates attended and the degree(s) obtained from each (if
any).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">From</P></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">To</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 23%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Institution</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Degree</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; padding-right: 0; padding-left: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; padding-right: 0; padding-left: 0; text-indent: 0"><B>B.</B></TD><TD STYLE="text-align: justify; padding-right: 0; padding-left: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Please provide the following information concerning your business
experience:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>B-1</B>. Indicate your
principal business experience or other occupations during the last ten years. (Please list your present, or most recent, position
first and the others in reverse chronological order.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">From</P></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">To</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 23%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Name and Address of Employer</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; padding-right: 0; padding-left: 0; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Position </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>B-2</B>. Describe, in
greater detail, your present or most recent business or occupation, as listed in your answer to Question B-1. Please indicate
such information as the nature of your employment, the principal business of your employer, the principal activities under
your management or supervision and the scope (e.g., dollar volume, industry rank, etc.) of such activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>B-3.</B> Describe any
significant business you engage in or intend to engage in other than as specified above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>C.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Please provide the following information concerning your financial
experience:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-1.</B> Indicate by
check mark which of the following categories best describes the extent of your prior experience in the areas of investment
listed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 38%; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P></TD>
    <TD STYLE="width: 17%; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Substantial&nbsp;Experience</FONT></TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Limited Experience</FONT></TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-size: 10pt">No Experience</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stock &amp; Bonds</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Penny Stocks</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Government Securities</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Municipal (tax-exempt) Securities</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"></FONT>&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stock options</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Commodities</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Real estate programs</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Securities for which no market exists</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Limited partnerships (tax deferred)</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Investments generally</FONT></TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&#9744;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-2. </B>For those investments
for which you indicated &ldquo;substantial experience&rdquo; above, please answer the following additional questions by checking
the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Do you make your own investment decisions with respect to such investments? (Please check the appropriate
box with respect to your involvement in making investment decisions).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Always</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Usually (i.e. most often)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Frequently (i.e. regularly)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Rarely</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">What are your principal sources of investment knowledge or advice? (You may check more than one.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>First-hand experience with industry</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Financial publication(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Trade or industry publication(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Banker(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Broker(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Investment Adviser(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Attorney(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Accountant(s)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-3.</B> &#9;Indicate by check
mark whether you maintain any of the following types of accounts over which you, rather than a third party, exercise investment
discretion, and the length of time you have maintained each type of account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 18%; text-align: justify"><FONT STYLE="font-size: 10pt">Securities (cash)</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="width: 37%; text-align: justify"><FONT STYLE="font-size: 10pt">Number of years</FONT></TD>
    <TD STYLE="width: 18%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Securities (margin)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Number of years</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Commodities</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Number of years</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-4.</B> Risk Exposure:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Speculative</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Aggressive</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Moderate</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD>Low</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0"><B>C-5</B>
Please state the approximate number and total dollar amount of your prior investments in restricted securities (e.g., private
placements):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Total Number ______________ Total Amount Invested:
$________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0"><B>C-6</B>
What % of your net worth is invested in restricted securities (e.g., private placements): $____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><B>C-7 </B>My current net worth,
after making this investment and exclusive of homes, furnishings, and automobiles is: $_________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-8</B>. &#9;Please provide
in the space below any additional information which would indicate that you have sufficient knowledge and experience in financial
and business matters so that you are capable of evaluating the merits and risks of investing in restricted securities of private
or thinly traded enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-9.&#9;</B>Are you, your
spouse, or any other immediate family members, including parents, in-laws, and siblings that are dependents, an officer, director
or greater than ten percent (10%) shareholder of the Company?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>C-10.&#9;</B>Are you, your
spouse, or any other immediate family members, including parents, in-laws, and siblings that are dependents, employed by or associated
with the securities industry (for example, investment advisor, sole proprietor, partner, officer, director, branch manager or broker
at a broker-dealer firm or municipal securities dealer) or a financial regulatory agency, such as FINRA or the New York Stock Exchange?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Yes, please provide
the name and contact information for such firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>C-11. </B>Are you a senior military,
governmental or political official in a non-US country?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">____</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Yes, please provide
the name of the country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">___________________________________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>C-12. </B>If you are over 65 years old,
please provide the name and contact phone number of a trusted contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-bottom: 1pt; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-bottom: 1pt; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Contact Number</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>C-13. </B>Time horizon for the investment (#
of Months): __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>C-14. </B>Liquidity Needs (check one): ____ High
____ Medium ____ Low</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>C-15</B>. If you are over 65 years old,
please provide the name and contact phone number of a trusted contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-bottom: 1pt; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 35%; padding-bottom: 1pt; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Contact Number</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT C</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Non-U.S. Person Representations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Investor indicating that it is not a U.S. person, severally
and not jointly, further represents and warrants to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">At the time of (a) the offer by the Company and (b) the acceptance of the offer by such person
or entity, of the Shares, such person or entity was outside the United States.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Such person or entity is acquiring the Shares for such person&rsquo;s own account, for investment
and not for distribution or resale to others and is not purchasing the Shares for the account or benefit of any U.S. person, or
with a view towards distribution to any U.S. person, in violation of the registration requirements of the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Such person or entity will make all subsequent offers and sales of the Shares either (x) outside
of the United States in compliance with Regulation S; (y) pursuant to a registration under the Securities Act; or (z) pursuant
to an available exemption from registration under the Securities Act. Specifically, such person or entity will not resell the Shares
to any U.S. person or within the United States prior to the expiration of a period commencing on the Closing Date and ending on
the date that is one year thereafter (the &ldquo;<B>Distribution Compliance Period</B>&rdquo;), except pursuant to registration
under the Securities Act or an exemption from registration under the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">Such person or entity has no present plan or intention to sell the Shares in the United States
or to a U.S. person at any predetermined time, has made no predetermined arrangements to sell the Shares and is not acting as a
Distributor of such securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Neither such person or entity, its Affiliates nor any Person acting on behalf of such person or
entity, has entered into, has the intention of entering into, or will enter into any put option, short position or other similar
instrument or position in the U.S. with respect to the Shares at any time after the Closing Date through the Distribution Compliance
Period except in compliance with the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">Such person or entity consents to the placement of a restrictive legend pursuant to applicable
laws on any certificate or other document evidencing the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">Such person or entity is not acquiring the Shares in a transaction (or an element of a series of
transactions) that is part of any plan or scheme to evade the registration provisions of the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">Such person or entity has sufficient knowledge and experience in finance, securities, investments
and other business matters to be able to protect such person&rsquo;s or entity&rsquo;s interests in connection with the investment
in Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify">Such person or entity has consulted, to the extent that it has deemed necessary, with its tax,
legal, accounting and financial advisors concerning its investment in the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify">Such person or entity understands the various risks of an investment in the Shares and can afford
to bear such risks for an indefinite period of time, including, without limitation, the risk of losing its entire investment in
the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify">Such person or entity has read the Company&rsquo;s Registration Statement available online at sec.gov
and acknowledges that such information is sufficient for such person or entity to evaluate the risks of investing in the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD STYLE="text-align: justify">Such person or entity is not relying on any disclosures concerning the Company made by the Company
or any officer, employee or agent of the Company, other than those contained in the public reports filed by the Company with the
SEC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.</TD><TD STYLE="text-align: justify">Such person or entity will not sell or otherwise transfer the Shares unless either (A) the transfer
of such securities is registered under the Securities Act or (B) an exemption from registration of such securities is available.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">14.</TD><TD STYLE="text-align: justify">Such person or entity represents that the address furnished on its signature page to this Subscription
Agreement is such person&rsquo;s principal residence if such person is an individual or its principal business address if it is
a corporation or other entity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dated: _____________, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print name of Investor</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print name of Signatory (if different from Investor)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT D</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Accredited Investor Certification</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The term &ldquo;<B>accredited investor</B>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association
or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;
any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any insurance company as defined
in section 2(a)(13) of the Securities Act; any investment company registered under the Investment Company Act of 1940 (the &ldquo;<B>Investment
Company Act</B>&rdquo;) or a business development company as defined in section 2(a)(48) of that Act; any Small Business Investment
Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of
1958; any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or
its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; any employee
benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 (&ldquo;<B>ERISA</B>&rdquo;) if the investment
decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association,
insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or,
if a self-directed plan, with investment decisions made solely by persons that are accredited investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Any private business development company as defined in section 202(a)(22) of the Investment Advisers
Act of 1940;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts
or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total
assets in excess of $5,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">Any director, executive officer, or general partner of the issuer of the securities being offered
or sold, or any director, executive officer, or general partner of a general partner of that issuer;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Any natural person whose individual net worth, or joint net worth with that person's spouse, at
the time of his purchase exceeds $1,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">Any natural person who had an individual income in excess of $200,000 in each of the two most recent
years or joint income with that person's spouse in excess of $300,000 in each of those years and has a reasonable expectation of
reaching the same income level in the current year;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the securities offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">Any entity in which all of the equity owners are accredited investors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be an Accredited Investor, you must
meet one of the following tests. Please check the appropriate spaces below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.75pt; text-align: justify; text-indent: -0.25in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 18pt"><B><I>A.</I></B></TD><TD STYLE="text-align: justify"><B><I>Individual Accounts</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.6pt">The undersigned certifies
that it is an &ldquo;accredited investor&rdquo; because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">1. _______ I had an individual
income of more than $200,000 in each of the two most recent calendar years, and I reasonably expect to have an individual income
in excess of $200,000 in the current calendar year; or my spouse and I had joint income in excess of $300,000 in each of the two
most recent calendar years, and we reasonably expect to have a joint income in excess of $300,000 in the current calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify">If you checked &ldquo;yes&rdquo;
to paragraph 1, please specify the dollar amount of your income in calendar years 2017 and 2018 and your projected income for 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$____________________
(projected)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">Please describe type of income:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.25in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual</FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trust</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficiary</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partner</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 14.6pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>OR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify; text-indent: -1.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">2. ___Yes____
I have an individual net worth, or my spouse and I have a joint net worth, in excess of $1,000,000 (excluding home and personal
property).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For purposes of this
Certification, &ldquo;individual income&rdquo; means &ldquo;adjusted gross income&rdquo; as reported for Federal income tax purposes,
exclusive of any income attributable to a spouse or to property owned by a spouse: (i) the amount of any interest income received
which is tax-exempt under Section 103 of the Internal Revenue Code of 1986, as amended, (the &ldquo;Code&rdquo;), (ii) the amount
of losses claimed as a limited partner in a limited partnership (as reported on Schedule E of form 1040), (iii) any deduction claimed
for depletion under Section 611 et seq. of the Code and (iv) any amount by which income from long-term capital gains has been reduced
in arriving at adjusted gross income pursuant to the provisions of Sections 1202 of the Internal Revenue Code as it was in effect
prior to enactment of the Tax Reform Act of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For purposes of this
Certification, &ldquo;joint income&rdquo; means, &ldquo;adjusted gross income,&rdquo; as reported for Federal income tax purposes,
including any income attributable to a spouse or to property owned by a spouse, and increased by the following amounts: (i) the
amount of any interest income received which is tax-exempt under Section 103 of the Internal Revenue Code of 1986, as amended (the
&ldquo;Code&rdquo;), (ii) the amount of losses claimed as a limited partner in a limited partnership (as reported on Schedule E
of Form 1040), (iii) any deduction claimed for depletion under Section 611 et seq. of the Code and (iv) any amount by which income
from long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202 of
the Internal Revenue Code as it was in effect prior to enactment of the Tax Reform Act of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the purposes of
the Certification, &ldquo;net worth&rdquo; means (except as otherwise specifically defined) the excess of total assets at fair
market value, over total liabilities, including mortgages exceeding the estimated fair market value of the property and income
taxes on unrealized appreciation of assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>B.</I></B></TD><TD STYLE="text-align: justify"><B><I>Corporations, Partnerships, Employee Benefit Plans or IRA</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Has the subscribing entity been formed for the specific purpose of investing in the Shares? ____________
(yes/no)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If your answer to question 1
is &ldquo;No,&rdquo; CHECK whichever of the following statements (a<FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT>e)
is applicable to the subscribing entity. If your answer to question 1 is &ldquo;Yes,&rdquo; the subscribing entity must be able
to certify to statement <B>(2)</B> below in order to qualify as an &ldquo;accredited investor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The undersigned
entity certifies that it is an &ldquo;accredited investor&rdquo; because it is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a) _______
an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, provided that the
investment decision is made by a plan fiduciary, as defined in section 3(21) of such Act, and the plan fiduciary is a bank, savings
and loan association, insurance company or registered investment adviser; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) _______
an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974 that has total assets
in excess of $5,000,000; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c) _______
each of its shareholders, partners, or beneficiaries meets at least one of the conditions described above under <FONT STYLE="font-variant: small-caps">Individual
Accounts</FONT>. Please also CHECK the appropriate space in that section; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) _______
the plan is a self-directed employee benefit plan and the investment decision is made solely by a person that meets at least one
of the conditions described above under <FONT STYLE="font-variant: small-caps">Individual Accounts. </FONT>Please also CHECK the
appropriate space in that section; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e) _______
a corporation, a partnership or a Massachusetts or similar business trust with total assets in excess of $5,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">If the answer to Question B.1. above is &ldquo;Yes,&rdquo; please certify the statement below is
true and correct:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______ The undersigned entity
certifies that it is an accredited investor because each of its shareholder or beneficiaries meets at least one of the conditions
described above under <FONT STYLE="font-variant: small-caps">Individual Accounts</FONT>. Please also CHECK the appropriate space
in that section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>C.</I></B></TD><TD STYLE="text-align: justify"><B><I>TRUST ACCOUNT</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in">1.</TD>
    <TD STYLE="text-align: justify">Has the subscribing entity been formed for the specific purpose of investing in the Shares? <B>_______________ </B>(yes/no)</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If your answer to question 1
is &ldquo;No,&rdquo; CHECK whichever of the following statements (a<FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT>c)
is applicable to the subscribing entity. If your answer to question 1 is &ldquo;Yes,&rdquo; the subscribing entity must be able
to certify to the statement (c) below in order to qualify as an &ldquo;accredited investor&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The undersigned trustee certifies
that the trust is an &ldquo;accredited investor&rdquo; because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">(a) _______ the trust has total
assets in excess of $5,000,000 and the investment decision has been made by a &ldquo;sophisticated person;&rdquo; <B>(Note: Complete
Section 2 below to show that the investment decision was made by a &ldquo;sophisticated person&rdquo;</B>); <B>o</B>r</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">(b) _______ the trustee making
the investment decision on its behalf is a bank (as defined in Section 3(a)(2) of the Act), a saving and loan association or other
institution as defined in Section 3(a)(5)(A) of the Securities Act, acting in its fiduciary capacity; <B>or</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.9pt; text-align: justify">(c) _______ the grantor(s) of
the trust may revoke the trust at any time and regain title to the trust assets and has (have) retained sole investment control
over the assets of the trust and the (each) grantor(s) meets at least one of the conditions described above under <FONT STYLE="font-variant: small-caps">Individual
Accounts</FONT>. Please also CHECK the appropriate space in that section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>D.</I></B></TD><TD STYLE="text-align: justify"><B><I>Any Entity (but not an individual person)</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.6pt; text-align: justify"><B>______ </B>All of the equity
owners of this entity are accredited investors. <B>(If you are checking this option <U>EACH</U> owner of the entity must complete
<FONT STYLE="font-variant: small-caps">Individual Accounts, </FONT>by checking option 1 or 2 or both, as applicable. Make copies
to do this and note each owner&rsquo;s name on each copy.)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>E.</I></B></TD><TD STYLE="text-align: justify"><B><I>Investment Objective:</I></B> The undersigned hereby certifies that (a) the undersigned&rsquo;s
objective is to invest in speculative securities in order to achieve maximum returns, and accordingly to speculate in micro-cap
entities such as the Company, and (b) an investment in the Company&rsquo;s speculative securities is suitable for the undersigned&rsquo;s
investment profile. (<I>Please initial to acknowledge that you have approved this statement</I>) __________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dated: _____________, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Print name of Investor</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print name of Signatory (if different from Investor)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">18</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>8
<FILENAME>fs12018a2ex23-2_american.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;<IMG SRC="image_007.jpg" ALT="" STYLE="float: left"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right; color: #333399; margin-left: 100pt"><FONT STYLE="font-size: 9pt"><B><U>A</U></B><U>udit
<B>&bull; T</B>ax <B>&bull; C</B>onsulting <B>&bull; F</B>inancial <B>A</B>dvisory</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right; color: #333399; margin-left: 100pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>Registered
with Public Company Accounting Oversight Board (PCAOB)</I></FONT></P>



<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: rgb(51,51,153)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><I>&nbsp;</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2.15pt 0 0; text-align: center"><B>Consent of Independent Registered
Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2.15pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">We hereby
consent to the incorporation by reference in this Registration Statement on Form S-1 Amendment No. 2 of </FONT>American BriVision
(Holding) Corporation <FONT STYLE="background-color: white">of our report dated April 4, 2019 relating to the consolidated financial
statements of </FONT>American BriVision (Holding) Corporation <FONT STYLE="background-color: white">and its subsidiaries, our report
dated April 1, 2019 relating to the consolidated financial statements of BioLite Holding, Inc. and its subsidiaries, and our report
dated April 5, 2019 relating to the financial statements of Biokey, Inc., which appear in such Registration Statement. We also
consent to the reference to us under the </FONT>caption <FONT STYLE="background-color: white">&#8220;Experts&#8221; in such Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.3pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.3pt 0 0"><U>/s/&nbsp;KCCW Accountancy Corp.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Diamond Bar, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">June 25, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X (<# 2(  A$! Q$!_\0
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M".7]WDD 2?)]X8K5\=>)9O&'C3Q1XINMRRZWK6HWRQ%]PCCE ,%M&.\,:C)
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MD''.3K#U\33PM>*@_P!Y*"J4II):*;5TWS).W+*+?>R_?PZYHQ@^T#5=-:#
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=]G0IV"5:M6YX5JU6I!OX9U)M*_K-ENBBBND1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ? 00# 2(  A$! Q$!_\0
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M^%6BZ/X#T76/$_C#XBZ_X=L+WQ#J3_;-"T/PEI7V:2^N-5U&?^R$ZGX!?\%
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M>VY=4?R+NSGAGBWHK;)!N53P"M*-$C18XU5$0;$10%1$7A511@*JJ JJ  H
M   %%>@[7=KVN[<S3E:[M=I)-I63:23:;22:2_ %LKVO97MM>VMO*][?YW/Y
MZ?B9\3?AUHG_  <;?!Q=7\>^#M)&F_\ !-#QKH6IMJ7B31[&.PUB?XM:YXAM
M]*OI;J\BBM-0FT2VFUB.RN'CN'TV)KU8S;CS*\,_:[^*W@?]J/\ X+;_ /!-
M?2/V(-=TCXC_ !5_9PU+QGJO[6_Q;^%%W;:WX:\(? O5I='?4/AI\0O'N@"\
MT2[:[TJ'Q7:0^&;W4;AM/UOQ;I=A#%;:OJL@M?WJU3]B#]C'7+S5M0UO]DC]
MF36M0UZ^NM4US4-7^ _POU.^UG4KV>6YO+_5+R^\,3W-_>75Q/--<7-U++--
M)-*\CLTCD^Q_#SX4?"[X1Z+_ ,(W\*?AOX"^&7A[]T/["^'O@_P]X+T;]P'$
M'_$L\-Z?IME^Y6218B824$CA<;VS];3X@P.'^JUZ.#QE3%83AVKD%.%>KA8X
M.;Q%#,,/6Q=>%*,JU6"CF-25'".T?:4</.K5_=J)Y<L#6FJD)5:4:=7'QQLG
M"-1U5R3H5(TH<[Y(-NA%3J:M*510BN:[_ 7_ ((L:]H7[,GQ;_X*9_LB?'+7
M](^'GQOTO]M+XA?'G2] \7ZK:>'Y?'?P=^*MG8W/A#XC^"I-;NK67Q/X:N8=
M'E^VZGIZ3Q:9)<6EKJ$D-TSPQ=Y^QI*/VB?^"UO[?/[7'PRNK;Q!^SU\.O@%
M\*?V1=-^)6@R+/X1^(GQ9T?4='\9^-M-\/:W LFG>+E^'TUM<Z'KVIZ5=W-I
MIU_-IEC]HD<M&G["_&3]EW]G#]HA]'E^/'P(^$7QBG\/;ET"[^)/P\\+>,+[
M1(I)#+-;Z5?ZYIEY>V%I<2,6NK2UGBM;H_\ 'Q#("17J'@[P3X.^'GAK2?!G
M@#PIX9\#^#]!MA9Z'X4\'Z#I?AKPWHUF'=_LFDZ'HMK9:9IUOO=G\FTMHDWL
MS;=S$UGC.(*&(GFN-AAJ\<QSK+J.7XN,IT'@J$8QRR&*KX;EC]8G+$QRG#JG
M3K1A'"^VKOGK6HN-T<#.G'#4G.'L,)B)UZ7*IJI.[Q#A"I>\$H/$U.:46Y5>
M6#]UN:/YL/\ @@9^T)\#_@;^RS^VSX8^-'Q8\ ?"SQ/\*?VZOVD?%'Q(T#Q[
MXHTGPOJWA/0[J/PW'!J>HV.K75K.]M/<>&]>M(39I<O)>Z7=6:(;E4B?!_X(
M^?M:?!:3X5?\%?\ XA>-/[/EO]8_:O\ VK/VF-0_9[U2:R@^*VO?!S_A6^D^
M*KH2?#C7VL?$!M-9T2SN=(E&J:7;VEOJEP=(U-[>Y#PG]_=7_8Q_9&\0?$Z3
MXU:]^S%\ =;^+LUY%J<OQ*U?X1^!-2\:2ZM!(DL&LR>(+W0Y]1?6H9(XWBUA
MYSJ:&./;=_NU ]2\._"#X4>$-?\ &?BOPI\,OAYX8\4?$:ZEO_B%XD\/>"O#
M>BZ_X[OIP!/>>,=8T[3;;4/$UU/@&:?6;B]DE.2[$DFNC,.(<LQD\\K+ Y@J
M^>ULJQ5;FQ6%A2PU7+Z^&K5L/2=.FZM2CB'2JN&(ER8FBW22IMTYSGG0P&(I
M+"1]K0Y,''%4X?NZCE4AB(5(QG-2ERJ<%.*=-<U.5I-RM*,5_*7\6=.\-?\
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MP'X+L9OB#\09+73-'D\5>/&\8:@EII_P_M]3USQ0K:5:ZIJ<]3XMR:5\;_\
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M2E*#K8>=?W)NG*"K4ZU.;C+VM'V<J4[4W\/.Y4VE/FC:%6I&49Z*7\TOP#^
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M+X=$DT)]//BJUL;NZLX/$4EN^L1V]S/$+S9-(K:WQ._99_9Q^-6H:3JGQ?\
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;BW1C4PT_MY>_^\W\_P#/I_4E &!BBLSX,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )Z U(# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&: "BBB@ HHHH _%[_@LG_R$?^"2?_::']C'_P!1;XX5^T-?B]_P63_Y"/\
MP23_ .TT/[&/_J+?'"OVAH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQ]_P""R?\ R3S]@/\
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MX:Z$Z6&H3:'XMTY?A_X+\*> /#-C(MG=O:Z;I'A70K-UADL-/MV";VC? CX
MV/@+Q+\/O#WP:^#UG\,/B+X=T[P_XQ\$:-\._!=OX"\=^$K/X>^'OA9I.A^)
M?#5CHZ>'O$_AVU^%/A7PG\.=.TW5+*^TR#X>^&_#WA"V@7PWH^FZ=;@'\[G[
M8'[$W[)'[&WP?_X(P>(?V7_@!\+_ ('>-/#?_!3?_@G!\/=/^)GP^\,Z;X;^
M+.I^#OB/KFH>'/B-X;\4_%;3HK?X@^-M,^)6B:MJNF_$*Q\6^(];MO&]MJ5Z
MGB2'4A,0/UH_X+!\_P#!*+_@I)_V8[^U#USV^#7C ]@?P[9ZD#)'W?X@\ >
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M/2?&MC96NI65E9>+=.\+>']*L_$=I:6>L:O:6MMK$-Y#;VNJZE;Q(D5]<I*
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MM-&\&3Z;)X<TJV\!:MX:\.:KX+@L=-@B\+:CH&B7VAI8W.E6$L'H= !1110
M4444 ?B]_P %D_\ D(_\$D_^TT/[&/\ ZBWQPK]H:_%[_@LG_P A'_@DG_VF
MA_8Q_P#46^.%?M#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %?C[_P63_Y)Y^P'_VF"_X)@_\
MK47A&OV"K\??^"R?_)//V _^TP7_  3!_P#6HO"- '[!4444 %?G+_P5U_:;
MU;]CS_@FC^V=^T#X9G\567CKPK\$O$7ACX6ZIX+TG1==\1:'\8_BS<6/P?\
M@UXBMM)\07$&E7MEX=^*?CWPAKFMQ3Q:G,NA:?J4ECH'B34$M?#^I_HU7Y6?
M\%NO@!X\_::_X)4?MJ_"CX7:C>Z=\1_^%56_Q/\ !']F:;=ZKJ^J^)O@#XR\
M+_'S2?"VA6UC>6%Q%XB\97?PSC\)>'=16X*Z3KFM:?J<EM?1VC6-R ?%GQ^\
M8?![_@E[\)_^"$F@>*_B;?\ [.?[.'PG^+7_  K_ .+.N>,=4N?"-KJ]J?\
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M]C+]IOX3Z%KK:;JVJV&H>(&G\>_$3PKX>6P\-66LZQ:#77U.>Q@T.SU?4K$
M\$^+G_!2GXZW?Q5^+WPM_82_X)Z_%;]NN']G7Q//\/\ XY?$_2_C=\#/@#\)
M=&^* T+2=>E^&'PT\7?$[Q!<3_%SQMX,CO;W1_C'I>@Z1IR?"KQ1%I'A;5+C
M5-?U2^T_0_ _%W[6GPO_ &U?C+_P1*^./PMM/&/A^UG_ &Y_VF_!7CKX=_$K
MPKJ?@7XJ_!SXL>!_^"?O[97A[XF_!OXJ>#=8BBOO#7Q"^''BJTOO#?B?3E>\
MTR:[LQJ&B:IK&A7NFZK>0^!?#/\ P4K_ .">/Q<_:B^'OP'_ &*O"W[>'[/O
M[1O[3WQ:_:Y^&GQ-T7]I'X9_LV^(_A)XE_:6\=Z]XV^*'PL^,7A[XI7VNWOB
M#3?!OBV_ANO"'BSX6Z!J@U/P5<27&HZ/+XP\S0$D^"__  3K_:/^#?B#_@GE
MXF\8MX+^(OQ*TK_@HQ^VI^W;^VUXA^%^IKHGPB^'GB[]K7]GK]K2PU/3?A#H
MWQ"U#3OB+KWPV\/_ !#^*O@7X?>&XKN'Q%X[U%)[CQEKVGZ-H\VHVWAT ]Q^
M)_\ P5"^+-M\:_C7X$_97_X)\_'?]M/X/_LMZO#X5_:.^.OP@^(GP@\/VVB_
M$+2M-?Q'\1?A5\$/ GCSQ!HVI_M&_%#X:>'T32_%?@GP+K5EJVF_%*YM?A3J
MB:3X@E-S'^2/_!-K_A&OB#_P3^_X-_/!NM^*OVE_A]<^/_VYOVG/&?A?_A3_
M ,5[3X36\^H?!GQG^VI^T7;> OVA?#%SX5\7R?$KX6^(K'X7GP-XP^%]AJ_A
M27S=4>5?%7V73)--U+[X\$^ _P#@J#^P?\4?VK?A%^S3^RC\)?VM/@_^U%^T
MU\7_ -JCX-?M!>)/CKX<^!^C_L^^./VHO&WB/QA\0?"?[2WP_P!8O/$'Q"\?
M>#?A5XWU&PUG3M3^ VA:CKWBWX9"YM[>Q@\>NFB6_GO[#?[!W[87P?\ @+_P
M1"\'_&#X<:7IWCW]D7]IO]LKXD?M.PZ+XY\$ZMH_@7P_\8/A;^W/H/@W6=%N
M8?$UQ)XHTK6/$/QD^'>G6&D^%CKVNZ)9^([5M;TZQM=%\0W.D@'TEXU_X*J_
MM :E^T5^UI^S%^RQ_P $R_CS^U+XZ_9#^(/A#PSXZ\:V'Q?^"?P<^"NK>'O&
MGP6\(?%32&T7XA?%+7-+OK[XKG4_%#Z!<_"71O"FN16'AR#2?'6J>.=/3Q%9
M^'(.Q\0?\%=/ ?B3]DC]DG]I#]E[X"_%W]I+X@_MR>-6^&O[.?[-\0T?X4>.
M=0^('AFR\<ZM\8O#_P 2/%?C>5O!GP[M/@KI7PK^)[>,?$\M]KOAG4+SPD;G
MPMJFM^$=2C\86_O7['GP3^)_PK^/G_!2CQKX\\-_V'X7^/\ ^V%X3^*?PCU$
M:UH&J?\ "6>!-._8]_9?^%E_KWV+2-4O[_0##X[^'?B_06TSQ+:Z-K,IT0ZE
M#I\NBW^D:E?_ ,VGB#]D#]H_P1\#_P#@AU_P3O\ B9\/_@?XA^.,WCG_ (*4
M_%8?L\?&/]H'Q!\%-!M/'/@3Q1XI^)/PP_:$\(?M,_LZZ;XU^*>G^.O@=X%^
M*]S)X,^'_P &)-3\33^)_BYI'Q2U#2-,MOV>-4\;_#< _:K]F?\ ;/\ BC_P
M4%^*?[:O[ 7[5_\ P3Y\3_LLCX7?!'P;IWQFM_&?QH^#OQTT/Q%H'[4>A>+]
M,\(^'=+L_#&@ZKX1\4:;XH\&^'?'U[=:I&_BOPSIM]X;O_"?B[3[75IUTJ;1
M_P""#?QL\<?&;_@FC\%]-^*;?$27XI?L^Z_\3_V5?B!-\5-(MM$\<'5_V>/B
M!KWP[T>T\1VB6]CJDNO:/X,TOPMH'B6_\4:3I/B^^\4:3K=UXHM)]:DO-4U'
MYQ_X)H^-/!G[''[3O[7_ .Q1\7?V:/A5\#OCW9_!3PO^W9\2?C7\%_VF/C7^
MVFOQ=^%=O/)\-5A^*OQ0_:+TC3_VI3XY^'=SIDP\&^!M;T76?#O_  BNMZA?
M>#[729M1-UXY]D_X-\? _P 3M"_X)H?#SXG_ !AU;5=;\<_M6?%+XZ_M@W6H
M:]8K9ZU?Z+^T5\4/$'C[PKXCU.1;J=;^X\>^&+S1_B1'>?9]-<6OC&VLIM.@
MN+*9Y0""?X6^+/\ @I#^V[^U[H'Q;^-'QE\(_L=_L5>(_ /[.O@7X#? SXN?
M$W]G'6_'_P"T+XB^$_@SXV_%?XL_%SQ[\%?%GAGX@>+O#?A_PE\5/A=X:^$6
MD6OQ"T3P^M\OCYO$/PUL;W3++Q1X[]EO=>\)?\$C_@>/"7_"9?M:?MD/\8OV
MD)_"7[(/[.^IZQIGQH_:(.O_ !5EG\3-\ _ ?Q)\>ZOX9UCQ/\*_A;9Z9X_^
M)EY\1OVA?B)JFL?#'X/:%K</BKXD^)(_#6@6M_YW\1/@_P#MP?L8?M7_ +2'
M[4'[&WP>\-_MD_!7]L)/ 7BKXN?LJ:I\:K/X'?$WX;?M%^ /">D_#R'XT_"?
MQO\ $N75/A+K/@OXE?#3PYX?\,?%CP=K3^$_$ECK7@KX:ZKX.O+_ $JW\2Z:
M.4^./PI_X*??&7P-^S_^V4?A-^S/X8_:P_9#_:%\2_M"?!+]BF/QYKVOZ?XY
M^"'Q&_9VUWX*>/OV>?BO^T7)?>'_  3X=_:J?0/B=\2YO"_Q'\':+K?[.GAS
MXA:5X(T34[SQQX$.M?$28 ]H_9\_X*/?%_Q#^TCX+_97_;5_88^)'[#'Q+^-
M7A_Q)K/[-VK:M\5_AU^T-\-?C7J?P_T?7/$_Q*\"V_Q#^#R7.A>"/B%X8\%Z
M--XZTWPMXK>VN?$?A"RU_4H)K"YTJRT_6N;_ .";7_!47XJ_\%(8= ^('A;]
M@/XT?!C]FC4=)^(>G7O[1OQ/^)/PLA\/:G\4/ /C >'3X2^&/@*QU$_$;XE^
M!M7L'ED3XPP>'_#_ (6L?&&A^,? ;V=Q?^&9M2O*'PP\'_MR?MB?M4_LQ_M#
M_M5_LL^%?V(/A5^QGK'QH\7^!_AK=?M!^#?CU\;OBM\:/B5\(M6^"FG:]J-Y
M\+-$U#X5>&_@3H_PO^*WQ,#6,OB]/BMJ?Q3T?1)Y-&T?P)I@N?&WL?\ P1[_
M &=/BQ^R;_P3E_9P_9^^.7AE/!WQ3^'MM\4HO%/AQ/$'A[Q0FFGQ+\;/B1XQ
MT8#7?"NHZMH%_P#:O#_B#2;W-AJ%Q]F-R;2Z,=Y;W$,8!\%_#;_@NE\9OBU\
M O#W[8'@#_@E1^T[XH_9#TJ/5I/C?\9M(^(GPV;7/ ,'A+QUJ?AKXA:Q\*_@
MYJ46E_$[]HWPEX"\/6UEXCUWQIX T2R\+R:I;^-O"6GZG=WGP[\2:BGV'\5_
M^"HW]H^*_!'PP_8%_9E^(W_!1'XI>,/@-\./VI-2@^&WC;X>_!OX1?#OX _&
M!YC\(O%'Q%^-OQEU30?#FA>-?B_96FK:]\+?A-9Z9JWCWQ'X4\->)_%NJZ7X
M;\.Z=9ZCJGX9_P#!+GQU_P %7]:_X)#_  D_9I^ ?[%OP0^)7P]^-N@?&[P7
M\)_VM]2_:)T;PMX'^"WP\^('QU^)G@_Q3>?M#_!+7UTGXL^+/'/@2>3QWXKB
MB^"$NO\ A_Q%X;U#X?Z?9R1>)8/%NFVOZ'^&_P!D#]K_ /X)6?'*7XC_ +"O
MP B_;^^!_P 5/V3?V/?V4_'/PO\ $OQE^&7P#^._POU;]A'X<:M\,O@S\2[3
MX@^.9-!^%OCOPEX^\%>(_$EG\2?#]MX<T;Q78^/9/#6K>&5@\)QZMI<0!ZMX
MM_X+;>%?AO\ L??M4_'[XG_LM_&'P-^T1^Q#\1O@?\.OVG/V)+[5-%U#XK^%
MY_CY\:/"/PK^'GB?X?>,-.LYO!?Q7\'>.]&\2W_C7X6>*?#4L6@?$;_A'-1T
M"SU/2=PUJ+Z3TG]M[]JR[_9TUWXT:I_P2Z_:8TSXC>(/BPW@3X"_LX0_$K]G
MR_\ B9XS\!>(O!UGXE^'/QD^..J/\0['P;^S/X:O-8N9O!OQ7\-:_K?C?QG\
M(-<LIIIM&\7Z=);W4OYO?&C_ ()[?ME?'3]G7]O'X\>-_AKX/T3]L7]O'XY?
M\$S_ !!9_LX^ ?BGX?USPG\&OV=OV,/VC/@W\0/#7ACQ?\0O%=IX3\.:]\>?
M"WA34OC9KGQJUSPAXGU?X:>)+W1_#/A[X-V^JRV::IXV^W/^"O7[-_Q__:"^
M'?P O?@]\+5_:A\!?"GXY0>+?VB?V(9_CKJ/[.=A^UM\*O$'@OQ1X!B\)ZA\
M1$U71?">LV'PX\5>*-"^+&I_"KXHZC:?#+XI:1X2U/PUXD_MB5M.\*>) "?X
M3_\ !2?XY_%[P'^U5X0T3]@#XCZ1^WU^R+KGP7MOB%^PWX@^./P=L!K_ (0^
M/6I17WP]^(7@?]IT7LGP-U[P_??#O3?'OBV]LCJ5MK^F:_\ #CQ#X#O]*M]1
MU'POJ>N_A#%^W[^V3^V/_P $4-0\8?\ !0'_ ()/>*_VP_V6M=^$_B#XH_M
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M:07_ (S /MKX)_\ !3'XO^)_VE/@]\ OVGO^"?GQQ_8WTG]JB#XE3?LE^/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_"W@?PI9+IWA_0H]:UO4O$>JII]FKN(1?:YK&IZI<@,1)>7UQ*#\Y ].HHH
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M_"?Q;\,X/V>_#?\ ;$-AHWA#Q9<)\;+GXCV^O:MJ6G^&_#UQ\.[[2_%G0_\
M!7?PIH7PI_:!_P""5G_!2CQ-%//X,_8@_:OUCX7_ !7N+KQ5I_AKPUX.^$/[
M??A_1OV8-9^*FO)=^%=9EO5^&?Q*U'X1>(9637_#]M'X8_X2S39;74=0UK2=
M6\+ZWQE_X)Q?MD0?'[]LCXE?L8?MB?"+]GOP?^W[/\%=8^/=_P#$+]E7PU\8
M?C;\/_$?PK\(67PLUBZ^!OCT^)/"&AW/ACQI\+-'TG2CX&^.WA7XNZ-X*\37
M7C+Q3\.'\%:QXYU^]F /TY_92^.<?[3_ .RY^S9^TM%X9?P7%^T/\ O@[\<X
M_!TFKKX@D\)Q_%KX>>'?'R>&7UY=-T9=;?05\0#2VU=='TI=2:U-X--L1-]E
MB_D$^ -T_P#P36^.?[8'_!8/2-4U2T_9X\8?\%<_V]?V3/\ @I?X6N/$/B6Z
MT6S^%OB/]N*Z\+_L^?M2Z%X3TOPWXKGN-?\ V>_%WC/7]&\5:+HMJFL>*_!W
MC)-)\(65EK>H^);KQ)_7;^Q]\#[_ /9C_9)_9;_9LU77[/Q9JG[/?[.GP2^!
M^I>*=/L9M,L/$M_\)_AIX9\!7FOV.FW,]U<:?9ZS<:!)J-M8SW-Q-:0W*02S
MRO&TC>&?LM?L-Z3\%OA1^U]\'/BKJGASXP>!_P!K/]JS]LOX\>)?#MQX?N+#
M1F^'G[6WCW7_ !-J7PL\0V=WJ%]_;8L- \07GAS6]2B:RM=7CFE:&PM8VPP!
M^<VD_ME^ _V'/#__  7]_;*\56T?B;PQ\*_VMOA=XG\.:1#?7&GV?CKQ7XO_
M &"OV%O"OPE\+-XBMM+UI/#>C>/_ !]XJ\'^'9_&][IMWH'A+2M<E\7:T8]
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M?%;XW^*M?T[P&W@#Q1\:?%GAU?B_X ^%7@#P7X>\0?#>Y\4^,_'&F^,M8O\
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M!QO&'C;XKWDFEP:;K&H:[*?B'<^,->O?B%KVN7\FI1>$H=!\*Z4 >0_LN?\
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M_BOQS^P7P+_8]O?@S^VM^VM^U4GB_2M0\.?M4^ OV/\ P1X<^']AH=UI]YX
M@_9>\*_%GPU=RWVL2:C<VNMP>)O^%DVT^G06VGZ:=)ATAX)S>O/'-'X'=_\
M!-_Q1<_L(_\ !1']CX?%/05UK]MWXG?\% ?B!H/C8^&=0.E_#^V_;/\ 'WQ
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M  63_P"0C_P23_[30_L8_P#J+?'"OVAH **** "BBB@ HHHH **** "BBB@
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M.U#5-'^W7\%NVJZ%?0O9:AJ-A/%+8ZA>6\_ZAT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !117S5\7OVSOV/OV>_%%IX'^/O[5
MO[-?P/\ &E_H5GXHL/"/Q?\ CK\+OAIXGOO#6H7VIZ98^(K/P_XT\4Z+J]QH
M5[J>BZSI]IJ\5F^GW-[I.I6D%S)<6%W'" ?2M%?"_P#P]"_X)H?])$?V%_\
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M_P"(/?$?_P"CGH_X5U_P4 _Z.R_9<_\ $'OB/_\ 1ST ?:-%?FG\;=>_;P^
MG@G3_B;J_P"T-^S'XZT73OB?\#/#.N^%+3]C[XB^$[[6/#_Q'^-WP\^&WB"#
M3?$K_MF>)(M"U:+1/%M_<Z1JL_A[7+6QU.&TN;O1]4M8YK"X_2R@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_*[_@G;_R
M<=_P6&_[2.Z1_P"L$_L1U^J-?SC_  2_;5\3_LT_M@?\%9_"&A?L(_MX_M2V
M^M_M[Z'XDF\<?LN_#;X->+O .AS3?L/?L;:6/"FKZM\1/C[\+=:C\86J:8NK
MZAIUIX=N]+MM%UGP_<Q:U<W=_=V.F@']'%%?C[_P]B^(?_2'G_@L%_X9#]EW
M_P"C%H_X>Q?$/_I#S_P6"_\ #(?LN_\ T8M '[!45^/O_#V+XA_](>?^"P7_
M (9#]EW_ .C%H_X>Q?$/_I#S_P %@O\ PR'[+O\ ]&+0!^P5%?C[_P /8OB'
M_P!(>?\ @L%_X9#]EW_Z,6C_ (>Q?$/_ *0\_P#!8+_PR'[+O_T8M '[!45^
M/O\ P]B^(?\ TAY_X+!?^&0_9=_^C%K?^%W_  5@TSQS^T5\ OV;/B'^P3_P
M4+_9E\2_M)Z]\0?#'PQ\;_M%?#'X$^&?AO>:_P##7X3>-?C/X@TK4=6\$?M'
M_$/Q';W4W@_P'K8TQ;/PK?K<:F]G!<-:6;7=_9@'ZQT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Q=
M\.#C]OO]K09./^&9_P!B,@9[GQ[^VR"0/7"C)ZX4=A7VC7Q;\.,?\-]_M:YZ
M?\,S?L1#\_'W[;0[4 ?:.1],#)SP0.>3Z#@T9'/MC\ST'UZ?F*_"SX&>)/V_
M/#__  6<O_ 7[5/[0WA3Q+\*/BC^Q;^U?\7?A)^S-\'-!GTWX._!KPQ\/_VG
MOV2OAO\ "[5-3\7ZYI&B^.?BS\8O$'@K7]<\0?$#Q%XLL8-'\'^(_&?B;PI\
M,[2S\&20M=7?B=I?QH_X*&?MZ_M2_LV>#OVS/VFOV0?V?/V$O"7P \.^,--_
M9=E^&'PX^+OQ1_:<^-W@O5/C&=?O?BEXO\#?%Z[U'X&^%/@;XN\#:+9>$(-,
M\&7>L?%74/%6HZUH]W8>!?!/B'7@#]Q\CKZX_7I17\LVD_MC_MP?";1OCS_P
M3.NOVBI]9_:C\#_\%+/V;OV'?V=/VWO%/@KPE\1?%2? /]IOX/S?M@^&O&'Q
MKT76](T+P9XN^/GPV_9K\(?$KP5/XHMOAM>>$?&?Q0'PXTW7_"LEE<^,?BW)
M]+7WPX_:;_X)C?M=?L+RZ1^VW^T]^V3^S+^V3\9M;_9!^-7P]_;4\?>#/B-X
MZ\"?$76?A9X^^+OP+^*_P*\0^!_A#\,XM!CT@?"3XC>'/BMI_B#5=4MO$FB^
M)- BA\/ZKK=KHGB+P. ?T!YY(]/ZT?Y_*OX;_P!F_P#X*W_'[X _$#P)\;/B
M+^TA^TQ^UQX]\1_"7]I6_P#^"H'[#/BCX)>)K7P[^QM^U)8>*!X4_8P_9X^
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M>&_V?O%EK^W4?VE?$'[!_AO]@;Q1XT\$VGC/4_VW] B\-7&I_#JS^)J:G:^
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M^$@UK3=5FU#5=35 ^FW=I%";&YM=3 /UEHK\KO\ A O^"U__ $=%_P $QO\
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MBORN_P"$"_X+7_\ 1T7_  3&_P#$(OVH/_H\Z/\ A O^"U__ $=%_P $QO\
MQ"+]J#_Z/.@#]4:*_*[_ (0+_@M?_P!'1?\ !,;_ ,0B_:@_^CSH_P"$"_X+
M7_\ 1T7_  3&_P#$(OVH/_H\Z /U1HK\KO\ A O^"U__ $=%_P $QO\ Q"+]
MJ#_Z/.C_ (0+_@M?_P!'1?\ !,;_ ,0B_:@_^CSH _5&BORN_P"$"_X+7_\
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MA%^U!_\ 1YT?\(%_P6O_ .CHO^"8W_B$7[4'_P!'G0!^J-%?E=_P@7_!:_\
MZ.B_X)C?^(1?M0?_ $>='_"!?\%K_P#HZ+_@F-_XA%^U!_\ 1YT ?JC17Y7?
M\(%_P6O_ .CHO^"8W_B$7[4'_P!'G1_P@7_!:_\ Z.B_X)C?^(1?M0?_ $>=
M 'ZHT5^5W_"!?\%K_P#HZ+_@F-_XA%^U!_\ 1YT?\(%_P6O_ .CHO^"8W_B$
M7[4'_P!'G0!^J-%?E=_P@7_!:_\ Z.B_X)C?^(1?M0?_ $>='_"!?\%K_P#H
MZ+_@F-_XA%^U!_\ 1YT ?JC17Y7?\(%_P6O_ .CHO^"8W_B$7[4'_P!'G1_P
M@7_!:_\ Z.B_X)C?^(1?M0?_ $>= 'ZHT5^5W_"!?\%K_P#HZ+_@F-_XA%^U
M!_\ 1YT?\(%_P6O_ .CHO^"8W_B$7[4'_P!'G0!^J-%?E=_P@7_!:_\ Z.B_
MX)C?^(1?M0?_ $>='_"!?\%K_P#HZ+_@F-_XA%^U!_\ 1YT ?JC17Y7?\(%_
MP6O_ .CHO^"8W_B$7[4'_P!'G1_P@7_!:_\ Z.B_X)C?^(1?M0?_ $>= 'ZH
MT5^5W_"!?\%K_P#HZ+_@F-_XA%^U!_\ 1YT?\(%_P6O_ .CHO^"8W_B$7[4'
M_P!'G0!^J-%?E=_P@7_!:_\ Z.B_X)C?^(1?M0?_ $>='_"!?\%K_P#HZ+_@
MF-_XA%^U!_\ 1YT ?JC7Q=\-_P#D_O\ :U[?\8S?L1\_]S[^VUZ\5^9W[=7Q
ML_X+.?L0?LA_'[]K+6?CE_P35^(&G? GP%=^.;GP5IG['/[2_A^^\2):WUA9
M?V;;ZW>?MR:I;Z6\GV[S!=2:;?A?*\O[,QDW)]SZG\'_ (9_'O\ :R_;C^#O
MQH\$^'?B3\,/'G[*O[$>C>,?!'BBP%_X?\1:2/B1^VG?16.IV3R$3QQ75I:7
M"L'1EN;>.>/RV5 H!^;7Q'_:K^.VD_\ !4SPY^U!8?\ !+'_ (*:^*_A=\*?
MV0/VCOV2=1N_#/PG_9_NK_Q;XR\7?M%_ 7X@^'/''@>+4?VF],L]6^&>H^'O
M@_XFEBU;5KW0O$;2ZIX8^S^%+B#4=2GT;W3QK%^T3_P3Z_X* _M?_M,^&OV3
M?CI^V5^S9^WIH/[/_BC5#^R[8_#3Q#\;O@I^T)\"?AI:_!9_"GB#X>?$7XG_
M  PL];^#GC?X6>$-&\76/Q%TG6[C4/#7Q BO_!^K:)):^(?#NHI[5_PXI_X(
M^?\ 2.[]F/\ \("V_P#C]'_#BG_@CY_TCN_9C_\ " MO_C] 'YLZG^P]^WC\
M2]+^+/\ P48C^!>@^$_VO?$7_!4SX$_MV?"[]C#Q1\1?"5A>>)/V9?V9O@!>
M?L<?#[X4?$7QE::QK'P^^%O[27C_ ."7BSQ_\2-;OM/^)7Q"^'&A^-'\!Z9?
MW.AG_A*_"^B_5]YXK_:5_P""D?[57[#MY<_L.?M'?LD_LM?LA_&;Q=^U7\4?
M'O[6J?"?X<_$[Q?\8O#GPA\:_"SX$?#OX0^!_AQ\5OC=>>(_#=X?C/XU\1?%
M*_\ %&E>#],33?#MA;:)XZTCQ#8)X8\8^[_\.*?^"/G_ $CN_9C_ /" MO\
MX_1_PXI_X(^?]([OV8__  @+;_X_0!B^ OAY\1OVXOVZ;O\ :9^,?@SQG\._
MV7/V$/&/Q'^%O['WP=^(^C>,?!_B+XM_M.V9'@_XF?MVZMH/]H:+I5U\/?#G
MA:^\7? []F#3O%>D^,/[8TS7OBA\9K.#PC/KG@IIOR8_X)5?L1_M7?!_]M#]
MF+Q-JO[)?Q8_9R\>_!SX:?M4>'?^"K/[6'Q ^,D/C+P+_P %(/B5X]\37K_!
MCQE\.KYO$_B3QA\:-4U+X@-KGQR;Q/X_\"?"S4?A7X:U*Y^']WK-S#;^"M$\
M6_L#_P .*?\ @CY_TCN_9C_\("V_^/UZ%\)_^"0/_!,7X%_$?PA\7O@_^Q#\
M /AY\3? .K)KW@SQKX9\&06&O>'-8C@GM8]1TR[69O(NHX+F=(Y-K%-^]0'5
M64 ]/_X)X_\ )G'P6]?L'B[_ -6%XMK[1KXN_P"">/\ R9Q\%O\ KP\7_P#J
MPO%M?:- !1110 4444 %%%% !1110!^'5G\!/VH_VD?V,?#OPE^$GB7]C0?!
M/QOKW[3_ (>^-'P\_:R_9X^*_P <;3QNMQ^TY\2KC3;?3)/AU^T/\$K72M)B
MAMY3?6NH6>KWKWR6=Y8ZA9F$H/GCX)_\$;OVBOV;?B=X;^-/P!\$?\$1/A%\
M6O!PUI?"GQ#\$?\ !.W]I[2_%'AX>(M!U3PMKW]E7[?\% )_LIU;PWK>L:'>
MLD>^73-3O;;<J3OG[^^ GQ0_:1_9^^';_"75O^"=7[7/CRY\,_$/XT75OXS\
M _$'_@GW_P (;XITCQ5\9O'WC#0-=\.KXZ_;G\#>,H=.U+0O$&G745OXH\'^
M&M<MC(UOJ6C6%W%);I[-_P -;?'[_I%[^W1_X<#_ ()H?_3$: /RP^)?_!(O
M]J#XS?&!OC]\6/!__!#7XB?&.0V;W?CWQ?\ \$R?CGKFKZI<V%W<7MKJ.NPW
MO[<<NF>(M726YEC;6->L-2U26V%M:RW;P6%A':^D_M)_\$[/V\_VQ[#PYIG[
M5>I_\$:?C_9^#[RXO_"@^)G_  3R_:1UZ\\.7-W;O;7G]C:J?V\X-7L+:]BD
M/V[3X+]=.O9HK2ZN[2:ZL+":U_0;_AK;X_?](O?VZ/\ PX'_  30_P#IB-'_
M  UM\?O^D7O[='_AP/\ @FA_],1H _/#Q?\ \$Z/^"@GC3]F;_AC2^\<_P#!
M)OP_^RR8-#T]_@=\//V(/VL_A?X%ET30O&5AX]7PU+8_#G_@H)X7N6\-:]XE
ML!=>--#^UC3_ !U;7^MZ=XPAUNP\0:W;W_K'QE_97_X*H?M$_#3Q1\&OCS\6
MO^"2WQ>^$_C:"PMO%OP\\??L#_M+>(/"NOQ:5JUAKVDG4-,N_P!O(QO<:1KN
ME:7K>DWD317FEZQIFGZI87%O?6=O/'];_P##6WQ^_P"D7O[='_AP/^":'_TQ
M&C_AK;X_?](O?VZ/_#@?\$T/_IB- 'PK=?L\?M'?LO\ [%^J_!_XE:C^Q-I?
MP1\'_%#]D+3_ (+_  T_8W_9L^)?[/FB^";F\_;+^%VN>+IM8MO'7[0'QILM
M9BU_4M5.L22V%IH^J7?B&]UW6];U+5;W5)9*_=*ORM^/_P 3/VDOVAOA_IOP
METC_ ()V?M;^ +C7_BW^S[J][XV^('Q!_P""?O\ PAGA70? WQ\^&GC[Q/KW
MB!/ ?[<OCOQI/8Z;X<\+ZK=&U\+^#?$NN7DT<5KIVD7ES,D1_5(<#'IQU)/X
MD\D^N?S- !1110 4444 %%%% !7XO?MK?\IC?^"(?_8 _P""GO\ ZSY\*Z_:
M&OQ>_;6_Y3&_\$0_^P!_P4]_]9\^%= '[0T444 %%%% !1110 4444 %%%%
M!1110 4444 %%']>E'6@ HHHH **** "BBDR..>O3WH 6BBB@ HHHH ****
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M_'[_ *2A?MT?^&__ .":'_TNZONBB@#X7_X9)^/W_24+]NC_ ,-__P $T/\
MZ7=1_P ,D_'[_I*%^W1_X;__ ()H?_2[J^Z** /A?_ADGX_?])0OVZ/_  W_
M /P30_\ I=U'_#)/Q^_Z2A?MT?\ AO\ _@FA_P#2[J^Z** /(_@-\'=&_9_^
M$'@3X.Z!XB\4>+M+\":.=+B\5>-6\-MXM\27,][=ZGJ6N^(1X.\-^#O"<>JZ
MKJ5]=WUU!X9\)^&]!MI)S;Z5HNFV,4%K%ZY110 4444 %%%% !1110 4444
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M 'Y-_P#"5_\ !='_ *(-_P $F_\ Q+7]L'_Z"FC_ (2O_@NC_P!$&_X)-_\
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M\0Z=X<_9*\5Z)9WXN-/G+0Z;XBU:V$9C*W18M&G[\5^./_!OK_RAD_X)]?\
M9#U_]3'Q50!U7_"5_P#!='_H@W_!)O\ \2U_;!_^@IH_X2O_ (+H_P#1!O\
M@DW_ .):_M@__04U^LE% 'Y-_P#"5_\ !='_ *(-_P $F_\ Q+7]L'_Z"FC_
M (2O_@NC_P!$&_X)-_\ B6O[8/\ ]!37ZR44 ?DW_P )7_P71_Z(-_P2;_\
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M (2O_@NC_P!$&_X)-_\ B6O[8/\ ]!37ZR44 ?DW_P )7_P71_Z(-_P2;_\
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MIJM>>-?^"Y=C:7-[<? ?_@DZ(+2"6XF*?M9?MA2,(H4:20JB_L4EF(12< <
M$D@ D?K;6)XD'_%.Z^?^H)JH_P#)&>@#\T_V8/\ @H%XN^/W[-/[/'QWU3X:
M^'/#^I_&OX&?"7XMZCH%AXBU.[L=#OOB/X!\/^,;O2+*ZN-,6XN;33;C69+*
MVN)U6::&!))5#LPHK\_O^";W_*._]@K_ +,O_9;_ /5'>!:* /MG_@@S_P H
M=?\ @GE_V;AX2_\ 2C4J_6^OR0_X(,_\H=?^">7_ &;AX2_]*-2K];Z "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH XGXE_\DX^('_8D^*__3%?U\,_\$>_^447_!-O_LQW]E__ -4W
MX/K[F^)?_)./B!_V)/BO_P!,5_7PS_P1[_Y11?\ !-O_ +,=_9?_ /5-^#Z
M/T<HHHH **** "OQ]_X+)_\ )//V _\ M,%_P3!_]:B\(U^P5?C[_P %D_\
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MI1V4MP;NQ%[IU]^NE% !1110 4444 %%%% 'XO?\%D_^0C_P23_[30_L8_\
MJ+?'"OVAK\7O^"R?_(1_X))_]IH?V,?_ %%OCA7[0T %%%% !1110 5^./\
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M.O7GC!&#Z=^,D #J*** "BBB@ K%\2?\B[K_ /V!=5_](9ZVJQ?$G_(NZ_\
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M_B-J/P;^,9U[QCX1.F?!#QWHG@+54\8ZGHD'B_74U;3/"UM;>#M3M;F\O])
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MC?9:-X+^(=]\"/$G[/$WPHU:\_:OT[]J2V\56/@&P_9.;X,Z->:I)+\?-?\
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M !1110 5^/O_  63_P"2>?L!_P#:8+_@F#_ZU%X1K]@J_'W_ (+)_P#)//V
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MP_&C]F/X3?M7?"#]B_\ :J^+G[9?Q!\&?#[XX>$_VX-7_P""RWPWMOA/X_\
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M/P?H^@1:PT8U+7$U+52U\P!_.GK7[4WQ?^$_[)G_  6K\6Z=\?=4^%^LV_\
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M%\2?\B[K_P#V!=5_](9ZVJQ?$G_(NZ__ -@75?\ TAGH _G1_P"";W_*._\
M8*_[,O\ V6__ %1W@6BC_@F]_P H[_V"O^S+_P!EO_U1W@6B@#[9_P""#/\
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M'O\ :%^*7[,OQU_9@U+X.GX*_$CPA^U)\>/B;\=_#FC?&G7_ (M_%;X>:O\
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M'B?1[/3[/46FG:V_=VB@#\6_'WB3X]_L_?\ !8C7?B9:?L<?'_XX_L^?M/\
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M1K5IO [>/=7U+6-1\8_\(Q=R7&CCQ)<:I??VP+07T,[03Q ?FC_P3=_X)V?
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MX5^(6H6^F^'_  _^^6!Z44 ?Q?\ PF_X)_WO[)OPY\8?L>?&7_@F=_P4@_;
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M(/!VM:GX>OM1\'>,M(:\\->-?#%QI'BOPMJ>J^'M9TW4;GX\_P""PWQA\3?
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M+_@FW_V8[^R__P"J;\'T ?HY1110 4444 %?C[_P63_Y)Y^P'_VF"_X)@_\
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M:_#NGZ+H7C'QQX1\2_$[P-X@LO!?[-WQ:\>Z%<ZWI'P/\):U\(OBIIFI32>
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M: "BBB@#B?B7_P DX^('_8D^*_\ TQ7]?#/_  1[_P"447_!-O\ [,=_9?\
M_5-^#Z^YOB7_ ,DX^('_ &)/BO\ ],5_7PS_ ,$>_P#E%%_P3;_[,=_9?_\
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M6M7M?B'XNE\-^-[O3OB1X:,_@KX=:?X*^ NEZ'X:FT_P7\)_!]R]O<U^Y=%
M'R5^S!^S3J/[/GC3]LKQ5?\ BZR\41?M3_M::M^TKIME9Z//I3^#M/U/X"_
M'X-+X2OI9K^^76+V&Z^"]UKK:O;II\,L&NV]F+".2REFG_%/]L/]B_2?V%_^
M#<SQ7^S9X\^)D'C3QY^R9X,\,>.?@S\5/"WP[TU+[5/VG/#G[2>G?$O]FNR\
M-> O%6C_ !<@:;QG\8M:\#_";5]!GM=4;Q5X>\4>(/#KZEHEEXDN+[3OZ8:3
M'7GK_ACZ_P">E 'X)ZY\-1_P2H_X('?%/P?\5M57XL?%3PW^S-\1E^*^MZ;<
M>(]3U#XW_M9_M27VI:;K%K8:SJ7A6;QGXDU3XD_'WXM6/@[PUKWB;PA%XEUR
M._T2[\2:-IM[->VUI^AG_!-3]E2[_8@_8(_90_94U;5;;6_$OP:^#/A/P]XW
MU;3[Z]U'1;[XBZA;/XC^)$_AF\U3P[X2U>7P@?'FM>(E\'KK?AO1M=@\+KI%
MOK=DFK17C-]P8YS_ )Q_G'Y4M !1110!^+W_  63_P"0C_P23_[30_L8_P#J
M+?'"OVAK\7O^"R?_ "$?^"2?_::']C'_ -1;XX5^T- !1110 4444 %?CC_P
M;Z_\H9/^"?7_ &0]?_4Q\55^QU?CC_P;Z_\ *&3_ ()]?]D/7_U,?%5 '['4
M444 >;?&7XGZ%\$?A#\5/C1XILM7U+PQ\(OAQXX^)_B33O#T%A<Z_J'A_P
M^&=4\5ZS9:%;ZKJ6C:7/K-WIVDW,&EPZEK&E:?+?20)>ZE8VS2W,7PW^PY^T
M_P"*8_\ @G-\%_VP?V_?C#\-/AI??%KPQ;?'+Q1XQ\=^(/AK\,?AA\+?!O[0
M/C:;Q+\#?AD?%XNM"\)26'A/P9XY^'7PRT#Q!KVH'Q1XSU:"PG\17-WXQUJZ
MADYS_@M_HNJ^(/\ @D9_P4,TK1-(U+7=2F_9=^)<\&F:3IUUJM]*FGZ6-1NK
MB*RLH;BY>.PL[6XU"ZF2(QV=I:SWL[Q06\DJ?EQ^U!\=/V?=0^'/_!'/X9V7
MP@_8'_9]^%GQ,_8UOOB[\ ?CK_P4RA\1?&GX-?LUZ#H7P6^"EAHO[/'A*+Q#
MK7@G1_BC\6O&/@#QC:Z)>ZS\1OCI\/F_X1/P5K'CE+KQEXS@T#P?XB /Z:_
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MJ/Q#U[7]"T3P-9:7=W5SXLU?6M(TW0(M0O-2LX9O-O"G[7'[*7CQOBTO@?\
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M_AAXF^!GQ/\ B+'X"/CS3[_3OA'XW\"Z-X5FT*.Y^(M_XK\<ZEH/A?\ H_\
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MUIUEHMZWPK\!^)@ ?JS_ ,$I_P!ISXJ_M'?L[^//#W[0,^H:Q^T9^R;^T?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,O!7Q NM"M=1DMIM0MM'N/%FB:M+IEO?S6=I+>PV3P1W4EK;/.LC01%?8J*
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M];U70/#FH^(4MEU>]T+0]4\2^(]2T?2+F\ET_3+_ %_6KRRMX+C5;Z2?H:*
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M9TR34=)\1V,'AD:)H'B);V_BNX=4?1K=(;J< _H)HK\D/^$H_P""\'_1#_\
M@DA_XE1^V/\ _0<U\A_M[_MD_P#!</\ 8M_8_P#CK^U#XE^"O_!*JVT7X/\
MA:P\07MSX>^.?[6WQ&UF%+WQ/H.@!K#P/JO[/GPFT_Q'.S:N(UL[KXC>$X8"
M_P!O>_N%M#IM\ ?T5T5_/1_9?_!U1_T,?_!!K_OQ^WG_ /**C^R_^#JC_H8_
M^"#7_?C]O/\ ^45 ']"]%?ST?V7_ ,'5'_0Q_P#!!K_OQ^WG_P#**C^R_P#@
MZH_Z&/\ X(-?]^/V\_\ Y14 ?T+T5_/1_9?_  =4?]#'_P $&O\ OQ^WG_\
M**C^R_\ @ZH_Z&/_ ((-?]^/V\__ )14 ?T+T5_/1_9?_!U1_P!#'_P0:_[\
M?MY__**C^R_^#JC_ *&/_@@U_P!^/V\__E%0!_0O17\XW[,/[47_  7Y^(OQ
M1_:S^!7C+X=?\$A_&?Q!_92^)7PV\!>,=<T?XG_MC?"GPM<7/Q,^!WP^^.6B
M_P#",PR_!SXN:CXFL(O#?Q%T:TO]3U6/P3>6'B"SUO38M%U32XM-UZ]^RO\
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M'_\ H.: /UOHK\D/^$H_X+P?]$/_ ."2'_B5'[8__P!!S1_PE'_!>#_HA_\
MP20_\2H_;'_^@YH _6^BOR0_X2C_ (+P?]$/_P""2'_B5'[8_P#]!S1_PE'_
M  7@_P"B'_\ !)#_ ,2H_;'_ /H.: /UOHK\D/\ A*/^"\'_ $0__@DA_P")
M4?MC_P#T'-'_  E'_!>#_HA__!)#_P 2H_;'_P#H.: /UOHK\D/^$H_X+P?]
M$/\ ^"2'_B5'[8__ -!S1_PE'_!>#_HA_P#P20_\2H_;'_\ H.: /UOHK\D/
M^$H_X+P?]$/_ ."2'_B5'[8__P!!S1_PE'_!>#_HA_\ P20_\2H_;'_^@YH
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MF:MX@B75-2U5M0O=.T_]CR6SLI7EU)X_(@FF15C4B0[B  ?T.T5^2'_"4?\
M!>#_ *(?_P $D/\ Q*C]L?\ ^@YH_P"$H_X+P?\ 1#_^"2'_ (E1^V/_ /0<
MT ?K?17Y(?\ "4?\%X/^B'_\$D/_ !*C]L?_ .@YH_X2C_@O!_T0_P#X)(?^
M)4?MC_\ T'- 'ZWT5^2'_"4?\%X/^B'_ /!)#_Q*C]L?_P"@YH_X2C_@O!_T
M0_\ X)(?^)4?MC__ $'- 'ZWT5^2'_"4?\%X/^B'_P#!)#_Q*C]L?_Z#FC_A
M*/\ @O!_T0__ ()(?^)4?MC_ /T'- 'ZWT5^2'_"4?\ !>#_ *(?_P $D/\
MQ*C]L?\ ^@YH_P"$H_X+P?\ 1#_^"2'_ (E1^V/_ /0<T ?K?17Y(?\ "4?\
M%X/^B'_\$D/_ !*C]L?_ .@YH_X2C_@O!_T0_P#X)(?^)4?MC_\ T'- 'ZWT
M5^2'_"4?\%X/^B'_ /!)#_Q*C]L?_P"@YH_X2C_@O!_T0_\ X)(?^)4?MC__
M $'- 'ZWT5^2'_"4?\%X/^B'_P#!)#_Q*C]L?_Z#FC_A*/\ @O!_T0__ ()(
M?^)4?MC_ /T'- 'ZWT5^2'_"4?\ !>#_ *(?_P $D/\ Q*C]L?\ ^@YH_P"$
MH_X+P?\ 1#_^"2'_ (E1^V/_ /0<T ?K?17Y(?\ "4?\%X/^B'_\$D/_ !*C
M]L?_ .@YH_X2C_@O!_T0_P#X)(?^)4?MC_\ T'- 'ZWT5^2'_"4?\%X/^B'_
M /!)#_Q*C]L?_P"@YH_X2C_@O!_T0_\ X)(?^)4?MC__ $'- 'ZWT5^2'_"4
M?\%X/^B'_P#!)#_Q*C]L?_Z#FC_A*/\ @O!_T0__ ()(?^)4?MC_ /T'- 'Z
MWT5^2'_"4?\ !>#_ *(?_P $D/\ Q*C]L?\ ^@YH_P"$H_X+P?\ 1#_^"2'_
M (E1^V/_ /0<T ?K?17Y(?\ "4?\%X/^B'_\$D/_ !*C]L?_ .@YH_X2C_@O
M!_T0_P#X)(?^)4?MC_\ T'- 'ZWUB^)/^1=U_P#[ NJ_^D,]?E5_PE'_  7@
M_P"B'_\ !)#_ ,2H_;'_ /H.:K7NN_\ !=N^LKVRE^!__!)'R[RTN;5B/VJ?
MVQQM%Q"\)8@?L<AF50Y)57C9NBR(<, #XO\ ^";W_*._]@K_ +,O_9;_ /5'
M>!:*^T_V3/V#?C5\!OV5_P!F?X&^+==^%VI^*_@Q^S]\&OA1XFU+PYXA\677
MA[4/$/PZ^'/AOPAK5]H5SJ?@/2=2N-&N]2T>YGTN?4-*TR^FL9()+O3[.=I+
M:,H _76BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\7OVUO^4QO_  1#
M_P"P!_P4]_\ 6?/A77[0U^+W[:W_ "F-_P""(?\ V /^"GO_ *SY\*Z /VAK
M\7?^#B'_ )0N_M\_]DK\.?\ JT_ -?M%7XN_\'$/_*%W]OG_ +)7X<_]6GX!
MH _:*BBOQO\ ^"O/_!4#XI_\$YOA=)XD^"_[(GCK]I3Q+I_@O5?BEX_\9ZK?
MR_#7]G3X*?"W1?$WAOP7-K?CSXLZEI]S;>)OB'XB\7>+M"TOP3\$O 5OJGCG
M6='A\3^,=7D\.:'H&FCQ0 ?LA17QY^VY^U=>?LC?"?PSXM\+_"O4OCK\5_BE
M\7?AM\!/@=\%-'\8^'/ FH_$SXK_ !1UA[#1M(/B?Q&MW#HN@Z!H=AXC\>>.
M=?L="\2S^$?A]X1\5^-=2T;_ (1KPWKVJ:9\<^ OVW/VV?@M^U5\!/V;O^"B
M'P _9_\ "'AS]K:W\<:!\!?CS^R7\3/BO\3/AEH/QB^&OANY\<:I\)?C/-\7
M/A'\*+KPEK/Q$\"V6N^(/A=/I<NKW&L7?@KQ/81V&IV5OKFJ^"P#]B:*_ U_
M^"CW_!2+XI_!#QA^V_\ LQ?L._ OQA^QIX/;Q_XD\,>$O&OQ[^(3_MC_ +1'
MPC^$?B[7M.\2_$GX*?#SX=_!CQ9\)G7XG^&/#VI:O\"] NOBEKL_CBT32/$F
MAWWB31O&7A.UU+S/XO?\%U_'NEV7Q6_:5^ 7[,N@?%#]@+]E7PG^QAXO_:9^
M(/BGXI:=X-_:(\2:7^VCX!^'?Q=T>7]FSX86<&O^!_$TWPA^%/QC^%_B#QG:
M_%KXB_"V/Q;XNU37? /@V_>+0KKQ@H!_1]17YQ_!G]K3XH_M+_MO_&[X;_!K
M2/ 1_8U_9(L=8^$GQK^+NJ1^*+SQS\2OVS[B^TNYU#X,?"NV%KI?A?2_"/[/
M?A..YN/C9XNO[[Q!>:MX[\<>"_!/A?3K;_A'O&^I67Z.4 ?DY^PW_P I#?\
M@MA_V<W^R'_Z[H_9>K]8Z_)S]AO_ )2&_P#!;#_LYO\ 9#_]=T?LO5^L= !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQA?>$O!EEIOA/PW<Z_>QS:C+HOARPM-&TY[@VMA!';QHH /S9_8;_P"4AO\
MP6P_[.;_ &0__7='[+U?K'7Y.?L-_P#*0W_@MA_V<W^R'_Z[H_9>K]8Z "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<#1_P][_ &=?^B"?\%(?_%8'[>G_ ,X&OU1HH _*[_A[W^SK_P!$$_X*0_\
MBL#]O3_YP-'_  ][_9U_Z()_P4A_\5@?MZ?_ #@:_5&B@#\KO^'O?[.O_1!/
M^"D/_BL#]O3_ .<#1_P][_9U_P"B"?\ !2'_ ,5@?MZ?_.!K]4:* /RN_P"'
MO?[.O_1!/^"D/_BL#]O3_P"<#1_P][_9U_Z()_P4A_\ %8'[>G_S@:_5&B@#
M\KO^'O?[.O\ T03_ (*0_P#BL#]O3_YP-'_#WO\ 9U_Z()_P4A_\5@?MZ?\
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M()_P4A_\5@?MZ?\ S@:_5&B@#\KO^'O?[.O_ $03_@I#_P"*P/V]/_G T?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWX!N/%C^(X]5@^(2_%W]GGX<_'N/5XM&_L737\*GP\OCYO"TMA)J?B :E_9
MUQ+ZR_M!M'L/K4,I8J&4L.J@@L. >1G(X8'GL1ZB@!U%-+*."P'89.,G&<#/
M7CDXZ4Z@ HHHH **** "BBB@#B?B7_R3CX@?]B3XK_\ 3%?U\,_\$>_^447_
M  3;_P"S'?V7_P#U3?@^ON;XE_\ )./B!_V)/BO_ -,5_7PS_P $>_\ E%%_
MP3;_ .S'?V7_ /U3?@^@#]'**** "BBB@ HHHH **** "BBB@ HHHH ****
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M/IEY\5I_#LGBGQQXC\7^*O-/VR?A-\=OC%_P6P^ OAK]GS]JSQ;^QYXSLO\
M@EC^T/KFH?$_P?\ "GX/?&#4-;\-6G[6W[-=A?\ @6Y\,_&WPKXN\)VEAJ6I
MZKHNO2ZUINGVOB*TNO#EC96U_'IFIZK:WG[-?L_?LO\ [.O[*/@QOAY^S7\$
M_AG\#O!4M[<:C=>'OAIX0T;PI97]_<W=Y>R7NIG2[6"?5+I9[^[%O/J,UU):
M6\HL[5H;..*!/-_VDOV ?V*OVP]>\-^*/VI/V8?@W\>?$/@[2+O0?"VL?$SP
M9IGB>_T+1KZ\&HW>F:;/?Q.]O9SWP^U/"GRF8LXP7;(!^.'[-O[-.E_'1/\
M@LA_P36^-WQ:\"?M9>*?C%X6T/7_ (X?M\>$O#NA)XYUCXD?&7P[\2O@]X-^
M$WQE^'FDZ_XC^$?@O]H']C'PM\$/AMJ_A3PQ\/5^$_ABR\,:K\.-7F^"G@WQ
M/)KWCWXC_&'[ ?QE^)__  41^,'_  2*_9!^)V@'0?$7_!*#P7\7/C7_ ,%
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M +,=_9?_ /5-^#Z^YOB7_P DX^('_8D^*_\ TQ7]?#/_  1[_P"447_!-O\
M[,=_9?\ _5-^#Z /T<HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2_9S\-?LO?$Z>Z_:*\2? AOAE\<_V"O!.AZ#\.].^$'PG^,7Q>L/#WA3P?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y(?\$&
M?^4.O_!/+_LW#PE_Z4:E7ZWU^2'_  09_P"4.O\ P3R_[-P\)?\ I1J5?K?0
M 4444 %%%% !1110 4444 %%?!W[5O[?O@/]E[XD?"_X'Z7\%OVD?VH?C_\
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M%O _@7X6?M3>+?"_A2^\?^$_AO\ #GQ!K'Q<34_AOX]^-'P_TC7?&WP<TO\
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MK/VK?@K\5O&__!3_ /X)+_&7PCX&UC7?A9\#M-_;^B^+WC:R?3AI'@*;XG_
M_P !^&OAZNM)<7\&H.?%>N:7?Z9IG]FV5^$N+60WOV2(I*WY1?\ !.C]LO\
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M!/\ T;1_P4W_ /%7?[=G_P XN@#]4:*_*[_A[I\"?^C:/^"F_P#XJ[_;L_\
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M3\*7_B3PEJ>F^*-!L]>M;"XUCP[J%EK>GQW&F7=O=2=5_P /=/@3_P!&T?\
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M4:*_*[_A[I\"?^C:/^"F_P#XJ[_;L_\ G%T?\/=/@3_T;1_P4W_\5=_MV?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOVZ::Y_8?]C#XT?$W]OW]ICXB_ME^%/'7B70_P#@G[\*(OB)^SG^R1X1\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-'PS_P#.1H_X<U:A_P!);?\ @M'_ .)H^&?_ )R- '%?M;_"'3?BMK_[,/\
MP2Y^ ?V:+XM^$?@OX!E_:#_:Q3PO8V/Q5_9K_8,T58OA5XUT[X:_&/1U;5/A
M=^TO^UP^F:G\.?A+H]EI=WH=[X%TK]H7QQJ=M#;> ],M=5_+_P#;N^ _[5/P
M^_:.^-_P[_9M^&/_  4.T/XM_#JS_8"^'W_!$3Q%^SQ+XM/[#?P+^$'PY\)>
M$=&^+FB_&&Y\/:C<? RTM3X]M?BMI?QQB_;7TCQAXA\0_"1?AKIG@N"Y\%2I
M!<?KK_PYJU#_ *2V_P#!:/\ \31\,_\ SD:/^'-6H88?\/;/^"T>&5T/_&:/
MAG.V1&1MI'P1W(VUCLD0K)$^V2)TD5'4 _83Q7_R*WB7@ ?V!K&,?]@ZX_+G
M/KZ^U?G;_P $8O\ E$O_ ,$X?^S,OV?/_5;:!7WH^AMX8^&4GAMM9USQ&?#_
M ($.B'Q!XHODU3Q-KITGP]]@.L^(M3CM[2/4==U0V_VW5[Y+6V2[OY[BX6"$
M2")/@O\ X(Q?\HE_^"</_9F7[/G_ *K;0* /TQHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2_X*+?\ T5E'_#D;_@GA_P!";^TS_P"+$O\ @HM_]%97ZRT4 ?DU_P .1O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<PK)%<0Y'BC_ ()=^-_B=\&OACHGQF_;G^.OQ%_:S_9V^*[_ !4_97_;NM/
M?P7^'WQR^ HN-&\(^'];^'UOH?@/P7HO@#XJ?#3Q]HOAO4])^+OA'XP:#XUL
M/BWIGB>[M/'0U8Z%X3ET/]<Z* /RR7X4?M??L;_ O]J+XZ3?M _M*_\ !3_]
MIJ^^%=GI'P?^$?BG0_@-\)? [>(?"TGBF3P%I7A;X:_"GP[\'? _AZ[UCQ5X
MZFO?C+\2[C5-0\<:]X \.Z+8:;;ZG=>!O"OA^\^Q/V1OAG\5?@S^R]\ /A1\
M=/B?=?&KXS?#WX2^!O"GQ2^+-Y?:YJMS\0?'FC:!96GBCQ1+JWB6>X\0ZN=4
MU>.ZG35M;:'4]4C*W][9V$]P]C;_ $30!C/N<^O\_P#(H _(_P >?\$C_ASX
M\_9-_P""A'[)MY\8?'MCX=_X*$?M+?$[]I;QEXNMM&\-2:Y\.M<^)VO?#;7K
M_P +>%+.6W_L_4M%TN7X;6-O976LK)J$L6J7KW$C216[)]J_M#?LSZ+^T)XI
M_98\4:OXHU3PY<?LM_M,Z1^TOHEMIMC97B>+-9TCX/?&CX0P^%=6ENBK:?I,
MMC\9M1UB2]LTEO!<Z+:6R*JWD\\?TW10!^1_Q._X)8:Y=?&;XT_$S]E3]MO]
MHK]ACPE^U5?:?KO[5WPG^ NC?"C5O#OQ0\>?9]0T/Q7\8_AWJWQ0\$^-M6_9
MN^./C_P=J*:-XS^)_P $CX7U;Q%X@\/>#/B)K5MJ7CGPX-9O_J+X:?LE^)_A
MC^T=HOQCT_\ :=^._B'X4^&_V4O"G[,VB_LR>+?$;:W\,(M<\)>(M%U2U_:
MU!Y94FU+XQZEHFCMX6UGQ ]A#+J.FZIJ3SS-YL,$'V=10 4444 %%%% !111
M0 4444 <3\2_^2<?$#_L2?%?_IBOZ^&?^"/?_**+_@FW_P!F._LO_P#JF_!]
M?<WQ+_Y)Q\0/^Q)\5_\ IBOZ^&?^"/?_ "BB_P"";?\ V8[^R_\ ^J;\'T ?
MHY1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?DA_P09_Y0Z_\$\O^S</"7_I1J5?K?7Y(?\
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MK?@']6T%[9W,EQ%;W=M<2VC[+J.">*62V?=(FR=(W9H7WPRIMD"MNBD7&Y&
M^9OVLOBC^T]\)_A]H/B']E+]E73/VNO'^H>.--T37?AWJ_Q_\)?LZ6WA_P $
M7/A[Q1J.H^.8_&?B_P *>,-/U>XTWQ!I7ACPX/"<&F6]]>Q>+)-:AU&.WT"\
MM;C^6/\ 9*^'^M_LU?\ !8G_ ()D^'_#GPH_X)T?LR6?[1/P2_:8O?$/P_\
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MWK]A3_@F9^P[^UE>?\%F?B1^T[\ ?"WQXU_6/^"IG_!0#P'IL'Q'N-6U72?
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M3EL-!\/:;;:1I%G)J6K75]JNH26NGV=O ]]J=[>:A=LAGO;JXN9))GZ&BB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\))X=_Z#^B_^#2Q_^/T?\))X=_Z#^B_^#2Q_^/U_.C_P[>_X)W_]&%?L7_\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L +P# 2(  A$! Q$!_\0
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I%C#)CYC['-6M!;6!?74>H[V@ _=NR[><]!^%;]%)SNK6"P4445 S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,  !@# 2(  A$! Q$!_\0
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MS ^/O^1OUO\ Z^1_Z M<7/\ ZF3_ '&_E7:>/O\ D;];_P"OD?\ H"UQ<_\
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M7^NW]=]SH/JK49I[>8!6(B-M;QR1N T<A,*[U='&#NS@J>_7KBOFSXO?LM_
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M:G^??\9/^2L_$3_L:]5_]*&KR;5/^/*7_>B_]&I7K/QD_P"2L_$3_L:]5_\
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MVJ?\>4O^]%_Z-2O]#*G_ "))_P#8,ORB?POA?^1Q3_Z_4OSIG^C3_P $N_\
MDR'X+_\ 8L1?THH_X)=_\F0_!?\ [%B+^E%?YY\0_P#(\S7_ +#:_P#Z4S^Z
M.&/^1%EW_8/#\D?Y]_QD_P"2L_$3_L:]5_\ 2AJ\FU3_ (\I?]Z+_P!&I7K/
MQD_Y*S\1/^QKU7_TH:O)M4_X\I?]Z+_T:E?Z&5/^1)/_ +!E^43^%\+_ ,CB
MG_U^I?G3/]&G_@EW_P F0_!?_L6(OZ44?\$N_P#DR'X+_P#8L1?THK_//B'_
M )'F:_\ 8;7_ /2F?W1PQ_R(LN_[!X?DC_/O^,G_ "5GXB?]C7JO_I0U>3:I
M_P >4O\ O1?^C4KUGXR?\E9^(G_8UZK_ .E#5Y-JG_'E+_O1?^C4K_0RI_R)
M)_\ 8,ORB?POA?\ D<4_^OU+\Z9_HT_\$N_^3(?@O_V+$7]**/\ @EW_ ,F0
M_!?_ +%B+^E%?YY\0_\ (\S7_L-K_P#I3/[HX8_Y$67?]@\/R1_GW_&3_DK/
MQ$_[&O5?_2AJ\FU3_CRE_P!Z+_T:E>L_&3_DK/Q$_P"QKU7_ -*&KR;5/^/*
M7_>B_P#1J5_H94_Y$D_^P9?E$_A?"_\ (XI_]?J7YTS_ $:?^"7?_)D/P7_[
M%B+^E%'_  2[_P"3(?@O_P!BQ%_2BO\ //B'_D>9K_V&U_\ TIG]T<,?\B++
MO^P>'Y(_S[_C)_R5GXB?]C7JO_I0U>3:I_QY2_[T7_HU*]9^,G_)6?B)_P!C
M7JO_ *4-7DVJ?\>4O^]%_P"C4K_0RI_R))_]@R_*)_"^%_Y'%/\ Z_4OSIG^
MC3_P2[_Y,A^"_P#V+$7]**/^"7?_ "9#\%_^Q8B_I17^>?$/_(\S7_L-K_\
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M_CRE_P!Z+_T:E?Z&5/\ D23_ .P9?E$_A?"_\CBG_P!?J7YTS_1I_P""7?\
MR9#\%_\ L6(OZ44?\$N_^3(?@O\ ]BQ%_2BO\\^(?^1YFO\ V&U__2F?W1PQ
M_P B++O^P>'Y(_S[_C)_R5GXB?\ 8UZK_P"E#5Y-JG_'E+_O1?\ HU*]9^,G
M_)6?B)_V->J_^E#5Y-JG_'E+_O1?^C4K_0RI_P B2?\ V#+\HG\+X7_D<4_^
MOU+\Z9_HT_\ !+O_ ),A^"__ &+$7]**/^"7?_)D/P7_ .Q8B_I17^>?$/\
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MW_8/#\D?Y]_QD_Y*S\1/^QKU7_TH:O)M4_X\I?\ >B_]&I7K/QD_Y*S\1/\
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M5GXB?]C7JO\ Z4-7DVJ?\>4O^]%_Z-2O6?C)_P E9^(G_8UZK_Z4-7DVJ?\
M'E+_ +T7_HU*_P!#*G_(DG_V#+\HG\+X7_D<4_\ K]2_.F?Z-/\ P2[_ .3(
M?@O_ -BQ%_2BC_@EW_R9#\%_^Q8B_I17^>?$/_(\S7_L-K_^E,_NCAC_ )$6
M7?\ 8/#\D?Y]_P 9/^2L_$3_ +&O5?\ TH:O)M4_X\I?]Z+_ -&I7K/QD_Y*
MS\1/^QKU7_TH:O)M4_X\I?\ >B_]&I7^AE3_ )$D_P#L&7Y1/X7PO_(XI_\
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(:P\+II]C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !X (0# 2(  A$! Q$!_\0
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MX[?\&_7[:W[,?CC0?&O@>Z\+_M"?"_P[XFTW6+[5?#LH\,>---T33KB.[O\
M4-1\,:G/-;SK9VP>27[#JDS2"%Y$3)"C^J#_ ()(/'-\!-;FA??"WQ'\1,A
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M2^)?B9XFTPF/0[KQ=K>CS:9INDZ5/+B0:%HMN+6U@FE/[R7[5<@ 2!C]&_\
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M4^&-A?Z?=P7VGZA9>)+^*\L+^TD$]I=VTR+OBG@E5'1@01@#IT]V_P""?_\
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M>3%R9"21D L/Y3!_P;B_\%-BVW^R_@<6.<J/'DF1P.< [@/^ CKV[>>_L.?
MO]H[]LO_ (*?6GPV_84_;J_;*^*_[%7[,'CKP[K7QJ_:2^,'CG4?["\7ZCX;
MU S:CX7\(Z?I<L>F:O9^)[B":PT:WND<W&EJ^KW2):S0$?ME^SS\7OBSJ?\
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M &@/A9^RS\2/%^F?Z-/JOC[2_AYJ?B&W>,*A@O+O4/\ B8L\0 18[N1FC4;
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M@'XA\4^*M7L]!\/:#I?CO2[K4]7UB_D\FRT^QMHY"TUS<R_)%&O+-Q7\@/\
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GN?TW[UQRR_3<#1O']Y._?\N_Y_I117R)8Q\,0>#QUX/<T444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M +P# 2(  A$! Q$!_\0
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M@8Q][!P<GFH[>Z\926\IN D,FR*2,);;\[GPR]L;1@X//OUKL\2?WT_[Y/\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img_ex4-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_ex4-1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .\!-4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<9I3]W\*KQ-\^>U*X^A:+8- 85#)PU+DB,&G<1*6 %&1ZU"S?*/6EW?*,47
MFS3';:1S2*V2!^=1SMM<9Z4P)F; 'UIV:KLWW>1UIZOER/I23 EI"0!S4>_#
M'FD=CCK3 E#9H#9)'I3$88IJ-EV]:2 FR/6C-0[N#^E)N.0*8$Q;%&1ZU$YY
MYZ4X'(S20#MWSX]J7(J+/S_A2LV.!1<"0G%!;"YJ/.!QU-(Y)CH E!!%+4*-
MPH[T]FX]J8#\CUHR/6HF.!Q2KR.: '$X<#-.R/6HF/S*3V!I<\9H DR/6DR*
MB#'/-*&&T=>E $N1143,<#Z4N[ ![4 29'K1D>M0AC0&Z_I0!*3QZT%L&H"Q
MS2&3GBDV!/O'M^=(6X_^O5?S._\ 2@R9[_6E<"R#Q2;OFZU '(''2F-(2WK3
M N%J-P]15?S,,32&0MUI7 L!\]J4,#WJOO..O%(KX/\ C33 L%N#VI V#U_6
MH1)D')S1N'I1<";=G';FGU6+'\,U*S'%%P),CUHJ(-QSFG!C@XI@/S14;MC%
M+NQWXI7 56R3S3JKQM@L?>IMW%,!U%,W$CK2Y/K2N ZBFY/K1D^M,!U%1E\'
MO2DG% #Z*CWX ZTF_FE<"4G H!R*B,G%$;Y!HN!+2'I3<GUIC294T7 D4Y%.
MJ*%LI]*<SX-,!]%1^8:/,YZ]J5P)**C#Y/>E+X]:+@*W3.:<.E0R/^[^M.C;
MY!D\47 DI&.%-)DU'*QV#%%P)0<BEJ*)\K3@Y-%P'Y%%0%_G_2I2Q[47 CE<
MK( &P/2INU49V_>#UXJX#D?A38"EL"@'-1%N/>EB8G.:28[$M%-).3Z4;J+B
M%)P* 0:A=R0!2HQX%%P)J,CUIN3ZU&&.>>E%P)J*;DC IF\AC1<"6BF*^<TC
M-@9HN!)13=V0,4CM\I-%P'T5&K$J*=NHN ZBF[J W/-%P'4444P"BDW"@')H
M 6BFEN>*<.@H ***0'- "T444 %%%(>!0 M%(#GB@'- "T44W=@\GB@!U%-+
M<^U.H **** "BBD)P* $!P6I&8;>:/[U(PR/I^M 'GPUO4;-_+-].;I'\F9'
MC\U2P8!V"@#! ^9=I((X(!Z[WA?Q&^K!H;D#S2'DB?@%XP0/F ^ZPW#C_P"O
M5#6=$O+:\-WIXEEW,77A6\@L6WG:,,P.[(ZD<US&G3/87D$QG9)F'VALX !"
MD<@C<1C=NY'.[^Z,^C[*G5IWCN<O/*$M=CT#Q%K#:7:!8S$+B<.(C+(J*"%S
MR3U^G>L;P]XC>>\\B5II()G6.&28KYB/LW$,!C@XR"/\*R]=OTU6_968VP,6
MS#QY(02'+>^&4Y QP1U) JC'%++?">>?9,]PD6$4-Y9\PA #MRW,9)Y7@  ]
M@H8>/LK2W'*H^;38]'U#48=-L6N9_N*57J!R3@9)X'7\JYF/Q)+'=7'G%Y?*
M9C<QF1<0XDPH0XRQP#D?0U%J>IOJ=M82/MAR4P/E.Z1UQCY^,888&"23_" 3
M60D"&SC9&V16\@$;I&A,FY5.27.!PZCZD#WK.E1CR^_N.51WT/2IY4CA:1C\
MJ L3CL!7)MK\LNJQF#),PB,-N)$VR1G)9V/.#^/;WI+N^,WA^.R#!%6)=TY8
M?=4)M.&.,G<N=Q(&#U'7#-NLOVB)&4++B8RI"K%6W#"A22N26R,<8;/'(I4J
M4;/G'*HWL=_:7L=_96UW"2(YEWKGKBL36/$#1D&&9X(HVECW@*3).A4+'CKC
M);/3I[U7TJ_:VTWR%99=[%HY"H0#.2054D !<$;3SGL<UBQ6RIY10Q7&]1;L
M9(U^3K\[;693PI#'[WR]\TJ5&/,^8J4W96.\L+_[:DNZ)HIH7\N6-B&VM@'&
M0<'AA5'6-8%LQMXF:-D:(SSC;B%'8C.#U/RGL<=3TK%\/70TS[0'D>6,+M;;
M;K"0RAFSM4D'/(Y((^7(YS69J"LM_-=2B.:2.5I6B$8);KE5;=EPI7(#*!\I
MQZ41H+G:>PG4?*=CHNK-?PQI,CI,8O-5F 'FQ[B%? /&0 <''6I]5U$V,&R&
M(S74D<CPQ@@9VC))R1QR/SKE-*4Z9J[.98SY9<RPQP[=JDXP'ZL%P>" #@X/
M')K:2:K?[\HHD15A1QD@!CR&# H7SS@,,%<D=E["/M+= ]H^7S-W2M:,\GD2
M2-<1M-Y4-V551*1&'(P,=/FY QQZUK75W%:0B67=@NL8 &268@*/Q)%>?P@M
M?VEY ;>W\S888C"0PPQ_B_@) (X!X.36SK=V-52W\L 6H/SK(F_>S*,#:",%
M=RX(.=QP :<Z"YTEL$9OE+5IXCD6[E^TAV0*SS(L8!M,2;%!/?/)ZD_*2.#7
M0W$B0Q222-L1%+,QZ #DFO.4M7\@*JVJ^2^V1W5YO/8@$' P6^^&W$Y^9>_3
M?U"_DNO#R6RN3-M032DEP0NPGH 6W@CCY>&.2,45:$;JP1J/6Y,=?F75%18W
M*.ZHEKY8\QT*;C)G/0' QVP>];MM<I<VZ3Q',<JAU)'4$9%>=BT<>;&J0^>2
M)$F)DVQQ[MOEA1SUX"\_ER.CTC41!HXM2<R*2(VA!"*K%B,!N5"!3P<\ 8R"
M!15HQ23B$9N^I8U3Q"8.8'5(XP[;GBR)V5@OEKSD')QG'I[UMV=XETC$*Z%6
MV,CC#*V,X/YUY[]D=(X8I4AEE9-D?S.FV7!9I#N&03M)+9_A/<8K:\.WG]FP
MW N75DV^:?)+D!@&+$[\-E@/I\G8]74HQ4+QW",W?WC6UC5A:N(86"R%T625
MXRR0JV>6Y'8'OW%2:/JR:E;*"K),$#D%" ZY(W+['%<9J0D>XN+F]17B,CM*
MAD?+)GY4/R[6"$@?+TYZ\FK>AF?3=59Y@@B*F,JLDCNJ[@%!W?*0ISD*<C)X
MZT2P\?9WZBC4?-J=;JFIIIUL[[7DF\MWCB1"Q;:.3QT R,GWJII.MK<RR6LS
MJ[B38L\496.1M@8J.3A@,\9/W3]*Y[6I+C4[QIK?=Y2J(X/WC*P!)#;< KAQ
MC 8Y(QTR*J:8'ANK:XLX@MJ'22%#*^[!.&*K]SYAN4;R,]J(T(^S=WJ#J7FD
M=Y<745K&LLK87(7A2Q))P  .2<]A678>) ]T$N=JQR!F7;&V8,/M"R\G!.1R
M=N.>.,UFZ_=M?BVCM3F!!YCEV>,;MJLK JI8%<@\X49&>>F,MNZY,<>ULD7I
MEG*"25?FYV9S@MGLHX]:*=!.%WN5.HU+0])N76.,R.P5$!+,QP .Y-<ZWB%1
M?[=H:W\X0!!$_G$^7OWA<9*]!C'OGM2:SJ#W.C)!%N::4*)E;@%<@,K;<D;N
M@VY)SD>M<KLN//=E:5K],$2-<840$A0-^,XZKTW$Y'7BE2H*2;D*=2VQZ7;R
MQS0)+&X=' 9&'(8$9!'X5B:CXA2UF80&.5(8VDE+;AN 8*50XP6SGUYP.]0Z
M?J/V;PZ85.RYBCV0JI#A1A@A!. 0 IR6Q]TYKF&BD=HTEBF>0 FS2.8%5F/S
MN06P1DA7P00,\<<A4Z*;?,.=2R5CT>UNH;N 2PL67)4Y4J00<$$$ @^QK+NM
M46UFB@@:%[J5@H61RJJ,%B6(!QP#QWK.\-:@(+2Y^UR+@_O=RS";<V,N=R]S
MD87'3&..F!=RO/=71O&F6V>4FX"2J <?+'D @J0,*<$Y(P3FE"A>HT]D$I^Z
M=MI^J6^J0+-"<-M4NA!RI/U R.#R..*=J.IPZ;8O-,R;L'8A;:7/M_CVKFM"
MNKB'5G2[RN5\H[I$<J P\I2% *<,PY[D9YIFM7L]Q>3M SB+R@BE"@)C/^L.
MPG+ @9#?[/ (R2>P7M;= ]I[M^ITEEJ:73O!*8TNXV*M&CE@< '() SU],BK
MDUQ#!$))Y8XD'&Z1@HZ^IK@]/N6M=1MFA\S[$&,L1::/E6'[QMO^L?H<'Z^E
M;/B*_+7%K%;NV8R7!1T4^;@%,%R P 8DJ/[R^N*)T/?Y4.,_=N:5AKT-Q/''
M.88?.4/ !-N+J3@9X&#[<]1S6E<LH8$D  9)/:O.89+B)MUJ)MKD"Y$DB(//
M4AE7+^Y'R@YQ73^(=1CDTH)&<B?"S#[A$>=KC+8"GJ!N[TZE!*247N*$]+LF
M;Q%;"["LUN+/SO)%UYXP7V!NF,;<<9SU[=ZW(V#OE>00"".017FLSW(N7NV:
M=M25MKY*)MA*A=W.5!(Q\P/4G'%=78:D;?P\@7"W<4?DQ1,-QW;28P<=?E )
M(XX)SBBK044N4(U+EF]U^WM;MXD\N9(5#W+K* 806V].<G.21Q@"M%;B&XA2
M:WE2:)QE7C8,I^A%>>[I712K3L(ES:(H1S*^XL1E,AP&!QR.#SZ5T7AZ^,=A
M<+=B2(AWG)F*EFR<R-E?E(#'&!STX&:52@HQN@A4YI6-FYU);1XX(56:ZE;"
M0F0*<8)+$\X& >W6G:;J-MJ5M]IM9TDC< _*P)4D9P<=#STKB+B26^GE^T2R
MV\+RM).R!1L<*54 C)7*')# '@^IK5\-7$T=_*EQ'+$LJ+&HEC5 -F?+10.A
MVEOO<GCZ!RPZC#FZB]HW*QT5[?PV%JTLA!)PJ)D NQ. HSZDBFV.H17;/&=L
M=Q"Q26'>&9#_ ('(P:Y?6[R2;49#'Y@C\L0[U0%?))&YO[P(;HP&WWINGWEQ
M%K,4T@F-LA*B=HPL91@"[E@<D@J!G&![=CZO[G-U'[2\CLY98XD:21U1%Y+,
M< "J6GZQ#>.L;+Y$DD:RQ)(XS)&V2&&/H<CM^-8_B6\D-W!%;Q&7[.Q<[8O,
M EQ\JL/0J6/&2..E8-L)K<1-9I<WA41S,T<&_#)_JT!SPG';G'KS2IX=.',Q
M.K[UCT;=\P],5G)K-O)>>404BWM&D[, KNN,@<^_7O@U4U^]#Z>D5J[R?:2
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M4GS%;B+=]I^5@2#G!"L>1[?D0I.4G$)325SL0<G&*-QKGO#>HR3(+265Y!'
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ML:?//YEN(YB9CAD')Y\N011J< Y^;YB.Y89Z50COM2F\MKN:21(W_<.9,X?
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MQDM)(<,9%&>!R HP3CV)HTM[NX+>S#3;B7[04MPOG%&*["JL4$9.2J@;?FV
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MSE-R-[RPD@I)U#..NTXVGI@ <<<0OI+Q6-H9)X>2V^)LL+15R'88 W')^88
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MMH7@,F^8Y;8"2T3@#H"0&.?N[>.]#LTU+8$G?0BD:WEGG^RE%D8&6*YC=6)
M'WB1\Q!!Q\YSDC&,8J6V\FRU29[.!4VS&,2 ?,[^85*,<\EBHR"/X@1C&:--
MM]D*V,B01^:!)-!-/Y80;00F0N2YVAB,# "C@=6?99-3U"":"6-)5EV-*D@(
MC<@[95('S*V21R/FW#D$BAM:KH"[CKMHKC4E,_[R5V6(N&7>DA< J.=P*DY
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M7=[>S+/&D-L061BV6)S\H'3MCZT.ZOJM M<HI/;636UFUT79FWA8U+%U=!"
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MVGTB.ZC:8W*!?)A4%T<9 QR,],]QT)[TW=--R_K^MP6VB)+\&.46KLQS:HH
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MCVIT<JSQ+(F"K#(.:7:/3FD,8!R.14]1="!MJ6@ HHHH **** &?WJ&'R@$
M]N:!_%^%([!8]S$ #DD]!0!RVJ^%]Q:33X+0*9%E,&SRV+@8&)!G"Y . /7F
ML.6'4K.S1(?.\ZW7 MXC()&D"KQA2,@L'8L<@JW4$ 5KZCXM(:2+3FMY IV[
MT8RRD[-P(B &5)XW;O6L-KG4[N..ZB%TSS1AEG@64L'*CY1M!P%D)!4D !.5
M8G-=])5$ES[>9SRY;NPL/F7Z2R30M#&50RL@ AD&694D^]M8'YMXX.X9 )J)
MU:UL[E)MT5H8F18GD1ED!5@!A7;.25)8@ 8)S3K29](2>)KF81N%$D:\(A+L
M!)(R=&;.TJIW':-QR>*ENT4\%UL2*"VD@D97MXU@;8%8Y.P@E<J 0P(^;&<C
MG=WOY&?YFW<O?V6KVVH6BQW2RVWE#.[8X(0_+M![KG&.0:AN[5WO)C*I5UA2
M/RPWS'=QM##/(XP<8X],FBYGO]/U."Y33VN86M?(%K*6(Y"'J%;)!&""">2:
M@N4G.I31E,3&V$:JS='*?*"W7IN7\?4U,4]&K;#+412TB1GE*!G)\B14FWC'
M4,O!.X G' P!@<9B^SR_;TN!*T@^5_M&%6/>1C<5QDKNR01@?-R>].MYU5%-
MZA22/"RC)(+E>%Y.XD?-D9)VG:<DJ*B665KMI6C,EK$C?:6WY(/EE6!QP<G<
MH_X"%X%3=JX(9=RZ=!&;87%P$B4PAHLJVT*1R"I^8*C<C&0.GK9CO;!46"2^
M9(MBPF,V[.\F&ZLS)MZN  %P.U<[*(X9[NZNT$\T;"(Y;Y&<ARQ? &?]6>#D
M?,,D@8I+:Y_T4I'&(7:.1W>QA Q$!R^U<*P&2/NJ?1L@K6SHJUNPN?4V#+HU
MQ#,;V\WCEHV>V=\IM+#=E/[H)XQ4#6NE!DCCOVS&V4C5+A%1BVSA<-SDXZ]Z
MI64=W#OB+(;='SO#.(T3D,"XP$/0D/T],Y!UM'U^,7D*7=E;R(Y_CMBDI3<5
M#JF#OX7<2-N!GCBB2<+\CO84==R)X;&;,TNJSA'B&XDSX9 NY2PV#("G/T-3
MQ6VD6*/]CG47'*!4M'0,=VW#$@GJ".".E=['9:=<Q1RQVMI)&ZAD<1*001D$
M''2@Z3IQY-A:\?\ 3!?\*X_K71W_ *^1O[$X:.XM&A@EEG@E"IAQY,@890'A
MR&!"A@P! '(/I26;QP3DM/,\N]OFGB"C=E@-VTN6VX8 <=&&?3N?['TP\?V;
M9G_M@G^%']B:5_T#+/\ \!T_PI?6(VM8/9/N<3*]J+5(XKMFC1-J.D6[*@?*
MQW%2& <<@G.[.!FE0VY54\^")54;S.A:1VRWSX4X4C:P!#$X7GI7:_V)I?\
MT"[/G_IW3_"F-H6E=?[+LL_]>Z?X>Y_.D\0K6L_P#V31PBV.FS^?]JO+3ASY
M1*DY3@@Y&"#\R]21\PX]8X[.&W6.*QUCRX48819S@_>XY7:1PW&,<&N^70M)
MR?\ B5V//7_1D]O;V'Y"E_L#2"<_V599]?LZ>_M[G\SZU:Q:\_P$Z)Q,D3S*
MRMKAV,@B*_:-H(& !A0/[P&?<4RWTC2K2U,D5Q:EHT)5>"0<'@,W Z'J#T-=
MT=#TLXSIMIQT_<K[>WL/R'H*3^P-)QC^S;4#&,"(#U']3^9]:/K2M;7\ ]D<
M<S0E("TMO)MRSJLWSJ2I!P#\N0S+T(SZU#I[P0(@%U%-@M(%,+1)R,#); QC
M.<;B02.E=JV@Z8&R+"'.<YQWX/\ , _@*!X?TS81]C4 C! 9@",$8Z],$C\3
MZU+Q$;6U_ /9,XZ<P1VRVPOHB0GD[]C2!^3CA<D'+<@C!/?/22S\AH%"S6I0
M)M>25S&<DY^51R!CCG&>XXKK#X=TO@_9?FSG/F/G.0V<YZY /U /:HU\.:2Z
M.AM/D^Z5$KX(VXQUZ8)'TI_6(VMK^ O9M,Y2*SBDDG#7,,,F=JR1S^6TBCIR
MIZ?49YQFB"UN[1H_LFJJ5!R6$T19L<X);#8]?FKK?^$>TPON-N^XG.?.DSG=
MNSG=UW<_6G#PYI@0(+=PH7;@32 8QMQ][T %'UE?TD-4F<E<1ZE<@Q2ZE$(#
M&(_+W0JF ,9P2^&ZY(Q4 T>-+7,US'<K$,JDMR90>.,+G^1%=FWAS3"2Q@DW
M9W9^T2=<EL_>ZY8G\33#X9TDKM\B0#&W N),8P!_>] !^ H6)25EI\D'LGN<
MTD48MXED6-X'(,H29<JN,C,8"\ X..6Q26<I613+?6]SM9F\M7)+ \!<, %X
MR"3C@^PKJ/\ A&M,SN,,N<[LF=SSDGU]68_B::?"VE$8\F3IC_7-QP!Z^BK^
M5+VT'W*Y&<W+_HT/E"\MHYA&5,DDA"L3D[@X'?*9!P?D'48S':Q"781Y<SF+
M$LWF[%W C;@D9;C/\.WICO74'PQIF<^7+D?]-3_M?_%M^=0Q>&--) V2D#MY
MA_V?_B5_*CV\//[A.FV<Q#IDHFN6B9;=O,P7C;8)2,X;&"&/?(P.>G:ECMM;
MM%#*ZNSL&>5U5VD')&2'/TSM!QQ74'PII8P/+E('3+]/O?\ Q3?G2#PCI6,>
M7)C.?O>X/I_LC_)-5]9C?7\A>R9RUTNLWT2V[K%Y00($,2M@C/S@NP^;FDDT
M*[>T,E]-<W$<:!C$\H). << ')Z\$GKVKISX,TC9M\J3&,?>&<8(]/1C_D#"
MGP9I+$$K*<'<,L#SD'T]5'^2:KZU%?#I\B?92ZF)9V;K90J;66."3B0Q8VHF
M#VY?DA0>O&3Q3(3.9(Q=^0ZH2!'#*9"R<?*J\D9Y'4#H>HS6Z?!FE%=I$V!T
M^8>A'IZ$\_CU I)/"6F^8#B3);<2=O7=N]/4?EQTXJ?;4W=N_P#7S*]G(Q)%
MO(8D1S&ET QS,^W<3G#*W3[NT'!!&TCC.3/:6\MSL\Y)IYF7$KP2#RD;.!\S
M=21UQNQVQ6A)X)TIT"$3X(P<,N?N[>N,YQ^O/6I/^$.TOSMX$N=V[&$QG.>F
MWU/Y<=*7M:=K7?W?\$/9RZG.6NAW0FNS9VYMV#!)%C V/R3@!Q@\_P Q@CL]
MH=9MY&9XO.E;"O)/;.[LN<XRN4'7'I711^#M-B 53,5 QAMASP!_=]OSR>]*
MWA.QW^9YDV<YQ\N!R3C&WIS^0'I5_68MZZ_+_@B]D^ASTIU.YC$7V&%D !_>
M6DK,'!/S@@#!P?\ "JDVC:A>6]PVH&1X\*[[P%SMZ="6)'OZ]*ZH>$;,QE3<
M7.",#E>.%'''HH_,GO0OA.T#N5GG7)SA=H Y)XX_VOR ]!2CB8QUCI\O^")T
MF_Z_X!SUK:+!;P,L,]I%(X)E1 V!@_,S D@\8SA0,G(/=UJ)0T:7<<:PQG:"
M)8WRO&0H0[FS\W&.H4C!K=?PA;L!_IUX, XPR\9V^W^S^I]:1/"%O&P9+Z\5
MN<$,N1]X^G^U^@]*3K0>[&J4K;&-*M[$J%D#7:KN?<RJY8 X;YOE/&T9&<9?
M@$YID4#W4<8GA>6:1"TD<860(_R\,>%^;G/S \?>YXW3X3CV@'4=0('0&48S
M\O\ \3_X\?6@>$D5-BZGJ(7T$W^]_P#%?H/2E[:'?\&/V<NQR-OH1AGNULK4
M1L,+,CQQOSU]?4= <^N[@U8GNM4%PSW5I#<RNAC9I]T2^63DJ%8#GMZ=.M=,
M?"I+#_B;ZF.AXF/8@_TQ^)I&\)L5*C6=348Q\LQ]"/ZY^H'I6CQ,9/WG?Y,G
MV4NAR[.7010Z39*O$@*2E)1,"<."O8!L8[>N*273K[48)9-2+%,*\DJ6HC8[
M,XRS@=B?N@YXKJQX8F#AAK&H  YV^:V#R#S\W/3'T)IC>%[@1;5UR_'RXR78
MG[I&?O>IS]0.U'UB"V?X,7LY7U3^]'.V=E:6UJCP(EJ)G"B=K=F'?DN0 !D=
M^<X^88J]$LV";JQ*HSA9)9<*#'P26?C?WQC)RH(-:P\,W7&W6+D+G)7YL8W
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MQWK2\]'MC"Q7<HPPDC8NJ]2K=,K@?ZOK@'#$]88DGBM3%_9VLDDE@$$B@<9
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M+E2"3PV:8ME:D ?V1?D#INLQQPO'*G^]_P".GTJ];-:0, -*U$E,\!-O][N
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MH,<TP#8O< _45&(4SRBY]=M34T9)S0 WR8^Z+_WR*:;>(L<Q(?JHJ:DS\V*
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M#0 C_=HC_P!6OTI)#\G3K6%_PF.BQ3FV>Y=9DD$;HT3J4);:,@CC)(^N1ZT
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M;</*(OE()7S"=IVH2P0;A@\9W'T:=93BHV.:<.5WN17BH(BL?F#4U$0L?)D
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MY:GYDM;EXC$\GE S1SI(=@=(S)C&<$, W49PPQP*MR33[B6ATW@L_P#$ONR
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MAK3Q%;S?\(SH8BFD"0N/$$FV0YX"G9\QR.E.?P?:K=K:MX/TKSG!*1G7Y S
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MM ",<8]*7MQ0V>PH'2@!D9.X@T_.1QQ]::G?ZTX$YY% "CI111GG% !1110
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M&W9X\Q\'/&>,8%*U[I<5I':+\0KO[.D)B6'[ Y"H5"E3\W((['//(P:2 T=
MN[WPU<Q2QZ5<W$XMS#=P>:6*XD<@*<8+C!+ #:%&<[B0:=XKWUW->W<<Z%KB
MYDNWM)Y#&/W( \K(^?)4;>!EE((QC#8]2L(K\WJ?$22.<!L$Z4^!N8,Q W8)
M)&"<'@>U#7EBT0+?$:1R"-DDFE2NZXR5P2V<@L2">F>*& :QJI\K39;JTMXS
M! ;)_/D8B6*-HG!5@"=WK@$ HP/!J.T1KBXT^YC4-'Y\;QPW%P(FCD4%@Q/F
M+\N#'@8.,$A555!DFT5'U&WT^^U.\U2VCTI;RTF@@\HQH,\.6WD+\H.>3N;@
M5I:#I>@W]T@CU%K2=[O:MLWES1W@10Z.@9!@8? )&0-RCBF!ZL"/7G/>I!R*
MC3D9]3FI <B@!2<"D&.<4M-7J: '8I.<^U+10 QL$8]Z0<$4Y^E(.M 'DGV4
M2^#8EC2(\N OR[2=J<?+QT&3]#FM:"UBUOR-4^V+%=D%HXP 3;"2,&%!Q@G@
M'G/WOSK6#W+:';)+ 3$Q),C[MWW"6&&).#&&'_ ACIS5M7NK?0=2B\YUO=/N
MX1!N&21@K$ .^&R._P!TCFO6U;:3UO\ @SDZEJWDDOAJ%U)'Y;%)YC&6+ ,L
M?E')]RS$>V!VIUV-2ATFWU%/)-C D43C=^\() &05PW+ X)QAN .IDB>>"WN
M%$(F>2V=IY=V,,1DD>O!4$CN#QSPV[FU"/2+.]2"(Z?$D,4QW_,3D ;E(^8
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M(K'/X8]Z[!-:\1D_-I%E@GDK)<?_ !BD@.KXYXH7I7,-K/B15R-'LOQFG_\
MC- UOQ #\VD68/I]ID!_6.F!T4@^<<UXK8W=UHDNM:FVY]*U"XN;"X5 #Y<N
M,QM^.\C\_:O0WU[7 YWZ-;#'<71_^(K!2U8:/?Z4=!1[2]E,\H.HC<9"5R02
M/EQM!'TI,#+D'_%#^ E&!_Q,HAR.,;VKH]0 /QAT3&2192YSGCAZH3VWVCPU
M;Z'-X<9[.''EDZC'O0\X(;/N>WX4W18FT/49K^+0[NZO'38+B[U6*1@O'RCI
MCH*$!R.GZL_AS5-8U8$B*Z>^LUVCI(FUT/YMBM+PMI_]E^%_'=FP'F1:>BN
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MYFF'_M049D(&-X^LDO\ \>H\EMV5@0@\\J ,^^(:>+>0JN;1,G'3&/\ T13
MX[Q0I?3?%(SDM+9*#DGG:WJ2?UJ]=K=?V]KHMRP4V%JC)L.Q\*&P[ A@,;AA
M>3N]N:?B16CTOQ&&A"L;JT79_P  /LO\A5J\M?M'B?77,H"Q6UIB+RU:25BB
M@>2Q&5<<CC@E@"5X(74"UX1\3FUFL=*-_8W-@[2!9%,C/'EL1Q@8^5<\+N_A
MQTX!]%D^^*X[PEI#W\=EKE]?>=.HF40*B;%)D).[C.\$9/. V<5V$GWP:8#V
MS@?6G#J::_0?6G \XH 7/.*0]*/XNGXT'I0 B=Z1.K4X?2D7JU #J*** $;D
M4M(3BEH 0CYA2TG\7X4M !37^X:=2-]TT  Z"EI!T%+0 C9QQ0O04IZ4#IQ0
M UOOK^-+U%(WWQ]#2B@!%(I.=HXIP [4#E1]*  ' %+1@44 %&:*,4 -;]*&
MXH8C'6ANHI,!H^M*:2D;'J120"D<'-,_B ZT\XQSS3,C< .,>U/J!)11UZTF
M*0 #12T8YH :WW32C=GM2-RI_"@#DD'K38"-C/7G-2G[M1;>>3WJ5ONTP&]L
MBE7.*0<CJ*>/:@!I^\*<.E(>N:4<B@!BC.?K2KP#D8I$[_6G#IR<T +1110
M4444 -XW=:;AL=<BE/WO6ES[4 &T'FE! &!0#GM1CTQ0 C#C.2*2/[OMV-.8
MX4TV,D@T .) &32$Y4TI&12/]TT )%]P4XC--C^X*?0 U>AI<\THQVI. >U
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MB&SU98YKF62>U>1")W(1&8G!R>3(<[1P,=330'J"\@'UJ0# J)<-C X!J6@
MIJ]33J:N<F@!U%%% #6[4@ZBE:D'44 >4:1',=*@-F@=@8I"%<+A!Y@8@ICH
MS G'0LI/0UIQS01-&QD>(M'"SLI "'&9'QC VC<R^C;_ $ -'3[F&+2=-25/
M,G#,5$RL0P*X'WN?O;./RXQ5>.9)M.U#7=Y_T&YBCA/L,-(?0L2P).#DKZ&O
M5Y>9Z[7_ #.2]M2](EXEI>&2%HH65%MF3(+,"S/]"!OR1^.3G+[J^N(]*M-]
MB[Z88X!-*5+1LXQMS@Y7D+S@\X^E*T\+([+;$L;62%9HU(4[L-DMU VA5SUR
M']#4=S?O#I=I:36DS6#I )&*L8G<!2!NZJ=R@<=2,GD\I)MJZ_JWYA=$FI2Q
MSS7<85XT-O;2EY8_W<8 <!6?#*H^?<"5(!4Y]:JV.F)=6T\UG$+^>-&,L=G<
M,%F.T8CDE&%*X5054$L1DD XJYJ"I+JC36<$)N1;1&,A 72,AR6^ZW.5C7."
M5'3&<U2CO?M:S6PFNY)XXW\ZXA9%EACP-S!QC>%W8*L"#C(P<"E[W+[I76Q'
M =0O)?/'VC[/%+LBFB5S",'E51 /+.-O7.TEOF+# V;/PQJ=S>F^DFCC#^4S
M&=&8.RH4<M <#YR<Y)!QU&:R%LKZUO Z/]IB8A2(HG>*(AAGY IVL4R '7Y>
MF<8-7+3Q)=6%ZEJEW:I Q \N;Y;=&V@R$2\X 8X"KD9W#H!ASYVG[.Q,%'J=
MUI6F6^DV$=M;QHH5?F9$"[SZG'>M =:S]*U2WU2R6:%U)V@N@)RA/;D X]#W
MJ^H&<\5YDKWU.I;#FSBF_C3F.!48Y.012&.!^8#.33Z9TYI] !1110 4444
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M@]:"<&D(Q28"?G1GG -+2'U]*  D<YIG&X<XIS'%-ZN.1R* )**3 /44H-2
MF/6EHH&#30"$G!&?3K2<YQQC%*WW2.U'<8QBA@(_0?6I#TJ+)![8S4IZ50"
M#&/QI1TXIN,^M.7I0 C<$4HZ"D;@@]Z<.10 Q,Y/I2\8-(G?ZTN2>U #ATHS
MS2#H*6@ HHHH ;_'1C@YI<?-FD*C% "_PYI,G''6E'W?PH7I0 T@!3D?E21=
M^:<2>AI$SSG% #CGM3<Y0TXY[4-]TT -B^X*?3(_N4^@!H/.!TH."3ZTZD(
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M",9Q7I4GWQ0 ]N /K2C[QI'Z#ZTX Y]J %I&^[2TAZ4 (O>D489J5.]"=6H
M=2$>]+10 =:*** $_C_"EI/XOPI: "D8X4TM(WW30 #H*6D'04M !110,XYH
M :?OK^-.[4T_?7\:<>E " ]OUHQ\M Z4#D4 (>U.I,"EH **** &L.](1S3F
M.!2-U%)@)2')!I:;GYB,]NE) '8_,?K33C>._%.( '0XII^]_C3 DHHHQS2
M***,T(!"#M/-'(/%!. ?PI<Y&138#=I)'/&:D/2F9Q@GUIYY%,!.@Z9I1TZ8
MH)VKS2T -;J*4=!2,0",]*<.E $:?>//X4\?3%,CQN;UI['M0 M%(,X&*6@
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M &F:Y9[C3(?+D?QGKHC*Y5A;2[2..^<'[P_,4"?3Q*L?_":>(1*[8138S\D
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MDU*PN+^?2[:96D5+!(HU>9L@JQP>"2N\)CY?SI@>B*#@?XU(.E1* ,?XU+0
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M1V;O(J0'<$!1RY&59L#Y5^ZVW:,9K:PCK<317$"S6\2SR2Z<;MIW@Q@M*6<
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M9O96FB37 "-Y,K *-RL &POS#J0>,9Z]14DBQ&VNY)-@ 4;") ^]U!^\V3G
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M.WWI,#:\6WR^,YK6WT*"XO8[7>6>.,@$MCN<#''?%=3H&A7WAOP>]I;36_\
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MW]W#;HQPOF/C/T'>I+#5;'583+874-RBG#&-P=I]".WXUYYX/)\2^+;[6-0
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M6 )Y!QD&M;5-)L]9M6M;Z'S(CR#T*GU![5Q[?"RP,V[^T+@QYSL,2$_GC^E
M&G)XBEU/Q=9Z7HTJO;0;I;^95#*5QPH/U(Y'?IT-<KIEFVD_%KRIFV"2:8IN
MXRKHS*1^/'U%>BZ/HEEH=F;:SC*@G+.[;G<^I/\ 0<56USPU9ZZL3RO+!=P_
MZFZ@.V1.^ ?3_(Q0!@_$R94\,Q0YR\MRNU1U(523C\*R=5L9=-^$EK:W *3&
M1'D7N"[EL?4;A^5=0GA!)KVWO-9U*YU:6V_U"SJJHAXYVJ,$\#KZ<YJSK?AX
M:]"L,E]-% .3&B*0S9X8Y[B@#S;5M!C_ .$&T76;:)(Y3E+A\'G<3M8_3&/Q
M%>BV.J#5_!S7N%5VM9%D53@!U!!Q[9&1[$4MOX1BB\/W>BS7]S/:3#$8<*#
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MO_/C25Q) 0_V6Z$)5VFDE*\CE0' 'XU;DT>_-VEWYCR*-3-PUFTP$93(VO\
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MNMN=Y'JC-@''4DFH;C[,^FF>6".UEDBN6ET^YBXG#3-E$8<B3(7!&<_+QTP
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M?]WU%.N])@LH1)<>(-3ACSL7=,ARQZ 90DGC@4@YBG]MN0H_XF$)_P"V</\
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M1_X_6?93+)I;7MYY,9C:02-':#;A&89'[MO[N>IH UFO=8#?\>UF1GNTP_\
M:='V[5@<?9+,C'02S#_VE6:9[-I8H6+AYF(C!L"-Q SCF#T!-7!;)CB*4#VM
M!_\ &: )1J6K;R#8VF.V)IO_ (S31J6L* #IEB0>I%U./T\BF"V _@F//>U'
M_P 9I?LYVX,4G;G[./\ XS0!(=3U8#_D&V9]OM4W_P 8I#J>K<#^S+/.><74
M_P#\8I@MF .89 #Z1 _^T:06[X "W&.O^J _]HT 2'4]7*_\@RS [_Z5-_\
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MVN3>2>'5)+JTOK=#-''&R3E9/NECP3,#_$:G_M/4=BL-1TS:>?\ 5+@_^1Z
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MY.SV'Y4 5W$@^)L1N'/E_P!GG[-G[N=XWX]_7VQ5/PM]K&B^(VL!(8_M5P;
MYR&.#]T?[V/QS6K=7C7L/EWOA_SU!#!965P#Z_,*EBU2XAC6*+1'BB0 *J3Q
MJ /89H Q?#,NBS^"](%P\9:&X0+@YD%P).. ,[B2">.AYXYJ'Q>]W_PEUD^F
M!3?+I]QY9.2 <-T]6XX]ZT3<6D-VUY%X=2*[?[\RF .?^!;J9/=64]VMS+H*
M27"Y"SL]MO P1P2^>A/YTV4D6/"]Q:W/ARSDLXTC3;MD11@AP?FSZDGG/4YK
M;3D'D_G7.V=U8Z:C+8Z*+9)"&98I+9,X'7'F5:_MP8)^P7!/IYUO_P#':1=S
M78C(JPARJL<Y!P<=\]*Y]O$$8)!LY_\ O]!_\<J6/Q#$,HUC= ,,$^9!_P#'
M*$$MC?CR=W0<U+R1TK!3Q%""=UK<=,GYXO\ XNI!XEAZ?8KOZYBX_P#'ZHS9
MLGH.G%<AJ]IH=OI.HM:WH$PCE(B6])&_DD;-V.O;'>M;_A)("?\ CRN^#U_=
M\_\ C]8]G8&XT-[:;]R9O-R!$I*[G8@C!ZX(H$4E>2>>W8VZW4D;;HXWUSS5
MW;2,[2I'0GM6M;B5W<3Z9;P8QM9)P^[UZ1<5#_9-Q-<VTTNH12"WD,BJM@B$
MG:5ZY/&&-:8BFXPS-P.D" ?A\IH A,<0?BVB.>A*G_XU3&@B!!6UAW8_YY?_
M &FK!BG!!PP/_7%?_B*=Y4P!^23/;]VO_P ;H K>1'N;-O$>,;A#G_VC3S'$
MH $"[<_\^Q_EY-2^3.5.82V>VQ?_ (U3)()64 6YSW^5?_C1H 88$8G_ $->
M>_V4_P#QFA+:-02;8 'J%M.W_?FG&UFYS V">I5?_C-*+9QN_P!'3&.!C_[3
M0 @B #9@?ICBT]_^N5!51NVVTV<=1:8/7_KG2M ^"%A7IZ8_]H^].-N>ODQ
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M41U#*(I&+&) .G$+9_/RJ8"NA?Y=DP';*8/_ *)IJP2%MB^81]>GY14+$CJ
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M_GYE67CE56W$<IG@MZG_ &:K!9 ,^8G3H2WM[4%Q 3LH )NER.<S'_X[Q_\
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M,8S#Y'[J7GJ-AQ3B6&,1S8Z_+&<?SHD@VC 63G.!@\?^0Z=Y;!=HR/KGD_\
M?%&H"QN0J@_:4PO0$@_^AU95SG[]R._S.1G_ ,B5# CJ!]P<'@[OY8J91)P0
M8OQ+_P"%,A[@9F#!U>4D#./.&/\ T;BFF5-@_>R'';[21CZ_O>:4B7J?L^/K
M)2>:Q. 82WMO_P#BA0(;]H5SQ*3SC_CZ_P#MU!DC=3F8':>2+H__ !VI#*X;
METQ[!O\ XNE$I(W!^>G\7_QR@"MNB.1YR\?]/)/_ +6H!MVPIE3=QG_23_\
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M%K).;8$&Z812$EAN[Q1%'4A^<$'(!^4]"WU.:RNUO4GN[6.[E=8I8Y49Y&P
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MI3"S#>T 9N.67G_T338#MC+@!+OGTCQ_[)0%;DXO!]<C^E)Y&!Q!&!W&P_\
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MSF-,Y_*G%)2,_/@]_*3_ .(H K-$@D!%O&N.>(#_ "\JK(A3"Y@!]OLQ./\
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MN[^:/_CU,:;Y<"YB/; N&_\ CE(KD@?Z3%]!,V?_ $;0(D:Y;'^M?'KYR_\
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MEA;KD<\6O_VFD!*(,#@L,^KG_P"-TGE,%R64G.>7/_Q%,,*!CM@?_P !.O\
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M_P C4&XD#$>9+C_KH./_ "-0!'OMQS]IA / !F)/_HVF));K)AIXNF/]:?\
MX[5G[0Q ^>4?68?_ !ZHTG+'/F2]!@_:!S_Y&I -,UJ6 %S#_P!]'_XY3DD@
M5.;B+D\\8X]/OT\W )4>9)GT^TC_ ..T"Y\SY2[@GM]I7^DM# "$P2+A,#T7
M_P"RI5)*D>=D>OEKBD68,P^]D\<W(.<_]M*4M&5Y3_R9''U^>F Y=Y8G?G/_
M $Q7K^5(PDRO#,?]F-1_[+3 T!!.U 1ZW(Z_]]TUQ;-M4I'G.!B8'_V:@"8K
M,< PDGJ"4'_Q% AG$FXP,1Z$+_\ &JKL+==N @[]<TJK:.<8CV]>4SS^ ZT
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M<9&.0,_^/T!K@. 3(??S%Z?]]5&T\:X_TB+'''F__;:436[,?W\(^LV?_:E
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M4V\8'IY1_P#C53VUHP7<"_')S"I'YXILLLR[MJR-[F-<?^@4R7J.Q'&@!@4
M]EA9OT\JH-@F8J+90.Y^S'G_ ,@T/%/R2K,<=E7_ .(J2*VFVG$# L/1>G_?
MJ@-A1$I.[[.23US:'_XS3Q'AMWDO^%K_ /:J8;>8-S;9'N!_2&G&!B IMP1Z
M;?\ [302#1Q8/[B7(Z 6?_VJB-%"#]S<9Z$?9?\ [7220#&/LT8^B$_^T:%A
M 5<V\>,=?+.?_15 #_+..([D?2(#_P!DHD7"XQ= 8_N\#_QVFO%\Q/V:)F)Y
M+1G_ .-4TJ_ :"+/IY+8Q]?*H E0':I+3K]'X_E0'Q\HGGQT_P!=C%"1-LXM
MX1S_ ,\FZ_\ ?ND"N!\T*$^OV=C_ .R4 *Q82']^^#ZSX_F:4R#&!<C/3_CY
M/7_OJF[9,8$/0=HC[=MM+SLP893GT@/Y]* *\\I$@(N8O?-P>.?7S*LK(Q0'
M[1"/^VS'_P!J5#.2LH)2<>IVG^6:LAV.TC[6/3K_ /%4 0-)D9-Q'CU$[#U_
MZ:TL<QQS<Q'VW'/_ *.I3(1R6NCSU\S _P#0Z(Y-V%\^XY[M+_\ ;*74 :X
M) N(S_P/_P"VT@EXSYZ?]]'_ ./4^5@N!YTH'!YN".<>\M1F=,DM,^ /^?O'
M_M:F WSGY'V@8XZ'G_T=3A-(6_X^1^F?_1M1FYC7_EN03Q@WG7_R-2^>F/\
MCY7W'VH\?^1J )_/F(XE;(]-O_QRD668G(=L'U=?_BZB\V,*2;A.O4W)(_\
M1U)YT!8#[3#TZ&<Y_P#1M %D27!49+>P,B__ !51L9">8RS$<CSEQ^'6FF2W
MP#Y\//\ TT/_ ,<INZ++%;B/ZCG'_C]("7<S+@VYX'7SE/\ 2HVC0\FU0CDX
M+Y_]DI<J6)%U'CKM6,?_ !5.))4!9^^!^Y2F W$18$VL/H#DG&?^V=5M12%8
M+<+#&A^W6G*9'/GI_L#^=6L2=/.(]?\ 1EJ#45E$%OO9L?;K8_-&J_\ +9/0
M4 =)']P4^F1_=!I] !112 YSQ0 M!.!DT44 ,8YQ@UG:Z?\ B0:@1S_H[_\
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M/IN &&!3J "BBB@ HHHH ;_>I#]T4O\ >JEJKWB:>6L4+S[U'R@%@NX;BH)
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MP,=RIS^3TQ;:HHL(-V,(ISD83J>W:ATAN+.2WEY65"F[R3D C!/W/>M"16<
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M0?7K3M'T#3KO1X+B22/SY%YQ,01@D?\ /0>GI5?PU<RP:M>6$5T9;;#E&,A
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M_$5: *J<^4<C/);C\A5*2$&0?N')'0_9>?\ T55H!2Q_<S9)'/V;&?\ R'0
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M_+.8D''W6 _]%T**03Q=62:D]_)%<DOQYK 'GYKG'_M45)OBC) E7/O<\_\
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MMUSGG%I_7R:L2PJ8BODN.F?]%P/_ $559(9?-0+;-P>A*X_]%5/+!)Y1S:@
MXZX]?^N--">Y76 @<1S# ' @(Q[9\H5:CB 0;4NA\O418S_Y#JNL*A?^/55;
MCD)_]KJ<)LC!^S0X"CG8?_C5"&R!@=S!C=#+=\Y_]!%6 ?*@.))U9NS3'I]*
MKQ0 N6,46!R1Y+=/^_53-$TI"BWA7)X_<G_XWQ0T 1H>6:9B/1ICV_$4UII7
M;B6,X_Z;MGK_ -=*?*K+%L$"_*.<1<G_ ,=HC!12QAESV'E'C]*8!)*8 H::
M/<1_SV;_ ..5&KF1C^_0 ]S(V1_Y%I9&E=L!;H>P0C'Z_P"%*\K; BO=JO\
M$Q+#/_CU $8NE",J2J%/4ASS_P"1:?\ :=F2;J-F] >G_D:HQ*R@XEN=Q)Y#
MMZ_[XJR)-J9DGEW \#SR/T\V@9$C-R[72]<@$]?_ "-2-<S2'Y9^.@4;>O\
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M#A!] W/_ (]397?:$R0"#V)_]J"G,&0XVWH&<?*"/_9:1@S$;6O%].6_^)H
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MTY"9^TQ^G4__ !ZHWN?+1R;E.#TW?E_RVH$,1K4LJ%(< Y^\/UYJ0_8L@?N
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MK1>7+$VPH&&U/L[KM.<<_NAGW_0=[._6S_KY#78[?PV /#]@  ,;N!V^9O\
M97^0^@Z5M'[H_P!X?SK&\.L&T&Q;U4_^A'_:;^9^IK9/W1]1_.O+J?'+U.KH
MA_:FMU'UIW:D;M]:D!:*** "BBB@!DD4<L;)(BNC##*PR"/>LQO#VGJQ,*7%
MN#_!;74L*_\ ?*,!^E:U!Z4 92:%: \3:@>_.HW!_P#:E*=!M=V1<:B.<_\
M(1G_ /BZT5X-/I(#+_L*WV[1=:B/^W^;/_H5*-%C P+W4/\ P+<_S-:=%,#(
M;1DW8-]J XZ_:3S2?V(I7_C_ +\9_P"FH./S%:;YW<^E/7[@^E &2-"48QJ-
M_P =MZG_ -EH31<AL:C>CGTB/8>J5K@8'-,B_C^O]!0@,G^QB,*-3O>?]F'_
M .-U(-%8<?VK=GZI!Q_Y#K+\13&'7-$0S7BP3O,LT=L\F7"QDCY4YX//%5)9
M'DDT)[>[U%(+W4'1HY)W#A CG8<G/WDSSR,XH WSHS*,_P!IW9[_ .K@_P#C
M=1C1Y#UU2[(QC'E0?G_JZ=>1%_$EG'Y\ZQO:3NZ),R@E6B"G /8.WY^PJIX1
MEFN?#EM<W$\T\TI=F>5RQX8@8]!@4 75T>3_ *"MUUX_=0<?^0Z8=%=L[M1G
MY/\ SQA_^(JMX?,LNKZZLMQ<2);W0AB5Y2P1?+5B ,]<L>3S526^N-!UF>WN
M7NKR*]3.G_O"27SS%[')!#'L.O% &M_8TF,#4IL8Z>3#S[_<J*+1FR1_:#GC
M',$/_P 35[2[.:RL4BN+J2YG(W222-G+=P/0>E<I>ZC?07>NI;7MP;FW:+[%
M %\P,S+DH1@Y!/7T'0B@#>?1'\S_ (_V''_/M#_\30-#?9@WRL1SDVL6?Y52
MUK6;RSDLYECV0VQBDU+ SM5_EVCUQRQ^B^M6-?N9[:?1OL]U)$MS>I!($(PR
M%6/<'G@<CL32 D&A2CG[>".>#:1?X4IT.;O>QGG/_'G'_A5*Q^W7VK:S;+JU
MW$EI*B0@+&0N5W'.4);GU/2KWAW5)]3L9ENPGVNTN'MIS&,*S(<;AGIG_&F!
M&VCRJR9O(L9[V<?^%,DT=]X87\ /M9Q\U'XKU>ZTVVC:RC9F@Q<W/R;L0*P#
M >YS^2M5?Q!<7RP6=QI,HDEDE4+!A-DZD%L9(R"0."".OXT%))EMM.G!VM=V
MP)Q@BR0C^=*=)N4E66.[MR"<Y%FO^-4X+TZM)I,UG=S00W+2)-"$0LC(N2K;
ME.&##![4:0VLZAHLMU#J6ZY2::-(Y8(_*<)(R@$* P)QU#=>W:@'9;&@NF7<
MB9%[;Y'K9CC_ ,>HETJ^RF;^W(SVM2,>_P!^DT75AJFDVVH1J8UG3)0\[3T(
M_/-9]OK=W;:W<Z7J4OFV\DXBLKLJJL9-BN8VP,9PWRG'./6D@:L:']FZE&21
MJ,)4<8,#Y_/S*CBM;\F3=?Q \<^5+_\ ':H#5[X)86"W*RWM]<3J)G1=L443
M,"V%QDD*/Q)[#%2/=7=IK-OISW.]-0#K#.T2[HI%&[! P&4@'' .1W[""VES
M3_L_460;=0A(&>=DW_QZD73=3&,ZA <=/DG]?^NU9NDZY<SZ5/%=>7;ZFMNT
M\3;<I-&.5=1GIT!&<@^E=!ILDTVFVLT[*\DD2NQ5=HR1G@?C36I)0;3M3"\7
M\&<_W9^G_?ZF_P!F:H5Q]OMSS_=GZ?\ ?ZFZKKQLM>L;-45K9Y!%=2_\\W<'
MRA]25.?0$'C(HU?6)+'5["Q:XALHKE&*W,T9=7D!&(QR #@D\]>@H 8VFZI
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M3[E6=7U.32].6\MXHYU9T1E+$9#D '/IS26>IR3ZO>:// B7<$:2JP<LC*W
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M6B*U\,W;F.TMM)FD W%8XXV('K@#WH$P1)L9W$CL/(7I0(YATWG QGRD!_\
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M;.:$6M[ C2$VW%RT9);+D_<W=PVXL3G:*@MF74;VPN//G#07D)9KB3S2%9B
MJ%2J@%EPPV]P?F%7S/EMTU_7\R=+ENSTG3KR_N]1ABD:&TD59=WWONA@3ZJ
MWN<=^U5+N%GTF[(+<W=P.%V\[D)Q[[=Q]^:NV6DV%]JMU>P[_LUK*$E S\QP
M",CH5 /7KC-,,KK:SPFTD*?;)9?/))7=SN4C_<#_ (D<&B[YM[VMOT%;0BM=
M,GUZ>/5U984E#>3%,"4*)@1^9DG)Z\^IS_#S!:NU_/KUUC;F&9F7!R'2+8<9
MS@%FDP/RI]K>7-KX>UOSW$QLC;VT,+CC8C?*K8[X)!]\T60N(M-U)3",26LA
MN9"W +!V. 3C&[(/^T&Z8HE?6_31>FX1L=[X?.[0[$X(X;KG/WF]0#^@^@K7
M;[HQZC^=8WAO:= L"I^7#8Z>K>A(_(FMEONCC'(_G7ES^-^IU]$/[4C=OK2]
MJ:W;ZU("BEI!2TD 4444P"D8X%+2-TZ9H 1:=35IU) %%%(Q(4E1DXX&<9I@
M1N/G-/7[@^E8YOM8+?-HT8^EZO\ \33EOM5*X.C=NUVGK]* -:FQ_P ?U_H*
MS/M^J;L'1' ]?M4="ZAJ2EA_8DY!/47$7'_CU) )?:7/>:MIU['<QQBS9F6-
MH2V[<I5LG<.QXXX/KTJ75M)_M-+9TG:"YM9A/#(%W ,,C!'<$$@\CZU&=1U
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M-[?3%FD.C1*EG*'!_P!(0!B2/XCM"K_P)Q]+>KZB-5T[PYJ5IMQ<:C"\2NQ
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M\3_\<I!;:[VU.Q_\ &_^.UJ+UI1C)I(#,,&N;?EU"PSZFS?_ ..4>3KG_/\
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M$_\ QRD!6^V:HC_\@60D="+J+G]:DBU*_.]AHLY/HMQ"3_Z%3FM-<+?)J=B
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MZ?-&)(;16NHE(!,D>#\OOP8A_P "-7]/EFT'4M%\/PVMN8Y[9I9Y!PX=02_
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M[V21;8K]KE:$LQ5?EDYW?*>-WH5;<7QP,BOH\WFPL+F6\_M-GC2VBC7<\D)
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M.T#/#;@/7@&@#K!TII^\>,UC3^)K2WWN\-P+6*86\UT%7RXY#@8/S;L D D
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M%: ('6O/:L['2M@;--P1V'XBG-SBFX]S2&&#G(/%24S&3[T^@ HHHH ****
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MN+,Z@T,"N\=E',63)!.U4)Y]AG&34$?BE)M<L[6."8VUQ;-+G[-)YBOO" $
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MBW!MDJ!UR.AP>]4[/57NM8U'3VMUC^QK$P<29WA]V.,#'W?>@#36G4U.E.H
M**** "BBB@!AR3]*RO$98>'[LINW87&W.<[AZ8/Y<UK'CMUK'\3X'AR]W!2N
MU<AL8QN'7<"/S&*NG\:]12V9QZS1Q:?;H)W"36,3O"K842*JY9AU^Y@X[[ .
M<X.9")4@M=0,@^S:BTD,<;_<0)PO']TA&W<_=  ]Y-4-O!9:5'M\LSVULDLB
M?Q*Q'/'0 1D\>@J]KVF0VGA^W$LAA_LV)GBCB8L%E9MT0SSN R<YZ[>>M>E&
MR:7?^OSL<KU^0Z]N(I)"1<R-*L]J(DE8;DC&UC@X]9,'/)([YX;<:39C5K"*
MS\N*]3=]K_?Y#C'!"Y)'(SC QS]:0RPR:3#,%!/VR$AB<-L9B=I/4C?Y@ ]J
M272H%U2Q2PFDCNU+?:P]SNW8 PP4GCGG@#'-*/NNU[;^GS!W:*LTJW\UU;QN
MT;)=7"@1JT[,#)N.4B.\8?=C*E2#R.!4TMGY6ERZM90P"6#;&TTJK'+&O"_(
MG)5^GS.2YY  R!4.IWD;7-^LETJ1_:I&E!9DR!)M!.UE) 4;1PV"K?*=P-)"
M6UFT6X:%W@@EBB5V?=+$[8(P6/SIRI,;'C(VMQ@.SLGT_K\QZ:D%A872K!/*
M84,CLRM')$#(N %)\QMX92&.">&;)).5KJ=-\$"%97NKI4%P&$L-I&$#J[;F
M1B<Y )(4KM./TY.S,&CSR01:A!%$TA#R%U)9BBIL=6;S,*R[MI#9WD?[5:FD
MZSJ=G,$66Z\MT:2WMIE\X3J&_=QQX(V8C*@DDY)![&IJJI*[@PARJW,CTD?=
MZ \4J@ @56LKR.^MS)$&&&9&5QM96!Y!!Z&K0ZYYKS-CJ0K8Q33R.I'TIQ[?
M+FD)/48H :>7%2U'^0-24 %%%% !1110 W^]5+4+X6,,?[MY9)I/*BBCQEVP
M3C+$ <*3R>U7/[U17-M!=VYAN(8YHF^\DBAE/X&A-)Z@SS"[U74[VX99Y9Y1
M:20"]@D=8]AWGS8U5/ED5EX!;/ Z\FH9;9-3CB$^I074$T@,,DC.Q+[2N%4*
MK9;<Q/S#G:,X%;>H>#9X6@E@BM[JVMEB4(J>6ZQ(P+(%'$C,,9)QG;C'-9=X
M-3LI&O8C+<!_DG<JXB52H'SB0A"2XX!P #@XXKU83@TO9NS_ *_K\#EE%INX
MR[N)](M5F$+Q6MSYP1U<&5F4DNTC#M]YA&IV_*<D]*=I$Z/+IT4DZ2NTL3PC
M<7V@APY!9F(#9C49()8 X4TU['S+2*YN+<QP_/\ 9DG?;"P+YW1NWW0^ 3&Y
M'!X)'%/TQA%>Z=%-<Y=IQL!<3;&V2 Y9,J';>BXSDA2Q[8).+CIOK^HM;V+V
MF6E_;ZE=V\%_"+&2<&<*H(W8 P"1D,0 <>PP?6O<H#HSN8ED'GW'RY^\1)TZ
M>A8_A5C3+74++49[6"[A^P37 ,R[58[@ .&SP3@'&,C YJ&%[J33Q')"AMC/
M/(&+[F5@[[A_N[,C&,_-UXHO[[?I_7J-;$EKI"W\L>MW,PM;B:%I XP%A!9!
M$!CC:5R/<%O7C/TP-<QZQ=O R.ZS;E!Y#$JN<C')*,>/[U+;R2V7A[5P96>]
M6Z@@A#D.0JGY1SU 7*GL<'M4UM'/#I]^A:+R!;?O/, S(/F!/3'W@1SP5'(.
M1AJZ;UZI?+0(VZ'=Z(<Z+8Y!SM.<@@]3Z\_GSZUJM]T8]1_.LG01C0M."A=H
M3C:01WZ8XQ].*UV^Z,^H_G7E2^)G4MD.[4C=OK2]J1NWUI +1110 4AZ<TM<
MWXZ1Y/"LZ*R!3- &W)NSF5 ._K@]\@$=Z .CP*1N!7/P3:C>W]]8?VBL4UBD
M:F2*W \QW&X,5;.% P, YZ\^EW0-2DU?0+._FB$4DT>75<XR#C(SV.,CV-)@
M6[J\MK"W:YNYUAA7&YW. *G0K(@93E2 1]*X"6*[_P"$?\;&2>%HVDN%91 P
M)?RD&<ECQC QC\>PUAJFHZ1=^7?3074']FRWBI%"8V0Q;?E!R<@ANIYR/PH0
M'5X%&!7.Z-J.L73V4LUMOM;FW\V63:J"%R 5"_,2RD''KQG/8:&N7TMEI4K6
MZ%[N3$5LBD M*W"]??D^P-,"TLL<N'BD#KRNY6R,@X/ZC'X5,!\@ZFN0\-B;
M3;W4-"\N6#:/M5F+DAR4?AL[3@@/Z'^(52O=3US4/!AU&5K*&&=[<1BW,BNI
M\]5))ST(QQZ9Y- '<EHV8Q$J6QDKGL?4>G!J)[FVM4+7,\4*,P13(X4$D#@9
M[^U<O=ZK+HNM7UW?V=D\\>FHYEMT96=C)M"%B3A<X[<?A2^(5U0Z+>+J!LI(
M_-MS$T$;*4<R ,#N8YX(P>.O2ET#=I'6 <KCM3A&AR2BDGKD=:Y>Y\27KWE^
M-.M#.ME<" PBVE=IVPI;$@^1,;N-V<XYP#4]KXBFF\0MI\SP6V)I(UMYXG62
M10#M='SM;.,[0,@?2F!O&WA1G=(8P[_?8* 6^OK42VMNJ"-;>)4W;@@08W>N
M/6H=8U V$=LL<:O/=3K;Q;SA0Q!.3[  GWZ5S7B'6+Z+2M<TZ98EN8+(3K<1
M$H&B<LI.TY*L"I&,G/J* -6+2YFEOWL;BQFMKM_O2)O,)"[-@P<%1CA>,9-:
M&FZ39Z9;6MO#&K-!&$25E!<@#&<]:DTFW^S6"1FSM;,@D^3:_<'T^5?Y5R4<
ML.@W7B_4[+3[4RVLR8&!'\IAC9@"!T)YQW- '9FPLS"\1M8#&YW,GEC:Q]2.
M],6TMI8Q#);Q-$N,(R J,=,"L@^(;JQOI8=5M8(8A927JM#*7(5" RD$#GYA
MTIKZWJ%G:B^N;" 6LD*M&$G)<2,5"(W&.2PY&0,'KQ2 VFLK7>S_ &6'>S!V
M;RQDL#D$GU'K5D<BL"ZUN]L+HVMW:P--);23P-'*VQMF"R'*Y!P>#W]!51?$
MVJC3;.^DT> 1WDD"0(+OD^8.I^7 Q_6F!T/]GV<=P;E+2!9\D^:(P'R>ISUH
M73;%/-VV5NOFC$F(E&\>AXYZGK6)/XFGL;NYM-1L8XYTCCD@\F;>LP=_+ R0
M"IW$#H>N:ENM?N["XFM;FQB-P+1[J#RYSLDV?>4DJ-IZ=B/I0!IC1]+4$+IU
MH 5V'$"C*XQCITX''M3TM8+5!'!"D:%LD(,9/K6/;:_J,NGQWL^FVUM#-Y9A
M>6]4*0RDDL<<<@   D[ATYQ0N/$5Y?V&E75G;^6\NH&":-900=C$%0V.5..N
M.E '27MC:7\:Q7EM%/&&R%E0, ?49J.;0]*NUBCN--M)$A&V)6B4A!Z#C@>U
M8D.KQ6E_JS26TRW!N[:'RS<F0/(Z*$"@\(,$9Q[FKMQXADL)[RWN;,^?!:&\
M01R;EEC!PV"0""..,=Q0!J)I=C'=K=):0K.J[5D5 & QC&?3VJO/H6DR&9GT
MZV8SOOD)0?.WJ?>JUIK\\VI6EK<:>8$O(&FMY/.#YV@$A@.APP/<5I7]TUI:
MM*L)E(Q\H8+U/4D\ #J30!770],\R60V,/F2KLD;'+KQP?4<"F-H.E3+'$]C
M"4A4I$-N-BGJ 1R![5F_\)<D>E7=Z;!V>TNEMIHXI%;)8J RMT8$L*L+XB2"
MZOH=1M9+,VMM]K/S"0-%DC(V]P5/% %J;0-)N"[2Z= Y<#=E>N,8/UX'/M4A
MT;3FO7NS:1M/)%Y3L<G<F,8(Z'CCFL2YN+B7Q;H+203VRRI<?+]HR& 0$;D!
MQD?C]:TO%&]?#.HO%++')';LZ/'(496 X((YH ?::)IVFR;+6U2'(VJ0Q.!Z
M#)X''04R[T^UO52.\@658I Z D@JP&,@@@]"?K6':RS0ZWI42-?6Z2VKEHKJ
M9G%VX4%0A+,H88+')!QV/.-&/7O[1LK.:.QF\RYN&M?*WH&0KG<3D\8VD^O'
MO04GW')X;TN5/(%FBP^9YQ5&90'_ +P /!K1FT339I;B26T1VN(A%-N)(D0=
M 1G!Q6!X<U"6RT3'EW=XQN[A%+/N("R-]YW; &!CD]:THO%-M<)IKQ6TS)J$
MAB1LJ D@SE6Y_P!ENF<XI()/4M6WAS2[*>&XM[=EFA4JDAF=FVGL23R/8Y%7
M;RWAO+*6WN%#Q2H4=2<9!K,/B:UD@>2UBDN=MY]C*QE<E^Q&2,CW].>G-2VF
MM1ZA(4M[>9X-\D?V@;2@9#@@\Y&2#C(YQ]*9(V'P_IL,UE-''.'M 5A)NI3M
M!ZCEN<^^>@]*)_#.E312H]NY$EQ]I_U[@I*23O0Y^0\G[N*M7M]#80PLX=WE
MD6**-!EG<] /PR23P ":Q=?\4BST/5&MUDBU"T1 T;Q[C'O^Z^1E2, D'.,C
M!YXH W;.SBL+?R83*R@[BTLK2,2?5F)-5;W0[&^EEFN/-*S(J3()F"2*N2 R
M@X/4_7H<BG:0J1Z7$J->D9;'VXDR_>/WL\_3VQ7)ZKXDNK[PYKCQR7%I)9W#
M+%-%"\8V*ZKABW\7)R.#TXH W9M(L3+?'9,5U!62X#3N0X(V\#/R\$CC&!4#
M>#])EAE-PMT4FMQ;R)]JD =!G;NYY(R<>WT&)K;7;,W$\4ZW%N]M!YY^TQF,
M-%TWCVX[X(]*?;ZS%>W$=OMFBEFB\Z%98BHDC_O#\QD'!P>E!IHQB:3;PZ@E
M^DEU]H2$0$M,6#(,X!'3@G/KDTRQ\-6MO*TL,MY#"S-)]G%PWD[FSDA?Q)QT
MSVIFLW\MI/IMA:.B7E_,4$K#<(452[L!T+8&!GC)_"G"UU"&XAN#K,QLTW&Y
MCN]A!7:<$$*-I!QGV].X'H6+/2[;3YXYQ/<W4T4'V>)[AE/EQ\$J"%&<D#).
M2<=:74]*&NVJV]Q/<)&KK(/)=5^8'*G)4]" <?GFH8==L7D@55N/](0R6[20
MLJS*!GY!C).#G!P2.0#54>,-'GA>0W4QAC0LS_9)=J@-MY^7@YQUZ9&<4"T1
M9O=!MI[Z*^6[O+>_CB\DSVSJID3.<."I4\\].OX5E36LMQXUA1)-2A2'3O*6
M>+/SMN#;6=E(/'.?7OGBMFSUK2I[H6RSR"?RS*JSQ/"'0=64NHW+[CZ]*FMM
M<T^XECA265/.0R0@V[H)U R2A(^?CG Y(Y'%(3:*4GA:W/\ 9Y2XN+-;!R\"
MPLC9<A@68NK%B0QSD\YSUYJ63P\HU2:^LKV]LI)]OV@1E"LNT8!PZM@XXR,=
MJ6U\6Z#=%Q;WQ<*@=CY,@'WP@&2O+;F V]?F''(J/4?%EG!HDVI69$YBG6W,
M<@:)ED) (967<" <XQ18.8L2:"ES=02W=U+<107#7,,#JNU'.X=<9(&YL#/\
MA4>F^'WTA5BM=6O3:1@B&V=8V$8(.!NV[B!G@$]AUI;76X;C5[H)J%H]C#:I
M*5VLKH2S9=G/R[<#\,58CUK39GD5;@QND1E*S1O$2G]X!@,K[C(H),[_ (1B
M.WT6SL5O[@K8W*W,#LB%@020#QC&2:J7'AN*ZDU%9+RX$-_()VC3:#'*-N'5
ML9R-@XZ5>C\1Z1J%U%#9W\$KRJ6B52?WF "<$C!(!Y'4>E7,\\J!^-)FL49L
M^DW5[9-!?:M-/*'22&=8DC,+H<AP ,$^N>/0"KMCH\\.JKJDNI27$SVX@E#0
MJH902PV@?=Y/O4=QJVG6=REM<WL$4SD*(V< Y/0>V>V>M6H=6L4O%L7NXA<.
MP58MW.XC.WZD G'L:!RBK:#==T8:UH]QIXF,"W"[)'";CM[CJ/SJIJ.@'4;U
M;J[G62-K*2SN(HXL;U<Y++EOE.0/7I6U=7MM8VQN+NXBMX4ZR2N%4?4FF6NI
M65Y++%:7EO/)%Q(D<@8K]<=*#*YC6^CZDNG363:O%,/(\E6>UVMZ;F(;YB!G
MH ,\FJDWAR==.TR 7:+=::<P3^3N1AM*[60GD$8S@CD9&*WQJ6EW+2Q+?6TC
MQIO95D!(4'D_3WHAOK6=4>VOK>>*1_*7$@8,V,[01U. 3CVH*31DW.F7E\+"
M66\@2[LYGE0K;$1$,I7;C=D#!/.>IJMKEI8Z?I5Y!?W"O>:KG:JC#RRA0$6-
M<_PG;C\R>M;4=S97;R+!<QEXGVR*CAMI]#CH:DGO(M/V^=<0Q!B2OF2 ;NW&
M338>A6T6!]+TR*VE?S9.7FD/+22,2SMG_>)_#'I2:IH\VI:A:7D,MN$A5U:*
M>$R*=V,.!D?,,'&?[QJW->6*!O.N8H& WG>X&!QR?;D?G45[+<:?:W-S%$KR
M11,X5B0&P,XS@^AH#0PK/P_?Z=_8T?VFV;^S/,',;#S-_![\<?7FK \.3)J-
MW=6?]G21W4_GD75N7DA8_> (Z@XSCC!K1TO4X=9TRQFE:);N6VBGDA1LE"Z!
ML8ZXY[U8\T).8EEC\Y.64,"0/4CJ* T>PS;*HE$;%7^8+D9P><9]:QD\)/+;
MZB%%K9?;=/DM&CM&;RV=P<R%2 !CL .YYK>1XIT+)(N_&XC(/'K4EI=1M'\K
MH8CR&#<>_-,):HRK/2M736;+4+J2Q*06K6K11;\X)4[@3U/R],#KWJ'2O#VH
M1:?I.G:C+:FWTUHW4P%BTS(/DSD?* 3GC.<#H,BMG4M333[#[4%\XLZ1Q(&X
M=W8*HSV&2.:CANX[Z272[ZWC%TMNLEQ /WD6URR@9(&[.T]J"#E=/T:XU*PL
M]2LQ;R/#>WK+%<EA'/%+*><KG!^4$'!^G-:[:+J5M>6>I:?%IT=S%'+#-:[V
M6)T=@V0X4G=E1DE>:Z*(0H@C@V!(P$VH.$QVP.GTJ0$-QGIZ4 <^UAJY\16.
MJ!;' M6MKE/-?Y,N&RGR_-TQSMK4U>S>_P!&OK*-E1[FWDB5CT4LI )_.KA(
MS4<K[(B<\GIF@#E5T_58KZPOVBM'N8;,V5Q;BX8*5RI#*Y3KE>F.AK1T/33I
M-K=3SLKSW=U)<.$SM4MC"CZ #GUS5^)<DE@P4<DGI1(S2MG:<9P !2-++9&+
M=6>H/XIM=2M(X98Q;M;RAY2A3+ALCY2#P*SX]#U2#PM'8&.U-W%J*W:A;@['
M43^<1N*<'MT]^*ZSF!"=O[P]P.%K+U;4I-)TB[U(VSW"P+O=%8*2/7)HN%KF
M*-!NH[^_2?3K2_L[R[^U!Y+ED\O.W*LFTAL%1CU]JZLP,L32!=S $JF<%CV&
M3P*FCC1(A(^<XR><XJM>WDJ6DTD<1<(I;:I&6_$\"D"\CF+"PURQM=,LVAA:
MV@683QQW6SYV?<K%@,LH!8;1WP2",&HO[$U<>'-%AB,=MJ=@^PLCC:L;!D<K
M^#!@/]GUKH]'OEU+2;:^C1DCN8EE"L<E0PSS3[RX>VE@06=Q<23L55(0N1@9
M))9E 'XT!9(P=,\/SZ9K<WE[$TB(B:TCW9*RLH1A] %)]S)^4FAZ+?VVHP/'
M#=V-D(G\^UFN%EBWDY'E88E1G)YQV&/2W;>*;9[(7D&E:BT++(4D9(OF\L'<
M/O\ '0]<9[5NV-['?:=:WJ@QI<0K*JOU 8 \_G30G+L9FOZ7<7%G:26*"2>T
MO(KKR78+YH4G*Y/ .#D9XR!TZUEZSI.H:G%J]W%8RQRWFG"PBMVDCW$DL2[D
M-MP-P'!)Z^M='::G%>V_G0Q3*-S+B:,H<@D9P><<9%.DF=NX'L#1<2BV0P3N
M;&W22%X)0@5TD*DH1Q_"2#Z]:Q&CO(-9UB2+3Y;B&^M(UCECD0 ,JLI4AF'4
MGMQ6U)DISC'\J= I;:%&3CTHN5RHY>"QOXK+PJ&L9-^G-MN%0QY0>2T98?-@
M@LP/!SCMVJ/1=$G@AL=/U'3;Z0VER\\=S'.OV;)=F63;O#9^;IM/)-=E(]M9
M1K)<S1QH65 9& !8G '/<G%,DU.T^T7-JTNR2U17F+J5558$@[B,'A3G!XQS
M0A-KH%PKP:;.UO;"XF"G;$2/WGMSQ^=<Y;:&LNK_ &W3](?2[;[+-'<12!4^
MTLV-@V*Q'RX8[CCJ,9YQM6'B&TNWAB6.YC>XWF 2P,OFJH!W@] I!&,XS6B9
M'(PNW/H.?_U4R-SB]/BU.UTO0+=-'NX/L\'DW+110^=Y@1!P6) 1L'+'DX'2
MHK/2[FSTSPQ]HT6:<6+S17,(C5V4,K!>IY7)'-=H1Y6Z:>?9&@W-EL!0.I)]
M*N*Z/&KHP9&&0PY!% V<#;:9.MT^GZI:ZI*/[2:[1H!%Y#YD++(7X<8SR,YX
MP,CBNSU:WN+O1;VVM9?*N);>2.*3=C:Y4@'/;FG3Y\T=,<4ZSOK:^$WV>3?Y
M$K0R<$;77J.:!',"U-ZVA%=.FM3IP;[0)(2 B>65,2]GW''W<C ]<5;\%60L
M]'*2636]SYC"0O!Y98;B5YQ\P /'ITKI&^Z:1,X.:74#&U#;)XDT]7MII(C!
M/&["%F0%]F QQ@ A6_R:R+?2[[2-?TK3HXFET:*X>>WEY)MQY,BF)C_=R^5)
M^E=EG%,,B+(L9=0[ D+GDXZX%,#@]$T\DV=GJ<>IK>VET\K?Z.OE.YSE_-"Y
M*L#R"V3TZ<5<TW0WAU<Z;):)_9-G<M?6[M&,,SCY4''\!+G/7A*ZY^HP>*5>
MW!Z4 <#:[WU_2;Y]-FMI%O)TN!'9LHC#*P 9\$ODE3G.WGMBJTB8T.S@N=*N
M3K-O?1R7<_V5F/$N7D$@'S*1TP2<=N*] U'4+72;"6]O9?*MXAEW*DX'T )I
M$O+1[O[+'.AN1&)O*W?,$)P&QUQD$4 <3KQ%Q?3W']GO'/;ZE;.LD=F[R>6&
M3,GF?W=N[Y5]#GJ:["RU6&_O[^UACF'V*0122LH",Q4,0ISSC(SP*GEU.S@U
M"WL))PMU< F*/!RP R><8I\5O%:IY<$81,EL+ZDY)_$DF@#G?%#13ZC9VD]B
MLT4D$I$LEN\Z[OEP@0<;CU!/3''6L.RB@O(/!\5[#*^R%X9UEC?@[0JJ^1TS
MQSUKT:F$^] ' INL+:YM#',--M];+2PQJ^$MF7(P!R4\SD@9'7MFM/P_)9?\
M)1JXLX/)MYHK=H<0M&LF ^YAD 8^85T\]Q#;0&:XFCBC7[SNVU5'N3T[4Q+^
MUGN9K6&XBDN(0#)&K LF>F1VZ&@"PG%.IJ=.>M.H *0'.:6B@ HHHH :_3%9
M/B+=_8-ULW;OEV[<YSN'H0?R(K68=*Q_$P1O#MXDFW:54'=C'WAUR"/S!'M5
MT_C7J3+X6<-%')<:AHX"$B.%3* &)*?9XU.,9/'F,?\ ]=0V0FEUJR3_ (^(
M9-WDVV_=Y;Q%D0O]W<N5)QZ =<4EW+]ANM"O&A,JQ)"^Q1C<[P[$'TWHI_*K
M4ND2::\VIR3P71:$^9L02 DY60Q*> 58@DG.=HS]XUZ:DEOU6G]?UV.;?;H0
MQ>9%90Q2NPD2Y@1L@==S$_JQX]ZL7.E1IJMBMC+,EV&+7L<LS,N< A@">.><
MCL>>:JVT>-(MG5-H^U6^Q0P&T;I,=>ORA>.^>*MSZ2T6JV#V<MU]H)9KN.1\
MI&W!#+QCJ3T/(//--NSW[_TQ-%>\E=C<M;2%2M[<%S*P@#LT@((,F%)"XC/.
M1L&,@G,8T]=.TEKNU@>XA5H]R1R$VV\# D=LC?@_PJ=B]VI;J)([J\-O"D):
M]D4R*JR;&\S;QO#!?EP[?=+;C\P"&D2[^VZ<T4$SPVIDC\UE 2!V;GRY$4'9
MG^^% /&X'.2O>MIL5H%K=ZI(8C)++&&)!29FV&, ;2B [&4DN2%5LXV@+PU:
M5AX+OIE/VE88HL$1^<[221*6W*8\$;&5< YZD>@YSK%=3M9!:3S32XW-&Q>4
M1JFQ2H0H @&[S S C;D8.!BM;2O&5PN^.\D@N+>)<F5_W#H@<JK<G$K.H#_*
M% Y'<"LZGM%?DM8(6;]X[BUMH;6(1P1K'&,D*/4G))]:L <YJ"WGCN85EAEC
MEB;[KQG(/XU.#SBO->YTK84Y[4RI*8W)XH&)@%ATS4E-SR#3J "BBB@ HHHH
M ;_>JM>WL-A;>=.3C.U54%F=NP4#DGZ59_O56O;&"^A19@X*-O1XW*,C8(R"
M.0<$CZ$TU:^H/R."NO%NH7<D<:.D=NYA$ZVRMOA1V(D#D@,CJ.XQW..E9T]E
MJ$D;%8_L^X@F2$B&(I@Y#,5*-\Q4KG=PN<DG!NZAH%]87"R2P.L#F(W5Q!,S
MK(JL-[RLWS*<=-HX!8Y.*S#)'IUY OV2!@P.R&-5/E_*I#JT:;UP2RC!;/7)
MQSZD%"R]D<LKW]XL3W@LK..UF,C0+YGV>2YA_=!@W*QQM]U5+8WL"<=, 5)I
MT9GNK%[JV,<Z7*>7E1%O.R0N2JA58IM5LXXW%22.L4L+:K"B2/<7$%L9=L"H
M#*IWD/\ =QO4_,HD08P<$*>:=I5GLU#35GC2.7<#&/+\IRH63?A2%.T-Y1&0
M<,2!D42LHZ;ZW_K\Q:WU+NEV^H6VI7=BD]O]BN+D/)N )#@*"%8$<X .W&1]
M.:KVUPZ0)(HDD(N9(HS#,?E9I&9F('W@ $X/ ^;/W:M:7!J=CJ$]A$UNUE-.
M))"Z@D,H .U@PZ[<XP2.?K52.-'L$(7S7,TCLKLJ;<22!6S@C.&<8P<CGC;D
M$FFW?R!)VT%.D^?<6D[Y&0B!=V%5BBD?+T.T,5'H<#G?PW[0TEK=[DN$9(D@
M^<G;*DA^78.,8*@C!Y!.3G)%ATCEOK?$D@5DY5;<,JL02L8;)9@V2V03N)W;
MNA5DD:R6=[YD8!?##;)'*)6&<*2@P" Q;!!)ZY;!I*3ND_ZU&EV.XT;/]CV!
MR22F23G/?U)/YDUJ/T'U'\ZR]#P=$T[&/]4#QTZ'V'\A]!TK4?H/J/YUYC^)
MG5T0[M36ZCZT[M2-V^M(!:*** "JU_86VIV,EG>1"6WE #H21G!R.1R.0*LU
M2U+4HM-BB+)))+-((H8HP-TCGL,\#@$DG@ &@"$Z!IY9&$<BLL8BW)/(K,@Z
M!B&RPY/WL]35Y(HX84AB18XT4*BH,!0.  !T%9$6O3M(EK+ID\-^\C*L#.I!
M555C)O'&SYE&>N3C'6H1XJMV$(:SNEE>]^P2(=G[F4XQN^;D$<@C.?8TF!;D
M\.Z;<?;1)%-MO?\ CX1;B15DXP?E# #..<=:E;1K-YK:5TD>2WC:)&:9SE#U
M#9/S@X'WL]*I2^)H;>/5Y'LKP_V4H:<#R\LN"VY?GQC:,\D'GI4EMXABFU!;
M22QO+=Y(#<0&55Q,@QG 5B<\C@@&A 6-/T*STLK]E-P$0%4C:XD9$!Z@*3BI
MKG38;RYM;B5I0]JY>,)(5&2,<@=>,CGU/K6+H_BB2YT?3YKRUG:]N_ECCBB"
M^<V&8[-S8 "J222/S.*F;Q?9+%"WV6^+R3R6QB2$,R2IG*'!//'&,CG.<<TP
M+=YI$%UJ,=Z9[F.>-"B-%+M !ZC&/\X%1CPY8-H+Z.3.;,D%09263#!AM/48
M(!%1VWB*&^F5(;"_R/*6;=&H\AG0.%<;L@@,,X! SUZU7TO7XAIZ,]Q=WMQ/
M=S0PQ-"D<I*,<KC( "@'DD?GQ0!:/AFRE=WN9KJY$D MI%N)-P=!TSQG.><C
MG-,_X1J&>QDM)=0U&2'<F!).&*[>5P2.QP<GG@<U'_PF6FBV>>6.^B$5P+:4
M-:L?+DW;2I(RIP?0GMZBK,/B/3Q'?M/Y]K]C59)UN(BA"L/E8#OG!Z<YXQFA
M!U3&GP[;KJ$EY#=7L#W!#7"PS;5E(&,D8X/J5QFK":)!]KBGEGGF\B:2:*.0
M@K&SYR1@9XR<9/&?85$=>L%>9+EI+5X(A,Z3H5/EDX##UR1C YSQBJ=KJ4]Q
MXQC@4WL=LUF[F"XBV*&#( 1QD]3U)Q[4 :VJZ=;ZG;+#.74HZRQR(VUHW4\,
M#Z_XUG7/ARWOK6\AN+FY>2\18YYP5#LBYP@P,*O)/ ZDU'K6HS:?XGTI6N9S
M:W$,^^WCCW[F4+MP%7<3\Q[XX[5+;^)M*N/L@BFE+74K11KY#Y\Q<[E;CY2,
M$X- &U;QM% D;RO*RC!=P 6]S@ 5B3^%H9DU*-K^["ZD0;D#9R0 ./EX^4 5
MIV.IV^H27,=OYI-M(8I"\3(-PZ@$@ _A7-:EXFGGTSQ +65K2YT]F\F1(]VY
M5"Y)W+M&2<8Z]^G- &Y<:#%=7$%Q<7$LKQVSVT@(7$T;XW!@!WVCIBJD/AJ,
MZ>VFW%_=W-D8A&D<A7* $%3N W$C P2>W>KEAKUC>SBT25_M(A$Q5XG0,G0L
MI8 ,,GJ*2RUJPNKF*&*<EIT+P%HV595'4HQ&&'(Z?7I2 CDT/S2[W%[+-<F!
MH(YF1<QHV-V!C&3@9/MVK'\069T_0]'L(IKIQ#>Q;9HX2SQQKGGY5(X&.HY]
MZT?$EQJUA8WVHVMU"D5O '2)H=^YN<Y.1CM^M/CU";2XUN-9U& V\ZQK$5A*
M$.<E@<9X^[@^QIL!TOARUN;:X6[FGN)[A45KIB%D 0[DV[0 H#<X ZYSFEF\
M/M=),UU?RRW$EN;99MBCRT;[VT#C)[GV&,4'Q5HOV59Q>CRF ;)1OE7<4RPQ
ME1N5ADXZ'TJ>Z\1:597)MI[L+.$$GEJC,Q7U  .1]* *S^&V-KI4::C,DFF-
MF&38IR-I3!4C&=IQGZU7;POY-I';QZC<;H[YKV.9E5F5F))!XPW+&M1M>TP6
ML%RMTLD,\9EC:(%]R#JV "<#N:R[W71/XDM-,MKZ&!/+2X=B@<S;FXC&?NY
M)S[B@!)_"@N)+^274)M]W+%.&6-5,4L>W8Z_0*.#UJS=>'WOEN6N+TF[FMOL
MOG)$ $C)RP5<GD\9.>PJP->TU^!=H<(9<G(#(,993_$!D<C-2:=K>EZK/)%8
M7\%S)&BNXB?=M#=,T 5?["D-YI%S]M._3HWC_P!4,2JP4'//!PO:K&MZ6VJV
M20K<&!HY4F5MF]25.0&7(R/;-5O$6NMHJ0M'%YOS"2<?W( 0'?\ #<*T[N]M
MK.)7GE"JY"IW+'K@ <D\'I0!@3>%KFXM;^ ZKE;RXCG8O;Y*LA4@## 8^5?U
M]:FO_#8U2_N)KBZ 2XT_[%,B18[EMZG=P<GISTK0@UW2IX9)8M0MW6/!?;(,
MKDX&1U!)!&.N:!K6F)&)VO[=8F;8&:0#Y@<$<]P2,^F: ,_^P=0>]TR[GU6.
M66P+@9M<!T8!3G#\-@=>GM6CK.G'5='NK!9O)-Q$8S)MW;<]3C(Y_&H+OQ'I
MUOHEUJD%Q'=0VX(/DR*<M_=SGK5N&Z@U"S2XMY4DB8CYHW##.>1D<<'@T 9K
MZ5Y<UG?:I>PM'IJ,\02+RD4[=I=LLV<+GT%4-#LX)=7U+6[*8R6<DA^S?+^[
M#,J^=(G3(9E7GU5L=374-&P& 05/9N:0.J *R[ !QZ?A0".67PU>VR6@-_:R
MK#<33E7M6*,9"3]TN>5).W)[TJ>&9Y/#!TK[>B7,=W]IM[I(RIC._?G&>O+#
MMUZ5TR%5?RP<J0<<Y_"H75HI!M&>X-(NR>AG0>&X[37X[Z!]MHD"(MLJX'FH
M"BN?HA*_EZ#$,'AQEUB#4Y4M8IXFD9Y;5-C7.X$#S!P. ?4Y..G2NBCDWINQ
M@^E.?E#3(,K5]+EU!;*>WD$=W93B>$N#M8X*LK8[%21GM[UEZKX;O-3MM3<O
M;Q7=^D4)&69(8XV+#!QEB23V'8=LGJ5Y4&DED$2%ST% %9I94MD,RQB8KEE5
MB5![X) )_*N0GT/59=*U:P1[)H;RY,T3RNX9 Q#$$!2.,<?4^G/4R/O).<G-
M)C*BI;-%&Q@ZGHUUJEV\LLD$:7&G-92[78F-B2V5^4;P#M&#MR/3I4FBZ?=6
M*JMQ8:1$RP^6;BT!$DO3DY4;0<<C)YQ6Z(W<#:.QYJ1+8XY.T]P*86BC!UC2
M9-0%I/;3+!?6<OFV[L,KG&"K <[2"0<>OX%)K/6=7L9[&\MK2VM[BVD@DFBN
M'D8[E*Y4%%QUSR3_ %KI$AB0YVY/KU-2 84$],4R7(Y>/1M2N5TH7L5NC::P
MFW0RD_:)%0HH&5^53N).?0#GK6?J&GW.D?#C4;.XCB$JN64I(7#;Y0W< _Q8
M_"NZP"!5>]L+74;<P7D"31$@E'Y!(H).?O=#O=?R^IB&S*6MQ;Q)!*9N95VE
MV)5> !PN._)[4JZ=J5TFD"\M4B;2V\YC%+N\YUC**$Z84[B3NQT QW'100Q0
MPI#&NU$4*JYZ =*DP1TZ4 <=:Z7K=IX32PBB$=U'=;V"3 >;$9-[*K_P'!QG
MCIP1P:K/H>K+IFM0K:H);F[ANH5-SO#*H3*EV^;=\AY;C)XKN.".,BD(R:3
MX[5-&U/6;W5'^S+;?;-.C@222575)$<O@@')4[L9QV/%6;Z&\OK^UU"2Q-O)
M:0S 1M(C,[R*%*J0<;1R<G&>.*Z9OE!)( '.:SYGWL7);&<#(I7*BKLY&VTW
M48=(\,1/:MYFFS#SU5T' C="P.[!&6SZ]>*VM(OYM4LWNFMQ%"9&%N0Q)DC!
MP'.0,9P2!Z$5I;>O?V-*BY9LKR%)R*1K:QR.OZ?J]^NK0):R2(\L#VWE2(D;
M*C(6+<AF?Y2!G@ #%6FM;_\ MN.YL8[RV#WBS7$<A1X70 9?!R5<CY?E]/2N
MF0'<V0?NFFYS@8#"F*W0I>++>YU'P?J-I:6[S7%Q 8HT7&=Q[\XQCUJIJFGW
M=_JD+V=O-:I-I5Q:^:%"F!V*E V#D8VMTSC-;]L2IVG@-V]ZN $'G%%S.2LS
ME8;2YO8] C^P36,FFLKRLZ+A%6,H8T()R&..G&!SS66^@:K'!=K'&V-)O&N=
M*0-_KM[B1L^O!9!_O-7?$!5.* O.31<DS=)M)+?3T-PBI<SL9KC:O_+1N2,]
M\?=SZ 5F2VTEIK^JO/93SV][!&L+10^8"%#!HV_NY+9YX.3S72\ <CO4AZ50
M[GG5MX=*ZAI%KJ^F->1Q:8]O-(8/,02%E*J3WPH89_6NJU"20:5?!%DF+0NH
M15+,21@8 YZGM6SC(X_G3#$DA^9<GZT#3.!M-/\ (B\*/!82P3QP-!=.MJ5*
M,8E7Y\#.-XSD\=\XYJ/0;0>7IT.KV^HK>6+R/*!8MLD)#;B90I\Q6!SM!))Z
MCBN[FM6ZALX]>*KLC*H!&.< 4BDDS@8='EC\))-:Z;.EVMPHN5%NPDDA$NXK
MM.-PQM..F 1[5H7 MXK6:\MH;N>.ZNX/.$FGR*D&T']XL( +]@>HSC/2NMB8
MHQVC(SR/6I0PY8;NAR#1<=C@EM430;NUEL+MT374FCC^PO\ +#N0L5"J0%P'
MZ<8)'?%7[S3K:'Q+?+8::8KJ33%;3I$@9560"0'! PC8QUQV[XSUL3F-@>0I
MZU? !XY/>F1)6. L(=/GL1*YN//M].:&XL_L+KDMMXE^7YV##CODL?6MSP5I
M]K;>'[6XAA>.YFMHENB^\,9$7!!#<@@Y'_ZJZ7:/?\Z,"@D\Z\;SB>?6(%MG
M6[M;%9+640/)(S#<=T1'RQ@'AFZDX!Z#+M071]2\27DUP(I;9]+C<,V0IDR2
M2.VX*5]QGM7>W#^6G!Y/ YJGO;/WN:5RXHX32O+BD\)W\;.ES<PR17\LCL3+
M+Y:X63.<D/P >G:G^'6AD339-1U%;?5X!)]NA:%HY7R#O$K$X*=P2 .!C&!7
M=;P@+*27(Z^@]*7YL9D9MG89ZT7&T>;Z<MM;^'M%U59FCNH]3CCGG:9\K&TK
M;E8D\+LYP>,'/<DOUR>RFT#Q';WP\S64>7R-RMN6+/[LQX_@VX)(X))SUKT6
M29F4J"5'I2P0.PR25';GFBX-::G#:O?17VN74=YJ=K;V4MG&UA-*&:,9!W/$
MRLH$@;OR< 8QGF22XMC=ZA9ZW=.TB6\1L?,RAG4Q\O&JXS(7SG'/&!QFN\(B
MB!W'+ Y.3D_6HI+@$84?,.A:CU)U>Q@^#M1T]?#VAV8N(C=2V2;44[ON* PR
M. 1W'6NCENH(AN=T"CDL6  _&JL;,YW-Z]J1AOSQD'MBBXU#N<GX>OX1\.KC
MRYHRJ0W&]BP^4DM][TS[U6T\1V<GA65-0D"WUN89PUTS))B$$  G:I!Z;<8K
MM4MMP($*X;DY &?K4G]GQ/A9$C90>!L& :$/W4<!83W-YI%J(;];AHY[QI+>
M>_DC,R+*0I\T'.5!7 8XPP/85U6B7 NM!TZX"S R6\9 N&W2'Y1RQ[D]<]\U
MK-I-BZ[9+.WD&=P#QJ0#Z].M6O+12 J@?A18GF//;*YEOM&.I_VG<'686N-U
MF;@JK2)OVP^3G'0*>!N.,DU8TF>XNK2"X36;>,&PD,R1WQFEF<*/FVD 1%3G
M.W(YQ[UVC65J)S="VA%SC'G!!OQ_O=:B^QV'S[;2!GE_UF(E^?O\W'/XTQ-W
M.%FMF;PAI.HW6LWTS74]BSM+*"L1WC)''!&>3Z@$YJWJTLBKXMLSJ,TT4.DQ
M2('D!P2LV[M@;L+G'K]*[(:?;-;/;M;0"W<Y:$1C:QSG)&.3GFHY=*TY5+?8
M;4'&"?)7G]/8?E0(Y6*XO+.YT417D]RDNG33?9RPVN5C4J % [DU)!=^3X;C
MU^37[L[K,M-&NQAYC #Y4/RJ58XP>/[WK721V&EQ-&XL[17BYC98E!3KT(''
M4]/4TT6.DI+,XL+<R3Y$K"%<N#U!/>@=F<?=7-T^F^+;">Z9XX-/254>X$Q1
MG$FY"V!UVKD=L\&KJ3WHU+3]&6^EE@?3OM"OYZPM(V0,!E7HHYP.N><XKH4M
M]-B)2.PMT4QF+ B490_P\#[OM2KHNES6<=G)I5I]EC)9(C$NU23DD#'XTKA9
MD6GB\73K4:C-#/>! )98ON,<]1T_IS6+!=:O/:W:0W$LTD.KRPL@>..5X57.
MU"1C/0]C@'FNG,,5N$CAC6.- %5$&T*/0 =*8-#TL#Y;"!<N)/E7'S<\\=^3
MS[FF(@\/WRW^AP3^;<2<NC-<JJR$JY4YV\=1C(ZXK!NKO5EM_$TT>K3(=-R]
MN@BC(.(@^&^7)';UZ\UV$<$5M;K##&L<:#"HHP /I55-(TY1<@6<(%R"L_R_
MZT'J&]>M+J!E175YJ^KWMJ+V6R6WMX700JI+-(&)8[@<@$8 XZ'-8VG3WNMZ
MUX?O9K@6]S)IL[EHXU(;$D8.W=GAASQR!76/H6ER+"KV,)$*&./CHAZK]/;I
M4ESI&G7<EM)/9Q.]L<PDK_J^G3\A3 AUN.]FTFX_LRX\B]5"T)VA@S#D*<@\
M'I7/V^N375G/JD6I2PV-O8H#YD*R9N&&3D  DKE05!&2>V.>P<=,>M4_[*L1
M8R67V2'[-,6,D6WY6+'+''N30!Q^K7VH'1O%5C=R2RI#IPFB\X(LB;@P*GR^
M/X<^O-7]1U:ZTC5-2D"),EOI"W,:% IW;F&TMUV\9]LFMK_A&=%VR+_9T.)(
MQ'(,'YU!R WK^-.CT+2TN/.%DAD,7DLS$MF/'W3D\CVH Q)X[F/Q;X<:YO\
M[29$N'"B-5"_NQDC'..1USUZUJ>*[ZZTWPQJ-_92+'<6\+2(63<"1VQ3X/"V
MBVTL$L-BL<ENVZ)E=LITX!S]WC[O3VK1N;6"]MY;6YB66"52CHW1@>H- &/+
M>7R^*5TQ;F,0R6+S@>7ED<,J@]>1R3BLK3M9UAM/T._NKF!UO[@020"#9@-N
MPP.>ORY],'\:W8/#&D6UPEQ#;.DZ1F(2B>3=L/8G=DCTST[4J^&],2P@L4@D
M6VMY1+"HN) 8V&>0=V1U/&<<T <C<->PZ1XMNC+930QWK[H+FUWAR%CQG<^
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M999O+4+F-@!@@D'DD\'IP*RIM,OK2"PTH/:)>S:A+>03[G"JNXNZ[N"#\^T
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M(TZZM(;-KO2)GO+&W:*.4W:NN<!?W0+<;L=\8QBM+PG8W&G>&[&SN[8075O
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MR.U '1R>(M-AF>*2=OW<HADD6)VC1R0 I<# .2.,]ZTI9HX(VDE=411EF8@
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MEXG$B;E=0=[?,Q)<GJ<G^=8]^U[)X?\ &1N'BD@\R4;=[,R,%3 &> H'TYH
M[_<"01T*YIB\3LH/) (KG5UJ^TR^:#4DM7@_L^2\1K96#((RH*'<<-G<,'CZ
M4[3-:U+4+VRW63&"X@,KNMO+$+=L A2S@"0') *@=.F#0-&S<JD"L[$+$ 6)
M)P ![]JCM;N"Y@ AFAFC/&Z.0,/TS6-?;=1\;V=A=KOM(;)KF.%\;6FWA<D'
MJ5&2!VZTFJP66B&36(;&(WI1+51&!'YF^10 2!ZXY]*DI:JQMR1-&VWJ.V?_
M -52VP/FGT KGKK7;ZRN);"YM[6>?[(]W;2(6C5MA =6'S$$ @@]\]!44&OZ
MPEC8W3Z;8[=0E@2)1<-N D7=DG:1Q_G-,&]+'8'.WBE!PHKEI_%%WI]Q<V>H
M6,)NHQ"T!@F)242R>6H)(RN&Z\'C.*EN]?OM/N[FSN+.!YTLVO(&24A)%0@.
MIR"5(R/8Y'3FF0=&PRR_0TIX7\*YF+7M3?3HKVYL;*U$X0VYEO/E(9-WS?+G
M.>  #5&?Q!?ZCIWAZ]LX?(>XU!HI8?.P'*"12F[;]TE-V<=AQS0!V*\'.#B@
M9P..U<I:ZJMA<:L5L2+J74H[8)]I+K+(R+@Y(^0 <D =!4M]XGGTQ-1BN=/4
MW%G;BZ CF)66+."0Q7((/48[\4 =1D@"G YK!L]:NY-7BT^[L! 9[4W,+K-Y
MF0"H*L,#!^8>H]ZGUG5IM+B4Q6\,I*LW[ZX6(''\(SDECSCC'')% &J21U-(
M#CI7.#Q/+-)I"6NG&0ZI:M<Q;Y@H7"J2&X/]\<\U):^)1=6D)%JRWLEU):?9
M=X.)$R6RW3:%&[/N!UH WB<'G-4IW\R55&"!P/K7.:(\L?B7Q+YD MY2]ME%
MDW@$HQ)!]^O3O3AJ%X?&#Z<;>5[(V"NVQU7:68@OG(;MC Y]!WI,N*MJ;TGR
M8C'.T\Y'4TA)6W" CYFSR:Y'P[JC6NCZ+!/:W#P7<K0+=%P?WA=R 1UP0I&?
M;W%:,_BFR:92!NMOM?V,2[AG?G;G9UV[LC/X].:1:>IN@ 6_0Y+_ ,J(Q^ZE
MP .*Q/%EU<66FV,<"S-]INX8)#$0&V.X! )(PQ!P#VSU'6F_VQ#HUG;P2V-Y
M%;[H[?S)74[&;:%!RQ+X+ %AD YYX-");-^=3YIQR<#O2W)SY;GH5[UDWFMH
M+V5;:RN;J*&5;>>:(+MCD..,$@MC<N2 0,^QQ!=:^EYH-S/;PWJ0"TEDCNX
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M,<B- +F&W>!4N87F59YBLF/W)<'D.,D!A]X8YJYIALI84:WEG<!MKFX5-RR
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MI'S#GO3NW%-/4>N:0#A2T@.:"<4D M%(.E+3 *#THI#TH 1>M.IB]:=GV-)
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M5C%80B& R% 2Q,LC2,2>I+,23^=4X_#NG11A&B>:-8F@2.>1I%2-OO* Q/!
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M3_$%G]LCM&AN]SPM!A@1QG^$$9W#!!/OFC7RV8UN95\\;O/+/%-+%!>2EE:
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MU#4959IY9+6&>%;M&01A.N]"@X?!VGJ<CCUS5>T;4W@\[4H;ASDPS";S';(
MVH$?>0<$GE><<*,UZ-.,H?&_P.:3B[V)VLWM[""\NA;VS7*J\3J-T3-G>K;$
MR8WZ%M@*GU4YINES0PZA8PPEY2SE 8P2HD2-@J?-ANC'+$8P% Z9$5_=R:1$
MH6.>VMYU8Q3B8%R/, 8LP'RJ"V0B<#.2#VGTR8/>V#3O!<7BEO*+2"5EC\MR
M?FRQ +!<9;DAL<"J:?+=^8)ILM:'JY>Z>VN([F346N?DG&-AC&/E;GMSQ@X/
MMTS;>TQI<"K*(<,UR%V,1(I"QLHX.#^[4]N'Z\&M;0]6:2[>&Z28:A)<C9(J
M?NWBXP,]L<\=0?;-4+5YX="LB1 MHJ,!A2K'YMS C/0E5&/?WX'?F:2MM^0+
M;4L-J*K=1V9V?:WQ<>6"=Q90/E],GKS_ ,M/IFJ'E[;&X$DL<ID\J=EV!?*C
M4D?-N &29%ZYR-S$\U ?.;0-0NGM774X+]+CYA^\((8!2/\ <R3_ +Q-7DDN
MKBQEF@"26Q2+#C<&4;]P"@<\,Q7CGY<\< UR\NW?_(E'?:*,:)I8(Q_HT?\
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MY%8_AS L)O\ K[F]/[Y] /Y5L$9&* *DV8_EVY1SCZ'/-6MN4 Q0W:E XY%
M%9X6B<-$3GGY2:L<E*#]]?H:4]#0.]QO;WI!P!WI:0'@#VH$+V]JANI#'%@$
M MP*D=@JY;& .IJA-*7.Y@>>@R*"HJXU$=Y OKW/X^U6YW$<>T9!;Y<CTIL
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MJ?J*AN&'E;/XF. *F7 &!0#V%I.<^U+1GG% A#T--CZ$XZTYNE(G(H =3'P
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M-O*DNFM-^Y#EQE>4SNVY4\X]^E16_BNRN+:&Z@LYGMU$*RRJ%"V[2E $//)
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M/;W5]Y7V<Q,\<[R!0P\LG.2,Y Y_6LZTU30[:"VECM$M%U&8P-_HZQD.,\2
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M"G3S#^[ ^@SR?;) !I^&@&TKS 24EN)G4GT,C8[G^=;506=K%96<%K FR&%
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M2S;;S402)=291C8C<E8EQC.<G!Y.68@KE#2=/DEN@MF5U?486Q)?7&?L5HX
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M)M?\+ZG&T0PLT]GOP.N,Q,QQG\*;'I]CJNH-J7A?7X8;M(%@, C26((O1"F
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M]Q'&D43*).5 R8R??&>OMQ5(ZGXAA6ZL(C/<ZDEP6";(RR0HBG&\A$8.Q !
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M?&.*T8]9U!-%O5=]^H?;#:6Z%5:120"-X&%8A2TF!P5 [YH L0Z/?2S+)=M
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M+.?]*ZY_X^Y?_BJO(<GTXI]) 9QT2R)R3=?^!<O_ ,52G1K0C&ZZ _Z^Y?\
MXJM"BF!FG1[=3E9;P''3[7)_\50-'@(S]HO1D?\ /W)_C6@W6E7E1QB@#/.D
M1X&+J^'.>+I_\:8NE(X?_3+\8..+EO05J&HHOX_K_04">Y1_LI&*C[9?=/\
MGY:E_L9,8^W7Y^MP:O@<J:?0,RFT2+K]KO3QWG-1C08#R;B\XXYES_2MANAI
M@&,\GKWH S#X=MF8G[1=<_[8_P *8/#5J"?](N.3G^#_ .)K:HH QO\ A'+8
M9Q/.,^@C_P#B:8OAVV.?WTWXK$<?^.5N4Q#\V/:@#(;PY!G/VF;_ +]PG_VG
M2_\ ".P[0!<R >GD0?\ QNM<]0*<.!0!CGP_'G(NYOP@M_\ XW2?\(^G:]F7
MUQ!;\_\ D*MFB@#&_P"$>7(_T^<X[>1;_P#QJFOH*KG_ $^?)_Z86_\ \:K;
MICC)7G% &0="(P?[2N>3T\BW_P#C5.&B3J<C6+[//\$(_DE:K]OK3Z ,;^Q;
MCJ-6NB>^43G\@*/[&N@#G5KD_516S2'I0!C?V1=DG&IR=.,H?Z,*1=*OLG_B
M8AOK$W_QRMH#%(/O-0!DMI5\<8OHB<G[T4G])13#I>J8 _M"U_\  >7_ ./5
MMT4 8ATS5LC&H6G_ (#2_P#Q^C^S-6QC^T+3K_S[3=/^_P#6W10!C#3]5 4?
MVA:Y Y_T>7G_ ,C4?V?J_;4+7K_SPE_^/5L?Q?A2T 8W]EZC+\L^J%(_2TC,
M;'_@3,_'T /O5ZUL+>P@9+>/:7.YV8[F=O5F/)/UJW37^X: %'04M(, #M2T
M % SCFBB@!I^^OXTK#(I#_K%_&G'H: &#@\T=J ,]Q44\ODVLDVQGV1E]JXR
MV!G SQF@#"\975_;:5&MC*T!ED\N2<+E8U*D#)&67DC! )S@<9KE'U"ZAC_M
M)VDU" E;:.RN94E82EBJ\J2C'&TG!R>3R,U:NO$5YXAM/LT5A:O%+*&6WFYE
M>/)\LE&(7!*K\XW+A@<'G&=;RH;B35-.1I8H95L-$MY(PF;AA\TA7 X7<Q.1
M@8(&,4 7]+T62YEET997<L0^NWF\LS$\BU5NI&"=Q[ ]MP V6U^X-YJ6A:79
MPP:E8!&MK>?A;B$!<[<$ =<#G R,XY 9J%LWAGPU:6MGKEOIUPTXWW=W'O\
MM,K9+%C_  ECDEN< 5SGB!/%XEM+^71X9K^R;?#?Z>=^Y.<JT>"S*<]L=_6@
M"&!H+B*Y^R2^))HYYII)M-M(PC07#')69P0V,_=/ P.3P170Z=9VWA2UCO\
M5YY9-6OHDCFM8F$GVF8="J8^:3& 6_'ODW+VYM--2#7/[' \0W\*6\=JC_O)
M'(SL)'&!_$^. .>@JM?V5QHNG-J]S<K)K-S)%!-?E-R6<;N%;R@>%103UZD
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M%%,!K=1Q2CH/I2-VH /!S0 ZF#J*?35Z]: '4G.[VI:;GYR.: '4A&1Q2T4
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M%_RT^O\ 04\=*9%_RT_WOZ"@3W%'8CK4E,&/EI] Q&Z&F]:<WW3@9I@Y .*
M)**** "HT'SYQVZU)3$^]U/2D XGD"EIK=:4=!3 6BBB@ IDAP5-/IC]5Z?C
M0 K?P_6G4Q^WUI] !2'I2T$X% "*>U(OWFI0<YXI!]YJ '4444 (W2EI#TZ9
MH)Z<4 '\?X4M)_$*6@ IK_=-.IK_ '>] "CH*6DR !DXI: "C.:#TI!TZ8H
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M/2D7UI3TI%[T .I&^Z:6FO\ =- "1?<%/ID?W:?0 49Q2 Y[4M !112$9[T
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M;V;)RS, 5P00  .YKT6FX^;I0!P3^')/+5(O#[$_9IXXF=;6(PRLRE7_ '9
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MK'+/<RV=TK6EMJ[!K:XP ;>^CP-Q 9L$D!<[CN(QGFO29PJ0.SH'4(2R\?,
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MATJM/@2#TJR.@H 1ONFA>AH;[IH7H:74!:***8#'SD#GZTX 8%(W) H!  %
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MTND://97MS<SSQ.9D5-L494#;QGDGM@53U'P]=7.H7<T<EHT=SL)65'R-N,
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M3T9L'",3P#D-TZYVUU-EXGB-RMCJ]NVE:@>!'.P,4IZ?NI.CCIQP>>E)@/\
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M@!NC^'M-T19GM(Y#+( &FGF:1RHZ#<QX'M6-JFOIJT%PEK>-::+"2MYJL?\
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M67'IT5K=&<O)/<L-K33-N;&>@[*/90,X&<FM4=* &O\ =-"]#2M]TT+T-+J
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M/[G$94KPS/@\$%L C- &;8ZQ;6<R16FKWF@2[48V&HK]IM<,JL-K9W*,,O\
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M7]YNW*&&<Y"ISC.%P>G-#?O-WZ_U\QI:%R'6+5?#OVU%,5D[K:()069XE5L
M^Y9FY^E9EA&EMH$UM$Y^U((<@;MW##."N#P6"\'.5]Z:XD94L#%_HD5PUV#P
M-Q(X7V(8G/93CTJW>1QQZ?>@P[!(D3J\JH-X# .>=PQD*<,,Y/2A1479=7_P
MPDVU=G>:<!_9E@!R/)3!_P" BKS_ '1]15+3_P#D'6/7_4IU_P!VKK]!]1_.
MO).LXN^TS4+S59UEM9C'-<X\["%!%C;ZYR!_*I[33K^XN)HKJV>!FM)(7GX*
MR.S#Y@ >X&:ZTA<C(I"HX^M+D1T/%3LE9:?U^AQ2V6HF92+&Y$G \O:GE"3R
M_+W;\YVXYZ5IZI:7%OIVE6T,4MPEO-'YOE1[B0@R#@GU KI H'04;11R(3Q#
M;3MM_P ,8WAR.YCTLQW$4D>R5Q&)$"L4SD$C)]34OB-)Y=!N8K9'>20!,(NX
M[2<' ^F:U<4$9JK:6,_:/VGM+=;G$6=G<1327AL+EX!,!Y)AV.RGYP^.>5;(
M^AI)K6\6PTF$VEWY<=O*'$<&YE=@5&1D8X;/X5VX4"FLH'X^]1R(V^M.][?U
ML<+H]A?VUXD<<=W'',2LH:T$4>T1D GDG.2*([6\M[ZU::UO%^RF+<L5J9 Y
MC4J"K@C@@],5W2@9^E*%]:2@K%/&2;;:6IP[Z?=P6%I)]GG4O!",I 9&BDC<
MO\RC!P<XX[UJ>';2X683O%(D:0F(&5#&SL7+D[3T SBNEVC_ ":  *I02,YX
MF4HN+1Q%D;W^VX)6M;A97NI?-W6KA0K #(;I_ /^^J?KYN#>WJB&<J+1$A9+
M=W#-NW') QVQ79,HSG%-1<J,?SI<NEA_67S\UCB;V>_NM2R\-PC%XH55+9R/
M+)!<[B".21U_NTS2[Z]M9Y)A!*\DD,@D0VSC&P$IR  3VKO-@QBF1X._KP?Z
M"CDZC^M*W+RJQY]#F&YLI#+.4ABC5HA#*"Q&<JHQM(;..:LW"36L-I872>25
ML)%5MC, \C?=RH/0*/SKN .1UZ>M2#D=Z.0IXM\U[?U]QPUMJ%V+II_M4\[F
M.9W@ D\I0$^4 $#OFLSD?8]MV$$<48.5EPK*22=@&#V_*O2V4%>_YTP=2,TG
M#S%'%\KNH_U]Q4T:YEN]*MIY_P#62+DD+@'G]*OD9.:1>E.K1'+)W;:#M44>
M-_'I4M11C#X]J!#VZTHZ"D;K3ATH 0C(Q5;4+%=0M&MVFEA)(99(6VNC Y!!
M^H'!X/>K5% '.IX3CCG%TFH3B[,S323>7'AR4"?=V[1PHZ#-/G\/.SM(FJW<
M$D\2PW#0JBF0+G!''R, Q&5QQCT!K?J.7JOUH Q3X:MD82Q3S17 O?M:S#!<
M$X#)D]5(X.?KU I^CZ"^D21JM^TT,:% KP1ACDY&7 R?ZUL/T'UI1]XT <['
MX,T_[-';73RW,<5I]EC#G 4%B688[G*Y_P!Q:1/"4<<9D^V2-J FBF2]:-3(
MK)&L9^H8*<C_ &C72TUNM %*STY+74M0O!*6-XT;%".$VJ%X]>F:@N]<M[6Z
M>S@CEO;X ,;:V 9E!Z%B2%0=?O$=.,TW7;35+ZSC@TR>.'=,OVAFD9&,7=48
M D$],]<9P0>:;INBM8V[6\<D4$!ZQVL>PL>Y9R2Q)_O9![YS0!3O6O)H?-UC
M5(])M&.!;VLO[Q^> 93SD^B 'G )J6U::*,6NB:(+:WZ^?<CRD.?XM@^=FZ?
M>"Y_O5JVVEV5HP>*W42 '$C$L_/7YCD\_6KE &-_PCT-U/'<:M,^HR)S'',H
M$,9]1&.,^A.2.QK8  Z 4$XI: &D?./I3J:3\X^E.H *:_W#3J:_W: %'04M
M(.@I: $/TS0.E!SBA>E #7^\.G?DTX8"]C37."/H:7<-H]Z %&/;--'W1Q^-
M*"!VIH)V@=J '9X'%.IIZ"E'2@!<CUHIO&,CB@-^- "$>O/X4A7#9_I2MU)H
M)!YQ28$,L231R12QK)&X*NCC(8$8(([\5AZ=X.TO2[\WMLDJMO9UA#;8EW*%
M^X, X"\$C//4X&-[(SGG\Z>.>: .3\2^%I=5NDN;.>"&5C$LR2PH58*^[?G8
M2S8 &#@$#&0":FMO"EI%HDEC-Y,UU+F22]$ 5C+SLDP#D%<C'S=O>NE.<$MC
M-,W#<!3 X_2?!MW#K1N]0GLI88YC*J)9I^];9M#\C*$'D<L<ECGYJU=9\*6N
MK3^=]JNK64["PMY"H8JS$-@?Q?,WS?0\X%=!^%)D#OBI0%6QL;;3;&&SM(BE
MO$NU%)+;1]3DGK5D(!G@9)R3CK1D8'!&>E.IH QD4@I-V0<#F@9R<]128"E?
MPYZT\]*C/'3UJ1ONU0#1T(QFE7OQB@$ =*4')- #7.,9_E2G@#C/UI'(R :4
MXP,\T ,C^\3C J6HH@3NSTS4M !2 8H8X(YQ2T %%%% #5R>3P?3-./(II(#
M9QS2[A0  >O-+2$C'UH&,<# H #TIJ#J<TXCY3_6D7I0!YS(=:.C:AJ\5W<Q
M0PB_\R1KUV,@!D5 L9&$VL%((/1>^33=1O+^PFN[:6[FM )+/;"^HR-N1I"'
MD$S#*H1\A Z8SQD9])*Y7%12)&XRR@X'<9H X.XO\6%H$UB-5+3LZ)K)(D("
MXVW!7&Y0<^4< [LGI44.LS7FI0+<:O>0V4MS$"TCB!@#8[\'& I+D$CU/TKT
M".W@:':88RAYVE1C/KBEEM8)@?,AC?)R=Z@Y- 'G9UF]FO(H_P"U'DM5CN/)
MD-ZEMYZK,%1]V"&XR,C@]:LW>OZG9ZE>)Y[RV,NI6EI!*F&,#E8"RL1U5U=N
M>Q'^T*[F2UMKC"S6T4H' WH& 'XTOD0A=@B0*"#M"C&1C!Q[8'Y4 <_HT=P?
M$NL1OJ=[-%9R1I'%(X*@/$K'/'/)XYKHV< %V("@9))X%8-]KC+=W5IHMJEU
M?1?\?,SL([>W../-?J2!@[1DX]!S5![6"]9)-0DO/$+O\R0P($M$^@R$8>A=
MF/'% &FWB)+]GAT2 :@R<-.'VVZG_KI@[B/1 ??%07L%I#:*WB34TG1S@6VW
MRXI#V41 EI/]TEL^E6#9ZO=6WER7,&F0 81+$;Y%7TWNN!^"\=CWJ[I^D6-B
M3+##F=AAIY&+RM]78D_K0!DHVLZM&D5C;_V)IHX$DB#[0R?[$?2/_@62/[HK
M3T_1-/T>W9;.W5'D.Z65CNDE;U=SRQ^IK3IDHRM !']WI3A]<TV,_+CTI5Z4
M )_%3Z9D;NHS3Z *TV/-&?:K/:JTO^M&3Z59H 1ONFA>AH;[IH7H:74!:***
M8#'.,=:!S@Y_"E?M2 $F@!],'44^F 8(QUH ?2?QFEI/XS0 M-)QVS3J1AQ[
M=Z %'2D;I2 X I6Z4  /%+35[TZ@!%.1G!'UI,<]:=35ZF@!U%%% #&&/QKF
M/'*LV@8568^:.$!R1M;/12>GM]2!R.H?@9[5ROCMD'A]2^W:9@/F('\+^I S
M^/TR>*TH_P 1$S^%G.@P+XLU!9CY1\JX87&541+P&RQZ Y X[FL_3/(%S=R-
M 8TBLX[>1(I0KRNNT%E)'/S%3N']\$GUM^(D2W\21S7#!;8R[)T=MJNC+N52
M>RM(I'_ 34VJ^3=VLT:[+&[:**X:16*EQ*O[Y5&>0 V2/?Z5Z2>GJE\CF:?W
M$5M&TCZ>B;D+$@*6VXS# <+[X(^G7M5JSTEK+Q)";![N:U\D%VG79L?)!7H
M 5[=!P:=-;S*--VAEEEEF;"8Y VJ ">GRJN/\*CMM*GTW7XWLI+BXM3"9)'N
M4V8?D%3A02"N.,'G'IQ#E>^O1_F*VVAB7-Q.-)$XAD#?9N5C?"LGEE58@8'W
M1D*1SM++@$U>L6^U6UO*]R)KJ[GE:2RVD?<4A9$V\@G"_.HP0^"#M.8[:%M0
MLK61K2[D$"^3MMH5DP!\H1C)LVOM"JP4G=MYQWGU6V,>FB2&1!+<RF.[M% >
MYD8KD!]VS. ,[,*N#_%CFW)/W=G?^OZ_$=K.Y5\I+6266T6.1E7_ (]UGA8V
MRAC( WER$LBN2V H]"0N:71KK^SM0CC@GMMD8B6.^!D6# 4CRF5!M+,.<DDG
MW(P+5A:%GAW:C:R;  9H;AV@5F!P3D?*WS@X/)X&X XKK-+\)66DK#B6:5HP
M@3+F-#L&$)1<*S#U(Z_08RG6A&+B]?E_7];EQA)NYLZ=<2W5C!/+"T$DB!FB
M8D[#Z<@'\P*M#\#]*:BX'X4\=:\V7<Z$!Y[4S!+$#(I[]N"?I3#QT5LTP G+
MC)Q]:FJ$YW#^HJ:D 4444P"BBB@!O]ZD;!3!Z'@TO]ZL?7[V6ULO+CDCM_-5
ME^U2L52'CJ2!UYXZ=.M-*[LA-V5S/U/0=%BCWH$MF .VWCSL?>-A_=+U+ [<
M@9KD[ZUM5FBD^5)#(V+$A?\ 2-V"Q,ARAR57@8(_WB,KQ-<&5PT3B0J+5W:2
M:0/$4.QWPW/51@\YJ_:V,$DH;S)7CW991A/*;C[[>8^W[J@8 Q@8Q7I0BZ6\
MK_U_7^9S2?-LAKVS?8(&M[V;4 \4?F7496%U(P1O:0;"01P#\X'7.,U%9*ZZ
MA;6D=OY236LP!/S%,J%#[D'EL, *JKP,G/) JMJ7FP?8X7:&>.YMXY5C@B \
MA68?NXT[9]^7PP/2M#3<M/#9Q[U$B3N)1@J<H%/S# //+'C!VCDG-'+:*?\
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MYKA)M=T@.JP6-B[EPJ&*'SR6SD#C:,YQT)YIP$[&1'\/QIY>T,KP+&I# @
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M<*3C;M(^9%).!V]/6KIBTK[1"4@E,3G<[DI]_<6 '&.I/&>^,8%#P=N_W?\
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MOXP#G*]<&D77=:-O+/Y]FZPC]X  60C=D%1R#G8,8S][VI?5I=T+VL>S.U+
M]<_CTH#<\$UQ\>J^(719?]&$+896;:,J=OJ1VW^G\/O41\1:NC%6N=)5MO1I
MD!SM;_;Z9V?@6]J7L)=U_7R'[1';!AM/7\:!QT YKD(]<U>9R(7T]TSC*NC'
M[R^C]<;OQ ]Z2;6_$%OY:/!IXED&(T9MI=MIZ?/TW;1]#ZX!/82[H/:([ G)
MSCO4A<;>:XR?7=:@F56M[=BS?(B(6=ANZA5D)/'/IGOWI$\0Z^Z[#96Z3[=P
MBEB:-F.T$X#."1NR,C.!@^U'U>?=?>+VB.R+ #.:%;(.>37&#Q-JY8[+..5
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MS[9"02%.>I)_"J"8@5DNL-]X_O'((R<DX[DY4E"-HXR2V<1/ DTYN)H%U>/
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M,<[),0S6P=5B9F7<.=V3V+ X5ADXZ9F*"V0B.R2.5PA\VVE$FUMN'7:6P0"
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M%86VH&E)"R;>@P5)(  88X[57+*WO"37-H;&F27ZQ&Q-DZO$\DB7K%E*[B2
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MWF2-E22J;6D'"+M8*V<#*\,.HY1[FY1TM)=1N/M( 0LQ0C?A2?D*,'QO7)+
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MHEFM+C5)!:64;6008:6U&X,%8L1D9.,*.PYJVMU>6_[CSE2\\L!]MJ@CW8&
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MO_!&1SOI@U.U@M;2&?J+A3;;53H !D#W _ ]*)YM-26VBM8(9),DW$9@*J@
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MAZ<T[R((M4N-,2[NF,:C#PSE5W,.!C)P>.O;\:CT^6WA66+^R4C1UQ^_F5%
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MCCN(7,\=_<.QMWF$\EJ)&V @DY:0M@<#%6I6TZTV?;;?4MA_=*)X3B0;-@Y
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M_ ?NV*0MM0CA2Y74(?(,FQ(XV?J"1M0;"0<C@+Z'CN'+I]X^G,\?V ))\LC
M2!V;.,$E=Q;/'//:@ZG8010P-JL:M',9H2\!_=L6;(DYX^^1S@XYJ]<:I:FP
M:"74G6XSO$QBV;<-PP!&-H.!DY[<TW[1-67X"TMN9[?;#FT=--S;)&I25&;;
MQTZ'/&,#W[TWR[D7/V<K:6\J#<R)--%A2,\!2!GIQ4226=LTUW=:P#<L<F4C
M+AE!*L5V@   XXQ3[58$N7N[O6%GGDQLF4;MS $*!A0IQD_*,Y)]C6EM/^ ]
MR?G^(Z.*;SFMYH;(S*@D*7+R/QSS\Q/8'WX-23&ZE>.QEAL89%V3!%+)E1D9
MQVX!QGT[8JI;-:FXDO+O7(KB4)D2;@25 (X 4# W$G /6G0&WEOVO=0UV&X.
MTQJY(&T#<,8"@#DDY/7 [4<O7]'N#'M%<?;!$L-G;RS1Y("E1(F>,H3M(^HZ
M_6EB6[AN((&@LBSJ6BB9 B-VR%7 /&<$COQUIL*)=:U&]]KEO<3,OE1Q[U1@
M"<[=H P21WY]!34:&[O5N[_6H94CRB%<)M!PQ 4 9/ R>U%OZL_P%Z#WANFN
M(HGCM,R',!FB60D C[C/D\9&.HY ':G213-\DUI:-/<[B)Y6W,Y! ^4L3QC:
M.!MY YR*9.T,NHPW&H:Y:O#$<0@R(@4$@\8^\>%&>@QW-.N-L^IA+W6(?*L\
MLD?RH(UX')')." /KU)H2M;_ "8V2%IHUCC:SMMQ!C25G*L^.OS@Y/N1WXS4
M4\4JRA9K6+YG,8:6X9P2/=]PSZ\\4V=H[VZ@>77;5K* $Q$21J!QM^9AR3VQ
M_P#JI;^&2[N[2V;5K9K8?O+:,%/FR"H)(Y8?>^O>A1_JS!["RFXM=RM:*H)*
M &\>-"^.%)&%SC.:=?&98?(;3K:!!)\Q2;8K''"NVTCD<X/H#45V#>210)J]
ME+802!HU#QYWX.-[9R>I.!U^G1^H[YH(575;,Z8L@<$E/F=?FPSY_$X&?Y4)
M:J_Y/_+<3LK_ / $NUFA\P?V9##&P\N51<"2(CJJLI0J,G/ICKWI$BFLP^_2
MK5EV@LJ.J(3V\PA"<<?Q''&<<<.U2.=XSI\>IV9M8"DDJ%T$@*XY8ELCD#M_
MA4E_!</9/9Q7UN+-"C3D%0ZD%< L6^7) [4K72OU]1]W_D07=O<DL9M+MGCX
M8R22"0[<##,P7D9Z%L].IIUPMP()A/92,TZ,WF_;2<?* &"JNT#H,XXQ4M_!
M=SV*V%I?VC0W6-X!7>^, A"3CJN.G'/2BZM;^;2S9V5U:O!=1GSB &;;T.PY
M' &1G'Y4E:RO;\0>_P#PPQ&D@MXU.E$C8"TD5V59^.7(1<$>I/%1/;<!AI7R
M,=P,<\39&,[OEBR1[_C4DJ77]B2VME?V31SH89V)#E=Y. ISC.&.,]>M6);'
M5(M.:VLWB+2*T$_F+YC)G)QP1SAAG\^E.]M=/Q$]64EC\L+,=+.UA\K)/%EO
MH5CW'Z@TMPTLL2-%ITD+.1MN4O!([#N Q^8CCH#V]*GB@U"QL#!92VSW&QHY
M1(=[Q@=20#UY7=UYQGUI]I9:GI6G1I9&"6XV<B;YV"8QN&".I';V]Z=UOI^(
M697E,TD)=+&8PRKL837@FC(SN').[([;6!S4,(:*!6?3-]NRA65)1MQQ\I9W
M;C@9 QG Z]*N6%IJ6C64:6S0-=9VJDY^;!  ( (Y)7H.P'O@T^QU+2;!7MEA
MDN V DN<9QR0 >#VQGH*&TD]OO86;*<T1GC\[^SY'B+*?,,N!D$_,2DJJ2"3
MSC/)YYJS#)-+8L6M;S$@'S)+&D4>!M'"N!@ #@DTMG::II5D9LQM.7++'+\J
MY.22.XQD@=>!4FG6FJ6EHUR8X9)BYD,3Y";B2<CV&>/J3V%)VZ6TVU&D[B1,
MILU7^SKMD"@.Z/&4SWRFXJ,<$X_6J<D"3 .EI>NB]'RC*OJ00U:%E9ZG:K<W
M;PQ-/)(TQA?*HS$Y&!UXYQ[D^@J*TM-35KN]FCB,LTAE,/S;"<C ]<#!Y]6-
M":5VFOO!K4JVL,9CWQ6%ZRX&?+1"OI@\D&IG*S6Y2RLKT,K B0Q"55YYPH.U
M3WR #4^GVFHO/>7EQ"H>9@WD\["1MPN3R>%/YTME;:I/>7UW<6Z*\H!$/.T@
M ?+GJ<XYXQ2E+5Z[>8D5GE:X5S':ZA*I3RVCDCW# ;(^92"ISSGGW%16RJ\;
MPG3+X0^6(G1 \Q*=-@.%"Y^F<$\C)JS;6^IW.KW%W/ D1=0!$C-M*KQMR0,Y
MXZ<8'YRQ0:I<ZI+>3VXMU\L1K%%G:0 W&2!R21TXPHH;2NM/O*L9=W";ZY=&
ML;Z8;AEMSQ9*G@L K G/<;>_'6KXE,L$R-;ZAO9?D1-/)5"JA5Z@D]N<Y-1F
M+4[O6_M#VT=H@B$0CB8E2!NYR0.26&,#M[5;BAU2YU59DLTLD2$QJ$;<IZ\D
MX&.HXY]Z;:\M/,13D$#0 3V>IF=5P[_9F8CIP&(+8_$ XZ=J@BM+:.<-#;7:
M2(2%==,<LO']X,#W/UJ\8]1NM8CDCLULHXD*#!+;OFSN)P!TX[YS2[=1N=8M
MC%9&U%OD;@2V_)'S$X'  .><G/?-"?2_XB91-I9"21Y+6X9C\Q(TY]YQ[EB:
MFN)+:.T9+6*Z,^X;O.MV56'?=@?-_P "R*L7/]H7&JVR169M5@8[I%<L922.
M6X'IDYSW Z\K=/J$^H6T<-F]NUN[%YPY8SDCCMTS@G/09Q1O:_YA;3_@%:YN
MH9#L7S6C$;1B-XA$0,JQ*L!C^$=5(/(S4%N]LD:PEKGR@FUC+M=RN.0  .HX
MR22.@&<8N:G/?RW<-O#:21R12%WG$@)EX( ''')SSP,4Z_GO99XK:.VECE24
M2/<K)DN,'A .G7@'@8%%O=7^8WHW8HW,UM*-CO=,@*@M$44''/*L.,]\%AGM
MQ@2M=P/$_P"_V.R@Q*B$NI"XR9,YR<<D >G-6]5N;YI(;,6DB7'F+(]VK_>4
M=54#GV Z=#UJ/4KF_9([1;:3[4SQR/<B0;=H(W #KZC'J<T+5)?J#ZE4G2[J
MUB\^8&8@>9F .K$C.2,C)Z9SG%5T:RCEA>WO#N0XC9)'A"<'HN' ZGVY[5K:
ME<W_ -CCM1:SM>RB-OM(D 1 -NX 9SGKP!WJ+5KV\AM3;FWG>[F5?+N"X"1C
M SGG.>N>.<_2B+>GGYB:2U_0S%736$D<EU&J2X+Q[I)$8=LIA%XQW%3.^F6U
MGNL[I#)D;52$QJ,^F.5S[$=._2KVHWUS!II@>WNWNYHPL$^]56/T+9.=W<\$
MFC4;Z>#2"D]M/-=31,EO(I7;&<G:6+'KC:>A/%--NVG7N%DK_P"15DO;'"*D
M\3QE"JK%"T;QL2/F!P58]1DX.">1SF&VDLO(,#WT[JT7EM+)$5.TY4M@;BS'
M.,G&,*3G:!5VZO9;;2 ;NUFEEEB9('3:%5LG#-DCG&".#P,^M/DNFM='C:]M
M;BX9H]L9B"D!O4[B..F"<]_:GT5E^(O4HW4MO< QB\EC?A T$!;)^497E2F=
M@!'/<9Q4ZRV@AFEADBA8QCR_W;F1R!@EBH4#<<9'S#/)YJ>VNS;:-#+?VDUS
ME=J>3&#E\<DDXR,].W/L,+871@TN*75+.6Y7[A6"($LV!UZ9'4>F3[5+3Z+K
M]XU_6Y4\C3)[5=]S$KD9:/R6 QG ^[@+GV'7UIL(CMY(9(+X*(,+&HD9L <!
M<F-3@>F2!5G3KPQZ8DVJV<DR+\I$42EF;'0XQQUZ'KQT%,TN[V61FU&U=H!(
M05CB4N"20$.._3..YQTXJO>L^J3[H6CL0F*!DD274"\,J_/&URZ(0#C)PK=.
MF<CTIWV+3;&WD,%Q:RS+QY:* 3R 06;.<=>0/PS5C3;K_1I);ZRD%N)2-L<0
M,B@EBJG'(.-N<'C\:+&Z)6[ENK-TL%ER,1 RJA)VJ<<@GCW ]S2DY6:_R!6(
M[B2UVA#<V3H4=6='R^[Y<%E<_-MY&-_&>,$"J]G);QKY<FI0#"-&[%5A R3E
MC\W;(. HR54D^MNSN4?[;)-:2+8B0LFZ$&5(\C''49Y]^,]:;9W$<ES>'[(R
MZ>?FC+Q;I%3*@\')Y)?'TZ46LFK?E_5PT?4I(RR3>4][:E%B6)UEE'EX5<8!
MW8/.",8()R<=[4C0%GGAN[&(^4BMF]#OM RP!W?=#<$8Y'//0OM9HI[^[>*T
M9;(',9DARZCY0S ')_O8]<=.*EL[F&?4[I(+,?854;#+"2P&/G8 \D#CT!ST
MI.Z>VWH-6(DF)U"RE6ZBEE$3*6,@9N$/S$=0 &'7G"Y(JU:+?VVM2V-VRR"6
M#S2]N3RIW# )&0<J<8XYZ4V"\C;6)6T^%A:^6%\R6$AMP!W-SSQP.PY^E2Q7
MPGUEH+**62U:+:Q=60M)AR<=". O0 <_2E)2U5N@XVT,4I!]CMA-&DD20;V>
MX#2!$V"3"D,N JG /);:>1Q5R_DN=1BAL8W\R*(EDMV0DLPP R/P9$&3P/F&
M03N%4+V.-+*VMMQ$DL(,;O*47<5!^[N"[=V05"\;>>:MI+_9MK#:W)BV0K*8
M@@Q-*'<?.0P'EJ#@;FR3Q@'O36TEJ]1)]&/L-3N7W7,SQ27L08RS)Y6 RAR1
MM49P-HR<_P >0>@/2Z9X@_M !);;RV+!/,C?S(MQ7=LW8'S#D'C&>]<L98[E
MFCV2;S&TBEII'#J$9E+[F(;(7L."1SD8$NG64VHW"7,5M$HGV;XWMO,A4;.6
MW$C#@Y! QFLJE.+3;T*A)Z)'?1T\8]15>SA%O;11*2VR,*&/4X]:L*,#FN%G
M0A2,4S.#DC\*D;M49/S'*\4# D%Q@BIJA/#"IJ "BBB@ HHHH ;_ 'JS=5T^
M6\@$EM/);W48?RI%QCD=#D'@X'OQ6E_>J.:5(8#)(ZHBC+,QP /4TXMIW0GY
MGG%UI5W9VZVUQ;3&T$A80R*&4Y4$;I0<99Q@CKR,8SS6BE,-Z@\E(BV51D7R
M9$4MMR#R #D8WC!Y!(X)Z#5?%7FAK:WMQM9"2)2 \BA=W"$$;<'DGG@C&>F7
M;8O-(91$(U)"+Y")S&Q(91M #ABH R.&'!.!7IQE/E_>+<Y&HW=C.NH))[AI
M;^\EC:UM!%!Y-JS++&#M*MC)4YR"#W.>F,W=,^R1,]K>L()H$$K+;Q'<TX&U
M%7 Y=>2?5FQ_":BBV$(T<LC-,YEMT8J3YWE-E25X;#+%T'W@HZBI+"R@!NF'
MSYCDC21PNU, 'SE Y&W<<@\@D<@YJYN\+-[?U_F)7O="I:6FM7,$]PLJ6[!O
M^/>-7>)SR8^0Q*G.Y2,\9'8U+;?9K58+:==ENY^9UB "1'G<^. 7QCOM3)[B
MDAMULH+A9TF2T11&Q(8L</'M.[ .<&7/)R,L,!JD2SEN-6^T7N7>*1-T>\;6
M#/C84 XX;Y26.[;TQ6;DMKZ="TM;]1ETEOJFV)0[0HZHSM$#*(P,)*H/4\J&
M'7A"1S@Q)%!HL\WV=)98E93"9+?$DC @G<H .Q<J3P,D*/K/:6_DWD+;/EE0
MRRY&0%8 2+[  ;1S@;,'G&(?)EOV@B:X,4;PJ87\Q05PJ,S,"-S?O Y8Y&W:
M23FBZ2Y;^Z)?B2W@LG5['3'-V4C+1ET_UF?OJ&('SY!<?[6X?1B:?9V*K+'/
M<2Q-"K2O):[&0?PA.!N8G 0?-@@G-+=VX6XCGMXO(:3"QQ;LB%@FY1M(R6+$
M,<$'Y@1W-2Z@'E,\:RD6OGN'(90=^X J"P.-HS@ $D,0*4796OHQM7W%^T:<
M8X\2+YUWM:>)XFV0,HP@<$<+M^0YY((8<9JC;Z5Y'E7<<L@OVE97M9("D:$9
M+;I.,J,-DY.5Z#.*DN].CMK.$-'YK6J-&_SK'YQRR!F+ J,*@3' !;&0 *FN
MI)5S%'*K.85\TX 78?,P1N/REPD*Y)QRN<YYI.VD7N)]V/6XTY+9I6ED:2,_
M9U@$+!Y8WSO=5QQN)R.P"(.*HR:;;RW-Q=W4[0M 4:(6]L[+*A (9&7[N[YN
M!C!J7^S(S82"1C,TC^>9,C.P[F9 0-N"R$[@#\N"!P*6&>6*R@DMW E)D,**
MZLN?++-DKPVUP&X'4GC)(H345[K$]]46H9;=I'6]N4@NK=5N&8*Y7SUX" X.
M_:2Q/4EG/I5:2RM]2DA D-G9LC/&XA+X;@&-UZ!E^4 D<K3+73EE-S*TADW@
MQQ[BNR*16 60;&((Q)G!.1QG.<TZS MH)(U=HH5\M9#YBAD(>-1G;@*2K2KC
M (*M]X 8-(ZQ>H]UJBU:>1(8;:]D;;.# )&+G,)/+$MDKNQM4$C@D]ZJWRP7
MR@6\^8V=8Y[L*_  (5R!@LCX7U 8-V:I+>SDOM32:]5=H9?.MU4!65BJE>I.
M5RJG(' *C&*99PK%?@# \T!Y!O&-KJ"0!U^4*&R<YV[LCH9ND[IZAOT$MQ#I
MJF/[0MS;6\R&"0JX#2Y) "\@*HV.Q'''OBIKR"T@WVUG*+J2!&96C/S!7.YR
MK#JRL6; ZJW0XJNR76I"TQ-L_=JT<VT'>=J2'>2PQN;)  /W?]GA+FVCM-0\
MVSW1#K;H3G9M!8DG.3N?=TSC<O!#8JEJ]7K_ %_P0?DA8["+3T>,W\<UO)&7
MF>/?MA'3=@DAF/ 7N2>>!6D1:,D!CEA<WFV2.VW<1LGRHN[^'C"YXPZKBH-3
M>60300R,D*SN#+&GF/%M?: !N7 4#))/&_CK5>XT\Q6T:R;S)&FRX,8WF:0[
MXP5!(Z*I..O([@FD_>UD]?Z_K^KAZ+0KVUB8G@O1<QRW$K[3:*767@_=)+$#
M:0?0 +D'CF\AT]M+>Y-Y"+:/=:LJ\[@YWNX7_>PP'=5/KPVZGG>W=0?/DEA5
M9%7,F 1(&=0,%BXC7'(SGMDY@_LYC:L;B=FN"WF"<\;82<E-N>&W(1][  R#
MC(+?O:S?4%I>Q%)IK-/+<274%FULV# 9')P0-Q0\@AASG!W="!TK2LTB,T^V
M:&VGM"EW+'(X!4J,)&Q^C'<>Q91VJ.":6&QA:/.]-WEPR+LWX174,IR5V,Q.
MWD >U1P:=-(;DS.[;V_T:-@R>3-NQDALD@^86R,$XR><4.3<7S/;^O\ ,%HU
M;^M"K+IB7DD45G-%;0&(2I),S!9%#';]T@AE/!&1@\X-7[""*YD@LY)4BDNH
MWAC8,-SJ3^\D4X'!QM4X&XDMC IE@#'&\*22)%O3$KJ4;EDC/&3]Y6'S \D#
M@%>6PI-J-['-=JUO9R;1+#&6'RNJA<,0 =I*K@?=+''.32DVTTWL"2OH+J,*
M7DX,$D >68Q27'F?(CA<,I(S@-M!!'4$C(Q4=O''8,%F:*4V\T8699 4:0$^
M7&#U)&%8DD[5)%3VJ2QWCI(TI+_>)!"QY!9<$D@[2!QA<<X!4U7N&NKLP^4B
M)Y:%FPC$2#"L_;:NXG&">0 .G5ZVY;Z"\RQJ-A!:0RVQ=)I[2-49]P)1"Q*R
M,/12S[A@\8/ YJJNG?9/-AN[FWEWQ22/*DH=8%/WW8XW=SP.&)&!C-32P?V9
MJ3F!I6ACW&*)LD.JJVXL>GS;6XQR /F!(I^I/*5DMH=BL)6!N-K';M>1$R%!
M)P$9B3@ \^E)-I**>C&TMR]);0LD1<*QO/\ 288%D&_&W:54^OEA#[E6'0UC
MV=A(KP7<DJ7,-QL"QQ2(S-S\H"E1C&3],'/M)+I[6X@82R1.$4W'7B4ED !&
M<!2I.>?F.>I-6Y;EDBE?RTWO$2VWY?*RK[VRH)Y*\8!ZMCUI1;BM'>XV/:U@
M^R"X%Q!]E.ZU+L_RF0R;]P/7:)/E]=N3[UFFPN6:XN89/(@MG*M'-,@:,_Q
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M=\D3R*"&V1,BH#M^?:(\MQW8$Y%%[(+17OK1;:U6?Y83 I$2XX,F.,L<;5X
M'S-Z$K<W\=W=?9A;I9P&%5_='<R$'8DPXY3!QT^:/))^7;5;NZ6C_KY_\ 7J
M]2*TOI)YS]E,D3.X,D@5T:887+#  '.]@K87+9(ZXE@1HBTD5O''.L<$FV%
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MK"B@-,^[< RJS%7W#8/G;&!_#SDD5:BF@L)+>"[#?9VR92Q3='%C<0R_Q,^
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MKX6)W6\W7+M&C2 +*W/E%D*J3D[6,J$$Y(!(SP*KKIB6WDRLDD=^)"T@F5#
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M2P,LTT4T$<DPC,3$7#EK<J=NYR23@\MT_N]:[/PE;JMA-,S^:6<QAVE,N0H
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MX^W[2_VA2<B7;@,">>F!Z8XQCBN3"W+>6D;7#W,Y26"66Y&($/*JQ4 *<\8
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M.*C<Y!Z9Q0P"$'9S^&:AMK"UL6<VT"QF0Y8K[=![ =AT'-3PG,?>G,>W>CH
MG6JRV-NEX;H1_OB.6W'';.!G )P,D#)P*L\X[8HH0"J..M5)]/MKBYCGD3=)
M&000Q .#E=P!PV#R,YP>15L''TIIP>E%[ )(/W8 JO/8P7T"QSJV!R"CLA'&
M#RI!Y%6).$XIT7W ?:CS $C5%"J % P% P /2H;VWCN+=HI%RC=0#CW!!'<'
MFK-1S?<H\PL165M':VZQ19V@DY8EF))R22>I)J4H&4C P>",=:(ON]:<I[4
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M!SCFEHH *3:,YQ2T4 )@>E+110 8%)@>E+10 $9&*0*!TI:* "D(!ZC-+10
M@4+T&*7&:** "DP/2EHH ,"DP,Y[TM% "%0>O- 4#H *6B@ I"H/44M% "
M# &!2XQ110 8HHHH :8T9LE03]*=110 A (P>E  '2EHH *,9HHH 0HIZJ#^
M%* !T%%% !3=@':G44 &.,4@51V%+10 =:0J#U%+10 F !C'%*1D8-%% "8
M[4M%% !UI H':EHH *3 ':EHH 0J#VH"@'(I:* $*@]J4 #I110 A4'J*38O
MI3J* $  '2@J#VI:* &A%':E*@]12T4 -V+Z4H4#M2T4 (5![4FQ?04ZB@!N
,P>E.HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex3-6_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 :@ !  ,! 0$! 0$           4&!P0#" (!"1
M 00" 0($ P0&!@@$!0$)  $" P0%!A$'$A,A,4$4(E$R0F%Q"!4C-U)U%C-S
M@;&R%R0U-CA#8G1R@I&3)316H<$84U1VDL(F16/A_]H " $!   _ /JD
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5;J5<MCLK$KG/2*1(6*R5&+PKF+WGC+U;PE/$ULM8PN;CH3]GAVG5V>&O?\
MD\ON%SV%S-/XS%WXK</<K>^-?+E#M()-UPW]+WZNOC)>;52QRK42-6$Z
M
M                      #-^L>$SV6T>U6PW<LR2M?-&UW"RPM1>6'SMTCZ
MO0ZA!)A<Q7>M#O<]CXV\R1R./IC3<)C&9?:,MC[$-BAFG5[+5:_O5SE1RO/#
MJ72JT>E^P5JT#(8(L?V0Q-3A&-13*/T8?_D=I_MJO^#SZ5KU*E1)DKPLC\25
MTLG:G'=(_P W.7\5,CZNNS&<QF1P&(9*Y8::V;;H?P^Q _\ "0I/Z-NS,?CL
MG@9[,2.BD2>K#]]6N^VI](VJU2RL'C0LD6&5)8E<G/9(WE$<GXIR?*GZ3W^T
M=7_L+)N^A5JESIKK56U R:*3%P(]CTY:4O\ 2-_=_#_-(/\ (\J?3C:(M=Z,
M2VF7(8K?QTK*['^?+WO-[FU>@NW5=E8]K)V4I:TC49YS(]6JBJ[_ *>TG#YY
M_2.VF[0Q..P<'+&7^^2:5K^.61?<-)Z1XZGC.GF!2OS_ *Q6;9DY7GYY4Y<9
M[^D?B*C]:QF9^=+=:XR&+\&2\N+ITRV6[L739ENZKG3QPS0/D>_O=*L3>.]3
MYI_1[L05M\FEGE9&Q,7/RYWYM/INHRIU(U7+QSSPRP?K:=M*PV/E&LA?\CVF
MC&/=2-7J[5MN)Q4W:BRX+(+%(YG=X<B/BX<8-I6RYOI)M5O$YJGQ4L/9\3Q^
M'I+&?2RWZ&1ZB:G;HV&3UY<%?='(ST<BOB*Q^D;^[^'^:0?Y'E3Z<;1%KO1B
M6TRY#%;^.E978_SY>]YO<VKT%VZKLK'M9.RE+6D:C/.9'JU457?]/:87^D;J
MM9:%'9H/DLQ3M@D[&>;T=YHYSC1>C^ZILFFQ2V['=<HHD5I7/5[_ ,)'_BXG
M-82/*Y"]LDJ=S)7+!C?=$K-_YL:_2;R52TY.]7QV.M7;$C60PQJYSG>A\/;S
M8VG [_B=DOLE@LV4BM1-G^9(/K"GX1'W/1O5,A3KW*DS9:\\:/BD;Z.:[T5#
MY1_2>_VCJ_\ 863=-)H4\ETMU^E;B9)#/B(6.8].47EI\T=-+US2^K-G7(+#
M[%66Z^E)Y]C7*Q?*56GV7D[U?'8ZU=L2-9##&KG.=Z'P]O-C:<#O^)V2^R6"
MS92*U$V?YD@^L*?A$?<]&]4R%.O<J3-EKSQH^*1OHYKO14
M
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MKC&.=WP77RKV.]4[%C0L/Z.^SV<GK5S%67\KCI&)"YS^55CS>
M
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MM=!9]9R\&3QNX3QSQ^O^JIP]ONUWSF\@
M
M       <CD<@<@
M                                                       <G/8N
M5J[%=-,QC43S5R\%#R?5'3<<YS'9)LTB?<A3N<4?(=;8T\L;@YYOQF7PBL3]
M7]RF5?"Q]*!/Q>KSA=U.W]_/%NHS\$BY/+_23OZ?_P"2K?\ LG1'U3WR+[;Z
M4OYL[28J]:=FA\K6#KRI]63%NI=:L _RNT[=9WXL16E_Q.Z:WE^$I96"1?IS
MPI:6R,<G**BH
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ML^E,OW_M0FR4[].Y"R6M,V2-WFCFKSRAU\@
M
M            C\CE:6,K26;EAD43$Y5SE/GO9^K>1R$CZ^ 9X-?WN/\ 5?\
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M*5]?N.^P_P#\*FL-?SYHOD?T
M
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MWJMZO'8KS-DB>G+7-7E%0ZP
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MU2G;+#*G<U[?<[@
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M>O@N7[S3ZWK6H+,,<T,B/C>WEKD]%13W
M
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M7'6V:[?E_8/_ /DI%_R'TDUQ_0
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MRH0O"R,1$>UDL:HZ-S?+M<T^L.G&UIL6!B?,O%R#B.RW_K-#
M
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MM<06F\^GT<?8L;N?Q/T
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M=9J<03<^:JYGN:.
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MV3X_EJ09"'O3^TB/J5H
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M?BWU!TG'79*=O-P168WJQT;D=SW-/!.I>AQHU%S]9%<Y$\T>A;@
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M'7=7Y>CVJG,C>U4X]3@K7G4+N,R5>)6K5LL>U%]F^A]S1O[V(Y%Y13]@
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M[U.S6H4*RLH34V7XV=_R0/\ O-C8><,S]BZT2+X$=K'X.B^-LO9Y06Y#8P
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MJSV,K?G=%#*Q'I65/HXT/1:6.TW"8+67JLF0F199H8E\3A_WY?;B-#0@
M      I\E=25;9ZAY5Z+Y100QE*A@AA5\2><D3W->XZ3FM1SNB<L3N.SYW_^
M%/)2-H9.?#Y">S1=SPKD8[V\U]3KIW(LCD9[5GCXOE)$7V7ZEQA:R3M5/KZF
MQ8FQ)+0A<YW<O;PY2;I5[/CLD8U$1J\\JI-;+%$_$/FD;W> J2M1/XD\BI/A
MLO<WP:C'H].5<]>&DW6P<DTB.L3/?S_R^>(O_3W4[\C0?%7EFCLN8K47CA"
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M_D:[XFS0K'BTD_9+\(GIXC1T5YOT=BVB3F)^;R;Y5K^T?8;$
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MYK6JYRHB)ZJI_*=ZC:23X:PR3L7A_:O/ 1[%541R>1_0
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MO]X   #G-;]IR(.47W
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MQRQ\?EROT5"GUX'OGM2+Z-F;V_DO)O\ T1K.9C,Y8_\ VM__ "<FY
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M+&*@EL+AYWPQ1L?+)]UJ.+++L#&Y+%UF5I7Q7(W/;,B?*SA4\G$F
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ME..QKVKW_P""%>TS#.?A</!:H9.>[61B25;"]M:.1/5ZIRXWD
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MQZ4H'\JG"O>OFGY%4CM2RR*]&\1+%_\ =I]+]%XGLTJ*1_\ SK<TO]SS6P
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MJB!%10
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M"=970*U)?+CM5WH2H
M                 !XWZ#;=.S#(B=LD3FJBGPU)CY<9/>Q4W>LE*=T*]OWF
MM\D/["]RIP[GN1?F\N.%^B'2<MIBJU)$7S:OUXX_$@&0S/G^$8_M9*]%1.Y5
M1%]N2U/QF0U:[5?9XXD\Y%:[R_+DU:#]6761SU5EX<U%[GHB<<^WDJDB]*;V
M\+.KG\)Z^:'+/0H2.KJL4"\N^=53S1JE>R=2*KDI%J0JM98F]G"<+W)Z(AYN
MN7W]LDT;8N&]B]K/FX4_-6S9Q;9TC:O#'-[6/3CG\3TR&8I2.B1D'SNLI*YB
M.[6.1R+_ ('1:NVUH1KWI"K6<N8QZ\O;RG/]YZ79\<V&5RW)V/DG61&*U%^5
MW/8U5Y]B2QCH4Q6$2-ZJ_P =DDRKYKSVKW*I)YI<9DZJ5YK+D;XB/16_5!AV
MT\=2;7BDDD8SGA50JNNRM^+MN<U$D=>E5OY*I)5=:MQ9^3)-D8J/D<JQN7RX
M<<EB1S;.11T;/.W-RJ>WF<D5FJF(A^9$D6)B<JG"%6S>2?7A6-(V=ZKQ\K^%
M\R R.KWZV,9EII&HV3A53GE_>I#5$D<]\CN'.?Z\N7S3Z+^986IPB)ROD?U3
ME=XKWJU$D[$5.[A>$1?NJAJG2##+=V'(9=_V*<?@1_BZ3S7_ "GTPWT
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M'C>#Y(\LP
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M^+X#'KSV-<XNM>O!6A9%#&V.-J<-:U.$1
M                                   "L;=@8,]@+M";[[.6.XY5KT]%
M0^..RTU9:]KNCM5WJR9/='-\E5#VJ3/C5O'+53T_ ]U<Y?55\CPFC:]/54.&
M"Y<Q=M;M63F1.>Y7I\W'U)RK"N=OOR>0L.9XLCG1,5RHB)_XO9"]U9VU610)
MX3XOE8V1DBO[?_%RB$[,R6M55Z->YSG(C>QWDBGC<=,Q*:P(UL;W(Y[6^CGN
M].XG*E9CZ[HXI9$X<JHQOEPJ>O*>RH=M;'QL<LCVIXD*]\347AK5=ZH<->2U
M8;6\-J-?]AR*[A.?Q+I@YY'M=Q82/GCY53DG+/QD3%>ZTSL^JL*=D,PL+955
ML4G:G**C$*?2OP-CL/M55ELSNYB>J>36N]N/8G:.+P;86,L67J_U5%;RQ."X
M4<8B,[JV0YC=PJ-5O)RY"!:C7S3K"_N=ZHU$55*K;R]**/YJ_<YRHC&(O:JJ
M9[M'P>02!+,_#_-GA12*YK$]_/RY* N0S6%;)C:LJOKV>U\3U]'QD=3K+&U4
M[EYY15[?15^I*(B(B(GI]#H^*F\-T:RN[%3CCGR\B*?^VD\N>./IY%XZ=:\N
M=V>-[F\T<?P^1?9TOW6GUPQ
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MR7@\GWZ3X7R?">!,Y/M,4KB.R60D\"LCI5;]J1WV&?FI_,W@H/U)96"P^>W
MK))9_=S%YY:PR[)XV5\]!D+%C1S.6<2JK>Q/1W_2A"YWX>6Q3K5W]\=6'PU>
MOWQCL=+<G^'@X[^.4Y]S]Y&C-0MR5Y/5CE3\^")GE1/)$5R_@>+(Y9'105XU
M?9L/[(FIYJJN]SZ_TC6(M;P-:DB]TWVYY/XY%]5+B
M
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MNXY^I&*Y6-?+*Y6M;S\O/U]C>.E.EO9QL.2BXL2,XJL7[D;C>49P
M
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MX^HV1M:B(B<(A^@
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MXUBHL4*^LY]1UZT,$+(HFHR-B<-:WR1$3V0]@
M
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MQTL[_E9&Q.7.-NTOI3+(^+([&QKG)PZ*EZL9^+S?XXVL:C6M1&IZ(A^P
M
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M]BP0+5IK]JS+ZJG_ $M/HG5- P6M-[Z\?BVE^W9D3E[B]HU$
M
M                          (_)XG'Y.L^M=JLGA=ZL>G*&,9OHQ4XDEP=
MU]5WM _YHS*LIJ.W8=SGW<2Z1C4X\>O\Z<%69+5[_E>L;^.'<IVN/1D+NU$;
M(U./?[2J?O\ UCCY47G\5\E/ZZQ:[6M<UJ(WT^95/:'(W8$<D,W;W>J(Y4Y/
MPMJ^_GMX1%7YOG4\^V9Z\(YS?KSYGY^6-W<Z5&+QQRB^HJ,6Q(D5&K-8D7R[
M8F>2F@X;I?M^25BV6Q8ZO^/SRFQZ]TLUC$2,L/A6W:;_ ,Z;S-+[$1#^@
M
M                                    =J$#F-1UW*(OQV,KSN7W>Q%4
MH-WHSJ$W+JR6:K_;PI.&E<GZ(_\ [OL4[?P?%WD=+T:S[/ZK.1/_ #AX/%.C
MFS^^7K<?@P[(NBV4?_7;$C?_  P$Q6Z(8WE%MYJY-^#?D+30Z4:32<B_JULZ
MI]Z?]HIH-7&4:,:1U:[(8D]&,3@Z.Q
M
M
M
M
M                                         4#J#U!FUJQB\7C<<M[*
MY!ZM@@YX:<%]>JN'PD&46_2R-F'A]O&LKI$CF\<N2.4D,%MUK=-)9EL1;3'6
M6\K,CXDGX=&GFPS#ISONZ;9C<W?O[+4QT&/="CG_  +9$XE-)HLZD=FR09#*
MUXEJRQR4+C:C7-FAX>KD5G)FW3G?=TVS&YN_?V6ICH,>Z%'/^!;(G$II-%G4
MCLV2#(96O$M66.2A<;4:YLT/#U<BLY*7T>W3=-V?D+5_+5HH*,L*/A95;^U:
M_G[Y//WK9MDVN_@M9K1UZM"PC+F5E1)$;]6-8>^X9/J/J^'EL5YJ^61[FM=8
M2!(75/Q\-.Y'H4G,;IO^/ZE8_4$SM5[+*P\V5I,Y;XA?V3[^S.8I:F;J97&?
M'NK9/LJ-ADA<PTJQ/'7@EFD=PR-BN<OX(8[K&V[EO=R>UA?"Q.$A?(QEJ:))
MY;#O;Y#HJ[YL6"W&IK&SUHI8[KY$I9.+AB2_1',*SU6WC=],S.*@I96L^#(.
MD5C'U6\PM:XM^<?U%J164P^RU,C<J20K9IK1;$Y(I34;"R-@F6).7HQRL3\>
M/(P'<-GZEZOH^-S]G+P);GDACFI/HL;X3I&JI:]>O;_?Q&J9=<Q%8CR+H76:
M[*36^#%(Q55_?R4O*[KOV-ZFXW45SE66.PZ'FQ\$UJIXA(=8-\V[4,WAH<7>
MKI7OL7Y'UT<L:L5$.SJ5F]]TG7696/9*UISK<<*Q.H,C^VBGOCLKOF2US%VZ
MVUT?UI?QGQE>@^BU$<B<<_/R:CK=K+3Z]BI<K&L=^2JQUIO';VR*GFG!)@
M
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M
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MF\]'6CC2-D+;[T8UA8=5U7$ZKB6XS&-D2NDCY.)']Z\O),
M
M
M
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M\4>I[=-,]L.8UF2QGV-9D(KL\$K$8C.U8BZ@
M                                                         '-G
M\/2SN%OXRVKO LQ+&]6KPI\,YC5-YZ5Y^3*4?%6M#)V17D;^SE8_T:]#>.F7
M4?#[GF<8[(PS1Y^K1GC[V\)7?&]6<E(_2>_VCJ_]A9)C";7/+4Z1X']46HHE
MEKRK:F3M:]86*U/#/I*U5KUXLG<AB:RQ+!^TE:G#G>$U>WE?P/BCH1_\7ZEO
MMY'_ %J?X2>QXLOSN\;EOSGVV>$6-J5LED;\2.2>XV%LRJOEQ"BHWA/[SX>?
M=2CUWMVU@FF2+/SO6.)O,CB_;UO>,ZEMQVJ85/AG264FDFO_ +#A\?DC&\=Y
M]%:9J='4->KXBK,^5C%5[Y'^KWN]5/CE;2U.O5FPE>:=8]@F7PH4YD>?2W3[
M-OV':-_FGQTE5&35*_@3?;[8T>WEYIU6I4H58*M6!D4,+$9%&Q.&L:GLB'RG
M^D]_M'5_["R?0O3+]WVJ_P L@+'D[U?'8ZU=L2-9##&KG.=Z'R;UBU&W+JN/
MVR_XD61FM+\16<SET3;'+TB5_P!(>#9>B6TU<SHU&LG8V?',;6DC1>5X:G#'
M$/\ I&_N_A_FD'^1Y0.F'5'":;H56ODJ5_F2U9=#*R)%B>2?2_3(MDV6UO\
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MM[)'^*Z,V&O4J5$F2O"R/Q)72R=J<=TC_-SE_%3]
M
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MN79+V=LU.7XJ*2**E/V<)*]O*2JU?="W
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MO_I7&?\ L-)_&8G%X:HE3&TH:L".5R11-1K45QU
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1C(WQIV._%'<FE@
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MZTX>>(N7<J\N
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ML^OL9CJV,H5J5=O;%#&C&)]$:
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MPW0NGF/Q?4'9,I7X6O!(L=9/9JR+RY#<P
M
M                4GJ3C,_E=7O8G$U(97W(_#D?(]6=C3*^DVC[SI5^REJA
M4DKVE;WO29W+.T^BC#-UTKJ'/O<&<P.0C\%&-3PY9'(C37=:Q#\+BF5Y9O&L
MO<LEB7T[Y7^;G$L
M
M            #^/>QC5<]R-:GJJKPB".Y2<Y&,M0N<OHB/154_H  !_);$$/
M"2S1Q\^G<Y$$<L4K>Z.1KV_5J\H);$$/"2S1Q\^G<Y$$<\$R+X4K'\>O:Y%_
MP/Z ][&-5SW(UJ>JJO"(([565W9%8B>OT:Y%4".U5E=V16(GK]&N15 9+$]S
MVLD:Y6KPY$7GA?Q CM597=D5B)Z_1KD50
M
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M3AR->G*<HA[@
M                                              Q_I7_OEU4_G;?\
M9#BK_P#$1=_D ZC_ +UNE_\ ;3D'U(UG7_\ 2EH;/U55[<C9G==3L3B?\7DI
MUTPF(J:?@GUJ$$:U<G6@KJUO'AQ.YY8TM&^V\U+L>"P5"K5LP6:T]B:M8F6!
MDJP.8B(YR-=RGS?9(';M;ZC[+^JWIA\/1MTK3)8;L5U[IF-]VM_9H;6>.2R%
M/&4+-ZY*D5:!BOD>OLA1M-Q;;U_(;C;:Q\V31B4>8D9)!3;]AKOQ=]XHVUX3
M&[OO*PX1T]/(XF)WQ.8@_P"5,WR9 .F.R/P6=NZMLM&.MFYY4<EUK?\ Y_\
M%[O=QO !F67B@W/98,9'/#)B\+:27)1OC[O$M)RC(V_@GGW$#U'8]>JG3!W"
M\)/,7CJS^[G9_P#LSWZ<\LT#5F.;PJ8V#E"E]*_]\NJG\[;_ (R$]U(U'*Y:
M7"9K!I$N7Q=GO@\9_$:QKYO*;U!W#+7] M4[6MW*%N[&R&7XE.V%'O\ N1.;
MRKW&M:=C+6%U3"8RTK/&J4HXI58O+5<Q":
M
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M7VG\1>WEY<
M                                                   ");K\T^6^
M.R60=:9#,LE*OX:1QP?BOFO>]/9Q+
M
M
M
M
M
M
M
M
M
M     QSJKGMTTW#OS%'.0/B?>9$RL^FWY&OY7[?)(=)-BVG9\(S-Y7*POB=)
M-#\*RLC/-GH[O-3/'*LMLQ=UU2PV&PD+G1RJQ)$:K4Y^RO')\Y]'^JVW[9MK
ML;E9J[H$I2R\,A1B\M/I(.1RM<C5X7A>%]>#Y[ZE;9U+TZQ2BIY:"^DE6:Q,
MJTF1^$R%6M+STDZC_P!-<-*EMB,R%16MG]FOY]'M/?)V-Q9O%'$0;##'6N5;
M5IO-)KEB;"]B)'SW>?VS1   ?,?47JAN^J[Q)AZEZL^JY8GLYKIRULI].
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MD:^54K\N]VP^:,)H
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M/9/# V>N^=[X^./*:7Z]_N6[?:_5AV[X5=>D>F,3CT7B+G[_ ,0;4
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M_P!7]OVRS]/LQF\3M>9TS/96;(V8V):I67^:K![]ZFN
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M6W[*[M+Q%5? M.@Q//QX?:<U(
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MBN/U>PV'MWJ=ZS1@FM5%5:\SVHKXE7W:IT
M
M
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M.!+8@AX26:./GT[G(A^6W*2-:Y;4/#O1>]/,_4DL<34<^1K4YXY<O!_0
M
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M)_'56-L*G_/=Z_.AKN*J6*&+I4[%Z2Y)!"UC[,GVY7-]7*=(
M
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M-75>5B>J>;3K
M
M
M                          !YY?-8O"U$M9&TV"'O1G>[E4[E_(J475/I
MY(O9%L=1WX-[E/1_5#0F.8Q=AJM<]>&HY'%M   #G-8USG+PB)RJE7QW432+
MUZ"A4S]66U*_L9$G/<YQ+W=CP./R%+'V\E!#9M+Q!$YW#I."1#7->U'-<BM5
M/)47E%
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MZYAM<9G[%OOHR-:L+XTY67O\T1AVZOL6)V3#U\GC)5?!+]4X<UR>K7$@
M
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MX-%UW!X?7L-7H8J)K*L:?)PO*O7W<Y?=5)
M
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MT\UW):SJ6/QF1O+8GB;Y^[8_I&S\&EH
M
M          !#;EKL^S:_<Q#+_P (RSPV63PDE56>[4150I73KIF_0IKW@9UU
MJ"RC?%A=71GSL]%[N33@
M
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M;V3<,+> >='(T;L4LE2PR9L<SXG*U>41[%X<T]
M
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M'9=5K(_NC5B)+RS\$4X^F'45N]8NY8=06K/6E1LC.>YG#_3AQ?0
M
M                       #Y1_2>_VCJ_\ 863Z%Z9?N^U7^60'SU^D]_M'
M5_["R=6__P##]I_YT?\ (\:I_P .>P_G9_SM.K]&1C'X_;&O3E%EK?X/(/\
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M7?4)M2EQ*?T86I\ DCO*LG#$>3(
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MTQR3R*[F61[_ #61SO=RD'TZZ=8_0\?<@@N269;,C72RN;V<]GIPTNX
M
M                                 <UKVN:Y$5JIPJ?5%*;%TSUVK8GF
MQ<M_%),C/$BH6%K1N[/=6L)?&ZKAL5:6XQDEB^K%8MZR_P 6QV+]Q7KY\$V
M
M
M
M
M
M
M
M
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MGHXMX <YK>.7(G*\)S[J5#9^H>KZI(R'(6)'6721L\")G>]/$]'%O
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ML1=QM[<HUK68^R7C',:O'Y]Y;M<QD.$UW%8N*SX[*M5D+9N..]&)QR2(
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M_0
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M!3MMW_!ZA/1BR4%UZVD<K%@B[T:C/XBXT;U3(4Z]RI,V6O/&CXI&^CFN]%0
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M0.H746?48H5BP=FQWV88O'?PRO\ M/H_S7N+^
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M<;J,.PT</>MQ3TDLQ+V(V-C5]IEY^4BX-_V[(:S6S.)U!9&)42:=D\RQ=_\
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M'7,9:[/&J89D,BL7EO<PN73+]WVJ_P L@*1TK_WRZJ?SMO\ C(<5?_B(N_R
M=,\E1K=0>I5":=C+5C+>)#$[U>QCGFB93^CD6PR(F/:N7LXJPY+38T54BBX1
M6.>9WTOPV/S>E8N:+.Y^%\$2030LNOB:R2/V8PT/4]?UG 7\^S&W)Y[DTL4M
M]9IEFD[W<]JJ6H Q+*__  +KECLG=\JV5QJU*[F^TC>/MFVGG8O4ZTE:*:=K
M'3R)'$U?5[U]D,AZ<YI).H74:C<NJMI]]JUHG\\K! KT'73!IDL)A'UZ*37_
M -;P0P.1.9.'\N<U#DZC_O6Z7_VTYV]?O]S<=_.ZI;.K/[N-G_[(HUW_ (=V
M?R"$N^B?NMP7\D9_D*K^CW^[F#_OK!Q=/$YV+K!_,W?X2#I?AL?F]*Q<T6=S
M\+X(D@FA9=?$UDD?LQA=\'KNLX+^E<>,N33W)FI+?6:99I.]6.[54JOZ/?[N
M8/\ OK!P],\E1K=0>I5":=C+5C+>)#$[U>QCGFH2?T=BW*NWX!GZWL4I'?%-
MC3E(8E:BL>\S7IFZ)NT]6G2MY8F7Y>GX?.-4GDV;6\C-@F183 ,EL,BAKLXF
ML)[N5?+PG'ET,_=3-_;7#M_1[_=S!_WU@V 'S[?P>(S?7J]2R5*&S N!1W9(
MWDZ-96OTTW=^L? .7&99Z/IWE;P_O_\ V3W>Z--,ZG-1N@;#PCO*K]W[7DY"
M*P^NXG/8:ID:VR;&M:W CVH^^_GM?[.,QZD8;6\'TQJTL#,Z2E6V./Q55_B=
MCTY[SZ!?/@,SK\D[U@N8V>#O?SPYDC/4PG;=AH5L]TGGJ/DHX%_,_@.3LC9Q
MPC.YI] 9VI5NX;(UK4#)89*[^^-Z<M7A.?,^:]>HVJ?Z.F:^(A=&LL4TT?XQ
MO<WAQLV@N>SIC@',7AR8:-6\?A&5CH5>LVM&?-;G?+:?DK+YG/7EZO<OJXC:
M_P#Q$7?Y *__ !$7?Y *_P#Q$7?Y .H_[UNE_P#;3GOL=2SA.J]#/TXUOOMT
M'06*$/\ 7QQ,XYE8A[VL5F=NW_!YF;%V<;0PC5?$MEO$UB23V[!NVASYK8KN
M9UK8I:.>JU(XYHFKPCVO\V(]QTZ!O.PV,_D=4VJJQF6KL69DL+>(9(35@8EU
M'_>MTO\ [:<VTQ+:.,[UDU&E1^WA8I+-MSOL=C^/)HK_ /$1=_D!Y=2J2ZUN
M^N;NR66.LLS*>1['_.]KOL-1IHNOM;E-FSN95O?#"]M*FY_FZ-8N4G[/HUZ\
M% K_ /$1=_D!XYC1<]'F,OL.B;&K9Y<BY;M&3E('S1\]_>6C0MVO[/KV;K96
MFZOE<8UT%YG'#>]6J9?H]FY5_1]SD].62.=CK78^,V;I1>J7.GNN+7F;(D-*
M.&3CVD8GFTI6*P;X.O&9NU*/953$HMB5B<-\:?AWG^+CIZ5_[Y=5/YVW_&0X
MJ_\ Q$7?Y ;:"E]6?W<;/_V11[O_  [L_D$)[U-=Q&R=(]0Q5^\ZHLT%3X69
MOM8[%[2OKGNHG3C*5(]AM.RV FMOB;<^U.WO^PKR8ZC_ +UNE_\ ;3DAOBTV
M]0]-AM6[]6.Q3MUV35)%A<DCWLX1SR6V'0-8=C_$SN=R\E.&9DO%F\]S$>A
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MG=?7P33O\"/ N\!CEX:CGJSGM/7K]_N;COYW5-@
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M72%B<?5B/\U-'Q=!F,II69;MV$1[G>+9E6:3S]NY3V
M                   /#.X:AF\/<QEU'_#68^R5&+VKP0>IZ;@-2I35<16=
M&R5_?(]Z]SW_ $Y4L8               %ZC3R%2:I<KQSUY6]LD3TY:Y/HJ
M'YJU*E"K!5JP,BAA8C(HV)PUC4]D0_0                   *7;Z8ZW-G[
M.=@?=I7IVJDLM.=8.[DDJ>GT*EN"S-D<I=="[OBCN6G3L8_V>C7>CD+$
M
M 1\F=H09RKAW=_Q4]66=G"(K49$K47N_'YB0
M
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ME\/N/I"I'9AJ0LLV$GF:Q$DE1G8CW>Z]J<\'Z
M
M                 !B74?\ >MTO_MIRQ=8?DU>E;DQ;+M:GE8)[-=_V%A1K
MD57B37NCD>(7++BL(M/P?%21(F>;"F]6;.,L]+=;GQM9:])^1I.@A5G9V1JU
MQM^:R..Q^"O6[-J..!*[^957Y?-#Y9L:YEZ70?$<UED5,M%D'MC\U9 X^K,%
MF*&9P]+*4U=X%F%LC._A'(CDYX<99HF*M5[G4W)/5BP7LI/X''OX/>>7Z/?[
MN8/^^L'%!_Q#W?\ ^'S;4L5^8T\:/E_V/F3YOR
M
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M
M                                          B,KI6I9BXZYDL%2M6%
M:C5EEB1SN&G;C,3B\-42IC:4-6!'*Y(HFHUJ*XZ@
M
M
M
M
M
M
M
M
M
M
M               "/V#&_&8F=B7+=9T;72))6E6%_+6KY<I['R+T@SNT;9MC
ML;E-HS*P)2EEXCMO8O+%:6[<=GW;I?LL/.4FRF'NO\1C+;EDE8UGJSN4^EL'
MFJ6;Q%+*4U=X%F%LC._A'(CO9QZK<I,<K'6H4<B\*BO3GD_I_%N4F.5CK4*.
M1>%17ISR);$$/"2S1Q\^G<Y$"6:J1)*MB+LYX[^Y..?IR&6JKFO>VQ$K6_:<
MCD5$_,16JDCE2.Q$]W'/#7HOD(YX)D7PI6/X]>UR+_@&V*[I%C;-&KT]6HY.
M4#WL8U7/<C6IZJJ\(@CG@F1?"E8_CU[7(O\ @%N4F.5CK4*.1>%17ISR)+=6
M-_9)8B:[Z.<B*5_:=LPVKXJQ?R%AK4C\FQIPKWO7T:U"%Z8[M+MFO+DKKH(9
MI;LS(X&N^RQJ^32Z9/$-R=1('7+E;YT?WU9EAD\O;E#XOVO:>H.I[)-9@V&_
M-0CREJ&O%-.^5%2L_CB4^L=9S]/=]2KW(K+H'6842=*TJI)!)[M1Y#Z%CYDF
MS5J?-92RM;*7*C&6+3I8TCB?PU5:[W+['<I.<C&6H7.7T1'HJJ%N4F.5CK4*
M.1>%17ISR'VJD+NR2Q$QWT<]$4+:JL1BNL1(CTY:JN1.?R/[)-%$WNDD:QO/
M'+EX0\<PQ+6&NMCLRQHZ!ZMF@D['IPG/+7(?)G0W=-GRNZ209;/W+%9,=,_L
MGF5S.4<T^N(YX)D7PI6/X]>UR+_@?V2:*)O=)(UC>>.7+P@CFBD9WQR-<WZM
M5%0_,=VDY4:VU"JKZ(CVJI^H[%>5'+',QZ)ZJUR+P9C5V+,;?MV6Q>+MI4Q&
M*?X-Z9O]?-,OM$OLWR-.DFBB;W22-8WGCER\(+K(;U22NRXZ)TT?R20OX>G_
M %-5#.M9W')1;;DM1STD<MZ)OCU;4348R6!?XF^SS10  '-[FN;RJ<IQRGDI
M\:]4,[M&M;TF'QVT9E*OAUUX?;>YW,AL'4+ [5KF*3/:]M&4>M#YYZMN=\[)
M6$_TDZC_ --<-*EMB,R%16MG]FOY]'M-*EL00\)+-''SZ=SD0_K7->U'-<BM
M5/)47E%"V(&RI$LT:/7T8KDY#7-=SVN1>%X7CZH?Q;E)CE8ZU"CD7A45Z<\B
M6Q!#PDLT<?/IW.1#\MN4D:URVH>'>B]Z>9D/6"3?&08UFKW$C:DO-EL4G9/S
M[?\ D-3P]NW%A\;^N+=3XUT#5G>QZ)&Y_NK/P.WXVBUC5^*AX7T7O;YB2W6B
MA\>2>-L7'/>KD[3'M>ZLU<_U#EP]"6),5!2F>ZP[R\:5JM3EI&;]:ZDOWG#.
MU[(Q)C/+[,W$7/W_ (@W1[V,:KGN1K4]55>$01VJLKNR*Q$]?HUR*H?:J0N[
M)+$3'?1ST10ZW4C1CG6(FHY.6JKD1%3\#^M<U[4<UR*U4\E1>44
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MVC_@:?5?3[7K^ PMFK=O_&R/OV)TM<\NF9*O*/<6D
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ME<EEJN5K'.Y6*+[L9?@
M       #-VZWF]7VW(YG#Q):QN4?XV3K?\]LOLZ$T@_-ZQ)4I3S15Y)WL;RD
M4:<O<OT0H6K:?DF;)D-LS[H6Y2=BP10P.YAAK_3GR[E+^        #(.NV,S
M.;UBKBL5B+=N=UQD_,3.6,;&BG5T0QN6PVGNQN4QEFG/#:>_]LWA'I*:J
M                                      # I]6O5-USMS8]2_7]&_*Y
M]2:)J69:T<:\,B[7\#,].\?M"T*^%TYF#ABMQR6[D\+89^U/:)C.>\WT
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M5&I^*\&?9+K3K>*R4>.OXG-5K3^.(WUV<\._)YIX '>Q'(SN3N5.43GSX0
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M=R6+#YJGE\11R=1'I#:@;+$CTX<C7IRG*(>X
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MAGU8\[KD,<B1R-]60\\(KS?=-S& S&NT;."1K*",[(HD;V>%V_<X)<
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M9.]E[MUV0RME>'W7L[%9'[11MY7M:5G8='VNAG+^>TS*5Z]FZK$L49F<0/\
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M
M           I>[]/H-JLXJ]#E)Z%_'R<U[,2=W')TIA-V>GGN47;^&-8U?\
M.6+'8RGBZB5:W=V]ZODD>O<^61WJ][O=R^ZG2                      )
M8VRQ21N^R]JM7\E,SUWIMF=79<K8+;9(*,LRR1UIJK9TB_)5>6FIKM_XR"SF
MLQ^L7UW=]9B0)!%&_P#C5B*[E_T4L8     /Y<@M2TYHZMI*\[F\,F5B2(Q?
MKVJJ<F?ZOH&8U_-Y3)-V9)DR5M+%V):36^([\%[_ )300
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                  %<>4EB-GVY&M_->#AFS.+@3F6] U/Q>A%2;QJC.4?F
M:R?WGDW>]2=Z9JL2E;8L-:3F#(P/3\'H23+5>1/DF8[\G(IZ]Y^N0
M                   YS6-<YR\(B<JI46]3M 1_A)L%;OXY[>'\DYB-LUS-
M+,W'92&=T2M1[6KPY%=Z>3B2     [V(Y&=R=RIRB<^?"'C?O4\;2GNW9VPU
MX6]TDCO1J?52AVNJNL4+M""Y7OPQ7'\5KKX42M(GL]'<\\&A'+F,SB\'26YD
M;"0P([M1RHJ\NXYX\BMXGJ/JU_64V!)I:]%9W0HLS.'J]OMPWDE]1VS%[;AV
M97&MF2!97Q\3-1KN6$N
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M&5V/[$?.Q&(]??MX51!N4$^P6L+'A\HLM>1K)IO!;X+$?SVO5W=SVNX+
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MWKQR\OVDJZQ0NYA[55^5M/L1/?\ UJ55\X6/^BL12V@
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M87:VXZ9;%22Q#-5_Y7@\(K7)Q[]QJ
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M-<WE4Y3CE/)3@P^$I8=D_@RV)I9E;XUFQ(LLS^S[**]?5&G>
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M1J\*K5.P
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M*,R=-55B\):A]I&'V'A<Q3S&/@O4Y>^&5J.:I*@
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MG?SV>S2X@
M .,)ZL[B^!C,!0EXGG3FR]/N1F!(V-C60Q+VM;Y)P3>)6K7L,2>%)(U\G(I8
MY<7AYVN5EA:TG=PC)/-JK^"D#96;#6^&3,65J>K5Y1"KV+,D]EL:.5SWO3E?
MQ.O.Z[?P:UYI7H]9'.7E/-":BL[#M4%:@D#7,C3CO[33,#T\QM!&36D\:7^'
MV- 8R..-D;&HUK4X1$/PJ.7R;Y*@[EX]>'']C@<Y_LB*G/\ Z$BRNC6+SZIY
M)S]5.AC$[?M<IRUGY\>JGL[A?/Z3G$J,Y<G8GR<M5/JBE0S6D8C*PN5T*12I
M]]J>2J8_8PF>TZZL]>)'Q<\=_!4Z-3(;+EU;)*JROY5TBC(5)L/?2I._ES&I
M\_L6"KFI$J.B6*-SE\FR*GSL./E54[68N>:JMCY6Q=W:CG+QROX$*]BUYE:Y
M53S7E"_]-]L=K^8;CYW?_#KC_D7VBE/JUBGZ                     #W*
MUCW(G/#55$,TPW5;$RY&?'91CJ-B-ZMXD-'BS&)=%WQW(E;]4<43;^HNNX+%
MVG_'123]BHR-IA72K&9S-X[9,G2M+#<LRHC)2S1]#;^5YGSV;FFE.R7$=0=$
M;XU&VZ_0C]87<\M::WIVZXS9J*30.[)6\))$OVF*6<<H #/^K>?=B-2LI$[B
M:PYL+/\ S$%BM<@PO2NW!*Q.]U3OE7ZO+9TRF5VC85[_ %6!A<0    #!^MU
MV2S^IM>@7E]RPBN0O&2V;$:1KM>LKN961(R&!OVG*4#6-2R^U9QFS;&U6M;Y
MU:J^C3?T1$1$1 <.9RU/$XZ>Y9D1D43>54P#7\3D.HF?7/Y=CDQL+_\ 5(5/
MHV**.&-K(VHUK4X1$     !4NHNPS:[J]F] Y&R(YK6$QJ.6DR^OT+S_ #=-
M$URDJ                                              "O[/G:^#P
MMO(3KY1,Y1/JI\:3W+5VQ9R%QW^LVG][_?MY^ZA)8JO$U?'M-<Z%%XX;Y<JO
MLAZSP(ZUV01/1%^RUWJ>MJ:+X1BS.?\ $L^5K?P*G8LR33HQ7+W2.\U]5\SO
MS>LW<!'4F2;N5_*][%^S]"P:]@<OL\D4MV9ZUH6M;RXW;&8VGCJ[8*T78U/7
MZN7ZJ2//(5B.0_*HK>/,]/![U1R__;W/9O/'DBHB)YH=D<3$Y5Z?97Z_==[H
M=,4/8^-$3A&]\:-^O/HI^V>))!(BM5'K%'RGXJ'+&Y[G*SCYGKW?5J>AX.@=
M''Y>C6IRB^W/L<%FO#9C?',Q'-=RBHXP_;='FQ\JY'$<HC5Y5J>QFV)QUW.Y
M9L$\KT555'.<OV3\Y"F_#Y)U)TJ.5J)\_L3V*FK\S>- KGHQ?#3GR[BP,_::
MP[Q/+PK3>W\>[GD@KL:6U>^O Y&,9PJ_@GNI!.9XT4D3W.5?+ARIPO/LOYGU
M%TMVN3-8/X>W*KKM-4BG^K_H\U!%                     !5]ET'6=@^>
M]48LGL]$^8SJ?H9BD?\ L<M>8SZ(\R#JYI&O:GBZC(72RW)W_;D-JZ!X]*^D
MPO5/ZV17FQ!S4<U6N3E%/G_>,/-I&P5MGQ2*RM)+VW(FEXVCJK@L%@X;394D
MGGC[HHVF7-FZF9?"OVJ/+>#$C/%CJISPK#==!V*78=;IWY4XE>Q._P#,L@,&
MZNS+=VS4L5]Q]CEY:^IN42EK28R'SL77-@B86' 7<3KF.Q&$GLM9.L36QL]U
MX0MI0]SZATM=?'4@A=9N2?8@81FE=3X\]DY\7>@^%N1_<-/ "N:GJJ( !/:K
MUV.?-*UC43S55/CG;-GOY;JDLV)@^+?618X/=O/U-EU7IY8FN-S>RR_$WW>;
M6+YMC-A:U&HB(GD ?/?4?(6=GV^AJ5)Z^ QW?;-^QF.KXVE#7A8C8XV(UK4/
M8     'SI^D7F4@Q5'&,=YS/[W&H])Y>-#P:/<G/PL9>@
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MMX;MF+?:^'6%S)%8]A<P
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MELMEBMELR+,Y/IWFF@_CWLC8Y[W(C43E54_F.RM#(POEJ3-DC8Y6JYI^@
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MK,7T]W_BXJTC7QS_ -6OK[+PKG+Z&I=(,JE/9+^+=Y,N1),S\XSZ;
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MDU/3H]-LE!+)B)[R.9\]U?-S2&WWK53RV#LXO&TI7+.SL<Y4,ZJ5=MSV!PN
MAQ4\=-CT\23V<:)BM=VKIMGYY\9CW7:$_'*)]HN<_4G=K'[*EJ<S'K[R&6YC
MIQO,F3_I3:IPRSK/XLE9#5\3UJH5HFPY7%6*;V^2_)R6*+K3HW;_ %]C_P!H
MY)^M.F-3B*2R]WT2(J&2VC<=\F_5V)HRTZ#_ "EL/\E5IM&JZ]6UW#P8^NJJ
MUJ?,[W<I/@                                          'RUU<O\
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MAEGQ$E[V^4C/=_OP>>OW8J&S8*]WJK(K21O=_P!+C[8:B<
M                     !6M7CE    9EU"W)F/JKB,>U)\C;3L9$GL9)T?@
MGUW<<K@\G&U)YF]Y])6]4P%B">.6A#Q(G"_*A1Z?1G5Z=I)F.E5B.Y2'[A'Y
MWHU@,ML?ZSG>_L]XC6,?CJ>,J1UJT38XV)PUJ'I9K5[#%CFB:]J^RIRA$1:9
MK3)?%9CH>[Z]J$Q%!%"Q&QL1K4]$0_H!X6<3B9^5DJ1/5?=4Y.!^G:Y(O+L;
M#_\ RH?N/5\!6\V8Z#GV^5"3B@AA;VQQHUOT0
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M<<*XKLDJ)4?VL[70JQ5_-%/N?!Y/X_"T+3?2>%C^?P<G)(
M                        %&WO<(\!1\&NGB7Y_EKPH0.@:1-4>[-YE?&R
MECS<KO/L*AN<25.L6!GA^U-'VO/H8
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M^1]:],[26-&P"_PTXV_^C2^
M _-J9M>M-,[R:QBN,0T&G_2K-WMIO<N[)G156>S&FR9G-8[!T9;-N=L;6-Y5
M5, T]MO=M\GV:6)S:-9JQUCZ,
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MJG%6J0MCAC3AK40[
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M:)CO^ISG&I@
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M@   ![V,:KGN1K4]55>$0YL?L.%R<U^&A>BL24Y$CL-8O/8]?93I
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M?(BN:CN5543\B0H9*A?HP6Z,[)Z\S$='(Q>4<BG[
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M=AUUVPMR4=6O5M7$FI4ZTJR15T7GN:WE&FB@
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M*N=*Y55>5=[H[V4U#I#B/C-COY1_FRG$D+/SD/IH
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ME%X4\I%X:<:O2*)\JJ[A$\N?=%]$/JSI?@GX?4J;9F\6+'[>;ZHYYHH
M                               ,OV?6=Y;O=#9,%9K6(F57024[4BQL
M8UW'/8O#OMDUXW4F]S4LXG$TX9ODDLQVWSOC:ONC'1MY+9BL74P^+I8VHCDK
MU86Q1=R\JC6G4
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M^Q]G0L[6\>P
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M+O6*-\KT\_9O//S>R'U#TLU>3"X/XBTSB[=XEF_#Z--2
M           *KDMYQ6/S+<1%4O7[WA+(^"G&V18VI[OY<T\XNH6 ;>H8V>.U
M5R%NPD4=.>-&S)SZ/<B*J=A;@  !)DJ,5^"@^PUMF6)\L<7NYD:HCG)^7(
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MPU?8L3LF'KY/&2J^"7ZIPYKD]6N)
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MT0^J]5U+&:UCTJTF>:^<LKOM/=]5+4
M     57;^G6M;A/1FR\<[W5$<D2,D[$X>6BK4J4*L%6K R*&%B,BC8G#6-3V
M1#]
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MLUU2C[0>DDB'TGB<1C\53CJ4J[(86)Y-:G!)@
M
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MM6<>US*GP55?6>7[:_DTWG5^FN U]S9TC6S;][,J<N-&1H
M
M                        "M0K^:U?!YR+P\C0BG3V5S454,JRW12DO+\1
MDYJR^T3T\1AG>1Z<;S25W-&"XSV6)Z]Q4KM3(4^4O8JY#[+W,\B-9-0:OR+V
M+^+%13U6:!WFMH>+73S2T?F2>H[^LE1_YM53VJ,=.OATZ5J5?HQA:J6C;M??
MS!ADA[OOV'=A?L7T7N2\/R^87\88&\&I8'0=8P2MDIX^/QD_YSTYD+JUO"(
M
M                                        %3D_*L1WJA&6<'B;2JL]
M""15_B8BD9-H>I/^:3!TE7\8FGDS0]08O+,#23\HFDC!K6"KJBPXRLS\F(A,
MLB8Q.&M1#]HT
M
M
M
M
M
M
M
M                                               I/4#>9-:@I5<;
M59>RUR=(Z]'OX>Y.%Y>9JZ[^D-#BOUD]F+5K8DE=52/]N:MH&]X_<\/\5"Q8
M;4/#;=9?6)ZEIDMU8W]DEB)KOHYR(H>]C&JY[D:U/557A$%O*4H*\LGQ4/+8
ME>B=Z)SPG)0.FNYV]KU6?)3>!%9?9L)%"B_88W[!-:S>V&OK4EC9;="2ZQ\J
M]]=R)$J(G+4,4P.X]8MMIS9;#V\%6INFD1D$Z_/&C3Z&PLN47#8_]92PONK
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M]KD7_ _H
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MI:LDGDQ\?'$A]"@
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MA98O=K"QX/'[EMV\T,_LN!7%U<3"[X.!7_.LSS=0
M
M             "G[GIN7V%U7X#:[V)9&Q[960)RDW?[N^9I(:9J='4->KXBK
M,^5C%5[Y'^KWN]5+         "I['I,6:VC6L\^\Z)<0][FPHSE)>\MA46Z7
M#%O\VV_'N61]#X7X;L\D_'N+<
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MV:?9&ZIJ$5;X^.#XBS8M?U36>S"-U[=-^Q.W5<!N5*&5+Z)\);J,^1'&S@
M
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M=3*F*S3<;2?DWI9G8SOG1_<[L["9HWMTT;?\+@LCG9<S0S/E')8<OBQN8;Z
M
M                91U)T#+Y/+XC9M<?6CR]!_I*SRE0JKMYZSRXI*B:%*RX
ML2,^-Y]'^[^PNVN].$J:3E,5F)OB;^5:]^0L-7A\DCO/A7E*Q68ZN:?B*N 7
M3&9-*L",BMUY?D["?M4.H68Z69^/.L9-D[E7]A3AB1CF%ZTW&7JO3_"XZS"Z
M&RS%,B?&_P!6O[..%,MZ5T=VU^E?U3(ZXYE6-EN1N01_+))'>C6ECZ0X',8?
MIS+C\C1EKVEEM+X+_M</*EKFI['6Z&YO"S8N=F0E6?LK??=RY"SV](OY?I!A
M\-)7='DJE*O)#$]>WML0IZ/*I/LG6S.8VKAX]7DQEB96,FRG=VGOU+TG9'+I
M=V*A_2)N)C=%;BF^W:5WN\K^QT.INV8"M1BTZ+$X[&2Q2)21W,DO9Z)"6/.0
M;G0ZDUMNQ6L3W8+N,9 L+E[)(/3GQ23RF*W;3=HSN:US#1Y.AE)&23U?$XG\
M?SY?^#"4U'+=4LYL#ILGBXL-BH6-[Z[V))+*[\'%LZCXV[D-%S]&E7?/9GJJ
MV.-GJYW)TZ'C[%/1\!1NP.CEBQT44T3_ &5&\*U3"I^F>?PO5/ 6Z,#YL$R^
M^Q$V-.(Z:2>;F\$S>H[_ *-NF=R."PJYFAF976)(V_(Z.0Y=8P^^7>I&1S^<
MPJUF6L'*R-&>;(^[CLA7ZO+CTAP.8P_3F7'Y&C+7M++:7P7_ &N'CI#@<QA^
MG,N/R-&6O:66TO@O^UP\RK^A&X)T9H8EF&L)D69])_ ]T9Y_.63/W^KVPX]=
M6M:K'$DSVP6\FC^89&)ZN:7+<.G=IN/U>?6&L^/P+VMII8D^3P" FW3K+E'U
MJE/2DQ;WS-[K<[O%C8PE=MUW8;6^=.+B0R7&4'2_&VV1HQB&JYZY?QN%O6L=
M06Y:BCYBK(O"RN^@PUZ[;P]"Q<IK4LRP-=-75>5B>J>;3J,+W/1]NP^WS[AI
ML55\TM9S;596?,]55.59]7/./*[-UAV.JF(JZ=+AULO1DEU9>>QA=,KB\WI'
M3R#&:ECOC;S.R%7,8C5Y<GS3JTR?5+6^:YQ8;TLFM9-Z.6QDI9N9YG/\W&HY
MC%Y_J!T_FBR.%_5F499\6K7DE\DDB^PYY6,CM_65*5C%+I"/M=BP+D(W\Q/=
M[R-8:=T^U?\ HGJ6/Q2^4[6]]GAW>WQG_:[2J[U@<Q?ZC=/K]2C++5IRS+9F
M;Z1%RWW$[!E-=EBP&3DI7HI&RQ.8JM\3L_Y:JGLID;MFZQ9O%)A)M/EI3VHD
MA?D_%6-(_K(7'-=+JSNG$.M8[L6Q4[)J\J_L6R66??D*ID=OZRI2L8I=(1]K
ML6!<A&_F)[O>1K"Q5.D]=>FM+6IY5BLQ/;:61CN]J6R&FV?K)8B?A%T^%++F
MK N461?A^?>7C@DFX;9]$Z7U,=KV-6WEG.1)D8[O1DDJ<OD:9UJEK?-<XL-Z
M636LF]'+8R4LW,\SG^;C1]CQ&T=0>GJMMXO]4Y.&ZD\-5Z]Z.6$K,V\=9I\.
MZB[0I&VI(?#=<Y\N?=_8:ETTU*?3M1J8NU.V2?O?++V^B/?ZM:7$RK>L#F+_
M %&Z?7ZE&66K3EF6S,WTB'5B]OD>/K4-8Q$\_P 4UWQ%F'[<34^XGXN*)K6:
MW?6*?PN)Z0O@:K6)(])OGE[/=Z\%DS\W52K>PNT8RI//'/58R]@%>O$+SSK8
M_==_SN+FV/!+B<5C7^+)3D>LK;<OW.6DAF,1M6EY[*9S5\6F5K9:7ONT>>)&
M3^SV..3!X/<=KW##[)LF'CQM3&QRI4J)+S,V;R^9QM8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                        $LL4,;Y97HQC$Y<Y?)$1#/(.J^L6\FM#$ULC
ME9$B[^^E"CX^/S<YI*Q=0L V]0QL\=JKD+=A(HZ<\:-F3GT>Y$54["W
M IMSJ)KV/W"IJTS+2W['9V*UB+%^T+D>5^VE"C9MK!-,D+%>L<+4=(Y$]FHJ
MH5?1M_P&Z17I<4RRB57,;)XS$9YR%DS&53$TELI1MVD:[AS*S$>]$XYYX<K?
M(H&"ZOX3863NQ&$SEM(5:DJQUV+VJ[_SDOK?437<[E+F(C2S5OUUXDK6F)&]
MWY<*I<0  ")V3/4]:P\V5NUK,L$2IXB0,1[F-_B5%5/(J3NK>J,U&+9UCN_
M/N?"HWPF^+XA?,/FJ>7Q%')U$>D-J!LL2/3AR->G*<HA[@'G=LNJTYK"5IYO
M#;SX4+4=(_\ !J*J&;TNL& N9>QAZN$S<M^#O\6NE=G>WL7A>?G)/#]3M4OY
M.7%ROL4+S)DB2"Y&D3WO^C.%<>VW=1,!IMK&U\HRTLEU'>#X+$>GRJB>?*H7
M,%1Q/4?7\MME_6:S+27J:R^*KV(D?[%W#N%Y+<4VYU$U['[A4U:9EI;]CL[%
M:Q%B_:%R
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M$X[TE-;
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M-S5Y<UC'G;^C1/'638J4_,=B9T$D4;FKRYD?)].@
M
M                  SG<-3R.0S#KC,%B\U$^)C60Y"58TJ*SU\+AK_MD=@.
MGT+<M4R-W6\/B7TI$D@907Q'2/\ J]ZM9PB&K@
M
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MKR4  EEBAC?+*]&,8G+G+Y(B(*-ZID*=>Y4F;+7GC1\4C?1S7>BH
M
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M&P3K.0;/%)0@6"-(4C6%O'V>>5[B_@
M
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MOX1U*1BOG;X<KY45.&QL)_I7GZ-G5=>QE=LTDU;&1)9>C.&0/:GV'FB
M
M
M
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M-G@1,[WIXGHXMX
M                                    %N1T52Q(W[3(GN3\T0R;HG;L
MYK 9'8K\SY;^1N.;.Y?L(V'R8UB%[W'4*.V85N-LS/B1D[)XI&^?:]A7,]D]
MU?MOP%1[,9AXZ:R.R4D+9VR2^S.'*TH$/5#:)M5W>Q2DIVY\+;:R.\K?";)
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MNOW^YN._G=4V
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MX<;?BLOC<S42UC[*3P*Y6I(WE$Y:?L
M                                                           "
M5)/"D\+CO[5[>?3GV,UU77M^M96*]N5^E(RIYU*M9O[-9%_YKO3A[#0<IC)L
MA42NRY)7:]Z>,K$^=T?NQJ_=5?J>]6I4H58*M6!D4,+$9%&Q.&L:GLB'Z
M
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M4ZS$DF?^/"JGD?G#[SB<GEIL2^"W1OLC;(E:XQ(WO8ONSA7%C
M
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M$[(*6#[^8I?*TZ5_L^/V:;L
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M&*5^N5,<VG0D=S,E2?ZN/"+'4LSU:QV9U!LB01HK\U9;RR"7O]&?BYQ]!@
M
M                           %3Z@X7,YO4<CB\7#7=/<:D2^-(L;6,]W>
M2*=F@XS+XC4\5C,I% RQ3A;!^QD61KFL3A'<JB%@   !X9C%4\G22"97,5CT
MDAE8O#XI&^CV+[*?K#MRK:?AY-87S,D<U)8_))6)Z/5OW57W:>H .;+PY5]1
MD6-?''+)*UDDS_\ E1KSR]B>[ACL93Q=1*M;N[>]7R2/7N?+([U>]WNY?=3I
M
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MJ$?5'#-JT+=G$Y>G1M/8V.Y/ UL/S^BN5'J7QKFO:CFN16JGDJ+RB@
M
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MO8E,'@<9B6SK*VG69"DBIVJY&)QSP2@
M
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MD1/->5)(
M                                          !S6O:YKD16JG"I]44A
M<3B;V'O)4J)&[#NC<Z.-R\/JN]HXT]X_\I-  /[D8[L1%=PO"+Y)R0F'Q$[+
M'ZWR_8_)O8K41J]S*S'>L42_XK[DV
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
;                                #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex3-6_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 <P !  (" P$!              8'! 4" P@) 1
M 00" 0("! 8,# 0% P +  $" P0%!A$'$A,Q%"%!40@5(C*2DQ87-C=25%5A
M<7-TLA@C,S5"4U9R=9&QTB0T8H$E.$.AT8*4HL(F1,'B18-C983A_]H " $!
M   _ /+5?^7B_OI_J?3?5DYP6-_98_\ 0VX
M               ?&Q_'<U%X7E.0%3DQ$Q=!MAMA*T22M3A']J=R(=EO&T;,
MD;I:\<BL3AJN3GCDPW8#$+WJM"O\I.'?(3UG#[&L)^3:WU:#[&L)^3:WU:#[
M&L)^3:WU:#[&L)^3:WU:#[&L)^3:WU:#[&L)^3:WU:#[&L)^3:WU:#[&L)^3
M:WU:#[&L)^3:WU:#[&L)^3:WU:'!-7P+.Y4QE5.Y>5_BT/U=8P;D5%QM;ZM
MS6,$UJ-;C*J-1.$_BT.7V-83\FUOJT'V-83\FUOJT'V-83\FUOJT'V-83\FU
MOJT'V-83\FUOJT'V-83\FUOJT'V-83\FUOJT'V-83\FUOJT,*YIFK6VL])PU
M.7M7EJ+$B\&,_1-0?,DSL#161%5>Y8FG>S2]69"L3<+32-7*O;X2>:F--H6G
M3R,DEP%%SFHB(JQ-\D.$W3W2II7RR:[0<]R\N586G5]K?1O[-X_ZEH^UOHW]
MF\?]2T?:WT;^S>/^I:/M;Z-_9O'_ %+1]K?1O[-X_P"I:/M;Z-_9O'_4M"]-
M]%_LW0^I:&]-M%:U$37*'U31]K?1O[-X_P"I:<']--%?Q_\ JY1^J:8LO2G1
M):K(%P-5$;_21B(\QHND&A1/[OB2)3NL])M#G;$BX*NWL3A.QJ-,3[3>@_D9
M@^TWH/Y&8/M-Z#^1F#[3>@_D9@^TWH/Y&8/M-Z#^1F#[3>@_D9@^TWH/Y&8/
MM-Z#^1F#[3>@_D9@^TWH/Y&88UGHGH$[%3XM6/\ .Q_!@KT#Z>^R&Y]:9<_1
M#0)F1M^+WL[/:Q_"J8B]!.GSE5? M_6A>@73WV0W/K0O0+I[[(;GUIDQ]#=
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MW/K0O0+I[[(;GUH7H%T]]D-SZT\-5_Y>+^^G^I]-]63G!8W]EC_T-N
M
M                                       ?+&O_ "\7]]/]3Z;ZLG."
MQO[+'_H;<
M                                                      ^6-?\
MEXO[Z?ZGTWU9.<%C?V6/_0VX
M
M        !\L:_P#+Q?WT_P!3Z;ZLG."QO[+'_H;<
M
M                         ^6-?^7B_OI_J?3?5DYP6-_98_\ 0VX
M
M                                       !\L:_\O%_?3_4^F^K)S@L
M;^RQ_P"AMP
M                   .4'<@Y0<H.4'<@Y Y0
M        ^6-?^7B_OI_J?3?5DYP6-_98_P#0VX
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MZ&W
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M3R           /EC7_EXO[Z?ZGTWU9.<%C?V6/\ T-N
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MBH[S3A#9
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M_89SRQL?\_9/]JD_U+XWE%=TZZ=HGMC@-QU07MW?1H5<G>Q/E,3YJ'IK(_\
M(7?U+_\ 0^9-'^<ZW[0S_4]&_"0_YK6OU,Y@='/N+WO]5$;O57<] ,\G;Y+,
M4MTM^[_7?VM"6=?OOA6?V6(O_H'][V+]LE(ON_WYM--/$O'P@;?Z7F)A962[
M-U0>QR*BI/\ O%@] &SIHKE?QV+;?V&@WAC7]9=.1R%4]?OOA6?V6(G^J_\
ME]SOZ9BD^EWW?Z[^UH>B<!]_O/\ [)-^^AZ,           /EQCOYPJ?KF?Z
MGU%A^8W]!R
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M.9F>O_N?4.FQT=>)CGJ]48B*Y?-3N
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MRQ&=0KO#U7F",FV#1R_!]RG#WIQ9D*AZ7?=_KW[6AZ)P'W^\_P#LDW[Z'HP
M          ^6U!52[55$Y5)F<)_W/J'2>]]>)\C.QRL15;[E.X
M                                                          %(
M=?/N-K?XG 6GKG\P8S]EC_T*,T%Z,ZD]07+Y)+.>5<G8BLYVU-$O+'VG.:OY
ME<7UUN[/L<TW_BU1?15X@,+H;7N)2VJY C%6.IV(B^]QE:5RO1?="E--^ZC#
M_M3#T_DO_,#!^QM+/ZH?>]V+]E/.M]B,Z&83A'ISE8U7O-[UL^XG4OU;2/\
M03^7V+]A4H"/_FF_K$_U/2'5:O+9EZ=0QIR]T'^P]67TXQMI/= __0^83$1;
M*(OM>G^IZ*ZIU7=G3>M Q5XJ]K$^@3#=$5.LFF(HQ'W]-D_89S5]%?NUVO\
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MNPL+"0,F^#[E.Z3M[+,CRHNEWW?Z]^UH>B<!]_O/_LDW[Z'HP
M^7&._G"I^N9_J?46'YC?T'(
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M6:_6D_QKWM^#[=X7SO/0JSI=]\#7OVM#T-KSD=U[V']EF_?0]'
M 'RXQO\ .%3]<S_4^HT/S&_H/T
M                                  '5D,92O0>!;KQS,[D=VO3N3E#M
M8QK&HUJ(B(G"(AB18G'PSV;$56)DDZ_QKT:B*_\ 2I@NU3 OX[L757A>?7&A
MWWL)BKT3([=&&5K6*U&O8BHB*?F,P.)Q==:]"C!7B5.%9&Q&H*FOX:C2FJ5\
M?!%#*Y7/B:Q$:Y5\U5#$JZIKU2PVQ7Q56.5JHK7MC1%14,F3 X63+IE5Q\"W
M4;VI85B=Z)[N38W\?1NT9:MN%DT,J</C<G+7)[E1332ZIKK\7#C),56=4C<C
MF5U8G8U4\E1#ORVL:]DJ]>M=QE>Q%#_)LD8CD88^+U+7,3XSZ&)JUEE;VO\
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MGR^DV8U8YJ_-3E>5)D           ?+C&_SA4_7,_P!3ZC0_,;^@_0
M
M            ="7:OI7HRS-\7M[O#Y^5V^\YV;=>LQ'2RL8G/"*Y>#L5R(BJ
MJIPATP7*D[^QEB-R\<\-<BJ=*Y:@MY*7I47C]JJD7<G=PAE2V(HD17O:U/)%
M5>#D^1C&JYSD1$3UJIP@M03(KHI6/X]K5140Z6WZ;['@)/&LB?T$<G<9$DL<
M:)W/1O*\<JO!^@                    'RXQO\X5/US/\ 4^HT/S&_H/T
M
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M]<S_ %/J-#\QOZ#]
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M&A^8W]!^@
M                             < #@<                      'RXQ
MO\X5/US/]3ZC0_,;^@_0
M
M    #Y<8W^<*GZYG^I]1H?F-_0?H          ,&YE:%*)\EFU%$QB<N5SD0
MJ_,=;]#QR]L=V6W^H8BH0.?X1V/2-5AP\JO]SGFFD^$G;Y5&:]']>=$7PDLF
MBKWX"%WZ)B0P?".QRQ,6;#RH_A.Y$>3C$]<-'R'8U;,\$CE1O;(PM2CF<9?9
MWUK<,R<JB=CD4S0
M                                            #Y<8W^<*GZYG^I]1
MH?F-_0?H         (7M>_ZYJ]=9+]M._P#HPLX<]3S%LOP@=BO+)%BH&4XE
MY3O5>]Y1V0R^3R<GBWKLUA_*KW2.5R^LUW"\?F.U()5A?,C?D-<C57\ZG2=K
MHGMB9(OS7*J)_P!CCV.^3ZE]?D<I(I8WN8]JHY/-#-QN7R>+G2>A<FKR?A1N
M5JET:MUYV;'SPQY9R7*J?6GJ+4^HNL[3&JX^WQ(GG#+PUY.
M
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M$US5X5%>B*ASANTYI&L99B<J^Q'(JG>     #C&DB(J/5%]:G(
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MQ>KY/J3MD>?S"THFW)U8OO7O+:Z>ZETXK;+!9PNR/N6HHW+X1Z'0
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M^
M       #YDZP][-@Q;FN:U4LLX5WD?39        #S'UWZA3TT^QN@]4?*SF
MV_\ T8>2#-@C6>"2-D3.6-61SU7U]J&.BI'V/8]4?Z^?9P<ZS(I;$;9Y?#8J
M_*?QSP9V(FR=>\QV.DD;,Y?#1S/<XL6MHU;%7D3(R16%:J-?$U?FO]J*;YUR
MKCK,:8]$CF\7M^0G"+#[4<J&_FK(^TVZVQX3I9E<]4G=\MJ^:HG!;.'P,-A4
MNR>(KIVHYDG])W'DU5]I8GQ9!+#&Z.ND;WKR_P#,;1\38:_$:<<>I.$Y-)=Q
MM=T#XY*:2IP_AJIW?^Y3NR=%L%E<?/8IUDHWWM16(SU0)P>8]APVQ8*)<5?A
MXBC?WM5OK:O/M12,6*R0-@5)HWK)&CE1B\]O/L=^<QCNKP+/*V-'-:J^U3@]
MG8OJ7E/8J'H;H9O\^/R;<!>LKZ'/_(<_T)#V4  1/:MVP&K0,ER=KL5_/9&U
M.7N-'K?5;3=BGBK5;KH[$GS(9D[54L@ #U>\*UO/F=-B>O5B=+-(UC$\W.7A
M$.V"6)\39(W(Y')RBH?JM:Y451PG/(5&N\S\1C47GA!+%'+&YCVHYJIPJ+ZT
M411QPL1C&HUJ)PB)ZD0X6H*G>R5[&JZ+E4<OL-75R^%RDDU6&Y7G5$X>Q%[N
M$.Q^+Q,51('58&P,=WHQ6HC$7WG14V3!6)UKP9&N^1/-J/\ 6;6S#7G@?'.Q
MKXW)PYKDY14-9B]>P>-7OH8^M!W<KS&Q&^9GW<1C[RL6Q4BD[$]7>U'<&E9J
M6L1^*C<13;XKNY_\4WY2DB6I76OX'AM6/M[>WCY/'N(C#H&GP7H[D.#J1S,Y
MX<V-$\R29#%XZ_56K;K13PJJ*K'M1S>4,R.*.-C6,:B-1.$1/)$-34U["4\A
M9R%;'P169U599FL1'OY]ZG#)ZU@,I;@LW<97GEA_DGR,1RL-R1#*:#J64NMN
M7<-5EF1W*O5B<N_22#'X+%8NDM6G2A@@7_THVHUIPQ&"Q&'A?%CZ,-6-[NYS
M8FHU%4QK^L:]?R,=^SBZTUF/CLF>Q%>WCW*:^[HNGW;=BW9P%*6::17R2/B:
MKG*IV8[2M5QMMEJEA*<$[/FR,C1KD).
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MFS=9<1A+->FE&Q/:?"V5\;$^8CB7Z/ON(V^C)/25[)(E1)HGIPYBJ38
M
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M9!4;^A[3W @ /._5/-[MK.UT<S2?--B.Q$DKHJ]GY^\JO:=A9U#S.)IXC7O
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M(8MAVB5+\=AS9>SNB;PQQZ8
M                                  !\TM.^Z?#_ +4P^EJ>W](
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M45ZJO+G*A(P
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MS?)7J6)C.L6%K(]BXI\$+$_DHV^M"19MN#R,V&MXY?"L3V/':]$X[V,\^?\
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MW( .$]F&O#)++(UC&)RYR^2(=.*RN.R5-ENE8;/$_P"8]ODID@
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M;T,S/;EL6V])+5VLD;'QR>'D4_Z"3=!9=I7 <7&1ICD_Y1?)Y?P
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M3S5OR7,+W
M                /FEIWW3X?]J8?2U/;^D       K'K%6DGZ?9KL1%[$:]
M3P! D#IV).]S8U=\IS4Y5$,ZRS%QO>VN^:9%1R-5R=GZ%]2J:WY<;_<YJ_\
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M<^$X/QK6-\D/T
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M[M+%U+J50RFE/SU][8$@]5E/<\@.J]8LILV_5Z%2)(,:]B\-<G+W'HY/(
M                 !7(GFH
M   /FEIWW3X?]J8?2U/;^D       ZK</C5YHOPV*W_-#YG;/AI<)GLECI4]
M=>=[/THBF&MJ)L4"QPQHY$X>B^OE6^T_<EEKN3?$ZR_N\-O:Q/8UON0YP6LM
M:I)C8I)7UVN67P$7EJ*G]+@W.&VV[B<)DL?!Q_Q3F>M4Y[43GG@QJ6"FMXVS
MD7WH(NQ4[6/=\M_Z#'S>*N8Z]X4D[94X163-7EJHIA5[]JG:5[)>Y>5[DYY:
M[])G7<WDWOJ_+?$D,7;$U%]2-=POJ_R)E7WRUG5J4=GG6S2BF297JG,GJ_H(
MI8T&^:3CO!AKP/9 V'A60^7+O8OO++CR6#RF)6\RRQR3(CXT=PKG*Q/<OFI1
M&:RN7WB25N-Q45:O'_+VW_)54]TBDMUCH_AY,59DNY".>>5JL:^#ULB.%KIW
MI-VAZ5%FWHE6!L<K_-.4]I%=HU[&U9L/5QMWF'PI?XV->>Y&*B*5S<IO9XG@
MWVK%XBM[5<O/*B7#3)"LZ*U8XXFNEY=YN7V(:>G=L4I730<)RU6JBIRBHOL4
MQ6O<QR.:JHJ>2H;6"Q/<2.JORE=)W.<[UKZC7VGQR697,:C6*]51$3A$0]Z]
M%:7H>@8Q.%_CE6;Z9:X!YCZI+?U?J#A]N97?)5[4CGX,K:NN%:W3J5=429]^
M>1GK?'\Q#EU5VS8<+C=8J2^!'=LLYL6^SU1/;PB]A3VN2*O5K#O?F?C)5MHK
MK?*KWJ6OCL;3O]><VVU R5K()7HCO>CT(]U.I8!^_=D.1DQ%UD'+YWIVQ.]W
M:J&3T=S&5GS6R8Z9([BR02O??;ZU>]IA]*<SJV"QNT8[8&QP65?Q(R9/GM3G
MEIQZ;4[*XC>[M9JLQKXW)$WR13?Z!A\?;Z+99)J[%619E<[VJK"<]!/O?0?M
M<I'NN]2S4GUO/,3NAHSJR3]+R69;K+I]7 OOU+\<\[F<Q5O)_=[E(GN&R9#9
MNC=C*W:/HLDTK.&<\\MX7AQ NH-5%Z;:%8\+R@@8K_TM)1U'P59FD:[GL>C&
MS8Y8>Y8_<].5,;1;DN^=39=BE8OHU*NB,1?8\],P9;'/OOH-MQK98G+XT7Y2
M(:C<_N9S'[*\\>8;15R73=NPXZ&5,C1MN5RIY2,-[TLS]S/=0<GDK*)X[\1.
MKU][D5"#ZI5R64CV![<70MRN7F26TO#HE7GULY12T-4U*YF.C^9I^*R5\=GQ
MZB-=RB.:1"#.W-VBTC5D[E6!W;8_^CCM)SU7FU:AM6/IP8%^0R;(&L9%(_B)
M&_T4[2.]'K-Z#?L_ M5M574[*NK,\F/:J<-./376L#LLNVS[&U%N,?S\I>%:
MJ\JY38])UQ%75=_6U-,M%GA(^2/U/5G#BG\X_%.Q<#L5A)(:[9E1+TC^7R+[
ME0]U]/II)M*UV21ZN>ZA"JJOM7M*(ZO/?GNH.O:ZR1(%_&./6BR&+H%-^I]4
M,E@KDT5STF!W=9\WF!-JN7@O;.FE['39C7?\Q%XSF/83WX/?$>I9)SO)+9J=
M7=%O'57)Y:=/$IXOEE5/W5&YO6#KCKMBT_F!Z,2'EW'8=]Y\5CK]&D;D>B4T
M1W ZR:G@,/J<5BECX8IY,K$KY41.]>[DLW(;#:UW0*^3K4O2GPUH?XKGCE%0
MHG.]><[=Q5NG'@WTIYD[63H]55"KOC36J%K6):R67SP2NER$LD:-<]SN.$;Z
MUY1#V3L>[ZSCM=JY^SPYLC$EIL<B>(JN0J[0<5F=IV"7=LXK8D6%4HP&'TJM
MT*L_4'QY6,D255]?GVIW&3T3PE'-Z5F*=^%):TMUB]ATLQ6/Q'7.E2H5F001
MT6=L;$/3S?)                     'QL>B=S47A>4
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MY2-6M"GEZE-V=;34B972-(BS$
M                          !\UM'\+[+,+XO/9Z4SG@^E*>W](
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MCD[5&Q]0]4UNRVMDLBC)E3GPVIW.0WNN;+A=AI>F8ZXR>)%X7CS1?<IN
M
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MI/?@YUHTQ.>G21$\2S$B1>UO')Z1
M                                          /G'TVB\;>M?9W]O-M#
MZ.(        1'>]0I[3@;5&6-%=QW0O_  9$/G9E\1>P^0L4+L2QSPO5KVC$
MY:WB;:6:JM1_8K?E)RBHXUAGXR&G/D*L5R=88'2(DDB)RK6^\]*V,Y<UQN*B
MQ5E)]8BY\-\"<^._R[)C90Z=A\ADZ*XUD=+/^A>E3-CB22FBNX^2I -VQ.YT
M_2V+C(WK)RVU<K+WI*4YCJT4UV"K9E97CDD:CYGI\Q/>;S:</B<79DCH79IX
ME=S%*YB-9*S\)JHJFKP>%O9[)5,=1@[IY%)[U%Z;IIE+$JMET\T_?XKD3AB$
M(QV%RMV-BUL3/-RO".:3BKH;<>V"79KJ1+YQX]B]T[^?W21X/(99D[L;C:"T
M_0;*228E7JY9^WEKN^3WIR1CJ;@]9Q-^!V)LIXLO+YZOGX*K["K'N5[W.5$3
ME>?4;22YCGXF*NVBC;39.76.[YS?=P:D]1]!] G2PFR7HN&(WBHU?WSU@  >
M>MJB9BNLVMY*9%2*["L/=[$5AONLV$S^;PV.I8VHZ=GIK'3(Q.51$+7Q=%,?
MC*M1B\I#"QB>KCYI1TVM9^[UK7+SXMR4(&<1SJB=OR2<=3\)G\GKK7X.U-'>
MK3ME:QCU;WHA2'Q5U-WW)8>#-8]:M6E+S-*Y..Y4)=UC1,ML>I:]#ZWRSJ]W
MO:B'H>.)L<:,:B(C4X1#RMLL6TZ'O>:S&.Q*VZF21_#_ '.E-MHV@YR;1ML=
M?YAMYAG+(BL/C[:[&I,T1-=E\1DJ=TA;LO0]UZG@7OSMBI/3I,B5$;W\/1/-
MI -;Z<YF+JI-5DOV%92595N*WUO+KR_1C4<GFY\O)Z2D\TSII$1WJ5ZJ5OG=
M]V_3MLS<%[%K=@F5Z5'\*B]AO.A^O7X8<ML-^%\+KS^8HO>TQM J+E>J>UY>
MS6EYBED;"Y[>.$5QF==L'DY(<-G:2/=\72KWM9Y\/(=1S%[J9O\ @+/H$T5+
M'IS*=.6DCT_JKF<GG,=)/3N).^O*V/OX5ZDHZ$8F\MK/9A85@J69$2%BGI0
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M:SL<Q6)\LU#\9TON/;X5/(LC?(JP-67U.0D&K5M%P._LQ].I?].@G6NURO\
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MW<Y&-1J*IRM8^K>9X=B!DK$7GAZ<H=\%>*O$R*-B,8U.&M1.$1/S'Z
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MJM:G8W&K6A9%#%FY&1QL3A&M17%L@  ^;.AQK+N&#8BL15M-^?Y'TE0_0
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MB6\@SZIA>*)P   #RSUZAM8K-X'/4D[9D9)&^0P]>T_Q^B>3E>WFQ._TN/\
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MNTWM2:7VN89;<C%U,ZEX=T2/=0HUDED]R//6"
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MP:-J4#.R'!4F-YYX2)IM8,#B:LJ2PT8&2)Y.:Q$4V:,1/(
M        TK]:P4EM]M^,K+.[YTJQIW*;I$X0
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M><6B  #YU]+/O@:[^UH?10
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MT?,J]\[T\E>5GUWV2=E3'ZY45?%OR<R\?@(7#INNP:[KU#&Q-1/"C3O7WO\
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MY-(KNFN[+JN4PN6V6S\=56/[.V6151JGL' Y2IE<31O54XAL0M?&GN14-H
M  '>15W3G^<MW_QZ7]YQ:(  /G7TL^^!KO[6A]%
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M_><6B  #YU]+/O@:[^UH?10
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M>E_><6B  #YU]+/O@:[^UH?10
M                             .\BKNG/\Y;O_CTO[SBT0    #C+(V&)
M[U\FM55*;S219/$6LS;<KIK2MBQ4/M8QR\\I^=R(7)&B]B=R^OCUG(<#A!P
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MB=MCN/H>      "I^MOWO\G^MC(K\'?[E\E^V(>@@
M                             "INMOWO\E^MC(M\'?[E\E^V(>@@
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MVQ]#)S))-E)6=[V*U((UYC8COS^U2IZNB]0-;R,];6LM59B)Y5?V3HJK#S^
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M'?[E\E^V(>@@
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M+PJ.7L_O'T!3R      !4_6W[W^3_6QD5^#O]R^2_;$/00
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MM^]_D_UL9%?@[_<ODOVQ#T$
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M-4L823,1Y1B5&*C7S*G",538X#:M>SK9WXO(1VO"5$D5G]%5-R   '/:WS4
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M'D84NLZ_+E4R;\76==1>4L*Q%D_S.:Z[A%RJY3T"'TSE?X_M3O\ \S<@
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M2      [R*NZ<_SEN_\ CTO[SBT53D-8UOD@'  1B(O("M1WF$:B(./SJ!P
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MZE)V5?5BB?WN:UG>CE*B_@UTO[1R_4%F].NF,&DOOK'DGV?2.SSC[..TM,
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M-=Q%2K9OY**"*PG\6]_DXC_VT^GO]I*I)<)LF#SC'R8S(166-7ARL4Z<]MF
MP$:/R>0BKHOS47S4UF+ZAZ;EIXJ]+-P2SO3E(_)219;,X[$5%M7[+(($<C>]
MWERXV$4L<L;9&.1S7)RBI[C#GRE""W7JS68V2S+Q'&J_*=^@S'.1J*JJ8N-R
MF.OI*ZM:CF2-W:[L7GA3NM6H*D$D\\C8XV)RYSO4C4.5.Y6MP,GAE;)&Y.6N
M:O**ABW,E2INA;8L1QK([M8CEX[E]R&OM[/@J5B2"QDJ\<K%X<QSN%0ZXMOU
MV9ZM9EJJKPJ\(\WE.Y5N5V6()F2QN3EJM7E%.NS=JUNWQIXX^Y>&]SD3DZ_C
M.A^-P?30[H+E2>3LCL1.7W-<BJ+5^I5:KIYXXVHG*JY40Z*>6H7XV/K6HI6N
M3E%8[DS0][6-5SE1$3S51%+'(Q',>CFKY*B\HI^2SPP\=\C6\KPBJO!PFM5X
M>/%E9&B^7<J(8_QE0_&X?IH9C)&/3EJHJ'5-:@A_E)6,_O*B'Y#<JRJJ1S1O
M7_I<BG<'S1Q\(]R(?GIE?^L;_FA^I(QS>Y%14"687+PCVK^;E .$"R,:Y&JY
M.5\@?C;$*KVM>G/Z4/T=R =R#E #!7%UDR;KS9)5D6/P^.[Y''Z#.
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MRY _P;,?_6A/@          45\(3[AH_\0B_=<9_05JMZ>P<^VW*7,
M                                         >(/@]_=U+_A\O[S3V^
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MU>UJ*2GHKGKN9TQ&77ND?5E6%'K[6&DZ<JVEU#WJA6>Q:[K2R<(GDJ*I?H
M        *"^$/.B:=6A[5Y?>8IN.@J*G3VOR[SM2ER@
M                             P+62?7F6-*5F3A$7N8U%3_4\5] (N_>
MU7N<G;1E4]QH      "B?A"?<-'_ (A%^ZXS>@7WO8?VR4ND
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MA>PO$          'GWX1#V?8G49X_#ENL5(B1]#:R5^GU%._E9)GR%O@
M                                          'B'X/?W<R_X?+^\T]O
M       HGX0GW#1_XA%^ZXS>@7WO8?VR4ND            X6:<%N"2">-LD
M;TX>QR<HJ?G.<<;(F-8QJ-:U.$1/)$            '     X0  <(  . .$
M X0BVYZW-L>&7')==7CDG8LRM3GOC3S82#&8VKC:->I6C[(((T9&WW-:9(
M        /-WPBT9\38OW^DDYZ*5HX- QB,\I%=(XM@
M                             \0_![^[F7_#Y?WFGMX      %$_"$^X
M:/\ Q"+]UQF] OO>P_MDI=(
M           !YK^$7_-6)_7J6)T;^X'#?JRT
M                       5]L6Q9.ADW05[<$;.QJ\.3UGF+X/?W<R_X?+^
M\T]O       HGX0GW#1_XA%^ZXS>@7WO8?VR4ND
M                            \U_"+_FK$_KU+$Z-_<#AOU9:
M                                       *BW'$Y&UFG2P5W/9X3$Y0
M\_?![^[F7_#Y?WFGMX      %#?"%D8FDPL]JWXC8= OO>P_MDI=(
M                                         !YK^$7_ #5B?UZEB=&_
MN!PWZLM                                               %2[?F;
MU3,NBB>B-\)B^1Y[^#W]W,O^'R_O-/;P      *#^$,DGV&0*DJ(Q+\?+#9]
M OO>P_MDI=(                                                !
MYK^$7_-6)_7J6)T;^X'#?JRT
M           4AO7\_O\ U,92'P>_NYE_P^7]YI[>      !YM^$8]WQ-BF<K
MPMA25= _5T^@_:Y2Z
M      #S7\(O^:L3^O4L3HW]P.&_5EH
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M4O!;=4QT&,CLIX3U<]96(T]$=&_N!PWZLM
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MVKY(X[5Z-:"JHOQ0TQEZ): LG?\ %SOIAW1+0%61?BYZ=R>QYQ3H?H"6EG]
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M$>O*FX              $B/5JHQ>%"<\)R
M     "D-Z_G]_P"IC*F^#K).FP9)B1(L2U>7//9
M
M                        !2&]?S^_]3&4S\'B5Z;A:CY?VK1>>U0
M
M                                       "A.H*W$V.3P6QJSP(_6Y>
M%*Z^#G_.^6_4(>P
M
M"D-Z_G]_ZF,J[X.?\[Y;]0A[
M
M          *0WK^?W_J8RK/@YL:N:RK_ &I7/80
M
M                       !2&]?S^_]3&5?\'/^=\M^H0]?@
M
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M:Y.44#E .4'<@Y0<CN0<@
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MB1ZKVES:)B=KQE:VF=R_IKY7-<SS7L]Z$Z
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M#Q6L=1]-L82A-X4L[W3(SUHG:3;K;!-/K&/9#$Y[OC>OZD+EC14:G/N
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ME8C[#O?(3<          'BGKE;LQ;_;8R9[42M";?X.?\[Y;]0AZ_
M          '  X  ':@' ' '  ' X"M11P!P./SJ.!X;>>1VIR%1%4*B*
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M#UV^^#;_ &:$W_P<_P"=\M^H0]?@
M
M            'B'KM]\&W^S0F_\ @Y_SOEOU"'K\
M
M                         \0]=OO@V_V:$W_P<_YWRWZA#U^
M
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MNWWP;?[-"3GX-D$2P;#,K$[T? B./4H
M        *SZP79J>@9ET7F]&QD)^#[@L=%JTF52)JVYIWQK)[48PL+<>FVL[
M59K3Y")R2Q+QXC%X<]ON4UV]9V/0=&8N.A_DNRK61?)I0&,BZI9W"29^/:GL
MX>KXX'65:JHA<G2[J':VG6LDV[)QD*C%[E1..Y%1>%/.&#V[J=G9Y\1CLM=G
MDG7E55ZJK4:=O4'"[[2Q&)GV+)RS,?RC89)%<L;BU];J;?@>EN3R\F;E=$_&
M,?2C1ZJL!ST"UMVT].,TQF<L^G).B13OE7E$X7E"I.FNM;1D-IM)C\DM.:LJ
MI9E1ZHY4Y];2X,WMF:;ULQF*K96TVDCXF2UT>J1JIG]7^H^:Q.6K:]@U[+4B
M(KY4\T[O)$(+8EZT:A?HS6[=F\R94Y8CW3-_0O)=^Y[-M#=3JW->Q$[[5IB.
M5%3UP(IY[RF7ZP8.E'G;V8>V.54185E559S[V%I7<YLNX=(O3Z5J*.WY6W?,
M16,^>B%1=&*VYS7K"X6RR*DR6-UWO<J$VVCJ;N69V^QA-4D[&02/;W)YO[%X
M5RFPUSJ1N6 VJM@MN[)6SJG9,>G"INJO4?[#Z$$56-)+]KE(47R:B>;BETSW
M7),3\=^-(M7CQ%0M/4MZRN\:-F$IK'!F8&=ON8>:M%J;E8W*U'A[+(LEVR>,
M]SE1.WN3N/?-!EME&NRT]'3)&B2*B\HKO:>1>O"(N[83]6T]66<)BKU=D=JC
M!*Q&=J(]B+PBGD^IC&ZIUSKT:#$B@EGX:SW12$WZA]0]I?MD6KZPBLL,?P^3
MVN<::+J#O^E[/6Q^UO99@L*G$J+_ .[%-[U=ZIY;!Y&KB<)*QCY8D>^?\S_+
MM(K%L_6C$6JD]C_CH)%X5C%[T+EZE9S(4NGUG(P-6"=4CY8]/+N155%-3I^[
M6ZG2U=AS4R2O8KT;V^WW-*KPV]=8=JM3W\/&Q*T#_7%Y1FPUCJUO.5W['XFS
M%'!$LZQSUT;ZT-MU*ZJ[3K&[_%E!(9:J1QN\)6>MZN(GG^HO5["S4\ED*WHU
M2;YD*M^07U]G5J?IS%L56FLME\"*E9GLD5"B/MD=9EQ$V;2M&RC'[5B+"P.^
M;/M'3?*7:=:)<K O8[W.147ER(>?>EMO=(,Y)]CL"2.?PECN;RU&%S;QMU['
M]5L=0;3I/9VPIWOA194[_/AQ.NI_4^/3V15*T'C7YT56)[&%1R=5.K>)BJ9'
M,8Q/0)%3SB[$<7:[?V93IYDMAPS>9X8.4C=Z^QY2> ZT[YEZ<E*IC$NY-7=R
M/8SA&L)/TWZK[5E-J7!9ZM'XR]R=R)V.8YAZ2]AXXZ_+&FX8A9?F) G>3AFS
M=!>$YQE/_P"V86S@\EJ&/U9^4Q,,5?&]BRKV,1B%%S=8]WV"_/'JF%[XH_7R
MK>]W83+IYU@GS69=@\S12K=5>(_<J^Y3"ZA]7\IJ>X+C(Z44U9L3'K[U[C9=
M+.H^P[5E\E%>ILB@8SOB5$X5I>@
M     /$/7;[X-O\ 9H2??!K_ .3V/]; >H
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MA9DXHXH^SOC_ +A=T4T3E7M>B_H4_0
M        >(>NWWP;?[-"3[X-?_);'^M@/4
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MMRM)-[$+&T;I];UBU9FES]B\DK$3MD;PC2RP
M              >(>NWWP;?[-"3[X-?_ "6Q_K8#U
M                    "%]1KMNCI&>MU)WPSQ5^62,7A6J>;^D757-?9!'C
M,UDI+$%KU,DF=W*R0LCKML6:PV)QJXV_-6=).O<Z)RM4L_1+EFWIV!M6IGRS
M2T8GR2/7E7*K3;KL&'2XE1<A7294Y[.].39NL0,A\5TC$9^$J\(<H9X96=\<
MC7I[VKRATK>J>.V'TB-'JO",[DY.B]EL?08K[5N*%J?AN1!1R^/R+.^I;BF;
M_P!#N3+FFAB;WR2-:GO<O"%;]3=DLXK3K][%74;8C>Q$>Q3AT@V+*YW367\C
M:6:=;,C%>ON0L1V1I-56K:A1?:BO3DRF2,D;W,<BI[T4*>--JZD]0_LVS.+Q
M=Z94BN21PPL]S5%S?>M.MUO2,I!(D#WHG?/'W'I3I[NR;7K4.25C87HY62LY
M\G(35]^NU$YE8U%7A%5R'ZLC$;W=R<>\Z8[U1[E1L\;E3V(Y%,;,92'&8RU<
MD^9#$KU_/P>4M7W/JENN9M/Q>0CKUF2(Y[%>K6,:ODTL_&W^I:]2K4-M)OB5
M)9$8J*G9V\C>.J,^&VC%X"C''WRO8L\[EY[&J7=&]KT56N14Y\T--L>P8_7\
M39R-V3LAB3_NY?<AY3?U+ZK[3:G=K]25E9)%5C86F?JO5_;L3L46)VQ'+&K^
MQ_>G$D;E/6R.3CDZEMUT7M\5G/N[DY.Q%14Y'I,2\\/;ZO/UH%L1=O=WIV^_
ME#\6Q"U$57M3GR]:')KFN1%1>4#I&,3E51$#9&/3EJHHY/SQ(U=V\IS[@Z1C
M$Y<J(A^MD:Y.6JBE2[AU/KX/9*&!@JK-:F>Q)%5>&QM>;OJ/LF8UW7_3L732
MS,EAC%9[FJBFZT[*9;)Z]2MY.MZ/8E9W/C)+W(.1R@[D'([D
M                            !XAZ[??!M_LT)/O@U_\ );'^M@/4
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MK#Z5#*4-CEO-D5O\2RRKWM5?9(UQ[&U:]E[6!H2Y2KZ/<?$BSQ^YQNP
M                                  IX7ZYVXG=0KR)S\B&)I9'P:_\
MDMC_ %L!Z@                                      ! NJ35=T_P!C
M_9BL^@5-D^F9:O8BYCEL]KFN//?4C2IM7V:S4A8]U5Z]]=W;_04O+;-7FRW1
M?7IX&/6S2J02=G_1V%/XG.Z+4UJ."]K+I\O&JHU53ADB>]RGHWHS05<5:R+]
M>K8])^WP59\][#S[U;P-O![QD%I][(L@BO3M]J/7E6GJ+IGKLN!T2I61O;9F
MA69_ZQZ'DS&R8_$[M=DW>A/95))%D3CNYEY\U1?-#,PF1Q\O5;&Y&MC?0:*W
MN8XD9VHC">]8*5_7.H=#:*U=5@Y8]7M_#:8W4WK%B-EUI,7C()T?-(UTRRM&
M-7,1]!)_0%>U5OO\?WK$0/7;W3Z#5+460QD]C-*YZ1<,16EI_!NM0,^/ZSEX
MF<L+T0]5.\CQ;B<;0R?7#+5KU6*>!UZSS'(G<U?EGK'&ZGKF,[74L34@7N[D
M[(T3UFBZI?>^V/\ 92N?@[?<KD?VM"$=7*UW5^H^/V>O75T+U23_ .MA(]UZ
MUX'(ZO/3Q39WW;D79V]OJB-AH& N83I+F%N,5DMR%949[FFG^#7_ ,EL?ZV
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M[UUBC3J%=X8GK@B+"^#7_P EL?ZV ]0
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M:*]Z\^N)HEZ;:1(Z%5UZEQ'SVHD33M@Z=:3!V+'KU%%9Y.\)HGZ>Z5/86:7
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M %4?!9GP:_\ DMC_ %L!Z@
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M,O4+(=B+\B-D:_I:67\&O_DMC_6P'J
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M>W@MCX-?_);'^M@/4        '( '(      '*
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M\1N"Y;4?CNI3<JOA5[(57UJJ>PR-(V/)9[ LO7<:M&9TCFK"J]W"(2KE
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M^>9"^:%.&C3@J0(J10L1D;?<UID
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M;OT%2"JB8-:_<^;M\WE@(
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M,3O=E%15]Z(KC"@;#!U^OHB(WOQ'^;E5"^$DC[T:KD[O=R<@
M
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M=^<FJ
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M'FOUI?\ \';[ELC^V(>@P      0S>8X)<;1;,G*)D859_?X<3-
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MCU1?61[.Z#AJN$N.K^.R1D"]CO$7E"8:A%X.LX:-?-M.)/+CV$B
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M/U'-7GA?(     !SVM\U1
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MK^>UBN3N7@SP
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M[X&.<Y?>J&>
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M>AO@\P2LT^W,J<,EN?(+\      !%-N@BEJT.[YS+\3F+SQPY$7VDK0
M           ![&O:K7)RBIPJ&%C,30QE=:].!L,'>KTC8G#45WGPAF@  <(
M#4;1KM7.X*YB[#U:RRSM5R>:%/8[I]U"Q4,>/I[@K:42]D?+5[D86)CM&HTL
M->IK<M2S7>$LW'/7QI50D6#P6+PE".GCZS((&>3&H;(#M0#A!P'L^2O;YE(8
M71=LI]1;>RSVJCHYWO8YJ>?A.4N\ <(!P!P@X' '
M                                (]MRM;KN454<J) OJ;YG?J?'V.XE
M47G_ (2/U\\^PW0         #O)3Y^]9?OAYK]:>B/@]6I7Z=:@54[(KGR"^
M@      1K:+#*\%!SW-3F]$U.Y>/6J*25
M                                                           #
M3[%.D&&ORJO"-A5?+D_=8<U^!QCD=W(M6->[SY]1MP         '>1\]>KCY
MW]0,ZLT:,5+#D0]+_!]JLCT=\_*]TUQ__P"!>8      (3NTD\<&)6+CA<G$
MCU5RLX;P[R5";(
M                                        :+:6L=@,DCN_CP%^8G*G
M;K'+,!BTY57)5C155>?8;@         !WD?//JU;BM;_ )YT?/#;+V+^EJGJ
M/H%][V']LE+I      !'-F6!(\>KV_\ [='V*OL=PI(P
M
M         #0;8L*:_DO&7B-(?E&7@)4EQ%"1ODZNQ4]?/FAM          '>
M1\X.HWW=;+_B,W[QZVZ!?>]A_;)2Z0      1C:)XH8:"R*Y$6]&B*B]J(O"
M^:H2=
M                               "-[DR*36LJR151BP<*J)R9NMQPPX/
M&QQ.[F-K1HU?>G!MP         '>1\X.HWW=;+_B,W[QZVZ!?>]A_;)2Z0
M    0_;K,51N*FEF[&>GQMY\DY5%\W>PEK+%;A565B^OWG-;4'"KXC?\SBEN
MOY)(W_,_5M0KY2-_S"68/PV_YG!;5=%X61J+^E#DEJO_ %C?\T'I,*+VI(WE
M?9RG)R\5G/"*G(2>)6JJ.3A%X\SBD\7/J<G/Z1Z1"G]-O^:'[XK/>@](B7R<
MG^:#QXOPD_S'CQ?A(/&B_"3SX\S]\5G*IR@[V^OUCO;[QW)[QW)[QR@Y0<H.
M4'(Y'(Y'(Y0<H.4'*
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M]X];= OO>P_MDI=(
M
M#O(^<'4;[NME_P 1F_>/6W0+[WL/[9*72       #BJ2)+RCD[>/(Y
M              #N;SV\IS[@
M                                       '>1\X.HWW=;+_ (C-^\>M
MN@7WO8?VR4ND       231QMY>Y&I[U7@ZX+=>;E8Y6/_NJBG8 YR-15541$
M,/XSH?C<'TT,N.>)Z?(>COT+R?H     Y  Y     Y     .*UH%F2;L3O1J
MM1_MX4Y
M                      !WD?.#J-]W6R_XC-^\>M^@:<=/8/VN4N@
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MRIQPJ&U           #O(^<'4;[NME_Q&;]X]==!I7R=/JW>]5[;4K4+E
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M3R12#.3KE)077YJ'B5GQI"Z=[.[EOYWGH?0-535M9I8SO[GM3OF7V+([S)B
M         '>1\X.HWW=;+_B,W[Q[!Z%VWS]/Z2JB(L4TD2%O          *J
M(BJIAT\KC[;;+H++)? >K']B\]KD-7@=IPF>6^VA861]67PYD5..UQ&\IU3T
MO%9*7'V<BJ3QKP]&-[D121ZSN.!V)EM^,LK,M=Z,DY3CA5)" #H].IK<;46=
MB2JU7)'S\KA/:=X   #)&/15:Y%X7@ QH\A3?=DJ).Q9F(BOC1?E(BF28-S+
MXZE-!#8M1QOF7B-KEX5QF.L0-D;#XC4>ODWE.5.0.MMB!TRQ),SO3S;SZSL
M  '*!DC'IRU45   &R,<JHBHO'F /$9V]R*G 144          T^9UW$Y:6H
M^W DBUI/$B7W.-P.0          ?DL3)(GL>G*.:J+^A2-ZOJ&'U>K/7QK'L
MCEE\1R.=W>LDH             X0  #@ =J>X#A !P@     ,>[6])J3PH]6
M^(QS>4\TY0B'3[4GZGKK,4ZRDW$[Y._CCYQ-P !P!P@     '
M >B]J\+PI\W.H"2-W;8DD?WO2_-R[RY7N/870FO)!T^J(_SDL2/:7"
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MQEH[IB(,5TXOTJ$LU6&K61(UB^?ZC>Z#%:BT_ MM=_C^A1++WKR[N5"7
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MDA=VRM:O*M7W*984A]/#ZBFQWK,$59<DJHL_"(KT5"8"6:.-$[GM;RO"<KP
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MOXV.6=4X<\VVNZ?K^NQR-QE"*#O^>Y$3N<2,  !SFM155>$$<L;^>UR+^A0
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MS^6RVMWY<E?EL/9;X1\KN5+HK6JD[E2.>-ZI[&N13F
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MN()1TS;L,LM[0<\RWC99E_BN]2R>F6YW\PF;P^3Q\5:[25RRK$G#7.-+T/\
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M5E_&IVJQWFZ-A8.I[YA=GL9&&@DZ.IR(R59&(GT28@
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M$7L<G^:'[XK.43E!R@[D'*#N0<H.4'*!50)VH%5!RT<H$[4'*#U#E!P@ X0
M =K0  !PGO'">\#A  .$]X ,')T(LA0M59'*C9HU8O'N4\QU=2ZP:LRUB<'<
M9-0=_)/55^26CTQT&]K;+]_+VDL92Z_F9Z*KBV0%1%0!&-0 X]C>>3D$1$!U
MRUJ\DL<CF-<]GS7*G*I^@[.$YY"M:JHH5$4ZHZT$;Y',8UJO7EZHG'*G:%X4
M(B(G"&-9HT[/*30LD3_J3DR41$'"!$1##EQN/DNQ7'5XW3QHK62JU%<U%\T1
M3,'"<\C@!&HB*@1$1#KG@1\4K$7A7M5.4]G*'F#P>J^F7YZ=2B_,4U=S7E?\
MOL)-T\U':K&TW-JVB)&67Q]D$2^;$4OT/8U[51R<HI@U,1CJ3W.K588G*GRE
M8U&F:^&-[F*K456+RBK[%.FYCZER-&688Y6<\HUZ=R<G.*M##$V*-C6L:G"-
M1.$1#E-4AG@=%*QKF.3A6N3E%0P:N$Q=27Q:].&)_''<QB(IGRP1RQN9(U'-
M<G"HOK14-;4P6)HS.FK48(I')PKF,1JJALP:YF$Q45UUQE*%MAWG*C$[_P#,
MV*L:YJM5.45.%.%:I!5A;%#&V.-ODUJ<(AS.B[BZ-[A+%>*5K5]7>U'(AU4\
M90I=_HU>*)'>?8U&\\&1:JU[,$D,\;9&/3AS')RBH:G%ZW@L3_-^-K5OU;$:
M;:W0JVXVLGA8]J.1R->G/"I[3L5J*U6JGJ5..#HK4JU2'PH(61LYY[6)PAJ[
M^LX#(6X[5O&5IYX_F2/C1SD-O6IUZL+8H8VQQM\FM3A$-/EM5U_+2-?D<76L
MO3R66-'*AMZ5&K2KQPUX610L3AC&)PU$.TUN<U_#9B%L&1HPV8T7E&R-1W"^
M\Z<'KN'P=5*V-I15XO:C$1.3:6J=2Q8BGDAC=)%\QZIRK?T*=ATW*=:W6EKV
M8FRQ2)VOC<G+53W*A&\=HFI8^?QZ>#IPR>Q[8T14)-<IU;=26M8B9+%(G#V.
M3EKD]QJL-KF%P<$L.-H0UHY'=SVQM1J*IH;G3?2[EYER;!U5F1ZO<[L1.]R^
MUQ-HXF1L:QB(C6IPB)Y(A$=AT+5\_<CM9+'1S2L3A'J26EB,?CJ*5*U6.&#M
M5&PL:C6G1BL)BL17=!CZ4-:%7*Y61M1J<J8M?6<!5R4^1@Q=>.W-W>).C$1[
MD=Y\J=^-P6'Q3[+Z%&&NL[^Z58VHU7K[W<&T
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MM0<)R. K45!V-' 1.$"M10C40)&U%YX X"-1 B(@5J*/#;SSP.!P.U$Y' '
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M$7CEJ\G(    C.Y0QS:UE(Y..U8?7R;7"*SXKI*Q45O@,XX=W>SWJ;$
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M1PER[BF->R>TQJ<?_0GM-'T$6JN!S'HR.2'T_P#BT=Y]I=.6C9)C;K'M16K
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MK[4,"Y!S?%7B*5[.(W_H4WF9W/6L)+%%D<G%!)(G,;%\W&CM]3M2A7)QLO\
MBRTH%DD8Q.?(U/3CJ/7VO&RLLN1EKQ97>$C?*)HTRGHWQEL;,1D?2K%N7OM-
M_ *MT&_K.H[ANJ6[_H\<-I8H(W>M7-15/1&"VK [)5DDQEUD[41$>WR<WGV*
MA1VI8UM/KAL+(&O\%M:;_MR]"Z,YNVMX%ZQ7KZ-F1.?!8G>\R]<VO![)7?/C
M+B2M8J)(GDYB^Y4-KE<;4R./L4[4:/BG8K7L5.45#R9H&C8:UNVU8FTLKZ]2
M1[&-1W:BHBFXSJ9'0M\P5;%Y:R^E=7^-KRRK(7?-U'TZ&U;K/S$*/KL5\ON1
M$.^+?M8EP3,RF01*;G*Q'JGK5_N1#HP7475LY<]#IWE2QQRD4C>QRE0]4]LQ
MMS:\!@9+KTH).[XR8B%A:[B=!P#\EL.,M,@JV%[5_HQ,X]C4-[C.HVH9*^E&
MMDVK.KN(V/3L\3^X;.]N&MT+[:%O*P165\HG+ZS4P]2]+F2TY,U C:[N)'*9
M,6_:G-?H48LK%)-;1%@:SU]QTYGJ)JF&LOKV\AQ*Q>'LC;W]G]XDN(SF)RU'
MTZC<CGK^Q[5]1 -@WK3+E;(XJ3)<H^)[))(^>UCO<KB)_![C5NIWGJOJ?=+\
M    -)MM9DNO9")W:[N8B*B^1L,5$D=&LQ&M1&Q-3AOD98         .J^YZ
MU9^SU<1N[?T\'S$RKK#LG=6=S'2K,[O5ODJ\^P^@O3&-T>B:ZBR*[FC$I.P
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M?PBJB$T >]K&JYSD1$\U4,>U[4<U45%\E0
M                   $;W&9(-:R<J\?)8ANL6KI*5=RN5>8FJKE,H
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M6*KO,WE>Q#/$R6.1KV.3EJIZT5#]
M           --MD,2Z]>21J.16)W(ODJ<FQH>'Z+"K&M1OAIPC?)$_,9
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MI@]+V;1@-'R>.GP5F*[ KYJ_>B=DBN+.T*]LMS6Z\^?@;%>D55<B)Q\DEP
M                                        ([MS)UUV^L7/?VM[3?57
MO?#&]\?8Y6HJM]QV          Q,CVK2M<KZO!?S_D?+^RD*6)DB>YS$>O:J
MIPJH?17IO]PVM_X?#^Z38      $5S$2KL6$5.U6-2157S5%Y0E2
M             <(. .!P@X0!414X4C6-U7'8O,7LA2=+%Z7ZYX&KQ$]_X?;[
MR2\(.$'" #A!P@X0=J#A#C-"U\3V>7<U4_S*$J:/U'UBS/7UK-5'4)9W2=MA
M%Y83W"ZKE_3V93.Y9;=QC')"QC.R*%7>UJ&SU_3L?A[ER_WOL7K3E6:U+ZWJ
MGN0EH' #FM<BHJ<HJ<*<(8(H(F11L:QC4X:U$X1$0Y]J>XHOJ1I&Y9_:<5>Q
M[:/HV/\ 7$DLBM<Y5+LI-F6"-]B-C)W-1948O*([W(OJY,@=J #@< #@
M                                         CNW.5NN9%R.5JHUO"\\
M&]HJKZ\2J[GY"+SSR=H         ,/)_\A;_ %#_ /0^7;_GN_2?1KIO]PVM
M_P"'P_NDV      !'\F^;XUQ;$B5T:O<KG<<\*A($
M
M       (COK7KJ>36-RM>B,['>Y>25UV*R)C5<J\-1.5.8         ,/)_\
MA;_4/_T/EV_Y[OTGT:Z;_<-K?^'P_NDV      !&LHDZYK$=J.6+N>K^$Y1%
M]A)4\@                      #C/&Y\3FMD5BJGJ<GFAR:BHB(J\@
M                                                         $5W
M:SZ/K=QZ1*]>YB?HY4E4?D          8>3_ .0M_J'_ .A\NW_/=^D^C_3Z
M/PM*UZ/O:]&T(4[F^2_))B      "+Y:.ZN?PRQJJUF^(LO]_P!7:2A/(
M
M                       B.]HQ=:N]TBL1',7O_!);'\U#]         !A
MY/\ Y"W^H?\ Z'R[?\]WZ3Z-=-_N&UO_  ^']TFP      (?F6.79\$[Y2L:
MDJ+PU%3E50F">0
M                                       !#M_1_P!BF1[)$8OR$[E)
MA%SVIS[C]         !AY/\ Y"W^H?\ Z'R[?\]WZ3Z-=-_N&UO_  ^']TFP
M      (GF)GLV/"1I%W,<DG+^$7M5%0EB>0
M
M!$MY>K-9O*D:O];$5OESZR6,^:A^@         P,LY6XVZJ-552!_J3]!\O7
M+RYWZ3Z1Z#7DK:;K\$J(CV4847Z)+@      0S,Q))M6!\U[&2N]347VH3-/
M(
M                           AN_+,FMV5AF6)WBQ\/]Q,F>0
M!AY/CT"Y^H?_ *'R[?\ /=^D^F>JPLAU[$Q-^:RI&B?Y&]      !$\NL_V2
MX5K(T=%VRJ]RL15:J*G'!+$\@
M                                                  "(;W7\?7+*
M>)&SMEC=W/\ 4B<$O9Y          &'D_P#D+?ZA_P#H?+M_SW?I/IUK*<X3
M&_LT?^AM@      1K*2-3/8EBL8[E)%15\T5./6A)4\@
M
M         "#]14D=J]EK..731(I.$          ,/)_\A;_4/_T/EV_Y[OTG
MTZUE.<)C?V:/_0VP      (EF&HW;,(B>R*7_5I+>41.3$I97&VK-N"*TR26
MLK4E8WU]BN\N2.9#?M/QMN2I<S5>*=GFPW>&V+"Y59O0+L=A8D;W]B\]J/\
M(V8     -8N<Q*9)F.6[%Z4Y%5(>?E<(;, *J(G*F!7RV.L6)H(;<3Y8DY>U
MJ\JTSHI8Y6(YCVN1?)47E#]
M                                     !"NH+W,UN=S55%2:(FH
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M;,"_>]M;B%[J#D5(O=VJI,ZTTNB[92Q;'N^)<FKO 15]5:9/Z"?F4N4
M
M         $.WR.-^NS-DD[&^-%RXF*          &IV"&:7#9".&56/6N_M<
MGL/F&Y%Y7D^GFLISA,;^S1_Z&V      !%,LZPS8\*K%>C'-E:_A>$7E4XY*
MHZA1/^VEH"S/187/D[6EW9G+U,-CI[]KO\&+CO5J<\(I5^Z]*-=VQDN2IO\
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MT497S5H9)(W,<YB*K'>:*OL4[@
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M::,MO59T8JN5ZK^ <]_E3:]NP6K57.?%#-Z3?5B^J-&%]M1$3@
M
M    $)ZA]OV,64<G/,T2<=O<3:/R0          PLG_R%S]0_P#T/EX_Y[OT
MGTZUE.<)C?V:/_0VP      (=E?NKPG=,Y$2&;AO/".7EI,43E#!J8K'TY[<
M]>K%%+9>CIWM:B+(Y/:XS@        .!)$CXWMY5.Y%3E//UD7UK3\/KS;"U
M(W+-._NFGD]<LB^]RDH
M                                 !#M]JLM:]+$YJJBSQ>I%X528MXX
M\@         #69N=M?%7Y7(JHVN]5X_0?,%R\N5?>I].M:]6#QO[-'_H;<
M    $/R?B)M6&5J\(L,W/RNWE.6_YDP3R
M                                                           (
MMND228"RBO[4[V$HCX[4X/T         &AVID4FOY1LKU8Q:S^7(G*H?,I>.
M3Z@8"7Q,10D5K6]U=B\-3A$Y0V8      (?EG\[7@HN(_7#.[N<ORDX5OJ0F
M"
M                           $5W1[68.5SO))HR5-\D          (YN+
MG,UK+JU514JO/F>I]/=93G"8W]FC_P!#;       B.7K,7;L*]$;W,@F]:^?
M"JTER>0
M                                !&]K1%Q*HOEX\9)$          (U
MNGW,YC]E>?-%3ZH8J@E"C7@5_=X4;6(JIQY',      $<R/>NS8N1$5&^#*G
M//'KY:2-
M                                  ".[2]&8OO]7"3Q^?D2)
M   "-;I]S.8_97GS14^J8      !&K\KF[#BV>,B-=%+\CWJBH25
M
M                  ",[? ^;"R(QW"I-&OGQR29J\H@         !&MT^YG
M,?LKSYHJ?5*O,R:%DC47AS47UIPOK/T      $0R$T3=NQ$:=J2NJ3^?FK>Y
MA+T
M                             -'L;&R8N5CU3M<]B+R;QJ(B<(
M    1K=/N9S'[*\^:*GU3B>CV(O"IRG/K\P      "'W'RIN6,1(U[5I3]SU
M7A/-A,
M                                "/;0Z5N+7L\UFC14XYY0D*
M    $:W3[F<Q^RO/FBI]4P      ",V>Y-IQWRN&+3GY]7FO<PDP
M
M                 !'-H1ZX^+LY_P";BYX7CU<*2-          "-;I]S.8
M_97GS14^J8      !'[*5V;#0<^3^,6"5K&_FY;R2
M
M        C^S*J8Y%1O*^D1\)SQ[R0(          1C=NY=6S*-7A?17GS34^
MJ8      !&)7HNVTV*[_ /8Y5XY]?FTDX
M                                                          !#
M=Y=QBJJ=BN5<A#QPO''J=ZR9(          17>IHH-4S4LCD:QM5W*GS64^J
M8      ! ;#WIU&QB(Y43XJL_O,)\
M                                                       17;^U
M:%5?2$A<EV+M=RK>5X7U(2I          ");[5BM:CFX)>>Q]5W)\V3ZI@
M    $;EAA=M%.5T;5>VK(U'\<JB*K>4122
M
M$!Z@I(M#$K%)V/3+0*C_ '>IQ/D          (UNGW,YC]E>?-%3ZI@
M $9D\?[*:WRU\+T23E/S\M),
M                                                  0S=VHM+'.1
M/E-R<*HO/''J<3-          "-;I]S.8_97GS14^J8      !HGO5-@KM]7
M"UW_ .J&]
M                                   (;N\D\="@^%CU5,C#RK5[>&\.
M\U)D@         !#^H+)'Z9G6Q.5LBU7=KN>T^;A]4P      "%S/G3>Z"-<
MBQICIU<WN\E[F<+P30
M                                            @O4!+*XW'+"]4XRD
M'>B>UO#B=(          1#J%7?/I>=A8_L>ZHO"GS;/JF       1M[(4VFJ
M_M:DGHKT[OZ7;RTD@
M                                          !"]Z?.S&TG0N<C_C&#
MUM7A>.'$T0          C&\/9'JV9<Y41J5'<J?--3ZI@      $1DB1=TJ3
M)+ZV4)6JSG\)6KR2X
M                                           B.YN5F/J.:KD<EZ+C
MM<K5\E)<@         !#.HB1_83G^^-9$]$7Y!\WSZI@      $1<^)-WJ1M
M8WQ74)5[_P"EPBM)<
M                                           1#<[DM2G1D9YK?B9P
MB]O**B^TEZ          $#ZHN5O3_8W-545*I\YSZJ       $.F:OV;4GHY
M?5CYD]7YW,)B
M                                      07?E1*&,5%[7)E(.U_EV^I
MQ.D          ()U0<C= V-W:B\53YS'U4       (G(L7V8U4=&U7I1E[7=
MJ*Y$Y;RB.]A+
M                                      "#;[(V.ABE[4Y7*PHJN7A&
MIVN)R@         !!^I20?8-L'C]R1>BKW*T^<A]4P      "(.?-]FU5.U$
M9Z!+\OV\\M)>
M                                      07?W5F8O'K,WE5R<"1>OCA
M_#B=(          0'JG][[8_V4^=)]5       "'+._[.*L7KX2A(Y/=YM)B
M
M                          0C?88Y<;CE5G+F92!6>OCA>'$W3V_I
M      (#U3^]]L?[*?.D^J@      !#^UB;S6?PG<E!Z<_FY:3
M
M                 @W4-KOBK']GK5,I KOS)VN)R@         ! >J?WOMC
M_93YTGU4       (@KX/LRC8JKXOH+U8B>[EO)+P
M
M     "(;FYWH=!K9',[LA$CG)[&\.)>@         ! >J?WOMC_93YTGU4
M     (>YK4WBJ_QDY] DYC]OFWUDP
M                                                       (GMSU
M97H*Q4:[TZ/ARN5G"<+[4Y)8@         ! >J?WOMC_ &4^=)]5       "
M(KX2[E%PB=Z47\KQ[%5OM)<
M                                                 0S='OCK8Q\<
MJQJF1B3NY[?5P[VDS0          @/5/[WVQ_LI\Z3ZJ       $-269-V1B
MQ\L]!=VOX1>WRY0F0
M                                          !"MYC[J..7E?5DX?\
M1Q-4          (#U3^]]L?[*?.D^J@      !#G<KNT/,".XH/XEXY[/6WU
M?FY)B
M                               0W=FSNK8IK6L5OQE"KT=[$X=ZT)D@
M         !6O5YEE_3[.^ Y$XC17_G8?/8^J8      !$FM;]F"O6=>Y*2HQ
MGN153E26@
M                                  $3W1SHJF,5&]RKD8D5/<BH[UDL
M0          KSJPR1W3[858_MX@/G>?5,       C]EEZ/+I.RFCF)#VH[GY
M7*_Z'=\97&HJOQTW"+QPWUJJG3<S%V#Y4>)LRM_Z43DYQY:[)!%(F*LHKN.Y
MKD1%:%R]IBN[L7:\UX[41?4=K<G8<U'?%UE/S*B!F3L/:COBZRG/L5$Y./QK
M8\3L7&VN??VIQ_J(LO*YWKQEMOJY];4_^3FS+2^*YOQ=:X3GUJU.%_\ <_9L
MP]B(JT+:_F:Q/_D[$RC^/^2L^7X*?_)UOS#T5_\ P%OY+47U,3_)/68T&=?+
M,]GQ5>:C>[Y3HT1J]O\ W.^?-K&L;?0+;E>[A$:Q/\U]9U.SS&RR1+2N=[5X
M[?#3U_H]9EU\GXS7.6K8CX]CVHG/_N<6Y5JQ/D?6L1HWV.8G*_\ N=+,]4>C
M?XJRG*^V-/\ Y.$FQ4XVL58K/+G*B(D:?_)U.VC'MB;*L=GA7*WCPTYY3_N=
M/V7XS^KM_5)_\G)NV8QSD3LM)^F(Y_93C?#<_ML>KV>&=\6QXJ6-[_%>B-\U
M<S@[DSN,553QUY1.53M.E-EPKDY2XBI_=4ZUVO7T:BK?1$5/4O:H^RS7?R@G
MT5/UVU8!CE:^\B*GFG:H9M."?W=M]B]O'=ZE3CDR&9_$O<C6VVK^A%/R38L1
M$[M?<8U>>..%.C[*,'\G_CF>MW">I?,Y+LV$Y;_QK/6O">I3M9L&)D^;;8OK
MX]IR78,2G=S=B3M\SC]D6&_'H0NQX;\>B.29_$JUSTNQ<-X15Y\N3L=FL8UR
M-6W$BKSPG/N#,UC'M1S;<2HOYSD_,8YG/?;B3A>/6H7+X[L1_I<7:ODO)R?E
M:#'(UUJ-%7CV^\YID::L1_I$?:J\(O)D07:CT<Y)F+PO'J4Y^D0_UC3H],K=
MZM\=G/K]7/N/UENLYW'CL_[*/2ZW=PL\:>OCS/Q;E9%5%GC3CV=R!;==$15F
M9POEZSN=:@:BJLC$X_.?OI$']8W_ #"68%Y_C&_YCTB#^L;_ )GXVS7Y5/%;
MZOSA;<'K1)&_YH<4M5_9*S_-#]6S78G*R-_S/QEJNO'$K/T\G%;==%[?%9_F
MAS],K_UK/\T/QUVNJ]J3,1/=W(%N5T1/XUB(OM54.*VZ_/'C,^DAR?=K^7BL
M1/TH?BVZZ?\ K,3_ +H?GI=?GCQF?YH<UN0>R5GTD.*6:ZO[5E9^CE#FL\/'
M/>WC])^);@7A&RLX_2@6Q G_ *C>/TH$LP]W"/;SQZDY0_?&BYX[D_S"31KY
M.0>(SWH/&C1>.Y.?TCQH^?-!XC/>@6>)%^<G^:'[XK$]J#Q6>]#\\>-?Z2?Y
MCQH^.>Y./TCQXE\G)_F@2Q%Y(Y/\T'I,7L>G^:!98T_I(/'B1?G)_F@])A_#
M;_F@])A_#;_F@])A_#;_ )H/28?PV_YH/28?PV_YH%L1*G/>WC]*#TF'\-O^
M:#TB+\-/\T/WQ6>]!XK/>@\9GX2#Q&)[4"2L7R5#\\5GX2#Q&<<\H?O<@5R)
MYJ.4'*#N0=S?>.4'<@[D'<@Y0<@<H.4'*#N0=R#N0=R#N0=R#N0<H.Y!R@Y0
M<H.4'*#E!W(.4'*#E!R@Y0<H.4'*#E!R@Y0<H.4'*#E!R@Y0<H.4'*#E!R@Y
M0<CE!R@Y0<H.4'*#E!R@Y0<H.4(;NLU=M?$),Y4:[*0HG"<^OM<3)
M   " ]4_O?;'^RGSI/JH        !P@X'"#A!P@     ' X' X' [4':@[&G
MYX3?<@\)ON0+$WW(<'5('*[F-B\IPY53S0Y-AC:J<-1#B^"%[D<L;5X7E%5
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MYCXDR"M:CL[<7AW*_G3W>9Q7!9!.$9G[K6HGZ?\ ]([EP][EG&;N>I?7^?\
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MJYXWVOL^L;VM_BD[N?:T^>9]4P
M
M          "J>M;U3I]E?SO8AX"7S4^J8
M
M                 !5_66!)NGV9Y>C>SL>?/Q3ZI@
M
M                          %6]9Y7Q]/LOVM1>Y6-4^?RGU3
M                              (UDLI=CSF.Q\#HV-GAE>Y_F].Q43U)
M[O69LE;,+(US<BU$]J+$BK_J=;*N;5TBOR$:(JN[42)/4GL]IUOJ9_L=VY.)
M7>SF%/\ Y,E];.)4=V7F*_M]7,?#>XQZU7/K7;X^0B27N3N[8D5.#*]'S*,F
M<R^WGNY;_%HG">Y?68,U;8^]_A7X.U?+F+R.KT3:'+Q\9P,3GYR0HJH94M//
MN:SPLPR->%[OXA%Y_P#<Q6U=I:ORLA7>B+_5<<H=\L6Q.D58[%=K>?)6\GYX
M6Q_C%;Z(\+8_QBM]$>%L?XQ6^B<)(]F[5[)ZJKRG'+1(S9ULO[):J0\_)Y3E
M3N2/8.QZ+-7[N4[5X.V1N:5J]DD"+SZN4.F2/8%>Y635T;[$5IS5F>\+A)8.
M_P!_!P9'L*.Y=-75/=VG3''L_8G?/51WMX:<_"V/\8K?1#H=D5%1+-9%]B]@
M\+8_QBM]$YR1[ KW*R:NC?8BM.B:+:%C?X5FJC_9RT_(H]IX=XL]7V<<(<DC
MV;NDYGJ\>KL^2<V1;&L#%=8K))[41OJ,>2/;4>Y&34^WV<H<ECVKQG)XU3P_
M8O'K.",VWPW\S4^_U=OJ.IS=S14[7TE0.;N?*=KZ2H.W<^]WRZ7;[%.QC-O6
M.17R4T?W)VHGK3@X2_9EXR^'Z"D?L557G_0YJFWI%)PZDK_5V>:)_H&+N"QJ
MCTI-=['(Y5_]N#@]=SYE[(Z/FG9R]?+Z)W/?MJ/7MAI*WM]KU3U_1/U)-M1'
M\UJ7_3_&+_M.V1^S_+1D-3U+\E5>OK_,OJ.MC]L[_EPT^W\SU_VG=9?LK$8Z
MO%5E]?RFN>K/_=$4X++L_/*5ZGS_ )OB+Y?1.U\FQK(Q&UZO9ZNY?$7G]TQ(
MI=O;%*U\%)SE7Y*I(J?_ *(=+M[62<5:+G?T4\54_P#T3)\?9?Q.I]<O^TZO
M%VKU?\+3]3OZU?6GT3GXVT=[E]$I]O"<)XJ_[3EX^R_B53ZY?]IS?/L7:WMI
MU>>%YYE7_:=3+&SJU%?0IHON29W^TREL9]$>B4ZZIXO"?QJ_-]Z_).'CY]))
M$]"K]OK[5\5?]IA>E[<LZ)\6TDB]?*^D.[OS>KL,CTK9O!<OQ=4[O%1$3QU^
M9[^>WS.KTK:E>_\ \-IHWU]J^.[G]PYI:VGT957&T_$\1.&^.[CM]_/8='I>
MW_DNC_\ <._V')MO;/7W8RE^;BP[_8<DM;4O'.-II\GU_P >[S^@9%:QLJQR
MK+1JM=ZNU&S*O^:]IC-M;7S,KL=31.[B-$G=RJ>]?D&7';V-M9[GT:_>B(O:
MR55_]^TZ&V]F61O..JHSVKX[N?W3KEN;2KW>%BZBM1RHBOG<BJGT5.UEO8T8
MJOQU?E&\\-F5>5^B="9+:'<-3$0I[N9EX_=.B/*;7X*+)A($D]K6SJJ?NF1!
MD=FE3E<3"S^],O\ M.3K^S(_L;BJZ\^3O&7C]T_&7]H\1(W8JNGR.5<DRJWG
MW)\D19#9'K*UV)A:J<HQ5F7A>/\ Z3A8RFS0M:C,/%)\WGMF7S7S_HF%'F]N
M67A^NL2/GS295=^Z<[&9VQ)XF08"-S%\WOF5O;_^*G=%EMF>]B.P;6I_359?
MW?4?LN8V1K&K'@^55RHJ+(J>KW^1WP9#97,>Z7$PM^7PU$F55X]Z_).R7(9Z
M-JI\5,<]&_T9%XY_R,-,CMJQ+(F&K<HGS%G5%Y^B<W9/9N]4;AHU;W(B*LR_
M[3J3*[9XRI\1P]GX7CK_ +3FW*;2KGHN%AX14[?XY?6GT3N^,=EX15Q,/K=Q
MQXR\HGT3K3);3V2N7#0>I>&)XZ\K^GY)DK>V-BJOQ9"J=O*<3+SS]$ZZV4V5
M8'.DQ,3)/P4E5?\ W[3!=E]OY3MP,/UZ_P"T[YLIM+4<L>$A=Y<<S*G_ .B?
MOQKM*K BX6'A4^7_ !R_)7Z)QDRFU-1W9A(57U<(LZ_[3I;EMQ<Y$7 UTY7S
M6P[_ &&2_);1ZT9AX%7NX15G5$_=.+LGM;9&-^)8%16HKE2=?4OT3]FR.ULM
M5FLP]=T"LYE?XZHYKO<B=IF/OY]OK9C8E3A>/XU>>?\ (Q$R6U^C3.7#U_$1
M6JUB3KPY%\_7VF.[+;>C6*F!@55\T\=?]IVQ9+;7)W/PU9J>[TARK^Z<GW]M
MX<YF(J*B>2+.Y%_<.7IFW_DJC_\ <._V#TO;_P ET?\ [AW^PZG7]P17\8>F
MO"(J?\0[U_\ X'=Z9MOA/7XKI=_J[4](=Q^X84NQ9O'OQ_QGC86-M6HX$\&5
M9%1ST5?:UON)N          59UGGDAZ?Y?L=QWJQBGS_ %\SZI@       _'
MSQ,7ASD3]*GZUS7(BHH ?(QB<N<B(?GIE?\ K&_YH&V8GKPUZ*OZ4#YHV<=S
MD3]*\#QXD;W=R=OOY/UDC'IRUR*      .0    .0!R             "(9!
M_P#^MV&8J=R+5L+QW^2HYGK[27@
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MF\RP[Q<UK)5$KO55?1E[N4F86,"(7GL^S'#M7S6E95/E>YS/82\
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M_P!7;W-Y7M).
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MTFCZ)J^%K=ZN2&E$WN_0A(R)7J'C;=B+2JG$-.PU&\^USF$M
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M5C=8UQCV\\Y6-4]7<O*-<3Q          "I^MOWOLG^MC/ B^:GU3
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MC/ B^:GU3
M                        X  X0#@<(!P.!P@X'"#A!P.!P.!P.!P.!P.
M. !P .!P             "I^MOWOLG^MC/ B^:GU3
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MK+&DGC1]JKPCNY.%4[@%5$3E3I;<J\-=X\?#EX:O<G"_H.X
M      J?K;][[)_K8SP(OFI]4P
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M>V2>%%D3W/)2                  "H^M\C&=/\ARY$[IHT0\$+YJ?5,
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M,\[63(SY",B7S5$0GN'Q=;%8VG0K)Q#6B;&S]#4X,\
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M7V2T)59%'W\I(;W0]SAVG"^E^#X$[']EF#GE8WDO
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M61:3E7N['>Y"5= ["V]?S$RM1OB7N[M,.G._5^LMO'P\,I9AGB]ODBRGH=
M
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M,<T3*BTN[M143M16^17'P?GQ/UO*NC9V,6\BM:8FZ(DO633&QQKWLY5ZGHD
M
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M<L'5=3Q.DXN[%7G?X#I%F<K_ .B5YH=)^S[MF=SDX=5[G5Z'YV(OF7V
M
M           "G^N<??H%S^.<SMGC7^\>#%\SZI@           .8UWF@1J)Y
M       'Y)$Q_'<B+PO*<^\_0 #IAI58)9I(H6,=*[ND5J<*Y?SG<   #KMU
M(+5>6&=B/CD:K7-7R5#&Q&(H8FA!3IP-B@B;PQB&:
M                                                         "G^
MN;8%T"ZLJ-Y2>/L/!B^9]4P
M                                              !*URLX:_M7W\<@
M                    HWX02M316\M\[\7^CCP\?5,
M
M                            HGX0GW#1_P"(1?NN/$1]4P
M
M                                  "C?A Q/?HJ*UJJC;\2K]%QX>/J
MF
M                                              49\()[VZ*U$54Y
MOQ(OT7'A\^J8
M                                                        !1/P
MA/N&C_Q"+]UQXB/JF
M
M  43\(3[AH_\0B_=<>(CZI@                 ->UW/"HO'F
M
M                 43\(3[AH_\ $(OW7'B(^J8                =(QB<
MN5$0AN?W_6,%RVW?:LW'+8(OER.(,W.]0=MLJW$4UQ&+_')TYFD8OM8TLK6-
M<;@Z+H77;%N1[^^6>9>7O<2$
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ML\D53<@
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ML4%IXNND4;E17KYN>J>URDB
M                                         *)^$)]PT?\ B$7[KCQ$
M?5,            &ASFSX;!UEGOW&1IY(WS<J^Y$("NT;ML"]F!PWH=9R\I?
MN+QRWWL89M'IGCYK4>0S]F3+7F^3YOF-_,UA9-:I7K1-BAB:R-ODUJ<(AW
M       *J(0'/]0\+C%?5K/6[?\ )E2#UN52-187=]M;W9VV[%4OQ*LY5?(G
MN>_U%C:_K&&UZDE3&U&0Q^WCS<OO53>G53O0V&S.8U_,<KHU[DX];?<=H
M
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M)^E27@
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M$,3'9O&9)7^B78INSYW8O/!L
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M:U$]ZH8S,A2DE9&VS$KG\JU$<BJJ(98
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MSBHLY'CI:]BRR%4@7Y:J\OX
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M]3IU/1[<.0^/=AMK=RR_R:K\R!/<PM
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MVF?#KU5:&*5W9)?G]4KD]O8TL[6-0Q&NUGQTXE[GKW2SO]<DB^]RDC
M
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M&X/IH/C.A^-P?30[X+E6=_;%-'(ON:Y%.T
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M[%2/L$7P=,4U(^_.V7JCN7<1D]T?I5C-0RMF_6OV)7R,5C6N]2-:6H
M                                           >:OA&_P TXG]>IY /
MJH       <+UVO2JS3RO1D<;%<]WN1#SW/\ "!Q:23+!B+<L#'JB2EG83?\
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M                                  _&O<LBM5BHB>T_0
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MHAZ>Z5!*R6+7:#'M7E')"TE-6A5J1)'!"R)B+RC6)PAD<
M
M       \T?".;SC,0[GRF<>0CZJ       &FV7")G,#D<<]RM;8A5G<>6\9-
MU@TC'VL3'B%M5(U5D4O'>U.?P"8Z#T\SM#6-DMY*'_Q')1?(B]K3%IZG9H]%
M;>-S4S,?+XZR\RE:YB]O7VMJE.VZFF+8D?8]'\R/;Q\E"?[#J6;V'IKI"8V!
M)G0PP*]I)^J.DY[+:SKE6A V:6HYC96M4A?4;0-I?F\'?K8SXSAAJ1Q/K)ZV
M(K$.W0-+V_%]0H\I8PS*56>!ZO;#ZHHT>J+V&;6Q>\:_U0R]JABGV*5ZTKI)
M>/4C'J8&0Q/4'5NI&>R6(P\MV&XLKT1J\,5)%-GTMUW;H,OLU[,XV>"2["]>
MZ3VO<2CHIJM_!X/+-R%-T$\]K_NK6%19K6<OJ^U9[C4X<Q7LR*M:6:-'(WN4
M]!=*L5F,9@9'9+'4Z4]B1'K#7B2/AO\ UF-U=TZWLFLKZ"SNN59FRQ)^$4K>
MRW4;;\'2U5^O/A5'L2>RY?-&$FZ@]/<]*W1*>-J.M18^+P97GI=J?)XX/.?5
M33MEK[-2VW78%DGB;_'L3WM(1E>I.][G537JF#6O+.G9.]">;7H]K#=(8L-5
M266RR:-\J0_TWJB]QF[+B,DO1.A02I(MIE:LCHO:BHPUFY8++R](-;I1TI73
MP.J++&B>MO#%,7J7K62CQ6I[#2J++-CHV)/$B?*,_6.H>Z;?MD$-/&)6Q#$1
M;:2-*KV3 4=7WS++E<%->HSK+)5X_.I,\%@YY^G&W7X]=916W7XK1L7E[V%E
M]#:=JGH-5EB%\;GV)'HCO<I;X
M                                               !Y?\ A)3]M?!P
MH_S61QY+/JH       !P#7Y["4,QB;.-N1]\4[>'E(L^#UJK7L5;UMZ(J+V%
MZ4:%6A3@J5HDCAA8C(V)Y-:WR0RN .  !P .  $B:B\\#@ *G(1C6^2!T;7>
M:!&HB<!$X
M                                !Y?^$A(ST7!L\?AW=(J1GDL^J@
M
M                                          !YA^$?4A?3PMI>>]CW
ML0\DGU4
M                                                    /*OPDK<S
M5P%5..QZ3/4\JGU4
M
M /)?PE/^<US]5.>7SZJ
M
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M0V>SYR,4V66S&-Q--]J]:C@@9\Y[UX0U.%W+6,Y.L.,RT%AZ>;6J20
M
M              'E;X227/\ P!4[_ XF[_=WGE0^J@      !&MT^YG,?LKS
MQSTIRG3ZC!E$VFK!*][X_ 62))#T/IV1Z39+,L9K^.JLOQ1K(U[8&L5$0C+<
M\^3KC+2] I(C$5$G\%/&^F1W;&,?U]PJ/1%1? -AO^S/I]6\933&T)$;X/\
M&R0HZ7Y7N<;[JGU,S>H[3C*=1L;JCF=\S%;RYY"LOUDW_'7:EZQA6UL9.]5B
MCD3UO:7OF=_QN+TR+8G\K%/$Q\+/:]STY1I0L'67J&M:7-K@6/Q2/[/S(I:W
M2/J'E-Q@R[[D$42UY(D;V?\ 66_=_D)$_P"E?]#PAJ3M6CZC93[)4A]#YG1/
M'3EB2=R'H7 6.C-W,P4<73H/N,]<3VPM\T]RCJ3U5?K5^+$8NGZ3D7\*K?8T
MCFL]9<NFQQ8G9L6RCXOE(J\=JD[ZE]3*VGUH(HH?'OS_ ,E#Y(B%;X;K=G:N
M3I5MCPJ5H+7"MG\E1"V.HVYV=9UE,I1K-LN?,R-GNX>BKW$HU?,3YC7L5?EC
M2-]FLR5S$\FJY.33=1FVGZ1GTJH_QUJKV=OF>*-,K:E>RF#I9-',[_';;>_U
M-Y54\/@]@:%J$6GX/(14LHZ]#*JS0\IPC>$4\E;HS>\U1=L6;1[*OI"11,<J
MHB*[\!I['Z?1,ET'7HW^3\;$B_\ =A5FQ]'>GN PN4R=M;;F1(KF<R<$=Z!Z
M.]7OV:URB)S'5807J9=Q&3ZK64R,RLHQ2I!,^/S1L9;O2S6NFLV6?EL#?LOG
MA\H)?4L:./1?DT\A=16W=OZK5-=5[_1('(SC]YQK\KA(.G/5##?%4[TK3^Q_
MX*^;5);UF9:S^\:YJ\5KLAD];D_.XA.[:NG3+=,%:Q%EZ12^7<ON5$<>U*SV
M31->QR*US45%3W*<@
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MN\'A1\(I_=D]8K-[%5RR'I7"5I:F+I02<=\<#&NX\N40V(
M
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MU/IKO.?V*CD-M6=8*WXP]7O<>O$3@
M                                                 'DOX2G_ #FN
M?JISR^?50           Q,QAJ&4QT]*[$V6&9O#V+Y*47)\'C4EE5[+EMK>?
M4PN+6]:Q.MXV.AC8$CA9_FY?>XWH    '"<\@   <(!P@
M
M      !Y+^$I_P YKGZJ<\OGU4
M
M           /)?PE/^<US]5.>7SZJ
M
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M?]CBR]4=W<3QNX\^'(=L<\4G/8]KN/<O)R
M
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M%+1ZHW;E7):KZ/.^-79'A>U30OP\G4#=-GJ9#)64QN)G2!E5B]B+)RJ=QH<
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MTU"2MW1-[N'/5AL^FU.W!M'4.6:![&2Y5.Q53S];R"OQF03%]9?^%E_CK?\
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M>Y4@NR5)9F*UL[/G1\^U"-:#IL6IX9:2673RR2K)-,J<=SB;  <   <#@#@
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M[40*U%' 1.          #QY\(ZQ&_-X6%(^'1UY%5QYN/JH
M
M                                >,/A$?=/C_V4\]'U4
M
M                                  /&GPBY7OV/%L7R95<>=CZJ
M
M                                         'D3X25>)F3P$R)P]\$R
M./,Q]5        .Y!R@  '(
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MK7?#&[U-@8BKPUIO0
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M0!^3UH9V(R6-KDY1>')RG*'Z
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M?LAY]/JH
M                                      %1%"IR%8U?-!PG' [4XX"M
M15"M14X4(U$3@(QJ #A.>0.Q.>0. K44      'BOX0_?]EM3\#T1.P\_GU4
M
M                                             /$_PA63)N%9SG\L
M6HG8A09]5
M                                                      #QA\(C
M[I\?^RGGH^J@
M                                                        !XN^
M$0]/LKI,]K:AY\/JH
M
M  >*/A"R0+N,$:<>*RHG>4$?50
M
M           \/?"![_L[5%C1&I5C[7%&'U4
M
M                    /#OP@9Y';X^%5^1%5C["C3ZJ
M
M                             'A?K]]\*S^RPE)GU4
M
M                               /"_7[[X5G]EB*3/JH
M
M                                 >'.O[VKOKV(Q$5E6+EQ1Q]5
M
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M(.Y!W(.Y!W(.Y!W(.Y!W(.Y!R@
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MH?C<'TT/U,A27RM0_30YI=K*[M\>/GW=R<G?Z97_ *QO^:'7Z963_P!5G/\
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MW^DQ<>_N3@X+D:/"*MJ'A?)>]#P_UZEBEW^PZ-Z.:M6$I<
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'>..5.!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex3-6_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 <@ !  (# 0$! 0            8'! 4( P(!"1
M 00" @$"! ,$!08, P 3 0 " P0%!@<1$A,Q%"%!42(R0A5287$(%B,S<A<V
M8G.!DQ@D-#4W5%9T=9&QLD-5DJ$E4U>4TN*")D1D)SB#8X3!PM'_V@ ( 0$
M #\ J+A][V\@87J3P[D7]!@B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_G9Q82-_UW_O07]$
MT1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$7\]N(8#+O\ A.HO/PE\E_0D(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(OY\<06C!R!A?].0L7]!PB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_GKQ' ^;?\'TSO
MPF\ROZ%!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1%P+PI_G_ ([_  /7?3?RA$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1%_/KAZ>"'?\-ZH_.\L8OZ"A$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%_.SBL$[
M_KW\+07]$T1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7\\N)K$L&_X'P=UYS^#E_0T(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(OYV<5@G?\ 7OX6@OZ)HB(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(N ^%O\
M/_&?BZ^3EWXWV"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+@3A5K3O\ C>Q[->N^V^P1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1<#<)_P"?^._P/7?+?RA$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%_/GA
M^>:+?\+Z;/+SD+'+^@P1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1<!<+RAF_XH']?DU=^M]D
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$7 O"A W_ !O^!Z[Z;[!$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%
M_/[AJ 3;_B.S^0EZ_H"$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7\^^'1,>0,-Z8)_&?+IW
M707]! B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(BX&X3_ ,_\=_@>N^6_E"(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B+^?'$!<-_PO1D^<GZ%_0<(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(OY]\.R1,W_#^
M<CF]O('2_H(/9$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%_.OBS_ #_UW_O87]%$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$7\\>)H'S;_@?']$_D5_0Y$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%_/_AJ=
MD6_XGR'YR6A?T 'LB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_G]PW5BL;_B?/\ 02\+^@(]
MD1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$7 G"KNM_P 9_$/7?;?8(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(N N%Y/#?\7^!Q[#@N_1[(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(N!.%7@;_C?XM>N^V^P
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1?STXDLRP;_@O#]<W@5_0L(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(OY_<-0>KR!B#YD>!+U_0$(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B+YM68*T+Y99&LC8.W.)Z "K"7E_4/V@*=>2S;/9[?7B\V-6WQW)>
MFY&S3JULH#9L2!C("WIX*Q,QRIJ&&OSTK]J:&:-Y!!C6$.8](+ _XNSX_?T5
M+\9N.%R6OS9JG+++682"0S\7R]^@HE'S#I4M@5H[=AT_?7IB(%RS:_*FES6C
M5DR1KS=]!D[/#LJ2Y_9\1KV-&0R-CTX"\,#@.^RY0E_,^BL +[T[0?8F)!S-
MHO@'F]/X?O>DMSE>1]8Q=2G;LV)A7LPB2*81]L(<F"Y(UG/3R0XV:>9S(R]W
M4?R "U-CF+2*LIAL7)XI1[QNB *.YCTAC?)]NRT?<PK89'D_5,=6I6;-B=L-
MJ%LL,GI@M<'++USD+6]CM&#&33S$#MSO3 :%(\SG\5AZSK%^Y'7A;]7%0.#E
M_3)23\38;&"!ZIA_ IEKVVZ]GG6QB[S;(@\1(]GL"];V1[8V.>X]!H)*UF!V
M#%YJD;E"<31^HZ/O[.:L?8]EQ.N8_P".R4YB@\PSL#LEQ4&=S1HC "^_. ?8
MF)>L/,6B2@']IO:"0 71K<Y7D35<//'%>NOB$D39&2%GX'!R^&<F:(^,R#/0
M%OW *W6 W+5\Y++'C,I%9>QO;@SZ+?K RN9QN(J26;UJ."%GYI'E0D<L:-\0
M8OVJ0S_[MX'TE.L3F,;DJ;+=*RR>)X!8]A['14,S?)FI8+)34,C<DAFC^[/D
M5JAS+HQ8'_&V/'[^BI=J^Y8#9XK$N+M&80.#9 1UT7+VV'9\9K]=MB\91$3T
M7,9Y=*%1\SZ)+^2].[^42F&#W+6LZ]S<;E(9W- +F-/3AVO/9=RPNLMA?DY)
M8XY.^GM9Y!12/F;1I 2R[.X#W(A6^UOD35=BOOI4+KWSMC+S&6=?(+8[!MV"
MUYL1R-L,=*>HXVCR>_\ D%I6<H:6>F2Y3T9B_P !#(SI_:V>>W;7\!:@@R=E
M\ E';92SN->6*W[5LQD64<;>-J0M+BZ)O;&_S*WN6SF+Q%8V<A;CKPC];RH7
M'RSHSYS%^TW!OMZIC(C4MQ&U:]DYY8:61BGE9&'N:P]]-*T=CDG1Z\[Z\V>K
MLF8_Q+'=@@J72Y.E#CW773M]$,\S(/F W[J/X?>M1R]ME:AEHK$I_0Q2A8V/
MRV-MS7(X++))*TGIS-;[L=]BOW)9*GC:<]JU.V&"%OE)([V 4*_RI<?]=_UC
MK(.4N/\ _M'66QL;WJ->E4NRYB)M>PTF*7]+NEYXWD'3,I<BJ4LW#-/)\FL8
MI/>R%.A ^>S.R*-@[<]QZ 4+'*&BE_0S<?CU\I/$^"FU'*4[T GJSLE8[V<P
M]A12]R'I>.MS5+F;@AGC<6N8[W!4KIY&E9ILN03,DA<SS8]OS:6_=1>AR!IF
M0O14:N;AELO=TV)ON2I>O"[>K4X'S6)F1Q,_,]QZ 40'(^D.^0SL'YO'Z]=J
M9T[U2W"V>&9DC#^4L/843R/(&G8NW+4OYJ&"=AZ<QZP3REQ^ "=CK*18/9<'
MGHYI<5D(K+(G!KRP^Q*W:(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B+@'AB>*+?\ %^;P/,.:U=_-]@B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(N2^>=NRC\TS6:TQ96\&&;KWD+U?7'^H8_6L!3@AKAD
M[HFF>0CI[GK79_CNK:VK![#3B9%9K6@ZQ]/4C5,_TE>CD-<_C'.I_KVPXU^,
MTO60()Q<QS/B8_S]1AH5BZCK$&M8^W0KR=UGVY)86==>#7G\JYCU@1Q<[9,?
M)K1=L_\ O6__ *0HQ4C<,^(Q&Z7O'X?SEJG^%U&ULO'.L4<N][3#)#,]CAV7
M,8T]-*B'](.O!6P>$@@C:R..4AC&J6\?X*GGN*:..M,!9-"0O#DO#LQ'$(QG
MEYBHV",./W8TA8/]'C_-?)?]\"K7E2.JWF.J)0WTCZ!?VKQR.>PVS;7_ %5B
M?!:J&A.^R/$.#9&EH8HGR#J[,'P\W&RSF=].2/PD6TX&9#7X^EM=?,VI2\_P
M8J7K3S<F\I,;.Y[J$<CW,C]PV!A79C<3CVT/@FU8A6\/ 0AH#>OMTH7I.BQZ
MKD]D?7+!4N6&/@C;^@-[3DC.6J&#=3Q_XLC>)AK,'_V7*E?Z/VROJV\CKEH]
M$GU8@?NU7]NFIQ[/0H5)G@0,O1S2#]YK 1TJ/_I!4J=/"82*O R-D<KFL:P=
M !2_4-*I9KB_%4KL<?G-6;)'*!VYG:U7-],TN-<?6<[LQ6H&$_R8Y:+CO.8?
M"<2NLVZT,[W7W,$#OUERMK7=#JX+:<EDJ$4,%.U P"!@Z#'JR"N+=XR=_<.4
MV8%\[Q4BO?#LB)^7X%UO/K^*DPS\5\*SX3T_ 1=?(!<B:+FKVE\E6,"RP10?
M>?7D8X_+^#E//Z1L,7[.P\Q8#()G@.6=ALYA\3QUJE#U:]FS<="!"\!W0>WY
MJT=2TBIK&4V"6F6BM>G8^.(#H1^/:W^TMKG Y03'^S^&?Y+EO^CL _+9<'V-
M<+!Y>Q3=,W+%Y;# 5/7:7@1?+IS%>6X9$9OAV]DWQ@&SCF2]?8E53Q/G\;@>
M.=@NV#&9/78&1GWD*N'7M0JMV''[16BB@,V,+)X6#H%[_$@JD>0=DR&N<NQ9
M.Y7,M>  0,^GIJS<A+J_)-.G=PEJ$92E.R2,S "1K?JURV_-C >/<CW])HRH
MI_1Z+(M5RS__ -K':J[)Y*[R)RA!C9YG''Q6WMC9]HFE=AMP>*;CC2%*$53[
M0^ \57&JZ"-9W3,V:4 CQUF%IB'V?]0JRY:TB?8-GM28YC!9@H>LY@'SE3A7
MD4O:-6R[W=AOA4<?_859'%>-I4;FY15XFM$>9?&W[^+2Y3W;\]%@<#=OO]V,
M\8V_5SW>P"Y=X@V?)XO?,EC<TY[)L@\^L)/?X@+J;:\&[/:UDL:V0,-EG@7?
M945RYJ>NZ[QM!7J4FL?':A8R0 !SCT?FY>G$.HX#.\;EM['02ODLRCS<T%RE
MEC4WXKBN_AKC62F&L_KHJN_Z-M6L8L_9,3#,QT+6O46WO.9'<>2(]=,K_@8;
MY@9"/8]>[BNJ9M2P1P#L,*$1J"/Q;$6KE+C7,Y/5N17:[\0_X1]M]=\1]NPI
MQS?JTV<V?7ZE*.,6YZM@DG]?IEBC?#^^VL!DCJV;!B@+RUA?[Q2JW=;U;'U.
M3=HN0UH>A'"YCP.BPS=DJY"N,^2=HRVT[T=8AGD91CNB#T?WW,/1)74#=*UR
M/7W85F/A^$\/'P+1\R!^8KE;0\_D].Y$DUP77.QWQSZ[V.)\/\:FW](VG6-/
M#VO3'K"1[/-;.C5TZGQYJAM8FC;LVFP1M9(T%WE(WLN5@Z'H8U');&*Y;\%:
MGC=6;WVYH;WV"K+1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1<!<+PQ2;_B_-@/B'."[];[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$0KBWG;"3X[=(LNR%P@LAC_ #_TV+K'4,]!FL!C\BQX?ZT#2?X.
M6XEO5&3Q0/F8)'_D83\RN5OZ1_@_):RS_0F4VUOCBAC,KJ6:Q$748J'XO^)=
MUTY6KC]EK7\[D<77C<\4HV&:8?D#W^S5R;0Q=;+<UYFI.YX9)=L_-AZ/YEI<
M[A)M W^I-DHOCJGK>JQ\@[]5B[FPF8Q^5QU>_3D]2&9@=&[^!7/'](O_ )JQ
M/^O*L3AO_,+#?X%C\V_]'^3_ -;&HI_1X_S7R7_? JUY9K5K?,%:"< Q/$#7
MA7CA>-L?KF\PY/#UC'3DI3QS#OY!Y<TMZ3F^1C./L@'. +IHP%JN#1ZO&CX1
M[OGG"H3CIYU?E*.I:D?%U-)6>2N[&O:&^ZQ8,C2L_$"&PQYA<&O#3WXG^*H2
M?+[)EM^O9/#86/(5<>'TH7R3%C 7'\3ATT_NJG-CBSFG\BU,Y<H,J>O:,[6Q
M/,C/X@$@+N'&WZEZG#;KR!\4K ]C_NTKG'^D;_S3B?\ 7E6]QJ]C]%ULM/?5
M"'_VJ _TA/\ ,:/_ ,0B_P#1RJ;3^-ZN>X[BRM* NRL>0^_NQA76-G/X^CE,
M=C)7.,]H.,;6COY,]R5O3\PN([T3\+SEZ]P=,=E3*/XM>NV))6,C>]QZ#02?
M]BX<Q-=^T\Q33UR]\#LE),7_ &C!5H_TC/\ FG$_QG<M-J_%^+M:KK6P8SUG
MY 2Q23-[[!"ZN"T.UR-CU_*N< 0*S^P1VN7OZ.A'[8RW^H"\_P"D->%S9<1C
MH@#+!"[_ ,Y5;V<I3T.#IJ<XZEAQ,;7JC^.] QVR:-G+,=<292.5@K$E=1U\
MQ!A,;KU*T"+%DQ5VQ?4.\5',I0UO>K^>PN2IQB?'RAD<@^<G3N_Q!<T;5I6>
MXWS=*]3O]POFZ@F82'_R<%T+RQ;FN<6SV91T^40O<H]P"SU=.S$?[]E4_HL#
M=9Y8AI70YGA9D@':ZWW:QGZ>#L7,/>C@FKL+R'QAX> J;XLY!WG;\XZ.W=K"
MM SSE:(?F]67 \NY-O,(Z#<6SH_?M4ES3QX_%6_ZRXACVM=+W88P?D?^^K)X
M)EN6]7OY"W('R6K[GN?^MQ6-OF4N93<,7BZ6,DR$&-/Q5R%GL7_H!5,\IC-0
M[%0V9^$EQYE()\C[O:NOM1V&+/Z_0R4;AW/"USP/TN(^859<_&L-#/JAQ)O1
M!G\^G+TX"_Z/8?\ ODJG6_RR0:=G)8H_-[:KNF*C/Z-P#J&RC[R0*N!3&M\T
M1"V2R%F4+P\_5CO8KN9\C&QN>2.@">UPYBZ)V'F:PZKVZ Y269SQ]& KHS:G
MAO*.E]#WJ6__ %C5?\W<=36FG9<8PF=G7Q,;![C]]9_ 69R.8CS\]^<RRL^%
MB#S[EK Y=%N]EPUF19P7-4EB8 ']JF5OV\7E=Q.>T,<XD=#L]KAIL$F?YGF%
M,-<TY5[O)@_0T_F5H_TC"/V5B1]YW+34N-*PUS2]@H&=]CN!\\3G%PZ>WLEJ
MZP'U_FB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+@;A/
M_/\ QW^!Z[Y;^4(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+3
M[#KF*S^.DH9*NV6)_P ^C[M/W'V*JS&\49;"2/9A=TO5*OZ*YC\VM4MU[1(\
M=DCE<ADK&2R/B6"Q-[,:[Z-;V>E$=UX;CVO)ONSYZ=A#CZ8](.#&+VJ<:;/3
MQL6.@WRXRM&P,8UL'1#?L#YK>ZEQQ%K>,S,$.7LOL7Y Y]HC\843J\(4ZN>=
MEXMAO-G\_,/#>GAZGVZZ!C]MPL%._,\31$&.QUV\+$T+1[&H5)*@S<]JN3VR
M)[?%K%J=^XQEW"SW-GIH8&'N.$1!P:M[H.EVM3H/HG,RW(0?[(/9X"->6^Z-
M8VVJ*9S<U6O^J-C.P\K4Z1QI/J!D96S\\L,C/QPF/II?^_[J*Y[@P9K*/R5C
M9K!LN>27F%7?A*%JCC:]>W>?;EC:&F=S?$OZ^I'94*Y T!^XQ1U9,S+!680[
MTFQ^0+U\:/Q[_5"-D-?,V9H/=\+F],<[[K&W?B? ;7/\8][ZM[Z6(UAT^/ML
MCJLJS;Y>=" 6D"/IY;_C\U)H=%KX_5;.%Q-Z>F922;/YY"3[DK'T#1Y=/H34
M1EI+<+I/-C71^ 85I]_XREW.>/U\VZ"&$GTHQ "M_H6GVM3QC\<_+/NPAP,/
MFSP],*+[[Q78W*_'+9V&2*"'L0PB$$#M2K1]3R6KT64'9DVZL3>HFF$,+/\
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MP]B"2.EIN/- RNEV;4#,S\3CG@.$3H^B)%D\DZ-E-NJ? ,RC(*K") STNR9
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MF)3%!WX^9[*Z$XMLY+)Y?>),U6]*XZW"V6 CMK //H*QMN8R/5<LQC0&BHX
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M!_2+_P":<1_KRI]Q( >.\4#]82N:-/)H\QP0UI06?M*2/MOL6+NU<H?TC?\
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M\)2WZ/<KDYIT7^L6&ARV/89+=5OY6#\\93BC?,3'K%7$Y:T*MRFWTO3F^7;
MJ;W;'XS.<J0PXF!KZTCHO4,+?D3^HKH;EC(8G$Z#DL?V(WSP^E6A:% OZ/>5
MQ\6&OXV6<-M&</;$?JU0'FO*4;NZ4'59?5;5:!*6@D @KL'!Y;'Y?&0WJ<WJ
M0O:/$KE'^D#EJ=W/8>M6<9)*;9!/T/8DA=*:-F*.3UG'35)?("O&QP]BQP'S
M!5:YK?CK/)V0JW62''3UH.W@=B)X4?Y;;IFP4JQQS66LS8E:*Y@';B#[^:O;
M4<9+B=:P]";^\K5(XW_S:%$>3=ZJ:YB9*S)B+UEOA T#\H/N\K4Z[QOJ-C7*
M1%J:VPP]OG;(0V4D?,]+G;"WZ>B\FROHSF;',G?"7@'^Z)5\<I[7@9*&O,BN
MM>79&O:'B#_<]'\:MF[4P^S826!Y;8IVF?(CV(/L0N=..=/GU/EN[CW%SX10
ME,,I'YV%S5[?TA<E2G@Q]&*</LQ3$R1#W:MCIO(.MX+CBK!\:);\5<CX0 ^?
MFM+POH^2M9F3:LI&8OF3 PCHN>_W<NJUR!_2%R=2UF<)# _S?5$HF ^A)"N7
M6N2]09J]"6?)QQ/CKQMEB(/FU_7LL;0=PCV+,;;E3)*RC 860>?R 8 [LKG6
MGDJ0YG.2]8?!_M>23UOT^)*Z%Y7VK$U<+B0+;29,C!,0WW,(!6EYJP];8]0J
M9K'%LQ@F!9(/K&]2K4L14T[CXB[,V.2: R6I'?61X5#\!9>C2V6]6L2>#[$7
M42V7](R]5LY7"00RA\D$<PE:/T=D*_N+[]2UI&";!,UY@IQ1R@?I<&JI?Z1-
MJ%U'%UQ*#()B2Q3_ (5O4Y])QL$<X,D+>I6CW:OCEO<JN'PQQD5IK+UYPC;]
MV1GW>O3%<:X2#78JE?-9,U7P?HLN;$\$>_2YNT7-0Z1R//6?;[H>N^O(_P"A
M:#\G+M\7Z9H"YZ[/0+//U/T^/W7#E/*X\<T')&RSX0Y>203?I\25W9'-%+$V
M5CPYCAVUP]B/NN+.3\QC_P#*[!<9,)(8#"'EGT+5?_)VMQ;GIDKL<6331O$U
M=X4"X*VS'T<5/KM^45[<5@O8R3Y=@K3\U[&W8[>,UW"O-M_K%TPB^8#U8W[)
MI:9Q9+0M3LC?\*?,GZS/4AXONT;VAX**&=DABH113 ?I<&]$%4/NG'9US>\3
MDJ4?6/LW6_\ YDBO#DK9GZU4Q%]LSP!DHVRQ-/YXB#VM=M4?'>X:]/D+-BK(
MV.,^G9[ D85'OZ/F)O4]:OVIR\16;#?18?LQ7GE<?%D<?:JR$^$T98>OXKD'
M1?4XZY'LXW*R^%25KX63$=,?]G*Z>5-WP]#5<C3@O1OO6H0R&-A[=T5HN#=-
MEPF"GRE^,Q3V^BT.^D05)[5DZ5KE^6S#.UT(R('FNQH<!C3L,F>K2=2S0F*4
M-_)(.P03_$*2(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+@;A/_
M #_QW^!Z[Y;^4(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(A:"OP1M'SZ
M"_5^>DS[!?OB.NE^>DS[!?+J\;VN:YC2".B"%YP4Z]>".&&)C(V-#6,:.@ %
M[EC2!V%^>BS]T+]<T.!!'R*^&UXVM#6L: !T!TL0XG'=O_XK%^)Y>?PCYN^Z
MRA4A+/3]-OA]NODGPL/D'F-O8'7?7SZ2>G!9#1+$UX:>QY#OHKXDH4S*V0P1
ME[6%@?U\^C[@+&BPV,@:YD=.%H<TM(#  05^U<'BZKVO@IP1EI[!:P!?EG!8
MFQ.Z>:C7=(X]EQ8"5L   @: >T(!]U'YM3UN:RRQ)B:CYF=^+S&.QVM[%6A@
MA;$R-K6 =-8!T %@OP&*DD$CZ4!>&]!Q8.P%YG7,-Z4;#CZ_BSOQ!8/EVMD*
M-=D @$; S]WKY!:^YKV(O2B6U0KRO!!\GL!(Z6Q$0CC\8V@!H^0]@J[US4+<
M.TYG9,H(A=L$Q0,B/;60JQG,:YI:X=@K7'!8OUQ-\%!ZH_7X#L+.=5@,'HF-
MICZ\2WKY=?9:UFM85@>&XZL YOB[J,?,+\_JSA"P,.-K>(^?7ICH+;,ACC8U
MC6@- Z "C^4U+6\M(7Y#$5++N^^Y8PXK)QFN87%AHH8ZO6#1T/38&]!9=[$8
MV\8W6JD4I8"&E[0XCM8M;7<+3>Q]?'UHW,'32U@! *'6,(XEQQM7LGLDQA9]
M2C4IP^C6A9$SLGQ8.AV5A2ZYA9Y9)7X^LYSW%SG%@))*S:.-HT6.;7KQQ-<>
MR&-#02ORSC*5HS>K6C<).O,.:#WU[=K64-9P="U+9J8Z"&5Y[<]C "MVL*[A
M<9<D$MBG#(X#H%[ X]+(KTZU6N(886,C Z:QHZ 6M.L8-Q).-J]D]DF,+UDU
M[$SB/U*%=P8T-9VP'IH^@6PKUH*T3(HHVL8T=-:T= !#6A=.V=S&^;6D!W7S
M /N%K[.OXBS/)--0KOD>>W.<P$K%J:M@*<YGK8NK%*7>7FV, ]K>  (M);UG
M 6WR/GQ=60O?YN+HP>W?=?']3]<\O/\ 9%/OH_/TA]5GUL#B:M2:K#1@9%+^
M>-K &G^86 S4==#GN;B*@+OS'TPEO4M<MM LXFI( QK0'1@]-;[!;EN,HPTA
M397C;%^X&@-_\E^7L70OUA!:KQS1AX?T\!S>PM!4TG5:LSYJ^$I1/<>R]L0!
M*];^IZWD)7R6\14F<XDDOC!))6SQV&QF+CD92J0P->07B-H:#TL+(:Q@,A+)
M-<Q=69\GYB^,$GI>^,P&(Q?D:-""OY !WIL#>P%@9;4-9R]H6<CAZEF8-Z#Y
M(PX]+?1X^G!493C@8V%C P, Z8UH^@"C,NC:C-8$\F"HNE Z#S$U2*;%X\T/
M@'5HW5RSP,1;^#Q_=Z46''NE?]G:'R;X_P!RWV4LBI5:]1E5D+6Q-9X-C Z:
MUOVZ4//'.C'WUK'_ .Y:I7C,10QE-E2E6CKUV?-L4;0UH4?S&CZGF++[-[#5
M9IG.!,KF O/2R<+J.NX22:3&XR"LZ1Q+G,8 5G9G!8;,1-@R%""U$UP<&RM#
MQW]UYX;7,'A6S#&8ZO4;*09!$P,\B%LK]"G;C;'9@9* \.\7#L CV*QLEA\7
MD?1%RG#.(W>3/4:'=.^X42?QEH[KGQ)P%3S[[Z],=*=000UHF11,#&-'36@=
M !?JTV:UG!9IL;<GCH+7AWX"5@=X]J+XCBS2L79EGKXB(O?]9 'AG\E/YZE6
M:L^O+$U['M\7-([!'V4+_P G&B_]FL=_N6J6XW&4<;4CK4ZT<$$8Z9&P=-"R
M41$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%P-PG_ )_X[_ ]=\M_
M*$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%%[V[ZM0N&G:RT$<X]XUN
M*V:QMN8107(I'F+U &GO\/W6LDV_6XWO8_+5FN:>B"Y?G]==9_\ G%7_ .I;
M-^?Q46+_ &DZ[$*I/0F[_"M8=TUK_P";U?\ 8Y9]#/XB^7"I?@E(]PQR]LCE
ML?CF-DMV8X6$] O/06MBV_79I&1QY6LY[CTUH<DVW:[#*^*7*5F/8XAS2[H@
MA?']=-:_^;U?_K6_QF2H7JQL5;#)8^R YA["U=[9,)0F]&UD((G]?E<[YK-K
MY7'6)XH8[<3WO87M:UP)+1]5F(O%ENL^Q+ V9ADC +V?4=KV1?,LT4+2Y[VM
M'U)/06BCVO7WSB!F4K&0NZ\?-;F"Y5G>YL4['^/7EXGOKM+N0ITH723SLBC;
M[N<>@M/6VS 6IFQ0Y2LYY]FAZWDMJ&.%TKGAL;1V7?3I1^+<-;E>QC,M6+G'
MH /6ZNWZ=&L^>S.R*)ON]QZ 6H9MFOR1RR-RE8MC';B'>R\F[CK1(:W+522>
M@ Y2&_E*E&JZ>>9D43?=[OD M$-PUYT;WC*UBUI )#O;M9+-BPSX996Y&L61
MGIY\Q\EZ0YS%33N@BOP.D'NP/':RI;].*7TI+$3' =].< >E\?M.A_UN#_ZP
MLJ*>*0=L>UW\0>PO"2]3C>6/LQ,</<%P!7Q^TZ'_ %N#_P"L+[9>J2$AEF)Q
M [(#@5\?M.A_UR#_ .L(<C1 !-J'H^Q\@G[3H?\ 6X/_ *PLF"U!+\XY6/'W
M:05@G-8QLMB(W80^$]2-+@"U>U#+8^X^=M:S'*8G!KPP]]$K)MW*]2O)--(U
MD;!VYY]@L+]KXTL$GQT'CUWWYCV6 [:L QQ:<I6!#_ CS^JWRQK61IUI(HIK
M$<;I._ ./7?2^/VG0_ZW!_\ 6%DBS#Z)E$C?'KOR[^72Q&Y7'.:'-N0$$=@^
M87JS(4Y'=,LQ./V#@LB6>*)A>][6M'U)Z"Q/VG0_ZW!_]83]I42>A;@_^L+W
MGN5X?$231L[]O)P"\/VG0_ZY!_\ 6$&1HGOJU#_L>$_:=#_KD'_UA/VE0_ZY
M!_\ 6%DRVZT+&N?/&T.]B2 L;]IT/^MP?_6%ELGB?\FO!_D5\3W*\) DFC9W
M[>3@.UX#)420!;A_EYA93)8W@EK@5Y37JD3_  DL1,/V<X KQ_:=#_KD'_UA
M9$%JK-Y%DS'^/OXD%8YR5 $@VX?_ *PO6*[5D/X)HW_X7 KW1><URO#T))F,
M^WDX!&68'F,"9A\_R]$?/^2\Y+M5CBQT\;2/H7 %?AR%+Q!-F+H^Q\ATO>*S
M!*XADC7=?8@KZ?(Q@[<0 L9MZFYWBVQ$3]@X$K)0D!8QOT_/P^(B#OW?(=K(
M-B+OKS;WUWUW]%CF_3#0XV8@/OY#I>_KQ"+U?4;X]=^7?RZ3XZLXM:V9@\CT
M!Y!?2(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+@;A/_/\ QW^!
MZ[Y;^4(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BTFS6K%3!Y*> ]21U
MW%BY;XBVW3A6R-#/L8+MZ4E]F8>0F#OH5<.GZ'#KFV92UCF#]FV:X]/H]^+O
MJU4+S?AL=4W>C\/ R+XIC3, KFR.G<?VK<&KQX>J+<F.?*+$; )&>ET%*=0U
M=]'1(,+EJ['AD;FO8?FTKF_B/"XN;DG(T9ZL<T$4$X8R0!WL\+(YDPN,U+9,
M1:U\"G-*Q[G1P?@#2TA7_D"<YQB+.4K,DFDQC9GAX[ZD(5!< 8K'W,]=FLU8
MY7P0@Q%P[\2LS^D+AL?5SF%LP0,9+;9+ZY'ZR"%/F:/H'PFJXN?#PFU=I?.9
M@#7]@#M[E,]2PES2]*RM1K3(ZO/8DK_=[/TE49Q;G=,REW+C:HH)<C=E[$ME
MH>T@^[%:.K\>C7^2I<EC(0,5/0D\2/9CR6GQ"O1>-VU%5K332.#61L+G$_8+
MC_4M_L'E>Q<MGTZV2)C /T83VQ=C!'N#6DD] !<?[KM64WS=XM7QUIT>/%DQ
M$L]I.O=Y5VP\.:)%BS2_94;R6]?$. ,JUG'NHSZ/?VN!XD?2)CEKSG]0:'*F
ML5F+7*7(D5:_YG&1!\C:H/30QA5N\B<8ZU-J]R;&8NM4N5F>I"^%@9^51?@_
M>K.:@L:[DR9WQPE\+G_/N/V+2JDY#U&S!LVS7</1:RGC[3 ]L8Z]/S[(("O/
MC?=*.\:O:PV:#)K<,/4C)/F)F ?G69Q5I."CU:V+./@F?8L3,,CF DQ?0%4'
MD<-!HG*,$4]5DM(60^$2-^1B>NN][M8Z'4,K-<@CL0^CTV-P#@]Q]E!M!XSP
M^-T[PR6/BFM7(0^R)&]]?+\JHCB_6\)D.1;^/O563U((IW-CD^8[8X*T+?'>
M R$];,ZO3+'4LN89F#Y->UA(+@I'SI@\7/J-O)OJL^,@D8(YOU@**<4Z)K.Q
M\?"3(X^)\YLRCU_:10[CW,YS7^2GZY#;DL4_BGUG,+NVAK/9RN!_%F-S>X;%
ME<W7>^-\P%5G?X7!<_8#4L59Y8M8&=I?2AMS-#/NUA70F&XUJ8#?&7<?5ZQE
MC'31S,]PQY+50/(.KXNCRE'B:D8BJ3OB=Z;!T!YKH+DK3M:K<?Y0P8J!AI5C
M\,X, ,:K+AO2]:V+5<E+E:4<KQ9 $I]VJ/\ '=O(87E&3#8VS-/CQ:EB(#CX
M> /YUG_TB<70I9C$6:T#&2VF3.G>T=&0@A7[Q5B:%#2,*^M UC[-6.68CW>]
MP5A9"E4M5):MF%DL4K>I&.';7#[$+@ZKA<8>83B#68:(RTD7H?H\ 5=^S<;:
MOF3E_P"KV,97R&.N1?D :QY[/;5T'7\_29YMZ=XCL*MN8<9C[VCYJQ/68^6O
M#YP//NPJ@>%]5P6QX79F92JR4L,7IR'\S.PY9'$.:RK-LL:O/.^YBW-D88W_
M #:T,*TM_7L/'S5#B&4XQ1-[HUP.F=*P>9=/PNO8>/.82,4+0L-B(@/@',*L
M'C:[)N''D'[:8+'9="_U?Q^H&?J*YMUS4L58Y6M8"TPRU(;4S WV[#"K7SO%
M^JWJV2DURG-'D,;:C8YC3^!ZGG+^!QE_1\E<LU@;%*'S@D_4Q43PMJ>N;!0S
M\^9JB853$6$_0$%37 \=XB78L#FL7CI3AKU>3UX9NB& ]$*L<GJF(;S W QQ
M%E%]WQ,:MS9>*-0NQY2M@JTD.2H-C>6L_*[S]FJ;;-K]/)\=-CR=+J:O0:]H
M=^>)X"HGA#2\!LT&:ERM8S.@?$(_X>:;/?RW'W(L%7%Y.U+6/I$PRR%W8?\
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M>#GR@-9$2O3B?C/^J%2:S<>U]^=H#NO:,**\I\59.UF3L6OGNV'A\L/L7/\
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M&9O+3#N4O9$QZGW.>*KW-&MSNB[DJRL>QZT_ FP6,KK%NA8D,GP+V,9W](W
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M#_P?-LK'J7:;%E68"H_(Y&6W8F8V1[W_ "Z\OTA2.S8BK0R32O#6,:7.<?8
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M_P!OF_:[Q)VNZS[%<28\O;SU)X?_ #F92_\ I(=#*ZQ_*;_U8NEM6'>"QO\
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MB(B(B(B(B(B(B(B(DDC(F.>]P :.R2JSN\JZ[7ANV8(;ENK5($]FO&'1,/\
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M%@>R6'Y&%6[MFR0X36+N78YLGA&#"/H]SO8+G"ES3R!=G;!!@&/>NALULEO
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M? :'?-S6=N6/M-1^/YBU.[2_O;S)&6 !^AG2U<.&H6^><K%:K-D9\ ^4-?\
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MY%4K_DJS#-EMY^#;IHKL_8<X5A[$]]?G3.<4Y38YH3FMML6(&2>?PX@#&?\
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M87+R;+-):KGN:5X_^Q&%MM]T//9;/8K-8/)"M:@_ _R_<*;QH.P;!CL/0BS
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MRV229Q& ]9N2P6*R7B;U*"?Q:6M]1@=T'>X7EA]>PN%BDCQF/@J,>07MB8&
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M=S'WK]7)Q2UZG]^]OZ%$]!Y+I;-<RT9MQMZM]5(NNGF%3',;;KN%D;'D<G#
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M#K^7@JIT X/_ "*W69ESQ3-J4/\ #\RC_(,F<ET+$]4(Z.(BMPQUH'GRG>T
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M!BFNOLBVS?=EER@;+'AI_AJ=9_S8.R>Y/Y_):6WA:>.YPQTU9@8+55SW, Z
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MO)9=*CEJ?&]EE[(BUWC&^F/3#"P=>Q/9[53ZW<Y0@T&E:PYH04*T)=\W$S2
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M@6WW#=3@[-+'4J+KN3M]^A6!Z'0]RXK15.2K5'-08G9L2<=-8/5>5C_5A?\
M[2&KTV_DZ/6=DQN+L4'F&P273D_0?N!:2MR[=9L^.QV1UV6E5NN_XM/,[ISA
M]RU2W;=WM8G,X["8W'MMY"UVX,D?Z4;6#ZD@%>VF;?F,M?S5#*8IE"S1>P>
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MB9@_,#U^;YK8ZIIM? NM69;<MV_9(-BY+^=ZF2H[?,;:P>Z8?<(*Y?78PPY
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M1]BH=O6W0ZQA7V@P26)'B*M#^_(Y5U;SV^ZBW$Y+/WH;=.W,UEN-K.C7>_\
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M1^S89&].Z;^M031.6X=?PK,'G<?=%NEU#$(V>2Z&U3(9:[AXK61K?#SS$O\
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M%_"-K6O" _OM^:F<%ZG):G@;,UTL(:7L'NWR]NU[(L:O?JV76&03L>Z&3PD
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MVN:T=V*=Y\2.V%C%(\'LF<SN@-RU9L$5Y\)D8'?-G86!JG(EJ_QU=V2_7'G
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M@K$I8NA0#A5K10AWN&-#>^E]V<90M3,EEK1/<P]L<YH):LE" 1T5JV:_B(K
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M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BXA_H]_Y\R_\
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MH;UE\QM^P8FW4BA;1>6,\#VK61$10[<-ER&'CHQ8['"Y<M6!''"7%C>OJXD
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M?^ZQ_P#HMLBYRR7_ /$#7_[DQ=#3P0SUGQ2,#FO:0X'V(*Y<XMF_8?)FV8>
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M_P"785-7.0=U;R!E=?J8V*4,A?\ #Q?^DCW+51<E;]AMCGU[+XVM;ORM!J"
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MB>:"R9IW,^;8F-^Y7AL62I_Y;\*PR=%E4L/\W]+RY,O5:G).@/F?T(7RF3^
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M&F7LKKV+:UMS"5OQSB!O?1'R:%B9VUP@:=A]?&3&9_Y1#&&].4OQ.2XGMX/
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MS;+] 7Y'>1G\?GYE?%_.<,7LJ,C:L8YUH.#S.8_<K)R&?X8R-[XZ_:Q\]KH
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M)3AD;&,#6@  = *)YC0]1S$]B>YA:LLTWYYBP>:W6*P>*P^/%*C3B@@^D;
M/FL'"ZI@L)-;EQ]"*!]A_E(6@#M:O*\>:?E;GQES"UGSE_F^3P';S_I*7UZL
M%:"."&-L<;&AK&-'0:!] %%+O'VI6\Q^U)\17DL]]EY:/F?N5O,MKV&RE:.M
M?H068F$%L<C YH(6*[5-=.*;BCB:OP0=Y"MZ8\ ?Y+*P^ Q&&BEBQM""K'(X
M%[8F!@<0L+.:EK>=>'Y+%5[+FL+6OD8'.:"OG!:?KN!@DAQN-A@#V]2%K1V_
M_$4QFH:SBK+K-##U*\SF%I?'&&N(*5=/UBG?-^KAJD5DEQ]9L8#_ ,2,T_66
M9$Y!F'J"V23ZXC'GV5D4-6P6/JVX*V.@BBLDF5C6 "0G[IA]3US#NEDQ^*K5
M2]OBXQ1AI<%XTM2UJAD'WZF(JPV7=]S,C >?)2$@$=*&7^.]-O7/B[&#J/E+
M_)S_  'XBIA#7B@A9%$P,8UH#6@=  *,V]&U.UD7WY\+4DLN/;I71@DN4I9&
MV-@:T  #H +%RF)Q^3IOJWZL4\+R"8I&^33TH_!HNH5S&8<#19X/\V=1-^3O
MNI)?QM.Y4?6M0QS1/'3HWCMI6LQ.N8/#!XQN-KU0_P#,(F!O:UV5T74,K:FL
MW,%3FFD/;I'Q@N*W\.&QE?&#'QTXF5@WQ$ : P-^W2BV8P9Q6LYF/6J,->W)
M$XQB-@:'/*Y\U7/ZA5QT&,R^D3RY2N.G$5Q(9)1[EQ*LS1=,BFM9C*6\%#CZ
MEYC8V8WH$%H_6]6I0UK!8RC-4J8RO!#+^>)C UI_F%DPX7%UH)X8J4+&R@![
M6M #A_%:N#3M8KT)Z,6&J,K3]>I"(P&/Z^X6U_8V-;BQCOA(A5],1^AXCP#!
M^GI?N/QE'&U&5:=:."!@Z9'& UH6&S7,(S(/R#<=7%MWYIPP>9_VK;RP1RQN
MCD:'-<.G _,$*,PZ5JD$=AD6$I,9/_>@1 !ZDT<;(F-8QH#6CH ?(!?J(B(B
M(B(B(B(B(B(B(B(BXA_H]_Y\R_\ A\J[>1$1$1$1$1$1$1$1$1$2U:@JPOEE
MD:QC1VYSCT %#ZO(.FV[ @@SE9\O[JE\$T4T;9(WM<UWS!'L0OU$>]K&N<3T
M .R5H\/GL'G&V'XZ[%9$+PR4L_25NO2;]@GI,^P3TF_8)Z3/L$])GV"\&R57
M3NA#V>HT N;]0"O5M>)@Z:QH'??R"^O28/H%B6(:#)8[$S8@^,'Q>[H%O?OT
M2M?%?U^\YPCLU97-<"0"">UFU,=C8H^ZT$+6GO\ (T='M(L+C()VS1TX62M'
M0<& $!?5G"XZV\.L5(9"/J]@*]X*-6O_ ',+&#H#\(Z^3?8+W7X0' @CL%:K
M^K&$_P#EM7_=A/ZL83_Y;5_W86-'J.N-E,C,14#R.B[TPL@ZS@P.SC:O^["Q
MSJNN>FYIQ53Q)[(],+%CP.I7O(LH493!+\^F-/B\)6US4)K$\D..HNE'RD<U
MC25[PZ=K%=TTD6'IL=*[MY$0[<5Z18'6I7O8VG2+F^X\&DH=5UTN<XXJIVX=
M$^D%B2Z/J4DC'OP5%SF,\6DQ-^07N-5UJ" 1C$TV1@=!OIM  6OKZ=I-4.$&
M&QT?9[/4;%Z,T730&AN H=!G@.HF_E7N-'U/XF2<8.CZKQT]_I-[(60W3M;'
MMB*8^1']T/8KX?INL%H:[#4R/E\O2'Z4M:WK(B?Z^-I^F?D[R8T!:.'0>.YO
ME%@,6_\ E$PK/AT'3(2#%K]!O7?74+5Y'CK1R_S.MX_O[^BU>K- TQCY'LUZ
M@'/_ #$0M60[2M4<XDX2D3_JFKSGT749['KRX&B^7]\Q-[7HS2-3CZ\,'2'3
MO(=1-]TOZGJDD/5O$TG1M/E^.-O0(7Q%K6I7XH)V8RC,SKN-XC:1T5^2:-J#
MY3*_!42_R#O(Q-]PO1^ U29[6NH47N8[R \6D@K,;KF <.QCJO\ NPOW^K."
M<"/V95_W81NKX%C !C*H:!T!Z87W_5C"?_+:O^["'5\&00<;5_W86%/@]9IP
M^<M&G'&P>[F-  61!K^O6(F2Q4*KF/;V"(QUT5Z,U7 L8&MQE4-'T],(=9P8
M'9QM7_=A>7[ U[U0PT*@<1WUX#M/ZM:\P//[-JCL]D^F%B#7]4NMEC&.HR@$
M!X#&E>@TW6!+ZHPM/S\N_+T@L6?0=-L?WVOT'_,GYPM]W+XAX]TJ"5LL6NT&
M/;[.$+5ZOT?3_/U'8*CY#]7I-7N_4M6,;_+$4BV3\W]FWYK(.M:^T=_LVK_N
MPL>+":N7/$=*D23VX!K?=9C-;P3P",=5Z^_IA??]6,)_\MJ_[L)_5C"?_+:O
M^["]:^,QF/\ .6&M##^'\1:T-^2R<=DZ&0A,]:S'-&#UVP]CM9"(B+\9+$Y[
MVA[2YOY@#\POU))&1L+GN#6CW)6'^TJ!_P#UN#_ZPLQDL;_RN!_D41%^33Q0
M1N>][6L:.RXGH+6X_.XK)/<VI>AE+?<,=[+9HB(B^++JT3#)(YK6L'9<X_)?
M./N4K59D]:5DK'?E<WV7J3TL4Y"D'^)M1=]^WF.UDQRQR-)8\$ ]?(]K]1$7
MY//%!&Y\CVL:/<D] +XH7ZENNV>O*V5CORN;\P5Z2RQQ,+GO:T#W)/0"\OC*
MS(A*9XPUQZ#RX=+X;=JNE$0F87D=AH/S(^X60B(B+&OY*E0A]6U8CAC[Z\GG
MH+)BD9*QKV.#FN'8(18]_)4J$0?8L1Q,[Z\GGKLK(:X. (((*(B(B(B+#FR^
M.@N04Y+43)I3TR,G\3EF(B(B+SNW:U.N^:>5L<3!VY[CT HYC-UU;+7#3HY:
M":?ZQM]U)A&WOM?IZ *P,=G,3=LVH*UR*6:N0)6M/?AVL]$1$1$1$1$1$1$1
M$1$1$1$1$1$7$/\ 1[_SYE_\/E7;R(B(B(B(B(B(B(B(HGGMVP."MUZERP[X
MB8$QPQM\GE>NL[M@,])9BJ3/]> ]20/;XO8L#+\A:YB;D]6>>5TD#>Y1$SS$
M?^)2; YW'9G'07Z+S)#*.V.(Z5,\]V<E!K-41=_"/N,%H#ZA9N$K<;[IK9J4
MJ-7Y0]"(L#98G*<:30OX35,=3R;XQ)4@#"X>WBP+62\JZ9'9$3\BX O\1-X?
MV7_FI#F=OU_#05IKV0CC9/\ W/U]3^2QX-QUNYE;N(COL?9@B<^5@]@T?(K1
MZ!%HT;LU_5J4/[LAUHCV#CWT MKF-^UG#S2Q6;I\XB!*(V^?I_XUOZF=Q%K%
M_M*"[$^L6>0F!_#THO1Y,TNY8$#,J 72!C/)I D)_<4[7S9GCAA?(]W3&-+G
M'^ 7)./W/(1<K19J</9C,LY\%=WT?"T_A<NMPDLC8XW./LT$G_8N;<7)/RAM
MV6%N>48+'DQL@8[H2DGY%ZL7,<4:A8H.93Q<5.PQA,,\ $;PY9G&U>_C-/IP
M9,.BGK^3)/,_9;B+>]3GN?",S-8S_N=K=9+,8[&5OB+MJ."+V\WGH+37-WU6
MC+5BLYBO&^P 803^8+;W\UC,=%%);MQ1,D/3'./R)615S&/GHNNPV8WPCO\
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MG&.F;'J^3S3K(K04K;P^*M#*7ABN:Y_<2?X3_P"BY1XQAVR3*[@<+;JQ,^,
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MSO:V2U.0Z#KZ,'@Y67P_K>TZYB+U',/8(Q,#6C#R[Q5LWZ%.[6?6M0LFB?\
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M/WW!..7OS/(NYYD^#Q#-Z$;_ -0:2LFV9L=S?":\@;#D*/<K%(.:?GQ]D?\
M6QJ3\>,<S2=<:X=$8^'_ -JF%B0QQ/<!WXM)Z^_2YWJ<N[9E(,M%C-8DGMP3
M^'@P]LC9]W%33CKDIVRQ7:E^J:F0I_WT2U>1Y"S]JM>R.#ITGX^H\_CGF\))
MPSW\&]%9L7*0O:!<V3'T/-]<]35W/Z\5&<#RQLN7?@Y(==>^I.\,M6&^P>K_
M )I1%#+([V8TD_R"HRMR)N>1IWL[C<'4GQ4+W,8PSD3N /Y^@U8'*^78*>F9
M26-P:ZRR4L;\RMEF>4=AQ.7HR6]:?!A[,P8RQ([I_3_8D*;[KNHU]M"M5J_%
M7[TGA5B[Z:?XDK08+>MAK[7%K6QXZO%9EB,D4T$A>QW\""&K!VKE*Y@=OCQ#
M\4]T)B+F2-^;IC] T+/Q7)MIFL7\EG,4:,\=P015^^S(\]]-6BN<G;%K^8HC
M/XVG'1MGH/K3^J8?Y]AJO:*6.2)LD;PYKAV"/8@JB-RNSYWDO ZP'/%2N/BK
M;/H]3/D':\WJM*+)5,9%;J@^,_<A8YA/L?8KQV/=<OB]/J;%3QD-J,PL?.SU
M>O /'?8/2S,?N%V[H+L^8J\,CZWK-8'E[!]@3TJEWO,Y&;$:3E<O5$$K[8E=
M%'\^FE2S-\E['A[U2W:UMT6&GL")DSW]3?C_ "DM4KY&VO*:UA&WZ5!EAIE:
MQY<[KP\EFY;=*^%U:KE+C"73,C$<+/=\CQV %!K>^[C@;6+FSN%B;3ON _L7
MESJ[C[-=\@HSS9995VW29S$^4,=*?!GN[V4C_P IFRX_9L=6S6O?!4+[_&&0
MO[>W^:O+M55L.X;!)L<N UVG4DLP1"6>2S*6-'V8T %>4.PY7-Z=M(RF.%.S
M3:^%S \N#C]QV JYU'<=AH<=4OV%A'6OA(S\1-(?%@_@Q6[KO(%?):(=DGB+
M&11DS,9\R'M]P% CR9ND&+@V2?!U1AYY UC!,?7:U_L_\JG'(]J*YQGG;,7?
MA)2#FK'T6"M)Q=BXS"SP=BP7#Z$EBU' G^8$?_?9E,.0MHNZOKL^4K5&3F-P
M:6N?X]=JLIN4]P?@(,[5UD&A%&U]F21_7?W\%:G]=\<S3ZVPV'&."6!D@9[N
M)>.PQ0"SN^_4*#<[:U^O^S7 .="V4^O%&?U._"O#DW9LED= CRNNW&"I/T)G
M^TG3U,>,:V?JZMCH<GZ :RM$(!'[A@'ZEK^:"T:%D"[V$T2KT\A[7B]>Q=S$
M:PXX6"")IF?\BX?<!6H>2\*=+&QQESH'$,;'[.,I_0H!?Y(W/ RXZ]F<91&/
MLR@.;!-ZDL/E]'?(*_J=R*S6CL1'MLC YI_@55NS[IG&;7#K.#JUGVS 9Y99
MW^#6-3$[/N4V%VAEK&QLR>/<!&!_<R>_L5EZ'M^8V;2)LH886VB^5K&?I[8L
M;1]LR6S:WFI,C7CBL5GR0N#"J9X[W#9\=I HZ_KL]Z6.U*^>;VC8"KLT/D1N
MU8JZ35]'(5!U/6)6/QUO]W97[$;E1E5E&9K0P.[4;N<C[/D8\ED\!5Q[\73<
MX><\WC)/X^Y8.BI9KG*&+RNFV,_.PUVU_E/'[]/^P46N;UOM?!0[-^QZAQTA
M8X5P\F81/^I_"M5RWGMDGUC#6Z74&/OOA$K'_*3R?\PTJ[];.P-I.&7=7]8D
M=>C[ *FN9;>TQ9+ UZ,L'PDMH=,)(+Y1]U/<GMF4UG666,W'!)DII_3B@KGM
MKWN]AVHME]NY!UJ"#)Y?%TWT"\"<0/)?#W_-H5PXG*5<ICJUZJ_SAGC;(P_<
M.5=\F;EFM7@QDU.C%+!/9$4LKW?D)6/RCN>?U6GC+=&G')!-*&2R'W!/L %$
M]BY"W_#Q09B?"UX<7+9;&R-[CZ_3_8N5C[;O4.%P%:_!#ZT]LL%2N3XEY>H)
M;V_D/7LWAAF*E:>I?=X%D ^<#UD[MR/GM;W.CB6XUDU>=O;/ ]R/2IR'MF+P
MV?R&RX453!,QE6+OKS<_OY*-Y#D_:L-\)D;<^-LU)GM$M6$GU(.U/MPWRY6Q
MV#_8-?UI\L1\/(\?@8T_4K14MUVK$[]3US.6JMN.TP>E/$T,(*S,[N>?M;L_
M6L/9KTGPP%\DMAH<9#]FA;S#[9F\?KV=N[-!%%)0?T3#\V2C[M597N3=N&%A
MSU>]CA$\A[\9T72",_Z:OK4MC@V' 4LG%&6^O&"YA_2[ZA;Y$1$1$1$1$1$1
M$1$1$1$1<3?T>H)CN=B8,)C91D!*[91$1$1$1$1$1$1$1%1^_8S3-KSYPM^X
M:>4J1!]:7Z.#U$M+9LU["[GK!R!M,KL+(+H<3T[]U2WA[8L?%J/[.N3,KV\<
M]S)XGGH@+/XWBCNY[<,[5:6TKEX" @]"3P+NWK,YGQEZ]I4QJ%Q?6LQSN8/J
MUBT;^2->RW'EJ>2^&V/@_3DB?^?U% H81F>"XHZ;G23496/EB'^@I'J^^\;S
MZ_6FN4ZL-YC1&^MZ0+W/_@ICM,.LYG#83%YVO\&RYT8.CT89 /D%!M1FSVJ\
MA0:NS+.R&+GC\VD_,L6UK7JIY^N^$S/EBC%_^>"%JMXR%7#<I5<C3R<%2W'2
MZM"R2V.0'KQ8%)=1H4<CMTNRY++T9LE) &0UX'=LC9_,]=E8%.:L_GW)&%[?
M^:BT_P"/L+XS$M/_ "XX=H+1**74I7U8V"/,\@Y?$3Y,XVO49TXQGTY9_#[O
M6AXJR5"MNFY8ZK8::UB9Y@[]W]=]++XDLP4,MO%2W*R&=]]K&QN]R?QK0:<=
M+I[%L>'VK&U&6_C7.AEL,!["F=^/5;^#VNEJ6+K-(H]/M5V!K"[]Q;/BO:L1
M/H=2!]F**6E 8IF$AI'@%C<)7Z=FKL8@G:_O)%_^QW:LK<H\%-@K%?-?*G.]
ML;G']+G=]%4/!%L_'6Q8>C6R_P"T,-<F]-D3G?-JD^=GK_Y;,)$)FET=-P<O
M+D&2!O*''OS8'B27S7MEMBM93DB]@(+,.,CCB_M[@_OY0T_E:5K..F8JMR/M
MD5*Z9X_I(^3S<]W:8$@<]Y__ +I-_P"\+;9QS?\ +/KX['?P3U>W_P -49K)
M@'+^V@EHD,?X5A[=6AN\P:B*<7<]=CY+;OLQ1K"0:P>1-TQ^?[AL6;Y?5)/A
MVSLJT=7QV@8K:)JF'K W_0>9I8^G!@!'R<Y6C)+'&PN>X-:/<D]!5OR-@=:R
M^MY*U=A@\VP%T=D %S2/L5\<6&2EQ]AGW.XPVN'=O^C%8E7)T+=+XJ&S')"?
M9X/X5'=L_8UW6\E'=FA-8P.\B2"%6VJX.W=X9&.D8\/GI.+ MEQ'>@/'D+''
MP=4$D<X=\BTM4,TS7#E= W6>(D?M69YA/W:Q3KB_,1S<;TGS2 ?!P&&3Z%OI
MA:/A>"&#$[!G)28H+MWS8Y_R'@SM6)L@I;)J&7BJ2LGBFKO;VP_4*)\692)_
M&U1\LQ/PD+XY [W9X!0'0M>FS&@;K88U[#EI"8?Y,4[XGOP#CF#U7%GP@DCF
M#_TEB@NBZ[)E]'WN>%YZRDSO0^7N&*;\2Y"J..X@]_@:8DCG#OD6%JU/"L,<
M5#9LRYY%>W>\F.<.AX,[5X8K+8W*5Q:IVHYX>^@YA["A?*G_ $?;'_W5:[3Q
M1'%N+$OI^E^R6>8/M^14]K5R+7^'9+.1I_$,MWP*T$H_ ">^G+'Y+J2C#Z[<
MR&Q"W=ELQ%E>+\,#&?4L"G_+)J37-.>3&\&\.BKZ:!\RM?F\57RN*MT+#.XI
MXRQS5REKMC)L^(XSD:\D93\<OT]!I/DKRY)S%+7=2#O@()FFQ%#!'(T&-KCW
MT2J:Y&\:EG5[][.R7KKK+7R-;)U&P']QJGW.%JN_5<9X2M/GEH"U8'.M:1^&
MP-T%OI17HP4YTRN-?J6,@%J-[Y+T,@8#\RP**<G08TW]"OVXGR8<1%DK?<-:
M>E/I,!Q5#\'>8([#O,"KT_S>?L&A7<7=-)52[[E<5G- VD1?B=5)C>Q_YF2,
M=TJQT;&NUC?L3C\?=F-6_CA+8@/S#2[I331R,+R/N>*E#6F[,+</T[8OF0/R
MW-49@ =!C*)$LH^8\W$?)7+^T\>ZX<>;,9L!G9B[_%TJ5T=G["Y+W#$N?'&R
MT_XF%GMVU>4]1V:YO]1G4M7&TQV_W#)%ZZ/U@>2]PP[PUC;C_BH/IVP%>#(9
M<MSI/8@<7P4:0:]_T#E*.:B!Q]D?];&I-QR>]'US_P /A_\ :IG;!,+P/JTJ
MC>'K%>&;;Z3^F3Q93M__ )N6G&/=D>5=LM8H 1#$R0R3,]O7<5'^,'\?RX=^
M-V''8^+)U9"U_KL'D\*T9OZIS:7M#,'5@AHM86ET3 QDKED<.%IT'#].]F*R
M,C/6KTK$MCOTFQDOZ^RYERN!OZGC)]ITS-^6,E GEIO_ "%CEG[UEXLCA^/L
MC:C9")YHI7L^C>PI+SP]@U"D[Z?M6 KVW/9: &HU(8(8[=\@U;<K0X51]7A5
MYD(J>,Y>UD2967(RD=33S2>SU,\\83S-KA):>J;R$YRA?%C,-D'U?7K5KH,[
M5D&3AJ?$MR#,=C")&@LB$3?4[/Z5<N.#10KAM<P#TF]1'Y%G\%0T#W4N?;GK
MO<\6<>1"KQSN)ARV%NTIAVRQ$YA'7:YCU-^3S6,?QW9$W56VX6I?8-@C^7@F
MN_M.KD+O'$GJF,9(2-D^@K-[\E8/+\T4$FK/D>QD3<DU.=I&MU"D\'VRL#EF
M\I766>-GSDL'JN@<%$N3WVJVHZ?E8(O4BIOA,BL2?D/4;>$KWOB()WO\7PUO
M=YE/LT!5OR?-+8W#CM\\;8)'%Y>Q_LPGI9?/9 AU[_ORZ&B(,;3[CH*C=QU#
M&['G[^1U_+&EGJ#FMD_0L36]GSN6U'<:6<<Q]S&]POE;[/6^XMDB?QA4Z<#X
MUI 5#.-MCIX7A[*6I(Q.:\\OG M%LGI7N-*N5NYLF:8P.@H0O\((6]?E# K2
MVJQ!-P]?='*UX.,C'8*V>CVZIXPQ3Q*WP9B@UY^Q#%I. W-.@,_[[*L_FTC^
MH&2_C+&M-<\/\@;?_!X@J]O5IYN#L'-$PO;6N0RR_P &-"OFSGL)EM*GONL-
M%6:B7'YCL=A4=!C9Z? )<\._'.)_Y,*OS1\QC;^OX<060\FE&X@GMX'7U49Y
MJ[_J!DR![2QK(P&3H1\98^>T^%D8Q+/,#H ?@5!OQ=ZMPEC9I('OC&7;9=$1
MV#$05:-"YPW;PL>3_9F,9VT'T71-\P_[*Z,/-ZN*I/\ A?A_*%I]'ZL_T54V
M]:AB-ESDTF.RIH9ZBQG3_8O8Y8W'.Q;';J[)@<W(;%K'@QBPT^8?\C[N6!PW
MF\7CN/KL-RW'"^M;E]8//1'DG$.2IVL)MS89@7.M2/#?KXD.6PX)LU6:$8WR
ML#F7)O,$IH%*"SO&Y92E &4'RF)CNN@]W9[+5I]&QI?>Y4HU>V?\=+(_X?G4
M3XLFX^_9LN(V/&TX\G!,X$V(QV\*8[1%@[G'VS1:OCXVU*]ECO*)H#92WOLA
M;S4>2=5MZ76?>MP,D@K-;/ ?NU:'E7+29/CO$9&2JZ!LF3KR!A]PSHJ],'FL
M5E:XFIVF3-#6]^/T[5/\R2MJRZQ;E[$,61'F]:CEFY#;_8.>HVOB*5"]U8$7
MS:"]3W?\QB+G'V5F%AKX;-;J(-(\GEZS>+L;;QNDX:"TSPE$ <6_;L*)<[2,
M9JM#MP_YV@*Q>;+U.73L,^.=CA+DJSV+<<PSU7<?3/,C"UT\)85 .2/B1K.D
M;#4F=+4J>GYM'Y?Q*Q;G*NGV*->2C.R[<D>ST*@_.'N45Y%N10\D<=OM/9&8
MWRF5;[G&K-8TH2PQ>J(+\,T@'[C05I:F\\37,(RS)3J>L]H!I^B#*7+XW;<+
M57^J6*<TX>"^P.GL#WKM'Z&*OLL=3Q/*.L38[(F:&-_=J>1Y>>_XN5A;7@M8
MW?.Y%T&0^ RU#H1S@]>JPJ,XT[3L/'VX8B_,;,F-F8V"7\WJ^'8(6ST[=>-3
MK%5N2K5(;U>!K)83"/)[P/TJ\=-N,LX.M89C/@HW]F"#KKQC^A(4C1$1$1$1
M$1$1$1$1$1$1$7&7]'86OZSWR'@0BH?-J[-1$1$1$1$1$1$1$1%&LSIFK9FT
M^S?PU6>8@#U7Q@OZ"V&'P6*PM4UL=3BKQ%W99&T-!*T63X^T_)W?C+F$JR3E
MY>]Y8.WG_24JQ^/IXZK%5J5XX88V],C8 UK1]@%D/:'-+2.P1T0H+#QII4%N
MQ99A*Q?+WV2P*3XS!8K$4OA*-.*"'KKTV- "B]7C33JF5&2AQ$+; >7M/0Z!
M6]V35<'L,$<&1IMG8QWDWM8>NZ/K6NODDQN.B@>\=.D 'ETO3^INLC+#*C$5
M1=$A?ZX8 _S/U5%9W*ZL-_SC-TQ+STUL5%W@)(_1_?6)4P&C9?/XK^J&.M,G
M@G:^6S^2*.,*^F:1K4>?_;D>/8V[Y%WJA+NCZW<SS,W-0:ZZUP+95@YKCC4\
MUFQEKN/$MC_[!6;5T;6ZF=DS,-!@N/\ U_98XX\U5NR.SXQ[?C2\O\OIY']2
M\-JXSU/9[?Q.0IN,W0'JL=XN("DV#UO%8#%,H4:XB@;WTS[D^Y*@5SAO1;F4
M?D):#_4>\N=&'=1%2/5M$US5C8.+J>!F/;WN/96YV36L=L.(FQV0\_0E()##
MT[Y*'8?BK5,1DJ=Z!MJ66L.H/6E+VQ_R!6?<XZUBWL SDU9[KK7EP>7K[V#C
MO6<[F(,G=KO?8A+?%X=U[+!V'BS4=AS'[4OUI73] 'I_0?U]U^T.+]0Q^?\
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M4S%W6=AAC9%Z$<M:=_L2_P"Q^A"KK3M=NV<7O."Q]Q]G#.:8ZDSO8N'[B\M
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M!Z_DO.UA<7;IQT[%*&2!A!9$YH+06^W06IV4P8G"R9&+$BU)1;YUXFM^8/\
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M(V-\T;7'V!< 2CKE9MEM=TS!(1V&=CR(7JB(B$@ DK QV<Q-VU:@K7(Y9JY
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M#OY-^:@W'7(&5S^P[ +5&YZ1LQLA8T QU@._SJ<9+D7#U,G;Q\-:[=GJL+K
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M60@PXM0F/HU_?TI7==E:/GRE4<-?L/@C,IM!A>N@:G[/K4XJ\/HLB8P-8QI
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ME;]RIY1T3&8W:H,[;S<\]][#&/4'7FHO5Z.?VF+4ZS)Y+,Q=D;L[^HXG?/\
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M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%QE_1V$G]9[W][X?!G_
MNS41$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$7(']'/_G?+?Z@+K]$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%
MR!_1S_YWRW^H"Z_1$1$1$1$1$1$1$1$1$1$1$1$>]K&ESB  M5B<]C,I);;3
MF]80/#'. _!Y?8%;5::WL.+I9.KC[%@13V 3"'?(/Z]P"MRBBN9W?6L-(Z*[
MD6-E#?+T6#S>0L*AR/I]_P!,1Y9C7O( CD!:_LJ;HB(B(B(B(H\_;,%%L+,%
M);\;SH_,1=*0HB(B(B(2!VH[C-LP63RMW&U+?JV*O]\UH^32I$B(L;(Y*GCJ
MDMJU,V*&,=O>[V 6)KFQXC/X_P"/QTYEA]1S _KKLM6T1$1$6#E\QC\32DMW
M;#(8&?F>Y17$\C:OE,I'C(;4K+3V]MCDC\>U..U%]FW/!:V*W[1LECIW^,3
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MCG2'Q_ SQ36^2]7V'(R4*D\K+#?:.5G@7C[M6KV[)Z)#M>$CRE9\F2#P*I#
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M=K.BO#%ZEJ.TZK0GMYO(6:PA82QULEC7-"U'*,.+9QK@8,?YFDR_5CA+_<L
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M]G'5GM=%3!)8]7ZJJR^B9F?D.GL<&38(86!A@<WV8O/):1GK/(-7869"%L$
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M?5Y[:MKH^ZY2[E,KK><#&Y:H20^,=,E8#UY*N&8S9/\ +?<A;FV"P,>7>N8
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M_!X8J1X^SNL:O\;KVV4(XK4-EQ9-)$"%?VHY[%Y*KD;6.I,@QL;P(YN@SU2
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ML-QY>/X/4/Y#Q6;Q'(4%G#M'_P!OH75Y!]G$@N*NC,:M&_0[.O5?R"B(8O\
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MD9"WKS=[N/W6[(!'16OBP>+KV/B(J4#)?WPP!WS6P(!'2PHL+C8?6<RI"SU
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M;1$1"M+3V? 6LO+BXLA$^Y&TN? WYN "W2(B(M3F<_B<'5^)R-ME>'OKS?\
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M/ETJ XXQVJ;IK5R#,2LFR]NT^267WG'V/:N>#/ZKJ-.EAKN=:'P0AC/5)+R
MIG2R5&[6%BO.R6,^SFGMJT9W36607YSEH RF\,L.[^49<M_1NU;E:*U7E;+%
M(T.C<WV(/U7JO.]=K4JTL\\K8XHQV][CT %%J&^ZADK,-:GF8)9I/R,_>4M7
MY+*R*-SWN#6M'9)]@%#H.1-+FL101YNNZ61_@QOT)4AR^=QF)J&U>M,@@'ZG
M+2X'>-9S\P@H9%CY@WR="X>+VA>^<W/7<)8BKW[[8I'CML8';NONHYL>3P&T
MZ3GO@K;+5=L!#W,^C@HGQUMNO8#0,$<GD8H"^,^(*N^C=JW*T5FO*V6.1H=&
M]OS!!^J]%%MAW37<&X17[K62$=B(#R>0JEX^M8BWR3MMC%OB?5D <U\?L5-,
M55T0\A9*Y4N^69= \3Q-/R !'DI/6W;5K&5_94>5B==\RWT!^?L+.O;)A*&0
MJ4+EUD5BS_<Q'W?_ "4,O8S1[/(=2Z^Z!FX6?@@#O<-4[RF8QN)K^O>M1PQ]
M]>3ESQLV:U[,<JZ//B[<<\@E>VP6J_\ ,;%AL(QC\C=9 'NZ8#[N/\ O+!;5
M@\]"^3'762B/KU&^SF?S"PW[UJ;!=\LQ7!J_W_S_ "++U[:\#L44DN,O,F;&
M[I_7NU8N?W/7<$\0W[K62N'8B:"YY"HK2;&(L\VYJ?%OB?7EIS/!C]NR\+I]
M:#8-JPV CB-^SX&1W4<;1Y/>?X!8."W?7LZ^S%1M$RP F2%S?%X5:U.6Q9WZ
M6AU:90CK%HC]+\;YE>X/852<I\B.U:G#!6AF^*G</"3P[C:U:/DO-X_/<:W;
M44,P:R>+^^9T5M<!R/I6'P& ISY 1N^"A'B&_D^7ZE;9RM!F/^,;.ST"SS]7
M]);]U!JW)VISW:U3XN2-\YZA,C/%C_Y%6 "".PM9G,[C<)0DNY"P(:[" 7G[
ME0Z]RIIE&*E)/D>A9A$K.F]]-=[>2F^/S.-NXYN0JV8Y*[V>390?P^*A8Y0T
M_P",CK.ON89'^+)',ZC?_)RW.<W/7\%-4AOWF1R6#U$W[IAMTU[-Y.UCZ%]D
ML\'YVA2A0G,\AZQB+LM2S;<9HF]RLB9YF,?Z2VU3;L#9P!S<=YGP77SF/Z5&
M).6='CIQVCE06/>X- ';CXJ25MOP-G G.1W6_ @=F7[*-'EG2!1AM_M/MDCB
M&M#>W_A4@K[CA+.N/ST,SY*3?=[6]D=+(QFVX;)8&3,T97S5F@]N:WYCQ6%C
M-\UK(8.SF(+P^%@/4KW#KP6BEY<TF/'1W?VD2QY(8P-[>>EL)N2-3BPT&5.0
M#H)OR!H[>5O]9VC$;%CQ>QTWJ1D]?8M/V*W:A=[D+5J.7EQ5C(AEF-A=(WKY
M,Z2KR'JMG"S9=F1 JQ/\'N<.B'+&P_).L9;)0X^&>6.Q,.X62L\/,*#[UR=-
MA]PP^&9!.R$6 ^U(T?-X_<8K.L[?AZF&9E;$KXH'GIH>WIY)^@"U6#Y'UO+Y
M X]LDU>UW\H)V!CW*>+%R&0IXVG-:M3-CAC;V][O8!02CRCK%N[!6+[,!G($
M$DT89'+_ (3VO+E#9XL+K%\-CF=--7>(BQO;1_%Q4+XU@P.PZ%1P%JI,YHB$
MDA+ UOE]VE7S6K15:\4,8\6,:&M'\ H9L/(6 P=X4)?7GM==F"NSS>P?<K88
MC<\!E\/:RE6T75X"1*2WHM4/9S1I3Z-FRRQ.XQR^ B$?<C_XM"FVI[=A=HQO
MQV-D<]@=XN8\=.85(E"MAW_ X*X*4[IIK1;Y?#P,#WAJR\!NN!SV.L7Z5KN*
M#^^#ATZ/^84:CY=TV2I?LLMREM:41]!G;I"?W O?'<K:C?P]G)LM/8R!P:^)
M[>I0X^PZ6VU#?<!MD<[L?)*'PNZDBE:&R!>>Q;]A,%<92E;9L6G#OT*S!(\#
M[E9^N;=B-BJRST9'^47RDA>/&5A^Q"QM>WG$9S)7Z$$=B.S4)$T<S U?./WG
M#W=GOZ\&6(KE5CGO\V -+6_5JT[^6-0CNY.J^U*'T_SGP_.?LQ9NI\CZ]M,E
MJ&BZ=D\ [=!,P,>0H!C.3+]W?,A :&1%6K$Z-E>)@)))_/(K\"T^>V#&X*@^
MY>F\(@0 !\W.<?H H7C^4\!9RL.-LP7*,\WS@%F,,#U)=EW#$Z\*XM>K)-._
MQAKPM#Y7_P @HW5Y3P,V;JX:2K?@NSS>FV*:(-6SAW[#OVU^M206HKH!(+V
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M?$^[Q$/HQ2C?= S_ /\ HM<UOT_5PP+(F/4>R>D<F7=JPN>EGH.M1$AP'Y(
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MD7S#"H=@..N2J89B+&PL9AV_+\#R9"Q=%4:5>E5AKP,#(8F!D;/LT*#<I_\
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M :'!BVO)N#Q6.S>G6*-5E=[+W@T1CQ'2Z$'U_FL'+V<76I2?'R,;#(1&XO\
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M.8JQB:#[E/T)A;@#NO<MZ*ANHZOD[N]W]HL8E^*A,'I,K>SGD^[G+#PV WK
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M8B3%211T)"UDY]GJ>(B(B(H5OV>S.#P0MXNC\3,;#&%OV:[ZJ3UKLK<;%/=
MA<(@Z4'V:?JH]N>SS8+6+68J51:$30[KOH>)^JV.J9F?,:UB,A,UK7V:K)7
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MVU-&9)9IW=,A8%'-2Y,R3]K_ *N9I]:>21O<%NM^1ZO95URGJUS9=3GIT_\
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MPFFW)"UYCV%=I/85H<S2Q1:+;#G@=SQ!JT^^R,DXCBE8X.9Z=8]A-BSN(O\
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MW$RGQ)>LW9>/==S]L7+$4D5IHZ%F%WA*L[7=-P>NUY6T8"'RDF29_P Y9/\
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MT_R(*^EY_$P!_AZC?+[=CM>G83U8_#S\AX_?M?'E$7=@C\2^T1$1'R,C';W
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M6]DBY%R&8ER8.,E@+8Z_F2>_Y*RV31EWB' N^W:_?6C\_#R'E]NT?+&P=N<
M%XV,C4K599WRM;%&TESB5H=4V[';+C7W:#CZ7K/C!=[GP4D-B+Q)\QT#T3VG
MJL\?+R'7W1LC'CMK@0CYXF$!S@/YE/)O7?:_#/$&@^0Z^_:^;%VM4JR3RR-9
M&UI+GD_(!:#4]LQVQT)[E-P,8L/B8?W@P_F4AF!=&X-/1Z/14!T3"9_$MS(R
MN5%OU[A?"._+P:I]Z\73OQ#\/O\ -?K)&/';2"$EE9%&Y[W!K6CLD^P"B6O;
M=C=C;E!2D_!7LF!LG?Y_?\356?%\MX;7O,-W+6+'PMP1M]5RO>&>&5ODR1KA
M]VGL+\GMUXN@^5C/\1 7VUP< 0>PB\G7*XD$9F8'?N^0[22S!&0UTK&GKOHD
M!>GK1B/U"]OCUWY=_+I&31.C$@>TM([!!^2^(;=>4GTY6/(_=(*^GSQM>V,O
M:"?8=_,I'9@?(YC9&DM]V@@D*'Y7=,;1V'&X-CA):LO_ !M[Z])@^KE,FN#@
M"""#[%'R-8TEQ  ^I7S#:@D^;)&O_BT@JM.5]DGP6K2OJ63%:GGC@C<WW'FH
MK5XUO5[F#RV*S,[;3/ Y#SE+Q,KW+@QI)/06/'=J2N#668G$_0.!*R%\SV8(
M&CU)6,'W<>EBR9*BRO-8=:B].(=O<' AH49TW=:FS,R$M8Q"%ELQ0.\^W2,:
M?S]*83W:T'0?,QG^)P"_8Y8Y&AS'!P/L0>PL:WDJ54=SV(XA_I. 48WAC+NH
M9<1SN:#6<1)&Y13A9S(N/,>]\P(\WDE6S6LUI_(QRL?U^Z>U]J%;Q-4GUG,0
M_%^#Q7<1X2!KP0H!PY"<CQ?)#/9>WU9IV&13O1-=KZEKC:#<L;4+92X2NZ:!
MVII!;JS$AD\;^O?Q(*^!/6G;(QD["0.B >R%"-(UBM@;6POAR9LFY<$KF_N>
MZFUV[3A 9//'&'?A'DX GM<]\:,ABY)W2*&1[XV2N +CW[.70LMVK"[QDGC8
M?LYP!7M\1"(O4+V^'W['2PYLKCX(V22VX6L<>FDN'16<Q['M\FN!!^H*C6RR
M8ZUB<C1FN,89:[QT'@.'2KW@0]\?Q?\ ?95<Z22,C:YSG  >Y*UM3-XNZ7"M
M=@D(=XD-</=1"QOM#^N-3 UIX'GT9'V7%_7IEA  4]?;KP0^H^5C6D=^1( 6
M/1RE"\QKZUJ*5A'?;'=K)GL0P,+Y9&L:/=SCT L&GF,9E(I35MQ3 ?(^#N^E
M2FBX^+'<G;A7B>]S!\QYGLJ[OVKC_B6U_BXO5<\M#._GV%G+5W<YBJ,\<-F]
M#%(_\K7.Z)64<G1CJFR;,8BZ_O/(>/2P)-EPL?PWGD:[?7 ,7;OS K3[Y5@O
MZCEXWN=X&N7 L*C/$S&2<<XQCST'0$$K8:/A<'J& OQ09@6(8IR^:0^S%]:9
MR'C-BN92*.U$ RX8ZH[_ !21@G\2L5:C);%A<8]C+M^&%SCTT/<MI%;@FA$T
M4C7,([#@>QTM4=DPK([$AR-<-A>&2.\ODTE;>&>*:)DD;PYKAVTCV(*QK^3H
MXZ$RVK$<+![N>>@OG'Y;'WXC+4LQS-'U8>PJWR?)V)K[E4P45F+IH>;<KO9A
M'LT*%[K%2?RGQ_DH'^1MEW;_ *$,5ZPYO%2W74X[L+IQ[QAW;EDW\E2H0&:U
M.R&,'KR>>@O+'9O&Y$.=4MQ3!OOX%>4F>Q,5B6!]Z 2QL+WL+AVUH^I6?C\C
M3N56V*L[)6._*YI["\[^2HXZ RV;,<+.^B]YZ6%0SN)R3WLJ7897-';@P]D*
M&:]J6MT-USN8IY5S[DY<98 >PSS/94U_;N)$EF/XZ#R@'<H\OR?S7Q0V+#Y"
M*:2G?@E9%^<M=[)CMAP^4DDBI7X9G,_,&'OI13/:YJ\^YX/)6\AX9"#L00=_
MG*K#F"HQN[Z5:$0#GRO:]ZO_ ".7QV*@,]ZU'!'W^9Y6%A=KU[./>,;DHK!9
M^<,]PON79<%%<FIOR,(L11ND?'W\VM9[DK-PN9Q.9IBY0MQV(">FO9[$K[R6
M4H8RL^S<LLAB;[O>>@%IL1N6LYJ9\..RL,\C1VYK?=>46\ZG+EABAEX3=,IC
M$'ZO(+/R6SX+&7ZE*[>9#/8/4,9]W_R7IF-CPN&9&[(7HX&O=TWR]R5Y8G9\
M%F()9\=D8;$<?YW-/LM:=^U 069SFZWIP2".9W?Y7.6?C]IP62Q]B_1OQSUX
M>_-[/GUTJVT_EK&YO/YF"6P8(!)&RDQX/;U.\WO6L8.S\-?R#8Y?EVP N+0?
MJY;[#YC&9>DV[0M1V('$ACV>Q(6>B(B(B(B(B(B(B(B(B(B(BY _HY_\[Y;_
M % 77Z(B(B(B(B(B(B(B(N>-_LOM<K:/0E ,#'EWBK_MTZUVK-6L1-DBD!:]
MCAV"%A'7,*W#,Q)H0FF&AHKEH+ !_!1[:]/P.P86+"6&LB8WHU_#Y%GA]ESC
M-!R/Q5*\UWFWAP_^<:Z1P6RU]FU$92%A8):S_)A_2X#YA4[PMC-GGU":6EG6
M5:[K;_"(P"563H^!V3%Y;9)\U;%DV9(3#,/JQ@<JHP#S'SYF!?#"]S9A!_M>
M.EU&/9?CHXWM>US00X=$+#BP^,KXT8^.G$RN&> @#0&!OVZ7O7JP5*T4$$38
MXHF!K(VCH-:/8!4'ISXZ/,6WT&%_5@/G_P!H<N@EAY,VA0M?"]";TG>GW^\N
M/L -2S->]C-F;-5V62R7"Y-]7]J;<NTCC*VH7H9NKL,C(3.P].<%O>>:L']6
ML5D0WJU!>B;'+]0'K5\O!UG1M8G>^8SOLU_[7Z N"\-UX_R6OXJ3:,=L-Q]^
MIU).Z5WYPMON.8GSW$-/,.FDCFE] R!A\ 7$=D+:;GF[>+T3!04IGML73!"/
M3<6/\"T]]%5WE-6VC%WZ>3UO7+E6TR8"8B8O]5O^FIGMF5OYW<L!JLMAU6&2
M#U[T<9^;C]&+=8GCNUKVX07<+/Z.'EA<+=7S/Y_X!5MAM8QD_->=INB?Z+(I
M9?D?U^875)8"P@KF :7A'\VWZ!CD$)H&UT']'U"0I=L4EG-[W1TR.Y-6H5Z?
MQ%D1GI\G70#?)1[:*M_C;.8C(XFW:?C+,WI6JLLA</(KI-I[;V%2V[U,K>VN
M"/)W34UJ" R/D9(6&21:7BS+][5LE"CDK<^,A'G )G$D+98B*;?\_G+%ZS,S
M&X^P:]6"-Y:)#]9'*.ZEAI,+S=?I&U-,QF,<87RO+W"/L=!;&U>RD'.,-(9"
MRZJ^MYB(O)8/-8AELT.=!5@M3B":#U7Q%Y+>WIM$MFCS+K8@M3L9</<S/,^#
MEZ[YFX(>0V8S8+=N#"NJ#T#$\L9ZQ^KEL7ZA!'HNT59LG)<I2/,].5LI+BP=
M]!Z\.(]5HQZ1%?BFG99M0/!D:\CP[_=4:T?7,[L&#V"K9V2VR"&ZX,+?SO>W
MOYN/:]..(]EVC&9G W<[.RM0G##*SLS/[[Z'?V6\XKRM_'9S;\!9N2V8*,SS
M%)(?F/!:&E=DW.++96W7ST_G/(RB*9 AA8W_ &A;O67[V- V&KGOC:L]:+NK
M9<[J4A:+5=7V;9-#ANW-CLL;'"\U8(B0#_&0J4::V?<N'[,&3GDE>!*SS+NW
M'TUX<"8*E_5>'*=/%CUYH_S*^[T1-29GFYI,;OFT]$?)4!PO)?G=N=6>]/,8
M[+&,>]Y\A^9:#2=>V#.9;<<9;V2[%!5NADO@\N?([Y_J4MXLMY;&[#LVM6YY
M9XJD_<$DOYNE=6<QM6]BK=.R"Z.:,M>!]E07#6KXH-RMD-D]2IDBV'\2CNNZ
M]<SW(F]5OVC:K4OC)?B! XM,A\CT"I-QT#K>Z;/K<=Z>2E7C=+ Q_LP,47JF
M]O<N6NW,+;R$/Q#F598YO"*-K?;P'W5J<2P[=5Q^2JYV*PQD4[14]=W;_!2?
MD/8;6OZID<A58#.P!D7\'.7/,VL;/?PE3*086\[-=-E%[USY$N4TY&US-9'0
MZ.8ML+<U3@;\26._,P_G"RWY^++\48FI2 ^*R#8:3(P>NG==N3?[4VNTM5U+
M$"<"RX,ZA/@]\<8Z+>U$3KNY8+/XR[KF MU8?/QM0F4O8_\ BY;7<L?EK/+.
M'K5,I/#Z]9Q))+O1;\N_37G-A9M*Y/UAE#(V98\MYLL^LXN+RU?.S:AAY^8\
M;&^.3JW$^>;IWN]=(4:D-*G!7B[#(F!C03V>@J<V:U;V#DBOJ;[,L5"&F;-E
MK'%IF4<VO&6..,KA\K@Y9F8Z:806:A/<8+UG<\83'38>ADC&?7-^"'R_T'*X
M]=US&X*H8*3'ACO'OR=Y'Y+0<EU\S8U>>+%6A!*Z5@E<3X_V/ZNBN>+];5\-
MLVJSZO/.'"?T9YF-ZBE78H^JY[Y2N,H;;@Y\[1GM8)L;_.(#M@E^CG!;/4]>
MTZQB=KEQ$T5G%Y!K7BO_ /<G,#ODM3P7@<+%J!S3Z41NMGF G([>&L7IIE#&
M\AVLYF<RWXJ-EDPTZ[_R11K[U*_;U??,UJ3'O=CF576:K'GLL#?8!>&B8;';
M_#F=ASD;;3YIWPUH9#V(&*4T]9N:SH&;QUB^;+6Q2>AW^B/Z!4OQYL$>3UO'
M:2R=L'QD\KK4T@^7I?N1_P 2NIM9U?"ZU0%/%UA%'^H^[GD?5Y6NY"V&Q@M6
MOWZS1ZK>F1?8%ZKRYHFONT&>W9K-FOOI^O)=('K&0^Y[6+Q#2AN\17:\O?@]
M\Z]>',93RW%TE&Y$)(I;4S2"M)Q2^GJV=VW7[;&,EKETK)G?F?%&K X\P]>;
M'9;,N@])^9G?,.OD6Q'LL44XH@9B\OR+ QSWLK7P 7>Y#/->^BXRAOU:]L>>
MKQVG/L/AJPR#ML$86CX]Q8U[?-UK1#\$#'F($]_A6EUZ/,[S2R&0NZQ4OFX^
M5K+DLY!@\/9C!X'I2/#:WM%?C3/XO8G/8(AYU2)27 !:#5N,L9L?'M6_>MV9
M++*SS5_&0R%;O3]OOXWAB;(F3SLP2/@@)6]I\;83*:4^SE(V3Y.W6]>:Z?QR
M>H1W^$K*X#^7'T7_ 'V570JZY4JY:SIUYF-\S(',=)&SWDB'NU53J+^/-ARN
M"EQE-F)RE&42/K>F&>L%[G5=>GYQN49,97-88SUO1+!X&3L?B6[V&"#8>2J.
MIVOEC:5 V# /DV1WR !6KWO PZ'D<3LFNQ,J,?9;7LUX_P +)!(MEL\YV7DV
MGJUY_6,AJ"R^'OH3/4EQ?'46$W4YC%S1U*#X/"2E&WIA>JKS6Z0ZGO\ N5CP
M+IY?&.$?0$GW*M[2-,P-;O/>;+U^Z1.^Z0/=_P SX?968_R\3U[KDVW=P6,V
M_8:V\X43&Y8)JWG,$@9&2>NB5+]NUG$0\.314;AM05 )8)@H[C>(,7F]#IY6
M2W._(RX^.2%Y/3& -[#.EON/\Q=R?$N79<>YTE.-\(<?JU2GC&O':XQH02#M
MKZS@HUPUC(?ZK;)C[3&31_&.C>TCL. [3AC7,$!F;7[.@-FMDBR"8L!>QJO7
M)W64:%JR_P#+%$YY_P!BI3CC$8?=,/D=CS>.@LW+MN1O<C _P8/9K%J]",N(
MW?9M,=.^7'B.5\##[1@'I1'1.-L5G<ANF-M6917IW1'$R,]-[^?3UU/A<5#A
M\11QT+W.CK0MB8YWN0T=*DZQK;GR9FJ>38+%#%L=%%4E;VPO[_.5IMBK,T#D
M/ /P;!!4R?DRQ58>HSTO2? XZ;GB6 4H#"*'K2,(69R;C(9]ZX\H1/?7C)F8
M#"? L'R]EA;?J.'U#9M4R.%8^&9UWP?V>_-9F[SY/.<H4\%%1JVZ]*J;'PMB
M0LBE)^KODY>N#T';Z6^LSK8,=CJ4GRL5J\I<'#_R:H;%I^)S',VP8R</96,,
MTCF,/79\ETAI^JTM5PL>,IO>^)KW/[?[DN56<S4;[+>O9<X_XW&T97FY6]P[
MM9W'LNE9?-V\UK\GPSWUS':H> 9\W?J6'IE&K1Y1W*&O$&1]?E'\2HSB=)Q-
M_D_;*<WG\$.WOK ],>7%8%?2*=;EV[K].>6#&OIB>>!A\1(S]PJ1086AK7,.
M/AQ,0K07*3S) SY,61OE&M#RQH5MC.I9WO$A^X8G,3VC:M(C)>'&P\K><G8S
M%S9C7<CD[G5:I(__ (F!YOL/=[-:%7^'=:9S/5G&(DQ<=FJ>H" TN"]<KJV.
MR7-UN@\>G6GH^O9C;\A,3[@J_P#6-4P^L8]]/&0F.)TAD/9[))5+\DG(Y/D/
M6L0R:'T0QTK89OG$]_\ I!>QXXV@[=C,YZ^/J"#Y2F#\'DM=RKBH=>WC7]L@
MB A^)#;'0_4IL&U]JY,COL#9:6%J]1N^\T_7_P"*HA99G<KRWG'U7U7/IP>G
M$V<=AK%N]1XVRF%VBYE+%VHR"VQXEJ0MZ8?)1OCW2]<O;=O M4&2QTLEX01.
M^;&@ERW''>,BPG(FXXRH\MJ]^8B'R:%F\7P0-V[D?J-HZRH _P#-ZBVRW\KH
M^X9V];Q+LAALL\&24_,L_P!%6WQD=:_JR'X%[S3EL/D#'CHQN=[L*L%$1$1$
M1$1$1$1$1$1$1$1%R!_1S_YWRW^H"Z_1$1$1$1$1$1$1$1%17*&+./VG5=I:
M.X:MD16/L/-7HQ[7M#FN!!^8(7ZJLY"BV5E_!7L)1?9DK3N,C >@6?8K79K:
M,UF]?N8^#4<B+<P]&1DK0(F=_4N6TP>&M:;H+,<*C[5@1D.CK#LN>\*%\67M
M@U?7'XO)ZMD^Q.9&/B8']AZDMW.[AFL[CJ%/"7L?0]</LW)>F.+&_I "U?(N
MCY=^P4]MUP=WZ[@9(/8RA;:ER=>F@]";4\JW)?6!K 6=_P",E3#5AL,K;5[,
MD1267-,-1I[$#!]#]W*6I(X-:22J,T1LN1WC=L]'$/2$Q@@</UJ0Z-OF7S.:
MRV+RF(^"GJGR:"[OMBL#.3WH,7<DI,\K#(28F]=]N7.&S7:&X:OU;UNW'L?A
M&UDH@'Y_X/[_ "K>\B:KEW<=8#J&2U?QI@,H'V:#Y**;YLFQ;MJ55U'7IXZL
M-F)\SG_F+_LP*9[_ (W,W^-,&UF+G$\%BK)/!UV]@8T]K.V+:(]RP-G X2C;
M=;L]1SB:/P; SZEY7MR/BHL/Q8,;"XF.K\/$TG[-7CO.LWL[Q_B7X]A==IMA
MFA ]R %H-7Y%W?8JPQ<6 =';[$;[I>6L9]WE.3=>S^&S.%VK#"2W/58(I_E^
M)X'U<I!J^Z[-NE['B#%28^E \26YB?SD?+TFJ*Y*Y>U7F2Y??1M6(,A6+81"
MWOR<XKI.O--+6B,D?IN+07-^Q^RY[V?(SZQR]'FYJ,\]6U0$#/1;VX.3:?VQ
M@=QPVZG&SF">D(;\+?FZ%9&T9FMR%:PF&P\4L]5MQD]R<M\1&&+H -\6]+F;
M=\V<9RG6FSV/GM8N.L?@HV-]4>?[X"]=6SEX<G9>2W@KT(RD/<0+/9OW<M9B
M=EN<<;EL&/R-&U+C;<YGBDB:7D+9ZUF;.5YFDRDF)MP06,=Z47FS]!((>Y9>
M0$K^?J[1V1'0:O#>IV:YRCAM@L5+#JSZQ9+)&WR6ES>>R.;Y+T_(1X6VRG$2
M8"Z/J61I]R5/]@V'5LAF\Q@-IQX#(7CX2=T?D/!:'CK!W1JNYUZ?J?LV>9XQ
MPE^1+1VL7B?=F0:Z<%;H68YJ+)#++X?@$86ZX@S<$V"V&(LDC#+DDX#VD$LD
M[6LX/R43\AM4#HW,,T_KQ$LZ+F#M8>@302\F[K$\/#;<D_I.Z(#AVM3AL_E^
M*LO>PU_&RSXR>8RUI8E;%S+Y/)Z;L67N59*U62OU4@<.Y"S]YP^Y6CXRRU>+
MBQ[YP^/X.*2.4$+3<,W7SZ!E\4P2Q68C*[YMZ[$B<&[!)!BHM>_9MGUXYY9)
MY7,ZC8NA+4K8JTLCA\FL)*Y]X<R4;\WN\IK2Q"Q:]>-A;^D>2]N(\M%:V;>I
M'Q2Q&U<^(C#V_H;Y+'T+.-R/*.T3"M,V.?R$3RWII#'+HFP'/A> /=IZ7._'
M.8NXC,Y_ OQ-E]A^2=(Y_743(QWVXE9?&M\LW;=V/JSMCNWC+#*YO0(:2L/
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M$1$1$1$1$1$1867Q%+*XZQ3N1-DAE;TYC@HWJ&%S."BM8ZU<;9IP%C:,A_O
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MAL%8@K6GRNL3 F.")GF\@>Y61K.X838#;^ DD<ZN6ME#V>):7*0J/[9FV8/
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M\@M_ZA__ **FN!:U0:(^3TF^I+;E$A40QE&2K?Y3.$<!7C[8QGLWU"2L_C;
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M"CIXH_DYP'\ROT/:6^0(Z3XB(@$.'7?7?87Y\7!WT'M[_F$?*QG7DX!?J.(
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M,0^9[8SS]W%5;F=_SN"S.+?1V*7+P2GJW#Z)Z9_A74->=DT+)6=@/:'#L=$
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M)SX,)Z8KES="KG=?NU'?BAM0$#_;\PJ X9US+R9*67+%Q9A#)6J-/WD/XO\
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M]%<M8VM-8B_),]@+FK:W,;3MP-AL01RM!#NGCL KSJXVE1B='7KQQ!Q[+6-
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ME;^5\D8<0LJMK^'K7Y;\-"!EE[?%\S6 /(7E9UC"6LM'DYL?!);C;TR=S07
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M.TVFAE6\09'XG("Q_P 4A>SJ(1^# %':N3Y%Q_'&-RF.EIUZ=2A$61D><DK
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M!L4$8Z:P?^I4*N<3:1<S#\G-BVNF>27,_0X_<M5@28J@,<:)KL]#T_3$0'3
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M.42P&<=R%LV)R,6/EAQV,B,I?(.B;+O8!7LL7,X?'Y3'3TKL+989F]/8?8J
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M078'GRZZ:X$K*99KOF,0F9YCW:#\P@M5O7]'UF>?[G8\E^S6H(0#)*Q@^[B
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MBN#,:'J^:P..J^DR"&H625GQ#\@"JO=\AD\GR9KN/H6XF,9 )8'S-\XBY_U
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MPUI+,UUS6U81\O,N6FQ_(5^#9ZFOY[%,IV[+ Z$QR&5A_@20U>^R[[=I9]N
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M?79"HW!<J;'GF9NM2USN[6E#&1B3M@^Y>5YX+EK.W(LEC)< ^7-UIA&*T9_
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MOC]PU0_$<IZF_1HFV;K&W64?3?4/YR\!0?3]INX'A>Q/C1W99?+7$#OTFO\
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MC'T,E )87.#NOJTCZ@J 0<):#!$U@Q[Y.I0_RD?V5(<_QSJ>>ITZMO'-#*S
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M'10O>.G2 #R(7E=T+5+V:=E[.*ADM$]E[@"L_':I@,9D+=^GCH(K-@DR2M:
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M$1$1$1%@_M;'-OLHFW$+#AV(N_Q=+.1%AY#*T,>QCK5J*%KCTTO/7968UP<
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M -TN':^!D*?B7"S%U[=^0Z"_9+U2,@/L1-)'R!<!VORWE*-9H,UF*)I( \G
M=]K):YK@"T@@^Q7C=F=%5G>P?-D;G#^8"H_3=ZKY/!YZ]!\4_*1P"2WZK>HP
M_P"T:\L9GJ6V<<9IT5J]\3%"#:G?^ F8_;HGY*1<2W*M;0<)ZT\;.V=#R*M8
MV8&1>J9&!G[Q/R7Z+,'H>L)6%G[W?R2*Q!)&962L<T?4'L+65\_B+%B2O#?@
M?*P].:'#L*';YI^&S]O#SWLH^L:D_; #^?M3VQ>J5/'U[#&%QZ;Y.Z)*QW9K
M%MNLINN0B=WM'Y#R6?+/%#&Y[WM:T#LN)Z"UU#/8K(N<VI>AE+?<,<OW(YO%
MXWP^,N10^7Y0\]=K+JWZ5B)\T4\<C&_5I["U,6U8&:?T(\G7=)WT&ARWJ.<U
MC27$ #ZE47S+EL/=T[(0P9!CIX96_@8]3SC^:.'0]=DE>&M&.A)<?\*D%'9<
M+D+ @JY""60C\K3\TO['A:%@U[5^"*0 'P>>C\UG6,E2K4C;EG8R'H$R'Y
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M7E!JG)SW@3[J6-[]VL)7M_5+D@,?UO$G8;VT>DLC^J&_]?Y^S]^'_P!P^O\
M]:^HM/WTAWJ[]8!\CUU!W\O_ *UZ?U-W?_[X-O\ _!__ ,M/ZF[O_P#?!M__
M (/_ /EKQ=I^_P#KAHWR<Q$?-WH_/_R\U[?U,W?_ .^#;_\ P?\ _+6OR>I\
MDP4Y),?N\L\_TCEB]-I_VAQ6@P^@[_E#5RN;VB2K?@#F0L;'ZH8UW\R%+QIF
M[?3?[7_X./\ \=/ZF[O_ /?!M_\ X/\ _EI_4W=__O@V_P#\'_\ RT&F[O\
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MQW3Y7'^3NEE\O/KMRVH!SF!XOJ]@?D2#[E<^Y'/#.<BY?$29,8J"JPB66/\
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MW]H>S*MM"U(SO\D#OF&*V..I7Y6#)[-.P!V3E#HONR%G?35&^+9HI=KY&+)
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M="M.=='Q[ZG@ZKUT_P U)^%[<$^B8QD<@+HAXO6MYWBD=ID4C8R]L.1@>_\
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M+!T/FL7%\=83'Y.CD38NVK%2,L@=8E+PP?P!4]DC#XW-)([!'8]U7^ XUP6
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M [6CV7,LPN"R&2< 17A+^E2-;'<B9_7,?L=+8;++LSA**799 8G+H&C):%6
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M  ?)8DN*H/M-M/K1.G'M(6@N'^U9<]2"Q"Z*6-KV._,'#L%&11QQAC6@- Z
M'L@C:#V %\7*5:U"8;$39&'W:X=@K]JTZ]6)L<438XV^S&CH+YM8ZI:?&98&
M/]-W;2X=]'[A?3:\+)GRM8 ]_7D[ZGI?:$ KXAJPPAW@QK YQ<[H==DKZEBC
MEC<R1H<UPZ(/S",ACCC:QC0&@= !!$W[!?J_&01L+B&@=GL]?4K]+ 7=HYC7
M'L@(CF-=[@+Y9!'$P-8T #V ^07T(VCZ!!&T'L +S;6A9+)(UC0]_7DX#YGK
M[KT# $# /9 QH/8 1/$=]ITGB">T\0"A':(6@GM$3Q )3I.D+041.D(_B52F
MYZYNE3;XMGU_TK#Q6]!U63Z-7[7GY'VJ(5,ABH,32E9U.\O,DI'V:.@KDHT(
M:E6&O#Y-BB8&,!/SZ:O;I"T%$3H)XA$3I.DZ1$3I.DZ1$3Q">(3I$Z3I$1.D
M3I$1$1$Z1$1$1$1$1$Z")T$Z"(G2(B(B(B(B(B(B(B(B(B(B(N3_ .C>]XES
MK ]_742ZP1$1$1$1$1$1$1$1$<YK?<HB$@#LHBB.Y;KC-3HQ6KT<[FR2B-@C
M:#^(J3T+L=RG!88"&2L#P#[]%>Z+'R%ZKCZ<]NU*V.&%OD]Y]@%6CN6<%%)3
M=8IY"&K;>!6MOB'I/5I.D:&%Q/0 [[5:7N5=>IB67X>_+5CF,3K<40="'C^/
M:L7'9*I?H5K=23SAGC#V/'ZFN7NB(B(BU>?SV.P6.EO7I3'!'[N [37\_0SN
M+KY"B7&&8=L+AT5M$1%H]AV;#Z[2^+R=H0Q>0:#[DG[!;7%96GD<;5O5'%\5
MB-LD;B.NVN7NB(B(B(B(B(B(B(B(B(HIM6YX?5XJDF0,H$\PB9X-[^94JCD9
M(QKFN[!'8*_41%K\QF<?AJ$UV[.(H8_S/*A>$Y0UG*9>+&GXJM8DZ])EB,,]
M3_"K$1$1$7S+.R*)[W'IK022HQJV[X78YLG'CS*\TY&L>YS0 2[OV4I1%I]A
MS,.#PM[)S,>^.M'YN#?<IK&PU<_A:>2JM<&6(PYH=[A;A$1$1$1$Z3I$40V?
M<*N#?7JLKS6[]@.,%6$ O>&^Y6+IN^X_9C;K"&:M;JOZL5I!TYI4Y1$107==
M\H:HVH+%:>1]B0,C\0/%3IKO( HB(' D@'V1$6KSV9KX7%VLA/'*^*!GD]L0
M#G=+5Z1MU7:<)^U*\#XV&9[&!_O^%2A:O/Y=F(Q%V^Z)\C*\1>6,^;BL#4MD
M@V7!ULI!$^-LO8+'^X(4C1'.#022  HUM6RQZ_@9\L:TMB./Z1+]TW9OZQ8"
MGDVP^D)V]^'??2DB(B(B(B(B(B^8[$+Y)6"1I='UY-'N.U](B(YP:TDGH *H
M,SR1E1!DKN!PC<C2HR^E/*92PD_=@ /85A:OGQG<%1R(@?#\1&'F-WN"MW%/
M%+Y^#VN\'%IZ^A'T7TB(B+\DD9&QSWN :!V2?8!?E6S7L01SPR-?&]H+7#V(
M*^D1$1$1$1$1$1$1$1$1$1$1<O\ ]&O_ )'L?^M@74"(B(B(B(B(B(B(B(J$
MY;VS8<7EL/C*M!YK366/]9C^G2EOO&K49LYHX*;(YFO\ 6./<;CV5!W\JFCZ
M$^6U_(4Z4[@V*PYH/O[=K!Y@V_,8G!U/V5 70W)&L-MKO;OV:U3*IM\V-URS
MDLYCY:#8&L_ 3YN<HY!RJQEC'G)82[2J77=5K#P.BO3FF"*;1K)>WLQVH7L5
MAZQT,'C?X58__18FS;3C=>J-FMEY<]WA##&.Y)''Z-"A=7E&M!D8*.>Q5S%2
MS_W!G \'+7\VY*Q!IUB&*G-(R61GE*W\C5O]4^&S^L8NGDL&\11U8'ADS 8N
M^OT+9[[D[6-UK(25ZEB5Y@<!Z(_)_$JN.'[5>]I=3$S86R8)&O\ 5E<P>@]2
MZ?=</@P<;B\5<M08]H9,:L8=' QJDVO[?B-@P[LECGOE8 >X^NGM/V(6+JN\
M8G9X<D^BRRQ])X9-%*P!W:PM?Y&P6<L9.O#':AEH@^NR9@:1TH[_ );])^%N
M3B6SU!*&>'ICR?W]6JU<1E*N2QE3(5B3'8B;)'Y#HAKE&LQO&)QN2&-:RQ;N
M^'F:]9@>]K/N>R%^ZON^$V:O:EHR2--<]312@->Q1VURUK4 LS-ANS5()A%+
M;BB!A#BMYL]FAE](R%B%PFK3T2]I/LX%1[B:>&MQUBII7AC&0DN<4FYAU>)[
M"Z&_\,^0,;;]$>@5)=AWS7<!3IV[=EQBL]>B6 .\E';G,6FU<K'0,\[_ #>&
M>NQG<(*LO(Y:E3I2V[$[8Z[&^3I#[=+G'E7?<%FM/MU8:UL%\C'0321=1O5G
MZCF*&'XWP-Z].(H(\=#VX_X5]XCE#6,EDX,<3:K6)W 1,GB#/-;++;_K6)S$
M&*MW?&U)^GKY,_BY9.J;O@=F;>=C)S(:TO@\$=?R<FS[K@M8] Y2:2)LO?@Y
MK.Q\EG4]EQMO!#,0&5]=T7J!WB._'[@+!K;O@)M>.;;9<VIV0)'CHG^06IQ7
M)6M9+*,QK99H;+_G$V=GAZG\EL-DWG!:_/#6M22/LR@F*O"WSD<O37-UP6PB
MS\#.?.#KU8GM\7L6GGY3TV(9'O) _!_*7H?_ &&K/L;_ *Y#A*F6^*<^&SUZ
M#&-[D>?L O?6]WPV>LS5H&V8K$([D@FC#'-4M>]K&ESCT .R56U_E;5JD[F^
M5J6%DGA):CC!A8?XDE39^;Q;,6,DZW&*AC$@F[_#XE0NORIJ4MED+[,T D?X
MPRRQ^,<O\BM_LNXX36JL-C(V"QDIZC#1V7+09+E;3L=<J5K%UX=.T'R#>VL#
MOWE]9[E/4<*^-LUM\Q=UWZ#/,,!^KBI+=V_"4==9G'V3\$]@>)6COR#AV%#,
MAS!I]#'T+CYIWMLQM>UC&=N8'?OK/R_*.IXO'U+KK3YV6&!\;8&>;BU2S";#
MB\UB8<G2G\Z[V=^1^GW!4,L\J:[!W+Z-U],2^F;K(@8 ?Y]K=Y[>M?P>(KY.
MQ8=)!/UZ1B'EY]J-Y+F'4,?8@A>^R_S [?''VR/OZ/*L*YG\91P[\G+9:*K8
MP\R_0M/V4#BY7UTW*5>S!>J"V.X)9X@R-ZR-_P WIN/BHQ;!6]?SG:88_ /_
M !K8;3ON U05AD'2@S?D#& J//YDT]N5BH!]IWG(&-G$?]BI]L&PXW 8]]V]
M+X1-(  ^;GN/T:%!+7+6$Q]F*'*4,C1]9GE"Z:( /5D8K*5\C1BMP-D#9!V/
M-OBX+GWFW-/?/A\2ZE=$8OM>2&#PE\/W%-\_GM/IQ4MAS>(M06*LOA6]6)OK
M E;.CRAJM[.4\1!8D=/8C\V.\?P?X24S')F!QEFU!Z-RU\-_?OK1A[(OYGL*
M18O;<%E<1+DZ=L2UXQV\CW9_ J&_Y8M0.+GOL?:D9'/Z0C9'V]_\0%DP\KZI
M-K[LRR6<QA_@8 SN;O\ PK?Z;O.$VJO:FQYF#H'ADD<K0Q[5M\]DWXO%6[C*
MTDYAC+A'&.W.51\4;KE=C@R4U^G=>VS;)B?T'01-_<[4<TW9,-K&Q<B^N'_\
MY]Q5X6]O<&E_Y0KHTW>L)M=6U/CC+W \,?'*WQ<U:+,\CUJ9OBAC+E\4I/"U
M)"T>G$I9J>UX?9<8S(8^4NC/R((Z<T_8KSW/+8G#Z]=LY.L^>J&]3,# _L%:
M+6MFP3=(@S$55M+'Q0>0C:/DQH4>/*CH[F+%C W(:F0>!6G=]6E2+9-Y9B\M
M'AZ6.L7LBZ(S&"+],8^I*Q:>_NNZ_E,E!B;(EHR!DU:3\+P?GVMIJ^Z1['JS
M\S3JO [>/2/YB6+RT[>ZFPX6[D?0DK?#2%DS7_IZ4/=S%6^'.3;A;QP_K^E\
M;TIIL6\XO!Z_!F7LFFK3^'INB /Y_8E0W)\R8NFR":/'VYZWR]:RP?V;"59,
M^U8:K@&YJ2T!3?$)&R_=KO;I5\.6*T%JB<EAKU*E=/5:S(T=%338]NQV$=6@
M(?/<LGJM5B'<DBT&!Y)IW<X_ Y"I-0R7Z(I/9_\ (JR>P JQR7)#&Y&[0P^'
MNY.6H_JRZ$#P8M]JV[8O9Z=F2CZ@F@^4U>0>+V.5"_M[.2<PRVI-=G?9BQW@
MVH3\VCL?C"Z3Q>+Q\+Y;[,?'7LV@'V'!H#W._P!(J)Y[?#2RL^,QV)M9"U P
M/G$0 ;&%ALY),FE3[$S%R^$%AS)X2>GL#%LV;Y#-HPV2M2ED;X"1T/L[I9F&
MW:C?U-F?E:8*YC+SW[@*%R<L^A4JY2? W8\5/*&1V3[].]B6K0<Z/9-@,'?C
M(, OQ'S6YL\RXNI>JL=C+HI2R!C;9;TURNICVN:' @@^Q4(V7<X\3?J8RI3E
MN9"P"]D$?T8WW<2M1C-^R&3QVPF+!SQ7<=X@UI3T7%P*AO#VU['FCDY[E1\L
M=BX7OG+OPQG]P*<Y??)X\C-1PV(FR3Z_?Q3XSTR/^'?W6RT_?,3L\,PK^<-F
M$]3UY1T]A6DO<C/.7R%#$8B>^:0/Q,C#TQCA^E9M#9L9M^G9"W#%-UZ#V3P^
MSV.5><49V# \2S9"7HB&U*0SZN5LZIL.3S4'Q5C$24X7-:Z+U#\W@K8;-EH,
M1A;MZ>K)8CB9V^-@!)"B^-W+'MT5NP5\9(RNV+S%>(#L!0Z/FCXS!LOX_ V;
M+VEQG:/R1,;]2Y6EJ6T4]GP=?)U 0R3L$'W:X>X4&YBS^?PVMRNQU1ICE:63
MSD]>FHYAI<MD>&K-2W0; UF+8VN\N\Q*SK\RC&F<C7</HU"+&8"S?^$9W;E_
M)'&%>U'?<+8U(;$)',JEG;OW@?W5 K/*^3QTU:UE-=?7Q,[@&6A*'2#OV\V*
MYZ%ZO<J06J\GG%*P/C</JURKW:M_.+S-?!8W'/O929GF(._!K1]W%>FH;W)F
M\CD,7=QKZ=ZGUZT??DU>68WNV,^[!8''-O78F%]@OD,<40_F Y:[6^3WY:Z[
M%38.W%DX92RS$SI\<0'U+EF97?<@[8IL%@,2+MFN";+Y9/2B9_(@.6GUOE3(
M9;,28B?7+$=R!Q%AK'>;8^EKI.9W,R6;Q_[%>;-,EL4(?V^1X6^'*3/ZO8:P
M,>\Y/)#^PH ^Y'OVY>&!Y1M.V5F"S^(%"U+U\.62>JQZW^R;K9I9ZE@,51;;
MR4[3(62/,<<<8^KB 5%X.4LJS9!KMS7G#(A_1;#(7L+/N"0%M]AY OP;*_ 8
M/%,OVXH3+/YR&-K /]A7IIV_W-HPN8DCQP@R-(^#ZKW_ "\U ^)LOM^2S.P7
M;5&![9[K&VYG2EI9X=_*-O2G.:W^^,MDL?@\9%<?CV_\:?+-Z+ []QO0=V5N
M./-^I[;C9IQ"(+4+PR>#OOP*E.:S-'#8Z>]<E$<$0[<Y5!=Y W:M0&?&M1'#
M]$^)E(L"/Z2$>*ELVT6,]I9RNO01SNEB/;)G^GX#KY^P=\PJXX&EV3^KK(_A
M:KL8ZQ*?5]0B4/\ \/2N?97Y:IK]UV&BA-ID9,0>>FA4YQ)E]TN:Q>M"M4F9
M-8GE$SYB'NF[]BWI2?2M^S>T2YZK)CX*=JCTP1&0O[D7QHV_Y_+;-D<'E:$%
M:>DQWGX/[+G K9,V_+#<,]5?'!^R,;#W-/WTYKS[-4*M\E;E)BI]AIXW'C%,
M_&R.6?J=\?WZZ6]S'*,XT"#9L519+Y/#)6/?UZ3E&K?)^]?U>JYV#7XA0$+'
M32O=\W$^Y:%M>2=AR^0XU@RV+E;!!;A89OW^I![!>NNS[QBN.:<\$520P487
MP1?4QAOL5)N,=TO;5KMJ_;,$<K9BPQL_2%L=%V/,YIV;DM,A^&@NN@JRQ_\
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M8G/*F^DZW;DV?.[5D:_H3VWEE>#W>R(GL^:AM4W-?Y7V!U"G\;!989;#6/\
MQQ%Q4OT;7+DNRYO:LG6%:S<);!7[[='$3V?-1+CIC#RIO+NAY"Q+_P"]8O)3
M\36Y*UZ7+^;*+ZSF%X4TN:WQSCI\9<?%Z\[YV,K>+Q(\N*T.V_&8?EC&Y7',
M;8FGI/9/7#_$B-A:MYB<#?RO(DVRW*\=>""#TJK0X%\G^DY:AV6GS7(.<Q^(
MDKX[T&%EV_[SR>!ZZ8L;B/T:V8W^#XXV.KX#9GN[?+^=;+B"Y7%?:8/78)AD
MW?A)^_DH+J>.U?)[AM>(V. &^;LD@>7=-D <KFTW&Z3C<KDJF!I]21@"S,P
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M>PW=XV+#WO0;!4_NF,5J(G:(G83M.PB=A$[4>VRY=JZ_DK%*<1310ES'EOD
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M%1O=-HY,UF?'YNR8/@)9_!U*,DAOE[ E-KVCDVEC8]FBDJU<?YL J?G=X/\
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MW?8%0_A_5(B<_89DKT0BR'@UD<I:#X]_G^ZQX8]]R.\[5A(-DF8QK218/?;
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M7[[B"]=,:WA(,#@Z.-A #:\+6?S(5'9S,5,MR1D,1GLN^OC:<9,57LM9.?\
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MQUZ L?(!V6$D$K3[EOV'R>]:5DJ(EEJU)7^;_'W+U+N8LQ0AOZMW)V67!*6
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M+;\,9FFZCLGEYQDW3/T]I!\#VM/Q_;J9G.<B4V"5G[3G=- 2P@%@)4<T_?\
M,\?F?6<WBYYO0>?0,:Z-TZ_G\EC9,AEH_1=:E\X:W_W&+Z K\WVU#5U3+R2D
M]>@6CH=DDJK>';T-3B[*,G;(QU9\IE!;^^M=P1;C@UC.0RM>Q[)1(0YOT(*U
M'%5VPX;W%3;*RS8/K5NVEO8':TNGYZW'J&?Q#,%:GSDIE=8G>S]/U+WK88G-
M69.%,G3?C9PUD0KL>!V7O*L+%Y-C.&8'FM8[BQK8"SP_&7 *$4\JYO!$]4U)
M_6(, 9X*<87(//#<!-.?S90%?TPWMY< H_@<'EL[PS/A?A7U[M9_X&/_ %%J
MT>J\F;O!5@UPZT^;(0M$+97DC_:Y9W+57,.H:U2DBLW;D#A-:EC9VQ=%X+*U
M\ECJ]V!DC62L!:)!XN'\PMBB(B(B(B(B(B(B(B(B(B(N7OZ-9'P>Q_ZV!=0H
MB(B(B(B(B(B(B(BY^YFR56'):S&]KWF.WZLC6M[Z8K9QFJZK!?.6H8FK%/*.
M_69& XARD60QU.[6?6M0LFB>/QQO';2M7A]8P.&,AQN,K5?/KS,3 WOI>;]3
MUV7(27W8FH;3_P TQC'D5N[56O8KR03QMD8\>+F.'8(6APVH:WA9I)\;BJU5
M[QT71L#3TMCE\+C<Q2?5R%2.>!Q!\) ".PO+%8#$8F!\&/H05HG_ )FQL#05
M@X_3]9QETW:6'J06.B/5CC#7?->HU;7FY8Y48NL+Q<7&SX#U._OVEW5->NY>
M/*3XNO);C_).Y@+PM\JZY$T]^=I07*)\<I0?ZE-__JU9>*?6V["B#/X5@GBD
M;\15G:'-;*/J$=QEHCI(W_U<HCP^T35,,?B\?C:+*E.K'!"P=,C8.F@*%GC+
M379Q^7=BHS8<XN(('AY?O=*?=+75,)C:M^]>AKM9-:>'32?5W2SK]&K;IRUK
M$39(I6^+V.'8<%$,%HVJZU+-;Q^-BAE+"#)UVX-4/A@L;GN%'*")[,/BP3 9
M!U\1,[Z@?8*XE%MCTC6]ALUY\E1;.^$$,)3,Z5KN:I5*=['1R0UQU"W]P?8+
MRNZ+K=W#5,1/0:ZG7Z]*/[=+8T=9PU'"G$0U&"F6D&$CL$%:.CQCI^/H7*T.
M*B:RTTLD) +RT_3M;(Z5KK< [""@QE-W7E$WY=]?=9."U7#8''3TJ%;TJ\I)
M,8/R)*U.O:!K&NOM/QU!L;Y^P]Y^;NC] 5Y8O1=:U^:S>H4Q#,^%[7O[]P51
MO&NKZKLES:&6_/XQE[MCXW>#PP]_E*Z-U[5L-KV/=4QU80Q./9^[C]RM5C]
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M<3@YL?\ $?J0\?ZF,1%BSAZ_PK)1((O ?F'U*R,SINO9FA6HW<?$^"#KTF
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M2V/-SY&U .JS7O+F1=K4[7Q)<L;+-GM>S+\?9F),OBIKJ&D1X:A:%^R^]=N
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M6"TR>;//\BFG^7_D/_K-;_=)_E_Y#_ZS6_W2?Y?^0_\ K-;_ '2?Y?\ D/\
MZS6_W2?Y?^0_^LUO]TG^7_D/_K-;_=)_E_Y#_P"LUO\ =)_E_P"0_P#K-;_=
M+$=SIR$6R#]HL'G]F+V//'(1#!\=#\A](T;SUR$T@_&0'^<2Q7<X<A.$X_:8
M'JN[_+^5!S=R%UU^U%E'GGD(S,D^,@^0(Z])>AY^Y#((^*K?[(E\Q<]\A1QL
M9\9 [H>[HE]_Y?\ D/\ ZS6_W2?Y?^0_^LUO]TG^7_D/_K-;_=)_E_Y#_P"L
MUO\ =)_E_P"0_P#K-;_=+QBYXY"C=(?C83Y'ZQKV_P O_(?_ %FM_ND_R_\
M(?\ UFM_ND_R_P#(?_6:W^Z3_+_R'_UFM_ND_P O_(?_ %FM_ND_R_\ (?\
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M_I(5Q3#F81QG^K#)TQ8T_P#22>)6B'  LZ'9=,O>?^DA$)@(<&3']S*L%_\
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M "^JG_"(V?\ ^7U4_P"$1L__ ,OJI_PB-G_^7U4_X1&S_P#R^JG_  B-G_\
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,$1$1$1$1$1$1%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex3-6_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_004.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 ;P !  (# 0$! 0            8' P0%" (!"1
M 00" 0,# @0#!0,* @$5 0 " P0%!A$'$B$3,5$4014B,F%"4G$6%R,V<C-B
M=!@D-U5U@9&3L;(()3135G-#-:$F)U3!1$5C9*(X98*2TM'_V@ ( 0$  #\
M@_\ \/K&.WIY(]J$J]PHB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B&)AD#
MRT=W''*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+POT#G,.^
M, 87=].5J]T!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X7Z!LG=OK#%)VAM.4O7N@>R(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B+Q!_\/?^>9?^SY5[?1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>&N@,)
MDWOD2.;V4I2O<H1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>(?\ X>_\\R_]GRKV\B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B\0_P#P]_YYE_[/E7MY$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X9Z!68H
M-[ >?,E*5C5[F"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P1T0#3O\ 0Y/'^$]>]V^P1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1>#^A38W;]6[XW.XKR$+W@/8(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(O#70&>.'>^'_P =*5H7N4(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O#_\ \/A WI_[T)5[
M@1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1>%>@K)W;Y&8@SQ4D+^?CD+W4$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$7AGH#8BAWL!_O)2E8U>Y@B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\)]!XA)OL),
MI8659'+W8/9$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X9Z QR/WOEDI9Q2E)_<<A>Y@B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B\(]";,L&^UPP<B6M(QR]W#V1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1>#NAEF6#?:H9[2P2,<O>(]D1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@SH;!)-OU,L]HX7
MO*]YM]@B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B\$=$ T[_ $.3Q_A/7O=OL$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$7@CHBTNW^A^T3RO>[?8(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O W1/_ #_C
MO]#U[Y;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_Y_P =_H>O?+?8(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(O W1/\ S_CO]#U[Y;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_Y_QW^A
MZ]\M]@B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B\#=$_\_X[_0]>^6^P1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1>!NB?\ G_'?Z'KWRWV"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P-T3_S_ ([_ $/7
MOEOL$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$7@;HG_G_'?Z'KWRWV"(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B+P-T3_P _X[_0]>^6^P1$1$1$1$1$1$1$1$1:&8S-#$4I+5N81PL]S\GX
M"B>M]1<!G\K/C(F6H+43>XQ3L#'.;\CR5.^5$\YNV!PF2HX^Y.X6+3N(F-:I
M8B(M#+9G&8FH^S>MQP0L]WO*C,/4;2)WMCBSM<O/L#R%+:&1HY&I'9JSMEB?
MY8YGL0MA$1$1$1%QK6QX6KE*^,FO1,MSCF*$^[EV41$1$1?$]F"O"^61X8Q@
MY<YW@ +7Q>6QN1B?-4M1S,:>"6'GRMM$1%I397'P7(*DMJ-DTIX9&3^9RW41
M$1$1SFM:7./ "C=?<=;M9/\ #H<K7?;X)$0/E=#)YS%8ED;[]R*!KCP"\^ZZ
M@((Y"(B+E0YW$SY>;%1W8C<B9WR0<_F:U=5$1$1$1$1:.2RN/Q=5]F[9C@B;
M[O>> MO'Y&G=HP6ZDS98IF!\;Q[.!]BOM$1$1$<YK&EQ/  Y*C^(VW7<M<L5
M:.0CL30>9&,^RVHL_B)LO+BF7HC=C;W/@Y_,T+K(BT,MF<;AZ;K5^TR"!IX,
MCO99\7EJ&1HPVZ,S9H96]S)![."R7K]6C6DGGF;'%&.7O=[ +5PF<Q&8IB[C
MK;+$)<6B1OMR%O(B(B(B(N9F,WC,-4=:R%ID$(\%[ENXW)U+]"M;J2=\,\8>
MQ_RURS+A9':<!B[]6E>R,4,]C_91GW>NZB(B(B+0RV9QF&IOM7K3((&GATC_
M &67#Y:AE*$-ZG,)8IF\QO'L05GNW:]*M+-*\,CC87/=\ +EZ[LF(S^.9?QT
MYFB+B >.."%UUPMAVG":]79-DKC86./#![EQ7;IV8;5:*:$DLD8'!W[%?2+\
MGGB@B?)(\-:T<N)]@%RL)L.%S<,\V.MLLLBE['%OMRNLBU,GDZ6-J2VK<[(8
M(QR][O8+2PNSX;+8EV4HV1)6!<#*? ':F!V;#YR.S+C;39VPR>FYP]N5M9C-
MXS#4GV[UID$##PZ1RS8K)TLCCZM^J\OBGC#XR1QRURV$1%&K>XZ_3S=3#S70
M+L[^UD(')4E1$42V+>M=UV:*+(6G->\$AC&]Y 6CB.I>G9C(5:%'*"6Q.SEC
M.%+,KE\?B*4MR]89#"SW>Y1;%=1M6RF19CH;;V6G_HBE9V%RG"(B(G*B>2W;
M!8_/4,)+.XW;3P&1-'MS]RI8B(B(B(B(B(B(B(B(B(B(B+P-T3_S_CO]#U[Y
M;[!$1$1$1$1$1$1$1$4.V3><-K\\%:<3SV9?+:]=@?)P/N02%BUG?\#L5F:K
M6=-#:B_57L,#)%47538IG[GJV,^AN&"*TZ1[0P<SEOL8E<N-Q^#R]V#8QBG0
MW>PL#YF!DH'P566Y]0,O0ZAX3"U:ED5V2ATPC\NL#X:%K=51!/D-*R<L4D+Q
M:_3)X+ [R0Y35G5O4'9Z/$B:<NDE+&3^GQ"2I?L6T8K7ZK9KLI'>[MCC8.Z2
M1WPT*/:_U-US,Y5V, LU;8]H;+!&YZG\TS8H7O/LUI)_[EYGUJ,]3MQR>1R4
MC9<7C)>RM5]V'O\ 8JZ]AT'7LOB)J<V.@'<SACFL <PCV(6AH^-EU?4:U7(/
M;']*UW<\_ 6C'U:U)\X!ELL@<>&VGQ<0N*E>:VO!X7&LR%ZZQE=_'8\>>XGX
M4>CZHZ8^W4J_BC1)8B$C$/5/2A!<F_%6]E>41O\ 'NX_9B[NM;?@MEKR38NV
M)0P\/'LX+G9WJ'K&"N&I<N/]8#\S(V=Y9_5=O [/A<Y1==Q]MDT3??Y:?ARC
MAZGZ9Z%^<95ACJ/:V5P^7?9JZ%O>M9J8BMDY<BSZ>P 82/+G\_ 637]ZUK/B
M=M"[ZDT327Q.;P]H5:4>L5"QN5ZE)+-'1B'I1?D\OD4FS\.A2[Q@W9"4G+L/
M%6(?O]W!3;-[#B,%6]?(6FPL)X'/NX_ "Y> WK6L_+Z-&\#.!R87CLD 6U<V
M_7:.3BQMC)1,MR.X;$?=:^.WG5,EE#C:F7@ELCWC!4K48RNZ:OB+;JN0RL,$
MP9W%AY) 6P=LP8P4V9BNLEIL:29F>0H-TZZG4]GEOLEG;%(ZT15AXX>85.]F
MV/':[B9\A=F[(F#@>.2YQ'@*OM8W+&[GJUF"[-#/9EK2NFK=OLT*(=$LMA<+
MH]VW>OQP,-WA_?X#5Z"Q66QN2I,N4K+)H9!RR1AY!"X&0WC5,=<^CN9BO%/S
MQV$J4P3PS1-EC>US7#D.'D$+#=O5:-:2Q8F9%$P<N>X\ +@XC<=9S4SH,;E8
M+$C1R6-\%5)OM.M%U8T&RR,"6>202/\ D,5WY++X[%0&>]:C@C_F>5I8;:]>
MS;WC'9*&P6?J#?<+9S&P8?"Q,DR-V.O&X\ N]RLF&SV'RT3YJ-V.=C>.2S]U
MR+NZZM0N_16LO7BL>WIDJ35+-:S!'/#(U['CEKFGD$+5R64H8RJ^S<L,AA9^
MI[SP N/A]QUC,SF''96&=X'):WW5?]9MMK8?6Y*<-PQW;+V- ;X(C6I@-.TC
M9,;@KF.>UEC',BYE@':[GCV<M/KSC:[\1ALBX#UH<C%&T_M(K/&[:K'?;C79
MBL+?MZ7<NAE]GP6'EJQ9"_% ZP>(0_\ C7UFMDPF#BBEREZ.LR1_:US_ &)6
MU>V##T,8+\]R.*J6AWK./ X*Y6)W+5LQ<-*AE8YK C+S& 0> H[C:.D_W@Y"
M[7O!V9= YLT /LWGR>%)#MVMMOV:!RL M0,+Y8B?+6M]R4P6WZYGI9X\;DHI
MW1?K#4V#;L%KXC.1N"(O_0P#N<5OX;8,/F*QLX^[%8B'W85&;'4O3:N1GI3Y
M4,?"2'O[>8PX?;E2/);)AL;CF7K=Z.*L_CMD/WY\CA:&$W;5<U<%6AE(YYQ&
M7F$ AP"DQ( 40N[]J%&Q)7LYF".5C@UP^"I++E:$&/==?9C; &]QE)_*&J,R
M=0-/BHP77YRL*\I(CDY]R%*L;DJ5ZHRW4F9-'(.6/;Y!"KKJ7U JZEBOR/\
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MAQ=%_*&_*S8'<]?S6*L9.E<#H(3P][AQV*G^I6]Z1F=5R])EIDT_H\UGF/\
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M#KUJ\?J"0N7B(3@.LV4P^-BXH7*?K3P#PQI7*T;2,!E]RWH7*D;Z]6\8HJQ
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M2,,3R]=7JEJE[9M8?4HR 68K#)XN?9Q8HC<Q'4S,:#9QEUE0V[7IQ$.)'9&
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MM;Z:[YC<=D, _-UH<0_O,;XV=\SN5+=1T3.T=(OX#)Y)G#V%D!A'F-I4?P&
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MN.!PT+ZV70=8V*9DV1H,DF;X$P\/6UKVH8+7_7./JB-\Q!ED/E[_ .I6EE-
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M>8S(P.+5OV,50DI?1RUXGP\<>F6@MX'VX6KCL)BL8WBE1@KC@#B-@;X"Z2$
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MZUNM8#W13,D#3P>T\^5D1%^$@ DE#=@_^J-X_J%^MD:X M((*(B(B.<UH))
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M<9;HF[7MQO@Y/$@/#5RZ>W:[>N?25\I!)-X_(#Y7;M6Z]:%\LTK8XVCDN<>
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MGK,V-T_!&V^,Y8L^IF)]V-]P2G5G2]9IZ:)ZN-AAEJ2QB%S&@$!;>^8O+7M
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MHZ5?%Y?!/I04JC(XI7>\A"N&>)LL3XW>SFD'^A7F['/S/2W+9:O)BYK6!M6
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MAEJZDN_97$'0,M,^:.6*6L&L:"#WERJG,8GZ3H9BX[C V9KX)6M5_P"MN:[
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M<$ C[*G>E^0S,V;W:ED,I/<^BOMBB?*?8?F5RBQ$7!C7MY^.0OU'6(6.[2\
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M1Y=$YH_J0O._3K/7-)Q-_!9K$W0Z"P]\<D48>QZFW3W#9.7*Y[9<I7->7(S
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MB;F,L^LP.[2>.."NTB(B(B(B(?(2-A8P-+B[C[GW47S&Z:_ALE4QUVYV6;!
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M5@%J!A?+$3P6M:M+&;_J.4DFCIYFO(Z)I<\<\> OC$=0]3RV7=C*629-.!R
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MUB--U"A@*^2=4CK.&+$<D[/!#' <E5%:EM#I;DZ6OXP.PL37.DO6CV/D_=C
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MG]'KT@>"'8R/M*K#;KEF/I/HS?)I'Z4V./V:KURV+U/8==HR6@PT(NR>%P(
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M&A')$ . UR8C%X[^YNNSZ2+MEQ+)9!QX<\M]RM#4\)7SO1VCC9Y_1$K/R/\
MB11:KL>RZO<Q>O;IC66: G:*]OW\L\ KU$""%3G4&]CAM&MP5<>+.;:9'4N^
M3LBB^72*!4ZV7K=9L1+E[L$]R2GS)Z0X:SCCPI#])5M=>IQ/"R0,PX>SD<\.
M!"S9F../K5@I6M >^D_N/SQPL>BY"&QU1W7ZS_Z8)2R ^W^$PIG/IH^M>!?^
M0/DIN#BK]'Z5Y[ZK5*-S?] KWHV/KR23"1KUO]:L)A6:G5F;"R&>M:B95[/_
M &!1W=ZD5_;.F%?),]1LC'B9LBF76*HVEI%XT*L;!+:B%@M''Y%,<?#0NZ/7
MAD+'5GXT _=O':H!T8IR6=!NU)G-EJNL2QP<_=BKO YF[K>,V71N2+S[PBHC
MY8\GN<O1U7$T\!J8Q\;^(:M(QAQ^_:WCDJK.C\-.QTJGBMRB.%\\[7O4+F.W
M]/Z8Q>2I1Y;6S*T->?X5..M$]:WIN$LQ_P >2K.9S[\$%;.^3&#?^GLLS.8.
M^9O)\-:\\<%=+K53JV-(L/> 9HK$1@/W[U!=[JSR87I[6RO#YC)$)^5)>ND,
M3-3QQ8P#LRL 8NIOFI,V6+$?3945LU5B=+4=QVE_RH[HVT9QNZC![;CHCE(Z
MSA#=:.7EB] 'V5#Z!=A;U&WRM;Y^KDN<PE_OZ325CW2HW^]O2)JH)F<)#8X^
MS&<+)U#DB/5+IXQCO:697PJ[ZHYG'8K59GW<>VXV:Q'$R%WAI>52?4_&WH\-
M@KF3S#'6?K(6PT(?$44:G/5E]>6UI_+V.:;X6;KK%!_9O&2E@[VY: -*G^Z:
MY!LFL6Z+V-<\L#X"?X9![%4;J&<R>TG$:?DHGMEQDYDNN^SV5_R-8O4@1$1$
M1$1$1$1$1$1$1$1$1?S[Z.SQ0[_A^_N_.\L'"_H($1$1$1$1$1$1$1$1><=T
MHSY'J[@Z\-U]604R8YV>2"K$H:)=DSU;+9O-29"2K_\ 16>GZ;&$^[N.2N5L
MW2IV4VP9^AG9\?,\!DWHMX+DP?2IF$VN3,5<S;$3V_G@^\K_ )D*W<7TWFH[
MS:V<YR262?O#H3$ .UYYXYY6CMG2M^0V(Y[#9J7&WG^)71-_6L6.Z1_2[16S
M\^R7;5F/];GC@R%7*JWW3IW!L.1HY2KD9:-^H?\ "G8.5K8O2LY=R-');/EF
MVY:9<8((F=D8/V>[Y*;=TZN9[9:&9CS\E5U'_P"CQB(/#2K0@;*R)@D?WOX'
M<[CCDKB;3@WYW7LCC1-Z/U$7:)/?M562]/-PO58\)D=F$^)86N[S%_CO+/9I
M7<W[IA3V;'4OI935MTO%>8+GZ;T^S].Y!;V//3WW5B'5H2\NC8Y-JZ>9VYO$
M>P8C-?2%\(AF\>0P*WZL#H:\<3I72=C0WO=[GC[E59U#Z>6L]D\7EL3?^EOT
MW\!ZCUCI5L4NQXW-':IWVF>)Y2W@_P!&*+[)1S\_6M[,);CCMPXUCP^;V> K
M)H:1E\GGZ>;V:U#-+3;_ ,UK0C\C'%<S+=.-A.Z6LQB,Z:4-T'ZH >5EU?IM
MEM=S>8LU\Y(^M:Y=Z;QRY[_L7E;/3S2]DUB]D#;R4,]:V3(]C1P1*OG?]"SF
M5SV&S>$O,K7:IX<7^W85:6*JVJM""&U=?:E8P!\SQP7GYXY*C^\87+9K7;6.
MH6&0/L$,?(_^11[1-4S&&P<N$RSZUBHUI9"6^Y8?LY1NGK&]ZE-;H:X*<^+L
M3ET+9WECJY*E.N:3<P>"S;A999RN1)DGG?X:9"N!TGT_;]2BLTLE)4?4D/>/
M3>26O5SKS5UKCMR[=I$=1[6SE\W87>P/+5)K^N[YM=^K0S[*E;%U9A)/Z+R\
MV7CV^P6UNFB[)-L&)S6MV:T$]2+TA%*.&!BY Z;[>W=L7L+LQ#+*6<7)'-]O
MVC8K2VR;#28#*UK\T9B,#A(PN'*C?236VX+3:##&6366-FF!^2N1/I>U'J>-
MEBGK"KZ7HN9W$.+$V33]LM=0<7GL?)4%>K^1S7O(<6)O^F;3F]JPF2QDM6.+
M'>8R]Y#R7+%U$Z9W-AM4\UB[+:N8@ \\\-<MO4=2W+ZX9#:LJRS+7Y^EA82Y
M@<?XRL&L:EN5'>LGF[\](UK@/>R/RY*NH[>SJI-LDKZ9H/C,' <?4]%:F7T?
M=H>H-W,X2_7@J7&ALY>27CY(:KMKQOCA9&^5TA:T O=[G]RJJZEZ5GLU=P>3
MPD\4=['R.+/5<6CAZY;-<W+:\BR#:A!7J4)V3"*#\\=IRMR_<Q]:"9MF>-C!
M&2X.<!^553TCUK$5(\OF:4 $=VX_Z1Q'D5U<ZK?J;I%O:,1#]!.(KM:<20.<
M>&E138M'WG/:I%C;F7@ELFR)Y7GD =OLT+OY?5=FR>B08%UNNR=\3([,H]BU
MJ^F=/77^GL6M9>=CWP -@FC'MV#AI4$P/3#?:_&)N[,YN&81PR)Y+W-'\"]%
M4ZL-.M%#&WM9&P-8WX 6ME\/1RN-GI78FR0S-X<QRI"IHF_ZG8,6KYB&Q0[S
MQ5N$@,"F&#UC9K62J939<G'++6!,-2!O$+''^(G[D+6VO0[D^>AV3 6F5LK&
MWL?Z@YCE;\.3"ZAG;VP5<]L\U9]BI&6U*T/F.(N]W<KC9+0=IFWY^SP7ZH<U
MW9'$6^/26/KXUYTNJUOAQR<"^!KG4O)XFMAKN0I,Q[X&,GG829WCX4NV+IQC
M,GJ=;#5P(#4:WZ2;CRQS%%&ZUU*S.,&$SERFRCR&S3QDOEF8U=O?- MYK7L;
M@L9)#6JUGL<._P!QZ8X:%WX]7O7]'FP>4L,,CJWHF2(>"JDQ/2S>O[-7,#>V
M)L5+R(88N7A_[.*E>'Z9Y-O3BUKF1R(DDE8"SCRR!X6[J.I;AB-6N4+>5CEG
M$ AJ,]XH6A.G6@7]9QF4QM^U#9K6B#V!JT*6B[7K,EZMK&3KLQ]B3N9#.SDQ
M$J7X#39<+K^2K1W?4O7BY]BV]O)?*[[J/].=$S&J8W)T9LA%(R<]T?#/9RV^
MG6CY359<Q)9R@G%R</+&LX"LZ:(21/8[V<T@C]BJ(Q_2?,T+N2JU=DFK8BU*
M7N@A!:\_#5W-0Z8OP&/R=";,3STYQ(R*O[,8UZ=/>G63U69XESD\M1CG^C4'
MB,=Q_45;<L?=$YG/N"%3=?1]SQ<=BIC-EB%.S-(^1DD')C#_ .3RI1#TYPT.
MDOUD<FNYOF0CAQ?_ #JI(>E.WVJUG 9'/3/Q4$(^C^"]6;2Z;41H;-9NV'SL
M Y]3V(<H%K_1S-5)(:61V*:;$1/[_HVDAKU-]TZ>V]ARN*MQ9?Z9E!W^# (@
MYJ=1-&S&TUZ$,65;"R"5LKXBSP]P^ZLVE'-'6A;/('R-8 YX':''Y 49W;63
MLVN7,9ZQA,O!;)QSPX*-X31\Q5U"UB;>=DEGFB;$)"WO9$P#V8TE,'T^MX?3
M[NO1YDR1R\B.9T/F,.6SJVCW==U>WA(<P90[GT9G0CF+N]_'*:-H4^I8>_CX
MLJ;#)G]["Z(-["L.E:!8UB;*]^7-N&^>Z:(Q!@[U I>B^3H9FW9P&Q34*T\G
MF-G@AA5UZSK='7\:VI6+G#DNDE?^N1Y]W.7WM&N5M@P5W&V3PR=G'/'):?E4
MU2Z-Y&7!2XG*[-:EJQ BK SPQI^SG+MU^EUYFO86D-CLQ7*$@?%9#>[L_P!Q
MHY76I:)D+.?H9C/9<79J'>*C&1"(#G^-WDJSE5?4#I[/L=_%9/'7S2O4W$"4
M>Y!6GG>F%_+NP_.RSL^@\@F+O,DOW>XER[&\:)D-KJTJDN;->*![97!L(=WR
M-]G>Z;9TYI;3A:=6_:)NUF 1WFLX=RN+J?3/(8Z_5N9G8+.1^D)^E@?^B/X<
MKB5>=0] &T1T9(;IK7*DG?#,&K!F^FN/SFM#&7K4LUEI+VWY/SRB0^Y49UCI
M+=I6Z$V8V">_#3>3!4>.8V_!7<V'IQ?RNX5]B9L,D$M<CT8VP@AH7<W_ $ZY
MM.&909DS49ZK7OX9SW\+%D],M9#21KDF8>'%C8WVA%Y<QOV+>5BJ:1=K:0=<
M;FWDAGI,LF+R(_CCE<FKTQG@TB36SGI2P3B2&?TO,:U3T[S>2R5 Y_/F]4HO
M[X!Z?9)([YD/*N)5AOG3*'9\I0R$&5FH6JH(;+&WDJ/.Z,P'-XW)G.WG3Q F
MS,2?5F<I(SIY-%OTNT_C<I)!9]-V>/3^S.>4R_3R6_N]'9!FI&&J0(X!$M/<
M.EL&=V"/.4<M/C+K1P986\DKCX_HR(=BI9N[LEVW:A\E[QPY[E>"\X]8J#LG
MNVC467#6=*Z8"<>[%-8NGN6MYFI-G\])DJM0A\,3F=@=)\O')6;=NFLFS[!1
MRHSLU=U3CTHQ'WM"L2_B:N2Q<]*ZT2Q3,[) 1P'*JZ_3#)TZIQ53:;3,2XD&
ML6<O#/Y0_N5HX?#4</C:]"E$(X(6!K&J*S:#CY-[9M!EYE;!Z?I=GCO^S^5*
M\[B/Q3#7*)G=$;$99WM'):"H)A.F=7&:ADM<.2FEK63X);P6+FNZ87YXJU*[
MM5RSC8GM/TCV?J#/8%W<NMNO3JKM,5"(WY:L=0\QQQL\+MYS3:68U^OC+EB6
M26$-,=D_[5KV>SE%:/3O(V7U3L.PV<C#7E$D5=PX;WM]G//)[EU-TZ<T=LNT
MI[>1LQBM^AC!XY6SMVB5]HH4:5O)V61P$/(8/UO'L2M7)]/F7SA93FKL5G'1
M.CCL,'#W!W'OY73P>DU<?EY\O9O6+M^2/T_7F]VQ_P K5,56^V].*>7RC,S0
MM24LI$/R68_O_K6]KNE,H7GY7(W'W\H^,,=9D_@'PSX"Y>?Z85,QL;,V[,W8
MK,1'H=GM%Q\>59=.&2&O$R68RN:T O(X+B/NN#MNIX[9\++CK_<&.>'L<WW:
MX*N'=$=:GQIK6[%F>;O!;9=^MK1[,"ZF1Z0:O?BQ4<DMP,H "%OJ*0[AH6+V
MBK2K7[5D-KN#P&.6CE]SUC38J.-NW9C((>(P?SO<&_)7QH6-+SEL_-5$4V7L
M^NQA'#FQ>2WE6(B(B(B(B(B(B(B(B(B(B(B_GETF+QU!P':_C_G"_H:B(B(B
M(B(B(B(B(B*!S].<!)LPV%T]TWVR=S7^J> IX"/E$1$Y1$1$1$1$0^RJ^+IO
MV;P-H=F[+Y>"#$6>"WX]_96@B(B(B(B*L-RZ=6=BV#&96+/2U'4?]BQL0=P5
M9L8+6@.=W.X\GCCE?2*E;71S'7-YGSUNT^6"1YE-9WWE5U  #@(B(B(B(BJ?
M=.DN*VK/ULI9OSL[ &RQ <A[0K/H4*N/IP5*T38X86!D;!X :%LHB(B(B(B*
M%;YH\.V4J].:_+!%'*)"&-YY<%(\)CGXW&5*;[#IC!$UGJ.'!=PNDB(B(B(B
M(B(B(B<A$1$1$1$1$1$1$1.41$1$1$1.41$3E% MAZ:ZYG\O'D[\MQ\\)'I!
MLI#6*>@<(B(B(B(B(B(B(B(B+@9G4\!E[U2W=H1335G<Q/< >%WT1$1$1$1$
M1$1$1$1$1$1$1?S]Z-OF;O\ B/3[/)(=ROZ!!$1$1$1$1$1$1$1$5.;KN69&
MUX[5<'/%7MS-[Y[$HY[&_#5H; [J3JE2*W%G(LG5]9C9S-#Q(P.5Y-=XY3D)
MR$Y"KO9:^^.V;"OQ%N./' GZMA5B<\>Z<A.4Y7Y/*((9'D^&M+C_ -RI;6-F
MV[=),I=QN0KT,?#,8H 8A,^3]W+JZML>VOV>YA,ZRLQ[*OJ1.A]I1\KAZYM>
MS2]5\U@;EUKZD4,KHV-;QQVN "O$$)R$3D)R$Y3D(OPD $E0"GM%[-[)-4Q+
M8C0I/XMVC]W_ ,C K Y")R$107J-GLQ@=5NY+&01R2PD=W?[,9\KL:?EKF6U
M;#7[;P9K%..20@< EP4BY"CVV['#KN#MY*2,O$0 :P?Q./L%45_9.K5*MCLO
M%2JVZED NHQ#\\?>/ [E9&@97:[V&E?L./\ I+8F( ]N6*;<HG**+;KE\CA]
M:R60H0LEG@C[@URTNG>?R6P:IC<A?>UT\S>7EHX"ZNVY#(X[7\C;H,C=8AB+
MV"0\-4<Z5;5D]EU&+(WS'Z[IWL<6#CPU6(G*B6^9K(X/5LCDZ$44DM=O/#SP
M.%K].M@R6?U/'9"_(UT\S>7EHX"FO(1$47VC)Y;%U67:5468XG<SQ#P\L^6K
MJ8'.8[-XVOD*,OJ0RM!;\_T*ZB<HG(1$Y")R$Y"<HB<A$Y"<HG(1.0G(3D)R
M$3D)R$Y"XK]AQS,]7PQ<XV98'S #V#&$ \_^*[2)R%&-TV$:]KM_(CR^-H$3
M?E[E6D</5".# 96OE&W?J.QUVF061L[_ #^17ESP/*X]'-TLF_(PU)>Y]27T
MI#]@_P JM>G.Q;1D=EVVKDK,4T5"T(6$#C@^5<7*<A$*J+9-]R5G.?V;U6.&
M?(\$SSR'_"K@+)F/[S\7C3=BRE.\Z*(OFKF#T^?]!\J2]/=@R.>U6A?O%OK2
M@EX:. IIW!.4Y"=P3D)R$3N"<A.0N)'L&/DSDV(:YYL10B5_'': 5'\S6W.3
M:\+)C[<;,4WGZR,DAQ4[3D)R$Y"(HINU3/W-?MP8.SZ-TEOIO[BQ=K#MR$>*
MHLR,PDM-A:)G#V+^/)"Z)>T<<E$]:/N[>X<_"IOK3E<WB->JW,;DY:W-MD,@
MC\%P>K.P%B67#8^261SWNKL))/))(76Y"*L.K65RV+T^W<QE]U>6.1@):/)!
M2J_9\STOQS\=?[,I8H1$3R$CR1Y/*F&K5LM3U_'5\I<^HMQP-$TO//<Y=YTC
M&^Y 7ZOP31AW9W#N^.5^\HAEC#@WD<_8(7- Y)0S1CC\P'/LCGM:0"1Y]D#V
MNYX(\>Z_&2,?SVN!X7ZGU$(=V=PY^.0BQBU7<\L$C"1_#R.5D=(QHY<0 @GB
M+^P.'=QSQSYX6.2U QX89&-)]@2 2LG(7Y]9 7=K9&]WQR$?-&SCN<!S\E?)
ML0B3TO4;W?R\CDK\?9@;(UCI6AQ]FDCDK(7 #DE88KM61_:R:-Y'V#@5D?8A
MC<V,R-#G>P)')_HL3+E9\IC;/&7CW:' E1?/;IB\/E<3C7RL-FY8#!&3QVL^
M[RI='(R1H<QP<#[$'D+]1$1$1$1$1$1$1$1$1$1$7@7HH0-_QO/P]>^F^P1$
M1$1$1$1$1$1$1%1W57IO>S%N#/X2P692J/8>#(HKJO6&Q#.,'N=-[)B\,]8C
M_P!X4ZZG[G9Q#\+BZ<LL3\C*>Z>$=SVQ-]^Q0.MGMFQFZ4!BK.6R&*F 9,RY
MR>Q;^PYK<!U@&'Q^6>V&6N#Z;R3&P.^X:E"]LNJ=3,7A[NRV\E6OQGCU?LY2
M7=<KFZ'4C2JL.2F94MR/]2NWP#V+;W79<C/MF+U'%7#6EG!DMV6_KCC^&*-[
M+;V7I_F,=D&Y:W?PMB5L,\=EY>YCBL7578MDQVT:O^#95XAN<\0<EK"1\J?Z
M1B-ZQM_+'.Y9EJ"5X=#P22TJQK$+989(W>SVEI_H5Y#RN*W/I5F)[>&]6QA9
M9.7 ^6_T>KSTC=M8W#MNUHV,R4</9*QP'J,!]P#\*H[!S<G6W-1X,116'U7L
M=++Y#!SY>I/J.?VG#]1;6KYS*&['+ 9H92NEE;FRYW-[#"<I-A<?C1VQ/:>U
MTSOL]9^F6S9_8-2RCK%Z.2W!*8XK''(*KO7<QU:V*EE8ZEV/OIW@99B\@O))
M_(Q3/.;Q=EV1N FS8QGTL ?;M,87N?+]V-6IH74'*S;5<PEVW-D*I#C5NF$L
M+N%EIY_8MERNPBEL_P!!/2LOCJT#'^L G@O\JUM-L[!/@*;\ZPMO<?XP6/?,
MK+B=1S5^(_GAKGM49Z/8XTM%QCRT]]H>N\GR7%ZX%O);CF,YLPARYQ-'&O=%
M 2./5>/N5T>GFYY?*Z?E+E_LGM4'EA>P\^MPHG@MAWS/X=V>QNQ02VC+^?$E
MGAC%Z(JRR201O>PM<6@EI^Q*AF_;<-7PCK4;&RV9)&Q5XB>.Y[E4N^4.HL&D
M9&]>RL4[)X0+M,1\,A:?NPJ30;4-5Z0X#(- ?,:=>*%I]N][%"<IU#VC#C&7
MF;%6R@E>UMNI% 6L9^[%*NL7XG?TL7JM_P!.F]T3G5S'Y//L>Y2[ 0[-1THR
M'(PV;0HL=6#H^QK"&^Q()Y49Z>;GM6QZ;G;\TT+[T4A]'D<,47UC<>JNTZ^^
MQCA48^%\AEMR_P ?PQ@4]Z=;[?RVGY+(YD-;/2D+9R!P"JZGZG9^W@[&<J[!
M5K2,D+H,8(2_F/X<]61B.IT;^GS-BO5S&_N](Q#W?*HIL9ZE'4K>8GM5N)8'
M&;'=GB*)WP_[O4RZ.?Y"PW^A2O<_\LY?_A7KS3T]R'4V?48H-:I5*]6N7%T\
MGO.5:^F]3)[>JYRYG(O1NXGQ;C:%7MOJ5L4V$&:AV2I#:_6S$"(GF,_+ONY3
M_*[%_:?H_E,E+"8W24R)&#[/6CI6PPZYTBHY.5O=V1<,9\O*P9*YU3K8"+9(
M<C#*\QB27&>G^1D2[)W3-YWIJ=BP;VP7H/,L/'J EONU8<5M>P9SI@_,Q95D
M>0B!D?(UGCEGNPA=3IMNUO8--M93(WHWV(WO]4-:&",+H].[&8RFMNO96P^8
M7'N? 'CV@=[*#],['X+N>VZL &0,LNGJQ_# 5?;G!K22? 5,0Y?:]QSN9@P^
M6&-Q=&7TA.V/ODED"V=3V[-5=IMZCL,K9+C&=]6TT>)F?NH99VSJ'/O.?URA
M+%(\!WH//+&0-:KETC^TW]GZPV$,^O!(>6GGD+%ON;RF&UVQ:QM5TUDO;'&
M.0PO_B*J7*9O;M:RNKQV=E^LEMR!MNJ_V:2NWU3V+<\)E\.,1/":EF4,](^'
MEZCNP[!U%U3,8*UE<K#)6N3%EBO&#Z<?[!2?JY?W##05LOA\I)%18\,LQM]P
M#[/7=V;89F:!!>Q61F-BPV%E28>7O?(K!PT60BQ=.&_8,UAD+1-)_,\#R5$.
MHF<SN)PT1P]4R6I[+(0[CD1AW/+E7&0VK8M3V_7\;9SXR=6\>+ <S\["%+]_
MVW)T,Q@M?Q;FQ6\G*1Z[O/I-:H9M.9WS5=GPV)K[ ;4&3<0Q\T7>]G:MGJ#M
M6[:]L.LTJT[)OJV$.A8SCU)6+:=LN]:C@\_<V>:"5_K1LHEOAAD?RHIFMWS^
M&J4,E4VH9.P9&BU0;"X1^?)+%--KZD214=5BJR?0RYA@D?.]O=Z$:C#=[RV)
MW+&5*V:FS6.M?DD+V$&(K<V+:-XCZHG XR]"8GP]T3'CM8T.7'FV3J)K6\1X
M:>^W)'(Q\PA_+6-D*Z+\MN^J;U@*V9SHMULH2)![,86J5=0]PLU,_CM>K69Z
MXGC=+9L0-[Y6-'L&J+:UL>RT]XIXZ&UD;V'M?QVFDR1%,SF=]_O4NX*ADB]D
MM8N9SX9 QY_7Q]RU;6MY+:<!U*.LY+-6,C4LUO49+*HU'KMRSULRU49F] 36
M?,V9CR'EG<.&+U/$TLC:"XNX'N?)*JO>]IR,69PVM8F7TK>1<>^S[F!@49V,
M;;H#:.5BS]O)8]LX9=CG)+O/W"^^L,#,UHT&5K7YV0=\3Q$#^20/5BZ)ACC\
M'6+\A;LF6")W^/(7AGCV8I/F*;[&+MQ">2%TD3FM>SPYOA>?.B6$NQQ969V6
ML!L%\LD@_@D(Y\E<[5XMCM[SO]+%6Q4CEON,UKW,?!/L%,>F^6V2GG=DU[,9
M!U[Z,]\<[W$NX44DVV_L5G,2R9K*4HZ]E\=2.E'^4@?=Y#ARK!Z1;1G,[A[K
M,LR8RU9PQDSQQZH*L_(/+:5IS?<0O(_\%YR_^'NO!8&QY*64/M/G8"O2[FAS
M2".00J]W;-5],U66>A7C8]\HA@C:.!ZDBB%[7-WQ>NNR\&SWILI''ZLM=Y)@
M=\L 7-V3>,KFNE#-@QMV2E.)6LF;&OC5*O4W,1X3-3YLUZOTOF'DDN''AY'W
M)7%U2SU(VD9J@S-2000V7AU_DF0N'LQ@7<Z?[7L6(SF<UO9[3YY:==UAD[B7
M?D8NIKD.;WNG<SS\[?H02R/CI5J[RP,:WV>Y;.@[-GI[N=U;+V2<C1Y$-G[R
M,'CN*K+#-ZKYJ[M6(J; >ZG;#7SOD<"' D!K/@%6+?;N9O:WB[^1EK4HZ(?D
M[L3RTOE: " ]<G0-JOR;WF];&9FR- 12206)'$O;P5S]4UD#J7M59V5R/^&>
MX2-F<Q[N3[/*DFWY//X_J9J%:+*S"C=E=S7!('Y%O[AG<ODMRI:ABKDM3F$S
MW+,7A[&?#5'LY8V?I]E\3=?F+F1Q%B80V18>7O8X^W"=2,CME#>M9BQ&8E O
MEX96/B(%JYN5DWC3MKUV>UL5G(0WYG-L0NY;"P_#5Z5"*L.KUW*X[3;EO'7Y
M:TL4C.71J+[!D]C_ +FL;EJF3LLM-IPR2R@_G<"WR25%;F,WB[T[J[-+M-EL
MT%6.>&O&3PX?+SSY<IO+U#N0=*:>?DD!OS1LB;S[&4A<BSJ&X'%8G/XG-VY\
MP\QOLB24^D]C_) "VNN/K_V$H>N&B7\0K]_'MSPY:74JYE,9H.NW\?DK-64/
M@B/HO+ ]KPNWU"R&3@Z9P9*OD+,-J-D)$L<A:3W K6O;EE*'3?6'03O?E<C%
M!&R5_GR]OEZBG5'2\IBM3NW3L]^UR^,6(IB2QZE5QU^#H91MT;\M6:#&P/[X
M_<@-3)6,K_<C1R-7*6*UF&A!,96$A[N&J$OPV_9K08M@L;)9CEBK,EK5F./#
MV ?K>?YU8^+W#+CI(<]*_P!6Y%2Y[C[N<H/9Q%]W3-FV?CM]N7^E;9,XF/L?
MX%:O2VQE;FIT;V1OV+$MF-KSZO\ "ISE);<5"R^K%ZDS8B8V>W+EY9RWXCCM
M5GS><V.[7V4DOKUV3GAC/Y"T*8;?F<];Z/XW-#)2U[3H(72F(\=_>U1>WA=I
MFZ9P;+;V6WZ]>M'-7B8XA@8K*L4<KM'3?$WXKT\65%&.Q%/&\M)D+5P^DNQ#
M^Q&<L9*W,^[7FD?:,IY<IGTKI3Q:O!>GEE=+D>+)#WE_8'>0 I=L\F5BP&1E
MQD?J7&PGT&<\$N7E_83#A]:KWK>R7/[4>I'),QL[CV=WN"K=W'<,C0Z:U<Q2
ME,DUED+1/[AOJ DO5?;)K5?%:%1V"AE;3,D?0>^V)3W3%X6SU*CRV-Z;X6Q#
MFK[IG3Q"4OE),AE!/E;>%P&?P=1FY97.R3/CQKW20=Q[!SP6-4'A;G]DP@R3
M\#F;.1FYE@OQR?D9\!@_E5A9#;MRP?2R&UDX)(LN^T*K2[WX/L]0._AMQCJ8
M^SB<!FH<G&]IEL/EY]7Y+E(.JSMEEQ^HV?7GK7YRQLU9CSV"0K4ZCZUEM5I8
MO98LY:FR@M".>21QX)D6+=-4R=76*VXV,_;FR@ECD)\M:QLGDL8I7O&[77ZK
MJT-.:3U\PV,O(/;*6<>0%%K&D;33R^/NZU@YL8^)_%AYG)]0+I]4\7D7]0=0
M%')30V+CGAI)Y;$6_=H7,SVFS:-MFK9&ADYYIK%ES+DTA\RO*[/4G6\/-U0T
M_P!6J'C(32_4AWD/#%Z'QN.I8VI%4J0B*"(<,8/  6VB(B(B(B(B(B(B(B(B
M(B(OY_\ 1J&&7?\ $^H >PES5[_'LOU$1$1$1$1$1$1$1%2F;W^?6>HUFAD6
M3?A=BO"62^2V%ZCO56?3]CJT8:#H[68EGC%9T0\]O[E9^IF(RV&JZEL->/UG
MX7ALT879Q75N'9GU*6!H6OK7RL]8RL BB9]R2HWDY&CK_7/V^F8Q:^]6Z\/6
M/5'R2<-AX]4_'*['5+)5:O4O197N)%>20R\#V#^%\;_"-;ZD8;;)6.=1D;Z%
MAP\^FMWJ'G,-MF/Q6"P]B&Y8N78G@M\AD;0>7J+]8):-';-*A8[\E/GO 'Z&
MDM7IZ&2.1@D8X.:[RT_8@K6OO>VG9<PD.$3B"/D!4_H/47$9;6HJ^=NQ,NQM
M,=AD_N\#[J&:EBL4>KDUW5F\8N*N?7?'XB#B?+&K?PF0HS]>\L89?'T3XN?F
M0."9C(4SURQ[(PWU(JG8]WR]<.#9\-D]FV,[I*[FE*YE''O!<S_N;]W+K=$\
M_2>W:J'B'_',\49'#NSRN[T5R5"Q#L<$5AKI#D3(&?+"2HUG,_/H_5:]?R,'
M.-R3/UM5G8CJ%3V'+PP8*NZ>K'&Y]NTX=C6<>S&JL]EQ&H;;5R>>H7FXW,4W
MO,IY[27M^[E:O2G*YK*:3C[.5+S.? >[WD8/9Q67JIC_ ,0T3.1!CG/$0D8!
M\M6OTMOFSH&$>&#F*J(_Z]@5-U-DP.9V/9I=RO<"K.64\=(28R//\"Z?2':<
M%3P^S0L\/;.Z=E;C@F)1_9<5K<6-BW34<F*ELR,>^JQWWD\EJ]1:]<NW<)CK
M5R,1V):['RL'LUQ"J/K?!D(<9B<M6C#F4;K7R+%OG4/5\ITXR)@R$;I[D 8R
M$>7!RA^?@L9'HQK%V@Y\@QX@=-&/;\C5/L=U9TB[KM>:>6/ZDL:#1[>7EZ^^
MJML-Z;<V8V5Y9'0<P_!4XPUNO8TVM-%*U\9QP(</]"IWH?/#'H^Q%\C1Q*5W
M>A5B!W3R:,2 OCM3%X49U"I^-:7U!QE64&>2T_AJR=,^HFKUM9&$S_HTIJ8$
M;F2,\2A;?46P[,=-_KL=0,=6#*LEA8&\<P,YX>N[DNI>MW^GL]R2]&V::IV&
M#^,2GW:NKT4N5[.AXT1/Y,/,;PIOM\;WZYEF,:2XU7\ *KNB.9HLT&-EBW$Q
M]>:3EI/!#5$\=KEO,8SJ?DZT+BW(RO%%_L)&<DE;^A]2-(=K=.MFC%!>I5A
M\2LY+PQ3//9B+)]*,Y=CK&I6? X5FCP3%]B0JT?B9LGT)QQK\N?5E9.6-')(
M8%;6 W+"7]%;?-MG$=+MF8X\.:\-X(7"Z)8E\&CS/GA?%];.]X8[^15CBJV6
MQFU9K0(*[OH;EX2/E:?,=<<KXS&-R.J;AD]8P\'_ #+/%OI<>/3:O6%&E7Q]
M""G .(H8VQL'PUJHO3XH;_5_;\C&'\5^^#]N2Y7]/&3"YH]RTJ@.FF6CP.P[
M/KV5<V"=]SUH.?9[5T/39E^L=:W3'?#0I$6)QY;WDCAJC^OY.(==,_&+0].6
M"4<<^"\/7I$*I^K^SY7 :[&^B'Q^O8;%)8;_ /:F%43NF2TFH<!:P<XMV8[+
M'V;;^7O/[/>K(ZG9S&7KNDOKV&O;/;]:,CV+%CZ]N;Z.O?\ '*\LKC:N7PUF
MC.T/BGA+2%YHZ>T=D?LE?6[<)?C\%<D>\N_G]F+U>%3O5_8[^(Q^.AKW'U(K
M5D,GL,_4R-4;N-G0ZFS:M+@;,3X8Y7OMV1Y))(X+RK.ZL9C"2OU&_#;,%J28
MR4[WLV.+[DIC+VO9W:<-E<KN-&S;IAXK586<,Y=_%ROOJ7D*5;J3H$DUAC&Q
M/E,A^ >%*^LF*LY+29Y:H+WU+,5D-'GD,7"U_K/K5S#P&T',R78&FL&>72*.
M]17YK#9/4-PGI\&%@CNPCR&.<IQ!U4PF9EKT=>BDM79GCP6 -B9]W/4+O31/
MZ_P\/![:C6%?&[SQ-ZS:CR\#LX[UM]8+56+?=(<\"1D,DAD8L/4RU<U+?\7M
MM>J^6I+#Z$Y:5-J'5+&Y^YCJ>!@LSR32CUWO8 V"/[ERBL.2K'KY:(Y+78[T
M 0/'>F8OUSUOP\7>>8ZIC/CP'N6#,YJGKO6V2[DN^."7%")CP.?*]$5;45BI
M'+%SVR,#@3X/!5!]4*MS$;CJ^T1Q/=5K/++3A[-6YU*V;!Y_78L1B[;+=F_8
MC$+(O/CY*=4_H<)TXKXDO:) 8611L'N&*TM-O5;NMXN>"7N8:T:D%OS"\#^4
MKSQTOV?%8NYG\1:>]MV7*.+(NU;'3#)UW[SOL+)>18O&:(@>'-:2L&#R$<G6
M':J0 ++4$@#_ -VE1[4=WAZ<WLKK6;JV&5FVR^M(P=RO?4MDL; Z_;@@='C@
M]K*KW#ATOOW.4PFB;)$]A]G-(/\ WKRWC9Y>EN]9&M9B?^"7W=S9PWPQ75-U
M*T]M9LD&5CL/D83#%%RY\A^ H1U)IY_,=.66K-/TK<-R*TZLS\Q8QJ[474K7
MK6H&XZ\PSNK=I@]I#*1QV\*M,AAY]=Z'LJ7.6V9[#9O2(\@O\\*\-,R=?)Z7
MC+,3N3](UK_V<&^0J<Z4[EA\9>VC'9"W' 3?,D/=_$NIA<?_ &SW79M@@#XZ
M#Z!H0O(X]7_?:G3+8Z.JXZ]K.=G-:S2L/,;Y/:1BZ>EUZ^4W39MN9&6TW#TJ
M\CAP7M]RX+F]*\S0DW+>H_4(=<R'JP CCO8"Y:&^9VK#U-J4M@]5^#CJA[(>
MWF-\I^[@N'@,_AX.K\EVMC+%6K8H^C#&(0TO>2/*[HV2KK/5G8CD()P+<8,'
M8WN+SRLG4',5_P"\K0GO9+'Z!>^4.;Y:)%EW66?5NJ6*V6;GZ&W!]-.\>T8"
MS]0LWC-TAPV#P%IMV9]Z.=[XO+61Q_<KXZBW:L74[0FE_BN]YE=QX >LW63(
MUJV4U1CR[EMWU'<#GAH4PVGJ;B-<RN*J312R,N>?68/#0K,!Y"K'K#>;6T/+
M1]O<^P!$T*#Y?,5*W0:I!R3)+1BK!O!Y#PU=>#*TJO1*M,]W<!BV0=OS)Q[*
M&5\)-G^A]2"GRZS4D;+V?NP+/KG6*Y-@Z.)K8:>3+B,0@<<1^/'<NMUD-QF@
MX>I<D,U\VH'R=K?<L![BMG?*3\WTEQ\U1KWF 5Y^T-\D,:H5MO47$9?IQ#B:
ME2W):,,0D'I\-B+ NAFJ66L],=.R>/K/=)C&PNEC+?/#6^2L6^]4\!L^CSTJ
MD5OZR5[.Z/T_#"%*LC<9%T&;%)%*R0X^. -<WR7K#8RE:3H$(P) \465NPM\
M^HT+LXJ_7;T8KR'OXCQ38G#CSW@*/ZAEH/[E[W96,TE2L]DL#QPJPP6Q:I#K
M-'%Y;)["ZN6M?-59%Q"3\-/?[+UKIN?P.7PE>7#2<UHVB-C?8Q\?8A?NX6,C
M7UO*S8YI-IE=QB'[KR5C,_@WZ#EZ;,1;FS]N)XL6?2Y)'/DN>I;>S,5[H;7I
MBO99+"((1WM_60T_H4RN6X#T%9&''O..CA#>//>![*8]*;[;FBX=A9VN@@;
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MS.;N91U5_,#)O#&_N1R>2LVY]-<5L^3I7Y;4\$]?P'Q>[FKFUNCVJ4\W4RL
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M@N,HP"Q#%Z<<H8 YC/Y05EGP.*GG=/-2@?*3R7N8"5\YG!8;,1LAOT(+,;'
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M#2X<GV"(V:,DM#@2$,C&D D>4$C.XMY\_"CV8V;&XJ[C*4TH^HNV!%%&/?\
M=RD*+\?/$S@.>!_4@+]#@1RGU$/!/>. >/<(A*PMMUG.+6RL)'V#@LSY&,:2
MYP ^2L<5J&5I='(QX'W:00H5CMYJ7-NR>%A$9;3C!=-W^[_N%G9O&)?M@U^*
M0/G%5\TCP1VLX( "YFVZO?S.9P=R#-/K0UI2980[Q(K"=-'&0USV@N/CD\<K
MY%F S>D)6=_\O(Y65[VL:22  L4%VM*3Z<T;R/Y7 K*BP.NU6R>F9XP_^4N'
M*SE[0TDGPL$5NK*.(YV/_HX%5]E]4O6=XQ.9AS3X8HF\25>[P]6*^1D;>7.
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MDS/*NL*L.J6H7L_B*]K' _B%&<2P?O\ +5#LSMF8VS7[&M18"[#EIVLCMA[
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MZU5A9!$R-O)):T<#DK-Z;>>> OQT;22> HA;UN?([+!?NRL-:D[NIQ-'GO\
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M)+AXAD:P&,K4SO4S7,%GX\-?-B.9XY]3L'IK1PW5; 9;86X=D-J*25H-=\K
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M5E[WKF9@&QUT?#=OV*;74>R!\$I87*>5]$P.(VNKGI\Q:EO2O+(Q.[O+R[R
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ME5E'T=A>DUY]VFX9^LFMTKK?^:PQ%U?GV?(Y=3KECA+K-2_'PVQ4NQEK^>"
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MUCX&B7O_ +/$H/U,LB/4M-9,9/H7S0&R&*P>ICZ4G37.NB=&8_I1Z:IS:O\
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M[R$Y"+BOV/&#.1883<VWP/F[!]F,(!)_\56N2V79*W5?&X@61^&SP%[8V_\
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M>C)V>J_D#@E372]9R>L3Y43YQ]C'22-=5;*[DL"L2"U7EY].5C^/Y2"ODVH
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MCX*PFL25!_C.>?9O((X"YVA[#M$.YV<9*Z]=Q$O>Z"Q:'YV*[\YE!B\/>OO
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M1Z]C*Y)]1V2AD _9BW.KF7HR]/!)'(7"U)"80!Y<%!=X^KN:MIVV87O>[&M
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MKV!K@Q@'+1[ ICM>PN,EEEI8ZO ^0DO=&P-+N4KX##5LA8R$%"".U-SZL[6
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MPC6AOL$<T.!!'(*^6Q,8QK&@!H'  ]@OKL''"  ((VHG"!C>>40,:$+040-
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MYB-OHO[.9Q6NL'CUFO5YU9X;,,<T+^]CVAS7?8@I>O5Z-6:>:0,BB87/>?L
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MKWGSRH/TN=1S.4W*Y>XFONN&)Y?Y(A//@*6X;4M8U>#/4L<__$MQNF?"[[-
M/  4;Z&\'INYG_[U.N?TOI4Y=9W"J^%CH/K)1Z9'+>!W+E]&-1U^[ID^1M4F
M369))H>7^>&+=Z.ZWAGT,\V6HR4PWW11&0!Q:Q;G2BLVCE^HE&,GTH,B&L']
M.].BOH=^X@2DO_$1WL^P'YEM]+ P;5U'#..T94<?^+UP^G9 ZG;[R?'KS)2E
MC[-OI:C0%SUI7NMW+1[8@[SX:0'=RQ=-2#T9R8^#96QTKGFK]'[LL+R'M-@A
M:?3C7<IFNG_H5MCCB@M]XLQBL'O#C\N[E:_3O48=2Q=G%LRQMM;/W^6\%BGK
M@"TA>5M.UC"9;J;NT=VE'+''-,UC"/ Y>M_:L5!5Z@Z?A:=ME"M7@<:_+ ]H
M?X4QS73UT^S4-ERFSN:^L]@8!"&?]W(<N-M]DX+JYBLU?[W49JIB8??T7K[Q
ME2//]5SGL9$_Z*"J63V2.&RO^ MZW)##OF69KE46<M/$/JYIG\0UPN;TBAG@
MRO4*"P8S*R\ _L'#.?SK5Z4ZEKU]FS3W,?#.XY$QAL@#FAH)6QCI:<W6RW6L
M^!1I&.A#Q^1O!'EJR]0V58.J/3^QPQKGR2"1ZU>M'^>-&_\ LLBR]0)6'JYJ
M[+-Z6O&(7>E(#QP\\*2W.GF(&>HY_);!;DM0O8(W//N0N!MN#V[#[3>V?5S'
M9;(.+M4GSR%LZQ>U_<M(S\0A&-FMRAESX$S^3RH:<OLVJSXS7]RJ"UC/7;Z%
MMAY(+/#5ZH;P0J;ZXVIH=-C#'$,ER$#)OW8I?D</@LIJ9A$$3JOT)$/(!#6<
M<CA0KI!-8FZ7#UW.)8)F1?Z OOH)_D"/_C9E<ZH_K7@'R8FIGZD8^JQDX>7?
M?TE"=TLVNH.%CR6-8.S%U&67/ \OF?Y],+OX+8QO]_4("7/CI5C:O@_I]=G
M:MO9*]>SUDUUL\;7@5'NX/SX6/?JT,7530+#&<22OD#W?(:M*!E:[U>V2I;R
MMRM(Z$"$PS&(D-*E.,TC7,%N4&1ESENSD[+7]C97<O</N2M/IDYHVWJ3_P!J
MC_U>N#@8HW]?LV7M!XK2_P#O"Z$,+(.O.5$0X+\.YY_=Q(7&Z?4\?D,[MU:[
ME;]3)G(.?+'%.8>]O)4_P^JZ?KMS,,Q<\S[LU1[Y@^3O\**]"M?PT^G/NS4X
M9+$EQX<]X!/#%=UC'8F6_4LSUX'6H?\ 82. [V_Z5U%3O7/ZG^PTIB_0+D)F
M_P!'!4\T]U5^J85]8 0FE$6 >.!PJAUVO*[KGL=@<=C*T@/_ 'N4KZUL#M O
M_(GBX4MT)EAFG:_'/W"1M&(/!^>%TMGDQD&!R4F3_P#HC8#ZWQVKS+L3LO=Z
M4&S&(<=B6OB^DI-_.^5G!_,]RE>?X?T)Q7_#5%(=KQM.+HQ9@CA CAH1/8%)
M]%KPWNG6"@D >R3%Q,</ZL5&8G/933H]ATM\CC9,X9C#QSXD7I[7L-6PF(HX
MZ$\QUH6Q@_/:%N7^_P"CM=G/=Z+^./Z*GNA=SU=.LPS2$V8[\IF!]^7+F8"D
MZMULV+Z0DU7TW/L=OAHE>?8ITSQV/EW3J)(^&,O;D#&W_0XN5]PP15XF11,:
MQC  UK1P % .J-["T]1N.RL+I8GR,:R,.[2Z14=U"CSLNJ:]>R&4KLB=<A]#
M'0#EC6'V)?\ <A6-UPLQ#18>&,D#[\ !73V__H@R'_9D:D?38@Z+K7_9\/\
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M$3R2R)_R%U,AI^T09W(Y#"["V&.]+S/!)#WM;^[?*PP=+JM;5\OC6WWON7[
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MBZEB2Q!3ABE?^M[6 .*^[>$QEV42V*4,C@. 7L#B MR.&..-L;&AK6C@ >
MM/\ "L>+9MBM%ZY/^U[1W?\ BMU8KM"G<B].Q"R5@//#QR.0C,;5].%GHL$<
M1!8./#>/A?GX;4DE,SH8RXN#B\CR2WV6;@<<+3CQ-"&PZ=E:)LKCRYX: XE;
MB^9JD$[7-DC:YI'!#ASROIL3&@\ #E:D>&Q\,\MEM6)LTH(>\- <[GY*R0T:
MT$(@BA8R,?P <-"RBO$R,,#&@? 'A?L<$<; UC0UH^P6'Z&KZ\DPA9WO;PYW
M'DCX)604J\==L C8(V@ -X_* %C90J,LRV601MED_6\-X<?ZE9U^&-I/) 1T
M;7-+2.0?<+''7C@B;'"QK&M'#6@< !>?+=GJ)KFUYRX-9;F([3RZ&=CN#'$/
M9BV\17SN_3XRW?PD&+I4K0?[]TTKF> T>!P%?!JP.F;,Z-OJ-! ?QY /V64-
M Y0,:"OQT?NX <J@+T74_/[-=P=^'T,"^P2Z=C/U0M/AH<K]IU8:M>*&)O;'
M&T-:WX 7VG8WGE.$X1 QH3@)PG"=H1.T(B<!$1$1$1$1$1$1$1$1$1$1$7\Z
M^EG^?]=_XL+^BB(B(B(B(B(B(B(B(CG-8TN<> %Q:VSX*S:%:+)5W2D\=@=Y
M7:1$1:-O+8^G)#%8M11OE/#&N/EQ6\B(B(B(B(B(B(B+\FBCD:6O (/N"L!N
MU1)Z?KQA_/';W#E;"^?1B$AD# '$<$_<@+Z1$7X^>*,AKGM!)X')XY7ZB(^1
MK&ESB /W7RVS 8?5$K"WC]0/A?4<L<C ]C@YI]B#R"B$@#DKB97"8#8F1/R%
M"K<8PGTR]H> NC3HTL=4CKUH(X8(F\,C8 UK0%L03P3!SHY&OX/![3ROI$1?
MDDC(VESW!H'W)X"12Q2L#V/:YI]B#R%^HB(B(CG!H)) "UI\E1JP,FELQL#R
M UQ=X//PMD$$<A%^.FC:]K"\!Q\@<^2OU$1$1:5S*X^G)#%8M11ND=PQKCP7
M%;J%C3[H&@+!<NU:5:6Q8F;%$P<O>X\ !:M//X>UB?Q.M=C?6+>[U_X> MG%
M92AD:45VG.R:*4<QO;[$+87Y9L0UH9)97AC&-+G./L %HX;+XS,TFW:%N.>N
MX\"1A6[:G@KP222O:UC1RYQ]@%SL-EL/E8Y)J-N*9D<G8XL\_F'V731$6ID,
ME2Q]9UBW89#$WW>\\!;%#(4[M*"U5E$L4K ^-X]G ^05]HB(B(B(B+BV=EP5
M3+5\78R$<=R?_90?Q.7:1$6.S8AKPR32O#6,:2YQ]@ M+7]@P^<H"]CK;9X2
MXM[F_(711$4<SVW8# OKLR5YD+IG<1M^Y4C!!7(SNQ8G TS;R-IL$(/'<?N5
MT,3E:>2QM6]5<716(VR1DCCEKAR%G1$7S/8BAB?(]P:Q@))^ %']:W' ;$;O
MX7;]?Z9X:]P'@%RD2(OB::.")\DAX:T<D_ 4('4W0R_L_'X._P"[>#RNABMY
MU++6Q5H9F">;^0'@J5(  B(BYN7RU##T9KMV7TX8QRYRT]3VK%[-B?Q/'B3T
MC*Z,>H #RU=Y$) !)7,PVP8O*_6_1V&RNK3F&0#^%P731$1$1$40W/<:>JXT
M7+$$TH<\,:(Q]S\J48RX+U&O8#>ULD;7\?ZEG1$1$1$1$1$1$1$1$1$1$7\Z
M^EG^?]=_XL+^BB(B(B(B(B(B(B(B(J7ZS;?%B,"ZA!<$=RS-&P@$AS8C[E,9
MI>A9ZKBK="2$2XST^9H&]O/CV<IT_?-0BM?2/S5<3%W 8I%<RE&A4-NS8CBA
M'O(X^/*Y,>WZW)9Q]=F4@=+=C[ZS.?,C5(E56>ZF8W'[=C<$V9@Y>?JY'^S/
MAH4'ZK4*T^RZ7EX7@AT_82KOAV? 29-V-9DH'6@3S"'?F74NWZE&N^>S.R*)
MHY+G'@+E87:]=S;WMQN3AL%GZ@P^0N^N=D<WB\:86W+D</JO#&!Q\N)6A_:S
M7CDW8T9.O]6WWA[O*Z]W(4Z,#Y[,[(HFCRYYX"T<9L>%R;^RG?AF/'/##YX6
M-VSX-ELU'9& 3A_9Z9=^;N^%O7\MCZ C^JLQQ![NUO<>.2ODYC&BRZO]7%ZC
M6%Y9W>0T>Y*QT<[B\CZGTEV&7L_5V.]E]5,WBK5J2M!=ADE9^MC'<D+<O9"G
M1@=+/.R*-ON]QX"UL=FL7DVN=5N13!OOZ;N5^?B^.]:>'ZN+OB;S(WN\M'[K
MZQ^:QF0CEDJW(9@SW[#RJ]J]4,'8VVWB&7(6QP1>92?>3V+0K/266.-I<]P
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ME=<9;'NQQO\ U,9K]O/J<_EX^5#]DQ<&>QT65Q5SLNUF.?4LQG_O+#\M*VM
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MQPXM'''<K4J=0]1MYD8F#)L?9<2&\#\I/P"N]G-@QF#I&U>G$<?(:/NYQ/V
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M]S_[ _\ ]%3G0WC^[D_\7.HUT5QM&;.[E;E@:Z:.V&,>?L'\IH3'T-WZA5(
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MPX/>IUI73R]KNI9#$NRSWFP#P1X;$3_*NWT^US+:]@8Z>2R+[<P?SW$DA@^
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M:DKRU2QDG8_AQ#OCA5!U<DR%W9]"?1E-:W,V;TGN]V%W"WNF^??JV>OZCGF
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M+[BZ6)T0;Y49N](+5?.V[F!V2UBX+4A=/# %V])Z9LUC/9;)_B4]@V20P/\
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M>?*MUC^6MY/V7ZG(3D)RBY.?R\.&P][(2\=E>(O*H]E_JID,!5VC'6VO=/\
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MU]+?\_Z[_P 6%_11$1$1$1$1$1$1$1$5(=?/\FUO^TX%:FM?_<'&_P#"Q_\
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MXYE$CQSX*YNA7\E>P>W:EF+AEFQQ=$R4.)>6A1GIGH-#9] ?)DKMI[!/*((
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M?6\B<I-18V/F,>B01QW]W*930KV,Z2282H&2VV<3R?N]=74<[M%_3[1M:^Z
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MY2 .F?>:PTH/9TA>J<ZHY7>XM>$.<Q-/Z6S/'Q)#(287_!Y:%Z*UD\8+&_\
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MIF/EC;YY:P>05+<+8Z07\!6R-G'8F)QA!EC=&WEKU'NH-RI1R73?-14?2QD
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M\GTVW_,W+%&6;$Y:8RE[/)#E9F$VVUL<T^3@BGJX2&J\!T[.UTTCON "?#5
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MO4-BQ4N-O>KZ$A!>(W%A/"P8K4</B]?_  6*$OI<%O9*>_D%5^WH5H#9'/\
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M,KV2S]'JL#B%G;CJU'%NJ4J,0B9%VQP =K/Z*'Z#JDF%9E+D]6"K/D)Q(^K
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M[0Y9*]:&M$R**-K&,'#6M'  6"[BJ%Z42V*D4A;^DO:"0MF*&.&-K&-#6CV
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M+MN&SFNG,4W/?6+7=P(_,./=I"X'3O,ZSDZ.4GP= 5:XM>>6AG<?/G@+4O\
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MNWU4K8>SKD;,IDGUH&7(I.&-[W2N;SQ& J;W.WF[FTZ=DY,1^'01V"RL2_\
MQ7-/\P4EZJ8FI>ZBZ+ ]G LOE;*X>Y X6/J3K.%Q.?T^WC:<55PN>EQ$T,Y"
MF?5_4V9S6Y;D$'??H.]6 CW('NU1)FWLW;5M>P[)2+E^9K+K/B.']:]!P010
M0,CB8&1L;VL:/  "\S=1ZLESJUJD$=F2![QP)6>[585GI12R6<JY/,9>WD3!
M^B.7]*=3XL R? 6;MJR;$%GFK2A')L%5AD[>Q2=7-1MY*A'1=9 #8XY"\EGP
M_P !=_:L%C+W67$,M5F2Q3TR9(W#P[M4MW?6<)A.F>RU\?2CAC,7J< ?=<N[
MYZ ,_P"QHE,NGM6";I[@(2P=DF-B#A_5JJ?5\I%TYV38=>O'MJ3,-JG,? \>
MS59W2W'RQZ^_*V/_ *3F)OK)OV[_ " ISFK^,H4GRWI&M@)#'%PY!+OLJ!W?
MHN/J9<WJ]CZ2XQ_J" >&_P!6$*1=+]QRFQ:QFJ^6[C=H QO>?=W(*C'0;%8^
M?7,O.^I$^8S]G>1YX7WTPAKUJO4+%WG"&G7M]KPWP&#\RX62LWYNF&1J:_28
M,#69YM6O$LW[L8.5(-CX?T"QO'D"I5_]BE.CZG@(]+P.39CXA<CQWJMF '=W
MO9R2H/TEPUW-ZK;XV6S ]]F430,'/O\ =WE2[!].L7B]8V;6XLX9WV0P2EX[
M!$3[*#UL_F=1?B]7V_&,GQT3V"K:C\^6>&KU(YQ$;BT<^.0J+Z67)+6V[\^X
M.RT;[>&./+FM!<M79*TE/K/K-FAP9K43A: ]^P<>2N+C\92R/7;.1VX&2L%:
M5P:[R.>Y>C,1B,?B*,=2C79!79^F-@X"XVY2QG6\RT.'+:K^0H#TEA,/2^$<
M =\4SUK=#7M'3D^?:W.L'2E['8+<0'C_ .FRK5Z*8VE_=OD;)@8999)P]ZQ=
M G'^Q^59]A:6;IW+/#JF]20#F5MR4L7<Z'S4I="JL@]V2O$X_P!]<G3J$%;J
M-OD4#3].>2\?;O=ROGHWA\6:NS<U(CSDNS@C[-+E??@!5S=H:OOU7)TKU9CW
MTKDE<^WJ1EIXY:51#,3E^F._XBI0O234+\A'I'[M4PWIH'6K3VK)U=!AW_1)
M(7=DGJ2?G74V'+?4]2G8[7:==F8%4BSD9/\ [5&"/ "X?3COI=3-IIW,L+ED
M@_XI\%_!7WTZC8>J>\N('(L2_P#WWKF]0WT(NJV+&9>]F/EJ=D3XSVN:5/V:
M9H..S6$R39IGW!*UE3B;O[BN!M6I9(9O*;5IN6'UC)'LM5?L][3Y"G?3/:SL
MV =9FJ"O:CF+++0. 9/NY6*B(B(B(B(B(B(B(B(B(B(OYR],WEF]Z\X<>+87
M]&@B(B(B(B(B(B(B(B*DNM5//9'&XJCC<7/9'UK)I"P>W8MKJE)E+^DQUJN(
MM2SV#&][&M!](-^SURMKU7+9W3=?OTZ+X<OC6L<V"0</X \M6'*['L>Z:]^
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M2=4LFKZ;XG>2T]O"JCI;1WS7;T^O3XQ@H16C*;;SX+?ABOG)/L1X^S)! 99
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MG^7*?8?J('].F;)=8WN$7#V,^\BA.2=U)RFF7LS8O5Z_J0.<,=Z7(]!_R_\
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MWN6[KK['4FQE[]C*7*V-AE]&O5KREG/Q(Y9-4V'-8G=KVF9F])<9Z1?5LO\
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MR,K3PP#EP^W#ET8L5F:'0R?'6X9Y+4L'#(0WES [V:K"Z8&X-'PT5N!T,D,
MB+'>#^0*L]^U"2?J)AIJ$_I_BC'Q7F-\<QM(7HBG6KU*\4$$;611M#8V-' :
MT>P61$1$1$1$1$1$1$1$1$1$1?SCZ;POGWC 1LE,;C:'#POZ.!$1$1$1$1$1
M$1$1$40W_6(]EUZQ09XF:1+ _P")6+CZME(MCP4V(R\#VW88A!?@D]R?8D+D
M5>BFFP0SP.CL31.!$;)7\B+G[M79BZ6ZTS5H,"1.*T=@3A[7]CW2@$=R8SIM
MBJ>6JY.U>NW[%8$5W6I"\1 JQ5 ]WZ<X#;W0/N>I'-!XBFC]PHQ#T3U=EVG=
MFLW;$\)Y+Y7_ *U+MUT#!;?7ABR#'=\7/I3,_4U<K3NEFMZI9-NJ))K/!:)I
M?L%NY3IO@,EGV9N>>[]=$X&)[92 SCX77VO2<5LV/@IY*:P8XWAX#'EO+Q]R
MN7E^GN&R^ HX>[9N/@J]IC/>>26> 7+;SFDXK-:_!A;,]D5XV-'Y'<$]G@=R
M_9M(P\^IP:Y9#YJ<4;6L[_U#L' *A.O]%-:PN1@MBQ8L")W<R*3]'<I?NNA8
M3;:\4=X.$T/F&=GAS%!?[C<%(^K/9RM^:Q"\$2.<KOBC$; WDG@<<D\E1/<M
M-Q>UT&U+8+.R0/CE:.7L(4.@Z<7I<BR'+9RU?Q-<-=7KRO/F0?SCSR ISMFG
MXG9L4:&1CY9SRPCW8?D*O-9Z.4L%E*UW\9MSMJR=U:(CAK%*=CZ>8[.;'C\U
M+=L,EI\>DQOZ5N[;I6.V7Z22:26&U5?WU[,7B2-<O':!QDJM_,9BSE)JW/T_
MK#AD?/WXY/E3_(8^"Y1L5IQRR9A81^Q4?U74L=K6$9C:HYB'/+B."\E-9U3&
M:VW(-H@M;:L&9X_] %#^IE^3(X]VL8WMFOWGM9+'_P#4X?N\K!N6HXB+IW!A
M)+<T$%<1-C?&WN+WM! !"D_3K%Y3%:CB:>2\6(H0'-YY[5,,CCX+M&Q6G\ME
MC+"/V*HNET.@KQ24I-CNR8LO+_H>.&=RE&)Z7T\?IUS6_P 3L.BLOYED _\
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M(B(B(B(B+^=?2S_/^N_\6%_11$1$1$1$1$1$1$1$18W10MD]4M'<!QW??A9
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M&\@R>62S^!RX*46>D&DP9:.X_*&""Q.V2O5]F<J^;5NM2KOGGE9%$P?F>X\
M+E8G:<!F9)(\?DH9W,/#@T^0HSE\#J4^[XG)6[C1DXQVP0D_K*F>3R^.Q4!F
MNVHX8_YGE:N'V3"9ICY,;?BL-9X=V^X0;-@^^VW\1@YKCF;\WZ/ZKZQFRX/)
MU+%JE?AFBA)#WM/(:0J\P_57#Y7;[>/K78_I(H/R2$>9)%;BI'K?LD5#768^
M*Z(I[-J-LK/N85OT-'T'+LP^2QSVL.-[>R6$=@=_J4N_O TT6?I3FZXF,A8&
M^>"X*27LM0QU%]VU9CB@;[RN/@<KB0[MJDMRC49EX#-;8U]=@/F0.4G?(UC'
M.)X !)*IFIU:Q-O=IL<VXQF/B@(]1S3S)-R/91#*-I4.O$=DF**-U/U9"KNP
MFZ:OF[/TN-R\%B8-Y+&KHYG8L-A(1+D+L<#">!W>[C^P6CKVXZ]L)>W'WFR/
M8.9(B.'M_J%)2> H?+O^I17;51^7@;-7873-_D#5DUW>]6V.=T&-R;)9&@DQ
M^SN FP[QKFO21Q7[O;*_RV)@[W\+?PFVX#-8Z:]0O-EBB'^(1[L6MA-UU?-7
M75<=DF696,+WM8/99[>T86IE1C)[099,!F[./ 8U<./J9ICZ$UX9>/T(Y?3[
M_EW^ZLE;J/J%C#NRC,JSZ=K@UW/AX=\<+K:MN>N[)#/+C+GJF(@/:1PYJU<W
MNVO8:P:UNV3.!R88F][P/DK/C=PU_)8J;)U;['5XAS*[[L_J%'CU6TCZ W1E
MFF+O+  .7DA=4[Q@I=:FSU29]FI&//I-Y=S\<*#],>I,^SS9$6Q-WRVR:[ W
MED<?PKGDD#8W.X/ '*H6GU8-S?YZ);:CH0UG-$7I\O?)R/S%:FQR8W&=8,3>
ME,<##1>^>56+@>INJ9O+_AE2U)Z_DM[F<!X'PNIL6[87 S1U[#I9;,C"YE>!
M@?(0%@UO?]>V&"T^I.]CZ_F:&5O;(Q1R;K-I4=.[:%F9X@G;$6M9Y?S]VJ1V
M]\PE?'8RVWUYG7V-?6KQ,#IGM(YYX6+7>H6"SN4L8R,6:]V'R^O.P,?P%DRN
M^XJEE'XR&O;NVF-YDBJL#_3'^]R0L^L[M@]EBF-&5XEB\2UY&]LK/ZA4CM&P
M&UU9U_U\5D2RDQYAA#!WO>>/+1RKZQN'QC\@[/-H.ANVH )"\ 2 ?#ES][S&
MN8K 3/SD#IJCR&NC# _E9(]JP&.TVKFV!\-#Z9CHF=H!#7#PT!1O$=38[5['
MUKN#R%07Y *4KV LD5I*$;-NU;#7*N-@J37,C8!=%6B^!]R5FU+=69MF4BFH
M3TK-)X$\<P]N5%+_ %48#:FQF$NWJ-8D37(P!&.%J;CO]Z?I^[.:W Z2.5O#
MY'^# U=SI9F,K?U?%BY1EC:RI%V3O//K>/U*RT1$1$1$1$1$1$1$1$1$1%_.
M+IQ+-#N^!?#%ZCQ;'#%_1T(B(B(B(B(B(B(B(BJ7J?M5_&G$8?'2^E:RDQ8)
M1[L8/<A0[J9HN-Q.HS6Z]V\9F31AY?,7"7GW+PNCNNRY/&ZYJN*Q;Y!;R+8V
M\1?[4QM'D,48O8W9L?G\%:U7#YN..(D6Q:=XD'[\$J7Y_)6-FZCPZJ+<D5&K
M6,]ML3BTR/! [%V]<U#-X'=KDT%M[L'-5\0OD+BV5<*+_I]O?]BKXVBF9=LR
M$NS9>:OAXXA]$R*4L#G%?'1W(S7_ .UU%F1M34J]IK*;I''O8PARA> U?9L_
MDMUQ,>U6XH:>0#2X\O?*X%P')7=V#*Y2/8,#I<LV1LQ5J+7WS5_VU@IK\>TX
MG?X/PW%Y2+!VF@3,MGPSY<N]3+M^VW88+%VRS&8J401P0R%@D?Y_.Y1?!8R/
M7.M\M%DT]B-^/(C,AY+ XA>FQ[*D=UH9"_M[!ELC/3UR&F7E\<QC[Y5R.DV;
MM3;%LV'AR$T^-@+_ *-TI+W!GD @E<G5J.VYK9-OQ1V2Y'5JW>R6SR3,>WD-
M8%(NF=K,8/8]JU^YD'V*]0F2)[SR0 MO7WS]1)LK?M7[4.,AG,-2"O*6!_'\
M;URNGU"SC^I6W5I[LUHL]I927/(Y7H->:\ZS<;O5+)Z]C]CLPP3U/6/+SQ"T
MGSZ86#!_VBT3J+C\#8RLU['Y/PPR*39S&V+FPYZ?:<K-5QD'C'".4QAW//G@
M+ZZ+[#D,K2V"E/>FL-J60V&>1Q<XL=RMSIKE<J[-;U7R&3GM,H7PR-TA)[6C
MO6KA?6ZC6<O>FRUN#%P3F"I!7D,?J?\ [5Y"XW37'W\=U%VRK=O26Y6>/7D/
M+WA>BE2&7RV>J]8,-49D)WTK$!)K D1M7$WC,;E!U,P^.Q.7+8[<7#87>(F+
M7G&UZ?U U>I9VRWD*V1>\2-F\ +TDJDWO8LD[8<%K&,LR5Y;SBZQ89^J.(?"
MQLP&VX'<,3^&W[EW$3L<+@LRE_8?Y@M?8VYJ?>9_K<O:H8"M2!#XIC%WRN7-
MZ4[9=O939\2_*2WX*TI=4LR$DEBC^)NU-AR&8ARFS7Z.=CMRQTV"9T;&MY\=
MC5)>H57(Q=(:T&1E,EV$U_6D)Y[G@*,['AMQQ>J0;-7V>WWP0P$U8P61,B7H
M'5LP_+Z]BLB_]=FK'(?V+@NRH-U'VF36M8LW8>/7>]L,'^MZ@]G2<M-KGXQ%
ML&2&;-02.E$[NPGW+.%R1N.8S_1Z[EHLE)5R-+_;/B\$EJ:C@-YS7]DMCLY]
MYC;$TO@/WB(_^^2O0_L%2PEL[SMV:H/N3P8K$O$,L$;BPS3%0BIK\F"ZTX^N
M+4\U5U<N@]0\EC/'Y%V;^8=LVVY^I/!F9J&-D$#*]+V,GGE[SR%LZ!/MN$O9
M^+(U[S,+%')+4DN'\[0WV:FKXN?J%KMW.9*Y9CLSRR,J1LD(C@:/A3[4Z.Q4
M-,DJY^<2W(HY6AX)=RP#QR2H1T9^M/2^84BT6/7L>D3\JN-F,&$U-DMO,SNV
MCUQ-*8I2[M!^Q5B[KELG?Z04<LVW/%:EA@>XQ/+>XO:M+7M7V&O4P>TY/8;3
MC7IF6>L2>.WCPU1/'/S.VXJ?+7\'D;DUF1[JDL,O#(/@,'V4TQ&;W+6^E^0M
M9MDHO1/#*QF\OX?[=ZRLZ:4;>H&]+/._+2TO4-OU""'.')"Z/0/QT^B_XR56
MIGF7I,3=91E$=DPD1//@!R\C[+B\!A-6CFEL2V=GCE;)8LQ/+PQWW#GJRM]N
M9#*](,5DH[4D4KVUGR@._6'M7!VO1'LT2+97Y*Q)E:D$4HD[RUC&?R,:I)G=
MORW]W>LMAL/;D,O' PS\]O <WESEH=0^F6'QND9*]4DG%R"(&:8O\SC[AZM;
MIQ_D76O^SH?_ &K>W2+-RZYD&8>9L-LLXCD)[>U>6-NAP.%Q.)M4+-B78(IX
MOK+K"2.\_K#GKV#@[+[N.J69  9(6/=_5P4%ZL#)_P!BL@Z@)2]KV%XC]S']
MPJRT^CH^<RF!R. D&.O5'--JC[%[0%U\94AH]>,O%7!8R?&&:0?+W$)DJD-7
MK=BIX1VOM4WF;X<00H]?U>OD^L^3QQM6(J]C&F:P&/\ +PXCEBY9T6' ]3:N
M&Q61M5J5ZH>_AQ[^SQRWE=._JM#3NJ>H.Q#Y(X[Y>R5A7I]4EO\ :?E]RUO5
MGS%M&P'S78_;U0WCAJX_4?4,?J]:CLVN5H:%BG88)&1 ,9(QZZ_5:*GD^GGX
MC/4B,Q,#FDCDM[E/]-P>(Q^&HR4Z,$#I*T?>YC TN\+>V_*R8?6\KD6$@P0%
MP('/E5+HNH83:-(^LR==D]W(\R36I 'R!Z[^?U::ATPDP7XP.V!C&NLS?D!8
M/L52^WSXFG4U>SKV'ECAI6F1_B)A$;)"5:'5NOE66]>RS:'U^-IR.=<J>X<3
M[.(70Z>VM*R^6N9? <5IGPAMFGV!A#OYE$M1U?&[#M?42+(F22LS+>8.>&.=
MR_R5O]+Z4N W7<,% >*;)@^-B]!'V7F'.6J6N[GLDVV8)UVADI/^;V_3$G8P
M?PKNY3!8&GT9SC,9:%JF2^U _P!NSO7>IUH+G1BG#.P/8<-&>#\AJQ=/*%.]
MTKHPVZ\<S/IGGM>.1R&KG=!L3C3IC+IJ0FP;4S3+VCO7-@P.''7*[4^@@]#\
M([_2[!V]_(6[UC-.E:U*RZ(<0W>!P/(:M_J#<9D-SU77[,[HZ%DOEGC/ALSF
M\=K5)K?3O$#:L7L%644GU06R11M ;*H/OU"O!U:T.TQG$T[WB4_(8M7;#ELQ
MU@9C8OII6U,?ZL$=CS&'$CDKK8K0MFI[M%GY+=*"*1O99A@' E49PFFXF_U0
MVNI;9WU(WF3Z8>(G$GQW!=76\76P/67-8>BQL5&?'F<P-'# L^J8C&1]4]LC
M92A:Q@!8T-\!7^J1Z[PPNUG'O,8Y_%JZZ?5S(G$Z.YE<F+ZFQ#7Y9XX:]=.Q
MI>N3:2,=%6@= RF3%*&#GGCGO"J+&7+6:Z"Y;\0!E^CY$#S_ +BF/3GIQKDF
M"UC-SPNDO"O',)%>CO8JB=8JU?[V]N=Z3.YHY:N-N. QF6ZOX:&W%W1S4R91
M]G]G"R;/B*&"ZJ:1+C:T5?ZLR,E;&T-!#5I9B/(Y[K#8K06JT,N/K\5A/&)A
M^[F@J5X7I]G*&^OV.YEJ[S-WM>(V>EZG*NTC\B\LU=?Q.6ZX9RI>JLE@$,LI
MB/Z'.#EO;7@Z6L=3=,FP51E<VR]DD,7Y&N#5*\J[!X_?LG8QM:3)9V>#M^FX
M_)"W[ES_ +!<SHU#-%F=\@L00PR"^P/AB\QL_7X:N28&:'U;$G^RQ>8#_P"C
M7JR,!6@S64V3.RM9)$][Z=7[CT8^0X_T<H%TAU37YX]CGFQT#WMONA9W-![&
M>?#5J],M.UX[ANQ?18\4+_HU@\<AC'$KMZ3CZ>.ZG[C7J0-BB:WD,:N;I4>8
MR>T[Q-6S+*=DWRU\,L F>& N4DUW08=;M[#)/F!:EOPR2.@],,' ^_')4'Z'
MZQA;NM9:[;QL$TKI3&V1[ 3V*0](!6AP.XTX1P(;;P&_MPY9?_A\=#_9*Z .
M)!>_.KZ=[%>>]>EB'7+9(S""]U:0B3X <LFTT*5_J_K\%NO'-']&\]CQR/LL
M6Z8^K0ZI:#-5C$3IG2-?V_#%SS!/D>LV<A&9DHSB#LB+&>7L!]@5,,=HF(P&
MU295^<FDOW(Y1V/''J ^7* =)]9PF:R.ZF_2CG(M!@+Q[!Q*V+=-\G6E]&.X
M<8R+&B.H8O@$<!JFXT/%XO9H,Y9SEF?)2!S8Q)X]0KG=%;(L-VE]@!M]^1[K
M ]W?=:YHR4^NA=0?PRS0,ME@6SF_^F77O^!>KU;^D*N>KE:*QT^SY?\ P1![
M5P:6"CV#I#A,<^T(#-1K]DGP\,4'H[/M&LY?#X+;J$5FL)V_26V>["SP"O3B
MJ#?].R&3R57,8#(^CF*49#8R?#V%1+$;KE<IAMLQ^2QK8,]6JD2%H[1(&+'T
MMPV$SVEP0OSF0!8#'8K1VBQ@4EV'#8#"]*-GQ^%>]U: 2 ESN[\_/E33IJZ,
MZ/K([A_]SH?_ +S5-T1$1$1$1$1$1$1$1$1$1%_.3IK8CK;UK\LAX:+87]&P
MB(B(B(B(B(B(B(B*D^L6KY>]'B\WBF=]G%O+_2^6E0#<>IT.TZ18IU\5>%SN
MC=/S%_A,75VC%9O+=/-6S].L\9+&LC)'9P_V\K:P'5?9-FCIXNEB7Q7WO:VQ
M9(/I1C[O7.ZF19O3]\J;;C:YEKS0]EC@*?Z?NF<W'*13UJ+Z>+@83,Z3R^60
M^P"B\61:SKY.YD4CFFC],7\> \%<#(YVOA^K&5L9_%3V26]N/[&^KQ\%JZO3
MC*Y;'[WME?(8B>%U^0VG #N$2S]*]@HR;IN47;,TY&\9ZQ<P@.:TE:W5.MF]
M;W+&;EC:SYHA&(K("D6K]1LKNN9JU<?CI*U*$E]V:3X]A&%#OQI_3#>LW'9H
MS28O)R^NR2)O)"UL-LTF?ZQ5<I4H6XJ[ZGI^6<.<SY<O57GM7EO;<K7H=697
M;-4FLXZ.N?HX0SO9W$^" LFG[)>CZHYAUG!6X&78B6-[?,;![%R['2S,Q3[Q
MO$<3'&.Y;-B*0@CEK25EP-V!_5[:ZCVO[+4+V,DX('+2H]J>T#IMF,OKN7J3
MBD;+GUIV#O71T+9(\CU3SDWT5F**]#WQ%[%Z37FW-[#0U_KG/:NN+('XQL1?
M]F<KMV"-VZAX&_B^7X_#![Y+7LQ[W\<-:HHS.TJ74;9#L6-M6[39G?A7$?J=
MC/ABVNC.3EK;'ME*UCK,$]BQZQ!9^2(,YY!75Z;7JEC<.H-/E_-VV^6%W'AS
M 7!1K2=HK].LMG=<S%>=D'U)?!.&<\K9T+9SE.K>8GBKSQUKL#W-$C.'>"O3
M_P!EYTVO,TJ763 .D?X9 8I3_(7K2W2_4CZSZSW^17X$I^S"5M]7K,,>]Z0X
M\O$+Y#( O1H\@KSMUBKY3#9[7MKH5W2"HXLG4CQ'4X;=>JX_ T[##^NU/,WM
M$3 H-LF7Q$75*^S:89IJL$/-",CNC7QH6:9!U'SH.%FIF[$9((.S@!ON'/6/
M<,IHFV86U:OEE#/0$@-:"7ND;\?(6;9\Q=@Z-XB#*^JZ[9=%X?R7EH"FNW9:
MB[HW+*)#Q9H11Q>/=Q"83<ZNN=*<#DS6GG$4$,#F,'LX-5IZMLE38,-5R-5C
MVQS-Y >."H?U7UNWL&GV8*C2Z>&5D\3/YRQ1/"=3L"--97N2^CDHJGI.ID'O
M<_CCPN!!KK]<Z'Y6&V"RW=C[S'QY#G^0Q69THR4%W2,-&SD/K5V02M/N',"L
M<KS$_.V.G?4C.R9"">3&99YG$D3.?SK4BVUN<ZP8BW#0MMJB#TXBZ/AQ#OXB
MF<R.?Z:[_E;XK26<7E)72OX5DZ]F<UO45RP^HZIAWU'Q,8_]<TC_ .)5-I^\
MY7IT;>LY;$3RLCG)A?&%>6)RV6=JF7S.;::[;#'21UQY]&+^$*K>G-K)#H]G
MZV/$T=^%TA;XX/YU#<;FX[73B_AL5K=@Y*2#_G]CL\$#W>7*29#,OM=#ZD'T
M-ACX?0@8"SR\QM/)"N/2;\.R:-4#X7-<:H@F9(WC\X"HC ;/M'3"W:P%[$R6
MZ?JN=7>Q6M=QNR[AT^RAR#/I[5LB:K6'GT@/9I*@V!ZG9B#5)\+-@+TN6J0>
M@/'+'<#@EY4LZ!RV&Z8^M/3FB,=IS@]XX#P]6+O=?(V=1S4..[_JWUB(@P\%
M>:JEC*YCIA+@,7K,K)*P:;<I\!Q9\?+BI'>OY&WT=Q]!V(M-G!@BB8&\EPC'
MEZF^S7'6NDDD<5.R9K-2.!D79^<.44R6M9'.=*-??1K3-R.*$0]%X[7$Q#RN
M+M'52[F]*NXA^#MLR4D?99_)RQ@"NGI99M2Z1AH[%.6N^"!D7#Q[A@]U]]4H
M<I8TK+18YCWS%HY8SW+%YWS63MYOIM1HXC69X*]!\4MN3C@![!QX^5Z<T._:
MMZOCI9Z;ZSS"UH8_W[0/=:^\YK+X7%UKN/I.M=MQ@L1-'),)!Y5(W(L)M.\8
M"YK6/LUK<,IENR&$1 -^7+L[T_,:MU*J[/6QTUJK8J_32A@7.DL;C;ZFX'+S
MX%S(7P<,C#N3&P\>9%W8FY5O7"Q=_"K)JNH_3";CQ_K63/0YG^]O$768:V^I
M!$873 #@\K'U$ASLG4'4+5/"VK$5![B][1X=WJ_1Y"I;JEJF5EO8K9<+"9+V
M-?R8ON]BYN1S>4ZBT,=BZ>&M5J\DL<M^>=O#&!O\#%W^K5/*3ZHW$X?$367R
MRL\1CQ&QBFFE3WWZUC1=I2U;+(6QRQR#@AS0NWFL;%DL9;I3?HGB+"%Y6P;N
MJFCWIM<I8WZR R$P//E@5D;QJVTW^G;(>]UO)FY':G8T<!Y\\L:H)ME?J9LV
MM4V2:ZRG#2L0\5@[E\A;[.5@YG+;[BKF#NG$R6X)*CQDJL![F1'QP0N3I6 G
MGWC*[54Q#Z&/?4='# ]H8^1[O)=PMGI?6V&KL>V39/"6JS,E9^HCD< &^"?"
MR:K4V%G4W8[MO"V(:EKN$4Y_00PJ\52]S-;6+&Q8O*:I9R-,SRFG(P!['L)\
M \K#K>@7X.FV7Q$\8AGOA\GH ^(>?(8HIBF=4IM.DULX%E45JWI"T]WE[&^
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M):VP8B?$G*07(WU>SO\ 6'D!JBHZG:8<?/>&588(Y?3Y^[G?[H4CUO9\/L-
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MZ3#V!XY'+BMOJ;0IT)M-JU(&0PQWP&1L'#0%?3?O_5'>RI+IA_F[J3_VL/\
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M=P/5C<?](7)R\U<]=L;&Q@#V4N'O^5Z$;[!43UY@YP&*E+(RUN4A!*DO5/\
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M-=B9;L<F&$GR_A=9%Q,KL^#Q-RC5OW60RVG$0L/N[A=M1_-[9K^#?!'DLA'
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M1#RY<[%='S5V*AGK>Q7+-R%H,CG>\CU(<GH62DR^4O8S9K-$W7\RQL9WL/\
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MNS8K6\<;M^4LA]1K/ Y)<Y=>A;@N58;,#NZ.5@>QWRTKE;)LN*UO&NO7YC'
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M<-+?5/8QA]G+#FNL5VA+%<BUR=^%=*&?7O/8#^[0MG8NK&2I0?B&)UV6]B0
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MY Y42S>?ZC:I4@R>3-6_4#P+4<,?880MS?.H.2H:?1S^OLBEKV"SF5_NP/\
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M&!GCR>"M3&::']G*2;ADZ&9Z.07:=,5X"^#LA^T? 79WF6D.D-D3N9R:,7I
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M=[X2&%7WJLL,N Q<C'![35CX(]CX71R?_P! M_\ V!__ **A^@-W'LU6_$9
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MJM_NKWZWAI\-=VHFBWQ"SR[N ]@Y77IFOS:[KU+%S77VC .!(X<>/LT+'O.
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M0%&G1AYGG8WNE?)\-7.K[-L>J[Q2P><OF]1R'/TMIPX>"/L5S,OL^]1=3[N
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M9D4HM5G/+&OY(X4<P&HY'([M8V>]BF8Z,UW1" ._/*Y_N]ZADNF=1]/V._\
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M68HHYZL+V1^&-<T$#^BVX*%6K6$,4+&1\<!C1PT+2J83%TY?5KTX(G\<=S&
M'A9I*%9D[K;8&&<MX[^/S<?'*H*UEM^VG8;.M6L6*>.,Q]><?>%I]@5Z#J58
M:M>*&)O;'&T-:/@!9$+&GGE:E7&TJCI#7KQQEYY>6- Y*VW1M)YX"&)I Y"^
M9((WL[7 .'P?9?18T^4+&D\HOEL$;'.<&@%WN?E?I:"4+"&.[3P>/!4:P>N"
MA:N7K5DVKUEWYYW#CM8/9C!YX 4F3L'/*!H"!HYY3L /*(6@IV-3A$X1$X_<
MH@: B(G"<(B<)PG")PB)VA$1$X7/R^)AR5(U99YHVN(+A$XL)'P2/LMG&8RE
MC*4%6K R*")H;'&T<  +D;74RMK WH,;'$ZQ*PL9ZCRQOG[\@%0OI1K&P:O@
M)L5E&UN&S]\+X7EW(<K23A.$3@(B(G 1. B<!$X")P%Q]AH7[V'N5J5H5YI6
M%C92.>.5#NF>F9+4L18Q]J\RQ&9N^( <=JLE. B(B(B(B(B(B(B(B(B(B(B(
MB(B(B_FYT_;"_<L$V9CW1FVWD,]U_2,(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B+'9M05H7S32-9&P<N<X\ !8L5E<=DJD=NE8;/$_\ 2]OLME$1:SLA3#^P
MV8@?;M+ARMB.:*3N[7M/!X/!Y7ZB+39DZ#L@:(LQ_4-;W.BY_,&K<1$1))&1
MM+GN#1\D\!$7S/:@@ [Y6,'RX\+6&2HD@"W"?Z/"VVN#AR#R$1%R<IEL1AZ_
MU-^S%7B!_4Y9<)GL/F:YLX^['8B!X[F+HHB(BY6:S^(P=7ZG(W&5X>>.]WRM
M^AD:UZC7M57]T4S ]C_;EI\A9G.:UI<X\ **.WO4Q<^D.9K";GCMY4GIW:MF
M-\D$S) 'EI+3R.0LB(BT\MEL?B*,URY8;#!&.7R.]@L.#SF/S6.@OT9"^&8<
MM<1PNDG"(B+CY_8<5K^.?>R-CTH&N#2[CGDE;&!SN.S6-@R%&0R12CECB.%T
M$4>V;:<3K6.=>R,KF1!W [1R24=MF(CUJ//%[VU'P";O+?S=K@MO6]AH9[%0
M9&D)/2F\L+QP5UD1$10^GO&&M;9:UN,3_601E\A+ &<-*F"*$[)U$UO7+HJ9
M.>:)Y +>&<M*U:G5+2K#03E1"2\- F86<E3^&:.:-DD;PYKARTCV(7ZBUK]V
M"C4GLS$B.)A<[CR> N7J>T8K9\/'E*7J>B]Y:!(WAW+5W0X.YX*(B@N7ZA87
M'95V+9%:N6V,+I(JS \L'R[DA?6%ZB:UFLC'CJT\PN.:28'Q]KF\+'7Z@X]^
M\2:R8)F3QQN<7O' <00.&J>(B(B(B* 9;?Z>-W#%ZZ:DSI;?M)[,4_1%6\O4
M$1]08]6^@=YB+S.XIFNH+<;N6(UT4'O?<</\8GAH"LA5SO?4"/4GT&/H2S&S
M)V!X\,"L9I#@$1$57]0NH<^HRXUC,6; M2=O>7=C&JT&.Y:"B(XD-) Y5=:Q
MOMK+;1FL-)C#7^A\%SG<EQ5BHB(OR5Q:QQ:.2 > JWT#=<IL.0V6M<I,K&A9
M9"& ]Q5DHB(M3(V)J]*S-"QKWQQN<UKCP"0H!TOW>[M^%MVK5:.%\=GLX859
M2(G(7/S$UV'&VY*4?J3LB)B9\N4=T#(;5;U]DNQ51!>+SR ./"D.8GN0XRY+
M3#'3LB<Z,//#>1\JO.D>YYC:<)<M9$Q^K'9[!V#CPK41$1$1$1$1$1$1$1$1
M$1$7\W- +AN6#(G]$_5M_P 3X7](PB(B(B(B(B(B(B(B+C9W8\/@*HLY*VR"
M(N#03]W'[!1J[U.TRC:@K6<JUDDK0?D-#O;O4PFS>-@QAR+[<;:W9W^MS^4-
M43Q74G4\I?CI5[Y$TG^R#V]HD_T+9S^_ZQK]WZ/)7'0SGL[6=ON'+L9C8L9A
M<4[)6Y7,KCCEX')\KB'J%JS;&-KOR ;-=C#X6$<'M<.07+#2ZEZ?>RPQE?*,
M=.>0W[,=Q\%93U%U'\8CQ?XK%]2X\ ?;GXY4IR.4HXVJ^S;G9#$WW>Y1/&=1
MM4R5UM*'(=EAQX9'*WL+_P!VK?O[KKM#,18JS>8RT]I=V'[ ?*U,7U#U+*94
MXRIDVOL_P#CP_P#H5"=MZL5<1MV+PT)+0+/%^1S/#6_#5<U*Y6M5H[,$@?'(
MT.C</8M/W7'S>SX+!^A^)WXZPE/$9?\ <K)E=EPF'I17+UYD,,A ;*?T^5J7
M]PUO'5*EJYE((H+(!A>3X>#\+0L]0].K7HJ<V:KMF> 6M_JI9+;K05W3R2L;
M&T<EY/Y0/E1*MU"TZU:96AS,)E>[A@/(#OZ%=W+[!A\-79/D;L5>)S@ YZX]
MG?M0JV8JT^;K,ED +&<^_*ES7!P!!!"A>][E4U/!S7I07RG\L,8'NY0EFTX[
M<.F]H69HYK;L:'VH^WCAZQ=-]HU_!:!@CE,E#6#V>.\JZ*.5HW*$-RI8;)#*
MSO;(/8@J)3=0]-AN?229J!LO=V_MW?'*FC7-< 6D$'V(44WO)VL7J.:O53Q-
M#7)C5*],\/HVU:X1;XLY8D/M3//^.'_+7*R^GFO7<!)L=6?U70F^'UII#RZ1
MGE=_);UJF,LNK7<Q!#*WW85V9L[BJN+_ !*6[$VJ0#ZQ/Y>"N*S>M2E=08S,
MUR;G_P!''/F11_&8O3AU#OY"ODP_+2P/$E<'GM (Y4NS.TZ_@W1-R>1BKF0$
MM#O<\+9PNP8;,UC9QUV*S$/XF%<.YU"TVC//!:S<$<D3^QX^'*74K=:W5AM0
M2-DBE:'1O;[%I^Z^UYWZX[-?%=F"QC'OD#?JKA;_  11JUNGNS,V+5<=?#PZ
M9T09/^T@'E3)5[U3PU7*Z7EV/B89(HO4A<_^!P56Z+T^UG+=.Z=JQ5#;9C?*
M+0\2!RV>B.VY*3&9V#+7WSUJ+V%EAYY8UJM63J-IL<%2P<S 8K$ICC>/N0M_
M/;IKV"#?KKH:7#EL;!WO(6QA]JPF8QTEZC<;+$P?G(]V?L0O/<&Z8+.]4YWY
M.<OQE>L^.HR2/E@>2/*M>O!I>@MR%]L_T[,C*V0Q>_)'/B-JD6O[MKNP";\/
MNA[XOUQN':]JY=CJ=IL#KP=E6'Z7CU2%]GJ7IXAH2?BC/^><>BW[E=+$[MK>
M8L7H*.19(^I_M?@!<0]5--;.R)]][6OD+&S&/_")'PY3BWE:-&A)=GL,9 QG
M<92?'"\[=4M_U/.:G/4KR/=9]6.6 21\*[])GFFU3!RRQ]DCZ41</@EJX/5>
MSDJNC9B6@7B4, )9[ABKSIG+T_V+3ZN%DJ5!99"!9A>P!SGCP9%.<#CH^GFK
M9&-XEL5HK4DD#8AW2%CES>FO4=FR1V&V(K#9I;<I:..8VQ\^&\J49/J'KN.O
M2TW2S2R1?[80L[Q'_J4BP6Q8K-TQ;H61,S_[[3\."BV9ZEZUB;,]=\D\\D#N
M)Q!'WB+_ %K!L=_"[5H.5GK2MGJRUG$$?(7!Z;YBCA.E^,OW7ED$4?+R%9.O
M;%2SM5UJK'.(@>&.D9VA_P"X7:FECAC>][@UK022?8 *K).L.HLF?PZT^NU_
M8;C8@8.5*LWN^OX3"Q92U;_YO, 8BP<F0'X4-GZU:9##4E[[;FS-:26Q<B/N
M^SU9)SF-9B!E398*AB$OJ_;L*I/?]_Q.7T7+"+'7_I[##'!:?"!$7J7]'/\
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MCS>_[+@LAF<:ZO4IN8XU*TL?<^:/Y<?LN?\ _#R>=8R7_&A7Q?=8;4G,!:)
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M_6$<REZ@GX];M]--2IWY7MKSY 0SDN/YXHU=?434,+>TVU''4BC=2A+ZCFM
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M:IE#EVO?3,?;*&>[OV:J$V?\7O=+JED>C1Q;/0^DI#_%>^/CP7//"L;=>_\
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M*-;SL[]8UZ;),K>N\2-BCCYXY>]5A;W[=,!?P,F<KT14O'AXB=^:,E=[J3U
MR^I7\0V#'MFJ6'$/E!Y=_0!0K)=3>H. OPY#+81C,19D B9[/C!^2K VW=[\
M,NNTL"QDDV7/,,\@YC8Q<37]XVJKOSM6SDE:R7Q=[+,([5S]@ZC;=0WVW@:N
M.9./1)JQ-]WEWZ2XJ#;OD^I5S5()\RZ.G'^),@,+1P92O36LQ;!#CNS,VX9[
M!?SWQ,[&]J[5^*P^G*VO,(IG-X8\M[@T_/"\V=-L;LDFW[N\9>)CXL@&V3Z
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M;.1M8;'S9" PVGP,=-%_(\CR%Q]\=G?[+Y+\&/%SL 80>"!]R%YPV&:EKM'
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M=UR.MEZ%!E^J.)C/&.7K=Z@LPLG3V2Q@<9'!CX\S!('1,#63,:'\R*QMCV+
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M"LO1=L.>U2AE;!9%)*SB7[#O"F M0.E$;96%W'/;R.>%\27:D3^Q]B-KO@N
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MZM5\[9OZ^<=A;-IM6QZTKVCPN#O,6UTNHF&V"EA9[\7H<0UB>/3>L&'BW_\
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M5:'C=MQ=;/4<W;DL5V2\4I7N+G.CX*J32]J@Q='/X.@0[*W<D]E6/GM#??\
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MV:>NF<TH<W"++R>0[]?*MC9[&%M=-[SFRM;2DQX[#RL/1S@Z#AO]"F6U&=N
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M*JR)W(X\L"D6TSV*^!R4M=[FRL@<6%ON"%6NI]4]=R. JQYJV*UST0R=D[2
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MB;&(PUWG\H4#@Z4:17R O,Q$?JA_>/@%6,CVM<TM(Y!'!"KU_2W3#-+)^%,
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MUG,G-5S]7-Y.Q-?JS@/CF>7%K6\J3]/7Y7(VLYFI\C:?4LW9!1A>X]K80?!
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M)&/\(/4>ZL[;LN-S>'QE6DX5)+(=WM/#YW,^P4TV/?LCKV(JY&[K]@,>YPF
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M6GW:#RI/N>];@-#P.P4Y_I))Y&,GA[?+G/"T<_D.J5#"T]FFRT,3.8B^FSD
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M(]XVJX\KC\?LNM3UBX2U[=?ECA]P1R"%YYZ55,[/G8<'?K/-/ S3'U3[>L2
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ML0Q@]RJPU7J1BJ&ATZ!AL#)5:K*PJEA[GO X6K=Z<YO^ZTUAYRKKC,A,SY>
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M=%*?DKMZSILN-N9'+7KGU.5N A]CM[0QOPT+B:KTVN8#9;N:=GWV7W"\V(S
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MRVI:UEK$<U_$U;,C&\-?)&'$+;R>NXG)8SZ"[3BEK>.(7-! X7-&E:RS'5J
MQ-85H91+'%V#@/\ YEM9;5==RWH"_BZMD0-(C]2,.#.?A+FK:]<Q]:A:Q5:6
MM  (H7,!:SCP. G]EM?#*#/PJMQ3\UF]@XB_TK8RVO87*O@=?Q\%@PGF+U6!
MQ8L.3UG!9)L3;^,K6 SCL$C [M78@K0P0LBC8UD;  UK1P  L=>C4@FLS10,
MC=._OE<!P7N^2OVY2K6ZTM>S$V2*1O#XW#D.'P0N3A]9P.%,AQN,K5>_CO\
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M+ \?D7K"%KVQM#W]Q \GVY*_5%-UVF#6,%/D)&][NX1PL_FD?[!5M>I=2:^
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ME<^'LXH&Y+ R"**,\]K!]WKK8O'[#7Z7OQ5C&GZZ"H*S(FG]8'@%;/1_!YG
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M!V\H^M),R  N:Q-1V2/8L'4R<41C;.WD-*D*(B(B(H5ONUS:I@I<G'0-GL>
M6\]H'*[>LYJ3-:_B\BZ(1&U79*6 \]O>.>%VD107?=BSF!H59\9BC<>^PUCF
M_#2IK4GDFK1/DC,;G-!+#[@G[%941$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1?S2T[_,^'_P"*8OZ6C[_U1$1$1$1$1$1$1$1$<YK6ESB  JOV
M'J!I,T%_&6+[7A\,C'D-)C!'V)4:Z+&D.ETOUA:*QL3B7N]NQ373_P"Q&&U6
MW;P3^<?%(Y\DK//)"D&M;A@MBAFGQEDSLB#>]W' !<L>.VK!Y>[DJ-:=TDE,
MEL_CAK2H]H5?1H[6?EU]_JROL@VC\./*ZN>WG6<+*:UZZ/6/O"QO>X _*JCI
MP["OZC;8_$&,U'#EAC\-5K9G?=;P\[X+-MQE9YD9$WO+!\N71K;7@;6%.7AR
M$3J0'+IOL%PK/4W3:V-AOR91GI2^8^!RYRF&)S6.R6.BOTYVRP2-[F2#VX4!
MV#J'I);;QEN^UX?&YDI#.^)O[.*B'0%D#-?R[().^,7^&.5ZW+E>G6EL3RMC
MBC;R]Y]FA0>;J?I$-)MMV;@])SB&?+B%+\;FL9D,>+U.U'-"YO<V1I\<*%.Z
MJZ0VWZ!RP^/5[3Z7/QW*493:L#AJD%F_D(Z\,WZ)'>Q6S0SN)OXLY&K9;+6+
M21*/;@+B_P!N]2_#F9#\8@%1S^P3'V+E\6=_TZM:95FS=9DSNWM9S_,OK*[W
MJ>(LMK7LQ!%,>.&<\^ZE(MU_IO7$K?3+>[OY\=ORH.>IFEBW%6_%V<O]G\$1
MD_'*[^6VC X<0'(9&& 3'B/N/ZEHR[UJ<61&.?F:PM%X:(N5#^IO4NOJT,52
MJ_G(2R,X!;RQC%9N'RV/RM1MJK8$L7/ (!')"W;-F"I"^6:1K&-'+G./  4.
MAZAZ9//#!'FX#)*_M8/(#BI%EL[B\35^IOVXZ\ ('>XKEQ[AK4F2KXYF5@=:
MG ,4(/EP*D<DC(V.<YP  Y)*B#^H&G,@GG=G*HBBD[)'<^SEV<)L6$S<#[&-
MO168VG@EA\ KB7>H6GT;<]6SF(HY(3Q)[D-/P2NY/L6&JXD966]&VF6APG]V
M]I7Q@=HP&=9/)B[\=D1<!Y9[-)6N=OUU@R7.2B'T+^RR?M$?@KF6>H>FUJD%
MJ7-UQ#,SNC=_,E_J%J5#'UKTV4C,-AO="6>2\*3X?-8S+8^*_0L-FAD;RQX4
M5RW4;4<5/Z%K)M#P_M=V#N##_O%=^ULV$I8AN5GOQ,J. +9OX2"H]>ZDZ;1@
MJ33Y>,"PUKH^/)[7?<K%N6^X[7M;_%6=TXF9_P V,8Y:XN31]UK9?5Z5NU;!
MG949);Y' :XA:\/5;3I/2=]9,V*1_:R8Q\1N*L8$%<7-['A\'$R3(6VPAYX8
M/=SS\-"XN(Z@:WE,D,=%8D99[>?2E9V$K;RN[:YBLK!C+E]L=J7],:Y-'J?I
MMW+Q8N'(DSR/+6?EX:Y3]><>ME^>GFM7EO4S/AXYB^PSW#W*0W\-HW4+6Y'X
M:&K]2Q@]!_8&R1'X*LBO>K:_KE67)S,@;! QLCC[ @*.5NJ>LRY&&E*;58S>
M(99XPR.3^A76S6]Z_ALO4Q=R=[+$_P"CQ^4#Y)7$_O!TK/8C.]TSY:E4=MD%
MGA[#]VKLZAD-:9JE:UBH_IL:QA<P. ;P/DKAS]6==@BAM25[XI2R^FR[Z0]
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M>N[1DSN>,Q&Y8J-N4B8\4[K/X^5Z(5*]1[&5SF8QFL8F"&9P(N6Q(\L8&Q^
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M6,15D@@_V4+HP6L7W/J>N28J'%RXJLZHQP<RL6 QM(_9;^+Q&-Q%05J%2*O
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MT;PZ.5ODM*[&K:MB]:Q<=&A%VQ-/))]WN^2N\B(B(B(B(L=F%TM>5@?V%S2
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M5]9*&&]B[47J?EEB<WN8?V]P0JEZ)T70:GDH)"XGZ^9A?S[\+2Z05&T<_O\
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M7JDEL<Y!]WIT?S^N5]BW&M 16BM6P^G#V=G$3>Y=;I'EL9/M>]LALM)LWQ+
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M&2KXV>AC;+F_2P2C@D*\[;9'P2AAX)80W]B0O*^GS[W@[&QX4:^ZS;MS.?\
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M\ +](!]T+0?=.!PG8WGE" 4X1$X_<K7R-6S-1FC@L^C*]O#9"WO[?WX7-U[
MUL'CF5(7O?\ G+Y)'_JD>[W<5VD[1RG")PB<(G"<(B=H3A$1$X1$X1.$X"<!
M. G 3A. G 3@(B<!$X"(B(G"(B(B(B(B(B(B(B(B(B(B(B(B(B_FEIW^9\/_
M ,4Q?TM'W_JB(B(B(B(B(B(B(B(B(B22,C:7/< ![DG@(R1CV-<UP<".01Y!
M1$1$1S0[W1?DL\4? <]K>3P.3QR@:![))/%$.7O:T?)/"_47Y+/%$!W/:WD\
M>3POR2>*( O>UH)]R>%] @HDLL<3"Y[@UH]R3P$:X. (((*Y^7Q>(R5<PWZD
M,\/W;* X)A\5B<74$./JPP0<\MCB:&M701$1TC&< N Y1%PLQJVNYF:.3)8J
MK:?&.&.E8'$+KTZ56E7C@KPLBB8.&,:.&@!9D1$Y7Y%-%("6/:[@\'@\K]1$
M06(B[L#QW?'(1$1?$5B"5[FME8XM]P"#POM%I#"XPV_J_HX1+W<^IV#NY_JM
MU$+FAP'(Y1%JNR5 $@VX1Q]B\+]CGJSG_#EC?_0@K9#0$1'.#023P N''L.!
MEN_3,R%<S=Q!8'>5W$1$1"0 25RJ6=Q%^[9J5[T4DT''JL8>2WE=5<:]L>%H
M3>C9R$$3_?M<[RMZIE*%PL]"W%(',[AV'GPMM$1?DTL<,;WO<&M:.2?@+D8+
M9</FV69<=:$[89?3<X>W*["(B(B(B(B(B(B(B(B(B(B(B)([L8YWGP"57VL=
M0Z&PYS)8VK5GC-/P\R@-/*L%$21P8QSN#X'*@NJ;W3V3)9BI7JS1&A*&.]4<
M$E3I$46W/:H-7P<^3FKRS-8X-#6?)75UO--R^!QV1;$8S:KLE[??M[@NHB(B
MA>^;<_5,*[)"@^RT/#2 > .5(-:S3<O@,;DA%V&U79+V>_'>.>%U$1$587]V
MRU?J'0UT4(A7FC,GKE_)<%9X1$21Q#'%HY('LJ\TW8=HRN2S;,EBA5KUY^R!
MW/ERL-Y(:>/=57JFYY[)[EG\1=JQUXZ7(8UIYY5J%5YK&8VVWL^R07Z@CQ]>
M<LJ/XX+@K#1$1$1$1$1$1$1$1$1$1$1%_,W4Y#'L>)?V.=Q:9X;[K^F341$1
M$1$1$1$1$1$1%S'9S%-LOKNO0"5O'+"\<CE=&2S##&'/D:T'[D@!:-C+XVO+
M%'+<A8^0\,:7#DKH%[0WNY'"J;JIDL9<TK/UX<DP6*\8D[&/\J2=./.BZU_V
M=#_[5,)K,$):))6,Y]NX\<KZFM00M!DE8P'V[CPOBSD*E2OZTL[&,/\ &X\!
M:\N4Q\4L<4EN%KY/T-+AR5MV+U>O'W22LC;\N/"TCF,:+3:KKD(F+>X1]PYX
M6_),R-A>YP:T>Y)X 6I4R="WQ]/:BDY/\+@5"=ZU)FPR8AS\LZF*M@2>#^I6
M#WMC9R7< ?<JB>MLU>3!8RQ!<)D;D88RUDG@M>KVA_0/Z+]FECB82]X:T>Y)
MX 7GOK&/K;.M-JY!P[[H86LDY8I_U#U$[+0J0#*FH8;#7]WV<IK!)5H00UY+
M;>6L#0Z1P!('W6Z;,#(?6,K P^SB?"A>]X)FR:U-0;D?IO4>QS9 [AIX4CPM
M%N,Q%*H;#IA! QGJN]W]H]RH)U4L59M'S#XKY9-!&)6>E+P20NWT\E+M'UR1
M[N2<?"23^[5+&7JDC^QEB-SO@.!*ROGBC+0Y[6DG@<E8VW*KIO2$\??S^GN'
M*SO>UC220 /NO.W6K(RPOUZS0R<K#]6&D12^%Z#,\<40?+(UH^7'@+ZKVZTQ
M/IS,?Q[]I!61:\MZI$_M?8C8?AS@"MALT;F=X<"WYY6N;M4,<XSQAH/!/<.
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MJ\$@EB>?90K?*]>UU@T^*9C98W^X<L_66E2=O6D=\;>)'O#RMSK<# =8DKM
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MWL0:5^*K!2/>&??E;O4?3LQM6*H4:UZ*(1RB60N;[O8L&W:!>V35L35L7O\
MYC4["+'\)<U;.1Z=C-ZL_%9O)S6[!>)&VB/,;A\!0[7.DF<J3U(,ILDUG&5)
M ^*EY+'%JE.Q]/<AEMYQ^PC+"(5/,<?I K-NG3R?9\YC,D<M]-]#YAB$(?Y*
M^-_T"]M8QW&4$'TL@?QZ7/+E#.LE6^^'5:[+?%HVPT3@=OYU('Z#M6;-2'9=
MB$]2M,'_ $\4? FX^\A4RW71<=LV,AK/E-:>!X=6G8WET2BYT+8,JZE#L&R.
MMTJDP<RNV+M]?CV,IY6YU"Z?W-N;4C&8-6*!P>V(1!W+U);.M2Y#5)\+DK[K
M)E@]*2<,['._=53C^B]U^&FQ>5V>Y/5#"VO7'/IQ$>SUV+?20S:E2UZ+/SLA
MBD:^20Q]Y>6*69339\CI#=<=EWM<8F126O2\O8T?'*UL=T^KQ:8[6<E>=?@'
MB)[V &,#VX4 U[HBZAD&?79J6S0ADYCJ?P.^.Y6EN.C8G9X8!/S'/ >8+#/U
MQK@UNGER>[0L9O8[.2;3>'PPN9V,+A]W^3R5V]WTFGM>/C@DLR5YXI!)#89[
ML<J\N]#ZN19!+?V"[9O-F#WVY/+G-'\*EN<Z=_79&CDJ.;MTKM6#T8Y@.\EO
M[^0NMK.EP8>2[=FLFWDK//K77LX<?V"Y>(Z>5\3LEC/G,6YK$P=ZP?X:X%<+
M<=[UK+8Z_@*%EEN]9D%80\*R]<P=7 X:EC*W^SKQ!@/W<0/<KM$ @@JF<UT;
MQMW8Y,Q0REB@923-'"/U<KOZITQP.L9:SD:4E@RS1EA#G> "HQM?0[ YW-2Y
M&&W)3,C^961LY#E9.#T_"X7 ?A%>LWZ8L[7@CS(3[ERK.#H)J$60%DR63$).
MX5_9JLS9M3HYW7WX:21]>!_;XB'LUOV7#_NVPKM.9KD\L\]9AYC>_P#6PCV+
M5P7]&-7DQ7TDSIIIN6<6Y/,K0W[-74S72K6\MCL?1>^S#%3'$+8W*<4L3#6Q
MD=!TDD\;(^PF8][G#]R55$_0K39,L+K&RQQ]X)K-_0K.R^L8?*80X>U48:A:
M V(#@,X\ M57Q]"=0;3DKODM2^>8G.=_LE:V!P6/P6-AQ]"+TX(OTM7&W'1L
M%ML->'),>X0OY8]AX*CQZ0:.9<:\8UH%,$!GV?S]WKICIOK8V9FPCZD76/#F
MD2'L"9KIQKF8S\6;LBR+<1!C<R4M X6YMFAZYM@C.5J=[V?IE;X>%Q,?TCTC
M'VZ5J#&_GK?H+CSR?EZLQWAKEY8BPV V7J_L5:U,_O['&!\1XX<'+T#KNFX/
M >J^E7/JR>))Y#W2O_JY<NYTWU*[L$F;L8YLEI[@X\^6<_/"Z6/TO6\=D[V2
MK8Z)MJR7>I+P.>'>X"T\/T_U?#91V2HX]L5D@@O_ &<F<Z=ZEFLD;][&1RS_
M 'D^5T:.HZ[1R1R%;&5X[)8&"0, (:/L%(RT$$$>%%:>D:M1R=C(UL3799E)
M)D#1R.5^8S1M6QF2DR%/$UXK+SSZ@8.0MD:AK+<H<FW#U1<]4R?4>F/4[C]^
M5(D1$1$1$1$1$1$1$1$1$1%_-+3O\SX?_BF+^EH^_P#5$1$1$1$1$1$1$1$1
M.$X1$X1$X1%575O$[%F<!%C<319,9)VOD+C[!BF^L17H\#C8[L AL-KL;)&'
M=P! 7>X3@(B<(B<(B(B<(G"<(G"=H3A.$0M!1$X1.$1.$1.T(G"(B<(G")P$
M3M'PB<!$X")P$X")P$X")P$1. B(B(B(B(B(B(B(B(B(B* ;;T_K[+D:=J?+
M6XA6(,<<7Z0[Y4^B9V,:TN+N![GW*_41$1.41$1$1'-#@01R%#<1H.LXC-7,
MO4HAMJP27.^S>??L4R1$1$1$=(QGZB B(B(B(B(CFAS2TCD$<%1FEI>K4;S;
MU3"TX;+7$B9D0#@2I,B(B+E-V##F\:0OP?4 \&(._,NJB(B(B(B(B(B(B(B(
MB(B(B(OYI:=_F?#_ /%,7]+1]_ZHB(B(B(B(B(B(B(B(B(ORU8;!!+)VN<&-
M)(:.2>/A1#2]TJ[35O6*T$L3(;'I<2>'*8(OR.1S@>6EO!(\K]3@(BB.W[IC
M=6@K2W8IW">41Q^FT$=Q^5+F.[F@HB*$4M\Q5W;[>MQ16!:K->Z5SV\,X80/
M"FZ(B(3P%#<1O&,RFQW\+!%,+%,'U?4: .1X\*9(B(DL@C8]Q]FM)*B&J;QA
M]GER+<>)_P#F<@9*9&!OEREZ(B(B(B(B.<&M))X "J;*]4HZ[+ENCB+5RA4E
M]*>TS]/=_NJS,-EZ^5Q-*_6:\1V8FRM[QP[AWD<K=1$0G@*N</U#BR.\7=;.
M/FB=6C>]TC_OV$!6,B(B%P ))52Y?J)DG3Y5NNXB/),QOBV3*6$/^&  \K'3
MZKP6L)B7LH/&5R,A9#0/R/<D_P JC^3ZOY_$W)L;<U5_UPL!C!'(71/9]W!W
M"OJI-+-6B?)$8W%@+F'W:3]BLBKW==UO:YDL)4KX>6W]=*6N(_@X5A HB+!)
M=JQ3PP/F8U\OZ&D^7<?"SKEY[,U,)B;F2M$B&O&7.X5-'J'O$-7&9I^ @DQ=
M]S1&R.0F6,/]B[PKY!1$6M)?JLMQ5'3-$TC'/9']RUO )53[#O&;QW4C 8&*
M*$4K?'>X^7N5PHB(B<HB(B)R$3D(7 #E:V.RE&\RP^M,)!%,Z%Q'L'L/!"V5
MS69C'37[%"*TPVH6ATD0\E@=[<JMM6V#89]_V;%WK@?!5_V+&CM "ML$)R$Y
M"<A.4Y"<A.55.V;'DI=NP^LX^X:ILQ/EGG:.7M XX#5T]3K;K1R^3KY>X+E+
MP:MD^'KJ;U7VQ^$']G961V_79R7'CF-23'?5MHUA=+38$;?5+?8O^_"V^0B<
MHAEC#@WN')7"V38J& Q<]^W( R,>&\^7'X"ZF)R$=^A7L@<-DC:_M]S^9;*"
M>(N+0X<C[<H7-:.25^&6/N#2X<_8(2 %^,L1./#7M)^ 0OHO:T@$KC9S8<;A
M,79OVY@V*%O)677,]!FL'0R$+.T68&R]I/EO>.>"NF]S6M))  ^ZH)DMC>]M
MV2C/D;->AC)/2KB"7LYE^SBK)TNAL6&Q,]7.Y46W-G/HSN=RXQ_;N)4TBFCD
M'+7@C]CRAGB#BPN'('/'*1R,D:',<'#Y!Y26:.)I<][6CY)X"PNNUFN:PSQA
MSO8=PY*SN>UK2XD !:\5VI*\,CLQ.<?L' I->J1/[)+$3#\.< 5G?8ACB]1T
MC0W^8G@+3=DZ#9H8G6H@^7]#>X<N_HD.6QTMMU9EN)TK6\N8UP+@%B&9Q9N_
M1BY#Z_'/I]P[ET9IHH(W/D>UK0.2XG@!<W'9W%9$N;3O0S%ON&.Y*S2Y6A#:
M95?:B;,\$MC+O) 7Q4S&-N330U[D,CXSPYK' D%5]E^I>+I;A0PD=F$_K^K>
M?_M1:1P%9]6U!8K13PO#V2-[FN'L056O5';1@=9O_36V1WGM A'/!'/NY07
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MEK<\S_I>WT")N[E1:',UL7UQR8RG$1GK>E5F>K;DGUJILU9_I1_B=V/TQ(T
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MP.>Z5ZUBLE9;%Z]:LR&3W+)NSPHIB+NYZ+L^'P64F%_&690RK,?+F<+N4_\
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MW++K4MJ]9/,]N;R]RXV"Z<08;9KV<BRMI\EI[G2Q$<-=W%64HEN>E8;;,?\
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M\2<=O8OO:^G.L;-?J6\E ]\L X;P> 1\.4RJU:]2O%##$V.*-H;'&T<!H'V
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MGE_HP^[%R>EFPYB77=@LYN\Z=]2V[O>XK4UZ+8=ZQ\^<ES=['12O>*=:L\M
M8/9SN".5'>EMJWA'=1I[\KI[%6VTS/=[O>.]<L[9D\UK\^89ELQ#D7\OKUZP
M/H, _@]QRN_:V_<K_2:?+D35+T! DD X[V?SA<:W'U"GZ>0;))M$L KTHI8X
M82>9A\RO5@CJ-)7Z7T\_-YN2QLB8P^SIG+@;#K>T2:%;R=G8KYR)J"26NQQ$
M)!]V!JF'1S_(6&_T*T%0/4?-[CC-YUJOB;O,=T/$=4DL87-_G4;SUWJ9H^4Q
M^6R>8-RG8G#+,8),3"5,MUWTG8*6OTK<\$4U<3S6H&]TH8?8,7"U+:-GI;FS
M%"QD;^)L-_)/98?48Y<:?+=1;_4G.X"GG".8G]I\M9&P'W:%(]F?U"UOIK5?
M9S)=>BMM;8E8XN)C=^ZD^U[7DL3IV%%24G(W_1BA>[SP7#R]<3:,1N.KXB7/
MU-HO6YZQ#YZ\Q+HG-^_ 75S/4SG3,7DL?"3=R?9'7C]PQ[E$>H>J;-1TF]>E
MV>_9D]+B[ \ET+PY=*]FLIANC>NV*#WQDP562S,\NCB+/+@NGK]:W-G,3D,)
MMEO)8IP(L0RS%Q8Y74/91C=,=?O:_=CH7+%:RUA?%)"\M=W!5+TZRUW.].\S
M%?S5UE^O*XR3F4B1BS]%]NGR>O99F2R,T]NM+WO,TA)[%N86QFK.B;#E_P 3
MNL?;?++4+Y"\Q0@\L[%J8YMC8>CS9,C>M22?3&5T@D(<\M^2MKH[A60:91O"
M[;<9(7_X)E)A'/PQ0W2M;R^?Q^RP19R:C6&2D)9"/SR.\^YY"G'13,92>AF\
M1DK,LTN,MB(/>KJ5(]=+.3I:W4MT<C8KN%QD3F1O+0\/7'I8G:\21N.1V%\T
M$>,<]\))#0YW'#5%8F9G8=69EC7V*?-RQ=]>:)W;6!/MP.Y3+*9G?(>DIGO0
MV(,DR81V'<D2F(>[UH:G6UW+Y/!Y+6<U:BF@F'UM*S*>YS%R-J9L=GK!)B:&
M>LP,L5P>>XD1L?[ABRW:.P]/-SPIJY6U=QM]_8^.9ZZV1R5C9=]S=.>M?L8W
M%<PB&J[C_&Y]W)I+MLP&PYMEFKD68$12R0.MGGL+3X35L$SJ5K^2S67N3F:Q
M,^.M"'_DKAJS;'I]RKTCNPY^Q]7<H![X7AQ("[G1/"T*NHT+T3")IV?G5SKS
M-U^Q- V,)=$/$\E@1.?\L4PWIXU35*^.PLCH9[]QD(=W\/ ?[N!6KM?3?'XW
M7;=_$V;$.3K1MD%DR$ND[/LXJ>=.=HFV35*.1E\3.'9+^[VJ;KS=MS+&J]3\
M+E#/*<=?F/J1EQ+6/7,ZG24<#U"P^5@,TL/KMEOL!_('_P !5A;)3QNU;KK-
M<,$L-6!]R27]B6]K5#,GCWYWK9E:4=N>HTXKLE>SP\L!'(:OC7,/'I75T8C'
M>L<?;I<AKWKK9&B(>N6)G$KC]34)+5L6&1[9U2O8G*=LN.QD),=-WELC^>.]
MP4QUC1VZOLF7L4;;8\;;\QTQX:UZK/5-5H;%MW4*/(/E?5CROFL#PQ[B7\%R
MZ_33'C7MZVW"TYW_ $3'![&*_E$>H&/H7-:R@GK1RAE9Q;WCG@JO.CF'H?V#
MIVWX^!DY$G$G'+G!9>C+8FT-DB:  ,H[PM?I?&V/;NHK&$-8,H &#^KUGUC_
M *6-Q_TA<V6T*_7^0?\ U7%"-7^%&-VR\^&U7,9*  R5ZY<P%5IH&G8'):1%
M>R-&M9MY"%TT\[@'/)>.5K]&*4-;7MDI_JC9>>SS]P.Y<OHC3JF;=ZIA883<
M8SL^W'YUK:_!4T7JMD<;Z0AH9&)SZJLK1*\61N9[9'L!=?M%E=Q]Q783PH=I
M./KXWJ=NL4 X9PYX"WNGL%;9,MLN:R<<<]MEPUX>X<^E$"?#5'<'C(,/UQS4
M-:!D+#C996-8.!Y(6MJ,.P[#D=INQFA/,ZVZ"1UD=SQ'R>&#X:I/IVB937J.
MSTLA:K24K<9>RM&HKT=T;7LIIT^0R5..V]TTK(VR@/$0'W8OK3+LVO\ 3K=Y
M*)(-.T\0JP^GF%Q<W3^O)(QD\F1JB6Y(\<NED>.3W**](\2#JNU8R&8Q@VWP
MM>HA!?CURE%IVWX4,IM?Q7R$0Y\@^'KU;CG12UH7Q2E["P$2?(^5E<T.:05Y
MSB96TKJY*TAD6/R\+W,(' :]1JMF9L1U0CV7TC%A\O++%'-]G,)Y[RK5J32W
M;6Y;'"UKS7:ZI0</<MCY#R%!>G>"S>=T.R8,_ !>=)]2PUQ(YSS_ #O)6:QI
MK]:Z3;1C;=N*T8?\1@'D1E=3ISH& ;IV(RUG'137C"++)3Y/EO("X72^/-Y\
M;+?CRT-6U/=/KQOKB9Y#N?N2%973;27ZD,O"_(LG=:E9(6-;V!BL]><^OM6.
M>+7@8P2;?8LG6'7,!A]*H&E0AKOAOP",QL 6MN%RUD]EZ;4+A)J3\2R_#W@!
M3KK+BXKFCWK!($M.1D\157=2),E>T?1;]P.,A=!ZSS_.]>IH?T-_HOI>9\]B
M,9E.O,=:_"R2$46/#'CD.<%M=3<!C\7LNI9/'0-@LFWV'T_R=R[.6?6J=2;A
MUW'?59J:N19=*_L@@8?N2 5Q.D\E]F\[M#<L!TYL$RB/Q&YX*80N;UWV(M]Q
M2F74Z37&W-FW>:Z_F^;H'GW# 7)7->#K]>[>UOJXG_Q<2%?BKCJW9L5M"S+H
M6DES6L>1]F%;.DLQEK0,1'6:/IWX]C2T_P"E5)H=&>IIF_T@YCZ$,[V0J5]*
M\50BZ8LX@:?J8)'R\_=.@/K#1G<O:8_K7]@5W*D>KGC(:E_VBG77L?J=-O\
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M$>X8HST:R^=&-K86;"20QTN]D\\AX'<%?*IKK9@;>1URM:IUGSST[C)"QO\
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M62EMSW,C8;Q+:F/DCX"BN\='<)M5Y]\69*EMWZY&-Y#E*-4T#':UKMC&4YY
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M(0/R@N7>1%H6<QC:URM4GLL9+.[B./\ B<M]$Y42J;Q@KFSSZ_!+(^Y"Q[I
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MKP,_0U7E-U)U&"?)0RY(--)W;,2/NM]V[ZX,%!FOK>:DO'80/S.)^P"U\-U
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M]2"Q$^.:-KXW#AS7#D%8ZE&K3B]*O"R-@//:P<!9GPLE!:YH+3[@K]#&@<!
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MFE6@HSE=SUC$616OY6""7CGL*[,&8QLE WF6XG0>_J _E4>?OVHLI"X[-51
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MU7J'1;P:4$[FP%OEJE_2G&T(>FC'QUV!]BN]TQX\O("= W\Z$&?%V57!D_\
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MH ^ MA?#[,#9&Q&5@<?9I(Y*^T6%EVHZR:XG9Z@!)8#RX +[^I@,WH^JSO\
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MQD@!=Q)QX(;[D+YUW9,1GJ)NXV?UHN[MYXX\JH^M^T1X_!,Q<-IS+%FS$)6
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M9#.9:]@LHR W:H)]> \QRABLG:\GD,9@KUVC!%+-#&7!DCBUJH;&=2>I6PX
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M:1Y> 59>Z[+?&:QNKXJ;T;MTETECW]&(*G>J.N7,+9U]]O/7LC5?;',<[B7
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MJ]AWD?\ <P+H2VG;+U9;A<MQ+2H4C*VN?]F^<$ O4]Q?3O#X3:[&;HRB".Q
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M>>R,*)-NX/6NJ>S1;)5A^FR4[YH)Y6!P;R5;>LY'11LKH,!0K&R^!TD]F",
M <CP2I+N7^6<O_PKU6_1;,47=/:X?)%&:[WM>TN4-UK,NQ>#ZC;-!4$E>S>Y
MJLX\'RY17/OP-_I[!D[^;^JRLWIEE8./IPC[L8Q6UF+^.N=$[;J<D?IMQD;
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M(XRU+WQDN[&,73Z<#-MZC;6<P8?K".9!$>6!+%+>]1W;/VL/@CD:>5F,GZ^
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M/"0XS(6(IFUF-9 ]G\@79V?!MSN R.,DD,;;419W_"I*#I1MUK7Y\)D]G?\
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M#U:WHUI&EKFM\%W/W)4-@Z.:;%],"RW)' \.9 ^8NBY'RU6JR-D; QK0 !P
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MHW_5)D>S@^R=*\ME<]TY?->OSR62^:-LQ<>_PN!H.V9C'Z)LU_+VYKDN.G<
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M3*IW>M/QFRYITF-RQIYZ@QI!'NYCDZ9;)G[\N=Q&P1L-ZC(UKYF^SPN1TN$
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M>F:IEXLSD]CSXA.2M<,C9$2YL,/\G*CE#3MVQ6_9BSC[L,>*R-GU[#W#E_\
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M5^\#A$X3A.$1.$X"<!%I9;$4<KCYZ5V(212MX<PA<G5\#/@L<:+\C):AC?\
MX!D'YHX_LSGD\J1\!. G 3A. G 6*S%,^O*(2&N+2&D^P)53]/=%S>M97+V[
MF1CF9>=WR,:/XU;J(B<*H<_T?Q.;W!^<N79G,<035X\$A6['&R-C6,:&M X
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MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_FEIW^9\/\
M\4Q?TM'W_JB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_FEIW^9\/_P 4Q?TM'W_JB(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B$\)&]LC0]IY!]BB(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B_FEIW^9\/_ ,4Q?TM'W_JB(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(G(1  !P$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$7\TM._S/A_^*8OZ6C[_ -41$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$;$P.<X#R[W*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B_F?J,C(]DQ+WN  M,Y*_I@$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7\R]69"_8<4
MV9H<PV6=P*_IHT<(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B)R$Y"=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P
M3N"=P3N"=P7\PL%?CQV7HW)&DLAF:]P'OP%['_Y0FC?R9#_RFK-!U_T6:4,)
MNQ_N^(+X;_\ $%HI)_)?']8@LU;K[HD[RTNN1>/=\01G7W1'L!+K@Y?QP8@L
M\W7?0XFRD6++RSCPV,>5DJ==-"GB[W6[$7[/C'*U)NONB12RL#KCPS[MB'!6
MN?\ X@M%''Y+_P#Y03_E":-_)D/_ "FI_P H31OY,A_Y34_Y0FC?R9#_ ,IJ
M?\H31OY,A_Y34_Y0FC?R9#_RFI_RA-&_DR'_ )34_P"4)HW\F0_\IJ#_ .(+
M12TGMO\ _E!/^4)HW\F0_P#*:C__ (@M%:XCLOG]Q$$_Y0FC?R9#_P IJR?W
M_P"B^CW_ //O?CL](+X_Y0FC?R9#_P IJ/\ _B"T5KB.V^?W$075/7'01$U_
MUTW].Q:(Z^:)VL/?<_\ +"3=?=$C]GW'_P!(@OS^_P"T3OB'-W\_W](>$GZ_
M:)%.Z(&[)Q_&R(<+'_R@=%[^SB__ %](+/\ W]Z'],)O5N<E_'I^D.5MR=<M
M"8Z,"[,[GX8LK>M^@%@/XC*"1[&-:$O7K1(XF/$MM_<?81CD)+UYT-E<2B:T
MXD\=@C'<MJOURT&:,/-V>/\ 9T860];] !8/Q"4\_#%]_P!]O3__ *SD_P#+
M3^^WI_\ ]9R?^6G]]O3_ /ZSD_\ +3^^WI__ -9R?^6G]]O3_P#ZSD_\M/[[
M>G__ %G)_P"6G]]O3_\ ZSD_\M/[[>G_ /UG)_Y:V:_67I],'\YCL[1[/8D?
M63I\\PC\9X[R1Y;[+:DZM=/F5S+^/PG@?H'ERQ5.L/3ZRQY.;9'V_:0<+5;U
MIZ?D$_BKQ_5BZ-CJUT^@A,GX_"__ '6>2D'5GI[+&''/PL\#PY?L75CI]+&'
M?VA@;^SD9U7Z>O)']H8 LO\ >GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_
M>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_
M>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_
M>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_
M>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_>GT]_P#KDJI_
M>GT]_P#KDJI_>GT]_P#KDJK$>K'3X3-C_M!!Y!/<LG]Z?3W_ .N2JAZJ]/@6
MC^T59!U3Z???8ZJU6=7NGQM/@_'8QP/UD?D6>/JOT^>9!_:& =I1W5?IZT2'
M^T,![%@?U>Z?-J"Q^.,/@'TP.7K'_?%T^].!_P"-#\Y]NWRU9QU9Z?&.5QS\
M/Y"1PC.KG3YX@/X]$/4'W'Z%L#JGT]_^N2JL;>J_3XR/9_:& <+)_>GT]_\
MKDJI_>GT]_\ KDJI_>GT]_\ KDJI_>GT]_\ KDJI_>GT]_\ KDJI_>GT]_\
MKDJK7DZM]/HY8X_QZ(]P)Y \!<]G6OI\?_UH\?U8OC^^WI__ -9R_P#EI_?;
MT_\ ^LY/_+3^^WI__P!9R?\ EI_?;T__ .LY/_+3^^WI_P#]9R?^6G]]O3__
M *SD_P#+3^^WI_\ ]9R?^6G]]O3_ /ZSD_\ +3^^WI__ -9R?^6G]]O3_P#Z
MSD_\M/[[>G__ %G)_P"6G]]O3_\ ZSD_\M/[[>G_ /UG)_Y:?WV]/_\ K.3_
M ,M/[[>G_P#UG)_Y:?WV]/\ _K.3_P M/[[>G_\ UG)_Y:?WV]/_ /K.3_RT
M_OMZ?_\ 6<G_ ):?WV]/_P#K.3_RT9UOT EW.1E'!_D3^^WI_P#]9R?^6G]]
MO3__ *SD_P#+3^^WI_\ ]9R?^6G]]O3_ /ZSD_\ +3^^W0/^LI/_ "U\,ZWZ
M X><A*/V[%CGZYZ#$UA%V>3EP'#8PLYZVZ!_UG)_Y:QMZX: 8^XWY0?CL7Q6
MZY:!-"U[KL\9/\#HPDO7/06>UV=WM[1K)+UOT!C"1D)7_L&+F6.OVBPO#0;L
MGCW9$%\._P#B"T4'VOG^D01G7_13'([B\./L8@OC_E":-_)D/_*:G_*$T;^3
M(?\ E-3_ )0FC?R9#_RFI_RA-&_DR'_E-3_E":-_)D/_ "FI_P H31OY,A_Y
M34_Y0FC?R9#_ ,IJ?\H31OY,A_Y34_Y0FC?R9#_RFI_RA-&_DR'_ )35B9_\
M0NEETO?!? !_(1&%D_Y0FC?R9#_RFH?_ (A-'^T60_\ *:C/_B%T@M',5_\
M\H+%-_\ $-I@9S%!?<[X,8"U?^43J_+/^97$9_\ $3JY/YZ5P+-'_P#$1J)M
M3!]6\(?X'A@)*V?^4)HW\F0_\IJUI_\ XA]0#HO1K7G@G\_+ %A/_P 1.K_1
M!XI7/J?Y.!PN?_RC<3_U3.G_ "C<3_U3.G_*-Q/_ %3.G_*-Q/\ U3.G_*-Q
M/_5,Z?\ *-Q/_5,Z?\HW$_\ 5,Z?\HW$_P#5,Z'_ .(W%<'C$SKD?\I)_P!,
M2< /6[_#?6\<+7_Y2ES_ .MR+_ST_P"4I<_^MR+_ ,]/^4I<_P#K<B_\]/\
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D$7XB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex3-6_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_005.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 ;P !  (# 0$! 0            8' P0%" (!"1
M 00" 0,# @0!!PD& P 3 0 " P0%!A$'$B$3,5$4014B,F%2"!8C,T)Q<A<8
M)#4V57-T=30WD9.QLD-68H&2)5-4H<$F9-'2)SA$8X*$E*+_V@ ( 0$  #\
MJ_HG_M_CO\#U[Y;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_[?X[_  /7OEOL$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$7@;HG_M_CO\#U[Y;[!$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)
M_P"W^._P/7OEOL$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@;HG_M_CO\#U[Y;[!$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1%X*Z'Q&3?Z7''Y87N7O5OL$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@;H
MG_M_CO\  ]>^6^P1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$CD8\$M//GA$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_[?X[_  /7
MOEOL$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1  $1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$7@;HG_M_CO\#U[Y;[!$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1%X&Z)_[?X[_  /7OEOL$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@;HG_M_CO\#U[Y
M;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1%X(Z(GC?Z'CWC>O>[?8(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(O W1/_;_'?X'KWRWV"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P-T3_V_P =_@>O?+?8
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(O W1/\ V_QW^!Z]\M]@B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB\#=$_\ ;_'?X'KWRWV"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P-T3_V_QW^!Z]\M]@B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B\#=$_]O\ '?X'KWRWV"(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P
M5T/D+-^I>&GNB>%[U;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_[?X[_ ]>^6^P1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1>!NB?^W^._P #U[Y;[!$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X
M&Z)_[?X[_ ]>^6^P1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>!NB?\ M_CO\#U[Y;[!$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1%X-Z&UY9M^J%@\1P/>Y>\F^P1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1>"NA\LL>_4@QY ?$\.7O5OL$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@CHBXMW^A^\3U[
MW;[!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1%X&Z)_[?X[_ ]>^6^P1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1>"NB$3Y-^HEHY[(GDKWJWV"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+P-T3_ -O\=_@>
MO?+?8(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(O W1/_ &_QW^!Z]\M]@B(B(B(B(B(B(B(B
M(B(B(B(B+XLR/C@E=&WN<&$@?) 5?].MIS>Q4<E)E<::<L%GTVM^58:(B%0;
M&;G+:W?)8 XV1K*L?>+/V<IRB_/5C]01]X[B.>.?*_41$1$1$1%",GOV(QNV
M8[798YS:M%O:0T=@!4W1$1$1$4.V/>,3@;4%2:.S/9E:7-@KL#W]H^YY(6SI
M^[83::MB?'NEYA<&R1RL['L)4H1$>X-:7? 5<'JKJ0R(Q[I[(M]_9Z/I#NY5
MC@\HB*([!NV(P.5Q..N";U;[B(2QH+1Q\J7(B(YS6M+G$  <DJO+G5+3ZEF:
M WGO,3NU[XH^]C2I/A]IP&8AL38[(1V&PM!>6?V>5HZIO&#V6;)LQKI7_1O:
MQ[W-X:2[GV4J1$1$1$1%CM6H:E>6:5W:R-I<]WP H]J6YX?9ZUNSCO5+(9O3
M)>WCDJ2HB(B(2 .5$L;O.OY+8K&"K67NMPL>Z0=O@!AX*EJ(B(B*-#<<#_.,
MX V^+P9W&/A25$1$1$1$11?*[GKV)RM3&7+PCM6"!'&I0B(B(B(B(B(B(M3*
MY:ABJ4MNY89!7C_7([V"SX[)4KU&&U3F;+%,P.8\>S@?8K(N);V7"U,M5Q<U
MUC+=@$Q1'W< NVN3G,_B\'2-O(61#"'!O)^Y*ZE>Q#/#'+$_N8]H<UWR"OI$
M1$0GA0&]U/TNAD#2GRH$@>6/<&\L8[X)4\K68+,$<\,C7QO:',<WV(/W"^D1
M$11O,;=@<-<IT[MT,GLNXBB Y<5)$1$1$1$1$1$1$1$1$1$1$1>!NB?^W^._
MP/7OEOL$1$1$1$1$1$1$1$15;N&Z9&#8*.LX-L1R-EO>^63V@8L6)SF[T-T.
M'RS67*<L1?#=CC]/M_9P7Q;VK8<WM5O#:Y/7AAH^+EM[>\A_\#6K'JV[9J/9
M[>K;$V(76L[X)XAPR9JC3]_WQ^Y9O7JE"O/*SGZ8>S(P#^M[EUM'W+;W[CD=
M9V05S9BKF5DL 6C%N>Z5.J$6NY*W :,I+HCZ0:7L4SN9W89.H-'$4;$8I,JF
M:Z"SDCVX'*CN;W^_;SN2Q>(O4JC*([);%CR73?P-:FG]2,KF:6<IRU8#E<>P
M]O#R(9^/=P/"@^+ZL;]G<19FQ6%C?+!*!/(/(:"IWE]VV*?8L?K.-%:K?=3$
M]B:?RT<\?D:%+=8S6R3T<XS*U8FVZ<I8P1G\DH\^05S>G.Z9#8</E;>2K,K.
MK62QS!]@%P:^Z[CLD>1N:WCJGT5:4LB?.\AUCCX'"DNJ;^,]AKI%8LR=-I%J
MD?=KVJN,)U<VG.U+L./UTOOLF_03Q%%'^[E8G37>K&UX^\+=45KE.813QA60
MXD-) 528#J'D,AO^0UV;%-KBM#(_U._ESNT@+CR]7;T>VY+ #79GRP]X@#'<
MR2N!77T_J5<S&PV\!E<,['Y")A>(^_O! 5?4LUN%GK+>B^FJRS5JLL3(3,61
MLA+PK8V#<KL>79@L#29<R7:73![RR*!OR\@%:&K]0K<N;?KVPTV4<H /2#'=
M\<P^6E6HH#MN\?@]NMC,?2=>RDXYBJM/ #1]W%<7$]2K#,W!A]BQ)QEN?GT#
MW]\4BQ;9U4AUK:8,/:QLOIO')GY_]H7>T+>3M4>4#\=+4EJ3AA8_X<IKE<G4
MQ5"Q<L/[(86=SW*I9^K#J@JW;F#LPXJP]HCM$CD!WL7-75W#J.-<K5+S,9+;
MQ\[ 6VXC^3RF7ZD14<#@\G%2,_U_8&0L=RX%XY4IRNU087769/*1.@/:WF >
M7F1W]@*$P=4A!DZ%/-8:UC67 ?0EE]BH-U,L08GJAIV3MN+(&AY<[]F*?8;J
MWA\AL-?&.HVX!:\U))F!HD4DV3=:.&N5L='!-:R-D'T*L0\E:>J[]4SE^_BY
MJLU3(5.3+!)\#X4<FZRX&'.7\4ZG<]6 $, 8.Z5X^S0NYI74O$[+>LX\P3U;
MT')?7E'V"V<UO4=7+R8?'4)[U^-G?+&SPR-G[E<G7NJV)S%W\.-&]#>9)Z<L
M)8"&%;>;ZB1U+]FGC<7;R+ZG_:S !V1+OZCN6%VNBZUCI7\,=Q)&\!KV*36Y
MC#!)((GO[&\]K!RX_L%YGP>VW'=6<[--@[SGO@[&QA@]:)K"K5S6R8#6++A6
MQADRN1(>:U=@]60C[O6;7NHF-R&2_"KU6?'Y$ $UK  +O\!6CF.JN Q.Q/PU
MED\<D;7.DD<WABD&E[I2VJA:MU()HFQS^GQ*.'*7+SI<K%_\H%AB9[40]ZM"
MSO\ B:>V0:W9BL,M3\>@_M!C>F<W_%8/8J.&O066R6^/0D:P%A7-V#JMK. S
M[</<^H$W/YWAGY L. ZL8/,; W$?36H'S#FLZ9G:) L6Z[7J6/V?#4+^)-G(
M>H/IWOC!$0?]PY3'9MLQ>N5XWVR]TDK^R&",=TDCO@!1S%]2Z$F1BQ>7I6L7
M=E\QQV  U_\ <5M;-U'PFO9NEBK@F;)/Y,G'Y&M33.HN,VJUD8*L,\9KO_MM
MX[V+O;C!>FUG+Q4B1:=6<(E0'2#>]>H8H:UE(6U+(D()>WADJN75M0J8#*Y^
MQ2;&VGD#$]D;/9I =RJGU'9,+JF;ZC36^6QC+!L4,3>7N\O\-"N;3M\P6U5K
M<V.=*'0.[7QRM#7M7#N]4L!7MWX(*]ZY]&";,E>(/9'Q\DD*2,W/!'5OYQ,L
M.-/L[RX#R%!X.MFE3149!)9'U,QC#3'Y9^[U),WU"PN)ORT?1MVYXF=\S*T8
M?Z8^7<D+I:WN.#V2G+9QUKN;%_6M=X<S^\*-3]5M>A$TWH7GU(Y3&;C(@8"X
M?!Y5E4;,5NM%/$3V2,#@3\%:.:S6/PM":Y=G$<,8Y<5 X^JN"^IHPVZ61IMM
M<>E-8A#(SW>W)#BNMMF^X75Q6^M,A=.>(PP<@K'A.HF"R^T6L'5;.^6!CGF7
MM'IN[#P>"IK9 ->7]V._]%YHT/>M>U+'YYEU[S(_*/+((6=[^ 2KFP>_83/8
M.UE<:)YFU_ZR -'K!8=.ZB8?;;%F/'U;@%?CU72L# "5T8-PHS;39U]E6T;,
M$??(\L'I ?W\J2VK4=6M+/)SVQL+G<#D\!5*>M^D_2V)Q):/I2AA8(QWE2RY
MOF$K8[&W!Z\QOL#ZU>)@,SVD<\\+\US?L+GLC9QT3+,%N#]<$[ QZR9S>,1B
MK[,=V6+5QS>[Z>LP/>UOR>2%2>E9JCFNM66O4XI8XY*$O+9/#^>X*X<YU%P>
M'NR4C%;M3QCF5E:,2&/_ !>0MK"[]KV9PUK*5)W^C7',['-XDC_O"C4O6?2V
M8X76SSR<R.:(61\R$-749U1U-^O,S3;;S X\"(-YE[OCM77US>,!L.*FR-*P
M?2A_K@\</C_O"BS>L^D.BOO%V3_1WAO'9YE_X:D6 W[7M@Q=B[CIWO\ 09S+
M"1Q*Q5YHO4V;-['G8;=>T(S/''4B#.1&!S^M2J"SHEKJ-/'!!WYID#S+*&>&
MAA"D&P;KA<#-%6L.EELR-+F5X&A\A 6/6=\P6PSS05GRQ6(OUUYVAD@6A;ZF
MZI4S%W&2VWB:K&]\I[?RCL/'":GU,UK9\C/0J&RR>-O=Z<S PN"L!%!\GU$U
MC&YO\(LVRVP&%\GC\L8'RM# =5M1SF2_#JMJ1DY=Q&V5@;WKMC>,#_.,8!\T
MK+Q<0(RS@%?MK=L#3V&#!V)I67)G 1L[!PY:F5ZBZMBLS^%6KX99#27CCPQ,
M%U$UG,XW)9"K;+8:;^)G2#MX7,J=5M4M7J]7U;$0G_J9I8^R.0_ *KCJ^(HM
MYT:;\C3WR\O<K0J]3M0M9R+$07^^:5Y#' <,<?@%=W8=MPNOLB^OL=KY3Q%$
MT<R/_9H6GKV\8//6I:E:26.U&T.DKS-[) %JY_J'@,)D#0G^HELM:'OC@C#R
MQGRY=[![-B,WB79*C/W0!SFE[QV\%ONH;-U:U*&TV)\MCT2\L%KT_P"@)^.Y
M69!/%/$R6-X<QPY:X>Q!6+)9*IC:<UFQ,V.&)O+WGV 5<U.K.JV9V,+K443W
M]D=B6(-B>5)]@V_ Z]6AL9&X(V2GB/CR7+0H]0=6O9J+$U[QDM/9W!K0"%-.
M?"K_ "G4W5L9>LU)K$KG0>)WQL[V1GX<5,L7G<9DL7'?HV&RP2-[A+]E ;'5
MO38;8A-R1S/4[#.UG,(*L5^2I14C;=.P1=O=ZA/Y0WY5?.ZM:3&>9,A(V,\]
MDQC_ "/X^"NOD]\UW&X[&Y">Q(*MT-,,H;RT]RV]@W#":_2@N9"=[()2 U[&
M]P7+VJWJ.6TUUC*V#^%66,?ZH\<\CD<+I8B_K6)T^E<J2>CC(JK'1O=]H^%R
M\9U*U3(VJU6*Y*V6P0(&OC[?4_N6AL'\PIMRP;<@YIS$3R*S /\ WK@[SU0A
MP&TX?$,,C6^L'W7AGLSX:NEN>4T/+ZY2FSSY&59I6R0>.V4N"L!F2Q&-PD=L
M2B*HR!I#W> &*+T>IVI7+,%<7)(GS?U1F9V->NWL&X8#7VPG(W6Q&4\1M]RY
M<6SU/TZ#)MQ\F3'JEX8"!^3E3X'D+6R&0J8ZI-:M3-CAB;R]Y]@%7T'5C4)I
MX(_J9XVS'B.62/M82NEOFS0X37;ECF8N?"X1.B;W>2J=Z<P:ILVET\#?HSOD
MED=))+V>\GR'KT;B\=4Q>.JTZ[.V"O$V.-I^&J"Y3JIJ>.R,U*6>9YAY$TD<
M?='&6_8E</J+U)9B-3I7\7ZKI+X::\W;^1K"IAJ>WU,MKK,A*^9@BA899)AV
MCDA<'_*]J0G8"^VV!YX9;,7$!*LIV3I1T77#.P1!G=ZG/Y0WY5;0]7-3EOP5
MB^S&R<\0V7Q@02?W%1CJU5K',:A9])GK?7!HD^_"LO/[K@=>M5JU^>036.XQ
M,8WO)X4JJ6F6*T4S&N >T. <.".?E?2(B(B(B(B(B(B(B(B(B(B\%=#XC)O]
M+CC\L+W+WJWV"(B(B(B(B(B(B(B(O->]7WZIU9QVQV87FA8K"%\@'LK(@ZCX
M3,Y6CB\).+<DS@9GCPR.)0C1;%?5M^VS#9&81OO61/5>\^)&K8R-9N:ZRXI]
M64N9CZADG>SV^W#5FU:S7?U<V]@D;WD> M?ZJ"'K]8#W_KQ/IM7QUNQ3ZL&)
MVBI'_3T+(#B/X'*8=.(Y<G0R&QVHO3LY:8O'RR$<]@52ZS8US6][VG$[)%$7
MV;7J5[$S 6D*W<;E=:GL9FMA*<!C@K/^HLQ-#6!Y'ABA/\GM[/YMY1O(Y^L"
MZ.Z:IK6X9NZ:>2=2SF.X;ZBS]*<_L5ZAG\;G)A+/BY1"9N>>_P %<;I[&;>I
M[U7@(=+);D#&KO\ 1;+59M-AHD^G9I/,4T;O!"U=/J1/W[?,C6[/I6N,9>/N
M\\IT7G@FI;+V/:[_ .Z9*=+?39MG49C. /Q4<#_[+U=[O8KSI@/^_O/_ /*2
M_P#O":]_W^YW_E9?_>$O.X_E"5_^38OK'!E/KUF#+*UHDQ[W@G]W!9-1G-'J
MYM5>]/Q+:[I*_)\.9RG4FJ;/4O164R&6"Z0O>WW#1PO0OG@KSG"\T>O5M^1/
M#9Z;FU7/75ZS4GVI-8;5D N'(!L+5R]RK4Y^L>J17?(]+P/<%Z]#Q00QOE>R
M-K72.[GD#W*JCK<V;^8=LQO\"Q$9?W8N#A-0T'8]2J69)I#$^!AE/K<%KFA2
MX/TYO3UD+N]V($'IQ";R7M X;PJ&Z?1.UC=<=6S]25D$\3_PM\_GTNY61UHL
M^A8U265P^C;>YF5D[(=2LTH+^5^GFA@D$L+CP[S]N%6F_N99ZC]-RZ,@/?,2
MQZS]7*\7X_IMSDB9EXL:?V<MW;[L4W47&5<358_-LK/)GE?Q'#$2//'W*BFK
M4;>/ZVY!ES(-MSRXMTLDH:&#N>X+8PE2K/UXSKY8^Y\4$CX_'L>Y;8'H=?YA
M T 28WF5:S\K/KO5K-RFI+;K6:X=)Z [GQJ0:A@;\VW;)M,U2:I%;:]M>%_A
M[@[R7."BG3"C4RLVS06<Q?K6VY$E\,%ET0(/*M#4-3U37<UE&8VS9?9D#'3M
M>_O5C.]BJ1UG_O8W'Y[ M#$.:SKGG!:#_6-(^@2? CY7SUCJN_%]2LTPP7A<
M[(GIM-&"YUEUV.W$R3MJ.?P?D<*]ZM.K6:\PPL9WN[G=HXY<?N5FGL0PM'?(
MU@)XY<0.2J!D]0]?Y?28'@8H=ZQ;77CFZRZH7R]G9"7C]R$ZKV2WJ#H,C0Q[
MQ++^18=Z@BEZSZI%(QCV%OD/6UU,B]'J7H$E:-@F=)*.7K;ZO00NS6GSEH]5
MMXM!_8K4V>>8];L"R\6_3-@/TG/V>5T>N=*N_6J%SO[;<%^(0'[^5P=X@?=W
M3IC#D6%[Y _UFN^?"]"5\?2KS698*\<;IG]TKFC@O(^Y6IGLQ!AL3;R,[7.B
MKL[G!ODJJ-LZ7:UNM,9>B\5[EA@E9.SV?S\KF=(KVTT<IE]8S5D3?0 =AY+N
MU.G&*H3[]U ORPAT\&1,<;_@/+DTVG6QW4[=XV'B,ASRN;BI),C5V6OIU:*+
M'/?(;-VR_N,C_AC$Z;@.Z*Y1CO(YLK<Z+ZS@[FA16;%"O8F-M[P7L#B',7-T
M.G<S&P[HV3-V:-XY ^O&S^V.7*=:]HFNZ[DLI##EI9+EZN\RA_@@?=RJ8OW+
M0<=/BLICV9/67R<=_P ,*]0X.Q0LXBC/1_[-) QT/^ CPJ6ZO/[]FTFK:[OP
M]]IYG'N"X*9=7*%2UH&9?*SDUVB6+]GM51[B^>]T>U&2[%S(ZS4')\DM+2O1
MV*P&'QPKNIT88710B)CFM (9\+LW/ZB3_"?_ $5 ](<'B9G[+?EIQ/L_B#XA
M*YH)#"3R%CTG'G&]5]KJT8HX: C)?$WQ^<E<[-3'IWU(.1X+,3EVO,P \-E5
MH]/*5A]._F[;.+&6L&P?D1^2P*PKG]1)_A/_ *+SWTEUO!W?YTVK5*&:9]]T
M1+P'?DY*Y&PT8I^LL6._$YL?",8UE9T)X^/R!3F'0,3A]CJ9RUGK4V0>?3C]
M7WD*YO2)U2UDMON32A^0=D"'D^X9R5H5*L%3KMF!!X[\2^1W^,D+E=.<?+E;
M^TAFQ3U;;LBXS1,\N>.3Y*GNOZ?KVL6<]'5R<L]VQ6=),QZBW1# X>32)[[Z
M,+K4LT\;YBT%Y8OOHM@<7#'L$XKM,D=]T3"?/:Q;_2JM!!LO4:O%&UD3,F&M
M8/  _.N/TWUG!S[COKYZ$,IJY+L@+V@]@)<M7%XAF%ZXWJ6*C$=66B9)HQX:
M ]2'I1!'7V?J)#&.&,RC0!_]EZQ1O[.OUKM'OADTJ8VNJFYRWFGZN%YBKGXA
M!7UN6/;1ZJ:5D:K R2U))'8/W> M*7%T+G7VP)Z['B+&"9@(]I 1Y67*5(Z_
M7#%V(_#K-$^HK_9*P<-Y'/"+S9NVNX_,]7L!!9C!8^N7R^/U]B=8M=QF*GP.
M=QL,=:XV]'%Q'X+@5W<VXGK+KI/WHO6/?PP=4.G1'')DFY7'W37L?E>L>"BL
MQ@LDK]\S?</#$ZPTJ.!PM&IC*D56M=R+'VA&W@/X5OYO7M8S>'I_7,C-6MV2
MQ/:> P-5/=7*E7.;=H-9O8^&R9?\);X6WU2Q&%Q-[3I*U2&LR&[V-[&AH#%W
M]^FPD.Y8.XR">YFV-=]'39^@_N\J"8BQGH^MT+\I'!#:GI#U60GEG:5V=P@V
M[4MKR.T8FJR]2M#BU']V+XRVPXB]TBR]S!M=5$]CFU"/[#Y.2\+:QN@2;+H]
M"LS;9C1DBB>R(0CL8 /;CN5P:;BZV*U^CCX<@;;:S?2$I^_8JRZU7.RM@JLT
MSVU)[[1.!]P%,NH.&HW]&RE,M:V)D'?$0/#"SV(5-7(_K>@=!]IO>]DL8C)\
MD !6_I6D:QC<=B+E7&0MLLK-_I^!WDN^2K%F:P0N#CP.#R5YMBA[Z&U8S4,>
MVU'/)(;^0LN[(^1_99P'<KCZWD[M+H)DI8"_U!-+&'@^6!63JFL8+.]*L/C)
MVCT):L;WEON)./)4-W^[CX,9I^L4;#I,:^P(I'@^X@X;P2ICUAH4X^GMB.&O
M&&0R1-A 'AH4,ZC1NAZ0ZPQ\(C+9J8<P?LPJ3=3'1NZ3$QL+&%D'#5\9&-C^
M@+.YH/&(B*W:V#L9_HWB,=7G$<TF.@+.?8D-4$PVS";,X#";EAWT[U&4?1V!
M[$A2CJ%#$SJIT^E#&A[Y90\K/U(_[T>G?_%F6QUWBA?I<;GR<%N1A[5P]^GE
M.%T.D[@U9YH3.T^SBT*:=6\53LZ#E9'1-[J;1+ >/T%JJ_>R_)=)M0N78PZP
M^:H#(??A[5*.JNJ8.EH$0J4XX33GA,1:%<VLES\+CG.))^FC))_N50];[LS<
M7B*/J%D%G(1^LY2_J%@\??TG(UBQ@;#7[H7 ?H+?A0_4;MZ[T=+[G/<VD]C"
M3SRQJD?1S_8+"_\ #5FSL#XGM+N.6D<_'*\J7)]BZ>R9&E9QHR>O79B\S_L]
M=GJ9+AI>E&!.'>XT6VZS8>[W#0TK>ZH7+<'3C 0Q#BO/)699>K+SV Q&5T>;
M',#'5?HP8#]F]H\$+S?+DLF>B6)9)([T#E1#*>?/I#V:O1EK6=2SNJXVO*P'
M'01QRP.:>.UK!X5;]7+OKU-1LXCLF#K(=6^'+9Z;7*V3V7,/V&$C98IB.)/:
M.+XB5_HB(B(B(B(B(B(B(B(B(B(O W1/_;_'?X'KWRWV"(B(B(B(B(B(B(B(
MN9G,#C<U0?2R-9DT+R"6."Y^NZAK^NQR-QE"*#O\O<!Y<L>QZ7K>Q%AR6.BG
M<S]#R!W!;6OZQA=>JNKXRE'7C<>7]H\N/[K%7U#7*V:GR\.+@9=E<7.G#1W\
ME:O\Q]:_'I<U^'L-U[RXRGY*D68PU#*8V:E=B$L,OZVG[K[IU(*=6&M P,BB
M8&,:/8-"C6Q:'J^PV&3Y'&Q32M' DX\K<H:?@L9A)L75I-AJR\AT;?'/*T-=
MT77-<GEFQE(0OD;PY:>=Z;ZKFLC)D+-(MM//)FC=V/78PVH83#8:SC:E<M@G
M_K"3RY_R25K:YH^O:Y),_%TQ 90 ]<7+],=>R&4GR,9L5+$W(F=7D,?J<_("
ME.)U7$XC#/QU2$Q0O!#N/#GD^[B5R=4T+ :I';CQ<<S18X]3O?W)@M#P."RU
MS)TF3-GL\^KR_EI4S4)@T#!U=HGV*&:V+TKG=[O5/:0Y*73_  ='9IM@BFMF
M]+WA[W2DM(<5@?TXP'\YCL(FN_7^H7=_JGA8MFZ8ZUL.P5LO<8\R1- <P>TG
M"V=FZ>X//SU+,AEKVJHX@LP'L>Q?> T6ABK[\C/;M7[Y;V?5VG%[PSX'*FR@
MF]:!C=IK1.<3#<@/,%IGZV+!B- AJY6MD[^5N9&Q PB V27>ES[EJU]CZ9X_
M-[#!FSE+T%F'CT_3/Z%9,3.QC07%W ]S[E:V4Q5/)XZS3N1B2&=O8]A^X5)4
M^A&#IY*1\>4M_0//+J7V=_>5.MCT*KFY,0!<FJUZ'F*"$?DY'LM;=NFN/VZU
M4EN9&S&*X(8R,>.2MZWH5#(ZI^!92W/=C#N632_UC>%",!T4QN*R=>Q8RD]V
MM [F"K*S\C"I9G^GE;-;-5SDN5M,GJNY@:P>&)NG3\;-?QMLY>:!U.0.C#&<
MM7*VOI<S.YVMFJV:L4+L3 PRQ-\N 6C2Z-XZELL.9AS%[D-_I6$DND=\EZD.
M.T 4=RN;&W*S/ELAPDB+.&D./*U)>G;QO;MK&;E#P"/1,?([/CGE5W#B*FT[
M=M>1QVT3XF1ED1,,3O+RWGE_N%T<7_.;7MPQ>/&W/S,-N3B:&4DO8S[O78VK
MH_#D\W+FL1EI<=;?R9/3'A[BK U'4:>N59VLFDGGG>'V;,OE\KU*G@EC@#P>
M/"J7$=-\IC=LM;%_.1\L]ESO6B, [2UQYX'E=3;^G4&;R]7,4<A)0R5?PVRQ
MO/</@ICM(N3YJIF]@R?U]VO'Q P1AD4)/N0%H9WIM>R.Z,V6'8Y:\T1 CC;$
M" T*U@H#U!TANVXF.NVV^O/#,V2)X]E@U/0&X7*V\M=R<N0R$[!']1(SM+6+
M5ZB].I-FEQV0I7S4O4G'T90HS8Z,.O7\;DK^S79[T!YEE>.XO^ WSX4FS?3F
M3*;CC=B&:D8^F&!D)B#DV_IY:V/9,=E_QQT'T)Y@B$(> LFZ]/;&SY7%73F7
MU11)<R-L0=R2M[?M+CV&BR:!YCR5/E]2RSP6/4<Q6EY_.Q8F[MV3,SX.)118
MSL8)/EY73W+I[:V+/8O*19V2H^ASZ 9$'<$JS*[)&1,$L@>\-'<[CCD_/"Y^
M>Q/XIA[E$S.A^HC+.]HY+055531]UUV&*C@-E:ZE[=EJ+N,+1_ I;JVD,P0O
MVI;\US(V_P"NN2^Y7(TG0\CK>6S=V;-&T+\G>\&/CE_V<L&(Z=7J6XY;/6<R
M9OK&21NB$?'AZCV(Z193&2Y2E6V:U!BK#RX01^'E;^M=,,GA-:RV*;G9'"R'
M-B:6\QQ@J0=.M,R6H4)\=)DA9JEP?$.SM+7'W4;VWI--;SS\[K^6DQMZ0GUB
MSP'\J08/I])4PF2CO9&2YDKL/9-=D\N ^S0H8SI]U"."9K\VQ028UX:R7EG,
M@C'V:5>.(QE;%8VG0@']%6B;''_<T<*.[MIM+:\7])-)Z,K'A\,X;RZ-P4'.
MC;ME&18S-[$R;%,\O#&<2S=OLUY4@WKI])LE#%XVODOH:E9X?Z3(@[RSPU3K
M#5+M/'006[ILRL: ^8L["_C[D<E;[V![2T^Q"IB/0MMP.2R4FMYR**M<E,KX
M+$??V.4VUS7X,#5LW;L[9;UC^ENVG?VG?_D:%!-XO:YN)P6$J6([4T]UDO+#
MX9''[DJZJT,4$+(XV!K&@-8T>P 7Y;9)-!*R-W:2PAIXYX)59:)H&0U:Y>G?
MG'6&7#WS0>D&-[_D'E?'4;IG!MAJVX+9JWZO]5, FGZ!=Q]MN2SV7GR=^,%D
M+I'ES(FE<C-=++\.QV\YK>:./GG/$D(9^0K7U?I7F<7N#\_=V*6S(0>X\>9>
M?<.3;>DMVULLN>U[+NQUF;GU>SPI1KFAVL7B<H9\O-8REZ-K9KDGYRU-!TK(
MZKKEW%G("?NE<^)W;P&<K5Z>Z=G]9_%F7+\,[+<GJCM''$B:;I><P.>S62LY
M.*5F1E=+-&UG'YU7&JP[9)MV_P ^ MU@1E.)(9Q^1_)=P>5;NIZ?-C;=O,92
MT+67N-'KR@<,8/X&*,Q].<U4W#)Y*CGY(*%^SZUB%GA[BLD^AYYW4C^<[,A"
M(Q_1B/CSZ2W-GT/)3;+%LF R+:M\1^G(U[.62M_=;&%U+.3[!!GM@OQ36:\3
MHZT$+.(X@\@D\K4@T;-0]2K.S?B,1@E:Z(Q$<D1? 7WE='S-SJ#1V!F2C97J
MM[&Q]G+B%&<O5S=?JWC)*F;DFAE>?6I@GB*%7TO-N^P9J?JOKS<189#:%8D.
M?Y:IQ5TW8\WF*&2VBW7[*+RZO3KCECC_ !O)X3J'HF8R^3QN:PEME;)4P0TO
M\!P*C,O2S9[^:PN:O[&3=@=S,0WPS]HUVMAT7:<AO%;8JV4AC^F ;$PCW:IY
MN.J4MJP-C&6O =PZ-X\ECPJAU_I3MT#XL?D]GF.&B 'TT3R/4'\!4FW+I[EL
MOL6%N4YZT-;&<>A$0MCJ-H^<VBSC16MPP157^IY\N+UH[?T_V#(Y_#[!B<FR
MOD(6!D_=^@A<AW2[:#NU#/'8.\]G^DRD<.!^&!2RQKN[4LKF7XG*5A3N3.D$
M,S>[L<[W(6SK'3RO0U7(XB\YLIO%S[):.&<GX"K'']+.HF$F_#L5LW9B7N/>
M0\L>T'X:O0V%P]/#XZM2K,XBA8&M^3^Y7'W74,?M6'DH6.6N#@^*4>['C[JN
M&ZEU'M8UF O9>J<<6!DMP<FPYG\'"[^WZ!:NZG3UW#2Q5*L;V$\CW#%,M3I9
M;&X.K3R$\<LT30SU&?=K5W+$(F@EC)X#V%I/]X7GC!],=VQ#\KAZV:BBPEIQ
M<9&<^N5(]"Z<9/$ZSDL)FK;)JLY>&P1^6@.42J]-.HN&F&+Q6R%F'DDX<>\A
M\;/V"L+:.E>.RFHU,35>89*9!KRGWY'W<JHVW7-[HZ/,,]GA+!6F8(XH^27_
M  7N5O975X]JZ?U,=ZH:\UX7PR>X:]H4 N]/.I&;U5^,RN;JL,(8V"O"#V2
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MU6!W;R.>$$K) >QP*HK)VLO%UCQ=9^1E?3EK.>R#DAC"KU[VM9R2C)&/'+7
MIR$3D)RG(1<;9)LA#A,C)CW=MED#C$>.[@A0?H_GLIG-.%[)6733OMR N*M%
M.0G*<A$Y"CFX[''KNO7LD8^\Q- 8S^)Y537(^KC\;C,OBLLR66S"'STBWAD1
M>/9JL+0AM\&#>=HG:ZT92X?LQ2C#9VAE66I*C_49#.Z$O^Q<WP>%TDY"/<2T
M]ONJ?U#8]GM;SL>+R=B,Q5/ZED?@ *X.0B=P1$Y"<^%2V3V'9L_M^5P.#R4=
M*&A 3)/V=SWS?"E/3J;<#BK46S,(M16"QLGVD9\J26]DQE;,T\2^4_566.?&
MP#GPWCDE57LNW;)1ZH:]AX;09C[3P2P#AQ5X<A$Y157N?427%9>K@</1^NRL
M_P#\+GM;&/ERT;,O6"A#]83C+C&-+I*;.6D?LQW"EO3S:KVRZ^_(6JHK2FU)
M&80>>T-4UY"(B<IRB<A.0G(7(L9_&P9:MBWS?Z5.QSV1 <GM;QR2HIN,V[1Y
M3 '!-!J&?B[\@*PDY"<IR%7FT[%F];RD%V>%LV$>6QSEHXD@>?9W[A6#!-%-
M$R6-X>UXY:X>Q!7TB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(O W1/_;_ !W^!Z]\M]@B(B(B(B(B(B(B(B+S
MSO=2.+J_HUD<]\[G!WC^!;O5ZE7?L&H7BS^G%WLY7,ZJ8EMKJ5I9AGDKS7#(
MQTS/<!BX&V:SC-'ZB:?9QGK$SRO,WJ/)+R%,]CGEV?JC6U>P_G&5*WU,L'VF
M=\/46ZF:EC<5N.I7L=2C@9-/V3"/PWD+H]0K67SW42KK,5**W4JP"RZK)*8F
M2GY<0"L> TS<,=U!AR=7#T\9CY&F*S#!(71EG[>&KA1:<_+]5=EQ;;EJ&EZ+
MS*YKOW\-7H?2=5CU77Z^)CMOG;&XGO<..25".K&*L7QAS/D8(,1#/WWV2G@.
M585<MA*G5S"'6ZLE6G;:(I&]@B9*/EH"W]NUZU8ZQTHJN3GK"Y7+C(T_G8/N
M L<>&IZ3U:P5/%/G]"_&6S-?(2NSU=P]G#Y7&[+4?*VL;+6WV,\!WPXJ:;E?
MCV!FNXC'V7 9&9LYE9[MKL]RK3AB9! R-@/:QH Y^ O.NW9[,Y??K&';C[UK
M&T&<R053PY[_ )<OO0*^[4=OMQ'&9&MA)XW<,LR<^FY<O5L7L^;VO<\:=BNL
MHP6RR63N)E<02&@%<W6<=N46XY[3X,].RH"7OL\DO:QAX';\$KN:P<EJO5J7
M7OQ&Q:I3U@[B5ZU\M5VF]U<R6&K9VS#%/4,@D!/,$+R/# E&;8.GW4&CBI\E
M+:Q.3<0PS.4LSC".M.O-/_X$_P#]6K/DK&0VK?+VN_73UL71@YG$+S&^61<2
MW:R73K;\34CNV;&$R)+3',\O="\)U7_G%@LWC<O6SF09BYK 9:B9(0UA4UWC
M(V;[-=QN(R$\,V0N,>)H#P?0:#W%0C9]MNS[M_-YMS)5L=1CYGFJ^9I'_!/(
M\)HVP[/6W&]CY9,A<P\P>^">T/SLX6M)M\VQ9+-NERN4I5ZTSH*D5('_ .W>
M00I1TDV':;)R-#,QSRM@(-:U,.'O8K=R?_8+G_ ?_P"B\F].\+O^8TWTL1F!
M0I1VI"PL)$DCU.](ZB9BMA]GK;$2^YA1Y?\ =X"BD^S;#EM=&7;G<M'DG,]6
M*M7C+:_[-\.4FR&Z;;9Z309QD[JUYDXCF_)P9 N5FY^J!U.'9W90TVUHV/\
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M-RW-*ZER9RRQ[\5DF%D\C1XA>MK,WZ6];CKE3%/^HHTGNL6YV@AH^&A6IM^
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MC7"(?QEA45H['KN8SVQNW(OGL59BRA1>SO9Q\,8?=RW^E6R82EB-HHO)KO\
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MO*B^MMSG^7"=^4=7CLG%]\C8?+."1X7>B\=?KW_15'<L<MD^M-FG'E78UT5
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M@SH;$Q^_5"Z0,[8'D+WFWV"(B(B(B(B(B(B(B(B(B(B(BJ3J#K]Z#,8O:\7
M9+- \3Q#WEA*FL,N!W+7B>SUZ5EO!8]O!'[$?(4,UWHUI^!R0OQ12S2L>3$)
M3R&+8ZB9=ENA8U>AW29.^!& WVB8?=[RIKJV"AP."Q^-CX[:\+6%W\1 \E=J
M6(R1/;WN;R".1[A036-!J:]D\C?AR5R:6Y)WS"1WAQ4XO8^M=I35K3 ^*5A:
M]A'/(*XN#UC'8;",Q4 <ZJQI:ULGDEI4&9TIJ4)+GX+FK^-ALGF2"%Q[%.\)
MK&*P>)./I0ED!YYY\N>3[EQ^Y4.UGI9@]=RS[]2>R1R3'"X_D82IAF=6Q>4O
MXNY:;WRT9.^+XY*UMLTS$;-3K0Y!A/HSME80/A=Z;',_#WUHGF!IC[&=@\L'
M[*&:=H=751?;!?L6&VW!\HE^[@H_B^E4>,V2YDZ^;M,JSSF9U%HXC+_MRNKJ
MN@' 9S,Y4Y>6R_(2%\C',[0"5DI=/:]3:+F?;E++K%D/$K".&$.7$I=.,]CJ
M^3J4=NFBK7)'O=%].#V%Y\]I[UWW].<8-#_FL)7B'LX$O'GO_C43AZ/B75)\
M/?SEJT_AGT\C_P!-?L]@QJT1T:LW]=BQ^7V:[-+$6>A]XH0SX:NUG^E3LOB<
M)C_QZ=K:'GU)&>JZ1R[^W:7?V;7ZN+FS3H>US'32LA_K2S]N5I;%TY;G-/IX
M>S<+K-1C!!<[.#RQ0>UTEVG+X:*EE]MGF$+V^DSR6*>YOI_-DM/KZ[^,3")O
M:'SO9WO>&!:&3Z;7,AIN/UMV??'%6+ 96P^7M8. ".5V<AI=V[I$>NNRY',+
M(9+)B#G2,:H'N&-AUOIK!K-G*/GEFE9!5E(]/A81J?4+$T RAO37PQQ M]4J
MR.G6;S.8UF&QE7L=8$KXR]GED@9[/"F>1H5[U&Q7G\LFC+"!^ZI?4.F.=UN6
MS'%LTWT0[_0K<?DY?]WJ2:#I.0U:MD8Y\M]2;<ID/Y..UZU]-T/(8/*YZ[;R
M@L#)2%\L79P"5";W1K+T,Y9MZWGI,=!.>7Q,)9VJY-6UFKKN,%2&629[GF2:
M:0\ODD=[N*D;N>#PJ>'3[.Q[^=F9FP[U&%CV%G'#/LQ=7<^GQS=ZIF,?>?2R
MM7^JF'LX?#EIXS3MDR66HY3:<A#*^D>8*T#>(N[^,K%LW3G)YG<*V>CS0KNI
MN9],T1!ZGFRZS4V/!3XS($EDO![@/(>/[05-8+I#L6/GBHS;1/)A6O)?5!+1
M(WX(6WU9AIVK&K:]5NBE9DM!T)'AD;&+4S&,ZFX*B^W!N4-F& AW$[B"]@4F
MS&I.WK7<%FN74,Q' R:*0?V"\<EI7V-'V7.3T/YSYF*Q6J3"05HHN&S.'W>N
MWU&TN]M-"E1@OLKQQ663/Y9SY:M+=](RNS8S$4/Q8,96D;)+(6<F1[/8K[W[
M2LGM6!I8X9-D9AD8][C%XD<U17J528S4L#K,N3 NSVXF13$>FPB,$%Q6G:U[
MJAB\>36W:*81-YXF>L.W7\[F^GF)RS\F<=<8]I[ X@3/5W:S)D9,#C'W^?JG
M5F&?SS^<CRMO,4K-S%W(()#&^2(M:_X)5>=/=-SVJ:[?QK[D4W+^^ _9KG+G
MZ+I>TZYF<E;LWJUB/(R^K9^SN]7$JNZFZ+?V2''V<;/%%?I2]\)>N-M&B[=L
M.O8O'6LQ"^5DWKV9"W_X@]@Q=[;-7SN?U"##_4PLG)9Z\Q)//8%\7.GK,UI5
M+"YB826:T36QV6^[7-42U[IEM3)H:6=V!]K$P=KHX \GN+5?@' 59]1= ?LY
MQUJI=->]1>3"_P!V^5#\OTGS^4M8G)6=FEER,$G+IB/#!\,"U=WQ=K.=0</1
MH9I]:]CJ3I))W_+^..%BR<G5/6G#)3YZI>JQ.!DKEY#I.?LT+XVJK9V;?\8S
M&9=V.OT:3G3]WO&YW'# L^4DZE:P:M^SLE2[")FM?5+N#)W?9BDN:T+.97=:
M.QQ91L K!GI1%G)'R"IUMFJ5-GU^?&7C^O@LD Y+'C^T%3N)Z1;/":U"]M,T
MV'B=YJ GM>T>PX6WU1K#(YS6,%C;SJ=MCC+'Y[86,:L66@ZHX&F[)NVBM:C@
M(?) \\![5OY73LKL][ [CB+AQM]]1ADC>%^0],-GBW*IG?YSR.D,/;:EXX?_
M ( NEM6@[#9W2ML6#RC*TCH/1L=WV8%\;KTK?F8*-^AD)(LU4C:UELG@R\?=
MY6YI&D[#5M0Y3:,L^]>AC,<#.\O9$#[GDJV^/"I#:- VP;R-DUV_!#)-&(YQ
M+]@L.+Z7Y_&[RS.C8'S-?&?J)'CB20KM:UI>PXS=,MG+-^&6*\7E\?W;R>0E
M?3-B9U)L;+):K&!\1@$8]_23*:9L=KJ)1V&.Y *U4=K(_N6K6VW1\U7V8;1K
M$S&WW\LG@E_1(TKL8?5<]<SM/.['9A^JJ1OCKUJ_F-G>02[O7"W?0MFM[;0V
M#7KL,%D1>E.9/X%I1=,]F9NF+SDNP&<QQ'UY7CSS]F,:NP=-V5G4>;9F6:OH
MNB]#TC[^DF6TW9;'4&KL$-JKZ%9I9'$?<M6AM^B[?+O5;8=?NP0/, AG]0GP
MU7+CZ\]>E7AGLNG?&P-=*[P7D>Y42WS2Z^U8CZ<O]*>*0203 ?I>%";V#ZF9
MO%QX;*.QK*CR&VIXY"9)6#X:6A2G;]6OVM,DU_"-@B8Z%L(]0\ 1A.F^"SVN
MX*#&9$5^(.1&^)Y/(5A*A=AZ?;E0W"SG=1N5X3;Y=9BG<0TO*P87IWNYWBIL
MF8RM5T@C E]/_P!@4ES6F;%:ZB8S/U[-<5:WY#&?#NQ6#LF#BSF"OXZ5H[)X
MBWS]BHUTSTUVHZW'1E],V7N[[#V?=RC_ %!TK9,_L6$N5)JXK4'EQ8]Q!)*^
M.HG3W)YR]0SV%LLKY>J1QR2&$*&9;0>J^R9#&SYC+48FUI@1Z!/A3+J#TQN9
M^.EE*&0,69J- 9/^@2K[U/2]M=<K7]LR_P!7+4)-:!CBY@?_ !N)6'7M*V>G
MU&RFRW):IBG+V,8QQY]-Q2?3MK_RJ.V1CZHI&/T2!(0\QKEYWI]NF-W&YG=2
MNUF"WR9XIR0WDIA>G^\1[U%L62S%=Q, 9,6#W^8P%TK.'ZD4+>Q0T8\=;QUV
M>5\#9I7-?'ZI^.TJ1],-*FU'7A3L2,?9DD]28L\M!^ K%F9WL<SGCD$*B-?T
M7?,%GLJRKE:[<39LF?YE<1[!=;I]JFW8/.;);R?T9BR4IFYCD+G=ZQZWJ>W5
MMYS>7R3:1IWVO!#'DO"B5WIOONN9R>73<DR*C9DY,#WD!A4_&G;#!J&9B^N9
M;S>0:/5GF)#/V8/?PU-*US:,)HEC$VVU#<C:YE4M>2P@_P 7A.DVK;%JV#LX
MW+&N1Z_J0F)Y>K1L0B6&2,GP]I:?[B%YWPO3G?L)8S&)QF7@KX>TXD3<%\RZ
M>B=-<]0P.4PV;O,=0E$C(ZT?W[S^LE1;#=-NI^)G=AX,_P"EB)"[\['GEK%9
M.V]+Z64TVKAZ3C'+18WZ21WRU0G6-1ZFVKM"GLU\G%1'N>QLA)>8_ !4@VO3
MMTO=0J&=QKZ<=:H UO=(0YP5A[?K;]DU:]C'D,?-&.'_ &:\*DHM ZHWM7&
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M]!E2"&5[&Q^_AP 5T@HB*$[KO6+U2I&Z<.DL3>((&>[RHQ2R756[7==&+QL
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MV870RQM>QWZFN'(*^36@$3(^QO:T@@<>!Q\+[1[&O'#@"%^-AC8P,:T!H'
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M23OD+W2NB:7%RE7"BEO1-3MY;\3GP]62UR292P$EQ^Y4JGK0S0/BE:'->.'
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M;0Q0_P"%_P#"5FUJM>K!'!!$V.*-H:QC1PUH'L %#,]TVU'.9*6]>QK)9W\
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MPR7TS(V/F/N77R>\ZQC)J,-G(M;); ,+?NX'[KG_ .4S3OQD8D91ALF0L_\
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M-EG+JS059>1QVUV-$V&>_5,^3R+ &4F#O;"W[,32:V<QG3)]6;%6&7:\+XQ
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M/@<9.VQ;LWXI@QGGB-H/)*X^W9ZM0WO&Z[F+DU; 14V^&N($C_\ ZUS-'S>
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M)H8*7)$W!>\CGPNE'ONTZ]OM77<_-#:JV2!!;#.P\*_^]H^Z->UPY!""1A)
M(Y'NH'U&VF;6M;EMP=OU$DK((.?L]ZAS-:Z@4LE@LA5V&Q;8\C\0@GD/9Y]R
MT*[6RMY(Y'*%P'N4[V\D<^R>JSY'D\(][&#EQ " @K7N.<:\H9)V.+2&N^"J
M8Z0Y;.W+^WU\ID)[#ZMUD;?4=SV^ZN^1X8QSO@*C,1EMHW7-9HTM@_#*5*P8
MHHHV=TC_ -W^0NM@<SNU/?/P',6HK%4TY9H++(^QT@86A3X[-BAL46#]4NN.
MKNG+1[-8T@>?_%=_E X'V*(]Q<UP:>#QX5&Z#GMAL;[MF.R.1DGCK2%L8/@
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MZK_ #'*';#JF*USJAHWX<PQ0SS//HC]#"U=+;+M_9-\OX=^)?>Q]"'@UQ)V
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MY['3U71D5^'>3P.Y2;J7MNU5<'JU^G;DINMEAF@]B'E8=[N]1-:?BMAGS3#
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M6@H&@)PA:"@ "+YFJPS,[)8VN'<'<.'(!"^N%^>DWGG@+]0M!7RRO&QSG-:
M7>Y ]^%]$<KXCK0Q.D>UC6EYY>0..2OLQM))X"%K2."$#&CG@!8#C:;[+++X
M(_58.!)V_F ^ 5DFJP3CMDC:YOPX<K'3H5*4(BKP,B8#R&,' 6=?C8V-\@ (
M0"."$$3 >>T+]+01P0OEE2'N+O3;[#SQ\+Z0QM)YX"+4AQM*">6:*O&R23];
MVM +O[RMLQL)YX"-C:T$  +5;C*3+;[3:\8G=^J3M'<?[RMIS&GW 3L:&]O
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M@9+$[RYKQRTK6=@L2RFVI]%!Z(?W>GV#MY_N7V,)C&TC4%.$0EW<8^P=O/\
M<ONGCZ=)A97@CB:3R0QO Y6P0"."N36P&'K7'VX*$$<[OU2M8 XK:LXK'69V
M3RU(GO9^ASF@D)>P^-NS>M9IPR/ X!>P.*V)*%>2M].^)AB+>"PC\O'QPM6A
MB<=CP]M2K%"''EP8T-Y*SV\?5NQ>G9A9*SGGM>.1RON"E7JP"&*)C&#V8T<
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M*A=M]D]D\11@<DJ2HB(BXF?V3$:_3%K)6A#$7AH^7./V"[-.S#:K130DEDC
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MSJ'I;-NP I%P9()V/8\J383$5\/B:>/K@".O$UC>!QSVA5S#I6PQ=2)MG-Z
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M1SB3 [M]N]:/3[1<[J>)RM)U^"7UR'1<-]GK8T71\U@J6<K7[\4XON[^&MX
M>5PW:-OD^M#7+&;JFB6MC=(&<R>DW[*XL%B(,/B:..A<71586Q,<?<A@X711
M$1$1$1$1$1$1$1$1$1$7B'^3W_MS+_T^5>WD1$1$1$1$1$1$1$1$[@B(B(7M
M! )\E$1$1.0B(B(B(B(B(B(B(B(B(B(BCVUX.YF\-8Q\&0-/U_ROE#.\]GW
M\A<[1=3EU7"MQCLBZW&QY,;G,["T?"F2(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B+Q#_ ">_]N9?^GRKV\B(B(B(B(B(B(B(B*DNI.XY&OGL)K6/M_1OOO\
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M6PZO/B64:L!ALS!KIG'DJY6.Y:"B(B(B<HJWZG;)GM>P'UV*BA)$S&2/?Y[
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M&1Y6BUHBE#R]CBP*.ZOK_5>ZZ/%9Z_Z.,A\2/:299@/MRO1+(&1Q-C:T!H'
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M)9!9TWIA9F?78^W#5,MEA\M?._\ 4J1SD^!RO349+)YI]C)OB88*S3Q' _\
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M[+L8,P?Y'*A9QQ^#MY_OX41QA$O0"V&>2*9"LWICD:<VBZ\&3,YCHQAP^X+
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MR%2S+[)A,*&G(WXH.?;O*W\5F,9DH#8J6XYHP?=A7)L;?KE>Y])-E:[)_P"
ME2%CVO:'-((/L0OFS:KU87RS2M8QHY<]QX 7%EVK QQ03/R=<,E',9+O#@NI
M^)464S:^IC$7'/J]P[>%HQ[%AI#5#,A ?J/ZG\WZUER.;Q>.[?J[D4//L'E;
M-/*T+E;ZBO8CEC]^YIY:N94VG V[,=>#)0/D>> QI\K<ER^-9>CHOMQMG?\
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M9% *D_$;1X'+PMKIE7@J]2-W@@B;'$R>1K6-\  .71U2H(.LNTF !D387<L
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MG#K+?4+Y)WL]FM\#\JNL,K5H&P@-8P-[6M\  ?"I32M.Q)WW9LS6Y]""T8X
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MXNZ_L$?=RYA^7N7H0'D<JMM[W*YAKF&Q6/CC-W)2EL4DIXB8&^Y*QX'*;?\
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MW^P"KZ]O.]X)D.3S6NUVXV4L[_1F+Y:X/\7+0NMOG4B77<-C<I0Q_P!96MD
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MX>/,/8R>JQ@=%R\./!]@ KEQ[J[J%<P0NB88V]L9 ':/L.%1.>LR4>M^(EM
M?2STS%6<?8.76ZX0Q3:MCV,\SG*0"'A1OJ+#/7W/IO%.SZF5AD#VN_MGPMGK
MLP__ )MO8/SB]PTKT*SGL'/PJ8WC*QG<<+C,;5JMS#HW.9>G /H,/'Z5 \96
MFQW7"M'<R\ER0TAWSO4EUN.%W6W9I2/SBN_M<M')?_Q P?\ ),7HSD!@5",M
M39?;]G@UZ:O0AC?VY&[P#++)Y_0M;HI)3BI;A6?.7D7!ZKW'DO;^91')8[/:
M15.<UJ[]=K=EWJ/K.\L8QZLO-G>LYA->OZ=9AI024^^2)SBSWX+0.%'LOC.H
MS.G6VQY^Y'/,?3,78XN_HF\]ZF/3O+:_D^GF*KRRP/CBIMAL12$>[ H-U&R-
M"W@]6NUZQ&*AR+6\ ?D#1X:K8WMF/O:3F!*YKJ[ZI<'*G[C)8N@>/9.""3"6
MAWP0ISN4$!Z/7&F-O#,=$6+J:IC(<QTMQ%";RR?$QL/_ -JJ3U>]D),<_IU+
MZQLQY4-D(]A69SWJ?]>&2QZICPQ@%1E^+U%T&ZWTTO82/)2O$M0QB;\\O*X'
M488^>GHGIUC'5=9C[(I1P0SX*N#;VM&LYC_E7JHM9$MOHD^O2F LFF\-X*T^
MF^"T;/ZA3^IX]:*,1V8C+QY3J#!A:73D08!A90BS3&3=GL>.>Y69M%S"6>G^
M1<R6+Z-]#\O!''"U.CA'\P<-_@71ZI_]WVQ_\JN=J<&.?TLQ4=L,%=^)9ZO_
M -HJNP60QN$Z-NELT19AFR3A4BF]G]_EA*XW5#'Y".CKES(YPV)Y;$?%6/Q!
M$/V"N#J#KF*V<8VK%?%;+QL?-1E'PW@.4<T39=EJ;6=9VF!DET0$UK@\ES%J
M81@9U\SGYFNYHRG_ ,7A?&SZQGZV<RFR:3E6!WJ/^OJ D R,5E=+]K9L^LLO
M/ACBL"4ML1L]B_Y4SS.,BR.,MTYARR>(L<%Y1UW+9*ECLKTZXE%QU[T(9 /+
M8CSWN6>C9RFHR9_0&!\[K=AK<<3]V/)Y<5<V^XV#%]*LQ0@'$5>@(V#]@HO(
M8CT  B_W3&I!TZ-*+IKC616&N)QQ<\?!+?*XO0YD7^3B7P/SV9^].A[((\5G
MF0<>D,D0Q7)D_P#L%S_@/_\ 14ST/GA;T\[#(T.-N=9NC;(C4V<\#DY1W*CF
MIP.%KJU7J,X(N$1L9X_C7+Z5X?1LWJX@O>+4!(M1/D[5>>B_S;AQEFO@ZSF5
M(++V-/'Y'O\ N6KA=8,*_+Z-DHXH^^6 MGC'[L7-Z+[-6RFFT:SI0)Z0$#V*
MR<QGL=AZ_K6I@WEP:U@\O>X^P 5)9BXS']<Z5B\ (;- 10&3[/74ZUB*7$X2
M*  W792'T0/U\+4ZB!K^I73ELGG^EF63K!!6?EM1?(QA>+_ )^%DZ[00G7L7
M.1^=F5A#2L?5YD$MG462AI8;XY!6SUV[!J5'GV&6@6[U7?6'3:=U8#T>Z$Q\
M*$;[:>=3T/*/K.,$;X'2_#>0K@W2YC+&E9:=\L;ZTE0D./D'E4)G:LM?HQJ;
M)F\%]^J_@_!!5L]71&S0+('  EAX5@:R\'!8QP//-6/C_P %VD1$1$1$1$1$
M1$1$1$1$1%XA_D]_[<R_]/E7MY$1$1$1$1$1$1$1$7"S&K:[F9XY<CBJUE\8
MX8Z5@>6K#F].U[,P58+^.AFCKGF)KFCAJ#3]8$M*48:F'U&\5R(AS$/AJ[V0
MQ].[4EJVH&312#A['CEKA\$+Z=0J-I_2^DWTNSL[./R]OQPM3'8VGC*4-.G
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M&-5U_(LO,]:S-'YB]7V8NQG.FN+S&RMSD^1O-GB:! (W%HC(^[2I3L6N0YS
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MD+KZ+IV=M5M:V*?8[3W"F'_3^>S@@=K5$KM&G!CL]:V3)2R9^261U9L+R\Q
M%=/ZG^<O0>Q9R)?--48>'O\ )[XO *D_2/ 46:14O,,K)YZSFN>UZXO2#*3U
M6;P^S;EE95LM+3*XN]@]9]+P-;J)@[6=SMBS)--:D;!&V0AD ;_ LFAY/)8S
M8]CTN_<GG$#))*LY/YPP**]--=N;%)M5.]F;WTL5M@<UKR'2D!W'+U-.CDEV
ME?V[!23R2P8^\(X.3R& <J]W$-:2J Q$0W_;]F&4E,V,QLX@@J<GTW'SP\A:
MM)K]&ZFT,/4EE&)RD9#(/<,>H^[6\MFNJNRT(<K8@J^D\32=Q<_L)\,"OS2-
M6.K8&'%?7/M"-[BV1S>T@'[*6HB(B(B(B(B(B(B(B(B(BIW=,?=GS;WQ0/>W
MT6>0%0?\GO\ VYE_Z?*O;R(B(B(B(B(B(B(B(J:V[![M%N='.X&&"1D=8Q31
M2/+>\%:.T#=-QQSL&==^B8^9AGLRR<LX'\"[>]:-/=Z?08?&Q]\M(PF ?IY,
M0(7+_FQL^WZ'/1SD#*EEOI&HSW+7Q@CEZT\;D^I+<*->DUPMMMB$#;YD_H./
M8O*[>3Z8QOZ;1ZY!(#-"ULD4I\!T[57F#FZT,J,P$N.[(V\1?6O]VQA2;J)K
M.?$.LU<%C3:AQI#G/)\GM7#W#5-HPFVT-HU7%O,MEA-RO'[ JP<_F^H$FNXR
M]A\1Z-Q\S?J:TGYGL:K2K.G?!&9VAK^T=X!Y *Y.Q3VJ^%ORUJ<EF7TB&1,]
MW$JD>C=#9\'C,OCLE@+, =S-'(?N?A=[I/2SV-BS<63Q$U;ZB<V8B[]^26E:
M/3>#8*>Y[8^]A[%:#)6'6(WO'P5>Y7FB27;-<ZD;!8BPDF1=?)%28G@-:3X'
M*RZ)A]O&P;AC\OBX_3R+R^U:8\AC7>?$:U-6RFW]/I+>MOU^:[5$[W59X_'<
MNGTYQFQSYC=HLOAS!%DI7/DDY\-D\_E"Y6HY+;NGWUVO3X"S=A]<NJ2Q>Q79
MZ3G8V;-N,N2Q3ZXM6#-+\,D!/Y%NZ;8MS]2]ENG&6XZ]KD12O9PWP5SJ+]IU
M?J)L4%/#OMP9:QZ[)3^1@6WL4]R#J[A;8QMI\,$/I22-9XY>MC8\;F-5WX;7
M1IS6Z5N,Q78H_+HR?/<%\9.1_4+8\,RC4F9CL=)ZUJ:=G8>\^S %AV&S8'5_
M$668^RZ""(PRRAGY07K5ZM_7-W33YZ]6R13<]SY&-]@[A2K:.JGX!LV,Q[\5
M(^G9:QS[7\/>K@!Y54]97/=IEF"*&2266>/L8P)-EHI>EAM^C,.: C,?;^</
MX7/Z'9>&SI\%)['QSU"6/80KF*\NC/R8?JAL+\QA[5ZRZ0LQKV,[^QO/AH67
MIQG<C1SV\_B>&M02V938>.SQ$1SX*[?0W+&>AL?KUI(7_5B?@C[.Y3I-EJ]G
M;MY[(Y@+EWUX2YG + 2NGUHP,DN/HY^D_LNX^<",@>2'JQ-*Q-K&8*%EN0R6
MIW&>T\C@F63RY2LKS7E\[5P'7&Y<N=WHG&!A+&\]O*Z]V9F_;UA30+W8O%%T
MD\Q'#)'GV 6B<S4K]=[DTK961&D:@>6>/54AZN87(N.&V2@QTDV(E+G1M\$L
M<M/:=YQ>UZD_%8EDLV0R;6Q"N6D.BY]R]<KJCBWX+I?KM![^]].W4C)'W+&E
M=S:-\IYC69<9B63.R=WB 0EA!B^2Y<G;-#RF*UW4[>+9ZMS L'>&>"\>.\A;
M>V[]B=FU,XG&1S27\HP,$!808ODO79R^5BTG":QB[M8V:'HBM:X;W^P]U M7
MQ6)'5!LVK-F;C75'&UP"V,$K4_G%G.FFWY>F_&RV<5=G=/#VJSZ,V8WG 9Q]
MJL^I5GA]&K6?[N^7N5>:-NUC4L:[5,UB;QOQ/<VL(6=X>"NIT-ERC+VUQW*-
MB RVVO(</R-<.>6KT1,7B-Q9[\'A>6,+LOT>P;5#?P=JWL%F=[:Q]/GAGGQW
M'V:MCI'=NX?5]JJ7,;98Z N<\EOCGR.U2+H;D8FZ'>JOCE9+5G>]X+?M(G1S
M+,%/9@^M8C/UCIQWLX\>5R>FDC<[?ZA12Q2P')3F1G+5']4W?8M ;/K>4PT]
MD12D57M4\VK,9R?ICG;6<KO@L9!W97J-'<8@?("W<5D8&=&XR]DC3!C1!(TM
M\B1H4&Q.)FVCHK]#6KRB[0G#FQN''+F)!U698T:;$/Q5MV6CJ^@Z,1_D3&Y,
MCH/=@L5IHI"PP1 M_6IGALM .C,4DH>ST<>*Y'!Y[VA9.F63JQ]+^9B^+Z2&
M2.8/:005%.FE"3.=*,_@&@Q3][_U#^-:6H=4\G@,=!K5_!6)+U-H@A$8]PU2
M+J=ELLWIY6CR</\ I]ZQ&]\+>3Z877V[*57='7O:)";5***(!ODN(7 MNGR?
M0FDVK6G<^O%"Q["W@\Q!63TWVB+.X2$Q4K,3:T4<;C,WM#G\>0U6%9:70O:!
MY(*\W:#E[6+RNP:W+BK3[%C)/)>&_P!&V,\\N+E@T_(S=-LWEL)EJLHQT\_J
M5K3 7A2[6<4_8=_R&XFN^*F*X@I"1OF4?QA74O.NWW;>K]6JN>-&>>K<I?3_
M -&SDIN5ZW:WW0[3\9:8:H,EEH9R&>KPMKK!D0S+:W&VK9D]"X))'1LY !6G
MU%H;!A]LI;SA:IL1>@&3P^S@U2?5=ZV7;\C3%+%/HT(B'VIY/=W_ -#5<JI/
MJ]H][,14<QB(^<C1DY#1X+V+[PO6C!2X^,Y2"W5N-'$L7I<CO4EP.4S>RV9[
MKJ[Z>),#XX8I1Q+,7_VW? "K33LE#TVR>6P.;8Z&K//ZU.T 7,<T+O:I5DV+
M?<GNC*\D- 5?IJPD;P^3_P"M<SICEXQO6ZP&"5HO7G30/<W@$1DK!U>R8Q6[
MZ)?,3I! Z=Y8U;VZ;+!NU>CKV ;+*ZS/')8E+.&11#Y6/<\'=UC;L+M..J36
M:L-<5K8;[MC:FY9:MU _",#A62R@V8[4\Y9PR)C%S>J>3@QF^:5-'!(]M#O=
M(&L\!KN%/.JM_,'1I;.%,G,CV=Y9X?Z+@>51>=S,>2T/&4<)K=F*M2LUY+DW
M9V?TK058W52UD+.N:UL$%"4""S'(^%P_..X+M[9L_P"/=,<Y;;CK,#;,8CKM
M>W\[^5QH\)-MG1S%TZ<;VW*4<!8R0=G,D+5O0=3(QJ,E:W6LMS3(! ZJ]GE\
MI"BV<PDVK=%X,;98\W)[#)'1 <\/<"2%*\UF8<AT4FG$4@DFHLA](-)(>I)T
M>NFSHN*86]KZ[/1<TM[?+59-R5T-:=[!R61N<!\D!>4=AS>F[GKS[.0QUF#/
ML8 TQQ>7R*_^G5;+5-.PL&2+A.RNT.:X^0NCN6Q18+!VKKHWO(:611L')<\A
M5QTJPF$R6KLOW*$,UVS,^2T^2/EQD*AG6;'4,)=U[(XJ@([<$Q/]"Q2K=]TI
M9CI9=M0UYQ)=:(!$6>0\J7=*\C!=T;#-C#PZM79!('C@A[ JUU?.SZ_O^Z8^
M7%6Y9\AD!+!V,\<<GR2D^8;7Z\F81/\ 3?5%1[NSP'KD[7:RN@=3)LW#3?-0
MR+29&,'NY6=J&P[#M>39E35?2Q$,+FMC>2'SR%1S5;X/5C9BVO.8Y^6LE[.&
M<@J,Y/+9[IOO.:MG'/MXW+SF;EBL/";1MF8QV2SIH?2U&5W?15B27R_?O<%4
MNU935-OUZM:?C[+-EDBC[ R+@&5>FM6@R,&O8J'('_2V58VS_P",#RHMU6UR
MWG]0LPTVDV()66(F_)8H+3ZMTI-1%>:&R<UZ @-4L\NE7>U_'SZ3TKE9981.
M*[I)6>Y$DBXW0/,4QK1PTG?'<CG?*6/81RPJ_%YTZR9F2/.:W##3FF%>R99G
M-"=:]BJ6\!@X*T<TGKVX[0(9[,8N]U8S,%CIS%-%#.?K'P.B9V>?8GRHANF(
MR6<TW4]DQ4,OU&.A:3"1P[@KIXCJ?M.V"#&8W!OK7'^9[#R0R)JS[C4OZCO]
M;;JU1]BC/ 8+O8WRSV/>F?R%'J-FL#CL2)9:E>?U[<Y;PQH'L%K]3<EZ'4C2
MWLJ6'BD][I"UGCAZLGJ>]K^G6Q/'L:JK;6NH=.OH.*Q<5*V_(F@R""'T_$AX
MX#@5AR'2W)P]+:5",!^3IV/J^P?)\N8%U8^J<5S6W4#4MMSDD/H?3>GY]5<O
M:->EU[HS!AG0E]QSV.E;$.?SD*R= GDET+'P"*6*>O2$#V/':0]C50>G7\W!
MA]CPT6LRV<M/))]3<>2/_$J1]/X,QD.E^;P,V+G:&QR=DA\=Y/V"D72?-Y!F
MNQ8J7#V(HZ5>03SO' [QX#6K3Z34F6H-PJ6:$\+KD_(,C. 6>5KZ3GI^G4=_
M7<]4G97CG<^K:C9WM>I1J-1][(Y_=K<#@+<9929[O$"XW1>Q/%8V>.S5M1":
MSZ\+9 M7IR^\SJ+M4TE"Y%!>FDDB<]G \.7HP^0J"G-G0=[R^2DJ69</E>99
M98AW&*7]VK8QHM[GO]/."G(S$XN%PK22C@RO>1Y:%P\/E<E5ZPYF7\+M_1VW
M&(O[/9W/AR](HB(B(B(B(B(B(B(B(B(B+C7SL[+!%&*N8>!Y>2#S_P"!7CK^
M3W_MS+_T^5>WD1$1$1$1$1$1$1$1.$X"(G")PG 1$1$X1$X3A.$3A. G"<)P
MB!H"<(1RHAG-8GS63JFY==]! 0\TP/$D@]B\J7H1RG:..$:QK?8(G8TGGCRG
M8.24#&CG@+!,US(93$T%X8>T?)5 :Y_E$VW,,@V*LVMCZ-HOE:!VF9X\-:O0
MR./ *\]XYUR3K9=OR8RTRK+4=79(1RU7_7K0P1AD3&L;\-' 64QM)Y("$<K3
M_#ZHM"R(P) #RX>.>52W6^6W9Q6-Q]2A//(;L<Y+!R V-7)BK+;M"I:$3F>K
M$UW:X<.'(]BNCPL'T%8SML&%GJM! ?QY *SEH/N$:QH^R&-I]P@'"Q.HUI9X
MYWQ,+XP0UY'D _!64- 18_I8/7,WIM]3MX+^//'QRLG8WR@8 #P@8 @:![!?
M+X(W\=S0>#R.5]%H(X*=@XX0- ' "UX:%6!\TD4+&.E=R]S1P7'Y*V/3;QQP
M$]-O;QP$]-H!' 0,:/8+7_#Z@M&UZ+/6+>TR<?FX^.5L&-I]PA8TCCA T<<(
MUH;X")V 'E"P% .$0M!]T[0A:"A:"@8 B+'+5AE9VR1M<.>>".?(618+V-HV
MRP3UXY T\M[QW>5G#0!P$[ .2J#ZBQ9F7?-2NT\+;GBQ\SQ*\-'83(KY9$P.
M>X,#2X\E?9'*!C1]D+&D\D(6@A/3;QQPA:"..$[1QP@: .$]-O/)"%H(X*=H
MXX0- \!%^>DWX"_4+04:T-]D<UKO=/3;QP@: . OGT8Q(7AH#CX)^Z^NQO//
M"^)ZL,P'J,:X \@$<^5]AH"!H!Y1S&GW"!H X7YZ;?@+]1:OX71%WZSZ>/U^
MSL]7M'?V_'*VB 0@C:T\\!$+ 4,8/NA8".$X''""-H]@CV->"".01P0L%''4
MZ$/IUX(XH^XN[&#@<E9RT$\JN.JC,G9TW(T<=0FM3V@(^&#GAJW>G$=R/3,+
M!<I2UIH*[(G,D'G\@4Z6(58?6,O8WO[>"_CSPLI:"B!@0- 0-"  (Z-K@01R
M"C(VL8&-'  X " )PB$ H G:$1$1$1$1$1$1$1$1$1$1$1>(?Y/?^W,O_3Y5
M[>1$1$1$1$1$1$1$1%J9'(TL;4EM6YV111CESW'@!5L_J5+;:V?"ZYDK];SW
M3M8&M7=U?J#@MCO2U:;; EAC#Y62,#>W]BINB(9&=W;W#NXYX5?YW?JN'VG$
M862I,\W >96CD,4JSF;I83%V,A<<1%$//'DD_8!51DNL;,-,QN5P%^NV:(O@
M/')<K)T[9V;)@8,G%"^%LI(+'>X(4D1$) 1$1%RL[G<?@\?+>O2]D+.!X\DD
M^P"AV+ZG8&]F:^)DKWJEF<<Q-L1!G>I9L&Q8W7\>;^0>]D >&%S6]W!*AU/J
M[I%I[0W(2M:1^MT7Y%,,+L^"S3'/QF1AL '@EA7;1$D>&,<X^P!)7 US;<)G
MQ=..L&5U:01R CC@KOHB(B%S0TN)\!</!;1A<U)?90L^L^I+Z<HX]G+N)PB)
MPB(B<(CG!K2XG@ <E1O![GKN;O7*E"Z)I:QXD: I(2 %'\7MN"R65N8ZK;$L
M]7^N:T>&E2!$7Q>O5J%6:Q/((XHFESWGV "YNN['B<]C_K\=.9H3(Y@?QQY:
MNJB(B(BC5S<=?IYNIAIKH%V=_:R$#DJ2HB(HT=QU[\?9@_K0Z\0>8FCVX^5)
M>41$1$1$44V7=]?UM]>/(V^R2=P$40'+G*5@@A$1$1$1$1$1$1$1<//[/A\#
M7$U^T(FGPUH\O=_<%BUO;,%L<#YL;<$K6'B1OLYA^"%(41$1$1$1$1$1$1$1
M%&J.Y:_;V*?!PVB^[ USI(PWP.T\%25$Y4:@VW"S[++K[)W&Y%$9)&@>  I*
MB(B(B(B<J&W]]P%'9:. EDE=<LO#6L8WPU3)$1$1$1$1$1$1$1$1$1$1$1$7
MB'^3W_MS+_T^5>WD1$1$1$1$1$1$1$1>9^JMR?.;]KNIF<BJZ1KYX_DE>D:=
M."I6BK0,#(HF!C&CV#0HY!JE*CLU[-PR!CK$(9*P-X#B//>2H;ENHN6$V0?A
M,+'=J4I"R>>2;TN7-]_3 !Y6W%U.IW=)L[#C*DME\! FK>Q8HA4ZVR78,.ZK
M@WS/L/#+/8XEL+C[ %<?!;5O%OJ)E@_",>^(")T!E+1!&K&V#=8*&]X+!G$B
M26R>!:?X[ ?X% NO>7S$+,5CF5A]&^TQYE!\N>SV:K(OY4'7+64SFN.)I_F9
M#P)3_B\K?TW8Z>1U.MEC5BI0%A>6 _E8 HG=ZK30PNRD&"GFPC9"PW0?)_=K
M?A3'*[SA\=K$&?)>ZO8:PP-X_.\R>6M45H=3+L>PTL/F\%-1DNG_ $5X=WAR
MC^_[MLM#=\#AJV.>8#9[QVN\V>U6G=VR+%XJK/D:TL5BPX,948 Z5TA'Z6J,
M4.IU/\?;A,MC[..M2^8/6 [7JT5#-FWG&8&S7I&&>S=G!,-:!H<\K2UWJ#0R
MF2.)N5;%#)-8'.JS@ G_  %5QUESUN*]@:7X;9? V^V4NX'9*6^P:K9JTL=G
M;]7-V<1/!;JES838:&O:#_<2M#JE_P!WVQ_\LN+T@KPR=/<5&Z-I:^,]P56]
M3]9&CY3';3KW^B S]D[&>&\N5^G;\;!K=/,V).(K$3'1L9Y<]SQR&L7&J]3,
M.<S'B;]:[C[4W]2VRP-#UT,_O>(PN4K8MT5FS=F:7""NP/>!\GDA;.!V_$Y[
M'Y"S#'8C95>63,F8&N!7&Z=9O3<FW,G7X#"UED&SS&&=[W<K>RV^XFAD)Z$<
M%JY8@C+YHZS \Q-^7<D+%@>I6H9R+NK7RUX87.A>SA[ /E:D?5749,=:OMMO
M,,4_I<AOEY\_H"D>H[CA=GQK[V.>\AK^US) &O85'LGU0UG'W9ZQ-F80.XL3
M0QA\<)^'GE;>8WS$U-2.P5S-9KO9^3TV\GDA1SIKOK=@P40O&<V!&]\SW,XC
MX"[.@6=%GL9YVN_:=ALO^SW'E;&;ZCZ[B+SZ+W3SSQ^960,#_3'RY2#![-A<
M[0?=H7&S1-_41[M/[J/1]3=.DJW[+,F#%4D#)#QY+G?9J[6K[I@-DCLR8RR9
M3 X-D!'!:2I%9G;!#)(02&-)/'D^%$-?WW7=@EM14)Y7R5V<RM+ .$P&^Z]G
M,G+CZ<LSK$32Z1CF!O;PML[;AQL3\!ZDOUS6=Y9V> WYY7(R74K5,==GJ2W)
M'RP\^L(F=XCX^5(*.R8?(XAV4IVA/6#2[O9Y]EK8#<,'G\9:O8^:26.$\._+
MP>5\:[M^#V9EO\.F>\UR&S!S0WM+E3_32HYO4??'QQ<0LMO9^P)<K7SN^:]A
MK@I6IWNG["XQQ,[RT?NJLZ>7\7D>H^UW,:08)FAX7H10#+=3-5Q=V>I+:DDF
M@_KA$SO$7^)2W#YS%Y?',R%*TR:NX>'CV5>Y[J;J3([U-\LLC>'PR2MCYA:_
MX)44Z0YRC@^EPO7"\0,O2\E@Y5OZ[MF'V#'37L=*^2%CBWN+>/(6OKVX8G/Q
MY"2H90RI)V2ND:&CE1NSU8U2M9@8^2SZ,KRP6A'_ $"D&P;OK^!@J37;?BR0
M(0P<]RT:/476;V>O8B"RXS5872RR<#T^&>#P5S?\K.I^IXDM&N7AC;0BYA>X
M_9I4\S.?Q^*J"Q;F$<9(:WY<X^P 46PG436\SD3CH)Y([7G^AF9V./"KG?JD
M$75;0+#(P))I)!([Y#59&9ZA:YA,LW%WIIH[+B QH8"'<J1;#LF.P5 7+SGL
M@,C8^6MY/<Y=.O.R:%DC 0'-!\^#Y4?S^V83 B$7[78^4\11-'<]_P#<%AP&
MX8//R6H:-@F6N>)8GCM>U5'E:,4'7+&6F^#8IES@MO*]4YHNH5/$P,LLI0,?
M]1PSS*Y6OEMLQ&(HU[%N9S!-QV,#>9'$_ 6A@]]UO.69ZU2X?7A;W/BD;V.X
M7'=U8TT-R3A>>YM,#O(;[GX:IQ@LWC\UBJN0HR%\4[ YI(X(6#/;!C<%2=;O
M3=D8/  \N<3]FA1;#]2L!DLC'0?';ISR>8VVHQ'W_P!WDKI[%O.NZ]8JULA;
M[)9SPQ@":]O6NY_)WZ-"P^22H[\WCAKQ\M4MM68:L$DLL@8QC>7./L %6$G5
MS4V3P@NM&M+(6,NB,>@2HKUSJTY]?P^1'!>S(PMC?_\ 0]3"?JII]7*18XW'
MN>3V&1K.8@_X)4NS^QXS 4#=OREL?<&@-\N<3]@%'L!U'U_,Y5N, MU;;ARR
M&Q&&%P6>_P!0=;HY_P#!9[+Q9#"Y_C\K %J8+J?JF;S+\76L3"?W9WL[1+_@
M4FV#:,5@H(I+DQ;ZC^R*-HY>]WPT*,P]3]4;:=4O6)J-D>\%B/M>N_FMNPN'
MK59)YW'ZC^JCC;W/>M#6M[U_89WUJTTD5EGZZTS>R5JF*@.:ZDZUB;\M%\D\
M\\7]<R!@?Z0^7+OTMKP5O 29N*\TTFLY,OPHD_JSJ+<,,I]1*872O8Q@9R]W
M9[D!2NGM>&NX!^:JV#-5:SDE@Y<%H:OO>"V:Q99C#-*R  R/+ &@N]@M^#:<
M9-L,^#893:A9WRCM_* NKDLE5QM&Q=M/[(86%SW<<\!5K-UETN+&1WOJ9W-?
M*YC(VL!>0SW<IABMVU[)82?,5;H=5B'YW\>6*(R]9=*93@L_5RN9+8,30&*1
MYK>]?Q!KMDGDEDFB]2.*%O>]S?E?6N;Q@-CH6+6/F>YT(YE@<WB5G[$*BX=U
MI7NKLMNU!.ZK6HOB@C[.7-)(\\*VHX-,TXVLK%7,4N2>']C6\R.)\\,"ZFN;
M]@,_8EK5Y)8K,0Y?7G9V2 +4GZG:C%+DXS>)^A',Q ^_P%MU>H.MV-;BSHM.
M;5D?V-!;^<O_ (>%CPG437,ODGXZ*:6&V.>(9V!A<!]PECJ/J=;-3XF7(AMB
M%KC+R.&M[5\:_P!2-6S^5FQU.T_UV>0U[>WO;\L79V#;,)@&Q?76>U\O/I1,
M'=(_CX"U]6WO7=A=/'3G>+$7ZX)&]LC%HYOJ)KV'N25)GSR21>9A#'WB(?+U
M(M=V7$Y_'-O8V?U8R2WGX(77<X-!)/ "K7)]5=:H32L[+D\<4A9+/!$'Q,*E
M?\ZL)^ .S;;C74@P/]5OGPH.SK+ICZU*?UYP+,YB8"P<^/N5:P((Y4)V/?\
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M);PF]4:U?JIH$\3.'RO>U_\ <Q?G5+U<7OVG9NR][J$$I:[CR6%,BROMG57
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M X/HKAVNGFW4-XR>4P&4@KU,AW&=[QW/87? 6QI/3G9<#L>9M6\Z9ZEF;O\
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M+*Y'%=;IGT*)MV),6V)D:[F$WG>,;O%/ ;/'3<+?/HO@4AVC?;<&SC X^>K
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MAT%V8VY'#RWD\DD*LKW4;9[&-LY[$U*!Q<)<6LFFXGE8W[@<%=V[U*GEZ?\
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MZ_TYJ4L)98*D$<<$KR?SEBD.K97):[HL5[/OA$%>G"8FPCSQQ[%<BUM/44X
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M10QE\CVL:/<D\ +2Q^8QM]G?5MQ3-YX_(X%;%JY6JQ&2>9D;![N<> E6]2M
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MJF*@QH^L>R)LL9?^@L"WQ5W'&],,?3Q<'IY>"&*(MY]@T*Q->?EG83&G*?\
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M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1.
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B\0_R>_]N9?^GRKV\B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\1_P G
MICSN\SN/ H2KVXB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\2_R>G-&ZSC[FA*O;2(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B+Q-_)ZBYW2>3O;XH2>%[91$1$1$1$1$1$1$1$1$1$1$4#VK
M=AB;U3%4*GUN4L^8J_/:T-'W>5%\MU(SVOQL.:UHQ&281QR0RF2(D_N0%<C2
M" 41%@%VL;+JPE890WN+.?("@&2W++5-\QN BP\CZL\7>ZVK&1$1'.#023P%
M!L#ON,S6QY3%4@7_ $7ATOV<5.45;[;U,QNIY%M7)4K?$S.:\L3 YKU,M>RU
MO)8N&U/1EJ/D]XI/U +-F<B,;C+=PQN>((R\L;[NX7)TW:6;-@8<E%6D@$CB
M"Q_OX4F1$E>&1N=QX )4/U#<X=D.5$%.>$5)Q%S*..Y3"1P8QSN#X'*K[5NH
M6/V/,97'05IXGTW<'U  K!1?+IFMC>\>0&DGC]E#=+WJIL[LJ*U6>+Z281_T
MHXY!4T1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>*/Y/,!=N-F?N;PRB
M\<+VNB(B(B(B(B(B(B(B(B(B(B(O-W5C$;'@]KJ;IB8A,(6!D[%*=<W_ %+J
M%0&)O1>C:?P^2J_Y;]V%27>MWCUMM"I V)]Z[)V0-D=V1@#W<XJ"T>J.3QVU
M4L1F7TYXK; 8YZIY#'E3#9=ORXV"OK^OU8YKI9ZEF20\1PL6OKFXYZQG<MKN
M3IQ,NUXC)#,PGTY JOT.?=[O478Y9I*TDL,GHVWGV :?#6*T[>[96#J13UTT
M6-K20F03\\EZW-FW&_!F*VOX.I'9RDT9D=ZCNV.&,>[G$ K@X_J'E\;M,.N[
M+1CA?/\ ]FMQ.YCD6;9^I\^O[>S"2X:25DD7='*QW+WN^&M6AB.IFP_SMH8?
M.:_] V^SFL>_N*NU5[N.:EFM5=;QTI%Z]^M[?_@0#W>5 M!Q-##]2-HH481'
M!#$UK K_ $7GWKHR-XUL2%P:;PY+0O0,7AH7+SN29C,3>NO@?*V&$N,;?)<H
MMH&VT<UJ(RXILI1,>]I8#^5@8N)_/_.Y&&Q?P6 %O'0N(]=\IC,H'WB !6?7
M^I)SFKY;,UL:_BI+QZ1=Y<U=_4MT&R:O+F*E4L_,\"-Q\DL6KIF\,V?#7;OT
M,D3Z\G8^+GD\A-$VN'8Z^5GCQ_TK8+A9VGW=[\ERY63W_*2W+];7L"_(_12=
MEF0O[&!WPT@'DJ =(,E%>VS=[LT9@FEL&0PO'YFCR2I3/U3R$_XA<Q.OOMXN
MD\ML6B_L/C[L"W\WOUF?IM+L>'J%SW,\AYX]($>7+5Z1YK+V]4K.NU97,;$7
MBRY_<92I#HFYXO9!FOI<>ZK)6L 3=PX+B>?)6E;WW)V;5R/7\$^_%4F,4\SG
M^FSD>X9P#RNUJ^]8_8:-V6O#,RQ4\6*SP!(QP4%Q_6BM?-ZM5PMV2Y%+VLK,
M')(4UT7>J6W5KSXH)8)JLH9+$]3I$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1>(?Y/?^W,O_3Y5[>1$1$1$1$1$1$1$1$1$1$1$4&.W4X]QOZ]=>R,^A&^M
MS[2 _J"IGJWIV!Q?T>=PLK:N1-Q@#(CQW\_=H"=1C+C=CTK-YB SUQ"66Q(S
MN#"IX,ATHD./EIU<=/9DD!JQQQ OY41&Q0:UUDS RG,%:^P^G,Y7#5VO"WLV
MVACY8K,QB+YGQGQ&T>W*JOI_DJE'?.H<=E[8R^^7ASO@.*W<Y-$SK1K?<\#F
MH]:U5_X5UPO/OL 9?J.%68KI=4H1;S^FUX@UU@WN0/N&K#LAB?UKU\GCQ3>L
M'465D?4KITY[@ )9E??N"J&RFK]4JNUYG*X:UBW,MN #I_+V,;[,4+TF#?SU
M(S@LVJC+(/-X\<AP^&+U#-E*->W!5FM1LEF/]&PGR[^Y;B\_=<9A&[6CZO81
M?5_M>T-YYY''/*AV7SE2_A-D;3E!-)CXI7^[0Y4AJ<DO^0',^D.'<3>RLKIK
MD\1-TXQHBDC BI>G/[#AX;Y45Z,BM_-/9Q >8OJ7]G]W#EO]$;$$73=YDE8T
M-M3DIT<GAGQ&S21/#F.R+R#\@]RU.F3IH]?WA];\T_ULG8TG^];/06_5DTZ>
M!T@^J9<>9@??RM3IX:#-KZEW92T^G>/_ -H2Y<6A-9SFE9NSBIX\3A ^8L@C
M\RS.^7'QVK6U2(OZ!9F-A#WD3$-"M3I?-2?T\PPK^.*?#_\ &&^57G2#U>>H
M7H^7_4>/_!ZF'12W!+I<<'AMB"=[;#/OWKC:Q0G'53=+-;AM1L;FR\>QD>MK
MHS7@;%M,H:.]^3(<?V'<OCI?+7BW+J+6! <<GRUG[ N5XQV(97N:R5CBWW (
M/"^T1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>-/Y.U.-^RW[1)[HZA8%[+1
M$1$1$1$1$1$1$1$1$1$1%^2.[6.=QSP">%YLSV?P&7S+G971KSYFG@V&,!D#
M6+G4LGHV)R<.2MZWGGF,_P!"^<>L&//P"5,\UU US.8^:CD]8R\M8N/># /!
M46P68Z:Z9.;=76\W',_P)9H ]RS;/NO33:H!)D\!EY!%^03"N YG*R:WO_37
M5ZWHXS Y6'O YD-8%[UQ<CL_2C(["<[:PN:?:+PX@P_D)6Q=W/II?V2'89Z.
MP.NQ.#HSV?D:NGLG4?IWLD,,>0Q.9)B?WQ2L@#9&']CRM?%[_P!/,=E'Y,4=
M@LW"P,$]F/U7M;\-)*T<AN732_L4.>L4]B^MC>#&0S@-6;8-RZ;;'F:F3OTL
M^+$'B(LC[&,4Y9URU$B7_1<IRS[&#R5\'KGJG^[\O_\ ZRC]+J?T_I9K(9:'
M&9D6[O'JDP*R3K.#V;*Z_M;3,U\$7?""..0_V[E8*\Z;_-TUS6:<S+Y')BQ3
ME,8:QI+&?("T+6?T>6J88MQV.)G@ ][W#CX]UNT-EZ8X[5K. @RM]D4_)EE#
M.)"2OO4-MZ:ZOAK6*BR]R>M,_DLEB\!0V.+I#2OSVH<K>%5_+GT3'Q$XK>Z7
M]0M/PN-S-:W*Z%D]POCC#/["5I.C\-VS+'E<A]%,\R&B&?T!*[NM[)TOUVKE
M(L=E;S#=))(C\,^.T<K'I>R=.=4EOOKYV_/]7P9A)%[N7!O.Z7OSD^4Q^PY+
M'^N29HH(N _G]PX+IZ]DND.!OW[=3(WR+#"Q\3F\LX*Y&.;THI3VVG/9&6A,
M28Z)BXB83_\ 9\J0:KF^E6N8:YC8\E<G;9!$KWQ+4U#,=-M5-T5]BORB0/$+
M'Q<-A:_]NY;FI;!T\U2_>GK;%>F%KS,QT/Y7N^?=:MK-Z S+V\EAMFR&+EM'
MFRV*#EDG_P!CN"D.(WOIMA\9:J5\K;]:SRZ>TZ/F:1Y_MN/*X>I;'T^U6:V^
M#9LC(VR#ZK)(O!?]G_J6]HEG1JVUR34=BO3W,@7-D$T7 D<[]^Y6GK&AX_7L
MME[]>S/(Z])WEKSX:ITB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+Q1_)YLS
M-W&S '?D?1>2%[71$1$1$1$1$1$1$1$1$1$1$3M"%@*=H0L!]_*_/39QQP$]
M)GP%^&%A!!:.$;7C:T-:QH ' \)Z3/@)Z3/@+X?4@D[#)&T]KNYO(]B/N%]^
MDSX"Q"E6;.^80L$KF@.<!Y("R^DSX"_#7B+FN+&]P'@\>W*^PBP/Q]5[GN=!
M'RY_>?'N[Y6O^"XPUOIC3@](.[NSL':#\\+"_7,,\E[\?6)/N3&%B?JV!>TM
M=C*I'[QA8;^F:[<IRUY\;7+)1P0& %1S$]+-*Q9G,&)C)E!#O4X?X*D<&I:[
M!6C@CQ541L:&M;Z8]@LPU? QM:T8RJ !P (P@U; QM\8RJ 3SQZ863^;&$_W
M;5_\L+79JFO1M>&XFHT/<2X>F/)*^QJFO\, Q=7AGZ?Z,>%E_FOA/]VU?_+"
MUG:CKCY"\XBH7%O!<8Q[+9&L83_=M;_RPG\V,)_NVK_Y86G+I^LRO[Y,/4<[
MY,062?4==L!HFQ-1_:X.',8\%;,>O8:&>*>.A7;+&[N8\, +3\A=5$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1>*_Y/$\;=OM0F %[J3R)/NW@A>U$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$7B_\ D[0$[7=G^S*3@O:"(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B./#24C>'L:[@CD<\
M%$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1%KS13F0EELL'P&\KQE_)XX_GA:_I^#]"_\B]JHB(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B+6GIQR2%W?)\>'<+QE_)YBC.X6I#, \47@,7M9$1$1$1$1$1$1$1
M$1$1$1$1$1 X$D ^0B=PYXY1$Y"<HB(B(B(B(B<HB(B(B(B(B(B(B(B(B(B(
MG(1$1$1$1$1SFM')*(B$@>Z%[0.2?"(B(B(B(B)W!$0$%$1$Y"<A$1$1$1$1
M YKN>"B(B(B$@ DE&O:\ M((1 X.]BB(B(B(@>UQ(!'(]T1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$7B?^3S"3N=B4/'BC(O;"(B(B(B(B(B(B(B(B(B(B(B(H
M+OVW'7<6SZ=H?>M2"&I%\N/W75UK$6<93?)?O26;D_#[,KW>.[X:#[-7<9?I
MO=V-LQ%WP'@E0G=X<ICX3G\5/*Z6H.9:O)[)XOOX^0I1K6PT\]AJ>2J$F*=@
M< ?<'X*;!5=:Q%V)EF:!WI.+98G%KVD#[$*E.A=K-Y>KDLEE,U=M%D@BBCDE
M+F*RNHM:X_5LE-1NV*UJ",R0OBD,?D?/"^.G++C-0Q=J[?M3SVJ\<TSIWEQ!
M<%.?J86\<O;Y_<+Z[AQSSX6(6Z[G]C9F$_ <.5E=(QHY<X +\=8A! +P/CR%
M^H3POAEB!SN ]I/]X7V7M'')3UH^_M[AS\(7M'N0@<".04!!"IKJ=DLWC\MK
M'T>4FA@FN!DL+/ >IAON/V/(X$P8&Z:]L66$N#BPF,>XY"EF/CG@I5XYY3)(
MR,-<\GGDCW*V3-&'=O<.4[AP#RG*C>W4<U>UV_!A[@K7'MXADY+>#_>$U"IF
M:6O4*^7N?47&1@32!Q?R5K[Q;OQ:QEGXZT(;<=<NC<N1TKR5Z_I.*LW;4L\S
MV<O>]Q<2K#$C"2.1R%QL]L-#"56SVG'ATC8V,9P7O<[V "T]NIYF_KF0@P]O
MZ>Z]@$4G/'!7UJ-3+T=>QT&6MNGN-A;Z[R>>7*1B1A) (Y"<IZC .>?"(BC.
MWV;,&O9.2I:,$[('/8]ON.%7_2_(YW8.F]B:;)3/NRS3-9,]QY"F.@8O8\7K
MS*^>R1MW/5)>_O,G ^.2IJ)XRXM#AR/MRCY&,'+G !&O:\ M((7X^:)A <X#
MGY*_).7QN <1R" 1]E3G3#(9>;.;O3O9.>VVED&Q0F5WL/S*Y62,>.6N!""1
MI!((\*/8_9:.1S&3QU9Q>^D(_5>."WE_/A1C+87<)=\Q>2J9GLQ36\6*A>0/
M'PU60YS6@DE&2,>.6N!"<A ]O/'/E$<YK023P$:]C@"T@@H7-!XY7XU[7#EI
M!1TC&D D!#-$ #WC@^QY7[ZK"SO#AV_/*@V^X?+YO!PP8C(_33"W'(Z3O+1V
M-YY\A3*N'0P1MEG]4M: 9#X[C\K,Z>-I#2X G]U^\JINKUNW!J<EFAE):TL5
MF/GTG\%[2MW/XO.Y[1*L&-R9K6WQPO,I)'>./()4YQ$%BEBJ<-NWZ\T<+6R3
M'^VX#RY=(SQ-XY<!S[<E.4%J%Q[6O;S\<A?J_'2QL(#G@<^WE'2,8.7. "_3
M(P#GD<+\]:(.[2X<_'*_4) 1EB)Y(:\'^X@J';[L9UW5\ED6.'K1Q\0M^7%5
M7C-=V_*:U@\SB=JM_B,[8Y[,4TQ,3P]7M<R,.,QTEF[88R.%G+WGP%#V9UVT
MZ=9MXRT^I)-"\Q2 _G;PN#T6RMR_HT5G(7))IC;E!DE=R5;H<UPY!\+Y-F!K
MN"]O/QR%]*/[5L=/7,'<R=D_DA;X;]WN^P56:Q%NV[X[\6O9N;%U)_-:M5\.
M+?DN\)F;&]:EEL$'9J2_B9[K8YB]G$K2?9O/)5Y&1C 2YP Y7ZR:-XY:X%"]
MH(!*_/7B()[AP/?ROPSQ @%P\^PY"^B>%^"U"\]K7M)_8A'/:T<D@!/6C[@W
MN')]ARCK4#26E[0?CD+4R.4I8RC-<L3-CCC87.>3[ +AZWL<&S8**_5YB$['
M=@=^H+GZ+@,QA:5]F3RSKLTULOY)Y#0IL;4#"09&@_N0OT.:0"#X3UHP''N'
MCW\K]8]KQRT@A$7PZU UW:9&@_!(7*S]*QD<)?JUI_1EFA+8Y0?TE133:5C4
M=,B;G<FV1\(<^68OY:W]@5L8G:JFV:QD+N/FE@'],R)_L_\ )_:43Z(9/*W=
M/GM9*X9N^Z_LD>[EY5SM>QPY:00ODV86.X+V@_!(7ZZ1C1R7 !/7B):.\>?;
MRA( Y*_63Q2'AKVG^XA!-&7E@>.X?;E89;=>)X:^:-I/L"X KZD#987ALA'<
MW@.:?(_=4QTMGN_SAWVO:O3V16R+(V/F>7'@=ZNIDL;P2UP/'P4;/$\D->T\
M>_!7P+,'#SZC/R^_D>/[T9:@=$Z1LK"T?V@00HO@MSQN7R^8I5)6/;1=&PR=
MWZGNYY 4IFMUH.&OF8SG[N< OMLL;V]S7 M^05A-RL&EYFC !XY[AP"OCZ^G
MZG8;,0=SQQW#E9Y[4$ '?*Q@)XY<>%]!P< 0>0ORQ=K0<-?,QG^)P"_(+,$K
M2Z.1CP/NT@A8S;KASV^LP%HY<.X<A989HY6=\;VN;]BT\A?J(B(B(B(B(B(B
M(B(B(B(B\;?R=8)#L61F$Q#&5>#&O9*(B(B(B(B(B(B(B(B(B(B(B(J W"L,
MEU<U.M._F&"%\H8K.WNID+FKY"&C>94F<T?TSGE@#?OY"\P[:S7,3'K-G7(Y
M?7BE8V:^QO#)2?W7L2RT2TYFN_M1.!_^R%1_0JT^.EL6('F*C?'IG_'RKQR#
M"^E9:/<Q/ _\%1W0*%]? YB"3P^._P ."M'>I!%JN9?\5BH'M3+)Z/F>.S-7
ME@H0R<Q.(]A[%0C$=/M@SNEU,M-LMLVWT&/JQ<D,8..0"D&_YW_)9,ZR]T60
MCOQ8\RCW_-RI;G^FU#&8"?(8NY;@R=:'O%H//=(1[]RCN?V:[L/1J'+BW-'<
M9*QDAC>6ASVK1RFJ9C_)N=COYV]^)04XI&-#R&,;_ KUT6]9OZA@;=F4R334
M8GR//N26K0ZCQYZ35K#<-,8K)E8'/#NPB+SSP5Y[V3(XK6K^N38'+V[%B.8,
MMGU'&-Y4VZM9'.UMJU"#&Y*:'ZE[^8P\]G+5R-\I9C4<W@LT=BNV9IK?;,TD
MM:IWU?Q>:?@G9;#WK<,M;^NCCD+ ^$K'=V8R]+,?/CK<C;=R*"M ]K_SB5P5
MK82C-0Q5*I-.Z:2&%K'R./)>X#@DJH^K?^L=2_ZBNOU?ERM75G7<?E)ZCX++
M.?2)!>"L6V[7DL3I^&%24G(WQ%%"]WG@N'EZC6[:=E,-I]K,1[%DY,I48'23
MF=P:1]^&IL%_+CH]@<I7RMJ"TR&JY\K'D.>'-4KW.UDQTOFOP9&>"S!5BF$S
M'$/*Y64OY>;HK6RC,I8BMC'13/F!/>\EJUM?VJ[B.CU7,R/=/8;$&1]Y]W%:
M&6T[(VM'M9N7-WOQF:EZDKA,X0D.\F,-6QJDN<AZ-4WX5I=?[.&*![3D[&L/
MP,F.VF[/DC*QN1:Z9SV.>I/UHP;;63URRRS.R>>RV+]9[&?NT*?[Y2OX7I[E
M7X_,WF35OZ43OD+Y7?+>5SCM=_$](L=F);9FO2TH1&^3R3+(%SAI.=;JDN1A
MV;)_C$L(GD>)G"-SO?MX7*9N>7S_ $@R.49?FJY&B.)GQ>"2%Q:6#W#)]-8\
MQ-MET3,K">"%KB&<?_65<G3+,7<OI>(M6YC+,8@)'D\EQ ]RI\HEO6R.US6[
MV18P.E8 R)I]B]RJO(Z?D;6D6LQ<SU\Y66B9'N;,X0@/\F,,^%N=(XQ-TH>V
MK++ ?Z?F1IX<'_(6QTIRF9M]-+5LSR6;AFG(?([ESG*OM4M0YW&2]NPWZ^UM
MDYD$LI9Z@Y\L4WZJY:Y3R&!AR!LQ8&1Q^LDKDAY?]@5V=-9!!;R&1Q6>?<PA
MK<Q0NF+C"_X *CFI8B3J#3OY_(Y:\&OM21TX8Y"QL+05UM$V',TMLR^G9>S)
M;?6:Z6M:>>7NC'ROCIFP/VOJ6T^QRO\ ^5Z=+K%IF>WG&&:=]6ID0R!KW<B,
M<N36C:?O^XXAU^V:@!+&&4_D+SY+5&.EVJ4X]IW2*&Y>B;1R+8XPR8CO'+OU
MJ39:WD6=8,+5%Z<UI:KWB N/8#X38+^0V;?AJ<%^:O0K5C-<="XM>]W@=BXV
M9DR'3G9L&:F1LRX:XXQ3PSRF3L<MC<\CM3.I^-Q^(RTK8K=8GTW./I,^7<+D
MSU=GU;J3JE>;9+=Z'(<LD]4GSVKTM[ JDLO9R6T[_:UP7YZ^*I5N^SZ#RQ\K
M_A<FY)FM W'"UX;]NQA+Q]+TIGF0Q.6KMT6U?Y5*V+I;#9A@N5W$#D\0CQR6
MA6QHVLY'7<=9JW,M+>+[!>V23W 45ZR8B\_ /S%"_9@GH#R(G$!\;O=1#:[\
M%SI-AK]"W.RRR.$0>F\A_=V^05V,-L%,]'ZDL$KIIY(F5>QQ\NG*UNI.-RFO
M=.<9#1OV@^"6&*P]KR.\'W+ECZG6\K5T37;E/(V(9#+!$]K'D-D[P3^=<SJ%
MK6PX[ 0;%+GK+\BRQ&9F->6PL#O=L84MW7:LJ^IJN*Q]@U[N9<WNE9[L8!YX
M42ZKZ#5QFK,NTK=HOALQB<R2DB4'[E2;?WVH>EM:>M:GAD9'!_5O+.[D+7W2
M3),Z149VV[$%H0U^XME/DEOLXJ+9[4]ACZ?MS]S9;C[M6HR1L;7$1!JF6>VG
M.5^D.,RL$DIMV8*XEF;[L#V^7J,[=@X<1H]'.8S*W(,@3#_3"8ETID'E7CIE
M.S6UZDRQ>LV9'QB226=Q<\ERK#KLQ]? 8_(P3S13Q78X@6/+?#UDZCNL3=,J
MMOZN=D[! X/8\@DN!7"ZBR9G'=.M:L5<O:$X?7AD(<0)N\>[USMNTO<L?A9=
MI.T67Y"$":: <L8T?=K%>&A[%/G]7QF2G:&S30CU./E0SJ5G\G'E->US'V'0
M2968B29AX<UC5P]SUZUH]!FPX"_<XJR-%J"64O9+&L?5,4]DZ:U,Z&O8][(G
MQ#N\ 2A3CIMJU+#X#&SL+S/-3B]4]Y<SGC[+H]1\13RFI9."TTN8R,RMX/'#
MVJN^E>#QM/1(<MR\3/I2A[G/\ $*'],M1O[#HG,F=GK5([,QA@@''+_EQ4HT
MG:LMC.GFRV;DYLRXF1T<+G*+BK?S>I?B+,=GY\U;A;.RTSAL/>?/#?S?H5[=
M/9]DFU>F<_ ^*\WECP_]1 ]G.5:_R@S;_FS0: /IC?9ZJMS3HZ\>L85D''I-
MIQ!G'QPN];JUIXVLGB:_AX> X<\$>Q5,9>Q;VKJ'+KQLS0XRA7+[(B>6&:4G
MP"N/F3D= V["OH6YWXG(2F.>O+(7AC_EJ;J=D/53&4,;EI8V6*Q/8]Q,<7R6
MM7+VS4\YJNEYN9FRWIW/N1&,EY'+?/AP3):5M-O3X,^_8K0R<59DS8FDB)K0
M/TK]FZCYN[TRQ$\4Q&1NW!4=(/<@>'O"E&RZ$,+@),EA,E=AR%-GJ"1\Y(D
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M6CP!]@%06#JU-\WC9;&5B98J8N7Z:M [RSR3^?A:%.*30^IE##4#)^%99OB
M^S'J,RZY-FNKNQXB+*6:L,D$AE+?)>T._0O16CZLW5-?AQ++C[#8WN=WN''N
MI6B(B(B(B(B(B(B(B(B(B(9& \%P7CO^3G*T9[)Q?<UE[$1$1$1$1$1$1$1$
M1$1$1$1$1%0?4>L_&;_IF?)>*S9C%.]2CJ_C<SD].FBQ3#(]MADDD0/ZXVJJ
M=JEW;8]*Q?H:T*U2G+"]\0/#W%G\#./#5Z!IYF635QDLA5--WTQ?)$\^6>%7
M_1*F_P#F_?RLL B?D;AE ^6*Z9&!['-/L0O-^-?DNG&Y9P6*$TV&R,IF9/$.
M\L4IV38[.WTY]?PV,M$V"UMFS,SLBBC7=ZB4XZ73+-UF$EL5$,!4$U#J)7JZ
M)C*(QMUUUE%L<,;8^1)P. \%'=.LJ[I<:;V=^5=:;?<SVYE_@*VYNILU_7)\
M<,5?9GG0^B:PCX >?!/<N7L6 LZ]TCI8)M.2:])(Q[VPMY'>I+L-R2UT:F+Z
MLK+$U!D7H\<N#U(^E%J>72,1%/"Z.2O"V$M<.#^4+B=;(,K-J %-DKXQ<B-F
M-GWB51;_ '[69P6OS8G6[4&*JS,X>YG:>[X#0NMU0R4L^Q:/8FI3PF(.?,PM
MY,8>6J3==;=9V)PL3("^5]YDS'AO)$;5>,+ZV2QC' =T,\(]Q[M<%073S3;-
M7<,W5?,3B\3=+ZL'V]1Y/#EZ.7GWK/E(:^1UE@8^22*WZSVM:3PQ2'K'D*QT
M=S6%SW69HC"&@DE1G><=>SG3[7LKAG/?+0;%+V>SB N3L/4V?9NG^5@@PEH3
MBJ/KGO'$42D5_&W<CT-QD-./U)FT*T@9]R&-47RN]3YWII/C*&(MNGCHL;=>
MYG#(P%)+5Z/_ "!QL=%*QYH1P!A9Y+P%H8G'3Y[HB,90;_I< !<P_P 3 N75
MZH&QHC\,[$W9,LRKZ!8(_P AX\%Y<N=%DLTSHG793J6XG0V61SD#@OAX/):M
M#;,I0O:+B(L!K5F&G6M0OGF,?'#V_93KJ??MW=;UG8J]*9L<-J.1\3QP\!R[
M^Z[9C\UTRS=J"M;C9.T0P"2/@R./PN!!B)]FZ(TJL49DMU(V&)G;P>^$<=JZ
MNO=4,.-1AALB2+)Q5Q":98>]SP./"X=O$RZYT8RD-^+B[D27.9&SV?+Y#5V<
M/FJK>C#7O8\&"@*[V!I[N\!:?3[8&8#I*^Y6H3335'GUH..TEZM30]N&U:Y!
MDVUS Y[RR2/WX>U<KJEKEG/ZA<JU8P^>-[9H0?EBJ*MU4AGTJ3#VL3?_ !(4
MS"0R'F,EJD72>\,?TJO/MUIH1!ZI_1^L.6#H[F#1Z;9,,A?]33F?(8W-(Y[U
M&-R?JVU4*&1QE.:+8I)8^(HV</Y^_>K$V':X,/?Q^%V6BZQ3GI#OF#/5_IAP
M#RHKHFMTW;?LIP3'_P WY:IA(D' =,?A9]!R_P#D^_$-;S[98F-LE]2<,+F/
M:I1IE5^:VO.;G+"^."2/T*0>WAYA'W(49Z7YMCM\W6!L$GIWKCIHI"T@<-)6
MA'L,FB=0MIALTK4\.4E]>#TH^2YY*V]'R.8?U/S\M[$3PFTWR .1#\!ZQZ]F
M;FL]1]OQ\^,LS.R5OUH/2;SXY/!6UL>5A@ZR:_)PYPCB,,I /#'.6ULE.SJ'
M49FV&"67'7(C#;+!W&)Q39;>/WO9-<HXUC[-6M-Z]N8LX8T?"UMCRM2+K-A#
MVR=D4)A>X,)#'O6+J;E8:_4?27AKW_1/>9^&GAHD7HKW!5 YE][3NIMG.SUY
MGXC(0]LLC!SZ<B9Z\S?-IUVOA"9:=*0SW+/'#6?#5I;3L%*'K'C;!CG,-6$P
MS2!GACG+T8WV"ULE1@NT;%64<LEC+'#]BO/W3+2,M0S&3JY'U?H<7/+'2:[P
M'^L?+UAUC2[^.ZC9'%$/_!*TOUL,9_1ZOLQ2SK;=EBU(U(:TDKYIV$]H]F-4
M3ZDVWV^G>LQ5JL\DCIJ\W 9[",*2]2,C)E.G,3H:<[IK3H7")C>2U1G;\;E+
M^N:?LV(K3NLXQK>8".U_!"X^_P#4&_M&JBMCL#=:!-&;SWL\1N_@:ICNTUJ?
MI33A=0LLLR-@'H%O+QV!:F]Y5L_26KZ=6QWO,#!&6?F!8#[KK9W(&]T8F=]-
M*V>:BR+T>/(>N#;RUB+H9$P4R)8J\56:*4*!878-2IPXJOE\9GI(:L;'Q1N<
M9(@_Y#"O6> SN-SF-@R-&7U(91X_8_!4#ZP82SE],L,K0OEF@GCG:QON0Q5-
MLFWW=AZ=_1XO"VBRLR$6Y96]G8]H\!GRM[?+EV?I)KDMNI+%89=JA\;V\$N:
MTJ2;-U#@RVMS8K'5+7XM; @-<Q^8B?<E6II^!& UW&XSD%T$#6O=\NX\E5EU
M8P&5;D,'M&+K^K-C)"98V_K<PK0VO>ZNVZV,-A:MF2[D.UKXC'QZ3/OR5N=3
MZL6)Z9P82)A=(!#%$Q@YY[ IQTSR,-W3L(UO(?#4B9(TM[>' *0;14GM8')P
M0L+GOK.#0J T?893HEG V<3>C?5KRQSR"/EH^ /ERE/1M[\=T^M06X98I*\\
MI>QS5'="HNSNL[GA9*]B!]R8R1ND9P.'DD+C:MO^VZ=&[5\G@IK,]7B.J6+T
M?J[LU)AX9<L2+4Q,LD7/(B[O/IC^Y<OJ#J#-JUNUCG.['\B2)WP]JIW1-_M:
ME1BU[:,?<@EK MAF#.\=BL6OMV2V>]!7P566*FUX=9OS,[1V_P $841V*K>T
M_J.-H%:Q+C;D#F6RP<F(K%E\@-_VC7H<36G-"C,9K=F1G8/V#5H;AG_I.L6&
MG-.=T<,7I2N#/E3CK'*#T^NO9YYEB(7 K=1H9-1@H4Z%MV7?28QE8Q^.2..>
M5QLOTOO5>F6,J0?GR-&<6I&?8D^7@+K9#J95S6L24*>.N2Y6Q (C6]/@-<?<
MDKF[KCYM:Z1X[!^C+-9+XNX,'L0/*L3 92[E- ;+4@E@MLI!GIN'!$@"I'2L
MUDV:AG,/%@+EC-3OD=8E<W@.!^[WJ4:G6RN7Z19#$#'31.95=&US_=[@N[TL
MV>[8UBMCI\798*%1T<LSF<,Y9X:T+2Z8027<3M>+LU+-<W)W/89&<?D?ROC2
M<W9T6G9UW.5+C_0G/TEB./O9(PKMZCC+QFVO:<C6DB.0+C6@(X>(?/Z@N-T4
M,]#!YR&Y2F@<)Q,&O;P"T@K7Z3W)H<[N9.+G@^KG^I@86<,[6\^%-M ZB6=G
MMY.C>Q#Z-JH[RSDN"L'8,9^*XB]2<[AL\+F>W*\MZGNFUZ(Z;6+N#FM>F]PJ
MN"N:Q+GSH66L9N/_ $RQ&\B"/EWI!WEL848Z=17;_2^QC'57PVHH7Q!CUR>E
MN=RL&JV\/<Q,[!09,R:8C@#[!@71Z+2W*.HY''WJLL#X)G2-#V^[7KBZ!6FR
M>.V_7[F/GA;?>^:&5[/RD+C:GNNWZ3$=:R6"FLOB=V4W-4VZALS\O3J:KD&/
MGR5RP'B*$=PC'\"G/3.V9M0Q4#X)HI:M>.&5LK>#W-"GZH#K)JN6GOX?.842
M"TR3Z=_I_K+7JT\=JU2GJD6"8WB-M7T20JBTG,Y/0*][7LW0M.KQ2N?3GB9W
MB12_0*%ULFQ;-DJCXYLC8,D49_6R$<D!1OI?<M_SQW!S\=8B@R-DV89)6\>
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M=]]/F9H'"Z'1B*./0<2&, [@7.5ID@!5MBMDTN_OEZE5H$9>.%_K63$ 2QI
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M/# >Q3'/[-B<!79+=F([W=L;&CN>]WPT*/87J3KN4R Q_-BI;=^B"TP1N?\
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MLW[)XK5(AR]ZT=7Z@T,[D+&)EJV*>2@;S+6F"K7)L>.OU1_!#74F\+I]0?\
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M?1_=@73R72K$7M>QV#&0NQ5*AY: >[N*[%[1JU_4X]>LY*TZ%H:#+_;>&C@
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M8"QK+<)-$XQ!W>V4^91)]Y.?E1^'I<9Y<<,QL%W)5J?EE>;PTO\ L3Y*MH
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M9C'>D?2O0HWQN_F[3/:SMX=&""OBWTHT*R6$Z_4C_P"&P,1O2?0FD'\ JG@
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MQ1LMLE[0]G]MH^Z[>7V'%XCZ<7++8S/*(XF_=SBJYZO;-LVNXJE;Q,L4<;[
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M3A&:;2+;%V4\-CBY'CC[E<[0(+5;J7MD-K(_62AGF?M#.Y;/32I6?O/42T6
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M981$Z<C\[@% F]*YY(ZU&YL]VUBH9&O%*1O\'L"[E6_!#%!$R.-@8QH :T>
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M>9V?,KU8>+W7*GI4[89@V6VRIWD>P<Y14#8Y^G;=IAV2W^)N@%DM]4B  ^[
MQ6!TMO9C):M5R&2R4MJ2T&OX>..Q2K9_Q+\#R!QT_I61"XQOXYX(5.:7F,WE
M>DMZ]8REKZQDLSVSAY[P6*3=/,WG,YTZENW[[S;D]4LF:?+0%'-%VW:,OTYS
MF1GR1-NL\^E*YG*X^MNZD;=IXNS;"^BP"21LL?F67A3[I;G\MG]!9;N6B;0?
M+%ZON3V+2Z9Y_)RX79;>6R$EDU+C@9'_  WE:.NQ['O./FSS\Y<QK)'N%*M
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M&/79WG5L;A^F6?@HM+6"%CR7_G_0J\=HUB[TNJ9N;*6Y;D%"&:G"PD1QM:/
M 4QFWW(P=(J&6+R<A.(Z[9">27N'ZE!LMHNS31U;6(Q-V#)QN!?<?8),H7IW
M .R;L/0.2 %PP,^H //#^/*ZJ(B(B(B(B(B(B(B(B(B(M6QFL;5E]*:8-< #
MQPO(7\G6249_), ;V&JO8Z(B(B(B(B(B(B(B(O.^[/S6+ZGX_,'$37Z3*A9
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M)+8]*1Y>.7\ ?J*^,Y9@W7IR:^(9,^;&?3S$EO#2Y@/+0I)0ZHZ_9TSZFS<
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M"^QCZUN*1K_+2URW$1%SJN:Q5C(V:$5R-UF  RQ \N8"NBB(B_'R,C:7.<
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M&I(&2GCP"5WD1$1:%_,8Z@^%EFTR(RO#6 ^[BM_D*,_SSU]NQMP)M$WN.3$
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M#A^<EWL %H8??M;RV1..AMN9:]_0E;V/(71SVU8?!^DVY8XDEY]*%@[I'\?
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MN"E'67&0W-%R,Y#/4J/9-&3\A<#;;7K]$63Y!KC/+1@_^Q(6JP.G'^PVM_\
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MUI7QB4%YX4DBZ<6H]QJ[/<V0NL@ACV,@$0E'P>'*XD5?[?J6M;D+5"T/])K
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M:Y>MUS:AF9$;H/(?&_E2S6-2S^&TFUA?K873M865Y0. T.^5IZ3H>2PFJ9/
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MY3L"=@7YZ33]@AC:GI,^ GI,^ GI,^ GI,^ OU?,\$,T3HI6->UWNTCD+Z:
MT<!$1$1$1$1$1$1$1$1?),K90.P=O'NOI$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7D#^
M3G_K?+?\ +U^B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\<?R=82<_DI?5?PVMQV+V.B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B\=_R=&RG.Y,B3A@K>6KV(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\@
M?R<_];Y;_@!>OT1$1$1$1$1$1$1$1$1$1$1$1%KS7:D,<TDL\;6Q_K)/AO\
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MT2O[(Y3'Q$[^YRZV?W77M?-89&Z(W3GB)H')<M6MO&K9.[DL=%?8]]:-QG^
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ME_Q8U).G/^P^M_\ 3X?_ &J7S@/CDCY\N:1_XA>>>E#&8&WU%B<\<4[@'/\
MA[UO]-\1CMUQEO9M@K17;=BP^-@E:'-A8S[,7$Z88C'U=SWVG$ (89)(HX3Y
M'8NCT,8V.?=*S!Q"RZP-C^P'YTZ7U88-]WUD+VQQQW',; %OZ=4K4^J6Z,A9
MV,X+UFU2O5W39-BRV5@CLPTK7T]"*3R(F>>3VKBZ]A:&%ZZ9*M1A$4+\6Z4,
M X#2]P6UE\9@:>T;#/E&G,Y&WR:=-D8>^%A6'HS39;TK.8Z_!S"VVYI@D\AJ
MR]%,!A8H,W.RG"9H,@8XIB 7ABP8.G6I=><PR"KZ+'8][R/DEP\KI8"C0V_?
M=KLY>NR<8JP*M2%_YF-'GDKES43I'5/"P8H"+'9D/8^HWPQI"Y$^HT,CUNS&
M/M<_334W6)(V> _EP\.67$8V#5^MQH8M@AJST_,0]O*].@^ BH7K!CJ,N8U:
M=]:,R/O!CG$>2U??7"E5KZ52KP1-AB_%H  SP!X<N1U'T;7<=I/XA%#WWH9H
MG?6G^MD)^[BG4K-W+.#TW$Q2=QR78^4R>&2!H]GE8,QTLV6?)8F[3@Q%)]24
M<N@'I\,7I5OM[\J!]2<=8OZK:BCRC*+!(PS2./ ,?W:5Y]VJ/#?7:D_7L2ZM
M%%:$<=XL$0F5C=9JF199P&4^A-[%T9G.N5?</^"0MOI[8T_,9#(YC7R*EJ:M
MV3TNP-['_9RKBJ_$82?-87>L2/6O67/&4# \.+OORI%NQE@P6CZIB;;+4-OL
M#9'_ )(IV1#V>5DS73K;+>4Q.5QE#%XFS5?P\03'RS^\,"R;-AL;;ZPZ^R>M
M&6OKOD>./#WKI=5,3D:0P&0QN+9:Q]![S9HAOY/V=PNCT[RNF9S,7,GB8W5+
MKX VS4+ Q7.O/NR8S'V>L>#;/5BD#ZCW/#A[GPL^Z"#([YJ6M3!K,:UIF?!_
M8E+> T$)U>U;&4\)6SN.@94NTK4?9)$.WP5=N!L2V\93L2D%\D#'O/[D*(=4
M6\Z!L8'O]*JKT'IKJ>8T"K8N4Q+8L0<F;W>Q1_%Y/*XWI7L=6*\\_2WQ5B>?
M=L9Y4AL].\[G]9QE)CL3#!$UCX)8V?G:KVUNO<J86C6M6VV)HXFLDE;[/+0N
M;ON4M8K4,W?K'B6"N2PJ'Z%KN)GT"M+-!'/-D:8FM2R .=)(]O/+E'.B=%M;
M6MAI2</#+KF.6[T<K,9B-FKP 1@9%[& > WW5<U\E7U89'5MQQ3Y:UJTZ09(
M>7/)/AZD75RA2&H:I)!*;,<5F".*QQ^MA4UZMXJBWISE/2@8STRV0<-7/Z<=
M/-=.%UG/21227Q6CF$I=]W!?&HUJ];JIN3(8FL;[\!1^#5,7L/5S91D6>K!!
M^;T#^A[EBM8&OI?5C71B&>C5R@>R2!I\*3:E###U6W(1,#00"L%2""#K[DA%
M&UG?B"]_'W<2%DU>G5'5O;G^BSO:SP5&L7^.9SJ-MTT$M%\]24UHF6&^T//V
M4CU+2,EIV5S.5L9"#MGKRO\ I(&<-Y"V.D4%//X6]L61B9/D;EJ1DDK_ "1&
M/9@4<Z6U*]+J/NM:!@9%'.]K&_ #EZ35+[E%B*^\8?(SR26[D==[*V-C8'N>
MXD?F40T*S99U;V"K/CHJGU-9\KX6IJVJ8B?J5N5*W6BGK"4O$)',?DK%C]1Q
M%;K%E<(V$?ALM SNJ#Q$?(\%JWXL)C]<ZT8YN,A96@MT7=\$;>&!=37S2V'J
MEL\UZ-KW8_\ H*L<@YX:#Y<%S]VHR:OOVLY3#,$#;KS#:C9X$BY&<U_'9/KI
M)3F@:8)*@EGC]A(MZQAL'@.L>!90JQ5&3U2/3C':PN76W28T.I^L6\I/QC?2
M?Z/<.61RK0EIXG/=8*=FC!'9ABIDVY WEG>"%Z+:. %277IG=ID!^,E NEMP
M Z09#_ID:B>/TW!R]'VR_20BS8Q;)7V"P%_=PHSELG>_R&X",2^);,$#_P#!
MPIQLW3;*[#@Z<!SU0LK]CJW;4;$&-'PX%6_KL#Z^%Q\,EP671P,:Z<?_ !"!
M[K1W/_9K+_\ *O5(:'H&MY/IJVQ:HPRVYH'D67L#GL7&P&5NU.@]R2*=[7BR
M^ /^[&*V=>U/7;?3JE0$$4D$]%A?(UH!>[M_6HWTCM6_YIY_&322R1X^9\4+
MW#QVJ-=(+DU'IOM-J']<3RYJFW2G'TI]"$\T8FEO!\EM[_)D>?E5AHER7#:[
MU.L46ACX)&^D I)I>G7L[T\KUF9NN*UR/OFC-1KW"0_+^5UL[J<>%Z-Y7&6K
MGUKZ;"]K_M&X?8+/TZZ=ZX[6=<R\M8/O>@V<3GWY>%"I,SF]&O9C&Y_$?682
M_:D?]2SSXD*]$::<.-:Q0Q<QEILKL; 3[E@'CE:^\9.QB]3S5V#S)%6<6A0?
MI+CJ-KIU5BEA9(VV'FQSY[R5'>D9GQVQ[C@(?./JW#Z?_P!"ZG2V-C-LZCM:
M  ,L/_5ZN]1[878*U%%BLH&/;>=Z;(GCD/*\[;)TGSVK7),UI]][(V O?#W$
M/ 4@SNW6-FZ,39)P]*9\C(9UV'Z1D]HU#&U)-H8RB:T3@R.J. 6CY[E$.J&"
M94T?6(VY(W(ZER*OZQ\%P*NS':1J^),EJEBX(IC6=$Z0-'+FGWY58]-9/P_4
MMVDK, ,%N0QM"YW3G7;^?T)K8=FEA;/++Z\?I!X+W^_?Y4HAZ:"EH&7UJGFS
M-*^4/8Y_Y&M?\*&4MINT+>)UG>L,!Z$K/I;C/;N8O3X6O>MQ5*L]B5P:R)A<
MXGX"HC4Y-QR,^5V2OA:4PRK_ .A=/8=$]D ]F@!CE'M"N9#3^HF0P.4C97BR
M9]6%C'E\8?\ 8 D!>H$1$1$1$1$1$1$1$1$1$1$7D#^3G_K?+?\  "]?HB(B
M(B(B(B(B(B(B(B(B(B(BI7JQ0LU;^M;-$PEN,M'U>//#)/NK-R<,>;P5J*M,
MTMLP$1O]QPY4[K=?J1KN".!BP5:;TN8X+7K$-_O([59&B:J=8PI@FG]:U-(9
MK,GV,A4&Q5,Y_JWE<NQY=2Q</TS"#X]57@JHZMXS8\S@!B<3CQ-Z[PZ20G@,
M#5T-49GL;HE>I9Q;FW*E<0,B:>0_@<!RC?2?&;7@_P 1JYG&!@LS^N)F'D<J
MZU5?537<YDL;0O8:/ONT;;98V?(5:;1KW4_;ZN(NV*D-62*<%M4'V^7O*=7Q
MFG[%H0; R7(<2'TVGP7@M4LS8W+=A5P]C 28VE]2U]V:1W)(9]F+9ZA:7E/J
ML+G-<BYN8SP(>>"^)<[-R;IO$=+$2ZY-C*;IF2W)IG?9GV8L_4_#;'+8UYF'
MPIL5Z$C7^'<%9^L-+8LO@,35QV'EGD-N.>4,\^F6*W</8LSXVI-8@=#,^%I?
M&[P6.(\@KC[M+F:^N7;&):]UR/M=$QO]O]E1VS8[,[D[$O&FST,HRVUUFVX#
MA@;[CN4IZKXO-QY+6MBQE)]Q^,E>70C[AZBFTU^HVQV=:R<F&9"QMD/92:\N
M+?WD<NQU-U+:1G*&VZ]'S=B8&S0,74TVSO6TW8+V>IBG0JGU(H .'2RCV*P:
MQ!L3.J6<OSX2U#0N!X;.\#W:5A=6V!G6F?*LPMDT36^E,P'CC^-7X%5/6*ME
M<AJTN,QV,L6I[$C3^0>&!JT=/V'-XG5<=0MZGE?JJM<1<,8TM=V+IZ?9VK)9
M7-Y;+T+-*,,;'3J//VX/)44Z<8_.C.;D,MA+->++2F9DCP.Q1O 1]1M NV,'
M2P@R-":=SJS^\M:U=+I'/=_GGO$&1CA%J2P3,(_(#O((:5J48]WTG;=B@QNL
M_65\G;[X']_:QJZ'3/![K0W/9;F6H,9'8E>9I&N\.DY_L+I:U#L<?4_.79L!
M9CH7NYHG>N/9QF\:1N66MX#"'(8W(O,KH&GM['+7P5'J+9ZGG.WL"((YZAA>
M>_\ )'&OC#TNHNN[;L<5?"-O_B$W<+LDA:UC5(NE^%W7$W\_2RE&)E.69[_6
MY_6__P"CY:M31\=O.O9_+XIF'9^'3WS*+CCP SS^@+[QU+:SUDN9>?"3"C)"
M^LR?V:&<^"LES![3J.[W\UB,>_(4,D\NM0L_6QY7?QF%R^R;;6V+,4#3KT&.
M91JR>9"Y_O(]<>GBMI9UFM9B?$O^@D@? R;[",$+XR.&V>7J[4S Q3SCXHS$
M)%TK6U[EC^IE;$SUFG$67ED#PQ7,JEZLZYG,EC:%[#Q>K:HVA*V'^-1O=<;O
M6TZ;CH)L.R.\;PG>QC_$;6+O[OC=ES>@04(J#C?F](RM)\,+0N7G=*SFP]/<
M5!*QT&9Q[&>GY\%S N1KK^KF:9'A\Q6^CK#@3WGC\[V#[!>BF-#6@#V"JGK#
M@-@S&L,CQ3#*Z*U'*^#[R!JK/;,5U)V;!8BW)@HZSZ<[.RJQ_,KE9&=S&^4[
M>!L0X)UJ.2K*,A6B?W-:[QQP2HGI6KY4[KFL^S '#US2?#%7/@ND?Y[@M>S:
MWO)ZH[!9O4IKMEX[!9/Z!\/*[.:Z8Y-^@X:A3MG\4Q@8^)_)[2\#R%J8&;JU
MGC%CLQ5%"NUX^HM^TDC1]FK:ZDZOM V? ;#@*OKRU06/B)7=R5_J+2EP5B/%
MQVR:THR%>-Y# \EO':>%S-1UC*OW[);-8Q3<;"^MZ+*_W>2>2\J[%1?4K6=L
M.SX'8->A]6: %DC%N;CI&Q92IALO6EK#/4'!_(':QWRT%:>4CWK<!1PV2P+:
M-/UXY+LXE+NX-^S%>,$,4$3(XV!K&@!K1X  7.S^-ER.'OU(R 9H7,!/MR51
MVO0=4,!@(]?@P%1W8#&R[ZYX /WX[%,H.F--FC7, ^=TDMGF2:R?=TWRJUU?
M!=9,5Z. ]:"+'CEALD=_8P?P+T7@<-7PV+K4HG%S86 =[O=Y^[C^Y3/X6',8
M:[C['B.S$6.5#8# ]5-:B?@*C:D]#N<(+3CY8PJ0=,]:VO6\+G(LC%'++-*7
MQ /)<]RU^F.$W'$MV*/(T1 RV\SP\/Y+7KB7J'43-:G^ 9778)YR&L;>DF)(
M^9/923;.GN3EZ;8_"4)C-9H/A>PN_MF(+6RU3J+ENGUVG<I0NNW V(0@\>G'
M\E3?IU4SE'4Z%'*U&03U8Q"T-=SW-8. 5$M;PNUP=2,[E+6.CCHVP\!X>2?!
M\+#DL)N.#WV[G,11BO5;T?\ 31%Q8YA78PNLYG+[/'LN?A97?7864JC'%_8#
M[N>5'-BUG>,3O]K.ZXR*Q#<BXFCD) !6/$:AO-;J7!G+<T,T<E0,M2^P'/NQ
MB^\EK>\T.I=R_A1&*N0A_//*.6Q+0W+1-RQFT#8M2>!-/XM1^W+RIQI^%VVW
M)-D]KG8;)@=###%X;&Q_NJ_H:?U#TK,WZVMB*UC++N6"=Q'85U>GFD;KAMNR
MV3RDM5T=MQ,KVGR]Q*OU4+N&K[K%U&AV/7X8)6OK"%PE/ :M>AIF_P!;J(S.
M2VZTGK5>V>;CPSYC8%UM1US;Z6\YO,9"E69!??)^B4ES//A8J6"VYO5JSG9\
M?']') :X>'^S%GRVN;=/U-QV;BJ5_H:K/3Y,A[RTK'M6I;5B]T&SZVV.9TK>
MRU5>XM#UTL5A=BV+8Z>:V/'QTV8X'Z*K'*9/SN]WN) 7+L:IMXZK_P XXZU5
MU(L]#]9[Q$MC8]2VRUU"Q>>I0TS6I ,X?*0]X7$ZB5=CR^]8^OKYK3R5*CS+
M'9',41?Q[K2I;#U+U2&)^3UFG]'ZH$SX (N 5Z0:0X J"]2=>N[!J=VA3##.
M7LDB#_;EB@<V"ZC9'IQ>Q=IM/ZN<1Q,A\M#(6KN4->W"+I@W"F*J,BRN(&<O
M/IABTL/T[RD_3B;6LR(&21'^@EA>7*)8;2NK3&MP]S-1-Q; UCGMD<7F/X8O
M1>,QU7&T:U.LSL@@C#(V_#6KA[E0R]_6\C5Q8A-J9GIL,KN&CE0O4,!MV%T"
M3%R5:ANQM+(/Z4]A#ONX]JY&D:!G*6G976<[%4=7F)=$^)Y>07+GX3'=4]7Q
M1P->A3NP?HK7#*1Z+?W':K"P.I6]?U"W2J%DUZ=CWRR/\-DF>H=TOT;8L#AL
MOB,U%5-:W]XWDE<##ZAU,U6Y;P^$GK/Q$SW&*6;R8EW= Z=9O"R[)#E+44U2
M^\CP/S/^'J'P:!U.U;(ST-:R;#C)I26%[C^165GM-S[NG\^#H666;MM_-JS8
M<6]Y?Y<5U]#PNPXK4X\3E_0]6",Q0OB>7 LXX'/("K<8?JI#K]O7;%&C>@?^
M6&P^=Q+&?N"Q6]I&O/UW6L;C)) ^2"("0CV+E(KU2&Y4GKS-#F2L+7 ^?!5%
MX;7>HFCP6L?AX:>1QSY"8.]YCEC+OO[%3C3M2R. Q>5LROCL9:_(9[+^>QAD
M45Z?:MO6"V',6\DRBZ#)R^M.63$O8]7<H3ONK9+-TJ/X=<%:U5MLGCE/[ J(
MWX.KEZF['N9C(?6/#[D<KNX,_9O8I1!T[Q-?1Y=:9R8'Q$.?]W/^[U4F"Z;=
M3<3QBH=B9%B2[R6/<) %+>H/3W-Y+ X;$8&2!D%21KW,F):7%GL59].+-'!,
M;:]$WA!P\M/Y/4X5<]--/VG ,RD68GJR177F1[(B3PY0YW2W><-G+W\V<XVI
MC++R2SO+2Q3Z?0<E7TV2A2R+GY.6PR>2[*3W22CGDE1NSI6^;);QD6RV,>:=
M.<2%T/F257P!PH+U"UW-[!ACC*%N.!DSAZY=]V?"[NMT+F/PE&G:,1EAB;&3
M'X;PU57U"Z8YK8]FK92ID8JXK, B5P8891F.@9DI(WV0/Z5T?AI*Z*(B(B(B
M(B(B(B(B(B(B(B\?_P G/_6^6_X 7L!$1$1$1$1$1$1$1$1$1$1$1$6*_2JW
M*LM6Q$V2.5I;(QWD$%1K5=8.NP6:D5Z2:F7@UH7C^H9_ #]PI3P%S\YC;-_&
M2UX+SZKY?!E8.7!OWX6MK^NXO7Z#:6/A+(@>22>7//RX_<KM)P$X"<!$3@*E
MNH.F;9G=KP5['Q5!!CB2"^4M>\N5TM'W*(G"(B(G"(B<(B(B2-/:XM]^#P/D
MJAM&UK;,;OV?R-[&Q,JWWR/[VR$\$N5\\(B)PG"(G"(G"<!<)NM8QN=ER[@^
M6R6]C'R.[A$T^XC^%W43@)P$X1$1$3A$1. B(B<!$3@(G 1$X")P$[1\(G 3
MA. G 1. G"(B<!$3@(G"<!$3A$(Y5-;/TVS,VSS9[ 9Z2E//XF9]BMG'Z#G[
MT\$NS['-=CAD#V56^(G$>Q>K<1.$1$1$3@(B<(G 1$X"(G"(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B+Q[_)S8TYK*O^XKKV$B(B(B(B(B(B(B(B*L][ZA.U
M"S59-C))XK![8Y&._M+0N]4)<(P2Y_7K]2!W 9,T"1O)5HX?+T,I0@O4YA+#
M,T.C>/8@K:1'.#6DD\ !4UF.IN78<A9P6 &1Q])_9/9]4L/</?L !5D:OL,6
M?PE/(Q0OB;.P.+'CR%W41$15[LO4*C@,]C,58IV2ZX_ADH [%82C>R[;A]<K
M,DNRN[I'<10QCNDD/PT*,V>J&'H.C&1H9*EZ@'IF:$ /Y^.'*R?58(^\G@<<
MDE 00""OU$5?[)U!QV!S^*Q$U:=\MQW <T> %8"(DL@CC>X^S6DG_P"PH9IV
M^8K:G904(YV_22,8\RM#?+E,T6#(7H:-2>S+R(XF%SN!R> N+J^WXG8<))EJ
M1E$ >]G+V@'EBU]6W;"['/DX\>97&E(UDCG-X'+N?92>S9CKP22O/#&-+G']
M@HII^\8':_KW8Y\I%20,?WMXY)4M1%^3S-@ADD=SPQI<>/@*-:=N>(VFA-=Q
MXF#&2^F1*T-/*DR(B<!8[]ZM1JS3S2!D43"Y[S]@%60ZLZ\TT'SU<A7@NGBO
M9EB B>NCF>HN(Q=J_!])>L_1,#K4D$8>R+]B20M/7NK&J[#F8L90=9=*^/O#
MBP!BLQ%$,9O&'R&SW]?C%AMNH'&0N9PPAIX\%2]$1 YI)X/LB!P)(!\A$1$1
M$1$4(V[?,7J]G%P6V3.=<E[6]C>0 IOW#CGE$1$1$1$1$0O:"&\CD_9% MOW
MJ#6[^(INHSSR7GD-],>P"GH*(M+,9:GB<;:O6I.R"!A=(Y52.K/H?AMF]@KD
M%&\0()_?W]N0KC!Y"ULE<^CHV+/I/>(HR[L9Y<[CX4:TS<8-GUTY6&!\;?5>
MWL/EWY%J:5OE;:)\Q'!4F@^BF;&[U?#O/*G*!["XM#AR/<(B+Y,[.\L#AW <
M]O/E5[BNH,&0W>UK?T$T;J\+WO>_QY80%8B(L=B8P0R2!CG=K2>![GA1#2=T
M&SULC,RH^ 06?2X?^I3-$<> J^U[>GY7:\QAOP]T/T/(+WGRXJP57.-Z@?6;
M[<UEN/>PUHI'NF>??L('@*QD1$1$*J?)[_FS<RK,%@1>KXYYCLS/E,?+Q[A@
M =RIAIFV1;/@H\E#!) '/<PL?[@M7%S_ %!K4,RS"4*4]_)$=SH(AX8WY<5H
MTNI<0S=3"Y7#W:5VS+V0@M#HW?ORK01%"]\VFWK&%9D*^/\ JR;,<19R6\!_
M/E2^A9=9J0S.C+.Y@<6GW'/RLJ(BQ7+<5.K-/(X!L;"YQ_8*.Z;MM/:,*S)4
MP6L?(YA:[W!:I.N/L>5L8K%6+D-7U_1;W.C!X):%5^,ZIY3*XE^5HZQ:FJ,)
M!>'*8Z1U!PVW57NJ/>R:+Q- \</8INB*M]LW')U,S2P&$I16,E9C=)S*_LCB
M8/NX@%?&D[CG,CD\EB,SC&P7*1X<^,ET4G[CP%9:(B(H+U$V3*ZWKEC)T*D4
MYB([P]W':WY7<U3+SYC6L1?F:UK[-9DKPWV!<%WD1$1$1$1$1$1$1$1$1$1%
MX^_DYD?C&6'S %[!1$1$1$1$1$1$1$1%YXZ^_DIX&4^&-O#DKK=4-RUR?1<A
M4KW(K,]IC60QL\E<;"Y_,Z%TOP]J7%OM<^7<GL$3'J38+JADLIL%*$8.2+&3
MUG2BX\_"^;W4O,/H7<MB,34M8Z$GL?)9].64#W<U@:5UJ^YVMGT>7*X&I%+.
M6%LT,KRP1^//D J"]";&=.LQPFA6_#?7F[YS*1)S^S.%+9=[R#[=^IKF'K3U
M<?RR666?T6]S/[,8 <MO5^J-7.ZGD,M'4>)ZG'KUFGDA0FGUPN7J=.>KK<TG
M?9,<Q#B6,"[V8ZO,QFR7<,<1,Z6&)Q8.?SR/^P 73I=32_4ZV4M8R2*[9L&"
M"B#RY[PN1%U6R>.S=&ALF"919;\0S13>J%.=HW*+$6*V.JUG6\G9!,%9O@$#
M[N/V"\\[MFLUE-VT^'+XD8^>&9W@/,C'!Z]=C[KS9UEJ9C%;-KVSQ5#9JTCP
M]OV:5,H=CUCJ9K<U"*T(K#NQ_I/_ %QR!1[K'G-GP^#H4:\)DK3ED5FW[%SO
MLQ6/2V>7%ZK/D<OC7T&5F- C[N]Q"C3NI]^M0@RE[6;L&.>1S/[EK3]R%/W[
M9@V:_P#CGU;31+ \2J"/ZI.KLJW;N O5L98E:R*R\#D]_P"DEJCW4J1S.H_3
MM[&]Y$LRG>Q;S^&YFKB*&.DR%N5A>^.(_P!6 1Y<I_6ED?!&Z1G8XM!+?@J%
M[3N]3!7*..BK2VK]OGT((_N!\E8,!N$F5R62Q-[%STK5:+O+'^0YI"I70-KQ
MV O;S(RO-*^7(M^FJL\O<!WJ\M(W['[52MR01O@EK/[9XG^["N#?ZGP,?=?0
MQ%VY4I2%ENTP#L9Q\*58[8<=L>M29.@YY@E@?QW#AP\>Q4 Z#>>GS/\ G9EB
MZ6L:S;.H[6@ #+#_ -7J[;G]1)_A/_HO)_3O<L1JTVYS7C*]\E]@CAB;WO=Q
MWJ]])ZAX3;(9C4+XYX>/5@D'#@M3(]2<75LW8Z]&_<93)%J:O&',CX4EU;:L
M/LV,9?QTI?&?!:X<.8?ARZ^1G@JT[$L["YC(R7M Y/:JXTG:M1GUO(W\+CGU
M:5:4E[&Q!A/[\!:_^6+59<7];5%F=Y<\-KMCYD/8I=K>ZXG.ZX[-PO?' P'O
M#QP6%ONHF.J^.-5E_P#!\I^'2/#([8B:6$E278-WQF R&,IW(+)-YW$+V,!9
MS^YY7UMFZ8S5FU)+\-ET<\HB:^)@< X_/)"@?6O.3U=4GJQTK9;.Y@?,T#T@
M/@E;V/FH9C2:+[>MW7BE#"Z&$Q-Y<[M/#HO/L%$>E&<M66[%!;PUV47,D3+(
M&!S 7<\B12W#Y/1,'NIUW&805K_80^5L+6@A2G8MVI8>S'0AK3W<A(PNCJP
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M6HLEPMJ+&W'\5[C_ !WJZE1W7')9F#6Y*M?'%]:22/UI^?9=2AFK<6C&_E<
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M![M9PUR[^G;U3V:"U#Z+ZUVL_LM57^['*%ZQ_P![&X_W!=_)[WDIL[/A]>Q
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M!"I#JX0,CJ7_ %%8^KPC?D-38_@\Y'V3KE7K,UG&/$;0YF6@#%>,/!8T\^.
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ML>NQ8P2&OZ#F.K2M]V%BA%SHP,G08S*[%;NVV3,<RU*WE[&#W8Q2C;M FV#
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MFL0P@&21C 3QR2 OH$$<A$1$1$1$1$1$1$1$1$1$1$1$1$1>0/Y.?^M\M_P
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M#A/3;QQPA:".%^1P1L_2T <D^%^N:'>Z<>$;&T'D#A$<P.]P@ XX3TVH0"$
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M(B(BY>8S^(P\<;\A=CKL>X-:7GW*Z@(< 041%S(L[AY,J[&"[&;;6N<8 ?S
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M6ARX73BOGMCUS.6H<O59/<N/]>.6 2N/^(DK;&#R/3;0-E$&6-B9[V=C1X$
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M[W>"X_*X.Y:?E,_=QCH\R*\%6<3>CZ0>'/'L3Y"G3&R>F X@NX\GCCRJ<O\
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MK=L;/ONIZOF[>ROK263:CBHB+RWE_*AF0WS9<'^%W8-G.8?,\?54_0(;'RK
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M(B(B(B(B(BH'?ZLN W[!;:Z OI\>A;<P<N:OOJ#GL3N.+Q^#P<L=RU9MQ/\
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M?:1['PJ]ZWY&K5TN2*1W#Y[436!2$U6YGI]]-7<U_KXT-:0?V5/=->IF"P&
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MY :2O,.,J:ULW5/:*M^B+,<S'>D][/ +'>>"O0V U;"82JZ#'48J\3N._L:
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M'CTX7L!:SCVX"WZ&/I8ZK%5J5V0PQCAD;!VM:%K9O7<%F&1QY''06@P\M$K
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MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O('\G/\
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MR+]W%:'3QE'.Z-A\5D,%-Z$=.(\S1CTI"!X<Q6M+6$5"2&LP,[82V-H\<>/
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MV/\ <N1B>IS'['!@\MBI\?;F;S")?(>M;,=7<-BLWDL7/5LM?3A>XDC];P>
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M9P/CN44W."#$MZ?Z])DC:Q;)G">0CD.=#P K)ZRU:K]#G_(.(K4)C7/Z@?\
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M[!](;A=*\^P>%-.K=:O9T#-OD]XF"2+]GA1W*22R]!C),XF5V'B+R5-NF_\
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M%K]EWX15;#)KD[K,#96<>&\^'*,:YL6*N83/296G:M;+:=(#_1=[@/L&DGP
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M(]ONUCN2%O39&I'*R%T\;7./ 87#DK7BRV/EM/K1VXG3-;R6-<"0%E;D:3K
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M9+)"0UH;R_PI+CMQP>0UZ7-TYWRUF<\EK>7#A:^K[O@-F=9_#9I)1!QZG+.
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M[C;NX75M-UJE9;/)9$<;NUY9Z[(PN'E-+V;\:Q60U[61BI('<3%DG >%EW/
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M[IT?HLQ^=W^FSRV'),8/_L%ZW=8_[V-Q_P (7) QV.V?;?PVM+F<I<ED]4<
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MH\6O3'HL#!PO1P('/]Z*JNL\;':-<):"6V(B%U;WGIY+_P!,"YO1N-@T+#\
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MQ_&N;OVM[CA=Q=M>L,?,)6<V85,=&GW78+,66S\'T5>)A%>JWP7EW]MZMP^
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M]U<IKUS&7!' 96LGJLD/YGE7FWGCRJ\ZG8#/Y_7GXS&10<S2-+WRR%G:&_'
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MBP^ A\=* =L D^SRK2X")P$+0J3L]-<]DMPR%K)YZ:3#R3B5E4//G@^&$*[
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MR.],WO'5*E*,X1S>9YB%8_*)R$1$1$1$1$1$1$1$1$1$1$1>0/Y.?^M\M_P
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M?9IM;SE2"&\QG=%)#)WQ3*WE5&\;YE]5S&.B.,AEH6W!GU!D+?3>G4;=\[J
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MR.2S$.O,H&#&DLD?8DX,LGPP<+J:-U!GVG6\A/%4:,C3\2P$\,<Y-&W/.Y_
MYNU-2@;;K6"QD(?PTD<^"575/JUNN1I7VTM>$MJK/Q.6^6,8O16'LVK6,IS6
M8_3E?"UTC/LUQ'D*$]2MJR^KX$Y&C4BF#90V0O=P6@J)X+J3L=_*TII\ Z'#
M2U3,;3O@<?F7)EZG['DL?E<SB&8UM"K*6L9/)Q+(T??V4HH=5(+73R38_ISZ
ML9$;X/L)5SZ>U;]6L:_/>J5)Z%Z1HEEK^3%W#GA8-KZG9W![N,)'B!-&^+F
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M>OEPR/# <-P%J[^^E/U0Z>@%CSWR%ZMS<>!K.8_Y9ZK#3O/1H?\ (O7<Z2"
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MQ?N+Z?:SB\L<I5I=EL\\R\^3W*49C#8[*4'TKL#9HGD%S'>WA;<%>*"%D4;
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M=U?D4\,O<62-=VG@\'GA?J(B(B(CFM<"".01P5RH=>PU>6.6+'UV/8>6N:P
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MBE9&^4?I)=SX"D3YHV?J< @<#[%'RQL\N< %Q\ZRS/A[@J7'5Y?2<63-')'
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M6V+&7\7:U[*YV]V/#9Z]KDL=^_N5+^H6SW:^;UVKD)KF-Q-EA=8FA):X2>.
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M[9Q\<$56*4M//+G=C@%<"(B(B(B(B(B(B(B(B(B(B(B(B(O('\G/_6^6_P"
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M./"\^;;1W+$]48\_B,,;L5BF*_'/ "Y^Q8O;;/4+5\H<'/,*+6"U)&!Z9?\
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M)(P.("V:VM82EC'XZ#'5XZL@X? U@#"/W"P8O5-=Q+)VX_$U:S90!((XPWN
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M-F,3)E*-GOK-<YID(X'Y5@US;M?V(7'8RV+'T[PQZ[\\T4$3Y)'!K&CEQ/V
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M(5:=#O/3<CYLSKC=#&-9?W5K0 !>C7H6Q&UT3V$^[2"O,'3[8M>T_*[U#<N
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MO"Y^6]7K">.U5)$M:9@;(J:&S2NZS/L28C).XQ?9%6],&5A)'+N.5;5RYK6
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MVK.9/<<ZR\XLJ.JQV:L/\$1!+5R)KFQ9K'9[:*6<LP-IVY&TZC21"Z.$\'U
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MS7\_;BV:AK#X#B1EV/BCEYCAE8._EC2 ?"ZFNLW&;J5FX\I!39*<:UE@1/)
M;QPTL\!9-=N5L7TRSN)L/ M49IJSH?:0DGAIX4SQT>K4-6PF V&2H9H<=&'P
MSCX:G2J'Z;%YJ" N_#69.7Z GV,/)]E\]-;,$N2W@,D!/XY([_[!+E9U2SCY
M)[3(9(W/9(?5:W[./RHAN^Z8[6J08^=@O6 6U8C]S\G]@M+0)<)!5L5&9."U
MDY'?4Y Q>099%KXWZ:3J#FWXU\C',9&,DP_H>_SVD*SD1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>7_ .37_P!CV/\ XL"]0(B(B(B(
MB(B(B(B(BX.T8&'8,%>QDI[1.SP_CGL</8K'C<-W:]5QN5BAG[86QRMX[F/[
M0NI#A<9%C(\=%1@948 !"& , '[+8K4*E2 P0P1QL//+&M 'E:&-P&'QDD\E
M''P0.E=S(8V!I<5LC#8W\0-_Z2$6//\ 3=H[^#^ZV+M&I:K.@LPLE8[]37CD
M+@LT[6(V1L;AJ;6LX+1Z0\<+<R.O8;(M@;>Q]><1$&,2,#NQ=.Q1JR5'5I(6
M/B<WAS".6D?'"YF'U["X:.6/&X^"JR0\O;$P,#B%B?K.!?EAE3C*QO#VLE@]
M3_Q6YF,'BLM6%;(TX;48>'^G(T.:"%FH8ZECZD56I7C@@C'#(V#M:T? "-QU
M%EV>Y'78V:4-:^3C\S@WV!*X]G4=<L9<927%UI+@]IW,!>F<U'7,Y<@LY+&P
M6I(>>PR,#EWH:L%>!D,<;6L:WM:P#@-"YE# 8?&SVK%*A!!+8=W3/8P-+S\E
M<O':I3Q^PY7+0N#77..^-C0UI(_M'Y)6[FM5US,S1R9'%5;3HVD-=*P/XY3$
MZQ@<)ZQQ>*K53)^OTF!G=PH_K6L6J>P;#FKHC$UZ<>DQAY[(V\J>HB(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\H_P FXW._/!H'H?T7
M?_C7JY$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1%Y;_DUAWTVQ'O\>I O4B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B+RC_)NNAC\]4+?+_2>O5R(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+RM_)MIPN&?M'
M];#"P+U2B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B\O_ ,FO_L6Q_P#%@7J!$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$0D!$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1%Y?_DU_P#8MC_XL"]0(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M/C;(TM<.04    1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$7E_P#DU_\ 8MC_ .+ O4"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+R_\ R:_^Q;'_ ,6!
M>H$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$7E_\ DU_]BV/_ (L"]0(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(O+_\ )K_[%L?_ !8%Z@1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>7_Y-?_8MC_XL"]0(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(O+_\FO\ [%L?_%@7J!$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%Y
M?_DU_P#8MC_XL"]0(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O+_ /)K_P"Q;'_Q8%Z@1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1>7_ .37_P!BV/\ XL"]0(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O+
M_P#)K_[%L?\ Q8%Z@1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>7_P"37_V+8_\ BP+U B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B)R$[@G<$[@G<$[@G<$[@G<$[@G<$[@G<$[@OYXZ+U(RNF17HZ5>*
M067,+N_[=BG_ /G$;/\ [OJI_G$;/_N^JG^<1L_^[ZJ?YQ&S_P"[ZJ?YQ&S_
M .[ZJ?YQ&S_[OJI_G$;/_N^JG^<1L_\ N^JG^<1L_P#N^JG^<1L_^[ZJ?YQ&
MS_[OJI_G$;/_ +OJI_G$;/\ [OJI_G$;/_N^JG^<1L_^[ZJ?YQ&S_P"[ZJ?Y
MQ&S_ .[ZJ?YQ&S_[OJI_G$;/_N^JG^<1L_\ N^JG^<1L_P#N^JG^<1L_^[ZJ
M?YQ&S_[OJI_G$;/_ +OJI_G$;/\ [OJI_G$;/_N^JG^<1L_^[ZJ?YQ&S_P"[
MZJ?YQ&S_ .[ZJR1?RBMC:_F3&5G!;;/Y1^8!@+L) 0UO$@]7]97V_P#E(94R
ML+,% & ^095F_P Y/(_[@A]_;UT?_*3OEOC7H0?^.G^<G?[_ /9Z'CX]=??^
M<I<_^7(O_/3_ #E+G_RY%_YZ?YRES_Y<B_\ /3_.4N?_ "Y%_P">G^<I<_\
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M^Z9T_P XW$_[IG3_ #C<3_NF=/\ .-Q/^Z9T_P XW$_[IG3_ #C<3_NF=/\
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MO_4/_P#":W_E)_E_ZA__ (36_P#*3_+_ -0__P )K?\ E)_E_P"H?_X36_\
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D(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex3-6_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_006.jpg
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M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>!NB?]O\
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M]5D5=TD!))79Z<5ZT?4#J"Z<EE@7CV _-A)6/0[3+'4[>76@766SED+_ *1
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MA=U.Z><QM/=+-RG5RR([FLZ\PF*I?MDSM9X:6M^171ZHZ9@(=/OY"G2BK6:
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ML9\EUL!HEK"[5)D,7G9SBI&$NJ%Q<"]6H^1D3"Y[@ /<D\+X@N5Y>?2E8_\
MNN!1T\+9 PR-#C[#GR49:KOD<QLK'.;[M!!(7T;,#7%I>T$?+D+Z>]C!RYP
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MC<2T$J";_O$.I8R.80&>Q-((X(O8%Q41OY7JKA\9)E)X,?<8UO>^JSECXQ]
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MN1A7%IF0IV]>Q\M>9L@;7C;X^O"T]_NW*&G9JW3D>RQ%#W1EGNHIA>I&HYW
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M<"1Y'ERJ;-.Q73CJK0GH$LK31<68_P" /7K>I:K6H(YX)6R1O'+'-\AP5?\
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M_#"Y=#Z<!9V?<;RG5VCD->VC%;=C8 XO_83CZO*LG4M8O0: <=>8&6K$+WS
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M7"U(K <7"5L8#U]C3=8;E_M9F(K"[WE_K]@[RX_O+#DM(UG)9F/*V\9%-:8
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ML_S?P/O+OY/6<'D,6S&6Z$,M9O'9"6CL9QX' 7Q@=<PVOU75\92CKQNX[@P
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MT\,%J*1\+N)&M/):5NHL%O'U;D?99A9(SGGAX[ARLD%>&"-C(V-:QHX:T#@
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M2^5O =&N5^MRB(AD#ALD,03P+WICM+E+\GO."H:S]OB1\],@%KH0'*"3=;<
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MEDG!M/(\11+9W5VF['KD'VEEFPTGS-FCE]N2Q3RE/C:&)ADBG;\,R%O;(X^
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M<\M$T)9_Q5+:5IO4+!XFWC+.3J?"QQO%2,<N)+OXRI+T[U+.ZQJ=K%6'UY)
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M ?,.5HR68(WQ,DE:TR.X:"?)/Y+*B(2JKQ6]9:SU*OZU/1BAAKUWR->'<N>
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MS3.FM79:4$ F^'CGEB?^'M<%\8_J.QO3ZOL=^$,?*T 1L\]\A]@%%<AO74+
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MZV^>ZR?V9YBCC5B].^H,NP83)3Y&)E:S1D+++ HA-U)VK*5;V7P5*A]EUG/
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MJC2(8P8Q'PT<M'L/R7VB(B(B(B(B(B(B(B(B(B+GV\=+-+W]L7L/Q,!*\5]
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MG/=D%=O#&B8@*78W'Q4*-:I$YYCAC#&EYY<0WQY*AVS=-M<V/*PY&^^VZ>$
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M6-4K.RDLSK;)'LG,I\][5+&9G&/M.K-N0F9H!+ \<@%;TMB*)O<][6#ZD\+
MZ]4:&]UB(=PY;RX>5FFOUH^ ^:.,'V[G +Z,\+8O4+VAGUY\+"<A48QKS8B
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M 7!5#T]TO [%J9RF8JMN7LER^:Q* YX3I?/D<=F-CU&V]T]6C(17=)[B-:&
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M1H/C>YY\&5W'E5#F<7@L5IN19;]6YLC)1)/;B_:"%X^KRK)VBI7R_0VE>O\
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M%G@YG9$R$'GW!\E1^_UMQT-2K=J8FY/5< 9I^.&,Y6QD^M6%@ABLT*=JY7[
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MX^&Y%%6@#R^7@^Q=X"GW6:A5ORZG!.SEDEP,<KAP>IZ[A7O?C<77K$@-<]C
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M6*M+OD1F/EE21S%[J'LB(B(B(B(B(B(B(B*M+W2?5K=^_<+[T<MN9TDQBG+
MXN4OP^KXK#8-F)JP\50PL#'>2>?<E5]0Z):+4GLRFBZ<2<AK)3RV-2_"Z'KN
M%P=G$U*O%6?Q*'GETG\U$8NC^$KL-6#)9!F-<\/EH>H3"]=N[M>H8J+(X..W
M#!+3J$?#@=H:WCCAJX?13'SU- JQV&<>O+)*!_J/6C?Z$Z?<RKKO,\;'/Y=
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M9K_1V[E'L#W03S%K/JY<')[SLL6!J9JIM0FO/+'RXQL+O3#7>> I%NN_;*-
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M1$?)#/DMSI#?K4.E>1^(+F&!TQD:6GD!R?T?9VNU:_6,0:^.WR?'!(>HCNV
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M6I4\N8H+E"#T>R1GEX71WO*?%=)[%B2DRC%/9::M?V/I>2U=38+U1W0TRF4
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M2E<])]JO%/.XDM+@'.(^J[+7-<T.:>0?8HM.SBL?/89/-5B?*S\+W-!<%N
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M%5UC>=^PU>#,YK!5F8N1X$C892Z: .^;N6A2+>=_FPNJU,YBJK;<%A[ )>>
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M"%0O1/);7?9D[\\U=]>6[WVGO/WR]2]NY[7L.6RD&LTZIIT7F-]F=Y'JO^C
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M<K":!K6#O&[CZ9AF<TAS@[W!7W4T/7JF>?FXJ[A=?W]TI=[]ZQQ=/]>BV0;
M(I?CO/+R_P 'E8=PZ;:OM<\<V0KO]:-O EC/!7:UC4\+K-(U,96$49(+W?O/
M(^;BI$HAN&A8+:35&2=9(@)+&QR%@Y*^,]H&&SF$I8O(2VWUZ_'8/5(<XM\
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M;>RX'3\KD,G!5Q<D39LC 7D>IW $!H44UFUCJW5R 8&M8IT+5<\PO8(VO_,
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MJ%*?=NHTTL37O&1,8)_@<7+3ZZ4XH<9KWI=C(XKS&-C"T^L,D#-KT@W[,L5
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M)C8KF2NXB:$N$MP'OC>M*M:ZA7M_V+"ULX1"SWF?S^Q9]6,^JZ^C979\+O\
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M;R/ )YY"]#*J^L[9CHEPQ0.E(L1%P'R: ?*BEKJ'@[FD5\=C7.LY&S69 RH
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MM:7&$GR %BP^YZUFYYX,=E(9Y(N>YK56MOJY5;OU7$Q6Q#0BC>+,CV?BDY'
M"M#);9@,7%7DOY**%LPYCY]W+/@MGP&<%@XR_':]$@2]O[A*[)/ 4/O[_J%"
MRZO9S$+)6O#7#W#2?J5(;.4HP8V2^Z=GH-9WF3W'"\VZ7G-:VC8MKFV$Q3.L
MV&PTV2 OXB//AJO37-<Q&F8>Q5JRR"JR1\O+SSVJ!8+J[0RFVY"F+(BHQ,#8
M2YI[I9%8<VZZO%;M5),O7;/687S1D^6-:OV#=]8EP;LS'DXC3!X,WR!6G@NH
M&J9RU'5IY)IL/]H7CL>MZSM^ K9AF)EOL%P@GTOH!]5JXK?=4RV3=CJ65BEL
M <]@^?\ );6P[A@=>;&<C;$9?^"-H[GN_D%^4=QU[(86SE*MX/@@_KCQY9^1
M"H?1-IU_8=HVR?,O#S;E$-1LK>?V!Y^XK/J2Z7TWHR41:=&V24R^C^-ZEV,V
MS 9/'39"ID(I:\0^^\>S/YJ.'JII0JNL?:S#'ZWI-^KRK"BECEC:]C@YKAR"
M/H5^JJ\AC=&L=1J%J><NS;&<,A:?X?FY3&UMVNU,G]FSY&)EO@N,)/D >Y*U
M\1OFJ9;(FA0RT,UG^!JE:BV?W77-?D9%D;[8Y7CEL0'<\A=7!;!A<Y7?9QUZ
M*S$UW:2SZK<OW:U&I+8L2!D4;>7O^@7FW#;)K.P;ULLV:L0R5V?Y-29(TO!8
M3Y+5:..BT_ISCY:SK_H0SS&5D;SR?Y-"EV V? YYCY,=?CG$?'>T>'-)^1"Y
MEO?-5J9.;'392)MB*-SY6_)@8N<WJCI!ILLC,Q=CW]K!^\2LU[J3J%'*1XZ?
M)M$[G<?5H/T)3*=2-1Q63;C[>2:R8D#ZL'/U*G$,L<L;7L<'-<.01[$%1_8=
MLP6N0LDR=UL D\1CYO*TL=O6M9'+'%U;[7VA'W]BYV2ZG:AC;\M.Q?<'QN[7
MN:SEC3^94M=F\6S%G)FY%\(&=_K\_=[?JHECNI^G7[,5:')%KY3Q#ZC.ULG]
MPJ29_9L/@*S9\A:$3'.[6#W<\_1H6EKV[:]GIY(:5E[Y8AS)$YG:YJT,UU%U
M/#6GU;60YG9^..)O>6?S7?QFQ8?*8W[1IW&2UN.2\>PX^JCL/4O2I8+,[,W
M8H'ACWKOZWM>#V"F^UC+0F:T\.^185'<IU,U#&7Y*5C('U8W<2%C>YK#]'%8
M]P.&V/1<C(Q\=FK)7,L3Q]1[."@&@;YJVN:+@XLEDF1RN9XC'ERMVS:Q6?UR
MU+!+'9J3UG\.;Y:X<*E.A-ZMC=*S-J?D0PV@7D*XM?WK6<_>EJXVZ;#XF=S^
M&^%L1;;A)-BFP(FD^-C9WN9V>.U2-\K(XW/<X- '))^0"K<]6=*98=";\GA_
M:'B/[A/Y%2G8=LPNO58Y\C9$37N :T#E[C^06M@MTU_/1S.QUT2NB;S)'QP]
MG\PJQQ75VO>W*_2<RRRHQ@9%$8_OF3YERDV6@T"??\9+9E'VY%XBC!_X=ZEN
M>VS#8$P-O3D23$B.)@[GN7.Q_4'6<EB<ED:MJ1\5'CUQV<.;RJ*U?<L!FMSV
M>YF))966G_"U8GQ<CT7*TX+>B=-6'',GEB^)D,OHC]JY6#@-BPN=JNMX^XRQ
M$T\$M^1^A7#SV_ZO@;(KWK_;+\V,;WE@^KECS6]X:AK$F>@F-JM[,=".[EQ4
M8Z7=1#M% Q7)9#>+Y)'-#.&,C4@R74W4,;??3GR!]1AXD+&=S6'Z.*E-;.XB
MSBSDH+L4E7L[A,T\MX40/5326U76?M9GI";T@0/+S^2^[G5'3ZE[X*6^_P!<
MO#6L#/?E=W8]KQ&NPP39&22-DL@C86M[OO%2"&W&^JV9H=P6=WD<'A4$.LM!
M^^BH'SLQT->1C^6>7S<A6QG=SU_ 00R9"Z(_6',; .7O_D$UW=M<V&0QT+P=
M*W\<3AVO"E#G!H)7GO(]6G#J%5Q<;+,=&$/9.TQ_?D>M'=:M&OU4T;*CAGQ9
M<Z4D!OX%;N)ZB:CE,N[&5LB'V.3VMXX#^/HNQG]HPV KMFR%H1-<>&-]WN/Y
M!:6N[SK>?>^/'WPZ9OXHGCM>U2E[PUA<?8!>9A9DZE]0KE">248/&]W,(/B5
MP/[RMS.=-=2RF+=3.(K1<1EL,D<8:Z+^ZL73;#7]<U7X#)N -:Q*&/\ K$/8
MH_JII#;?H'+#_%[3Z7/T[E*<KLF'Q6+^T[EQD=7QQ)[@\J+Q]5-+>Z@W[3 -
ML<Q@C_J0=4M*)N\99G%;\;EU]:W?7-F;)]F7FRNC_&P^'A:^?W_6<!:%6[=/
MKD<F*-O>X!=37]JPF?J/M8ZT)6L_&"."P_F%'']4]+:;_.4;Q4\2%;UOJ#K%
M;"5<L;I=!8X]$-'+WD_(!9L'O. SDMN"G8D]>NWF2%[.UP598[JS'=WNY3XM
MLI0PEC(A'Y<_GRYZE.SG0+&Y8&'(L[\NT\0, ^OS>ICL6T8;7:K9\A8[ ]_:
MQ@'+WN^C0N+@.HNO9J_\ PV*UOW$%A@C>0%ESG4+6\)F:^*O6G,LR\>./#0?
MFY:&,ZK:;DLO#C(+SS-*>(R6<-<K%11_8MKQ&OPL?=F(<\\11,'=)(?HT*@,
M]L^+S_4[1'U(9XI89I!/',P,>%=SMWP\>TC77ML-NGR!V#M+?J"L>1WO$8_9
MZ.OSPV19M\>B\,'IE5)UBB8W=]'?V .,DBM#9^H^"UB^*61CM-D>.8BV,$2?
MDU=_8-JIX/!NRUV*<0M[>6,:"\%R[&*R<60QM6Y#%(QL\0D D':X!WU"V41$
M1$1$1$1$1$1$1$1$1:LUNM$_M>[@\?1>*_Z/?]N9?]WRKV\B(B(B(B(B(B(B
M(B%4.+%G([SL;-9@B@D8?2R5^<\\$<^&,4<Z70W*,?4>O7LB>Q%.&LE^3R _
MRI#T+MT+6CVZ<SV&8VG_ !+'>Y#US>HS,;C^G5W'Z] 8ZE7)1LM!@\?/N5C8
MR#6-@T?%QVVP34Q6B> >.&%@58[M<KS;=TZXE PK^71*=]9J52SHF0F?V>I
M]CX7'W[E5_4-CY^G&CR7B]]HOK!W>?)Y'E3'K3B<3#H=4,@CB$%R%L :U;NX
M8FA^IR=C(&L9!2BEB#? #@N#LKC-T'Q9D=[U:O+C_<4LH:G@;G2VOC@V(P24
M&2>J&@<O#?QJJM>GP#.C-=F<9)*W[3/PT33PY\@6'J*_<GQ:Q-?AK4V&TWX:
MI >7Q#\W<!2/K/#'/MNC13,#VO?*' K/UO@AI,UI]6-L3HK@:PL\<!=_KDQA
MU7%O('<,K76KULGYH8"G+:,-6:\SUBMK/=,J.:@IV[^T3R053WQ2D> Q<*_/
M#=ZOX&A;L/EJ5:#9:I?Y#Y'<>2NGU;J5G9K3[?8/6%[L[U?(]BO/>W8NAD^K
MVOU[M9D\)J/)C>.02.%R>K&OT<+F=<S6'A;7O&V&<1CCO7=ZRX"W#]G;?CCV
M7,<\>K^;%LT<]^GN?UOX5Q-*E$V[<^GK$?<8KT5"9BO!%UKPDL<;6OEIO+W#
MW<06KD[9KV,R/6'"1SP@LGJE\S?E)V+)N.%QV-ZJZ'-4@9%Z[WAX8.!]Q='?
MZ&R87=H]OQ=-N1A96]">M\V-70T6[J6<Q>S7L;7,,]MH-^J_V9( 5K=$*U=_
M3B0/C:>^S.'*#=->FVO9YVTOR--KHFW/1@##P8U)Y\10Q/5K6*M2(,CCQIC'
MUX9V@+9WZ")G5/I[,!P^1\H<N;N&O8W)=8L1%-%PRQ5+IPWQW\+4W/4\#C>H
M>D5\=393BN&5D[(/N!P"WNHVKX'#9O4;.,H0U'B]V?L6AG(6]U!%F_U0UK%B
MXR&)D3Y(^^,2-]3Q[M*V['37,_IGC-A?FZW?"\&1S8!"7J([)KF*O]<8*]B"
M-T%BN)98OJ?]==8X+$X/K'A68RI'5CFI/[XX@&-71C@ADZ]V.]@/9A@YBQ]3
M<9F\=LN*VJCBV7X*<);- N_TKS&L9B3,9'&Q&K:M/C=<J?P/;SY"DW4O+W,/
MI>8N5.1,V/M:X?N]RCVCZO@[G3G'02TXI1=ILEG) )?(YON5P^CT]^"GL^$L
MR.?%B[7HP$GGAOE:_1*HYMK<9R!V/R+0W_V[E?[O8KSGTZ _6AO7^TR_]:Y^
M3U'#9;K?:H35VBL* L21-'B1RD6[:CI6$P="H97UHFWA.RK&P2.LO_A )"B.
M8.3FZJ:1<N8=E 3O(C9SS(0W^-=G<<!C<EU@PT$T0#)ZKG3]O@R<<>'+[VO"
MXK"]3>GWV;3BJB5TC'B(!H(8MSJ'B]DPVY1;?B:3,A%'!Z,U<^\84DZ:YO 9
MJCF[F-A?!-/-ZENH?W).#[*+]% PY3>2&>U]G ^GXUHZI'D\QOV\V(,M%5L1
MVS"T2P"5QBY/@<D*6:[TYAUO*9:T_,"P+\$IDI" 1L)^H )4%Z2:3KF:Q><=
MD<8QY;?#8F/]X0.? 7IJM!#5ACAB;VL8T-:/H LRH/+U8(>MN&GC8&OFIO,A
M'S((7%W+6\=E>K^%AG8 R>L7V!_XH8MS:\/C,+U2T27&58ZOQ3I&S"(=H<&K
MT5\BJ(R@QE7J%E+5&*;+9::KV"KVCTJ[/]=ZUNBL$U7+[U!-!%#)'D&!T41Y
M8P_?\-5_N +2"J-Z95X#N74>0QM+VY3@'\B7K1UR://]6-DDOUF/./!AJAWD
M,#3[A:NZ,_1GJ=JUW$L]-^1+VVHF>!+P0M'*ZIA\UUTLU;59A@%'XF2/CQ(]
M.J^CZW@=2H#'460N.5B!>/?AZ[/5'2M<H: ?A*$<3X)XBR1H >2>>22FR:A@
MJG2&Q(RHSUX:D<XGX^^9/J2K/Z>S23Z3KLLKRY[J$)<3_=4.ZXXVO;TF220?
M?@M1.85I?HMAM?TV3.8O&M.2CQ7B7]]Q>!R25&]$U6_L'3IE2'8(H:MQA^)C
M%5KG]Y^KNY=V?5==UOIW?Q&4SLMBG':')#>'!WG[C1RJ\ZB,S,N%UFXW$14,
M96LQ15 9";!:[VY;QX5K=3-<SN0GPF9P[XY;.++I?A9/:0%1_3=TQ^>N9V[]
MENI["VF[O@Y\2L;\UN=#JM*[JU_(SL8^[<N2"T\^Y7.U>L[ =4MEP-4<4)Z;
M[(C!Y:TKA]']8P62S>UV;E"&9]6X!!WM!#.>5U^FO95WS?J$/$-7UY/N-\!H
M:2%S(W?!Z_L]#6*3LA4F?,ZUDK+NQG@^S..[O76Z<2R2]&+W>XGM$[0G3;I[
MJ64T"M-<Q<,D]F(E\[@"\+[Z/-MTL3N>*];OJ4[!9 5E_H^@.U;*M/SN+DU;
MD/3;J1?J3?LL1EN98W_)CPK-T"L<A-E]EG!,V1LD0$_NUF$]@"F6R4'Y'"9&
MFR01NF@<P.)XX)7F*OG;> HTM0W?!N&/9V"&U#]8_ *LC<'Z])M>O7H&R7\H
MV(FI28.6N#N.)"3[*+:<W,0=;,T,G#%!//2DE?'"\O9Y<%*-78QO5C<N N1M
M,#G]:=6='%&28N7DK<ZAT-GQ.UUMLPM9EUD-8PV(">2&+K]*L[K>;^V[E&B:
M-Z:1AO5OEW>?(6ETNC8S:^H[6@ #+#_Y>L61-6CU!RLV'@.3S%NOVOB=]R*J
MSY][_*XW1Z.W0GZ@PSB)EB&T \1>6!P#_P *Z/1BMB\UJV8LW@R>[=MO%TO\
MN<%)1KN"UC4-DQ&,F+@V)\DC''ES._V"B^K7YL7T2?=I^)HZ;R%W>D.+Q\V@
M5RZ"-QN FR2.3(5&^F5*3&Y_>==X]3&PRO[&^[6KE]+="UG*U=A-ZDR81Y#L
MA#OW "?9=[J_J+(,=C]AQL %G%.9SX]X5LQ[!2Z@Y/7*$/$E6*(7[OT9*WPR
M-7H?PE><L"!^OO/_ .R2_P#6%OT/A<EUKRS+_#WU*I%.-P\  ^X6'J/2DQ6_
M:IF\?Q'/8E,-@CWD7H3Y'^:H=C8_U_6B[CQAO"T.J%.MDNHN@TK<+):\CY@]
MA7YU,P5#%[+IM['0LJN9;,7$30U,\;]_K>RNS(1UG08WFL^2(2@$D>P*D,'3
M<U-TJ;+<V%GQ+Y0UT;:PB$I5PVHR^M,P$\N8X>/S"\T=$YX\3LVU8*QR+)G#
MFA_N1$2%Z=Y"J/K#EIX-'NFD>X26&03N:?P-*ZV+UW!7.G]6@VI":LE$.#0/
M'<6_B5+8)\T_1;9Z=LB84'N9 _W4KZ5:!JE[4,3?M8N&:R29#(\ J,:5JV"R
M75';A<HQ2QUK,OI1.'+!RY;5G!Q:QUBH?8D?I16JSWRPL\!H4GZ-R5LE:VC)
M68P<D^\1*7^9&L<3X6E#3DP/6I\% ]E3)UG2S0@^"Y1S3=7P67ZG;FR_0BGC
MAL3!D;QRP<O4VV6AK.$S^M18ZA)/DZL+Q1I1@"/CQ]]Y4?U5N89ULO'+LK1V
MI<6Y[VP'E@Y+5(]9$?ZW-O/CO[%K]0F,'5#IV\#R99EK9ZPRYUSQM2^ ^"O3
MYK-/L)'+/UPI,@I83.5_%^M?CCB?^3UQ^I&+@R^\]/8<E7;S:$@L@+;ZGZ]A
MZ.;U"S4IQP/%T1_< :"U>AQ*QAX)')/A?I/A4!2M,O\ 7.\RX213I/%1I]FG
MD>0F_P -=G5/I],&-$CY)0]ZV,Z&-ZTX!W@%U)Z^.H+V?K-Z<^1R)9EH=:/[
M<:-_BR*<=5]1&PZU-+ T_'4CZU8A5YAMIGW_ !NM83P^5DHERO/R; O2C1P$
M1$1$1$1$1$1$1$1$1$1%P\AGZM*P89(Y20T'EHY'E>/?Z/?]N9?]WRKV\B(B
M(B(B(B(B(B(B*H;_ $I$VQWLI3S]VE%=E+[=:'P)5OZKTOQVM9K)WZMZ<Q6O
M:M[,:%$<MT.K29DW,1F)Z$,Q)GC8K1HZ5BJNJ.P![Y*KV%K^[W>3[N574NA5
M6G9 9L-WX$.Y-0#@%65M>CXC9,*S&S,$0BX^'D8/,1"B5?IUG+4<-#-[--=Q
MM=[2R(,['2\>WJ'E=S>- AVMN,8;SJL=23O#6QAW*;MHUK:L32Q[\W)79$X/
ME+8N?5<U9,OI-S)Z7#KSLR]GW&1RV1%YD:P>W'*@6]8";7^D4N'DR!M""6-D
M<CF]A#5EP&D[59UG&8P[3QC'U6%X9%^U_P ,.Y]E*]KZ7XS*ZA7P])HJFJYI
MJOX\M+5#+O1_-9/&T3?VFS+>K2,])Q\LC8%WL]TONY>[@+$FPS..-]GRQ][W
MD^[B25U.H^@6]L9C1%D17-:3U.TLYY*R[SI62VG"8['G*-B,$K))'B+\;F+I
M['I-38]:9B,C,9'L8WMLD?>#V_OJM,!TEV&M)!2R>SV)\1#[5&N(:X-4KZA=
M-_TCEIY+'VW4\G4/[&4*&9#IAOF:&(GRFT]\\$_>]@'B/\VE>A:[)&0,9)(9
M' <%Y'')^JK7=='RMW-X_/86_'#D*D98&2MYC>"L>/T[,Y/+4,QM%J&2:GR:
M]2 ?LHW'YDJ2[+F]>AHY&I?N1#BN[U(N?O<%13HYKC,)J43Q&]C[KQ.0[W#?
MW0K853Y;3=@M=0Z6?AM5Q5K,[!&?Q%JR9S2\Y/OM'8*MN 15HQ&(7CR05@V[
M3-BR^Y8/+UK59D&.\QL=[\N67-XKJ#6VRWD<&ZC)3LPQME@GD+/OL^G <FD:
M#9Q7VY?R)A&0R;WF1D/F.(.^35'M'T??-<,^.=E*OV2R626%C?+Y7'Y.6YTV
MU+=M;R>4^T9*;J5R4RD1O)(>LW432=EOYS$9S7;,<5ZJ"QPD)#2"HY?Z=]1,
MOGM?S&1S=7UZI)>(QPV'\HU)LWJ6V6NI.-S]9]3X*NSL+7$A_:F]Z;M&6W#7
MLICGU1!C23]]Y#^7+\ZEZGM^Q7<.[%"I''4D]4ODD(=W+-U$Z>WMFKT,C2LB
MOFJ@'IR@EK2M/6-4ZA37JIVO+QSU:KQ+%%&\N+Y![%ZRY'4-JGZFP[$!3-.'
MB)C.\A_IKXSFI;A/U)H9ZI\$:-8",->\AY8L6X:5MQWVKL6N6H(G.@$$YE^3
M5V;^.ZC4LQ4GQT].[6^$$=EL[S"9'C]X<!Z:)I60Q66S.9R3*T-J])SZ%?S&
MP*P<WB*V8Q5S'V@3#8C+'JG,%@.H^JU9\'CV4;M+[_PMF:4QNC'Y@-<ISJNI
MVM=UVW#&]EB[.Y\TSS]QCI7*'=--2W76[V4.1%$U[LPE>(Y22URNTJB9M"W+
M&[SDLI@KM2*G?F+K#I/,C03R>T+//J.[-ZF?I+ *7PQ;Z#F&4AYA75ZH:'F=
M@?ALAB)HF7:,I+&S>&$.43R^A=2<ID\!FI\O2=?J2$N:&EL40/\  I#DM(VB
M??Z&>COP.@J0-C =R'2?5;6ZZ9L69V[ 92G/7BBQO)'<3W$N3-8WJ3#LUR_A
M'4'4[,$8?!/*X 2-^8X:5DTK2<G@X<]DK(K'*Y&4O+6?U47Y KG].],VO6\C
ME;-Z:H]M^?OF:PE<?<^EN?\ TK_2'4KT=:S*7&</<6*4ZWJ.SUJ=[(9?(BSF
MI:YAC/),43"M?I?IFR:G'=KW[5>:"=_J?<\N#UQ]OFVVGU'PTF/RX=4G=&QV
M.$A_]WEBO;SP53F:U';K/4FEGJSZ8HUH^P!SCWD)F=.VBUU*QF>KS5A0K,["
MTDB3A-\TS:<ON.OY3'/JBOCG$\2/+7^5<:H&WH.[8W><EE==OUXZV0+GSOG'
M)9W%='2-%W#7MJR]NQEX9J-R7U97=O[29ZNFSZX@D,36E_:>P./ )5%Z7JW4
M3";+E<A:CQSX,G/ZMEK9G<L/U'W%U]GTO9*^W.V;6)ZXGDC[+%:8EC'A9\'K
M.?S.>J;!M$4,4M-I%*I$>X,+O=SBN-;TO>/UFR;+!/2%8CTN.XAWI?12+JAJ
M&?VBE0I49X(H8YQ-*)/<N;[)N6L;)L&J5\5%9KQR\L,[CY#BQ,MJFR9/0&X*
M2Y RRX-BEE'X3&T*1Z+ALI@M?JXR]/'*ZLT1Q2,_@"X_4W5<YLN)CQM"U%"P
MRB24N/OVJ083#VVZW'C<LZ*9XA]%Y8/#VJD*_2C=]=RD[=9V 08^9Y[FO<06
MA3;,]-)[FB#"LR#I+S;(MFS)_P#99_F7*-9GIOO6PX2J,MGXGW()8C'"T'T1
MVJ3Y?5]YBLX>_B<O#+<KU7QV?7Y:R8N+5FUS2LQ^E-S9,[/ ;4U3X800>6!B
MXD.D[GJV8OOU2:F[&VY"\U;!+!$?RX!4PUO3[F.?E\K<G98RU[DRR#[L;?HU
MJCW372]CUB]GI;TM5[+TA>.PKXUG0<WC-FS>5M6:[V9,2F5C/=A>HWA^F>]4
M*>2P+,W!#AIB\L+ 3,I'H'3S-X;6+N)RF1863,>&Q1>6L[UI8?5>I6OXR/"X
MZ[CI*8Y#;$G(DC!^C5/<3J#L%JEFACG--J6,E\\GGU)7>[G+@=,--RFG8^Y5
MNV()(Y7B7EOR*Y74RG@=JCP6/AD9-<EO#TBP\\1#\:N6E4@IU8:\# R*)@9&
MT?)H7*VO#6LMKN1I5YO1FFCX9)_ 54<VI=1L]1K8;/V:!HL>TOLL<7SO#%L[
M5TWS@V;%Y[6KL4-B"%D!;/[!C%I4.FNVUM]BSK\\'L?#Q9FXXD=]6!JZ.4T+
M;&;U<S.(RT=:"Y'Q8Y'+@LVP:+L5S>,5GJMR ,HD-:UQ/+VK<SN&ZA0;7<RF
M L4S7G@C8^O.\M'+%FU+2\GBI<SF+;X/M:_Y<V+^IC*Y^EZ7M."V+)Y.U?KS
M,R,A?98SEH#_ *A<NWT\VZAO&3RF!RD$%3(<FP^0%SV%QY/:%FT[ICF=>VO*
MW)<P9Z-EI[P?#YG'YO"X%CI/M>#S=JSJ.896K67_ 'XGDM[ K2U_2WT-=R-*
M[=DMV[S2;=I_XGN4/Z?Z!M&'H2XW+Y.)^/:7B.K&.\/#_FXE:F,TWJ#J+[E'
M6[5*?&2/+XF6GECXE-=8T^[@L%DGB=DN6O$RVIW>&F5RY73O3]DU>:['<OP3
MUK+S*[@</]533/9?!0U+M:_;@ ^'>Z2-Q\]B@71G6J>*UMUV.N6/O2F5A>.'
MB'W8KA*I+.=/-E;U .P83(Q5F68BRT7^7-Y()[0MO;.G&4MYNEL.'ROI9.O$
M&'U!XF ^JW\/J6:RF9Q^>V>2'XFFQPK581RR,N]W%RM-4YM_3O-7MPI[%A\D
MRM8;&(Y>\+0SG3S:+NUX7,19* G'QM:'R#R\CW)"[>]Z9L&P9C%3UK<$4%%X
MD;&[W<]:747IM;V6Q0RV.N"IE*S?#PLFHZ7M1MU[^VY8VYZI!K0L>71M=_&>
M?FK@5.;GTNERN?CV##Y,T<BSW+6>'E?%+'=8[$XKY#+8V&J>0Z>)A?*0II8T
M/$R:G8P+P\PS<E\CO,CI#[R$_55]A]2ZCX;&_8=;*47T!&61SO!]6,*0W^GL
MM?0#K.'F9&).&S32#R_ZE=+I[KF8UO"_9EZS#-'#P(','!X5'ZW%LKNIN[28
M6>N)&V9NZ.;\+^7JY-6TW)1Y:;8-AL16,K+$(PV,?LH6?1JCE_1=LPNU7,QJ
MEBH([SN;56?EK5+-=U&Y6RM_/Y6>*?*SQ^DQS!PR*,>S0HKJFA;5A=KN9F;(
M59&WI2ZTP-^OT74W;0\UE-BQF9Q&4%2Q PQO)'[A4;J]*]E@W:MFW[-+,!%Q
M+.?$KO\ 4 6_F.FVP/W^3/8O,"I%9C(L.XY>WR#PU;VX=/<WE]FP>1JY<1,Q
MP'9W#EZZ6_=/G;%8Q^3I6OA<G3?S%-QX(7,ATW:\WEJTNUWZTU.F\25X8&]H
ME?\ 5ZW]NT+*9O;L+EXLL(&4.2QG9SY6MOFC[!LE_$SULK%#'4<']A9^^HMU
M0JYIF8U^S2SKQ>#FL;3CY'>3[O7H1O/'E5#O?32?-YBKG,3DGT<G%PTR#YM"
MC\O2?8<CF\/E,ILTDTU8DN('X/R8I5O^@6]AOXK*XZ^*>0I$]LG'N"N!:Z/6
M+V7Q>6N;+;ENPN+YIB/)^@9Y\!=[<NG=O9<YBK_VR8!0:?2!B#R7%2C-;=KV
M!9'7S&6@BFDB)X=X+U".DF I009?-PUO2;DKCGUA](%<B(B(B(B(B(B(B(B(
MB(B(BT[%;'22ETL<1=Q^\.2O%O\ 1[_MS+_N^5>WD1$1$1$1$1$1$1$1$1$1
M$1%'=MT[%;/194R,ECT0_N[(WE@)6]@,#1P6+K8^F9/0@;VQA[NX\+J(B(B(
MB(G@^%6&5Z2ZQE-IDSML2RO<[N,)_ 7*SHXV1L#& !H'  7ZB(B(B(B(B(B(
MB(B(B(B(B(B(M+['Q8RDF294B%I[!&Z?M'>6CY<_1;J(B(B(B(B(B(B(B(B(
MB(BPY''QW*5BO*]S6RQEA[?!\JN=(Z68#49GV(.Z>R1P)I!Y:%9B(B(B(B(B
M(B(JOS/2C7<SM7V]<,CWD@F ^6'A6A'&R-C6,: UHX 'L B(B(B(B(B(B^9X
MG20O:V0L+FD!P')"K37.FE; YV;,19BY-//R9Q)[2EWS/E6:$1$1$1$18I*-
M/XL61"SU0SM$G'WN/IRLJ(B(H#M?3;7=FRM*]?9(YU?QP#P'A3FM!7JP100Q
MMCCC:&L8T<!H'R"RHB(B(B(B(B(B(B(B(B(B* [%?P$&2<RV;8D[&_@/CA>7
M_P"CW_;F7_=\J]O(B(B(B(B(B(B(B(B/D8P<N( 02,<WD$$(' A.0CI6-(!(
M")WMYXY\IR$Y7)SN>Q^#QL]ZY)VQ1CD@>7'\@%TJ%V&U3@L1M<&R,#QW>#P5
MD[@BI_JWGMDP='%7,7>$,+KC(9P!]XEZN",DM!/T14C-M>Q5NL+<$;P-!T'>
M(@WA7<UP("<A.41<2'8L79RMK%P60^U P.D8//:"JOUO:MGM=3\WA;UN'X2M
M%(8H6>YX< "KK!!3D(BA'47+YK"ZG?R>*=$)ZW#CZ@Y'8NII^7MY;5L-?MO!
MFLU(Y9.!P.7!2-.0N/L%K)5<1=GQT,<MF.,NC8]W:T\*)]*MJRNS:FW(WW,]
M8V9&<,'  "G60FL14[#Z[&OE;&2QI/ )"KKI9MN<V/&Y.?*-C9-#;],,:..P
M*S^0B(B(YP:TD^P5,W-LW#/RYL:JRO'%CI?2]68=WKO\\AJG.B9C,Y;7*]G+
MTW5KG>6R1$<<\?-2U$1$Y5-/W?88>JPUN5D IF,O9QY<03X5R@\A$52Y#=\U
MDMFMX#6Z]:1]3S:L3O(:TCQV@ %:%'>]RH[5BM?S>$J!]IYXLQ3$L+1] 6JZ
M43D*O=YO[K5EQ(UVJR5LD_%DN'/#%80)X\IR$Y"(BKGJ3O;-0QE6=K!)/-8:
MQK#[=GS*GM"[!?IP6H'AT4S ]CA\VN6RBHK=>HFUZOLL6.;BZ]J&Z?\ (G=Y
M85ESO4_9=7N4QG];BAJ3G@SP3F7M/T\M:KIQ]^M<IP6J[^^.9@?&[ZM<LZ<A
M:N1O0T*-FU*?N11EYX_)41%LO4_-8)NQ885_1?-^RQW;RYT2O'#V[]C%4I;T
M @L/A:Z:$'GL>1Y"Z"<A.0G*<A">%46+V[9']5,CKMET0I1U7S0AK?)'(X)*
MMU)I6PQO>X\!K22?R"I'&;GN.V7<E-KD5%F/K2]C'SN/?*5VM2W'8;>QW<#G
M,?!7M5JYDYB>7"7\QR N5KN[[/:ZH977KOH,J00RO8V/W\. "ND%.0B<A$3D
M(B)R$Y"(J4ZJ;KM.KW,1]FB 0690Q[W#EP*NJ-_+1R5"]^N;93P;)M;A$MSX
ME@+> []F>>5*\9+?=CJIO<"QZ33*![=_S6UR$1:V0=9;3G-?M]41DL[O;G\U
M6O2S9]ASU++OS,L1DKVQ$P1#AH5IIR$3D(B<A$Y"(57&#L[Z=TS462BB^QV\
MFJ\>_O\ =4O&P8K[;;A_B.;AA,QC ]F @<E=CD(B*!]2<UF<)J5[)8KL]>%S
M2XN'(#%U=*R=O):E@[EN8R33TXI)'?5Q"D_*A/43*YC$:GD<CBWQMFKM#R7C
MGPL73?.9#-:AB[U^;U)Y(_ON4[Y3E$3D)RG(7$DV+&,SD.&];FY) ^8,'R8P
M@>?^*K6YLFSU^J]'$NM,&-F@<^.-ON?[ZN5IY 1.0G(4;VUF>EP%YN$D:R\6
M_L7.7YIXS\>OT1G)>^]V<S'GE27N"<IR$)5$=2-IVC#[IK5>ID>RE<<08FCZ
M*]PB(B(B(B(B(B(B(B(B(B(J4WB*1V>>0PD>C&J,_H]_VYE_W?*O;R(B(B(B
M(B(B(B(B(3P%YMR.:O;3N>>I2QYA^)QQ,'HT#[R<^'O\A;73"SL9S6<P]F+)
M#$D/-62S^., \ +BS[-G.G6V7*.7N7K^/M0N^ )D+R%:^DT\QB\!/D\Y=M/L
MS,,SH9I2\0-]PP*HZ&8M;G0R>7G&PF3UW_!BE_45P/;]X<E236]WVK%].\U=
MS<$YNTGMCA=-X,I<L@U;;K^H5,[5SU]^=E:R81F8LB:V3RZ,-6SU+O;'C=,U
M^Z;TU;)"U7BL>A(0QQ>"7+N=6)<K6U!M^GDK%2Q!/%R87D!X<J]ZQ8TV=+P&
M5DMV#/ZD$9!>2P]X]U-,QF;&C]/8+4=RS;LSF&-DD[S)VO>%7>PYS/8ZG3R.
M(SV<M78W@V8IF'T'@^Y [BI]LF[Y6U!J^%HEU3)YF-CI7_.NU0KJWK>5Q&-Q
M+OMV]<J&_"V5EAY?]\>S@O44/X!_)?J\O;A]J#K?",1Z9MOIL:#)X:Q9[&>Z
M@Z1M&.9FLF+N,O3!KWGV:NYOF;VG6MQQ$PS$XPMR?AX_@4RWW+Y/U\%BL-?D
M@O7K0(<SV$#/QN*LFNQ\<+&OD=(6M +S[G\U\WZSYJDL8F=$Y["T.;[MY^:\
MM=,M8R3-WVL,R]CLI6S'+-\YCR?Q),<^_K-L-?"B%EJ:!X,\G_V)G=Y(4MT_
M9-LQ_4*SK&?R3;+#5]6)Z^\EN\F3V7-X]NR_9%?'2>DTL87OG>MKI3ON8R^3
MRF(R+W675B3#;+2T2L"O!0'JG_W?;'_LJIG$7^I<G3VC<QKZ]&I1IQ^FWDF2
M=C![JSJ74*9G36+9;<#3,81]QI\/D7 EDZFNU^+98LNSUC$)CBC'Q&(U--4V
MZ';=.?DFL#)#"]LT8//8\!0KHQD*^,Z73W9W<1069WO6?$Y+J)LV$MYNO?KT
MH7M<^C4,7J=[/J\KB]'LPZAI^S9.^.'16S+*%Q;?4K8[.!?L,&Q4J\K9.8L0
M&%_,;ODYWS<I/F>I6P2].:6RXJ"**43".RQXY[2LVK;7U.RV=Q%B3%,BPMJ(
M.<>/('U)5[+EYW,5<+B;N1LDB&O&7OX535<GU*S6 ?G\?=K5Q,#)5H/B[@83
MY\O7>UG9K^XZ;+/!.VC?9S%/]P2=CP% NBM#/M9E^<JP5XLCQ-&8@YTI\_OK
MT8M>]8->I8F#"[TXW.X'SX7GO#;?U%V#7KF:Q^2H#LF/%#T@7AH*[G4#=MFP
M%/6KE6:-@N%C;%=\?/DKM]5MFSFM8.EDL99C876F121OC[P0]-GWB]3Q6!K4
M&L=ELKV"LQWE@^;G+DOO;_KVU8F"Y:.5HY!Q$Q;%V&%Z@^[6,E1ZT0S8NDZS
M;-)HCC/@*08O=M\Q&]8W7]D-.=EP<1O@''"]!H5Y-W#'[CHF\9'9<7 ^>A;D
M<^7Z>3R6O5H:OO&G;U-C'3 19.K+ZL4#_</'T6IN&]V6;2[7JN7AQC(H.^S=
M<PR.!/[K N3H_4++V-NNZ]/DF9*N(GFK?["PO+5P*VY=5,KD=GQ%%E9]JK+Q
MZ@<0(A&2"UB[.Y[GU!U[%ZJ^1\$<MEC&7"1R_P!13K?]U=@GXBA#89!8R,A'
MQ#V]S86#W?PJYJ=0\QA]OQF.&>&;Q]EW#Y?1+)(W*29G9,QD=ZOZ_#L'V0RO
M"##]SETSU.=$N;<^KD(=@>Q\T%GTXI6#ALC!SY"G".(#225YQV+6_P!8F4V6
MTZ<?"XYCJN/\^#-^\]23H=G)KFK/QMM_^58V7T2SZ,5U(O-76R=E?;=)F>"0
MQ\I6OU0V([M7JZ]@L=:FD-L/FD<SM$?"[&Y9W;>GFN:Q4QX@=%%''7FE/DEX
M73I;9OV/MY7*;#2B9B&T#/"&>[#X[8R5#;O4+8)\&S/5MH@BM^'_ &.V(EO8
M?D7?-RF^<R&;VWIA]I5;1H2OJF26(#GO^K>5K])SD,9HU3(V<H'T65GO%;T0
M"WV_?45EWS,YC#7,Q!M3:$_EU7',C<X%H^3W+OQ[]LV2Z66\W7D;!D:?BQW1
M\ CZM6+5,EU8S,^O7W21,Q<L ,A/E[_'XW+@,V?JIE<GLV(QDT<L].YVF;\#
M6,82.&J39;>\U!>PFN7,C'0N&@R;)7""XL/TC"T-;W[+U=_CPDN4DR^.L@".
MR6%I85+#E-BVW9,C4Q61=1QN.>8GV(V]SIY5!]/KYNMUIOP9BU\19CQCVB;C
M@O8'#@KTRL=B%LT,D;O9[2T_R*\D21;CTCS%R2G6-S"3S<E71I6RZGN%TYJD
MPLR44!AD8_PYK'*JI3GX^M6PMPT,)N259 PS'AC 7C[REVG[=N%#?[>K[%<9
M/WQ&:&5JZ5[*;9F]FSE&ODI<12QS/NR]@)E=]>>0L?3G=<YGM>V&*:U'+>H/
M[63]OAZKO6MMZO[1CKDF/,7,5H>I,XD'S^XQ3C/[ODY<^,!]N18LUJX-VX&&
M1QE^D:P:+U%RTFSY#7LC=.0B8QSJET,+.\,6'$['L^U/SMG';(*5NI.YL&-+
M.6EH^IY5S:G8RD^MXE^2+OBW5HS8#O?OX\KOJL=PV?*#/8O6\/(V*W<!?+8<
M.?1C;] HCF=AW#1<YC!D<D,GB+<G897L[)6.6'J%N&[87=L31H2AU2YSZ$0;
MP7GZ.*G/3Z/J##]ILVB:&0>J/0+"K)7GCKW*88-?D$(E+;OAA6AM>?ZHZW]F
MYNU<K-IV)F,DJ-]HN_V:IUU2V//XK6:N3P<[!&^5@E?QR0U_S";QM^6PN@T,
MC!)_E-AT$1E/GL]0$EZT<9/O%'-8%T.>.:Q-QX$\O;VF+Z'W*NH(ORY_42?W
M3_\ "\FZ W>+5G;*F#L15X?CNY]B3R0[SX8%9G3#;\_=;L6-V"PQ]O%3=A<H
ME-OMK.TLGDZNU'&N8][*E(1D]X9\WD?5=7$;_M64Z89++11MCR5+PXN;XD7&
MU/.]6,_!@<E7E::0D[+!)/?+]7%>F M?(W8:5.Q8E<&QQ1E[C_)4S@IMQW##
M6<[!G9<<)G$TZL;>YH8W^/R%L:9O&:S>OY^E9,;,YC>6$GRPN'S5::SLO6':
ML0ZSC[D)97M<2.+B'O[EZLIOM?"PBQVB7L'>&^W=\^%E?SVGCW5%ZUM.S6>I
MF<P&0O PQUY#$QC> W@@!0G!Z]LTG5'/UHMIG8^%O,M@MY?(.?#>WE3;*;/E
M+N^6=;.PNQ<<, ,3PSS.]3O13M+*N2KYVPZPZ*V17G/CU8O/E3E0+J)MD^MX
M+U:C ^Y/,V"LS_6<JQW_  V[5-#NW+6?DL%\(%ZLZ/[@#O?M/*SW[^9Q72#6
M<CB\@^O+#7K!P'[['-4TW'*YN'IP_+4[[X;<%>*8R?5<S/Y&UE>B<^0M/[I[
M&*8^1WYD+B:I%G']'J3\+;?!=BB]2,C][@>6KK=(MRN9W6,E+E,C)+<@F/K!
M_P"XU2'IM?RV3QN0OV[\T\$UQPI=_P H6^Q5CJJ^H61V49+ XK&3/JU[TKFV
M;S!YA 4,UK:L[C>IGZ,R9U^3H>@>V1YY<%WJFRYROU>MX*>[++1?4,T47R82
M4R><S]7JIC<8,M)\#<A<\P?(*OSKUH=;K=;[>M,E?4,[9_=_D@^FNCO#\W6Z
MF:^S%,$]TT2QCY/ 'MR\K)!;W?5>H^$QU_.S7ZF3Y'[3\/Y]H4TV3.Y;+;Q'
MI^-O/IL;5,]NS'_6<?1BC-_-;)T_VK$UKV8GOX>\2"^<DR1N6/>-AW:EU(HX
M_%73-':A/H0$EC&_F]=&6#J'K^B;5;R><+[;)/4@>.7\,6Q@?TKV+I=B!3R\
MS+TTS/5LEY]01\>3RH'OPSF$R>-PV'W#,6LC:D\L,SN&-4WV_/Y;4-<P.'?E
M9I<E;>&2VCR^3@?C+5#+N<V?$9_%38*]FLE7)+;45SDL5B[/G<SE-WHZGCK;
MZC/A_B+D\9XE#/HU5AU%PEO$[UJ0?E+5N"68F)MAY>^)>LQ\_P":(B(B(B(B
M(B(B(B(B(B(BJK;9YV9AP8^$#TF>''@KSM_1[_MS+_N^5>WD1$1$1$1$1$1$
M1$1PY"\IY+,Y;IIU"RT[X#-B\I*9R(VJV=6WF[L5N_DH8I*^"K0\ RLXDE>H
M+D\'C^IF.S&>FO3PLI%[,>PM(],#]]P_-='I=N+=KUN? Y$2?'0UBPEX\2L4
M"TG>;G3B:_K6;Q]@PLF+XGQCDJT<S#G]UZ>9E\],P23GU*4'[W8SV[E!-(ZO
MLQFO5L)=Q5LWZS!! QC/#U)NIU+/V.FM2>[YMP6X;,[!^YX/+0HOO74FEG]%
M95I5K,\[O2?9?Z?#(^%UM_EDRG2#"7887@1359)&N'!:&M*S;EDG;QTW,^(A
MF>^A/!,>6^'EH=R&+'@.N=2WB:].3'6I,P6B,1M;S&YZTNI1RVO;%I^TV6&8
MUV]EOT_ #UI=5NHFO;!K^*@QDDDQ-Z&=_P!S\ :O3F-MQ7*-:S&'!DL;7M#A
MP>"MM>:-FMU\3URHW[S_ $:LE5C&3._"NSU!NTMISVO8#'AMJ1EL36'L'+8V
M-^KE8O437&[!JF0IM8#*UOJ0?D]BK?HR,WF6?:^7#N:, HU/S'[Z] H[V7G/
M4-AH8#?=[I9%YBDMY$/@'S?Y<FNSTOUZ[!(;3 _T9&,;]3WK'>EHR=?N)+(9
MQ1#&_G)]%Q,'LM7I[OFST,W'*VO>L^K%/PKIU7;:>QY:^[%5>:,+0'VB./4D
M/T5A*O\ JJY@Z?;%RX FMP%&L#;KS=&ZKF/\,Q(8[\G-"KV.A)F.A%7X*;E]
M.5LLD;?GV*V]>VW"V="AO?$,#(Z($K'$<M<&^RBO2&JRGT[R5V9A@^*?+*&G
MV#%%M&K29+H;G*=8ATQ?/X4FZ9[_ ($Z+6K7;D5>>A!Z+V/\'A@4/TUS=@Z>
M[[5H'OGGG+V1GWX<25O=.=QZ>-UBK6S#*=:]38(GB6/R_A=S>,E!<Z5V[<=!
MM.O+<::\?L7Q>>'\*WM/M5[6MXFQ$\/8^I&6J0JO>JN,M9+1LQ!6/WPP/X^H
M:N5TWV#&S]/<<38C8:E,13 GRTL:N7TB8?T;S=\^(+=Z62(GYL'*P]%;M66O
MLL;)F%_VF7<?D2Y7BM;+Y"M1Q]JQ,'&&*,N>&CDD+RMLNOXZAC!O&F9=]5IX
MDDKAW'/<NOU5FO9/2-2S=F,,)E@?.WZ&0<K+UHVW 9+4Z%6G>9+*ZY#+PWY-
M7/WZ]+C/U<['%'ZM:G']]P^KP%:QZGX#)LHP8.R+5VT]H9"!YC!]S(J_R3P.
MO];EX\4V!?&\RP1=8=,>Z4#C\:])H?95MKFZ4<ODMCP^0GA%BI>EC;&[P'P@
MD!4YMVKXBCU,UPZ[PRS++WS00#AL2W<_G8-,ZN7+=^#OH9&'[\A;[<JS,1LV
MNY'8(J^NUZTS!&]]NVQO:UC?IS]2HSTMOTG[EU"8)V%\N3[XQ]6@N7.Z]O8(
M=>'(Y^-6QU9N6\+G-/V5E?UJE,R,F/\ B*1,WS4\M>Q\>"AAMY&P]KQRP Q
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MZ=U5K;%/3,E"S3$!<K"H;[AL_F*M3 US9>]I-BQV\"*)0#1MLJZ=LNQ8#/\
M^2&:X9H9G?@*87:<)E.N%J[5M UWXTP1O^3W@A>EEK7I'Q4[+V'AS8G$'\P%
M6>D[QA=IUZK#D;<!N/A#;4$GCDJ :SKU"CUALOUU@%""KQ;+/P-<\CE@3 6X
M/U]YS]LWS7F8W^8>%U,Q+3'6[#]CF>L*9$JXMG.8/-[9M%/;,D^*O1F,5.IW
M$1/:.?)"TNB^3Q-2?<ZL#Q$7O[Z\3O?L8'*4]!+XN87-.>]AF?>$C@HWD=@&
MC]7,G+D8R:61\F8GGL#E:5#<,+F<[(<)7CLQ05WNMW0W@ #VC:5566PFG[!B
M+.X8#(G'9.,>M*UCO9_S:0KQZ=Y?*9;4,3;R')GEA!>3[N4T5 ;=(_ =6,1G
M[LSXZ%FN:[Y?W&'Z%;75F[2S57 82E.V:W9R,,K SSPQ@/)6AU(OTJ_5#0HY
M)P/0?(93] ]>A&D$<@@@HO.77V>%C->87@.^+#EU.NMB!^CX]S)6$/OP.:G4
M&]4;TFIDS,_;"L(_S\*57;^MG2\)'EQ'-1NB" D^6M<YIX*J:'$W=%Z@X6AK
M>2DM4LB]QEI]_(: KX9O6O'9I-=-HMO-_<(\$_0*8+YOO:VO*20 &.)_+PJ(
MZ*9"G,S:HHWCO&0[R?JT]RC.EM@R.[]1H(I 3.^;TWM*Y?2_J+0U6O:UO88S
M :TKRR56[<V"E>T+8<E'#Z%#TG"L2.TO'S=POCHM<JV-%QC(I6O=".V0?0JV
M5'=NQDV5US*T8B0^>NYK2JJZ3[5B:&K#$Y*RRI>H.>R:"0\.X:M70:U.5V_;
M4Z0MK6K,OP[W> 8_*V>@%ZE)I\]1A'KQW'&17PCO8KSKK3Z4O6_8Y19!D$$C
M6,'L[[RYS,K0P'7'-6LK8%:&6H\,>[Y][@I'L]#1=ZOY&E:E;4R=4#T9_9SV
M+8Z(Y'-3XO*TKTYL0T;#8:L_N'-"O!4AUNJWXL1C<O5C+_@+K7R#Z-7(W;JC
MJ69Z>Y&.M=YM6ZX:*_[["5AR,HN]!:#JX+_0K5Q)^7ICRL.R]1-7N=+9:=>T
MZ2S/19&(@WRPC^-=49*G/T$\2!PCQ;(G,/C[X"D_1Q\4N@8H @\-+7*H-JQ.
M7US?+6+Q#.*NQC_AYY<O4N&Q=;$XRGCZX_8UH6Q1\_1HX707GGJOGW,V7"8;
M)79JF%L OLOC'EZKVKE]1Q75JE<Q<(AQ0A$<;HX^&O=]0ISL&5JZ[UGK92_,
M(:EK'"+U%P\GM^+R/5W6KL+YV5&#L$W' >NOL&>J:YUO-Z]]RO-C1%WIF=CQ
MTG5K5+3'GLEJ\'GP6=_!'*WNJ&1J4NHV@RRR>(9)3(M?-3,U#J\,[<:[[.R-
M<Q^O\F.)!6SO=[%[?LNLX;'2BTYECUK#H_+&1A-LRV.Q_677S-+V,%8QG\B[
MA61U)N-JZ'G)@YO)K\,!\@DJM]0W"EKG2"OD">]\ ]$,'OZI"X73"?78Q>V_
M8<E"<I8D>[SSS&$ZCW[F=PN#W/&5G@4+LC6-^9C/L]2C#=9F;%#5HXO&V!EI
MB ]I',,7U/*XN[Y*WIW56EL=B!S\?9J"N^1@4=ZA;S@<_L&IV,>V26&M.?4G
M+%ZVA>V1@<T\@^0B(B(B(B(B(B(B(B(B(B(J0WK_ #^__!C5(?T>_P"W,O\
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M+SOT]V_<;^T[)\9AC(\V(XIN'^*W9R Q69GMWMP96?#X3%.R%^%@?,TN[(F
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MW2L@L,CE<WV\<\J7ZM-C;VCXXP!OPS\>T!OT'8J?T*BRMTRW0, ? 9I!"X^
M\-*EG3NNU_2:",1-<'U).6D\ IT*8V3IP(G>S[4P*J]N<GTN?;=.C8_FU./L
M_M'/ >58G4_"OPO2J#&T?,%1\#)2?<L:"M3#:5T_V#5ZF0EOVQ :S#*P6.&-
M('GEJT>JC<6WI;A(\87FDVW6; 7_ #8&E7!C*V-_12G\4V-L/V>QCR1X#"%0
M-FKN&@5IS7;%E=5>>71//($;E*^K=NED.F.'N5.(X);55\3/H""M/J%>L5<3
MH'?XIB6)\IY_> X"M?J"RA8TK-BRYI@-8N+E1F=JF+H7@1:B>7F>N8_R!:K#
MWB"L>CLX<SQ'2A+ /D0%+-"MUZO3_79YY6QL&/AY<X\#V4\9(R1C7,<' CD$
M>Q7-S61^S<9;N>GWB&,O[>>.>% <QJFK]0\%4OS0M$D\ ?#89Y>WN5:=(ZF=
MUS=<]K,DQFHP,>[\@\%27IM:ABW?J+6>>)'Y+O:/R!<OO4K$$O5;<#'(UP+4
MZ9Q0'=>HTA:WU!E. ?GP2Y8+./ADZXU+%5O+XZ)?;37;$3>LNV0<#U7UGEA4
M.TFAKUK;]KQF=>\9 W7O:_U>!( 3RIG<U?5<95VJ#7HY!D)*),CP>]C%M]&<
MMBKVAUZ<DD??!W1SQ/6_N$F$=TNV6+#PQLJP1/A:(QPSEI\\*3=-'Q.T?6AW
MC_-\/_2IP[V5&]-9&LVSJ4.X!WVIX_XO6ITML3-W+>H<EXOR7 _@_0%R;-18
M_K+JTM6;B8P/=9 '[C. %?H]EYWZM006-[T&&=X9$Z6;N<I/UL@I2Z<?5:#-
M\;$(/KWJ.9;*R1[+JV#ITZT.692'-Z;RZNT@> %Q\!%8H];WQ2YOXR3[.XEL
M2^[O(Y:%(XF1GK[;YX/&&74ZI9J"I:U_&PT()\A:LDU))_P0EONY5YG*$V/Z
MHZ2^]G3?MR2.-@GPV-3#J.'T=VU7*XT^O>Y>SX3GS+$M^IKV1SV_5=@R52*M
M7HQEE:+U.Y[W_4A1K)__ *P-?_8V*;]5<_0Q6%J13XZ"W-8LM$#9P#$Q_P#&
M56&ZT<G5R>HSY;8?B[4EP%T+?$,?]P*3]3I*AZB=/7V"PP&6;DE=SK<RC)IX
M$K 9C>A%?Z]ZBNV53#NW2RO.T<L#VO"[W5P@9#4O]XJ[V_/^:_)I8HHRZ1[6
MM^I/ 5<]4*V&NZ9D_C"T@1<PN\$]_P NU5MNM+(U^BF"B),;H&5#8'Y!BNS5
MIH;>KXJ5C^624HR#^1:J)U&Y?UC;=R@QV/ER=26R?VL/'+)!R URLKIOKF0Q
M@S62R9B%W*V1/+%&>1&H=UW#7UM?B;$72NOM["KR.2H5[,%6:S&R:0?<8X\.
M/"WU0'705V08":W&\U67AZW"ZEK7^F Q]?)RGUX2]I@!D#W%Q]@ L&V9ED^_
MX_!XZM7K9,5N3DI0"Z%COW6!177*$.*ZRY"O]JON/.)>9+,K^2^0D+?Z6YRG
MB-IVO"9/B"[-=,K'N_?X)5N0Y+"/R.8IT1&)O0,EN:,#@.X/;W$>Y5<=#^S[
M"SX]<SM^//[3YO\ =?'1WT!G=^; '"(9)G8'>X'+U?1]E0&G9#X?JSN-*_P+
M%B0O@)^;&E9^HU..UU#T-D$KV6?5E)+![,6*801=>W26'!C7XK]B3X!<M?8;
M]=O6C60VQ'Y@+'K-+/%5Z^R^I+V!^)# NGO>HMV7*MOX#+BMG*$;>.#QWMD]
MN7!8>GVT9Z\[9</G(6_:=)A:Z=@_& "%RNAMJ.KJV<-IX#F6R7M<N/6FFV+4
M,]E:EYF'Q0,W94K^'3.Y\NE/A8].,;N@F;82/_LRF.DQ&7HZQ@^=)ZKK!MG?
MT"O>DTN[;CB\#^ *V:N>Q>0Z5FQ!*QC!C0PMY [' >RYW1Q\1Z7N[)2_L]?O
MY_=*P]&)8V=*[I<\ -EL++T,;&>G,G@<OM3]RU>E-2F_7-OJ.#65S>D8?H&>
M5%^GN4S^.UG*8O$5(+U0VIF5+)E]/N_,A7%TTU%NJZY%3?*R2P]WJ67-/([U
M8+B "2O-.QZGE&YC)[9I66'KB>7XRMSQRYI^\%U)]M_2?HOGKTM<03B(LE \
M-+U(\*(QT=I=G'^9F*%8K8J&'Z*4)YZ<=T/<(! _S&7G^-1;?ZE_]&,#D<GG
M0^>6U7,="+Q!%'^05A];WX^QJN&E:Z)[SDH.QRG/4:'OZ=YYD#.3\'PT-51Z
M%KG2S.:M1LV8(#:@K-%ON(:>\!7CHS-?CP,7V)4=#2]1QB!:&A_^NM7J3'/-
MHNP1UVN,QJGM#5R.E>4IWM PP8]O$%40R?D6!1SI-6BARV^68./@Y,IQ [Y$
M-+U\=*;,$^T]1)(I YC\H"P_4<O5YJ$9O;:^+VC"X>T&B+(PS<2'Y/86@!53
MU<Z;ZZ<%<SU!D=2U7'J$1@!LJC&V?;EGI+J^0OF6=D4\3IV2>>]A'@E3.&QT
M:R& 9D?LZA'R ?2$8;,'_18^I]RNR711Z#H(S9:\-( $8^BO;(D?9]T\^/1?
M_P#"\V:!7GN]%MCJU)^9R^7[GT6/I>_IE;U>&'+4\>+\'(F$\8[RI_8.BY;2
M#3-5M+%V[Y@KEC QO?YXE5<8?],.GFU83$'(_'XNY)VQL!7JY5KU1S_V=KSZ
M5>3B[?D%>  ^1W>[E':'2.>KB(L?^EF4;"(NQ\,;R(E$.EUF+3]TSVH6+G,;
MI>:Q/U8O3:(B(B(B(B(B(B(B(B(B(BI#>O\ /[_\&-4A_1[_ +<R_P"[Y5[>
M1$1$1$1$1$1$1$1$1$1$1$1%3N_:Y;I9_&[CCH?4FI>+< ]Y85-N->WC6BTL
M,U*R!R".'-(_^'!1.MT?UR&6L);=^S4K/#J]2:4F)A4NV[8:N!Q,LK@7S2 Q
MUX6CESY#[ *NL!AX=5Z>Y2?8S/%+?E]2Y\-X>._R N9IN]=,]9HS5,=<R4<#
MI.?2F!>MO9]\Z:;-CO@+^1O" O#G,C:6<K4UC;NEVLU9ZE#)9 UY?>*4%[5$
M(H>BS+MV0W;YKSN+OA0SB(%2C4-IZ5ZKCKE.C>N%ED\S=[%S-8R?2+7,C/<K
M7;DA)/I,?'RV(.7.OW^G@R%JYA=DR>+-I_-AD#2UCU-,;O'2[%X27$T;EN&&
M0$/>&??)/N2Y<S6=FZ7:S7NUL;E<BV&P/+' G@_4+3U'8NF^JW;]FMG\C(+7
MF1DC/!/U]TQ6P]-L=L>1S V#)2OMAXFB>SD$/4>QL?2&C=L3G-7Y*4A+A2,?
M[+_W\^5(-4V#I'KC,C!5REIXN'AS7L\-:L>L#I7J]^6Y#N)G9R17@^4/<NKK
M66Z;X#8;V0AW4RR6^7V.\?<>2N!M6)Z29S+R96KN,=&S(_ND,8Y!*L+4=LZ5
MZUAXJ%'88 WGESG_ (W.4G_6GT^^>QUE7VY7.CVV%DUO/UXK3/P6(_#UPX+>
MM^A\';ZLRV*)/WH""'%OT[^58=7<NDU7##$1YBD*?I]AA^1"K-AU"HRQ0QO4
MWX7%2N)%4-)+ ?D"I3/ENEOZ&_HS4VJ*O5+>"1Y<5^8+-=.\1J,VOC=V/8YI
M:)_(<P%;>E;#TTU'&RT*NWQRP.D[VM?^ZL.1S72V_M^-V)^S51-5B+.SCD.*
MEE_J'TTR-&>G9V&J^*9A8\*BH-5Z4U[;C%OQ%%Y!DJ?QJ>;CDNFNR8>CB6;C
M!3JUBTM8P<^6+N5=MZ>Q:R<++N,4P]$Q"9_/=PH+5.GQXL8>QU/,V*Y'=5["
M"6C]SNY7>VS(=,=@PM#$1[=!3J57-+(XQR.&+IY'/=*\KK$6"R&T0SQ1L:&2
MGP\%GL5%JL^EF!F/O]23:Q<;F]E0\CEK?D\KO[EF>FFSXNKCCM\-6O"\.$<8
M3+9GISD]6KX";=QZ$;6M<_\ ?D#%V,9K^O[-H$VNX[8S;@A+&"PUO)9Q[!6A
M@,1'A\/0Q[)"]E6!D0>?!=VCA;&4QL60H6JDSRULT18>/< JLJW32YB:L=7
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M *J/^3>2IWM&"BSN R&,E_#/$6\_0JO^G.<=4PK]<RC1%DL5&8S#_P")%&.
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MV1O+AR!R.2$-NNUKG>JP<>"21X60SQ!G>7 #Z\^%\Q3Q2#ECVN_,$%?LLT;
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M::#)SQUWW.Q]9I(8Y7F/G_-'/:T$D@!?D,\4OF-[7?F""DUF&%O+Y&L'U<0
MD<L<C>6.!'U"_#/%WEG>WD#VY7ZR>*3GL>#Q[\'E!:A+@P2-Y)XXY"^76H&R
MMA,K&O/LTD E?LUJ" ??E8P?5Q 2*>&5G>Q[7M^K3R%C-ZJ 3Z\8'=V\]P]U
M$LENV,I['C<*)8WSV 7/^\ (VA3-CVO8' @@CP0B(B(B(B(B(B(B(B(B(B(J
M0WK_ #^__!C5(?T>_P"W,O\ N^5>WD1$1$1$1$1$1$1$1>7^I9R0ZKZL<<R)
MUL-_9"4\,)7<V/2=]W;+4/MH4:>,@E),<,ID?_\ #5K]8<5)7GU48V5T<HLB
M*)A<?3"V,QKN1T'";'GJ^7EL7+@8P]XX[7N]W*#'2<_:Q=*WBM?L0Y?EDK\B
M;!YD+O)*L;>\+/E>ETU[8J3/M6E5Y$GS#TU>EC-3Z7,V*E4#;+\4R24C]]Y"
MKFOK.<S^NQ99N&M3Y>U$V:/).F)=RI/M!VL]'X[&8FMU<A7E:QX[SS(WZR)I
MO3W,6ZVM['+L=DGX+[T0)!$3F^&-*AFGZOG]MFVK&C-RQ4X;(+RXE[WR#GL4
MKV"QFQL6$TQOQER&EC6.M,A?V&P> .7K:TRANF*W+FKB+=/!O ;-!8?RUGYL
M7=HPS;_MF;?9NSMQ.,F,%>&)Y8)7_P 97"U7!C!=;+]$69IHV8IQB,KB]P82
M. O2GR7F#J)TYV3'[#/M6KS$R/>Z6:)GA[7*0]/>KT6;N08C/53!E.[B-_'#
M'N7$VG5<=<ZPX^.22R/C('RRELI!Y!"E6W9&Y8V+!Z30NRU(I8>^Q.QQ]7L;
M[-7"VNEE.G%O&9;$Y.[+BGSB*U5GD,@Y<I1MNSW\EG<#KN(M/K,OQF:>TT\2
M-B^C%N8G6MDU_;XA3OV;.!L1N,D<\A>Z.10";;L7J_47=+=R0=Y8!#%\Y'*;
MZ5JV<L7CL>:RLYDLR&>*C'*3#%WJX$ED$<;G'V )*H+&Q7^I&3R]J3,6:N+I
MSF&K!7<07N^4CUFTW9\]B=LO:5F[4EI[6N?4NO\ +W-4+P,V_P"8W79L-#M,
MS*\$TC'S.Y+F@'QZ;5+.FN;V+'[IG=6S&4FO/B!DAFD)=X8KWOP23TIF,E=&
MY['!KA[C\PO,?236[[]BV@RYJZQ]+(-$S&//$Y\^9%T S8Y^J.W5L,^*%TK>
M)++SYB'/R"Z^A97:<1O^6U3*Y2>]&V SQ3S$E_ *U<QM]C-;-G,<<ID:%3'2
M>BT4V\O?+_$X@A='I7MN>M97)X')OGLBMRZ"W*TM>]@^JNZ]7?8IS1,G=$Y[
M2 ]GXF_F%YDZ>ZMD+.Y[D1GKL8J7^R5S'$.G/)\O4WN9'/[=M^3PN-R<M#&X
MT]MFQ 3ZKY?DU:6)V#9M7WRIK>:R)NT;C#\):D'W^5L'9<[1ZR'""_(^A-%Z
MIA?[-+EMWLOF:G5K'469&4TK54O-<^6-((4/S^<Z@CJC:PF-R8>)JY=$'^&0
ML>K.U*SF==PCX=MS$3Y39=Z,CW$DL4H^V<?FJ]JOC<K'ZWIGA\3N7,/R*JSI
MOLVPC9,]@-CR4DMZN08 ?9S&^"5VZVQY 9W<,J_(R/Q&-:8FQ?(R^>54%[<<
MYEL(,O!G<I7R1YFAI0L/H%@^7(*LVGMVVY7I<<M!6(RCG>GX9_Q> H!L.?V#
M2K^!DBVF:_-8#1<J3/+P"5+>M&=V7#-PT^+RLD+)I0PPL4ETO'=1:^Q7[><R
M;):-B+N;"TGAC_HT*8;GD,MCM<R%G%U_6ML9Q$U>>L_E]DUBG@LC+ML\N1FD
M8+V/>\N:/44MZS9[8<9%@+6(RTD#)Y?,;/ >N1NTW4+6H<7LES8">^RR.:C%
MR(6=ZZ?5[8M@J5-;O8;*35X[3P?1'CNY7*W2/?-9@QNPV]HFD=)=B9-2CY;
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M>[N].+TOY=BJ*[KN9I=3KV HES,5EYA9GX'CL!5T=4==M9O3;<-.(/GAD9-
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M/XX[V>5Q] M<]0]ZGAY/JNGD@/!X> 5&-;V:K<Q>QF]C+=O9K1>SO$?<>SZ
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M6]KP'#Z'R$#0#RBP9'&4[M22M;B9-%)X=&X<M*^<=C*6.JQP5H&11,'#6-'
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MLS%Y&PZ1UEPY?&%(.FND;+K7V]2OVXI:-AY]$CR]Q\CN*YO3S6=]UK(V\5S
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MR4&RUPV2&<,AG]O6:K!Y3D)R$Y3D(JVZGY_8,#K_ -H8@P LF8V4R#GPY3C
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MY_?_ (,:I#^CW_;F7_=\J]O(B(B(B(B(B(B(B(B(B(B(B(BH#-M.;ZUXJA(
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MS&Q"F]W<^+A;&.U/ X[$VL76HL94G),D/[IY6'&Z/K.-Q%O&U\;$VK9_K8B
M0]<NATPT^C0O5(<7&(K7B4'R2MZYH>J7*-.E/AZSX*HX@:6#[@7?Q6(H8FDR
MG1KL@@826QL' '*BN2Z;ZADLH[)6L3$^PYX<YWU*D^3P.(R=%E._1AL0 @B*
M1H<T$*.87IYJ6$OF]0Q4,4_R> .6J:J)9[1-6S\IFR&*@FE)Y]4M'>NSAL#B
M<+4%7'4HJT///9&T-!*Y%K1=/M7);<V!I23R/+WRNB:7%RE<<;(V!K0  .
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M7 E9Y+,#)!&Z5C7'V:2 2D=RL6O>V9A#?<APX"U8<KCK!+8KD+R'EO >/<*
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M-"X.N=0\#G[\^.A%F"Y&WN,%A@8\A51NC&CK3I[P/+EW^KL,3LOJ$Q8#(+_
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ML>N4<F^NV SMY,8/=PI.B(OF>4LBD<UI):TD-'S(4$T/9\SGX<F[)XB2B8;
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MG5(W!S*Q8#&WC\E]2ZO@'XAF)?C*SJ+""*Q8#&"/H%MU,'BJ&.^ K4H8JQ!
M@8T!@!_)1_&:#J.+OF]2PM6&?GEKVL [/[JZN:UG7\U)$<CC*UHQ B,RL#^W
ME;EG"XN?%C&S4H7U>T-]!S06=H]APN6S4-9CQSL<S#U!4,@D, C'87CY\+L6
M\51LTC4L5XY('#@Q.:"WC^2CT.B:A!$Z*+ T6,+VO+1$W@N;[%;^3U77LE#!
M#=Q=:Q'#XC:^,$-_DL-C3-6FQ]:C-AJCZ\)YBA,8+&+/8U?7Y\7#C)L76?3B
M(+*Y8#&WCP. JJZGX\X75JM'$X9GV:ZV#;@A9[L4$GS_ $BR<;:L.F619D_
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M'4J+',K5XXFD\D,:&A9)Z=6:6)[XF.=$>6.(Y(/U"R+FS8'$27/C)*,#I_\
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M$[&]W*.C:[W"QS12N@D;$X-=V^'<<@%1S5]8^QA>GGMNM7+DHDLV2WL[R/8
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M3=W:]KN/! /*QFC6^(;8,+/5#>T/X^\!].5G1$1$1%HY;+X[$TGV[]ED%=A
M=([V'*S5IJMRM#9@D;)%*T.C</(+3\UL(B+':MP5*\D\TC61L'+WGV 4=_3/
M6/\ 3%7_ .W7;K92A;;&^"W%('CEO:X'D+;1$1$1  U$7Q8LPUX9)97AD;!R
MYQ]@%JX;-8K+4S;Q]MEB/O+ ]GMR%NHB(N-3V7"7,K9Q=>_"^Y!SZL(/WF<+
MLHB(B(L60R-3'U);%B9L4,8Y?([V 4:QF\ZGE+T=*EF()9W#D1^0Y2I$1$1$
M1$11G+[E@<1E*&.NV_3GMDB)O"DR(B(B(B(B(B(B(BB.Q[SA-?O8^G==+ZUQ
M_;$UC>5+D1$1$1$1$1$1$1$1$1$1$14AO7^?W_X,:JW^CF1]L98?6 +V"B(B
M(B(B(B(B(B(B*N,]%HKMVP;\A-QF8CQ5B!\GO^;E);^VZ]C\K!B[61BCN2^6
M0GW7+J=1=/MY8XR#+Q.L_3Y%8H>I>GRYDXEF49\3WE@''W2[Z KMYG:L'A;%
M>O>NLBFG=Q%'^\Y<AW4?3QF1BCEX?BB2WC]WGZ<I;ZD:;4RHQDV7B%GO+"WY
M-=]"5+;N0IT*<EJU.R*&,<O>X^ %%<?U#T_(W&4ZN8B=.\\1M(+>_P#-JD66
MS>,Q%8V+]N.O"/WGKSAOV?U+/;#JUK'3QR7&W0R3QP\,5J;]B=*R%G$.S]QD
M,D5CFOR>"_\ )3K*9C&8BJ;%^U'!"#QW.7-Q6YZSE[3ZN/RD,\[&]SHQX(5=
M97J[0J[S4PS++(JL7>+D[QX#ODT*UIL_BJN.9?FNQLKO8'-E)X!:?F%IX?:M
M>S9D;C<E#8+/Q!I\A5!E*%:#K?B)XF<26:CC)^9!"MP[=KL=V>B[*0-LPO#)
M(B>'-<5U<EE\=C8HI+EED+))1&PN\ O=[!;RQW;U6E7?-/,R.-OXGN/ "X>)
MVS7LO.Z&ADX)WM]VM/E;F5SF*Q%<SW[D5>(?-Y3#;!A\S7,^.NQ6(_JPK0RF
MX:WBI_1NY6"%_P#"2N_5R%6Q6%J&9DD;F\M>T\MX7#;MVO.F])N5K%Y=V@=W
MS7=OY*G1@=+/.R*-ON]QX"T,=G<7DR\4[L,W9^(,//"Z2T[^3HX^$RV[$<+/
MXGGA?F.S>,R0>ZI;BG#?X'<\(<I0$[X/BHO4:WN<SN'("QT,SC;[Y65+D4KH
MSP\,=R0LN0R5"A"9;5F.)G\3SP%YN]>E:Z\5[-29LL4M0.[VE>G6_A"KC=^H
M..UR6E4$\1N366,,1/X(S[N*L"GDJ%BH;<%B.2+SP\'[JYU39,);LFO!D8'R
M#GEC7>5N6,G1KSPP2V(V22'B-A/ERPMSF*,<[VWH.V%W;([N'#2L4VR8:&&"
M63(0,9, 8R7>'<K)<SF*I",V;L,7?^'N=[K-=@JY#&V(WS\12QEI<P_(_,%0
MOIWJV(U;"VZM/)BTWXDE\BEDF>Q$5=\[[\ B8\L+^[P"/DNA4NUK%=L\$K9(
MWCEKVGD$+C3[5@(+#H)<G6;(#P6ERY^X;EB]8PTE^U*/(_8L'DO<OO2]KAV'
M 4+7K1&=]=CYXV?N.<%OR;1@HK)K/R5<2\\=A=YY7<!!'(11^YM>OTK;*MC)
MUXYG>S"Y=MU^I!6=9=-&(P.?4)^Z N#+N6MQTA<?EJS:Y<6B3N\$A=^K=KW(
M(YX)621O'+7-/((7W9LQ5H7R2/#6,;RYQ^0"J# =5,;F]JRF/BFB%*(!L$I]
MY7*)ZY!0H=9MIL>F(8HJ\A+_ &8WERO+#['A,TV1V-OPV P\.[#[%,QLN$PP
M:<A?AK@^W>5O8O*X_)UQ8I68YXC[.8>0MQ>>]TV?)Y_>JNEXVR^"KS_ETT?X
MU.OU3:2* KMQHY!Y%C_[-S]>]:G3/!Y+ 2[-C[HF>&7@^&R_SZS#W*:7MLUZ
MA:;5LY2O%,?9A<NT<C293^+-B,1=O/J$_=#5QI]OUV"DVW+E:S('$@2=W@D+
M?DSV+BH,O/N1"N_CMEY^[Y7WC<QC,BR62I;BF:SP[L//!2CF,==DM1UK,<KJ
M[@V5K?W''Y%<*QO6IUKWP4V9KML=_;V$_-=;)YW$XJJ+5Z[%!"?9[BM.#;==
MLY(8Z')P/MF/U!"#Y[%SK7433*TSX9\Y79(Q_81YX#E^;K'K-_6Y8LW=;#0F
M[29.[A=O G#U,!0..F:ZDRLST'_+TP/!7#9U$T]]]E)N7B]9YX;\FN/T!7?S
M.QX?#0,FR%Z*M$X\-<\KC6M^U"K9BK3YNLR60 L9S[\J7-<' $$$+!DZU>>E
M8@FC;(Q["'M<.01Q[+R]TBU#6LKD=M%_$5; KW&,A;(P.# >5V^H'3>#7JLF
MRZKWTK50][X8O#"Q67H&[Q['J,>7M.9$^/EMGZ!S5O5^HNEV9:\4.<@=),>(
MAY <N#U)ZCU=5J"")_-^5S1&".6M:?F5.<9LV&OT);M>[')#%X=)[-"X]?J#
MIMFU'5AS==T[SPUGD<J8K6OWZE"I-:M3MBAC'+WN\ !1FEO^G7[4%6KFH))I
MOZMGD=RAF_=4:N RF/Q567BT^RWUWEG+8XU;>)R-/*5Q:J3MEA)(:\>Q7"W#
M9Z>M8.SD; <6L'#&M')<\JO]*W&IMNI3PW[$<]V6"9TT!9X#0HYTCVC!Z]TV
MAGR=UD#3>E#5?F(S&-R=%MVC99/"_P# ]OLHCD>I&GXZ]\'8RC1('ECR!RQA
M^CBIM3MUK,#)X)6R,>.6.;Y!"YNP9RI@\5:R%GN]*%O)#1R255_3/J0-G^T_
MCK0;-);)K5_FR)=?"1=/!NV3LXZ>,YB6-YL,9\@#Y4@_3W4A<M5/MB 35HW/
MF;\F!IX/*^,=U!U'(U[L];+P.CJ^9B3QP$US?M7V2W-6QE\2RQCDM(X)'U"Z
M><VK!8)C79*\R#N_ WW<[^06OKFY:[L??]G7A(Y@YDC(X>S^84F7%SNRX;!P
MMDR%QD+7'AH]W./T 7-U[?-:STIAH7PZ<#DPO'9( J>Z[;77BJT,-%.>YUQD
MEAH^C%.L9@-+V?+4=EHL<+-*3M[VCL#B/J%:9( ))4!R?4W3\9=?4L9'[[#P
M]S&]S&'Z.*F4>7QQQPR#;49KEG>)>?N]OU4(;U2TUT\,3<@XME?VQS=G[)Q_
M)RDN?V?"X"@+N2N-BA) :??N)^049M=5=(JOK-?EFDSM:6\#D .]NY=W.;E@
M,%6K6K]LL@G_  2-'<TK9QNTXC(X(YBM*]]8L+N\MX/ 2AMF%N8$9J*SVTRT
MDS2#MX"C%/JIIMN]#3COO;)*[M87L[&N7:R^[ZWALC6H7L@R*Q/^!BUJ/4'5
M+PR9@R32*/F<_(!<NMU7TZQ8K0-M3AT[@(^8N >5@W']7SMDPK\S)QD89!\+
M&/<]WU4YS.=Q>$J&U?LMBCYX'/NX_0!1C#=2M7R>0%$3RP67'B.*PSL+UT<W
MO.N82_7H7KPCL3?@C7,@ZH:;8RT>,BR8,[W]C/'W"5/T6MD,A4QU2:U9F;'#
M$WE[S[!5Y#U:U22W! Z2S"V;Q%/+%VQ/76SO4+6\#?BIY"Q+')( 6$,Y:>5L
M9S=\)A+M.G:?,9[0YA9&P.+ET,_L^'U^JV?(6A&'GAC?=[S]&A1_7^I6O9C*
M_9O9:JVN.60V8PQSQ^7DK9V+?L)@KC*4K;-BT6=_H5F![PWZGDA-<W_7]@K6
MY:DLC'5O,T,K>V5BC@ZT:4:-JT)['$,O8(^P=[_S:%V<3U(U[,X6_DL>9Y_A
M6!TD :/55==..IE[-;%F([U6[Q8LQLK,:.^*N!SX<5Z$48V;<,3KK*_Q9E?+
M.[MAKPM#Y7_R"XN)ZEX#(Y<8I[+5.X?P16HPPO\ Y<$IGNI>M8+.PXB]),R=
M_P"^&?<:N9A^KVKY7/1XF(6HI)?$+Y8^QCRN!U?9$_(:D7M!XR"FNW]0\/J,
M]>+(UKA$_/8^.,.8N_DMHJ8S6WYF>&;T&QMD>UH!>&E=#!YF+*XNM>A@FB;.
MP/8V5H:[@_4 E;Z(B(B(B(B(B(B(B(B(B(J5WB*5^>>6L<1Z,?L%2_\ 1W?"
M-LN,,9+S2?P]>TD1$1$1$1$1$1$1$14!OU."+JQH-E@_:3O>'GZABU^JV&Q]
M[J3H\$T XM.D9/Q[O X7)ZJ:/K=3+ZP^E1CJMEM>C(R$!@+4ZN8+#Z\[5[&*
MH05WQ6PQI:Q=WK+BZ5V]JCIHAWR7.QSQX=VE<GK%I&KXK7:%C'8R"K*,C#%W
MQ-#26O6]U-T/6<7H_P 13QT,5F">$^NU@$CUJ=1KUVSCM'P_K>E5O]IGF/EO
M+!X#@LF:Z6[9FK6+GO9:@QM#Q#Z$0B 8NCFA'FNLN/Q.0<U]6C0]>*-WD/D/
M"P]5L+C8=AU2_%78RP^]VO>T<=RU>OE>!SM>LF)IF%SM#U+.I-7 NNZW<R>1
M>/A92YE!K>\V3] % :<MVSUDQ=NUA1CG3U7$1^[W>WEZV\I1A/7BH'P-,<E)
MI3;&9')]6<?B*HJ^G2HB6&*?S&N[C.G.>K[O5V2:Y3@/M-% .!(%DSGCK/KW
M^PO7$ZR:RRE>Q>WUZX)K3M%P#W</DY2+,Y"GO67U?&UN),>]GVE8)^C. QG_
M +]ZNT#@+S]U3OB]N&HZY/*YM&Q,7VF_)ZG%WIYAF;-A\Y1+*1IDM>R-H:)6
M?(%53FX,UGNJV2AKP4++L?"17BM'AC1S[@<%=[3= VS";K;RDCZ%:E98\/AK
MN49GHX/'R;A2-*3.96W/([NC8'>FSD_B<?8KN=-JF0R71:_5IS/;:<Z=D)4%
MUNQJ%K$U=7V'&#$Y."1OI7/2 Y>WZE3'>9\IF.J&.P45:M<KU:PG^%LR%D,I
M*V<7H>Y4=\JYJI1QN-ID!MBO6F/8X?/]P+T6J*ZGXBE+L>O9+,78#BJW>)*;
M_O.E>?8-8H+J5FI4ZQMCQ6,EQM*W4\UGL#/#EA9JM3,=:,[C7SS0UC'+)*V,
M\&0!WEB[&&P]?4NM$=#%QNBIV*7EA4DPU:#==\V5^9#9Z^'G-:M3>.Z/R3R]
M1UFO8O!=;J$..@9!#)5+_28.&@KTVW\(7G7K'KF&GSNMVWU&>K8N>E,[YR-^
MCEU^J#V83!8O!8>G#7KW+HC=&P^DPL^;?"B6Q=.-HELXFUB==Q6.FIS>'UIR
M>1^?W&K8ZF8JQ;WW1N9O1N7&OCFEC/MV\>R=0NG&O:OH>;- 2GOMPO'J.[BT
MM#ES;O3[!.Z1QYR832WF8Z.9DKG_ (/HT+[P6DX;,=-3F<F9[5WX(]DDC^?3
M#/8,4XZ4/^UNE0AL^S&S0_\ LU1WHO4BET39*TOEAF<%P^E'3[$9_4)KV4,L
M[1-*R"$N^XSZNX4QZ15[+=0V/&MNN'H6GQ02'V8JSRF+URCT_O4X<:,EE(1Z
MEK)0-#F1/_.0JQLQC8+_ $)JVK@$DT.+B?&]&S1ZYT8IY+&UXH;<U"!IE:.#
MS(WRY1J+I_L.5TZE5K8'"A\L#)!D/7/K.?\ Q_@5_:52S-#7*%7+66S6XHPV
M1[7EX/"U.HF;DPFGY>]$[B5D7;%_><H3INCZ_D^GE+XNE'--?J":>=P!D,CQ
MSSRH?J!EET/<]>R3#.S%2&./U0N9TPZ?:_GM"ER.29)/*PSMB:7>(U/.@-Z6
M;2Y:I]H+9#2KOGBBDC=&]@<UPX(/D$+S5T[P]&3J1NO-.(Q5[;Q']WPP]RT6
MX2MG.M>?Q]M\AJF%[Y8@?$G:[V>NOKV'H:YUHR5'&P^C6.(,OI#VY)"X>$K[
M#M>P;3DX:^,M3Q6_1CCN'DPQ^?#/!5@]+](V34\CF1;GKBG9<'QQPO5TN]EY
M6TW_ "/KOL3+/W#+\5Z8/SY>%ZI4,W_-28;4<S>@D[9XH?V?Y.*A6G:3KF5T
M.E-;H13VK],2V+#P'R.E>.2>5"M.?9FT?==;R47KQXEYCB]1:?2[0<!GM!FN
MY* V)>9VQ!Q\1<?P*0]&J<>:T#)X?(Q-F@9:+&QO7*Z:Y:MI[]RP%TEDM-[I
M8_J]K.6J3TV9#!=)<SEPWT<E=@-N=_[_ 'R*)8C1L]GM HP0PXH1V:[)FR$?
MM?4(_&3Q[K%U%P%S&=*\'6R<T<]ZM=BB]9I[NP$'EH*L76.F>!KTJF6K^L,B
M^AP9R_GET@\N514,I4URA8U+<,(]L1GY9=9&#[GQ(K0ZJ5,7+TL+XGMGBA;"
M:TJB.SYVU1Z2Z?0@>6"[%6CE(_@X\A63O6HX>?0[-6*O&SX.L'U7_.,L599\
MNS71#%7[S!/:CDB:)C^(#A=';-%P-/I7-;IXZ$6F0Q3OL.',JN#I]/)/I6NR
MR/+GOH0DD^Y):IA<_J)/[I_^%Y[Z'_YQW;_;V*UNH%ZM3U+,S3RAC!6<%0V@
M8&&7HYF#?OFE6LS=QE_)BX>^6P[3L%%C\&YF-IV(65LC-]U[_P"3?HY6'U=?
M\9H. M3-:99+]0D_S!6?K?D9Z>LX['UF!L=JU&UY^7 ^2TMBZ;[)L-2DR67%
MUFU^TQOA9P0&J^,+!8BQE..Q9$\C(6B2;^,@>ZA'5.CB[VJR0Y#*FC#Z\;C)
M[]_'/W%0&_WI&OU.S2P;ZM6M*UE6S, V21OYL4TZP>=RT0_625>D6 #NX'N2
MHQNK&/UC,-< 0:KU!NEL;&],J9  YJR*"='M+U_(Z79R5^FRS,Z2=C!* X,
M_@6OI.3N8OI1N)I2O8:LS_0^K>4U;3]DS_3UE2'+8\4[D37E@@!>7_,O?]5=
M?3G79-=UN'&2WVV702OY>/E_J!2S*>:%O_ ?_P#"ICH''6&CRN''JONO]1<#
M6Z\$/7?/QQ1M8SX2;P/S>%R,=K.$R/7#,TK-.-U9L<DOH_N%P>L5[5<!%UN&
M,;0B^"E@$CZ_'W"2M_*XVAKG6/6F8FK%59:C[)8XQPU,C2S>9ZO9@T;=2.Q2
MA[8!/&) &J6ZCT]SF'W.7/7<O6#[+'^K% SL$A<5>1_"O/U";[0ZYY".Z[O%
M*F\5&$>&>1Y"U.KM-N)V36L_CH^R^;/8\M]Y%]]>?-?7?]M"]#0 !@X^@41Z
MAW;5#2\];JO+9HZQ["H)T]UW!9CI96QQ!]*Y#S9=\_549ZD5X-;Z?8O T9WR
MU3?CAED_(>[7*R-NU_#3=/KE"&!C*T54/@#/9A;[$*F;4MG(] XI<@PO?%.T
M0O?Y/:U=_(:EKK.B/Q45&(3"A%8]8- >9%)L+A(MGZ/8ZA./)Q[.P_1[&JO=
M3V>X_IW+K7:?M07&4&1^Q#7_ /Y@U2SJS ,/IVO8*LXPU!:@B,OR 8%U-CZ:
MY+9J='[4V:+LK??C,51K0/\ W[E NKN)ISYW0ZDC_69(Q\;Y/F\ M5J;!TTP
M@US-4\)5AISVF !P\ EGLU5/B=QGAGQ.K[OA'0FO*P5K+?!:YG@*0=8P!NVB
M_G+*NMN#H[76#5Z5ESO0AA=)&P^QD/"S=<<3'+K]+*Q@"U3N,['_ ##7*#=5
MH693-Z Z[&'.M1N]==#K'A\7A8M9.-IQ5C%;#&&,!I 7IB-P[6\GW7VJ2Z[S
MSQZC5CC>Y@ER4 >]:F7Z99//XN%E_>))JC.)6?L!P./H>]=7=<!@[W3JO'9O
M]XJUV&M<[>7%[0H!T6N0Y7,6ILY9FES%6)L5=DW[D2[&\7(!U=U"*_\ ]FC:
M3%] ]RM//8#5CG,;G\B_MLU7=D#R[AI<Y4_@J]K+=3]R;)F)Z-MDSF0B,>7Q
M J::_H='7-KOY%^>ELW+M:8F%XX)Y]WJ)=(-=P5W(;7=LPQ3V6WC& ]G/8PD
MI@\/5PO6G.5*+0RN_&22EC!PUI<0I+T9D8:VS,#O(RIY"NLJA9[0EZ[,AN.
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M>)H+DA=+7_,JSM&QNVEUK)[+9_RJ;Q%683Z<+%8RI7J'T\R-S*Q;-KT_I9>
MC[OL) E+;NISJQJ2Z=S<:>/7,G; ?S4JJZC<N:_EJ^:M&>WDF?Y20?V;/HV,
M?(!5GKMK?]*QXUU^NF_P7"G9BDX9_)RE6.U?8,+I.=[8A:S&4D,D[0> 'O\
MS6'IGA-GP&CY3%7,8!.PN,'#_$G>L/1O7]EUVED:.5H")LDHE9('<K4W[I?>
MSVYXO)5'B*O*.R^[V/#5<6:P5;*8.YC)1VPSP^F0/D%YUP^O=9-8[\1BYJ\M
M!LO$4LGGABEF_P"D9^UI=#$8V/XJ<6VSSS/>>7O'N5/L73V-VDLKRQ,K9%M0
M1@,>2 X#P>55-^GU.SN ;KF5P%24RM;SD'2G[GY\=ONICN&EY:?I]5UG$"*4
MQ1Q,+Y7%GB,+$[0+F9Z;8_!Y&.*"[4C8(I&GO#7QC@%<-U'JCD<.W5[M&I'&
M8@R?)MF)[HQ]!V^Z[NYZ1EGZ/2UO78H!%$YA>97<$M8MK.Z_MN2Z<,PL<5-E
M^6%D,W,A],, \D'A2;0\7E\3J^-QV39")ZL0B_9.+FEK/ /D!2?*"W\!8-2-
MCYNPB)CW=K2?S(!7G;5M7ZHZC8R-B"AC;0OSA\L8F=S_ -"W;FI=0]WFC@V.
MQ#0QL3P37A)<9"IWNNCOR&BG!X;B#TBPP,Y[6GL'L5563TOJ?L.H1T<C+6C-
M(QFO7;Y=,6?-Y4RV;3=HS/3.ACY70G*5989>&^&DQA9)=0VK;M)GH[-89%=$
MC)*WI#PPL!_&HK@=;ZNR^E@\ID&18QO DL,)<\L9\FE>CZ-."G5AKPM[(8F!
MC&_0!5MU8TS(;)@X&8Y[?C*]ALS&O/##PJOV;2^J6UXO'SWY*;+%>9ACK-_^
MZ]Q4IWO2]LRV+UV[":T^7H2<O_=9Y5N:]]NLQC/MB6%UM[BZ00_@;S^Z%FS>
M-?DL5>J-=VF6%S Y4MHFL]1L)@<AC+$E0QPL>RI$2>)"_P"K_DU=GIMJ^WZQ
MK5_%7(J;SRZ2LYDA([G^X=X6AHVA;'5Q6PXK8VU'U<B>\F!Y)#BH?4T+JKK$
M]G&X#)QG&32$1N>X_<!5^:?KOZ/82&D^P^>3DR33.]Y)'>[E(;,(F@EC^3F%
MI_\ =4+H6E;OKF6N4VV8(<.VWZH'O)-] MC#Z9NM3J7:V6>*B*U@R1O:)G%[
M6$KZQ&F;E3ZGV]ED91-2P7L<!*>\1DI:TW<I>I_Z3B"B:K3Z3&>L0[TOK^%?
M.V:1NF0W_'9VG%1]"BX")KY2'/"=1.G6=L9IFRZO;-?)<<3,!+.]=O3=4VLY
M&+,;7D&6+4,)CK0L)+(P[W*MM4]N>C9Y^TU-HUV>(7XV".6&8D,DC6M7U[:=
MKV+'9+8Z45*E1:7PU(Y2\NE/S=X"P=5-+W+:+]"/',I-J57=_,LA#WO5P863
M*G'0'(PPQ6NP"1L3R]H/Y$@+9RF-KW\?9J66\QS1ECF_D5YGQO3?J;KMZQCL
M'F6,Q4DO(>YY!#5;=WISC+>FOU]\LCR7>M\2[R\S_P#B%06OK758X:/7[=F@
M:3^(7VVO)G$*D>Y:%?GT.OK. ,+&1EG]<>.6M"3:EM,W2F+7"ZHVZ(VP/(>2
MPQM"D^@8G.8?5Z.-RQ@,U9@C:8B2.QJB>.Z8FGU,R.R/,1KO:7Q,^8E>>25,
MMYU.OM>O6,9(_L<2'Q2?P2-51:_T]ZECT<7E]@'V0WPYL4KG2.:/9BZ74+I_
MM68S>!FPHI1UL8SB+U'D%6'MN%SV8U,UJL\<.1[HWAX)# ]JKJ]I.\[9>QT.
MRG'QU:<H?Z\'F61=;J+H6P[#GL+=H6*T3*!Y:)%(-PTF7/Q4,A%8%?,TOO06
M&^W/S!43EU??MKGI0;,^E!0K6!*]D!+W3/8M[J%HFP[#L>$O4YJT4-#D@/\
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MSR5K2.J0V"6L^7&WH/3>Y65BNH^-S^7H4L!&^<%_?9F+.&QQA67:<&UIG./
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MOD#AM_TO,S'FA$7K8ZVYS$6]5Q38+T3S-D8)6=I]V!<SJVRE!<TC-3Q-N8J
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MW9;&-F8#7@E?RYKRK)CL1/[^Q[7%IX=P>>%A%ZHY_8+$1=_"'#E;#WM:"20
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M4R5RUL^H8&$1RQ3RF2:O+XBD(]@Y8;G3_;)MMP^:J8O$XL59?VOH3'F3^?W
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M1$1$1$5(;U_G]_\ @QJK_P"CG_G?+?X 7K]$1$1$1$1$1$1$1$7F'9_MMG7
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M2Q2->_S)+V* ;99ZJ;9@6TGZQ)4;%)&Z1H=R9UZ)U9F0AP..CNP"&PVNQLC
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M6 _4 .4BHZ1F<9HV6IU_0GR^0>7V97N+8RYZ^]'UG:M?T6WBK,=::VPO%?\
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MX"\6S\BU8[_5++/@OY'#8*.WC*KRQ\[Y^QS^WW+&@%3C6]^PN:UA^<9+Z,+
M?7[_ 'C(4$RF^9W(X2WD*>L"SAY ]GJ.EXF+/X^SA9^@?_=]%_MDJNAWL5YI
M=LS,#U-VYS*DUJS* (8(QY>5-=*ZJC.Y2?$9/&G'9 >8HG'D/7;UC>,GD=HS
M>$MXV*NZD?#V2%_>M:GO>3DW^]JT^*C8(Z[YHIVR\]S.?'(X5<8[-[S?ZK7
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M>-_V6/\ ^%U9IHX(GR/<&M:TEQ^@"I<;ON6<^+OZSB:DV,K2N8))I2U]CC^
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M0&R.]O*@._\ 4S&Z]@XYZDXELVF--7@<LX/[Y4SUK9Z>6P<5T7&2=L3?6=[
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M5))\==:&S-4_UG?,CMV:A=CJ,\&*@:769IAP7GY,"BFJ9^@_JULGB5K;3C'
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MYKOJ"OI$1$1$1$1$1$1$1$1$1$4.S<^'9?<+$,[G]C?+2..%YQ_HY_YWRW^
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ML\GDN_?D6WTKTO9]2^T:=^:K)2E>'Q%A)?RM7?>F>:N9]FPZUD14R1'$@)+
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M&<GERQ]0M&?N%*K2^UGU8HI1(X-C#^]P7QL6A#-:1!@9KA,D#(_3LEODOC'
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M [61L:M?<^G V;,X[(G,2P&D?V3&LY"LV-I:T!SN3QY*BVY:G1VO"2XRVYS
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MLGM:[F-;H;!+=FP<- 1/EB<0'S#@%[PIIJ6%QQQNS2TLJ;^*N-8^KS(7/C+
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MB(B(B(O(']'/_.^6_P  +U^B(B(B(B(B(B(B(B+\=$QW/< >4;$QC QH  '
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MIIU<KPOS&G6"T>HV]VAWY%8-IL26NLVO4+D7%6"$O@!]GO*VNN&*8<)0S4#
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M<.N]7\I]I<15LK&36G/AO(/ABV>H(J9S<=2Q]+B:U#.997L\B*)<7)/8.O\
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MT1!!['+EXF<=.M[S->_RS$91YFCM<$AC@? <MTRUMTZGXN_0?WX[$0%YLAO
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M>L<-EY0\B.1A@ 4 DFZ:GU#5P.?HO:\!YK1!O(/L#PY=^AU(U75X7U,+K.2
M,O$YDB[7EZC>8V74K6ROSMO3<B^TR1H(?X87?+EBWL]MF%VBUZUO3LD;%7QZ
MT1[)&+<U;;Z6!AFDQVHY20V#WOGE^_(]:&P[!@-P<+%_1\A*]G+/69]UZZ>.
MVW'T<%+AZ>CWXZ;P6O:WP7+#@=AQ> ^*^SM$R$(G9VR#ZK6PF7PN#OMNX[0\
MA#, 1R%.?UMY#_TED5&MGV^KM./%'*:7DWQ"0/!;X<"%&8+.J5J,=,=/KKXZ
M\G>3( YQ/^L5%-[WC%9O-:^),#+%6QI?')4/CD'CP%,L/F\'A+L>5AT_*RO
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MPP<]QA@\<E:5;)]1A<ALOZ=U#WO<[CPUS3]2>%F%[>[.8ANV.FM-]SRX6GD
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M>9G=L88U3&A=CN5(;$8/9*P/'/OP?JLR(B(B(B(B(B(B(B(B(B(B\@?T<_\
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M+G\+I4=FP=O%/RE6_#)5:#S,#]UH"C!ZHZ3\,+ S,189O2'YE3Z*6.6-LC'
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MRZ <,86</>Y;%[K;@JL>&>^E<8RZWN#I&!H 7;UWJEA<S+F28IZ\%$%YFE'
M+%QK/5^.I!!D9\)<;BII>([?CV/L>%.LIN^!QV @S4EGNK3AOH=OETA>.0 J
M#ZM[3F,GK5&&WKUJE%)=BD9+(O2>KMYP6-^GPL?_ ,+KHB(B(B(B(B(B(B(B
M(B(BKC9=DSF/RCH*G'I^FP_@Y\E4/_1S_P [Y;_ "]?HB(B(B(B(B(B(B(BI
M;:'8+'=0X+X?/?RKJOI5<:Q@<(_;[Y)/A<'IU%:BZC[:+-2"M*X=SHHCRT<E
M,K#V]>:#Q#PQ](<.^JV^HD<9ZD].6N:"TRS)U=GNNVC2\1'8BBAGLOD=ZC.]
MG>SV)"V,_P!-L_>V'%YIV?K">K)RZ85Q"Y1S=M8Q>7ZMX>K*P-CLUW/L=@X,
MJO/5]1PVM5K$&,B='%-+ZCF$\@'\E".MT;':!D.1[31K2JTH9NBL$ 8.'X5B
MB6DZ'KF3Z<,NW:XEL24W<32_?,7 _<7'PF8R%?H/8D@G+'BPZ /^88MVATRR
MV3TVC0B.+$#XV2MLA@]57YI]"[C-=QU"U;9.^O$(^]OL0U5WUERMB"ABL>+1
M@@NW&QV)!_ M_8>D^MY1N*?4[*#J3FELD+!Y8%%-KM#.=6<3KMUC)L;!$)Q$
M?+9'GYN6IU:P%'7'8?9\3"RI:BNLC>8AV]X>M7J+0J97?M"G@?)7DR ?WSL^
M[)P%\[UIF'UK8M1NXB,UW_&=CR/=_P"9*[O6_6HC4J[/6@!M4;#?5X'O$MC8
M<E4WLZ5C88@^.X1?LC^".(?_ )WKE;S)<R_4S%Z]5%?T*E7UF03_ -2]Z:]H
M&ZT-ZCS<@QM2K)RVS%7>>)!_+@*,0:#BLUU;V.E-$648V/>]C#QR\E=K>]*?
MK&"UYF-IR7\=0M.EM5)!W"4O^;EV>GLNC9K9SF,*!1MMI/BGQWIAG/)'+UQM
M8JUJ/738FPQ\,^%G?_Q>%T=5IXO?-RVJ]F:XMPT)Q7IUY@',8QR^/3;IG5+'
M8W&@P8S,-/?5:.(P_P"K5%8M&H6^LN9Q,[YFU)()+#V!_F0%P\%=S$8=FI=9
M&4,8/2I7*?)B7I9S^V,N/L 2O/6LU:&_[CLU[+Q"S5Q\P@J59!S& >?)"UZ<
M#M$ZITL9CB]F+RX\5_9K'IU(UW#/ZG:2):$+A=DE%H%OB7CC\2]"8[&T,;59
M5I58X((_#(XVAK0N!N.OXG8\1)B;[F@3.'I'YM>/8M7EZQ@^HW2VRZW0G-G&
M!WD DL(^KVJYSU&.7Z7938J<1ALQ1%ICYY['JLZVC9[9=)H&O@L4+-AC+ R;
M[#C8<XCDD_<6SU(PV:K=+L,,S)WY&M<CB,@>7^"%.M'Z7XVG\!G9KUF>Y-1#
M9NX^"7KD=**D>'R?4:K!R65;H:SGZ,#U%=2QF:W'!Y7(SX+'7Y;T\C7V;%DM
ME9Q[!H['< *::UJ^]X?0,_B+4\1L"+B@62%Q8%6^I6-"R5;#8RU3^S<_6G87
M6'Q@>L]OU<O8041WO88]?UJ_>/EX;V0M^;I'^P7GVW!A['2X8B6E=^U?%ESW
M1?\ XQQY5I=%MF.:U"""4_MZ'$#U;R\W=;H97['IAK3M99]601AP4GRF@;5M
M<\<.RYF'X&"8/%>LSCU3^:AO7/"T:F.UF*K V$0S""-S1Y8Q2#+Z'0TS Y[9
M,?;L')#&ECY7GW<\CEZ@>,T':=@TG'LAQF%#)X&RQV2XB?D_O$]BMAF N5>F
MCZ6<$%BU3J.8' ^H&]JY736#'XSIK!E8J<0L-J/<9 W[Y4&U+5]@V;3I)O0Q
M<YO2/,DTWF;GZD\+NV=2RN$Z/Y['YV6&S+5'?7 />(5O=.NEVO6=?P&9O-DF
MMNKMD!+ON<.'AI"B>D=.,-F-@W?'6GR_ T[WI1UV>!SR>'KJ;%6G&]:_J%(0
MR5*% >C'9\QO=X <?J0NO1Z>;)2WJAL;YJ$$ '%ED/W.0LFHPTMRWG:<ADF,
MLQXZ<5Z44H#@QI)\A<2/&4,-UY97H58X(7U.2Q@X'+EZ;'X53/4'IM@]UFLV
M:EH1Y.M^S+Q_\/57:UN6ZZ!F:>%V:*26C(X1QO<2>P?5A4OZI4L;-U%T,68F
M.BFDE$Q(_$MCJ'*Q^X:EJ#8A'C+$O?8B8.T/67J[J.*HZ\S.8NJ*ES'2L,;X
M0&?<7 V+8I]DM].<1=+OA<E&RS=C^3SPK2R73_ MV/$Y^![:1H^"UC0&R-^0
M*JWJ7F+V%ZC8V_3INL318Z0M8%,^F&+P&6KC9GVOC\M/YL3R#S"_^!H5SJC]
MO9@J/4.ID3-9OY,5NROBXF!P!/[Y<2H[T_CN1=4MEBEI5ZC'0.,E:+R >5BP
MVFZ[>ZI;3!9H1R5X3WM@/F+DGYM34(*^&ZQ['CJ$+(:HJRO$+1PT%KE*^FS8
M,WEMHSEUHDN_&F!I/GLB!/#0HIJ="G0ZYYVO4@9#$VI-PQ@X'XPO2Y\M]^%Y
MDS-_,Z7F=B&3Q!OX/+63))9;Y<QKEO[16UUW1V(XB3UZ<=B(P/>/O-4NW.*&
M7I!>+V!W;CXG-4-V.K!/T*PKWL!>VK5['?3EBE^N],]39B,5>EQ\<MME(=\I
M'XW.;Y<Y5OTQZ=ZUFH=I&0I-D:R\(H?K&!S[%=".A;L]6+-#'WH:0QE+T:<3
MXA*&Q#P2QJDV!Z:W,1N\F=LY> _$B4/BCC$0D[U#]$U'"7^H&YBQ2KOKU+CV
MQ0.'@>3[-4BTJC2PG43=:U./TJ[&%XB:MSI-+5V"SLFP6HQ)<EN=@>\>61>>
M&A8-/HUZ'5+<V56-BB;&YPC 7,T>IF-AM[;=9F:\5E]UT4@DK"9Q8>>!R2.&
MKKZ;T[FUG'[#1O9**>&Y 7&JT>/"A/1/1]:S>"R5C(T&3RBTUC"]>JHH8Z\+
M(HF!C&M :T>P 5%81\.5ZR[#-;83-3@,59K_ )-!]PM3J12EQ.^ZKG*!$4UB
M4PV"/>1;'5ZK&[/Z98+?OMN%@*OQOS_FJ2Z\=OZ)4B?]*UU(NH1KGIAFS P-
MC^!'8%7^/T?7G]'FR,IQLL6,:RP^?@%Y>H]DLID(^AN#8R<ALUB"&0GSQ$I[
MF^G5K:\11CM;+ :T0:^"2*FUI:/R(<K:UZJ*F%H0&\;7I0,9ZY]Y>!^)5WU1
MP><NQ8K(X-X=?Q]CUHX#^^%&]!W"AL6VDY;%&AGZ]9\(^DC.1W+DZMKV+N]6
M-P?>HPRF.5[X@]H(!<Y;&MXV'"=;<U1J<15I<>^;TV>&CDA;57F/);95U6D;
MK[<Y-^W8?Q!$_P _<'OR5K=&*O&D;'2L@.#)WM+%K=&-*UK*:8;E['13SONG
M[[QR0(EAQE/,9OJ7N0@SLV,LQS%C0V(2=\0)_,*8:KT\K:SM5C(6-C=9M7H9
M0Z$Q!G?R02[W*KW*7=ET"YEJ\V+9DM<O3OD+OR>O06E6L3:UC$R8H.;3^'8(
M6.]V@#V*J?K)?LC.:AC2[FE8LE\S#[.+%,^K>,I6]"S$LL8+ZK!+"[YL<%#Y
M;U^_T'LV;KW/E=CO+RK%Z9MC&B:WV<?]@A4WLRLBAD>\?=8TDC\@J%V+I5J^
M[TH<WB)/@Y[+!*'M;XDY^H48Z<YS;M;VF73LV3*! 3$>XN[%GZ<TGYC*;<^/
M8)ZEN3($S1,_?'E3K6M'P^J3YUD.5?/9M0/D?$X<<-4 Z'ZKKV7U[*2W\;!8
MD^,9PY[05)M_AABZF].>Q@;]^8+D;L;4_67#5I+CZ;!6XK3CZE2JSTZQ578L
M=L>3V*S)9BD:&ND_?/R"BNVTMRU39<ULFN]ERA:E)O0#R058W2K.XC,ZV9\?
M2-3]NXSP_25ZLJU/'!!)(]P#&-+G$_0+SYK4NY97.9S:<=BJ$T-T^C4?/,8W
M"%GTX8[P5%\')F]1ZK,^UX*U=F9[N6P.[H^25ZM"@/5,?_@^V/\ V553T]Z:
M8#/Z;BK%V6X0]I+XFS$,*MW+X7'8?2\C0HPL@KLJOX:%7'0S#8RQH DFJ12O
M?=>X]_UC7&TNO%D=YWFO>REVG;=>+Q'7L&,.:"58F U+5L!N%F:I<MRY&U7>
M^022=_CD=Q>H/TZ_[T-[_P!IE_ZUI/%:?K3FJM_)7*CI8.V!\4IBY /AJGE;
M2=3Q6XU,J,G:FR,[7AK99/4<\_-Q*A'3ZI5FZI;R9(6.(GF;Y^A>L?6*I5&U
MZ'6$+/1#Y &<>. 6J>=8:C(]%S$D$?87S1F<L'ES!RHMKVA:#L&L4[C\C?DB
M= TR,=:/#2!Y!"C&W'7<9?Z;PUC)]B,DE)#_ )\< $J===YZQTNOY![LC"6*
MUM8<#@<80?!JQ_\ PNVB(B(B(B(B(B(B(B(B(B+D7ZM"2P729"Q$[@?<:\@+
MRO\ T<_\[Y;_   O7Z(B(B(B(B(B(B(B(5Y]V#5=XH=2)]@P,4,[+,)C<9O
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MD7&S>M;IJ6[7<[K-0WJE]Y=/6YX\N6OC-=W^WU3IY[)8V*./TF^J6G[C&?P
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MP9I^R>9OU#0"K3T[:*NT8&IE*[2T2#A[/X7CW"D-^]7HU9K$T@9%$PN>X^P
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M@(#3\@LN)P&'P]=\..H058G'DLB8&@K6GU77IWMDFQ51[P_O!,8)#OJNVZK
M8# 8VEA;VEO'W>/HN71UK"TJTU>KCJ\,,IYD8U@#7'\PNG'4@BKMA9&UK W@
M, X "Y]/!8FC,Z6M2@AD=SW.8P-/E=-:>1QE#)5S7N58YX202R1H<"0OD87'
M>G#'\)#V0GF,=@X8?R62;%T9;++$E:-TK/PO<T%P7Y9Q..LV6V):D+I&_A>Y
MH)"RVL=5NQ^G9A9(SGGM>.1RM2M@<37F$T-*"-[?9[6 %=%'L:\$.'(*TVX;
M'L@9"*L08U_>U@:. [ZK;E@CEC=&]H<UPX(/D%:U3'4Z3"RM7CB:3R0QO:%E
M?5K.G$WI-[P" XCR 5D=&TGR OU .$(!]T:QK?9.P<\J.;/A;>9J,I-MF""1
MX^)[1]Y\?S:/HNWCL?4Q]*O4K1-B@A8&1L'@-:WP %L(B(B(B(B(B(B(B(B(
MB(BX&0SU:E9,,CX@>T'ASB#Y_D%Y?_HY_P"=\M_@!>OT1$1$1$1$1$1$1$1$
M1$1$1$1$1$1?$MJ"(M#Y6,Y]N2!ROM$1?!GB$HB]1H?QSV\^>%]HB(B(OPRQ
MAX87#N/L.5^HB(B,FC>7!C@2/?@^R(OR.6.0N[7M/:>#P?9?J%P ))2.6-[.
M]KVEOU!Y6)S:UJ"1KNU\;AVD>X/*C^)T[6<-;?:QV(JUIG-[2^-@:>%)40@$
M<%<K'X##XZQ9L4Z$$$L[NZ9[&!I>?J5U41SFM!)( 2*:*5I=&]KF\\<@\HB(
MBU+^+Q]U\!LU8I3"\/C+V\]KA\PMI[V1M+G. 'U)7S6MUYXR^&5D@[B.6GD>
M%]HB_)K4$( ?*QG/L20%^HB^)K$,+"Z21K&CYN/ 7U#-%-$R2-X<UP!!'L05
M^3311,+I'M:T?,G@)6LP3Q-EBD:]KOPEIY"^D1$1$1'.:UI<3P .2M;'9&A?
MA,]:Q',P'CEAY'*V41S6N:01R"."L5:I7JQ-BAB:QC?9C1P LJ(BT\CEL?C8
M3+;M1PQCW<\\+;AECFC;)&X.:X<@CV(*T;^7QV.,(M6HX?5>&1]YX[G+?1$1
M$0@$<%:ENQ3H5Y+-B1D448Y<]W@ +[Q&8QN4H16Z%AL\,@Y;(WV<MA$1$1$1
M$1$1$1$1$1$1$1$1$4-SF^Z]ALQ3Q-J=_P 78> V-C>>.?F5,D4,N;[KM79J
MFOOL/-V=_:&M;X8?S4S1%"L]O^ P66IXRVZ8V;+@(V,9R/*FJA&V;_@=6FIP
MY SF2R[B-L; Y3=K@X HB(B(B(B(B(B(B(B(B(B(B+D7\38GL%[)X6MX X="
M'G_B2O*_]'/_ #OEO\ +U^B(B(B(B(B(B(B(B+!D,G2QT!ELV(X8P>"]YX"U
M,?G,9DB_X.Y%,6?B##[+/9S&/AM1U7VHF2O!+8R[[Q 3'Y6A>;*ZK8CF#'=K
MNP\@'Z%;4LK(F.>]P:UHY)/@ +CTMEPM^<05<C!+)QSV,=Y6WD,K0QT0DN6H
MX6$\ O/"_<?EL=>A,M6S',P?-AY"^*.:Q=ZQ+!7NQ2/C_&UIY+5^PYS%V+\E
M**Y$Z:/GOB!^\.%BN9S%49XX;-Z&*1_X6N=P2NC7MUIHW212L> 2.6GD>%RV
M[%A3=-,9"N9^>/3[O*ZZ@>Y;_B];FHU9'L?:LS-8R$GCAA]WE3J.U Z)TK9&
M.:/F#X7/JYW$VK4E:&]#)*P\.8UP)"Z2H+K%0AFR^I3/=)S\;V<!WA7H;E42
MF(SQ]_/';W#E;#Y&,:7.( 'N2L,5VK,[MCGC>?HUP*SJMKVF0V>H538AEG1O
MB@[/A0?=6)+:KUP/4F8SGYN("^X9X)07,D:X#^$@K7-^GWEILQ!P^7<.5D=;
MKLE$3IHP\^S2X<K]EMUXGACYHVD^S2X E97RLC:7.<&@?,GA8X+5>;GTY6/X
M_A(*^YIHHF$O>UK?J3P%060=,WK1B2R_)+!-3>YL7?RQGM[*_F^P6.:Y7A(#
MY6,Y]NYP"^VR,<WN:00L9MP-8Y_JL#1X+N1P%DBECE8',>UP^H/(6M;G@#'L
M?.V,N:0.7 *D.C3K#,KO%:2[)8$-]C ]SR[D#O5\KGY*6 UIHG6?2<YC@"']
MKAX^2J3HKZ@Q^P"6=\SQDR#(\\N=QRKFFOU6/$;IXV'Y-+@"5%]YC?-JN6$5
MF6%PKES9(G%K@HMTH:^;IUC6]_#GP.'*ZG3W7K>LX.>M=RPM?MR[GGEK%8$4
M\,O=VR,<&^_!!7Y!:JRO<UD\;BWW (*^9K]5CQ&Z>-A^32X E9))XF,[G/:&
M_4G@+$VU YS&B9A+ARW@CR/J$FO58G=DD\;#]'. *S,D8]H<UP(/L0HKMHH7
M<%DZDN0$!,+N7-D#7M(4#Z#/<_0(RYW)-V97,N/L6>HX+%6K]N5K(HF$_P R
MM/3]BCSV QM_NC:^Q7;(^-IY+"X>RZDV9QD5F.L^Y"V5_/:PN')X6^"".0N1
ML.=I8+%6K]N0,CB83_,J!W<Q7VCIM+=>YH?/0$SF,?Y8[A<'HA?JT^G,<MJ=
MD;!;E)<\J\(+,,\398Y&N8X<M</((*Y[\WBF7&5'W81,[VC[AW+I @A43UVI
M0NPF(N\O$L62AC'GQP]76VY5C+8W3QA_ ^Z7 %;;G-:TEQ  ]R5SZF:QEJ:6
M&"[#))&[M<UK@2"JNZX589-'MS\N#XI&=JEO3K^PVM_[OA_Z5P^IIQ>6U3-4
M!<A^*BA]5K._C@A.CS@W0,.2?:-3FOL.&L6W58K\#Y@2"P.\^%LW,OCJ<D44
M]J*)\AX8UQX+BOJGE*%R>>&"U&]\+N)&M/):5N+'=O5J5=\T\S(XF?B>X\ +
MF#8<.9:T7Q\'?.T.B;W>7@^Q"PYG:<!A>P9')0U^X\ .*[-.[5LUVV()6R1O
M'+'M/((4?N;CK5*X*=G*P1SEW 82NN^Q1M0S,%F-S2PA_#AX!4-T#":QA*%^
MIA+_ ,2QMHF4_1R[$VZ:O!<=3DR]=LX]V$J)=1^HU76,=4^&FC?<LRL]-A]O
M3^;U8U7/8RWCCD(K<;H./ZWGAH7(QVYZQDK;JM/+5YIFG@L:?*ZUG+XZM:BK
M2VXF2R?@C)X<5\T\WC+IF%:Y#+Z1XD[7<]JY46Z:Q-D1CX\O7=:/M$"I#8LP
M5X7RS2-8QHY<YQX "\V=:\KK&:P566G;@GN5;T3.6^[&2+T#K@[,)CAR#Q6C
M'(_DHEOVNZKF&T'9J\*_P\X=$X.4MR6<Q&(;%\=>B@#W!K.\^Y6I/MVNU\E'
MCI<I7;:>>&Q%WE2)<S+YS%8:M\3D;D=>'N#>]WU*T:6VZ]>BFEJY.&5D4?J/
M+?DTK;PFT8',TY[.-R$=B.+P][/D5K83:]>SDLT>-R45@P\>H&>[5CS&XZUA
MIVP9'*0UWEI(:Y<?<QC,[I&4(>R>M+6+V/:H9TWV? 8'0,$<ID8:P>SQWE75
M1O5;E6*U6E;+'(T.C>WV(/S6')92CBZ<EFW89# S\<C_   HY:WW4*D-2:?-
MUF1V6!\+B?Q@J3Q9"M+4%J.9AA<SN$@/W>WZJ)P=0],L6(J\6;@=+(_L8WZE
M=C,[-@\*8ADLA%6]0\1AY\N*YLN]:E%D1CGYJL+1<&B+E9,AN^JXV\RC<S%>
M*P_\,9*D<]RM6K/L2S-9&UO)>3X 41H=0M0R%Z.G6RT;II./3!! ?_=*F:YN
M7S>,P]4V+]ID$(_><N3AMUUK-6/AZ.19)-V]QB(+7\+XRF\:UB\I#C+>08RU
M)[1_3\RMK7-NU_8Q;=B[@L"M(&/('CDK9SVR8? U/B<E;9!%SP"?F5&;O4[3
M*0I&;*L'Q3&/C ^C_8E3.QEZ%7'/ORV6,KM9W&4G[H:H;C>I^EY&RRM#E0)G
MO#8FR-[>_P#NKL9;<==Q-^O0NY!D5B9P#(USX.HFI6,V</%E(W6P2./W>1\N
M5\6NI&GU,L,9-E6"QWEGU:'?0E2Z]D*F/IRVK4K8XHQRYY]@H=ANI.IYB\VE
M6O.$[O+62L[.5U]DW'!Z\(?M"R6&3PR-C>YY636MOP6PBR<;9,IA#/4\<%A>
MI!+*R*-SWN#6M'))]@%7/ZU]*%EL)R+P#+Z8E[/V9<IUF,]CL5CI+MJPV.!H
M\O42Q/4;6<IE(<;#/.+,@Y#'Q]JG/*K[*]3M6Q>0GI3V)G/AY$QBC[VL(6W;
MZA:S5PU++26I#4LD".1K.?)70S>X8/"8JKD[LTC:TW'$@:#^)=*/8\6[ QY<
M6 VH^ 3>J[Q]PJ#5.K.IV+D%=TMB!LW]3/-'VQ2?R*K[J])#5WK1;+FM\22E
MRL2AU7U*[L@PD4TWK%Y:R4LXB>1]"K*7FK?+&.I=7]8N79O1C9'W/D5HX+JC
MJN:SCL35FF$W!+'/8&LD_N+N[)MV(UYD'Q;I'RS'B&")O=*_^07)U_J/K^<R
M+L<P6:UL>1!98(WN"@_5VO"_,Z?8+!WMO=@*MO.[!CL#CY+EZ4MC#N UHY>]
MQ]FM"\Z]7=PQV5H8FB<5?K6_CH98W6(@P=BOW/;3C-?KUS:]1\LQ[88(FATD
MA_(*.X7J7C;N9.%NT[5"^?+(9V@=X6K>ZNZO0S%[&V/B6258GN>2SW<WQV-4
MLTS;:VTX1N2JQ/CC=*YG#_#N6J3HB(B(B(B(B(B(B(B(B(BUIGY!DA$3(^./
MF>"O)W]'%[1D<RPQ@DQ,(>O72(B(B(B(B(B(B(B(50%^>':>KLF"R,7JX['U
M7R-KO\L?*"!W."YG4>K%INS:_G,,!5]>7TK447ALH7-ZAZX,QU:PD->1]=UJ
M'F:5GAP:%>.F:1BM0@OP8Y\IBLRAY#SR0&J =8,Y:BL8# Q3/CAR4Y$Y;X)8
MSY+L93I9B!EL)D,+V8U]&3A_I, ,C%Q^I5'$/W##W\W;9+CX8G]E#\;YI?'L
MQ1'IS9]'JSG:M6A+0ISUI)!4>T,4JTZG6J=5-RC@C#&>_ ^I*TZU2*OU_O>@
MP-$F,,K_ .;B%%]BL8;";]G)-PP@N5;S^:EPQAXB8I%?N4].Z43G WW3QVKA
M%:9ONQLRC>3T#.Y+6\?+C=8Q=>TT12LN0SDSO_-WW O2&LMR[,%CV95[771
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M;TY9 MSKOB8C#A<TP 3Q7V0]_P R'K[Z@YK)93;\=JU>"6>N*YGN01O[#+]
M2N?J^L;/AMUIV,9AY:&*E'%N R\L7>,C]]W+-8JYZPP^*<8GP-/ EF^KU$ZN
MLPZ]UEQ=:J]WPCZI,#">>Q>GQ^ +SQL&(HOVS-7]NL^I4;RW%50XN)_,,6/H
MWEK=_!;=1FLV3%!)Q$]Y/JL!#E%>FNL6MMU[*LR&:M&BRR3Z+3P97>?+RI5T
MDSMK&:]M5.5SYF8B;]D25O:KK$.]XN;8L^Y\D]Q[C6A8\AE=BP=$,<_%Y+=Z
M#WE[Z]^.,N^O'>KQSV4;BL1>NN [8(7/5)ZIK%;=<$[8=@EDL6K9<^(!W#8!
M]&+E=/\ (NUO1=TN,+I'5+;RTE1=FM9O9=<9DY,+9MY2W$)HL@Z;\)/D=H5M
M84;$WI9;9GXY&765I&$2'EY8/8N3IK"9^EM.(/>TNJO\L/#E%^C5'[6TO8:&
M0[Y!-:+9 \ITHLLP.9VS7\B\FU">]CWGDOAAY"R:@VIA]8V[=V5^PVYI9:[!
M["-0J/6\[M&O#)S86:UE;C!-%?,W 87>1VA2W8<=LL71VP,_:>R_4?\ =/>>
M7,632]$GDQNK;2_,3B6M0#_A_=A9V^&*'86I?W?&Y7*W]>EOS6YGLBL>K_4!
MOLV-3+!6=RTCIUFG9<?MX7M91+GE_'>MR#IEB\EI4UO(QBUEK=?XF6T\\N]0
MCGPY=7H'XZ?1?[9*KH58=8L3C[VBYB:>!KI*T7J0N^;7*'8MV-T_I'7SU"C#
M'>EQT7,H9Y>][?=RRZUTWU[-Z5!?R$/KY'(5Q8?<=YE8]PY^X5U^CNQY3(X[
M*XS)3NEFQD[8/5/N\+L=7L;3N:#FY)X6O?!%ZD1^CE&=>P>(I]*H[M:C!%8L
M89AFE8T!SR0H'TVT'%['T[FM9&>Q(&.F$,(?Q'&?J NGH.RWJ?1O.3QO<9\?
MWMB>2N%2TK.9K4Z$T&M47V[-<66Y4V7>N7GSR[[B]&:/%L4.MT8L[V?&L8&O
M[3SR![$JONO <=1I!IX/VM741ZD:!!C<(W9?C[,N8CLPF6=SSP?Y!2#J!LUV
M:AJF'9,^.3,%IG>SQRP>X";YH&%UW77YS7ZPI7L8&N;+'X+VCW[U\;IFIMAZ
M*C*2-XDE9$Z5+VR6<#T=UV6F\LLV8*M>-_\ !WM3=>FNO5]!O6/@A+DZ]82&
MV!^UED^;G%15V8OXOHCA?@W=LEBS% 3SP>UX6YGNFVRW(L=-B=?Q.*GJ2!S)
MJUAW)_GQ&%H=7,5//F]']>RV.].PQSS1^22./(*NS4^G6$U:[<M4I)WR3@!Y
MD=RI^JYZMU(+/3W.F5O/I1"1GY."KG1>F&+NX+6\_>LSS6V0,F9R? 8&^(US
M,1B\_M$FRY*&CB+<LUZ2%XM>7-8">&^QX"F.AZON>K:QGJ=J:%SBWOI11/+Q
M&H?H$.NW^FV?&9?";IEF-MS_ #-RI%T?UBH.GTK[F.:V>X)0Y[V>7Q+YZ-4)
M(-8V>C!+Q(VX^.-ZK3%W<'BZL^G[?A!6F,WC(AO>2\GP]3'K'CJ$6/U!K R1
MHF9&)?XV+L]5Y&UF:[K=!D4$-^T72-X[87!GR>N-F.EVUV<QB;=*MAZ8IO!]
M6 ^F>!^0:OOJS@H;W4'3&0/,,U[O9).SPXAJ;UJ5#0-;R,^ >^.3(W(:W)/E
MC#RM',=+-LN8G%5J-7#0NK=KFV(W%D@X_,-7:VZ_D9K^BZA?M^J+?:<D\'GU
M2P+XZX:S@*.MT;E/&5X)F7X8VOC8&D,5[:^YK\-0<!P#780/_94+U[IU>_7K
M7H,];XL,[U@Z]T*KXM>G$36SNL!GJ@??X7YU3TK"X#4Z-^A5'QK,A"7VSYF?
MSR27N7H?"VY[>*I6)G<R20,<X_F0J@ZN09BKD,!FH<6+].B9/B*I^K^.'+)H
M%W2\U:R66PT(JVGURRU3[ S@_5:?1.C' -LF:[Q)D>SL^@;W+E]/8!!O/4:S
M%P/0LR!K%O\ 2O&X[:<!F<ME&,GNW[4C)W/\EK%WZNJ5=3TC8,5!??8;Z;Y
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MBC'6K!2!@#WT7]Q6/J/-%!U'Z=2RN#6"6;DJ=;=U&Q.IY.M3R-6V1./V<L;
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M/B0 E;^9AIYKK)@!6>'FA6?+8<T\KG:[)&>ON<(>/-:7_K"9!\/Z_P"+E_\
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M_P",O>7+D9SI'I6:RK\E:HN$[SR\1GM:\_5RL7&8REC*<-6K R&")H;'&T<
M +[OT*]RG/7L-+F2L+'-^H*K&GT?TRH^,B"P^-C^]L$DI=$#]>%W=DZ>ZWL.
M2K7;\,CY:_'ID/X"RYS1->SHJC(U#,(&=L0<[V6GGNF^K9W'XZE=JO,=-@9
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M)KA\BX K#D+\-2C/9?*QK61EP)/ ) 7G36<'B>I6!NY7+V^,G-:D$!#_ #
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MU5-^OG=5F@R5B.)]P,D@#B&/3K%D[E&Q@!/)99A7V'?'FOX>MO1*= Y3(93
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M*O"971QM9WN+G\#CD_4K#8Q=*S)%)/7C>^/RQSF@EJV3&T\<A/3;QQP$  '
M1!$WZ!#&T^Z.8T\<A8[%*O8B]*6-LC.02'#EOA'TZ[I(WNC:71_A=QY'\E]F
M-G/L%^\+6@HU())9(H6,=([E[FC@N/YK91:S,?4BL23L@C;*_P#&\-X<?YE;
M):"."@  \(A8">4X '"<)PG8."$[40L!/)3A.T(B_!!&'E_ Y(X)^97ZB(1R
M@: A"!H"<(B!H3A$1$X1.$1$X1$X1$1.$3A$3A$X3A$1. G"(B(B(G 3@(G
M1$X")P"B)P$1$1$1$1$1$1$1$1$1$1$1$1>3OZ-XN>MG2W^HXB[_ .^O6*(B
M(B(B(B(B(B(B(B(B(B+C[#L.,U[&NOY"4QUVO#"X#D\E='%96GD<;5O57]\4
M\8DC)''(=Y"SHB+1RN6H8FC-=NSMA@B'+WN]@F%S>.R^.KWZ,OJPRMY8Y<K.
M[;K^!? S)7VP.F<&QL^;E(P041%Q,CLV!QERM4O9"*&:<\1QGW<NVB(B(B(B
M+C-V3!G,?9'VA%\;P28.?O<!=E$1$1$1$1%S<OFL9AJGQ>1MLKP=X;WO]N2N
MA7LU[,$<\,@?&]H<QP]B#\U](B(DDC(V.>]P#6CDGZ +B8+:<#G#;^S;S+)K
MN#9.WV:2NVB^+MVM2K2SS2MCBC;R]Y]@%R\1LV%RV+FR5*TV6LQ[FF7]W[ON
ML&!VO Y\W!C+S;'PSPR0M]@7+HY/)T<73FN79VPP1#E\CO8+YPF;QV8H17J,
MIEAD_ ];Z(BX>4VC!XJU5JW;S(I;#@V*,^[EW$1$1$1:N0R%3'4I[EJ41PPL
M+GO/R"U-:V3$;!C1D,?,9(2\L#B./(751$4/VC>L!K+ZD>0F>)+#PV-C&\E3
M $$(B(B+#DLC6QU*Q:F<6Q0L+WN Y\!<?4]KQ>RXG[2QXD](RNC'> T\M7>1
M$1$1%$]@W3%86W6I/9/8MS\F.M7:'R<#W<02%S,9U.UJ[ALEDQ)-"RD\,GCE
M8&R-)6IC>JFOW<K4QCX+U6Q9X,(L1!@?RK*1$Y'/"(BA&/W[%7=PNZW#%/\
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M]BT=1S8J\>M\*[LY4"Z-7<5>Z?UJO<P^GS'/&5WYQ@(=+SM'"L8RM3BDB<&
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M.WW=%M8:U9,ER<^M+;/NZQ]549Q?6O[&EU?X:(P,B;&VT#[L'R#E<O2O"9_
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M@IV19>NP"7@EO>LFGXGJ'F<K#=VR8114).8*X9XE?_&5'MHT'=<+NLN=U'M
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MX%RCD<A1ZVYXX^B;5N6"2.*/GAH)=[O*L;4-^SLVWW]9S]2""Y%&7QNB/+'
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M-;MG\Q%0R]FABJ#_ $0^#P^:50_4:>6I=;<G6R5U]J6/&O#)W^[XPX<+TO\
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M+U(/9<;*NH8R*_E?AV^HR#E[P/O.#/8*G=;P-S><*<_DLM>ALSO>ZI'!,1'
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MAELP0-YEE8P?5Q 7U7OUIXS+#,Q[?JT@@+"<A3()^)BX!XY[PJ]W?4(MCR.
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M#^4079R^)ZEX;/9&_A9(+E6W(P&"4GGY_?4NZ?:G;P-;(V;YA^/R%DSV?2_
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M#M\M":=O68RNQ9["9#'QP247N'>QY=RF#WS*V-]OZQ=QL41@BDE;.V0GN8"
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M:+7I?0;1?&7L#?+G!9-JWN[%MT&N4;D%(LA]:U;F;W@#Y,:%RM*ZFY*YM=[
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M7 ;/#6ALUK3BR::-6O+F,+D=:VB7$5HF460=K;+1V"9RR=&;$$VA8H1R-<6
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MP>2:JG.X=.,5LU.A3FL3U8*O]7%#X8I=A<8,7C*E$6)9A#&&"20\N<!]5T2
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M$?4:*7 'H-\-#0M;7=.P6N"<8RH(1+P7@+#/HNLSYX9J3'1NN!W(D*W]BU+
M[#!'%E*,4_:>6=P\M7QK^HX+7ZTD6-HQP->3W<#RY1FWTET>W:FL2X>,OD>7
MN4_QF,I8RE!5JP,B@B8&QQM'  "P9K"8O,474[]9EB%QY+'CEO(6+"X+&86B
MRG0KMA@;[-:M7,:KKN9FCDR.*K6G,!##*P/(!70Q6'QN)J"K0J15H 21'&T-
M;R5GRF*H9"C+4NP,FBE\.C<.6E1G!:)JV"E$V/Q,$,PY'JAH[^"I8^-CV.8X
M @@@@_,%17':-J>-NMN4L)4@L-/+9&1@.:NOFL#A\S (,C1ALQ@\ALC0X _4
M<K0UW3]?UZ.1N,H10=YY>X <N7SD=*U/(WI;EK"5)IWGETKXVEQ*[5C$4)L=
M\%/6C?7+>WT7 %O 7"P&DZU@)9I<;C(8'R>[PT<K[OZ9JE^_)>M82G-8<[DR
MOC!<2NGF,#ALQ"R#(4(+43'<M;*T/'*8K"XK#UC7Q]*&M"7%WIQ-#1RN3E-)
MU7*VWVKN&J3SN()E?&"X\*20TZ]>JVM%"UD36!C6 <-:WZ *%2=-=(?;99.
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MB(B(B(B23Q1D!SVMY]N3PB(B(B(B(B(HKF]&U7-7F6[^)K3S-//>Y@\KJXG
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M>M<0R<>GV#DOY^BAU_K+IM&6NQTMF02@$R1Q\L9S\G%6G3MU[=:*Q7E$D4K
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MXQP&J0;KC8<MU=P56T7B)]-_J,'CN'CP5SMDUO#Z_P!4]%?BJD=5MI[Q)'$
MQOW%WMTCU^EOT&1G=)D;IJ>E#B6,#^">/OKD=+F6*^^[7%)CF4.>'&K&>6L7
M3HSLGZ^Y3L!'9B2P_P P0FPSB+K-K7+''OJO9X5]CV7G',8#'9WKG9J7XA)
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MC!]7$!(K$+XS(R1CFCY@@A?-:U7L1E\,K7CDCN:>1X618[5ZK59S+,R,?5Q
MY7VV>(Q&0/:6\<\@\A?E*S!;A;-7E;)&X<M>T\@A?2(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B*J-NK8J3,/=8LV&/\ 29X9$'#C_B%6
MW]&O_L6Q_P"+ O4"(B(B(B(B(B(B(B(JMZN&R_6ZU>#AQGR,#'Q\\&1GGP%J
M]8JM3]!91)"SMALPEH^BX>];/I=GI[>QE2S&X^A&VO"&'[JDN)TK7/L#'VY:
M;9)(<0(F%X#@&]J@O233]<SFA@W*$4A^/D(DX D^X4OG4<3U0V:7+5X1&:;)
M )&=_+G>_"Q[;@M9;TLFR&,H^E!=L0VHXW>T?>">&A7?JE:O5US%Q01-CC;6
MCX:T< >%5N.P=#9\EOMS(PB:>&W)4K%WGTF1EWX%#\7F+VSX[1==R#WNBFEE
M^.+OQO\ A.&<?GSW*0W[QU+<MFKT&15Z=G#FXQH]FRQ$#GC\^]<J;$18KI[K
MVSP@-ROQ$%J:<C[\CIP2X$K8W_:(KNY?8MUE]^(I0E]V&JWN]5_T>.1X5D/V
MO"5].@N8%C"V;B&E QH;^U=[,X4#Z:QY+"3=1)LG/WS13L?+./8OX>N-'@__
M ,&T&YNA S?KLO.N._&6E;_4[(Q7Y,)+EL1<EP3JYFD? >")7<<*T=9QNLOT
MML&#[VXZS"YS>#P[[X7!Z,P-IZ;/7821#DK#!]2&E6;B\C-;K2/?3FKD2N8&
MR@!Q#?WO'R*@^Z=.\1L]CXC*6K#HH('"*)CNUC3\W+A]&A:.H6*L\AFK0VY(
M:[W?O1K?Z8\53M6,B^Y7IYF5D$/R8SDJTT1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$52[?F+E3,NBB+0WTF'R%7/]&O_ +%L?^+ O4"(
MB(B(B(B(B(B(B(JWZBV/LR'$9.*8MFBR,431[M>'@\@A:'6!UR35Q5JT9[#Y
M;<7X!SP&K:Z@NM6NGM[T,;,^Q:B8QL('WVEWE=7 V;4NCU7S49HIO@ '0$?>
M#@U1;HC5NT=)^&MU)H9&VY#P\+2Q,LU[JGL)LXFPRO-5$+'/8.QPC72ZJTC#
MH;L=CL=(YHDB;'% SPQK%J0[^^#!T*6/Q%]]\Q1QM#X@(V.^?>>5SX[F2U2_
MN-*2A/;ER,WQ%-T3/N2.DYY:2N?%J&5UC#Z7E! ^6;%\BY!&.7=D_!?Q_(M7
M69@[.W9G8LT()8JSL>:--LPX+N?+G$?S:HW!9NY?5<%I!H3Q9&O+ RWWMX8R
M* <%_*EN1F9JF[Y6_9HS34\O$ R:-G<YDK?W/Y'E<C6>FMNU4@OR7;6-(O36
M:U9GDQ-D/CE?>F:5G*N4WF"]>GDJSRN8P//]>7\D2%<$Y;(1Z54T%]*=^6)9
M6>WM^X(F_O!RM#+;9@L)*==EIW9'MJ 1M;$'MD!'  /*R]/\#;P.GNKSP>F]
M[Y;!A _J@_R&+D]'K7?K60Y@FCXR<[^'MX\/*L#![)C,R^\VF]SG5)O2F:X<
M%KE5W5'?!BK<&!]&VQD[ ;=F*/O+(C\F*5]/<WALEAQ!A\=;K4:;611F=@87
M+1TYT60VC;<AZ7H/AOFJ6QGALO82.]X^95GHB(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(J0WK_/[_ /!C49_HWU>S#YV?G\=B$+TJB(B(
MB(B(B(B(B(B+D;-KE'/8F2A<Y['N#@1[M<WV<%T:-5\%2"*2=\IC8&F1WXG<
M?,K,B)PB=OYE.$3A.T(0"B)V#GE.P<\HG8."/9<C$X*EBY<A+ 7F2Y/ZL\CS
MRYQ76,;2?(7X^(^D\,=VD@@'Z%1[6-:BP=>T#.Z:>S.Z>S,1P9)'>YX4C1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$14AO7^?W_X,:X']
M'"1AP&;9RWD68EZ.1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$5(;U_G]_^#&N3_1T[!K.4X]S
M;9RO0J(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(BK;9H\"[*.-QW$OIL_>X\*K/Z-@9]G["0[S
MZT"].(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(G*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B*D=Z_S^_\ P8U&OZ-\588;./;)S*ZQ$'M7
MI-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1%\OA:ZRR8.=RUI''/CROI$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$14AO7^?W_P"#&N!_1QM0
M.P.9@8")&68R]>CD1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1'$-:256&RU66<GZHQ3YP8F<2"
M7L5;?T;JTK,7GIR/N/GA#5Z81$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$5)[P'_;S^.>/1C7&
M_HZNYUC)CZ6V+T*B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(N;>URI=G,TDDH/ ' =Q[*COZ.
MW]ELC_M@7H-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%Y\_H[?V6R/\ M@7H-$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$15WLEO9(LFYM$N]'TV^WU4 _H[?V6R/^V!>@T1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1%2>\A_V\_CGCT8UR/Z.W]ELC_M@7H-$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$11/,8A]
MFZ9.)?P-'W55']';^RV1_P!L"]!HB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B*K]JR%J#+.9'D
M;$(])A[&>RA7]'4$:QD_/O;8O0J(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BYEN@9IB_B'V'X
MF!Q5'_T=O[+9'_; O0:(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BB^5NW8;99%/"UO:/#IW,/
M_  JI/Z.W]ELC_M@7H-CVO+N#SP>"B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(JXV=^K#*N%^
M.T9O39Y9[<*!_P!';^RV1_VP+T$R,>J]P>>#[CY+]1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$!!1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1% M@?A1D2+5F-DG8WPZNV0\?S)"K/^CQ/ -8R;#*T.%MJO^N^I"TALC?)Y
M/+@>2MGXRO\ ^(W_ (A#=@ /[1G_ !"U#DJ'SMP__;A;0O5C^&5G']X+]^,K
M_P#B-_XA/C*__B-_XA/C*_\ XC?^(3XRO_XC?^(3XRO_ .(W_B%\R7JY(;ZK
M #[#N'E?7QE?_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_ /$;_P 0GQE?
M_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_
M /$;_P 0GQE?_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_ /$;_P 0GQE?
M_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_ /$;_P 0GQE?_P 1O_$)\97_
M /$;_P 0C;,!/#7M)_F$%J$G@/;S].0OGXFN#Y>W_B%^LGA<>&O!/Y$+Z[@G
M<$[@G<$[@G<$[@G<$[@G<$[@G<$[A]4[@G<$[@G<$[@G<$[@G<$[@G<$[@G(
M3N"=P3D(B)RB(B(B(B(B(B!S22.?9$Y"=P3D)RB(B'@A8H(8X6D-Y\N+O_<K
M*B(G(3D)W!.X)W!.X)W!.X)W!.X)W!.X)W!.X)R$Y3N"<A$1$1.4Y"=P3N"=
MP3N"<A.X)R$Y"=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P
M3N"=P3N"=P3N"=P3N"=P3N"=P3N'U3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P7
MYZK.[CD<H;$(!Y>!P>/<)\97_P#$;_Q"?&5__$;_ ,0GQE?_ ,1O_$)\97_\
M1O\ Q"?&5_\ Q&_\0GQE?_Q&_P#$)\97_P#$;_Q"?&5__$;_ ,0GQE?_ ,1O
M_$)\97_\1O\ Q"?&5_\ Q&_\0M5V1I-<0ZU"#]"\+\^TZ'_FX/\ [<)]IT/_
M #<'_P!N$^TZ'_FX/_MPGVG0_P#-P?\ VX3[3H?^;@_^W"?:=#_S<'_VX3[3
MH?\ FX/_ +<)]IT/_-P?_;A/M.A_YN#_ .W"?:=#_P W!_\ ;A/M.A_YN#_[
M<)]IT/\ S<'_ -N%BFS.,AC?))>@:QHY)+PL,FP8:.M\0[(UQ%_%WA:/Z9ZS
M_I>K_P#;K]_336?],5?_ +=/TTUG_3%7_P"W3]--9_TQ5_\ MT_336?],5?_
M +=/TTUG_3%7_P"W3]--9_TQ5_\ MUAGWK5(8GR2YJJUC1Y/<JBV;J5JTF4+
MJU['SQ^FS[Y9W+R#3R>0HAXJVI8@[CN['%O/"W/TDSW^D[7_ #"GZ29[_2=K
M_F%#L>=((.3LD?XA7)=-,[MYD<>!P/*Z<>?S4;>&9&RT?0/*R?I)GO\ 2=K_
M )A3]),]_I.U_P PI^DF>_TG:_YA3]),]_I.U_S"GZ29[_2=K_F%8G9[,O?&
M]V0L%S/PDO/(63]),]_I.U_S"GZ29[_2=K_F%/TDSW^D[7_,*?I)GO\ 2=K_
M )A3]),]_I.U_P PI^DF>_TG:_YA3]),]_I.U_S"GZ29[_2=K_F%/TDSW^D[
M7_,*?I)GO])VO^84_23/?Z3M?\PI^DF>_P!)VO\ F%/TDSW^D[7_ #"GZ29[
M_2=K_F%/TDSW^D[7_,*?I)GO])VO^84_23/?Z3M?\PI^DF>_TG:_YA3]),]_
MI.U_S"GZ29[_ $G:_P"85GK[;LM:42P9BVQX]G"4@I'MFRQSB=F8MB4'D/$I
MYY6)VS; ]SG.RMHDGDGU"MBKN&T4Y?4KYFY&_CCELI"Z/ZQMZ_\ 4F1_YSD_
M6-O7_J3(_P#.<GZQMZ_]29'_ )SD_6-O7_J3(_\ .<GZQMZ_]29'_G.3]8V]
M?^I,C_SG)^L;>O\ U)D?^<Y/UC;U_P"I,C_SG)^L;>O_ %)D?^<Y98.I>]PR
MLD&Q7G<'V=*XA=C]<O4'_3<J?KEZ@_Z;E7Q)UAW][>#FY5]_KEZ@_P"FY4_7
M+U!_TW*GZY>H/^FY4_7+U!_TW*GZY>H/^FY4_7+U!_TW*GZY>H/^FY4_7+U!
M_P!-RI^N7J#_ *;E3]<O4'_3<J?KEZ@_Z;E6>/K;U"9$^/[4YY^9')"?KLZA
M??\ _JQ^^L<?6CJ$QX=]LO*WI^NW4*8Q_P"7Q,[/X&+/^O[J'_YFM_RD?U\Z
MA/:1\57_ /:)/U_]0_\ S-7_ )*^/U]=0O5,GQD'MQQZ2R?K_P"H?_F:W_*3
M]?\ U#_\S6_Y2?K_ .H?_F:W_*3]?_4/_P S6_Y2?K_ZA_\ F:W_ "D_7_U#
M_P#,UO\ E)^O_J'_ .9K?\I/U_\ 4/\ \S6_Y2?K_P"H?_F:W_*3]?\ U#_\
MS6_Y2QR]>^H4C"SXR!OYMB27KUU"DC+/C(&_F(ED_7]U#_\ ,UO^4GZ_^H?_
M )FM_P I/U_]0_\ S-;_ )2?K_ZA_P#F:W_*7R.O6_ DB:H"?I"AZ^=0B0?B
MZ_\ RE@EZZ]0I8##\?&W_7:SAZY_ZY>H/^FY5OR]=.H4L89]H1M_-K%FBZ]=
M0HQQ\9 [^<2R?K_ZA_\ F:W_ "D_7_U#_P#,UO\ E)^O_J'_ .9K?\I/U_\
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:$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex3-6_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_007.jpg
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M&8A*KT ^2J;8LIM5#:;];^;T^4PUF"/H,Z<&.'N.BHMI>L93$#;LR,)+4BM
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M@)L]B;-.O&_ZJ])S/,N8/R]=#6^1K^>TS+7:U)@RM$=35W'IO:@FO;_R?M&
MDGQ5.J)('O=-9E'3"W[1L"W]?Y'WS:L&YN(Q,++T)(GLRGJ$*7<;;[F]BPN9
M;<JL;DL>\,>W]1KRH;A>2>0\]6RL&/P,+K4$Y!>7?1$F$Y4W3+1VL36P+9<S
M7FZE^T36CW)4SX^WK/9C+9G$9G'LK6J9^?@4L[GL>9V/(8G6:==\5!_A:MSN
MZ:'_ (: "L^I[WD+&<O:WG:\<&5A!>P1GN.5BB4/+&PR[-G<)'@?7MP/<RM%
M$?D2P]=O<N_H/(>8RNPY3 9NBRM>K N 8>P0U7&?F%Y7W#,Y_0N1[V;-+UJ%
MY6KC<IJF_'#Y*I: LT)Q,UA_7;^6E5KO&;W#^D[7Z'I53$RT9:4(D($G[Y3T
MK?V;=I=>QN.99J!^4N$,CJ1O[:7_ '^K\!1R?D'8L%E*<6RX.&K2LD,%J&8R
MMCD/LUW;6J8[3N-+ 056^#K%NV_PJUH_FZ0J+XW?\S'M=; 9_",I/M,[KRQR
MF5CS^/F&J.],'/EMSI"QL>&[4DI[WG\GM-K'8C!Q6*%>;P?D#,0Q6LJ4SG,5
M;$;3<PD^(LDQ,?X'[R/^P 6_C.5H)-6.5R..FK3FQZ JCYE\GX:3TM-G*EVA
MF*=+/X,T8[;^H)6R^I_QKK[;REBM8SU7%VZTY]1GDZ4#Y+AX?FG&7,Y!C[F/
ML4F3_P!A+*NWM'*>)UO8*V*N5IQYCMTW7T+/@.4L+E,9FLB^*>K7HO:USIF]
M$AZXMGEKX+X.U>P%ZMCK4@$5IX'L[V)"EFT;S0P=;'.BC?;GO/ J0Q>\BP:Y
MOS<EEY\-=QMJA?9&9?2E Z+&^Y!7(S'*4->Q=CQ>)MY&.EV+4\0'IQE=#'<H
MX&[J,^P#UO1@^4\30#(PJ-/YNP3L2VY5I7+#_$O>R-G8B _;*[F2Y#;8T&78
ML+5ELDLZ$?L8S]R]<+A?9LEE-= R$5V60S32&Y(.XOX KO93DVI ^V:&,NWX
M*;^K=F%H]*-2G"[G@<MKYS=:P15 )<Y_0+.O<%53L_)T%[7LA*S!9 XJ>%T;
M;KF#P+U+>'/\PL-_AK>Y-V?)ZWK%J[1I22R^WG_<B'[140PVQ6\YQC(+M.YY
MC%@OL3 %DQZ]P5&M&Y.UK6M+PU6U\3-,(NWM@C\_!7G@=OPN9P S568BL027
M2#HLZ]P5 +?,.+@ZN#%Y!^*\_ WPP>!/[E)L]R+KV%PE#+S/FEJVRT1/A:'?
MK+G8SE37LIL<.(IF5Q? 9?6(Z8OG(<HXRJR:S#C;]JA \LGMPQ@QM(7'Y#S&
M+V/BK)9&B3/"YC'M(]V%1S6^7=9P.L:_1GCMRNAI0MFDBC[8Q6K=WS"5M99L
M,8GLTCUV86!SFK<U+<L=L^)DR-"*=L D+ 96AI/2R:YM-//&^:L%AC:LYA>^
M1H <X>_AT2I(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(O W"?^?^._U'KWRWV"(B(B
M(B(B(B(B(B(5YAVF"?0N3V;08)#C+I<)WL;^H7J_JFUX"SC&Y"+)0&L6>7F7
M *%Y_)C;M-V=F/C)JF LKV/_ -,1[EH7,XCS^)_F'4CDMQ,?3863L)Z+%RM
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MKD:.'G,<[\6//IW7DP>[5:?#VRX^7!P8":,5<E0 CFKD=$^/W5T+SAE&L/\
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M-?YD?WUY^XSQN\9;3K$&-RIQU&&:4MEC'<DKRK3XPV?8<AHV1=<]2QDJ+W1
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MH'$1PSL[$<S.CT5LFASD!%5__41B [;]'T-Z6.J>>;WKE[<3$8I?$>LS]?\
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MF&,3>D/RXJP:]B&>&.6)X<Q[0YKOR"OI$1$1$1$1$1$1$1$1$1$1>(?Y/?\
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M"T<MRY@*]N(/B?4)E9]GAO7R*;9AL?B.5-#EH0,@$Y>Q[(P&CIBZF>AB/-.
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MQ[V?9Q7,WC4<"[E?7J+:;(Z]WKUXV?2"NMR/@\9KF^Z/)BJ[*Q+BWZ!T.F=
M+;W+])Y7F>C1CNP0FI5$E8SL#VAQ79J\;9B'>JFRW\S7\C)_6"*,1^J5&J&I
M8C+<U9R.W2BDJ0,=)Z1]B_M;^.HP87GN:"A"UL,](N>UHZ#0\A9<!_V]Y_\
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M"'LE\V#ZC_YUZ%@I5ZU1E>.)K(FL#61@= -'V 5?Y3BK1\E.9IL/$R0GLOB
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M9R^.J4F6YK4;(7]=2$_3\UF&3I"B+GKL]$L\A)WTT-_*T,?LF&R$I95OP3.
M[\6N627-8R*V*LER%LWB7>F7?5T%]5\WB[%*2['=A= P]%X=](6G3V?!WYV0
M5LE!)([V8T_-1.YJV#?R%3SIR@;<%<Q_#?M]=?-3J[DJ..@]6U9CB9^T\]+'
MC\[C,D7BG<BF\/U@P]D)+F<;'<%-]N)LY:2(R[ZN@OFCG\3=L/AK7H)9&>[&
MN[(731)'!C2XGH =E>5[O(4[.6J-T%[,42^E'+[-> 1Y.7J<O:UA<3\@.^U4
M%3E;'6-]?AXK$'P4=5Q,_P"9NP/$*X/(!O:J:;E##_SWBPK+T(K,K2F>4_\
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M,3D=KR./BM0BG7C CG/O)(K9+FAI/?R 54LY4PS]U&'BMP_#Q5Y3/.?82M(
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MM^D*(.P^NU-=V.I;J#-9B1TLLMJO&'B'\$O*[^HW<K)P3D9:\KS/ V5D?Y#
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M@89I7DR,:I?D>.0_C9NM5Y@9HHV&*5_L96JJ[6F<N[#ACA\C:K05Z[&B-H[
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M22R$^Q<SZ6-7H/,[IKV#R-*AD+HBFM=^F%*U5?- B.@97SD#3VPM42S,]1G
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M?&SW! 9(7$AD7W:"I3O6A:KC>-,@ROCH0^G7#XINAY^2E/$,DTFA83S<3U"
M%Q.6,=C[,N!L93(LBH0629JI'9G_  &A54;%4<O:Q/C<+-BX)B &.8(C(S^
M4FW/7H<AS#BXX[4U<VJI,SXCT7!JULEK&/T_E/3SAV>A#>\V2,"DF1;%MG*T
MN&O 2XS&UB\UI/FQ\WY+5P=GU?"8'E/1'XRE%6;8E?YQQ-#6]L7I=P!:X%4#
MHN-BQW*&Z01'Z"XN  ZZ#BL.)QM:ASOEH8&AC)<8^4@?EY"C^'TBI?Y'V_&S
MW)_@2\OE@:>O4[/LY='CZHS <F;-K=:9_P "8I)&1*,:QQ[5V#=MQIS69V8Z
MK<<Q\3']%Y[/2D&IXK(Z-R:_7JMHOQMZ$RL#UK7\+K\.<VN79I?TGD+4CQ3A
M@'J/9'_\-4IX0O6;^B7:D\CR()71L/?S#"G$TT6(UG;9NWN95NO/Y)Z[6OI.
ML4-[Q=G9-AA,]NW,\0AQ[$,8]@Q9.%Z!QV9WND9"\P9%C/,GLGKS5F[_ +#8
MU[5[^0@8'3, 9'^ YZK%_&5++:8+]R:27,RT_6-MSR2)".UDX?JBUQ)<@,DK
M 99_JC=XN6+AVNW.<=WZ5N<O\[<GL[J0$K0XJN3839MKPF6LO?/#V^)TC^^X
MXU,>.<0RS4SN>#YV'+6I7P#OKQA/9:HWQ1-9QUS?H[UI\II6VM\WO+_U/--/
MP=?D>G>V'/2RS,DL.CJ50[J.%K%P>*ZC</N^ZUQ*^453* ]WN[P*XM6;*[S!
MDLO=P=[(,?.8JC8I.HX.O_*I3J-3<X- V:EGA=K&%H=5D+R'K@:AH>2V?0/B
M\EG+@ #WUH \EBE&H[KD*'#=G+SSF6U6<^&$N3#:!6S>EP9RY<LNS%FJ;(MB
M0]L+AWTOCB^;(U>&\K/1!DLB2<L:H?J]?";!@J46.SMNMLD18Z1D\[@UY'ZR
M]<^7A&7.^P7G[% \B[=L8R$LCL3CW^A%5#R&/)]GD+#C)I]'Y)K:[!8F?B,E
M&/0B<[LQ.4:AP65R7+^>QL6>M0Q^E)YR>9,AC\A] 74U*O9U'EJQ@&W9YZL]
M4O >?NY>BLQ0JY'$6ZEAI='-&6O'[E0/#.I8=CLQ<#9/5JY$LB^O[-[4=P&!
MFS_(N]T'7I(*K[,WKB/Y/?\ 6I%QSUJV\[)K++D\M:"!TL(=[ 1J.4IK6_3Y
MR]9PMG(0B<QU@)?".%OSZZ'Y5G<.4=NQ^,R-/.1S,CAF:*8E]_!=OEB3-QZ;
M<?BFO+P]GK%AZ>(?OTJMTZGI61R. LZQ:-*W!.TW:4C_ !,C%FV#%W\KS=:I
M5+CJPDQ;1/(P]/\ 1^X8F%PC].Y:@Q]"[,^I?K.>]DA+EDV3%XR;:\S9W"R9
MJW1;C*C'%SB/R&K8X4R$]S#;1C/5G9!6F K]N(DC:X.4(U'2MAVFILM9V?GB
MJQ7OXF:4$_-ZD>7GS-_:HM5$=K(T,72:V9@?Z;II1\BYZW-"Q&YX;=[,46*L
MU,))&[J)[_*-A49O3X*SM^PU-VELPW#.1CK'M%$Q>A]$QUS&ZW2K6K;;,C ?
MZYKO(/"@V]9F_DMPPNHUYS!!8!ENO8XMD+![-"C>_P"!N:0*&PX"_:;$R=D,
M]=[RYKFO70Y@Q&-S.F1YM[96S-](L ?TWIZL?0M>QV&P504P\>K!$7^3N_8+
M<W+5\?M&$FQ=Q_@)' QO^['A>;8Y^1>*)1$]GQV%$BMJ[R35GXYN[#AX^I@?
M 1N_N2N52S:?L.7PE2[%@K1S,WA-^D7S?/R*EO(>/V.7BRA-D[$D=^L^)LX#
MSU)_KKOZEQU:-S"[);S4SK?P0$L0;]'3P/I"CG&(=1W_ 'B!]B1[(9)/F\]D
M^!4?J&UOE_.WKF%GR<#+!BJ^,I9'"SY_JJ>:)B-VPVI;%2GA=$6=G&L>[MS5
M46!J:7L%"I2O3RX_9(YP7SS#Y3O7M2(#Q'S59<K;*W"ZS-%&X_%7'""$#W /
MNY4;R&-3J:SK3\+>\[V*+&#P!';/[SBO46H9Z'.:_CLFSWL0M<X?LN(^87==
M[+S3J%W9X-SY!&'HU)V/R9#S/,8^G]NZ]FN4DU;CC.2;58V?:K44MT'_ */'
M"2YC%!X==SN6Y+VG$MS=AE1P<9YB29?#OY1A;6Q_'ZQ%K.BU+EFZVS(XSD'T
MY',^T86G6T_:\5N&)NX/!3X^IZC18C$G;%V>8]6QD^P:_;<)/.U=,<JZ?)=Z
M75\;B=>PDDL9OV'>SNY"P>X!4;GTW9ZN4Q][7<'-CYXI?Z][IBX3-/[2S\RU
MLF=PU-E3)3Q/M%P:WR^B-[.AVU;>R\?936=4VN_#L]Z9SRV7W+/+KOLO6CHN
MDYC)8; ['<SMH.JCU(8OQ" M''_I/?:F0REW!3WV2SO96 E\&0!OL %(==O;
MEI/'V=DS,3_.![&4 YQ<?J6]4XXIYC3(<EDIK#\O-4,YLN?]4<CQV0%U^ _E
MQ]%_MLJL[9\#0SV%MXV\X"*<=?O!^Q"\L2X?D/BJU-/CGF[BBY6H<_B-_P"-
M<I;?48QS&%\\'?99,%%^&\5B:FD_SBE8[XFNZ?IRWM'P%/D3 V,YL3Y9YYK+
MVPL[Z; !^POG2]DR&M9K:-9OV9;;*$4D]:5WS(8Q8=-UJ#D;7K^<SL\DMNQ.
M]L [Z;!X?L*9X_#Y[#<;Y6EF[@L3QPR"-X)=_5JI=2R\&SZIA])JWHX"^/N[
M(_W#1]HUZ2U74\1K&/\ @\=#X,/1D=]WD?=R@G-4N5BU5OP]=\E?XIAN!CB'
M^DHOH>,U"_FJ&3UG(N@B9$1<QI/W*ZNEP_!<E;=2ADD]!OU-87=@=E8L?'\)
MSEE:D,CVP2XPS/9W\O-Q"AHUO,9GDG:L,W+V&4WQGUIB2^3KOY,6IO>G9#6,
M=JM&CF;<\HL^FSS)#/W=-4]OZ_;T.AL.TNSEBU;DJAI9+[&8JMAJ>:V#6ZF1
MK8"5^5LL9/\ I)\OS<XCOM=SDNML/]&>&FS<KVY**Y'$_IYZ<"/=RT-RT;X7
M1Z6RV,M;GR41B>Y[G$MZ>.^FJ=;+N]T:EJD%2RZ.[F61 RD_6UA'U%1SE7C?
M#8C4I\C2GG;/$]C97.=WZ_[WIF=GNXWC[1<13<]LV1K0@EAZ?Z;6CL!<V[IN
MWT<YC\EK>#FH/C?U8+IB[U?WN70Y.IYU_(NHFI;]*:T"(NW$MC>U?>U8ZUQM
MA\J:.7LV+.7N1L87D@M]_-ZC6;T#8O1H6L+KL\%V!X?)9]7N24JPMMS.>R%_
M4]2ED?!-?C#\E)&?P!V 5%.5^/<)KU#&7\2QT$1R$4<L/?R>3[.7J>,?0/X+
MSAS'JV)GSF!M/9(7V[OA+]2[F_VJVB:O#C<"PUGWKH9YCW#7>Y6OL_&&)Q.M
M6LGB9)XLK5A$@LA_3I2/?S4=V;-VMLX:@RTL\S+,<S&2@'ILCPI'HO&=T6-?
MV3(YNQ);97!=#]NC[-[5C<A[#9US4\CD:S09F -C_<YRJ>GQLS8=,H9J*T\Y
M^RR.R+DC_NY;^^Y#/L_F;JKKO4F2^BY8:[HN]-<W?^-<3J^$DV#7/7J6Z+VN
M[8[W8H]RC?N9;4]+R;IG,L7&1%_1^CMRR<FZ/'K^$QNP')V[&7-R%DUA[S]2
ME?*NM?S@TBCG!%YWZL3)#U]XW#MZU[>PTL[QC@,3CXP)LB^*H(0/U/ ?6LO)
M,EC X_6=.P49:+9\/H=X%[(U$[^C;/!G<-=US7'XPUQXS$2?K@?E9^2L;;M<
MJZ]!6O2P36F]>IWWZ?[VJ59GCVWJFB;1!C+]FXZU/'(X>SO!O?849TN/0<WE
M]=EQD/Z,RN/>#-7< WU@ M_<*L,/-NK3,[[F>'/78V$LVKEF'7K+R_&TJIFE
M@[^B1X('3@N)ON#KZ%GL-L.OQ"JV6P(9Z[!U$5Q^2<--;Y9P4=6[+7EN@=R
M_-BS;'K%#C[D/5)\3+.1;>\3![R2]>K0B(B(B(B(B(B(B(B(B(B(B\0_R>_\
M^9?_ $^5>WD1$1$1$1$1$1$1$0KST-5Y$PV[[#8PHJFIDYG/=-+_ '.UT./]
M'VK 9[8&7;4<M"Y\WS$?7*]1*MIG*&FY:_!K$L4N-GE)C$A+E:<N@S7M+R.,
MR$XEOWNYK$_V]<JK-;UCF+'P1Z^;<4&.\^G6 2YS&?B,KO<F:/L5NAKN,PE+
MUX*(!,LCR'=L5RT67\A@(V9*JR&S-7\9H@?-K7$*AM9U[D[7&6=:JP0BB^1Y
M;>]PP.4FXWT;-8[ [#B,TQOH6Y#XGOMSE ,1@.8=-N/Q&%#)J,DY].5X[C:K
M3V#CRWF=&..L60_*^M\69_L;"K.^_F3(:S:P-C!,<STA"^?[O 5U<8XC,8?3
ML=2RC&LGC'R:#WTS[ J%<KX#;9LUKV:PU8W!1<XFLHMFM?Y*R&VZ[LLN+K^H
MR0=5F/)$+?\ SNZ4HS6-VR3D_$Y:+#>=.&/T72A_Y]W+!R/B]ML[WK%S&X=\
MT&/)/K#V)>L6\Z[M6*VN/<]=J-E)A\+5;V>5$K[N2-GVK5\\W73!%6?_ %32
M_L,_)>O5_1+2O.F<9NFL\CY')XO!'(P9&/H-!\>BL.L8[>SRG:S.4Q@Z?3\)
M"#]$3'_,-"Z^H0;*WD?8;]_!68*UPO$4O0+0&E:6#QFR1\PY/,2X.RRC8;+$
M)C[>X(<H[K&7R^)Y%W:U7Q$]RE\?(+1A^;H_F>CTISK.)RVT;18VS(57TX60
M&+&PN_7+3_?>H=K53>->R.RXV/6VV[-R<D9 GP9T[OYN*Z?#M+:\'0S-"_@W
ML@:YS_5[^M\@_N,:NQQMB,P:&U8S*XBS4BNS&2)[P!V'J):GD]RX^-S79=?G
MNU_6<ZK-&NSQ&-OCV?9ILGA7P1WIS+,]_LR0$_2%:_(6OS;!J.2H0$B=[0Z+
M][FJB\/O.Y5M6L:[-K5U^0K5_1:]OV:I?Q3\?A^,LG'D,=9B,9D>P=?5*'_A
M."&VZ> OX^WCIH)66?/S>SKS#EP.5M.RTVY8K(8CU0_( U[#V+T'0I,Q6(@J
MQ N95@#&]#KL,"HOC0S7\SN\=[&3P#+3&>,2L^CQ4<UO8MAXT%[7KN%GM0?$
M$U)8_9Q*V>*X\];W3:+.0P\\#;GJ>L[[1/>?9<BA>VSBO.Y*A%B9+V,L3]P*
MS69+9KFG['ELS4FC^+8&4Z,8\C&U..K<U'C.6.U0LQRTXGL?'X?-W8Z^E0G0
M]=N9GC;.:W9H3UK E,L<CQT'DK5U_D/8,)K\FK6=?LRY.LPUX0/8A=GC2QLN
M!XXS;?T78%FO*98&/;],G?N HYM=3$[5-C'8/ 6ZNPR31R6/H#&1C[DE>K:L
M5@4HF69/4D$8#W?M'[E4#%#=XYW7+6GTYY,%DB9"^(>9B>"NIB87[AOL&Q_!
M2LQF.@<RK)*WHS2?D!<'6WV3S5D\D<?;;5G9+$R4L^7?DEXVI.<(L@S'VS58
MT5S*&?+R"]&2M<Z![0/GXD+SCH.2V77]@SN&EP4\C)KYE]7V:QGS[<OKCIUK
M^D7:+;\=;C@O22R0/>SH=>2^,-';DYFS-M^.MLJV89H&R%GR[)4=I/WKC38,
ME4I89][%SS%\35>FBR[1D1=RV<B=5-AS16I=]B&,+=WO-9C"XJO=QU)UHMML
M;/$!V3$0>U1TF+H[-N^)R.NX2[0GKS^>0DDC$3 N_!/E#SC:NC%3FJ^!U,2@
M?3\B/K67-6+S^8L3/%C;1@KL,#Y@WY=E<**WL&$Y$VA\NOS7[%R1WP4OX8G&
M)V37\KM4&3PDS1,#/)*WV!;]FKO<,7K\=C.TKN-L0?$3_$PN>U<GD3%;1K6\
MQ[;@ZAGCGC\)XVJ2ZAM.[;;EH+<N,?C<97@<2.R[UY#[*(;'L>'S6,N8[:L)
M9&18^5M.>.$?7T>AT5:_$F'R>(TBA5R+7MG[+_!WNQI]FJ+<F:[DL;LF*W+&
MQ&4TOE=C9^NZ-<W:=H_G_2H8/ 5+)%F=DEF66/P$4;%U^7G35=1KX7'T)[,D
MKV>/B.PUD2L#1<F;^MX]SX)(98X61RQO'1:\!<?DIV<@Q>,MX>G)9LU\G%)Z
M3/NT-<HWE.3,5>Q5O'2X6\<A,STA0DB'UO<N3K'%]UO&5_#W>X;=M_K=?L.'
ML%"L%O')6NU&ZY/KDD]I@\()7D]M 4ZY"BV2/C6G1GK37<C/+$;#F?,,<K/T
MZW:GUF@ZS1FK31UV"2)X^8("J70:^3/(>W6I\5:BKVY)/"1[  .RN ^#>..-
MDR3L;BY,CA[4I>UGL 2K$I7.0+.L[#EK,'P]R>-CL=2:>S$&JL=IA;NT5&*/
M5+5;8_78+,[F!L;>O?MZ]0XZO+4QU>&1Q>^.)K7._) 5,17<GF>5(Y+>%O-H
MT(GQUBY@Z#W$?UCE:FQXRE<PV1AFJ^L'UGM+6CZBJ-X2R>Q8N$X3(XFXVLZ3
MN"8CY,*]'9"P8ZDTHC>\,:2&-'9*\Z<2V,U7VK9A<Q-F**_8]8/+  TA>D'?
M)I7G7$6LK3Y>S-N3%W11MDPA_@.O/OL$KJ<NZ?FK<V.V/!$_'8[W8/=P7,P.
MZ\B;59Q]!N%-!K'AURX7'ZFM]P OCEV]DY=EP,%/'6IX:,QEG+6+O\GZM>VO
M"X[,XALL=ZGW+#&\>#RURB^!WCDG8XX,,S#.K3M>UMK(D^P6?EMEQ^XZI+7Q
M]JRRB7/E<QG8(?TK'Y(FDM<>Y40T[#I+4(8R(-^L%_S^I:O%TURUH].A=J3P
M25H! ?-@;V .OI5147[[QGE<C0J85]_$R6"Z!62<+LVXZ;F_TS&:L]WQ?4J@
M]B ,[Z[4.UK:=^H8.37)]7L37((#%',7?26@==N4OX.J9G'ZI8HY+'25C%:+
MHB_^_P":EG)%?,RZQ*[$UGS6X[$;XF,]SUVHM-R;/!2;7RVK92"]/&[J!L8>
MQW^_M<[C72+574\[\;4-2?*DN$'[#?L%P^,69ZGC9]/NX&41B6;U[3CTP,<F
MJY:_QF<EA,O0M2XX3&2K9A;YCHJ3:9KUC,W]EV._4, RG;*T,@^H0G[N5583
M/[OQE;M8)V&-VJ^<^A[M!)5PY"7:8="S=O*5GSW[@_JZ<7S$#7>S52]#0;DW
M']?+4L7/3S>.G[!:.GS!>A^.]LR><QD8R6*M5[,30)GO;]#W?D%?&]YW+X<X
MR6O0?;I/G++L;&![BQ55A=<JY/D;&YK7<3;QM.#MUWUHQ"'?@,:TE;N6FV75
M>3\CD8,/-=IY&+Y>G[ARPX2/<#RV,OD,*0R>D&2^'M!&Y9]:R.1'+>;G.*M"
MG=+XV2^'W:?D2MCF>3,/NX$4,99F^'L"5TK6=L5I9Z@S:M0N5/2?'\77[:)!
MTYI5!ZSM')F ILUDZV9YHNH8)R>@P*1<HXS9I=,Q&+-:QD+QG9/9FC';&EBZ
M6]LR=CBNI5;B;?Q,C(0^,,!,9:/9RX^:U3+YGCS6,A2J21Y7$PL\(7-Z) 'S
M 45VS?=GVK4),6=;L"</:+<H'T@M4DSNG9W)<::U/7I2Q9C%1QAD7]_Q 6S@
M-PY*V."'$'"FI-T/7R+W%J^.1Y<M7Y"U2Q!C+5FMC1V7M'?GYJP>3M4FVS5"
MVI%XW(GMG@#_ /ZJIM?WSDRS59KHP+OC0&Q?&/)9Z8_+EW>0]0V2B=8V#&O?
M=N8J(,L$DE\O[U$MZV[;-NH8['Q:G9AZLQSO^_UL^P7JG%3V9\=4FLUS!.^%
MKI(2>RQQ'S:J(YGM9)^2P,./QUF9]:83OD:SMBE6]Z^_>-0BLT8)8[D4C9ZX
ME'@5$K/(>4O:\[7K.!O-S\\/H^F6 QG\O[67:M;R.$XKH:]3I2V[3GQ^9B'R
M#U;.D6KLVN8]EVC-5L10LCECD 'U >X3>===L6L9/&M^3Y8_H/X>%YWU38>5
ML-5;K P;WR,ZB@GD]H6JP-UX_P O9PN"N5++K65Q/U_7_P#MR[]=<'9=WO;E
MC1JU+#78,E9D#;C9!TR)@]_FOODW4\H,/JV(PV,M7!0\.W, ZZ8N[RU4S6?T
M[%5J&&MR69)XIWQ=#N,-![#U8NMQ6;>IT8+U)]>5U1L<T+_=IZ5'<<<;YS%[
MM<FM><5#&RR-JA_]_P!0^[5.^6]*R6>Q]._BG'](8]Q?$/NX%0K ;9RCLK(L
M8<4:OA+X7+W9:5L[SCMD?R;A\M2P%RQ5QY <\ ?6K5W2_LM;#5+N"HR3SMM1
MNDK>SG1$'L*G[>!L;9OF$R=/7K6+^&<Y^1G?&&]RKJ;UB]DL<H8'*TL)9G@I
MD>I(  U=/?=8S>-VV#<L# )Y&,++5;[O8L4D6>Y#O8L6\3-C\15E$\GK?,SO
M'L U:&ZXG8IN5,'DZ>#LS4Z3FATK5DY;Q&Q9#<-;GQV$LV8*/;GR,]OJZ7H&
M%Q<P.+2WL=]'[+]1$1$1$1$1$1$1$1$1$1$7B'^3W_GS+_Z?*O;R(B(B(B(B
M(B(B(B(G01.@B=!" B=!$Z1.@B)T$Z"=(G2(G01?,HD]-_@ 7='KOV[5(Z#K
M.\8?;\_>R,51M3(R&6412D]/*O )TG2)TB)XCM.DZ3I$Z0L:4#0$+04Z3I.D
M]-O?:=)XA$(!0- 3I.D3Q"=)TG2(@: G2=)XA.DZ0A .EBGIP6 T31M>&N#F
M^0[Z(^ZRHYH<"".P5\QUHHSVUH'0 ^7X"^ND1/ =]HG@.TZ1$Z1/$(B)TB=(
MG2(&@)TB!H"=(B=(G2(A:"B=(^%DC?%[01^"B%C2B=(B=)TG2=)TB=(B)X!.
MDZ3I$\0B=?O*)TBQ&M Z=LQ8TO:" _KY@'W"RHB=(L;*T+)'R-8 Y_ZQZ^9_
MBLB(B(&@(B(G2(B(B(B(B(B(B(B(B(B(B(B(O$/\GO\ SYE_]/E7MY$1$1$1
M$1$1$1$1$6!U^HV[#4?,T2R,<]D?W+6] G_]ZSHBUY\A3@L5X)9VL?,[J-I]
MW*K=TY#R.O;/A<5'C6/AN/\ [=SU;0*(B*KK6]WXN1*NM"@&0OC+_7)_75H@
M_)%\16JTDTL+96E\?7FT'YCR]NU]HB(B(B(B(N)LF?IZ_A[62M-D=% WMPC'
M;EKZ?M$>R8&ODX8C$V8GII4@GF$$,DA[(8TN/^Y1+2-TJ[7CK%RM!+$(Y_3Z
M>I@HSMVV8_5L6<A=CG=$'!O]4T./973P&89F<)C\A'&6-LPME#3]@X=KIHB(
MBPW;D=2K/.\.+(F%SO$=GH*':/OV/V^+(2T*\[(H)&L\I1T3VINB(B(B(B(B
MA6Y[O3U:*D^Q!++Z\XC 8/932*5LK&O;[$=A?J(BBFZ;;6U;$MOSP22M,[(@
MUGY>I+1MQVZL-A@(9(P/ (Z/1_*S(B@^/W[&V]TM:U#!,)ZS)'3/>WIOT$#Z
M5.$1$1$11+==PJZIB'9"Q6FE9YA@$8^Y_*[>O9MF7P>/R$<98+4#90T_8/':
MZ3Y&L:7.( 'N2C7!S000041'.#023T$:YKVAS2"#[$(H%NN_T=4--MBI8D=9
M>&QE@'@IZUWD 41$15[L_(F.U_-8[$RU;#Y[;P&.  CZ5A(B(B(B(B(B(BA.
MZ;O3U2"G+8K32B><1]1COI32K.R:%DK0>G-!'8Z/14(WK>J>H4X)[%6>7UI
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MY8T%:.!X_P! V/6*5Z:_>EB,+7/:ZR>FO 7+Y*HZ]%QO@68QI-2+(P1P/?\
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MM]^U>?:)V$1/()V$[3L)V$[".=\CT51NN;3L\O+.6PEV\'4XH)7Q1@>(Z#@
MKR!!3M$["(B=A5IR-NEG 0X^EC_3.1OS". 2?JM'W<N-AW<H8K;J5/(3-R&-
MG[,MD,Z]%RN1%\RN<6.\".^CX_Q50\>[)M.2V7:J>6EB(H3MB:&#H!7!VG81
M.PG:)V$1$["BFZ[(W6]>N9'P\WL ;&W\O<JKEFY8A_0&7K6OCXK88ZW1#?!D
M/FK_ !WU\UP-LV*#7<#>R<K>VP,[#?VG?8*JL7EN6,QAX<W4EQK(9VB6*D1[
ML/Y>IGQQM&8SV*OR9.**&S!<="Z)GNWI6#V$1[B6GQ/S5;:I)OC=EST>9Z-
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MPV1EOT<;''.\$&3[]%*^AZO5SDF8AQL;;;G$F3]Y6N..M0&9=E1B8?BB\O\
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MIVPX6++Q8N6]$+CVES(/[Q 751$1$1$1$1$1$1$1$1$1$1%XA_D]_P"?,O\
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M#BI]R!5@CY8T&S&P"2:20//Y#5\<NXNH=GU+)A@$YN>DYWY"Y/*FOQ7.3M2
MLRQ?'E\;RP]%H8M;?N*]<UC3\M9H&8R&U&8_-_88I#K/'-/'T\5M-_)69<C7
MJ>J]Q>2WV^3?X!0;6L1F-RP&5R\^NX[)6+DT@^+GG(FCZ]A&/ KNPZML^.XE
MV'&YP-<8(F25 )"XM7&U7CG%YCCD93*VII9F5WFJ'2$1P-4BU#;;V*X6.0A
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M1S,T5*"_T3^N][P7!A*]1X+&.Q&%Q^/-ATWPT#(O4<.B[Q'7:IK/6CMO)O\
M-6Q.\8RG6,T\3?:9X('3ER-JI.X\V;!7L+*8,?;D,5FI_<_B MSGC 8N7%X[
M*^@SXDY"&%TG7S>QRN[!X+$X:IZ&.I15XST2UC0.S^2H#S*<N-,F./#SU9C]
M=K/=T/1["KS3V:)GLS@<C@ S%9"FX?$U T,]5JTGX9N=YMSM)]F6"$UWF7T3
MXF1H</I6[KU"MJ',TN'QP>*-JH'&'OY E=?:,=K\.ZY&_LKHK[)J_ACZ 'K/
M'Y/@5H\)R_%8O<,;X/CJLL#PB/TN8'ARB>D<:,V:EGX)\O:BK07^H8@>P'@G
MZRN_<BRF1W>;768R'*4L55;%%!<G+8^V_+U'#IW;EV=(U'=-=W"X]E2O4Q-I
MCGFO',7Q-?\ ;Q[ 4$EM:S0V/:*&[XD.M7+1=#># _P#B?8E>BN/L3%B-5QM
M2*XRS&QG;)F>SVE0WES.SP?H3"Q3NB&2L^,KF^_I!9,GQ-B(,IALE@?#'24I
M/K\!UZK%Q,S;9MW*+=:MO><91K.FD@[^B>0$#Z@N+O6+''V=Q6<UV,5H+,H@
MM5F#J(KG\A8GXGEO7603RUGW?>5GN%BVK6,=H>_:A+AS*#/+)ZWF\N+UV>:-
M<@Q^1Q.TP5>Q%:#;0'LY2G9OT;N>>U.A'&R: L-^9W0);&.NF_[^U'M\RF5O
M;[4UVKBHLA5K5/7?0D?X12%:6IZONN,W=F1@P<>+QE@^-JK%,71J/0:K%D.8
ML_B66YXJTD,QFZ>0]S"X?2MC<.-\'KS=4J &PY]WPEE>.B]BG'*;WX#!8[#8
M&K'7ANW/!\<7]7VH/D= W!MS%7<)K53$STG^!?!.7.D'Y?\ 0U3?9)K.R;UA
M-6OEIJQ5?BKT#3]+W*,<AZ1A,'M&JWL54CJMEM^$L48Z:O40^_\ %%YOV'6\
M%-S%BHY<; ^.U6?+.PL!:]_8^HK)R;CR=VX[I47_  OSF9$YGR\ M';]8AT_
M<=6R>&>]CI[#HK3WO+GRD_M+9Y%OYK-;_#K<%%ERI5K"R^FZ4Q,G*Y^K:?N6
M.WZMEZV"AQ5"5P;8KQ2E[ U>H3\@O+6FQ2LYXV,V1]?5IS/+_$"]2J+;KEYL
M+JN8R5< RP0%S056^I:!KF<TRI>R5&*U>R%8326WM!E#WCOY.7$TT9++ZKN&
MK9.9TGZ+D]&*4GZN@'*(\9\9U-IU*M?M7YXI8+I$'A[, ]UEL:,RSS#DL*RY
M+%6EJ&:8@_6^,D=L66]KPXWY&P#\3+**-\ECXB5,\=B:6Z<A;4[,1BQ6Q,XK
M05I/G&M"U6DT#D;$T\4PC&9GL/IL]FO;]P%#QIU'-<PY[$OL3Q53%*^0,=\W
MCR]E.MGT2M@=4QN-CS)AQ,-PON-E<6F9C_LH,RUC6<LZO-@\5-C:DX#0TL$/
MJL_@U27<=:Q-_F+!0RT8C'/&Z6RSP!$I_+UTN;<'CZVO:_/7B$0J7X8(8F#I
M@8]=#E#,WI\KK>JU)O39DY#\2X'HEC?LM+DK0,)A-??G,!3;1MXY[7A\'T>3
M%&^4^\[I&H[%(_PMRO@'_."V>2M I8K6:^;A<^3*16H76+;W]ND[7HW"7)K>
M+I6)G=R20,<[^)"J/FAEUN,QMGX22U0@MA]V >SF+0T&'1LML,&<UGPI/BJ/
MAM40P,/UD$%1#6-<JY[D;>J]R=_PHMR^I7:>A+]2[7',$6N\F;-K=663X0L?
M+$S[-\2N==QVOU<SMK]A;%FLE8E)J01,]62&/Y^_?ZBE'!60FL:+8KRC_JT[
MV-)*TN#_ /*.[_[<S_\ S6+CG_M1WO\ VJ7_ .Z]%+%D((GU)HY&AX<QP<#[
M$=+SUP7!#%:W6!C V,7&-#!^/K7/XXQU2'?M]I,B @:Z9@8HGQMQYC=DR>Q0
MV[,PHT[8'PC/DUY/?1*D.K0V="Y"V'!PSRRT!0DM-8%*>+,3CMKP.3SF;K17
M+5^T]KS*T/+6-_NA:&E0OP.Z;3IAC[QSXI+$$3OF Q0[BS1,1G<GLT=TO=3J
M6@&U/9A)[Z<5,N(PS$[ANN#J@BI%:/IC\!A*]"6V2OK3MC/3C&X-/[R%X[Q6
M2PV'9D=9W7#EMB6RYYR7B)'%[C\G=E3_ );Q^-_F7K%R"03^C;K1PS_ML>I/
MS70@M:.97CZX+4+V%1/=KSI_Z/L#--Z="\&NL_O\ .@5/LSQA@K&>Q.9IRC'
MOHO^8B8 ) H3N^+@S/+6#JV'O$4E-_J!AZ+A]/R6AE<#2U7EC43B:L-:"\'Q
MO9&O2Z(B(B(B(B(B(B(B(B(B(B+Q#_)[_P ^9?\ T^5>WD1$1$1$1$1$1$1$
M1>?-SX\VFCM1V;4)&,GF#C9B<2.R5+],U_9[$]C,;5.QUV2)T,4#!TR&-_OT
MJR9HW)>FYF\=5FADH67DB-Y)#58&1U':+.@9.@^6"?,Y%P-J1SR(_P"#5*./
M<;G\7K%+'9>*!LM6-L49B>7=L'Y[ 5=0:CO6*Y"S=W$F!E#(3&2264]] E='
M9M5VVSR/A<W3@A-2J1&X^H0XM3EO4]GV$XYF-JP/BJS"0ETA#RIML-?8;^FY
M"&&I$V_+%Z;8_,N9V?W]*,Z]H]^3CJ75\U'$PM!8Q\9\Q^YZKO 8#F;"G^;M
M:> 4![6G_6&,_#"I%N_'68CUW ,PSS;LXMX<YK_EZY^[R%P=FP'*&R6L!DYZ
M-6)\$W;*P<?H[^\A4JY*US;+4NK9W'0MGR&.<?4A9]R]:V[Z1M>PXC&YCN*'
M/4GN>R.$GH,=_=#DU>?E;/3UJ>=K&A4B<'SS]=23=>S5WLW?W''[!F8#@ILM
MAYPPQM'NPGOMH!]PG%6IWL$W.VK-,4Q?M"2*H/GZ+!VIQN1SC-=O384O^-CZ
M="QH[\_RU4'M&-V3=GXALVE2T;S9HS->=]FM]PIARC@MD_2NJYK"TGW9<:]_
M<7W/DHIME/E#9+FOY!V"C@CBL=BH'EQ8?S(5)MTQ>U7=ZU/)Q8ATL&//<IC/
MWD4JY3Q^7RVHS4\;1?-/+(Q_C^ U=W41D+6I48LE1?5L?#"*6)WN.ATJ"K5^
M1>.\O:QF&QCK^,GG+H%9EBEMAT?.7+U>2QEK\8#*<?S9"/LT+XT_&Y>CQ8^G
M<P\_Q,4,D?PI_6>HKJFD9V[Q/D]?N4Y:=OUW/A$BT,-M7(F*UR37YM4M3W8(
M/3BE[^18MC1M/SF3XSR.OY&@^F'O,M>9Q^9<5H:[MO)N"B;K<VN&U-#U!!8+
MB  %(^2L'MEO2\1BVUI\E?\ B63V)8_8%BLS&U)LUIC*=ZM-6EEJ>E+'*/J#
M@%0NOYKD/CX2X*77WY&%CS\/('D!6+G=5V79^/[<>2^G*261;@@![;%U[1*%
M,W3=Y=3M8.;4;1O1U_1+Q^KXCW<K+X=BRM?3*=?(8]]5\)Z8'^[V?E9^6--M
M;'KG='_KM6830?O(5=X7?N2\A'6Q!UDQVSTR2\X_)OY>6J<;IE,W6_0^OUJU
MN=MOIEJ\UG9:P>_0_)5:[1@+^@;?C\IJF+L/JRPEEB$-^A=WD3#YS.5M=VW
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MO*F$2S0F3PBA;^]ZT],Y(DS>;OX/)X\4LA!V0QLGJ,<T*U53N6Y*RYS.5Q^
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MF,1CB2P=0>BTR^?[/2D7(6N-S?'OA%3]"Q5C9/! !^H6#]15=C&Y/E/67QV
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M'8Q9N_'>9=WZIZ7QL_'.,S.89EX+EBC?:"/B:Q\7."Z&KZ74P<T]N2S-=OS
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M>]C&ESB ![DK\CECD8'L>US3[$'L+YGN5H>FOF8S_6<!VOEMN"1X8R5A/78
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M[/D.UEAFBE!<R1K@#U\CVOI$1$1$1$1$1$1$1$1$1$1$1$1%XA_D]_Y\R_\
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M^+N4HTF>5FS%$WOKZW +:CLP.B,K9&N;^T".EI.S6,BC+W780//P[\AUW^%
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MP^T8(Z5XAH#5Y5WO7\3-S%KT4E5CF7G^=EI]GE2OERD*_P#-*ICPRN&70R$
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MW$Z3I$0!$Z0#I.D1$1$3I$Z1$1$1$1$1$1$1$1$1$1$1$1%XA_D]_P"?,O\
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M*SH?6#2!ZA8L$.^8;^:HV&3UH*D@!9ZK0'N!4,BY<@AR%"'*86[1@N_]6GD
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M9,8'F3#9+(/+:$D 9&[[,5V7,OKC+V*>]\,MJ5_I52SISQY_,D?@?)4)AJN
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MX*-[M!@\9K>H4J=I\N*BR #WGV=X*R.8C#/QUDGQS,\.XWL4CX\>QFBZVYQ
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M;;>/*%E]-L&4U:9Y>^/\,>G)US$W]2TF7&PB.F^2,11==!C?PISS=6KQZ=B
MR-K0S)UFL_<$Y%R6,CS>JTZM%EO,EY^#=(_ID7[W*&6ZN7J<O:N<MFFVK+F^
M3R!Z88?V NS?H5;W/L0F#"V+'LE:'IS<#!8UEKR8L<ZVY]E[/I(D4IS6F:3D
M*-?*9#.9"S6A<)87RVC(.BKBC?&^!KF=]. ()5 ZM9!YEVIEUC6V2QX@_P (
M.3E.A#-O&D/K'JX^=X  ]V!=+EOY9'4__4E=X^_\5YO_ )0>'M/KX7,L!,=.
M8L?^[S5YZQFJV8PE&_%(UPF@8X]?8D+=MY6E6L5:\DP$L[_")GNYQ5):!) S
MDO?(K)>+;[;C$#]X@XK!N=2$<PZ9-4[,\H=\0![^+5JXFC%)SWF66801\(^1
M@=_KA8\M!"_G^H'L!\*C"$W3_MFTU=S/L:[F?7NQ[4WE1_?*T-CE_4(IX@^.
M0=.:X=@K<Y8Q$-78=$-2..*K!.Z%D87WG[DE;G7%&X"('U?"N3^2NGSK49-K
MV*=&/^DC)PMB7*Y HMFWSC:ID&LF[,@F#O9WLNER[6@_3.G3EH\V7BQI_<5>
MX^_\5";66PN6SF5U;(P1/+(8Y/3DZ(E:]4!R%HC=#OX[8M<G= PV6QOA[^[E
M..4[H+=*N6 (O*VQ\@/]PE??,=T0.UJWY]U8LB#+XJ=<AS8R?0\U+.1)6?6+
M@6J@LOZ^(T#CZY:8XQQ31R._<UP7H/*[7JTF BRKYH+,!<R2NT]$ND/MT/RJ
M=YAARF3VC1H*4OPMZ9DP8?+HQN/2Z_$>Q0X>>[I^6B$&2@G>0_[3KT*B(B(B
M(B(B(B(B(B(B(B(B\0_R>_\ /F7_ -/E7MY$1$1$1$1$1$1$1$4)VK0,1L%N
M"^Z2:K=A^45J ]2)K^BT,3??D9K=F_?+/ 6K3B][6?AJYE_C+&6]N&QG(W&V
MFN! :59*BNXZ;A-NI_#9&#OP^<4@^3V*,Z3Q1@=3N.NP/EGM=%K97_W6E-VX
MIP&VW8[L[Y(;+6>)DC]W!=?4./L5JN'M4Z<LOG8_M9_9[BN?J'&U75LA8M5<
MM<E$_P YHY/9[OR5FW[CFGMS\:^6[)7FJ/);(P=GIWN%J9OB[&9;#X[%.R-R
M*K5/?B/J,C_VWKJ9O1H<OKE3"2Y2RR".-K)"P?.4-'7U?-;NIZ='K>(EQT-^
M>:#H^GZ@^;/W!<;2^/H]4MY*>+)S3BX\NE8]O041V'@_'Y+/SY:EEYJ#IB72
M,C9WV2ID.-<&S2Y=;C[;!)[R=?67_MJ'0<(TW81^.R.?O6Q&T"IW]+(/X,4M
MN<=Q6-#_ )MNREA_MXV)/J(Z6+!\=5H-4L8;+6Y;QL,8)7R'OQ\ 0T,4'Q7
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M:O#Q]@KL-K-F:F'B7RD9X")0_8XL!NV[:O%2;%;94#I[4H';1'\NFJ^F@ =
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MW7S /N J K#-3\U6\@<%9%)]4U3(X#H-^SU?M.C5J1>G7A9$SOOQ8.@LOPD
MG,_IM#^NB[KY]?A?9C:3WT$7*S&MX?*Q/;>IQ2AP\?J:"[I=.O7B@A9%&P,8
MQH:UH^0 "A&\:?\ IV*K9IS>ADJ+_4J6/P?NW^!4@P,V4MXF Y6JV&UX^,S
M>V]CW(_<5N5<91HA_P +6BB\OUO!H;VJ]V7 YO:,Y!C[<#8L'6E$DI\SYV7C
MV'7X4RS>+M6,*^E0=#!Y=,'FP/:&?<!JRZWKU'7L3#CZ?GZ,?9^H]EQ/N2NP
M1VN8W"XR.]\8RI$)_G_6!H!^:Z?2U!C:3+;[3:\8G=^M(&_4?XE;:_)88YF.
M8]H<UPZ(/S!4?&H8"/(PW8Z$(ECB=&TM: WIQ!4A+00OB*M#&Z1[&-:7GMY
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M[@J1F67IQ';&$==$M7=SG'US(YG&9S+[2"Z@_N/JN(P>_P"#E&MTPV+RW+^
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M)]VK6V/BO9(MNGV#6<LVI+8D)F:26]>:GVG:;<Q-/*29.\;F0NN/JV3[^/S
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MALWB?TG0LA\'9!>>AX]*MMDY1UA^.R4 JWK-<QNC-AD0,!/\>UCX#_[/8?\
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M<6J):+CLUM5#-91D>,EDNVY/7%AOG(Q3C5^.+.$U+8L-D+L5B&PSS8P#L1D
MJ'<3:'KV;T>6YDX/B93)-%$'_,1?O8N[I%5L7$^PTY)?5%>:S&P'\ KJ\#4Z
M9TFO;%:(3B>5AD ^HA7@YK2T@CL%>?1C,?)SU9C?5B<R/$![&D>S@0NCO$6#
MJ[MBLC<?-=LBNZ.#%QQAY<3U]7S(Z"B7'%F=O+><K28QM 35GO?6']PARV[L
M$,/\H*/THPWSJA[OWN*XVRZ[C,IS@RE/%_435F/E:/EYKT+J6H8G5Z,M7',<
MV*24R'LJ%\V4ZT^CVW/B!='/$6.^[5"MGT#6Z_%<]YE1INQ58Y_BW#N4N63$
MZ/K\W%0NVJ<<]NSCFSNL/:#("0NKJL$-SA=D%F]\+$^F6NG/]P*L=SFDDT3"
MP8S!R-Q=.:$19&4!CW_O#?PY2[F#&QW=+UC(RO)G$T$3G_<^J%/AQUK&OXZ_
M?IUB)_T:^%\CCWY@^Y<O-.F[=8&)QNM7GR5,-/;<;%AGO)W_ '%ZHW*2/6^/
M,F_#Q^BV"J&P>E[,"J+ :;M&R:#4IMRF-%&Q"R3Q$ ]3S_+G?E;NW:M-BN**
M>-FR++,E+)Q=O'L&CL>"]'8RLR"I!"QP+&1M;W^X+%F<7#DL9;I3CMD\18X+
MS/I>Q/TG%[?K=Y_]?1+GU1^WV>E8V(UFOCN+IZ.3NFL;5;U;MG[A[_F53>W/
M=)H.+KXK7W?HFM+%X9*4!DDG_G#1W^LKGW)_CQ!?/1/>-C"X64JQ6. *WG_<
MQ<,C?XAJ[-&**SPO4AF';'86/L*JLG9LQ<&8**&3Q$]R&-_X((4HS?&>TYS%
MT*MB]BHXJP:8Y(H0UROG7H7UL)CX9+8LOC@8TS?_ *0@>ZI[E6U#/M&DXB[T
M:%FVZ2=I]B6+L<O8"E)I-FW#$R*;&ELM9S?D6?N"U\_<LY'A":[;>76)L3&]
MY*EG&D<;=%UKQ:/\GP__ %4TMPB6O-&7>/G&YO\ #L+RG#<RG'U.QKV>Q(NX
M"S*_JU'^'E2KE=F)GT/6;5!_JP,NU6UY">R8R"I9S)'"_0YS( 2VQ"6*N,W8
MJ2[OQ_4R3R:;:C2UA_4+R KKS^LZ]8S>(S]V8Q3T7]1N]@XN]@54&>Q5')\]
M10VXHI(F4F/\)/8D+>R-#&8SFC!&O!'!Z]5W88.@YZ]$M]@J%YI+!/JY>X@?
M'A=_FFK!/HMLR,!++$185GUS1-2J8K&Y$4(F6(Z?;K!'UGS;\W.*J&%LT^B;
M!A=9QXL8ICY7RY.R?3[_ ', #EO/O7:? M)U<?*1S(Y7=]$1E6MC-8UG8>/L
M31>P"F8(I8_#W#@%#^8&T#I.&%1X?'#E*T;'JRMZJ17-+S-=_P"JZH53D-I]
M3@%CV'HR,$1/X:5:N%PN&O\ 'E#'!C9*4F/8!]P?I]U5&D5#+QAN>)LR2205
M97LC*Z_'FI8*YQB'S4HGRV*SR^5S07K1X^.+EX4OQ9>T8J9EF8]ZB>T_IJ[Q
MMBF5<6R#"U'US%8E?U-. #T?!6[NL<;^(+WG]L?$0I5QO_F+K7_IT/\ ]5L;
M_KLF?U:_CXIVQSR=&(N/0\PJ,K[-D*4V'UC>L26-BGC-6[$[Y%\?R"[>XXJC
ME>7]>KWH6S1?".<6'YM)'2U-_IX_#\C:%9JU8XO*20/#!TN]M,M*/DF&;$U7
MW\]\*1Z#W^$$,?[;BHSQV<C#ROL<&39!%:? ]TL<![C+NUIZ=@,/E^3MW9?H
MQ3M9/,&M> 0.WIMM1D')&L8*&P,;2J5A\')UY#S*F=CC6P-CQNP9;;WRSUY1
MX=PAG?X;^LKQ5";C+#!R51L8FI)>S;*1!J]^$3&?+J1[E&-!=F8^9<TS*"&.
MRZI*9FP.[9WY!;N=&WZ+F,_F*5>'(83(V3-88#];>U;7&US!7-3HS8:)\5;L
M@1N/?@[[M4>YLO7*>D3?#^0$UJ**4C]@K;DJ4/Z+?AXHV&M^BF]-]V^RIVQ=
MEK\"T&53U'-:9'8+?L"/J4W_ *.(-DT['UAM=A]$1120_1] #1^/)13E*I2I
MZOI=2G9]>"":.)DO[0:IMSG-;CU&BR)_A#)?A$K^TSG'46P82!UW;[,E>,-E
M8\M[8%#.4,91=?X\J]FS!T8_5/\ ?;]*LK?M8P>-TO:[-#'PP2S5/%W@T#Y!
M1#3\-BCP[/)\%#YSTW.E=XCMY"<)X+%OX\OVS48^S8=*QSB.R0U;? T,K-7S
M%6;MI9=+2Q?'$E**EEN0ZC"',BOA@/\ QK!P[K6'?9V3)/K,?8;?=%&2!]#%
M@T<.QEKE2.@P-,%SJ%H_=YK2XFQ4N=U*<1;/9@F=._XFN!]W_<K8S.O5--XR
MV+'T,N;+S:8)W@>);WW]*LW T<5/QK3JQD.JNQ0'\?I4>X$_[/XO]ME5SW/[
M"3_5/_PO/?#(A]3>.GDO-WZA_P :P\*X:D;^W6WP0EXN^G&>OJ8#VG%@%'?]
MYQ]?Z*PM.Z9_J.7HJ<%T;F@]$@KS%IF<BT[;-SQ^3AGE?8M![)(F^8/NN]HN
M%R5*ENF>_1KZTE][Y*E8CHABZ/ L\,NCR,+P9Q=D,RBV/CNXWD[>8\9%_4&E
M-(YC/;UB5)N!9*TFE3 N8;!N/,_Y4;QE:YB.2=W9B6-^&^!DD,<?MZI*DW!%
MB";3)R^0.M&[(;'[:T^+I:C-WY"A9'\SD>V.'L&@N5^*A@P'GZS]9;UAUGWV
M]39NF!@Q=-LNQ=$0O>[QBBC=]WJ'8B&_3YM8S+Y!EJT:'SD# &M<>OI"[6V1
M^?,^H_('IG:W,]XLYNP<SY?[6F0 L/)L5:UR#QY%,P21/EF[:MSE]E9F4U&=
MX:',O]!_X!5[C[HB(B(B(B(B(B(B(B(B(B(O&?\ )U9 =FOO+1ZHJ$-*]F(B
M(B(B(B(B(B(B(BJ+==%S^;VK#9BEDXH10^<3'#OHE8MWTC9\SMV%S%.[ QE!
MP\&/_?\ K%;/(.E;!LF1Q4U._%!%3=Z@:1[O5K5A/Z#/7(\_$>9'MVJNY.XV
MBW""K+!.(+E9WT2]+FZ?QYL,%FG<V7/SW7TSW6K^9=&PCV>N7<XTVFMOF0RN
M%S(JTKY>;+_>0%_X:LVJ\6YG ;'F;?Z;DDJ66GH']>5Y^\BTF:=R@W7SKLF0
MH3T)6!CY9"3)&S\!=+9^-<I:T[#8#$V(6,IEDCC)[OD8NSO6L;9GM.JXNK9K
M?%'TS9<_L!Y:IQJM+)T,#CZ>0E9)8BA:R1S/8EH6IN^I5=IU^SC+#O O(?&_
MKOP>%2& XPY'CC9B,CL(CPP/S9%(YY+1[,4TY'XSDS\6-MX:2.K?H_*#^ZTM
M50\CXW>*V/P<NQYB*<FY&T01>W\5>')FF9#9\12.-G;'<JRB2+S^32JZSG'W
M)NU4<?8RN7K">.=KC4'8B:W]O][E(=TTK=+&:U_-X6Y ;]:+TI2_Z6+EV..=
M[.X8C/?I>"6P6=7)>BT1_P#DC"[&TZ;NMS?\;G:$=(0T" P/F<'2-_X5>(52
M<HZIG<J_#9/!A@R%"?N,N_#EJ[?HFP9[6Z%F:Y')GZ<OJQS >#.S[QA<RQ1Y
M)VZL,)EZ-;'U ]OQ=IKR\S=?L-Z"O.C3BIU88(^Q'$P,;W^ H+R;K%K9=4M4
M:C6FRV1DL/E[>35!OT#R);XRR.*OMK27)6,BAA'T^$3?R?NY=S$X7;(N+?T3
M+4A&0CJ^A&PN^GQ"Y6 X]R5[C:76\_"R.6)_=9[#VHA@,%S52IQ8(3P141U'
MZQ)+F1C]@KTKB<;#C<?5IQ$F."-K&D^Y#57G*FDS;5@/"H>KL#Q)!V>@5 -9
MP/*V6K08K/V6U\7"\-E]_7F:U2?DG2<S:R&"SFOQQ_&8YY B/R\VJO\ 8=2Y
M7V'8<%D+T%-@AD[C$;B1"#^VI'NVN[I<W_#YRAC8YF40WYE_0>IUR;0V/+:C
M/C\739)-:Z;*"\CP8MWCREFZFHTL=EZC():T0@ :[OR8T==JFKFJ\E:=LUYV
MICUJ%Z4N##\V,_B%:./PFXU=:R]ZW)':SMV,=L)(B9T" UJYO%F!V77M+R%"
M_2:)HY'/@8'?K^:U./==V>'!;!C,W2;$RT]\D74A]Y.R5@XCP>\8&*7%7Z\,
M%"M,]P?[OF<Y7JXN##T.RO/=?&;XSD^QLC\,SX=\9K !_M%W\G+;VS7-UK<C
M0['@JD$XEJB ^H>A&M'#Z3O5#DD9F6>"06JY-JQU]+"X@EC MN]K6VOY=9GV
M8R,TF=0^9D]V#^^M;-ZYN8Y9CSU7%1RU6-$8/J>[ O0H5:<K8K.YC5Y,?BJC
M9I99F$]NZ\0%R<MA]MN<4#$NI1G)/@9!(WS/7B![K/@L#M,/& Q$]>$7VP&"
M-CI"&^*B]#1-MDXJO:Y<9$VS&\.K>+R0Y<&WI?)^:TR'&79*\#*3&>C TDOG
M+/D/-=G9-)Y#S>L:[C7RTG2U2)9^WF-O;/9O0!5JY*GLE_3K$#ZM9N1F@],L
M$I,0)^_ETJMP/%>8_F#D-=S$-0R,E,U*6)Y/3RNSI&M[J->L8#:(ZTU!\!8Q
MXE)E;^&D$*O\/HO*VLWK6,P]R-N-FD/4A<2&M_*M+8=#M'CNQ@\=)ZELN$KI
M9#\Y9?N25VN.*VX5,&V/898O5 :R&-@Z+&-_:*GZHG=N*'[!O6*RS'!E4CN[
M]C]'MTI[R+KMK8-0R.-J$>NX-,8/L2U4P-&Y/RNF#$W;$$$-2)@K0,]Y2SV$
MA4TSFO[S9XPAPP9!->E8R*?YEH:P!=K&ZIG;/%[M<R$<3+(J>@WP<2WIOL56
MM/6.6+.K/URP8*U6"N8VRL)+Y0/9BE>*XWRMKC)^NYA\(L,(?6<SYB(J+8#7
M^8C5KX"[8ABQK2&R3=DR>F/LTKTG2I5Z=6&M SPAB8&1M'V:/8*O^1M'.S4:
M\M2019&G)YU9E!VMW[<8I-=RU&&G7@E8+UL/+S-^Y@Z"GF]:[FKVH28/"10C
MU6-B+IWD!L83C3#;'@L!%B\NRM_T;IL#XI"_R;^_L!3RY"^:K8C9[NC<!_$A
M>?CJ7*5G5#K5P8N2LX"/US*XO:P?N\%*M@XT-KCZEKU"<,FJ.BDBD=[.>P*'
M9GCKDG8M<97R^<@=9KO9Z$#2?2?U_>D<I#M'%MC8=7Q,4UF-F8H0-#)VCIA*
M:IH^\ON4YMKSIGAJ$.BK,>7M>\>SGDI<T;:7\H0[*V2H:H'@6EQ#PP+[V?2M
MKO\ (6*SU)]1M:F0 '/(<6JZU2W*>B[3M%O'''SUF157AXCD)!)78WK7]HV'
M3_T;!\(VV^5ID)>0SIJ[6$P.8?IC<3F)8C9^']%SXOF.E56N\8;U3PM_7K.=
MA@Q;W/+1"TOD>I)J_'&69I.1US/78I(7GJN(QWZ0_*B.&XWY-PY&*J["QF',
MOS+9'-D#%8^^:%-F-,@P^*D;$^K-$^OZA]_3!]RL#=?WNSI-^E?R5=^4G8(P
M1WZ;&+'J6BY2+0K.M9\P/![9&8OJ 8HSC->Y7P&/_06-EQT]1H(@M2N(<QBF
M+-%O8[0;6$QUIIN6 ?5L2?WWO_6*UM1UC;L)HEW$2OJ&VP.92>"2PM/[:X&%
MXOS+..K^M7[<(?(\2QOC^88]<-O&7(.2U,X7*YJ".*HQ@I00]EKRW]MREF3T
M7:+/'D6O_I-DUIX9ZTLI/0 'ZC5/-&Q&3P^LXW'9%\3IJT(C[C]NFIN^$R>9
MU^:KCK(@LF5CXI">NBU5M-I6[[)8QL&T3T#5ISB42P=F27I;>=TK;;/(E'8*
M=JJ*L \!&XD$,6;?M&V+/[/@LA3GK1Q8_L_6?J[<N;G./=I.\1;!@[\54V(B
MRX]Q)+>_V F'XMS6,WR;.#./EB?$3(]WREE>[W:5LZOHNTXC<<EFY+E0Q7YW
MNGB'X<5UN3>-QM4,%JE.V#(U3_4RJ/ZEH&YOR-.WMN;-ME,^4$ >96E_[;B5
M>RIG;M#V6SNE78\!DV5I7PB&QY_9BYN/XLSM/>'YH9^1\3X")I'#N65Q]VK[
M9JO)6-@OXW'6\?+1LR/(=,3YPA_N&CI63HVI0:IKU;%Q3.D#"7O>?N\KI[-K
MU38,+<QEO^SG;T?RT_8JC:/&W(E7&6L"W98VXHQ]1/Z)E_U/W!2_5.-?@-&L
M:YE;#++)R7D!GRC<5 ,7Q)OE"Q)C8-G?!AW^_@\^?\/!6-NW'3LKI='#8M[(
MI*3XC7<_[^F%LMT"?(:K;Q.<RT]V:P&N=,_VB>W]A5U@>)-QK3_ 7=GF_0K'
M@>A&\_UK/P6J3[YQQF\[FL7/0NP5J^.:!6CZ4RVG"[!FM1=CH[,,-JPUK+$O
M7T]?WO%<+!:5G,?H5W /NP.E\#'!*&_(-/Y7SI&F[%K&IY'$MN02/[+JS^N@
MTO\ ?M8= TC8=8JY>O8R44XMGS:[KLB1:6CZ%L^M3YI[\A6E%]A>[Z/:5=#C
MK2,]K$V7=;R$4S;I]0M:/:18]/T+.X;9\UEK>3BDCR!>98F,]RY17*<-Y:IG
M[60UK.28YD_?FQI+2.U8V)X]QU74[6%N/=:-OM]N=_ZTDCO=RJJGQCOU$/P5
M;83'AI6/)<.R6?AJL_C'2KVH8.6C9OF<R2!X9_<B_@K#N1S2UIFQ$-<6$-<1
MV 2J<T?0=DUI^=>_(UY3?!<>F>TJW.-]#S6JSY:6UDXYOC"'. 9_?34M S&%
MV[,9F?)Q2LNO>Y[!'T27%6O8>(X)'N[Z:PD]?@!>4M9US*[%+L6:P6V3XWXG
M(O\ " 2?7( 3]4BF6NW]SQFZT<#DLZW*P35'F7W<Z/KH=N*WK7'&QX"]?R&F
M99D!MO[DISC^J4RT33;&$K7;.2LBUD[[A)<F_?\ LA0G)<;Y[ 9RSEM/R0A%
MN;J>HYG]6UI]W!6)JNFU<#%=>^R^W<MN\K-J0=/D*K#,</Y:G>OV]5V":@+1
M[DK@EC5VN.>+)]3OV;T^6DGDF8 Y@'05SD$M(!^:IJ3C#+2;D_93LQ%H/^@?
M#@M\/V/=9=UXM=L&Q4<W3R\M&W%TU[V-^?0^X6 \,XS]/T\L,O>,K!_TDN/;
M[#OR7+>SW&4V6W&IL3<[+ ^L6>E"(NPWI;NZ\;U]FR^.R<63GHV*O8$D0^H@
MKEY;B:&]?P5B+.6X6XQO432/-Q/Y[[73WGCM^W2XPRYB2".J?(L;$#YN5D4X
M7P5XHWRF1S6 %Y'1/7W*RHB(B(B(B(B(B(B(B(B(B+Q?_)VB>=JNRB%I:VFX
M%Z]H(B(B(B(B(B(B(B(B(B(B(B(B(BK'DCCV?;Q1]+*FL:I+FL\.P]RL3'5K
M$%*O%8L>M*R,-?+X^/F1]^EM(B(B)TB)T$1.@B)TB=!.@G01.D3H)T$Z1.@G
M2)T$Z"(G01$Z"(B)T$1$1.@G2)T$3H(B=!$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$>UKV%KA\B"%2MK@[6Y,G+?JW;E1[W$]1*P=7TO":W%*
M*,1]24]S3O/<DA_>5*41$1$1$1$1$1$1$1$1$1$1$1$1$1$1%XS_ ).TMD;-
M?C$7<)J$O>O9B(B(B(B(B(B(B(B(J8=NVQP\L?S<E$ HF(O8 .W?N)*N<'L(
MB+1FRE&&[!2?88V>9KG1QD_4X-]U4^;WG8L9R=AL&UL Q]S_ 'O*N9$1W?1Z
M5$9SD_:<1MD>N_S>K3SSO_Z.\3D![3[=_0MC,<G['K.1@CV'61#2<>G6J\QE
M _\ =K5<6%S-#+8VOD*<OJ0S,#F']Q6ZB(B3/+8WEH[(!("K+CO=LIL=W9(+
ME5D!HVFQ-8%9J(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B+QQ_)TDC&?R3#)]9K?)B]CHB(B(B(B(B(B(B(B\N[;;R%/FN:3'T#;M_H
MYH@C!Z ?^7+M4=YW_7MLQN+VV*L^M<)9'- %O[=N&\:]OF,Q[KE=N)O3]1/,
M?9:T>X*F&ZY_.U,QKV*PT\39[D[O,.9Y]1,]W*R/J\?=>9)Z>S3<WSUV9=C9
M&4B]DCH@\,B)'TAJ^-_N7\=RAK$L%1MVV*_3&'Z?)ZD=7=][PNYXK%[-7IMK
MY'L0^C_<*[>[<@7:.PU]=Q<M:"TZ+U)K5C]2(+DZ1R3F;>UV->S!ALO^9AN0
M#ICE>WN%YCY'OP8[EK5+<_EZ<0[=XCLK[Y0Y4P.0US(8>G7M/GGZ9YR1=,"L
M#CUM;5.-*EF[:!B9 ;$CP>PWS7"_G)RCDJ'Z?QM6DS&O8)8:A^J:6-3'#<D4
M<GI-C/MC(-:+NQ /=C_PJYM<A;]!@:FT25J+,=,\?]#)^L-=[.[4XW?>\EB-
M/HY[%TV3Q3>F7EQ_4:]<'6-^V_,['3?)AGP86:J9!,]OX]WK=BV_;]DN7Y-:
MKU1CJSG,%B?WF>W[- !7"X3LWK66WF>]$(K,E^,S1C[/^M>@D1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%^&:%AZ<\ KR!_)S_ROEO\
M +V B(B(B(B(B(B(B(B+SY;OP4.?"Z8@,GQ@B:XK+R;9KYC9-4Q%*0RV?BO5
M?Z1_48IIREJO\X-6LB%O_3*I]:L[][5#N(9<MLCOYQY8'U:U<4J[B>R[]MQ5
M]KSIE,MC,1SM)8R$HBB?BPQCS[!RT-KNU;?+ND68)FOBD8'M=^XA=/F*R(-]
MT64%G;)9%QMGOTM9Y:LV\U7$V+OP="1[ YH*LC&;9HLV;QE+ Q5+$\Q/D^!G
M7I,"M?[+S5N\\ YGU+N5GT?KJQ.4)M6EU7(G)2UB3"1">P7^1_95-:ICLYD>
M$LS P/=U.7P1_EK?<*Z./-AQ>1T+'/9-$WT*8BF;\FACF-57Z'DF:YI^ZYY\
M9FJ2V_\ HT77T/Z[4?VAN,R/'=3,Y'-&2].6&M58_J& 'W:QBL'<9ZIX;J>E
M:$S1'5 D)[+ODK#8R2YH314/DZ3&@1]'W^E0'A#/XQNH/QTKXX+5*5PFC/TK
M7XFS%"UMN_\ HS B>_ZT7[V N5VXK8,-E)KD5*['.^K)X3M9_<=^"NHB(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+%+2K2O\GQ,<?R0O
M(O\ )S_ROEO\ +U^B(B(B(B(B(B(B(B*);1HFK[)(Q^1H,E>QO0E]GA-<T?6
MM:\GXS'LBD(Z,ON\A5_N'*CZ&;N:[0Q,]B[UZ;#]O)RL;2\%^@M>HT7.)E8P
M.F<?=TCOUBI.HAL&B:UG\C3NY&DV::M^I^#^YR9#0=7NY:')38Z,V8NO&0?+
M]5-AT/6<_DF7LC0;-.P !ZWL_J>$SV.BI9&JV6%A!8W\+1U;0M:U=KOT92:Q
MY'3IG?5(1_%2]5]E>+].RM^>[<QHEFE>7.>XKG1\.:,VUZ[L<9?8!DCO)C0%
M9<&/I5*8JQ0,CB#?%L31TT!57/P[J[LM)/'%)%4E:?5J1N\(W.5@_P V,,W
M'"_"M^#,7I>A]O%06CPUHE.I:KMQID$[>B^0^;V_P*Z,_%^IS:Y#@#6D;2CD
M$@#7].+Q]R5+,%@:&"Q4&-IAX@B'3 \^1 5>YOAK3LME),B^&2*61_E(&'IC
MU(-;XZU;6[=FUCJ/A+,""XGOII^S5TM=T_#:_/DYJ$;V.NS"6;MW8['X4G1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7D#^3G_E?+?X
M 7K]$1$1$1$1$1$1$1$1%HG$8S](/OBI$++@ 9O$>9 ]AVMY$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%Y _DY_P"5
M\M_@!>OT1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$7D#^3G_E?+?X 7K]$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1%Y _DY_Y7RW^ %Z_1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1>0/Y.?^5\M_@!>OT1$1
M$1$1$1$1$1$1$1$1$1$1$#@>^BOQT\0=XEX!_'87ZB(B(B![3WT?9 YKN^BB
M(B(B(B(B(B(B(B>01$1$1$1$<X-'9/00$$=A$1$1.PGD$1 ]I) /S"(B(B>J
MP.#/(=_A$1$1/()V$1$1$1$1$1%@-NL)?3]:/S_9\AVLZ(@L1>7B'#O\=A$1
M$221D;2Y[@T#W)/212QRL#V/:YI]B#V$1$+@T=DHRS"\]->#_ A 01V$222.
M)I>]P 'N2>@%CJY"I8@,\,S)&?9S3VU*UJM987Q2M>T$CMI["R(B(L3[<#7A
MCI6!WV:2 5E#FGV*(B+\DE9$TN>X-:/<D]!?%.Y6LPB:"5DC#[.:>PLB(OBQ
M?JPN#'SQL_<YP!*UVY&BX@"U"2?L'A;;7L>.P00M&_EL?0]/XNU'"'N\6^9Z
M[*WD7/RN9QN)K>O>MQP1=@>;S]RM^&6.6-LC'!S7#L$?<%:M[(TJ$!FM6(XH
MP>O)YZ"V:UF"Q!'-#(U['M#FN;[$%?2(BY.3V+"XN:M%?O10.G>&Q-<?FXKK
M(B(B(B(B(B(B(B(B(B(B(B\@?R<_\KY;_ "]?HB(B(B(B(B(B(B(B(B(B(B(
MB@^[;<,#!5K5X_5R%V3TJD7Y/Y*SUHYM:U^Y8O7I+4X:^::5WW?^&@^P5)ZY
MA,EOFJ6LZW,VH,W);D,)$Q$;6M]F *P]%V/+T;[M4V6<R9*-GJ0S]EPGC5M(
MBU[UJ.I4GGD< V-A<X_P5(\5<DS;)E\Y2NRGS,OK4V'[0J]EIY$EU2=C)S$]
MS"&O'N#^0J=X@ES%FCLQNY66U)\=Z;7R>X(\AVI;H&O['A(<JS,9<W3-;+XN
MR3TU6#V$["%[00.UQM@SU+!XNQD+3^HXA[?<_N"Z./O17*<%A@(9+&UX!]_G
M^5L>03L(G83L)V%S<SF*.'QUB];?X0PM\G%;^,NPWJ<%B$.#)8P\>7R/3E]H
MN5F<Y0P\$4MN3Q$DK8F >[G.75[3R"(BK/D??3K%6K7IPB?)7'^%:):.-USD
M6U3DGR.VR5[;R'".%G<;/W>X7WHNQ;1+GLWAMB<PVJPC=$8F],<P]]O5K]A$
M\@@<".P4[3L(7M!Z)3L(7M! )]U^&:,.#2X=GV"C6Z8?(YG6LA3Q]WX:Q*T"
M-ZRZICLCC,!CJF0N&S9BA:)9??LJ0&9@<&^0[_"$A?KIXV@$N [_ 'HB*CN9
M,GM> K5,KB<S)#"Z9L$D/[W>Q"Y6>DY#P.KU=CK[+)>:QK);->5GBWP<K8T/
M;1M.LU,H&"-S^VR,![\7M4N<?($ ]*M-5UW9L=L^P7,CEC9J3R=UF%Y)#?WA
M66Z1C!VX@!&N:X @_)?CIHFN +@#]AVOU$*\Y[7:R%3F;661WYQ#8Z#H?,^"
M]%LFC\BT.!=^.T=9A:[Q+V@_Q"_7O8P=N< $!!'81)!VQP_(7F3'19J[RME=
M??LN6;1@9)*UK9W=_(K+GL[LW'VXXJO)FI\AC+SSU'.XN>Q>E@1TL(N5G2>F
M)HR[]D.':ROD8P=N( 7S#9@D)\)6._@05]3688N@^1K>_P D!&2L>.VN!'[B
ML4ENNR0,=-&UQ]FEP!68N !)*QFU UGGZK W]HD=+(US7 $'L(B_"0!V2L<5
MRM*XADT;R/L' J)<@YQ^$U++W89@R>. ^CV>OJ52XCCROL&K83-5\E,S.RQQ
M3R73)V\]CL@KT75B?%"QKY"\M: 7'W)_*_56G*VSW]<U<V:1#)IK+(!(?[@>
M#]2CM+CR.7"QY*AM&0ER;H?-MT3N+'N(_94HTS+W*>EQ6\]</JPA_P 1)*[[
MM75T;<Z^TXF:["UL8^)DC8WR[<6,]G*537:T3@U\T;/P'. 65KVN';2"%AEN
M58G>,D\;#^'. *K_ )8A]?C[-O9,]ACC$@+"M7B29D7'V%?(6Q@1*SX+$$S2
MZ.5CP#UVT@KZ14SS#L-W&T\91@N&I'>L>G-8'NQBULGQO%6P=BYKN?RD=QL/
M<4HL.<V0*?Z-9G=I>!FN2.]4THC*Z0_/R+5)G7Z;?'RLQ#R'8[</F%%N0*D5
M[3\Q$Y[F@URX%I^X5?\ "U=E[C'X::1X8^:=BENC:YBM+P5V"/+B>!LY>^1W
M0#%O:7O-39?TLZN^,10W#% [R^J1GS^I3A$48W?+VL/JF8R-7KUJ\!='VJ5T
M76L'NV%9ELCE+4V7>7&65LQ#H2?P%.-"@R^!FVNMF+T\]>K-$8+<[O>/ZEV=
M,WZKLUS-"L8Q5@G9'6?Y?7+[J89#-8S'E@MW(H?,]-#W==K?AL0RL\XY&N'Y
M:>PN=?S6,QY8+=R&$O/30]W1*CV]5ZV1T_+,=(2PURX.8Y1GB">"OQWC)I)@
M&,82]SE9F*S6*R0E=4N13AG7EX'OKM;J+S[_ "@<10DURI?]!@M"['$)ON&/
M3 <(:M+C<;<-FZR<UFN<]C^OK/W47@S^Q<<[U!B,CDI;>(LOZB,KB2QBNG>=
M<US.,QOZ7R/PS8+ >S_SE2>YL.%QLP@M7X8I.@0UYZ/2Z%C*4:M+XN:PQD70
M_K''IH!4$WG!ZILF&JRY2\V*NQ[98IP5.:)I4L=#Z,@]%D0#'$_(, ]^U1/,
MF=U?+Z=<AAOP3689HWL8%9/'\T4.A:[)(\-8,="22>@/I71QN[:KD[GPE++P
M2S_>,'YKI7,_AZ5R"G9O0QSS'J.,GZG%:5;<=:MY08R'+5WV_?T6GLKK9+*T
M,;6?8N660PM]W/*\V<C935,_L6J7,;?AL31V_3D#/P5Z?"_41$1$1$1$1$1$
M1$1$1$1$7D#^3G_E?+?X 7K]$1$1$1$1$1$1$1$1$1$1$1$7GG.237>=<34E
M^N&E5]2$?@N5D\BX:ME-6O">2=OI1&0>F\L[(4 X,UBI!K-3+$3"S*7_ "]0
MEGBM7EPOQ>V:;FHGB+TYW1R/'NO0S3V$15/REEFFOB]>BLB*?+6FQDGV$+?F
M]5AN<-'2^0]?SF-?&:<S/0F#2.@ O2]S)5JN-GNE_<3(C)Y#[A45@<+FM[QD
M^P9#.W:PEE<ZC! \M9$P+)P;\8W';35FD<^2*Z.I?R[ZET.*+V<MY+=JN4OS
MSRU[K8P7N)\?UUM<8W<K+F=XH7<E8M,IWQ#"97DEK?J6+3+.6K<@;7C9LM;M
M5JP)@9+(7>"AF/R)V7-[%!>VC(8[*1W)/@8&REK&,!/R 6MRIALL- URUE+M
M@W(7P03Q^9<Q[R/UU+\Q0SV#XPGO8[8KHDC@BF)D<7D-Z/T,46,').1T"#/G
M9)X#!3CD@@A)\IV_=TKEOXY_).X:@,M^GC0\(2^%D'8?.6_=Y4KT[?;\G%DV
M?R'<LU-CVN_+RQ5O-L>4OZP_,19_-#*R#UVPP@BM_A@>2D6>VO;;W%=+.0VY
MJ5IKVLL #Q=+^\%<O8/Z3&ZG!M+\U+6]%C'_  43CUZ7YD*Z7),5G9.-<-L$
MER6%_I0O? S]1YE"M[0,18Q^!K-ER=FT)(HW@S.)\!U[!3)%YQYEP<\NQZY;
M;E++&RVA$V('Z8S^VQ3/<<QD]3UZ"C5R4UK)7+OI03S?,@.]RN#NN.V?4L5#
ML%+8[]M]60&W!.\F*0%7!JNP09[!4,I$WKXF%KRSW#"1\PNRA]EY;R=C](\^
MTHIW%C*O0A"]2!<RQ5Q]6>SD_AXQ.(B'R]?46-^Q*J'679O?Z&0S)SERC6=.
M^*G!6>6>(;]WIH.TYWX_-ZGF+1=?HL?Z-H_-\C&_<J&:4>1=G?L-,[--#6AM
M=.M>\O?X8I'QEE<O>_G/JV5R-I\].4LBLAY$@ 3C7*Y:IN&S8+-9:W9FKDFO
MZTI(,3%*M?MS.L[3LDN3LR463RLIP&0F(,83VX!56=CL[%KUC*R9',Q9.0N?
M5BJD^C$/LT#L+LP['M^3XDR.0L7;-*]0]Y0"'S )I>.Y&SDVM;#=R;A2AC!]
M RDF5@'ZY_)<N3B[M38\]L466V"_0R\-EXH-$IC9&U65L)V?'<23/GR<D.3J
MUFF6=CB7/("X5;=Y\/Q!C\L)9'W)8V0L?*?/N5X2[I>8FU*',UM@R;LVRJ)1
M(9W>!^Y8 N%>W3-YWB"3+09":"_4F#+!A):N3DL#MU_CJML]S:;+36HLDAK1
M^Q'V+G=^ZOCCG,SYG3L-<L.+IG5VB1Y]W. 4V14=S\2-+@_]2A4=SV2W+8-1
MIZ_C-:M,]>")EBS)T(PU;.PX',Z-Q1!7QN4DALPV6/G?'\NR_P!P"NGI^)Y*
MMY3$YK(Y@_!2U>Y*HD(\/Q]*U>/LOEY-^W*M>R,T\=9[FCS/VC*V,6+O(]_-
MSRY:U6Q568P5JT$A9ZI_;D74UZ7;-0U+8'9Z1LT>/[^#E+B7N8JE%R_GM:ER
MA.QS9OTO5CFB^FLSOV#1Y>R]"<;93-Y/4Z4V79*VVTEDGJ>[O'[J=HO+/*4.
M3GY1UF+&S-BMO9U%(?9I6EMV VW0;6,SK-DMVV/L,CLEY([<]=_EBA/7M8?:
MZ=JS\%+)&+D;'$!3/?,H,U!K>)Q<Q+LG89,'M^T#/<JWJ\3((F1L[\6 -'\
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M)BKV#\G3//W _"KKB;8Z>K4\EJ^=G94LU+3BPO\ :1=C5GU<QNVU;7&P"@R
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ME;/*MK+XZ+3(<OZUVDSLY)K/::1JXV;V&#(;?HV2Q>OW(,55F>R "(-<_O\
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M:(B(B)\D3H(.CVB(BYF:R]+#8VQ?MN<(86^3RT=E<G7-PPVP:_-FZQE9587
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M=M5O1Y;'_HUN0;9C,#H_,2]_3X?E02#E?29K;*PR1!>_Q9(YG4;OX.5C-<'
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MX*O>K!\3ZI>]A]G==)N.'QN-Y0X^=3K,A$CY YK!T.F+T5V.T49W7Y:QF/\
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M7QD=ASUNY^C6PO,FK/HU8X&VVEC_ !;T'+TL%1_/G^9M;_U.!=;;O^R#(?\
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MKM\KX/%5>.A!!4C8RK-#Z  _45IZU_D+&_[-'_\ "W<E_P!0M_X+_P#X5$<
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MN/JXVC6IU8_"&",1QM_#6K[RF-KW\=9J61W'-&6.;^05YJQW%?(FOW;-3![
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MM?,#++&?L9%3$FO9O';G?TJB\#$9*=MIW[H&'V"]7UX8J\+(XF!C& -:T?(
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MZ(B(B(B(B(B(B(B(N79US#7+#IY\?7DE)[+WL!*WZU6O5A9#!$R.-H^EK1T
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M?H:&@ #Y+3M8K'VC)Z]6&3S(+O)H/9'LHSN?I4M1R;(JSW#X<QQQ1-[/9]@
MJ]X=P=6;3HZ>4P_4]6RX]3L_;^[5>8@C;%Z8:/'KKK[=+'6H5*4/I00LC;^R
MT= =KY91JQR^JV%@?UUY ?-'4J_Q L^BSU@WQ#^OJZ/V[4,FT]U[;XLW?LA[
M*?8I0-;\FD_WW%3I<FYKV&MF,V<?7E+)#(WR8#TX_==401MB$8: WKKK[=+#
M4I5:D7IP0LCC[[\6#H+GC7L0,I8R0I1?$REI=*6COZ5UUJC$8\7#;^&B];[R
M^(\__=;3HVGW 0QM(ZZ0 !" 4]-J%H/NB=(0"@: .@OSTVK]Z'2!C024Z3I"
MT$$%8HJL,#!''&UK>^^@.@HUL^K?I]]6"Q>D92C=YS5F#Y3$>W9_ 4JC8R-C
M6L:&M Z "(B(B(B(B(B(B(B(B(B(B+R!_)S_ ,KY;_ "]?HB(B(B(B(B(B(B
M(B(B(B(BYM3-XJW?M4H;D;YZYZFC:>W,721"N=4S>+MW)ZD%R)\T/]JQI[+5
MD.6Q_P"D6X_XJ,62PO$7?U>(]RMU$1%KU<C2L3SQ13QODA(#V@]^)/Y6PB(B
M(B(B(B(B(B(B(B(L%V_4I0NEL3LBC'NYYZ"R,MU_AA8;*PL+?(/[^GQ_*5+E
M:W R>&1LC'#MCFGMI7W)(R-CG.< T#LDK#2OT[L!FKSLE8'%O;#V.PLR+YL6
M(:T+Y99&L8T=N<?D %\4[E6W79/!*V2-X[8YI[!65$1$1$1$6C>RE"@&&U:B
MB#G!K?,]=DK>7'RT&"B>+MZ.LTM< V60#Y%=B-S'-#FD$$?(A$1%S\OFL9AZ
MOQ5^TRO!YAGF_P!O(K?AFCFC9)&\.:X=M(]B"OU$1$1$+041$1<J'8,-)F'X
MH7HS<8PO= /FX-:NJB(B(B(B*&Y_?]7P%@07[X;)]VL'EX_Q4MH7JMNK%9K2
MMECE:'1O;[$%95'<WMN!PDL$-^\R*29P;$S[N4B "(B(B(B(B(A(':BV.W;7
M,AGI\+6N^I;A:YTC&CY#Q/14I1$1%@OWH*%2>S,[J.)A<\_N"Y>I[/BMDQ3<
MG0<\PN>Y@\QT[MJ[:(HMA]QPV6S66Q,#I?7Q[RV;MH#21^"M/%;_ *_DMGGP
M-=TS[4#'ND^CI@\" IJB(BU,KDZ^*Q]JY-Y>G PO>6CL]#\+A:9NV)VO'SW<
M<R<1LD\/ZUH:5*$1$1$1$1$1$1$1$1$1$1$1$1$1%Y _DY_Y7RW^ %Z_1$1$
M1$1$1$1$1$1%P)]JU^#*'%RY*%EP-+O1)Z/07YC=NP&2K7K-/(PR157>,T@/
MR8N35Y'TJU8BKPYN RR. C![ ?W^%*,GF,=B*;[=ZU'!"WWD=[!<;7]SUW8'
MRLQ]]LCXST]A^ER^=@W?6M?D9'DL@R*1P[;'[O(70Q.RX/+4)K]"_#/7B/3I
M&^P7+.^:B*EBV<W6]""41RO[_5<5U,-L.$SE9\^-OQ6(VGHN8?8J&ZY3TN#9
MMBNXZ^);\KR^U&T_*-<+&\NXJ[N5J@RZ&8^.#H/>P@OF5E9?:<!A7PLR.1B@
M,O?@#[E9L1GL+G:DL^.O168FN\26?E4_IE&K2Y2W&&O$&,]^@I4_"Z<_DAF0
M.2 S!KGJL#[C]I2+(;QJF,MRT[F8@BGCZ#XSWV.UM4MOUN[D(Z%?*0267L+Q
M$T]DM"QY;=-7P]D5LAEH()3[,*V<ILV)Q^$DS$UEIJM;V'L^8*B&@;_3VNA.
M^6:-DSK,H9!_>$0]DTW7-:QN>V.WC,F9YYY@Z>,'L1%RF67V7"88-.0OPUP?
M;S*ZE#)TKE;XBM.R5A_5<T]M7+;M&!ZO$9*#_HI G/E\H^UGPN?Q&9KFSCKD
M=F('KR85TT?(R-I<YP  [)*Y)V'#BH^T;\'H-?X&3R^D'\+*W.8QU$WFW837
M'_[4.^D+/C\K1R$)FJV(YF ]=L/8[6ID,_B,=(QEN]#"YWZH>[HE=**]5=7%
MADS',([#P?IZ7+&P8?TF2_'P>#Y/3:?+Y%WX6W>R=''P^K:LQQ,_+CTL5/-8
MR\P.K789 3U]+@OO(Y?'8Y@=;MQ0M)Z!>[I;%'*4K=;XFO/'+&?9[3VU<X[!
MAA%+(<A!X1R!CW>7R#OPNNQ[7M#FD$'V(1:E_)T:$)EM68X6?M//2R4<G3O0
M>M5G9*P^SF'L+0R&P8?'2,CMWX(7.]FO=T5U(+E>6 31R->PCL.!^E<L;#AO
M3LO&0@\8#U*[R'32NEC\G1NUQ/6L,E8?9S#V%R+NS8.C8,%G(UXI1[L<[HA=
MAERO\,+#96%A;Y!_?T^/Y7'I;-@[LPAK9*O(_P#9:[YJM><\?5LZ/9G>PE\$
M[#&NO@<=5N\68RC>G,$,N*B9))WT6_2N[H&$QN!U>I1HY VX&]N$OV>2OC:L
MOKDV,R>,NY&%AEKN#V>?3E"N!G-;QY&20 +DRL2ON6LV;[J,.6K/L-=T8PY1
MOD7D*AJ=)C/,&[.0(8__ )<5VLA+K^SZS?BDR+'4YHO"65IZZ!31,?@L9K52
MMA[7Q%-G99+^V5EEW?5(;YH29BNVR#T8R5(;&1IU*ILS3LCB [,A/R 7$GW+
M6H:L%F7+5FPS?V;R[Y.4AJVZ]J!DT,K9&/';2WV(7VOR61D3'/>X-:T=DGV"
MC6/W/5\A>-*IEH)9Q[Q@KO7LC3HUWSV9V11-'9<X] +E8;:<!F2?T=DH9^O<
M-]UMW,YBJ5NM5L7(HYIW>,49/U.*T8MMUR7+'%,RD#KH]X ?J7Z[:]?&5&+.
M3@%P^T'?U*C.?*=8R:Y:+!ZHM>'DKMBV[6QD(\=^E:WQ1'RB\ER>0L1KV7P8
MK9J\*U83LD$G?7U-769D<!K^!I/?=9#1BB8R*1Y]V_98KN\:K1GKP6<Q7CDF
M ,3"?<%26>[6JU7V)9F,8UO9>3T %&<9O6IY2Y'3IY>"6=[?(1CL$A0[<N4<
M=@L]CL.Q_4S[(%E[F_2R)='=;&DYS5V.R]X"A),U\4@)!+Q^%,,;)BL?@JAA
ME\*<-=O@YY]HP/EVH[3Y-TNY=;4ARS/-Y C)!#'G\-*D>>VC"8*NR?(W601N
M/3._=Q7 L\CZ?5M5JLV5C$TWCTS\>?MY*<M<' $$%:65RV.Q-.2U=LL@@9^M
M(Y17$<BZGE[GPE7(_P!>3]#)&^'G^]JZ.?W77,!-!#DLC'!)+_9QGW*^\5M^
MNY;(V,?1R4,UB#^T8TJ0V;4%:%\LLC61L';G$] !0F#DC3I[[*3,LSU7D!A(
M(8\_AI6[DMZU;%9$T,ADV5Y^FEH>/D[S_"VLUMNO8-U=N2R,<#IP3"T^[^OP
MNM:R]"ECW7)YVQ0AODZ1_P @ HSB-^U7,WC2I9-CY_M&06EX'W:JAMVJ>)YZ
MGE^B**;']RN]AVX@EQ5PX+>]8SUV:GC<E'-+&.R/R/R%GV'<]>UXL;D;HCD>
M"61-'D]P"V==VW"9ZE)<QMH2L9\G_8L_BN(SDC3WP7YVY6,Q5'M9(_[>3N^@
MU=?7-LPFR5GSXNV)FL(#Q[.83^0M?/;K@<'8CKVYW^J\$B.)OFX ?<K!B.0=
M/S$\%>EEXY)Y?:'KIZU\MR-J^*MS5[%IY=#_ &IC9Y-C_<XJ78G+8[)4X[E*
MPR>&0=L>WV*SVK4%6&2::1K(V-[<YQZ "K^'E32Y;4< R+F^H[J.5S.HG?P<
MI%LV?K8;#3WI1(YH:0TQ#R/9!Z*H;BBW@=AP%['9:*:Q<R=J22P\L[!7H+!X
M7':_B:]"F"VO SIOD>ST/N5$)^5],@EE8^Y,0R3P=((NV=JN^:*N)N3ZG>>Y
MH8^R!Z__ )"K/9R5IWZ79BF91IG+_ ?L=_CM2?/;%B\'1-N_8$4(( ^[G'\
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M)Z7C7ZKM>&,^&DEZ%N$KO<QLH6<#J#*TG=1\K!&X_=BW>8];P>'U#%RX^A#
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M;W_HJ27C8W/8(=5HAU]Q\,C=G?\ U4)_#&KE\-5IZ=W?JT\K))(K@:][?9Q
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M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BU<OB*&3Q\U.]"V6&4=/C<.P55(X-T
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M;G?@>2YV!.U[SB[>=;FK6/8Z1WP%6 D#IO[:VLE)LUGAW-_SAC$=\0O#^_N
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M^(^Y6WP3DL3!>VBJUQ@EFLM?%6+.B&,[6UQI/#+R=N[F2 A]B4M_?]:]'S/
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M.6)KV.'3FN'8(7Q6J5ZL38H(FQQM]FM'0".QM1]EEI\$9E8.A(1]0'X!68-
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MM#,X:VP6V^C-$YAD9\P%P^.,!C-?UF.A3R7QD4<SR90.NW*0V,]B*]ME6:]
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M9"?D HYC-ZU7)WFTZF5B?.>RV/V+@/N%T\YM&#PC8CD;\=</_4#O=R^<#M>
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M]#U:H(([1$1$1$1$1$1$1$1$1$1$7)NW,A#.614#(WH?5WTO*W\G/_*^6_P
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MV7;W/_-G+_[*]4WQY.^?A>YYG]1D[ G#F"Q-GC2_/)3B,LWKLE?U]3VA;_\
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MZE:6>:0,C8TESC[ !<C6MBJ9_&LR%0.$+WN#"[W('W"[%J=L$$LA_58PN/\
MN7G['':M_P /D<YC\_:H$3O91K1/+6$,^TBM_5'YV+ 4!GI6FZ&#UB#]U)@X
M$(98QY?4/I]_FHUF-KQ>+O8NE++W/>G].)H(_P#<JM>5LEGZMW6QB\S+7CGM
MACV,]G*[FS,\_ O'DOU$1$1$1$1$1$1$1$1$1$1%Y _DY_Y7RW^ %Z_1$1$1
M$1$1$1$1$1%2._<DYG6MLQ6.BQS9:L[>^V_.211ZSR=O6OY;'C8\'%!2M2_K
MM/98%(MXY+RVN;+B:<..;/2ML[9(P]OE7W1Y#V3'8#8;^R8@5)*T[&5HN^O4
M+^_H46R?*6SX>&GD;,F,GAED:V2G"XE\8=^_I3S;N0I*D>NU\4(_7S'1@EF^
M44;/R5M8#8=KBV6QBLW6@\!5=/#9@^;"UJC<^_Y_,2Y6SK[Z#:5$EO=A_3YW
M!;.O<ISYG1<IEZ]$/OT0/6K]] J(X[E?>,QCZ%K%Z^V5AF$5B3V8'N4FQF];
M?6Y @US,5*C6O87MEC/8<%++NS9C^?F/PE.*-\'PYFMO/O&%QLQO>1M;1/@<
M$:@DJQN=:FL/\0"/[C4X^Y%L9S*9/!Y2&*+)5'N^41[8]K%U^4\AL./U"_;P
M[XF.C'<SWGYB/[^*A?$QV%^D@V_A_@C5D]$M/<A/7NY0?C7:MFIZ/)2P&$-J
M6"Q+)/-(>F-!]@U73Q]R#_.+5K62O0"L^J\ML*'Y+DW9'8Z;/8S&T78B$D@2
MS]3S,_(:&E6GIVU5MHP%7)UFEHE'3V?LO'N%Q.1MOOZIAXKU?&BT'3MC?V[Q
M#.UJ;CO5_ ZE3S,&.]?U0SS'?38O-0K)<K[)7IT<I#K<IQ/<?K6I/I\O+]@)
MS)L.<.J4;>+?$,9>+!(\NZE/G\P%('[1LVO<?#*S8>M(8(H0R..<D>D0>WO)
M:N1B>5LWE,EK44& D^$O- EL?;S^X8I!@N1+U_>\EK<V($!K12/$OJ=N=X$!
M<C^EV\S8LM@G:W:?9@)$#(CY&0C]I=32N1<GF-AR."RV(^ NP,,@C#R_Z4N[
M[GK6>R]#7\-#<9C>VV#+,8B9/PP .72Q^[V[6D7<W9PLD=F!\C):8/9[8OO1
MMVJ9C2SG+%:*A!"][2P.[:QC%$;G*NP,H39FKJ_J85K_ *;+IBV1S/V_#I7!
M@<U7S6'HY&N"([$+9&!PZ(\ORJTW_D7-:CE*<0P3)Z5@M:VR92WIWX(Z4IW3
M:[&OXFI:J5&6II[4<,<)?X^7FN1M_(%K!6L1BX,;\5E;H^B /+6#^+EIZSR/
MD;VV6M:R^(92MQQ%X\)3(UZA&Z_]L^FJRK.[Y"GR#6UM^.C]&:(R1V?4/?\
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M34Y7F61Q=X2@MZ4 D9LMCD[;:F%>R!\PZDM.]X@NQQQF]LH;KE=5SF1DMF.
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M8SL1FFYY_ #"I_M-B";A[(&.5C__ -61^Q4DXS,#M#UPQ]?*C%WU^>E7N/\
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M-I,92>SP,(^0(6GA]&UG#4K-:EC(HXYQU*.AV]<["<;ZK@\@;N/I>C*8'PD
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M9SC,97J^K^OZ3 WM?=76<#4OR7Z^,K1VG_KS-C >5L# XEEMUL48!.Y_F9/
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MIZ(:X'I9T1$1?,TT43"Z1[6M'W)Z"5K,$\398I&O:[]4M/87TL3K4#9/!TK
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MRT<KEJ.)I36[<[8HHP27.*Y>I[-5V/#U\A TLCF[(:[]9=^2Y '!AE8T_@D
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MD0^J=ZU=_P 'NE_>,#DL?C6/@QCB6/+OU_-2+DG1K>VX2I/6+(,K6=YP'O\
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MSEP%#$'*RPQUW,=YEGFYQ8M?8^.CG=6Q^#FS$K!5\#ZWI=EY8MO-Z&<QJ-;
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M<.S9.[JC,CD,A=GFLGVG>7CZ?NQ1%\LN/Y\D;7):RW2'J+T./9'>Q7G/ ?\
M;WG_ /9)O_N%<^WU\E/KN19C[;ZUD0ET<K/<$+S[H6/W_:M8IW6[1-$R"^>F
M$DNE_)>5*=@IY')[%L+]@REC'XFJ RDV*8M$K_L_H+:XLS.7RVCYJ*SE)I'U
MGNCAL_W^@"J^X[H;?N&OY06=FM0UF3'V<2^5Y_*G?#N?S<^N[#CK4[[%G&R^
M,;G'M0'7;C]BH7IG[7?K;69CU"92QA:#^H K!Y;QUE_&XFMV;(GA;$)&"0^#
MW$'LO"W-3$.J\909X3VY@W%QRF%\I=&"1[,"K:QG\YE,!!F*.3SIS+W";T&-
MZK!I]VM'E^HIAM6S;=;XJAS'E-C+[+#!,UOTEX632,3R=<R."S>0S?\ T&2
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MHO:/U 3\FA?''8W#&[OL,V1P4D?QY,\I'S:Q27B^++0[%ND]_%6:PNW1,PN
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MR,7-<DT-]N/PY>?U&AGG)$MFE!SQZ7G')AH/,ESF%I!7Q:GY_@[^K&2_4!]
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M9:<&Q3@],)7:VS9YL#'0+*+K#K-EL#6M/1\G+AY?=,=1W+"X2QBW.N6!]$Y
MZ9W^"J]Y'V?;*>_Z[CX:#G518]2"(/Z^)<%FY0R4OIZC=R-?X4MO>4C">_%=
M6?F1M;-U(;&$LPXVS(6Q7)/D2K)VC;:&O5H7S"26:=_A7@C';Y'*$GDZWBK]
M:OLN"FQT=E_4$P=YM_@]27:]VCURUBFS5_.&[*&-D#O8IN^Z?S5AI6):+YH)
MIA$7M/7@YRK#F?:-HJ/H8RC3(J6WL/KM/SD/["O'7[^6M43)D,?\'-WT8_+R
M4<VW>*^"LU,=7JR6\E;[^'K,_P#EQ7#USD2_<V1VO9K#&A?+/.(,?ZC'C^)
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M> ^DKSW/G<E-PCC18GDD#\LV"0G_ /0M[^A7YDM+U79-5QM;TO0JPB.:N6
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M-:;EZALB6M6$$0/1,OBHKN>.S3,OI=W,6J\<ILED-& ?1#'_ !4FYZ_L-?\
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M $,G>020L.[\=[%>V'%;'KYJULFP=VO-Y#2Y6[KQSIQ4(S3:XN_/U/0/;/\
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MVZ[>MD<!Z"&_-ETG_%6A/_)]U$Q1"&U<8\/[>[\A;HX#T0/>2+I'V;ZJPUN
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M"\=GV^87Z^:-A <X#M"]K022 %\0VJ\I/IRL=U[^)!7VOF:Q#"WN21K!^7$
M)#8AE;Y,D:X?EI["^'6H YS3*P%H[(['R"RQ2,D8'L>'-/L0>P4?(QC27.
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M5H[(53\'P99^GBR<D/A#-/W6](=E_P"2]0_2<INLDFP8S6HH(WMOR336IO8
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MO!*8_P _6Y?&FYC-8#>+FE92[):K&(OJ3O/UAJ@U_4<:.:(L6+%ST7P"4O\
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MXC(ZYA<7"\FU6I!LK.OU/3 "[O*DD;= V ./1?!XM4#TV>$\,RD/_LJCV/\
MW%.%;E9O&5^$R@20OF,C?QY**<2YN7%Z!M#ZC/5NP/\ 59 H?<SFN9;1K\\U
M:6]LED=SSN9YNB'[BO1?%F3IY70\5%&U_4%5E>4/'79 5.U=4RN.Y#N:I4/6
M'MS-NR-^WHQKU>T=!4ASJ9SK= ,K/>QF1BDDD [# U-\W37\OI=K'XNXRW;R
M$8B@AC^;E"]NU',:[J>FY2K'W9PC09V-)]W^ZE5'FBIFH(*F-Q%QV6F(#8BS
M^K:?XJ^&^7A]1[/2\T\@9&AC>6]6MWG%L,;.R]=ODK)5ML.$P&&E9:FDNLL2
M.C/8C9&H_N6PP_TDC'[-\0W!PP$Q0M';)G?EP6AHVQ8IG*F1-+'2PT[D)97;
MZ7@0K+YEUM^4UKX^L2+F.>)HU]<6#*6-=O[!D(W_ !^2?ZOU?=C ?!5'C-NP
ME_(9FYN%2>;+Q%\52IZ7FV(?A@7=X5R9_FEG\5# 1='F]G;>@M_B#;]?P.FO
MQ^4O,K6XK4KGPR @KM\;XP_%;;M-B)\,>0GD?6#_ ']$]GM0[B<5\H-]H,GZ
M?<D[A_>WZEIZ/R1-I%>;6]@QUGNH]PB?$WM>A=-S.:R^-DOWJIK,FD[K0G]<
M1?8N6+?[L-/4LQ-*'%OPY: T=DDJGL'<IG@NTR9KR&5W1/8 0[S4@X]R52MQ
M2U\\CXA!!(R3Y$.#E]\!3L.CNK_4)(KCR\$?MJ6<K2QLT'/!Q^J2'P8/R2N'
MPU9@LZ)4K,?_ %L +)F$=%A*K/'[)D.,MLS5#*5)Y\==G,T4L:M3&[EE,Q4R
M^:JTIH\;!!_T9DP\7SO^Y(5'[2=#S^&BRV+C?4V.65COA8P0[U"I=R/9R.-P
M>BSY7RDM0RQFS]R7@*0[UN.)VG6WX; 2_&7+\K(_2#3W&W[ERB^Y8#9-/EU7
M.X^ 68L3297G8%*L'R;E]OM8^EB<5-6!D#KEB0=MC8/LU0C8+F7XZY)R.8%*
M2QCLD7O/\7%6EI>VY[;<J^W^CWU,0RN0/4'U32N5?:CL<.L;YN.+?C+3WW<E
MW6$3/I !*]-2-$C'-/L00O.V&SG]'FTYS%Y:*48V[.;%:V&+?UWRV[D:;:((
MGLQE.OZ,$KV=&5ZB62SV/'-\61:975&1"!TP8>@X+U-!-%+ R2-WDU[>P?W%
M4#R[+8Q6SZ9GOA9)JU*:3U? =GZE%.6]B9F\=KEB.E:B#[;I6,>SZ_2:1TXJ
M6\VW8[ND8OX:.63U;,,PZ9[, *X>\XO-V]<T_:,,R3U<9 "Z(CIX#EU<)RCL
M^V?#8S'862K;DZ,]DD^$+/R%Z%'8;\SVO-/(V2=%RKJ;V06913<3( "6CS4K
MW;<,35V&S@]BQ;I\1+#&Z.7TO,"11/CFA9QMO;KVOU;/Z,+.Z;91UYN"B>SY
M+5MOP3)G8FU6V<%HZCAZ$DJE7)&$SYX[U>U/%+-:H>@;3/=ZX._[GF=NUW&B
MEKEL4X[4+YYG#_\ ;-_N!2?D+#['-'KNX86G+#:IP_UU8_KM6WKO(&Y;I9I4
MJN'?CXF2A]RWY$]-'NT+T+]BO.5BME]'Y'R.7^ FM8K*%[Y'0CR?&25U\?6=
MN>_U=@95GCQN-@Z@?*SHS2.4<Q4]ZOS3DLB<5<^%L>I7$GA]RY>F50O+>MYV
MKF,1MF(C$\F._M85 -TVS;MVQN/K5M6L10QVHI9O\3[!3+DC ;.\8#;<76<S
M(TV#UZP/EUVMW6]DY"VR_0AGQ!QE*!X=<F#B'2_N:N?N]3)NY:UJ]'B[3Z]9
MW3Y&,[!6UR_2SEK8M7FQV&FM1UI27R!JN//8F#/8"_0G\V,LPEI ]U37#&D7
ML1-DKF49+Z\#S5J^?L(_[ZW>6=)SUVYC=AP!><A1]HA[N":[<Y/V*]!6S>/_
M $;1C<'SO;\GRD>S0N;%2VJ#F6UF!A+3Z$H-8S'V#/RO0SVM<PM=]_DO-&)T
M&$\N9)]29QQM*1EF1ON/7?[,7IA$1$1$1$1$1$1$1$1$1$15GM.LWLAEG3Q2
MUVM,;!T]_1^2HS^3G_E?+?X 7K]$1$1$1$1$1$1$1$7'S.MX/,^D,GC:]KT^
MRP2L#_'M="EBZ&.H-J5JL<,('38F- : HA:XWTFS999DP%/U0_S+A&!Y']ZD
M^0P.(NXYN/MTH)JP((@>P%@Z3#X'$8:!\6/HPU8W.\BR)H:"5T" 1T5#CQ_J
M)R1R(PU863*)/4#!WY+?K:=K=:A>J,Q=<5[<GG-%X#Q>5M0ZU@:V)EQ<6,KL
MJ2=^5<, C/?Y"X]RIB]-UW*7<1AHF"-GJ&"%@9ZC@JXU?-YGD'*8NY<Q3J>.
MH@S.8YQ(DG_N$*]T<T.!!]BH!<XMT:W:GL28.OYRCZOI"DV#UK$8+'FECZC(
M8222P#W_ (J'S\2:+-DGW78B/S)[+/:-6-!2K5JK*\<361-8&LC:.FM:/L H
M)+QAI4F3-]V&@,Q?Y^PZ[4VR>)Q^0H24[E>.:&3Y/C>.VE0:'BW2(:DU9F%@
M\)""[Y#M=3(:)JN0QT%"?$5S7A_LF!@ 9_!9[^D:U=PM;$SXZ,U8>O3BZ #.
MELQZCK\. &&..A-+[0%H+5FQNNX?&XZ2A3HQ0UG_ *T36@-*B%'BC2J&3AR%
M;%M9-&_S9^ 5W-BTG7-ALUY\E0;,^'L1DK]SNEZ]G:].&_09)'6'40]@U9LG
MI^"R. @PMNH'U8@P,83\V^ Z"TOY@:N-=DP8QT;:4A[+![^7[:Y0XLTUN%CQ
M(QP^';,V7O\ ON<SV+BMK*\:ZCE9XIK6+83%$V.,#Y!C6>P"Z&<RU#3M:=:=
M#,^"JQK&L9]3E7FM9=V^[-C\RVE+#0QM=P:9!T38D5W+G9W!X[-8^6A?A$L+
MW O8H=C.+]3QU^&Y%5DDDA/<(E?YMA_<P+9V[CK6-LG@FR5>0OB!#7L=X.6C
M?XITZ_7Q,$]$N90B$</S]V_AZVX^,M+BOT[D>&@9)6;U& T!JZ$&D:]7S\F<
MCICXY[W.,WW)<L=[0=:NYS],S4N[@>'B7OY@A,YH6M9G*C)7:0DL,Z\9._;Q
M5'[XW 93EC%X_)AQKLK^G*[\/<KEUKCK7<!=FO5HI);3_EZ\SO-X'X!*G:A^
MWZ'K^T,'QU<&5C2(IQ^NQ8-1T/$:T'S1>4]R5H$UJ3YO<OV[QWJMS,NRTV/#
MK9D\_44V4>V74L'L44462JB=D9[;VN-K''>LZW8DLTJO<[O::3ZGL;^RTK?&
MD:T-@DSGZ.C-YSR_U2 2"5\3:)K$N>_33\;&;OGY>J?S^5GOZ7K%[+NR=G%5
MYK7R_K7M!((3,:7K68R4-^_C(9YHF]-=( 5ERFHZYE_1-_%5YS$SQC,C XL'
M[EN9'6\'D:4%2]CX)X8NO"*1@<UO2U+6I:_9PPP[\;!\$/: - :U<P\=Z::]
M:#]!4Q'"\/8T1CW6]D-+U;)6!8NX6G/*&AH>^,$@-]@I+#%%!$R.)@:QH :T
M>P 6.Y3K6ZLM:S"V2.1O3V.'8(_!"X-#3=;QV/M4ZF*K0P60!,QK !)U^5SX
M>.]1@Q4F-9AZX@D(+V> [)"W)M*U6=E-DN$IO;5;XP Q ^F/PU;.7U77,Q+'
M)D<56M.C!#'2L#B 5O0X/%U<8,=%2A95\>A &@,Z_'2XF&T;5L+<?;Q^(K03
MN)/J-8 0#]@OO.:1JN=GEGR&'K3RO:&^JY@+^@NE@\!BL%2;4QU2."$?/Q8.
MNS^2NLYH<TM([!'1"B=70]3IR7)8,-58;/8D(C'U K>Q6I:YB!,ZAB:M;U6^
M+_2C#?(+%C-/UG$V'6*&&J5YG,+"^.,-):5BKZ5JU:S8L0X:HR2<$2N$8^KM
M=3'Z_A\72DJ4Z$%>!Y)=%&P-:>_R$Q6!P^';,W'T(*S97>3Q$P-\C^3TNC=Q
MU2Y"(K,,<K?+OIX['86LS#XR&K+6;4A$<GZT8: T_P 0E?"XVM%-'%3A8V4
M/:UH /\ %8ZN%QE,O->G#'Y-\7># .PM6AJ^"H1V&5,96A9/WZH8P /_ (J#
M;_G<MI^$I?H'#LE9ZHC\6CIK MW0L=EIF6<]G(!%DKH:/2]_1B;[-5C+\FAC
MEC>R1H<UPZ+3[$*,XW3-:Q=]UZCBJ]>=S>B^-@:I.YC7-+2.P5H5<)C*<OJU
MZ<,3^NBYC #TM]>7MY?#=Y;U_P!2C-+6@/A.3'VPKT)@]2U["26I<9C8*HF=
MV_TVAO:W[>#Q=RQ'8L4X9)&#ICWL!("^GT:T<SK;:[/7\/'SZ^HC\=J@+&8Y
M!VW,7M>DQ IT#,1-8_$32O0].G#6K101-\(HVAK1^ %SS@<1^DG9$48/BR"#
M/X#SZ/[UNU:%6J'B"%D8>[R=XCKLK2LZ[A[5CXB>A7DE#O+S<P%W:ZAB86%A
M ((ZZ6A3Q&-I/<^M4AB)'1+&AI*^K>&QMJ5LMBI%(]OLY[02%N@=!'L:]I:X
M @^X*^&TJT<'H-B8&= >('T@!?7HQAO7B.OPE>K!79XQQM8W\ =!?KXV/'3F
M@A8H*=> O,43&>1!=T.N^DMT*EQH;/ R1@((#QW\Q]UE# &]+F#"XIN1.0;2
MA%HM\?7\1Y]?CM4GS!)EY,QK4-'$SV1#8]5Y:KMQU"C ))X*3:[YSZDH#0UQ
M<?VETG,:]I:1V"%AK5*]6)L4$38V-]FM'0"^[%6">%T<S&O:[W:X=@K[CB9&
MQK&@!H'0 ]@%C^%@$YF\&^9'7GU]72R+!?QU:Y5EKV8VOBE;XN81V"%]5*E>
MK7B@AC;'%&T-8QHZ#0/L%D])GX"_0DD3)&EKP"#[@K\])O0'0Z"_2P$=)XCK
MI&QM'V1"P$]K%8J5[(;ZT3'AK@YOD.^B/N%EZ""-O:$ CI/3'72=(&-'L$0A
M $Z1".T#0$Z3I$1$1%6G(^O[IEH:(UW,&F]CSZH\S'Y _O"[6CZG_-O%R,FL
MNGMV9/5N6'>\LBF*(B(B(B(B(B(B(B(B(B(BI'>B1GG_ .#&JN_DY_Y7RW^
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MO52X+6\1F>5-O&3C^-9%*XMCF';/=;>H48\'S-GL54K,@JR5'RMB:%Z)G!=
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M^]VMC)ZAD<%Q%/@,=3-NY*P-D;'^V_YN<LVN8W.P<4OQTN'DBO,K&$0'W?\
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M$'>'D._QV$=(QH[<0 OPSQ @%P_<.T?-&SKR<!W^3T@E8YI<' A?K)&/';7
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MGW,?X:H]HMK;,9QW6N>C4GCCQS'U(6DL)'7]]1'#\L;[F<3#/CL&)RRWU9E
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M$Y#)!K:U0^_F577)E'D.GJPFR.6@MP3SQ?%PMB\1"[[>!7HC5AW@\;_LL?\
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M&NN&X2P =O#%EY?EBCOZH7O ZR*O-I!'80J@,KEK67Y.M8>O9@QC:]8BQ=:
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ML[NBTKSO@[6(UWD;>+,SF5ZS!YN_B2K<UC=]=V8S#&7/4,/7FPCIP3/[SK>
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M-:/<L6YRY)&,KJ+"X>1R'8"O-OW_ (HB(B(B(B(B(B(B(B(B(B*D-Z_R^_\
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M,%WS;TR%@]UJ<KT)*E75<3CL=+8%$M)\8@6>#%W>99;62U'$1TZ%M\LUJ*P
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MB(B(B(B(B(B(B(6@ITA:"G2=)TB(6@H@'2%H*=)TA8"G2=(!TB=+\;#&USG
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M#&JV_DX"+X[-=M^OP8O7"(B(B(B(B(B(B(B(N9F\YC,'1EN7[#886>[C]S^
MJ^'+VM-$4EJMD:L$@)9/-"!&59F*RM3)8RI=J.+HK$;9&.(Z[:Y;"+%;LLK5
MY9G]^,;"X_P"B^B[M2VO%SW:T3XPR<Q^+U+41$1<C&Y[&9.UD*].PV1].;TI
MQ^R]==%S<SEZ>'Q\URT7^C'\WE@\BH!!S'HTQ'A?FZ[Z+O2^D*>8/8<)FXGS
MXZ_%9C:[Q+F+JHBX&Q;/C\#!$^P)9'RO\(H8@'22']P7#U7D3 [-=LTZ@LQ6
M(1V^&=@8[I3M$1$7)V#/XW 8R6_?E,<$?NX#OLE-<V#'Y[$ULE3#S%.WR9YC
MHA=9:>2RE'%U7V;EED,+/UI'GH*#1\K:(^61C\QZ0;[/>PAC_P""L''Y"E<I
M06ZLHEBF8'QO'LYI]B%D1$49VK;\/J]%MO(OD#'/#&-8WMSBI)1O17:<-B,$
M,E8'CL=?)R^D1$1%#X-ZP4VV2ZVU\IN1,<YW;>F?2>B%,$1TC&M>>_U1V5"]
M:Y!P.?RU^A1]=TE7^T<Y@#5-$1$)Z"@&:Y)US%V_@P^>Y9!Z=!58)'-6K0Y7
MU&U,RN^Q/6LN>&"":,-?VK)1$1$1$1?DUMC*[Y6_-K6EWR_ 4+TC=Z>VT[D]
M>O-#Z$P8YL@4U1$1$5<5]_D=R'/J\E Q!D#I&SN=\W]$ =!6.B./0)5>Z_O5
MC)[9F\(_'& 4O9[G?4]8/Z0#_2 -6&-D!$1>Z9Q5DA$1$7RV>)\SHA(WR: 7
M-^X[7TM>]/)7J6)HXC(Z-A<&#Y%Q'V4)X[WB?;,;>LRT!4=#9]+P\O(J?(B(
MB(B(N#M>5MXG7<GD:M?UI:\/FR/]HK3T+9+N?UNKDKE%U6:7_P#9'_[!2I$6
M*Y-)'7F?$P.<UA+6D]=D* \<;ADMFI9.:Y5CKR0V_2]-A\E8:2/9&QSG$  =
MDE8Z=VK;JQ6*\HDCD:',>/8@K(B*([SE\UB->FNXBE\599*T>E^&'W*[.!O7
M;V&Q]FY7]">6!CY(OV'.'9"ZJ(B(B(G:(B*J.6-KV#6,14NXL0 /LMBD>_YD
M%RLG"WIK>*I6)W=OD@8]W\2%O=A4YLNZ[!CN2L!@X'1"A<(\^V_65(MUN[Q5
MR.&;KM6*:!\I%MSOL%8(/Y3M.T["=A$3M.PG:=IV%6O*N8S6%U6?(XN\('Q2
M-!^CLD.4HU')3Y+6,->GE+Y9ZD;WN(Z[)"D2(B(B(B(B(B(B(B(B(B(BI#>O
M\OO_ ,&-5Y_)O+!/G1]/D1$O62(B(B(B(B(B(B(B(J$YSHY<T\1D:T#IZU*Q
MYSP==@_AQ73PN_Z=O^(GQ-LB">9G@^K+_P#+%.ZOZ/TW4JL=JWW7H5F1F8CH
MN\0J_EY<LTI*EK(X&:OB[3@(K7F"_P"K]MJ[6[\H4=7&+<*<MF.V06S-^4?@
ML.*Y1K9:YE:T>%O^%>!\K26?.1@6_P ;;-@\S@;EK'XUE&&*<AT8  7#N<L.
M\+5W'86:SC*KRV>T7!OM]V!3!F_X!^H/V5CY#4Z^3>AY^7[*B]3DS(_%8B._
MKMFK%D)0R"8N[;T5;R*+[OL P>O7;H';PWPA9^9'KS?I\N7T3?ZU;,S>0S,
M?,_\3.7KA%HY5K7XZZUS008'_P#PJ!X%EI#4LPR=\88;7U-<5&^*[(AY&VM^
M.8\XD"=_3!\OD[Z%8#N==;^#OS,J72^&8,9"6?6Y2^QR/C(Z&(?#6LSVLC )
M:].)H,I!'?;EBUCD;'YG(V,1:K3T<G%[U9E5>S;%F!RQB7QX6W(:T$C8(3T#
M("1V]JLW(;!@L(:64GPSFYK(Q!H@C8#8<?<M)37N3:5_,OPF0I6,=DNNVP3
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M#S51I[JO=VP_[U77'N2Y L[7M!E92G>R]%%>+I2/ ,\AU%]*]*+YN=>A(/\
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MF3%=.3BJZ)]TW9V2 _21M= N]PP$]@+6O2@?R@8? @]TFA>C6^P7Y<_L)/\
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MZMD8RZW6#8H_[_944EJRS?R>XA'TXL8V4K<O[3@V<(04C?B,\F,CB;$/F[S
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M!G1[,@"D_#%B.31L?$.P^#MDC2.B"K71$1$1$1$1$1$1$1$1$1%2&]?Y??\
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MZDD8<[H*0P0Q01,CB8&L: &@?( !?JQWJ%2U7=#8B9*QWZS'CL%19F@Z<QK
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M?9_+/?M75B3WP_2_]%9_]4XO_P"S&C_LCU&_Y/7^;.3_ -M"O^Y_82?ZI_\
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MU_)PJ3.M9NR"/!C(V%>M$1$1$1$1$1$1$1$15GROI+MHP!%1H-ZL\25G'_\
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M9V )%'-MR-2KRS9GV?'6;N/9 13A$?JCLD=$ KJ:;G[$7*.8^*P]FL+L/<;
MWOTV#V+UM\8['5_GYN$'3Q'DKIFKR.:0'^)*^.4J><U[=,=N6/J&Q"V+PG;^
M %+=9Y,N[9D*-?$XJ>.!I\KL\H^E@_8:HQL^2T78;F<Q^TPBE=HV9(ZMCKHO
MC'MT5*>$SE1J\S;C[#X18ZJ.F]S$K+V.D^]A<C68?JDKN:%YOXTW6GA-0M:[
M+1O29-LLP$$<0/NL'%]QD'&NWQ3Q2,/Y+5-.&[<%?B^^V9_@87S&0$>P<N5P
M3<KU]4SC9GEA9/YN!"^^*+E+,8G<,2Q[VRV9WO9V.NV.[4;T?D271(;6M9^A
M9)J2O$4D0\U:\^Y96#3[&?R6- @EG8(ZON\0.!]U46:I:W8V7"Y;1;7A>FL-
M$M&-I9TT^Y<K*WC+Z9D,S>P&U0"-C(6/JV^O8O\ <!RY/"%;(59-@A@GDFPS
M+ %.63L>77W:%<^U84YK7LIC_M/ 6JCN-]VJ:MA9<!L@=2MTG'P\F_)[%T],
MC;.W<]PNM,$5U[_ANV]=Q?DA:'\GVW#'B<G0D\V3_$"0,<".V+T2O.7*S7X3
M>-3V1\,LE2!Y$Q8W]50_?MM9LFW:K;HT+1JUYGM8\LZ?*>QWT%(=\RE;^E_6
M;?4GI5R!.? _02L_--V [KJ3F^;Q5<YTW32? .(7WRK99C=\T_96Q33UAV7B
M-BR<P;#%E-*Q#XZMF*6S=CGAB>SZ_38I!O>;@N<2OE>7/ENUHA&/ EQ>0IAQ
M?:98T7 =,>TQ5&1.#AT>V!;7(U*>]I&>K0,+Y7U2&M5.ZIN$MSCB?&R8RRSX
M'&&*28L^1(Z# U=[BS(_#\7VA-6LA]5KP8^NW$/]O%1/CW#2[#Q?FM<EAE@G
M9.Y\1>.NR5H:MR7MFM4CK=W 33VZH]&N1V%Z2U-N<9@ZOZ8E+[CQYS?AI=_=
M"A'-O^8&2_Q(U!,'R37@T"CBJE"X_*MHLABA]+Z7]CH/[2UQ?D1Q11I,!_2E
M67XP,_\ .?=B^-?Y2W?*5&8:+ /.6!$;IW]MC;^7N6;E>UDJEG4HGU9[9JR"
M6S.T*W]BS=^+4Y,OB*SIG^+)&1.;]3F.5![/1PNRYC%6M:QMNKG/BF/G'AZ3
M6,^Y>0I=N&-O:IO-;<Z]=\U29AAOLC_7'?S\@%KYW(P\D9W"8_%03OH5)A/<
ML2,\&C\ +[V2Q(SES#VQCK+ZU6,Q22AGTM+ECY-GNC?=2LU:-B48YSGS/#.V
M=2)M,3\;S'KF9Z[JWXQ"'GY!I"M+><YDL'C*UJE1=;[MLCFA:.R8B#VJ0BPF
M+SV^8B]JF+MX]L#R_(2EGI-9^X *S>8\CZ&G3T6'N>_,RNQ@'9(<ISJ>*?B-
M<Q./>>W5JL<;OXM"@W,QMR:=-6JTYIY9;,?08%V=8?\ SATB""Q4FK.=6]"6
M.0=$. 5#:_>Y'X]NVL(S#2Y&H7D5_P ?N<TJS\EIVP;%H=Z++2@96U(+(9[L
MB>WV8%6T&U<EG2;>*DUEY%:L8I+LCO9K5.]0P\V;X8;C8CT^>FYK5$<1D.2I
M-*EUROJY#ZU<P.L2O^S?LT+KX'1MARW%4V!RE,UK<$OJ4R]<'![#RW4A@UI^
M%=ZW0B9;D_N,5FYFWMFM2:U%6I6<I1BIOCR);\W$CKIZB^J:\,ER&_9,;B+&
M.QS8'!WJM##-(?PT+4Q8WK7=_P!EBI8$V:V3N^KZY/3&-[/3UV,[5V0\LXS(
M0X*S+1K,]%]@>Q\O=R;%6S[>5<7DH,%;FHU8_1DG '7U?<)R'4V";?=5OT,'
M:M5\87.EE8!T?-<'EJ2[D=JP\$.).4AK5W3R4VGP>WOKYO6MKVZ6M:N,?9T.
M3'P6W-]:T9?-R]0@]A4+ROB-CCV?5L]B,4^Z:)>7L"X.^4=TS>6T_(.UR<S5
M?*2PR+ZF,\R.F]KO<SX?.YB#!C&8JQ9<R?U7A@'TK6Y%U'8\O#@MIPT,L64J
M1@OJ_P!];6L7^2]ILUV9>G^C:$,@?,]OTR3EO]P*^5YZY7Q.QY';M:GH82S9
MAHDNDD9[?60ICLN3W'&Y^&Y3Q,U[%R52R:LP_4U_Y49TG5L@-CS.RQ8@XF":
MHZ*"C]W./]]1W+3[KL6J_H;+Z=.Z^]@9#;_!'N\J2[3QODY^.L+C:CA-DL:8
MG#L_(^ ^8:H1M;.4]QUYM:?7Q *T\1,?O)(]H/U+M[WJNZR8_1K5;'BW/CX@
M+,#?8R+7V#!\FY38]<S[Z$(EAG<&5 XN97;^7%=[-XS<7<E8;+QX?U:U>/TG
MR-=[]^Y6;D+$[7;WK6+^.Q!F@QQ+O4[]R]:W(FE[.=BJ[;K'8NB/J>%=?2JV
MZ[%<9E=HA%6* $5JK?I)+O=SU K>L<AZ/M62GU:H;6/MR=F-73I.(ST<4N3V
M&9LF2L] L8/HA8/[K5.K,'K5Y8_VV%I_WA>>N/M=WS5LQD,5'4B_1/Q)E]=_
MN]H[Z#5V./<1MN/VG9;F0QK8*V3E=/T'>73P?D%AUS#[8.2,YDKN*$6.NM>P
MGOM1JUIG(FG9^_+I_IOQ]M_8A?\ ,,5BT->VVMJN<M69&6,]D6@OZ<6,9U[-
M85H<.X3:,!A+6*R])D439?.%P/9/FHIM.@;GA=SGS^GE@%EQ,L*FNH:SLMQ]
M_);;)&^S8@,#(&#Z8XRH;AJ._P"@7K6*QF&.4Q,LQ? 0[HQJP=*UC*8\YK-Y
M)C'93(R>HZ('L1#[,#E!=8Q7(-/?\EF+F*B^%OR.$@$A^@+T,JBV)G(F/VZW
M=Q5&*]C):S&&M+*6?4/N/D5R]1TW8:8VG,3TJM6[?817IL=]# ?LXIQ9JFWZ
MS@\M2N4ZO<A+XB)3\WJ.Z;H&Z0TMNIY*&O!%E6'ZV2$O$@6IB]&Y.GU"UK=J
M6G5ILC<&$=E\OX:I3@M8WS'\:7L5,:TELQB*K#^PP_DKMZ!A-IQ&CVL7>J0_
M$PAS*W3ST\']I:W$NG[-J=2_2R;*ABED$C'Q2%Q[5MWV6C2G^'C:Z3TSX!Q\
M03^\JE^,M.W+6<AFI,BRB8KW];W%*21*%K:GI6Z4=LS>4R,6/$&3;+ZHBE)+
M"]</7>.>0Z5+)X#]+05\-*^3I[03,Y61Q=JN?UG!&CE;L<W3AZ4;/F(PM'(\
M:_$<F4]E#F-ACC+I&CW,P4\V[6:^Q:[<Q<[BSUQ\G?LN"H36N-.3,>P8F;.Q
M0XASSZ@BD<7^*]'XW'U<;1K4ZL?A#!&(XV_AK537/C7/TVJQIZ)R<"UI-6Y%
MRN)JZ[=NTFXQT3!/:B[,A8W^[TM_=^+[.2QN ;A+8@L8AGA6#_DTA<#.\5;?
MF[F&RES8&OOPR#UCUTR)OYC4JWG0MCSEK"_#Y=@%#IQ>\?5))^T5T-\T!VV8
MRG(^T8LK4'<,[?;M0'*<4[QL&-J-S.TF26%[2(0"6*_\32?1QU2K).Z9T,36
M&5WN\M'N5%^0=/\ YV:Z^@)S#()FRQ/_  YBX]3CR6SJ=G#YW+V+[Y@SZW>T
M18"!X*/P:-O;L5%@;6Q0.Q8:(GEL74QB"MW#XBAAL?7H4HA'!"P-8U=%$1$1
M$1$1$1$1$1$1$1$5(;U_E]_^#&H5_)K#_AMB_'J0+U(B(B(B(B(B(B(B(B(O
MPL:3WTG220L>TM< 0?<%?K6AHZ">([[3Q'?:$=H A:#[H&@#H(&@>R%@*!H
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M;S:'+/!7B@B9'&P,8T=-:!T %]+0N87&VWMDLTX97@= O8'%;S8HV1AC6@-
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M9X,C:.@ HABM*IX;:LCEJ8CBAM0 /B:.NGCW*Y=WDH/R-NEA,1:R9J=BS)$
M&,*D>M[IBM@QL]NJ9 ^#L3P.'4L9'V(5?GG/63!??'6N.?!*&B+P^HA;=_FG
M6J5O&0/AM-%F(2E[V=!C')@>:==RF8&.E@M5'2OZKOF9T'J:[1NV(UU]:&P)
MI;-CL05X6A\CUQ,%R30O988?(4K..R!^;8IV@!W\"LFR\E8/7L_5PUP3-FE
M<9.OH8PK#@^5M=R6/S5W^N@BH/ZD=(WKMI7*K<PXD6Z<5_&7Z<5T@TII&#QD
M8?N5I\H;]EL#=QN/J4+'4\[";+?N/NQBE&S[+@&ZI8M9[&6V5)'^#ZTL0+S_
M +NUVL'D]>I:E2R%-HJXX56R1AP#?",A1!_+%&LYEB]B,C6QTK@(+CXQX.4E
MV+?,)@<+#EIG2S5INO3= T/[[41GYJU>&M6L>A=DB>QAED9&"V(O^SE;>+RE
M/(8^M<J2"2*>,/8_\ARSJI>7MOR^M8)AH5)2^=X9\0/:)<?8\G+F>),L^YC[
M<4L5")WE8:/K?^TTK4U[E/5]=T_6JUI]B604(1)Z,?F&*Z&;!BCA&Y<66BHZ
M$2^L?;P*@']+NM-=5?-!?AK6)"R*U)$!"XA6I!+'-&V2-P<UP[:1[$%%%MHW
M'$:U'7-UTCY9W^$,$0#I'_P"T,!R!A,SF;6($=JK=@!+X+# QQ _'1*Y<_+6
MH5LU<Q4\\T4U=KB][F=,);]@M7'<R:9=-L.L3UC SS(G9X%X_+5EP'+NK9S-
M0XJ!MR.>7]0RQ!@<I7L6W8G "!MITCYICU#7B;YRR?P"Y>%Y"PF3S$N)?%:I
MW6#OT++ QS_]7HE93ON(9N'\V7PVA<\?($L'ID)D=\Q&.V>A@)X;0LV^O1>&
M Q%<W-<GZWA\^[#VWRLF8PO?(6_0 M3 \N:QG,S#BH&78IY>_ S1!@<HSLW(
M65K\AXG#P4+S8(GE\K8Q]=C^ _"O.C:-BK%,8)(G2-#O"0=.9W]B!W\UE43V
M;<L1KOH1V3)+9G/4%:$>4KUQ,)R/2N91F(R-&SC;[P2R*< !_P# JN^>\SD&
M4:&,90L?#.N1OEG]F.(]F!6IC,?BL[4QTUO!35Y*#F^@VRP!S2![MZ)^2FZC
MFV;10UG$29"YY%H<&,8WW>]WLT*)XCD2>UEJ>+O8*Y3L6F%\'G\VN:%N:[OP
MRFT9' S8R:">HUQ)=\VD K'!R%&[=YM8GQ\T4P#G,D]VN;]BOK.[]\)EGXG%
M8V;(7HV><S(_DR,?^8K/JFZTMLH9$,K2P3U3Z=F&0?JN(*I31]VHZOCMAIU:
M,MJW\>]T5:$?(,:3[J]-$W6IMV(-R&%T,D;_  FB=[L<IJHKNN8R&&UR_>H5
M#8GB9VUBJWAW:=COX8R7ZCY8)+$TDETO6_8Y<L21W\AC<'+:Q%-Y;/<\_'_>
MP*67-[!U.IL./Q\MN!\8?(QIZ>P%<VARE0NZ5<V&.#H02EKH"[ZU-]7S=G,8
M:&]+1DJ&8]MCD_6\?L5W%H9K,T,+CI[MN41PQ#MSE5,W)^5JTV96SK%J+%.Z
MZG+OKZ/LXM4JS^_8S&:JW8((Y;=5X'@Z(?+Y_E1'%\Q5<ED\%4@Q<[VWF@/F
M'S9')]VJZ4GF;#$][O9K2X_P"H\\H;%=QE_,X?6X[6+@G,8E=.6RN'[7@&E1
MKFJ\R?#:G>E80))V2N8%),GRQD\==HRR:U/'A[,K(X[DSO!Y\OOX*:;OO$.M
MUZL<,!LW[C_"I /D'G\DKA8K?<U7VNMK6PXN""Q-!Y130RE['N_WAJXF<_[9
MM>_V&3_Y:N1S"P?SOT5WD._6D7HP??\ BB\T\GYB*CR;ITSX'$50]_T#M[_)
M26ARCG8-LH8K/:_\!%>_ZNXO[*D^W;GDZ.:I8##T&39&TPO:Z9Q9$P!:>H;Y
MD\EG<GKV5I009"G%WW%(7LDZ7.P?(V>M;P_5KV)JPRQ>1?,)B?(-/7T M4IG
MVZ__ #ZCUZO1CDB%?UK$_F08A^"WI1W.;]F;65O8W6:M2=U'OXN>>7P8'?L,
M^1[*Z7&_(HVRO<BG@;5O5G]2P!WDK.6IF,M4Q&-M7K+_  @@87R/5$7>3MMA
MQO\ ../$T3AR?HB,_5DL/L\CI3#)<FTF:KCLM1A]::\]L=:!Y\/K=^T5I8S9
MM[K[%0Q>9QU'PN1R&.>O(7M!9]C](59XB3?[/+F1>34=8K1/B?VXF**$N]FJ
MT,[NV?FV=^NZ]CHY+$$1DLSSDLC8L^A;MD=C&<H9&FV"[CY#')X'MCE2VD9S
M8\/=W.OA<')>N/O#O[,C#?)6YQWR1<SUZ_A<Q3^$RE<DF+\@+3UC_M8W'^ 6
MZ=\S Y0&L/HPL@\"1)WVYX3+[KL5K;[6OX*&HU]6$NFDLO\ 'L_AJSPY?.9/
M2MF;FJC:]NKZD1#/FQX_+56&C[?MD6C5HL!A&31T8^YYYG%O^Y@Z*N+6^0JF
M3T1VR68S"R)KO79^'L59VN5MEBQ+,VQF-=7>X/-02$S-B*LG(<E8ROIE;8(8
MGR?$EC*\'LYTC_L56?(=SD0Z/>L9.M1%6R&"6!OSD@[5P<<?YC:U_P"GP_\
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M(=RR/5BZ#N&8@T7/V\Q:]>?&2N9ZCS^MTJW=LNQ9;79<E%>V-F4E>)6" =5
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MT*\<?A"P_E??('',NPVZ.5Q^1?3R-0]12A0P<+Y&_DL=D\OL]F>U$_N1_O\
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M9PZ9$'K0@X/U^&O+4.2OOJ.)(K%W48<NG2XGQ]35;& CREL16'M,TGY:W^X
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M2(1P0L#6,'V 4*VCB_4=GN_&7Z;_ %_O)&[P<Y2/6=5PVM4!4QE80Q_+S/\
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MSVZ/WZ7ER37\K)S98J#/VO)M,SB8_K-82/H"L/:I=QEV#$X>E>DJ8]\!=:O
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M<<99K,;!QQZ\]V0W!ZL;9R>W?0N!QSM>6JZ7LV2S=V:Q+2G/Z[BY-9UR]N&
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M%&N+UR. 32!D8<>BYQ^P721$1"0%R_T_B!?CI&]#Z[B (@[MRZB.<UK2YQZ
M'94;.Z:U_I>K_P 2[E>_4L &&>.0$ CQ<"MA$1<W*YW%8IC'7KD4#7'II>?=
M=($$=A:N5R^/Q51]FY99!"T@.D>>@MF">*:)DL;P]KQVTCV(*_41$1?$MJ")
M\3'RM:7N\6@GYDK[1$1$0D =E<C&;/@LA>M4ZM^*6S!\I8V^[%UT1$1$1$1$
M7+SF;QV#QTU^_-Z<$77DY;.(RM'*48+M.82Q3-#HWC[@K;1$1%"MBW[!8&R:
MLYGFL!GFZ&!@>]K?R5V=8VK"['C_ (W&SF5O?3@1T6'\%=Q13:]TP^KQUGY
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M<A(J8^%Y9#$X?;P5EMR-"[P1)##:C)AQ,3)?W/79XPL0#BZL\R-Z96D#EI\
M68W:.^$3-+FW']L7=YG)&A9$_B:(I!L>''&L-VS+"]IQK08@X.[<1[*B[VOY
M;$<4Z]>DK$FOD#8DB<WV9*K.J[YQE:Q(MU:58W'_ "93]$>L7JZ\<Z9V/K&:
M$12&)OG&/[IZ]EYKQF8CTWEG8!FAZ%;(R2/AG/M\W+[S.X8.;F'!306VR0QQ
M&&24?JASUH93(XW2N4LT_,T'/QV1[>'EH?\ 42K&QVQ8#/Y(T-9H,,3JDILW
M&-]/P_#&D*MN-MWQ^E-OZQL=;X9\4[B)58XV7'9'4MMMTZC*N+CC\(I>O RG
M[NZ3B^_4_HKBE,H#(()62G\$!<S@W)T1Q_;A,P#X+$KI?W!RB6BO9L6L;_A:
MS@7SS%\)'N\.)6UQWRCC<#AA@]AKR5;-'^KC^C]<!=S?9\OM/&XR4.-?$8LD
MVPR$_K^@SOIRTMHY6UC-\;Y&#X@MR$\ C-;KZ@]3GA:S%-H>,#/>+MCU;"(B
M(B(B(B(B(B(B(B(B(J0WK_+[_P#!C4._DU_]2V/_ !8%Z@1$1$1$1$1$1$1$
M1$1$1$1$5.\BU*N2R.-EK;-!CKV.+W,[]_(J)7\IMN;Q\N+R6PX&"M, R>>&
M0ND<S]S2T*7V<3H5_36:R,G5,,,(\)._J#F#H/59:OJF987X9^^0#&/(ZBBE
M+G.8/MT>@%8N_P"A8;/XB@S%W:U6[0 ;4?Y@ ,_97%UK5=LGNU)-MVB"Q6J/
M:^*NR?U&R/'WD[63<M2S=O>:>QX#+T(7B(1RF63V6QO&KYO.,UR&KG*3O@2'
M3V9)/![WC[@+M;[JT6T4*$\66K0Y2E]<,OD.BY<26CN6S5:F.V.WBZ])DK3:
M,$WD^P6?[AT%L<B8'+YFQ@1@[&,9!0?Y]2S>/S'L  "L_)^&R^U83'4:%G&M
M(F;-8]2?KIS?LU6)@;$53#T:]JU5$T4+6/\ "0%O;0H#NVLF]F,?L6!R%.++
M53T1(\!DS/PXKGXS YK+[;3S^S7<?$*+#\'5@F\P"[W)) 4DR\.P3[IAK]+/
MP1XF$'XFOZW7F?X*R7S1_#NE$C/'Q[#B?I_]UYPJ:QN<'(<VT?$X@,E>X21"
MW[Q$_P %/.1]0P^VXUIAN58LC 0ZM.7!1++83=,_I,N%RU[&?%0NCD@G99)]
M8L^SQTN!D]3W[/ZI7H9+,XUAK&(P5V.'UE@]Y'+N;9K&V9C6,!BH\GBY9*LC
M9+#C+Z;>X_U0%(]]I;%L6JT\94FQ;)Y"Q]PNL?2TL^S/DN!N&N[5G=8UW&16
M<4R2J6/L@V?I+XO;KZ4W+3\ME;>$SN(N8ZIFX6CXIXGZ:2NQM5':-CT7]%69
M<2,C+*/6+;'47BW[CZ5I9;7LY=XRH:TR3&BW&V..1QL_1XQCKL'I;EK$YZ7B
MZ/6F2XL71$VNXFS]'IM'ZW?2TXH'ZWQ18Q=_)UH+38C#')!+Y]ERAV'P?*.$
MH5!2EUTF"$-9[&961BMHV'/Z?GJCI:]+-UWF .$O32\?<%335;EVO@,?#F<G
M7ENLA F<) >RH7N^$W'/YK$RXSX"7%4YVS%CYB#+(/X-*MYC7F,%[0'==GH_
M+M>>;>A\@5N0KNS8HX]C9I#W&Z5P\F./9!^E=+9-*W;);[B,_#%19#2\.F.E
M=V?S_=6]R9I6U[#LV$O8UM/TJ';NY9"TDN5LSVJK(',MRQ,+HSYM+A^/FJEX
MDU?'T9=@RU6/J"U>>VG_ (#2KK5&;YQEF[6PLV'6,@*N1<>INWE@<%(-(U'8
MJ=V;,;'D6VLB8O2C#>RR)GWZ*T\/I6R5-_R.>GO0FK<;(V2)OX)^2C]+C3;\
M3L^8.*S3*V)O2E\CAV9EN:KQKL>&9LE:;-EU6T7B"/W+R?:1ZYT^E\G7\)!K
MM^]CY<>3&);)),P:U2W/:9L%277Y]9MPPR8RH^!D<WR$C"6_(K%K.D9F3:I]
MHV-U?X_TQ%#% 2Z-C59F8Q-7*8VU0M,\H9XRQ[52>+T7D37:T^+PV;JG'N\_
M S-^MBF,.BV<;I%K#XV=@M61_76)1WYN=[N*^^-=4S>J8M^-N78IX&/[@\1\
MQVIOFL<<EC+E/U/#UHBSR_':I9F@;\_71KEC8*[\>0&/)9W((Q]@5+-FXQQN
M7U.EAHY7Q&C&UM2;[@L43U;C+:8[4'\XMCGMTZT@=#4$A<PEOL2NUG=%V6[O
M,&PU<M"P5V>,498IIN^"OY[6;N,JSLA?8Z:YSQV/!<7%:$(M!?J^0MFQ&6%@
MD ZZ"K/#\1[I0+* VV=F+#OG%&\CMJG^P:5F6W=>LZW?CI?HVL^!C'CL%CNO
MD5AUW0LI_.J39\_=BFO"/THXX6=,#5:EVA!:IS5YVAS)6%KFG[@JB:>@;YK0
MLTM;SD'P$LYZBL-[,;'*S];U&+7L"^E3L$SO[=):>WMTDI]WD*%ZYQGE,%L-
MK,LV5TTMMY=:8ZN ).U;L\ F@FC>>@]A;_[A4E6XPV2AC'8.IMCQBY>_,& >
MI&/V6'M=C8^+*V5UO%8*IDY*=6F6GH1AY>YJZ.=T&?,Z;5U^7-2#TPP/G$7S
M?X#[CM<;-<3U\EK.'QIR3Q;QH#:UP,Z(:M2UPU'8L8V^_8[YR,$@<^Z\ESY%
MV\]QG#F-BIYHY>U#-6 $08/U>E.\S@Z>8PUC&WV^K'.SQ?\ 8_Q5-XO@G%T+
MP+LQ:FHAX>:9;TUQ"E^S<>RY/-P9;'YN?'V(*KH6&%JSZKH\F+R4^9RF1?>R
ML\0C?.X=!C/V6JP+]"K;IS5K,;9(I6EKV.^8(*I1_%N9Q,%R#6]EGJ59Y/G4
M</I /OT[M63@M4I8+7&8FA(8FM9UZ@;V2X^[U%]1XW&LY6[=KYJS(+4GE+$]
MOTN5EV8&RP2QN) >PM_]QTJ4K\1WX<6</_.ZX<6X_74]/W'X!\E,]BX[Q.9U
M*O@/.2O! 8_0+?F6^F.@M3%<:X>IK$^%M226VSM FFD_6<6KA0\4V641BG[3
M??B![4NNNQ^"[R5B9+6,1D, ["SUP:AC#!'^R&^W2J;#\$83'Y)D\V1L6:L<
M@?'5>WIODIKMW'5'9<GC[TV1L0OI ^B(Q\@2M3:^+L5LUZC>M7[3+->/Q$K%
M/L51GHT8:TUV6RY@Z,TGZ[OWE0?<.-Z>=RD&5J9"?'Y*'Y-M0CLD+=P&BU,9
MD#E;EV?(9(L\#:F^S?PP=GH+0V?C'%YW/5\P<E<AM0?V98>PU6+4A?#6CB?,
MZ0M: 7N]W'\E0[== Q&U"G\9)+'-6=W'+'[@%1_+<28'(UL;6-NY%!4>7AC7
M=^H]WN]Q_*[FV:%0V?%4\?;OVVQP$$$'LN(^[DR^@8;,:W6P=YTTL, :(Y7'
MN0%JC6J\-:UKF5AR,<LUB6(?U7J^S"K>4,V[0=>VN-@R-?N1@ZCG9\GL4,9P
M] (F53LF4?3[!DKEY#'JV:N$QM/$LQ\59D=9L?IMB ^D-]NE647$&&IRV&4,
MKDJM*=_<U2*0MC>II;TK"S:N[ "-\%)S0SPB/B>EHZCI&+U&G)6Q\]DQOZ+V
MR/[;Y?D!4C%A:.R\I;4*^7FJ6HO["Q _IP(*O76M-QN"DL6&236;=@#U[4[O
M.1_2Y.P\9Z_F\P_,&2U5O]=,G@>6D+NZWJM/!0V?":6>Q8?YV+4I[EF=^7%1
MZ#BW6*^P/SL1MMNNG,KG"8]$N74V_C[6=K? [)UW.?#WX/8?%RCK^&-",E)X
MQA::_L&GH/\ WO7:VCC;5MEEJOOU3Y5QXL=$?#Y+'F.--7R[,7'8AF;%08&U
MXHW^+ %W<[J.&S>*9C\C7]:)O1;V?K:1]P5%\3Q7K>,R4%P/MV/0Z]!EB0R-
MC*ZVT<?Z[LMVK9R,<KWUSW%T_I?>SZ+K^SPU8\G"]X@'T$.Z(4HQ]"O1I5ZD
M#2V&&,,8/PUJANR<;:SG\O\ I.T+++08&"6"0QDA;6*T#7L5A;N+KP/^'M?V
MWF[M\G\2L^&TC7\+0NU*-3T8;70D8#[K5PW'^KX6.W'2Q[6,LQ^$S?<."X]7
MB+1*T=EC,2P^L""YWS+0?V5VXN/M9@U[]"1T0VF7 OC!Z+R/N]9Z&DZ]0PMS
M$UJGA4L?KQ _(K]US3-?ULS_ *+I-@,W7GU]^E)<EC:5ZA-4N0,FBF;XO8X=
M@A5U2XET:E;9:BQ#/-CPYO?S (5B7*56U4DK68FRQRMZ>QP[!'X(4+Q'&^H8
M?(MOTL3%%.WOP=^RIRN!L6IX+8(6192C%.&'MA<!VU<ZKQ]J-:U6L0X6JU\#
M0(CX#Z%T]CU+ [# R/)T(IPP_1Y#ZFK+@=>Q.!I"GC:K((0>RUJY.?T/5<];
M;:OXN&68=?UI \B N]/A<5/B_P!'34X7U2T-]!S06>(]ATM>IKF#I8V;'5\;
M7BJ2_KP-8 QW\0L6-U;7\7#-%0Q=:O'*.GMCC#0Y,9J^OXN=T]#%5J\A!!?'
M&&GHKYR&J:[D;;;5S%59YFGL2/C#G!=X01B/TPT>/777VZ43.AZ<Z6:0X"B7
MR@B1WI-[=VI13I5:->."O"R.)@Z9&T=- 65$1$1$1$1$1$1$1$1$1$5(;U_E
M]_\ @QJ'?R:_^I;'_BP+U B(B(B(B(B(B(B(B(B(B(B(J_SW&.GYV]/=NX\.
MGE?Y.>"N/+PKH$@F_P#U86^?X=[+5@X*T"%Q(J3O_<^18AP/H(G,OH6?SX>H
MC^!M <2?1N#]PF0\":!]H[O_ #EBCX#T0,Z?\:]WY]593P)H'[%W_G(>!= _
M8N_\Y:\_ .C.8!";C#Y@D^JM1_ &I?I5LC9;0I>B08"_ZB];4/ .D,\_5?=D
M_'U]+*S@/1 7^0NN_']:LAX$T#]B[_SD_H$T#[1W?^<G] F@?:.[_P Y65+J
M^*?K?Z ?$[X/T! &=_,,"K7^@30/M'=_YR'@30/M'=_YRU3P#I'Q/GW<]'P_
M4]1(N -*;-*9);KXS^HSSZZ7V_@'1C*TM-T,^[/460<!Z$&>UTG_ !5PX?Y/
M6OB:P9,E:,9Z])=2SP!I3ZI9!)=CF^TA?VO@< :=X-[GN=AG1^KW<L<7\GW4
M12].2W<-C_\ 3K.. -*^%+#+=,W7]KYK5G_D]ZF^"1L=RX)"P!KS]G**4/Y.
M1,KS<SQ# _Z0R/W"GXX#T -'T72?\5/Z!- ^T=W_ )RLO6=9Q>M8IF-QS'MK
ML>7#S/;B2NZB(J6WGB1FV[1!E)LF^*(1!LD0;W[*W\;CZN-HUJ=:/PA@C#(V
M_AK5M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(YH<US2.P1T
M5"L=Q[JN-R_Z4J8UD5GLGS'[U-41$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$14AO7^7W_ .#&H=_)K_ZEL?\ BP+U B(B(B(B(B(B(B(B+YMW
M*]2%TDLK8V-]W./0"^@041$1$45W7,Y+"Z]=R./IMLS0CLQEWC]/Y6#0MAM[
M#K&/R5IC&23-[<&J8HB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(J0WK_+[_\ !C4._DU_]2V/_%@7J!$1$1$1$1$1$1$1$7G#
MGJWG8H\3!#;:VE/.T.B_+PK&R.SY;5=7GO9PP3V#(R.!D/TB1SO8%13*9_E/
M"XN7.7:N/?680^2HP_7$S^/2MS6-BJ9_#5,E5:X1SQAS0[W"B')^RYS6< <A
MCH(G^,K6RE_NP%1#7]ZWO*YG%SC#%F'EK.>^9XZ<[K^^N-+R%ON1P64V3'1U
M*N-J2D"&4=OF 4Z=O65M<;#9*5%AL^B'NA+OI"@%;D[?\EK+<ECL$QS88N[%
MA_R!/_D"F]#9SMG&%S)31-:]]61DK1[>35&-1V@X3C'#1TV>ODYXNJE8#LO*
MMC7+&U'$3S9F*!EIS>V0P_,#Y>Q/07*XYSVSYC'79LW0^%E9/X1C\A6"B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B*D-Z_R^__
M  8U#OY-?_4MC_Q8%Z@1$1$1$1$1$1$1$1%0W/5-IP>)O&3H0Y&($?N<M+F2
MTS*ZK0O8ZT+%:I<A?.V/\'L@JPLML>(R&A6LD)V>A-1\O?\ *Q<1UYX-#PC9
MHRPF$. *T^9WL;HM[MP ]>)23%96K!IE3(,/JQ,H->/'Y]@-7GJG>H;'I><S
M&8ROH1>L_P"'QD#O",//[0'ZQ4PTW(49N&[,;+3>X*;FS?EA7<X]-0\3P?$N
M'I"F_P U%>.[$$'"N4?)*&L:ZPJ^UH9K4,=@-RKS/MT71>A;A)^<32O7N'SV
M+R^+AR-2<.@DB$@/W:"._FLF!V+!9N"6?&7V661O\7.9]BNHB(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B*D-Z_R^__  8U#OY-
M?_4MC_Q8%Z@1$1$1$1$1$1$1$1%R-FUS%[#B9<9D&%\,A!(!Z((^X7+PFCZ]
MA,)-B:M,&K-WZ@D^HR?ZRB+>&-/9*P@6O1;,)!6,A]%6Q'&R)C6,: UHZ "X
M&SZKA]DIBGDHG2PAWET#U]2R875\5A<(S%5HW&J 6ALA\B05#*'#^C4,A)=B
MQO;W=],>>V,[_9"WZ/&.I4<-=Q4--PKVI0^8%WS?TNMC](P./P-K#P5W-ISC
MIT?DN34XRU:I@[>'B@F%2Q,))&%ZVJ''VN4->OX.""3X*VXF1A>FL\?:[K$%
MF'&12ALS>GE[_(E;FH:;BM5I3UJ#2&RRF1Y/N2I4B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B*D-Z_R^__  8U#OY-?_4MC_Q8
M%Z@1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$5(;U_E]_^#&H=_)K_ .I;'_BP+U B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(J0WK_ "^__!C4._DU_P#4MC_Q8%Z@1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M5(;U_E]_^#&H=_)K_P"I;'_BP+U B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(J0WK_+[_ /!C
M4._DU_\ 4MC_ ,6!>H$1$1$1$1$1$1$1$1$1$1$1$02,+BT.'8]PB.E8'!GD
M.S]D1$1?C9X72.C$C2YONT'YA?J(B(B(OAT\+96QF1H>[V;V.ROM$1?CIHF'
MIS@._P E?O81$7RZ:-KVQE[0YWL._F5](B(A<UO791%^.M0 D&1OR_>%^MD8
MX M((1$1<UV;Q3+C*C[L(F=[1^0\ETD1$1%JPY*C-;DK,LQNEC';V-/;FA;2
MQ3Y"I&[P?/&S]SG %98[$,GZCVG^![1$1'.:UI)( "UL=DZ%YLCZUF.5K'^+
MO ]]%;*(B(B(B+'8M0UH))I7AD;&]N<?8!:& V/!9RM)8QMZ.S&QWBYS/8%=
M-$1$1$1$1$1$1%Q,_LN)P4#);U@,\SXQL'S?([\-"TM;W+![&9VT9W&2 @2Q
M/;XO8I0HR=QP#=B;@3:)O%I/IAJ^K>WX&GG:>%GN>-VR.XX@%)$48V'<L'@+
M6/K7[!C?;>6P@!2=17:-TP6LLKG(SEKIW=11M';G*5-<' %$1%"SOV#&VMUO
MJ<W.B>PP>FIHB(B(H'MG(V U:[2J9 6#)9_LQ&P%3QK@X HB(A< B(B@65WZ
MAC-PQ>NR5Y3-;]I.OH"^<_OU3"[+B<*^I,]]P_KM'TM4_1?C9&.+@' EIZ('
MV7ZJ]WS>QJGZ-:*#[+[<W@ /9H6MOG(;=3?CV?HV:<V9 T/]F!66T@@%$226
M.-I<YP:/R3T%&]NSTN UZ_DXJCK+H&=B(?=?>H9^?.Z_0R4E4UGV(PYT1/?2
MD*(B(B(B(B(B(B(B(B(B(B(BI#>O\OO_ ,&-0[^37_U+8_\ %@7J!$1$1$1$
M1$1$1$1$1$1$1$10S?MK9K. FN-'G.]XBK1_F1Z^]0Q%NAC_ (O)69)\A::U
M]J1_V=^R/P NH-GP3K?P@R5<S>7CZ?E\^UP=VP-JY7CRF-LR09&BUSX"#]+Q
M[ECPMG0MO9M.OU[X:(YOU)XOV'A3"Q:@KL+I)6,:/=SCT%R)=BPT/PWJ9"!O
MKCN+MWZX_(72GO5:\)FEF8R,#OS) "U(\SC+#X(X[L+G3,\XVAWS<W\A0?"Z
MGCZ.^9;+LSCY9;;'%],_W02I_>RE#'0F2S9CB;]W/=TLU:Y7GC$D,K)&D?)S
M3V%IRYC&PR2QON0M?&SR>"X=M'Y*VZMVO;KLG@E;)&\=M<T]@A5SF.1*%+<\
M7@8YX>Y \V7$_P!F1[!6,^U7B@$SY6!O7?F3T%@QV9QEYGJ5;44WV^AP*W%7
M'](6.EWD:[%+$0RM(^:4N]I&D ,58;8)8N:]4D9;F<R4]AI?V&+T;%=J2SOA
M98C<]IZ<T.'86>:Q# WN21K1^2>@OF&S!,"8I6/ _9(*_+DYAK3R-'ZD;G=?
MGH+SKI3(>1V9')9?*W([$=CQ@K03F-L+%-]5J;+B=MO8Z]EK-VF*WG5DE))_
M@Y6?9O5*W7K3QQC[>3@%GCGA>PO;(US?R#V%@-ZGX>7Q,0;WUY>0Z!5>;1J=
M?)[+@,NW./JOJ/\ [,._7[_"LB2>*!A?)(UC?RX]!8J>1I7&^<%B.4?^5P*U
MKN;Q=&:*&S<AB?)^HU[NB5T8IHY6>;'M</L0>POU>;^9MZOXK+XJGCI)!\+*
M)[?BK_P>7KY?$T\A ?ZNS$V1H_<X+HE>7-XQ;#RKA,>RW;CKY%_E88R4A9N0
M7YSCO)8>UALS;DH2/+'5)Y2]J]#P[!1-&E--/'"+#6EC7'YDN'?2V:N5H6I9
MXH+44CX7>,C6GLM*TCLN#;;^$.2KB;OKP\_GVH]R'M-? :UD+ LL99,#OAV]
M]%SE4VMZ'JNTZKBIF70S,^#+,]QOU3>;OF?)7C%L6#IO92DR\+IF ,/F_P"H
ME=F]EJ%*OZ]BS'%%]G./06DW8L,Z6&(9"#SE9YL;Y>[?RM?^=NO%LSAE:WC$
M\,>?+V)6W=SN)H4VV[-V**!P[$A/R*_<1GL/EH?6H78K#/<%A6#-[+@\0T?I
M&_# #[!Y5,: [&2<E[;+CGL?7E >US/8]E7=F[<]+%W;,,?G)%"YS6_DA>=^
M-8=5W6C>L["8[>9FF?Z@F/U,9]A&K U34[^L;3FG,GF?B7P,="9'$^!']U8L
M#RUB<MM=_'QSQ,JQ, AE=[RO5EY;/XC$1"3(78J[/R\K]PV>P^9@]?'W8[$0
M/NQ,OL&(P\0DOW8J[/R\K!!DL3G,5--3LQ68'QD=M/8((55<*104\5L,3 &1
MQ9(@?N [5HXK;=;REXTZ>3AGG#/,QL^?35WT>]K&ESG  #LDJ&/Y#TMDY@=G
M*XD$OI]?;R4DR>9QV)H27;EED4+?>0J/X/D'4,Q9AK5,FUUB0$B!P+7J2Y?*
MUL=CK-R<EL$#"]Y [^055<>\H5-HMY-D\QC+[8%2 CY^DIAG=\UG!3&"[>ZF
M'7<4;?-X!7>PN=QF8HMN8^RR>)WL]OV6MLFP4\!B;&0M>?I1#^X/(DJN=#W:
M#;\+:@N!TLDIF<YA9_5MC^S"5$^,L_@-6P>?-VRV"%N4+(V^Y/7:OC7]BP^<
MQK<ACK0FB/R[_!48RG)&JXRQ+#/<>3$_PD=&SR8QWX)4WQ]VK>J1VJTS9(9&
MAS9&_,$'\*/;#N. U[T1DKK872GJ-GW<N+-R?I4.5_1K\LP3]]?^3M2K+9W&
M8>@Z[=LMB@']_P#/\%P,'R#K&;O? U;CA9Z[$,C?!Y"^,AR'K6/S@PL\\PNE
MX:V-K >^UU=BVO$Z]#!+D'R,9+((V%K?+ZBN3)R-JD63_1TF0#+(87O:1T&
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MIPO^H,9V>R%,==T7'ZODLW9IW'^G>[>*OLUB\[XS=K>'KY?%,9+!!=RY;/>
M[]-A)[#5ZFU35M=P&.BCQ,$886#N8#ZY?WN*E/:CNWP5K&M9:*S=-2%T!#[
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M;LF>HU:!HMZBAA>7OD=^7D@*[)(_*-S2>NP52&LZ1NV$V&_$S)5AA+%LSO\
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M%WIJRE5&R\48W-[%^F69"Q4F>WJ<0_+U%]XOB36L5GX<Q4=/')&SH,#E6C,
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MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(OB6U!$6A\K&=^W9
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M-/YZ:S_IBK_QK[.W:[Z?J'+5?'\^:^6[EK;W!HR]7L^P\U^?SSUD?+]+U?\
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M34__ "$T;]C(?\IJ?_D)HW[&0_Y34_\ R$T;]C(?\IJ?_D)HW[&0_P"4U/\
M\A-&_8R'_*:G_P"0FC?L9#_E-3_\A-&_8R'_ "FI_P#D)HW[&0_Y34__ "$T
M;]C(?\IJ?_D)HW[&0_Y34/\ *$T?H]19#_E-7F7D7;ZNT;//DZT+V1.B8P!_
MO]*KQ$1$1$1$1$[*=E.RG9_*=G\IV?RG93L_E.S^4[/Y3L_E.S^4[/Y3L_E.
MS^4[/Y3L_E.S^4[/Y3L_E.S^4[/Y3L_E$7XB(B(OU$3M.T[3M.T[3M.T[3M.
MROKS=^2GF[\IYO\ VBGJ/_:*>;_VBGJ/_:*>H_\ :*>;_P!HIYO_ &BGJ/\
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E\IV?RG9_*=G\IV?RG9_*=G\IV?RG9_*=G\HB(B(B(B(B_%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex3-6_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_008.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 ;  !  (# 0$! 0            8' P0%" (!"1
M 00" @$# P$$!0@) 0$1 0 " P0%!@<1$A,A,11!42(5,D)A%A=2<7(((R0S
M-C=5=#56<W6!D9*3LAA38K$T)50F8V2AP3A#HM'21$7_V@ ( 0$  #\ B7!&
M!PV8R>39DL?!::R$%HE8'+UZW6,#&QK6XRJ !T!Z87W_ $:PG_#:W_MA=*"A
M4IUS##"QC#W^EHZ"Q08^G 8O2@C9Z;2UG3>O$'Y 6RB(B(B(B(B(B(B(B(B(
MB(B(B(B+&:=8V18])OJ!OB']?JZ/V[62&"*$/\&-;Y.+CT.NR?DI)&V1I:X
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M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7FKD]FT':YCCY*P@]"+H/\
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MJ[?9JOYHU$!X?X_@KTFJ3YZC>[2X7!OLS(P$KD\COEM<58\TY0X1FK).&'^
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M'UW2L#8V'ISY/LT*B.2(-IGP>OW\E'4IU66H604HW>;V!WY<0%..8*=*S>U
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M@@8&1M_D%OJIL_Q+C,OMG[<-^:(//^D0-'M,%NP<98V';6[$R]8$[7>T77Z
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M)QH/T5&"N#\^FP-6'(:W@[\CGV\;6F<YP<2]@<>PNM!7B@B;'&P,8T=!H'0
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M'4NS4\49)6$A];S4-PG-&3RAP[:^!,PGF$=J4'ID+W_ "E)Y!NGDMVMOQ#&
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M6O7'R?,[L?L.6P\F"F,M=KA  >W2O"T[/-MRI@\5D;.N2QBU,6/[?TUH"[N
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MUW1$ M[Z [^Y51'F/9YL35OX_6'VH(H6&Y8[Z8'_ '#58$7)M"?0I=GA@<?
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M4U:M7C[78-:FP)@=)5E/;R\]O<[\J(8_B"C!=].WDK=K%UY6R4J,CR6,*N0
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MF)B\PK$S.OT<KAIL;8=+'!*T-<(G>!\?PHYJF@8?5))OV79N")_S"^4F/O\
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M[>PYI'X*Y.&U'7,)/)/C,56JR/'3G1,#?92)$1$4:S&G:[ELG5OW:$<T]?\
MU;W!25$1$1$1$1/-O?78[0O:' =^Z(B(Y[&D D>Z(Y[6CMQ 1$1TC&= D#M$
M1$1$1LC' EK@>D:]C^_$@](B(B>HSS\.QW^$1$?+&P@.<!W\>Z(B(B(B(B(O
MR26.(=N>&COKLGI?J(OR6:.)OD]X:/R3T$?-&R/S<]H;^2?9?H((["(B(BX6
MQ:OAMAJLJY*J)XF/#P#^0M[#X7&8:DRI0J1UX&GL1L'0[6^BX.>U?!9[Z?\
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M'7] Q64XM.2R$T\\[:SGUB3[0#\,5L<)9">]H%!TSB3#(Z%O^%BMJ1P:TD_
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M6*8OB'X+?8*$:[I0SNY;C@#D9X<?'9>7,![+W,)#"5ZDU+7(];P5+%QSNF;
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MMNPX3 #7\EK>0?>K-]&MZ;06/'P.RN]B]:S&!X[S3)*4D^1OE\DD$/OT]_N
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MNY7ITH,5'*:37_35_5+1*UY'4A/2MK,[[)B,=C()J/EF+<8+*#'_  [[]N_
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MI)'?AH5![UMHRV:UFE9QMJC;BR >89P!VP_!"NW9=WQ.NV*E.=LTUNT_J&M
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MCD3+SZ=GLEGQ+WCR#ZI;UY@K'0K;QL^M2;$[/2TYI87R5*3!_F/2/N ]8?\
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MDQS*\$<32>R&-Z!*UIM<PT\KY9,?7<YSB7.<P$DE;\$$4$3(XF!K&CIK0.@
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MNCNLW[O6YE]NUS#3B'(Y**!Y:7='LGI=+#YO%9>D+N/MQV(">@]A]E'\AO\
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MPCX\ 'JS).5])CG?$[)GII(]4,[C)5A4[D-JK#/"262,#FD_@K[>]L;'.<0
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M7L&9\<3"X!\;)'.=*&KTI%&R)C6-:  .@%&-WQ>7RFK9.EC/ 69V>#'/>6
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M[.N_5/\ ;>5]ZOH&PXG;\IFIK\!COF4SQ-_+UIC5.1L/%>Q^*N4+%"U-(?\
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MULCGZ52;'R2,9-Z!(?7+EO<B\B7]>Q6'R6+J16:MQP[E)4>SO)6Z8MU3+RX
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M=5BKU:\<,,8Z9$P=-:%F46R&DZU=ST>9FH,=<C(+95CNZ-K=S/,S4U!KKK'
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MFKE/Y-TIHNG]LP]5>A*NO)N.O18:#+R9"-M.8 QR?VN_P%HX7D'5LU<^BIY
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MT[5/(TS< ,,EB(,8059X((["(B(B(B(B(B(B(B(B(B(BYUG.8>E.8K5IC'@
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MMU;@ZJWPWP<2/L\*'Y_^D,W-M2E%EP#'$70.?%Y"%DGRT-6]R;-D<?N/'DH
MN6XO6^WIB5_LMR?=^0]=W#$U-BBI&G?E<&-K^Y8I9O6]6<9FJ&!QT]>&W.TO
MEL3>[86!1G7>2\TS=AKV4LU;T<_^HMP#P7)R/(_(4>[Y? 4J,$[V->((F?;H
M^SW%7/H5_9[6N12[#6$%\O<'M Z]E >9LJ\T\3@8WM:<G;:'_P"!BL#.ZACL
MMJ4^ [,</I-CB</?P\% X.*7NXY_HS9O>4K)C-'.![,>F?P$NO<-Y+&2V/6?
M!1Z+E$-*Y!UO#\:UZ\UDOMLA<SZ=C27]D+6X7IW]8UK8,_DX9HJKVLDCCZ]W
MAJW[?(^]U\"-J->J,9).&1TC^_X'^,N4TV_?,M2T;'['BZD99.V)\@D/NQKP
MN-KO(VVYK/XUC, ]F,LL]K#EV=/WS-9O9MCQ%FI!!]$7-:&.+OU-58:7;WBY
MR+LO<U1]J-QBL/?\ ,/PQ33-[_M6)W^G@)JU5M6U./1G_,94WW38\SC+V$I8
MN&*2:[9\"'_9H5@^Y:5Y/WNQL.C\DV-FAIB:K:86JU\-L>H\AUZ!;*66:D[)
MQ ?9[7M4'YJL,BW'2)I0\M#Y20P=GY:NY:Y-V+%;;0I9?!"K0NO+8'^7;U*=
MXW>YA\AC,+BJC+&3ON(B#R6QL ^[ES]/WO89MJOZSGJ$,-R* S,DA=VQS0HU
ME.8LCCMJRV&EPW9@8\0-C/D^20+NT>4IV:5!E,C0]*_/.Z&&H#T9'A<B#E+-
MX;/4J&T4:L,-T=Q35Y?4$9_#E+-GW;)P;!!KF"I06,C) 9GF:0QLC:MG6-CS
M6<BSU#*8>.K>HED?@7E\4GGW[]D#V]DUW5,GCM?RK9XZK[MUYEDA'M QY^&#
M^0[6_J&J#":Y)0L>DZ6RY\MGP;TSSD^6C^05=<5V[>(V39M3D<3!5G<^J#]F
M J=8'>;N1W'-8)^)DBBI%P;8/P_Q*L)4YEM^V&YL.3PVLXVO.^@TNL2S2%GN
MWY8T %=_3M[GV/7;]T8XPW*KBR6KY=_J'V!4!Q_,>=RN-N,HZQ))E(9"'5F/
M[:Q@^7.*G_'>^NVC"6[-BL*MFK+X3Q]]]*/3<B;!DWW)M9UX7J-4EKYY93%Z
MCF_(C #E'N#\E+E<EN]^6#T7V+T<CHOGP)\UZ%1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$7/MU<D^8N@O-C9T/8Q!R\.<&OC;O]3S9WW \-7O-OP$1$1$1
M$1$1$1$1$0KSGC[D>M<S9J&\XQ09)CGQ2R'V+R5T>2K-;*[5J6-I=3VV6C*_
MP]PQBU]MMX[&<RX*Y8<R%DE1P=*M?=LUB[O(?'-FO<C?"))B7KJ<Q6ZT&1U,
MRRM;U?\ )1S?+-#7^5Z69RM438VY3](DL\@U6!0SW']K,XZ+ U:=NZ7D>I"P
M#T8ONXE0O!3PGGO.'S8!])(W^\^87HY>>.9*\@V;2KA]H8[#V/?^"XA>AQ]T
M4 Y4<P<?[#VX FLHYP_2QEK1\3*Z"&21HZ+B 2"%-MXS0P6K93(>DR4Q1?IC
M=\.)7F#:?I<IQS!F,EL!EM3.::V/C>6PP_R#%/<W8KR<$XKQE8>H*H*NW5G0
MNUS%&)S3']+'X]?'PJ4XX<#RAO7\[,O_ ,U^:-)'0Y2W@6GMB+YI'M\SUV"]
M2WF#67Y3 ,RE($7\:X30N'SX?<+G\:6[^WVV;1?!Z@JBK7!^[S[RO5WGV"@$
M&PXC-YC8=;R,</E6E ;$_HB6,]JA-]T:MJ&Q8*]K,LL4L]GKT6GW"EG+\C?Z
M;:&9/M))VLW/1 BU[_GEU]ZS=D[AKN(HLIP6Y(W']H3-!?$P]=B-1"E!4QO-
MF.8S,RW":@$TTTG9[72P;(SSYG2X#VJR_P#S"<Y0Q19/5+UZL9L7#*]MEBZ[
MM:X>CQ\>997KF%SV^EX==EQ^ &K)ONGPY[-F]@LM])L%&%A\._$O:[X6SQ7M
M>=R-O,XK8*OCDJ;FA\O7NX#[/5UH[X*\\Z[#*_G/8YV-[B96D#G_ ()>KWIY
M+&VK4T$-J)\L3NI&M/;FE;SW!K23\ +SQ0OV-FV;:?V79@Q%2"4MMV&- LV7
M>ZT>#'Q1NW./ZGU.[+.GN/N_V>I5PT(C3V<CKWRA4:U=I%KEQD ]_K#X!O\
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M(B(B(B(B(B(B(B(O W"?^W^._P #U[Y;\!$1$1$1$1$1$1$1$1$1$1$1WPJ
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M7C_#6CR^%<O%.0V.YJ<!SD4S;+'EH?*>W2,_)5DKS[RKQEE<GE&;)@)B,A$
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M$D[\#U\KRWJ&9VG';?OWT&!%P.O.,H8_KPD!/04EU'1MDR6X3;=L\;(INO\
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MW8CK5V#W>[V 48Q7)&H92V*D&3 F<[IC9&^'G_-JZ.P;GKVO/@9D;S8I)O\
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MG#9BQ*+++;R7N82)5.^&\/<Q^ N3SU/IV7;7K0Q?<1JWW?"I'C(@;=R2/O\
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MC<5B3DL19E\XXPXM>Q3;4-9S$N5RNT9JNR'(7(C''6!\_0C_ !Y+C\6ZYLF
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M9S"TWP69PP7()26L_O!:KU![':=HG83L(G81.PGD%^36(H8GR/<&L8TEQ/V
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MB\Q4I/K6V2&*>NXN_<(^?96[W[=JI;^W['E]@O8C6*U<B@_QN6ISTUK_ .P
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MV8(7UK1]6[V?;Y_1&U3SB/:]AR\.;HYEX?:QUD1.D5LW3,*TQB<&O##XDCL
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M[M8#U[KYIY7==5Y+QF(OYN7(5<C]WKJ[9N%J[N-O MR=RC5IQ=O?4;W-*_\
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MY)OTI^-L]+%.Q[751T0?RN=BPQW#E,. (_8K%4F6A?)P9@9!$7LANPOE_DP
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M!UJYG/VS-1[N!X>)>_<$+8VC2=<V9K1DJ37O9^Y,/:1G]SE\Z[I&!UZ66:E
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M-FG>Q@F#H0P].+EV\AM^K:WC,>^S<$$$T;17;]W!:-GE'2:MZ*G+EV>;R '
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M0_D_:G8R#,UM7BFQDTO3)1.?4:P_#GM#5+MSWFQ@;V$QM*@VS=R3R(FO?Z;
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MXMCTW.YFUF1CZ7G-X8VM_F@]Q/S*0?<E9](<R?@W,U(RQ\Y$Y$95B<0WJO\
M0+%1-G9ZHB?^GOW]E%N)Y'V\AR*?4\Y);G_G[/6]P9=BJ87*82R&Q7:ETF1A
M]G'M9,1!%:YHS^2I^!K04/2G>/CU2G$]J"ULW(<T3^VR9,.9_=V]?6IRUSRO
MN?@]BMG%[5KN3OV:57(Q368"1+$T^[.E%.6*5Z[HN8AI=F3P!+1\N8%%M W'
M!R\;P,ENPPOITO1E87>X+6K5X(O5Y-!LUP[]<-J4O_N>OOB"[3^BVR,RM)9D
M'O>P?/A[J#[!KS\52DW72\T(*SV"::MY>"GMNUAMXTS 5<^#6LY%@?#*![-E
M:%$]9N;1J.[5M2L9$W\?98?0?\EH4@XGOLQN:VW"W6""T+QE;W[%[>RD\<&4
MYMJRT@":-,FU*%R\@]@Y_J]N'_X$Q,W;KXOG.I;NED<$U!K(Y'K3V'/8NUS-
MK)KRQ3B(>F]WV8XK/G;=6CSQ!/9F$40I,_6Y9>:\CC[%;59F2-FBDM![>CUY
M,3E*>?%[OIF=?V^C$\C^3"5-^6KF-M:-:@$K97VI(V5@QWNYY57\H8\XK5-%
MH2O_ ,[ 8F/!]CVU37G=\1TFCT]OOD("%-(MPP&O8#!'(WF1"Q!&V-3^.>*>
M!LD3PYKP"UP^"%Y\9<.N\T77Y#J*KE('""8_=W:<C-BS?(.E4:19+-$^1\I8
M>_!GLM'*S0LY_KETC0/I6-7I-OPJRY;UYF:TZ]X@^O5(L0_WL5/X# Y+D?5K
M>1RC>C5HBOCR3W^MO[\BW.(WY;9<C0DR0<(]>@,$7\Y'K?YFFB9N6CESP V2
M7M;W)62I0<F:"7S >C)*9/Y!_2V^8[M2MD-4,TS&=7_(J-[KDOZ.<LXS9+$?
MEC+,#8Q,%AY-W_5\AD]:;0O"R(+8DD=%[@!23G3,X\ZUB(A."^;(0SQC\L:N
M-S=DJ=G':I-'*.I9F2@'\+N\[W*ITC'=3-/J7H7L_F "N3R7=Q$_&VNR/!>]
M_H?361\1GI<*GF=?V')8P[)N5>:O1(+(/2\1*[\N7JRO-!+"R6)X<UP[:1\$
M%?2(B(B(B(B(B(B(B(B(B(B\&<&F ;]4]5A/<#_!>\V_ 1$1$1$1$1$1$1$1
M%YJWVCB<GRQKU._(1&^ @%CNB'JVL1H&*H92'*3V;=Z]&TM9/:D,A9_A[6IM
MW&& V7+5\E.^:*Q%[&2(]%[5JU>)=*Q^4@R<--S'0,;U&#^@E@^7**;5O^&V
MNA9UG#LGFN6[(@>"SV:P'W>KKQV*JT,5!CX>Q##"(F >WL!TH=JW'&&UG(7K
MM.U<=)9)\P]_LOO$\=XC%;+=SL-NX^S.X]A\AZ]U\R\<XD[>=E%RX+9[[ ?T
MTK%NW&&O;=8CGM^<4[/831_):MW5./<+K&+M5:1>'S@B2P?]8Y:>F<<X[4I;
MLE2_;E-D?K#RL^$XZP>$SUK,U9[CK5CR]4R2$AWG[GM<N;BC 2[-+G/6L!\L
M_K20 _H<]6B6@M(/OVJEN\7>&2M7,)GK>*^I<3/%$.XW=J::OI^-UO%25*7D
M//WEG/O)(_\ )40PG%E;#9V3,U\W=-F5Y,Y>/:7OW/?NK55.[-Q%4R^QG-4\
MO8H3R=^OZ(_?676N(<3@-E.;BR%N67KV#_R?DN*Z\_'-23</Z2_M2S]6'^S>
MNV!G]E3#8M?JYW"7,;;)$5AGB>OD+!K6OUM?P=+&5W$L@C#?,^Q<?RHIE^-J
M62VJ#/R92V)X'@PL'[K %DW[C3$[;)!9DL2UKL/?ISQJ'Q\'8TY/&Y&SF[L\
M\![G>[YE*E6_\98G<HX72S&"W%[,LM;Y'I-*XVIZP99W7I;MTQF-EF4>[&?A
MJU-7XVL8'9LAFCG9+#KA>9HC"&@EQ7W2XXGJ[U/M!SLSWR^37P&+Y8X]^/?:
MY^P\1PWMB?F\3FK&*M2@^LZ!ON\E?&O<15L-M/[;.7LSO]+HA_R]Q^2XK;/'
M.:KORL>-VR>G3N3R2?3,@!$?J'LAI\E.-3U>CK.%K8RIV61CMSS[%[S\N42Y
M!XXCV>Q0O5;SZ=^H_P#189^%';O#$%F]BK[\]<?>@D[GN/\ >69=K+\;7K^W
M5M@9L<\+X UL<0B[ 8/L3VL^U<=VL]LV.S3,[+6-'W@B$0<&K'OW&L6S6*V3
MJ77TLI6]HYV*.LX9GFRN+RU_:;UFY6(+WO'9=_($N5[*JI>-))-\_I2<Y+YA
MWM!Z7L&?9G?:2<<6W[U_2G]OR"3OH0"'V]+[1]]IL7&LV7W&GL+<[)"ZJ6^C
M$(00%:JIV;BHNW*]F(LO8KU;;O.Q6B[;ZCEOXSC>S1WF?:/V](]\SG^<!AZ!
M8X]^/?:6>-I9=]_I2<W)Y@]-@$7L&?9O?:U=TX@P^Q9;]J5;DF/N>?;Y8F=^
M:E6G:30UB"<1S23V)W S6)?WW]*49G#4<KC;%*[&V2*9O3F$=A474X-%:"]0
M&S7ACI_?Z9OLU3G6./8M>U6WA(,I9/K]]S_!;W_8"T<!Q?6Q.M93 2Y:Q8J7
M._TEO7@N:.*<B^"O0L[;<GQD4K7?1OC^6L^&$^2D>]\=4MJQ]&M]2:;ZKP89
M&,[\1^ %P\AQ!C,CCJ5*?*W.H'&1[_ETLKOEY5B4,))4P3<><C8D+8O3%A_O
M(5$M0XXJ:M<MSULI;F%EI]:.3X>[^TH[-Q;D\?EKU[7MDGHLN2]SU^NVJQM;
MU;':_2DKU_*1\KR^>>3WDF>?N\J!WN','9S4UZ&Y9K0SR>=FK%[,D4@U;CK#
M:QD<E<HOE'U??<7Q&P+DXWB;"T-DMY9EF<QRR^J*GQ&'KHP<<U*VY3;-'E+0
MLR2.+V?#"TG]Q?>R<?5LGEXLS0R$N.R;!XFU$._-OX>.PLFKZ,,5>MY6]>DO
MY28%CK<OR&?AJT:/&U:GMC]C;E[CK;WDR CH.:?X3[I>XU@L[D-E.7LML-/L
MUH]O$?#59G0((*J>_P 9OBRUW)X#.6<9+<D)L1L;Y,=VI=J6FT];QUF*&>66
M6=YDGLR>[Y7_ )42J\6Q5MBEST>?O?6R.)>_KV<#[EI]U:[F!S"T_!5)R\*X
MDYRS>9DIV5IYO4FI]=L>NW1XAU>G4S4$9G:R^',\0?:-CCWTQ:C>*:O=>G-F
M<A/BHNG"G+(2WS8NYL/'>,S61K9$7+=.W7B\(9:[BTL6_K>F4<)/:MNL3W+L
M_M)<L'RE+?PHAG^%=2S.6?D2)H'R.[E9%[->K(I:WB:6$&)AKM93$7IAGY"@
M>O\ $.K82+)1QMEE^KC,3G/^6QG^$+'%Q#A&1QU'Y3)RXV,AT=!\I,0(5K00
M10Q-CC8&,: &M'L  H'NG&V!VFU4LV7S16*_LR6)<V'B#2H,C4OLI/$T'P?/
MV<?RY51MF+J9GG*&M)9DB!JL+)87^+FO"O' :/C\9=_:,]FS>R!C\#;LO+WA
MOX;VFS\?X'8;T%Z<2PW(/]59@=X/"8#1J.)OOR4]RU?OEOA]7:<7O:W\-[6.
MUQW@I]E_I Z>[]>'>SVRD #\)E>.L#DM@BS<T]WZR%P,3FRD-9_)JG3F!['-
M/P0053K.$]1&6L77ME?%*\O-4_ZKM=G&\5ZKC<9E*-:*5C+WM,\/Z?X_V05T
M\-H&%PV#OX>E/<94L_+3*>V_S8N;C-8UCCG%Y/(5'7&U6L#YF%Y?\*%2YO&\
MEYO P8V![J-1_P!5;FD9T6$?$2OU<79]8H;%BGX^^^80/<"]L;RPNZ7)Q^AX
M.AK%O 0FR*,_8(,A+EDU32L-JM.S4QIG]"9W99*\O"B=KB/1(K]C+NH=/'G(
M8R?\RH[P7+0DQ.>BK.!C^O[:W_[@]J4/X<T=V8LY&2D972O+C$\]Q=E=S7N/
MM=UZK>@QL,D(M?ZUX?\ K6/5N.M>U:W9L8PVO.=O4OJ2%P*X6:X8TG+Y2:_/
M7FCDE),@B?X-<5T=;XMU37+\]VC5?ZLC"SMY[\6E<NKPMHT&3LW#0,@D[Z@?
M[Q,[4CUOCK6M=Q]RI3J]QV21(9/=SPM?7.--5UR:S/CJCF2S,+#(7=N#7?9J
MS:UQYKVMY&U>QXL>M8!$GG(7!?&P<<Z_F<H<DXV(+G@6&>!YC<X'\KI:]IV'
MU_$S8^BQ[63?ZZ0G]<A_)*T-;X[UW6[=FUCHYFR3L+9"Z3OOM?&*X\UK"Y:U
MEZM>06I@[S>7]_*@^D::R#?,ML%*G/5HOC?$QDW[\CWD$N5Z.8US2TCL$=%5
M=-P[HDV2EO/Q?;WD]Q=_YI=_ \?:W@*%ZK0J>$=HGU23VXK#@..M7U^627'T
MO3>^$Q/=W\M<N#_4UI8]FQ6FQ^0)A$Q$3B/R%)=CT/7M@H4Z-R!S8:Q!A$)\
M/#I:>L\<X#7KS[\/K3VW-\?J)W>;PW\!9MHX\US9+D%NY'*RS".F3PO\'KH:
MSI^%UR&1E&$^I(>YIW^\LA_+BN;/QSJ\V<=F9*9=<,OJ"0N^"MG;M"UO;'0G
M*52]T1[9(T]/6E%QEID5JC89B(>ZK/&($#I;NRZ%K.QW*UG(TA+) ?TN_(_!
M6IG>.-5S@J"Y0]JS R$,/B&-'V"[MW5<+<P<6&LU&R5&,:UL3O?H-'043P_%
M&IXG(07(8)9##[P,F?YLB/Y8NULN@ZWL=J*?)5#,^(=,/:^,KH&M9:GCJEVE
MZL5.+TX&D^S0H=O6@XZWK^,PU'#/E+) R"3OH5F?=Q*M+!8B'#XBCCHGET56
M!L3''Y(:.EPMWT?$[;0BK7 &NCE#F2!O;VA-;T36M;DDDQ=!D3WM\3)\O(6M
M8XXU*QF9,M-C6R6GS&4R/]^W*<))&R1CFO:"UP((/P0M:ABL?C*3*M2K'!"T
M=,B8/%K5K8W"X[&?5?1UV1>O,992!UY//W*Y>4TS6<KD?KK^*@LS!@:'2M#N
M@%@RFBZME,C7OV\5#+/" &/<!\-^.UFV#2=8SUF"?(8V*=\/[KG +;R6JX'(
MXZ+'W,=!+7C $<3F@AG7X7 J<9:/5$ CP%3N(]M>8P7+MY74]<RSX79#$U;)
MB;XL,D8=XA:]O2=3N-K-LX.G*((A'$'Q ^#!]@MS):EKE^O4K7,55GBK-\86
M/C!#!^&JFN5JLF)&N0C#";7:TO=FM$W[CV8HQ>R?'6<J35<)H<\UX]>FSZ9L
M([/Y<K[T3#7L)JN)Q]V4OFA@:'_AIZ^ I:B(B(B(B(B(B(B(B(B(B(O W"?^
MW^._P/7OEOP$1$1$1$1$1$1$1$11.YHVK7,M^T[&*@DM=]B1S02I8B$ @@K@
M8W5<#C+]N]3Q\,5BPXF25K0''M=].PG:)Y!$1$#FDD ^X1$1$["=HB(B(B=I
MV$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$([4,_J^U49S]L?LV,V_,O$
MA_*F:(B(B(L5VC7N5):]F-LD4K2U\;AV"%S-?UO#X"G]-CJC((N^R&CY*["(
MB^;-:O8@DAFC$C'MZ<T^X(7!PNIZ]@WR/QF+KUG/]GNC8&DJ0(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(6@_*^6P1L+G-: 7?/2^D1$1$1$1$1$1$1$1$1$
M1$7@;A/_ &_QW^!Z]\M^ B(B(B(B(B(B(B(B+&+58S^CZ[ _^SV/)?C[=9LH
MB=,P//PTN *^GVH&R",R-#C\-['97S%;K2/+62L<X?+002%E5><@[F[ 5:U2
MBWU<I>?Z=2+_ .^Y13:\SD-2P&,KW\O8]:]; NWODQ ^[O33=-YKT/Z+00Y&
M:'&7XS*^\TDR%C.NF_\ CVK/R<(S&"D^FN3P>K#YQRQ/+'CV]O<*D^%YL_D;
MF<GS.=MV7491"(GS$L7HF"Q!(PNCD:\?D$$)%/#)WXO:[K\$%?GU, \^Y&_H
M^1V/;^]&2QRL\F/:X?D'L*O,5K^PU^0<MDI<OYT)HR(JOJ$]'O\ "L1\L40_
M6\ ?DGI?3)&/';7 A#+&"1Y#V1KVO +2"%6'*&Y7-;Q544? 6[<XBC>_]Q@/
MRY:%S!\A4L6Z[C]P?;MQQEWHR1?YJ18<]E,]:X@;EQ?GJ9!E5DTKV^SB[KW"
M[W%N4N7M)Q5J];DFE>S]<DCNRY6-V$;8B<?%K@3^.PCI&-^2 @D820#[A/6C
M#O'R'?X0D!?!E#V.]-P)5(:[LF]1\AY+#93T70RUIIZX:?9@80 M74,WOU[-
M;#@<S+Z%@1&6">,=LA4WU'<K-C)V]?S09%EZON0S]R:/^VQ6*B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\#<)_P"W^._P/7OEOP$1$1$1$1$1
M$1$1$0KS]F:].MS;A9FL:Q]FJ_S/]MRU^2J,9Y,T*6.$&:9\@?[]=ABX7)>.
MMS\LX&"CD)X);3>O5!_<6OM6KY#C3.XK.X:]/-!/,(;?JG]]SEZM:>V@KSWF
M)'6N=\;6E\3'4I^<0/V)5VYW7L1G\:*>2K-GB+P_Q/V(6ID--U^]B:F,LX^)
M]:OX^C%U[,\/CI=E\$<%,Q1L#6-C(:T?  "H7A=C)YMW@EA:8S> /M\]^:Z'
M$\#*F9WS&Q$_2U<B(H(_LQGZU\:74%+D7;L=!+*VLT$L9Y>S"XJ(ZAJM_.;5
MNE&SF[OT%>]X3 2$2S$%P;VY27C&'(83;=JUTVGR4Z[^X&N=V6M6CK4UFMS;
MGH'7+$L3*DY DD+_ .(+=PSW<C[-GOKIYV8W&2^C!6C>6>9=_&]8L9=R.G<C
MP:U]=/-BK\?<#97%SF/*C;\5MF4Y,V/#4M@N0U?3>))G.+RQO?LT*^]%U_(X
M#7X,?>ONMRL>XF0_@_9:7(VE5=MP,E(N#+3'>==_X<%YXP^W[YQQ9CQV?IR3
MX[OH$DGH?EA5V;EEL;F>*,S?QSPZO+3[8JCQ6N9R]Q5!D(L[8A-6 R5ZL7;6
M'K[O5E4,WL^6XDK6Z<CWY.2%K/4!Z=_-ZJG9,C3U:[K\F%V"U/D!*&9 >LY[
M'E3OFB;/UKFN6,7D9F%\_@*P_<+UEN4-KTFIG]DN[ ^XZ6M[0$=-^H>H=:K;
M%;UN#,5&;,[//8R0V.^H.B/<-'FI=M6S[?6X\PMJW!/5EE?&R_+&>I&,6[J5
M2J[.8RYJN>M6L4YCQ=@FG+^G'KH]*U*6LXRIF+V78Q[KEH$/D>[OH'[-_ 63
M#ZYC<1-D9ZL;O5N3F6>1Y\G.<J2Y*><3R9I>2A)\YB]D@_('2]%!$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%X(X1#3O\ 0[/Q$]>]V_ 1$1$1
M$1$1$1$1$1%YXY8QF:H[7K.RXV@^V*I(E8%&]JM;ML.SZKEX]=GK0P3.$'O^
ML@_=RW^2\G9QW+&LW88))GQL[,<?R0N]LMBYR'>Q6.Q^.MQXZ"TV>U/.WTQV
MSX 5^@=#I>>MK@.(YCP&8L BM<C]#S^S'-7H8(JFV[=LUKVRMK3X>67$OK'N
MS$/)WF5L<682]B\)<GNQF*6];=8](_+&E5S!EL[I>_[+$,'/;@R]LRP/8M_3
M3M,')FP6,GB2UEEA+I(_=D?X"W^,[,K-MW8S4;4(O7#8@<]G0+&$K7U:]:?R
MOL$W[/L,J6VN#)GMZ';"M'#LG9S?F;,E2?Z>>*6%LOA[=ER59[7&V[9GZNE*
M</E)?59/&SLQN70I,9O'(M'.5&2C&XF/KU) 6%TKOP%KX"_8AYBSDWT-@U+?
ME$V;Q_2']KT.JFY*R^<PMG!9#&UYIVQSGUX6?#HRN5M'(&GYG69X!!/:EL-+
M(JIA[>'KB,P%W7>#KV.MQ2?5SQDF$#W:7K-JEP0\,O[KSN>R!T1C#/U]E1@O
MS1X1IQ48+#'Q3L9:9T6N=$HUM=J/(ZG@'X76;=:C3FC,SBSH&13GE38Q)7TZ
MXVE8$GJBP8',]VM5J[35@W'0[K:/DXVH!)7['7NJ<T[EK+XK$QX'(82W)?K,
M]&#H?OEOL ]3S/;3D\+A<*-DI?4LO$MOQL;Y^ =]@H!@<7BX.3,3+IDDPHOA
M+[[0"(FL7J<(O/G(M;]L\EZ7CH20^ 22RG\-)"G^6WLXW=L1K_[/>]MQI)G^
MS2K$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7@;A/_ &_QW^!Z
M]\M^ B(B(B(B(B(B(B(B)TA"HC9=>VFWR=A\Q6QW=.DX,<_R]W!7N BC6WZO
M2V/&/J2DL>QP?!,/<QR-^"%]ZL_9&XP19P1?51O+3)$XELH'\:D2JW8L#R):
MS%J;&;,*U5SO\W%T?912[KO-$4,CZ^SQ2O'PTDA? U[FQU&&0;+")W=><1<[
MIJW&ZWS /-QVR/V^![K3JX'FN?TY)]DAA#XRYS>SVQ_X7W'K?-/TKW.VB$3_
M ,,8<XM2GA^=8'QO=FL>_P!R'>9+UO/J\Z%__2.&(\C[EJTG#GQD[(VSX<A_
M\8'L%G$'/@^+N%3TN?O_ ,NPJ&'GT_-W"K"^+GIKV-]?"GR^X"=<_F9\)GQ
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MC&1X#S["XE3FC5+EW%UH66S]9\.,8Z83]G+H4,UIEGD7(U*].09F&![9K!C
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M[.OYW)W]<R%:*9T$<<KHI0""'@^X7GG=-%M\=W*VQZ[?D9 ;09)!^/)=??\
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MM8F?%)8S$4COH:;/9KR[^VH77K9UG,N*LYD5VVIZA)9 2YC0U;M__?\ 5?\
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MHX,RF!@<'%[N^WJ8\84J<6B:X8HV^]2.0_XW!0BG#'#S[DO3'7GB"\_WDA-
MR4,7(V^4;;C]7+<\X0[[Q,)7YN=1O];>D35>S,X2&?K[,9TFA9&K'R3O=6X[
M_3);9= 7_/I,)6OEC ><\46!O9I=.<O08_=7GC;35',VI^N'?ZH^'7]M-M^E
M_KFU3UP[_5GPZ_MIRQ5:_D'06F,N<Z67L-7H8*D^9<),*6/V6FT"QBIP\G[^
MD5!MMAN[WC[.VXZ:1D6*\/HF=>\I^92I;HV:?OFP4<V_VBQE ,>S_P#6)^B2
M/[O%?'T]>?G^<O:'>AB0]G\G@A,S!$SFS"2@=/EHN\BM#;Q">9M/]1[ATSVZ
M"P'*1XKGFX_)R^FR>F88''X]R"%<<N3UN'9JL+86/R=F!P$D;0YPB9UWY'\*
MN.,Q6.[\BDAOK#)?H_/CVY-7EK1<O;= " ][/(-5[.^%17&MJM#NG(T,DK6O
M=E YH/X!<L%5\<W/UX] ^GB$S,$3.;,)*T=/EI.\E$L)4P%CDW;J.>?)'8FN
M/=5)D\ 6]E6SKNL:3A]K?-BXWNO25G>JYK_-C6=CY_F58]ZLVS2LPG^.)S>O
M[PO-?"U]VNYS/ZID7".83><0/L#X+TO9NUZU=\TLC61-';G$KSKR[DY,WJV(
MRE-D_P! S(M+RX==_AZMG:;=2SI&2L![3!)2)!/P05145:W!P$P6S[/LM>P'
M[1N7H'68:<>J8T5F,$0I,\ SX]VJKN%XL:9]LE:QOU;<AT]WW\"7+D?0/DY;
MVV7$L]OV3*U\GV$[R%(.!;</]#I\>?:S6N/]5A6358O/DK>K,3.X0"QSQ\>9
M[3AET!@V@ M\_P!J$N3,9=F1Y&FP]!U:A/!4/U&2+ 9RWL=QL7 X]L8J'D[:
M*T&2-@O:?&21Y>Z0@K)H@%3E'>!8(C[G>X>1Z]BY:^ZN!YETTKHRRMQG/4C[
M3G!EO'>$+BMKFF"O>9KM&'WORY!AA;]O ?*Y.\0F+F'2'.(Z<MCF<0?TPTDN
M>1*)W]!>A1]U07-IK^IK'KD>G]>.UW^0]=U[:KE+''*"IEX(GS5'C[,4<XZV
M';Z^XW-7V%[+,D%9TD=GY>6@KT _HL/E\='M45Q1],W9^1&0> C&4'@!^.WK
M6URK$.2]\BK@=R1O/_B5FX,R$=?!Y/ V>H[=*Z[S8?D^2S8NH+'-N:O4PUU:
M+'!DTC?CU7E8N.;].IN'(K9YV1E^6'@"?GW>KW>]K6EQ^ O-69U:ME+.3VG3
M<W)4O,GE^IB+O$/>U,EG,OM?"%R_<8#.R3]9'MV(ULW]DPS>#8*OUL1E?C&1
M!@/OY@+CRN8?\GZ#W^'L[5GXR_@J7%\$X]/Z88P%P/0[);]PHCH&,MX[A[("
MRQ[#9BEE:P_9A7);5FM< 0LAB]1S V0L_D MO6<SQ!;U6K+<H8QDT, ]:!T0
M+_-<+DD&#%Z1L-;&"M1JO]J[1T&,DZ+5;,O*^L6*4!Q5EMR].Y@AICV?V[\J
MO]_M0X[ES4;=PLC@#?>1WP%Z+Q>4QV1JLM4K#9HG_NO;\%4ES+8BJSZO8E/4
M4>0!<Y<7ENY7M/U[8*4YL4Z%TLG,?NP%RF^_[)A+_'63FK68YQ<A#(&@^[R]
M2'CC#SX?3L-4G]I6UVF0?@D*;HB(B(B(B(B(B(B(B(B(B+P1P@ =_H=GKJ-Z
M][M^ B(B(B(B(B(B(B(B(B(B(B(XAK22>@%YWVJ;0KNT',U=Z&-R431$]S07
M>S%I7LGJV8NTQG>0JMVA 0_Z<1&(/D'P7J1[CFN)-JQ(HVL_48YG^HF ]XE
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M2O0,FAD^8W#L*'ZQQIJFLVY+6.I=3N]O4>?)S1^ NQLFF:[L3JQR=%ECT._
MN7?QV-I8ZI%6JUXX8(F]1Q,'36@+0V'6\1GJ'T62K-GB\P_Q/V(6M#JN!AP7
M[&;CX?H>NO0+06%1/!\4:?A\E)?AH,?+Y]Q>8!$7^!64B(B(B(B(B(B(B(B(
MB(B(B\#<)_[?X[_ ]>^6_ 1$1$1$1$1$1$1$1$3L(B(B(CFAP((]BH9+QWI$
MLTTLFNT7OD>7N+HFGW*^/ZM]%_ZM8[_V6I_5OHO_ %:QW_LM6 \8:']0)CKM
M+L,Z\?3;XK3EXCT*5[7?L. =?@ +$_A_02XG]BQ+)'Q'H+!U^PH"OB+A_08Q
M(/V+$[S_ "OC^IW0?^"QH_AO07-Z_8[ G]3N@_\ !8T_J=T'_@L:?U/:#_P:
M-/ZG=!_X+&G]3V@_\&C5D8^C4H4X*M:)L<,+ R-C?AK1\!;"KW(\6:5D;UFY
M9Q+'S3R%[W_DE:/]3V@_\&C7P_AK07=?_BA@6.7A;09(1%^R_'^;3TY97\-Z
M"YO7['8%A/"N@_\ "_X_+Y6E)P1H#SV:MEO\A*N@WAK0 6__ (I:>F]+6GX/
MT"4L)H2,+?LQZ/X/T!U9L'T$@Z/[X?T]8ZG!>@5I7O\ I)IOPV1_8709PUH+
M6 ?L=A6%_"N@GTA^S"/#\.63^IC0?.5W[)'ZUK0<(<?P->T4))/+[R/6<<,:
M  1^RA[O+DL<+Z!/$8_V4(_YL/17W%PSH,<;&#$!W0^7+&.%M!#WO_9?ROAG
M">@,=&?V:X^ ZZ+EL#AO007']CL0\-Z"7M/['8OO^IW0?^"QI_4[H/\ P:-1
M7+?Y/VHVV?Z'-/4?_P"X%O8;@C2Z$;A9BDN//WD7<_J=T'_@L:?U.Z#_ ,%C
M6*/AG06!W_XH![<3[E9?ZG=!_P""QKLX+CO4L'=%RABHHYP.A)T"0ILB(B(B
M(BJK8N)L!FLV_+-LV:=I_9D?!_&2MW6^,<)A,BW(NFL7;;!U%+8/9C"LA$1?
M,T3)(WQN'8<T@C^15?:EQIKFJW[EVC$XS3$@.?\ +&'^$*PUCR%".U2GKR2O
M8)6EI<P]. /X*A>H<?X'4I;AQ;[(;/X^;7O+A[*<(B(B(B(G81.PB(B(B(B(
MG:>01$1'/:T$D@(UP<.P>PB+#D\96O4)ZE@%S)F^+@#U[*+Z[HVO:Y/+-C*G
MH&1O3^C[%2Y$<YK1V3T$!!'81/((B(B.D8T@%P':(B(B(B(B(B+ASZMK]C*_
MM.3%577 >Q8,8+PNXB+#9O5:P'JS,C'V\G =K+:O5JP;ZDS&!SO$%QZ[/X"_
M41$1$1$1$1$1$1$1$1$1$1$1>!N$_P#;_'?X'KWRWX"(B(B(B(B(B(B(B(JL
MW[=;F-R&)P.)DB9DLA)TR23]R)BX^=_K&U7%'(-ST>2@B(=99-#XN:/RP]N5
MRTK;+56&=KO)CV!S3^05F[")V%QF9_'29F7$MD)LQP^H]H^&A1'9:F\2[1@I
M<5:C;C6.)ML)(5CIV$["=A%77)6Q;+K>%?D,7CH9XXQW.][R#'^"&]*1:AE[
MF6U;#W[3@9K-2.63H=#R<%#-DR_(EO*WJ6M4*L457H&U:/[[OPP %.,MZR><
MDRF,SE7T<E0D#9?'X<K63L(G815%RCN>RZRRB<?1C]&6=D;[3SWXEW\(:K<8
MXEH)_"JK<-KVJ'-LQ>MXV.W+% 9+?G[!G?[@7?T7);E<J69=@Q\51Q+/18P]
MN_GY+7VK<C2OU<)BV"?+62/&/^&*/[O>IY"96PL;)+YN ]W===G\]*I]_P!I
MV;!YS7F47P"G;G].8N';U(=BVM^M92%^183B[#A&VRT?ZF7\/_D5.89HY8VR
M,<'-< 01\$%?J=A<C8\U#A,+?R,H[CK1%Y"I.+-\LVL5C=BHB"Q!;Z>['-9[
MLB>KT=DXZ^,^KN?Z.UL8?)Y?+?Y%13==BOX_2[>:P_I/?'&V4&3X\"LO'FP7
ML]J>-R%TM]:9G<A:.@2IJG814?R9O.U:EDZ8J5Z\U2V[QC<[V+'*0//*(KR2
M-_91>&=M9V?<_P!_BN]H>>RN;P)LY.J*UJ.S)#)&/RQ3+L)VG854\L;7L.L8
MBI=Q8@Z?9;%(]_N07*Q\+?FMXJE/,[M\D#''^\A;Z=A.T[")V$1%R\]F*V&Q
M-W(6'>,4$1<2H?QENS]NU[ZN8!D[)2R9@5B)Y!<S,YO&X:DZW>G$40<&]_<D
MKI@@CL(G:=A.PA*I6SL.TUN6*>*DNC]G3P.?%$Q72/A.POU.PB=IVA("^'N\
MXW>#^NVGQ(]U3W&F3SEO8-SKY+*RVC1NL@C)]F_?W 5R-<UP[!1TL;".W =I
MVAE9^4=(Q@[<>@@<"/8IZL?EX]CO\(A< .R4:]K@"#V"JQY3VZSKF#B-*1C;
M=JRR&,GY:'?+UPZVL;_BMGQ<U78Y[V-D_P#PP67$^/\ <%TN2=SO82?#XJ@Y
MD5K)2%K;#_B)H7+V6GR/KV)?>QNR.R)9UZT<T7\/Y9[E6Q@+TMS#8^U*\N=+
M78\N/Y(74$K"2T$=CY"%[1\E<W+-N38ZY'1E#+!B(C<3UTY1GCW'[3CM?%?8
M,BVW:$I_6'E_M_-Q4W,T8<&EP[/P.T[ "_6V(GGIKVG_ ,0BY6>R];#8F[D)
MW^,4$9<2JTXCY%M;93R4=]W5N"?L#_[AZN!5[RE/F:&K7LGB;\E>:H _V/LY
MJKS73R%E=0@V"OM<AL&,R?2R1=QE3'B??K.WX.P^XUK+=5[63]?#NU:7U$/0
MZ>.B?R/=?KY&,';G !?OK1EA<'#K\JALSDK6T<CV-<&4GKXNK2+Y?0D\#(]3
MK1\-GM?KY&ID\O\ 5U1,/H7O=V\1_ARGS)HWCMK@?[D,\0\AY#V^?=#8B_3^
ML>_Q[CW02,)(!!Z^5C-NN)/3]5GG_9\AVLG8 5/<QV+G]$WSX_*OA=#9C]5D
M;_=["K+UV1[L)CW.)+C6C))_N53<B;ADX-JP6MU+OT,5[OU[0_?:/Y+7VC7]
MQU[#V<GB-OR%H1EI?#,2\EOY:>U8-_;H,'J,.6ORATGH1GQ)Z<][E+,3DH[^
M.KVF^/4D;7] ]^[EE^LK&3T_69Y?V?(=K-VM<7:KI"P3QEWW:'#M47RLS(UM
MHU6U!DYQ!)9#'UPXABO:2S!#[2S,9WW^\0%F9(Q[ YK@0?<$+YGM00C]<K&#
M\N("_89X9(R^.1KF_D$$+!]95#'.,\?BT]$^0Z!_!6>2W R(2&1K6'^(D +X
M@M5YN_3E8_K^R05D6A/EL=6LQUY;<4<KP2UCG $]+<^J@9#ZIE8&_P!HGV7X
MVU7="Z9LS"P?Q ]A:5K+X^K1GNRVHA!"TE\G8("C>C;Q0VFA=M02,;U;?'&S
MO]98#[%22QFL77L,KRW862.!(8YP!]E%-UWS%:QBF6'S,?/.0*\7]M2ZGEJ-
MNB+,-N)\/7[[3^E8Z>>Q=^1\=:]!*YAZ+6.[(*S6LK0K3PP368HY)#TQCG=%
MQ6)N8QK[II-N0FQUWZ0=V[I;\T\44;GR/:Q@'9)/0"\O\T2XC*3:]=I762O%
ML1DM?^E6GR+K>%SE/&#(Y<4A7L->#\^:GEC)XS&Q1"Q<CC!Z:WU'>Y6.38,/
M'<;3=?@$Y/0C\O==26>*&-SY'M8UH]R3T H_5W'6[EIU:#*UWRM^6>72D4$\
M4S/..1KV_EI["_41$1$1$1$1$1$1$1$1$1%X+X/AEEWZD6-[#(7N<O>C?@(B
M(B(B(B(B(B(B(BI[E;CJ39H(+V,>&92I[Q'X#PJTU_EC-X:V[![Q0>^+]PSN
M';E9_(NZOPFM4#A/URWWLCK/C^ P_=JK2UDMSQ-W"7,5/L5F(O\ "TR\/T//
MY #W*S=EV#)9/;Z>HX^=]7R@^HN68SU(R/\ #%@Q6*W;#;RZO]=;NX*S"7>I
M.\O="5"];U=C^4]HC.3OCT??S9,6O?V?AQ4LW3*YJAR/I56#)S,J7)'B2!IZ
M!\%N;KLN1GVS%ZCBKAK2S@R6[+?WXX_PQ1[9K6Q<?97'9%F7N7\/8E$-B*R\
MO,96IRCL&S5=GU08++O;%>[+(OB,D?E<[:+.[Z5L6&R-O99[M6U/XSP'MK 3
M]FM7IMI[':@/*?\ N]V3_E5L<;_["ZU_W=#_ /%=O9+V1QV'MVZ-!]R=C?T0
MM/1<J4X9V:"YD]AK7X'Q9JU8-BPK[R-Z*C1L6I>_"*,O/_@J6P(VW=\;+GX\
M]9Q@?([Z*I$/T=#X+_<=KLZ-M^9R];/8C(RL9F,<]S"\-]G]?Q*N=;S?+>P8
M_*"K=B$M.X Z4D]R'[L:O35$V_I(/JW S",>H1\>7WZ5.<Z?[*X__O>LKGC'
MZ!_<J"VG0-VIY?*;!K^Q3&>>0ROK'MH('PQ2_C/>+>R8.[^T(O3R-%_A;9UT
M%%.+#^V]MW+/V8NYQ:$,#_Q&226A2W<-JOMSN-UC#R"*_:_7+.1V((@JKWW'
M;1CMBUB&[E?KZ+KH,<KV]2AZO?=L3'E]7RU-\0?Y0N+?Y.:HIPOFILIHM(S2
M=R5G& ^_9Z8MGD+;\CBI<5A\0(SD\E*60%_PP#Y<HIG[^^:/]%D[66.5H%[6
M7&/;XEA/W:NERO%=RVBVLICLPZ*F*GG) &=B=CUU^*Z&3@U/ RRY0S5WT(RR
M Q]%G8_*Y7.%*]+J+Y8<D^&..9@EB:/:7M:&5QN1H\0YOZS*ON^=!CH_)GAZ
M8_"A.KS<@LX^HVL3/5J4JD!?[DNDF(5D5.39G\7G97Q,-D?H,8]FF55[?WS:
M:.+JYB#9X+=I_B9\8(7> :[WZ8O1FKYYF:P-'(B!\3K$0>8W?+20J,Y_<65,
M"X-+B+BD^7WG<:>'DLQZE98?3!#B>_#^;PI;D8M@RNH0R8V^:N2=$R4/ Z#G
M=>[2J@QG)6>BUK+X/(V)V[2R;TJ[#\O)5JTKV9UC2I[^PY VK,,/JR_R=_8"
MK[ZODR_K$6U4LJ!)*!-'BVQ]L,16'E^[=N\98:W;J^C8EMUGRP_AQ:5I9O+<
MD8G6J.>CMU:E.%L(%,$R=L(^7E6%M6TY[^A>,O8.#UK5[T@U[/<1B0$ER@MS
M:=AU?<M=H6MC.2KVQXV6?=A74Y&V?<\/O.!H8J8/KW 1' ?8/<W\E<W)9SD?
M5=JPPR=^*Y2O3%CHV^S&%2OD+;,Q3V'7]=QDXK/R,CA):([+ %%MBRVZ:CM.
M&Q,&Q/GK920_YVQ'ZCXRU=;<-VR,.UP:TR]/78RIZMJU!%YRO_ 8.QTN3I.X
M;/!N!PUB2YD<8X 1VIHNI&./QYKT2J=W^]6S.P8C4GO:(93]3>)^T3/8-4%P
M,M31^5;&,@G8W%95OG"QI]FO5Y[GL(U[6[^2Z[?$SJ-OY>54K\?R;8UO';!#
MF[#\B2V1U!@ZB+'K7YPQMRQ@,#D9K<L4C;<,<M=O[GF]7KA:$]"F8I;\]DD]
M^<I[/7X4(WRUM)R6%QF,<^M4M.?];=9\P-:H+JVT9&AR4_6V;!/D\>^ ELLI
M+G-D6ID,IR))RC=P5/+@L-9TD?G[,BB>1[]?=P73U_,;7@>2SKF2S$U^K/6,
ML<KQT>RI#:S&9VK:LAA<5D'TZ./]KEJ,=RF7[,:H!7JY>AS/C*5^^^XV*J?0
MG>.GEA7I>:1[*TCF-\G!A('Y(7FV7+[-/@<KG\SL4^)MLF<*-$.(;[?9X"E\
M>R['E.(OVO!:+,D*WF7L;\J&X>'?\[H$&4&S6*[H("^)L?;Y)R/O(]3K5LMF
M=WXU$XO2U;Y\F>O$2TE\:XG#FQ79JV?HYS)6I<E5E_SK9I"[IC>_W%*N-?K;
MS,OF)<G=GK6;LGT,<SR0V 'V(6ORSG,CBL90]&>:O4GM".W9B_?C8M#2ZQ=L
M;+F%V>?(8(U'L]"68O,,H(Z4+U?'[)D=TY J8W)_0U7Y(_43M;W*#V[H,4JX
MTFS6,VC9-<O926[%5(=%++\KF[%!/+DL_:V3.6:,<4SAB(8)G#L-[_7XA=?C
MO/9C9.,+SI<K+]?&)&"?L^8Z^"5!=#Q>^;7K5*^-FEB;6ODL!)<Z3\EY7>OY
MBSM&U;%2LLS3J..D^G9!C_8%_P#;D/875X\M;W3NY:ADZM^2@V.1]*S:_?\
M;X:?<J!8+)Q9UF0-[9<A0V=TCA&QTKHHP._9@7J+$?5LQ=067ETPA8'GOO\
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M/0 [)48UC=<'L5C*18U[Y/HI&L>\CII+N_W5)T1$1%^331PQOD>X-:T$DG[
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MS\*]Q\%4-MV W6GR/%L6 JQ3LL5A6?Y_$:UL_A=Z?O\ B<S6QK)8:4;8WO\
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M^?8_A;\ +I:-A\SA<)!C<C-#**S&1P/C]OT-_*ZVUX-V;U^_C!-Z1LQAH?\
M)8J\@PO)^*IBE4R]*Y&SJ..:=I9(UGY/SV5)-2T>M@J.198L.N6<@_SNSO'7
MJ.53VN&]CQ.5LRZKGY*56>0>3 \L(:ICE^-KLND-P%'( 2S2B6[/(.W3/^Y4
MPTC!Y;!:[7QMZVR=U<>$3FCH!@]@%$<#H^RT-[O[#/DXGQ6R_P!2$#[$]A<S
M<>)[^1V0Y_"9A]"U+_K>O92C$Z%/5U[)06[\ES(W8@V>W,2Y1>70]XR>*K87
M+9VO)0:]AD+8_P#.D,5TTJ,%&E!5@;XQ0QAD8_#6JN,II>=N;S3SPRS/1JDL
MB@+/B-WRK/<PF-P'M[$!49@N,=CQ.WW\U#GHXV697OD8V+V?Y'OHM5ZN#O ]
M'H]*EG<:YQV]-V8Y]ID\?@P_'X8%=/V53;7QUD\UMN-S<.=] TR?19Z0?X*;
M['K%78]?EQF1?YME [>T=$/'\05*8/A3*4[3:EO8IIL0V0.-4>PEZ5E[UHTV
MSXJOBX<F:-6,AYC9$'=EOLU=+$:M*W5G83+7!>C] 1%Q9X]M5-4^"\C2R4L5
M;8YXL8]_O&SV>0K$W#CC]N:_C<)3R/T=.IX%K/3#R2SV;[J45,!D8-7.).6\
MIVP^BRWZ0!Z_);VN!Q[H,^F5[-5N9?;KRN#A&Z(,\7+D\C\45MKNPY&K=-2[
M"WKS#?WUOZ%QVS7/4MWK;[N1>TL,[_?Q8?X0N%F.(YG[+-EL)GK.*-HDV1"M
MC2^)VZWL][-/R\UA\@>UH</<AY[)>5<5BNV6O+&XD!["W_S"I2CQKLNK5@W6
M-B< XGU(++.XC_,!234-%DQN1?GLK:-G,SPADT@_<9^6L7*VOBV3+;=#G*F8
MFI/=&&6?3'N]JZ.U\=PY22GD,;;?2R=-H$%@?@?9RQX+0\F,Y!G=@S3[]R&,
MM@C\>HX>_DM3?N+,9MUNM=%V6I<A]A.QO?;4TOC&IK5VQD)<E/>O21F,6)!T
M6L*QX'C/]D;)E,N<S+.V\'^O ^+Y+USM>XHGUW/SY/'['/%#+,7RU1%^AS?P
M?=<?7\#)#ROD<KAKKYZLOK?M N9XLC>]P(8PJ]KU""[0FKV!VR5A8YOY!5*X
MSA#&TV7*LV9N3XZ4DLI?#&N^SBE'A:O1URSBH<[9#YIV2&?Q^ S[!O:Z<7&%
MVUE*-C-[+:R4%-WE!!(SKMWY>>RK?53;7Q13S^U09MV5G@+6-9)'&/WPU;L_
M&=*39*N<9D[44T#6LBC;^X&-_A3.<94\MLL6<?F+D=B%P, 9\1@+!O7$V#VZ
M\R[/.^"PV/P,D8_>71T?CK$ZA!8%5[I9INO.=XZ<L&*XWJXS9[.?CRUQ]B=S
MS*UWPX/6*GQA1I[;+L<65N_4R3.?(W[.#O<M*LY5OG.-:&6VBOGGY.Y'/ 1Z
M36?#>EGVSCK&;-EZ.1LWK4<E7_5MC/30M#:>*\-L67I9.:U8CGB8&2/9\R@+
M#4X<U"CG*V3K0O886="(?N=_E=7"\;X3#Y^WFH+-U]N=[B\OD/1\SV>UGCXY
MU^#:'[%'+;^O=(7%WJGQ/:PWN.,+<VO^D3[-L6VO:6>+^@ U-WXTUS<)&376
MO989[">/Y75UG1L#K6*FI8^#P9*WJ60_OR*%P<,Z[6B9!!?R+:KCW/6]4^G*
MK<I4J]*K#!%&&11,#6,'P %]HB(B(B(B(B(B(B(B(B(B+P-PG_M_CO\  ]>^
M6_ 1$1$1$1$1$1$1$1$1$1$1$Z"(X'H]*I<5H.7K;[:V>?*L>9O-AB$?\!/8
M"MH#I$1$Z1$3H(B)T$3H)T$Z3H)T$Z"*O]BT.&[G:V=QMLTLE$>GS-;V)6?=
MKU8 :L%R.PZM*('!LA:0QQ^ 5'-:U>'#?56)9W6;UMX?:LO'1>[^7X"E2=)T
M$3I.@G03H(G03H)T$Z"=!$([3KH=!4C:XJOY'<[62R.:EGQS[!F%7_[S5=P'
M01$1$1$3I$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$[1%\1Q11?I
M8T#W[Z'M[E?:(G:)VB(B(B(B(B>HSS\.QW^$1$1$1$1$1$1$1$1$1$1$1$1>
M!N$_]O\ '?X'KWRWX"(B(B(B(B(B(B(B(B(B*IZVZYT\FSZS/4K,@9 9F/#R
M7%JM@(B./050X#?\S>Y'R6NV:,4,5:*1S2'>1/@0%;Q/LJEQ.\9BWR=DM<GJ
MQ1UJ\$CV$'MSNB "K:1$1$1$1$1$1$1$6EE;KJ6/M6&1&0Q1%X8/EW2C6@[9
M9V? ,R,^.?3>Y_CX%3)$6,6(C*^,/:7M +F_<=JM\7O]FYR%D-8?C1&*T3WB
M<O\ =W@0%9B(BC&T[AAM9IB:]*?-YZBA8.Y)'?AH4(=O^UQ0ONS:9:;2 'N'
M]R_WEJFNF;GC-IHV;E)DS&QS&/J4!KE*41$1$1%KRWJT4\4#YF-DD[\&$^[N
ME!MOV7/XG+X*"AB_J:UF4BQ+_85@HB*O.1-WLZC0JVH<8;?J3!CAV0&A33"9
M>'*XFE?A'^;L0ME8/Y.':WT1$1$1$4=VS(Y#':_D;=!L;K$,1>P2'IJC_%6T
M939-0BR.1\/J'3/82T= @*=W'S,K3/A#2\,):#[#M5WQCM6<S]#+/RIB$L%T
MQ 1CV 5EIV$3L+1RLMJ/'VGU/ S-B<8P[]WL*NN)MOS>RXB_8RCH_5BM>#0Q
MO705I]A.PB)V$[3L(JDW[:=FP6<U]E%\ IVY_3F[';U;83L)V$[4"WZ?=(<=
M5?K44;Y#9:V7OW(8I59R<6*QCK61G9&V-@,KQ\=J!<H;#G,-JC\IAYHV$.;Y
M.>.STY2K3<G;R>JX2[;D\YIZ<3Y#^7."DR>03L)VL=_)5:52:Q/*(X8VESWG
M[ +'B<I2R6.JWZCR^*>,/C<1UVUP[6POD=MD<?4['0]E])Y!$["XUW8,=2RF
M/QTTA]>VXB-C1W[#Y)797.S6:HX;'SW;DGA#$/<K>I78;-6*>+OQD8'#OV/1
M7WYM[Z[]T1/()V$[1.U26.RN?9S/D<59R<DE,8]\T4(]F-[<%=H(14GN.8V"
MAR3J%*+(O;0NR'R@;[>[%=@<.R.T) 1LL;P?%P*H[F;+['B(,1-CLC)!!);;
M',(_8J[V.[8"3]E3W,F4SF.UV&[B<G+!U:9%,(ON'JS<!8DDPM"::0N>ZLPN
M<3[DD+JLFB?^ZX'^X]H7L!Z[02L+?(.'2-L1//37@_W$+]1'O8P=N( 1DL;Q
MVUP/]Q7Y+8BB'ZGM:/R3TC)&/';7 A?AL1 N'FWMOS[CV7S'8BF9W%(UW\VG
MM5N-5R@Y$ES/[=)K&$M%/M6/+/#"T&65C!^7$!9(IXI&^3'AP_(/87Q+>K,?
MZ;IXVG[-+@"5D:YKFAS2"#\%$1$1$1$1$1$1$1$1$1$1%X&X3_V_QW^!Z]\M
M^ B(B(B(B(B(B(B(B*J]MV7:8MHQ6!P\$<7U+#))=D'D(VM7+U3<]D?OF2UG
M*S5;?I5WRQV8@&J.3\A;_P#T[RVO5,=6G>SR$# ?9@!_?>Y=_2MPW([MD-;V
M05O7CKF:-T ]@%U[6S9_.[)>P^O200PT"!;N/'J=//\  &*OM5_;O]=EUN;]
M$VX\4YGG'[->T$=.7I953MNS;*-HQVOX01P/EB,TMN5GFQK0M/2=XS5C;,OK
MN8FK3SU@Y\5B+V#F!+6V;-L6=R&-U9T$4% ^%BW,WS!D_L-"KW11FH^9\N,R
M83<%&7U71>S#^H*Q[6U;+GLSDJ&K.K,AH=,GM2^_<O\ 9:%7>E/V)_,N2.;9
M$+_[,D[##VSY"Z/]9.^/V3/8&+&1.N1=BK$WW8WQ^7ERD=WD+.8G7L#6R4$<
M.>R/L!-^B)G7R]ZY&(Y.SE#;:N+S%BI<K6>_2GJM_</X<I1LFX9Y^X,U?#?3
M03BMZ\EF?W'7X 70Q&WYFOAMGFS59@L8N3HB'W;(/?W"@M;>]^M8"'8:T5">
MK(]GG69[R0-*FF[;])BK]##T#"+]D>9DF/443/R5&=7Y1O';!KF8->9\H'H6
MZW[KRNED]QVNWMN3PN$CQP^B \A9D+7R?S8 TJ;:'G<SEL')-EJHKVX[4D3X
MQ]O!2/*Y!F/Q]JTYI+88B\M'R>E0$O(>^1Z\W:WUZ,>.=( *9/ZRT_?M37<=
M]R>.TBCL6,IPRLG9&]X>[]P/"@5KE3D 8:KG8M78,<6 O?YJ49SE*XS2*.R8
MG'QSQ2D,L!S_ '@>N%E.4-UCQL6<I:[WB@QA?)+[/=W\D!6-/R;B8]*AV63L
M12@!D7W,A_@5>7N4MCPW['R.3K4#0O$$Q02E\L0<IUM>_/H186+$51;M9;_\
M$#B6LZ_)*Y>N[[GF;<-6V+'PQ6C'YMFKR%['+C[+RQF,+NLN!&#]8>!]#P?V
M^8N_<5AZ%L.<S>)EGRV+=1G9.6&-2+-WK-#$WK5:L9Y88B]D/?7F0H'IN]7]
M@T>_FVT&"Q$^3PK-=['Q4%PW*FXY_ S3XK7A+8A>\SN+NHF#[!OY*L[C7=CM
M>O"Y+!Z5F.0QS1J;V_J!7D, :9/$^ <>AY+SAQY=W^[MNTF>2FYT5R..Z2XG
MKP[ ;$F<R\V)YMO35Z;[-B3$B*"!G\3RI;IO(6<N;;=UW.T(JMML7J1!A[";
M'R-;&Q3X7#R4F/JL)LS6G^+//[,;T"MKCKD>78[N0Q5^"*.]4/S"[SCD ]B0
MK</PO,6']?9N;,F^\POK8KUFP-/NUA8Y>G/ %ONHE#0Q.IU<[D0[PAFF=:F'
MV:??X5=LVWD:]B';%1Q5/Z CU8:KGGUI8?S\*01<C?M31+N=P]42V:[!ZM5[
MNBQR@F$Y/WC-1X>U1U_U:SI/2M/^ 7G\+<')VXR;+F<%%KS)+D+B(8V/[8 /
ME[G+H:AR=FY=J?KFQXUE2T03&]I]G+J6]KV7/YK(X[534;#0(99M3>_ZS]FA
M9M0WG)3YJYK>>@CART(\F&(]Q3-4(L\D[V[8\_@ZF($EN D5XV#L -/[[BNU
M/O>[0T=;QTN(9!F,HY["Z7]R+P_B(63!;QL]?>SJV;=5LO=$7MLP^RK[,C;G
M\SQ5X\G$;#(BZL7L[9'$_P"W2LW<]MV[ 937*L(K^A;E8R:?Y<7?<=+O[KMF
M2Q][&8;#PQ2Y.\\^ D/3(V-^7N46O;AN&H7L>[9G5K6/LR>F;,#? Q.6MR3R
M!L^O9[!08N."6M=';?N^1<Z_O7(NNY[%/S]>E%C;TW0BC]W0_P![E=F?QEG+
M8Y]2"\:PD($CPSR)9]VCW'7:Y^8LUM1U"U/4K]PX^J!%%_)OL%6>-V;D.7'X
MC)BQC[U6W/&)&0-_5"QX5\!4QROO&Q:F[&/Q\,#H9Y/%Y=[N6/'[IO-&QF\A
MGL.R#%14S8@>P^[?Q&HC=Y1V88&OGH,GC@)7M)Q8!<\,/V\_RIYD^4H(=&IY
MRM5)LVWMBAKG_P"U*Y5[/<FX!^$M9!L%VK8>&6H(8^C"]RDFX[AE(,OC]>PC
M(SDK@+_5E_<A8/N0HU>V_;M/V+'P[!9CNXNV? 661^F8GK!RAO.V:[L6&JXP
MQ/JW/B,#M[RU=+%9_><'3SN3VUL#:[ #78P^X<?ABY&:CY$NZA9S<F3KM,U8
MEV-$?Z&PO]_W_N\+M\#RR2\?5O-Y);9D:U7'<_U$G^$__>7E32X]\N1[%6P$
MT%2$7Y'NL/)\W/!/30ISQ_R3EISG\9LH:+V.!<\L'[S6)A;6][IC[.9J9LXR
MJ9'_ $59L7D7L']L]A=;2^1)[F/S$&=8(<EBB1:#?A_7W"Y&#L[SN=&WFZN;
M=C:SWN^AK-C[\VC[O7?T'<[V=K93&9>-L66H%T=AH_=?_,*N=)V&'"X+9*E4
M.?D+.3?'2KQ?OEWNK2TVCNE#%RW=AS#[$[H"?I?LP@?E5WA]BV_9L/;RN-V5
MD60:\@8D,]F-7H##R7'8VFZWY>OZ+?4\OD.Z]U&][S67P^!EL8JDZQ:=(V-@
M'N&!W\9539+9MLU?8-9BGV,7C==U;K.'7@NCREMFWX+:L!4P\['0W">H#[>;
MF+0R>9Y*US/X&?*9."6"Y9].6K%V&,4YW;;;];*4-;P__2=T]^J?W8(_N\JL
M=^Q>QX[.:LRYF?KZCKP(=(SQD:]>G1]_[U4?+U_:,3A8LKA;\D+*[^K+&_=C
MEP-QV7.CCK$[)B,[-$X0Q^HP_,I>%UJNUW[7$U?)0Y*63(RL8P2@].]=WV6G
MR#E=QUK6->GBS),PL107'=>\CWK1YVI6W8+'66Y*=L9NPQ& ?N$N[_4MSD;#
M7:'&&5BGR<EQS71O\Y5"B.0ZO'.,S57+Q5:M*G"^*M'\OB ^7E6#>Y/%;CS$
MY?V.1O,CC8S[>JY:^<Q6^8/%#.0[++;L5V!]BFYO4+V_<-7WLF[6\CQO!LF(
MM2U)#+&',!_/RU2#;<KEX>-Y\K6OR0VH:L<WJ#[JN=S?E\SP[C,E;R4HFDBA
M=,UGLV7U!_&K7XZPMK%:UCXILC+8!K1>+'?$7M\-4URF0@H4;-B3_5PQE[OY
M]*AL++MN]X:_GJV;LT!ZKA0JPDAOZ/[:[@W/9<'QR<IL, CRAD]*.(CKS>?W
M>UH6M=WF+!MS=?:+LF2$0G?5>2*Y^Y8&]K.SDZS?XRLYZG!_IT/4<S/M&\_+
MEQM9DR62&&R.&W&S>>9FF]2GE/1:N7MNOS6>8:$<68N0FS ]XEC>0Z(>WLQ>
MC,94DIX^K6?9EG=%&&F60]O>1]W*D>>Z,K\!0G9=L,!OQ1&(//@?-2#8<C+Q
M]I)D9<MW;$CXX8GSO+_\XY<"_J.S1ZPW-0[/DOVRR$32 O/I/'R8O%6!QSML
MFUZM4R,K R;LQS ?'FU2?-V;=;%W9JK/*9D+G1M_)"\QX#*Y+9L)ZU;<K\6?
M;9#Y:3Y2QA;]VM"EO)>7S.(W34OH\G;BCMO(GA$A],^"^^:LEF,59PEO'Y:Y
M6]2QZ4D<<A#'!=O=MARMC8\)JF,LOJON OLVF'I\<8^S%L5,!N>'W&F:N7LW
M,+*S_/BT\R.80H/G8<O/SC9@QEGZ>67%ACY_#S,<:Z6!M[/K/),6 MYNSDJ=
MNKYL?.3Y-*] #X7G?ELY(;UH9QK6&WYS^B'_ !W[+1S\.YZEM>NVY=EM78[T
MY;9B>2V,'\ *5;SG\KD-TQ6GXV\^H)!ZMR>,]2!GX:N%M5;*<;VL;D\5E+<N
M+FLMBM5K#S)[N7SSI-'/1UF:)_E');:YI4SY#V;(4Y\%@,:]T5O+2%@G'S&Q
MOSTJ[Y7TR3 ZQ'/1R^2DA=<C%F&68O9(3_&5(]ISUV"EIF"JLM$9"$.L&M[3
M&*, %K%P*=3;,1N&/FU_&9H8J3IMN&V?98=G9M]OE^?#XO-V8HY*WF>W$MAB
M?\^ 6_L^/V/1]+%892W;@ER'5FR.Q(R$KK:9CL!<SV/RFLY^=]5D+FVJD\I<
M]7T$5)[-<N;!R)!J)M2P48JGU5CTG%CY3[ !;^%U38]=W">:ID7OP4L#G&"2
M0DLD7!P563D/,Y^UEY9Q0IV/0JU62$,[]_UE8M8L9G5>0Y=3DN36L;;B,U9\
MA[>Q1^IKN8RO(>VXD[#:CJ_,I^9',[]F)KM;):!R52P(R$L^,R#"(6%23'P"
MMSUD6>M*\.Q3I#YN[Z+W!<#,6;6V[MGZ<N-FR-''/]%E3U?!K7CL>?2D'&V#
MW/"9O)PV*SX</+&\UH7REYB(_<"@QFU>SE,OC=L-J#-R7)?0O/\ W6-[_1XN
M7I;4Z3J.N8FH^V)S!5C890>P_H?*[R(B(B(B(B(B(B(B(B(B(B\#<)_[?X[_
M  /7OEOP$1$1$1$1$1$1$1$14+O.U2G>\=KES(24,7)!YSS,<6.D[^P<%"-4
MR.H8GE\#&/\ ''2T/0BEZ]I)"1[J4X*2 \_9DQGV^CD!_P ?F%L2V(8^?+3"
M_HRXCTF+B:)GJ6G;EMF+SLQ@?;MB2&:3X> 2OB#8<;D.>([&/LLFADJ" /7I
MX?"H'==F98W^'6<EDY,?BQ6$LKXW%CIWGX82J]TN[K&/Y:R?T$[649:TL59Q
M^'N<0IAQUL]+6<[LV"S;Q4F?>,L)?[!RUL)GJ.7YNREBO8C?$_'200O;\/Z(
M6QQSM>.US-[+@LR\5)WWW21.?\/7QB-EP^2YTLV*=H2POQQ@9(/ASP0NYJ5Z
MG-RSMXCG8XD=#^9:5Q^8B,1M.KYV>HVU4C\XYHWCMJET&V<>3BJW!05+5Z9[
M1#7CC >"?N5K;QK6L[/G9X&9%]//TH&NBD#O'L%</0=LR@P&V5=L>;46+<(I
M9OW^P>P5$<KK\FCQ0[+J.?$E.:=C7U?L\.71VZY'B.1L3L.9H=X^]09%*',#
MPPJPZF8XT?F\6_#5*-G(3S!C)((QY,;]W$K@;3J>"VW*97*X+*&AFJ$[XI/A
MG;V*7\3;%FLQK]EF6>V2Q5L^B9A_& I9N>5=A]8RV2%=LWH0$B-WPY>:<Q=P
MV5XTFR&4SIFORQ!U>FPED4#_ +,;&I)F+].WP/1$$['F&"M'+_)X:K)Q>0Q,
M/&M22>6%\ Q30X#H _I^ %3\..M8W@4_4L\/5MB9G^!ZN-V1Q$_''K2R,?7?
MBV]CL?A4-:P&3@X1Q4LL3O&/("V^+\PN5CX^_P -Y#"LRDF,Q;7^ \XG1-\P
M\_PK!N&UOBOZ=A,?!#0=::UXG>P'Z4=>PC4=ZP>'Y?Q1&9DM/,#A9L32%Y,J
MD.6EK2<VX-WK1NZI=_S:O0K?A:.5<UN.N%Q  @?_ />5)<)OF'&N1\RSTA-/
MX+/P6^#^KV;IS?,6IO-.%;L$K-IKL/ZH\GY'^YQ<KT=\+S_Q]F,=0W;D."U8
M9$^7)^; [[@%RRL,!Y_L@EO_ $1TQ:>6?5_KVQH;[2BEU(HOCI]3Q?)&UU=K
MQL ^IN.FJSV8P0U6]K=C3&[/+6U[%TP\0.=:M0L#>B2.F*T3\+R\YQTGF:S<
MNDMHY;U?"7[ R.!7I(Y;'MKF8W(1&!V7^8Z53;YD)-KT/83BHGOAB>!'+]IV
MM[\BQ=;C;.XJUH&+#++!]-3;%."0"US&JO\ 3,?#%J6^Y:.0BK>G>:W?W8PE
M3WAR2.30,2&/!+6].49U[(58>8]JK2.Z?+$2W\?I*TMBCBS7,6 90Z>^A Z2
MR\'L+-Q?DHL)LNUZ_D?&"T^X9HN_8/:"5O3MCR7-%"6H0]M.@38D'P/=J^=9
MMU1R]MD1F9YO9VP?GHIR5M$T&U:_A/K?H*T_;I[@]GM'X8Y0".UIN%Y8QD]+
M)>4'HEL]B1Y?W*N[G[E7&\YT[=R40P&DP"1RZ?+&;QCI],G;9:YDEL2L/Y8M
MO?[#\+R3K6?G8/V<YA@DG^S"Y;O,5[&W]9IXZ![+-JU>A-=D9[/0[[>H=RE7
M91V7CRMZG?HA[5U.>W-]'7O<>]Y>B(.G1M(/8Z'NHKN^3QN-UZU+DH3)4>6Q
M3-_D]>?<CA7:!=Q>5U/.&Q1N66,-/S[\@]>KFDD>Z\Z\^O8V#7^R!_IJLO?Z
MIRV@9B*F?5=+4[C\3\JGN/-UX]9K%:MEJ]:"_4B$;A)$.Y>EEY$ER%O3\%GJ
M>+-2&M=$HA ]VQGW#E.V\QZQ:QD$E&1\]Z?IL=,#]8>H7LEJWKG*N%SV4C].
MO9IM@FD'NQCUW>5[V-V&AA,)0MLGM6,C#(UD?O\ H /;E&>8I:5#;='B,P#*
MY?Y?R';59/+=:?):!>?1[D\9(Y_T?QL"AT'*6K6= ? ^V([HHB(U7#MWFNUP
M%(PZ"R/OW;;D["NBR.X'@#^$]*@>,=@PV(&S4\A>CKSC)/?Z;_8]=E8\%@I-
MCSNZ;#7B+8+<4E>E*[V]1I/9(6?B?;L=C-=DPN8G93N8^0L+'^W86GKV*M;+
M?WW,5H6"K>\X:I/L)O<GR6WQ/MV-QFNR83,3QT[F/D+',?[=M70TET-_8-SV
MAKRVE*\QPN(Z\VCOMZJ;7M8.;Q>9SV&G,66H9!T]<_!?&>RKLU'E''YS73+*
M0,E# 73U2.BYS?DM50[+6TK)XJ3;L'DSC\P V0U6>SG2G[+TUJ=K(V];Q%C(
M=BW+5C=.".CYD>Z@/,N;SN(UN.3'&2)C[+&3SQGI[&*D=MS6F-CUV?!QRDQ6
M6/LVS%VX_P GG[E3??-@Q=O=N.LBPO= /.1W;/<-DZZ*Z_-.1AJ6]8>?<QW0
M\L7'W^R_7>1</MQJ2S4)81'+(SX:N-R?O^"S,^M_LF9]@Q6FR$@>P7JZ"02Q
MM>/AP[7/SF*KY3%7*-EOE'/$6.:O-W'6LY?)SW,#ER'XG"6GM;&X>\DI]@LF
ME8',8O?+^KO9WB*MDW6>?O\ R8I5SQ;@CUK'0N?_ )PY*&0,_+6)S!9;D^/,
M9DJ;'R0?65I^_P ,Z*Y7(.Y8K8^-+\M03 &6%C2YGL]Q#NPU=1]RF[@I@D>2
MP8MD1 ^?-5X<!;S?$6#L8YAEL8V</?$K+R')6M973Y8F6^[]FJ&"F&'U?4<H
M_+IF4P_"=FA,/]+8?JGQ+DY?DK%9/C%^*AK6I+\E!L<K&Q_HC+5LA]W(\!1^
M,,ADK!@Z</<LB5E\9;MC\]BJ56.&<3UJD8L=LZ8'J=YZ@<ABKU1KO$S0N8"O
M,.A\A3:%5L:WG\9:[@E<8GQM\U.-FQ^Q[MH%RV^LZ*<W&6:=4^SA%'VL^*Y4
MP+M0$5N65N2CK>C)5+#ZCI>NO9<_4ZMG1>,76KU%TDEBPU]F ^Y$;U [V*UC
M^DN%OZ+:F9;EM 2U&M(#&*<<A7WZ]R5KF9LUI'4_1?$][ KUP>6_:>.AMLKR
MQ,E]V"0=.+?L2JNYPJV9M-9+#$7_ $U^&9X'X:"N1L-N;D?0+,N-HV(I:LD4
M\(D'7J/8#V&+ZQO*U"74"RW%9.59 ('UBPE[Y2%+>)==M8#3*=:TSPGF<9Y&
M_=I>IEL=VU1PF0M5F!\T41<QI^#TO*>Y0Z;G\95SN%BFIYM\[.ZK(R"YY4MY
M/Q^9KU-'S=N&69]%H%P-'9#W*-\E;>=P@P\^*Q5PTX;H#Y9&='S_   I9R72
MR^+SF#WC&U'R,@C M1_#^EV,)R3F-TR%*IA\7/6A9.UURR[X;'^%J17XASY;
M(CE+'4#6#@SV]18]DR(AYFP74$T@B@,<I:WV:7KT./A>=^2<I!%R;I/<4SA3
M>\S=,^!(M[F:>>.UKSX*LDQKV_6?XCV#5SM[JY#%[O@]SHTWSU71!MKP'9:U
M9-QSM#D,8C X022AUQD\\Q9TR)L:^.=1%!0UNK#3>2VR"PQCV:QBW.4Z.6GC
MUC;,3#)(<<2]T77ZPV11'>.37[7JQHXW"7?-\[/7+F>S%(-NQF>. U3:*="1
MEW#,!?5D^?$A=C7N2=BW&Q4IX[#R4QYM?=LO]VL9^&+@W;UR#FIV491MBGZ(
MJ22AGLK,WS/7L2,<!BW7J4[RRW$UGD?!4]K.'QMKDC&9'5<?;J48HR;QDC\&
MCO\ @5B5.2,F>2)];LXPPUR7-@F/R[I7&O.?)^,V; [C4W'$5?7 A$4\:[VK
M9W<=UO4;5K&/Q6,K$R.Z>2;+O@-7$J7+_&VUYF.W3LSX2_-Z\<\0\S$5(-?J
MW-EWP[7]-)#C(*GI4O6'C(\N(/FHI!G;6&Y:VJ<8RS:J^!]<P-#GL]U*,5C;
MFU[U6V:>A-6QU&#QJ,L-ZD>\_P 72T)ZV=CYH?EH<3:-$UA6DF\!TN)N>(W#
M4-SL[)KU(6:UP'ZF$*=:C?W+89K&8R-,4(&0/CJ5.^RYSOXW*N\O'EMBU_\
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ML$X-]U>6(0??L+O<.;%CV:@,?<F96MX]Y9-$\]$!..J\&0W'<L[49U4EM>G
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MN3F6;^97.VW1,#LXB-R(B:+_ %5AGM(Q8L!H&O8.Z;E=DTMGQ\1/8?ZCVC\
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M@ICQ@!:.F-_"W\MJNN9;T!?Q=:T(&D1^JP.\0?PF2U3"9##1XBQ2C--@:&0
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MH/7NU59P_B:&%T=VPETSYS%*2.^V@+<U/7)=XP4N<S&1MBS<>\P-BE(9 S[
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MK'L1N,K>FK4Y8UK!:W>US(XRA'!,+@:XL]@_^;E,^2<?BI-IUW+Y&X7B /\
M#'!OJ/G=[>S H/@+UP<UMD=B!CC:I]/@^_3B#V5*:E&FWGNYU S_ *)]7X_C
M)'NO0 'LO/',>+EQ68P.WU6.+ZDX9,N)RQ>.=GQN5PU82/QL MSS_=C).BUJ
MF,V5@WG):;6:625'1'(6V_AT?0#3_P"M8J45/-<P9@7V-F..@ZIQO]PS\O 6
MAR)CX\#O.KY[&,$4\]ET=D,]C-VL>5@ECY]IR.9TR2F/ K/OE6./E?0)P?>5
M[PX?X%EY7G,'(V@2]@=2RK'L<L67YHQF)O\ @ZI4J^K%$[W#I"G+6,HC8=1R
M B LFX(R_P#+5Z!'W7GOE7'5LEO^@TK+289GSM>%J<EZOA,7G=/L8^E#6ZMB
M+J)@:"U2;>),14WK%9%AFM9AD#V5<<Q@Z>3UT][N_90K23F3S5E9<M496M2T
M))#$QWF "X+<Y&AEU+?\+MD$0]"<^C;4^UGT\SM>?V-@#X( *=)X/?D&_OE5
MMH[\SFMKW@0YIM"S)<]V.A$SRP%WP20K$T+CYFJ9C)S.S9M26P'N86!BMBY_
MJ)/\)_\ O+SIQ)K&%NV=IO6Z;)I_KW1-,C00&$E:F!PL&M\M[#C\:7,J.Q,L
MW@/AKBM3B?!Y#.ZO;_\ SGG@$EF43U6#W]_N3VL^=U&MIG'FUX^GF)+/JS0^
MJTMZ])A[7;Q6BQ[#H5&L-LLFBZK'TWQ[8SH?CR7"Y)Q&+J\8X&M4M?6L@OP0
MQSE2/D[7L=5XSK0PUA *DT#F- 5R:N/_ ,1XW^56/_[RZR(B(B(B(B(B(B(B
M(B(B(B\#<)_[?X[_  /7OEOP$1$1$1$1$1$1$1$14ERGE+%NYC=>;3MNJ2SL
M??FB9V S[-"LS^BFN!H#<55Z Z'^;'L%0&"GMZAR7FH:N,M_L6S,6N\6]@/!
M]G+[WZCM.M<AQ[5A<=)/!-$!,&*QM5SVR[9<JY TWX[&0L]VN<2^P]W\OP%!
M,?E<MJ/)&R4!BIK8R]H3PEB]) GI>=>2K\\?)NF%E*>44B]\A8W[/72YOGN6
M<;B\=3HRSO-QEAY8/@1JZ,%DHLCCH+;&.;YL'Z'#HM/W!6AM=>:QK^4AA87O
M=6>&M'W*I#C/9[<6F28Z3#6P*->5L\O7_@T-74X2EFJZ1D*MFM/$^"=[R'CY
M#UQ-"IOS&O[I@[%.S ^[*^2$R-\>PN)J7(NP:;1;KF6P-E]BN0R#Q7H[5)\]
M8P\<^8\6V9W&4Q-^(FN]PQ?>TX"OL."O8R?]R=GS^'#X*H/2MLO\?!^N;+1L
MB%DA->TQGF/%6,.0Y,]/%2UFE/-(YX$UF5GA% P_=17?L5D\#NF'W"* SUH6
M"*\6-_7U^>EM;CGZN[4:6 P7<S[4T<DTCFEK88V_E1#EV6M0VG3(8HYGQT&D
MR=-[Z:>E;W),\-GC;/SQ'MDE/R:57NH\GX:AQ]CZ\S)Q<@J,AC@#.S)[=!S5
MILX]S5KBNY%-$3D[-MM\0#VZ>.^FJ08CDO'1ZF*=RK9CR<,(K/J>GVXR==>R
MX;M:FU/A7+5;L9%RX.WL [(>_P!PU3GB6\;&@T(V%YFK1>DYC_8AP"I[!9RM
M)G<]#L6$NY#//E?'5;X>L(Q^&E_704CX1LRP8;/8&;'6H[;7/<]Y9U&%GX:V
M:/%47ZM:Q]T7(KDI>\1]Q,'Y<5@X]R%9_*&W_+6W))O0>&$->NCJ^6;H6Q9[
M%9UQAJ6[)L5+9;^@A;N&+-IY1EV"F.\;CJOI"?KKU9"N9IN:KS<M;3^B4-L%
MXA>6$-/@Y*>7@?SS>D(>&&D:C'='HR KT4J*YKU^V^GC=AQS7&[CIP!U^'KC
M;+I=ZWQJZ_- '9OUQ?F=UV_R=[EJGG&L&6DUV;-Y$A^1R;1,[VZ]@"6!4MA]
MEJ2YK/\ ])L%<N9Q\CV5HQ&)1$/[+?(CH+J<-YV7$ZWL=,XZR;4!]?W9U'[?
MPDKD;0W4LN,=FM:%NKGK-EG^8B86GL^[BY>M,<+;*4#;+_*81@2.^>W?=5/O
MV=P7[7K8/8<<7XZQ YXL!OEX2!0KBW%FGN.<AP-J>;7O0</4?[,,RYFJ;,S0
M-GVS'93'W9'VK?E!Z,?EY]=KN\3Y*]/LN[_4XNQ ^[9];HCV8??V*UM VREJ
M>1V;&YR.>JZ2X9HG.82"%)],J6]@WO+;D8)(*A@%:HR1O3I6?VTUCIW*NZ '
MYCZ4#K['GN,MDS-"UBY+="[8,\,K%9=*;-[[K^;?:JOIT;=814X7_OO_ "]R
MK#3MXV72JXUC):]/-+$XB!S%8>Y8_9\KQ;D3?A'U\CQ.8&?P,^T:Z?$6Q2Y#
M7,;4&-GB92JLA?+(.@Y[1UTU6#L=)]W"Y&LP_JDKN:%0G%E^]>U>759\598]
M@ECEG\.HV!-%V>70*EK6MCJV6>E,YU2=C/-DH4ZT'#W[.:SVSW8'5_VC(/IH
M'>SA%^7JU+CY65IWQCMS8R6C^:\L;%?Q>UZ[XY'7)X=H>.H',B]WO_/DI/O&
MHYM_&>$#X_J<AC# ^;\D-'N HWOF<VG==3I&EK5B.JR>)\KW_O%_X8%V]_US
M.3Z]JN=QU.87L6QOE7</U@%;F#W_ '+<)JU"GA'40'@W;A>0& ?+6)L-FR.8
ML599CK+JL$7HOF#?;MZ<C36AR'I\\-"S*S'/<Z=[6>W4B]! JGMKS$!V.[B<
M_@WV\.^NQ\$[8@_P?]U#]/T6:Q0W&"FV>##9!OC2BE/1=^'J/:IM^]Z;%_1B
M?67VY(BX0/#E96W:?G]IT-C+HC_;+)188!\,/_V04-P&[\FS4(\ -=?]?&1$
MZW(>@QOY<NWRKBLY5P6M6*S)KDU"=AF?^^XE9-ZR&?V'C>T9,%/%/9LM$,+?
MUN\!WTYZV;FHY'.<38O&?3S5\A29"]D4@Z[DA"UV<@Y^S@#B7ZYD1G7Q&+KP
M'I?@O+U@V/3[^+XJKZW0Q\UNX\L,AA:"//KW)75L4\O)PR,2,3;^N^C96] M
M'GY +F:^=UP?'.-AIX.?ZZI<8R:L\#N2'H]EJY\^HSYO?<%E:&OVL1% 3+=F
M>P1^;_Y=+T?U[%>>K<+M?YN@NRC_ $?+UGQQO/V>2"5-N3-.MY_'U+F.:W]I
M4)A) 3]Q]VJ+9O.[5M&M2X,ZM<KW;7A':>\ 0Q-/W#EU-_TFX_CJCBL5')-)
MCI('0L^\GI A<O/7-[S?'>1@M:Z^.Y:#(601GS=U]WO77IP9NOQ'%4_8]@WX
MZ+:PJ_Q$@**4],S.7XD;AIZ,]3(T91) R3V#WL7YK6Q<O6F1XBS@A'*P,#[T
MQZ\6K?Y/QVR.LZS!B\1:R+:+Q++/^2U7ICK4MFE!-)7? ^5@<Z)_LYA/V*UL
M]CGY'$WZK3T98'-!5%\<2[[B,'8Q%O7B(J+'ELA?^N4GX8QJ[/#]/8J%#.,R
MN(GJRS6?79Y_#N^US-,PNULO[[]5C9:CLE*Z6&;[=^ZB.NT.3JNIW=7K:PRL
M7,>7W7O\ ]=O'8K=(^(,AAI\ \63XPP1AW;RQWRYP4LPV+V*EQ3+C7XIYOQ5
MO19!W^^NGP[3S./U&*AE,9)3E@E/0=_&"NSR;A,GF]/R-+'L#YGEI#3[!P"I
M#)8#D//Z-3QAU^&C%CS&1#W^N=S/N N[N.O[IGM9U>FS"1MGK^$DWZ^RSP^&
M]J9<D4=FS>I5:%#%]SSEDDX+O:/P4XUGZQFO8^/(UA7G;"UDD??8! 5,X?2Z
M$O+F8FJ^^/IEDSXQ^Y]2Y>BE6'*NDV=IP;6T9.KM:420?@J!X5G+^695Q&6A
M%:H) RS;^)7QA3+8\/L>0V7%XKZ(.UV+Q]?]?O(1\>8_ 4$R.H[A@>0K68UC
M$L%1WM+&7]-E[6[OV"W'/Y_6LA7PO4=%@>\&3W+G]$M6URS@MKV$X5F/Q'FR
M&02R$O\ AWX6_P I8;;MAPF"J4<<SR$C)[+?+V8]BW.0]2R^TZCBY88 S*5I
M(I3 3[?S:M#(G?=OQ9P=G!,QL,I#+EE\A/;!]HQU[KI[_K66.D5=>P5$3!OI
ML!<>O!D83*:WL&=XM&*L0MBR388_T?8N8%QL30Y0CTJ6HYD5>U3$#*C6O/E(
M& @^96AE]8VG>,OA3F<!!0CJN\Y;+92][OY#V"]#-'0Z5([_ *QMQVW"[!@(
MHY9((W,?&\]*/[CJV_YC+:G9?2K32T6^4\C7EK"]_784AY8U79=C;AH\?3B)
MAF]60N>0 M#<];W=^RZ]L6)J0/GK0=2PE_LURY+-(Y%.\XC8[$U5\\C/]*^S
M(6C^ +L[AJ6[,Y"K;!KAA/J5A#(9?8- 5WXYEV.C79;F;+.(VB61K?$.=]R
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MT^,/;!(\AQ+OE.2=5W/8,IB'XGZ)D%.3U>Y7D.+US=MT/=;&XT-DP=JHRTR
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M*P5&C=M_42PQ!AEZZ[ 7?1$1$1$1$1$1$1$1$1$1$7@;A/\ V_QW^!Z]\M^
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MI6AAN5M=R^=9BZS;'F8G/$KF=1^RP3\GP2S3'$8>]DJM=Q%FS"T>#5)<7OF
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M9_?[!2G:-RNQ9J#7<#%#/E9&^;_5/C%%'^7$ KA8WD+.XS:(<!M%&*!UK_\
M!;,+NXWK6V+DW-8;=_V)+AB8"U_H&,^;YURJ/*NT8K9J6.VC"LI16_:*0%2K
M<MWS>'V_7\-6Q\+X[[_:8O6WO6_'!7\?B:;83=N$]/F=XQ0L'\3E%M;Y.R3=
MKAU_+OJ638/^CVZI_25ULQN6Q7-MMX' _21OIQ%\IL'WE=_8:IEH><S67PDL
MV5JBO;CM20OC'V\%O;9LM/6\-/D;/9:SIK&#Y<]WP%5]S8>3J.'&?EK4'U?3
M$LE-I(DC8?P>E*;FPV]ET9^3UZ1C72Q$GU?EHZ]PJ^X'9L/]'('"6 XXV)>V
M_P 8<O0TL@AA>\_#6DG_ ,%0]'=MTV*#)Y3"2T!6K2/;'1?[S2!OW*V]LWK:
ML3J.MYZ.&!ALB)MN!X]P^4*0;SM>;PNG5<W1; YX,9G8[X(>"?98LAR)8IZ/
MA<D(&R9#(Q1""N/9IDD"X%S9N2-:R.'.9BKWJEMPCD;69T87E1CD:Q-6Y:U6
M:"!\\C&=LB'RXKOP[OO>(W;$XW9(*<57)$^D(??TU?O?LJ(W/?\ ;,+O='$4
MZD,]>S'_ )J(>[Y'(-_W# ZUD+.R4(8KKKK8*0^&O[[]S_(*.97DS;-?OXI]
MG*X_(UIG?Y^"",@L7=Y"Y'V7 9S LQU>"2C=9Y,'S)(N)FM_Y1U?)T[.<H5O
MV9/-UZ<?OX!WPPN4\VK>,B_*XG!:[Z1NWHO5,TOQ#&N%;VC:]&S6-@S]T9'%
MVR6"R&>,D;TY0W[:]8V'#P8TPOJ7 >F>';WEJCF<R/+,V V=^5#*-6&#U6/9
M^_\ ]DU2/B^7*XS0*V2DOB6I%4>YM40@$'_&N3C]LY"S.NG/X?*59GOG'JXP
M1@F)GX:5Z&HS3S4H'RL+'NC:7-/V)7G'E6EG[>^ZICVY<L@MS.,# SVB<Q6)
MN&V9/6<?CL9'.VYFKTGA 2P1M/Y>6J*9W+\A:/%3RF2R;,G1?.&VX_#KTR?[
M!5XXO(U<G0JWJSBZ&>)LD9_(<%7O(VR9[&2XC%XB%S;60F+18\>Q$T*.X;8]
MCP_(,&M7\PS*UIX/,3$!LC"%QMFW3>Z?)C,'CQ'/"]G<,/NQO3_N]9<5L^\X
M3D2G@\_?AL5[P)B<QJQ;UL^V:YOV,CFS,T>)N3=^S?9GY8IOO^8RK+^NXW#9
M1\%N]:^&CL&$?+BK0'JB+HR%S@/WC]UYBEVKE.UON8UZC8K%S?/P^T<3 ?9R
MZFL[?O.&WJ+6MEM13BPT^C,N;=VCE"SOV9UW&9"L][&/+#(/!K&-*Z\NV;QC
MZN"UFW.PY^_.\&Q[N;'"FSS;UH$U+(#-S9/%&<,LB?W>TO79Y$W>S5_HU!5M
MOI4<H29KX_?B8NKK,&QP9FS%6SK\EB7U"8+DCBY[)?PJRP%[E#,YC:,+#EO>
M"UXS77./47CV/&,+LZ'M>VX;;;FJ;-.;#F0OEBG<2YQ#5RW[?=V>#)WX\_E:
M0$\@IQ58_P! :SX+R'!2+4>4,H=!RV2RU61UJ@YD8)!:)B]8[&$Y&O:Y!L-3
M8+?[3E#)_P!G@ED(8?E@"Y/,=/(V]%P&1R3Y8KHE@9/ #U&'O"G-G'97'\93
M'&9FVVU],R9LLKR\@ ?N#\!?&JNS>P<50#]JV67I("YEH//J>0"XO%&V79-5
MV$9N]8?;HRGUS+(7/ 3!9_,X#C3(;+=LVK4]E_G4CGD+_%CO=BK_ "&0V(X:
MCE()MC_;TG4A=UU6<QWN6- ?[-7IC3LGE<GKV/MY.KZ%J2(&6-25$1$1$1$1
M$1$1$1$1$1$1>!N$_P#;_'?X'KWRWX"(B(B(B(B(B(B(B(O-W,S6.W+1@\ @
MR2J=<S1/?H.2+ 2!-&Y_^%1C5\#QOFM6K6R\.A; !-&^3KQ<T>X+5&=IM8&C
M>XZMTHWLP$<\A/8_3]O$JP>8\AC9-%FZL1.]6S"8E'N4O;C;73^+M-2'F#(T
M?Z!S#ZB/N6>'P]_E<[D8AW$ (/8,5=<O80#P3B@?@U:BLBE0;!H4#,=$UKV8
MP"'K^;53'$V$TW-ZP^M=<YER*1S9XC+XJ1;;B]<P_'6R4]>+O2CM-%H,/?Y[
M"G."R."FXXK20NC-1F,#2P]>W3?@KA<"$'CZ+_G)5QLK%!_7MC7L=W*:/<K/
MPKR9%COK_5ZA^J+.B[V\_%= JC!9?DMOV6MKD5>FZ)Y;DLB\=RE_O[,8N#P<
MTQR[O&Z4R$6F?J/R?9ZD'#=2J(MGG$3/5=DG-+_N6^ZY.D&2GDN512B'E'=/
MI1CV_MKM\%6JDVDE@($XM/,X)[<2L7%9B&V<C-86]?M4=?\ F]6=N0)UK+@#
ML_2O4 X+,!X^J>B".IY//^;E&[E**US^0]C"(L:'].6?E3'4_P"E6G6X6 7G
M6_'MORYBLKD05CI6?^I)$/TSO)1OA+ZDZ!C?7^?)WI_X%R.?0#IE<?G)0+J9
MO!8NUQ8:;X6,B9CV/8 .@UP"J&S0GGX'QQMR-'A=8^(?EBNEN'QU'1(9ZE2-
MD\&*ZAD:W];?(#OHK3X6=4DX^H"$#Y>)1^7J.:/BV4-[WRE7)%(]DL9[,!/?
M06;A+%T*U#8A%$ 1?,7G]RP=K'Q1C*$&V;^60M)@R/I1O/NX,)<LNDTZM/E/
M<XZ_LPDN6/C;&X^;?>0;DL#'68<D61//RUKRY:#\36J<ZQF@WHNI&2RQ@Z#%
MW>,'-&W<D GW_:H_^^]8<Y_OFU[_ )&18>;-7DGQM38Z0(MXUX+B/DQIK&5.
M_P"T8O*@]T\73:]S/Q:E5]GV:J%UN"M_7/M,SG=3MA(9_<7+X#*\W/\ .20?
M3Q(+/Y.!"U<%C:=GFW8K,Q89((G&-A'W+OE-RQM:MR_IUFDT"Q8,CK'C_+X+
MEN<4W)3MF_17I +C[X<6?R!<L.SUI&\S:M-3(]5\+C8_/@WI8M?@@?SGL4KN
MS(R!_A[?ERPW'&#G]@B);YT0'KT8/=J\Y[^[^AW(F'VIC.JUD.BN%JA^7?L5
M#-P\D.+_ *2:YX,CZ]Q5/NU7;H,PS=C,[,Z(AMR?PIEWS]/'WTHQQK6JS[CR
M0Z2)CS^T_'L_@EZY?/#&QU=;8P -;<  77Y;D9':U![W -%\=E.=WLETR L(
M<!DX5R.4C')QCA>CV([%1TO1]PP-*[8UWBZ_A6929[9:W@'@R2]J%\CLQC\I
MQL*M=\,!:?2@>WKP9[*0<\P2FE@I@T^#,@T%R] 1_N#^Y4'R=7@L\B\>PSM#
MHG2S>0*[?.4-EVD/?#WX-NQ&<#[L7,H:KQMGM9@MOD[@= '.!G]V$**[E=PE
M/+<73Q![<.R,EC7CX9[!O:E?/%FO)IU4,F8>\E"5&N689#J6E3AI]-DD(<Y2
M/G6[4_H;3B]1CGOOPEH[40W_ .B9?XTL7_(46PD3/'\PU3K(ZQQ?195R,M=M
MI[Y6^@&N$CWN*U-TT\;)L%C)Z[F34S./ AG;\=K5U?9\YFM0W"EF(>K]!OHS
M/'R\KH\$7*L6@P,?.P/-N7V5OXC.XC*ME?1N16&QO+'EA[Z<%FS$E*OCK3[?
M^I$1]7[_ *5Y3RF&SNCPLS^KY,V,#,1(^N3[=/\ RU2CE3*_5X33,P8#'$^Q
M%(6O'LSS6YSAL&(EP.*J1W(WS/R$,P:#W^AJR<N7J+AJ%LR-?7-QKO/Y!"EG
M+LN,ET+)LF>Q[Y/'Z;^<BK#;XOV3JW'$>0:&& PB8'[=-5E\MVL79T#(M+V2
MF8L%;Q]^Y"HIN$3L9PMBJ=SJ.<15(RT_VPU6Q0QU3*ZC6I66"2&>DQKFGX((
M7F[%_MO&VLEQN!*3+?9X2=^PJ^_DO6E.I7IU(:U>,,BB8&1M'P&A4#S+//B=
MBTW/>!]"G.\2/_!>K R6_P"K.H06*UB&Y/(]IJP-]WN<5 \?>9B.:LM#>8(Q
M?K]PS%9>66PWM@TVM6Z=<=;)86^Y#$V>W!6YGULRR !]5S 4YGBH9'^C=" A
M^2DO-, _$8_?6GRL88][T S/+6"27R+%R.474,7RCA\EF8/J<7-#X$2-[8Q3
MJM+Q?4OXMV#Q6.GO32@U_IX@' ?=ZYFXZ/B-AS64RV%RKJ6;I/ZD]^@7!2CB
M79LYF\!:.6(-FO9,1D'\:XW.6.MSZM!:A+W"I=BEDC'P6J8G8L-DM+?DI)8O
MIY:/F\=@]=CX4(XJJ/I<43,N@PB832#OV_0Y9. 98CH(C#P7-N2JZK<D<4$C
MGCMK&$D?R"\J9[7JSX)-WTG,"IY,,T\!?X+K;WDLIL/#^)REN(-E-F"69.0=
MKU^?B^"C!D(I+$L4'C&SW/L%'ME-F+1^.\U!YRUJ$40G8WX[Z"N=_*FJVZ47
M[,N,M7I^A!4'[_D[[.5<;>^0<P:7Z[F"0 >HNAS-X'<=)D,K 6SO!83[KT0/
MAR\];59I0\RZP;'1'H$#^3UT><*5O]B8[*00B9E&VU\K>NQX)7WGC&;%16JM
M6I);E \:0B'JEY4>Y1NP4MNX\M7X611L]0RQ_+6_"E7,.0QU_6JV.JEEJY<N
MQ?31,(<?;OMRAF5?/J/)&O9?(1>%2;&QU992.Q&6J1<NW,=GZ. PU"6.>[:O
MQ21!GO\ H:N!RZ(*6UZ'"9?: O!)*N+D6$W=$S\<'3W/JDL5=\7[1@!Q]#4?
M,R6:M6>Z>O\ ?P"KO8=>Q6$H1;AIN<= )IF?Z(P]>SUZLP5RU=PV.LV6^,TM
M=CY&?V7$>X5(<K9"MB][T+(VB65X))C(]:7(^4K6<UJNZ8MYM8ZE9?%-*Q3#
MDO.X;)Z#:CK31V'W_!E5@]W%Q4]T_&SXO5\-1G[]6O3CC?\ WM"J?EG;K=+-
M8/"NN24*%HDV[;/D-"KFQF]/QG)NN6<-+&*+&^G/9^S_ .9*GN9OUG<W85HG
M'B*70'X+UCY#RU%G*FBQ/E#35>\S$_;S5C<G:RS8M4N0,;_I$/4T!Z[]V*O.
M'/VAL,ISN3@<#3JLI5''X/\ ;*]#._=*\W8W/U<5S5L4=RU'#!-"_MS_ +O#
MEU\H:VU<G:[/C3ZL&)8^2U98.V=NZZ:H]K^3H.YUS,PL-].6*6)C_L7^:ZG*
M$>2P>Y:YM3(7OI5SZ=@L6]R9M&%V#5(L9B;+;=J_/%Z4,?N[P6QL8U/%X[6]
M4V2J#4DJ$-L?/I/BZ:HOQE1;@N1LMB<-DI;6'-,R=_P!ZV-&VK$8CD'?*5ZP
MV$V<BY\;G?'Z"5NX^$;7RI?R]!A=CJE%T L^/0?*5$]+W5W&]W):QG:LYKQS
MN?!-&WM6'FW97>](STE6J^""3P?CV/;T^0,![)40U#F5E+7J^*OXVZ_*0,$$
M;6L[$A"[7*-3/6^,*D]]A-IEJ&>RP#WC]CV%VJ^UX[)\;9":".P(Z]%D1<]G
M0<\CX:M[A>U'-HM&$->U\!,<C7CI5+O&L9JMR3)2QH>VGL'^NZ'8/OV]7EO>
MK2Y'1;F(QK0QT4;# W_LU3FF\QW,;B1ALKB[;\C T10^ [,A'L ]>B-8?FY,
M-4DR_M;D;YRL^S"?X5W41$1$1$1$1$1$1$1$1$1%X&X3_P!O\=_@>O?+?@(B
M(B(B(B(B(B(B(BKW=..,;M=VA:LWK,+Z@/I^DIF[%P28OZ"X766.B$<AE]R\
M?EW:H_\ ^GW6QDY+ NSBL7]BLK-V31,%G\!'AIJXB@BZ]#TQT8_$=#I4=NW&
M> U;3)I_J9;-ADT<<#IC[,!^0P*Z'ZY0V72*F,M]B.6O"0YORT@?(41FX2U^
M?%RU)KEJ:0EOISR^[H@/LQ3/):#C+NFP:V;$\=2,,#'?+^F!<^]QQ2NZE3UR
M3*7!6@+>B/EP:.@"I/K6 9@</!C&6I9XX?9CI?D-^S56.R\'8#+Y:7(P7)J<
MDDOF\1M]BK$Q>EX+&:Y)A8(/]&D86R _,G?R7*L:O!.)KBQ7;FK_ -#*_MU4
M'H%3K4M4Q6AX.S RY(Z+R,LCY%%M&H6,UM69W&>%T44[1!0#_P!XP?E<;):Y
M,[F&ED<;=G?)WYWHRWID47X\E?ZIZ]Q)!/M%S,ULW<IBV7&S!!^GS\O<CR!6
MYK/%E'6\IE;E+)60RT"&P_9B[&FZ,S56Y%D.3L3MM/\ ,B4?#EJ:KQ]^P,WF
MLF_*RVG9%[G2,<SQ'947GX9$.4MW,+LEW&"PXF2*$+M:-Q94U'*WK\64GL&<
M=!CQT K4L0MDADC=[AS2#_<52F@2C4<OE-3N_P";C?8=/CI/X)&%23:>.XLS
MFZN;HY2;'Y")O@9V,\O(+-A-"%3+19?*Y6?)WX6ED$LC?%L0/X;V5Q^5,F^U
MBVZUCRV6_DI!&8OQ%]WJP];PL.%PM#'1CIE:!L8_GT%5W/$4DFD ,+1U?A6#
M$Z/LF5P%.ADMHDDQACB)B;%T^5G7NQ[NU*=SXWAV# X_#07C0JUG-+&,C#OW
M/8!236\%8Q6"AQES(/NF-A8)7L\26? !]RJXCXZV37Y[1U;8?0K33%_T<T?<
M;.U--=TEF#Q>29%=>^[>[=9N/';I)#]^EHZ%H$FIX_*5?VN^T++@\.=&&ECE
MJZ/QY9U6_E;1SLMOZ[WE:Z(-_7^?DK!KG'%G!;3D<X,Z^8W'/=-"Z$ 'S/?S
MVJWU7"Y>_NV^V\5F?H[,&3(#2P/9('%RN+5M(;ALA?REN_)?R-L_KLO;X]-_
ML-'947_JK>S<[N:@S5J"M:>9)Z\9(,CB>R"5U[_'T]K=JNRC-21^@T-;6]+M
MOBMW;=QUBC2RU&U<A?89 0ZK\O)?\!:/$FKNU[3Z<4L998L 33M/R"59JJ3;
M>+WY;9&Y[&YV?&W"P1R/A'R%K8SB*M0VFMGCF[DLT;!Y]_ORR?=[GJN?V;D<
MGS?G(J&7?0E;#(_UF-\^P'?"NO :*RAEY<SDLA)D<BX=,GD9X^DW\,'96CG^
M.!=V(Y[$Y>;&7GL+)7L9YB0+I:WHXQF1GRU_)S9#)/88_J9!UXQ_V6CLKG8O
MCL4-SN[*<Q.^>=Q[C\.F^!/9:DG'(?OHVE^7E+Q[-@\/;I68HWM>K8[9\<RC
M>#O2;.R4%OSVQ;F9US'Y/!3XF>("O+'X>('[H"^L-@JN(PM;&521#7@$3''Y
MZ Z[*A&L\:5M=S4^3KY>Y(^<DSL?[-D)^Y6]NG'E#;)Z3[60LQ"L>VLC]VER
MR;CH6/VO#P4;D\H?"08YQ\@K29QGBAILVORVIWME(<ZP?WRYJQ:[QCB<7B+M
M"[,[(&RP,EEF;[^ ^&A1G%\"ZM0R,=IT\\[(Y?-D+_A37;>/,9LN2QEVQ=L1
M/I=^F(E];GQ[1VEM)EO(W(Q7(< P]@N_)4TIUC6J0P&9\IC8&^H_W<[K[E5_
MMO&M/9<S6R,^5MQ/K >@V/X8IU9Q<%O%R4K9,S)(_"3R^7C\E4E6X!UF')ML
MFW.^ .[^F5E[7H^%V7#QXZW"&,CZ]%S![QKS[R3QYB]5TZM(RS-:G^O@C9)+
M_ SH^S%><VKXS:=(HXV\7!CH(7L<WY:X#Y"C3^$=6GHB&U:NSR-</"5[O=K?
MPU3++Z!@LEK46#LPN->)H;"2>WLZ^""HKJO#6L:YDHL@Q\UB>+_5&7X8NKG.
M-<;D<K:R]/(7J%^;YF@D(4@UO4,=@,78JP%\ALN+K,TA[DF>?DN*B>!XHU?7
MK=V["R60R,>&L=\1M/R&K@<6:C'B<KF+^/ALP8R<-;!%8]I"0KLR6-KWJ-BK
M8\O"9A8X ]'HJM8>(M6AHLHML9)U1L@?],Z<F(D*8;!J>$SN%_95ZMW7[:6L
M;[>'C\%J@];A?1J]&:H:3Y&OF#R]Y[?^E0CF''X.K#J>*+8X*@M!OI-]NHU8
M];C#5VW*]IYLV60'_189I2^*(?R"@7.9QTLFMUKCQX/N?K;]_!3S%\6:E0NU
M;D LR^@>X&2RE\;/[@I-M&IXC9J;*>19(^%D@> UW7Z@N'GMFU[0,-199;8]
M $10M8 ]RCNB=;)L>8VYU1T4,C&5J)>WI[HA\DJX5S<Y@\=FL?)1R-=DT#R"
M6.'W'P5#-<XLT_7L@;U&B?7^6OD/GX+J;?H6O;2U@OP$RQ_ZN=GM(Q:NO\=:
M_@;WU\!L3VA%X":=Y>0/Y*I-X@PN3Y=P>/OD.8:Y8YH^6O*MW7^/<!A;?UD;
M)9[0]FSSO]1[!^&DK:V#0M=SN1@O7JSI)H>O3=Y?"Z.>U7#9W',I9.L)XQ[@
M.]RU<G5>/M9U4RG%U"U[_9TK_=_2U\WQQK67O6;DT<\4\Y[DEAD,;G*2:_@,
M=K^+@QU",L@B'303V3_,KK6((9X7Q2L#FO:0YI]P056[.)M-9.'LI/;&'AQK
MA_4+C^2Q3G+X+'9+&/QUF/R@> ','L.@N+K6E8/6O,8N!\+7_OCR]BI5+$R2
M-['CL.:01_(JM&\1:0P_IQGB.^W-!]G*<W=>Q=O#.Q=BJPU'1AGH]#Q#0H/1
MXDTJCC+E"*@3'8'3WO/<BF8U?#,P;L1]%&*3H_ P  -(7!P/'6I8&Z+E#%Q1
MS@="3Y(6;(Z%K&1S8R]K',DM@@AY6;.:/K.;R,%Z_CV33P_N/*E704.S?'VI
MYG*_M&[C(Y; (_65*[6/IS4WTYH620O9XOC([:6_CI0S$<<:AALBV_2Q444[
M>_!WX5/\Q3XN?>-.K66,G9$Z0683^'D*W\)QMI^$R)O4,7&R8?N//OX*69?"
MXS+4G5;]6*Q 3V62-#FDJ+ZWQWJFN3F?'8YC)O\ [9WN\!;F;T?5LW?9<R&)
MKSS-_C>T$D?@J11XNC!CF4F5V,@$?IMA Z:&?'72CN'T;6,-!<CIXN&-EGVE
M;XC]:YT'&.CPWVW(L!48]OP P>(4[7'V/6,+GZ@JY*HR>,.#@'#X*R,U[$18
MAF+%*'Z-K T5RT%GB/Y*-8KC?4,1E3DJ6*BBG^6$ =,_PA3E<?/:Q@L[!%%D
MZ,5D,?Y-#P#TM)^F:M(RHQ^%IEM7OT!Z0ZC_ ,*RS:GK<^4_:<N)JON>8=]0
M8P7]K'D=/U?(WG7KF%J36"0?5?&"[V58;;R)G(\_D-6QF$D?8>P,@L _GY*M
M+4<"S 8"CC6_,48]1W]J3[N4AD(#'$_ '97E/%QX7/\ ,V8^KI"U1GBE#/5B
M[87AR]-XS#8O&5_1HTH:\70'A&T-'LL+-;PC)S.W'5A(7>1>(QWW^5TKM&I:
M@=!8B9*QW[S'#MI7$P^G:WA[,MG'8FK5D>.G/C8&E=>]B,??+#9J12>(Z'FT
M.Z6I'1QV)KSOJU8HFAO;A&T-[Z7G_C?%8W,[7M=O+X &6>WZ]9T\0(8TDKT9
M4I5:<7I5H611]]^+!T%@N8+%WY636:4,KV?NND8'$+>9$R.,,:T  = !<\87
M%BS]2*<'K>7EZG@/+O\ /:Z$]:&Q"Z&6,/8[]YKAV"OB&E6JP-@AB8Q@^&-'
M30LC6AOP%^.AC,C7EH\F_!^X[7ZM,XF@+9M_31>N?F7Q'G_YK<1$1$1$1$1$
M1$1$1$1$1$1>!N$_]O\ '?X'KWRWX"(B(B(B(B(B(B(B(G:(BC^R:MA-AAB@
MR5?UHXW^303[>2[%"C7Q]*O5@;XQ0QAD;?P MCM$1$18,ECJ-ZK]/;KQS1EP
M<6/'8["RM;'&T,:  !U[+Z#6]DA$1$3M$7-S6 Q>69#'<@;)Z4@D9^6.'W!7
M21<J# XJOE+>3CJL%N?V?-UV\C\=KJJ([GH^*VJO%6O6;361GR:V-_3?+\D*
M08K&Q8RA7J122/CA8&,,A\G$#\E;R(B(L<\0G@EC]5S/)I <WY'?W"@.H\<X
MO6+UR]#<M6+-GOU9)3\JPD15]=XRU>[L[L_9KNEM=@^)/Z.Q]R%8*(CQY-([
M(['R% <5QS@,7GY,[!-<=>D#O4?),7!WFI\B(B(B(G:=A$1$1.PB(N!L>J87
M8H8H,C7]>.-_D 3[>2ZN+QM;&T8*L (AA:&L!/?0"VD1$1$$C//P['E^$1%P
MLQJ>M9>RR>_B:MF1C>FOE8'$+N0PQ01,CC8&L: &M'L  N!E]2UK,7/JLAB*
MMF8#H22QAY 7?CCAK0MCC:&,8 &M'L  OUKFN (/8*YV8PF'R[&17Z,-F-C@
MYK9&AP#A]_=;\$$->)D<;&M8P=-:T=  +Z<YK1V3T$\V>/EV.D:]K@"T@A$7
M GU/6Y\J<G)B*KKGGY"<Q@O[7?1'.:UI<2  OQDL;V![7AS3\$'L)%-%("6/
M:[H]'H]K]1?D4T,OD62-=XGH]'OI?J(B(B(B(B+F6==P]JT;4^/KOF[[\W,!
M<NFB(B_"0 22L-+(T+,L[(;$<CH2 ]K3WT3^5G1%^331P1.?(]K6M'9<3T L
M>/R%.Y6%BM,R5COW7-/865$<YK6EQ( 'R5KTK]"YZWHV&2"-WB[P/?3OPLKH
MX6O?+XM!Z]RL&/RF.N/G;7M1RF%P:\,/?16T@C:#WT$1$1"0 22HG/N^I5;H
MIS9FNVPYW09VI8U[7-[!!"XU[9,)0F$-K(P1/_LN=[KJ5+M.UT8K$4@Z['BX
M%9411^SM>!J9ZMA;-T,NSCN.)2!$1$1$1$1$1$1$1$1$1$1$1%X&X3_V_P =
M_@>O?+?@(B(B(B(B(B(B(B(BHODW+;!BMLU0T\I/%6L3%LD+20T]*\VS1AQ:
M7#R[^.T) 1DT;_W7 _W%4YS)D\YBL3C+6.R,E=AOQQ2AAZ+@]7$QWZ 2?LJP
MY8OY.EJ<]K&Y*2M)%/&'F/Y(*GNOV)9,-0DED<][J["23V22%U&RL)(#@2/E
M.P@(*)ZC>^NQVM:[:95J3SO< V.-SB?[@O/V'FW3=M?N;#1SL]:RV>04ZD9+
M8B&'X>KIUB7.MP%-V;\!=](&?P_*J^EM&T;GL&:HX7)Q8VA0F\'2^'G-(5OX
MS/;S1W:EA,W-4DKSPRRQ6&,\3*&$>RN+R'2=A/(*O=XAW62;$.UVRR-@F_TK
MOY(5A ]#W*=A.PB*';_L_P#1G6+^2:6B5C0V%I^[RL''6V2[3JU+(2^(F/;)
M@WX\PIPHEO%O.TM=N6\-8BBM0#U!ZC?)KFCY"JG5MKY.V/7G9NF,<8VO<T5W
M>Q>6J:<=<DLVMMJK/4?5O5>A-%\A6?Y!.PG:J/8-ESE_=6:GB+8I.%,SSVRW
MS<!^&!=#2?Z?5,GDZF?F;9K,(-:U]WJS.PG83L)V$["*L^5\UG,+J<^0Q5IL
M,D<K XEO?L5*--R5S*:MA;MM_E//3C?(?RYP6MO.TPZQK]G(/]W]B.%GYD<H
M)6GY7EPT.29DL=*70^J:HBZ!'X#U,=$VBUG-6AR5TL9)V\3-'L&%GR%WM;V7
M&YZC-<HN<Z)L[X0XCKLL]B0NSV$3R"K[D_(YK&Z;D;V*L>E-!T7.Z[/@NIHE
MRS<T[ 6;,SY99:,3WO<>RXEJEO:* ;W9VSPQE/  QRV+0;+9^T3%6NY[+R#J
M^=PF/BS\-D9$N'F^N!X=*8WL?R+C,C1NPYUV2@]<-L5?2]+]!^XZ)6CJ63SK
MN1]KHW,E+-!!_J6$D-8%<P<#\%?CIHV?O. _O* @CL)(]L;'./PT$E47!M^R
M[ML-W'ZY9^BQE0]37_#R>YWX:NKL6-Y$PF,GNXG9'7'QQ]R0V(_D#Y+/<J?Z
MEEI\OK.'R$_M)8J1R/\ [W!2$31EQ <"1]D+@$]1O?7?NAEC#>RX +\!!'80
MV(F'ISP#_,IV.NT^IA#0?-O1^/<+\DGABZ\WM']Y 0V81$Z7U&^('N[OV 46
MUS;J6>L9F*NYABJV1#'('=^H??LKE5-:O0;]?S+\R9()8"R.IW^[[J?2SQ0M
M[?(UH_)/07[%/%(WR8]KA^0>POCZF'S+/4;V!V1V.U^P6J\I/IRL?U\^)!Z7
MVL,UNM 0V2>-A/QY. [4 Y0?,[1,Q:IWY87P,\VR0OZ[6KQ7DS+HV%DNW.WN
MCZ\I'JS_ #;X^78Z6LV]4<_P%B(N[_=#AVJOYI?<@TFW/5NSP/CF9V8W$>07
M-NV+@X/ANLMS,L-Q43_4:[IQ]E(>(YY[&C8>2:1SWEGN2K*?(QC>W. 'Y*P.
MOU6,:]T\8#OW7%P /]R^I+E:-@<Z9C6GX)< "LC9&/:'-<"/R%KNR%-K_ V8
M@?CQ+AVN=L6.&6PE^C]28!/"6>J/EJBV'UN;':",1'DWF1E0M%F(]$$#^%0C
M@&6R_7,H)Y7O>+WN7*[<KE:.*I2VK<[(88Q[O<>@H;K&V5-QUZ[9B)A[DFCC
M#7_K+&?#U!^&)HJ&&V VK( 9DB'/D<KTK68+40EAF8]A (<T]A:%O,XNE)&R
MQ=AC<]WBUKG $E=)KFO +2"#\$+\FGBA9Y2/:QOY<>@M?Z^GZL47U,7G(.V#
MR'9'\EAOYC&T TVK<4() 'F[KLE;C+E;T3,)6%G]KL>*YDF?P\=4679" 0]]
M!_G[+JUK,$\398I&O81V'-/8*Y=O8\-5LLK3WX(Y'?#'.]UT?J(?2,OJ-\/[
M78Z7,.PX;T6RG(0>#I"QKO+V+A]E (^5L)+NCL+%/%Z$,#S-9)]O4:0 QJL&
M[G\32CBDLW88FR#MA<>NUN8S+X[)1/EJVHYF-/1+#V.U@S&7HXBA/=NSB*")
MO;G%0[0-_H[31FE$C&2FS*(H?X_2:?8E2+(;5K^.LBM;R<$4I_@<5VZMR"U
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M,!D\3-E*M]CZT0[D?_8_O4;=RUH@K1SG, B24L8 /=:>2M<=V-WPTMB3SS!
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M3=]W,\5L09Y^Z\66,C,^6"40O$OHO+.WL7*X&PS'ZG7R'UUP$6)1Z E(A_\
M0O0#F M+?LO*VZ:-MVK;)<V;57.-9[S)+$P^X[]R"U3;0>4\1M%RO3RM(5<N
MSL1=CV*U=GW">UO%K"&YD*M&G"?5=4_?DD6#0<_M@V3)8I\N2LXY['NK6[3?
MUM(4:PECE'8,AMF+K9IT9K6PU\[WD%A!(#&+O<BY/:M=QVG>>9F]4&.*XV,D
M>J_\ERE/(FXS4<EA\)6GFA-SM\\T [ECC;^%!:&Q;-CMTJ,QLV7OXB=P;*+@
M+BSO\$DKH[%LDC^1K>(R^>NXJFR'JH87F-CR?NXA6SI5?.5*-N#(9/Z^)L_^
MBV2>WR1?EZF2I#930VO>X<';DB^@QD+IK+'GV?,[V:%$.-+8U#?,OJDEGNK8
M=YU"O3RC6Z?[,Y?_ )5Z\_<7[9>Q''9@@P%ZW*ZT\0OC:/2<7*1<;:3L.'I;
M%F,A_H=ZXPNBCZ\C&H?J.3Y8V[#VYZ>9#6P6VDN<XA[U+\]NF1O[1:P;LM:J
M04X.K,M-G<DLW_F.@$XYVC9W;!>PMQ]RYCR7BM?F;^L%OY7"CUW)'FBQ4&P7
M!,,;ZKK/\9'8_0I7N>W7J>Q8[5X+]J)HJ^=VU$SSG7$U;8-MI;I!CX[>2R&'
MG]O7M,Z?&XKYESG(N0W;8M:J9$>P<66/W! P%:NX9/D75-6P#+6<\[AL>E*&
M$DO_ !V]3-M[D'!-R^P9VU ^A'2,C:<3B?"0JMIMCS]K!-SE?/9EV3EZF;4C
M815'?OX >2L;)<A9ROIF&F-3T<QD7-B8#^ZQWW>HKR=JF<QVFVKMK:+]QWJQ
M^O!(X^D5=>A2B;3=>> 0#0AZ!/?7LL._:G'M>NV,8Z3P?Y"2)_X>U><L'NN[
M<<6H<3L=)\^/^&O^>A^6%7/F9\'LG'.3FPEDQ57L=*XP_H/G]VO 4$X7IFCI
MCLZ_)VQ%"9^ZGF?07=UFKLN\8.;-VL]=H23DBG#5>6LC8$T+?<O'#LF+SKG3
M6\1WW*/F0,6K@J.V;GKE[/'8+E2S:[-&""4B*,!='+G9?ZF,P-A:!?;6(=^2
M%&<%L=[/ZOKFKZW<,5F.E ;MQKRPP!HZ+6J_\%B#BJ0@?>M6CWVZ:P\O>XKK
MHO./,?\ MIHG_:RKT;_"[^]>;&4,[D>5-JJXZ^*<3^O7G;[RAOX8NIIUK8<!
MR/E-:NYBQ?K,HF>)TKB2 %S!DI=QR&9GO5<[)7JVC#5BH>S&==^[SY#W4UXJ
MGW.*+)4<[4MB".4&K-9/<A8I[MTDL6NY5\3RUXJOZ(54?Y/;*XTR=[9>Y7W#
MZ@5[R,8]CFO:"TCH@JH-_P U:PS=?UO!D59;\OI1F(>\<3/GP4?W?5LGJ6*?
ML.#SF2,]:0.M-FE,C9F_DK3Y%V;-W-(UK/8O)25A9DA;-$QQ <95WZVG[K%D
M,AD[^RR%DV->/&(EHAE]CTP?@*!:)@MTW;5'26]KLPU&S2",-[=(]_Y>NSH^
M]9G%8G;L=FIWV+&%!\)7?AOLNMK.K3;?JD.9RN4O'(6F&6.1DI:(ON T+)HF
M=S>8US:L#E+\[;^.)A^I!ZD4 T'5=HV_6ZUMVQV((:MPB./Y]7\ERG&SU*IV
MC+6MGOO&.9%X8^LR0]D_D,6AQ#8_;6"VW#VGRRTHI@V,2.]PQP<G#>J8<29F
MZ&/$M;)%D73O8 =KI8Z.6#GG)Q/G?)&[&OE )]F>;@LL$#=ZW;9:E^5[\9C'
M>@VKY= O)_>(7+JS7=(Y*H8&K)(<-DV@10N/?IN']A1R#!V<ES+F\7'F+E:
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M*I/<OVNS#6A [("V]5W&OGYLG RE9K3TGQLFCG:&N!?VI1;:#7E!'8+' _\
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MN*X=+DG)5-BKX;9,*,>^S[5YF2&6-Y_O(:L>Z<J.U79*6-L8I[JTX)]?R_\
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MY[7QC,3#"3-.TR/D>6A@"[>K8S,1ZO7QV=; ;#(?1>8G%S7- Z!]P%1#./\
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M.G>6LLPEAZ7FO!8[E_6*=K 5<;%:K=/]&=Q]FA=?0]%VZOHFR8B]"RLZZ/\
M,^_ZP5RXM5Y6OZ4[6Y*]2M4KQAGN?US=*Y^.Z69Q6HX^GF?39- P1M:/LQJK
MV'3,;?YBM9*"-CJ]: 33@? LO4^Y J;2ZMC;.O@NM5[;7NC+RUKV='L.4(@U
MK;-DW?#9[*XBKC&8_LD,D,KYC_Y!7R1[+SO/J7(6%W?-W,":YK920O=-)_\
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M1CTZAG6P.=-=#&P5ON97CX5<<EV>0!J;SE:=$59IH_5;"\E\)5^ZN"<'C?\
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M>BTR^?\ 9 5ZXET;Z-8QP>BPQ-(CZZ\1^%3'/I']#:W_ 'G I%F:9R7%UJM
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M;&-=,QQ<Q\OZRTJ=Y3#X_)TGU;]:.>%_S&\!P*C^O:1K6NODDQF-B@D?[%X
M\NEGV74,#LL#(<G3;,&'MCONU9\#JN$P%"2ICJ4<$+_WP![O_FY:.(T;6,-D
M9[V/Q<$$TK"QQ8 !T4IZ/K%#,/RM3%PQ6B7'U&@ _J4K4'O\<ZG>S$F5GQK7
M6GR^H7_S4RR&,IWJ4U6Y"V6&9OB^-P[:0HA@>/=4P%PV\=C(XI_'KS71V74<
M%LL$<.4IMF;&>V'[M7F[DK"ZWKNVZ;%CJT59D1)G#!_=T7+T=L&KX':J+(<A
M7;/%WYQN'L1W]P5P*O%.E5JE"K^S&RQU)3)'ZO3B2?RNOGM!UG.V*\U^B)7P
M,\8S\!JPYKC[6,V^L_(41,8(_"/L_ 4LI8ZM0H04HF=111"-C#[]- Z59W>&
M=$MY 774'QR!_GX1N\6$JQLCA<=D<7+0MUV25Y&^)B(]NE74'#.B0T[%<8WL
M3?+R>WA6-A\/0Q%""G3@;%!$WIC MF[1KW*DU:U&V2*5A:^-P[!!42U?0M;U
M?USC*?@Z7]][CVY<?)<3:?D,A8N/KS1OF/<K(G^#)/\ &%8.-QM+&4X*M6!D
M4,30V.-HZ  6R]H<TM/P1TH!7XRU2MD1D8:3F6A(7^L'_K[6YM''VM[+:BGR
M-=\CXF%L;@[KI-@T3 [!0HTK[)GPU>O "1=634\-)KS<+8K^K3;&&-CD/E[!
M176^*-.UO(B_1JR&=HZ:Z5WGXJR%Q-GU?#['BWX[)0F2)S@[V]BTC[A1$\4:
M@<'7PYK2FI%.90"_W<_\N7=FT77I=?BPDM4NI1O#F1$K/C-/PN-UZ3"0P$T7
M^7<;SY=^2BF)X>TG%96+)5J4GK1N\F!S^V-*M!1S9]/PNQQUXLG&Z9D3_,1]
M]-[6UK^OX_ XIN/I->(&DEH>[R/NH7DN(=(R.7=DI\>1,7^;FM/3'G\D+C<T
M&AC^.YZC?"$&2)D,2XV@<9:=D=:PF1DCEF,L$<LL)D[A,O7W8K\?CZC:?TOI
M-](L\/#K]/C^.E6C>(=*99$HI2!@D#_IO/\ S'8^_@I7L&HX//58*N0JB6&$
M]L9\-!6?7];Q6 J.J8Z$Q0EWEX=KA#CC4QLDN?\ H ;CW^?9]VAW]H!:&4XK
MU3)9.Q>E@F#YWO=.UC^A,7'OMZGV-QM+&4H:E2!D4,30V.-HZ#0%M+DR8#%O
MS4>6-<&VR$Q,E/R&E,E@,7?O4+=B 234W^<#S\L*S9S"8_,8Z6A=B]2&3KS8
MM# ZMA-?K6*^-IL@BF(,C6_#NESJ6A:K1???7Q,##<!;-TT>[3\A;N)U#7,/
M!+!0QD$#)&!LGBT O _M+]Q&I:[A;3[.-Q=>K*]GBYT3 WL*1*,VM-UVQGF9
MF2A&ZZP=";I9!J&LC*')MP]47/5,GU'ICU/(_?M?5O3]7LY,Y&7#U9+7F'&=
MT8+_ "7SL>I8'8HXH\G19.(SVPD>X75Q.'QV(I1U*5:.""/]V-@Z"W5%LEI&
MJ91UE]S#5)7SN+I'F,%Q<?NOG7]'UG7_  ..QD,4C6]>MT#(1_-RRY;2]6R]
MSZJ_AZUB7^W(P.*CUCB70YWQ/.#@:&=]-8 T*:XC!XK#UC7QU*&M"7=ED30T
M=KF[%I^O;$U@R5".?P/;7$#L+XP>EZU@0#CL7! _^V&CS*DZULKBL=DJAJ7J
ML5B)Q[='(WR:N?4US!TL;/CJV-K15)?WX&L 8[O\A8L9JNO8J3U*&*JUW===
MQQAIZ"[RY^0PV+R$D#[=*&8Q.\HS(T.+#^0OB;7\1-<%N2A Z<'OU7,!<LMK
M"8NW8-B:C ^3V_4Y@)]E^Y+%8_)575KM6*>!WS'(T.:5DQV,H8VJRO4K1P0L
M_=C8T-:%LH]C7M+7#L'Y"BQT?43=%S]A438#NQ+Z3?+M2D- '2XF4UC7\K9A
MGOXNM9DB_P!6^5@<6KKNQU,U#4,+#%X@%G7Z /QTM.MB,91>Z2M4AB<1T2Q@
M!7FS/PULIS&Z2>A--CWP"M(XQ]M)7I'$X3&8N 04:D5>, #QC:&CV67)8K'Y
M.JZM>JQ3PN^8Y&AS2OS&XG'8NN(*52*O"/B.-H:%\SX/%2V769*4!E+O+S+
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ML?#@7A1V$1UX]KQ>MT#E76YY'7KLW^;AB^2&=CR+B$XT_P!S&2'\[*G'#L$
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M[^W16GQWI-^K@-H98J/I,R<I]"F?F%@[4'UT<JX# 3ZO5ULGN5[8[[G_ *&
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M1>!:H3D1-6"IFZF#YKS,%]@B%V/J&5RMV3+8)NR05Z\,<N0GB/G)& 2R)O\
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M/YO*B^$YJ9F-APV.AQ$@@ML'JSD_N/72SG*.1A-Z?"8,7Z%-Y9/9,OA[M^?
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M!_\ O*E>&XXQC]D8&CK]J.'2KK4-0U_,<E;E!>HLDA@GF$47\ [>IGM.$U+
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MS*;'C];HODN7)XLR/H;7M;)L?9@&3M^O6[9TWP:2L/(4&>UK?:FY4Z;[-1T
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M $]M63?-5W#^FN*V+ L9,Z*,QOCD>0 N(-#Y%=OM+8);U/U3&/4E#>VQAO\
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MI<<XO5[V0M5K=J9UOOU!(5%\QP5J.1R4MUCIZQ>[M\47[BMG"8;'X3&P4*,
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M 0RY^BP.]WO;V7M/X!6*#!<UF!S9=DJ@F+^9(<LXUCEPQ@G;F!_2QLUKF O
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M1SL_C+RMFWLFZZOQU7R4L5*9[60CV/7@PA:^N;WR#F<CA91A0S&6:O<DY'W
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MW$Z[C.)[]#"S/EJ17@PO)[[?[ARM/3,#BJ&NX9M>LP>G7:6.([<"\>ZK'3A
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MCB'QZBWMZW_ [#JDF*P\YLW<D61-@:T^; [Y\ECY%J1X3B>I@I)?.RR&&-@
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MF!1BIM.S[+E<\_&[ S'S4)2RMCWL[$P'W>NS=Y&S&%X^IW\LSK+V'B-L19T
M]0"[R5L.#R&-G&RP9>*P1]779&6^B?PQ61NVZ78LK@,31OC'19)CGF_(WLM
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M=9P5RKPAL+WQO]2XPRLCZ]_!;^.Y$UEG%E?',M%]]F.$!J@?K\FA:^-R=-_
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MKW'9Z5(<NZU1S^7UJ.M8:R_-8,7M[GTON2KLK8Z:AA(J=1X[@@$<3B.AVT=
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M#L=KYN7Z=&%TMB>.)C?ESST$H9.C>B$U:Q',P_!8>PM?)9;'8^,.N6XH6D]
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M0'E$ <?;'_RJYG#O^P&'_P"S4*Y5EMP;]H,E. 2SM?/Z49/0)]DNY[?M6VW
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M;/)3787R:)I61N4[=NS*UD;(_J)#(&%4_<R.>_8F/S>,L;(<K.&%[WCNM/\
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M=8>>7O\ V5A&B0!IR4?;%?</[@_N6KD__P  M_\ 8/\ _O+Q]QYQY?W#6?\
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M-$(RYA_C:56^I:IF+W#N:IL$H]>0RTXW>Q+5M:#R[A,9KM?$9>M-#=I1")C
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M(B(B_G7Q9_O UW_FPOZ*(B(B(B(B(B(B(B(B(B(B(BP17:DEN2L+$?JL +V
M_J *SK$^>O'(QDDS&%WP">B5DZ3I?OB$Z_F5^=+\D<R-I<]_0'W)Z7R)JY@]
M43@M_M ^R^H'1SL\XY YOY:>POKK^93K^93K^93K^93K^90EK027>P7S#/!,
M'&.1CP#U^D]KZ3I/$)XA/ (& #I&0,:7%HZ[/9Z^Y3K^96M&*9MRB,L]8]!_
M1'G[?E;/@.^TZ_F4Z_F4Z_F4\?YE/'^93Q_F4\5\R.9$TN>_H#Y)/02)\4K
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MN\6M<X DKH"1CFAP((^057'(%S$Y'6LUC1DHFS_3&0!K_P!0Z6OPY_L%AO\
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MMJ1H=(QRZV=UQ^ X:R^)L6A:-:$EKRMVE!!9X9I1SQMD9^QHSXN]QV&JL\#
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MJ[?$]*K1SW(M.!@B@AR(8QH^&M'FN,Z1\& VJEK=+ZRH^29]N]8=Z<?GW\1
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M"^?,F)Y)[*A]+C'DC7KMBI@,\R+%R2?#Y' @*^M5UV+7\1%1;/).0XOEG?\
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MG^\#7?\ FPOZ*(B(B(B(B(B(B(B(BX6SYP8'!WLD8'S>@SR\&?)7SK&P-SN
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M%2_=E\(8ZD?9^Y]O@*HM^W78+^F94R:O/#CK< $5ESOUCO[O:I]J^=H8#C'
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MR5LNYP:IK>7JV)*9G,0LP,]B)'CL#M3'5\9R(=E_:F7R$?T,]7WIM<2(GGX
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MSY0WW)C#2L6 P/&.4U.M>FD8^"*!IF:^3]QX'X4>VS(4:N>XUO1PNAP<3?\
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M9H7]GWN6";L6KXFA'Y9VY>@7?"K# [QB[V3SF%R=F-EF"_-%&R3XEB!529'
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MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+^=?%G^\#7?\
MFPOZ*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(OYQ\;O\-XP#O5$?5L?K([7]'$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$7\Z^+???]=_YL+^BB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+^=?%G^\#7?^
M;"_HHB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B_G7Q9_O UW_FPOZ*(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(OYU\6?[P-=_YL+^BB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+^='&!>-]UXL'9^K"_HN
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B_G7Q9_O UW_ )L+^BB(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+
M^=?%G^\#7?\ FPOZ*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(OYU\6?[P-=_P";"_HHB(B(
MB(B(B(B(B(B(B(B(B(B ]HB(B(B$=A(HPQ@;V>A^3VB(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_G5Q;[;_KO_ #87]%41$1$1$1$1
M$1$1$1$1$1$1$(!2.-L; U@Z ^ B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B+^<G&L1FWK7V!P!-L+^C81$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1?SBXXL"MO& E/P+;5_1T(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(OYS<91"7?->8?
M@VPOZ,HB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(OYU\6?[P-=_YL+^BB(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B+^=7%OMO^N_\V%_15$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%_-_CN:"#=<#+,"8VVV
M]K^D 1$1$1$1$1$1$1$1$1.PG83R"=A.PG81$["=HG:(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_G/QE%%-OFO1R,#F&V.P5
M_1A$1$1$1$1$1$1$1$7Y*_PC<[KX!*KG3\QE<[5SV2DN/9']7+!5A'Q&V(GW
M7#XLR^=R8SDV2S4LX@LF"-COL!W[K@X?+;UE;F\5<?F2^:C?$%82_ 82[LI.
M-T@WG'Z\-JMRQ34W32R@=$>/0_*S;Q>W;5M;JSG/E\O[2$ >&>[XI/@N4WAI
M[9!F8)(-A^KJ2Q%LT+QT8S]G-()7%XTO[;<R&Q-S&5,[:5KZ5C1^6$@N7;WC
M:+F-M8;$8][&WLG/Z<;W_#&CY<N52VK(8'-9G"9BT^U]/3-NO9ZZ=)&WY!4<
MBV?;:V!H[C;N@U+%EG= #IHK2^[7 _VU)<IE\YG-HLX;$W?I*U.H)YK3!Y.>
M]_NQBQ87D8QZ5D,GEB#9H3&"<,'0DE'L.ETM(GV'(N;E\GFHR)XB6XZ'W9"#
M\=G[E<K.[Y>9NN!Q&-<#6==]&[*/[?\ 871V'-YJ]M1UG#V!5='5,]FYX>99
M^& +4QF^V8M4V"UDRP7<3.^"7KV:]X/0*Q<>9;<,V(,C;V&C9J/C!DA@9[M?
M^%OC8=A;R<S"&>)N/=1?8:T,[>? M'N58QNU67(:LDH$TC'/8S[EK>@2/_-:
M&P39>+%SOQ=9LMH]-B:\^+>S]R55."SV]8C<L?@M@L06H;=9\D,L;>B'M(4G
MS&PWL3O.%IOLB2IE(W,$)^8I(^NG-5C!$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1"0$!! (/8*(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_F_P >2-BW7 O=*Z,"VWMP7]( B(B(
MB(B(B(B(B(B+3R@M?L^S]/XB3TW>'E\=JO\ CF6B_49WUX70_P"DV/J&N?Y
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M-S>_D$*!:9KMW"U,WB[C8Y:LMQ\L#Q_&R4DD/"[F'U+7<(9CC<57K&0$/,;
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M!Q ;L=4DI_6GQ]]]CJI_6CH  )V*J 4_K3X]_P"LE5/ZT^/?^LE5/ZT^/?\
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MS_QBK_ZT_IIK/_&*O_K3^FFL_P#&*O\ ZT_IIK/_ !BK_P"M!N6LD@#+U?\
MUK:K[-@YY7119*LYX/1 >MW]IX__ /+(/_6%H?TKP'_%*WSU^^D6TX&=X9'E
M*SB>^@'_ (6V_-XMD;9'7JX82.CYC[KX_;V(\IV_M"OW#_K/UC]*TI-OUV/P
M\LM5'DT.'Z_L5LU=CPMIO<&1KO'\GA99\WB8&]RWZ[1_-X7/.XZT&M/[7J].
M^/UK]&Y:V6.<,O5Z'R?-#N6M^(><M5Z)Z'ZU\?TTUG_C%7_UH=TUG_C%7_UK
M(_;]=8V-SLM5 >.V_K62?:L!"R%\F4K-;(.V$O\ D+!_336?^,5?_6ON+<-=
MFD:QF6JEQ^ 'K\=N.MLZ[RU4=CL?K1NY:V]P:W+U2?\ &O@;IK/VS%7_ -:_
M?Z::S_QBK_ZT_IIK/_&*O_K3^FFL_P#&*O\ ZT_IIK/_ !BK_P"M/Z::S_QB
MK_ZT_IIK/_&*O_K3^FFL_P#&*O\ ZT_IIK/_ !BK_P"M/Z::S_QBK_ZT_IIK
M/_&*O_K3^FFL_P#&*O\ ZT_IIK/_ !BK_P"M?!WC5PX-.9J]GX'DOO\ IIK/
M_&*O_K3^FFL_\8J_^M/Z::S_ ,8J_P#K3^FFL_\ &*O_ *T_IIK/_&*O_K3^
MFFL_\8J_^M/Z::S_ ,8J_P#K3^FFL_\ &*O_ *T_IIK/_&*O_K3^FFL_\8J_
M^M/Z::S_ ,8J_P#K6%^\ZJV2-CLU5#G_ +H\EH/Y,T6.21C]@J@Q_OK%_6CH
M  +MBJ@%/ZT^/?\ K)53^M/CW_K)53^M/CW_ *R54_K3X]_ZR54_K3X]_P"L
ME5?+>5>/CW_^<59#RKQZ"T?TBK+">7./@QQ_;T7L\!;']:?'WWV2JL3>6./B
M9>]@@'@L9Y<X^^E]<YZ+X[\/XUL,Y5X^<QI_I'6"_?ZT^/?^LE5/ZT^/?^LE
M58Y>5^/HV!W](8'>_P -63^M/CW_ *R54_K3X]_ZR54/*G'H'^T=9:\/+?'T
MG_\ WXFH.6N/B^-O[?A_4TE?<O+''T88?Z00.[/7LM6+F'CZ3V_;36^X'N%\
M'F7CX,>[]L?'V#%K?UV\?_\ $Y/_ &T_KMX__P")R?\ MI_7;Q__ ,3D_P#;
M3^NWC_\ XG)_[:?UV\?_ /$Y/_;3^NWC_P#XG)_[:?UV\?\ _$Y/_;3^NWC_
M /XG)_[:?UV\?_\ $Y/_ &T_KMX__P")R?\ MI_7;Q__ ,3D_P#;3^NWC_\
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MSI_]1N)_X3.G_P!1N)_X3.OE_P#E&XSV\<1,DO\ E'8P,>8\1,7?8%RYS/\
M*1!JL+L#U/Y^[1+[=+3_ /J4N?;7(O\ WT_^I2Y_U<B_]]/_ *E+G_5R+_WT
M_P#J4N?]7(O_ 'T_^I2Y_P!7(O\ WT_^I2Y_U<B_]]/_ *E+G_5R+_WT_P#J
M4N?]7(O_ 'T_^I6[_P!7(O\ WUJS?Y2&6= YL6#@9)W[/,JYW_U$;/\ \/JI
M_P#41L__  ^JG_U$;/\ \/JI_P#41L__  ^JG_U$;/\ \/JI_P#41L__  ^J
MG_U$;/\ \/JI_P#41L__  ^JM&W_ )06ZO+#695@_/Z/-:G]?_(?_P"4UO\
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3$1$1$1$1$1$1$1$1$1$1$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex3-6_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_009.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 <  !  (" P$!              8'! 4" P@!"1
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MWT;_ -MX_P#Y+4?TVT5S2/V<H?\ Q"U!TWT7_P!MX_\ Y+4_HWT;_P!MX_\
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M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+\JU;?1/\
MR_QW]QZ]\M]@B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(ORK5M]$_\O\ '?W'KWRWV"(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B_*M6_T/B?)O]'L'/9$]Q7O5OL$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1"YH(!/NB(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(ORK5V= XY7[XTL+?%.4N7N@(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B/C8XM+@#P>0B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MORK5[?X/?^7,O^[Y5[>1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7Y5J]O\'O_+F7_=\J]O(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B+\JU>W^#W_ )<R_P"[Y5[>1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M7Y5J]O\ ![_RYE_W?*O;R(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_*M7M_@]_Y<R_[OE7MY
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1?E6KV_P>_P#+F7_=\J]O(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M+\JU>W^#W_ES+_N^5>WD1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%^5:O;_![_P N9?\ =\J]
MO(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B+\JUZ-_P=*T)S^2G+>9&5N 5['1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$7Y5KTE_@YL'XUE7_:NO82(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B_*M>E?\ !S_[
MWRW^H"]?HB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B+\JUZ7_P<F<Y3,.^T+5Z]1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$7Y5KTK_ (.?_>^6_P!0%Z_1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$7Y5KTK_@Y
M_P#>^6_U 7K]$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1?E6O2O\ @Y_][Y;_ % 7K]$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1?E6O2O^#G_ -[Y;_4!>OT1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%^5:].
M_P"#A7>Z[FI^#PUC&+UNB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(ORK7K3_!K_[%L?\ K8%Z
M@1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$7Y5KUI_@U_]BV/_ %L"]0(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B+\JUZT_P &O_L6Q_ZV!>H$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%^5:]:?X-?_8MC_UL
M"]0(B(B(B(B(B(B(B(B(B(B(B(B<HB(G(1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1?E6O6G^#7_ -BV/_6P+U B(B(B(B(B(B(B
M(B(B(B(B(B*I,KLN3SVV'6L-*^"*MYR-P>[./W&*V(PR&( N/#1QRXKF]PDC
M(:_CD>"%5V)V?)8;9GZYG)C*9RY]"Y])6?PO^SE:*HGJ=G]XT]WXS4RD4^/E
MM!AK2,\L[O/ 5GZ?ME#:<%!?JD O:/5C!Y,;_JTJ#[5G=RI;U@L30R,+*F1#
MW$&'ET8C5O@\#R4Y"UMK-8^K?ITII2V:R2(F#Z]JA/4.QNL,&,.M,+GFTWUN
M/HQ6/$9?3:9>._CSQ[<K[R$1$1%BY"]!1I6+4SPV.*,O<3[>%%M W2+;<",E
M%"(3ZKF/9SR00IFB(B(B(M%M&PP:]AK62FAEDCA'EL8Y*ZM2V2/8\%4R4<)C
M;..>TJ1(M7G\W4PF+LW[#9##".7!@[G+0:WO5+.:O-G8()FP,+^YO'+_ )%S
MTC=\?MM"U<HQRL9'/Z?SC@J8(B(G<.>%"\UON"PN>QN'MF86+G]F0WE@_F5-
M$1$1$1$1$6H.QX.+,QXF2]&+KF]S:_[Q"VZ(B(B(B(B(B(B/D9&TN<X #W)/
M 1CVO:'-((/L0B(B.D8WCD@<HB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(ORK7K3_!K_P"Q;'_K8%Z@1$1$1$1$1$1$1$1$
M1$1$1$18]^4Q5+$@_<B<X?\ P%2W0UDMO"YG-3\&;(7RYSOJ>U=^XU]ARFZ0
M4)[LU+7F53)+/'(8N\_8E:[I;FK0V3/X:'.2Y''UP#7DD))"RNNK&0X+%9!C
MGME@R<(8X*ZL98CNU8++.>R2-KQS]BJLZOUX;6%PT$S ^.3,UVO:?J"UZK.[
M!DND^X&Q4$K]<NR\/9](RK SUNM>ZCZ'9K2B6*6G:<QX^H)C61L>R9;);=6U
M+"VOA9!$9KEL#N=&T?0!:UF<V33]MQN+R^2=?QV1Y$5F1G:^.11;9,/F).LF
M/B_&YV"6%\D)X\PMY'+ I1U2V+:M:IX/X"Z/2EE9#8E+?G)4IWS<+>'9C,9C
M6A^5R,G96#A\@ ]R5%8[_4/7-MPM._<_%*>0/$C@S@PO"VFY;Q?J;37UW'7*
ME23T#//:G\A@^@#5K-/ZCY2;:GZ[F)*T[W,+X+=?PR1<IMJWC-Y[8*N EH00
MXN<PF*?R^=P5D:=ELGE,%7LY&N(;+B1+&/H6J3HJFZGV9<B,9JE4N]?*R_.6
M_NP,\.5?=*GS:EO.=T^T\B)[C)7)^O8KSW+/3Z_KE_*PU/B#78'>GSVJG1U>
MV>[K\.3QFK/FBC877)B_B-A'T:K!AWJSD]$&QX:@+,K1R^JY_;[?F *R>G6[
MV-NP,^1?3BKD3%@C$A>5VZ?M>:S5_-Q3XR&"O2M.@;*V4O\ 5<PD?8*=2RLB
MC>]QX#023]@%1UWJUD7Q7LCA\#\9B:DG9-:,A8[^;6\%2B_U'KP:$S9JU&69
MCPT^E]N1^\H39ZVR?A-:_4P$\\8BC=<D!XBA+O< JWL?M>,N:U!G/6$51\ F
M+G>[0?NJIV7J)9M:U>M-P%S\-L1.9%:_0^SB%*.CG^06&_U:LRS8BK0232O#
M6,:7.)^@"IVQU?K>A9R-/#W+.)@E[)+K0 U2_.Y.KE='N7ZI)AL4#)&3X/:Y
M0/HEXZ6S?I+.L/\ P?7!VMY0\ <WE?SG!H)52S=8M9ARF1HR"R#4Y!^3R]_V
M:%MM)ZEXC:;=NG'!/!:@\F&4<$M7?L&_XW$Y+\*AJVKN0[._X>!@<0/NY9NN
M;OAMA;:;4,K;$'B6M*T-E:JDQ_4/+W^J-B XS("K6JRQ"JP OY+A\[PI[L.5
MTC]L\%0R-3ULJ7?XL[TP?3[E+\_LV+P%=DER0\O>&QQ,'=)([[-"U6 WS"9K
M)6L8T3UKT!^>K88&2<#W(X)7#9-_PV!LFM-':L3!G?(RM&)#&W[O\A;77]NP
MN=Q;LC0LAT+1\_/@L^X<%$HNK6KR$O#;OPOJ^F+?I#T7/^P/*LX$$ KY>O5:
M%:6>>5L<4;>7O/L J[K]5]+GGBB&0>P2.X9(^/MC<5*LWLN%P5(7,E=9#"2
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M8W#^X%B=0F,'5#IV\#R99EU79X7=>88KKR618W_%0[V;(59-O6]<K[(S87L
MR,D?H,)/AQ/GV^_A5!HF-OYO.;G8;G[%*P<D1/78/=O+E+-=Z=XW!2;#1;GG
MROR$)<Z$M[>Q5;6S><TFHS5=HQ(LX=\@$5EB];4I89X(Y8G=T;F@M=]P52/7
M7(RPZ_0I,+P+5^(2$>Q8/H5+=UU?&9+2K-$5FEL%;FMQ[QE@\%JI>>Y<RO02
M-]P%SX9VQ1./V:K,T'ISKM7&:[E9:(.1BJL>9??YW!6_*2R)SN/8$J@>G$@V
M3==LS&18'6*LX@K@^?28>5C96"75^KV&..'HULSR+$+?#'N'NY=^O5B_K?LT
MQC!:RN\%WV)<NK<<7!E.K6 J6"[T7TW][0?SCQX*P\_@,9K7532I,36BJLN%
M[)(HF!K>&KMO_BF:ZJY:" 4GR4(.RNVP.0T<^2U;[5.G^=PNVV<Q->J-BMM>
M)JT+>UIY4!U/0<+G]YW>&W4YIUK;XVL8>T-)*],8#!4,#BZV/I,<VO WM8''
MDJI>LF8?$S"84V3%!D;/%C]8VJ1YCIIK]F;"V:790=C90Z-T;!Y9]BHEF0S8
M.L-3$7")*%*@;+(3Y8]Y(6)U-QL>K9;7]FQ%9D$K+0KS=GRB0/6LZF8>K=ZI
M:>!,^)]WEDQB\. 8M1U!TREK>UZK-@V34Q8E>R::-RV/4[2L7J[</GL6'-M,
MR3&22O=W/D+_ *E;?K/AX+>4U2RU[H;+[/I>LSP0"M!U5T'%ZY0QV9Q4T\=X
M9%C'3N?R]YE_?)61O_3FEB=7_''W)YLPRU%)-;<?,A<MQU=8VYHFO79VA]@W
M:H]7Z\/!)6_ZRX^L[IY(#'R8)8?2*A'4.I,.E&I.]29D[75(O)^[4W[I[!C=
M7CSUK(6[&9ADA[[#Y20K!Z@MER'2JW:EG>)F58YN\'R7+0V]EMZ_T;URQ3/%
MF>O5KL?]&>HQ,MTD,N&H6\39+,[$]CWW'2GF7GR_ERW/47%9^]0PU4Y!D=$.
MYR<AD,?> J_UNWB<?U1H4=:FM-Q5F%P?&?$3C]VK#RVLXF;K@RDZ$^C+ )G?
MWRMWULK&A7UH5K-AD;;#(Q$'GLX"FN^9>Y<S>NZO4M20F^\OM2QN+7MB8HWO
M.!L:/#3V/7[=EK:\S66(9)2]CXW+5=5[F2R$.H93#92>+XPCLB:\AG+_ &*Q
M=_P6S:L[$["W9;<]A]QD5CDD-Y?]&A3/JWE[=$Z^R>6S#B)IS\?+ \M?Q]&K
MOTS%<;)%D<+GYKN!?2D:R&24O]*0D*YU1=S(7]RWO(:^S(S5\50819$#RQ\T
MBPI,CF-!W?$8N3*V+6%R/+863$O?"6K1;%D-UCZMOPN.STXBGCY:UY/IQ!ZN
M70,7M.*P\U;/Y'XR?UR8Y2\O/9^I*W6UYZ+ 8#(9.0<BO'R&_=RJ6G@]MS^J
M#.R;/<@N6H/79 QQ$#6$<]A:M3TVSXU[HU=R7@OAL3=@^[U&K^P[6_#5<Q5S
MN6=E2QCY:?I<5O/N&@.5G[%E;V6Z-9*Y?KF&U)0'JL63BI\A6Z/8V?'V1!9C
MQ,3F/+>1X8L;3[&R9;I?'/'EYAD)6.E98<27+ATKW*]E=7R\N6R4C[U64B8.
M]XPF"VC,XKIYD-DS%N6P9#WU(Y?!+#^15=D-WV2*A5SE+8;<U\<&>B(B:H#_
M "0%--VWK:(M'U[/XYPJF=\8LQ^SN]X6YUFSU5LYD7,E\*W&V:ID9$PD^D?=
MH7/IAMVP92;;1F[()HSM:&@<-9X<HF_J'E<[6R60J;-#C60RN^"I^B7F<-^L
MCE*->ZE96]TTRN=GK#XVD"'MXX8\K783-=0+>+Q6:J9^K>CLRQ_&561 >B/L
MQ7\%077F/,#"T7P9'LJ/O11/@#?=Q4RR&=R&F:E):RUR.Y8+V1UVLC$0+C[-
M4<R.4ZI8;!Q9JS-3L-C'J6J(C["QGZ.5I:MLM'8L)6R53DQ3#V/N#]BLK.00
MSXJ_%*.6.KO!"\H=.-FW:#3WT=;Q+)OA;+Y)Y9/L[V:T*[-/ZF5,QJV1R=]G
MPT^.\7(U ;_539QB1G8),:*Y <*'<72]A^I/"O33]FK;%@*>4@;P)F N;_"_
MZA-IRMS$X*_>JUFSRP1%[8W.[051\'5#><QK<&2PN ]7TN?BWGV_E&I+BNJ5
M[,:)DLS2Q@=>I$"6L7+0:_U2W+-_@LM777259)1':G]F]Q^RE>0W+:<KG\AB
M]5H5964'=MFS8D+&=_\  . 5EZAO5_(Y&_@,S4;4S-<$A@/,<C?N%H-;WS;)
MM_DUK+5JD1B8YY+#SW\$ =JE[]DS3^H/X)!%$^G'4$T[_P!Z,GV"TM3?LY)U
M.FUIV):R".)S_4YY<Y@/AZSMCW7+#.LU_7:$5N_Z9?.^5Y9' /UX!564<GL%
MSK'BX<U1BK6:]4L_JG%['^WS@D!6;L&]91N8GPN I5[-F"+NGEFE]..(_;V/
M)7/0>I(V*:_CKU44\C4)]6(.[VD-]R"L6YN^RY2S?&K8F"W5I/[9;$LI9ZKA
M[LC #E$>C+ILCL>[Y2W5->R^X.^#W,9>7$M7HI>9<]F!@.M.2M5J$EF:7%<1
M01CS)*\A3?5NJ=F_GS@<WA9,9D'-YBC+N\.75!U,SC=]BUB[@X("^0\3>N3R
MSZ$#M4MVC;+^(S>!Q]2A%9-^1S7<R%KF!OUXX*G:(B(B(B(B(B(B(B(B(B(B
M_*M>M/\ !K_[%L?^M@7J!$1$1$1$1$1$1$1$1$1$1$1$54Y7#9G7=HESN&K&
MU5O.:W(5&>'\CVE8K%L8K&Y/T9;5*.1S/+#(P$MY3\.Q]>=UQM6,3"+L,C6C
MN[![-5<U<#?V?9ZN>RD+H*5+N%"H_P#.XG_[J]6NJ)VO+;3)F9P>FT.1CJSE
MM:RY_)(^CAX2/>NI4,#&Q]."UC0.&"=8$VW[[-<@N2]+B^Q""(Y3+RYJUFP;
M;MF8BBH9?I>9Q(>8V/E7?K-^WKLY%/IA9K3RQ\ES"'.7;F\SE<VSUMAZ8SR"
ML[F%_(?X73<VS'7ZM;X[IS-+%78&1M=&'-C_ $:LJ;J)7R.&%!^D79*+X@T1
M=H[>U:' Y?!X"\+N.T"]%.&%@>N[:]]PFPB'&9G3+KY'_P!C])1_<*X:]MV!
MU9IAH:/>A,A['2$<R%:6_:Z6"]+,_';)6=.2Z9C&<"3O_DY7#JDVH[9JE_ 8
MRC<JT(F-B>V2/TW'O5CZ_@:&!Q5;'TVN;! WM8''DKNSV$KY?%6*,T\T;9AP
MYT3BUW"U6J:EB]6QSJ..,P@,A?Q(\NX*Z=VT?&;7CHZ=Z>=C&RAX$96LBZ=X
M>'6;>OPV[HI3?N&0N+5DXC1:6+U2; Q7K1A>PL$G/#QS]EK,+A\)TUURWZN1
MG-)L@?S)^Z3]E$9+6'W[>,)-18+%/%1OEEL?0O=QPQ7J%TY#'P7:4]><<LE8
M6.;]P51U/H;0@@N4WY^^^@\N,50$L:QQ6S@Z05(-,L:ZW+V/Z^5CY)RW^#D
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MQ990MP2SAGL&.5D939L-<TFUD!-%)#)2+NWO^X]EJ>B^,L8W0J#)VEKIGNF
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MM[MV(S][4=3V6A2EBR&+8TF$^X!'E9>'ZN9K99*N*Q^&EAO3$":9WY(1]7+
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MN/AF9#);A;(X\!I< 5G![2WN!\*K.J62QL^F9Z&+(-%F"$2AL<G#EN^FH?\
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MR$LE[?H"I)6W[5LU?H1:]CA:R$LPY>^(,$,?U<YRG\^X8>'9H=><]YNRPF4
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M/Z_1S3ZK(,B6DRLC\Q?=BL#<<[G:V?U[%8>Y%%+<D>9@YG?Q$SW<M+ON\Y[
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MO3F+*9]F=QV4FQN0 [731M[@]OV(Y"S]<T@XS*39:_DY<CD'Q>D)WL[.V/[
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MN6Z!L2-I2QL#@]A)[>5N.CFMY?7M2%?)!T<LLQE$!\^D%:ZP\G_V"W_J'_\
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M"DJ<A.4Y1.0B<HB(B(B(B@N"VO+7=KSF)FQ#X:]1W$5EW[ZG2(DDC(V.<]P
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M<5ZE>.&('D,8.T!=&6P>'RC1'=HP6&AO'$C0[P4K:_AZ>+=CX:,,54@CT&-
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M.,QUFKM#Y:L3R_)D.) /(!<NKJ)#%_21TYC[0&"69:K:'UOZ;8H\G?M5()*
M97EBD,9#RIR=,TRALF+RMBY<LY)TH97=+.92H7G<!M^&SN7S^F78YX+,SS?K
M.//$H5C]+=FH[!KLEJ/',J3"PX3PL]O4/NY3G)_]@N?ZA_\ T5)]$)(F=.+9
M80)18G61T*GAM:QD9Y3S=EOO-HGW*P\)2BH];\W%0865GX\R3M;^7U25?B(B
M(B(B(B(B(B(B(B(B(B_*M>[N@K2WI[!S];<JN9$1$1$1$1$1$1$1%T7KU6A6
M?8LS,BB8.7/<> %\Q64H9&E%<ISLFBE',;V^Q"R$1$1$1$>]K&%SB ![DI%+
M'*P/8]KFGV(/(0D!&2,D;RQP(^X*(CG-:.2> @((Y"%S00"41$1.41$1$1$1
M$1$1$X"(B(G *)P$1$3@(G:/LG 7Q[.0>/!^ZHZMTYVJYL]R;-Y^2SB#9]5E
M4O)$OV#VJ\@  B<)PB)PG")PG 1.$1.$X3M")PG""-H*$(UC6KC)!&_\S ?/
M/D+D  BQK="I<C$=F!DK>0>UX[AR%D,AC9&&-: T#@ >P00L!!X"^HYC7-((
MY!6!4PV-I2/?6J0Q.<.'%C TE9L]6*Q"^*9C7L<.'-<.00L,X3'2565G4X3"
MP\MC+!VA=IP] T13-2'T.[GT^T=O_!<X,=4J5S!!"R-A))8T<#RL.IKV'J3>
MM!1@B?R27M8 5]N8+$VYG36*,$CR .YS X^%L8XV1L:QC0&M'  ]@BC^0U'6
MLA=%RYB*L]@>TKXPYRW_ *$8B],-';QQQ].%$HM!TV*R+$>OT&RA_<'B%O/*
MW^6P>*RM05<C3BLQ=X=Z<C0YH(6+^S& ;A_P@XNM\%W<_#=@]-<8-4UVIC+&
M/AQ-6.M8\RP-8 QW\PL>MINKU:%NE!AJD=>R6F:)L8#9.W[A9U#6L%C<?8IU
M<97@KS_GA8P!K_YA8F-T_6<6R?X'$5:XF9V/$; WO"Z<'INN8&Q//C,9#7DE
MY[G,: L&[T^U.[F3EK&*A?:+^\O('ERVU;5<%6MY"Y%CX6S7'$SO[1R_E=>#
MT_7L$+CL=CXJ_P 0?G[ !RL+#:)K6%O37:-!D4\G/<]<L?HVN8[-S9BM0:RY
M*7%\O]\\E8NT=.-6V6R+&1IE\H  D:>'<!2&OK6'J88XJ*C$RFYA:8 T!I!4
M0K=*=)K4;=2/%1AMAG8]_N_A;6GH>M4];DP,5(?!2#A[3[O_ %)^ZZ\'T\UG
M!XFYCZ50MAL^)23R^19VM:?A=:JVJV-@='%/)WO83R%'9^E6K.MW+%<6JALC
MB6.M*8F/'Z@*5UM4PU/7CA8:WIU#'V=C?!(6JUS1,)KF,NX_&FPR"R>7DR$N
M'\EAX/IKK>$JY.M3%GT[S0)^^0N)6K@Z/ZI!5;49/D36#VO]!TY,9+%:,<;(
MV-:QH  X "Q<WA<?E\78H7HA)#,.'M58TNDN-J<U/Q?(RXKW&.?(?14OV/3,
M5G,*S#SNEAJM XC@/8!Q[!9.L:U3US&QT*D]B2%G';ZKR[C] I"JUVWI5K^Q
M9:/*.GGK7&^\L*P\-TBU_$9ZIF8K5R6U"/>5W/<_[K)W7I7K^VV1<L&6"V&A
MOK1J0:CH^)U?'SP4C)W3>9IW^7O<M/KO3NK@<W>RD.5N2OMESIV2>SW'ZE<:
M73BG4VZ79!D[;K,A=WL/L0[SVJ8[%KM#/X6UC;W/I3#@\>X*8#!T<%B:F.J-
MXA@C#&_<\?4JO][Z38C:;T5^.T^E=8?,\;.2\+>:SH-+ 8JY#%<FDMVF\3W'
M?VCRL;2- CU(V1!E;,\<YY?'(/'=]U\VCI[#GMCQ>6?E)XS1/,<;6\A=V]=.
M<+N$,8MES+$0(BL,'EJU>F],*.N667+%^>_:C860RRC@1M/V"ZG].<K#E,S:
MQVUVJD5^PZ9\ BY <X_WE,]4U:CK>--2N]S^Z0OEF?\ GD<?JY2.6)LD;V.'
M(<""/T*JG6^EL&!S,]J',6C2,YFCH#Y(F/73:Z>93'YNQD-9S'P#+;^ZU7+.
MZ,G[A2_6-2@P3[MB2W)<NVWA]BU(.'/(4N1$1$1$1$1$1$1$1$1$1$7Y5KW9
MT#//3V'_ &R570B(B(B(B(B(B(B(BKSJS!#-T]V#U8VN[(0]G/T<%H=,VW4M
M>TO6(+^3K59):$;PPJV*&5H7:3;E6Q'+$X<MD:>6\*,GJ!IPLBJ<U )C(6!O
MT)"E[7-<T.!!"TEG9<'6R3,;/D866W,+FPD^> NG&;=KF5MRU:.4@GFC\/8T
M^0LNSGL16OQT9KT++$C2YL1/D@+)HYK&7H)9ZUN*6.,\.<UW@%:Z+:\!-8;7
MCR==TA=VAH=Y)6?D<QCL:UCKEJ.!KCPTO/')7;#E:,]+XR*RQT/'/J#\O"TV
M2;B=DUV["V^/AK##&98S[+JTO"T\%KM"A7N?$QPLX$O''>NS8IHK.&R5:'("
M&9T#PUS) U[2% NA=J>?06/GE<]YN2\EQ5MF]5$GI^O&'?P]PY7;R%4O5^V\
M:A8EJ9)\,D=B/D12<%P/T*L/7GO?A,>YSB2:T9)/\E3N^WL]4ZEZ;%!>D-6U
M*3\+WEK.6*^6RQ]SF]P)"^NEC:>"X(7-:.20O@((Y4=K[3CK&P6,/"_OG@A[
MY2/9O/L%55C8,_!UIBQ!R4CJ7H=X@]F^5?#7 @(2$Y7R65D4;WN(#6@DG[ *
ME8-[VC:,M=J:M0@%.L\L??G/@G]&KIS^P=3M7Q\ERY#0R$ \/F9S&YGZEO"N
M3#W7V\94L2< R0M>0/NX+-Y"(B(B(BQ:^0IV)KD$,[72UBULK![L+ONH'#LN
MS?TA3X=^)XQK(2]ME6,B(L:]/+7J3S1Q&1S&%P8/J1]%!>F^[6]JQN0LSU!6
M=%;,89SSX5AHB(B(B+%R-OX.E8L")\GI1EW8SRX\?90WIYO0V_&7+C*A@$=C
MTP">20IXB(BA=G?,-7VVOK3VV/C)O+7!@]-31$)X"A6,W_!Y':+6OUQ.;<#'
M/>2P!G##PDN_8.+;8];<+'QCQR"&#L4U>\-8YY]@"5$]7W7$;+/DXJ FYHS"
M.4O:&\D_92Q$6KSV9J83$W,E:#S!69WO[!R>$UO8*&=Q-;)4Q)Z4[>YG>."%
MM$1$18^1R%;&TK%J=_;%"POD=]@%A:[L>)S^,9D<=,987D@$CC@A;4N:UI)/
M@*-X/<=>S5^]3I6_5FJ/XE9PI(B(B(B+7Y3,8[%5S/>M1P1 \=[SP%F4;E:W
M4AM5Y6R12L#HWCV+3[%=BUEW.8NA8A@M7(HI)7<1L<?+BMFBP797'MO,I.M1
M"PX<MBY^8A+.6Q]:S!6FM1,EE_LV./!<LY$1$1%UOLPME;&Z5@<?9I(Y*[$1
M$1$1$1$) ')*!S2T$'PC7M<.6D%$1.41$1.X(B(B(B(G*(B(B(B(B(B(B(B(
MB(B(B(B_*M>Z^@7^;V'_ &R572B(B(B(B(B(B(B(B@/5/_-]LG^RJ!:5TUU*
M[H&/EMXZ.:>W1;(Z=X!D87-]F%5UA+V4PO3#:Z=:=X;#DF01R_8/[N5+9^FN
MPY[4L30&2Q[*T+&/A].$?_6KXUNA-C\#C:<]@3205F1OD]^\M'NJ'W76\9F.
MK>'JV8N([%1QG[/!DXX6#O.DXW3,QKN>P4+X/\=;%)$P^Y<LO=-:I9/J]BZ[
MB^!MNJYUGT_E<]=NZ8'&Z;@8\/AGR0,S&1C$[G.Y C'/A2[=NGFMQ:C9^ H0
M5K-*+OK3L8 ]I:M+1IV=_P"DS#DXR^Z(R897#R7,]GK3ZWM9'2":N(@R[ 10
M9$![O*GE[4J^*Z5V<(_C^JH_.YOUD'NY1/!9JQ@^B->_7)];TQ''^A>MC2Z9
M8.;2A-/&),G+6]=]X_VIE(Y)[E$-+SEO!]#[MNH>+ MR,C/V<Y8,NHY^_KU2
M2GK\S<J0R49)TY,CBI?L.P;;!A]2UVS,^MELF_LFGC/D,9[K!ZI=/L-B=2=<
MH&9DT=F(2O<_DS#_ $U>VM_]PXW_ &6/_HJ.ZO09"QO&B0X^?T;3WSB*7['P
MM9NN!VO1)Z^PT-BMVXG6&LMLD)\ERW/5EETXG%[/1M6XHBZ$6X&2$,+"I5O&
M>AR>K8F+%6'^OEK$+:Q8>'!I!)<K.JTF5L?'4$KW".(1AY/S$ <<DKSIJNH4
M8NINSUH;M^,0>0]DY#W<GSWE8NU5LG8ZX,@QUD03FBP"8CN[ MGB[6R:GU)Q
M6%N[/;R-6[#[SK<;+N$MS;[V%-V_5I4F#U'5!_62R']01P N'3G9]@.V7\'9
MFM6Z(C?+5M601+PT^Q5A=2K$M?1-AFC=P]M4\%0SH"Q@T",@>3<E5T7Z-6U4
MEKV8FR1R#A['#D$*K]WV:SKXPF"PS&B[??Z5<D<B-C?<K0;->W+16T\M-FGY
M3'F9D5N.5G8YO/U;Y*Q^J&^YO%T<!?P-MAJW2#SV_,]=0RW5VO\ C-ZW#3BK
M"KZT(/GT_LU:76]OZN[+K@R&,;2'HO?ZL\WO+^C&J:=/^ITV5U;+W,P!':QI
M_P 9#4QN3ZC9[!R9NE<J4XYF^I4J.B[^Z/W^9ZVFI[U=V+5LE/'!'%E:8+)H
M''AH>%5V#ZC=5,_B6V,5BXI#%9[9I@WW!^C0I];V;<\CM5[$T)*U"*C7[YYW
MM]3OD^S>>%PTG=-AVG!;#6[X(LG1>(VV .8W$\^>%'.CHVB6WFK$]R&6)V0(
MMO<.97O'*G='<\O)U,O:S/5B97BJF>-X/)< 0 ON5VS-7-FGP&!@@,E:+OM6
M)G<-9]F <%:O7]^S5/:QK6S5X(K<K>:T\)YCE6!>ZD;)5WK):^,'ZQ9 XU6Q
MGDO^SG_8+(UG?]A_; ZWL6.BAL/B$D3X3R%<5D\UIO\ 5N_Z+RQH&<VREC<]
M6P>&;:F%]SY97'MB9[^&JVNG74.;8<5E7Y*O\+9Q[^+(^BC,W4?9\I1O9G!U
MJ'X;7>\,$\O$TH9]0."MU7ZJ/O=/;6R4Z ?-7\3UB_@,*T6%ZJ[)EYL"ZKK<
MSZD_#+-GV ?]>Q;_ ">\YW(7<C5UJK2>RC*636+4WIASA[M8 "N&I]3;FPX#
M,2QXZ-F2H_GJ^IX>I!I6[7=GT^7,LH,BF[I&B#OY!+%J]3ZC9#.:KFLJ_#B.
M:F\M^'8\N+E%<;UASN7P9O8S4Y;$D3G>N!)Q$QJGVA]0:VS:Q/EY8A5,+R)F
M<\ABC<V\[-E<3>R.*UUDN,['".668LED9_&U@:5&N@MVM3TW,VYY R&.UWO<
M5(;_ %-SD.._&JVOQR8CD$2NG[9C$?W^SA;C8^J&+Q>K4\_3@DM067M:SZ!I
M/T>M=K_589K8J6-CQ$P@L0]S+7T)5FYS,5L-B;F2L\^C7C[W\>ZJZ'J;FHGT
M)<AK,D%2]*QM:=LG?X?[=ZT>YY&IB>KN#L6I.&,I/4HUWJM2RFQ,PMC'6:4\
M@YA]8<=ZW.R;_6Q>:@PE.E/=R4C._P!!G@-9]W%=NG;[2V.3)4GU)JEZH\-F
M@E4 IQ"+K[D^ WSB2Y=V<_SS:]_L,BO3]P+S-K6XXO6MHZB?$"26Q-E?ZBO$
M.7OX+U:VD=2L-MK988>^"W%YDKR>"N&6Z@LAL78,3C;&1-/GXM\7AD9^W/W4
MAT[<L3M.*^/H.=X(:^-XX<QR[-RR.&QFNW[&6K&>FUO$[ P/[A]N"HO2W77,
M;HE?.UJ4D&.:P".&-@!:M-+UKUEF.J6Q#;F#X@^80Q]P@_1Y5IX3,4,QC*N1
MJ/[X9V!\?/OP?NHIM'4#%ZS>JU;]2Z?B"!%+'&',)7#;NHF(U.:LS(U;I$_Y
M'Q1AS%O<EM-3&:Y^,35['H]C'.8UH,@#U';O4W7*%W&T[AL036V!X:]@'I@_
MQKC5W[4<]B,Y/WO=2I'T[)D9X<'<^0M+C=KUC#=/),KKM"8U62/9% & $R?=
MRZ>EG4&?8L01DC*ZRZ:9Y(9_5-8%O]/O:/:R&?M8%C>\2--R4,X!<>5DQ]3=
M/DJW[+,D#%4D:R0\>2YWT:MQK&YZ]LL=E^-M&4P. >TC@@E865W[7<9D'T)K
M$C[+&\R10L[RP?JF'Z@:CF;$%:CEHY+$GM#P0Y3&::*")\DCPUK1RYQ]@ JV
M;U<T9UID'XF[ATG8)2SY"IEGMKP6%ABER-^."*3PPG]XJ.W^I.F4+,-:QF(A
M))V^!YX#O8N4OLY6A3H/O36&,@:SN=*?RAJ\_=6=NU'/:;>AJVXIYXYF.AY;
M_P#A8K8Z<_Y#:W_N^'_Z5)LQG,9B*QGO6XZ\(_>>5Y@ZD9K 9G=M.M8NS#.X
M2N;,]B]-93,XS$5S8OVXX(N[CN<M?B-OUO-6)*^/R<4\K!R]C?#@JBRU**+K
MCBK#/>>F2]3+:M>T_*;)@I\C=$-^&3B",'ATG*FEW8L+C[1JVK\,4W =V//!
MX<LF[F,=0ABFM6XXHW^&N<> >5VV<MCZ=,6IK,<<1]I''@>5C4-BP^1E,56_
M#*X#DM8?("29W$QV)8'WH!)&PO>PN\M:/J5EU<MCIZ)N0VHGPGVD!^585#8<
M-D)3%5OPRN'NUCO*V%Z_4I0.EL3LBC;[N<> O.VVSXZWU4T2]2N"83R/:_M/
M(!8O2"U_XQC?6FB^,A[XF\O'</E'ZKNQ^6Q^1C,E:S',P'CEAY"XW\K0H1E]
MJU%"P?5[@%DP7:LD'K1RL<TCD.!\+I^/I]K7?$1<$\ ]PX*Y36ZT) DGC9S[
M=S@%W1312,[V2-<W[@\A=#K]-K^PV8FG^$N'*R#(P-[B1PNDW:S(P\SQAI/
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M!+/[JVN<U/7LY/5ER6.AM& $1^JT. [EI=LBQ>%TO(PQMCK5F52R-C1PT?8
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MHVQFM+0Y#>>6AO;[+S[JL5V/H5LYE!$+B\P*\^F%>"+0]<](#S2C<?YD*>V
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MOYH '")PG"(G"=HYY0- 3M'/*<(6@H&@)PG:.>4],<\KXV&-A>0 .X\GCZE
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M_&?"VNB;IG\O6S^+RC86YC&N+?'ADBA.N[;U8V7'9.&C#2CG@LD/LRDM#/\
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MLCTDE94N1RF)E8/ ^A+2MM<>S^@)OD?]T1!5ODJ=JUT.PLU<>HVM:CEE8/L
MISC=ZZ6V]?99GK46VC#P^F8AWE_V"NO79I7X+&]U)M3FNPFLWVB\?D"VSO94
M3TVMU8=UZBP2RL;*_)]S6GW(!>L>XT9KJZV3'@2"CCY&6)1[!YXX:NOHM=BQ
MQV+!WY^,A%=+WM?X+UUVZ1RO6F]8ICNBJXPMED'EO?\ 1JR.A=V.GALKA+19
M%;J73WL/AQY61B(&6^MN=O4V@UH*!BGD'MZQ*J.[K65S.=WR_C+WST,OZXJ^
M[9O+OF7H+I]U$H[5@S+9>QEV%G^-0JKL]K-"6E-NVD9@U93S++ #VAZO#0,_
M=S^J8R_;:ULTT0,G:. 2IB?9>?M(NQXKJ?NF-N-:R:[8-B!Q^K 5D;C!%=ZL
MZ4VL&F6 2R6#]F>$ZC683U2Z>_./$LI*OE'>Q7GC#7L73ZT[,;3Q'*8'>F]W
M@<=R[1;IGKV]Y<"V7$ 0E96=D8SK-K?+@.:;P%$J_P"S-7JGLU':*\$QMS=]
M66PP.#?/AJM3!TM#Q>XFKAZ$#+TM5[Y7P@=L; 1X5HHB(B(B(B(B(B(B(B(B
M(B+\K%^B_3'U?V$UWU"WGX&+CC[<*>(B(B(B(B(B(B(B(BU]_,8W'L[[=N*%
MO/'SN2GF\9=B]2O<AD;SP"UP6P1$1$1$1%\9-&]SPUP):>" ?8_JOJ(B(B(B
M(B(B(BZ[]"G;K.KVH62QN(+F/'(/"[(V,C8&L   X "(B(B(B(B(B(B)PB<!
M$1$X3@(B(B(B(B(B(G"(B)PA'*=J$ H&@#PG"<(A'*=HXX0- \!8[L=3?999
M? PRL'#9"/F ^P*R" 1P@:&^RZG58'3-F,;3(T$!Q'D KG'"R,$,: .>?"Z7
MTJTD\<[X6&1@(8\CR.?L5WR11O:UKF@\'D<KZ&-'/ 18^1QU&_5?6MP,GB?^
M9CP'-/"X?AM(,@'P\?$/]D.W\G'V7GO<8I;75C7[#:,L]6N?3G?V<L"OK'X/
M$8TRFE1@@+R2_P!-@;R2O/&^>E8ZL:Y(^K)+6@/;.>SEJ]%T,)B<>Z1U.C#7
M#B2>Q@;RLG)XNAD*DE6[7CGAD_/$\!S2L?&8;&8JL*]"G%7A]_3C:&A=;L'B
M79$Y T8#:_\ '+!W_P#%<AA<6/C^*4(^,=W6?D']:?N_[KIQ.M8+$><?C:];
M_5L#5T7]2UO(7Q>MXBI-9!Y$KXP7!+^I:WD+XO6\14FL@\B5\8+@N66U?7\Q
M-%-D<75M21#ACY8PXM5']2+,U#<\;/E<(Z_@(:I:R(-[VM>>.7%JTEMFD;9&
M*.N:5.VUW#^O, KB+]20O3V-JOJ4J]=TID,<;6EY]W<?592@^P].-0S\KYKN
M+B,SCR9F -D*DL&O8BKA_P ,CIQ-JEG9Z :.TM6JPFDZW@X;C*&-BA;9_M
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MW?3<&/Y:O0EN]4I0/FLSLBC!\N<> N&,S6,R37OJ6XIFM/!+#R OF1S&.QS
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M>UBK+!;+U-Q.).JG6C-/%&88K!=PUK K+Z)8[-8O47TLG0=6+;)?'W>[PY7
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M=%PI)KHV>KLLT$^6FR>)FJE\-KZ,>".&GR5@ZML&PS[]LV+NW ^"K_8L:.T
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MY(F@'EP(4-H=:8,G0MR8[#6K%ADIX@9[^D/WWKG4ZV8W(8ESL?C;4^1YX^"
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M_9ME];\A:\\+*VK1<+L^+BHWFO/I<>E/[R,4*FZ(:O/7JLFGMRRPO!]9[_)
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M:Y?V?&",>@"M[G=[UW"8VM?M6^8+ !A,8[N\%8&*ZE:OE,Y%B*T\KK#X^_\
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M*Q1'/C>NA;3($%ZEWSQA86#UC"7>K.W?$TV2AH<0QXY',A7H'#8:AB:$%2I
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M>?'/"C>_TH[NIY2"3(_!L?'\\WT:U>;MV?6&DX"/'8=XHT[5=D-^5HC?-^K
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M0HQO6I/VG NQGQ[JH?,U[GM9WDAJU=S2KEC1&ZT<L?[!L)LF+RYC?TY77B]
M;7T*76+%XRL?$6&8,[2 5 :?2'-NP4^'O[+/)3C;Q5A9R&_H7+=_T9Y-G3=V
MLLRQ=(]["7N'R@<>6A;N33,P>G3-;9DF-G$#8?7#/'8![+CKVF9G&:+/@G7X
MS,&%D4K6^&M*Z=)T*]A-0R& NW&2,E)]-[!Y8'J.8/3>H^!QQPE++4C1\]EA
MX/JQ_H IUA- QF-U>U@Y9'66V@3:F>.'2N=]55&+Z2[MAKII8S:9(,3*Y_J]
MKB'@?HU3_;M!OWM6I:]B;,5:M&09"X>7%JG&JTLGC<'3IWIV2SQ1AAD:. 0U
M;US0YI!5*6]%VO!;#>RFIVJK(KCPZ>G/RV-275M/O5,K>S^8L1SY:RSL[F#A
MD3/X6K1X'2MIQFZ7\W)D8)(KLSC-&1Y#">0&JXD<.1PJMUKIS%A=US^>[V$6
MGN]!@^@>>7*2;W@+^?UJWC*D[(C8X:Y[OX5!\GTYR]_II!K\MF)UNF]AJR#P
MP^D.&\J+YKIQU%SFM5*]_.P/M5I(S%6'(BX9^\Y_U<KWUZME:V)J19.T)[08
M/6>!P.Y:O=M5@VC7K6.E'EW#X7_PR#V*I/7M*ZM1&/"Y#,M9BPT"1[)'/=V?
MP,4OWK2MFR-W7(L+%3CHXTAW;(\M*V'575=IV6ECZ6+;5$4=@3S&9Y:>YGL!
MP"F_X+;]@U"KCZL--MIYC?:!D/:"T>S/"B^X:5N.1P>K68&P?B6+X#H \F-R
MUVP:IU/R>:US-O?3-RM,>V%O]E '?<J2]1==W/,6=?DH5ZLHIRMDE<7EI+UF
M]6<!L^>U^A3H4HGRBS'/+\Y^4L5E8(Y/\)I?B,;66O2;ZP:XN'<HIU.US(;#
MJ=JE0D(L"1DC!SP'EG[I5.YK6>J^?U.A4LUJ<8JR1.9 "?4>6#W*F&XZMNF9
MU7#V#Z+\Q4M,E+&>&*T-4?LSL:9<X86V97]WI1#Q&W[<K,V+&29+"Y"FT#F:
M!S!S[<E4II..ZC8O6[V,GQ\#(JM:2*NWGE\TA\ J0=+L%L>OZ3?QUZ@&6(Y'
MO@ =SWEZU73G5]BAQ&PXK8,>V)E]QD,C3SR7*$8?&]7M)N/Q&,J?'8XRGTGD
M<L 7H[6,?E:.+#,G=^(N2R&6=X\-#W>2UOZ!;/+8Z._C[520GMFB+#Q^J\P8
M"#JWILK\#2QC;5,S$03/_(%-]NU_;7=-Y,:]C\EE+DXDL%OD,+O<-6RRF(SD
M?1QF&BQLDM[X*. Q-^X"Q=3J[!C.E<M23#VFWX8GQ,@]GO40P&J[8>C^9P;\
M=/6N"<N8QWO,'+5&IU(R73MN";K#8(J;6#R_^MF+/LQ3S,Q[A=Z4249L&X7Y
MHF0"",][@S[N6XQ-7,MZ3BD_$V&78,>*_P ,0.]SF@!9W22KE:.GU:.2QTM2
M>LXL[7_4*PLM!8GQMN."4QR/B<UCA[@D+RQJ3-UH:SF->KZJ76I'R?$7)7]@
M6[UW5<_L?2Y^$NXT5'5R'4GO>>][V?4A8E78NI,>LV=<LZK))/#5]/XES^!V
M+?:SJ6=RG1V7#7&&O9)+ZH<M/AMTWJ'6GX%^MV9K\41@9/[-+1XY*[].CS>)
MZ096M-A[)G+WB*/CR\2*=](?6?I$-"U3G@EK<Q/$C> X.51ON;ATKSU^*MC?
MC,3;G+XF^P5O8W-;G9UC-9ZQ1]"P^)IHT?SEH:JHW 8/;:-!\&NW8MCE<T^(
M@P$C\Q<58.?V*Y@[E#%9G%27<3+0#)S''ZA$RTO3?6XZ>^Y>_B*=RMAC7+&L
MF:&\R$KT2?9><MDS^N9.SGL1M^)E$D-F44++(N7&/Z<%:O#:+G<ETDM4)62"
M061:Q\;O#N N>J]3MN93CU^37)GY.%@BC?[#[<O6ZZLU\[1P.LWYFFW/3L,-
ME[![O5O:ALDNP8QU[\/FJQO=_5"7PYS?NMUEK,5/'VIY.XMCC<YW:.2J*Z.9
M5ACSE6Q5L0FU<]: O9P'-?RM/B,B[IUOF?JWZ\PQ>1>9H9VL+_8J28$R[5U"
M.S15YHL90JF."21O!F<M'H^QPW.JFQR&M.UEMY9 _L\'M*WG6E\U2/7\B*\D
MD-:^'2=@6@ZJ[0S,Z9B968^W$9LHR6)CV?,8HOJ5)>JV;K6^F\,\$4SQ=? Z
M)H9Y]B?*L;0\M!D=5Q5F)CP378TM>."US0N_;[@I:WEK)9WB.L[Y>.>51_2S
M,14^DV;C=ZD<U9\G<"TCS*MWT5LBMTVN"5KV.KS3.>'!='0G)">AFXY@]D[[
M@F+' CP[E7Z?9>:M;V*;7.H>XXV;&69)<E?]6OV!9NJ9>";K-L(8UYAL,>UD
MQ!#26.77)E6,Z_/,?/8^G\,3PF?S5:+K7AP]DG9#!Z+WAO(#GK9;7G--S&8R
M^ VR PMK2\4[7:LCHC#;K4M@K1V99L7%=#:#W^.6#E7FB(B(B(B(B(B(B(B(
MB(B(ORQK_P!O%_?"_3?5A_\ :+&_I5C_ .BVZ(B(B(B(B(B(B(B)++'$QSWN
M#6M'))\ !0D=2-*]0-&9B/Z\'LY4QQV1HWJPL59VRL<2 YOLNU$1:;8-CQ.O
M41<R-CTH3(V,.XYY<Y;:K8@LP1S0O#XWM#FN'L05S1$1$18GXE2^.;2-F,3E
MO<(^?F[?NLM$1$1$1.0B<HG*(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B<!.$1. G 3@(B)PG"<(B<(B(G 3A.$X3M3A$+043M0MY1$+ 2B=C
M>>4+01P4  1 T!"P$H&@((V@\\)/!%8B,<K&N8?=KAR$,;2 $+ 0 4  'A".
M0N#:\3&%H8T GG@!<PQH!'"-8UOL BZ'4ZQM?$>BWU0TM#^/FX/TY7>(F@\\
M!='P58V18,+/5#>T2<?-Q]N5S=5@]<S")H>6\=W'GA=-W%TKC6BU6BE /(#V
MARRHHF1L#6M :!P $1$1$1$1$1$1$1$1$1$1$7Y8U_[>+^^%^F^K#G!8W_98
M_P#HMNB(B(B(B(B(B(B(BJ7K6_*LT>RZB7_V[/7#/<PK"T/)Z5M&FQ8:!D/#
M*[(YZKP 0[A3K3\#^S6!CQ[Y@Z.![^QW^A].5JK75'4:TO9)=D#/5],3!G,1
M=_-36QE\?4Q[KTMEC( SN,Q/RAJB&/ZEZE?R,%".Z]D\W]B)&=HD_DHEN?5&
M##;;A\*QSXV_$ W92WP&?9JD6XWM%R^MQ.S5UGP$LS71/\@EX]NU3*G8Q=3#
M5Y87MBJ,@:6$^ U@'A:*#J'ID\L$,>;@,DQXC!Y'<MWF-APV%A9-D;T5>-QX
M#GE:BUOVH5;45:?-UF32 %C.??E2YK@X @@A=5N[6IUWSSRMCC8/F>X\ +2S
M[;K\,=>27*5FLG_LB7>'+:LRU$TOC!9B] MY$O/R\+!.QX8Q5I/Q"#LG/$1[
MOS_R43?J>OOW^/.NR!^.]!S!!S]B/*G-[)4<=#ZEJS'$P?O// 2EE*-^(25;
M,<K#[%AY"[I\C59*('3QM=P2&EP!("YP3PS,+XY&O'W:00M/LFPT-?Q%K(W'
M]L43?_ESOH M=HVV_M+@*>0=&R%\K271-?WEJD;[U1C^QUB(._A+@"L@$$<A
M%1FY7LWL6RR83![",=\"SF=[9"TR/=[-4QT/6]DPK+AS.P3Y!\CF^GW/)# %
M8/J-)+0X<A5'L^&Z@YZ_?92RSL33@\5O3)[YW#ZO7'I/L6QY"'-XS..#[6+L
MB!TWOWKIS6QYK.[P[5\/<-.&K$9+=M@Y=]NP+LUG9LIC=SO:EE[9LGT_6I67
M>Y9]G*X4Y"<A$Y"<A.X(BQ,E?K8VE8MV9 R*%A<]Q^@"JW&7]WV:A-F\=?9C
MXG@_!5GQ=_J,^CY%H>GG5/)7,[=UW9?2BOQ2N:Q[?#'%A\L5P[$_),PUV3'3
M".RR(NC<6]PY"B_33+['F=<@R>9ML>^R Z-C(^P,:K"Y"<A.0B*);G-LU;$N
MLX%L4EB%W>^&0?VC![@*'=*]XR^U-R<E\P0R5WM9\.T?.%F[_MF<Q%[#T,+!
M#8N7'N A?]A]586*_$1CZXR#HS9[ 9?3_)W?HL_D(HYMM_(T,#?MT#'Z\,9>
MWO\ 9:?IILF5V'4J61R189Y">>Q3M%46S=2+$>;.OZY1%_)>?5)/$<*X9'.=
M3,%3%^UBJ%V%K.9XH)"'L_4?+Y"D(VC*9?0&YG#5V.NRU1)%#SR X^X6VT[)
MYFYK&/M9E@BM/A#YAQPI)C<IC[U46*D[9HW$@/;['A=J(L>*]5EL3UV3-=+"
M&][![M[O;E0"[LFS1[_4Q$&)[\8Z(.DM*QT1$<3VGA0W&[?"_.V<'D(OAKK3
MW0MYY;/%_$PJ9(B(B(B(B(M3G\N,/B;EXP23"",N+&>Y6FZ?;@W:]=;E?A?1
M+Y7L]/GN_*I>CWM8TN<0 /<E 01R$1$)X4;K;+5NY:U1JQR2MK-/KSM']6U_
M\ /U*U.J;W7V'(YBG#4GA-.7L[GC@/7"AO,=K<[^N"C,U]:-[C,?RGM/"WN(
MV?&Y*]=I-,D5FM(6R0R -=_>;]P5($6FS^?I8/$V,E:[S!"WEW8.XKJU39(=
MAPM;)5XG1QS^6AWNM\B(B(B(B+%R>2K8VC8N67%D,+.Y[N.> M+J6XX;9Z=B
MWC7/<R.7T^7CA21$1%BY#(U,?2GMVI1'!"WN>\_0+!US8L3L.-&0QTYE@+RP
M$CCR%N$1$1[VM:YQ/  Y*T> VO YR6XW&W&V#6<ULI;[ N6\1$6)DLMC\97=
M-;M1PQ-]WO/"T5/=M7N$"OF*S^20//"DU:S!8@CFAD:]CV\M</8@KDB(B(B(
MB(B(B(B(B(B(B(B(B(B(B(ORQK_V\7]\+]-]6'."QO\ LL?_ $6W1$1$1$1$
M1$1$1$1:W,7<96C@AN$=MJ80 $<ASG@GA>?=QZ+OJ6#F-3L_"3Q<O]#DM"RZ
M&ZY;/]']@N6.]EZK"8G2@^7KAKNCY#9.F^(H/V&-E&6".3TQ5!<P\??N6GWF
M&7!8G2M?=D#;Q8L\3SGP"8_#0KQV'5<!F#C;=L-9\!*)(9&^.&_95OU%CBEZ
MG=.W.8#WRS+?=:J56?29Y)(@7PVHG1E1/?\ )/&$TK#DR-KWG1&<CP'-8/8E
M3SJ5K&*R&FWF&".-]2+U*SQX],L55YY@SO1'%7\@3+:A?$&2_59NVZ#KM/I?
M)?J8Z(7(H8IS9(!E*N;0;,MG3-?FE=R^2A"7'^;4WZG6N:GF(;$37L-<NX/W
M"I+0>F.OY_1*UK(B6:S-$1&\G^Q'V8L/287/T7>-<O,]6+&RD,+UL.G737#Y
M[5L%DLC8GEFC<'Q>> Q@_<7.>G!!_A!QB-G'JP![_P";UNI:%+;>J.4IY9GK
MT\9"!!5?YC+C[N(6MV+&_L'N^!NX&)L%+(2>C:JL\1+0[E@9<KUI91]>6&"U
M6'>X'W8?<-5[Z1IE74<?9I5;,DL,E@R,#_W!]EJ>KM&K;Z?9PS1!YAC$D?Z/
M"@^N'%:GTBCV"C! +KJ+>9>WASY"%E:[T^PN>TZKD\EWSY*]7;9?<)YE8\CG
MP5LNC>Q93(8_+8W)6))I\99$/JN]WA7*J1W/HOALQ->RF/GFK9.64R]_/+"]
M9O2'/9J]CLKB<O*Y]W%V!!(\J24M5R=7><EFSE7OJ3Q%K:OT#B5N=K.R1X>8
MX&&!]PGQZSBUH'W'@\E5/T>V*7XO,X'+5C!EVSOGG/UE/U)3IK! _?\ J%.Z
M3B5E\L:S]"2L/;IIHNL^I>E^^PM>O1"\X=0\SN,/4C"4,/DY6-L,\0<D1K5[
M"_?=!S>(OS[%9R5&Q*(YFRD]H+EZC:[EO(5 ;?E-Q9U.Q>/QF5<(K-<D0N\1
M,4;V&SU$T[;,35K;#-E3E0\,CG'@%9V6&^ZCLV!LV=DEO0WIRR>!_(C83]&!
M>E0BH[K9D;GP&)P]=X'Q]QH>/JYC5<U2K%3IPUX_#(F!C?Y-"\W9CIQ'L-'8
M,SC"&96#-VG,?]) QRFF@=01LNOW:62>(\O6A>)HCX+P!^9;#%9]FN=)L9E7
MM#O1QL78W[O+55^3W;86Z]7S-;;?4ON+'R8UD+NP!WGM"W^W;3ML^DXO:L5=
MFI@AC;5=9VY[#GJW3W"Y_'9^5CQ#$)/KZYD"DEC;97]*F9B#(O\ BGU(Q'+[
MO,[E.]8CRL>"Q[,G8?+;]%IG<[^,A;L@$+R[N;)>G74&MLE2%WP%_O%J-OW*
MM#2L:<SD;&WWF/\ 4L@B@Q__ -RK%9.^[;>Q-G#XC%AGXADYBR%S_+6-'NY0
MW:K_ % TCT<H_,?BM RAMADD?9V<_;RY9'4??,UBJVNW\1(#4NN!<SCYW<KI
M$_4B>OL,V?AKQ8Z7'O?#&PDNB=]&+6ZGMT>'Z:XFI1D$N8GAXJ5F^7%RN?5(
M]G9C&.S]V.:V\ N9&SL9'^BVN:NMIXRY8(=Q%"YW ')5 ] (A=AV/,6"UUBQ
M:8O1LT+)(GQO'(<TM(_0JM=BBFT?0K;L!&P"D.6B8\\-4)RVQ;1F.D S,-YM
M>SZ/?8>P<%S5W=)XMK_86$P6JS8S7<:GR<N#EMNF>[;#F\KG:.;]&"S3>UK:
M[1Y4LQ&>RF1V_-5(?1=C:($9D_?,SOW5,;K+1J3?#EK92P^F7>P<O-?3+]N7
M;7M@?;JR.9>8R^]_U<.?R*P9=[S,?4QFL/IPLJF,O;('<EX6CSG4S9,=O9U^
M/#1S<LYA;&_ETG/L2M96ZH;EB]F.(SV#!?:834CKGD\K,J=0]SQ6V8O';-CJ
M]>MD2?2+#R8U,]VW=^(R5'#TG0"[8!>Y\QXCAC'U<HOK'4RX=L&NY>:K8=,T
M&O:K^&N/V(65UFK.JXG&;!6:!;QUYA;+]6L?[JVL-DH<EC:EZ(\QV(FR,_DX
M+7[7LE77,+9R-AI<R/@-8/=[C[!5;EMKZC8W!1Y^3&4G5B!)+68\F2*-RW>Q
M]1)8-#@V;$5XYXY.SD2.X+.Y1#(]2]X_!(LY3UUC<<R%KY997<//W("N_7LN
MS,X7'9%C"UEJ!DH;]NX<KEGLJS$8>]D',+VUXB\M'N51KNHN^08*ILTV*H#&
M32M_J1*?5#'_ ,VJ>[YN]S!ZI!FL?2$[93'SW'CTVO4#R_5?:JN/JY>MK).*
M^3OLR.[2_E3K9M[O8[4*.Q8S&-N02QLDD8Z0L+&O6VUS;)\MI\><DA@B=)"9
M?3:\N:W]"[A9&B['D=AU^OD[5)E4V/FC8UY?\BD.5R=7%T+-VR_MAA87/<J6
MS6Y;/E-6NY&/7&#$SP$ME,Q$_I.]G]G"Z.CN6JX;I//DK//I5YYGN7;-U7V"
MI0HYFYK(CQ%J9K63"8F7L?[.+.%T]8]EV"#!4SC86#'W'Q-?.7?.2_R&<*P:
MFTVL1J\V1SU%M Q$,;$Q_>7_ &X\!0R;JKE\;/5GS>N_!XZ>0,9.)N^1O/MW
ML5UUK,%F".>&0/C>T.8X>Q!^H78JUZK;*_!:K/Z$CF6K4C:\!;[@O4@U'#-P
M&LT*7!+XH 92/=\G'DK5:;N-'8[6=97Q\M9].P&2]X >]QY]U@X7><=DMXR.
M#&(D@M0Q/+YI  XAAX6AZLQ/PLF&VRGW"S4M-@DX]GPR^X>KCI6X;=:&Q$[F
M.5@>P_<%5EU?V7-Z_K$TN.K.)D/8^?Z0@K0X#*9/(]+I67Z$K&-Q30R:0]WK
M>/=1G2^I&/U_0\7%%2LW)88^9_2;\D7]XJ]-<W/$YS7&9JN\LK\'O+_'86^_
M*@=WJS'3:+[\'>.'=( R^ .QX/LX*V,7DZ>1HU[M64213,#XW#ZM*UVS[%2U
MW$3Y*VR5T$/Y_3;W%5C9ZV:ZW%P7*U2[.Y[ ][6,\1#_ $RK*H;-B+N"9F8K
M(%1T7J=[O' 4#N=6\93%>W-BLBW&3>([QC'8XE;K8>H^%P-*E>L06Y:EI@,<
M\+ ]BS,WU"Q&+QF*O/BLS17^/1; P/<2Y0OJKO>5PFLUY*5"U%);[1ZQX88.
M?H?]-6!H^;GRNO4K$]6U%)Z,?F<>7DCRX*3R2,B8YSW -:.22JLO=3,+8IY7
MX6CD;-> .CDLQ1 Q<D??E0WH#8A@U++SRO#8V6PYSE+Y.L6K,<QYBOFL^0,;
M<$0] J4[!O&"P-.G<MRR?#66\LG8T.8MEA]DH93!LR]9LP@DC+VES0'=J:QM
M&-V&@^]0]1T(D+&N>WMY(6FZ@[6[6-=MWXZTLL@';&&CP"?J]0+1]I?L6CSP
M7A9EM&I*Z621OR.4:Z3[UKNM:%4AR5PLDDM3$,:.3PO06$V3"YC$?BE&V)*_
M!^?V[2%"SU9TH'GX^4Q>IV>N(_ZKE<.HO4*OK6OBW4#IY;+/\5>P<Q_S)6PZ
M=[6<]K^/^(?,ZTVM&;#WMX[W$>X4EV'.U<%BK.0L-D,4+>2&#EQ52=.^I\>R
M37XKC)@^Q;[*\0'+&1GGP2M'H&7P&K9SJ&+=F.K7CR@9$W^1?X"NO6MMPFRU
MI;&,M"5L3@UX/AS2M5F>HNJX:W)5M77&6,<R-B9W]G]Y2?!YO%9NBR]0MLG@
M=[.:LZU.R""60D!K&EQ_^%Y>UAC^J>W7\AE>7XO'/X@J^\9+E<>R],]6S.,F
MK_A=>.5L9$,L; US"N[1ZM[ :;CZV8>R.2I#V///@-:L>#JII<UOX<9,L)/#
M7O86QN/Z%2;-[-A,%499R-V.&)Y 83^\3] M%?ZE:=0FJPV<M&Q\P! ^P=]7
M+NR_4/4,.^*.YEX6O?P0UOGPY;RUL>$IXIF4GOQ,J/ +9C^4@J/S=2=+@K5;
M,F:@;'8',:R,OO\ JN(I5[=K*1".<=T79\Q>%(L1F\7E<=%?HV&S0R-Y:\>R
MB5OJ9I=6<PR9=A>V0LD[&DB,C^(J41YW%/QAR3+L1J\<^L#\O"T;]_T^/'19
M YNL*LCRQLI/@N"D.%S&*S-,7:%N.Q7)X:]GL2LY$1$1$1$1$1$1$1$1$1$1
M?EC7_MXO[X7Z;ZL.<%C?]EC_ .BVZ(B(B(B(B(B(B(B*'[OJ;]GQ<%1E]]-\
M5ID[)F-[B',!4-LX_JVVNZC%?QL[' L-Q_+)0/OV@%277-#H8C4I<"^5TS9V
MN^(D/@O<_P!RJHQO37J5A;4N-QNQ-CPQEX![SWB/]&JPMLZ9T,IIL>&IL;'+
M6 -64^/G"B.L:%U"(JTMCS@DQL1;S7CD<\R!OT<I!U.T_8<K?P&6P,D;+F.D
M/8Q_MP]-UUO><UI=?&MFISW9)F/M2?V;/'T8 "LS+:+<V+2J&/R7I09&HQAB
MEB)>ULC%&,C5ZJYG#/UR_C:+6S ,GR#9B06?HWM6WW/1\P_1:&MZ\R$QP/C+
MS(XL+PQ9^R8;9+O3$XR&E&;\M>.&2,/) "DF@4LG0U/$TLC6$,]:!L1:#SX8
M. 5F[G_DUE_]E>J,Z<97>:VCP5ZF$BM,=&?A)A)P #]'J6XS3\W@NG^7B;69
M:RV0)?.QI[6][UN^DU#-XW5(<?E:)KRUW<,_TFJ(7L;LIZS0Y=F#E^!9$(3.
MLS9]>V; ;R-HP5(WH[##'<K \//ZM63-C\]M^VX>Y;Q4M+%XXF3LL>'RRK39
MROLG]+=;,-P=Z:A7C$)D8 1^I:O03?8**;WBY<KJ69H1 E\U8AH"J;2H-AV/
M1SK64PKJU2*D818>>"7L\,X"X:[N>6T["-P&<PMUUJJP159(&=[)0IWTQU^]
MC,7=NY* Q7\E9-BPP^7-^P*LN1SFL<6MY(!X"I:OU:L"Y=QUS6<@R^Q[A#%$
MWO#_ +$D\*3Z!@+^/ARN3R4+(KV5L_$3PM]H_LU<\;N=ZWO.4UZ3$OCBK1E[
M+//A_!6NM]5\#1RV3QEVM=BDK2E@/I<MDX6MTG#6LCMN;VZSCWTVV1Z52-XX
M>Z/W+W+36P=)ZDWLK:@(Q.58>ZPUO/IR_9R^Z]7L[7U+L[-&R9F+J0^C5<\>
M)3]VJ^OHO,?4?+P8?JOJ]Z?GTHF<OX'*D.YY>COL^*P.#)M,%QEFQ9:"(XV1
MJ?;#O-;!Y_#XAU*>5UTD![!R&JN=FR5:MUEP!>7$-@,3R&^&N<N/4[(UJ?4;
M1)9"2*SY#-P.2T/X61UFR56K>U<O))9=]0M:.3VJ?;/U H8$8@BK9LB^\>DZ
M)O+0U3\>50W7"A/%7P6<AC!-*Z&E_P!@]70+]63&?&%X]%T7J=Q_A(59=)LY
MB[E7.4JQ#"S*32LC_P!"0J+]5]%O5+,FVZ\\PW8FGXIK?WVE;6UB;65Z'T*T
M /K-QL$K6_<M:M#J'6?!Q8"K2R->R,E7@$?8(^?5(5OBE?SNH25LO69%/:K'
MU(1Y#"1[*A>F6!S66?)@<U7YQN&EF8]I/ATY\-\?9JYZ;A\Q6V^UISX^_$X_
M(&YR_P"S.0T+U0$5(=>;]2MI[(I&,?))<B[ ?<*Q=(RE+)ZOB[%63N8:T8_D
M0/8JJ^JE*UC-LU7:"QSZE.4ML?9G*RNJ&TX#,Z=+1QU^&U/<EC$+(_+BHIU#
M;%K.$T"I8DY?3=&'C]&#A79M-^E8TS)W89VNKR4W.;(/8AR\G8#6+V.U?&;K
M@K)DGIR.^-BYX\+UEI&]8?:L=%/4F:V8L!F@]W1E2ZQ"V:&6,^SVEI_D5Y>T
MV[5Z9;EF<)E28J-QX?7LGVX'MRK_ +NZ:]5H_%NR4+HR>&!AY+G?8!1#>+]F
M]TMSENU6^&?+6Y9$X_,&GV#E!\2PS=!++(QW.^"*E/1C,8N;3\509;8;+(G%
MT0]QPH5U*9DM-W:KM6.@]5MZ-U>=G/ [W*Z-$PDV)U^LRRWBW/\ U]L_>9_E
MRF+O9>?-$SN(Q.X]1&7[D<#I,J"P.]W>7+*S<T/]-& '>WD4GK39![!U^J^1
M_P!B8FZO8.LNG<N"[.LYC&[:/Y' ED6%O\^.P'5BCF,O4;/C;=7TN7,#PPA3
MS'Y/I]/GL3'KV-I6[GN)H(P!7B^KB5SZV21C0[D9> Z6Q$QBFFD49Z&IX.I.
M.)(:43'_ ,P%!>N%6S-IK)88R\5[\,T@^S&@K=9/9\->T"?)/FC]&>ESV]_U
M</RJGWXR3$="(X[)+'S6&3=C_! >K(VF>O/T<NRQ/#F/Q<?85)>F,\4VB:X8
MWAP;1B8?T(:MEO>:I836,E>L5A.R./CTS[/)7FW8WU+O3:K?NYYSIYW1.@H0
MO+((6_P!@4]W:U0'2*K%#886M;58WRM]NC8'](+G>&GC'Q%BWND5(;_3?!U9
M1RR7%Q,=_P#+%1V!LY?&6\ETX^<^I>XBG^C*WGN*]6T:=>E5AK5V!D,3 R-H
M]@T>P57=:X[+M$N.A/AEB)TPX]V+K9G,1=Z7.GK68Q&,:&<<@%I ]E NGV=H
MX7HM<M6JS;+!8E:8#[/)6NVUEJ?IK3R-[.M'K&N8*%<=D#&D>&\!2/J?)&_I
MIKKVO#@+M/DC^16=UP<+.FTIH9@^"._ Z8-62[5>F>8P+;KYW/JEK9.?6\JT
M*M[!XK'8R!KXZL+HVLKQ/X;X^@ 4@7GWKU!*:."G##Z;+[ YROV,@Q-(((X5
M*],2#MO4G_>P_P"KUKM=KL=UOV:8OX<RN\!O\W*3]:R!H&0'WEC4HZ?1R1Z5
MKK'@APH0\@_W5'NL\1DZ?Y;R!VN8Y8F*>P](*?\ N5BZ.ET$ Z75FAC0V2M(
M7C[GA5A@7V6= <J(&<@VI!)^C%.M9UC4]CTB@)<ODC2^'8)*SK9[&%@5IZ75
MP%/ U(,-(^2G'R(7.//*T_5/_-]L?^RJ%ZK0BI]'&%@:#-C?5?Q]W!5I6MWY
M>@7##RQE[LD_2(*S<=IVM[%IE)LN?R!J258R6&T3&P@?P*3NQNH,Z>/H,L&;
M$LK=@>J0Z;61A=JQV/V,3^*_.'?.>&QA_P! WZ.5D=>_.F5_TR<"M;5I&?@6
M-\@D58O^BBO5BS>K:'FI*@/?V $CW:PK$Z?2T9.F>-^%>PAF.XDX^CPSRJOZ
M128N/IOLYR;^VGZO$Q6EV*;,S]*Q\#4AJ8)CF"N'N[YY6\>'E7'A,%!L'2?%
M8R?VFQ<7!^S@U5)K&X9+&ZO?TZ20MS45H5*S?LPKTWKV&KX3#T<= 28ZT+8P
MX^Y[1QR5&.J(YZ?['_LRB73T<])ZX$+93\&_Y'>Q6@Z+:]A[/3^U9EHPOGGD
MF8]SF^2 G2AE>OHVSU,E-Z56&R]DG#O# HAF#D[/3"U!B*#(,%6 <V:9_,T_
M^F IAG^#T)Q/^S5%=NJ^FW 8L-X[15C[0/;V6=D_^P7/]0__ **E^@$,#=+L
M2A_,DEUW>U:G1-:PF5WS?KMZE'/+6R9;#WCD-[RY9.JU8,5U!WFO1C$,0A+Q
M&WP 5&^DN*R6;PF;FAS\<4MNR1=A?6$I/V/)<K>Z;Z93T^ID\=%ES;)E8]S2
MSM]-33/4Q=Q-^L2?ZR![?"\^?X/-KX6OL&)G CGCGC)8?#UZ7) "H;K7F'?@
MN*JPS'X:S?8)W,^H;]%-]^P>+R&DWZSXF^E#!WP\?N%GL0J>R(.3Z$8Z>ZP2
M2Q/C9$\^2  MSM>AZS!TILVH:$;+,56.?U^ 9'/_ %*8C1M8/25M@XZ(SV,:
MRP^4CE_?PL>M%'/T!E,K0_LI<LY6-J&I8!W2.S:?0B?//6=(^1P!=R%V])=2
MUW*=.;-Z]C8)[/,S!*]H+@T+6]-LO<Q_2/:)82XFL]QB /MW*SNF&)P]CI[1
M8(&2"Y7YM%S?SO(\\J"Z!0<&[_K,K/6Q=2P]L?/LP^5T](=)UW+Z'/9R-&*S
M*^>5C#*T.],#^!2CH56^"PF9IB0N;!D2P*\D1$1$1$1$1$1$1$1$1$1%^6-?
M^WB_OA?IOJPYP6-_V6/_ *+;HB(B(B(B(B(B(B(B(B(B(G 1.$48W'%Y;*X&
MS2QT\<,D_P CI'_1BUG3[6\EKF CQEVQ%-Z+N(G,''R*=(G"(B(G"%@1$[!S
MRB=HY)3TVD\\(ODT,4K"R1H<T^X/D(R-D;0UH  ' "^KS]LF.S-SJKA\BS7[
M4U"I_5/GX';_ 'PKYIT:M2+TX(61,Y)[6#@+MEJP/ECD=&TO9^5Q'D?R7%]6
M!\K)7Q-+V'EIX\CE<;&.ISS,FDKQN>S\KG#DA<KE"G8?&Z6"-Y9^4N')!7&6
ME6F9&R2)CFL<'-!'(!'U"[UK,]A*F9Q5O'VV\Q3LX<%!M,Q^PX^&QKN9@%JG
M!$T5K?NV2/\ @>/N%/*>$Q=*7U*U*")_;QW,8&GA;!S0YI:1R"N,4$4,38HV
M!K&CAK1X "T9U/79,E^(G$U3;YY]<QCO6^73!2JUWSOAA8PS2&20M''<X_4H
MVA4;;EMB!@F> UT@'S$#V!*[D6FS6L8#,NC.2Q=:R6?D]5@>0LK%8;&8FL*]
M"G#6A!Y[(VAH65<I5K=:6O9B;)%(WA\;AR'#[$*.8W2-3Q=IMFA@Z5>9OM)'
M$&N6=F-7P&8=&<GC*UHL_+ZK XA9)P6(;B6XOX" 5 T#X?L'8&CZ<+&I:MK^
M.Q]JE5Q5:&O9X]6%C &O_F%TXC4M;PTSIL;B*M61S>TOBC#20I M1F==PN:C
M$>2Q\%EH_*)6!W"T&%Z=:AA;0M4L/ R=IY9(6@N8I3EL/C,K3-2_6CLPEP)C
MD <TD+&QNMX;%8V2C4HQ0UW\\Q-: #RHXS":_I6)R5[%X=C2UAD>V)H[WJM,
M3G;_ %.RF,#\4^OBJ,@GL%_L^8>&M7H1%#I-!U>3/.S4F-B==,G?ZI _-]TO
M:#K5W.?C,U+FX'AXEY\@A+&@ZQ/GOQJ2@'7?5]02G[KKRW3S5\KE79.W1]2R
M7AP>2N_8-"UG/7X[>0I">6, ,<2L_.ZIA,[CF4<C39+"T@L:1Y;Q]0L/6M,U
MW5H)68NH(@_CO>?+W<?<J Y:K;WS9:E=D3VX+&S]\[WCCXB9OL&#[!70!PEB
MO#/"^*5@<Q[2'-/L056,72'2HI^\4GEGJB3T"_F'N_N*6[!J.#S]:"KD*HFA
MB/+6>S05C2:1K\F BPCZQ-)CP6Q=RVN"P6.P6/91H1>E78XN#/L2LS*XNGDL
M?9I7(Q)%.SM?&?J%7./Z/:-0I7*L>-[Q89VNDD/=(!]FE=UGI/J$^$J8<UIF
M58'][0Q_!<[[N6YR6C83)ZY!@++9C2B[.P!_#OD' \K3Y+-ZQTTP-&M(+7PH
M=Z<0:/4>M9H_9LV>O[@Z!\4;F?#4 ]O#S#]7.5N+A?I5;E.:K8B;)%*TM>QW
MD."I^MT/TR!]KQ8?%*>1 7_(Q2#&=,M;QVL6\"V)\E:P092\\N+EHX.BVI18
M:>@6RROD9V"P_P O8/\ 04CFZ;8!VFC6@U\=4.#@X?G[Q^^LC%Z!@:& LXE\
M3K$$X F,WETG"A^%Z(:?BLFRZ!-.&/[HH9?+&KAU9UFGGW8F)D-I^3#B*CV?
MD8.07&16_0@DKU(8I)3*YC TR'W<1]5&-[U5NSZY9H<AK^1)$\CGA[5J=!SA
MNXD8F\/1R=%GH6HOU;X[VKLU;I[0UO*Y&_7O6I7W.3*V1=-/IS2I[=-LK<G;
M=9D+N]A\-+7'GM*BN]]^ZY:EK6-^>"K:;-D)_P!QA9[,5W5X8H(F1QL#&, :
MUH^@"UVPX*OF\)>QMEY;'9C+'<>ZK?$]*V4=<N8B3.W)_6C$0E/CTXA^XQO*
MD& T.+":M9P<&4M=D@(;+QPYG/OVIJ^@8[7\+?Q#;4UFG9]XIAX"KFOT"QE>
M[+V9RV*,C^7U WCD*_,=CZN.I05:\38X86!D<8]FM"T>X:V_8<!;Q?QKZPL
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M!&>X^F&+28W1=L@Z7VM8FGJFS(>UIY)8UA6[P>GYS'=/I< ^6N;/IF-CP?E
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MKGL.R8G0->KP&RZ:<\,@9*[E\A^KG+3]8/0OZ'-8BLD]D\1!C=X*G6O7ZU/
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MA9="A6P'7,T,1597JRT1WPQCABWV4AQM3?,I=<),MD9H.RO18P.]!I]^XD^
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M<L8NW6<\S/82ED8X9(FV&!_8\>5O$1Q#0255V4ZHT:0M3PXN_9I5)W16K<;
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MQ@L3+#7BEI0.;"WM8"P$-'V"Q9=:P4T4<<N-K.8P<,:8P0 LNQ@L789"R6G
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MG\G7BJVLA)S\+$>YL84TW"KE;.LY-F+Y%PQCT"#Q\RIG,8KJ!N%*EB\OKE*
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M^QY8QD?8& *Q>X)R$Y"<HJTZD9S;-?H?B6)K06*\0/Q#'?G'ZA9'3/:<ELN
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MCZ ?<JP^FFYVMJP4MBW7$%F&<Q2L"G&4R$>/HV;4C260QEY ]SPJ(GZC[HS
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M2"U0]_3[,9.6I!GMC??H59621QF$,?*\?60\E<^HG2VAMEB&[#;?4O0#ADS
MLC2M GPEG\1RF7L9&^8?2;)(?$3#[M:HYM72"2]LC\YA<U)CK,K_ .M]-O\
MQ>I]J^D4,#C+5=TS[<UH\VK,OYYRH54Z=;'KS[%?6L^VM0LRESH)8N\P_P!Q
M3+$:7^#ZQ?QM7(O^)MN<Z:\]G+WO=[O(6GT+1,EJ>(OX[\6]>%[W.AYCX[%A
M:-H.5P7XW#D,E':JWW$NA#%',;TKV;#7;E;$[/+6Q4\I/HM]V@J4=.- OZE+
MDO5RSYX9Y.6PJU55O4S2LYMD$%"O?AAJ-E$KN6_/WM4NU3&9/$X2M1O719DA
M:&"0#CEK?;E5QM.@;-D]TJY^KD*S/@R/AF.:M]U"TF[M6$J-ALB'(5I6R1O_
M '"Y1#-],-JSF-H37]C?+DH9XW?:&-H]^/N5O=ZZ=9#.8[&V:>1/XS0/,-I_
MCO43S'3;J%LU*K)F]AA%F"PTMKQ@F'@?OG[N4TW[2]AV;#XO',R4 $+A)-*6
M<%\C/8A8.[:7M>RZYAL9\;6#X"U]ASOWWL]B%F;3J>SYW2Z6'%JM'/PSXEQ\
MAQ8%%=YJ92#2,%J\M]C<G/8BBA[/#)6QC]]8L.-ZX8N*6<9/%2,#?/<XGPU6
MYH6QV]AUNM=LQ!DW<8Y>/RN<SW<U:?JGKNQ;#@OPG$LJD3/!F?+(6=O"B6&Q
MG6+$8:IC((L*65X1%'(97<\#].Q;'6.F$S,V=AV2_P#B&3_<^L<2;]INV6MG
MQ.>UZS VS PQO;-[ %1N;IWOHWC'9]F5K2RF("S,]G 9]VL8K;W"SA1KF7BR
M,K'0"!PE9R.5HNDNO#!Z7CHS$633L$\WWY<K+5#['J6_W=]IY^E%09#2=V1L
M,[@9(_UX8I9OVE6=CK8^[3E%?*T7]]=Y_+^K5%;^$ZC;A6I8W-P4Z-*.<.MR
M12%SYNW[-X"W/4_3\]G\#0P^&AK-BBE;(7S2%I'I^   "NW-Z[M]_IM'A&LI
MB_)"R&=Q>1'V@>2#PN&-T7)7NG+-9SKHV20 -ADA<7@=@X:5&\;5ZL8_$#7/
M@JDC /1CR1E/R1?RX5L:?K%?6=?IXN!W=Z;>7O\ ;O>?=RA53ILZMU+O[%RP
M5'M[XXQ[F8^Y*ZLWTW_$.I.-S[HV&LR(F<$^3*SCM4KZAX?-YG5+^-Q<4)FL
M@,<97%H#%!VZIN9Z4.UHQ53<X;#RZ4\"%;3&8#<(>FIPDD%/XZ.N*\?]8>SL
M^Y/"UN*H9W4^FF1HY2>&K+7B+*]B!QDY[_YAJK[":[U6PU6@(<'B)HVL#R3&
M/5Y_TW<?F5U=/MORF>@R=;*435OT9A'.P>6GN5AHB(B(B(B(B(B(B(B(B(B+
M\TM._P I\/\ [4Q?I:/K_-$1$1$1$1$1$1$1$759M5ZL?J3R!C.0.3[<E5SU
M/W#*:GB:]RE5AF$EAL3W/?QVERGN(NR7<93L2< R0M>0/NY9R(BA.^[78U7!
M292*B+(8\-+>_M6]UG-29K7\7D71"(VJ[)2P'GM[QSPMRN,MB*+L[WM;W.#6
M\_4E<D1$6/=M5J=::Q8>&1QL+GN/T 51'K!3C=7MRX:^S%3R!D5XM':Y7+7F
MBFB9+&[N:X<@_<%$1$<X-!)42U[=\'GLGE*%1\AEHR]DH<W@']6I4W?!V=LL
M:[&977((WOD^4=@[#PEO=\#4VBGKTTSQ=G9W- ;\JEJ(B(M5G<]C<%0?>OSB
M&NUP;W'[E;"G=KVJL5FO('QRL#V/'L6GZA1>_OFI8^Q)7MYB"*5C^PM/T<I9
M!/%/$R6-X<UXY:1[$%?41$1%PL3PUX7RS/:QC!RYQ\ !<<9D:%^M\35L,FCY
M(#F'D+M1?)(8Y .YH/!Y'/W3P L3\2H_^;A_EWA99D8&=W<...>5T0WJ<T@8
MRS&XGZ-<"5D+A-<K5_#YF,Y^KG +[%9A?QV2,=S[$$%<D0M!/*(B+HGOU()H
M899V,=(>& G@N7>B(BP<GB<=E*WPU^K%8B[@[TY&APY'L?*[8_A:PBKL[& #
MAC!P/ ^P7?)/%'P'/:WGVY/'*Y(B(B(B(M'G-8P6=8UF3QT%D,![#(T.+>?L
MNO!ZI@,%&&XW&P5_'!<Q@#C_ #*D".<UH))X" @CD(B^3P13POCE8',>TAS3
M[$%:/ :SA=?@EAQE*.NR1_>\,'N5O>0?" <(L3(XNC?@;%<KQS1AX>&/'(#F
M^Q66B+!LXFC8O5[<L#7RP B)[O)9W>_"SD1$1$1$1$1$1$1$1$1$10C>M"QV
MV5ZS)[,L,]=Q=#,SW8HA2Z3W?0^%RFXY6[5\ U^2QA 5N8W&T\72@J5(&Q0Q
M,#8XVC@ !92(B*EKG1VE<W:UG+-^1]:2<3&H1R'O5T@ #@(B)X1$3@(B(B+2
M;7K-38<)9QMF5[&RD$/9[M(574=#W^#OJ/WFP*@Y#']I=(K-UC6:.OT#7@+W
MN>\R33/\OE>?=SBM^B(B(B(B(B(B(B(B(B(B(OS4TMW;M.&/ /%IG@K]*Q]?
MYHB(B(B(B(B(B(B(B\\]8G;*,UK<=:\QE&2T.(O_ -J/JY9?7$6H]&K?$R"6
M096'DM;PL#);MO>$PN.RD.$@CQ+?2C[)'_UW'W<K&VK>X\/KM&]"QK[%XL;5
MB<>!R_ZN*KW(]3MEUC/4:N:;0L5K! <^N_S$O0L,K)8VO8X.:X<@CZ@J-[7L
M]'6\4^[9Y<2X,BC'YI'GV:%0_4[);]+ILSLGB*K*EIS"1'*3)7/V=X4S@V\:
MCTQUF<UC-9DJP10P>W+RU*W4':,5L>*Q&R8JK%^(N)@FAE+@W]#RT*.=1<QN
M47436\=!%7^&-GU:<9>0)7L_C*LK.[M/@,=1&1I,_%+CBR"I#)WL+_U>0/"C
MM'J7D:6R5<+LF-@INM-)@F@F,K"?L?#5<JB>W[A0UJG'+,UTL\SPRO79^>1R
MA?\ 2;>Q5VK!LV!EQS++^(9FN]1G\GIUFS61I:=<94JE\-F/LDG!\1ITY$N7
MTW$8[*81II1TH3$Z3YVR<!6Y/*VO#(\,<[M:3PT<GQ]E4E+K'A[C,KZ%&XZ2
MM(&,@# 97KEBNLNNWJ%ESXK,=R%X8ZEV<RN=]FK>Z3U$QVS6+E0U;%:U6/\
M60R!<-AZB4,7E'8FK2M7K[6&1\$#0>Q@^KBM[JVWX;9<3+D:3I.QA+7QO;P]
MI43TO9]/S.<S3,-C3#8#NZU.8@PR.48IP10]?LD&#@/Q!>[^9(4NMY73'=0J
M-.6H7YIL)+)A&"&-6?E.H^LXG/MPUR>1DYC+R\M^1H6/@.J.JYW,/Q=::9LX
M)[/49VB3]6*1[%M.'U^NR:_/V![@V-C1R]Y^P"C5;JIJ)G=6NV)Z%@?_ '&S
M'VN*L:&>.>)DL3N6. (/W!10K?OV6?@)8=B?Q3=(W^9>/LL3/YO%:YI7KT3Z
M4#:@;5#6^WCPJUZ85M8V;2CB,G(+=JS+)9G#Q\X?]^5?>(Q=3$XRG0K=P@K1
M-CC[CR>UHX"T.<WO6,':%6_D6QS^.8VCN< ?J5O<1G\/E:!O8^XRQ!R0)6_E
MY"C@ZA:B<B*'XM$)R[M;_"7?8%;W*[!A\/%%)D+T4#'N#6EQ]RM=9W76*V2C
MQLV7K,M//#8B[RHUU%ZBT-3JLBY)NS<>BWCEH'W*G."S^)S59UBE<;88P]I+
M>?=<,_3K7</D*UB,2120/#FGV/A4OT9SN(P_3J%]^]%7;\;-^<J[QG<6<:<@
M+L1K_P#B@_* N&-SF*R3GMJ78INS\W8>>%]K9K&6;T]*&W$Z>$D21@^6D+8N
M <T@CP1P5Y2M:QAH.ND=$5(S5,8G]'CY XKU.^""2L87QM+'-[2WZ<?94CTL
MUG$TL_N-F*M&#!E'P5_'F)@)\-5YR'L82![#V7F'7I\+N6_;!%LLIDDK3EE"
ME*?D# IE'I=G [W@I,2^S^%.AE]6#NYCA<"%=@]@OJP+>5Q].6*.Q:BC?([A
MC7'@DKK_ !W%"\*1NP_$'_[EW?,LRY>JTX'33S,BC;Y<]QX"QL?F\9D6O?4M
MPS!OOV'GA5Y-U.Q7[:Q8..Q!Z+('NL3EW ;(" &!9&[ZMB<YD]?N6\P:WPDW
M+(__ !2Y61+-%!&]\CVM:/)<3P L&AF\7D034NPS<'@]CN5GRVJ\+@QTK&D^
MW) )76+M4R^D)X^_^#N'*[99HXFESWM:/N3P%U168)P?2E8_C^$@KSQN4L[.
MLVH@3R=COW.?"VW5NNX9W5)V6)@TW0PQ=WR%7H;$,1(<]H/ZD!?76(FQ>J9&
MAG\1(X7V*6*1@>Q[7-/L0>0DDK(VESW  ?4GA=0MURZ,>LSEXY:.1\P_1?9+
M=>(AKY6-)]@2 NT.:1R"NA]VJV3TS/&'?PEPY7?W#CE=3+=9[RULS'$'V#@5
MV\KJ9<JND+!*QSA^Z'#E=CYHV#ES@!]R5P?:@;(V,R,#C[-)')43WO#9+-:[
M8I8^^:D[GM<) 2WD#W:2MUAJK\;B*%:Q9,KX86,=*\\EY ]R2MK\=7^DC/\
MB%][VAO/(X1DL;QRUP*.< T^>%2.0R6:@ZO8RL,O.ZE9K.D^&!(C"NT>P7TD
M!&31O'+7 IR$Y"<IR$Y"<A.X*&;[4V6WK\D6OVO1N>LSSR02SZ@%2;%MN1X^
MJRY('SMB:)7#V+OJLWN"K/JOE,[BM7?=Q=[T"R=@D\>2TJ<8"S)+A\?),\O>
MZNPDGZDA961R-7'TI[=F01PQ,+GN/T"8K)5\CCZMV .[+$39&=PX(:X+*3D(
MG(1.4Y0GQX5;,EWT=0YH7,9^!"#EKE9*)R$1$1$15AM&<W6CM^"JXW'B?'3\
MBR>%9Z(B(B(B.(:"2H'1V^?+[,^ABZHFHU>1<N%W :_Z,9]RL;%;)L=C>LKB
M9\9V8Z!CC%:5BH[GM/'NH#A]RD?L=C 9>K\-;'+X'@\LGC'U"GR(B(B(B(B(
MB(B(B(B(B(B(B(B(B+\TM._RGP_^U,7Z6CZ_S1$1$1$1$1$1$1$1%1G6*:*"
MWJLLKPUC<B.7+CUNN5+&I53%,Q[69B /(6RZO2UY.FEM\!:8W&(L(5:[0(F=
M/NGERS 9*<(@]?QR."U6/:CZ1#''+1XS%RA[@8P(FE[W.]@K@J\"O&&Q>F.T
M<,^WZ*A>M$]BCDM3R+_-&O;/KK?=6\A2N=.KEBM:B>R1T4D9Y]PM1E=CKU^G
M^HM^%@LV[;(!5,S!Z44G;^=0/?L9<H;=IKKV9EOV)9GND<\_(P\CPP<G@*;]
M0YC_ $J:![" 22EDG*T?5HT&;YJMC+$R8Q[7M\/_ "%3VSJ?3J@^GDY6-D>)
M6B!YD#W%Q]@%;B\\=2YS#U+T26VP"HR1_#U,NLD%2?0LBZ4COCD8^'QSS(HI
MNOQ?]"-3XL$6/AZWJ@_?L5F].?\ (?6_]WP__2IG:',+VCW[2O/G1:H8<UO(
MEBXF9?:P_<?F73HM&A_2SN<K.)7LFDXD+?+"7+.QT'PO7K+1L>>V;%F5P_4D
M++M6P=VSD&LT^^_(S_[8WI'<Q0'^ -3HH3\!LD,DH?*W)'O6/TP@F;N_4,QO
M#8&Y+@L_7ER[8O\ /[>_W*N&;:T=:, [CR:+UA;5CJ60ZOZ[#;@9-'\(YW8\
M<CD<)O&/J5>JN@V(8PQ\[Y!)^O8NOJ39.$ZCZIFKD7?1;WL)]RPKCF&TMJZJ
MZY/B6MGBI1F2Y8_<+?' 7HIO:/ \(JEZUP0/T6V^2(.,=B(L6Q>]DG3,/8QS
M&'$M(:X<$#A='1T#]@L+_JU:!7FK:+>6TK=\SF+.&;?Q62\/F \QA9>1R>(I
M=([]G59GLK6;?MQVNA]7R6KKET/8]@U+%X\28R&M'#&Z%[6<O8N'5;$/@Z=Z
M_#<L-LVX+E> VO=WD'E<NH_3W7,1I#+=:L!=KSPDV^!ZLI^[RLKJRT6= UNQ
M, ^;XVJ.\^_#@5?M*K7@B#(8FL;[D-' Y77D_P#L%O\ U#_^B\S=).G6N;!J
M#[V3A,[W69&1@^T:W?3/'/H9+;]+N#XBA%*?3#UU=.I8-)VW8=6ML#(W\V*L
MOU>QBGW3FE%>?F-GDBXEREISH21P1 "2U6BO.62__.!K_P"Q,7HS]P*K^G/_
M 'CN_P#OZ7_ZG*T7%H!)*\Z[]TI9F[<NQZQ;$=XO+W,;X:]_W!6/TUZEY\9T
M:QM,3Q;/R0R/\/[A]'+TDB\[=:\)!:SFL6XGN@L/L^B96>_"U/4[2L9J[</G
ML8'BTS),9)*]W<^0O^KE.>J&'AOV<!;R619%B('N-R!SB#,3[!H5?Z\ZE5ZM
MTG8?%38ZA=H^(7,$8>/'D-"V@UG7[/7"[3GQ=5]<XOUS$6 M]4D?.L[JSB8&
M;'IMUG#2+7I%H"VF\W'YK?,/J,DY%![#-<C;_P#=?LPJ.=2M6JZ><;L^MP-H
MR16&0S10CM8YCUU]6:,N0N:;E:MJ2&6R\ #Z#E8'432V:A/B-DQEVR;9OL98
MFD>27ND5B=3<9>R4^#%BY'#A&R.?DNY_'*K[6,G1J]6(Z^O-?!B+57CTNWL8
M\CW< MGNO^>;35(NK?\ WCJ7^\5E]8M;FO8&;+TIGQVJ0)(9X]2+ZM6NM9[&
MY'I'1->O$Y]UD56.O]!*X*U-5P$.OX&AC(CR*\36%WW('DJ,=6:K9=#S<OJ2
M-,,/>WL=PJST[0;]S%ZML]G/3MDITP^&!C?E$0;X8%'\;#D=YK9+,6,+9N.G
MM2"M*)BT5PT^ Q2[$9C>-2Z>YM^<C/Q%4M91E>2\GO3^B]N:U&IE8;1=L,T4
M=@772'R\K<[QE,_B=6U_$?&O&1N2103VV.//M\Y!6EWC0J^K:]+G,!:LP7*3
MVR3/[_,_W+UF;9O61GZ78S+TY##/>D@BFD9X,?>"7$+1=0M>QVOZOALKA+DD
M=WUXHS98[B6R'_<K)ZJ4+]#2\)/'DK[)OCHFO9+,9/,O\2UW432LGB<93V9V
M>M6<E!8:9GN<6CA_T8IWU/O7)^GD>1@M357ET#W"-Y <'@^"MO?U^UM&OZW$
M,E+!6:R.6P8R0^0<*F=FQ=>_N=#6=8GL,=%YNV?5)#5.MVS%ZMFM?U.M)?-9
M\!=8?6\V)6LX  \A:+'6-DP.XT&8;&YG\)L$,LP7//#C]6^2I;8OY;<=SR.%
M@N35L1C.66Y('EDDLI]F*(18.3"]9,/6;<L3U13/PXGD,CV-''A>F&_E"J#>
ML[E;>QXC4\;:=4-QI?9M-\/9&/HQ1/;J^7Z;R8[)X?(VYL;)8$5JM8D,@)<N
M[J[8S]6MB=AQ&9O0TWN8RQ%$\AG#O(<I5N^7=:Q.N5L1D)F6,E9B;!+$\M<(
M^"2Y:WJ#MUW&Y?"ZY3LV(FSL+K-IGS3"-OT8HQB\[LE#>*$>.LY:_B+#P)F6
MP7F/^1)79L>2WJ7JE?P>)RS^):9>P.)#(&N6GVV3J=J^IX@6\](Z9][LE>QY
M/O\ DY>MIO;.H> IT=CDV.4GXF-DU*$$0,#E-^IF8R[=$CRF,O257F2$O[/#
MBQZVN?VB[@^G[<JS^ML"O$&EY]WO'N57V>K[=C=)AVF/9KK[[6,FGB#R8"'_
M &:N[;[N6O\ 2$Y&]<%B2U\/,WB,1]H<">%A9IO4*OI46PQY=M%M.&)[:,1+
M@Z,#W>]=^_RY'.]+,7FGWYH'200NF@B\1R&4*S=#PV0Q^)I/GS5FT'U8^&2>
MS?"G%VU%5K332'AD;"YQ_0*C<1>W3<\9D\WC\V^A7]1[<?78WR\-^LBWF%W/
M,XWIT<QLD$S;<+C&6?60K3R4^H-O7(]AASTD=UT0G&/#.(0T^>Q<'[Y?SW2R
M]GJ5IU._3\RB/[A;FAG\UENED63;??#>^##S.WR2YH4;QVX;79Z/6<Z+?%^$
MN/JO'/+ M7J.;ZLYZM@+T$L8H^H!.]Y/?+]W%3/'[)L?]+V0P=FT#292?-#$
MW[<CCE8NT[Q9.U6<!6S46+BKUNZ:V6&5YD/LP!8/3O>\UD<KF,#>MBY-!&Y]
M6Z&$,>UJB>+W#JGEY=GQM+T9;E6< R\EK8@PD%L:]&ZX_+28+&.RGBZ:S/B!
M]I./*AW4_;;NN86!])T;+%FRR%DLGY(P[W<5I\/:WO';#B*UC,QY+%68W.?8
M$?ECEK+_ %!RF1V#+4L5EZ5&MCR6&:9O>Z:7[-"YZ%U%SF>P^<KV8X3E*+26
M/'B&50;!=1^K.P8J>;&XN"8Q60'3!OT/[@:I!D=SW_";K@L1D<C6;3O%I[_1
MX(^[58FSY[-P;?KN'QEEC/B!));!C[N(F<+3;7N&PX[?];PM9L3*5]_E[AR7
M+8[UNF0QM_&X/#0,FREYQ[._\D3![N<M#C-GWO&;K2P6<9#<@M1=T=B&/L#$
MV7?,O)G,ABL)>Q]4TF@2SV3[RG]QH61TTZD6<_;O8;*>E^)5?=\/F.4-\$A7
M(BJG*[5L.5V&U@]9]!CZ8_QRW,.6L=]&-"Z-3WS,#99M7V2".*^UG=%/'^2<
M*+;'U/W#&[K?P5;#MF(B<*L+/)E/T>2K3T#+Y_*ZU!8S=3X>YWN;(SCCGCZK
M'ZEYR?!Z=E+D'/J]@C80>."]872O%LQVC8DM\R681/*3X)?(%I,!O>Q7>HV4
MURW7KQ0P02N 8XO\M( 6+C-YV?\ I&?K62CJ0QM#I&/'O(SZ *3V]FR[NH-7
M!4Q"ZN*WKVR?S1M6AZS5##@:><KRF*WCKC'QO^P<K1P.3&2Q%&Z'-(L0,DY;
M['N"CG4+.Y7 :Q:RF/A9))7>TO:_V[%@R[/F)NG-?/58HC<=298],_D\CDJ,
M2]0MB'3:#9*^.AEF+>Z8%_#6-43=U7WZWB*N3QVJE]1L ,\Y]BY6=A>I..NZ
M.=EG8(6M!;)$#R1)_ %%K6X=1Z^&9L#\%4^#\/=4$A,S(C]2>U;[,]1BW0AL
M^(J"Q'P.YCSVF-0VQU2W!^MU<W1P#9*<4+'6YGN[>7?4,"NG4]B@V' 4<G%&
M6?$Q!Q8?/:2/(6]1$1$1$1$1$1$1$1$1$1$7YI:=_E/A_P#:F+]+1]?YHB(B
M(B(B(B(B(B(BC&Y:AB-KQ9Q]UA[0\/9(W\S7!1FQTFU2S@Z&'DCG%:JXO 9(
M6=SS[N<M]D-#PU[6*^ LOM?!Q=@:/4/>0P<#DKN;I6$9JW[.%DCZ/I]@8]W+
M@%"M;Z*ZE@<DR_'ZT\L;^81+[,5O+5;#@,=GL7-CLA$)(9?W?L?N%40Z#:TZ
MH:TV2OR,:/ZEI/ABDF7Z68/(ZSC\())HF4^/0E'EXX6CO]$\';@HM-^UZT$O
M<;#O,CV_9;G:^EN+S]+"UV6YJIQP[8I .YQ8L_+=-=?R>MP86=LA9#YCG/F4
M.48U/HMA\#D8+DU^:Z8'DP,>WAD:NE0[=M*QVVXUM2R]T3XY ^*9HY<QP40_
MHWS.0%&MG-GFMT:KVD5A%V"7M]B\\J5[WIT^TX88P9(U(7/#I.(P\NX69I^
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M^VX+*8<TQ%C>2PRR$.)<M#U#I[+E]XP<.&=6DMU*CY9(IQS#$3PL#\9ZN:K
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M(AZ5(-GC+O+7AO!:JSUG!71T>V9XK>D;X?-!#]F+EK^Z:W4Z1"N;(%AE8PF
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M"?;N5<:#JVUOMLS&W6C-;A865(N21$'>7%7$B)Q^I1.$X1.$3A$X3A.$X3A
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M,>2QC#[R0#P'L6ZI=,M>I;&_/Q3W7772N>7NE/!#OH5+MAUVAG</9QUX$PS
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M)7,??V!H]0-7/6MUPV=P#\U6<^.J'.:73 -([5&']6-<8(IG07Q3DF$3+IB
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MT8UD;IGU_P!R1S> T$)U6U?&8O$UMBQ5:*I?I6HN)8@&\M*NW#6I;F.JV)
MZ2)KW >W)"I'K36=:FUB!LSHC)?X[V^X4?ZE].,)KV(BS^&,M>Y4LQ\OY\O3
M:LAF<_M.G8\-K2LEIBR89QQ&9"!Y<%F0].=LJ;IC,[6&+JQ,/%D0$Q]X/Z +
MT:O/.P,HV.M5"'-1A]+X#_%!)Y9ZBT]/7</<ZSV68ZC6EH0UN^;AG,;95O\
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M'!S>X<\$?5<GTX'R1R/8TN9^5Q'D?R7RS1K6X3%-&R1A/):X<M7*.)C&-:T
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M<3K>'>RM6;!5KL+NR)JJ)^W5>I4U/$XFG9%)EALUZ>>, -#/9@"OAHX".:'
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M+UHMAP6W:KBG9NGM&0OS5>'3UYR3'(SZ\#DKIWG<\[:Z>XO8\%8DKB9\8GC
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M/[[>2LFT&W^M..EJ@2-J43\2\>S?98VM&J>M.TGMYE]!W8[[#N6+9N,@Z_\
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M^^U@!69=Q5"Z&ML5HY6M]N]H<DV'QTM2*K)5B=$SCAA:"UO'V"UUK6L'9H?
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M[%WU[%-_Z3G6^G4FSX^DV66#@3UG/X$:C.%ZJ;1DY=?='K;W5;1#)K(/CO\
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MDY90EY^3L'/LMMHFOXO>L%>SV?K"Q8NV) T/\B%GVC7#0+,U#8]BT2WW6*<
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M9+,%H83[1CW<0JSZO:OF,1KU::79;E^ WX@^*<DCO\\.:O2.K#G!XW_98_\
MHH?U,VVQKF$B=2>!<LV&0P\CG@'W<J=S&<VG'7<=<PN6S%^0.#;4,\?$3A]P
MWN/"WW438]TK;-JD6'M&(7V\MJGV[V_1ZQLQ+U!U;9L!;N[$ZY%=F]*>#R(V
MG] L[KUBK+\35M?B4XA.0@B%;]P$\_.I=D[-O0M/N6I<I/?E#8XJPG^CU')<
M/U";K<>?&TSNR38/5=4X/H$'SPMC3W3*[+TOMYFC9;5OP,/JD#]YJA^G'J?L
ME' Y<YCTJ<4O]:PO(?,P>[BI7BK>=WN_L+F9BUCJ%.R8:K:Y+'O/GYGD+-UK
M+[;KNM;*_9N^5F.?_B]E_ET[%5EG9]ER. &<BS^4CR)8)8ZD,7%;C[>'*P3U
M#S5;IQ0R-B!PR]J9M9C7MXY>?WUKM]U?:*FD96[8V>U9D%9HM02<F(CZ]H5G
M]-_\A=:_W=#_ /2IJB(B(B(B(B(B(B(B(B(B(O W1/\ R_QW]QZ]\M]@B(B(
MB(B(B(B(B(B*,;-I6N['+6?DJ0G, (C)^G*P,QT]UC,P4H;E'N95C#(0#QVA
M9N7TO 9C'4Z%RF'UJP BC^@X7"WHVMV];CP,U/FFP@L9SY9P. 0N_$:;@,1@
MG8BM3:*CQP]CO)D_5RBV(Z0Z3B<LS)UJ+_6826![N6,*VVU=.M:V:Y'9R,,K
MY(QPQS7\<+6=365J/3;-P!_ %41Q]Q4-T#I]K65TG%O^)N&*S!&ZU R<B)\@
M'GEJM3)Z=A,CKPP+X7140&@1PGL\-7?K&K8W6<<:&/?/Z'?W-;(\OX4,VSH_
MJNRWY+\PE@M//+WQ>SU.<#K6.P>#AQ=1A%>-A;P?=W/@DJ)8'I9K.$NV[,#)
M7F7O#&//R1A_N&A:?&=%-3HR6 XSV*S^>*TIYC85(=>Z<8# X;(8NN)'PW!Q
M*9#RL#4>F5'6JUB.+(SS2OC+(Y7#^R:?HP+9Z;H5+5'Y%]>[8G=<<'2F3[A:
M2[TR?'FK>3P6>LXI]KDV61L[V/)^ON%)M?TRO@\1>K179WV+CB^>V_S+)(?W
MEI=$Z>R:B_)D9J>T+;@XA[..'+AJO3DX#9LKFG9B6RZZ7E\;H^T<N*LY59F>
MG$[]FDV#"YJ7'VY0?7:&=[)5NM9TF+#Y"]E+5Z6]D;7B6R\<>/LT<G@+0Y7I
MQ>N[G'LT6PR12Q$"*'T06A@_=/E6M&'A@#SR>/*B&_Z@-IUN?'%_IRE[9(7_
M $:]JA=KIOGK6DS8678I9991&'OD'+.& @,:I##J.7AZ>C -OL^(;6$#9^W@
M!JPL5I&4Q6B6=?CR+)9"TLBE<S@!I6NUOISE<=H67UR;),/K'F"1C?+"5K[^
MD[UGJ-'#YG*57489&/DF8"9I>Q7;5JPUH(X8F]L;&AK1^@6OS^"H9O%V<=>C
M#X9AY'U'V*I3"ZEU0U.2>EAK]&YC.?ZIEIY:YBL3!ZSE7VXLIL-YENXQO]3$
MQG;%!]^W[E0+>^F6P6MH_:+5\D*UQ_B4.<6*8ZQJ68H,MY#+9(WLI-#V-<[P
MR$'W8Q1OIUJ6[:UE\F+KZ<F/MRF4EDA+P_\ 0<+MZAZ+LF2V+"9O7K,,-NH"
M'F5Q"ZM^TS<\[KV)QU:]6L313B>S+,2SE[5MMUP.Y9W2H,5"*0N3Q,%PEY#
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M>YL%#3LC9Q+XV%C>9GN/#A']>Q1#5Y,^[I4X7X*S:XQ3?AGQR%SWLX_?! 4
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MAHC!\=B]0#GCRL'-92'%8RY>E:XQUXB]P:.7'A45=ZB;Q6UV#9O@*0H33#B
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MK&1_&.HN6N7,5<C+(O2H/DB :V-I^8D\^"5.]_H16]0S$!J23]\! 9&.7$J
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MJ6U.LV(R>.KQ4:\S\O.6L] Q^ \J\*?Q+:T+;#FNE# 'EO@=WUX7<\@-))5
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M^>];^YM\_P#1[!F:]UKK$L$9B=Q^>9X]N%,\#^,#$4QE9FR7#&#.6M[6A_U
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MA9"WU05O>HD\&>='IU9L,ERV#)*7>?AHV?OJ%=+,V-6RU[2<MZ44\4I?!,/
MD71FLU7U?K6_(Y-[_A+='THYN/#>5;U;;L#>ST%/&]ENP0?7EB\B%@_B*K^I
M/">O]TAX\8CM7":S7I=>)I;$C8F38CLC<[P'%8&5SN+FZRX%\=IA8VL^/O\
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M072]_P"&N'Z!_A']$]!?&]GX<\<OYY#_ "%C/Z%: ]H'PUEO!/M*NL]!M!X
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MR%R*W<QE::>/\DKV!SFK=1QLC8&M   X "X6:-.:Y#:DA8Z6)I$<A'+FAWN
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MZ.6Y+0001X*K#(=']&O90Y"7'<2%_)8P\1N/ZA694JP5:\4,,;8XHVAK&-'
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M)ZATMFHX6MAXK;F"]%*\F+C@A3/KAD:S]7P\/+O6EOPS-BXY<6,6'U>I29+
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MG<0P\<LX5B7-#<_1F:O7RLL</8(W3/9ZCBP+H9H%D:/!KAS<A,$C##:]/AS
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M!*BNNZQUEPS782O<JB@/ FD)=VL_T%--YZ7_ (EJ-&EC)#\;0X=!([WD*T&
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M6B(B$<A5G)TSHOVR/8SE;IM-=_\ ''\*LQ$1$1$1$1$1$1$1$1$1$1$3@(G
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MLSVN%PG; ZS5'+F.[NPO"P- UT:WK4>/&3^+[97.,G\U*I,C3:_L=9B:?L7
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MO!7I)>;>L[YV;AH[H(!+*'S%D?W/+5M<OMG4?7\_AQE10-&]9+#!%Y+/T[R
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MIM>RV<S/I0TXGGT7L]WQL]W*&7NI.U'!R;)4J4!C0>6023?U[XU<6G[/5V+
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M:]D,-K\K\BST[=VP;$L7\'/D-5>]1-?RL&_8BSA9_2DR[706EZ&H4X*52"M
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M$+?[Z=;Z]NI<UK8(JGKP4)7B9A'+?G6SH]0=/RGX<S!XYDV3E[&Q1>F!Z/\
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MGAPY\KJI8VE1865H(X6$\D,:&@E+N)HWWM?:JPR%OMWM#N%D1Q,C8UC0  .
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M] .//V<%&NI4VWLZC:Q6K6X/1EL%]*,^P>SZO7H3%?B8H1MONC-C_P"Z&/\
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MK51< 8]QY+XQWJ/9;7\]J5279M+RGK8B<B:2K^X&%3;(C#=0M5P$,\YHY&S
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MS/.QI#)+$AD+ ?MRLO;M$UW:Q6;DZ[GF DQO:>'+>XC$4,10@HT8&PP1#AC
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MB"*7V;V!1"UB;^J=*LEB<O=B\L;#7?#[\O\ W5JL9K767"XS',Q^5HOA@JM
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M1QJR+T#IF-S=3'S3YF8/OVYC-,&GEC.?9K5'.KU7+7]5DHXW&SVIYIF'B,>
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M#9=BR%O+&:"W-W00=W(8U6 R:-_/:X'C[%!(QSB X<A/49SQR.5"]YQVP97
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M8PW\<YY:']A9(.US2I%PB(B(B(B(B(B(B(B(B(B(B(O+_P#@U_\ 8MC_ -;
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MP5?72^Y6+A"PR$=Y:?=RZ<5U@ORRW\5=U^9N;A=VPTXCW"4K>ZAU)R.2V6;
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M[>LX*[>%RQC*TDX/(E=&"X)DM:P&2NQW+>+K33Q_DD>P.<U;EC&L:&M   X
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MR^K&U6;=T7!6-4_9XU@RF&!K !\S2/WU5>&Z&BC:,-C8+,V,#P_X/CM#U/\
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M?CAL#"IMI68EOX>MZE&Y YD$0+YV@=_(]V\$J5KA>O5J-6:>:0,BB87/>?H
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MRME6/L?3Z,*0]2]/FS)Q+<HSXGO+ ./E+OL"I)GMAQ>"HNMW[ BA!#?U<3]
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MB;]2%H.H4^9T??XMHHU)9ZEJ+LL-]@2IYJ6^9K;KHFJXV2ICX(R^2:3WD?\
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MX/7J> "QGV6KT78-AI;+D]7V)XM2UJKI67>>7&,*+Y;6;6,J6=QT?,.]"?\
MKIZCC\CVE7IHF<_&=4Q5T0"'U8&ES . #Q]%%^LW^0E__7Q+;1S8UO3]DD[V
M?"#&CDCVX[5YWM8FY!T+QIE@<YGXJRPX?:$@JSJ.+Z29C ?BIJ5! R)K' \
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MF7]_E=NQQY*_T/Q4L,SB\5:TMC[OC#5H=NSN S_3S!XVA"Z>ZZ2!L4(9YB+
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MB(B(B(B(B(B(B(\D-)"\\=-<M2'4'>8+G$=Z:Z71!WT8PGD*Q[XPV&DV$XN
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MKUSV72-EH;>[9M6D@,LK"+E:4EC9%M,3K.<S6PU-AV2&&!]1G%&G$XR",O\
M=SW$#RM1O.J;ME=QPN6QL-$0XLDQ>K*0YY<KIINL/JQ/L1MCE+09&-/< [[
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MX+]-U>2/PUKOJQ6-DZ#+U&S6D'RRQ%A'Z%>?M-R65Z>BYKN2Q-N>HV=TE6U
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M\<A[?ZF/[DN6KZE92K5ZDZ(^=Y JO>Z9W'@!Z]#M?%+$'-<'-<.0?N%Y@V'
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M*.LP6Y(Q&^?@=Y:/IRL^>"*:)\<K ]CQPYI\@A0G%].M1Q.4&1I8F&*<$EI
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MZ5R%T]>=DK XM[FGD<A<UQL5H;$+X98VO8[PYKAR"D$$4$3(XV-:Q@X:T#@
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ML4<E%-'7_M2W]Q5OKW5NAEMQR%%EML=%C RORWATDBM',[/@\,8QD;\5?O\
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MQ3C ];L%9P=9LOK')^F&&N!SS(L#JE?DKC2GY-S([(LL?.QJW/76:,:E0?W
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M_P"URJZ7>RI#IE_E=U)_WL/^KTU41GJON8;QP0M3TUP.(EW7?IWTH2^MD^R
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MDV8YUR(6G#D0\_-PMDB(B+&OX;&WGL=8J0RE@(:7M#N.5D0PQ01,BB8UK&@
M- X  7U%P?9@;(V(RL#C[-)')7-<9X8IHGQ2L#VO'#FGR"%AXG#8S$517H4X
MJT <2(XVAK>2LY$1$1KVNYX(/"(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B<(B)P$3@(B<(G 3@(G"<!$X1$3@(G *)P$[0B(B<+4[/@8
MLU@;^,DF,8M1]A>/)"IFC@.L^(#:%',XZ:DSAK)9P3)V!6?J^MS8SXFW?MFW
MD;7:;%@CC\OLUOV 4M3@(B<(B(B)PG"(G"(G"KGJ-IEW8Z54T+@AN5)A+"3^
M4E12E4ZV69!5O7\;!![2SL!<\C[M5K:[@:V"QK*<,CW@.+WR/\OD>[W<[]2M
MVB)PB(B(B(B(B(B(B(B(B(B(B\I=7-1FRFYSVH[#6AU>+P58G0+_ #>P_P"V
M2JZ41$1$1$1$1$1$1$1[@QCG'V Y5-4NK.(N;C:QWQ7I4X8>.7L\OF6@S-:C
M3ZU8JYXC,]-[YG*WL/N6L9BVZGC\M!/.P<N8T^0LC,;3@,+)$S)9&*!TGY&G
MR2N=#9L'D,;/?IWXYJ\0Y<]GE5[JO5C$9O.9:J;38(62QQTPX$.E]^2K=48N
M[IJ]&Z:5K+01V/X"ME8V'$01599;\+&6!S$XGP[^2RLEF<?0C8^U9CAC<>&E
MYX!*R/C*S*_KF5H9QSWD\-X6GJ;+A+TPAKY&"23Z-:Y4EO=4U^KND6S)XG<X
M<?;L5ZPYS%2W7TXKL+IQ[QAW+ELUAW,I0H]GQ-J*+O<&M[W<<E94-B"1KGLD
M:\ ^[2"%C_B%+O[?BHN>>..\<KOFLPQ %\C6 G@=Q 76^]487!T\;2WW!<!P
MN=>U4G<X,GC?Q[AK@5P,\,OJ1LF;WMY! /D*%:9K]_#V<\^UF7719MB1C2>?
M3'E3::[6B<&R31L/T#G %=P<TCD'PNGXRL9/3$S.[^'N'*[E\?(Q@Y<X ?<K
M"N.,].PV"QV/,9 >WR6GCW56](<GE;6,S0R62FMO@OF,22N5P-<UP!!Y"&:,
M.#2X GV"P<N^Q^&W#7F]*00N+'\=W! 52=&-AS><UW*3W[KYYA;X:YZ[NF&8
MSU[-[K7RMY\[ZM]D;1R>QGYO#5<:=[>>.43N"<IW!$Y"TK]AQC<Y%AO6YMO@
M?-V#Z,80//\ Q4;VMN[',8$X.5C:8E/QH<5)\OG*&'ACEMR\"29L; ."XN<M
MOW!.5K,UFZ&'H27+<O9$S@?J2?H%LV/#F@IR$3D)R$1.4Y"$JHLCLNP5^J6-
MPXMM&/GKF01AO#E;H]@G(3E.0BU6<FO18F])1,?Q3(7.B[_R\C[J']*=JR^S
M:DS(Y*1AL&R]A+!P.&JQ4Y")RH%NFVR8>3&XVBQK\ED9O3K-?X: /=Y44&S[
MUKV:MLV"&&UBXH'S&]&WL  6MM;9U)LX6ALF,I0/IS$.-#CF0QGV/<IETXSF
MX9:/+S9_'"IV6 *S.."!YY"LCD+!RLEV/'VGTF!\[8B8FGZN4?T*_L]O7(9M
MAK""^Y[@]O';X4NY")R%\FGBAC?)(\-8T$N)]@ N%&_3O4H+-28213-#V2-]
MG-/L5V)R$1$15[M^=V>AF<#5Q6-]>&S*[XF3^!H5A(B(B*H;^X[-E,UF:.LU
M*\C,5RRP^<\%\O\ "WP5.=)S^1S.!CMY#'.IV>]S'P.^A:I*B(B(B(B(B(BB
MNY[%/KN!M92*G\1Z'ES.>.&KEH^R2[%K=#)/A$3YV<N:%*$1$FGB@C<^1X:T
M#R3X 6FV++28G Y#)15S.ZO"7B)ONY8VGY^?.Z_0R,M0UGV(PYT1//"D2(BZ
MG686S,A,C1(X$AO/D@*N9NH,L6_U]8&.([XB\SN<K+!Y"(B(B*&;9N=3 NJ5
M&0NLY"X2VI5;[O(^_P!@M1J6^6\KF;>%RV(DH9&!A>8^2^-S!]0Y643P.0JH
MO=5L;B,R[&YK'W*7=-V03.:#&\?Q*U(;,4T#987A[7#EKAY!'Z*MG]0WLV/\
M .%N?&F7EGMV&#_Q>59B+BZ9C7M87 $^PY\E5ME^H;<?O&*ULXZ0_%G@SD\!
M66H%N&ZNUV]A:K<=+8-Z?L+F^S IZB(B(B(B(B(B(B(B(B(B(B(B\>=:-ARM
M'>;,%>P61BO$K@Z#EO\ 1[5[6%G^,R*XT1$1$1$1$1$1$1$1WLJ-UB&$=6MQ
M=V-YX6LV_%4<KU;P%6[")874WES#['@M6#L6)I8+J[ITN-ABKBV"R1D8X\-4
MASU7#XWJ#8O1LERN7L0\04@P$5V#W<7K#Z-0/@S.^P25XX2S(,!A8>YC/S^
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MM=6VWJCC:0U_]FGV9X (HYWG@1AJ](:_4R=3$5HLC;,]KMYF?]"\^_'Z*O\
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M05$JO2+1*PM=F'C=ZPX)=Y[?T8ISA\-C\-CX:-&NV&O'^5C5K-ETS ;&ZO\
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MS%29YK-+AWN;P?D35]MP^RU;%G'2/>R*7TSW#CRMCG,WC\)C9[UV4QUXOSN
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M<]9HV_A+66@CGYX["5(:EVO;@9/!*V1CQRUS3R.%RL6(:T+Y99&L8P<N<?
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M1$=[%?G[UE_SAYK_ %J]9=&_\@<-_<5H(B(B(B(B(B(B(B(BKC;MOR-/,XO
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M@ '@0.4LU'<LECLG4P^0TDXAER7ACX_9TA7?J=?9!U.S]ZU@[$%*V'AD[_\
M0*,I9UG6BSECA;/P#ZAJBP "S^\M?DJNY8/JCD[.,Q(MP9*'P\GAC#S[N*O^
ML;/PT;9R"\-'?V^W*H/<*>VX7J?!L.'Q)NQV:HK<>P:5E;#KVQXC8<7N-6J+
M-H5Q%DZT!]_N6+*RD69W?/801XRU2Q=*<3S260&/>[Z!K02KM5 ]0Z.TX_?M
M?SN+Q+[D;(S$YC5C[?#MEO;],R9URP\8\%]GT"'L!DX\-)X5P[+/;=K=^2K5
MF?,^ B.$-!?RY4[K6!V%G1_+X(XV:G? ?PUWCU.5#R-ZO]+G8:/6OAH*T3.Z
M4NX?-Q]F*>R5]C/1?\,L8>46G5(Z\4,7SN_1SU873>/(0:=B*M^C)5GK0MA?
M&_W^0<<K+W[%7,KIF;I5(N^>: MC:JHU_;<S2U"KKS-9R!RT%85@TL A\#CD
MO5E=.M7?J^J4L=*[F;S)/]A(]5EL>EBYU5HNK2'X:Y$Z?(Q-/@AA'NO0[0 %
M >J?^;W9/]E4>H8NSF.BU+&U_,L^'B#% L-E]XDTE^N#6Y8IJE4PR3R^&!C?
M^KDQL>>K]$[N-NXFP)Y 8J[6M\EA5J=*KT\VGXVK8I35Y:4+('B0<<EHXY"P
MNL6%JY'3+MD^+%-S98'CW[ENNG6#LXK783=/==M'U[<GN72/4[=^4KS]K=F^
M.KFP2NQ]AE2TU[6RO9QRYCETZ\ZRSK/E[;L98$%D/BCL%GAI[ECY%MP]<8KX
MQUHUF,$!D#/'(7HU_?Z1#??A>:<)?V3$[7M7Q>N3W<E:G+:]C]P,\^.?HQ.G
MF1S^'BV_'Y#"3<,EDDFGB\M#_([&K?\ 1JQ/CM*O4+M.>&:"627AS?=KUPZ.
M7K45K/4+./L0B>R;,,CV\!S4ZP:]9?D<#F<5+Z5\VA5'W<V17#K6$KX+"T<=
M"T!E>)K/'U(6PR<\=:C9E<'$,C<X]HY/M]%Y^Z061E*&U8^:G-%%=F=)$Y[>
M.]I46U[9]DZ83V]>OXB6U5$KWUI&*ZJN2V.QIF8RF6J,98FB>^"F?:*/Z-<5
MYEU7/:Y5PD6/RE#-NAED]2PR![A [^4:NG9=BI[#TRR0UF.PP53%')7+>Q[8
MN#X(5:['DK65Z;XJEB-7LPU:TD,EF7LX D:/HIUNF8GEZ44HK&.L0V9GPLCA
MXY<0P>ZNC3;1LZWBI'0R1.-9@<QXX+2 JRZ_GC2X#]LE"M/=ZA5+>EPX:A4M
MG*V*T==D)B\ E:/J+CCK?3[6-<[)9KK9XICV,Y;_ %0X<KJAD@W31R.US!>J
M<.:]O!#E5FB[K'IN*EUS8:MB*U2>1$YD?<R1BDFBZV_)T]IS%^M)#+FYWNC9
M)X<R$\D*N=6V?:.G=F?5KV&FMCO)JOC*GVQZMM.Q=/K9O<C*.MBY' '$MB#>
M>(PHSK75G:K<%?!OP4IRQ(A$KR0S]7O6?U.US8<<S ;/0G?/>QK RS]Y%M-=
MZD[#N,U2GCL1)3 >UUVR_P M8S[,6BVBUFM&ZCSY_P"#ELXO(CME[!Y85JL_
MLUG/]1-*R%;"Y 4X>7Q%T0#Y ]2KJ5:D'4?3+3:=E\5)SWSEC.> _A8?4S)\
M=1=+LPT[$D=-Q?(YK/'$JSNK-PR9/6!!5L3&*SZ[_39S\BUW63)P6':JW\.E
MF@FF,QEC\3M _<:M?A]ZT"GF*V2MUL\^^&^B);8]41<_8DKTY!)'+&Q\;@YK
MAR"/L41$1$1$1$1$1$1$1$1$1'>Q7Y^=9?\ .'FO]:O9O3?_ "&UO_=\/_TJ
M;(B(B(B(B(B(B(B(B(B&:,/#.X=Q'MRB(R1CN>T@\(B(B(B(B(G(6)D:,=^E
M-7=-+&)!P71GM< HWIFF8_4:$].C-.^*27OXD*EZ(B(B(B(B(B/:"TA5'CND
M^/K[/;RUB_/9@=8]:&K)Y:'_ '<K<1%K<U2MW<99K5K?PTLK"T2]O?V@_HHI
MTZT^SJ6#=C);HL,]8R-/9V\<J69BK<LXRU#4F9%,^,M8YP[@.5"NF>GY'4\)
M/CK=MD[3/ZD?:/96,B)P"B<!$X"(G 1$X"<(B+13:SBI<['F)&.ELQ-#8B\\
MMC_5@^A6]3A$X 7":)SHI P]KBT@.^Q^ZI?7.G6RC,MO;)L4UZ*M8+ZM<DN9
M^CRKK1. G 3@(G"(G"<)P$1$<P$$*C[FG]0<'E,G8U7*U70W;!FDCM^X<5O\
M!J^UV[=3(;5EF32UWA\52N.(6O'L]6BB<(G"(B(B)PB(G"A^]0;/-@)&ZY8;
M%>$K3Y^K%@:)K&6QD-J]G+8LY6WV^O("2UH9[-:I^_N[3V^ZI/)X_J7G?QG!
MWX:+<;9FX;:!(<V'[ <>2K?Q6-KXW'U:, XB@B;&P>WAJS>$X7R1K^QW:?/'
MA490U;?LILEB+9+_ '8F&QZL<327"4CV!5Z(G"<)PB<)VA.%JL[^)C$7SC./
MC/1/H=WMWJH]!P>\9'(P97;W>:;2VI"??N=[O<KQ1 T#V7PL:3[*([[A<KF-
M6OTL;*&6)..WEQ:' ?0JK<=M'5*K#%C3HS'/8!$VQZO;&K*T[7;V-&0O9.2-
MU^^]K[ B_LV=O/#6J;]C>.$+ 0BI/K71SF6PU/&8S#V;3S:9,Y[!X:&*R]6;
M8. Q8LU7P3"LP/C?^9I 4A+0[W"  !#&TE$+&D\HOGIM!YX0@%(H(XQ\K0T<
M\\!?7-#O=.P<A"$+04(5';SA]WH;A5V?#TX[\4-;T/A">'CNX)+4YW_<H12O
M8"OB*;SQ-)([U9>/] <!750IQ4JD%>+GLB8&-Y^S5WHB(B(B(B(B(B(B(B(B
M(CO9?GGU:MQ6M_SSH^>&67L//W:5[6Z;_P"0VM_[OA_^E39$1$1$1$1$1$1$
M1$75/D*D;NQ\\;/T<X KFV:)T7JA[2S[\^%T_'4RQKOB(^''@'N'"@MO6)9=
M]IYL9<M8RLZ,U"5/)+$$#1ZLK&?JX@+X9&6()#%(T@M(#FGD#D*&Z+K]S!TK
MT5K*&Y)+:,G=SSP%-/B8.U[O59PT\'R/"[&2,>T.:X$'V(2>Y!#X?*QGZN("
M^M>UP!!Y!1?'686N[2]H_3D+ZY[0TN) "!P(Y7R6:..-SWN#6M'))]@%K,!L
M.,S56:U0E]6)DSH@_P"A+/!(6T3N".< .252%?,[)M^<VBOBLPZC#BY?1@[!
MSZKSSY<K#TD[-^ Q-V$-^/:]S7N:>0YH]BI9R$3N")R$Y3D*I-_VC9L%G-?C
MHN@%.U/Z<W(Y>K;!]TY6#8RV/KWJU*:TQD\X<88S[N[?=0S=<GNE.QB&Z_09
M.R2?BR\^[&JP03]41.46-:R%&H^LRQ.UAFE$<8/NYY\\!9*(L>QD*D$\$$DS
M6OF)$;3[N(5;[;NF7Q&VZUAZU.!\>1>X%[GD'Y5:"@>\[!G\-%CW8K%FV9;+
M62_Z+5/&GQY1%5VS=2X,?EV87$TG9')N]X&'AK#]GE:W*;YNF"KBYEM28*OI
M]SY*TYE,9^S@6M5HZ]FV9C!X_(QQE@LP-E#3] \<K9(A< "25C&RU]5TT)$@
M+"YO;Y[O"AV@[+F\W1OOR>-=3EBL]C ?JU:O9=NS_P"/G :[CX)[;(/5L2SO
M+(XA]!X#E"\9U.W1^?IX>YK)$K;/I67L*]!(B+KK7*LSYFQRM<8G=KP//!^Q
M78B(CW!K22? 5,Y+J7F2S+7,+@67J&/G]&:4REKR?NQH!Y"GV-VIV4U*/,4J
M<CWO@]1L!\.^_:JWQ?5S(Y=]IF/U._8=7>&3!A'R%;V#JS@HK\>.RU:YC;9X
M#F6& -!*M**:.6-KV.#FN'((]B%]1%7;MVO,Z@?LV<.\0>@9!:)5B(B(B^-E
M8YSP' EON.?(4$CW*U^W<VN/Q,PB;7]5EKZ.4\1$1$1%\?,QKFM+@"?8<^2J
M^RO4&GCMQQFNNISF6T?$I'#%82(B->QQ< X$CW1$1$1$X1"0%&-OVJGJ^(.0
MM,>]OJMC:Q@\ESE(*-QENI#/&"&2,#P#X/!^Z[^$1$1$1$1 041$3A%C9"_!
MCZ4]J<D11,+GD#GP%I-2W'#;/3L6\:Y[F12^GR\<*2(@((Y"(HWM6V8K6* N
MY R>F7AC1&WN))4AH7H;=.&Q$"&RL#QS[\%1/);S@\=LF/P,[I3<MN 8UK?
M4O1$1%$9=XPL.U0ZZ3,ZX]A?X;\@"EP1$1$1$1$1$1$1$1$1$1$1$0K\YNIK
MHSONQ]@\?'RKW'TW_P AM;_W?#_]*FR(B(B(B(B(B(B(B)*"6'@\'A>:+F$P
M45G9AL1_&,O9?)\-%#_6OAC'ZG\JWW2J-^5Z0VZUF:0CF>-IY\M#5 .FG3K]
MJ=5IW;.7LQ"M>>8(V^6CA3O+58X>MF'E:Y_,U21[@3X!Y"T746_2J=1*O[30
M3SX%U/B)@'+&R?5RLS0\7A*N R;,+DC9QMF0N@X/F)OGY%&ND49_!MGB,TIX
MOO:'EW+_ !W*'=/=1M[$S98K^9N"@+SF>BR0ATK_ #Y>5,>D4^2JR;=AK%R2
MQ'BK@A@+S[#RM1KM&CO=K:I\_8=-+7L&*&MSP(&#GAP7=T:CR]RUF9;F6OS0
M4; @JM=,3&0K>W+._@&LY3)C@N@BY8#]7%59A=*DV758,UD,Q?.3NUQ.)63$
M-C+AR &K#UC8<CFNGVRX_)V)'7<8#&^4//>];WI1?R&8Z9327K]B2;OF:)B\
M^H U1;19<KL_3G:8+V2N69!(1&]\A#UL>@V':[5*^1^-N!S;,K?0$I$/\^Q6
M[MV<& US)9/CN=!%RQOW<56>.UK;,SJ\>4M;5D8<E8A;,QD;RV*/QSV%H*SM
M#V3(;?JV2IY*R^&_3>89WP/+'*']%M;/K[#<=DK8,=\,#6R$!_'/F0+T;/,R
MO!)*X@!C2X_H J0PDVQ=0*^2R<&?LXZDRPZ.E'7\%_;^\\@A;#I]M&P3V\_K
M^=E[K] GMG'L]JK'7\IU2V=VS4J&8\P603.]Y:0?/#&+TW@1E6X7'MR;FNN"
M!GKEOMZG'GA4/G=AZDGJ+D]>Q=N%_?6,E</Y8R%A/AQ6TR^V[?JNHX^ME[+'
MYBU<,0F'+PV+^-:3)[WFM;V+&10YFUEJLW'Q,4L):6<^Q:>7*3=6CS?U$_?(
MA27><_G*F0PN'Q+3%+D97!]PM[A UJA^O[?GZ'45^J7LNS*5_0+F6>WAX<HQ
MF(LW+UP@K,S!!$'? YT0>(F/_=#5/]WV+9\#?UF""U"Z&Q.V*=Y9P]Y3J?M^
MQZS;PK\9Z;XIYS')$6\N<H[L6V]3M>=0RF1BHQ4+%QL;ZC/G?&'^P+E8>_;=
M8P-&I'2C:Z[=G$-<O_(PGZN4!W/8NH>F&E8DR%>_6M/$<@?'V>G,?LKMQ!RG
MX=",@Z,V..9#'^5>?=X9G[?5K7J<.6$47/K5@YG(C*L?:-KR^(?B,+09'=S%
MP<!SOZM@#?>0@<J+9K:]_P!.NT+.<?7OXN9[8Y986=CHG%7C!/%8KQS1/#F/
M:'-</8@KS=L+=LEZQXZJ,JQL0C>^FXQ]S8XR1R.Q=_5"W9QFY=/;+V.M30^M
MX8.#(_PLJYO/4C!;1AH,W3ILI7Y.!'"2XL_FX@*:]3=NSFKU,=:H0Q&.6TV&
M5[_<%RV'4'<YL!CZ@@#1:N3"*%[_ ,D?/U*UFN9C>:^U,QF:=6M5I:CYHK<+
M.!RP@=JGV<OFAB;UL#DQ0.<%1O06 7ZN<S]H!]VU;\RE>@[52&S7EAE;RR1A
M:1]P57>PYJET_P!2IPUF"4Q>G6JQ//'*KVWU.V#!9"@_(6L?=J6)0R1E;GO@
M4BWGJ1DM=SN"AK4V6:=YA<PL\R/44S>Q]5GZQLLURC!0%8 E_P"_Z;_W6*9]
M,W[5%I>/EL?"RQ#'L-1@)!(X\!Y6VZ?;=E]IQ>5FO01068+1B ;Y 56X*/<S
MU0V4034_5 _KRX*>;IO6:UO8]?QL=2!\5YWF8GSRU;S;]QM8_)T,'BJS)\I<
MY,8>>(XVCW<]:[";5M-3<F8+-48WLF@,T-J$?*./=JUMK==JRVQ9K&8*I7AB
MQO(EGLG\[PLS5]QSVR:AF)V0P5\C5D='SSRSD*'=$9MFGHW<I//"ZG8N223O
M=YD>\+?3=0\WF'Y>?7Q1%2@2WOLR<.F=^@X*E?37?X=SPLL_H^C9A>&3Q@\@
M<J1;9LU/6\-/D+():TAK&#W>]WL%5]S;^I6*J,S-_!4CCN ^2**8F:)A^_+
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MYT8#.2IW=V3#T\/^*RW&?"%@>V0>>X'VX5%]2MY_$M1GBDPF2K0V9X35GFC
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MRUF@UIRS6=MI[6K=YK<,'AK$5:S8)G>"6P1M[Y"!]>$U_<L!L!F90N=TD/\
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M[M"QH])U5S!'^&-(8..6CL51:%7N6NAV9@IOXF<^<-5B])<I2O:'B6,,8->
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MY"]#<_*J)JSPY3K9>9;/FA2<*D1'(]QR\+!ZI4*^,VS5L[3C<RX^WZ<IC]Y
MNC=<%C<KUBPD%FN#%+5)F81^<-X\.5SZYJ6!UQEL8NFR 6).^0-6JZEQ59-&
MSPLM)B%8DD#DJKNG6@:KE>GM::YC8I;$\+N9W@&1O\BHWJ%">UTXW;#V2YU:
MG*17F>I+TST+6KVGX7*3T^ZXP^L)OKR MSTG@KWK>UY.PQDER3(O8Z4^7=A)
M6@@QQU?J\:^,>(JF0J/ED@;X:"MKTHBH92UN5JUQ-<FOEDQ=Y/82Y;+,:]C-
M*T#;X<+.]CWQ>J1SY8HYKNDY'8.FN-HLS55M2>HQXB%1I+7\?5_*P-VQV4P.
ME:OKDN2$H==8U\Q'R@-'ABE.X=-\UG64II,_7#JCP6.;6$7 'Z@K79.=F:ZH
MX;!9.P)Z=2@+# [RRQ,>/)"=5\1CV9_4+S(&MG^+$1</JU9G7>C5?A,9>,33
M89E(6-D^H:Y=?7?'4YM:Q5ET0]89"&(/^O:]:GJCT^US$Z;%<QM&*"S6M0DS
M\#U'@_=RWO4Q^2GZ7U)(R]X+JSK9^\7!Y46ZC3ZOG-+P%3$B.6UZT#:T;!R\
M,(7H'6</7PV%IT8H(X1%&.YD8X;W_4J.]3<1DLOI^1JX^,23DL<(_P",-51Z
MGL>K9K+82EF,2,7G,?.!#VQ@-?VC@M63F,!0SO7.S4O-+X&XL2.C^C^"/#ES
M_ ,3@.LF'9BZK*T<U-Y?''X8MSF(L50WVW;>V;+9*S5+8*+&!P@9^I)\!8G1
M?UH\GO4#ZWPP9D&?XL#R(_S^%LM8_P [&X_W0H_DO_S@8/\ 8F+T:/RKSQU9
MQL.4WS0J,SWM9,^=KBP\%:WJ9TYPFN8BKG,%":EFI;CY(/N"FQY+*;%OF"Q'
M;6<UF.%GT;'F)TDG'GCZD+>XC0MNH;Y5S@GH5ZKVAEID'+0\*_%YHW#6:.0Z
MP8N(N?&VY6+K/9X[P%SWO"UM0P5/"X5Y@KY/(@S][_I_ OFP=,MKMOQDV.AP
MU1]20%DD ](AH_4!;+K=C?4P.NY&=[7V8;L,1<![]ZUW7RG ^'79>P"4V SU
M![@%:WJOH>"U_7*.3HLE;?-Z)K[1=R]Y>#RXKMWW1\'3T'\<(DGR?,,C[;W\
MOD<X$DE23<;DU_HM2LR'B2:"JXG]2U8]SI/A;^F_&/DGFRGP3)&VY'\N#FA1
M>>_/GNB,-O) 3V*]L1LE?Y< Q67O%6"QTAMF5@=Z5&*1GZ."A&TXZK<Z'8"=
M[?ZV"O5,3_L2Q2[4>F>.J5<9G!//)DQ2Y?*7<A[GA4WCKF&HPV]7W/$&O;EL
M%PR?:'O+R?#W%3G?;%JSFM.U>K)!9JF(/>R5YCBLEH ;R0'+C'TUW9VX8S-_
M#8K'1UW@.96D/Y!^G8%OG5(MIZJY"KE2)JF*B/P]4^6%Q/N5H=JUS&X?JYI<
M]*K# VW*\O;& T%S%Z87G?JMC(<AO^B57221B=TS'OC/#E'>I.AXS1V8S8->
M=+6E9=9$1WK>]7-<;E,)C-MAJ<VZPB?/']XEO\UF:^[T-5Q=)C3#DB+-H>_I
MQ0^'#_B]755JP5H(X88FQPQM#6,:. UH]@ J%ZPX['RYS5+#Z\9E?=["?NQ=
MO7"A5K:35K5(60L.6AX:SP.2'+1[_P!/<%B=$%PUN<C%+"762>YY*=2\ID9\
M+IV"@> ,B&F4R.+6.[![/*Q<GTPW"YE<+=K8_"XTTB.]]9Y!=_P8%Z?"(B(B
M(B(B(B(B(B(B(B(DG=V'M]^/"_-K?/7_ &RV#XC@2_'S=X;[<]R_0_61SA,;
M_LT?_1;9$1$1$1$1$1$1$1$4=S6H:UFIA+D,36L/ X:][ 7!;C%X7'8VHVK2
MJQ5J[?:.-H:U1Y^B:@^XZV<%3,YD+S*8F]Y=]U*UHLYJNOYLL_$<=#:[/RF1
MH=PM.>G.C<<?LWC^/MZ+5*L9B,=C*XAIU8H(A[,C:&A8F=U_$YVDZGDJC)X2
M0>UP]C]PL'6],U_7&SC&460"4@O(]RM+D.F6GW\C9ORXUOKSO+I'@\$DJ3Q:
MSAJ^#?B8J<4=-[.ST6  <*'6];QVHZKG78+%ASWP\FO]'D*CL!!T2LXNF;X?
M#=CAYG9(."YZG&@:AB+T&P0U*\XURVZ,113_ )Y'LYY>K5PNCX+"X:YC*4<K
M*U@_.SO6)ANGNM8;'7:%2JX5[3>)F.=R'*/XOHSI-!EX?"OE^(:6?.>>QI^C
M5)*.@:W0UNU@*]4BG.WB7S\[_P!25BX+IKKF#PMW&TVS1LM#B68.XE<MAJNE
M8;5:=BGC38]"5W)9*\O *CDG2O$,OV;%'(WZ$5@DSUJTA9&]2REIV'H:U+A*
MPEAK2 @EK^)#S[DN6NP.@8;7\1?QN.GN15[/OS(20?NQ:S&=/]<UC"Y:O5=<
M,%F'^O:7EQ/'U"T_2+67X2AE)(_B&4K<[7U(9_$@8WGRX*WR 1P56E?I9@:N
MRVLPR>P?6G,SJ_M%WK*PW3RCB=GR&>AR%I\MQSW2QN_(2\\KA!TYJ5]QEV6/
M*6A:DD)>S]PM/[BTNX]'\5L&9_%8+TE&V3R^2)G/>I5B=%H8C7[^-I69XGVQ
M_76O>5[_ +KHTW0X=4Q-ZA6R$TD<[NYI>W\A6+H>AS:C/DGC,RVFVY ]['1]
MG#E8RJ4]*V,VN]F*^=N0P6YS+9IL\-E/ZE9E'IW+3WNUM(S,CGS!X?!Z0 X<
M5CVNG-N??XMH&:<PL\"$0_N#V:L?=ND]/8<N,O1R$N.O>>^2-OYU)-+T:KK4
M4TC[4ER]/QZUN7\[@%.G>R\QU(,UD>J6W3X++"M-"2PA[.^-_E7'KNGR8Z]>
MR]Z\;F4M-#7V"SL#&_1C!R?"TVM=/+V$V?(9K\>=+\<]S[$'HAK27%9N_P#3
MC'[?%7>;#JURL3Z-E@6FT[IG<Q=^IDLQG;&1L5V%L#'^60J>;;KT>PZ[?QDG
M $[.&O(Y[7?=<-1UV+7->H8N,AWH1 />!QWO^KE7#NF6;AVW*Y"AL<]6CD93
M)9B9X<25M]/Z;'5,SE+%+*SFG8\M@=]_N\IK'3[(8/;,GF79<3MO=SYF>D&'
MO<49H.69U%?L_P",\L?$8W1>G^Y](USSF@9._N]7/Q9GT!59Q%&(N>?N'+KS
M&AYB]OE?8(<NR&.NT,BC]/N\+)W+I]8V/.XO*-RYJFAYA8(0_P E0G:,5=V+
M?PS&[%)CIZ%(Q6IV.[3W2<<-8%@V8NHNF0PVYMJ%]ILL9\,]Q>7AR](@GCRO
M//5>M/;W[0J]:T8)GNG#)F^[#X4OCTK/YNW2L;3E(IV5)B^*K!'VL>[Z/>5T
M;GTYR.3V>EG\1E?@KD3.Q[N/<+7GI1=CVS'YV+/V'3M:?BY7^7R%9S-!V&/J
M&[91FHRQ[#&YGI^?3_@4DZBZ?8VK ,I061!*RTR9CR/JP%96(:_7,2#G<X9Y
MI'\OEE=PT'^%@4%QV'Q6=ZHV=@IN$L52JUCY&_D=.Y78M1L^*MY+ 9"I7E;'
M-/$6,<X<AO*J_7M!V+#:-D]?9>K%\K_ZF3CV#_S<K=ZMJV?P6EV</\57EG8P
MLK/]F\'[KATJU+.:I@[&.R,\+P9A)&(SSVJ=Y_'39'#WJL9#72PEC7'V!*IJ
M#3^HM[ 0ZUEK>/\ P\P,9+8;R^8!JDFY].#E-3QN-Q<P@GQYC^%>[_0"B^9Z
M:;?LV%I,S>P!]R&1A#& B(?<G[N4JW/IG6V; 4*K[;A=HQ@0VNU:G5M VIEB
MB_8MCEM0TW!T-4$ECG?=ZS+6C9VQU'AV9UV%L,7R"'W/IK'VG0<]E-VH9ZI<
MKQ"D0(6.'/*N4<_54[U"T/8LEG,9F\!D&07:P["'\@=A6GFZ7;$_;,;G!L!,
MX9Q:G(\_R8U=VY=+\O9V4[#K>3^#N/!]7R6]Q4WT_4;F,%RYEL@^[D;(XEG=
M[,9]&,44U30]IP6R9:5N7:W$S6C,R$>7/7/#Z5M=/?;FPR7Z_HV7D2PCZL6;
MGM'S-78Y=AUJW'%;F:19KS>(IUD:WJ.:?G#L6QS0/R+(C%!%!_90L6OP^E['
M1Z@WMBDL5'PVN\/:!P]C2>0 L:WHVRR]4(]F;)4^%8SL[.X]_:%=*JG<M+R\
M^>I;'KTD,>4A;V/$QX9*Q=%+4]JS6<QV3V>6JQE EU>K6<7L<\_O/)#5B;5J
M&XV=]QNP8MU,Q51V=DCRTEBNAO/"BN^21LU'-OD',8JNY"I;IW_2&=%J08N#
M'/@DCXAFEE+'QC]6AI4\FT?*8[I]8P6(GBENV?[>:8EH>7^7O6UZ<8#-8'7F
MXK*-KGT#Q"^)Y=WL_7D!1B74]GU78;N1UB*"Q5R$H=9IRDQAK_N" 5O-8U'*
M'.W]AV'T'9"4>E!'$XOCAA^P) 4%S?3O=,'M%W+:=;ABAMOYF@>2!R58F#TF
M5N#RE;.W77[62 ^+E/\ ^!@_0*I,=H75;7;QQF(R[!BGRN#'%Y^1BM?9>GL.
M:U 8=UE[YXN'Q6Y/+_5'U*KC":GU8N@8G-Y9D>-C<!(]CR9)6CZ J4;_ -.<
MA8M8S,:S89!D,>SLC8? >Q1?+:CU3V+\$MY"S0BEK3M>(F^P^[W*4]4=2VW9
M*.(K8YU=XAF$LY>\Q@O:NGJ)J^[[1B<)3KQ4F&$LFL\S$-]5GT;X6XWK [;L
M.H5L=7@IMLRF-UDNE(8TM'LP]JT6\PYN/IYC,0+#(<K,^&'T(G<B?@'EJBE*
MGU9PMCU1@,,]L4?AT48C5[:7L5C/:]2ORP>C+*SYX_?M<%A[O4VBQC:AU^1K
M+4=R-[N]Y8U\8!Y:2%7<NL[-MFS8R]F<)3QT-"4O=)'*999OL!RUOA91UG<(
M^J]C8F5:II/@,'F0AWIIL&L[A-U-Q69IUJYI0,["7/(/:M18U7?</O\ ELEA
M8X):V1<29)C_ &?)65INF[W@MNS%F6[7DI7)?6GEXX=*Y;76=;VVKO\ FLU>
MKU&4[H(X9(2\>?"P\CJ.V'JS#L5>"M\%Z0B=S(0>P*[U4/4S5-DO937L[A8X
MI+&,D>1"\\=P>L7(XK<=VDITLQCHL;C(9633ALIDDE>WV:/ \+$ZG:%G+=_&
MY[6G^GD*8[.P>.6K)TN+J3F[M>UM#8ZU2N[N;7#>U\DH]BY74J'V'#;D>IU3
M-U<6V:C58(A\W!(/N5+>I^DR[7KPAJ\-NP2B2 N/ 5>:Y2ZOY C"9<LK46<"
M6UQR]S/LTJ2=5M;V')XK#8K"T1)!!,V5_)XX]+PT+4]3,#MNS5-?;5PX#X>V
M:<%_AC_JQ;SJC@]CV/4L74J8YIM&>*:9G?X86+KW#$['FNG-?%Q8OB[((P^/
MGPSL"X3:ML62Z20X1]1D%^NR-C&%W(?Z06M%[J39UL8)NN>A:$38'VW/_JNS
MV+@I!E>GLT?3!VMX^3F>-C7-=[!\@5?34^K&7T>;!S8J.NR&OZ;WO=S-8#%L
M[6K[G_13CM?9CV/MES"X=_\ 9M 5F8F'93H?HSUS!DHJOI@,/N]OL0JOOX_=
M]JU2OB,KJT9O=K&_'32<=GW>MKN?2ZY/KN!?AIN,MB(HXX7\\=[6A-8CZLYN
MW5AV$MIT(7]TQ8.V68M73NVH[ACMU9M.KPLDDDB+;,)6CO8/J=F-UUG,7,=
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M7,/#5P[[@N2ECG \=BL8%$1==JY7JL#I9&L:7!O)^I/T5>=0M]EU)N/+,<;
MLR^F#W=H:58[7]P!1$1$1$1$1$1$1$1$1$1$1%\N?V$G]T_]%^9FP_\ ?V4_
MVJ3_ *K]*,/+-/CJDDTA>\PM+G?<D+,1$1$1$1$1$1$1$1=-Z9T56P]ONR-S
MA_,!49TDQ>-V'"9//9.M%8O7KTOJND <0%AZE29@.J.Q:S!$T8VS5-D0>[0N
M?2S#8N/:M]:*<7%7* 0>/+!R]8=;6L=G^JFUPW^^2NP!Q@YX8\\^[EVZ_C*6
MM]8\KC,9$(:C\49C%].Y:? MSVTY3:;WX/B<C*+/H--N4AT,8YX:T=CEO]"Z
M=[#@:NQU,J:HI7H21!%(7 $*%]+NG&'V+ Y-F1GF<ZO=#8O3?\C5ZPHU(J=6
M&"/GLC8&-Y]^ NY>4=GU>OE>M\M!DTD$4]82SF/P7KOR^IOZ>[K@;^"G='3N
M3>E+"7*5;5C]=CW6_:STHR@=6,=+&AGJO83[D,*U_19D[(=UQKQ/#%#9#6P$
M\&+D.4&T31#M1VZB_,VH(8KK/ ^?O=YX<]9FS]/<-C-\TK&/YGAM@LL%WO(6
M*=]6M IC4Z]K%0=DN+8 UC?K LNYLC<YTQQ4=-_-[(^C6C:'?,V3CEQ5RXF@
M,?CJE,2%X@B:SO/N[M'')6>O/?7S"T#A8,EP\3OOP1$\^.U;C-.IZ/T]L6\9
M,]D]F.&*-[C[O(6%!TZ]73H+L>6NC+?#"?XGUCYDXY6(-FS6R=&,AE7V98+L
M'(,L)(+S&M/H.G;%G,5KF<?LT[/2=X@ \>F%Z<0JA\3/F(NMN8Q]G(S25GT9
M)(HB\]K&N<%&*NH4H^MM^C'<NQL- V/59,6R!SB%M-YRYK;O2Q&:R5^K@C5'
M9+$\M]2;[O*M+1Z>0J19(39:3(5I+ ?3G?(9'&(\^%.46NS0E_"KWI$=_H/[
M>?;V7F'IM@=KR_3YYHY]^-A@LROB$ ^>5WU#BK1Z5[+F,[IEGX^U(;U:5\3I
M"NOI9FL[>P^PR9&Z^U8AN.8TN/VY4%US,9K8Z>2F?MEFGL,<KQ'CR\MB\'P.
MU>@M9?ESKV+&5)^-^&9\3S[^IQY6Z52;QL>8?LN#UC$VOA9+O<^Q9'ET4;5&
M]DL;/T\FH9+\;M93&RSB*>*SY<TN]B"NKJ)M6W5MHUB' W0ZOD6DPP$=O)'\
M:GNDT^H56[DOVDR$,\1(]$,)*L=0'JG_ )OMD_V54U1?U)K]/,?E:>2AJU*F
M/8Z&LP$ND8![N5@V>I1J],Z.Q2,!LSMCC[/8>J\*N,WON7QE6E=QFR7K\WJL
M]:N^N6Q/!]^/)4DZC[UM5'&:QDL2\5V7>TO@<WY^XJ9ZBSJ5^T-B?/VH31E@
M[F11$D,>5:2T>T7K]# Y&U0K^O9BA)AB_B<O/F>V3=-=UW"YB?97&_/+'Z^/
M<WP.];'K,R_?U;!Y-F1FABFLP-?5'Y.9 2'+9]1];SE;IYD2_9K4P@ ?('CC
MU6_P%9VH6[&L=,ZV9M9)\\0QL3XH7C@,\>&!=6'J=0LMK+,Z-E=#:L1BQ#4$
M?]4&D<AA65B-YS6<T+*787QU\M1Y;.TLY <%"M=S/5S9<+B<C2M,BA;+Z<A)
M)=-]WD+90;-U+L[OG<!7D@>(N0R<^(X&@^'=JVFD;-N%3><IK&PV!8,==T[)
M_KP%TR;V<YDLXT;"_$UJ4WHUBQA<Z5WGESB%D].MOV'9L;G<5<MOCNP>*]UK
M""\?==W3/:MDM9W/X;8+Y?;IEK8X^..6LY!>I&S9,Y+>VR]#)'+C,>#'#%QY
M=,WW\J!8?8MURN!&<Q>S06;3RPSXPP^(@?=K?*N[,XAN:Q_PLEF:*-S@9/3/
M!>WZMY6THTH*-2&M P,BB8&,:/9K0NY1[:ZN3L86Y'0O-K3>FXEY9W^./(5.
M="X,JS48[9R8%%D\Q?6]'_\ #WK)=U&N9:+*7L=L57'P1/<RK%)"973=GNYQ
M6TT?J@_):9E<MEX^R;' >MVC@2*'7>I.P3:_^.4\_3CL/ >,5Z)?Q&?IW_5R
MEN;ZE9"+0\/F((#!-<DCCDD>WED!</)6SPUS<&9S$^AFV9?#6&/?-8$0!8[Q
MP/<JV![(J0N9C<,SF]DCJY3\*I8MY9$2SS.X++Z=[KL.T:5EK=F2(7X'$1RA
MORJ(ZUM/53;]=?;J2U*XB]0/M$<.E</9K IKH'4"Q>TB_E,X\-GHO<VR]:^I
M-O\ LVOR9NMEHZ#)6NEITQ%WAT9'CO>L+H"ZP=?RYLDF8W^7\J^EK<YEZN'Q
M5R_9=VPUXR]Y545,CU*R^MC.8^_4B,X$U>DZ'D&(_=ZX1[3E-KZ>Y*S7M.QN
M0J MM!HY(+?=H6-T9I9F/3H+$]]AJS"5XKB/SR[]XO41TBUNQI;)6UNM69(,
MHY[K-@D,^O@  JS.G&]Y/*XS.1YH,9=Q<W98>P<-*BECJ)FLCAKV7QN;I5.U
M[OAJ4D?>98Q]7.6=7ZEYK(].;6P5*<++50\662%=6O;CU'S<^LVXL6S\,L,:
M+<I'EQX\O_1JOE?)96Q1O>X\!K22?T"I.MM6[;2S)W];=5KX^M*60OF;WNL=
MJWVO=0+<^AWL]E:!JR5N0]GTD(4;HYKJE=P V&(4O2D8)H\=V^3$?/YUMZG5
M."YH%W8&5RR>#Y)*_OVRK78K9-\DHXK+>K0OU+4K!+%!X= 'J$[O%M<O5W!P
M1W8W\2F2DSW9$Q6-N^Y9O"6-=Q%=U=EW)$@VG_V<98MKJV9VW\>M8S,L@>V.
MNV2*U".&RJR%PGE$,,DA!(8PN/'Z+SZ_>]]R>'R6PXR&I!CJTKA'!,/ZV9K5
M,7[YD)NF!V>O5C$XA#S$X^ HB.H6^WM:@S.-PL1@BJA]A\Q[#(_Z^D #X5B8
MS?:DVB0;)<:8H_0#Y&#^/[!0+,YGJ#D=0NY44*;:D\!>*Q>?5$+E*NC0XT'#
M^2>6*T5H-IV&IKV%MY*R?EB'#6_5SC[!4GE^INV8.CCLI<;BI:]B0!T$4I,C
M05NMSWW:,/4HYS&U8+.&LACN_P!GL#EO+>]6\M/A(-8$5E]M@FF+_:&+[O75
MU(W_ ">I3XD14&35[$G$DO/S#] U0W-]4MWPEBK>O:V(,5--PTN/SAJG^R]0
MZ52OBHL9/"^SDF"2N^4]L38OJ]Y43H]4,I0VZGALN:<L%M@,%FL[[^W*[,GU
M.V#';O<P)P9F(@YJQPGESW'V+ELM9WW8#N;];V"A!!.^$30F%Q>U=V;W38Y]
MIMX' 5*ADJ0]\LEB3L!/\ '!6WPF[W(]/R&8SU7X26K8DCDA;]V*!9;J1NF-
MQ5?/RXVA\!(]O-83<SL8_P @GPI7G^I+(=:P]_&0A\^4+!7$I[6,+AS\Y7/#
M[/N%?8L;B<]CJ36VHI'LLUI3(PEA'C\H5JA%6='>,A/U'OZS+CF1,AK/E9-W
M\N> 0 H]D>IV:H;K:P#\&9',@)@9"_O?,3[+(U;J-G)]OEUW/8AM.=\9EA['
MEX6YS.[Y!^P/P&O48;=V.)S[#Y9#'%#_ /(#EC:9N^:RDV:Q>3QK8,E0Y#N"
M?2?PLOI_O=K:V9ID]!E:>A,(R&R%[7$\K!UOJ)D,ME=CQD^)8RQC"X<12EXD
M+%7];K5LUZ#+BGJ[Y)ZTHY8'<B-GW>MI8ZPYZODZ..GU=\=F>L)&Q=_+G./L
MT+<XGJ?DF:Q<OY?%B"Z+OPT%;GCO>M;E.I>UZUE*0S>-H/J6Y>UIJ3F0Q?SY
M:%/=NW<XFQC\;C:@N9.Z?ZB N[6AH]W.*I3=<IN!S^K4=@H58R;OJ135Y"]I
M_3RT+U6/K_-%6.];?D,#E,%6BQL,L5RQV&=S_,96%U#ZDV=0S&)J?AHF@M$]
M\W=[<*,Y+JSL>*SF.&1ULU<9;>6Q/>_YR/HXKT"#R$7F'K'D]MCVO T89(12
MEF#ZT7<>'R,^LJWW6&;*_L'CI<K7ACM-RT!D9 \R-\ ^Q("9[J;MN)?3R3M<
M,6&DE:P/D/$I#O8D*QMKW:OA<51L5HA8L7GM94A+NSO+OJ2H#8ZFY[7<]CZ.
MQ5*)@NO/9/5F+_35\ \HB(B(B(B(B(B(B(B(B(B^7/["3^Z?^B_,S8?^_LI_
MM4G_ %7Z8U;$,]>*:/DM>T.!(X\%<T1$1$1$1$1$1$1$7R:)LD3V'V<T@_R*
MHW$Z_MNC9+(PXBC'?Q=N4RM9SZ;X7+?Z/K&7&7R>R[!&QN2M_)'&WR(8?X5&
ML9K.^87?,]8H-K''9&V9Y)7GV:L_7,5L\'4;-92SB1'2N\@2=_EO!75%A=G_
M *6Y\Y)B0*$D!J%_?Y[/XU%L]IN\ZGMUW,:DSUZMN0OEK*S\91VYN&R>4RC6
MV,E-"6PTF'B*(']U1GH[@=FUV'(T<KC6Q1S2B:-[2KO1>:<];R]/KE+/C:1M
M/9C6^K"T\$QJ4/Q^?W/;Z%B_B9Z&)QI,D8F\/GD*T/P.^:_U&SUNE@69"'(S
M$LM//:(FN*R=)QN\8+:=K-_$B:O>>Z=]AAX#G_:,)TBI9_%9G81D<#;J1Y"8
M31/< 6MXY\%9G4_$9B':M6V/'8R2X*<CA,QBMW'R6\CAV')T65Y9XSZD'=W]
MH(]BJ+Z:Z5!6W+/2LL.EH8NV^.DS]P/>5Z.14?UQ-FQ@L?1J4YYYS=9..QO(
M#8EO-CQ[MWZ>O8R%S;)8V2-KV^6S,45P>]WH=.9B[>*N_C+(!79#Z7AYXX!Y
M7?\ @EO4>D4^+?#+-<G80Z.#R?5D6^Z-62=/J4Y*\\4U4!KQ(WA6RA7GG&Y(
MR]?,C(^O*QC:CZK7<>"6."ZMARDFN]9SDYJ%J:O9QH@B,+.XERWVQ[1KM[,6
MM?VK%=E;X:.>"=S.\-+AY!^SE@=)_B\1A]HGACL28IEGNQP?X<^-O*L'0=^I
M;A3MRP02P2UY&LEC?[CN4[4?VRU\'KN5L<D=E9WD*INBUVO5Z:6C,\L,$TKY
M 1Y <L?HQD*[L'L;GES'&V92UW//8>4Z.YJH:>T1,+O7^*?89&X<$L\J(;+/
MHVSZX<\S_$=@: XQQM(D=.O0FC/SC]7Q;\R2;CH&F7GW]OWE+%0O4*O=P6\8
M':S!WTHQZ%H_5@*[>HN?Q>SXO'8+#SLMSW+D3_D!(9$WGERTG4:WC<+OF@ R
M'T:'?ZOU+&GCA>D()(Y6"1C@YKAR#]PBKKJS8@AT#.B1X!EA$<?ZN*C.,R5*
M/HO7F,P[8\4R)_Z2 >6J Q8R?-]$:+,?S+9H6&2NB \\QA2G6^M5"_BH8+&.
MLNR_B/T(H^0]ZTG5^_+%2U&/(N!NME;+8CC7I/'7:EVG%:K2B1DC06/'L05D
M* ]3LKDL5IN3M4'/;,T ![/S,!]R%YLVJYJMO1*!Q4,]F^Z>&>];>SEX/!Y$
MCU8?4*R,ATHPENJQ[XX;55[_ ![!C2I3M&=H[=TQS\^.$CPVLT^RC-&Q3VOI
M%%A,;(^2[6QT)( \!\8]EOM)ZA85FDUX\G<$-NG7]&>*3GU"6!1_5*4.-Z=[
M7F+3#",D]\D?>.#V?N\J6]%<C5M:-4@8\^I5^29A\%JT6IY;'S=6MJ:RPTF4
M<1_KVE8[;]*3KQ>XG'#\6:X_UOCY5'M<W!F@;/L&$SU=XK3W#+#.QJNK4MEM
M[)8N6X*1AQ;>&UY)!P^8_4\*LNJV.R>"V;%[+A6DSV2:<X'L\O5GX:E'J6EM
M9+$Z5\-?U+( \RR'\Y7GO;,;K=84=LT_*FM;GG;S39X)+UZRQ4EJ2C6?:;Q,
M8FF0<<<.(\K,1:?8K]>AA,C:L.XBC@?R54/0R>&QTZLU&2 R^O,',^H[U$>G
M&WX/4(+^M;$/AYJUQYCD>Q33,$;7H6RQXND:U/@&GPWL]?CGERC?3_JMJT&J
MT\5DP^.U5@$)B+.1+PIWE]APTF&Q538\8(*F2>6!D@\1#]WN4 P5)^I[_B<9
MK62?;Q=YA?9K\]XA9]'+TPDSBV-Q;[@%>6\-M.(R^Q;0S;YO4?#*8J5*0%T?
M'GD!GW6PZ2YS%08;;*?#H")99?3<WCL8I!T/LP-Z<S<R &.U,7J)ZG7=F]!W
MZG0(DFGLO,8^X)*D&A=2M;IZ=5QN2M_#W:5;T70.;\[BP+OZ%9.O=QV><T\/
M??\ 5[/L#RKY4'ZD86SF]-R]*MR9GQ]S!]RU1;IUMF(&BU(;=B*";'5A%9B>
M>'-[!PH]I.(,VH[KE(*SV#*3225XOO&%D])=JPATVAC#: MQQR!\)]P&+NZ+
M7JL]'9#%,UP.1+__ (/*T&FF/*9'JI7J3,>^S;)A\_F'+EINFVSZ3C<2<1LM
M2O5OTWN:3-&#W*=[5E<;;Z8;+9JTF5*LT?%;D=AF_7A3'I?;K6=$U_T96O\
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M$TRN)5UQ_E'CA$1$1$1$1$1$1$1$1$1$7RY_82?W3_T7YF;#_P!_93_:I/\
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M+ Z^V48VC'"9#S(\ =SOYE2-'L#VN:X>".% :'3+3J%VW;AQ4?JV&EKNX @
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M=/8=2EN[#+?OOL\OY=_5L'U[!R> O5K'-<PN:X$'V(\\KSKO;Y1U?TCU7$1
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M-@)]@%4W2_0-3S>H4+DT<CI'@ML,:_ACS]GA>A:.)HXZA%2K0,B@C9V,B:.
M&J VND^H6)Y)/0GB:]_<^"*0LA>?U:IGDM<Q-_#?A,]8?"D >BWPT-;[!:_7
M=/P>N"<8NL8&R\%[0?!X6EL=+]-GV&;-RXX26)'$N:[S&2?KVK:X31];P=^]
M=H4(XIK+B7N^P/T;]@L6ET]U:EGI\U#0:+DCR[O/LUQ^K5WT]&UZGFWYF*J1
M=>7%TQ/)/<FP:'K>>NPW+M3FQ$.&3-/:]9^!U3#X*O(RE"09/SRO/=+)^KG+
M68[0-:QN8?EJU+LN.+BZ7GR>]<F:%K3,^<VRGQ>]8R>MSYY*F*AVPZ#K>=N"
MW9K.;9 X^(B=V2\?S"VV#U?#8+&OJ4:PBC>#W<?F>?NXK08GIQJN(R3,A2H^
ME8;^^"ITH5LO3W5]DOUKF2I^I-![.!X[A]G)_1[JGXQ5R@QL8L5XPR(< ,:
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M47-J6S4;)*X>3RT\KTGB,50QU5L-2O'$P <AHXY4#ZN;!<P6H334Y',FGG9
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M(724KC?AG%OF+\WLI3K%6OOF;SV0SE=EBO2M&O1KO\L8//)+5KL7--I74Z/
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MHWW&S:_OF%S4MN=N)LVP;([R0V0J?;4QFP[5KV*K6W>BQK[EDQNXYC:1P/\
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M2_1BS>F64O36-DU++69+/P$IBBF/N8U$.GVF8ZWO.Y->'>A2N&-@[_/N5ZD
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MS5-)*--O04-;&Q@=B8Y#]B\A2OH\]SM"PO)]HE+MLDEBU[*OB<YKQ5?P1[J
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M2Z98BEL5K.Q7[_QDQ<7.,A_>/)5D!:3:=9H;'AI\;?!,4I!\>[2/8A0L=)L
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MVO&3[!/B(9 ^:&(/D/(X'/L%)$1$1$1$1$1$1$1$1$1$113>C(-3S1B:'/\
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MY&AQ43T?/W<9T8V-\ <'0S.;$\#^-;;!:-L69Z=XZC7R=$4K59DIC-8=P?\
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M<A?U>TRY.^4P6^UA?Y< 5=RJOK/R=$O\>_KQ*N=CT[)5]&9LC\_<=?J5XIF
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M.,H8^(Q4ZT<+/X6-#0NVYC:%F2)\U>.1T7Y'.:"05I]CUBAG65(K9!9#8;,
M&\GEOZK?3U8)X)(IF->Q_AS7#D%:IFMX6)[9&8ZLU[3R"(QR"M)MFL6<Y=PS
M'6 RI5M"Q*SZO<WP IB$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$53];?\WV3_UL:\"'W*_5-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$15/UM_S?9/\
MUL:\"'W*_5-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$15/UM_S?9/_6QKP(?<K]4T1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1%4_6W_-]D_P#6QKP(?<K]4T1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%4_6W_-
M]D_];&O A]ROU31$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$53];?\WV3_ -;&O A]ROU31$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$5/\ 7.61F@7. WA]B,%>##[E?JFB(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(J<Z[/8- M!S'GFU%PO!Y]U^J:(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(BIOKNVT[0;/HN
M  M1&7]6\%>$#[K]4T1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1%2O7NX^OH<K6@'UKD3"O"Q7
MZIHB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B*C/\((M&BMY;[WXEX?7ZIHB(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B*B?\ "$_R&C_WA$O$2_5-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$143_A"?Y#1_[PB7B)
M?JFB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(B(B(B(B(B(B(B(J)_PA/\AH_P#>$2\1+]4T1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$
M1$1%1/\ A"?Y#1_[PB7B)?JFB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(J)_PA/\ (:/_ 'A$
MO$2_5-$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1
M$1$1$1$1$1$1$1$1$1$1$1$1$14#_A#F;]CJP!9V?',Y7BE?JF;U<#^T9_Q"
M"Y7 \2-_XA/C*_\ XC?^(3XRO_XC?^(3XRO_ .(W_B$^,K_^(W_B$^,K_P#B
M-_XA/BX>> ]O_$(+4)]GM/\ \A/C*_TD;_Q"?&5__$;_ ,0N(LP\$A[?U/(7
M+UX^ 0X>?;ROHD8[V(*=P3N"=P3N"=P3N"=P3N"=P3N"=P3N"=P3D)R$[@B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B\
MY?X1=>4X#'3C\C+7!7CA;IVQ9QS2UV2LD'W!D*^C8\[_ .IVO^84_:3/?^IV
MO^84_:3/?^IVO^84_:3/?^IVO^84_:3/?^IVO^84_:3/?^IVO^85V_M5L7>'
M_BUON X!]0KE#MFRP=WI9BVSN'!XE*Z/VCSO_J=K_F%/VDSW_J=K_F%=K-JV
M-D<D;<M;#7_G'J'RL@;IM;60L&;NAL1YC'JNX:LB'?\ =(&=D6PWV#["9R[O
MZ1MZ_P#<F1_YSD_I&WK_ -R9'_G.3^D;>O\ W)D?^<Y/Z1MZ_P#<F1_YSD_I
M&WK_ -R9'_G.3^D;>O\ W)D?^<Y9=;JGOD#'M&?MNY^KWERX0=3]\AG$PV&X
M[]'2$M69'U;WYCN1G)_<E)>K>_2S1RG.V.6 C@$@+O9UBZ@,8&C-S+E_3+U!
M_P#6Y4_IEZ@_^MRK)BZW=0HS&?Q3N[#]6KF>N/4(SOE_$AY/Y SPL>+K3U"C
MD#_QA[OT<MJWK[U":T#XJM_RD_I_ZA_^9K?\I/Z?^H?_ )FM_P I/Z?^H?\
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M==[/\(O F(E^-LA_>%N/_LA-&_@R'_*"?_9":-_!D/\ E-3_ .R$T;^#(?\
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M_I3Z>_\ N2JG]*?3W_W)53^E/I[_ .Y*J[(^IFBR.8UNP527_D77_2GT^_\
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M_P!0_P#S-;_E)_3_ -0__,UO^4G]/_4/_P S6_Y2?T_]0_\ S-;_ )2?T_\
M4/\ \S6_Y2?T_P#4/_S-;_E+KBZ]=0HV!OQD#OU=$NS^G_J'_P"9K?\ *3^G
M_J'_ .9K?\I/Z?\ J'_YFM_RD_I_ZA_^9K?\I/Z?^H?_ )FM_P I/Z?^H?\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex3-6_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-6_010.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*?_
MP  +" B8!J0! 2$ _\0 :P !  (" P$!              8'! 4" P@) 1
M 00" 0(#! 4'" D$ 0$)  $" P0%!A$'$A,A,10B05$5,E)A<0@6(T)R=+$7
M,S8W57.2DR0T-51B=8&1LAA#4U8ETH*APCA$5V3!T?_:  @! 0  /P#RH7M^
M3W_3F7_E\O\ %I[>
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M[%55<SZJ^&GD9":UA/[-K?Y:#\VL)_9M;_+0^8)>WY/?].9?^7R_Q:>W@
M
M                                         #Y5E[?D]_TYE_Y?+_%I
M[>
M                                               /E67_ /D\0L7<
M+4OO\MHO/:H
M       !^-=*DKD5$[>/(_0
M         #Y5GHS\G5R_G#DF^-ZU?J'L@
M
M                  ^59Z$_)WI*_:[MON\HJ;F'M
M
M                           ^59Z5_)S_ -KY;^X0]?@
M
M                               'RK/2OY.?^U\M_<(>OP
M
M                    QBM5WO*O*\^?P              !\JSTK^3G_M?+
M?W"'K\
M                                                   ^59Z5_)S_
M -KY;^X0]?@
M                                                       'RK/3
M7Y.*0_2&957N\3PF<(>N@
M
M     #Y5GIW\G"*=;N:D2/F)&,17GK<
M
M                ^59ZP_)K:[V;8E[_ "\2 ]2
M
M                        'RK/4GY-\-M9<[*V3B!$B1[3U@
M
M                                   ?*L]6?DV>/X6P^GA]\!ZH
M
M                                         /E6>K?R;&+X6PN[/UX#
MU.
M                                               ?*L]:?DU_ZEL?
M][ >H
M                                                  #Y5GK3\FO_
M %+8_P"]@/4
M                                                        !\JS
MU[^3?5D9B<[.O';)/"B'I<
M
M       ^59ZW_)KD?[!L3.]>$F@/3H
M
M              !\JSUI^37_ *EL?][ >H
M
M                   #Y5GK7\FO_4MC_OH#T^
M
M                       ?*L]B_DX.D^@LTGN<>TQ'H\
M
M                               ^59ZX_)L_V=L/N?\ O0'IP
M                           _))HX^WN<B<KPGXGZ
M                                                      ?*P]H?
MD[?T6R/[XT]!@                                 'Y)$QZ(CFHO"\I
MR?H
M            !\K#VA^3M_1;(_OC3T&
M
M                ?*P]H?D[?T6R/[XT]!@
M
M                   'RL/:'Y.W]%LC^^-/08
M
M                      !\K#VA^3M_1;(_OC3T&            "+;ILZ:
MS@I\HM22=L3D16L_BI%,OU,3&:;AL_+CGO\ ;61<1M7W6+(67C;WMM"M81O:
MDL;7\?M&2                 '2,8G+E1$#7(Y.47E .0   .0  !R@
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M!B7[S*M*>UVN>V.)7]K/-5X(]H>UR;+@FY*2@^JYTCFI&XE@
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MOS0JVKHN^18_Z#=M;4QJ)V)(D/,_82O-Z$RWI+=;Q]M:4'#6*Y&<][4-II&
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M+3ZF6HY"*JO-5B)''\.4^+C-S/2_6\QFUS%F:^ESOY8]DRM[/V#=;'IV-V/
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M>]J2-[5<QW:Y$7Y*A!=4Z=8#5+=JSCGVNZ?R?XDG)/0
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M6GP+)"YT,KV>:<$<Z-9K)972&V\E<DGF6Y*BOD<6N.4'(Y0
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MIU1R&4P.;NY5C,=)73QJW<O/87Z               ?*L]V= OZO8?WR4N@
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M)/EXUKVK5MKHJRI[S6?!I;&CY.EDM9Q=FN[O9X#&_@Y$\T4E
M   !\K#WMT/B6+0*'+6)W2/=[I;H           '* <H  #2[+D+^/P>0MT*
MWM%B*)710_;4QM0RN4RFOT+>1J>S6)8T=)$2,  &'E,E5Q=&Q<LO[886*Y[O
MDAQP>:H9C%U<C3?WQ3L1\?/R4S@    :#/[5A, E9<E:2%)Y$CC^]3?HO(
M-7E\[B</"DV0N1UXU7CN>;.O/#9ACFA>CF/:CFN3XHI^@ Z[%F"K"^6:1K&-
M3ESG+PB"CD*EVLRQ6F9*Q_U'-]#L !PFNUXO)\K&)_Q.1#FV>-Z(K'(J+Z*B
M@   X7<?4NUG5[,+)8W_ %F/3E%/V""&M"R*)C6,:G#6M3A$0Y *J(G*ACVO
M3EKD5        !R!R            !P@ ' X0 =J?(<  #@J#J+I6T9++XG-
MX"^R.Y21S6QR\HSAQ@XVMU;S,3:N7EI4:SN6SRQ><SD_X$+@Q>,JXS'U:-9J
MM@KQ-CC1?7M:9H'"!411P!VISR. K47U .$M6*=O;(QKFHO/#DY3E#F$:B!&
M(B\H@"M:[U0>&WR.MU6!9VS+&WQ&HJ-=Q[R(IS<QOF[A"B-MR752QLU_$XFB
MSZ.D8C&3JG"-1WQ[BXM=Q$6'PU&@Q$1M>%K/+X\(;8&J=KF&?:]K=CZZS\\^
M(K$[C:*B*G!CPXZG5:]L,$;.]W<Y&MXY7YJ9'A,X5.U/,ZXZL$/=X<;6JYRN
M=PG'FIBOP^-6W[4M2%9^>?$5J=W/XG?=Q5"]V-L5HY49Z=[4<=E.A4I0^'!"
MR./GGM8G"<G8               ?*L]V= _ZO8?WR4N@           C6X;%
M'KFOW<DYG>L2(C&?:>[T0KQT/41^O)GZ^=_TQ\*3)CUCY@1J^?89F+ZI06.G
MC]AFCXEB_1R0_.8T$E[JG%A:>R,MLF656+)BD9Y,B>2O=MVR.+@PM#'5T^EL
MF]&P1R>C/FJFMGRO4;";3AJUQ[,EC[7NRR10HQT;S/S^Q[)+NU?7,2]E1J5E
MGGN2L[T[?DPZ]$V_.W,_G\+F)(9I:+N8YXDX1[31Q[CNN?RN<9@I:$,6.G=%
M[--YR3\$AGV_9*G3J3/3XZ-MV)G=+ ]W9P=V!WR5_3V+8\KQSX/<]&_%2.S;
M7U&7!+L$.)I^RJU)6U.]5E6)?^A(OY1HK/3NSL]"LCUBBY? YW'#R!5NJVY9
M+6V9/&ZOWLCCYL3O?PSEOP86_HVV-VC7*F49$V)9?*1B+SVN3U0E0*<ZG/L;
M!/2T^C(K9;?,]J1/U(8R/=#<M9I,R^JW_<LT)^6-+:W;;(M7PDF3DK23,9(U
MG:S[RMK/6RE'3@NPX>Y+66-JRS(GN,<I/<SN<5+4H=BJ5);5=\;)5:WR<V-Z
M<\C2=T9M&"GRL51T,;7N:SN7U[3*TW:TV3'V;;*KHF,L+$UW/*/[?56G5N.Y
M5=4K17+E.S)6=RUTD+4<C'?#DQ;?4/'U-4I;!+4MK3G8U_N,1SVH].>7&XP^
MV4LGKGTU7AG2!\:R-1R(CU:AI&]2==35H]@F6Q#5ED1D37L1)'_@ATXWJ9@K
M>7J8N>M>IV++4= EF)&=YU;Y<TAEG$UL] DT[YT]F;V(JHIN-CWG7]9GAAR<
MTL2R)[BHSEIM[>R8RE@OIF5TC:J1MD<_M3E&N.4FSXBOA8LI-92*M)&CT>].
M%X<1[!]1]4S=]*-2Z[QU;RC'M[%<9-[?M6HY1V-GR3&V6,<Y[?@Q&_,VNM;5
MA-AIRV\99\=C).Q5XXX4K[K72IS:98GD@8Z2&>+PGKZM-MBM[U'&4L=1N9FO
M%:2M$GA.4E>5VK X>K!:OY&*"&7ZDB^BF5B<[B,KCEOT+C)H//\ 2M]/(8//
MX7,P26,==988Q_8YS?@[Y$<WK=L=J6)?;L\ND=Y0Q)ZN<06[LV*VSI5D;-J1
MD\C*+'VXXD\XY5'3;9L#@] P2Y/(PUN]G#.\NJK<JV*K+,,S)(W)RQS5\E3Y
MFE=M6 ;96NN3KI*CNWM[OB;Y%14Y0@/4G</S6UN>W"K5M/<D=9B_%[B&:QT\
M9L.)KY7:Y[-RY:1)5A>_B*-'>B(TR;.J9;7=JUZ;$V[;L3)/X<]-SU6.+GT>
MA;5[)T,?"LENS'"Q/B]W!SQV6QV1C66K9CF8B^K%Y0/R5%EA8'68TE1CG=G<
MG*(WU4Z4SF*6OX_ML'A\\=W<G!RES&-BM15I+D+97\]L:N3N7@SWR,8U7.<B
M(GJJFOK9C&V7O9!<A>YC^UR-<G**9LUJ"+COD8SGT[EX.+;59TJQ),SN3U:B
MIW&*[+XYL_@.N0I)]A7IR:_:-HQ^OXF:]9E:UK4]QG/F]WR0ZH;+<]KB/61L
M+[%5._L?SX:O3YF#H6#L8'7V49LDMUR3/<LQ*Y+U5C^QT\;5^RKD13O[F]O/
M/D<5N5VQ]R2L1OVN4.37-<B*B\H#\6Q$UW:KVHORY/WD+*Q..53UX <]K?5>
M BHITWFR^RS>')V/[%[5XYX7@J?I#E<S?QV;7*7Y;4T>05G<]2WN0LC&KPKD
M/QZJK'(U>%X]2C>GV?V&YO>VT+V1DL159E8SX-3M4O-[N&JB+P4WJ>8V&;J)
MLU"_D7S15DXB8GNM1"Y.4'([D Y0<H.4'(Y'(5R(G)T8W*4+S;#Z\R2)%,Z)
MRIZ(]GDJ"Z^9E:9T*-5Z,56(Y>$Y*WZ8[3G=@KYJ7*I U\%I(8FQ?#UY+/ ,
M+*RW(J%E]2-'S-C58VKZ*XBG3[.[)E\-)8S6-]CG\7M1OS:3@  !5*[AV_,N
MW^?7W89R560>*EI5)][76;997=*U)7L5R,^*M:0;;]RNX'+8*E7Q;K*7Y58Y
M_/"1\$_                 X                     /E8>]NA[%9H&/_
M $2,YD>I;H          !6'5_"7\OI=J.GRLD$S)_#3U>C#&UW>M>FT6*U-<
MB8Z&BC9XE7S8]&\=I4M34;MGHS<EC@[9I;K;[(4^PSDF^I=8M=_->JRT]T=^
M&-L*UD3ESW$>ZHW,SCKVB[-:JJQU7E;+&^\V-[RRF=5-?R3*46$F=;N696M;
M B>\Q/F\ANQ[(N5ZCV<!E<F['8ZO%SPQ>Q;'W.<:GIU=UBCU%V.#&SL;7D;Q
M63[?!F;+JV&S+,AM6JY1U')QO>Z7A_8CG-]>393['?V+H=E,C?3BPZLK'.^W
MP:*>FM[H1CTQSW_H&Q2SL^?8GOEN:WG<1?TBK;99:L*4D1_*\*WAOFBE-Z]C
M8*W1;:K*>)'!:?(^%')^H2O2V]_1QJ<I_J3S)Z$SQ0=.&R2/1K&6I5<71C\C
M3N56V*L[)6.^JYJ\H=>0NP4JD]F:1&1Q,5SG+Z(B%(:GA]DSMO([=!F&U'Y!
MRM@C? DJ> WZA"=BJYK1^HF(V*]?2PR^Y66Y&1I&A:O6)\,_3ZZ]KT=&^6+A
MQ@Y^K4K=%+,-7^9;BH^PWO3I(LGTYPL$T7N.H,B<B_'AI3..RU[2+&R:3^EY
MLO\ _P 8YOR>IZ8UG U<%AJ6-K_S=:)K.?FJ?%3$W#!19W7<CCY6(J31+V\_
M!R'GK4,U+D-(_,N29&Y)UEU16_%D*&)JN;O4<#G='EY=>9>;5K)\>QW/>65U
M$J:KB,'@:,N/?8D@GC9CZS%X[E9\'$#VA=AFZB:+)L"5H6R32+'!"[GPOQ<2
M3KE$DJZVSYWR<]4M<3.Z==A8WF>#B:!?O85M@=B3<=>U77D7E\G"Y#CU2.N.
MJ<UB;?-+QC)TJ0(YRLD5.YG)),[TTL7LECLOD=F9$^B_ECXJK8OX.(IM6$Q&
M3ZV4:L\#7Q25$?,S[?[1?FNZSA]?J25\;5;!$^19'(GS4@_6=J.T.^GSFB(I
M<Z7ZF[0)7LH(MI:J3I97SF[_ ,3MT3&-VSI#%0OQ^C'QQ*[S^IZ.0T&B[7/B
M- S6+G;V9#'2^SQQ?%RR%W:-KC->URC0_78Q'3N^U*[ZRD2ZV11RZ)?[_A-$
M=3*E+$=)7^#V=B8IBND]$>O'JI!-2T37LQTO98MUFOM/JJK)W^;HN/@PP-=S
M>0I]"IYX9>)6V'0,?\FG"UTYVK,:Y3KT\9@V,<UDL=E'*V;\5X8>A]1IY>CK
MN-JY29LMN*!K)7M=W(Y40HO\H1MI%UR;_P#I63KXB'HO%V*]BC6GA3B)\37,
M3[E,QZHGQ\SS[AZU#<>HFTMS445B''/6O6J2^^SCGS?P8F4IU]'ZGZ]]%(VK
M0RJ*R>LSW8^6&LR^KQ93K7D\<RS+!!8H+-:['<.>UWJTUO4?IKB=6U>A)2LS
MK)]*L:U7_!LAMNH72NI0UNSL$%^>3)U7)/-8D=YRG9D=NOY_6]%Q,DSVRYER
M):DYX[VQI[QONH^@X/#:U+FL%3CH7,;P]LD/#%<TC74Y\F;Z>ZKGYI'MNS25
MO1WN<RM)KC.F$^(N7,Y'FIILE-0>Q[Y?)JRO]7\E,YZGKU/1)875_;,_'/XM
MJ_$WQ.QWQ1TBD_W.G5RW1["9.["V6VRO65LR_63O:3NCJV&I:':CJ1^RI9H,
M?*Z+RY<QOJ0?ISG)L1T8R641_,L,L[FFTUGIUB=AU*GE,I)-8R5Z!L_M;G>_
M$YZ<\,.K5<OG,AJFXX.]:E?;Q2K VSSP]Q#- TV_MNC26;^>M-AC?,D%=GV_
MM/+0Z(YG)7M6F@OR/?-3LK"CWKRO!8.W9KZ#UW)Y+_=X5<GXE3:[IUK8=6BS
MF1S%U<G=@2>*5DJHV'E.41K3KU#;,_E](VJG<MS?2F-YC]I9ZD,TC [SN6N4
M,@NT3QQPWO)BO55?\W./6/"HWUY4I#8X[UC9<P_/9>S0PD$2>R>%,L:22?/R
M.'138\EE*^P5;5Z6W'4M,2"61RN=V.Y+OM\-KR_<QRK_ -CRWH&&V/.Q9YM+
M.OH44R#W]]?RE>\G'3;9LI!C-MJ9B]-:EP]GM663U=ZG1K&+RF]X1^=R.7NU
M9IY'K3BKRJQD##9]--DS4E[-:WFIGSV\;+VML+ZRL^;C4]-H&)NW4>VYZIX>
M15./^KC:8.;);S?RU_Z5N5<3!,L%-E:18W2.3U>_@C73NI?QO4/;H+]U]F2%
MGG._S>]J'2FZ?G)>S4TF3RE:M7E=%2CH^7/_ !O5%0V.I[+NMK2MA^D'2P6J
M3$6O:D9[\C2-ZFWJMLVMXN_5S:,:RVJJDDCD=*P]1)W=O*^IYVFV#?[O4W,X
M7'9"+PHHGHSQ$X9$SGUX^+C BVCJ3B=WGU62[!?GGC189Y?)(D^V;BEL&WX'
MJ1C\)E\REVM>BY8Y6]O#S>7<[L-3JQ1QOTD]U"S LJ0?!JG;L^R[#B.HNL48
M+O-'*<LDA5/3L,3<-ES#][@UJ#-)B(%J+*EI6<K))\&(=K4W>77-FJ9/,)%)
M55JUK\3.5EBX<:;H-6R[M89;=E.:K[,O-98_/O\ GWE^6V]M=Z?'M7^!Y6TB
M_OCF;+2UJC53C(ND=;G>O">ON(W@L'IWU$R^0N9?#;)$V#)4F*]>$X1S6$>E
MZE[!E<?D\KB\K0I0PN<VM4D9WOG1GQ<I:733=5VO74O35_!LL?V2L)3G+EJG
MBKL]6!)98H7.9&J\=RH5=JV]9[*].,AGW0P.MLDE[8_JL[6$7Q&^]1-HUI+F
M$H5620]RV9YO)G[,:%D],=OM;7J\=ZTUC)TF='(UA(MHLYBMA;D^*BCDM1L[
MF,?Z.X('I&Z9[9M-RE]K*S+\;W-CA^"*W[9V],-VRVST,O+D&00R5IFQ^&PU
M;-\V2/7]GS?LE:>"A:=%!P[L21C.45_)IM>ZE[OF%P5B/6U6C/+V3SM)=0WK
M)7.I.3UI:<<<-:O*]LG/+G\+PA6E'+;K+U@N1/@ISV:]*1D<2RJR-L*N:61N
M._9#7<[@,:N-BD2^[SE\3TX.KJ'U&R.IY7&U4Q:25K+_ #L<FFN=5,UC<_C4
MRF"=3Q5QRLBD>OZ7[G.0GVZ;K6UJM51(73V[<G96@3R[U(/E>HFVZS=I5,W@
M(95M\I"^K*KO>^PO+4+HH6;,]*N^>!89',17Q\\JU5^!D
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MTUZ"M0I4'K+(B2I(^23Y-+CN93'T71-LVHHEE=PQ'KQW*9X
M                      /E8GJ?0/HW_0'#?L%H
M  CFUZKBMIQ;L=D&/6'O:]%:O#D<TR==US$Z]CHJ&.KMBA9_W<OS<;H
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M=#@V;$:S-L;7KD*4+%E5J^K_ %<A:")P
M       #Y6)ZGT#Z-_T!PW[!:
M   '                              -7G=>PN;:D>2H06FM]$D8CN#2X
M+0]4P4R3X_$5X9DY1)D8G?PI+@
M #Y6)ZGT#Z-_T!PW[!:
M
M    !\K$/H1TA6'\P<'V<_S*<EE@
M
M            'RL3U/H+T>5JZ%A>&\?HBS@                 %<U%1%4!
M)8^Y6]R<I\.0BHJ<H .4
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M:Y.?<-Q3R%FG@*]G-/BAF97:ZTK?J(_XFTQV3J7J%>W5?WPSQH]C_FUQWCD
MIG?^I6:U#+4ZJ8:"S#;\H'^,K5_ZIVEE.R]FC@'WLJR.%T4*R3,C=WM;]R*J
M(5'!O>\VL;2V&OBH)<;/.C/98UYF1B^CB]:\OB1,D5CF\M1>UWDJ?<IS
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MY0<H               #Y6'T9Z93,ET37%3GRHQ-_P"S2=
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M_4S0Y\W!4@>^>7PHH'=_8WY.=PA*<^UB]9]=Y^%-_!K=]?:M=3=9I-RKJ2>
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M:1@=APN1GJI9EB1T#%X[EE)#J6*ZC_G#'E<OE&I2GJ\OI\JOA/7T:B%P
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M2-9QPAW!DL<BN[7(O'KPH '([D   1S5541?0<CN0     #E
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MY@8WS8QOQ>6)IVUTMIP<.3IHYK'JK7,=ZM<A)R(;'N5#"V*])(9[5Z=%6&K
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MPMK*V<;%<8^W7Y\:%/5G'S-N               ?*Q#Z/=./Z#:U_P OA_\
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M3^C3OZTY3'Y+1<?/4M1RQ29.#M>A@=44DJXW2LG'-XE*I*Q)%C3W//T<6+U
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M!O>;UV=_9C;#'6*KG?=Z%H].ZWM=>]L4T"LGR\WC(B^K8?5B%D
M     'RL0^CW3C^@VM?\OA_\2:@                      Q6XK'ID);[:
MT;;#VHUTW:G>K4^')E  #A  !P.$' X  X X #XF/:K7)RB_!0B(B<(./O4
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MR-C4:UJ>B(AR               /E8GJA](NGB,32-;1CN6_1\/_ (DQ
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MSF     .Y.>  .4         !@6,3CYLC!>?78Z>!CF12*G+FH_CGC\>#/
M     !J-FP3LUKV1QR6%@=8B[$D1.5:0O0.G<6K1K/8NR6[SXT8LS_1C/L-+
M+               !\KF-[GM3YJ?2;1:SJVGX"!WJRA"B_\ 8E8
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M=@               !\L:_\ /Q?MI_$^F^K)_P#@L;^ZQ_P-N
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M-?:I7N=WO7GM[OLD[#D[FJG*IRA ,+T[Q>&V6UG*]VZ^Q.Q4D21_/*N)^
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M[GD;N])]'MY/V]^)8DGB*]6IY,<OWH6+7KQ01,CB8C(V)PUJ)PB)\D.0
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MKG'1FM V':9D9[[\FJ.7\.XP.GTM6GL74^69R-KQWU[V?=[YH\5-;R>F9V;
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M^RES@              'RQK_ ,_%^VG\3Z;ZLG."QO[K'_ VX
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M$ Q>_P"Y8W7YL!:UVS+D:\*PLE^"M)[T.J9.CISJ=^A+7>RTY[>_]='ER
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MSD:BJIIWY:*SB[EO'21SK$CT3SX:KV>J<D(Z4[KE-JP]ZW>CCC?'9[$:PL\
M   B^[;#/KNN7\I!4\=T#>>SG@UFJ[7>S.EPYA:G,[X%?X+/BY#CTYVO*;+A
M)+=^@M25LZL[">@%7[=U$EUW9<-B5QCI&77\>.KN$+0Y*XZ@[^NHLQ_&/?8=
M:E[$7GM8TL=KNY$4  !SVL15<J(@  .K(Y"KCJ<]J>5(X86*Z1Z^B(4XO62@
MRS3DEQ%]F.M/[8+BL3AY<[I$:Q7?)"'ZENM78Y\S#!!+$M&PD3E>GKSR3$#E
M.>    $5%               !\L:_P#/Q?MI_$^F^K)S@L;^ZQ_P-N
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MSGH]'>CAU0MYV77<1M.$S-N"KQ'X\,4BM:YDGGR2#<,V^]JF CP^1LLM9&Q
MVN^*14D5BM57*JFMWK9K^)O8/5ZD]]R/A5UFU#[]E6,^R1K![!MM';Z$-7Z:
MMXNRY&3I>9R]BI\6>\XS-WRV\4NI53'XK(RSLM0.6*!7*R./DUNRUNJFLZA?
MGL[(LO%UB,5G*R*QW/ZXSB=3J^K5]IFSKHE@;&Y:<*KV+%\WEC[1LF=GZ5MS
MV+G;6F=5CG?^#D(]#L.Q/Z,-R\63>RY%61[YG<O<\B&.O=5,GH\.8CRZ015H
M.]GO*Z6QQ\7EK:IN]BYTX3/6W)++% Y9NSXO80NK:W'-Z;+M;-BF@LHUTL-1
MGE UJ?JN)_TTR^QYO!U<MDLDR5+#/*%L*,["8YYMQV(OI4L+!/X+ECE3U:J%
M==,LYF]CZ?2VKN0D]K=-*Q)T]6]I@Z!M.?FU39;>2M.N6*$[FLY^/:1S&YC>
M<GKL.?QFS-LSRJU9<:D7E$UWJC?,DNS[!L.*ZC:G3@R#O8<CRV2#]@=4-EV;
M7,EA9<3=:D5J7P9(GL[C5]0]SW'7]SPE.BQLM6TSW($]97H([O6.+%YVU;]E
MAFK</@8D??W_ #:A*.F.X938=/GR>4LQK89-(CT1O;V(TVW3O,[!FL5/DLE.
MQT4\RK3:UG;Q"3T@_4:7,PZEDI<5/X4[&<N=ZN[/BC2!]'J67CTN&>3)-=6F
MBF>D'A>:.=\5>5[TZRNXQX_.8W7J<3Y_;'2/N3^[&WCDM[IQO]S,X3,/S'A1
M6L=(C;#FD(N=2=IO4;.6Q=_&P5F/<L523ETLT;2VNG^YQ[9K\-]L?A2HO9-'
M]AY(L_E6XG#WKZQJ]M>%7JU/52B)]\W^IK=/:;$-%E&9[.*7Z_8_T?R3'?-Y
MR^(U*GF\33CECG1BOD<[^:1Y [W5#?XJ$&;@U[G$HQO?(_R<_P";R3[9U8N5
M-/Q.PXRBR6&VY&O5[N/"<I&LQU3WBK1IYV+ L3$2(WESOKJ6-L.;JY_IEDLG
M3C21D]'O;&\TO3N[<H=*:ENG52Q/#65[(>>.\W73S?+.>U2WFLE#%5CBF?Z+
M^JTBEKJ'N5VC;SV&PT#\-7=ZROXFF9\VMX);>ZE4:NCP;)[+-^G[6Q0+\7N(
MO#U&VO&Y+#MSV$@CJ91R>#)#*KW1<_!W+6D9ZYW&4=ITVRYKGI$LSN&FR_EE
MSE#,TTS6M24,=97B.57<N-OUQ6&;5,7.SAW.5K]KRPMKVF#6\6R=8EFL3/2.
MM B\+(]2 ,ZK9'&YRACMBPT5-EO^:FAG\9O\&EVE3;_U/;I^5QE-^-?*RSRK
MI>>$1J?(Q\-U7CN09^U>Q,]2MCT[VO=ZO8OH:1.L.7@95OW]7DAQ-A[4BM))
MROO_ %3AUIVS.X^CCJN.@3V6ZYO=/SZ_)A8E;;KN,UJ7)[#090D:_L9#&_Q5
M?\D3E&D+DZL9/&9"JS.ZZZC4LOXBG27O5/VT+OBECE8U\;D<UR<HJ?%"+;=M
ME+6Z#)I6/EFED2."!GUY'J0N#J3D,?D8*^SX1<7#9\H)^_O9S\GF!ULRF6AU
M&U#4IH^K81&S3H_ZIL.GL-G):IA\?EL"U*T%2%T3Y?>1[FM]>"UK<Z5Z\LJQ
MO?V-5W:Q.7+Q\BNM&W7$YY^QSX[$R5W02M\;EG$DB^9'*G6S&6$OPIB[BVX9
M>QE5K>7N)-J?42ML]#)NJ5)&7*GD^K)Y*0/0-[VK,;+GO:\-*K4L11/8QW+:
MO')/LSU 97S$^)Q>-GR%N!BOG2/R9&AV:_U)PV:Q-^W"R=LU)O-FKPGBM(-'
MU[P4M%9HZ-ESUG1GA(GHSYJ3S*[Y!!/3I8VE/>OSP^-[,SR6./YO&H[_ (_8
M9[U)\3ZE^J]4FJR?61&FGN]3TCL7I*>#O6\?4>K)[D2(K6JTT_4/J)>J:3C<
MEB:<_&2C9Q/\(4>3O0,SD<C@H77,=8JO9'&UJR^LJ<?60F@
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MKO@P[NF6RU:&L[G:LP/Y@N++-!\>URJ1G:<#AL*M';-+RS(5DF:WV9B^J/\
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M KG<>FM#:<G3NV<E:C=53B)L?HTDV:UFKFM<FQ-Z9\C)8T:LCO-ZN3]<K/\
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M6KPBJAF=--NN;5K"9.Q"R)[[#V=C/DTG8 !U^U5_:$@65J2*U7(SGSX0[
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MJT,$$+8H8F(V.-J<-:B>B(=@  \1G*MY3D#N;W(WGS
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M%7QJ].4(MTBV3+Y_3F7\E8\6=]F1JN+*D:YS51KNU?F$]#]
M /EQCO\ :%3^^9_$^HL7U&_@<@          "H>JVDY+/0X_)XE__P"0QSU=
M"SX.12O-GRO4_:-4FI3:GX"LFB\63OY=*J?)A-=QU?8,QTOQ];V;C)5'02K
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MVU7.9V/,7Z:RV6-:WA5]QR-^:&9LNA:WL+:Z7:OOP>44L2]CV?<U3EK^CX'
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M6ETJ7"W:%MN7;6]G\!L?DY29]!5>S1&POAD8YMIZ^:>J.+I
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M' '"#A!P@X0<(!P.$'"#A  !P.   C40< #@<#@*U%'"!&HGH. $:C?0*U%
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ML>&R5CP*N0AE?VJ[M8O*\&5%E<?)D'T4M1^T,;W.BY]Y$,P
M
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M"I:H
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M.67/8YM1T=KMA^]I8(
M                                 !\N,;_M"I_?,_B?4:'ZC?P/T
M              KS9.G5/-[%3S3\I:AGJ\> D?HPL,K78.G+,QM=+.OS%B-U
M3^9C8WR:64     . .$                                        \
M5B2(SE.>.>                                        ?+C&_[0J?W
MS/XGU&A^HW\#]
M                  '"<\@
M  ^7&-_VA4_OF?Q/J-#]1OX'Z
M
M          ?+C&_[0J?WS/XGU&A^HW\#]
M
M                  /EYB'1MRE)9&=S4G9RWGCGS/J%%]5/P/T
M
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MZWU!P6?RM^A0\9TM7Z[GLX:=N%WK#Y78<GA8&3^TT7N;-WLX;[J\>2DO
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M5C70I^L]7^C4(+/U4EQ-W'QYS VJ45IW#)'<.+@:]KV\M7E%//757(U,9O\
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MY:-L4F?U?%Y&1O$DT+5E_;)2               ?-+3OZ3X?]Z8?2U/C^(
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MB/@C1)T^P\M8               ^:6G?TGP_[TP^EJ?'\0
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M>[P7$IUS0,7A;\N1?/8NWGIPMJR[O>B$Z        X10!P@X0<(  .$'"#A
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M*1/%:)JF);82GAZT?C,5DG#$Y<WY$@Q.%QF(K)!1IQ5H4](XVHUIF@
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MZL[V>G+3+                !\U-+=V[3AG<(O%IA]*T^/X@
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MW])\/^],/I:GQ_$           %>;/TYH;!GJ>4LY&TBU>/!B;]1I88
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M[)&DP           "L:H1
M     #C/"DD,K%<J=[%;RGWH5!I_2'':[E_I*7(S796*Y8$>WA(N\N$ <(
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M+MC*04&PV;;469ZM1'K^)O0
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MZ^YCQ./]FOXX^7<A?ZRQL5J.<B*OHBKZG(
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M;$]T\SG))$L"<*QR\]OJ;S;]-MYS+8*[#DWUTHRJY\:>CT4GX
M
M       !\Z^EG]/]=_>T/HH            L;57E40
M
M               'SKZ6?T_UW][0^B@
M
M                /G7TL_I_KO[VA]%
M
M                 ?/+I*L";_@?%:J\S^Y]SCZ&H
M
M                          #YU]+/Z?Z[^]H?10                 '
MX^S"QW8LC47Y<H&68%5>'M7A/F@99A<Y$:]JK^*'Z^1C$Y<Y$#)XGKPUZ+_U
M Y0=R#D=R#N0<CN0<H.Y .Y!W( .0.0
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M=?V?#9ZO/8QMIL[(Y5C54^9N     #2Y+9\#C+E:G=R$4,TR\1QJOO.-T
M     82Y;'-OLHNMQI.Y.4BY][@S37)FL9]()1]LB]H_^+GWC8@
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M4<4L_/A,<OF_@V(               / '1F>.'?\5WK]?EB'O]/0
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M33^H6*VRM!S4GE[+7W.)Q/[-MG4"@L+6S4,/765TOJBSS<=B%P@
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M2Z\F$TO',=$K)[#$GGY]>YQ98               / W1/^G^._8>>^6^B
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MS!C9,,^1]I>*KT?PV0M6G8FDIP.FB\*5S$61G//:ORY.P
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MD.IN.S%"M-&^K-WWYG_4=\D87>              #P-T3_I_COV'GOEOH@
M         *CV;6]KVO-6ZJY.?&8JOY,\+ZT[OF1#57[-J'4.'6K.7FOT+%97
MQ.E]6DDWO8LO9VG"ZKBK;ZS[/,EJ9B\/9&=<&2GTG>,?AI;T\^*R;'+![0_O
M?'*PGN\LS#M;O/Q5YU:S&Q7HYK>55$]6D2Z*9*_D]'CM7K4L\ZVY>7O=RXPM
MLS^:R>\T]0QMJ6FSP/'MV8_*1&?)ICSYC,:/N6/HV;]F[B,H[B-\[U?+ ]"\
M
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M<V._OF8C'GJ]GIZ\@
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ML+M&!P[<7+-'?[N9F_J<%A
M                                                   '@?HDJIO]
M#CXQO/?#?1            .!P%3D_(XF1HJ-:B<KSY'Z. K45>0<)*T$DD<C
MXVJ]GU55.50Y@
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M3_N<AXC$=V\IS\AW(.1R@65B<\JGD.4 Y'([D'(
M         /#'0%9$WQ.SXTI>3W.@
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M5X<QS3:Z#NUO)6;^"RZ=F6H/5LWRE:WR[T+.
M     !X>_)]>UN]/^^A+_%I[A
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M                             !X=_)^<Q-[=S\:$O\6GN(
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M@]'IUKL:QSOD=*K%]6H\K/)XYF<Z^Q^'YLI1,?+^,9Z<0
M              'B#\GSSWJ3]PE_BT]O@
M                               <(.$'"#@=J?(#@#A  1C;-4Q^RT%K
M3IV2L<CX)T3E\3T^*&QPM?*04FQ9*RRQ.QRIXS6]O>WX*J?,VP    X ' X
M"M11V(AI=AES$.*G7$UV36EX:QKW=J)S\>>%(GH.CS:^VY=R-M;>4N/[[$Y8
MP                             /$/Y/?].9?^7R_Q:>W@
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MR5,([)4*_MK4:CT:QW'+/FAHM$WB;;()+D>*E@JHO#)7K]=2?@
M                                     'B'\GO^G,O_ "^7^+3V\
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M2-K22>K'?8+OZ0Q+#I&+B5456<MY0LT
M                   \0_D]_P!.9?\ E\O\6GMX
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M$-.G"D4$2<,8;
M  \0_D]_TYE_Y?+_ !:>W@
M
M       >+OR=TD_.N[Q716>QNYE^+3VB
M
M                 #QG^3K+,FSWXDX['5%5Q[,
M
M                        !XQ_)WHH_9[UOO\ .*HK./VSV<
M
M                                   #R!^3G_M?+?W"'K\
M
M                                    'D#\G/\ VOEO[A#U^
M
M                                      #R!^3G_M?+?W"'K\
M                                                      <FL=G\
M/'E(,=)=C2S*U7,AYY<J--F
M       >0/R<_P#:^6_N$/7X
M                      !QGN00M57RM8B)SRY40@62ZF:Q4D6"&Q)<L=O*
M0UF=ZD:B?U*VA'_4PE&1WNN^M9["8ZUH>#P$LEF)CY[DGG+;G]Z5Q,P
M                                      #R!^3G_M?+?W"'K\
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M3G_M?+?W"'K\
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M;3MCV9WM6U9"2&%5]W%UGJD2)_QN++Q.#Q.'KI!CZ4->/[,;4:;4
M                            'D#\G/\ VOEO[A#U^
M                                        #797-8W$U)+5ZTR&)B<J
MYRE9/W?9-A[X]4PZK%Z)?M_HXO\ HB<\G;C>F;;EA+^U7GY6TCN61/\ YB+\
M&%JP5XH(F11,1D;4X:UODB(=@       !$M@WC 8-[(;-OF>3^;@C3N>X@2X
MS>=SD=](SOP^*7AS8(EYGE;\GJ6AKVKX7 5/9\;3CKQ\)WJU.'/5OQ<;HX6:
MZ30/C61[.Y..YB\.3\%%>)(88X^][NUJ)W/7E5X^*J<P
M                   #R!^3G_M?+?W"'K\
M                             "65D3'/>Y&M:G*JOHA5>1Z@6,E<=B]4
MJI=MH[B2P_W:T(QW3KVRVS);/==DKK7<LC7R@B^YK"TH8(H(F1QL1K&IPUJ)
MPB(<@.Y#\;9@[D8CV]R_#E#]      (WL.WX+ 0.EO6VM7]2)OG(]?DB%?+D
M>HFV,C=CZ\>'QLB\+-*O-E[%]'-:3+7M#P6%D6Q'"L]MWG);F]Z5ZDS'(Y
M                                   !Y _)S_VOEO[A#U^
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MJ*                                    #R!^3G_M;+_P!PT]?@
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MN9L$ZM]]KH6'JD
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MM=>R_2;$SK>FV*M<R3O-]Z;ETI96)WW3<M=CIT<W!/._TC82T
M                        \O\ Y-?^I;'_ 'L!Z@
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ML=_DM,[&Z3J>,MLMT<)3@F9Z21Q-:Y"3@
M       'E_\ )K_U+8_[V ]0
M                      !414(YC-/U[&W[60K8Z%EJ=ZODFX3O57$CX
M !6VVYO,6,S2UO"O2&S8B=-/:7UAA;]G[UY-SK6FXO NFL-<^S=F55FNS><S
M^?FI*7VJT:+WRL;QZ\N1")9+J)J..1R396-ST7CLB]]Y%[6^;'DWNBUS6;$K
M7.X;:L_HHD_B9":EN&:; [.[&^"-.Y):=%%8US5^"R$IU[1]9UYJ)CL;%$_X
MR\<O7\7$K                                     !Y?_)K_P!2V/\
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MV/Q-:%_//>C$[B4\                                       'E_\
M)K_U+8_[V ]0
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M6IFK)//(WN\)GW-(Y?VS?L;NM77/&IV_:>'Q67L\+W/P3N+[0
M                              'E_P#)K_U+8_[V ]0
M               ZF).DLW<K>SE.SCU^_D[0                       #
M!S61JTL?8L6)$CB8Q?-?P///1C;L1#5S\5ZPD#WW4F9XGEW([DL?8NHV)J,@
MK8J9ES(V96LAA9_%Q ]ZOP:_U5UW*WV+'6=7=&^<C^T;AALMU0T^Q5>Y:M21
M_-GA>Q_/R-SU)S&*J=2L1.^S+CYJ]9SW7>SO1_IPSM-WK]W3,EN468EVV&]D
M7QI'4@1OAMB0BV<V1VD=6K]R_ YV.R$2<R(TM?";[C-BR$4&$C?-"Q%=9G<W
MM8Q"%]+K5:7<^H7;/RLF1[F-^#F\N.K6[M:7J]M\#+'G+!(C40CVA[MCM/RN
M;US/]]?BZ]\4\A=FH[)C<[-DYL74XJ,E;Q9[>U)WKSRJ&^V?8Z&O8BQD+:2>
M!#QW=B<N7D\]7[U?9^JFG9#%.\:!($F>OV&DKZ[6H&ZYC(%D1)7Y6!S6?<TZ
M^K.WW\5)@,=7M+6K7W+X]EB\.:QI76=GTC$]1M1EQ=EOA02O6Y97EW/RY<3K
M,WJDO6777,F8J+2=_P#OX'4.Y6;U/Z?-65O,4DO>:SJ=D*%+J)@IZE^.G?@B
M5T\T_E%X?P:23!U\?DMQAS^1S]*6=L/A4Z\#O+S+O0
M                       'E_\ )K_U+8_[V ]0
M                                 X7*-6Y Z"Q"R5BJBN:].4-0_5<
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MTG9)[2L?8V%C?554]5-3A
M   >;/R;Z?9ALY95_P#.V(FGI,
M                   U.5V##XB/OOWHH&?\2FLI;QJEWGV;,5W\??P9&7VS
M XBU4JW;S8YK+N(8_5SR0A6HH[40T]O8,/4R57'3WHH[5A%6&%?5_!N
M 1;*;1JM6TRAD,E6;-+Y-B?Y\DFC\-S4<U45%].#FJHB*IBT<IC[C[#*]J.5
MT+NV1&+SVJ90!^2S1Q,5SWM:U/557A#$^DZ'^]P?XT,MD\4GU'M5/N7D_0
M<9IHHF*Z1[6M3XJO""M9@GB;+%(U[7?5<U>4.0 !PFM01<=\C&<^G<J(<P
M                            >=OR<X&,US+2HYW+[3#T2
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MCVF+C[!Z0
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M'EM6%D9D[42<(G;&O#3S]^3;_LO8.7O_ )^ ],@
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M?V^:=WQX.\                              \\?DYOYUK*M^5MAZ'
M                                                           X
M0  #@<( .UOR'" <(!P@X:!P .!P@ X
M  //GY.W]%LC^^-/08
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ME#SY^3M_1;(_OC3T&
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M",?D[?T6R/[XT]!@
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M:I(H9.OUKO8B]F'Y:7Q#%'&WAK4:G//D?H
M-+>9B5L+[1;:Q_">2E+?D[?T6R/[XT]!@
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M&22?J&5/TUK2;:_8TS-U+??\/3L^QZ^A98
M!5FV9+'5\NZ.?%LG?X3%[U?P0_\ )V_HMD?WQIZ#
M
M                         *\V/5W9+)NL);B9S&UO:OW$!_)W;QJE]?G<
M/0(
M                                               !2.]+QGG_ -S&
M:O\ )V_HKD/WQ#T$8F2OP8ZC8N3]_A0M[G]J<KP9%2U%9K131<JV1J.153CR
M4Y@
M                                              BV8U*CD[JV99Y$
M=V-;PWT\BI?R=OZ+9']\:>@PH
M
M         *\V3;+N+R;JT43'-2-KN5^\B?0"")FA^*B>_)<?W%W@
M
M                                    %(;U_M]_]S&=W0+^KV']\E+I
M
M                                             *0WK_;[_P"YC.K\
MGV2=='>Q[.(VW'>&XO0
M
M    I#>O]OO_ +F,[N@7]7L/[Y*72
M
M              >?>HE?)2;)(Z"\V)G@1\-6-'&YZ!?U>P_ODI=(
M
M                                    !2&]*GT^_P#N8SNZ!?U>P_OD
MI=(                                540
M                                                  'G[J)C6V-D
MDD6U99S!'Y,D5J&XZ!?U>P_ODI=(
M?&V1JM<G**$1$3A
M                           #S?U,R.7K[3+'6Q\<T:01</63M)/T"_J]
MA_?)2Z0
M                                                   #SWU&P]*W
MLLDLK7*Y8(OB;OH%_5[#^^2ET@
M
M          'EGJSG<U2W">"I1\2)((N'$]Z!?U>P_ODI=(
M   5R)ZJ
M                                   #R'UCVC*XS=[-6N]B1MKQ>K2U
M.@?ET]A_?)2Z                  ^-CT3N:B\+R
M
M        #Q#UV_K!M_NT)?\ T*E[NGM->_S;/(TM\
M
M                          \0]=OZP;?[M">C.C/#- Q")\6JI:0
M
M                                       !XIZW_1[M^N=]E6N2").$
M:7_T423^3_&>(]'+R[L^YI:X
M
M        !X@ZZHG\H5S]WA/1G1GL30<1VEI@
M
M                    'B'KM_6#;_=H3T-T4K1P:!C$9Z2*Z1Q;
M
M                                     !X@ZZ\?R@W/W:$]']&_Z X;
M]@M
M                                                !3PEUQIJSJ'D
M/?Y[XXWGIWHW_0'#?L%H
M
M     *>&>N3IUZ@WNZ-J<0Q<'I;HW_0'#?L%H
M
M                      'A_KHYJ]0;G[O">D.C?] <-^P6@
M
M                                  OH>"NMK..H>4_T;L]#U+T;_H#A
MOV"T
M                                                 '>BGS^ZSN<[
MJ'F>5]'GK'HW_0'#?L%H
M
M     .]%/G[UE_K#S7]Z>LNC?] <-^P6@
M
M                  [T4^?O67^L/-?WIZRZ-_T!PW[!:
M
M                              #O13Y^]9?ZP\U_>GK+HW_0'#?L%H
M
M                                           .]%/G_P!9TXZAYGS]
M7GK+H\Q[-!PO+?6(LX
M
M  !WHI\_>LO]8>:_O3V#TK6TNB8#Q_7V1G9^QP6"
M
M                         [T/GKU<?._J!G5FC1BI8<>T^FSD71=;_<(O
M_$FX
M                                                #O0^>O5V5\O4
M'.JZ)S.+#D/:'3.&.+1==1C$;S1B<OXJTG0
M
M                   "^A\^.L'B_P H6=[^/Y]W![1Z;_T&UO\ Y?#_ .)-
M@
M                                             '>A\]>KJ3IU!SJ3
M/1R^T.X/:G3?^@VM_P#+X?\ Q)L
M
M            [T4^?O67^L/-?WI[,Z;_ -!M;_Y?#_XDV
M
M                              =Z'SIZGSSS[[L3I?5+LK4_!''N#IO_
M $&UO_E\/_B38
M                                                         !?0
M^<_4Y[W[[L2OE[^+TI[BZ;_T&UO_ )?#_P")-@
M
M                      %/G-U,A=%OFQH[CSO2K_W<>X^F_P#0;6_^7P_^
M)-@
M                                               '>A\X.HW].ME_
MYC-_Y'NKIRBIH^MHJ>F/A_\ $FH
M
M           #O0^<'4;^G6R_\QF_\CZ ZI,DNNXF1&*WNJ1KPOJGD;X
M                                                       "21L;
M>YR\(                                            [T/G!U&_IUL
MO_,9O_(]\:/26GJ>"K.?RL5*)KE_!I)P
M                                %1%]0
M                    '>A\X.HW].ME_P"8S?\ D?0G64YPF-_=H_X&V
M
M                                          D7AJJ?-S?Y4FW78I$:
MK>Z_,O"_B?0W64YPF-_=H_X&V
M
M          D:CF*B^BGS;WV".MN>PPQ)PQE^9&I^#CZ':RG.$QO[M'_ VP
M
M                                          $BHUBJOHB'S:WV=EG=
M-AFCY['WYE3_ +GT/UE.<)C?W:/^!M@
M
M               ).>U>/4^;F_K*NZ[$LS4:_P!OF[D:O*<]Q]#=93G"8W]V
MC_@;8
M                                                 'Y81?">C5\^
M%X/FGN"3MVG-MLJKIDNR][O7E>3Z0XB.NF/J-@_FFPM[?/GR,P
M                                                  2,5[>$<K?O
M0                                            _+G\Q)^RO\  ^9F
MP_[>RG[U)_$^EV*@KUJ5>*"3OC9$UK7_ '(=P
M
M                     .NVG^CRI_P._@?,S/-[<WDV\JO%F3S7\3Z38%C4
MQ-%K?)J0,-B
M                                                       #\N?S
M$G[*_P #YF;#_M[*?O4G\3Z:
M
M         'Y<_F)/V5_@?,S8?]O93]ZD_B?30
M
M                      _+G\Q)^RO\#YF;#_M[*?O4G\3Z:
M
M                                  'Y<_F)/V5_@?,S8?\ ;V4_>I/X
MGTT
M                                                /RY_,2?LK_ ^
M9FP_[>RG[U)_$^F@
M
M!QN<)!(G_ [^!\S-A5%SN4_>I/XGTU
M
M               .FTG^CS?>QR?_ +CYEYR%D.9R,;/JML/1/^Y].@
M
M                                      #\N?S$G[*_P/F9L/\ M[*?
MO4G\3Z:
M                                                    '3?>R.K.
M[[,;E7_L?,3*6VV\E<L(WA)9G/1/Q4^H(   .+)D6:2/L<BLX\U3R7GY'(
M
M                                      &+D%1M*TO'/$+UX_Z'R_MR
MMEM3R)$UB.>JHUOHG/P0^I0
M
M       !B9%.:-I.>.87_P #Y?6(TCGE9WM=VO5.YOHI]3
M
M                               ##R?^H6_[A_\  ^7;_KN_$^J
M
M                                        !AY/_4+?]P_^!\NW_7=^
M)]4
M                                                ##R?^H6_[A_\
M#Y=O^N[\3ZH
M                                                        &!ED
M>N-N]J\+X#^/^Q\O7?6=S\SZH@
M
M          &!EG-9C;KE]$@?_ ^7KE17.7[SZH@
M
M                       &%D_]0N?W#_X'R\?]=WXGU0
M
M                               -5G6328B^V%_8]:[^UWR\CYA.YY7D
M^J0
M                                               !I]@M)4PN1G5J
MN[*[UX/F*Y>55?F?5(
M
M   U.??V8?(.\+Q.*[_<^?D?,-WJOD?5(
M
M                  C6Z>6LYC]U>?-%3ZI@
M
M                    $>VYT;==RRR,[FI5?RWG@^9JGU3
M
M                                (UNG]&<Q^ZO/FBI]4P
M
M                                  "-;I_1G,?NKSYHJ?5,
M
M                                     C6Z?T9S'[J\^:*GU3
M
M                                       (UNG]&<Q^ZO/FBI]4P
M                                                      )6N5G#
M7]J_/CD                                               C6Z?T9
MS'[J\^:*GU3
M                                                        (UNG
M]&<Q^ZO/FBI]4P
M                                                          ",
M;LY&:OF7*O")5>?--3ZI@
M
M     $2WZ9D&GYR5WHVHX^;)]4P
M
M           ""]3E>W0-B<SGGV4^<I]5
M
M                 "$=2N$T78>9%8GLJ\N/G&?5,
M
M                          @O4V)TVA;$QOJM4^<Q]4P
M
M                               "#=3)?"T+8I/E5/G*?5,
M
M                                    @O4](UT#8^_GCV4^<I]5
M
M                                         " ]4_ZOMC_=3YTGU4
M
M                                           (#U3_ *OMC_=3YTGU
M4                                                       /QR/
M\7N1Z]O'U>#]
M (#U3_J^V/\ =3YTGU4
M
M    (#U3_J^V/]U/G2?50
M
M      @/5/\ J^V/]U/G2?50
M
M         K[JM(QG3W8E<O'-?A#YV'U4
M
M                 *[ZLK!_)]L'B\?S'NGSO/JH
M
M                         5CUCEACZ?9KQ8D?RC6L^YQ\^CZI@
M
M                                     %7]95@3I]F?%Y_41A\_%/JF
M            .4'([D'<@[D'*#D <@
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MNHR#(4U156%>Z-[%,O&;983=\MK5KM5\<26()&_&-?@XGP
M
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MK<%FDY);4N.5MR-WDD<2*WAR*6\
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MDU>O=/M7UR[)=QM!L,[H^SN-3B,+DI>H>>SLL3X*RP,K1,=_[O9^N66
M
M                "I^MO]7V3_O8SP(OJI]4P
M
M                     "I^MO\ 5]D_[V,\"+ZJ?5,
M
M                            J?K;_5]D_P"]C/ B^JGU3
M
M                                  *GZV_U?9/^]C/ B^JGU3
M
M                                       *GZV_U?9/^]C/ B^JGU3
M
M                                            *BZX1=^@7_?<G;-&
M>"5]5/JF
M                                                     4[UT?.F
M@W$C[/.Q'W\G@Y?53ZI@
M
M    %+]>8E?H,R]C%[+<1X4/JF
M
M           4=^4#++'HO#'\(^_$CO\ LX\.GU3
M
M                        *9Z\4TLZ%._OX\&U$\\)+ZGU3
M
M                                  *4Z^>/^8;_  Y.$]LB[_O3AQX7
M/JF
M                                                43^4)_0:/_F$
M7\''B(^J8
M                                                     !1/Y0G]
M!H_^81?P<>(CZI@
M                                                           %
M$_E"?T&C_P"81?P<>(CZI@
M
M      %$_E"?T&C_ .81?P<>(CZI@
M               'Y(]S>.&JO*\'Z
M                          43^4)_0:/_ )A%_!QXB/JF
M
M                                 4%^4/)QIM=GB)YWX_=/%)]4P
M
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M/WN0=R#N0=R#N0=R#N0=R#N0=R
M                                              % ?E$)%^:%7F1.
M_P!N9PT\5CE?F.5^8Y7YCE?F.5^8Y7Y@'X   #] '(Y'(Y'(Y')^]RG[XC_M
M*/$?]I1XC_M*/$?]I1XC_M*/$?\ :4R?;[O:K?:).%:UO'=\&^B&4[.9=RIS
M?L+P_O3WU^M\SN_.3/?VG:_S%'YR9[^T[7^8H_.3/?VG:_S%.^MM^S57J^#,
MW(W*U6JK95]#\9MFRL<CFYBVBHWM14E7T,FKO&W5&(VOG;T:)Z(V5QE_RC;U
M_P#9,C_G.'\HV]?_ &3(_P"<X?RC;U_]DR/^<X?RC;U_]DR/^<XR&=3]\:C$
M_.&ZO;SZR.,RIU;W^M%V-SMAWWO<KE,G^67J#_;<H_EEZ@_VW*/Y9>H/]MRG
M9#UIZ@Q2-?\ 2[G\?!YM&=?.H36\>U5U_&(_?Y?^H?\ O-;_ "A_+_U#_P!Y
MK?Y0_E_ZA_[S6_R@G7_J#\9ZO^49T_Y0>Y/C5(8:L3N[UXY._P#]0VU^'Q[%
M5[@S\H?:D8B/I57*=G_J(V?^SZH_]1&S_P!GU1_ZB-G_ +/JC_U$;/\ V?5.
MV#\HK8F2L=+C*SV?%O)WR?E'9M6O[,-715DY;[_HPX2?E&9]4E[,36;R_EGO
MG?4_*0R\<:I8P<$KOFDO8=\?Y2>1;W=^OPNY=\)SL_\ 4I<_^N1?YX_]2ES_
M .N1?YX_]2ES_P"N1?YX_P#4I<_^N1?YX_\ 4I<_^N1?YYVN_*3G2*/C7F=_
MZ_,YUL_*4M?'78_\\?\ J4N__7(O\\+^4I:X9QKL7^>94/Y27,$RRX'B7]1&
MS&S9^4;B^QO?B)N3]_\ 4;B?[)G'_J-Q/]DSC_U&XG^R9Q_ZC<3_ &3./_4;
MB?[)G'_J-Q/]DSC_ -1N)_LF<?\ J-Q/]DSC_P!1N)_LF<SV?E$ZQ[)W.HVT
MGY^H9D?Y0VEJZ7O@OHG/N<1M.S_U":-]C(?Y33KB_*&TM>_Q(+[>'KQQ&T[?
M_4)HWV,A_E-'_J$T;[&0_P IH3\H/1OL9#_*:=DG7_162N8GMSN%X[DB:/\
MU Z+R_RO?Y33@GY0>C?8R'^4TSF]=]#=X_Z>RG9\XT]\P7?E!:*WX7_\IH_]
M0FC?8R'^4TY?^H'1?E>_RFG7_P"H31OL9#_*:/\ U":-]C(?Y31_ZA-&^QD/
M\IIWP=?M%E5R<W6<-YY=$@DZ_:*SN\[KOPB0.Z_Z*V%LG-W]A(DY'\O^B_\
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M>=/RAUJR:U1>EAGBI;3B,\;@
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#\__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
